data_2g46_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2g46 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.476 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 22.3 p90 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.445 0.641 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.14 146.86 33.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 110.251 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.83 -22.65 3.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 110.836 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -90.14 -37.51 14.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.998 . . . . 0.0 110.688 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -152.03 -172.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 110.453 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.04 161.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.212 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -97.02 135.46 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 110.765 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 28.4 mttt -139.62 142.71 37.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.78 . . . . 0.0 109.161 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mmtp 52.04 64.31 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 119.797 -1.814 . . . . 0.0 111.217 0.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.477 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.549 -0.719 . . . . 0.0 110.088 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -115.2 61.2 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.159 . . . . 0.0 110.331 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.56 24.1 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 67' ' ' ILE . 54.7 t -103.22 154.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.978 -1.307 . . . . 0.0 110.092 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m-85 -113.95 127.85 56.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.301 -0.874 . . . . 0.0 110.127 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' A' ' 101' ' ' ILE . . . -90.23 92.08 8.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.416 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 7.0 ttt180 -58.31 -22.8 54.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 0.0 109.47 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -88.85 178.25 6.49 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.507 -0.746 . . . . 0.0 109.487 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . 2.513 73.9 m 98.58 17.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.231 -1.543 . . . . 0.0 110.351 0.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' A' ' 91' ' ' THR . 19.4 m-85 -108.0 164.36 12.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.1 -165.66 1.01 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.447 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 5.4 tttt -85.41 96.47 9.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 110.423 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.6 0.64 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -119.68 123.04 42.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -1.195 . . . . 0.0 110.433 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.476 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -68.27 96.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 110.0 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 89' ' ' ILE . 72.3 t -67.75 -39.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -168.49 164.42 12.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 110.258 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.17 141.55 18.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.421 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 52.7 m -144.96 -176.05 4.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 110.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.25 171.6 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.473 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 65.3 m -146.58 -178.22 6.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 110.168 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 55.9 mt -122.3 143.0 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.6 t -117.39 102.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.5 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.7 mmt180 -125.87 160.47 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -79.64 173.79 12.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 110.405 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.214 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.6 t0 66.52 -150.39 0.2 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.721 -1.237 . . . . 0.0 110.605 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.25 -36.74 4.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.369 -0.832 . . . . 0.0 111.307 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.5 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 57.4 t-105 -55.33 -59.79 4.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.56 57.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 98.4 m -73.83 -70.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.186 . . . . 0.0 110.607 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.67 -43.84 26.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.107 -0.996 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -92.12 16.73 10.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.265 -0.897 . . . . 0.0 111.38 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -59.98 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.984 -1.072 . . . . 0.0 110.449 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.1 t0 -179.03 -69.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.003 -1.061 . . . . 0.0 110.333 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 19.3 m-85 -114.33 61.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD21 ' HG2' ' A' ' 60' ' ' MET . 24.7 mt -111.9 117.45 32.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 111.027 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -88.25 92.64 9.24 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 85.8 p -94.68 145.34 24.91 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 111.497 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -109.77 -172.81 2.11 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.09 72.59 10.11 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.983 -1.073 . . . . 0.0 109.241 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.0 OUTLIER 169.96 -26.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.99 -168.13 0.93 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.283 -0.886 . . . . 0.0 111.262 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.432 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.7 p -129.76 123.98 32.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 0.0 109.806 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -109.43 169.16 8.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.071 -1.018 . . . . 0.0 111.054 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.408 ' HG2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.29 151.13 23.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.27 85.53 7.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 110.007 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.439 ' CB ' HD22 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -52.87 -69.02 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.452 -0.78 . . . . 0.0 110.708 -179.488 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -69.55 -151.26 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.486 ' CD2' HG12 ' A' ' 67' ' ' ILE . 3.7 m-85 -83.94 51.4 2.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -1.05 . . . . 0.0 110.66 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.57 -23.72 49.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . . . -82.55 -49.24 10.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 110.469 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.486 HG12 ' CD2' ' A' ' 64' ' ' PHE . 2.6 pp -45.76 -24.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.753 . . . . 0.0 111.701 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 67' ' ' ILE . 17.2 m-85 -62.2 109.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.844 -1.16 . . . . 0.0 110.024 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -82.1 -176.86 6.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.745 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -102.25 119.46 38.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.5 t -121.32 158.96 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.51 -20.37 60.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 20.8 t0 -141.04 63.77 19.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 110.486 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.434 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 17.2 Cg_exo -62.92 114.61 2.5 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.671 1.353 . . . . 0.0 110.025 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -90.95 24.17 2.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.746 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.66 142.47 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.412 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.1 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.37 168.77 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.91 161.26 30.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 110.092 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.0 mt -133.35 127.69 34.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.445 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 83' ' ' GLY . 3.4 p -69.73 -167.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.53 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 105.4 -177.29 22.9 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.14 51.4 1.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -1.128 . . . . 0.0 110.329 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.9 -80.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.826 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.71 130.84 35.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 110.716 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.748 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.5 mtp -115.89 133.6 55.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.9 mtp85 -120.28 163.58 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.583 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 30' ' ' VAL . 89.9 mt -129.83 98.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.476 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 26.5 m-85 -91.42 -176.85 4.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.432 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.498 ' CG2' ' CD1' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.73 81.89 1.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 111.075 -179.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 1.4 pt -60.12 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.12 -0.988 . . . . 0.0 108.571 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 84.42 121.77 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.363 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 84.6 Cg_exo -43.79 148.25 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.526 1.277 . . . . 0.0 111.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.498 ' CD1' ' CG2' ' A' ' 91' ' ' THR . 74.7 mt -119.91 151.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 110.418 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.19 14.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -63.5 117.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.61 5.05 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -104.03 178.45 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -1.21 . . . . 0.0 110.147 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.23 123.69 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.804 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 101' ' ' ILE . 73.9 mt -89.52 127.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 110.122 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 16.7 p -155.44 176.4 12.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.946 -0.471 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.436 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.3 pp -140.42 158.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.01 -1.056 . . . . 0.0 110.563 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.01 -164.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 110.369 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 109' ' ' TYR . 19.4 m-85 -124.16 -81.3 0.63 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.85 -152.61 24.52 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.817 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.13 -53.28 21.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -1.149 . . . . 0.0 110.05 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.91 -167.7 0.91 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.435 -0.791 . . . . 0.0 109.351 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.484 ' HB3' ' CG ' ' A' ' 105' ' ' TYR . 2.7 m-85 46.09 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 111.002 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.466 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 29.6 p-90 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.402 0.62 . . . . 0.0 110.601 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 2.9 t . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.352 0.596 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' C' ' 218' ' ' PRO . . . -123.97 176.21 2.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.336 -0.852 . . . . 0.0 110.222 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' C' ' 217' ' ' ALA . 21.5 Cg_endo . . . . . 0 C--N 1.313 -1.32 0 O-C-N 123.623 1.328 . . . . 0.0 110.594 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 22.3 p90 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.417 0.627 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.13 146.93 33.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.88 -22.69 3.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -90.08 -37.62 14.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -151.95 -172.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.96 161.83 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 110.219 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.02 135.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.818 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.504 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 28.4 mttt -139.62 142.76 37.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 109.161 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.504 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mmtp 52.16 64.23 1.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 119.796 -1.815 . . . . 0.0 111.233 0.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.47 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 31.5 m-85 -115.17 61.35 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 110.403 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.44 -171.52 23.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.426 ' CG2' HD13 ' B' ' 67' ' ' ILE . 54.2 t -103.24 154.03 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.934 -1.333 . . . . 0.0 110.084 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.479 ' CD1' ' HD2' ' B' ' 9' ' ' LYS . 1.1 m-85 -113.9 127.92 56.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 110.148 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.431 ' HB1' ' CG1' ' B' ' 101' ' ' ILE . . . -90.16 91.86 8.71 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 110.557 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.419 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 7.0 ttt180 -58.17 -22.75 52.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -89.01 178.26 6.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.52 -0.738 . . . . 0.0 109.518 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . 2.514 73.8 m 98.58 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.311 -1.493 . . . . 0.0 110.339 0.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.425 ' CB ' HG21 ' B' ' 91' ' ' THR . 19.6 m-85 -108.07 164.4 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 110.382 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.04 -165.65 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.425 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 5.4 tttt -85.43 96.38 9.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 110.466 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.01 52.66 0.64 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -119.7 122.98 42.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.0 110.411 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.481 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -68.26 96.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 110.044 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.69 -39.96 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.366 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -168.46 164.44 12.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.24 141.5 18.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.431 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 52.5 m -144.85 -176.06 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.923 . . . . 0.0 110.406 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.19 171.66 8.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.535 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.749 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 65.2 m -146.64 -178.27 6.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 55.7 mt -122.29 142.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 39.6 t -117.3 102.91 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.396 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.491 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 14.7 mmt180 -125.81 160.5 29.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -79.65 173.79 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.412 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.6 t0 66.54 -150.32 0.2 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.698 -1.251 . . . . 0.0 110.64 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.36 -36.74 4.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 111.277 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.491 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 57.3 t-105 -55.33 -59.86 4.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 110.181 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.35 -31.54 56.9 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 98.1 m -73.91 -70.64 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -1.233 . . . . 0.0 110.621 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.82 -42.93 27.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.081 -1.012 . . . . 0.0 111.002 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.5 mm? -93.48 17.37 11.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 111.014 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 0.1 OUTLIER -60.28 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.091 . . . . 0.0 110.408 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 47' ' ' LEU . 1.1 t0 -179.01 -69.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.95 -1.094 . . . . 0.0 110.345 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.481 ' CD1' ' HB3' ' B' ' 66' ' ' ALA . 19.4 m-85 -114.38 61.9 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.117 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.4 mt -112.07 116.67 30.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.169 -0.957 . . . . 0.0 111.153 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -87.23 92.64 9.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 0.0 108.795 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.434 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 85.6 p -94.74 145.36 24.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 0.0 111.529 -176.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -110.38 -175.65 2.78 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.541 -0.724 . . . . 0.0 109.48 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.11 72.17 5.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 0.0 OUTLIER 169.77 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.8 -168.17 0.96 Allowed 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.336 -0.852 . . . . 0.0 111.351 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.434 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 1.7 p -129.69 123.97 32.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.688 . . . . 0.0 109.781 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -109.45 169.25 8.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.002 . . . . 0.0 111.054 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.4 ' HE3' ' CD1' ' B' ' 47' ' ' LEU . 0.0 OUTLIER -104.59 149.99 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 110.26 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.66 85.44 7.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.255 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.439 HD22 ' CB ' ' A' ' 62' ' ' LEU 2.501 0.1 OUTLIER -53.0 -69.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.723 -179.646 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -69.49 -151.22 0.49 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.484 ' CD2' HG12 ' B' ' 67' ' ' ILE . 3.7 m-85 -84.02 51.36 2.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.422 -1.046 . . . . 0.0 110.652 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.49 -23.76 49.5 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' CD1' ' B' ' 50' ' ' TYR . . . -82.58 -49.27 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 110.398 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.484 HG12 ' CD2' ' B' ' 64' ' ' PHE . 2.6 pp -45.75 -24.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.491 -0.756 . . . . 0.0 111.749 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.481 ' CG ' HD12 ' B' ' 67' ' ' ILE . 17.2 m-85 -62.32 109.75 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.902 -1.124 . . . . 0.0 110.024 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -81.99 -176.46 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.716 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -102.78 119.45 38.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -0.841 . . . . 0.0 110.024 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 36.7 t -121.35 158.94 27.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 -20.43 60.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.42 ' N ' ' HD3' ' B' ' 74' ' ' PRO . 20.7 t0 -140.99 63.63 19.01 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 110.505 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 17.2 Cg_exo -62.79 114.68 2.51 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.627 1.33 . . . . 0.0 110.04 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -91.08 24.29 2.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.701 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.62 142.45 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.401 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.434 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.04 1.01 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.529 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.401 ' HA ' ' HA ' ' B' ' 89' ' ' ILE . 47.3 p-80 -142.42 168.72 19.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.755 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.89 161.27 30.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -0.827 . . . . 0.0 110.037 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.37 127.61 33.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.002 . . . . 0.0 110.487 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' B' ' 83' ' ' GLY . 3.4 p -69.71 -167.35 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 110.278 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 110.229 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 81' ' ' THR . . . 105.43 -177.22 22.85 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.21 51.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 110.291 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.92 -80.77 0.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 110.82 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.69 130.82 35.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.741 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.749 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.6 mtp -115.87 133.64 55.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -120.31 163.55 17.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.641 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' B' ' 78' ' ' HIS . 89.5 mt -129.75 98.65 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.481 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 26.3 m-85 -91.36 -176.8 4.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.386 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.495 ' CG2' ' CD1' ' B' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 81.86 1.76 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.148 -0.97 . . . . 0.0 110.996 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' B' ' 93' ' ' LYS . 1.4 pt -59.96 103.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.657 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 92' ' ' ILE . 0.0 OUTLIER 84.15 121.44 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 C-N-CA 123.541 0.736 . . . . 0.0 109.425 -177.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.425 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 88.2 Cg_exo -44.13 148.51 1.09 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.468 1.246 . . . . 0.0 111.436 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.495 ' CD1' ' CG2' ' B' ' 91' ' ' THR . 74.0 mt -119.92 151.91 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.285 -0.884 . . . . 0.0 110.421 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.18 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.364 -0.835 . . . . 0.0 110.344 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -63.47 117.17 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.05 27.59 5.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -104.03 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.236 . . . . 0.0 110.156 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.29 123.68 48.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.81 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.431 ' CG1' ' HB1' ' B' ' 20' ' ' ALA . 74.3 mt -89.34 127.37 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 110.181 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 16.6 p -155.42 176.43 12.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.664 -0.647 . . . . 0.0 109.798 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.3 pp -140.43 158.07 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.084 -1.01 . . . . 0.0 110.573 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.98 -164.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 0.0 110.37 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' B' ' 109' ' ' TYR . 19.6 m-85 -124.12 -81.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 110.327 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.76 -152.69 24.59 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.06 -53.31 20.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.287 -1.125 . . . . 0.0 110.101 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.86 -167.46 0.85 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.421 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.484 ' HB3' ' CG ' ' B' ' 105' ' ' TYR . 2.8 m-85 45.81 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.389 -0.82 . . . . 0.0 111.157 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.478 ' O ' ' CE3' ' B' ' 110' ' ' TRP . 30.1 p-90 . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 110.598 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.504 2.9 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.328 0.585 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' D' ' 218' ' ' PRO . . . -124.01 176.19 2.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' D' ' 217' ' ' ALA . 21.4 Cg_endo . . . . . 0 C--N 1.312 -1.376 0 O-C-N 123.644 1.339 . . . . 0.0 110.542 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 54.5 p90 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.327 0.584 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ARG . 46.7 t30 -150.14 161.29 42.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.82 62.01 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.618 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.433 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.2 OUTLIER 174.75 -34.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.0 109.218 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 16.5 m -156.55 -172.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 109.737 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 10.2 tt -160.64 164.29 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.4 ' N ' HG12 ' A' ' 7' ' ' ILE . 7.7 p -89.14 120.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.098 -1.002 . . . . 0.0 110.474 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 26.2 mttt -148.39 127.72 13.03 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.535 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 54.44 42.11 31.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.795 -1.816 . . . . 0.0 110.088 4.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.51 ' CB ' ' CE1' ' A' ' 19' ' ' PHE . 2.1 p . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.677 -0.64 . . . . 0.0 109.905 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 10' ' ' LYS . 3.8 m-85 -95.08 99.67 11.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.249 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.72 -160.51 9.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 79.7 t -113.1 138.32 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.837 -1.39 . . . . 0.0 110.414 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CG ' ' CD ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -104.28 140.99 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . . . -104.14 91.01 3.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 110.974 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -60.18 -26.2 66.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 6.2 mtpp -94.28 -177.38 4.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.566 -0.709 . . . . 0.0 109.567 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.431 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 0.1 OUTLIER 108.58 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.123 -1.61 . . . . 0.0 110.109 1.879 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.487 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 48.8 m-85 -114.76 160.82 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.652 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.2 172.27 6.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.978 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 29.5 tttm -72.03 80.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.552 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.43 40.87 0.12 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -119.3 158.52 25.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.386 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.519 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 1.5 tm? -92.41 128.11 38.14 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.428 ' CG1' HG13 ' A' ' 6' ' ' VAL . 81.7 t -94.37 -45.61 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -170.32 152.07 3.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 110.64 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.51 35.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.05 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.427 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -146.67 -157.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 110.743 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.91 175.47 5.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.415 -0.803 . . . . 0.0 110.551 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.734 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 3.3 m -150.7 154.93 38.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.393 -0.817 . . . . 0.0 109.988 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.423 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 54.7 mt -94.89 164.01 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.96 106.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -0.962 . . . . 0.0 110.65 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.522 ' CB ' ' CG ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -112.82 -163.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.205 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -128.7 62.45 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 26.8 m120 52.35 -149.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 0.0 110.631 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 17.6 m-20 60.51 -144.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.211 -0.93 . . . . 0.0 110.106 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -46.63 -29.05 1.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.009 -1.057 . . . . 0.0 111.149 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.522 ' CG ' ' CB ' ' A' ' 38' ' ' ARG . 66.1 t-105 -65.07 -44.45 88.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 110.232 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.37 -40.15 97.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.8 m -67.07 -65.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.31 -58.43 7.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? -90.63 50.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -0.4 22.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 111.015 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -129.6 156.8 43.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.942 -1.099 . . . . 0.0 109.681 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 33.3 m-85 54.93 24.09 5.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 109.857 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.485 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 7.5 tp -117.05 123.4 46.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 110.851 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 36.2 m-85 -90.04 118.59 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.1 m -96.35 138.43 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.112 -0.993 . . . . 0.0 110.967 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' CD1' ' A' ' 84' ' ' LEU . 4.3 ttp180 -109.76 176.47 5.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.449 -0.782 . . . . 0.0 110.228 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -84.18 81.6 8.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.03 -1.044 . . . . 0.0 109.221 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.505 8.9 m-80 148.29 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 109.733 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.7 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -150.9 164.81 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.709 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -150.63 155.85 40.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.531 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.44 ' CE ' HD12 ' A' ' 47' ' ' LEU . 27.5 tpp -102.61 159.68 15.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 110.135 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 60' ' ' MET . . . -87.39 94.26 9.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.101 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.438 HD21 ' CB ' ' B' ' 62' ' ' LEU 2.499 0.1 OUTLIER -55.34 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.804 . . . . 0.0 111.165 -178.978 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.53 -132.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.427 ' HB3' ' CD1' ' A' ' 67' ' ' ILE . 89.2 m-85 -90.16 39.14 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -1.094 . . . . 0.0 110.664 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -79.15 -20.27 70.31 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.97 -48.27 7.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -1.198 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 1.3 pp -55.77 -17.29 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 111.259 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CG ' HG12 ' A' ' 103' ' ' ILE . 4.6 m-85 -49.01 134.29 17.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.881 -1.137 . . . . 0.0 110.832 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' O ' ' CG2' ' A' ' 102' ' ' THR . 10.9 m-20 -97.18 -164.33 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 110.875 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -102.36 157.44 16.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.782 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 t -174.41 130.08 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.015 . . . . 0.0 110.565 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.65 79.36 47.93 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 18.7 Cg_endo -63.76 100.45 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.653 1.344 . . . . 0.0 110.451 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -54.85 -21.06 10.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 110.487 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.67 163.45 27.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.972 . . . . 0.0 110.481 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -143.44 156.71 44.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 110.241 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.423 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 37.2 p-80 -89.85 166.42 13.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 110.382 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -148.07 161.25 41.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.9 . . . . 0.0 110.405 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.9 mt -123.59 148.54 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.92 64.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.58 40.13 29.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.47 -133.79 2.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' CD1' ' HD3' ' A' ' 54' ' ' ARG . 2.0 tp -137.23 23.1 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 110.234 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -85.95 -67.16 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 111.065 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.14 164.12 12.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 111.017 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.734 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 4.3 mtp -134.28 148.41 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -133.09 167.3 20.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 0.0 110.448 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -133.38 95.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 29' ' ' LEU . 54.2 m-85 -90.39 -179.53 5.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 110.547 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.419 HG21 ' CD1' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -117.72 94.16 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 110.189 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 74' ' ' PRO . 10.9 pt -55.87 -20.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 110.592 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.9 mttt -137.71 160.15 66.08 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 110.454 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 23.5 Cg_exo -58.03 158.31 21.89 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.651 1.342 . . . . 0.0 110.507 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 95' ' ' ILE . 39.5 mt -144.57 136.44 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.71 166.07 11.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.585 -0.697 . . . . 0.0 110.831 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 3.3 mp -65.11 110.39 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.546 -0.721 . . . . 0.0 110.316 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 22.8 5.02 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -94.71 -179.36 4.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 110.094 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.19 122.33 35.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.846 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 23.5 mt -89.66 131.08 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 69' ' ' ASN . 49.5 m -162.8 147.62 11.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.474 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.4 pt -115.0 165.21 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.033 -1.042 . . . . 0.0 110.769 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.22 -159.11 0.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.373 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.12 -93.35 0.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.425 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.23 169.24 41.76 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.752 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.81 -58.64 7.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -39.21 79.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.94 31.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.937 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 179.359 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.4 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.184 0.516 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.48 174.84 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.423 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 25.3 Cg_exo . . . . . 0 C--N 1.313 -1.325 0 O-C-N 123.616 1.324 . . . . 0.0 110.583 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 54.6 p90 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.347 0.594 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -150.18 161.5 42.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.081 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.06 61.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.369 -0.832 . . . . 0.0 110.578 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.426 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 0.2 OUTLIER 174.83 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.342 -0.849 . . . . 0.0 109.21 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 16.7 m -156.48 -172.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.664 -0.647 . . . . 0.0 109.819 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 10.3 tt -160.68 163.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.977 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.59 120.72 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.967 . . . . 0.0 110.538 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 26.1 mttt -148.57 127.75 12.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 54.47 42.09 31.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.642 -1.911 . . . . 0.0 110.106 4.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.517 ' CB ' ' CE1' ' B' ' 19' ' ' PHE . 2.1 p . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.675 -0.64 . . . . 0.0 109.932 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' B' ' 10' ' ' LYS . 3.8 m-85 -95.0 99.69 11.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.054 -1.262 . . . . 0.0 110.495 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.71 -160.34 9.54 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 81.2 t -113.24 138.08 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.386 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CG ' ' CD ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -104.21 141.05 36.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.788 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.423 ' HB3' ' CG1' ' B' ' 101' ' ' ILE . . . -104.19 91.09 3.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.947 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.3 OUTLIER -60.27 -26.07 66.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 6.2 mtpp -94.4 -177.14 4.16 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 109.572 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.432 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.511 0.1 OUTLIER 108.69 17.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.133 -1.605 . . . . 0.0 110.133 1.755 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 49.3 m-85 -114.67 160.9 18.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.639 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.3 172.29 6.87 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.517 -0.739 . . . . 0.0 110.025 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.423 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 29.4 tttm -72.23 80.36 0.99 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.37 40.95 0.12 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -119.44 158.48 26.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -1.214 . . . . 0.0 110.336 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.511 ' CD2' ' CE1' ' B' ' 90' ' ' PHE . 1.5 tm? -92.35 128.07 38.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.968 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.422 ' CG1' HG13 ' B' ' 6' ' ' VAL . 82.6 t -94.35 -45.66 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -170.26 152.11 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.55 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 110.028 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.418 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -146.75 -157.4 0.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 110.757 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.93 175.86 5.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 3.4 m -151.12 154.77 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.953 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 54.7 mt -94.85 163.97 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.825 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.87 106.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.967 . . . . 0.0 110.678 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.528 ' CB ' ' CG ' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -113.0 -163.34 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -128.61 62.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 110.963 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' B' ' 41' ' ' ASP . 26.7 m120 52.42 -149.31 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.647 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 17.4 m-20 60.5 -144.13 0.5 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.232 -0.917 . . . . 0.0 110.14 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -46.63 -29.04 1.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.07 -1.019 . . . . 0.0 111.147 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.528 ' CG ' ' CB ' ' B' ' 38' ' ' ARG . 66.2 t-105 -65.04 -44.51 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.172 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.33 -40.16 97.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 98.5 m -67.15 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 110.434 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.3 -58.28 8.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 110.324 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.481 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 2.7 mm? -90.96 50.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -0.56 22.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' B' ' 49' ' ' ASP . 39.9 p-10 -129.45 156.89 43.39 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.009 -1.057 . . . . 0.0 109.779 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 32.9 m-85 54.88 24.01 5.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.155 -0.966 . . . . 0.0 109.885 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.483 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 7.5 tp -117.01 123.54 47.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.379 -0.826 . . . . 0.0 110.85 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' B' ' 52' ' ' PHE . 35.9 m-85 -90.17 118.6 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.601 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.2 m -96.35 138.39 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' CD1' ' B' ' 84' ' ' LEU . 4.3 ttp180 -110.23 174.06 6.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.498 -0.751 . . . . 0.0 110.32 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -80.82 81.33 7.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.506 8.8 m-80 148.14 -19.66 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 109.77 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.61 -149.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.481 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.479 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -151.38 164.84 35.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 110.69 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -150.93 155.71 39.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.86 . . . . 0.0 110.464 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.44 ' CE ' HD12 ' B' ' 47' ' ' LEU . 27.5 tpp -102.7 158.66 16.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.326 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' B' ' 60' ' ' MET . . . -85.93 94.19 9.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.438 ' CB ' HD21 ' A' ' 62' ' ' LEU 2.5 0.1 OUTLIER -55.45 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 111.206 -179.177 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.59 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.432 ' HB3' ' CD1' ' B' ' 67' ' ' ILE . 89.1 m-85 -90.21 39.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.414 -1.051 . . . . 0.0 110.745 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.46 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -79.26 -19.82 71.08 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.5 -48.1 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.111 -1.229 . . . . 0.0 111.145 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.3 pp -55.82 -17.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.166 -0.959 . . . . 0.0 111.355 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.482 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.6 m-85 -49.04 134.29 17.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.785 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.425 ' O ' ' CG2' ' B' ' 102' ' ' THR . 11.5 m-20 -97.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -103.05 157.3 17.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.729 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.0 t -174.33 130.14 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -0.998 . . . . 0.0 110.542 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -36.59 77.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 110.207 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.59 79.3 47.33 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 110.248 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 18.5 Cg_endo -63.7 100.44 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.681 1.358 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.93 -21.0 10.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -0.922 . . . . 0.0 110.524 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.65 163.45 27.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 110.506 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -143.42 156.71 44.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.427 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 37.3 p-80 -89.75 166.42 13.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.455 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -148.08 161.22 41.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 110.404 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 25.9 mt -123.6 148.52 46.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.81 64.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.56 40.16 29.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.456 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.43 -133.74 2.85 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.432 ' CD1' ' HD3' ' B' ' 54' ' ' ARG . 2.0 tp -137.25 23.15 3.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -1.097 . . . . 0.0 110.241 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -86.03 -67.15 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 111.039 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.13 164.16 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 111.085 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.742 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 4.3 mtp -134.3 148.38 50.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 110.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -133.02 167.34 20.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.498 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.403 HG22 HD11 ' B' ' 89' ' ' ILE . 65.2 mt -133.42 95.29 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.511 ' CE1' ' CD2' ' B' ' 29' ' ' LEU . 54.0 m-85 -90.53 -179.5 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 110.48 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.401 HG21 ' CD1' ' B' ' 95' ' ' ILE . 1.0 OUTLIER -117.76 94.18 4.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' B' ' 74' ' ' PRO . 10.9 pt -55.83 -20.77 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 110.514 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.417 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.9 mttt -137.7 160.24 65.75 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 110.375 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 23.8 Cg_exo -58.29 158.53 22.15 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.65 1.342 . . . . 0.0 110.421 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.43 HD11 HG23 ' B' ' 95' ' ' ILE . 39.4 mt -144.64 136.48 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.271 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.77 166.01 11.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 110.767 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 3.3 mp -65.1 110.43 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.515 -0.741 . . . . 0.0 110.293 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.41 22.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.73 -179.33 4.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -1.171 . . . . 0.0 110.102 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.2 122.25 35.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.821 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.437 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 23.9 mt -89.49 131.14 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.48 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' B' ' 69' ' ' ASN . 47.9 m -162.82 147.62 11.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.726 -0.609 . . . . 0.0 109.597 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.482 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.4 pt -114.98 165.2 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.753 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.17 -159.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.08 -93.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.937 . . . . 0.0 110.449 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.32 169.22 41.7 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.84 -58.62 7.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -1.121 . . . . 0.0 110.194 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -39.21 79.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.83 31.51 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.974 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.989 -1.069 . . . . 0.0 110.506 179.424 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.506 2.4 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.182 0.515 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.47 174.87 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.348 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . 0.427 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 25.3 Cg_exo . . . . . 0 C--N 1.312 -1.392 0 O-C-N 123.701 1.369 . . . . 0.0 110.572 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.471 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 25.7 p90 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.324 0.583 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.06 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.29 -22.11 6.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.583 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -81.55 -41.1 22.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 0.0 110.593 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.3 m -151.31 179.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.412 HG21 ' CB ' ' A' ' 19' ' ' PHE . 9.4 tt -152.04 166.83 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.168 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -104.66 125.15 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.958 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 20.5 mttt -128.59 142.73 50.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mtpp 52.09 58.14 5.75 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.717 -1.865 . . . . 0.0 111.066 1.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.433 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.519 -0.738 . . . . 0.0 110.268 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.4 91.66 5.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 110.57 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -126.7 -168.74 12.63 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 101' ' ' ILE . 2.5 p -113.1 125.95 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.299 . . . . 0.0 109.524 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -90.1 161.79 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 110.497 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.73 96.71 5.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 110.634 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -20.0 65.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.0 109.793 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HE2' ' CD1' ' A' ' 24' ' ' PHE . 14.2 mtpt -91.81 179.97 5.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.381 -0.824 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.4 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 39.9 m 103.9 16.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.166 -1.584 . . . . 0.0 110.403 0.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CD1' ' HE2' ' A' ' 22' ' ' LYS . 42.3 m-85 -109.55 168.5 9.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.367 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 -167.18 1.32 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.966 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.12 4.08 18.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.43 86.73 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -151.04 147.98 27.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -1.17 . . . . 0.0 110.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' CD2' ' CE2' ' A' ' 90' ' ' PHE . 1.1 tm? -86.3 122.86 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.257 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -81.88 -52.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -162.43 177.69 9.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.129 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.21 149.49 8.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 110.492 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.19 -157.84 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.275 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.8 mt -109.13 -178.51 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 85' ' ' LYS . 72.4 m -145.41 174.2 11.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 60.6 mt -116.2 125.18 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.886 . . . . 0.0 109.832 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.427 HG23 ' CB ' ' A' ' 84' ' ' LEU . 26.0 t -97.82 100.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 110.579 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.475 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 2.6 mmp_? -119.44 -172.05 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.383 -0.823 . . . . 0.0 110.214 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 36.8 m80 -104.29 -165.03 1.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.339 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 76.2 m-20 -91.04 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 16.9 m-20 58.07 -137.5 0.9 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.869 -1.144 . . . . 0.0 110.435 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.44 -40.04 7.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.996 -1.065 . . . . 0.0 111.498 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.475 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 76.1 t-105 -57.66 -45.69 85.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.87 73.71 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.98 -63.51 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.24 . . . . 0.0 110.527 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.16 -55.61 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.9 mm? -89.49 52.37 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 57.42 3.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 -76.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' CG ' ' HB2' ' A' ' 66' ' ' ALA . 5.0 m-85 -89.52 48.21 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.449 ' CD2' ' NE1' ' A' ' 43' ' ' TRP . 6.1 tp -117.66 109.64 16.91 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.399 -0.813 . . . . 0.0 111.243 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -89.56 105.2 17.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.105 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.3 p -97.38 161.02 13.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 111.144 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -127.97 -172.36 2.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.481 -0.762 . . . . 0.0 109.959 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -83.69 84.63 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.031 -1.043 . . . . 0.0 109.334 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.8 OUTLIER 153.19 -22.01 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.75 -0.594 . . . . 0.0 109.778 -178.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.59 -168.1 0.22 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.281 -0.887 . . . . 0.0 110.735 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.1 m -132.22 134.82 45.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.469 -0.769 . . . . 0.0 109.921 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -127.88 166.69 17.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 111.031 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.43 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 1.2 ttt -96.1 170.46 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.857 . . . . 0.0 109.822 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -86.32 -54.04 4.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.156 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.47 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.497 0.0 OUTLIER 92.3 -81.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.819 -1.176 . . . . 0.0 110.513 -179.51 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.79 -143.48 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.33 56.65 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -1.065 . . . . 0.0 110.358 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.472 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -89.74 -43.31 5.17 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 50' ' ' TYR . . . -63.39 -47.61 81.3 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.984 -1.304 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 68' ' ' PHE . 2.8 pp -49.53 -22.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.876 . . . . 0.0 111.441 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.489 ' CG ' HG12 ' A' ' 103' ' ' ILE . 4.9 m-85 -50.19 113.45 0.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.767 -1.208 . . . . 0.0 110.415 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -102.0 -165.82 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 111.204 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -94.46 140.89 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.531 -0.731 . . . . 0.0 110.449 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.44 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.337 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -85.47 -19.48 31.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 110.528 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.54 74.93 53.88 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.57 106.04 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.697 1.367 . . . . 0.0 110.467 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 76' ' ' ALA . 50.4 p-10 -85.06 -13.9 48.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 75' ' ' ASN . . . -142.51 141.16 32.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.985 -1.072 . . . . 0.0 110.46 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.05 -176.44 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -124.36 161.98 24.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 110.517 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.45 154.15 51.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.412 HD22 ' CD2' ' A' ' 84' ' ' LEU . 43.8 tp -132.42 139.97 48.26 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.67 -168.99 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.85 107.92 18.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 110.408 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.61 12.95 4.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CB ' HG23 ' A' ' 37' ' ' VAL . 16.5 mt 52.39 32.85 11.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.0 110.405 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 35' ' ' CYS . 2.7 mmtp -100.21 -62.29 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 111.147 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -97.49 162.26 13.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.64 147.59 27.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.145 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.02 171.92 13.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.376 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.78 116.25 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 29' ' ' LEU . 21.5 m-85 -108.11 171.07 7.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -112.36 87.39 2.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 93' ' ' LYS . 3.2 pt -52.03 -23.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 110.583 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.433 ' N ' HG13 ' A' ' 92' ' ' ILE . 5.2 mmtt -132.03 151.13 77.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.401 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.08 143.88 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.666 1.35 . . . . 0.0 110.292 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.0 mt -126.27 141.0 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.532 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.42 163.61 12.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 110.182 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.8 mt -63.75 121.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 110.511 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.6 38.71 2.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -117.54 170.34 8.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -1.17 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -114.89 126.06 54.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.269 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 18' ' ' VAL . 98.0 mt -96.59 127.21 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 35.6 p -156.03 176.64 12.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.489 HG12 ' CG ' ' A' ' 68' ' ' PHE . 2.5 pp -147.91 155.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.667 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 33.0 t -68.75 -149.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 110.464 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -135.89 -69.43 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.449 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.63 -177.92 30.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -64.03 -40.41 96.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 110.404 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -61.22 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.98 106.99 3.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.468 ' O ' ' CD2' ' A' ' 110' ' ' TRP . 63.6 p-90 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.638 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.295 0.569 . . . . 0.0 110.471 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -124.57 168.49 12.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.338 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 O-C-N 123.706 1.371 . . . . 0.0 110.533 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 25.7 p90 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.363 0.602 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.09 22.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.27 -22.1 6.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 110.627 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -81.55 -41.2 21.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.59 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 28.8 m -151.24 179.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.007 . . . . 0.0 110.559 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' B' ' 19' ' ' PHE . 9.4 tt -152.0 166.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.198 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -104.67 125.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -0.951 . . . . 0.0 110.957 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 20.4 mttt -128.6 142.7 50.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mtpp 52.06 58.2 5.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.738 -1.852 . . . . 0.0 111.033 1.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.426 ' N ' ' HB3' ' B' ' 9' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.513 -0.742 . . . . 0.0 110.28 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 91.76 5.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 110.579 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.81 -168.9 12.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.6 p -112.82 125.8 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.937 -1.331 . . . . 0.0 109.685 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.455 ' CE1' ' HG3' ' B' ' 100' ' ' GLU . 0.5 OUTLIER -90.09 161.73 15.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 110.497 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.67 96.63 5.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -19.96 65.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.867 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.498 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 14.2 mtpt -91.93 -179.94 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 109.799 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' B' ' 22' ' ' LYS 2.514 39.3 m 103.93 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.207 -1.558 . . . . 0.0 110.356 0.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 42.2 m-85 -109.48 168.61 9.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.404 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.59 -167.14 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.09 4.04 18.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.97 . . . . 0.0 110.9 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.35 86.7 0.12 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -151.05 147.97 27.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -1.168 . . . . 0.0 110.45 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.495 ' CD2' ' CE2' ' B' ' 90' ' ' PHE . 1.2 tm? -86.33 122.77 30.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.85 -52.62 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.405 ' CG ' ' CD1' ' B' ' 89' ' ' ILE . 1.9 pt-20 -162.41 177.73 9.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.25 149.56 8.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.976 . . . . 0.0 110.517 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.21 -157.91 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 110.237 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 72.8 mt -109.08 -178.47 3.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.423 ' N ' ' O ' ' B' ' 85' ' ' LYS . 72.4 m -145.5 174.13 11.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.305 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.478 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 60.3 mt -116.12 125.18 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.792 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' B' ' 84' ' ' LEU . 26.3 t -97.89 100.21 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.042 -1.036 . . . . 0.0 110.587 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 2.6 mmp_? -119.72 -172.15 2.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 36.7 m80 -104.07 -165.02 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.12 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 58.18 -137.54 0.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.912 -1.117 . . . . 0.0 110.413 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.43 -40.05 7.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.016 -1.053 . . . . 0.0 111.495 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.477 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 76.1 t-105 -57.69 -45.64 85.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 0.0 110.283 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.94 -21.92 73.67 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.97 -63.48 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.23 -55.56 33.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.482 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 3.9 mm? -89.53 52.43 2.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.244 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.33 57.44 3.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -76.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.487 ' CG ' ' CB ' ' B' ' 66' ' ' ALA . 5.0 m-85 -89.46 48.23 1.58 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.857 . . . . 0.0 109.424 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.451 ' CD2' ' NE1' ' B' ' 43' ' ' TRP . 6.0 tp -117.69 109.5 16.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.352 -0.842 . . . . 0.0 111.353 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -89.47 105.14 17.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 14.2 p -97.34 160.95 14.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 111.162 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -128.43 -174.88 3.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.535 -0.728 . . . . 0.0 109.99 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -80.0 84.41 5.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -0.954 . . . . 0.0 110.067 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.8 OUTLIER 153.0 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.41 -168.06 0.23 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.801 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -132.24 134.87 45.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -127.92 166.75 17.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.08 -1.013 . . . . 0.0 111.06 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.426 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 1.2 ttt -96.41 169.18 10.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.956 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.425 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -84.31 -55.02 4.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 111.487 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.478 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.499 0.0 OUTLIER 92.7 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.888 -1.133 . . . . 0.0 110.475 -179.181 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.85 -143.41 0.06 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.38 56.55 2.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -1.088 . . . . 0.0 110.362 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.469 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -89.73 -43.24 5.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.487 ' CB ' ' CG ' ' B' ' 50' ' ' TYR . . . -63.4 -47.6 81.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 110.396 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.438 HD11 ' N ' ' B' ' 68' ' ' PHE . 2.8 pp -49.59 -22.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 111.448 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.493 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.9 m-85 -50.23 113.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.701 -1.25 . . . . 0.0 110.43 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -102.06 -165.84 1.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -94.37 140.89 29.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.742 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.46 16.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.308 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -85.46 -19.56 31.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 110.49 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.47 74.86 53.07 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.14 -0.975 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.52 105.98 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.688 1.362 . . . . 0.0 110.494 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 76' ' ' ALA . 50.3 p-10 -85.05 -13.85 49.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.757 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.409 ' N ' ' OD1' ' B' ' 75' ' ' ASN . . . -142.57 141.19 31.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.012 -1.055 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.07 -176.45 2.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.318 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -124.39 161.91 24.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.545 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.4 154.21 51.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.407 HD22 ' CD2' ' B' ' 84' ' ' LEU . 44.4 tp -132.44 139.93 48.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.68 -168.95 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.93 107.88 18.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.63 12.91 4.85 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.423 ' CB ' HG23 ' B' ' 37' ' ' VAL . 16.6 mt 52.38 32.85 11.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.862 -1.375 . . . . 0.0 110.462 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 35' ' ' CYS . 2.8 mmtp -100.21 -62.32 1.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 111.123 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -97.47 162.28 13.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.994 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.62 147.58 27.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.0 171.97 12.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 110.324 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.405 ' CD1' ' CG ' ' B' ' 31' ' ' GLU . 96.3 mt -135.78 116.17 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.495 ' CE2' ' CD2' ' B' ' 29' ' ' LEU . 21.5 m-85 -108.16 171.1 7.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -112.4 87.42 2.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.427 HG13 ' N ' ' B' ' 93' ' ' LYS . 3.2 pt -52.15 -23.31 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.427 ' N ' HG13 ' B' ' 92' ' ' ILE . 5.2 mmtt -132.01 151.19 78.02 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -61.38 144.1 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.608 1.32 . . . . 0.0 110.213 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -126.31 141.04 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 110.531 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.44 163.6 12.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 4.8 mt -63.79 121.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 110.545 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.7 2.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -117.5 170.36 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -1.179 . . . . 0.0 110.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . 0.455 ' HG3' ' CE1' ' B' ' 19' ' ' PHE . 0.4 OUTLIER -114.88 126.15 54.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' B' ' 102' ' ' THR . 97.8 mt -96.56 127.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 35.1 p -155.95 176.74 12.25 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.493 HG12 ' CG ' ' B' ' 68' ' ' PHE . 2.5 pp -147.94 155.86 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 110.699 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' B' ' 103' ' ' ILE . 33.0 t -68.74 -149.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 110.483 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -135.89 -69.32 0.49 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.56 -177.97 29.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.98 -40.5 96.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 110.403 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -61.23 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.05 107.1 3.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.475 ' CD2' ' O ' ' B' ' 110' ' ' TRP . 63.5 p-90 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.688 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.259 0.552 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -124.51 168.56 12.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo . . . . . 0 C--N 1.312 -1.393 0 O-C-N 123.723 1.38 . . . . 0.0 110.566 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 32.5 p90 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.357 0.599 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 5' ' ' ARG . 10.3 p30 -153.31 -172.57 4.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 111.02 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.68 -85.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.737 -0.602 . . . . 0.0 111.26 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' ASN . 7.3 mtm-85 -153.48 17.12 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.976 -1.078 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 5' ' ' ARG . 93.3 t -153.05 160.98 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.967 -1.083 . . . . 0.0 110.92 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.469 ' CG2' ' CB ' ' A' ' 19' ' ' PHE . 1.6 tt -124.02 154.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.64 141.06 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.796 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 10' ' ' LYS . 72.3 mttt -146.9 145.03 29.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.441 -0.787 . . . . 0.0 108.936 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.4 tppt? 52.4 80.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 119.629 -1.92 . . . . 0.0 110.273 2.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.346 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -118.44 83.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 110.355 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.3 -170.68 12.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.459 ' CG2' HD13 ' A' ' 67' ' ' ILE . 95.1 t -97.14 149.58 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.748 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 1.6 m-85 -114.83 121.89 44.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.426 -0.796 . . . . 0.0 109.286 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' CB ' HG23 ' A' ' 95' ' ' ILE . . . -89.57 86.99 6.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.125 -0.984 . . . . 0.0 111.009 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.19 -24.95 65.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.237 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.458 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 14.0 mttm -89.25 -179.73 5.93 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.458 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 102.4 20.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 119.953 -1.717 . . . . 0.0 109.808 2.589 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 3.8 m-85 -111.52 152.13 27.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.534 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -95.06 -165.14 1.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -95.62 120.23 35.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.62 5.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.99 128.61 46.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -1.152 . . . . 0.0 110.486 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.459 ' CD1' ' CG ' ' A' ' 88' ' ' ARG . 40.0 tp -53.28 164.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.932 . . . . 0.0 110.057 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.419 ' CG1' HG23 ' A' ' 6' ' ' VAL . 94.9 t -133.54 -71.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.36 66.44 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.519 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.84 148.86 23.99 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.79 -165.59 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 110.408 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.35 160.1 15.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.865 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 53.4 m -134.41 -179.57 5.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 36' ' ' ILE . 75.3 mt -113.35 151.34 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 84' ' ' LEU . 52.4 t -123.1 99.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -131.58 133.75 45.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 110.457 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.453 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -51.31 178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.977 . . . . 0.0 110.675 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -75.66 -132.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 0.0 110.423 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.93 -145.79 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.71 -1.244 . . . . 0.0 110.593 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.71 -28.06 0.94 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.194 -0.941 . . . . 0.0 111.394 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.493 ' CZ2' HD22 ' A' ' 51' ' ' LEU . 38.4 t-105 -57.34 -54.95 40.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 110.25 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . -67.23 -50.27 46.49 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.11 -44.19 42.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -1.159 . . . . 0.0 111.108 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 -49.27 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.553 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.1 mm? -91.42 28.22 1.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.93 . . . . 0.0 110.874 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 75.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.02 -1.05 . . . . 0.0 110.573 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.47 -37.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 110.95 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 39.4 m-85 -133.42 50.05 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.493 HD22 ' CZ2' ' A' ' 43' ' ' TRP . 52.3 mt -124.11 131.02 53.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 111.423 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -91.2 105.93 18.15 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.7 p -87.78 111.43 21.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.114 -0.991 . . . . 0.0 111.058 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -177.16 3.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -0.76 . . . . 0.0 109.825 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -83.1 83.97 7.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.005 -1.059 . . . . 0.0 109.555 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.509 2.0 p-10 154.0 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.698 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -176.77 -160.64 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 110.673 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.421 ' O ' ' NE1' ' A' ' 43' ' ' TRP . 1.1 m -141.33 125.91 17.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -109.21 155.47 21.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 110.809 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.432 ' CB ' ' HB ' ' A' ' 36' ' ' ILE . 9.6 ttt -89.49 168.68 11.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.086 -1.009 . . . . 0.0 109.801 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.32 -24.89 27.48 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.241 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CB ' HD23 ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER 62.49 -92.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 111.096 177.914 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.72 -144.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 93.0 m-85 -82.59 51.47 1.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -1.084 . . . . 0.0 110.829 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.73 -25.9 23.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.4 -43.87 10.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.691 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.5 pp -45.09 -23.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.553 -0.717 . . . . 0.0 112.083 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CE2' ' O ' ' A' ' 64' ' ' PHE . 23.1 m-85 -55.17 142.21 31.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.61 -1.306 . . . . 0.0 109.775 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -118.83 -169.46 1.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.03 . . . . 0.0 111.254 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -102.49 111.06 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 109.974 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.34 19.69 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 0.0 110.659 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt 52.62 23.33 2.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -174.38 65.24 0.28 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.055 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.41 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 11.8 Cg_endo -59.63 83.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.632 1.333 . . . . 0.0 110.601 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.421 ' O ' ' CG1' ' A' ' 92' ' ' ILE . 22.1 m120 -59.12 -17.93 31.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.03 143.84 50.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.47 11.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 110.555 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -107.5 136.2 47.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.355 -0.841 . . . . 0.0 110.301 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -124.59 166.97 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.6 mt -126.24 147.96 49.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 72.1 p -71.98 -79.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.54 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.81 23.1 4.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.422 ' O ' ' CG2' ' A' ' 37' ' ' VAL . 43.7 mt 52.06 36.87 19.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -1.205 . . . . 0.0 110.512 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -104.52 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 110.751 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.421 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 8.1 mtt180 -84.88 179.29 7.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.976 . . . . 0.0 110.319 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.865 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.3 mtp -148.28 128.44 13.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.736 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' CD ' ' CE1' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -114.38 106.16 13.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.44 -0.788 . . . . 0.0 110.091 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.48 113.27 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 109.929 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CE1' ' CD ' ' A' ' 88' ' ' ARG . 1.3 m-85 -101.93 177.17 4.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 p -113.92 99.32 7.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 110.028 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.429 HG13 ' N ' ' A' ' 93' ' ' LYS . 4.2 pt -53.04 -22.21 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.135 -0.978 . . . . 0.0 110.399 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.429 ' N ' HG13 ' A' ' 92' ' ' ILE . 45.1 mttt -148.24 146.75 23.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.16 -0.963 . . . . 0.0 110.175 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.84 129.41 34.44 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.673 1.354 . . . . 0.0 110.243 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.402 HG23 ' CB ' ' A' ' 20' ' ' ALA . 71.5 mt -104.76 148.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 110.594 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 167.35 11.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.575 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -71.32 123.41 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.503 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.85 39.97 2.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -124.65 -169.42 1.97 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -1.188 . . . . 0.0 110.381 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 23.7 tt0 -135.15 125.13 25.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 110.15 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 97.7 mt -89.39 137.99 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 45.4 p -154.07 -174.2 4.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.651 -0.656 . . . . 0.0 110.073 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.455 HG12 ' CD2' ' A' ' 68' ' ' PHE . 1.5 pp -149.5 158.46 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.136 -0.977 . . . . 0.0 110.454 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 32.3 t -95.79 -164.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 12.8 m-85 -133.82 -66.61 0.63 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.211 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.04 -157.96 53.64 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 55.82 -86.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.948 . . . . 0.0 110.691 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.3 t0 -122.55 -31.41 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 110.644 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.5 m-85 -51.16 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.569 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 51.9 p-90 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.73 . . . . 0.0 110.695 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.206 0.527 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.54 170.22 11.66 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.38 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 C--N 1.312 -1.383 0 O-C-N 123.659 1.347 . . . . 0.0 110.507 -179.817 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 32.2 p90 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.356 0.598 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' B' ' 5' ' ' ARG . 10.4 p30 -155.1 -173.21 4.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 110.815 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.97 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.707 -0.621 . . . . 0.0 111.211 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' B' ' 3' ' ' ASN . 7.3 mtm-85 -153.5 17.3 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.989 -1.069 . . . . 0.0 111.064 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' B' ' 18' ' ' VAL . 94.1 t -153.08 160.98 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 0.0 110.98 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.465 ' CG2' ' CB ' ' B' ' 19' ' ' PHE . 1.6 tt -124.0 154.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.781 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.7 141.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 110.831 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' B' ' 10' ' ' LYS . 72.2 mttt -147.09 145.0 29.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 108.967 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.511 ' HB3' ' HA ' ' B' ' 9' ' ' LYS . 3.4 tppt? 52.41 80.62 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.539 -1.976 . . . . 0.0 110.356 2.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' B' ' 9' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -118.29 83.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -1.112 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.56 -170.62 12.66 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' B' ' 67' ' ' ILE . 95.7 t -97.07 149.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.947 -1.325 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' B' ' 9' ' ' LYS . 1.6 m-85 -114.9 121.69 43.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.406 ' CB ' HG23 ' B' ' 95' ' ' ILE . . . -89.28 86.97 6.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 111.113 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 109.225 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.46 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 13.9 mttm -89.19 -179.64 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.46 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.0 OUTLIER 102.45 20.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 119.938 -1.726 . . . . 0.0 109.805 2.493 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' B' ' 5' ' ' ARG . 3.8 m-85 -111.45 152.13 27.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 110.615 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -95.04 -165.07 1.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.217 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -95.6 120.22 35.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.61 46.56 5.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.02 128.6 46.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -1.12 . . . . 0.0 110.508 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.464 ' CD1' ' CG ' ' B' ' 88' ' ' ARG . 39.7 tp -53.19 164.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.944 . . . . 0.0 110.089 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' B' ' 6' ' ' VAL . 94.8 t -133.57 -71.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.32 66.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.529 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.92 148.86 24.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 110.201 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.76 -165.58 2.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 160.22 15.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.858 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 53.8 m -134.48 -179.66 5.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 110.228 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.481 HD13 HG23 ' B' ' 36' ' ' ILE . 75.3 mt -113.25 151.28 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.058 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 52.8 t -123.05 99.36 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.17 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.479 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -131.6 133.75 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 110.444 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . 0.443 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.4 OUTLIER -51.34 178.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 110.669 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -75.64 -132.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.415 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.0 -145.93 0.45 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.828 -1.17 . . . . 0.0 110.525 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.56 -28.13 0.89 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.211 -0.931 . . . . 0.0 111.443 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.491 ' CZ2' HD22 ' B' ' 51' ' ' LEU . 38.2 t-105 -57.32 -55.0 40.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 110.228 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' B' ' 48' ' ' GLU . . . -67.2 -50.32 46.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.04 -44.24 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.293 -1.122 . . . . 0.0 111.099 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.13 -48.66 13.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -0.99 . . . . 0.0 110.6 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.1 mm? -92.15 28.33 1.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.706 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 76.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.007 -1.058 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.5 OUTLIER -175.48 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.892 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.483 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 39.3 m-85 -133.31 50.13 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.102 -0.998 . . . . 0.0 110.447 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.491 HD22 ' CZ2' ' B' ' 43' ' ' TRP . 52.3 mt -124.17 131.21 53.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -91.42 104.9 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 85.9 p -86.24 111.44 20.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.102 -0.999 . . . . 0.0 111.327 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -179.91 4.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.436 -0.79 . . . . 0.0 109.878 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -79.01 83.63 5.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.512 2.0 p-10 153.89 -27.61 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.656 -0.652 . . . . 0.0 109.743 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.1 OUTLIER -176.57 -160.45 0.06 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.37 -0.831 . . . . 0.0 110.698 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.415 ' O ' ' NE1' ' B' ' 43' ' ' TRP . 1.1 m -141.33 126.03 17.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.946 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -109.36 155.29 21.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.421 ' CB ' ' HB ' ' B' ' 36' ' ' ILE . 9.6 ttt -89.56 166.85 13.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.59 -26.19 32.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.431 HD23 ' CB ' ' A' ' 62' ' ' LEU 2.5 0.1 OUTLIER 62.95 -92.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 111.125 178.568 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.68 -144.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 93.1 m-85 -82.65 51.87 1.97 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -1.082 . . . . 0.0 110.758 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -91.29 -25.61 23.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.483 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.77 -43.74 9.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -1.17 . . . . 0.0 110.683 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.468 HD13 ' CG2' ' B' ' 18' ' ' VAL . 2.5 pp -45.13 -23.56 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.571 -0.705 . . . . 0.0 112.069 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.47 ' CE2' ' O ' ' B' ' 64' ' ' PHE . 23.1 m-85 -55.06 142.47 30.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.544 -1.348 . . . . 0.0 109.792 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' B' ' 102' ' ' THR . 82.4 m-20 -119.11 -169.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 111.184 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -103.09 110.95 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.2 19.56 13.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 110.629 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt 52.73 23.31 2.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 110.206 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' B' ' 75' ' ' ASN . 0.9 OUTLIER -174.41 65.28 0.28 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 110.012 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 11.9 Cg_endo -59.56 83.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.68 1.358 . . . . 0.0 110.591 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' B' ' 92' ' ' ILE . 22.2 m120 -59.16 -17.88 31.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.08 143.8 50.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.46 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.575 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -107.45 136.06 47.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -124.47 167.04 14.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 110.305 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 24.7 mt -126.24 147.94 49.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.513 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.42 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 71.7 p -71.94 -79.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.55 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.83 23.08 4.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' B' ' 37' ' ' VAL . 44.0 mt 52.05 36.84 19.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.238 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -104.45 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.42 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 8.1 mtt180 -84.86 179.24 7.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.307 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.858 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.3 mtp -148.3 128.47 13.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 0.0 110.733 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.524 ' CD ' ' CE1' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -114.5 105.93 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 110.116 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.07 113.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 110.05 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.524 ' CE1' ' CD ' ' B' ' 88' ' ' ARG . 1.3 m-85 -101.98 177.12 4.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.552 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.9 p -113.87 99.33 7.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.431 HG13 ' N ' ' B' ' 93' ' ' LYS . 4.2 pt -53.01 -22.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.392 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.431 ' N ' HG13 ' B' ' 92' ' ' ILE . 45.1 mttt -148.16 146.68 23.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.193 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.77 129.42 34.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.633 1.333 . . . . 0.0 110.247 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.406 HG23 ' CB ' ' B' ' 20' ' ' ALA . 71.4 mt -104.73 148.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.598 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.3 167.29 11.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.85 . . . . 0.0 110.562 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -71.27 123.38 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 110.463 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.87 39.93 2.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -124.65 -169.39 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -1.177 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 23.7 tt0 -135.26 124.88 25.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 97.8 mt -88.92 137.96 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 110.35 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 44.7 p -154.12 -174.13 4.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.527 -0.733 . . . . 0.0 110.02 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.442 HG12 ' CD2' ' B' ' 68' ' ' PHE . 1.5 pp -149.48 158.46 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 0.0 110.444 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.464 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 32.3 t -95.8 -164.16 1.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.347 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.471 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 12.9 m-85 -133.88 -66.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.99 -157.92 53.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' B' ' 106' ' ' GLY . 14.6 t0 55.8 -86.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.499 -1.0 . . . . 0.0 110.72 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 106' ' ' GLY . 10.3 t0 -122.58 -31.4 3.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 110.646 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.471 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.4 m-85 -51.13 96.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 110.585 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' B' ' 110' ' ' TRP . 52.0 p-90 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.807 . . . . 0.0 110.557 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.283 0.563 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.5 170.25 11.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo . . . . . 0 C--N 1.312 -1.388 0 O-C-N 123.714 1.376 . . . . 0.0 110.536 -179.905 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 21.9 p90 . . . . . 0 N--CA 1.506 2.352 0 CA-C-O 121.475 0.655 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.93 144.97 25.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.27 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.61 -45.09 47.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.877 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -37.89 83.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.937 . . . . 0.0 110.566 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.419 ' CG1' ' CG1' ' A' ' 18' ' ' VAL . 56.2 t -150.22 141.04 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.413 ' CG2' ' HD2' ' A' ' 21' ' ' ARG . 14.7 tt -113.67 153.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 110.612 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.82 131.68 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 110.108 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 54.5 mttt -147.86 123.61 10.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.022 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.8 mptt 59.36 64.23 1.4 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 119.664 -1.898 . . . . 0.0 111.07 0.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.339 -0.851 . . . . 0.0 110.622 179.256 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CD2' ' HD3' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.82 88.64 2.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -1.159 . . . . 0.0 110.639 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.05 -171.27 12.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 89.0 t -103.71 139.46 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.93 -1.335 . . . . 0.0 110.331 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 2.0 m-85 -109.44 124.6 51.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.747 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 101' ' ' ILE . . . -89.85 97.52 11.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.29 -0.881 . . . . 0.0 111.137 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.39 -20.24 64.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.458 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 6.9 mttt -93.84 179.53 5.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.282 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.458 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 12.2 m 103.12 17.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.047 -1.658 . . . . 0.0 110.191 1.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.412 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 14.3 m-85 -112.03 165.5 12.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.557 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.33 -156.59 0.58 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 110.201 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 11.4 tttp -100.5 105.49 16.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.511 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.08 41.26 1.83 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.41 55.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -1.22 . . . . 0.0 110.444 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.515 ' CD2' ' CE2' ' A' ' 90' ' ' PHE . 1.1 tm? -64.28 124.31 21.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.383 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -102.74 79.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 109.984 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.81 134.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -125.21 159.68 31.0 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.287 -0.883 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.4 -169.16 3.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 110.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.15 173.87 6.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 110.485 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -138.85 -173.73 3.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.473 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 50.0 mt -119.55 141.57 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.263 -0.898 . . . . 0.0 109.998 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.8 t -111.68 122.38 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.962 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' CG ' ' CG ' ' A' ' 43' ' ' TRP . 27.1 tpt180 -150.11 131.92 15.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.398 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -53.5 -174.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.206 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.81 117.96 33.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.36 -0.838 . . . . 0.0 110.732 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.79 -141.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.76 -24.85 6.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.656 -1.277 . . . . 0.0 109.36 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 52.1 t-105 -56.59 -56.19 24.46 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.544 -0.722 . . . . 0.0 109.615 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.12 -28.39 70.54 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -72.96 -44.7 60.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -1.195 . . . . 0.0 110.679 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.4 -40.6 29.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.0 110.482 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.2 mm? -90.72 22.93 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 0.2 OUTLIER -64.64 78.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.101 -0.999 . . . . 0.0 110.454 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -169.18 -62.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.016 -1.052 . . . . 0.0 110.79 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 28.1 m-85 -121.98 55.84 1.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.057 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.492 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 15.5 mt -109.15 112.3 24.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 0.0 111.11 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.42 101.59 14.27 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.288 -0.882 . . . . 0.0 108.693 176.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.425 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 24.9 p -100.99 142.09 32.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -177.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.409 ' HG3' ' CB ' ' C' ' 217' ' ' ALA . 1.7 ttt180 -101.31 -170.96 1.91 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.479 -0.763 . . . . 0.0 109.844 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -83.43 80.76 8.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 36.4 t-20 155.29 -20.75 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.708 -0.62 . . . . 0.0 110.242 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.18 -177.58 1.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.968 -1.083 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.425 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' CB ' HD21 ' A' ' 84' ' ' LEU . . . -135.74 161.92 34.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 109.945 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.449 ' CE ' HD13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -95.75 169.93 9.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.865 -1.147 . . . . 0.0 109.843 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -84.97 -14.91 46.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.714 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.473 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.5 0.0 OUTLIER 61.1 -94.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 111.293 177.567 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -133.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.44 41.81 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.098 . . . . 0.0 110.747 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -81.05 -19.43 67.25 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' HB3' ' CG ' ' A' ' 50' ' ' TYR . . . -87.69 -51.16 6.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.0 110.656 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.7 pp -46.67 -24.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 111.491 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CG ' HG12 ' A' ' 103' ' ' ILE . 10.0 m-85 -52.56 142.02 19.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.642 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -96.88 96.53 8.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 110.022 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.5 m -115.22 143.04 45.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 110.513 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.95 136.48 57.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.21 2.95 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 14.5 Cg_endo -61.01 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.685 1.361 . . . . 0.0 110.508 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -58.09 -19.44 32.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.431 ' CB ' HG21 ' A' ' 101' ' ' ILE . . . -123.53 150.19 44.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 0.0 110.567 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.32 -172.42 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -135.46 156.26 49.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 110.644 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.94 124.24 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.03 149.79 21.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 110.522 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 p -94.64 152.98 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.15 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.77 -5.79 3.74 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.279 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 HD21 ' CB ' ' A' ' 59' ' ' ALA . 1.8 tp 56.09 20.99 4.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.826 -1.396 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -22.29 19.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 111.085 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.57 157.96 45.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.901 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.78 138.09 49.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.765 . . . . 0.0 110.051 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -116.55 151.32 36.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 110.616 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.88 121.24 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 29' ' ' LEU . 15.6 m-85 -117.81 -170.14 1.81 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.454 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -131.51 93.84 3.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.893 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 93' ' ' LYS . 48.4 pt -51.07 -29.79 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -137.59 143.53 41.14 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 50.2 Cg_exo -49.91 149.88 10.59 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.529 1.279 . . . . 0.0 110.669 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.463 HG21 HD12 ' A' ' 95' ' ' ILE . 69.1 mt -122.52 150.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.727 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.01 161.91 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 110.155 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.5 mt -65.82 96.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.249 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.23 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 35.0 mm-40 -116.94 168.46 10.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -1.104 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -107.14 117.95 35.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.989 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.444 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 97.5 mt -89.63 128.22 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.515 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.5 p -153.99 176.76 11.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.877 -0.514 . . . . 0.0 109.678 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.482 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.2 pp -143.65 158.94 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 110.435 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.62 -158.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.32 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.47 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 34.1 m-85 -133.19 -59.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.06 -167.09 36.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.55 -34.2 77.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -1.136 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.359 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.47 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 2.1 m-85 -51.99 110.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.703 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 34.1 m95 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.9 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.271 0.558 . . . . 0.0 110.586 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . 0.409 ' CB ' ' HG3' ' A' ' 54' ' ' ARG . . . -150.96 123.8 4.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.391 -0.818 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--N 1.314 -1.284 0 O-C-N 123.364 1.191 . . . . 0.0 110.568 -179.889 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 21.9 p90 . . . . . 0 N--CA 1.506 2.339 0 CA-C-O 121.49 0.662 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.91 144.96 25.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.58 -45.12 47.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -37.94 83.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.586 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.424 ' CG1' ' CG1' ' B' ' 18' ' ' VAL . 56.0 t -150.16 141.06 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 tt -113.66 153.04 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 110.645 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 82.9 t -89.7 131.76 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 54.4 mttt -148.05 123.73 10.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.8 mptt 59.49 64.17 1.39 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.726 -1.859 . . . . 0.0 111.037 0.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.64 179.257 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.459 ' CD2' ' HD3' ' B' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 88.67 2.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 110.588 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.01 -171.36 12.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 86.2 t -103.66 139.25 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.955 -1.321 . . . . 0.0 110.373 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 2.0 m-85 -109.41 124.57 51.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 109.759 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' B' ' 101' ' ' ILE . . . -89.78 97.54 11.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 111.14 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -20.24 64.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.714 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.449 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 6.9 mttt -93.78 179.62 5.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.274 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.449 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.511 12.0 m 103.2 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.055 -1.653 . . . . 0.0 110.17 1.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 14.1 m-85 -112.1 165.56 12.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.138 -0.976 . . . . 0.0 110.573 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.38 -156.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 110.159 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.402 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 11.3 tttp -100.51 105.51 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 110.549 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.09 41.27 1.83 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.43 55.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 110.437 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' CE2' ' B' ' 90' ' ' PHE . 1.1 tm? -64.23 124.3 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 110.451 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -102.78 79.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 110.017 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.85 134.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.511 -0.743 . . . . 0.0 110.741 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -125.22 159.63 31.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.428 -0.795 . . . . 0.0 109.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.53 -169.19 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.554 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.24 173.89 6.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 110.521 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -138.81 -173.81 3.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 49.4 mt -119.49 141.52 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.0 110.002 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 91.6 t -111.62 122.41 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.964 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.507 ' CG ' ' CG ' ' B' ' 43' ' ' TRP . 27.1 tpt180 -150.17 131.82 14.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.0 110.477 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -53.44 -174.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 0.0 111.154 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.79 117.85 33.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.73 -141.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.7 -25.03 6.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.609 -1.307 . . . . 0.0 109.35 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.507 ' CG ' ' CG ' ' B' ' 38' ' ' ARG . 52.2 t-105 -56.49 -56.23 23.84 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.62 -0.675 . . . . 0.0 109.628 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.37 70.37 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.1 m -73.01 -44.76 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -1.155 . . . . 0.0 110.598 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.47 -40.28 30.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 110.464 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.2 mm? -91.14 23.16 3.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.583 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 0.2 OUTLIER -64.78 78.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 110.4 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.2 OUTLIER -169.14 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 110.79 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.478 ' CG ' ' HB3' ' B' ' 66' ' ' ALA . 28.2 m-85 -121.86 55.94 1.09 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.985 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.487 HD21 ' CZ2' ' B' ' 43' ' ' TRP . 15.5 mt -109.19 112.35 24.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 111.208 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.49 101.47 14.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.71 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.426 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 24.8 p -100.86 142.09 32.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.441 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.408 ' HG3' ' CB ' ' D' ' 217' ' ' ALA . 1.7 ttt180 -101.79 -173.67 2.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.469 -0.77 . . . . 0.0 109.853 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -79.67 80.48 6.05 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 36.7 t-20 155.22 -20.96 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.621 -0.675 . . . . 0.0 110.231 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.09 -177.55 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 111.078 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 0.9 OUTLIER -123.88 143.06 50.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.536 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -135.8 161.92 34.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.005 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.43 ' CG ' HD22 ' B' ' 51' ' ' LEU . 0.0 OUTLIER -96.28 167.97 10.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.985 179.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -82.03 -16.41 50.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 111.142 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.47 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.501 0.0 OUTLIER 61.73 -94.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 111.29 178.221 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.25 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -88.53 41.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -1.104 . . . . 0.0 110.76 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -81.0 -19.49 67.25 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' B' ' 50' ' ' TYR . . . -87.71 -51.12 6.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.162 -1.199 . . . . 0.0 110.645 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.7 pp -46.62 -24.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.844 . . . . 0.0 111.528 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.477 ' CG ' HG12 ' B' ' 103' ' ' ILE . 10.0 m-85 -52.51 142.02 18.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.857 -1.152 . . . . 0.0 110.351 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.957 . . . . 0.0 110.662 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -96.89 96.28 8.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 110.049 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 34.1 m -114.91 143.17 45.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.99 136.43 57.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.3 2.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.418 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 14.7 Cg_endo -60.99 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.664 1.35 . . . . 0.0 110.536 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -58.11 -19.5 32.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.581 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.429 ' CB ' HG21 ' B' ' 101' ' ' ILE . . . -123.44 150.26 44.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.636 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.39 -172.48 2.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 110.186 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -135.39 156.21 49.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 0.0 110.675 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.93 124.33 17.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 110.187 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -91.03 149.7 21.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.544 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 21.3 p -94.61 153.01 18.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.253 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.14 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 110.182 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.76 -5.87 3.75 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.24 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.438 HD21 ' CB ' ' B' ' 59' ' ' ALA . 1.8 tp 56.11 20.98 4.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.843 -1.387 . . . . 0.0 110.272 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.56 -22.16 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 111.091 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.62 157.98 45.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.034 -1.041 . . . . 0.0 110.913 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.74 138.01 49.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.071 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -116.47 151.38 36.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 110.68 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 73.4 mt -125.85 121.16 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.882 . . . . 0.0 109.95 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.517 ' CE2' ' CD2' ' B' ' 29' ' ' LEU . 15.6 m-85 -117.75 -170.15 1.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.491 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -131.5 93.88 3.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.891 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.43 HG13 ' N ' ' B' ' 93' ' ' LYS . 48.2 pt -51.03 -29.83 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.681 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.43 ' N ' HG13 ' B' ' 92' ' ' ILE . 1.0 OUTLIER -137.6 143.57 41.26 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 110.361 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 50.6 Cg_exo -50.05 149.9 11.01 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.596 1.314 . . . . 0.0 110.631 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' B' ' 99' ' ' GLU . 69.1 mt -122.53 150.55 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.98 161.93 13.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.395 -0.816 . . . . 0.0 110.127 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 10.6 mt -65.89 96.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.21 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 34.9 mm-40 -117.0 168.44 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -1.17 . . . . 0.0 110.402 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -107.07 117.95 35.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.912 . . . . 0.0 110.042 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.432 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 96.9 mt -89.53 128.25 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 61.3 p -153.98 176.85 11.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.716 -0.615 . . . . 0.0 109.67 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.477 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.2 pp -143.63 158.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -158.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 34.1 m-85 -133.21 -59.68 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.98 -167.13 36.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.49 -34.27 77.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 0.0 110.356 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.474 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 2.1 m-85 -52.03 110.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.728 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' B' ' 110' ' ' TRP . 34.1 m95 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.878 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.283 0.563 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . 0.408 ' CB ' ' HG3' ' B' ' 54' ' ' ARG . . . -150.89 123.75 4.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo . . . . . 0 C--N 1.314 -1.283 0 O-C-N 123.322 1.169 . . . . 0.0 110.539 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 10.0 p90 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.348 0.594 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.93 162.58 37.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.85 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.539 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.421 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.9 OUTLIER 178.33 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.414 -0.804 . . . . 0.0 109.414 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.436 HG12 ' CG1' ' A' ' 30' ' ' VAL . 18.9 m -155.4 179.98 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 109.727 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.44 166.58 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 110.04 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.39 144.78 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.784 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 4.9 mttt -140.84 142.72 34.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.3 56.99 6.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.663 -1.898 . . . . 0.0 110.6 2.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.629 -0.67 . . . . 0.0 109.988 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -106.2 77.93 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -1.216 . . . . 0.0 110.505 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.97 -165.0 14.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' CD1' ' A' ' 67' ' ' ILE . 1.5 p -117.75 130.02 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.927 -1.337 . . . . 0.0 108.839 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.486 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -89.77 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 111.06 -177.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' CB ' ' CG1' ' A' ' 101' ' ' ILE . . . -107.0 96.23 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -0.764 . . . . 0.0 110.385 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 -70.14 -18.31 63.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 0.0 109.98 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -97.54 177.96 5.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.531 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.442 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.515 50.6 m 106.48 21.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.097 -1.627 . . . . 0.0 110.12 1.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 20.3 m-85 -114.47 155.21 26.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.395 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 1.1 mt-10 -88.17 -82.81 0.22 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.798 . . . . 0.0 109.885 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 24.5 tttt -175.91 92.19 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.924 -1.11 . . . . 0.0 110.012 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.67 19.34 4.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -97.59 152.36 19.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.235 . . . . 0.0 110.307 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.481 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -78.02 121.55 24.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 110.379 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' CG1' HG12 ' A' ' 6' ' ' VAL . 88.6 t -84.64 -46.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.65 145.37 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 110.201 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -128.76 149.39 50.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.425 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 64.5 m -140.91 -154.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 110.123 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -110.35 175.94 5.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 110.623 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.1 m -147.23 164.34 33.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.409 -0.807 . . . . 0.0 109.592 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.492 HG21 HD11 ' A' ' 36' ' ' ILE . 22.4 mt -108.14 141.75 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 109.985 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 84' ' ' LEU . 61.0 t -117.31 120.97 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 110.537 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 21.7 tpt180 -148.82 143.21 26.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.445 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.33 -169.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.46 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.808 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -162.62 -136.14 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -51.63 -25.12 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 109.518 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.489 ' CE2' ' HB3' ' A' ' 38' ' ' ARG . 34.3 t-105 -58.52 -56.59 20.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.585 -0.697 . . . . 0.0 109.462 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.84 -34.21 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.8 m -70.82 -67.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 110.404 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.53 -51.72 58.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 110.538 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.472 ' HG ' ' CZ3' ' A' ' 43' ' ' TRP . 4.4 mm? -90.39 39.57 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 110.62 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 61.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.775 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.482 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -179.5 140.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.236 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 9.7 m-85 61.41 31.92 19.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.248 -0.908 . . . . 0.0 110.448 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 47' ' ' LEU . 15.3 mt -106.3 134.57 49.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -108.88 103.33 12.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 12.0 t -89.54 127.63 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 0.0 111.553 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' CZ ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -101.91 -174.48 2.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.539 -0.725 . . . . 0.0 109.752 178.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.36 73.88 9.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.016 -1.053 . . . . 0.0 109.124 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.505 5.2 t30 169.92 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.878 -0.514 . . . . 0.0 109.988 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -176.15 -168.13 0.25 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.261 -0.899 . . . . 0.0 110.952 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 1.3 p -116.58 138.8 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.17 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -131.59 168.09 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 110.375 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.4 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -105.84 172.92 6.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 109.857 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -85.23 -35.61 21.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.478 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.09 -94.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 111.288 178.128 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -70.3 -118.91 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -90.35 27.34 1.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.345 -1.091 . . . . 0.0 110.934 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.445 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -77.43 -22.6 69.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.94 -47.37 7.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.452 ' CD1' HG12 ' A' ' 18' ' ' VAL . 2.4 pp -47.66 -25.88 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.208 -0.932 . . . . 0.0 110.789 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.487 ' CG ' HG12 ' A' ' 103' ' ' ILE . 6.5 m-85 -46.39 113.25 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -92.3 179.19 5.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 110.87 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -101.77 116.91 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.828 . . . . 0.0 109.882 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.11 130.71 51.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.373 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -52.62 -23.71 7.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 110.329 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.56 71.52 0.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 110.368 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.54 112.12 1.85 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.648 1.341 . . . . 0.0 110.312 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.409 ' HA ' ' CE ' ' A' ' 93' ' ' LYS . 18.9 m-20 -111.32 18.49 19.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 110.616 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.7 162.56 40.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.441 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.0 ttt-85 -146.03 158.55 43.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.431 ' HB2' ' CE ' ' A' ' 87' ' ' MET . 19.5 p-80 -110.09 158.78 17.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -141.35 142.63 33.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.429 ' CD2' ' HG2' ' A' ' 87' ' ' MET . 6.6 mt -106.75 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -90.08 68.2 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.15 34.41 11.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.24 171.68 38.77 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.423 ' O ' ' CG2' ' A' ' 37' ' ' VAL . 85.4 mt -93.45 32.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -1.148 . . . . 0.0 109.998 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -93.34 -71.76 0.64 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.331 -0.856 . . . . 0.0 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.68 159.52 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.431 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 1.1 tmm? -142.47 138.77 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.569 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.08 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -0.96 . . . . 0.0 110.124 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.05 124.4 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.481 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 17.7 m-85 -113.35 -176.5 2.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.432 HG23 ' CG2' ' A' ' 30' ' ' VAL . 18.4 p -124.93 95.78 4.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 77' ' ' ARG . 30.7 pt -51.16 -24.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.6 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 0.5 OUTLIER -145.68 157.05 52.21 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 23.9 Cg_exo -59.12 147.19 91.63 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.738 1.388 . . . . 0.0 111.179 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.8 mt -131.7 145.29 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.606 -0.684 . . . . 0.0 110.33 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.25 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.373 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mt -66.97 112.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.36 26.09 2.51 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -113.69 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.241 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -116.47 135.9 53.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 110.631 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.49 ' CG1' ' CB ' ' A' ' 20' ' ' ALA . 39.2 mt -99.89 125.95 53.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.748 0.785 . . . . 0.0 110.521 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.9 p -154.73 171.57 19.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.487 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.2 pp -146.96 165.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.098 . . . . 0.0 110.655 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.75 -164.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CD2' ' NE1' ' A' ' 110' ' ' TRP . 17.3 m-85 -123.47 -66.25 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.041 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.58 153.92 9.79 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.25 -24.33 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -1.166 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -55.1 4.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 110.064 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -71.56 60.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 110.661 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.467 ' NE1' ' CD2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.24 -0.913 . . . . 0.0 110.317 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.285 0.564 . . . . 0.0 110.402 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -116.62 167.93 9.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 C--N 1.311 -1.406 0 O-C-N 123.696 1.366 . . . . 0.0 110.534 179.908 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.0 p90 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.272 0.558 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.92 162.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.223 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.9 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.432 -0.792 . . . . 0.0 110.537 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.428 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 0.9 OUTLIER 178.36 -35.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.395 -0.816 . . . . 0.0 109.404 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.437 HG12 ' CG1' ' B' ' 30' ' ' VAL . 18.9 m -155.37 -179.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.494 -0.754 . . . . 0.0 109.791 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.45 166.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.31 144.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 110.816 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 5.0 mttt -140.83 142.8 34.56 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.31 56.97 6.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 119.703 -1.873 . . . . 0.0 110.626 2.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.407 ' N ' ' HB3' ' B' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 110.007 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -106.22 78.11 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 110.541 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.22 -165.27 14.66 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.446 HG12 ' CD1' ' B' ' 67' ' ' ILE . 1.6 p -117.39 129.8 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.295 . . . . 0.0 109.153 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.482 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.6 OUTLIER -89.76 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 111.088 -177.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.487 ' CB ' ' CG1' ' B' ' 101' ' ' ILE . . . -106.99 96.1 6.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.38 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -70.06 -18.37 63.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 110.027 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -97.44 178.08 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.447 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 50.8 m 106.53 21.27 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.066 -1.646 . . . . 0.0 110.112 1.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 20.4 m-85 -114.69 154.48 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.527 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' B' ' 94' ' ' PRO . 1.2 mt-10 -87.23 -83.07 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' B' ' 25' ' ' GLU . 24.7 tttt -175.8 92.17 0.05 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.921 -1.112 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.68 19.37 4.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -97.62 152.35 19.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.268 . . . . 0.0 110.297 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.481 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.8 OUTLIER -78.04 121.55 24.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.442 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.437 ' CG1' HG12 ' B' ' 6' ' ' VAL . 88.4 t -84.65 -46.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 110.163 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.69 145.35 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 110.192 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.69 149.4 50.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.962 . . . . 0.0 110.435 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.434 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 64.3 m -140.91 -154.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.13 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.31 175.96 5.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 110.645 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 11.9 m -147.33 164.26 33.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.453 -0.779 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.479 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 22.2 mt -108.07 141.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.001 -1.062 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 61.1 t -117.28 120.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.515 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.481 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 21.6 tpt180 -148.76 143.24 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.36 -169.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.45 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.735 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -162.63 -136.23 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -51.53 -25.16 6.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.557 -1.339 . . . . 0.0 109.571 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 34.3 t-105 -58.51 -56.58 20.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.555 -0.715 . . . . 0.0 109.481 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.85 -34.19 64.78 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 48.0 m -70.76 -67.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -1.144 . . . . 0.0 110.433 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.71 -51.45 60.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 110.547 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.486 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 4.4 mm? -90.63 39.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.36 61.28 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.746 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.481 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -179.51 140.18 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 9.7 m-85 61.31 32.02 19.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.306 -0.871 . . . . 0.0 110.369 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' B' ' 47' ' ' LEU . 15.2 mt -106.23 134.81 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.986 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -109.17 103.04 11.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 11.8 t -89.09 127.62 35.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.068 -1.02 . . . . 0.0 111.597 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.421 ' CZ ' HD13 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -102.59 -177.56 3.42 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.577 -0.702 . . . . 0.0 109.832 178.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.95 73.37 4.51 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 110.129 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.507 5.4 t30 169.8 -30.8 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.721 -0.612 . . . . 0.0 109.994 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -175.97 -167.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 111.078 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 1.3 p -116.61 138.73 51.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.214 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -131.62 168.03 18.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.444 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.431 ' CE ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -106.18 170.95 7.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.429 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -82.31 -36.96 26.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 111.126 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.479 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.64 -94.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.0 111.271 178.765 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -70.34 -118.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -90.56 27.33 1.76 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -1.092 . . . . 0.0 110.933 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.447 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -77.46 -22.22 70.73 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.61 -47.14 7.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.121 -1.223 . . . . 0.0 110.823 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' B' ' 18' ' ' VAL . 2.4 pp -47.75 -25.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.266 -0.897 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.488 ' CG ' HG12 ' B' ' 103' ' ' ILE . 6.5 m-85 -46.38 113.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 111.138 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -92.34 179.41 5.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.812 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -102.03 116.84 33.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.4 -0.812 . . . . 0.0 109.845 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.01 130.78 51.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.193 -0.942 . . . . 0.0 110.417 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -52.61 -23.77 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.58 71.5 0.92 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.318 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.38 112.01 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.685 1.361 . . . . 0.0 110.266 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.419 ' HA ' ' CE ' ' B' ' 93' ' ' LYS . 19.1 m-20 -111.29 18.51 19.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.395 -0.815 . . . . 0.0 110.478 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.67 162.59 40.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.54 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.442 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.0 ttt-85 -146.11 158.45 43.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.16 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.424 ' HB2' ' CE ' ' B' ' 87' ' ' MET . 19.5 p-80 -110.0 158.81 17.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.38 142.67 33.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.281 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.428 ' CD2' ' HG2' ' B' ' 87' ' ' MET . 6.6 mt -106.76 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.445 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.4 p -90.05 68.16 7.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.18 34.34 11.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.399 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.26 171.68 38.78 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.435 ' HB3' ' CB ' ' B' ' 59' ' ' ALA . 85.2 mt -93.41 32.29 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.248 -1.148 . . . . 0.0 110.08 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -93.57 -71.66 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.56 14.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.499 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.428 ' HG2' ' CD2' ' B' ' 80' ' ' LEU . 1.0 OUTLIER -142.57 138.75 31.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.563 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.1 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 110.114 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.04 124.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.495 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.481 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 17.8 m-85 -113.24 -176.52 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.344 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.434 HG23 ' CG2' ' B' ' 30' ' ' VAL . 18.3 p -124.94 95.91 4.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.097 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' B' ' 77' ' ' ARG . 30.5 pt -51.16 -24.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 110.572 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' B' ' 75' ' ' ASN . 0.5 OUTLIER -145.63 157.17 52.19 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.177 -0.952 . . . . 0.0 110.551 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' B' ' 25' ' ' GLU . 24.1 Cg_exo -59.5 147.33 92.0 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.704 1.37 . . . . 0.0 111.111 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 67.1 mt -131.67 145.4 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.577 -0.702 . . . . 0.0 110.308 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.28 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mt -66.95 112.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 110.348 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 26.11 2.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -113.7 179.45 3.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -1.226 . . . . 0.0 110.034 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -116.3 136.03 53.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.045 . . . . 0.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.487 ' CG1' ' CB ' ' B' ' 20' ' ' ALA . 40.6 mt -99.98 126.06 53.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.471 -0.768 . . . . 0.0 110.538 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -154.69 171.72 19.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.488 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.2 pp -147.0 165.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.927 -1.108 . . . . 0.0 110.669 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.8 -164.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.422 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.47 ' CD2' ' NE1' ' B' ' 110' ' ' TRP . 17.3 m-85 -123.1 -66.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.52 153.96 9.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.22 -24.41 4.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -55.11 4.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -71.52 60.32 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 110.693 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.47 ' NE1' ' CD2' ' B' ' 105' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.303 0.573 . . . . 0.0 110.432 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -116.64 168.0 9.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo . . . . . 0 C--N 1.312 -1.37 0 O-C-N 123.696 1.366 . . . . 0.0 110.561 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 21.8 p90 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.32 0.581 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.83 156.04 49.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.14 -18.45 15.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.791 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.428 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 2.1 mtm-85 -97.6 -29.03 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 110.914 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 27.1 m -153.45 -172.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 110.415 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 13.6 tt -154.81 165.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 110.205 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.77 137.83 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.98 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 31.1 mttt -142.21 143.64 33.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.536 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER 52.73 66.21 1.29 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.757 -1.839 . . . . 0.0 111.161 1.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.568 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -102.58 73.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.247 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.71 -165.22 23.4 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.43 HG11 ' CD1' ' A' ' 67' ' ' ILE . 1.9 p -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.951 -1.323 . . . . 0.0 109.553 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m-85 -89.79 158.55 17.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.564 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.09 105.32 13.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 110.645 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -63.71 -28.45 69.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.516 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 5.3 mttm -86.5 -178.36 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.442 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.507 4.8 t 99.53 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.031 -1.668 . . . . 0.0 110.493 1.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 22.2 m-85 -96.83 158.63 15.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.047 -1.033 . . . . 0.0 110.893 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 -155.69 0.48 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.479 -0.763 . . . . 0.0 110.011 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 58.8 tttt -95.94 30.88 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.27 86.21 0.06 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -150.07 124.6 9.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 110.337 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 3.4 tm? -54.34 119.96 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.3 -52.72 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' N ' HD13 ' A' ' 29' ' ' LEU . 8.6 pt-20 -170.73 97.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.25 152.24 34.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.43 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -150.36 -151.22 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.77 171.93 7.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 1.03 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 1.3 m -150.14 150.42 31.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 36' ' ' ILE . 56.2 mt -91.18 142.71 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 42.0 t -117.63 127.91 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 110.769 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 19.2 mmt180 -150.36 178.2 9.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -92.14 -173.73 3.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.111 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.57 -141.93 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.407 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.74 -135.02 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.06 -1.025 . . . . 0.0 110.826 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.63 -49.06 7.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 111.521 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 38' ' ' ARG . 36.8 t-105 -51.54 -46.71 63.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.26 76.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.414 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 44.9 m -74.46 -59.96 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -1.216 . . . . 0.0 110.826 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' O ' ' NH2' ' B' ' 38' ' ' ARG . . . -50.69 -54.48 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.639 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.1 mm? -91.91 23.3 3.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 45' ' ' THR . 2.0 pp20? -50.67 154.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.952 -1.092 . . . . 0.0 110.005 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 54.9 t0 60.86 147.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.778 . . . . 0.0 110.164 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.28 13.68 7.18 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.145 -0.972 . . . . 0.0 110.303 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' CD2' ' NE1' ' A' ' 43' ' ' TRP . 8.9 tp -112.52 107.79 16.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.87 119.06 29.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -109.27 136.0 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 0.0 111.066 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' CD ' HD11 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -102.29 -172.04 2.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.391 -0.818 . . . . 0.0 109.806 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.03 72.91 9.09 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.958 -1.089 . . . . 0.0 108.967 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 6.3 m120 175.08 -33.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.434 ' HG2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.59 -173.51 0.33 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.352 -0.842 . . . . 0.0 110.331 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -112.75 146.92 37.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -141.8 151.64 43.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.618 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.433 ' CA ' HD13 ' A' ' 51' ' ' LEU . 29.3 tpp -90.17 156.77 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.429 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -87.83 93.39 9.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.426 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.497 0.1 OUTLIER -54.53 -65.5 0.56 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 110.427 179.194 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -60.69 -159.49 0.07 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.418 ' HB3' ' CD1' ' A' ' 67' ' ' ILE . 5.1 m-85 -75.36 58.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -1.091 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -90.16 -36.34 7.16 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.7 73.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 110.661 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.43 ' CD1' HG11 ' A' ' 18' ' ' VAL . 1.2 pp -51.84 -34.44 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.188 -0.945 . . . . 0.0 111.24 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.446 ' HB3' ' CG1' ' A' ' 103' ' ' ILE . 11.8 m-85 -49.96 119.9 3.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.986 -1.071 . . . . 0.0 110.697 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -95.52 176.46 6.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.404 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -95.39 107.57 19.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.4 t -115.65 129.98 56.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -53.6 -26.37 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.26 76.52 0.4 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.857 . . . . 0.0 110.052 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 17.0 Cg_endo -62.32 104.37 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.719 1.379 . . . . 0.0 110.656 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -94.38 -19.82 20.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.71 178.0 5.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.327 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' NH1' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -149.56 168.18 24.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.409 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.468 ' CD2' ' O ' ' A' ' 78' ' ' HIS . 33.5 p-80 -121.42 127.06 50.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 26.8 tt0 -109.17 172.44 6.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.427 HD11 ' CD ' ' A' ' 54' ' ' ARG . 6.0 mt -121.63 146.13 47.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 110.487 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 37.2 m -117.07 144.7 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.484 -0.76 . . . . 0.0 110.273 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 85' ' ' LYS . . . 52.93 34.03 15.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.03 -95.65 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' CD2' ' HG2' ' A' ' 57' ' ' MET . 1.0 OUTLIER -124.12 26.58 7.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -1.15 . . . . 0.0 110.219 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 1.2 mmtp -89.79 -73.12 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 110.482 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.428 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -102.17 177.84 4.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.41 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 1.03 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 64.5 mtp -136.91 150.51 48.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 110.369 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HD3' ' CE1' ' A' ' 90' ' ' PHE . 15.1 ttm180 -133.5 104.41 6.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.93 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 mt -89.08 140.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.964 . . . . 0.0 110.314 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.497 ' CE1' ' HD3' ' A' ' 88' ' ' ARG . 1.7 m-85 -129.53 -168.11 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.4 p -125.36 97.1 5.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 110.366 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.433 HG21 ' NH1' ' A' ' 77' ' ' ARG . 49.3 pt -59.87 -17.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.534 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.43 134.73 12.67 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 110.005 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 97.2 Cg_exo -46.59 135.49 16.48 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.49 1.258 . . . . 0.0 111.255 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.416 HG23 ' CB ' ' A' ' 99' ' ' GLU . 80.6 mt -115.71 142.38 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.5 163.33 15.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 28.1 mt -65.07 115.11 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -0.81 . . . . 0.0 110.409 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.06 40.85 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.416 ' CB ' HG23 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -111.6 177.6 4.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.138 . . . . 0.0 110.347 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.58 30.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.463 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 102' ' ' THR . 62.8 mt -90.31 124.85 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 110.395 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 17.5 p -157.51 135.92 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.1 pp -100.85 170.44 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.965 -1.084 . . . . 0.0 110.447 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.4 p -105.63 -166.83 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.478 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -123.58 -58.56 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 0.0 110.068 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.57 160.32 0.44 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.6 OUTLIER 57.45 109.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.434 -1.039 . . . . 0.0 110.977 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 107' ' ' ASP . 16.5 t0 57.57 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.844 -0.535 . . . . 0.0 111.768 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -43.34 111.03 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.311 -0.868 . . . . 0.0 111.706 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 111.019 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.273 0.559 . . . . 0.0 110.339 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.33 16.51 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.943 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 C--N 1.314 -1.287 0 O-C-N 123.571 1.301 . . . . 0.0 110.538 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 21.6 p90 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.383 0.611 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.78 156.13 49.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.295 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.18 -18.44 15.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.764 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.421 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 2.1 mtm-85 -97.66 -29.08 13.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.884 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 27.0 m -153.4 -172.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 tt -154.79 165.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.95 . . . . 0.0 110.23 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.79 137.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 110.726 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.539 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 31.1 mttt -142.17 143.72 33.1 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.539 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.0 OUTLIER 52.77 66.3 1.26 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.861 -1.774 . . . . 0.0 111.083 1.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.568 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -102.52 73.3 1.3 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -1.231 . . . . 0.0 110.641 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.68 -165.33 23.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.436 HG11 ' CD1' ' B' ' 67' ' ' ILE . 2.0 p -121.69 130.72 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.322 . . . . 0.0 109.674 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.492 ' CD1' ' HD2' ' B' ' 9' ' ' LYS . 1.1 m-85 -89.83 158.5 17.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 110.528 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.18 105.39 13.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 110.581 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.418 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.2 OUTLIER -63.7 -28.39 69.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.441 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 5.3 mttm -86.54 -178.36 6.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.441 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.506 4.8 t 99.53 10.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 119.958 -1.714 . . . . 0.0 110.5 1.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 22.1 m-85 -96.69 158.67 15.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.064 -1.022 . . . . 0.0 110.921 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.09 -155.69 0.48 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.464 -0.773 . . . . 0.0 110.016 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -95.93 30.84 2.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.393 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.29 86.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -150.17 124.6 9.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' B' ' 90' ' ' PHE . 3.4 tm? -54.36 119.95 5.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 95.1 t -81.26 -52.73 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.841 . . . . 0.0 110.372 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.433 ' N ' HD13 ' B' ' 29' ' ' LEU . 8.6 pt-20 -170.73 97.46 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 152.4 34.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.433 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.3 OUTLIER -150.55 -151.33 0.39 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.645 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.7 171.96 7.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.521 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 1.034 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 1.3 m -150.18 150.36 31.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.516 HG21 HD12 ' B' ' 36' ' ' ILE . 55.8 mt -91.04 142.77 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' B' ' 84' ' ' LEU . 42.1 t -117.67 128.01 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 110.745 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 19.1 mmt180 -150.5 178.18 9.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.7 OUTLIER -92.11 -173.73 3.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 110.106 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.6 -141.95 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.35 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.75 -135.05 0.8 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.129 -0.982 . . . . 0.0 110.805 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.59 -49.1 7.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.001 -1.062 . . . . 0.0 111.506 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 36.9 t-105 -51.53 -46.7 63.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 110.046 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.27 76.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 44.9 m -74.47 -59.88 2.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.138 -1.213 . . . . 0.0 110.808 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -53.67 30.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 0.0 110.656 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.478 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 3.2 mm? -93.0 23.63 4.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 110.603 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' B' ' 45' ' ' THR . 2.0 pp20? -50.76 154.52 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.033 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 54.2 t0 60.91 147.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.504 -0.747 . . . . 0.0 110.177 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.2 13.73 7.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.115 -0.991 . . . . 0.0 110.18 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.465 ' CD2' ' NE1' ' B' ' 43' ' ' TRP . 8.9 tp -112.6 107.81 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 110.936 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.85 119.08 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.564 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 42.6 t -109.25 135.93 49.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -0.99 . . . . 0.0 111.094 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.437 ' CB ' HD13 ' B' ' 84' ' ' LEU . 0.9 OUTLIER -102.93 -175.19 2.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.74 . . . . 0.0 109.808 178.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.46 72.3 4.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -0.962 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 6.3 m120 175.02 -33.51 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.43 ' CG ' HD21 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.3 -173.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.347 -0.845 . . . . 0.0 110.391 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -112.74 146.89 37.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -141.74 151.62 43.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.446 ' CA ' HD13 ' B' ' 51' ' ' LEU . 29.3 tpp -90.32 155.93 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.423 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -86.65 93.4 9.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.851 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.436 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.497 0.1 OUTLIER -54.93 -65.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.369 179.246 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.7 -159.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.412 ' HB3' ' CD1' ' B' ' 67' ' ' ILE . 5.1 m-85 -75.4 59.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -90.34 -36.27 7.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.68 73.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 110.658 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.436 ' CD1' HG11 ' B' ' 18' ' ' VAL . 1.2 pp -51.87 -34.4 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 0.0 111.246 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.445 ' HB3' ' CG1' ' B' ' 103' ' ' ILE . 11.8 m-85 -49.95 119.89 3.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.918 -1.114 . . . . 0.0 110.709 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -95.53 176.47 6.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.869 . . . . 0.0 110.451 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -95.4 107.57 19.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 110.253 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 31.5 t -115.67 130.02 56.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 0.0 110.498 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' B' ' 74' ' ' PRO . 0.4 OUTLIER -53.59 -26.36 21.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.293 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.27 76.5 0.4 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.09 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.419 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 17.0 Cg_endo -62.31 104.39 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.715 1.377 . . . . 0.0 110.688 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -94.42 -19.78 20.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.74 178.02 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 110.295 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.437 ' NH1' HG21 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -149.55 168.2 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.962 . . . . 0.0 110.445 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.459 ' O ' ' CD2' ' B' ' 78' ' ' HIS . 33.6 p-80 -121.42 126.92 50.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 110.386 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' B' ' 88' ' ' ARG . 27.0 tt0 -109.07 172.37 6.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.428 HD11 ' CD ' ' B' ' 54' ' ' ARG . 6.0 mt -121.46 146.21 47.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.453 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.433 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 38.5 m -117.08 144.7 44.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.41 -0.806 . . . . 0.0 110.279 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.93 34.01 15.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.253 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.08 -95.72 2.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.437 ' HB3' ' CG2' ' B' ' 37' ' ' VAL . 1.0 OUTLIER -124.11 26.53 7.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -1.163 . . . . 0.0 110.228 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -89.69 -73.09 0.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 110.522 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.433 ' CB ' ' HB ' ' B' ' 81' ' ' THR . 0.3 OUTLIER -102.24 177.87 4.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.349 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 1.034 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 64.5 mtp -136.92 150.6 48.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.492 ' HD3' ' CE1' ' B' ' 90' ' ' PHE . 15.0 ttm180 -133.76 104.08 6.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.476 -0.765 . . . . 0.0 109.982 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.1 mt -88.39 140.22 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.461 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.492 ' CE1' ' HD3' ' B' ' 88' ' ' ARG . 1.7 m-85 -129.73 -168.13 1.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.89 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 26.5 p -125.32 97.07 5.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 110.397 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.437 HG21 ' NH1' ' B' ' 77' ' ' ARG . 49.2 pt -59.84 -17.54 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.42 134.62 12.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.89 135.75 17.49 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.467 1.246 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.421 HG23 ' CB ' ' B' ' 99' ' ' GLU . 80.9 mt -115.77 142.19 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.18 163.39 15.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.622 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 28.1 mt -65.06 115.04 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 110.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.07 40.87 2.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.421 ' CB ' HG23 ' B' ' 95' ' ' ILE . 0.2 OUTLIER -111.59 177.64 4.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.73 31.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.401 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' B' ' 102' ' ' THR . 63.1 mt -90.45 124.83 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 110.44 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 17.4 p -157.38 135.98 11.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 109.659 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.445 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.1 pp -100.83 170.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 89.5 p -105.64 -166.98 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.441 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -123.44 -58.75 1.59 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.939 . . . . 0.0 110.036 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.84 160.31 0.47 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.6 OUTLIER 57.41 109.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.432 -1.04 . . . . 0.0 111.003 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 107' ' ' ASP . 16.7 t0 57.79 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.867 -0.521 . . . . 0.0 111.774 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' B' ' 107' ' ' ASP . 0.2 OUTLIER -43.45 111.0 0.23 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.302 -0.874 . . . . 0.0 111.719 -178.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 0.0 110.934 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.214 0.531 . . . . 0.0 110.38 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.3 16.48 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 110.413 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.313 -1.305 0 O-C-N 123.538 1.283 . . . . 0.0 110.489 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 48.9 p90 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.345 0.593 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -126.03 148.11 49.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.415 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 26.1 t70 -46.51 -48.66 19.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.437 -0.79 . . . . 0.0 111.053 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.437 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 20.6 mmt85 -59.65 -45.7 91.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 110.495 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 27.3 m -154.81 152.16 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.384 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.428 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 11.6 tt -117.75 167.12 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.941 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -89.35 127.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.433 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 12.9 mttt -144.54 139.02 27.92 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER 52.61 73.47 0.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.585 -1.947 . . . . 0.0 109.798 6.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 O-C-N 121.869 -0.52 . . . . 0.0 110.135 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.58 66.66 6.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -1.2 . . . . 0.0 110.627 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.54 -163.75 17.65 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.487 HG13 ' CE1' ' A' ' 68' ' ' PHE . 2.4 p -105.89 133.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.238 . . . . 0.0 109.063 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.51 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -90.0 144.12 26.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 110.521 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.444 ' CB ' ' CG1' ' A' ' 101' ' ' ILE . . . -97.26 89.24 4.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.466 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.416 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.6 OUTLIER -63.29 -18.59 63.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.282 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HD2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.76 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.416 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 0.0 OUTLIER 97.57 8.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.414 -1.429 . . . . 0.0 110.609 0.812 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 14.6 m-85 -105.44 163.46 12.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.995 -1.065 . . . . 0.0 110.511 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.3 -148.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.027 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -107.94 82.47 1.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . . . 124.37 46.5 0.25 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.57 144.81 51.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -1.172 . . . . 0.0 110.531 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.492 HD22 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -74.87 141.76 44.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.477 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 28.6 m -121.81 -23.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.18 -0.95 . . . . 0.0 110.995 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 4.7 tt0 -171.8 153.82 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.104 -0.997 . . . . 0.0 110.216 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.46 ' CG ' ' HA ' ' A' ' 88' ' ' ARG . 3.1 mt-10 -146.63 151.0 36.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 110.484 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 27.0 p -150.59 -160.85 1.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.652 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 HD21 ' CG ' ' A' ' 86' ' ' ARG . 54.0 mt -114.73 -179.87 3.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.466 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.7 170.89 17.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.439 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 48.2 mt -105.78 144.26 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.226 -0.922 . . . . 0.0 109.793 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.25 89.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.005 -1.059 . . . . 0.0 110.386 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.38 177.81 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -88.61 175.06 7.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.121 -0.987 . . . . 0.0 109.771 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 5.7 t-20 -74.89 -135.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.099 -1.001 . . . . 0.0 110.252 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.3 t0 65.84 -146.86 0.21 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.69 -1.257 . . . . 0.0 110.379 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.03 -28.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.213 -0.93 . . . . 0.0 111.033 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.548 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 65.9 t-105 -68.41 -52.11 36.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.833 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.77 -23.53 55.98 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 90.7 m -83.76 -67.09 0.82 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -1.188 . . . . 0.0 110.748 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.63 -49.92 18.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 0.0 110.988 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.548 ' CD2' ' CH2' ' A' ' 43' ' ' TRP . 4.4 mp -91.86 31.87 1.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.02 64.09 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.939 -1.101 . . . . 0.0 110.61 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.42 -68.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.038 -1.039 . . . . 0.0 110.585 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 13.0 m-85 -98.34 34.39 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 47' ' ' LEU . 2.3 tp -101.5 116.86 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.549 -0.72 . . . . 0.0 111.01 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -89.35 103.73 16.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.117 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 33.7 t -90.77 139.93 30.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.148 -0.97 . . . . 0.0 111.561 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' NH2' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -121.63 -175.36 3.07 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.583 -0.698 . . . . 0.0 109.674 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 79.69 8.88 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 109.363 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.506 0.2 OUTLIER 162.88 -28.91 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.847 -0.533 . . . . 0.0 109.844 -179.307 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.84 -161.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.3 m -128.28 141.7 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -129.12 175.42 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.859 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.434 ' CE ' HD23 ' A' ' 47' ' ' LEU . 1.3 tpt -114.11 169.45 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' N ' ' HG3' ' A' ' 60' ' ' MET . . . -84.96 -37.28 20.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.083 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.433 ' CB ' HD23 ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER 76.14 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.005 . . . . 0.0 111.186 177.657 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -66.35 -128.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.446 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.19 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -1.049 . . . . 0.0 110.84 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.77 -26.71 21.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . . . -90.15 -35.78 15.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -1.114 . . . . 0.0 110.585 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.464 HD12 ' CD1' ' A' ' 68' ' ' PHE . 2.1 pp -47.01 -37.0 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.487 ' CE1' HG13 ' A' ' 18' ' ' VAL . 28.9 m-85 -46.39 129.37 10.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.343 -0.848 . . . . 0.0 110.919 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.49 -177.4 3.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 110.65 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -93.24 124.72 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 110.03 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 m -145.35 157.18 44.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 110.555 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.22 25.91 2.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.495 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.26 67.84 4.1 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 13.1 Cg_endo -60.55 110.24 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.764 1.402 . . . . 0.0 110.465 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.436 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 3.1 m120 -89.84 -18.65 25.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' CB ' HG22 ' A' ' 101' ' ' ILE . . . -151.55 122.66 7.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.13 -0.982 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.445 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.2 mtt180 -93.89 -171.23 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 110.033 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -130.39 150.59 51.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.177 -0.952 . . . . 0.0 110.281 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 4.4 tp10 -117.32 141.81 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 84' ' ' LEU . 51.2 tp -114.5 131.13 56.74 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 110.131 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -54.81 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 110.379 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' ' NH2' ' A' ' 54' ' ' ARG . . . -52.42 -23.27 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 110.389 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.54 -164.27 11.79 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 59' ' ' ALA . 8.9 mt -102.8 42.47 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -1.129 . . . . 0.0 110.226 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.23 -65.63 0.98 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.168 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' CG ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.46 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 110.886 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.97 24.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 110.13 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.46 ' HA ' ' CG ' ' A' ' 32' ' ' GLU . 0.4 OUTLIER -128.03 172.47 10.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 110.91 -179.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.477 ' CG2' ' CG2' ' A' ' 30' ' ' VAL . 16.6 mt -145.89 91.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.492 ' CD2' HD22 ' A' ' 29' ' ' LEU . 2.4 m-85 -98.41 150.39 21.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.586 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLY . 2.9 p -89.13 114.13 25.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.061 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 77' ' ' ARG . 13.6 pt -75.83 -13.53 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.62 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 8.3 ptpt -148.19 156.7 43.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.058 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.87 124.41 15.29 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.582 1.306 . . . . 0.0 110.597 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 75' ' ' ASN . 61.8 mt -111.4 145.6 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 110.373 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.89 156.61 17.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.367 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -59.91 111.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.864 . . . . 0.0 110.326 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.76 32.19 1.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -114.3 170.54 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' OE2' ' CG2' ' A' ' 102' ' ' THR . 0.7 OUTLIER -110.31 139.8 45.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.444 ' CG1' ' CB ' ' A' ' 20' ' ' ALA . 41.0 mt -109.02 122.1 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 110.619 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.415 ' CG2' ' OE2' ' A' ' 100' ' ' GLU . 58.4 p -149.7 143.71 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.479 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -111.61 169.86 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.021 -1.049 . . . . 0.0 110.571 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.51 -168.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 110.428 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 11.1 m-85 -123.49 -62.33 1.33 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.21 -0.932 . . . . 0.0 109.867 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 70.16 -169.83 45.65 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.87 -67.86 0.11 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.533 -0.981 . . . . 0.0 110.813 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -144.12 -39.02 0.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.994 -1.066 . . . . 0.0 110.767 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.6 m-85 -47.51 107.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 111.241 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 26.3 m95 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 110.908 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.417 0.627 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.44 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.209 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 C--N 1.312 -1.369 0 O-C-N 123.596 1.313 . . . . 0.0 110.447 179.892 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 49.0 p90 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.384 0.612 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -125.96 148.26 49.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . 0.409 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 26.1 t70 -46.56 -48.7 19.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.371 -0.831 . . . . 0.0 110.985 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.426 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 20.5 mmt85 -59.67 -45.69 91.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 110.539 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 27.3 m -154.72 152.22 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 11.7 tt -117.89 166.75 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -88.83 127.86 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.571 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 13.0 mttt -144.71 139.15 27.74 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.576 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.8 OUTLIER 52.71 73.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.52 -1.988 . . . . 0.0 109.851 6.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' B' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.895 -0.503 . . . . 0.0 110.097 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -90.55 66.96 6.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -1.145 . . . . 0.0 110.616 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.87 -163.94 17.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.483 HG13 ' CE1' ' B' ' 68' ' ' PHE . 2.5 p -105.59 132.94 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.021 -1.282 . . . . 0.0 109.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.519 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.054 -1.028 . . . . 0.0 110.556 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.437 ' CB ' ' CG1' ' B' ' 101' ' ' ILE . . . -97.21 89.19 4.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.6 OUTLIER -63.4 -18.54 63.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.472 ' HD2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.85 6.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.414 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.509 0.0 OUTLIER 97.63 8.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.434 -1.416 . . . . 0.0 110.625 0.786 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.472 ' CZ ' ' HD2' ' B' ' 22' ' ' LYS . 14.4 m-85 -105.34 163.52 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.024 -1.048 . . . . 0.0 110.487 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.36 -148.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -107.96 82.45 1.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.13 -0.981 . . . . 0.0 110.486 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 91' ' ' THR . . . 124.37 46.57 0.25 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.55 144.74 51.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -1.197 . . . . 0.0 110.575 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER -74.84 141.84 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 109.813 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.471 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 28.4 m -121.97 -23.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.12 -0.987 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.429 ' HB3' ' CD1' ' B' ' 89' ' ' ILE . 4.6 tt0 -171.75 153.77 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' B' ' 88' ' ' ARG . 3.1 mt-10 -146.59 151.26 37.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 0.0 110.434 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.411 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 27.0 p -150.98 -161.02 1.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.432 HD21 ' CG ' ' B' ' 86' ' ' ARG . 53.7 mt -114.66 -179.84 3.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -149.68 170.86 17.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 47.8 mt -105.76 144.2 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.791 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.18 89.35 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.41 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.28 177.8 4.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.361 -0.837 . . . . 0.0 110.163 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -88.54 175.0 7.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.12 -0.987 . . . . 0.0 109.785 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 5.7 t-20 -74.83 -135.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 4.4 t0 65.87 -146.89 0.21 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.712 -1.243 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.0 -28.39 1.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.169 -0.957 . . . . 0.0 111.022 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.544 ' CH2' ' CD2' ' B' ' 47' ' ' LEU . 65.8 t-105 -68.45 -52.06 36.75 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.79 -23.52 56.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.418 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 91.1 m -83.71 -67.16 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 110.699 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.73 -49.03 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.188 -0.945 . . . . 0.0 111.046 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.544 ' CD2' ' CH2' ' B' ' 43' ' ' TRP . 4.4 mp -93.21 32.44 1.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.13 64.09 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.564 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.46 -68.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.047 . . . . 0.0 110.596 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.488 ' CG ' ' HB3' ' B' ' 66' ' ' ALA . 13.0 m-85 -98.22 34.29 2.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.224 -0.922 . . . . 0.0 109.955 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.402 ' CD1' ' SD ' ' B' ' 60' ' ' MET . 2.3 tp -101.51 116.66 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 111.145 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -89.05 103.79 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.184 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 33.8 t -90.82 139.88 30.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 111.526 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.415 ' NH2' ' O ' ' B' ' 82' ' ' ALA . 0.2 OUTLIER -122.2 -178.36 3.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.587 -0.696 . . . . 0.0 109.696 178.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.25 79.35 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 110.253 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 0.2 OUTLIER 162.71 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.694 -0.629 . . . . 0.0 109.88 -179.474 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.4 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -177.67 -161.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.3 m -128.35 141.7 51.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.13 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -129.07 175.34 8.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.015 . . . . 0.0 110.955 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.438 ' CE ' HD23 ' B' ' 47' ' ' LEU . 1.3 tpt -114.47 167.34 10.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.0 109.793 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' B' ' 60' ' ' MET . . . -81.82 -38.74 25.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -0.965 . . . . 0.0 110.56 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.433 HD23 ' CB ' ' A' ' 62' ' ' LEU 2.501 0.1 OUTLIER 76.7 -95.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 111.202 178.359 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -66.36 -128.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.44 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.59 1.26 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -1.06 . . . . 0.0 110.788 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -91.39 -26.42 20.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.488 ' HB3' ' CG ' ' B' ' 50' ' ' TYR . . . -90.33 -35.73 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -1.093 . . . . 0.0 110.595 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.459 HD12 ' CD1' ' B' ' 68' ' ' PHE . 2.2 pp -46.97 -37.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.483 ' CE1' HG13 ' B' ' 18' ' ' VAL . 29.1 m-85 -46.31 129.36 10.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.322 -0.861 . . . . 0.0 110.983 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.5 -177.32 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -93.27 124.63 37.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.3 m -145.36 157.25 44.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.39 26.08 2.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -157.22 67.73 4.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 13.2 Cg_endo -60.47 110.3 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.727 1.383 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.434 ' HB3' ' CD1' ' B' ' 95' ' ' ILE . 3.1 m120 -89.91 -18.65 25.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' B' ' 101' ' ' ILE . . . -151.54 122.7 7.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.436 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.3 mtt180 -93.85 -171.17 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.327 -0.858 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -130.48 150.49 51.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.437 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 4.4 tp10 -117.23 141.88 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' B' ' 84' ' ' LEU . 51.6 tp -114.5 131.12 56.74 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.17 -0.956 . . . . 0.0 110.238 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -54.9 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.329 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.415 ' O ' ' NH2' ' B' ' 54' ' ' ARG . . . -52.4 -23.32 5.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 110.345 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.48 -164.22 11.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.436 ' HB3' ' CB ' ' B' ' 59' ' ' ALA . 8.9 mt -102.9 42.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -1.106 . . . . 0.0 110.144 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.46 -65.48 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 111.173 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.432 ' CG ' HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.47 27.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.823 -178.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.87 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 110.127 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.451 ' HA ' ' CG ' ' B' ' 32' ' ' GLU . 0.4 OUTLIER -127.78 172.62 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 30' ' ' VAL . 16.7 mt -145.99 91.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.52 -0.738 . . . . 0.0 109.964 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.495 ' CD2' HD22 ' B' ' 29' ' ' LEU . 2.4 m-85 -98.44 150.01 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 110.593 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.426 ' O ' ' N ' ' B' ' 27' ' ' GLY . 3.0 p -88.66 114.19 25.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.164 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' B' ' 77' ' ' ARG . 13.7 pt -75.82 -13.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.666 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 8.3 ptpt -148.17 156.71 43.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.966 . . . . 0.0 110.039 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.82 124.42 15.34 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.676 1.356 . . . . 0.0 110.64 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' B' ' 75' ' ' ASN . 61.9 mt -111.4 145.64 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.92 156.61 17.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -59.91 111.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 32.16 1.78 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -114.29 170.49 8.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 110.236 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . 0.41 ' OE2' ' CG2' ' B' ' 102' ' ' THR . 0.7 OUTLIER -110.29 139.88 45.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.957 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.437 ' CG1' ' CB ' ' B' ' 20' ' ' ALA . 41.5 mt -108.89 122.2 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.41 ' CG2' ' OE2' ' B' ' 100' ' ' GLU . 57.4 p -149.7 143.73 25.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 109.631 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.479 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.0 OUTLIER -111.53 169.75 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.51 -168.89 1.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.487 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 10.9 m-85 -123.12 -62.41 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.95 . . . . 0.0 109.936 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.15 -169.8 45.67 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.89 -67.87 0.11 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.521 -0.987 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -144.07 -39.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.053 -1.029 . . . . 0.0 110.757 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.6 m-85 -47.45 107.14 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' B' ' 110' ' ' TRP . 26.2 m95 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.437 -0.789 . . . . 0.0 111.004 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.443 0.64 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.45 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.312 -1.386 0 O-C-N 123.633 1.333 . . . . 0.0 110.48 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.473 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 10.8 p90 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.337 0.589 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.52 143.57 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 110.292 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.6 -33.15 6.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.953 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.431 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -77.32 -44.13 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 27.2 m -154.15 147.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 110.192 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 14.3 tt -114.81 166.1 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.907 . . . . 0.0 110.061 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.59 122.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 110.896 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' CB ' ' CD1' ' A' ' 19' ' ' PHE . 41.8 mttt -150.03 128.86 12.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 9' ' ' LYS . 3.0 mttt 51.44 40.11 25.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.718 -1.864 . . . . 0.0 109.879 6.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.409 ' HA ' ' HG2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.708 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 16' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 15' ' ' GLY . 37.5 m-85 -152.55 91.77 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.038 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.437 ' HA2' ' CG2' ' A' ' 67' ' ' ILE . . . -151.18 -169.25 16.67 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG23 ' CE1' ' A' ' 68' ' ' PHE . 87.2 t -100.81 124.13 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.031 -1.276 . . . . 0.0 109.616 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' CB ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -88.45 129.37 35.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.989 -1.07 . . . . 0.0 110.777 -178.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.22 85.27 3.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.557 -0.714 . . . . 0.0 110.082 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 4.7 mtp180 -56.09 -25.13 44.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 109.485 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.482 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 5.1 mtpp -84.63 -179.72 7.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.446 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 7.0 m 100.36 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.054 -1.654 . . . . 0.0 110.038 2.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 16.1 m-85 -107.63 142.79 37.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.75 171.07 9.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.091 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 18.7 tttt -67.04 100.81 0.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.45 -20.75 11.02 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.57 123.69 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -1.179 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.48 HD23 ' CE2' ' A' ' 90' ' ' PHE . 1.2 tm? -65.99 113.65 4.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.4 t -72.04 -53.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -174.14 144.44 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.25 157.98 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.436 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.1 p -150.56 -171.82 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 110.651 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.7 mt -100.61 167.65 10.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.783 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.7 m -145.15 161.59 39.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 60' ' ' MET . 55.1 mt -92.16 148.26 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.0 90.45 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.659 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 39.8 mmt180 -117.93 168.43 10.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -87.08 -176.27 5.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.068 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 26.2 m120 -72.24 -137.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.0 t0 65.97 -148.09 0.21 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 110.541 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.27 -34.74 4.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.243 -0.91 . . . . 0.0 111.109 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.485 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 60.6 t-105 -52.88 -57.21 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.029 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -60.34 -31.31 73.47 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.97 -65.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.522 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.22 70.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 110.14 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.6 mm? -91.74 34.03 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.686 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 1.9 tm-20 -56.31 -17.54 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 111.365 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.89 156.47 19.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.913 -1.117 . . . . 0.0 110.966 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 7.0 m-30 55.25 26.29 8.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.854 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' CZ2' ' A' ' 43' ' ' TRP . 10.5 tp -108.71 105.88 15.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.867 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -89.11 105.32 17.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.1 t -105.39 147.52 28.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.938 . . . . 0.0 110.915 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HG2' ' CD1' ' A' ' 84' ' ' LEU . 10.4 ptm180 -115.13 -167.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 77.62 9.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.075 -1.016 . . . . 0.0 109.264 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.499 3.0 t30 166.02 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.902 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -176.98 -164.44 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.947 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.414 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 6.2 t -130.2 141.05 50.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.459 -0.776 . . . . 0.0 110.286 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.424 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -132.71 149.42 52.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 110.626 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 32.9 tpp -93.24 155.91 17.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.52 92.1 8.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.704 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 36' ' ' ILE 2.506 0.1 OUTLIER -52.19 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 110.895 -178.605 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -61.05 -155.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CA ' ' CD1' ' A' ' 67' ' ' ILE . 31.6 m-85 -90.16 54.12 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.132 . . . . 0.0 111.152 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.481 ' HA2' ' CE2' ' A' ' 68' ' ' PHE . . . -92.83 -15.52 52.08 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 50' ' ' TYR . . . -91.72 4.37 52.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.894 -1.356 . . . . 0.0 112.355 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.485 ' CD1' ' CA ' ' A' ' 64' ' ' PHE . 3.8 mp -88.56 -20.75 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.716 -1.24 . . . . 0.0 110.829 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 23.1 m-85 -52.43 143.6 14.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.89 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -112.4 -159.67 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -102.01 136.12 42.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.405 -0.81 . . . . 0.0 109.414 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' ASP . 1.8 m -152.06 35.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.027 -1.045 . . . . 0.0 110.567 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp 58.11 -82.63 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.542 -0.724 . . . . 0.0 110.273 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' SER . 4.5 m-20 -99.33 91.78 1.55 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 11.5 Cg_endo -58.04 106.56 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.564 1.297 . . . . 0.0 110.524 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -50.48 -23.8 2.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.619 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.71 159.56 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.995 . . . . 0.0 110.426 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.47 ' NH2' ' NE2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -136.99 -173.89 3.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.195 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.47 ' NE2' ' NH2' ' A' ' 77' ' ' ARG . 7.5 p-80 -119.74 172.71 7.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -142.35 155.07 45.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.38 143.36 50.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 110.371 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.427 HG21 ' CZ ' ' A' ' 88' ' ' ARG . 20.4 p -72.93 -66.47 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.354 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.88 -35.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 110.524 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.66 26.66 19.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.436 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 34.6 mt 51.73 28.84 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.605 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.22 -36.25 10.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 110.76 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.87 135.8 54.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 110.691 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 mtp -126.85 116.72 21.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 110.199 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.427 ' CZ ' HG21 ' A' ' 81' ' ' THR . 45.2 mtt180 -101.35 131.92 47.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.25 98.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.022 . . . . 0.0 109.591 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.48 ' CE2' HD23 ' A' ' 29' ' ' LEU . 13.9 m-85 -89.76 -169.29 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.547 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 p -132.57 98.43 4.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.083 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 74' ' ' PRO . 33.7 pt -54.54 -22.18 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.106 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.72 161.23 38.55 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 34.1 Cg_exo -53.74 156.57 11.65 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.635 1.334 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 59.2 mt -138.55 134.91 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.3 167.86 10.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 110.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -64.53 119.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.341 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.63 30.75 5.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.19 141.06 36.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.113 -1.228 . . . . 0.0 110.325 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.416 ' OE1' ' CG2' ' A' ' 102' ' ' THR . 1.3 tm-20 -88.39 121.39 30.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 109.674 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 60.6 mt -89.11 123.59 41.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.78 . . . . 0.0 110.586 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.416 ' CG2' ' OE1' ' A' ' 100' ' ' GLU . 73.2 p -145.46 -176.71 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.436 HG12 ' CB ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -151.74 160.31 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 0.0 110.384 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.54 -173.05 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 13.0 m-85 -125.51 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 109.86 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.5 -160.29 54.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.94 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.988 . . . . 0.0 110.692 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -129.44 -35.54 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.067 . . . . 0.0 110.706 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.44 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -48.66 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.93 . . . . 0.0 110.928 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.476 ' O ' ' CD2' ' A' ' 110' ' ' TRP . 54.8 p-90 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.6 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.232 0.539 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.09 165.59 17.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 110.328 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo . . . . . 0 C--N 1.312 -1.344 0 O-C-N 123.675 1.355 . . . . 0.0 110.452 179.779 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.9 p90 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.395 0.617 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.45 143.69 31.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.69 -33.24 6.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.363 -0.836 . . . . 0.0 110.894 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.421 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -77.25 -44.19 30.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 27.1 m -154.04 147.43 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 14.3 tt -114.77 165.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 110.102 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.4 122.28 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 110.969 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.528 ' CB ' ' CD1' ' B' ' 19' ' ' PHE . 42.1 mttt -150.13 129.17 12.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.495 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 3.0 mttt 51.8 40.01 26.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.511 -1.993 . . . . 0.0 109.889 6.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.696 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' B' ' 16' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' B' ' 15' ' ' GLY . 37.3 m-85 -152.5 91.58 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.433 ' HA2' ' CG2' ' B' ' 67' ' ' ILE . . . -151.03 -169.15 16.43 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.463 HG23 ' CE1' ' B' ' 68' ' ' PHE . 88.5 t -100.93 123.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.254 . . . . 0.0 109.71 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' CB ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -87.35 129.37 35.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.015 . . . . 0.0 110.94 -178.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.31 85.25 3.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.438 -0.789 . . . . 0.0 110.13 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 4.7 mtp180 -56.03 -25.09 43.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.545 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' CD2' ' B' ' 24' ' ' PHE . 5.2 mtpp -84.6 -179.62 7.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.45 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.513 6.8 m 100.46 13.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.041 -1.662 . . . . 0.0 109.98 2.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 16.3 m-85 -107.59 142.63 37.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.195 -0.94 . . . . 0.0 110.275 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.48 171.08 9.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.415 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 18.7 tttt -67.05 100.85 0.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.43 -20.87 10.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.62 123.74 11.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -1.163 . . . . 0.0 110.547 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.479 HD21 ' CE1' ' B' ' 90' ' ' PHE . 1.2 tm? -66.02 113.65 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 99.5 t -72.03 -53.14 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.184 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -174.14 144.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.314 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.26 158.19 34.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 110.406 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.433 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.1 p -150.81 -171.96 4.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 54.9 mt -100.53 167.7 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 95.2 m -145.19 161.56 39.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.058 -1.026 . . . . 0.0 110.524 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' B' ' 60' ' ' MET . 54.9 mt -92.06 148.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.02 90.5 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.95 . . . . 0.0 110.604 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.488 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 39.8 mmt180 -117.96 168.43 10.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -87.07 -176.31 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.883 . . . . 0.0 110.167 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.22 -137.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.976 . . . . 0.0 110.148 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 66.07 -148.11 0.21 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.805 -1.184 . . . . 0.0 110.547 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.26 -34.78 4.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.219 -0.926 . . . . 0.0 111.123 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.488 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 60.8 t-105 -52.81 -57.22 10.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 110.077 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.416 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -60.36 -31.3 73.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.93 -65.19 0.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -50.54 73.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.256 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 3.6 mm? -92.79 34.41 1.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 110.465 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.416 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 1.9 tm-20 -56.53 -17.59 8.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.049 -1.032 . . . . 0.0 111.299 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.76 156.44 19.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.971 -1.081 . . . . 0.0 111.073 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 7.0 m-30 55.28 26.36 8.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.475 -0.766 . . . . 0.0 110.775 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.482 HD12 ' CZ2' ' B' ' 43' ' ' TRP . 10.6 tp -108.79 105.51 15.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 110.937 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' B' ' 52' ' ' PHE . 42.4 m-85 -88.56 105.27 17.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 3.1 t -105.4 147.51 28.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.152 -0.967 . . . . 0.0 110.907 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.443 ' HG2' ' CD1' ' B' ' 84' ' ' LEU . 10.3 ptm180 -115.66 -170.07 1.71 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.109 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.55 77.21 5.03 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.242 -0.911 . . . . 0.0 110.226 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.505 3.1 t30 165.94 -29.21 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.679 -0.638 . . . . 0.0 109.935 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.83 -164.15 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 110.934 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 6.2 t -130.27 141.09 50.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 110.241 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -132.78 149.43 52.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.637 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.467 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 32.9 tpp -93.48 154.84 17.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 110.215 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.07 92.05 8.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' B' ' 36' ' ' ILE 2.505 0.1 OUTLIER -52.29 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.949 -178.734 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.97 -155.15 0.03 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.48 ' CA ' ' CD1' ' B' ' 67' ' ' ILE . 31.6 m-85 -90.22 55.38 3.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -1.119 . . . . 0.0 111.053 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' B' ' 68' ' ' PHE . . . -94.92 -13.82 51.64 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.185 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.416 ' HB2' ' CG ' ' B' ' 50' ' ' TYR . . . -93.2 4.86 53.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.933 -1.334 . . . . 0.0 112.096 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.48 ' CD1' ' CA ' ' B' ' 64' ' ' PHE . 3.8 mp -88.76 -20.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.691 -1.256 . . . . 0.0 110.817 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.477 ' CE2' ' HA2' ' B' ' 65' ' ' GLY . 23.0 m-85 -52.43 143.62 14.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.917 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -112.33 -159.43 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -102.42 136.12 42.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.358 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 73' ' ' ASP . 1.8 m -152.01 35.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.085 -1.009 . . . . 0.0 110.646 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp 58.11 -82.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.428 -0.795 . . . . 0.0 110.288 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' B' ' 71' ' ' SER . 4.5 m-20 -99.38 91.85 1.59 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.235 -0.916 . . . . 0.0 109.789 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 11.4 Cg_endo -58.07 106.66 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.616 1.324 . . . . 0.0 110.476 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -50.59 -23.76 2.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.593 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.73 159.53 42.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 110.442 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.462 ' NH2' ' NE2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -136.95 -173.85 3.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 110.177 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.462 ' NE2' ' NH2' ' B' ' 77' ' ' ARG . 7.5 p-80 -119.71 172.62 7.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 110.618 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -142.28 155.19 45.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.38 143.34 50.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 110.428 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.433 HG21 ' CZ ' ' B' ' 88' ' ' ARG . 20.3 p -73.0 -66.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 110.337 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.91 -35.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.483 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.66 26.6 19.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.443 ' CD1' ' HG2' ' B' ' 54' ' ' ARG . 34.7 mt 51.82 28.79 5.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -1.182 . . . . 0.0 110.631 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.32 -36.15 10.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.84 135.76 54.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.705 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 13.0 mtp -126.78 116.69 21.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 110.258 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.433 ' CZ ' HG21 ' B' ' 81' ' ' THR . 45.2 mtt180 -101.49 131.53 47.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 110.397 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.3 mt -88.68 98.44 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.479 ' CE1' HD21 ' B' ' 29' ' ' LEU . 14.0 m-85 -89.57 -169.24 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 26.7 p -132.62 98.42 4.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 110.087 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' B' ' 74' ' ' PRO . 33.6 pt -54.6 -22.15 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.72 161.23 38.51 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.18 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 34.2 Cg_exo -53.77 156.51 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.6 1.316 . . . . 0.0 110.823 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' B' ' 24' ' ' PHE . 59.2 mt -138.49 134.99 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.35 167.93 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -64.51 119.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.59 30.79 5.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.36 140.41 37.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -1.22 . . . . 0.0 110.365 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' B' ' 102' ' ' THR . 1.3 tm-20 -87.49 121.08 29.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.01 -1.056 . . . . 0.0 109.946 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' B' ' 18' ' ' VAL . 60.6 mt -88.62 123.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.402 -0.811 . . . . 0.0 110.79 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.412 ' CG2' ' OE1' ' B' ' 100' ' ' GLU . 72.0 p -145.55 -176.69 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.708 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.444 HG12 ' CB ' ' B' ' 68' ' ' PHE . 1.0 OUTLIER -151.67 160.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.356 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.5 -173.02 2.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.437 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 13.0 m-85 -125.53 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.339 -0.851 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 71.45 -160.27 54.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.96 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -1.0 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.2 OUTLIER -129.43 -35.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.742 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.437 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.5 OUTLIER -48.67 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.929 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.469 ' CD2' ' O ' ' B' ' 110' ' ' TRP . 54.8 p-90 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 2.6 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.08 165.56 17.22 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.601 1.316 . . . . 0.0 110.458 179.775 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 41.3 p90 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.24 0.543 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -119.39 167.0 12.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.358 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.67 64.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 177.89 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 0.0 109.623 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' CG1' ' CG2' ' A' ' 18' ' ' VAL . 96.4 t -153.55 158.97 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.462 ' CG2' ' CB ' ' A' ' 19' ' ' PHE . 5.1 tt -134.95 158.94 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.442 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG1' ' HE2' ' A' ' 10' ' ' LYS . 61.7 t -99.24 114.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 110.795 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.497 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 14.1 mttt -127.6 141.68 51.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER 52.4 56.65 7.39 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 119.821 -1.799 . . . . 0.0 110.196 2.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.596 -0.69 . . . . 0.0 110.263 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CE2' ' HD3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -77.9 59.13 2.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 110.299 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -105.13 -165.59 23.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.477 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 2.3 p -114.03 131.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.903 -1.351 . . . . 0.0 109.502 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 11' ' ' SER . 0.4 OUTLIER -88.57 141.77 28.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.363 -0.835 . . . . 0.0 110.602 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.58 93.54 8.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.699 -0.626 . . . . 0.0 110.706 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -65.63 -15.75 63.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 0.0 109.877 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 6.7 mttt -108.61 179.05 4.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.448 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 20.1 m 102.25 21.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.012 -1.68 . . . . 0.0 109.727 2.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 17.5 m-85 -114.6 161.47 18.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 110.637 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.37 170.95 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -72.53 88.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 110.46 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.91 52.15 0.21 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.18 136.57 52.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.489 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 2.0 tm? -67.09 117.29 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 110.211 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG2' ' CG2' ' A' ' 91' ' ' THR . 38.3 t -98.53 85.42 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.32 -0.863 . . . . 0.0 109.563 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.62 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 110.304 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -154.13 160.53 41.96 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.011 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 1.062 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 26.7 p -150.75 160.96 43.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 111.072 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.9 mt -96.65 176.78 5.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.872 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' CG ' ' A' ' 87' ' ' MET . 83.8 m -149.25 166.39 29.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 48.4 mt -103.13 154.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 84' ' ' LEU . 41.2 t -131.17 118.49 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.893 -1.129 . . . . 0.0 110.641 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 29.7 mmt180 -136.79 147.77 46.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.58 58.78 2.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 111.297 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 1.9 t-20 49.8 -141.31 0.7 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 111.019 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 44' ' ' GLY . 2.3 t70 67.35 -144.8 0.14 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.036 -1.04 . . . . 0.0 110.169 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.13 -35.85 12.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.935 -1.103 . . . . 0.0 110.297 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.522 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 17.2 t-105 -63.73 -34.61 78.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 109.129 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -62.43 -60.38 7.94 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.418 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 54.6 m -66.17 -45.84 79.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.19 -1.182 . . . . 0.0 110.666 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -62.0 2.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 0.0 109.1 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.3 mm? -93.19 36.27 1.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.471 -0.768 . . . . 0.0 110.795 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.454 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -69.4 61.71 0.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.093 -1.004 . . . . 0.0 110.325 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.479 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 178.78 145.36 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.487 -0.758 . . . . 0.0 109.015 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 11.2 m-85 57.35 26.72 12.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.918 -1.113 . . . . 0.0 109.31 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.47 ' CD1' ' CG ' ' A' ' 60' ' ' MET . 3.1 tp -107.86 112.93 25.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 111.285 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -89.4 108.44 19.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.161 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.433 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 23.2 t -107.39 143.91 35.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.509 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.86 -165.62 1.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.522 -0.736 . . . . 0.0 109.781 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 75.4 8.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.363 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.86 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.507 -179.609 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.423 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 179.95 -174.6 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.591 -0.693 . . . . 0.0 110.324 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.464 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 26.0 p -111.95 134.89 53.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.336 -0.852 . . . . 0.0 110.432 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.427 ' CB ' HD22 ' A' ' 84' ' ' LEU . . . -117.12 174.44 6.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.47 ' CG ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -120.35 160.09 23.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.788 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HB1' ' N ' ' A' ' 66' ' ' ALA . . . -89.09 99.13 12.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 110.226 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.497 0.1 OUTLIER -58.4 -81.11 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.86 . . . . 0.0 110.922 -179.437 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.3 -130.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.88 45.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 110.769 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -90.5 -20.67 40.2 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.69 -43.56 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.434 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 1.3 pp -48.97 -25.64 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.213 -0.929 . . . . 0.0 110.367 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.434 ' HB3' ' CG1' ' A' ' 103' ' ' ILE . 9.2 m-85 -48.96 144.99 4.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 110.638 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -118.65 174.69 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.577 ' CE1' ' CE2' ' A' ' 110' ' ' TRP . 1.8 t-160 -101.54 109.52 21.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.07 146.67 48.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.44 127.54 32.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.78 71.0 1.57 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.952 . . . . 0.0 110.255 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.65 174.25 1.74 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.663 1.349 . . . . 0.0 110.595 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -117.66 -13.12 10.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 110.569 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.05 143.96 51.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.06 166.93 13.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -0.933 . . . . 0.0 110.081 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.21 158.99 17.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.731 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 87' ' ' MET . 19.6 tt0 -132.94 136.68 46.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 110.147 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.6 145.13 42.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.037 -1.039 . . . . 0.0 110.419 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 p -53.93 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 110.396 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.38 -60.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.66 42.81 1.86 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.427 HD22 ' CB ' ' A' ' 59' ' ' ALA . 4.4 tp 59.25 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.298 -1.119 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -177.2 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 110.084 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -113.3 140.1 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.756 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 1.062 ' SD ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 ppp? -137.24 169.85 17.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.113 -0.992 . . . . 0.0 110.666 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -131.37 -179.74 5.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.346 -0.846 . . . . 0.0 110.637 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.411 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 6.5 mt -130.21 108.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 0.0 109.646 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.489 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 51.8 m-85 -97.2 -170.68 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.48 ' CG2' ' CG2' ' A' ' 30' ' ' VAL . 23.1 p -128.35 98.95 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.5 pt -60.06 -16.58 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 110.696 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -148.69 156.94 41.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.189 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.96 142.86 93.61 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.582 1.306 . . . . 0.0 110.379 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.456 ' CG2' ' CB ' ' A' ' 99' ' ' GLU . 54.4 mt -124.33 141.97 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.671 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.76 153.66 20.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.882 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -48.25 -24.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.46 -0.775 . . . . 0.0 111.313 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.34 60.68 0.32 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.456 ' CB ' ' CG2' ' A' ' 95' ' ' ILE . 3.3 mm-40 -116.28 165.05 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 111.274 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.19 115.56 29.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.432 ' O ' HG12 ' A' ' 18' ' ' VAL . 58.5 mt -88.79 127.49 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.3 p -155.55 148.41 24.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.434 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.3 pp -115.91 155.32 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 0.0 110.749 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.485 ' HA ' ' CD2' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -90.61 -173.95 3.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 110.06 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.522 ' CD2' ' ND1' ' A' ' 70' ' ' HIS . 9.0 m-85 -123.63 -66.36 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.988 . . . . 0.0 110.093 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.43 -175.28 44.37 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.71 -33.28 68.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -1.166 . . . . 0.0 110.377 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -66.95 0.6 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.366 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.48 71.93 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.92 . . . . 0.0 110.493 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.577 ' CE2' ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.441 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 3.4 p . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.217 0.532 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.63 167.99 12.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.927 . . . . 0.0 110.39 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo . . . . . 0 C--N 1.311 -1.397 0 O-C-N 123.734 1.386 . . . . 0.0 110.425 179.8 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 41.5 p90 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.256 0.551 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 12.7 p30 -119.4 167.01 12.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 110.373 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.71 64.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 110.345 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER 177.87 -33.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.39 -0.819 . . . . 0.0 109.639 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.48 ' CG1' ' CG2' ' B' ' 18' ' ' VAL . 96.6 t -153.45 159.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.461 ' CG2' ' CB ' ' B' ' 19' ' ' PHE . 5.1 tt -134.98 158.9 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.412 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.432 ' CG1' ' HE2' ' B' ' 10' ' ' LYS . 62.0 t -99.27 114.81 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.483 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 14.1 mttt -127.72 141.83 51.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.483 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER 52.59 56.59 7.43 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 119.777 -1.827 . . . . 0.0 110.13 1.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.469 ' HB2' ' CZ ' ' B' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.554 -0.716 . . . . 0.0 110.304 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.48 ' CE2' ' HD3' ' B' ' 10' ' ' LYS . 0.2 OUTLIER -77.7 59.42 2.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 110.353 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 9' ' ' LYS . . . -105.63 -165.73 23.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.48 ' CG2' ' CG1' ' B' ' 6' ' ' VAL . 2.4 p -113.95 130.83 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.927 -1.337 . . . . 0.0 109.637 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' HD2' ' B' ' 9' ' ' LYS . 0.4 OUTLIER -87.71 141.86 28.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.835 . . . . 0.0 110.773 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.71 93.54 8.06 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 110.735 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.1 OUTLIER -65.64 -15.62 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.914 178.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 6.7 mttt -108.68 179.01 4.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 108.757 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.445 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 20.1 m 102.25 20.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.064 -1.648 . . . . 0.0 109.757 2.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 17.5 m-85 -114.52 161.51 17.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 110.685 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.48 170.97 8.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.964 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -72.5 88.76 1.24 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 110.432 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.85 52.2 0.21 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.22 136.58 52.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.495 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 2.0 tm? -67.14 117.38 9.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.483 ' CG2' ' CG2' ' B' ' 91' ' ' THR . 38.4 t -98.58 85.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.577 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' B' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.708 -0.62 . . . . 0.0 110.256 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -154.11 160.8 42.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 1.071 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 26.7 p -151.08 160.9 43.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 111.031 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.67 176.73 5.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.301 -0.874 . . . . 0.0 109.851 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -149.16 166.42 28.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.079 . . . . 0.0 111.369 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.439 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 48.2 mt -103.12 154.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.16 118.47 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.972 -1.08 . . . . 0.0 110.586 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.526 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 29.6 mmt180 -136.78 147.76 46.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.218 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.48 58.71 2.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 111.317 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 1.9 t-20 49.79 -141.33 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.127 -0.983 . . . . 0.0 111.085 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 2.3 t70 67.43 -144.9 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.022 -1.049 . . . . 0.0 110.116 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -48.11 -35.83 12.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.9 -1.125 . . . . 0.0 110.272 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.526 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 17.1 t-105 -63.77 -34.58 78.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 0.0 109.154 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -62.42 -60.44 7.86 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' B' ' 48' ' ' GLU . 54.1 m -65.88 -46.04 79.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -1.197 . . . . 0.0 110.64 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.414 ' O ' ' NH2' ' A' ' 38' ' ' ARG . . . -57.02 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.885 -1.135 . . . . 0.0 109.276 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.4 mm? -94.98 36.96 1.16 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.444 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -69.66 61.68 0.16 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -0.953 . . . . 0.0 110.274 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.481 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.9 OUTLIER 178.73 145.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 11.1 m-85 57.37 26.7 12.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.923 -1.111 . . . . 0.0 109.287 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.472 ' CD1' ' CG ' ' B' ' 60' ' ' MET . 3.1 tp -107.82 112.8 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 111.401 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -89.22 108.5 19.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 23.0 t -107.36 143.89 35.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.006 . . . . 0.0 111.508 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.46 -168.72 1.63 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.523 -0.736 . . . . 0.0 109.735 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 74.81 4.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.369 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.79 -35.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -179.735 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.416 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -179.75 -174.27 0.28 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.522 -0.736 . . . . 0.0 110.367 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.463 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 26.4 p -112.16 134.9 53.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 110.399 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -117.09 174.41 6.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 110.65 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.472 ' CG ' ' CD1' ' B' ' 51' ' ' LEU . 0.0 OUTLIER -120.34 159.76 24.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.421 ' HB1' ' N ' ' B' ' 66' ' ' ALA . . . -88.65 99.18 12.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.818 . . . . 0.0 110.238 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.496 0.1 OUTLIER -58.49 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -179.528 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.25 -130.39 0.01 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -90.06 46.22 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -1.162 . . . . 0.0 110.68 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -90.98 -20.16 40.41 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.25 -43.33 9.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 110.627 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.445 ' CD1' ' HB ' ' B' ' 18' ' ' VAL . 1.3 pp -49.09 -25.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.197 -0.939 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.434 ' CD2' ' HA2' ' B' ' 65' ' ' GLY . 9.2 m-85 -48.96 145.29 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 110.627 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.401 ' HB2' ' CG2' ' B' ' 102' ' ' THR . 73.1 m-80 -118.94 174.75 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.517 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . 0.578 ' CE1' ' CE2' ' B' ' 110' ' ' TRP . 1.8 t-160 -101.68 109.54 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 110.19 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.06 146.71 48.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.5 127.61 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.65 71.1 1.55 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.228 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.66 174.23 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.71 1.374 . . . . 0.0 110.555 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.412 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 17.4 p30 -117.65 -13.09 10.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.07 144.01 51.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.038 -1.039 . . . . 0.0 110.201 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.08 166.91 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.19 159.02 17.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.766 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' B' ' 87' ' ' MET . 19.7 tt0 -133.06 136.6 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.151 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.51 145.17 42.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.063 -1.023 . . . . 0.0 110.453 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 14.2 p -53.95 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 110.385 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.36 -60.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 110.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.59 42.76 1.88 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.424 HD22 ' CB ' ' B' ' 59' ' ' ALA . 4.4 tp 59.33 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.273 -1.133 . . . . 0.0 110.513 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -177.23 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.03 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -113.31 140.06 48.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 1.071 ' SD ' ' SG ' ' B' ' 33' ' ' CYS . 3.9 ppp? -137.2 169.83 17.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 110.71 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -179.66 5.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 0.0 110.648 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.405 HG12 ' CZ ' ' B' ' 68' ' ' PHE . 6.5 mt -130.32 108.13 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.817 . . . . 0.0 109.597 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.495 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 51.7 m-85 -97.22 -170.66 2.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 110.653 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' B' ' 30' ' ' VAL . 23.2 p -128.34 98.86 5.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.429 -0.794 . . . . 0.0 110.162 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 pt -59.98 -16.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.688 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 1.1 ptpm? -148.67 156.92 41.66 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 110.175 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.94 142.86 93.5 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.633 1.333 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.462 ' CG2' ' CB ' ' B' ' 99' ' ' GLU . 54.6 mt -124.32 141.9 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 110.684 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.65 153.7 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.805 . . . . 0.0 110.886 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -48.2 -24.97 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 111.243 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.37 60.8 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.462 ' CB ' ' CG2' ' B' ' 95' ' ' ILE . 3.4 mm-40 -116.36 165.0 13.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.267 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -112.31 115.0 28.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.476 -0.765 . . . . 0.0 109.003 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.421 ' O ' HG12 ' B' ' 18' ' ' VAL . 58.4 mt -87.95 127.6 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.997 . . . . 0.0 111.261 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' B' ' 69' ' ' ASN . 15.8 p -155.68 148.46 24.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.432 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.3 pp -115.86 155.25 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 110.793 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.484 ' HA ' ' CD2' ' B' ' 70' ' ' HIS . 0.6 OUTLIER -90.66 -174.08 3.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.527 ' CD2' ' ND1' ' B' ' 70' ' ' HIS . 8.9 m-85 -123.37 -66.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.201 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 -175.28 44.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -33.25 68.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -1.124 . . . . 0.0 110.371 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -66.91 0.61 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 71.94 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.578 ' CE2' ' CE1' ' B' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 110.417 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 3.3 p . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.211 0.529 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.66 167.87 12.85 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 110.439 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 O-C-N 123.709 1.373 . . . . 0.0 110.46 179.708 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 12.9 p90 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.145 0.498 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 5' ' ' ARG . 2.4 m120 -153.93 -81.96 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 111.477 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 6' ' ' VAL . 31.9 t0 -41.3 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 3' ' ' ASN . 15.3 mtt180 42.49 20.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.485 -0.759 . . . . 0.0 112.785 177.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 5' ' ' ARG . 44.7 t -158.34 156.29 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.667 -1.271 . . . . 0.0 110.842 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 15.5 tt -143.65 142.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.607 . . . . 0.0 109.717 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.07 135.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.936 -177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.9 mttt -141.45 143.86 34.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.548 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.73 56.92 6.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 119.535 -1.978 . . . . 0.0 110.281 4.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.776 -0.577 . . . . 0.0 110.034 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.31 68.29 3.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -1.189 . . . . 0.0 110.496 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.37 -162.88 14.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.488 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 89.0 t -99.87 136.39 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.281 . . . . 0.0 110.205 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -101.06 128.09 47.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.117 -0.989 . . . . 0.0 109.603 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.28 97.89 11.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.566 -0.709 . . . . 0.0 111.077 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 5.0 ttt180 -75.24 -19.73 59.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.77 4.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.383 -0.823 . . . . 0.0 109.224 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . 2.516 59.4 m 102.2 24.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.119 -1.613 . . . . 0.0 109.922 1.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 26.1 m-85 -116.0 160.49 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 110.909 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.37 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.429 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 16.7 tttm -97.37 86.75 3.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 110.145 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.2 78.87 1.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' C ' ' CD2' ' A' ' 90' ' ' PHE . 1.2 mt-10 -155.14 138.14 15.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 110.453 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' N ' ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -54.48 153.7 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.978 . . . . 0.0 109.612 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.428 ' CG2' HG23 ' A' ' 91' ' ' THR . 95.3 t -137.98 -49.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.981 -1.074 . . . . 0.0 110.218 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG2' ' CD1' ' A' ' 64' ' ' PHE . 7.1 tp10 -161.36 115.94 2.03 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.408 -0.808 . . . . 0.0 109.916 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -124.35 144.8 49.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 110.149 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.425 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 74.8 m -139.68 -160.96 1.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.089 -1.007 . . . . 0.0 111.055 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.427 HD23 ' NE ' ' A' ' 86' ' ' ARG . 3.0 mm? -94.54 178.56 5.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.371 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -150.91 159.34 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 36' ' ' ILE . 48.3 mt -105.57 107.02 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 84' ' ' LEU . 87.6 t -88.82 122.33 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.384 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 17.3 tpt180 -139.63 148.73 42.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.34 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.12 -172.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.622 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -96.81 114.43 26.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.511 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.08 -139.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.76 -26.43 3.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.801 -1.187 . . . . 0.0 109.733 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.49 ' CD1' ' HB3' ' A' ' 38' ' ' ARG . 20.3 t-105 -70.63 -43.77 68.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.638 -0.664 . . . . 0.0 109.21 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.88 -28.3 60.45 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -90.61 -63.79 1.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -1.137 . . . . 0.0 110.693 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.89 -58.81 4.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.161 -0.962 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.0 mm? -91.8 41.0 1.05 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.331 -0.856 . . . . 0.0 109.644 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -8.49 31.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.985 . . . . 0.0 111.052 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.43 169.39 9.36 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.894 -1.129 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 52.03 25.95 3.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.428 -0.795 . . . . 0.0 110.57 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -115.93 126.56 54.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 0.0 111.077 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -88.85 104.05 16.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 36.1 t -89.02 120.58 30.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.09 -1.007 . . . . 0.0 111.228 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -179.5 4.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.702 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -83.35 80.78 8.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.974 -1.079 . . . . 0.0 109.269 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.21 -23.69 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.777 -0.577 . . . . 0.0 109.922 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.71 -178.47 0.89 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 110.835 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 16.7 m -123.36 139.08 54.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.974 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -132.82 153.22 51.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 111.073 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.462 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 38.6 tpp -89.64 155.18 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -88.76 93.62 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.627 -0.671 . . . . 0.0 110.639 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.431 HD22 ' CB ' ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -55.95 -34.19 65.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 179.847 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' A' ' 33' ' ' CYS . . . -86.94 -136.94 4.88 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 85.0 m-85 -90.49 19.46 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.349 -1.089 . . . . 0.0 110.617 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -61.85 -21.18 60.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.52 -59.18 2.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -1.215 . . . . 0.0 111.144 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.488 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.5 pp -53.79 -18.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.283 -0.886 . . . . 0.0 111.648 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CG ' HG12 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -49.07 146.47 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.852 -1.155 . . . . 0.0 110.735 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.3 171.5 8.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -93.16 148.49 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.58 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.33 131.43 5.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.42 -27.9 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.495 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -117.53 76.51 9.99 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.89 . . . . 0.0 110.386 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.416 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 18.6 Cg_endo -64.98 104.18 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.665 1.35 . . . . 0.0 110.468 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.44 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 5.5 m-20 -72.15 -10.76 60.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.657 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.22 160.6 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.953 -1.092 . . . . 0.0 110.855 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.03 155.36 43.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 78' ' ' HIS . 21.0 p-80 -90.02 136.13 33.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.613 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.41 13.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 110.164 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.9 mt -121.82 161.53 22.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.499 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.437 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 24.0 m -131.32 119.58 21.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.44 -0.787 . . . . 0.0 110.082 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.11 64.57 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.49 -119.51 6.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HB3' ' CB ' ' A' ' 59' ' ' ALA . 60.7 mt -118.54 26.51 9.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -1.136 . . . . 0.0 110.346 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.73 -56.69 4.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 110.431 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -119.09 150.38 40.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.75 147.77 41.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -0.999 . . . . 0.0 110.603 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 3.4 mtt180 -125.25 163.03 23.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 110.324 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 31' ' ' GLU . 26.7 mt -136.08 113.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.442 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.529 ' CE2' ' N ' ' A' ' 29' ' ' LEU . 6.3 m-85 -112.58 178.08 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.908 . . . . 0.0 110.792 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.428 HG23 ' CG2' ' A' ' 30' ' ' VAL . 15.2 p -121.64 99.07 6.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.376 -0.828 . . . . 0.0 110.496 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 93' ' ' LYS . 21.5 pt -52.8 -28.4 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.044 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -135.04 144.11 48.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 109.974 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 44.5 Cg_exo -49.21 145.67 14.51 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.619 1.326 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.418 HD13 ' CG2' ' A' ' 91' ' ' THR . 73.4 mt -122.51 148.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.937 . . . . 0.0 110.568 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.88 152.26 21.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 110.294 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 43.8 mt -53.95 -20.29 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.79 . . . . 0.0 111.148 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.58 59.3 0.38 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.13 179.1 6.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.145 -1.209 . . . . 0.0 110.718 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.22 128.43 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 110.013 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.409 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 61.3 mt -89.37 132.54 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 110.548 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.8 p -151.37 166.24 31.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.641 -0.662 . . . . 0.0 109.888 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.428 HG12 ' CG ' ' A' ' 68' ' ' PHE . 2.2 pp -137.86 156.45 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.117 -0.989 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 37.0 t -91.83 -163.5 1.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.358 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 104' ' ' SER . 15.3 m-85 -132.32 -55.96 0.97 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.298 -0.876 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.74 163.88 2.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.8 OUTLIER 54.62 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -1.017 . . . . 0.0 111.151 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 2.6 m-20 58.75 -73.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 107' ' ' ASP . 0.4 OUTLIER -42.09 107.82 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.449 -0.782 . . . . 0.0 111.944 -177.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.801 . . . . 0.0 111.488 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.276 0.56 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.56 144.3 49.18 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.312 -1.363 0 O-C-N 123.623 1.328 . . . . 0.0 110.856 -179.66 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' B' ' 7' ' ' ILE . 13.2 p90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.266 0.555 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 5' ' ' ARG . 2.4 m120 -155.8 -81.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' B' ' 6' ' ' VAL . 31.9 t0 -41.59 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' B' ' 3' ' ' ASN . 15.3 mtt180 42.57 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 112.841 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' B' ' 5' ' ' ARG . 44.6 t -158.31 156.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.591 -1.318 . . . . 0.0 110.831 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 15.4 tt -143.9 142.28 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.65 -0.656 . . . . 0.0 109.789 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 p -88.56 135.47 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 111.088 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.7 mttt -141.72 143.85 33.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.895 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.568 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.81 56.89 6.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.617 -1.927 . . . . 0.0 110.297 4.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.725 -0.609 . . . . 0.0 110.037 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.28 68.36 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.428 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.6 -162.81 14.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.487 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 85.8 t -99.84 136.23 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.263 . . . . 0.0 110.247 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.497 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -101.03 127.83 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.84 97.87 11.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 111.139 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.429 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 5.0 ttt180 -75.26 -19.62 59.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.412 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.464 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.82 4.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . 2.518 60.7 m 102.26 24.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.187 -1.571 . . . . 0.0 109.909 1.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 26.1 m-85 -115.9 160.54 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 110.92 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.492 -0.755 . . . . 0.0 109.965 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.426 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 16.6 tttm -97.36 86.7 3.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.145 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.18 78.92 1.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.415 ' C ' ' CD2' ' B' ' 90' ' ' PHE . 1.2 mt-10 -155.15 138.12 15.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -1.179 . . . . 0.0 110.471 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.53 ' N ' ' CE2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER -54.38 153.73 5.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.123 -0.986 . . . . 0.0 109.602 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' B' ' 91' ' ' THR . 95.5 t -138.05 -49.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.001 -1.062 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' B' ' 89' ' ' ILE . 7.1 tp10 -161.42 116.0 2.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -124.42 144.8 49.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.083 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.434 ' HB2' ' CA ' ' B' ' 63' ' ' GLY . 75.9 m -139.68 -160.91 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.019 . . . . 0.0 111.004 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.424 HD23 ' NE ' ' B' ' 86' ' ' ARG . 3.0 mm? -94.53 179.03 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 110.405 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -151.5 159.09 44.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.278 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' B' ' 60' ' ' MET . 48.9 mt -105.61 106.53 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 109.798 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.424 HG23 ' CB ' ' B' ' 84' ' ' LEU . 89.9 t -88.13 122.37 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.51 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.487 ' HB3' ' CD1' ' B' ' 43' ' ' TRP . 17.3 tpt180 -139.67 148.72 42.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.372 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.11 -172.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.6 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -96.79 114.46 26.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.12 -140.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 109.488 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.74 -26.49 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.871 -1.143 . . . . 0.0 109.732 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.487 ' CD1' ' HB3' ' B' ' 38' ' ' ARG . 20.3 t-105 -70.54 -43.8 68.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.9 -27.99 60.12 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 88.1 m -91.03 -63.63 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -1.151 . . . . 0.0 110.608 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.11 -58.11 5.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.147 -0.97 . . . . 0.0 110.042 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.482 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 4.0 mm? -92.79 41.29 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -8.48 32.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 111.024 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.38 169.32 9.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.952 -1.093 . . . . 0.0 110.163 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 52.17 25.76 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 110.63 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.404 HD11 ' O ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -115.9 126.1 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 111.187 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.35 103.59 15.97 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 38.1 t -88.24 120.67 29.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.985 . . . . 0.0 111.381 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 177.73 5.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.725 . . . . 0.0 109.709 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -79.43 80.43 5.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 110.126 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.09 -23.82 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.913 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.64 -178.43 0.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.896 . . . . 0.0 110.817 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 16.5 m -123.32 139.01 54.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -132.95 153.04 51.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.014 -1.054 . . . . 0.0 111.112 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.458 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 38.7 tpp -89.49 154.73 19.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.452 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -88.19 93.6 9.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.431 ' CB ' HD22 ' A' ' 62' ' ' LEU 2.499 0.1 OUTLIER -56.03 -34.11 65.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 179.781 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' B' ' 33' ' ' CYS . . . -86.9 -136.75 4.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.431 ' CD1' ' HG2' ' B' ' 31' ' ' GLU . 85.2 m-85 -90.8 19.55 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 110.534 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -61.87 -20.94 60.47 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.89 -59.1 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.237 . . . . 0.0 111.076 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.487 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.5 pp -53.81 -18.3 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.374 -0.829 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.439 ' CG ' HG12 ' B' ' 103' ' ' ILE . 0.2 OUTLIER -49.06 146.54 3.39 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.876 -1.14 . . . . 0.0 110.731 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.38 171.47 8.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -0.917 . . . . 0.0 110.515 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -93.19 148.52 21.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 110.561 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.34 131.36 5.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -27.89 17.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.56 76.51 10.07 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 110.428 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.423 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 18.7 Cg_endo -64.94 104.17 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.667 1.351 . . . . 0.0 110.496 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.432 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 5.6 m-20 -72.13 -10.78 60.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.283 -0.886 . . . . 0.0 110.704 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' B' ' 91' ' ' THR . . . -146.26 160.64 41.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.064 -1.022 . . . . 0.0 110.822 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.05 155.31 43.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 110.13 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' B' ' 78' ' ' HIS . 21.1 p-80 -89.96 136.14 33.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 110.622 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.413 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.42 13.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.351 -0.843 . . . . 0.0 110.147 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 17.7 mt -121.71 161.66 22.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 110.526 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 24.2 m -131.43 119.66 21.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 110.104 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.01 64.62 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.5 -119.57 6.19 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.434 ' HB3' ' CB ' ' B' ' 59' ' ' ALA . 60.9 mt -118.47 26.52 9.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -1.166 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.69 -56.65 4.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.453 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.441 ' CB ' ' HB ' ' B' ' 81' ' ' THR . 0.0 OUTLIER -119.23 150.49 39.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.244 -0.91 . . . . 0.0 110.2 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.82 147.78 41.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.549 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' B' ' 79' ' ' GLU . 3.4 mtt180 -125.29 163.01 23.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' B' ' 31' ' ' GLU . 26.7 mt -136.05 113.3 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.53 ' CE2' ' N ' ' B' ' 29' ' ' LEU . 6.4 m-85 -112.58 178.05 4.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 110.804 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.43 HG23 ' CG2' ' B' ' 30' ' ' VAL . 15.1 p -121.63 99.19 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -0.862 . . . . 0.0 110.474 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.443 HG13 ' N ' ' B' ' 93' ' ' LYS . 21.7 pt -52.86 -28.4 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.443 ' N ' HG13 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -135.05 144.13 48.94 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 0.0 109.951 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 46.9 Cg_exo -49.44 145.84 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.599 1.315 . . . . 0.0 110.688 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.418 HD13 ' CG2' ' B' ' 91' ' ' THR . 73.0 mt -122.53 148.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.71 152.2 21.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 43.7 mt -53.86 -20.4 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.436 -0.79 . . . . 0.0 111.116 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.63 59.37 0.37 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.2 178.93 6.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.073 -1.251 . . . . 0.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.28 128.29 48.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.417 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 61.3 mt -89.13 132.54 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.88 . . . . 0.0 110.623 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 13.5 p -151.32 166.27 31.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.843 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.439 HG12 ' CG ' ' B' ' 68' ' ' PHE . 2.2 pp -137.85 156.38 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 110.596 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 36.6 t -91.78 -163.51 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.416 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 15.3 m-85 -132.27 -56.14 0.97 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.91 163.84 2.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.8 OUTLIER 54.67 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -1.025 . . . . 0.0 111.126 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 107' ' ' ASP . 2.5 m-20 58.73 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' B' ' 107' ' ' ASP . 0.4 OUTLIER -42.05 107.73 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 112.016 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 111.48 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.236 0.541 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.5 144.32 49.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.282 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 O-C-N 123.667 1.351 . . . . 0.0 110.788 -179.587 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 47.3 p90 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.31 0.576 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 39.1 p-10 -131.97 164.7 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -50.23 -24.06 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.717 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.423 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 6.3 mmm-85 -78.33 -44.62 24.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 110.707 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 29.8 m -153.37 -172.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.481 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.454 ' CG2' ' CB ' ' A' ' 19' ' ' PHE . 3.0 tt -145.43 143.21 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.349 -0.844 . . . . 0.0 109.777 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.66 118.34 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.951 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.514 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 10.3 mttt -121.77 144.39 48.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.412 -0.805 . . . . 0.0 109.197 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.72 71.55 0.47 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.658 -1.901 . . . . 0.0 111.641 0.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.423 ' OG ' ' CZ ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 110.069 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -91.8 104.42 16.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -1.134 . . . . 0.0 110.295 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.88 -170.6 15.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG21 ' CE2' ' A' ' 64' ' ' PHE . 75.9 t -105.52 145.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.969 -1.312 . . . . 0.0 110.49 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 1.6 m-85 -109.99 120.44 42.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.395 -0.815 . . . . 0.0 109.405 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.54 90.13 8.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 111.123 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.23 -24.43 59.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 177.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.482 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 13.7 mtpt -94.9 178.99 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 51.8 m 104.11 23.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.007 -1.683 . . . . 0.0 109.67 2.007 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 12.2 m-85 -112.23 159.94 18.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 110.567 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -91.13 -157.63 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.888 . . . . 0.0 110.316 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 59.2 tttt -98.85 73.58 2.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 110.564 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.87 77.12 0.84 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -138.34 18.45 2.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -1.141 . . . . 0.0 110.565 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 16.3 tp 59.61 147.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.49 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.8 t -126.97 -39.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.973 -1.08 . . . . 0.0 110.243 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.95 161.67 8.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.37 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.6 143.93 22.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.506 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -149.25 -164.96 2.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 110.399 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 34' ' ' LEU . 11.0 mp -100.36 176.97 5.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.358 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 153.59 41.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.484 HG21 HD12 ' A' ' 36' ' ' ILE . 39.3 mt -94.75 97.29 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.958 . . . . 0.0 109.268 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 59.6 t -88.42 114.63 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.295 -0.878 . . . . 0.0 110.466 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -126.07 148.75 49.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 110.391 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.35 159.87 5.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.242 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -69.92 113.22 6.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.38 -142.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.854 . . . . 0.0 109.543 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.52 -25.26 3.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.869 -1.145 . . . . 0.0 109.986 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 43.8 t-105 -66.06 -54.55 24.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.788 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.8 -32.65 59.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -78.3 -63.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.1 -51.86 49.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.669 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.478 ' HG ' ' CZ3' ' A' ' 43' ' ' TRP . 4.1 mm? -91.14 30.07 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 110.729 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.43 -24.7 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.291 -0.881 . . . . 0.0 111.547 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 3.3 p30 -99.88 151.8 20.88 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.947 -1.095 . . . . 0.0 110.55 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD2' ' OD1' ' A' ' 49' ' ' ASP . 9.6 m-85 61.01 19.27 9.74 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.779 -0.576 . . . . 0.0 111.048 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 43' ' ' TRP . 6.7 mt -104.81 123.2 47.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.017 . . . . 0.0 110.789 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -89.12 105.9 18.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 108.455 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.2 p -87.87 118.91 27.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.169 -0.957 . . . . 0.0 111.071 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.434 ' HD3' ' CD1' ' A' ' 84' ' ' LEU . 5.4 ttp180 -98.76 -178.83 4.1 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.73 . . . . 0.0 110.038 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -83.87 81.54 8.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.054 . . . . 0.0 109.373 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.51 23.6 p30 149.06 -20.76 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.769 -0.582 . . . . 0.0 109.914 -178.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 1.5 ptm -177.01 -162.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.286 -0.883 . . . . 0.0 110.612 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 81.3 p -143.17 153.18 42.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.402 -0.811 . . . . 0.0 110.114 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.436 ' CB ' HD22 ' A' ' 84' ' ' LEU . . . -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.717 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.474 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 28.3 tpp -89.44 152.98 21.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.049 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.89 109.11 19.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.852 . . . . 0.0 110.294 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.497 0.2 OUTLIER -56.68 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.785 . . . . 0.0 110.985 -179.775 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.15 -168.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.503 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -73.14 56.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -1.169 . . . . 0.0 111.323 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -91.5 -23.45 28.73 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . . . -91.13 2.7 56.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 111.502 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.529 ' CD1' ' CD1' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -90.31 -8.6 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.794 -1.191 . . . . 0.0 110.733 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.529 ' CD1' ' CD1' ' A' ' 67' ' ' ILE . 18.3 m-85 -56.03 131.93 48.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 0.0 109.925 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -98.48 179.1 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.974 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.57 115.92 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.832 . . . . 0.0 110.405 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.11 141.54 46.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 110.535 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -61.64 120.85 11.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.942 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.26 84.34 0.21 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.13 107.28 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.691 1.364 . . . . 0.0 110.467 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.29 -18.51 27.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.603 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.4 119.44 21.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.972 . . . . 0.0 110.346 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.73 -170.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.427 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 26.5 p-80 -129.19 163.07 26.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.838 . . . . 0.0 110.314 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -139.63 159.29 42.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.529 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 82' ' ' ALA . 8.7 mt -118.38 150.16 39.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.181 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.421 HG23 ' CB ' ' A' ' 86' ' ' ARG . 6.6 p -68.93 67.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 80' ' ' LEU . . . 51.24 39.83 24.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.56 -136.46 4.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.436 HD22 ' CB ' ' A' ' 59' ' ' ALA . 5.5 tp -132.08 86.67 2.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -1.107 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -49.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.514 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.421 ' CB ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER -124.76 123.62 40.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.1 mtp -95.24 154.7 17.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -138.75 164.23 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.043 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.31 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' A' ' 29' ' ' LEU . 18.3 m-85 -91.79 157.95 16.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 110.602 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.423 HG21 ' CD1' ' A' ' 95' ' ' ILE . 7.7 p -101.94 83.11 2.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 93' ' ' LYS . 6.1 pt -52.88 -23.48 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 110.555 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.44 ' N ' HG13 ' A' ' 92' ' ' ILE . 17.9 mmtt -137.48 134.57 18.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 89.6 Cg_exo -46.35 140.61 11.23 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.437 1.23 . . . . 0.0 111.119 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.423 ' CD1' HG21 ' A' ' 91' ' ' THR . 58.9 mt -117.95 141.81 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.61 166.49 13.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 110.449 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 3.0 mt -71.58 127.11 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.58 18.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -100.21 -175.77 3.03 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.139 -1.212 . . . . 0.0 110.022 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -126.16 124.47 40.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.106 -0.996 . . . . 0.0 110.307 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 102' ' ' THR . 62.8 mt -89.86 130.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.193 -0.942 . . . . 0.0 110.548 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 72.8 p -154.67 -166.85 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.435 HG12 ' CB ' ' A' ' 68' ' ' PHE . 1.2 pp -148.68 -167.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 110.444 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.409 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.4 t -102.71 -148.26 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 110.154 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.85 -86.55 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.418 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.07 1.69 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.49 -1.07 18.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 110.996 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.97 -40.39 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.967 -1.083 . . . . 0.0 110.565 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.84 105.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.952 . . . . 0.0 110.599 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 15.6 m95 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 111.083 179.333 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.724 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.98 172.72 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 110.448 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.427 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 19.2 Cg_exo . . . . . 0 C--N 1.313 -1.325 0 O-C-N 123.613 1.323 . . . . 0.0 110.443 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 47.3 p90 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.351 0.596 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 38.9 p-10 -131.98 164.81 25.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 110.226 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -50.3 -24.09 2.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 110.664 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.416 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 6.3 mmm-85 -78.27 -44.68 24.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.651 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 30.2 m -153.35 -172.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.458 ' CG2' ' CB ' ' B' ' 19' ' ' PHE . 3.0 tt -145.43 143.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.48 118.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.036 -1.04 . . . . 0.0 110.99 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 10.2 mttt -121.9 144.37 48.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.472 -0.767 . . . . 0.0 109.221 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.528 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.74 71.62 0.47 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.711 -1.868 . . . . 0.0 111.569 0.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.422 ' OG ' ' CZ ' ' B' ' 19' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 104.57 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -1.158 . . . . 0.0 110.364 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.1 -170.64 15.56 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' B' ' 64' ' ' PHE . 77.2 t -105.53 145.06 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.946 -1.326 . . . . 0.0 110.449 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.483 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 1.6 m-85 -110.0 120.35 42.18 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.466 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.41 90.14 8.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 111.18 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.415 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.31 -24.34 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 177.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.478 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 13.7 mtpt -94.92 179.04 5.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.524 -0.735 . . . . 0.0 109.031 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.444 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 51.9 m 104.09 23.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.095 -1.628 . . . . 0.0 109.677 2.012 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.478 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 12.3 m-85 -112.21 159.96 18.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.619 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -91.16 -157.62 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.261 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.434 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 59.1 tttt -98.83 73.55 2.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.548 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 77.02 0.83 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -138.3 18.4 2.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 110.586 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 16.2 tp 59.75 147.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.418 -0.802 . . . . 0.0 110.503 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 83.8 t -127.02 -39.82 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.042 . . . . 0.0 110.279 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.97 161.71 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.336 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.66 143.86 22.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.453 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -149.17 -164.95 2.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.398 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 11.0 mp -100.34 176.95 5.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.94 153.57 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.474 HG21 HD12 ' B' ' 36' ' ' ILE . 39.4 mt -94.78 96.4 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.393 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' B' ' 59' ' ' ALA . 54.8 t -87.21 114.7 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 110.651 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.492 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -126.21 148.71 49.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.31 159.88 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -69.87 113.15 6.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.451 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.35 -142.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.523 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.48 -25.33 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.812 -1.18 . . . . 0.0 110.004 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.492 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 43.7 t-105 -66.02 -54.55 24.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.593 -0.692 . . . . 0.0 109.781 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.85 -32.52 59.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -78.39 -63.23 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.153 . . . . 0.0 110.533 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.21 -51.4 54.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 110.69 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.1 mm? -91.83 30.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.484 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.52 -24.74 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.245 -0.91 . . . . 0.0 111.505 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.469 ' OD1' ' CD2' ' B' ' 50' ' ' TYR . 3.2 p30 -99.72 151.79 20.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.469 ' CD2' ' OD1' ' B' ' 49' ' ' ASP . 9.4 m-85 60.96 19.2 9.61 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.654 -0.654 . . . . 0.0 111.057 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' B' ' 43' ' ' TRP . 6.6 mt -104.89 123.02 46.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 0.0 110.893 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -88.77 104.98 17.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.706 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 57.0 p -86.55 119.04 26.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 111.322 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.425 ' HD3' ' CD1' ' B' ' 84' ' ' LEU . 5.4 ttp180 -99.49 178.67 4.8 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.473 -0.767 . . . . 0.0 110.066 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -80.2 81.17 6.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.957 . . . . 0.0 110.187 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 23.5 p30 148.96 -20.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.677 -0.64 . . . . 0.0 109.942 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.4 ptm -176.83 -161.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.934 . . . . 0.0 110.745 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.451 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 81.4 p -143.2 153.2 42.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 110.044 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' B' ' 37' ' ' VAL . . . -139.58 145.69 38.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 110.703 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.472 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 28.5 tpp -89.34 152.15 21.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.83 109.02 19.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.451 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.5 0.2 OUTLIER -56.68 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -0.794 . . . . 0.0 110.919 -179.908 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.36 -168.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.492 ' CG ' ' O ' ' B' ' 64' ' ' PHE . 0.1 OUTLIER -73.19 57.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.18 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.486 ' HA2' ' CZ ' ' B' ' 68' ' ' PHE . . . -92.52 -22.48 28.89 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' B' ' 50' ' ' TYR . . . -92.03 3.09 56.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 111.378 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.533 ' CD1' ' CD1' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -90.53 -8.55 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.811 -1.18 . . . . 0.0 110.724 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' CD1' ' B' ' 67' ' ' ILE . 18.3 m-85 -56.05 131.98 48.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 0.0 109.907 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -98.57 179.12 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.967 . . . . 0.0 110.968 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.56 115.95 21.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.84 . . . . 0.0 110.404 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.13 141.6 46.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -61.68 120.86 11.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.31 84.27 0.21 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.04 107.33 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.734 1.386 . . . . 0.0 110.484 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.32 -18.49 27.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 110.632 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.4 119.36 21.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 0.0 110.382 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.7 -170.46 1.8 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 110.454 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.426 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 26.5 p-80 -129.2 162.99 26.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -139.64 159.32 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 110.514 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 mt -118.36 150.15 40.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 6.4 p -69.01 67.26 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 110.562 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.3 39.78 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.765 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.63 -136.51 4.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.43 HD22 ' CB ' ' B' ' 59' ' ' ALA . 5.5 tp -132.05 86.73 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -1.083 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.4 -49.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.0 OUTLIER -124.74 123.7 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 110.171 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 22.1 mtp -95.29 154.57 17.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 110.656 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -138.64 164.3 29.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.24 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.978 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -91.79 157.96 16.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.418 HG21 ' CD1' ' B' ' 95' ' ' ILE . 7.8 p -101.89 83.08 2.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.183 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.421 HG13 ' N ' ' B' ' 93' ' ' LYS . 6.1 pt -52.93 -23.46 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.895 . . . . 0.0 110.548 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.421 ' N ' HG13 ' B' ' 92' ' ' ILE . 17.9 mmtt -137.45 134.37 18.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 85.4 Cg_exo -46.6 140.88 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.424 1.223 . . . . 0.0 111.08 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.418 ' CD1' HG21 ' B' ' 91' ' ' THR . 59.0 mt -117.99 141.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.616 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.21 166.61 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.51 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 3.0 mt -71.71 127.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.4 23.57 18.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -100.01 -176.04 3.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.258 -1.142 . . . . 0.0 110.076 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -126.08 124.46 40.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.998 . . . . 0.0 110.282 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' B' ' 102' ' ' THR . 62.7 mt -89.84 130.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 72.2 p -154.55 -166.77 2.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.0 109.664 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.429 HG12 ' CB ' ' B' ' 68' ' ' PHE . 1.2 pp -148.73 -167.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.459 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' B' ' 103' ' ' ILE . 3.4 t -102.64 -148.3 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 110.159 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.82 -86.57 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.98 -132.04 1.68 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.54 -1.03 18.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 0.0 110.977 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.89 -40.46 0.61 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.929 -1.107 . . . . 0.0 110.614 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 105.14 1.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.608 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 15.7 m95 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.517 -0.739 . . . . 0.0 111.06 179.313 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.175 0.512 . . . . 0.0 110.7 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.9 172.78 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.478 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . 0.426 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 19.0 Cg_exo . . . . . 0 C--N 1.312 -1.374 0 O-C-N 123.651 1.342 . . . . 0.0 110.439 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 15.2 p90 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.378 0.608 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.88 151.25 36.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.47 -28.04 3.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.3 -0.875 . . . . 0.0 110.825 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.415 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.12 25.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 110.352 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 36.0 m -153.71 156.24 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.272 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.466 ' CG2' ' CB ' ' A' ' 19' ' ' PHE . 17.2 tt -128.74 155.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -97.89 133.42 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.862 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 7.6 mttt -130.86 142.73 50.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.35 -0.844 . . . . 0.0 109.313 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 20.0 mttt 52.74 62.23 2.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 119.631 -1.918 . . . . 0.0 111.219 0.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.459 -0.776 . . . . 0.0 110.296 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -74.47 81.81 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -1.201 . . . . 0.0 110.353 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.467 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -121.13 -169.07 13.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 72.4 t -110.86 146.6 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.892 -1.358 . . . . 0.0 110.396 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CB ' ' CG2' ' A' ' 7' ' ' ILE . 1.2 m-85 -111.33 122.41 47.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 109.998 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.34 92.01 7.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 110.839 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.415 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.0 -21.63 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 178.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 22.7 mtpt -90.68 -179.3 5.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.88 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.416 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 108.29 15.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.167 -1.583 . . . . 0.0 110.378 0.922 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 40.1 m-85 -109.18 148.59 30.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.083 -1.011 . . . . 0.0 110.716 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.29 -161.33 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 69.99 3.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -137.69 122.23 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -1.171 . . . . 0.0 110.24 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.487 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.3 tm? -65.8 115.69 6.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.893 . . . . 0.0 110.417 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 85.3 t -94.39 74.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 110.057 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 30' ' ' VAL . 3.5 tt0 59.06 154.1 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.5 0.667 . . . . 0.0 110.821 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 88' ' ' ARG . 9.4 pt-20 -157.28 161.24 39.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.26 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.53 -170.7 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.622 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.43 HD23 ' CG ' ' A' ' 86' ' ' ARG . 58.4 mt -90.47 -170.24 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.436 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 14.0 m -147.18 160.77 42.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 110.024 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 36' ' ' ILE . 27.2 mt -96.07 102.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 109.345 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.6 129.24 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 110.663 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 6.0 mmt180 -145.81 151.69 38.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.437 -0.789 . . . . 0.0 110.127 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.3 -179.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.972 . . . . 0.0 110.369 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.37 112.37 23.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.53 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.25 -142.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -50.81 -25.25 4.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.719 -1.238 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.479 ' CD1' ' HB2' ' A' ' 38' ' ' ARG . 45.6 t-105 -56.12 -64.44 0.86 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.25 -28.39 58.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.7 m -70.54 -67.75 0.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -1.179 . . . . 0.0 110.523 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.03 84.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.558 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.473 ' CD1' ' CE ' ' A' ' 60' ' ' MET . 4.3 mm? -90.34 41.02 1.03 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.623 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.34 3.97 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.106 -0.996 . . . . 0.0 110.519 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.12 -81.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.484 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 66' ' ' ALA . 12.5 m-85 -96.96 52.38 1.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.368 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tp -111.89 131.45 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 111.167 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -92.35 -178.29 4.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -144.22 123.21 12.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 111.042 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -110.82 173.52 6.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.608 -0.682 . . . . 0.0 109.372 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 54' ' ' ARG . 13.1 mttm -82.68 70.8 9.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.0 109.237 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.2 t30 166.5 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.96 -167.87 0.25 Allowed 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 37.6 p -120.71 166.88 13.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.443 -0.786 . . . . 0.0 109.434 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.06 151.69 33.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.922 -1.111 . . . . 0.0 111.062 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.473 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 18.2 tpp -89.55 154.32 20.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -87.57 91.64 8.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD2' ' CD2' ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -55.54 -45.27 77.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.51 179.591 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.73 -141.22 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.439 ' HB3' ' CD1' ' A' ' 67' ' ' ILE . 29.3 m-85 -90.6 11.09 23.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -1.185 . . . . 0.0 110.903 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -47.37 -30.79 6.15 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.459 ' HA ' ' CG ' ' A' ' 50' ' ' TYR . . . -66.51 -75.28 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.199 -1.177 . . . . 0.0 109.793 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.489 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.4 pp -56.74 -18.8 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 111.364 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CD2' HG22 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -51.81 132.42 31.53 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.04 -1.038 . . . . 0.0 109.936 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.467 ' ND2' ' CA ' ' A' ' 17' ' ' GLY . 13.4 m-20 -109.05 177.26 4.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.957 -1.089 . . . . 0.0 111.451 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.522 ' CD2' ' N ' ' A' ' 71' ' ' SER . 13.3 t60 -103.0 157.56 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.522 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 29.3 t -149.96 140.93 22.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 110.603 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -29.78 50.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.87 96.07 39.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.0 119.71 6.75 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.648 1.341 . . . . 0.0 110.649 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.424 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 19.7 p30 -110.58 -21.77 11.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.35 149.93 34.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.292 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.401 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 3.4 mtt180 -128.19 -173.39 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 110.186 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -128.81 175.95 8.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.649 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -137.66 153.26 49.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.42 ' CD2' ' HG2' ' A' ' 87' ' ' MET . 80.1 mt -123.83 135.5 53.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -79.92 -168.76 1.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 88.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 110.467 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 87.12 58.38 1.89 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.423 HD13 ' CB ' ' A' ' 54' ' ' ARG . 8.0 mt 55.72 -111.6 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.375 -1.074 . . . . 0.0 110.084 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER 58.55 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.625 -1.297 . . . . 0.0 111.078 179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' CG ' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -97.38 139.82 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 110.536 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.533 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 11.0 mtp -129.64 144.47 51.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . 5.5 mtp180 -124.87 162.93 23.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.21 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 89' ' ' ILE . 81.2 mt -123.0 99.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.848 . . . . 0.0 109.661 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 2.0 m-85 -96.36 -174.2 2.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.718 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 p -127.48 98.89 5.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.401 ' CG2' ' HB2' ' A' ' 77' ' ' ARG . 45.4 pt -55.64 -25.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.617 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.424 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -144.53 146.77 33.72 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.172 -0.955 . . . . 0.0 110.438 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.12 125.89 20.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.685 1.361 . . . . 0.0 110.492 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.9 144.58 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.59 156.88 18.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 110.457 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 73.3 mt -66.8 113.68 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.38 30.71 2.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.92 -170.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.296 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 43.1 tt0 -128.39 133.7 48.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 26.4 mt -89.32 131.32 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.2 -0.937 . . . . 0.0 109.932 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.431 ' CB ' ' O ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -158.9 164.56 35.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.119 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.479 HG22 ' CD2' ' A' ' 68' ' ' PHE . 8.2 pt -132.94 162.41 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.618 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.437 ' HA ' ' ND1' ' A' ' 70' ' ' HIS . 1.4 m -91.71 174.83 7.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.205 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 70' ' ' HIS . 15.8 m-85 -126.86 -70.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 67.35 -163.67 45.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.66 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -1.045 . . . . 0.0 110.622 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -100.04 -42.47 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 0.0 110.341 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.432 ' HB2' ' CB ' ' A' ' 105' ' ' TYR . 19.1 m-85 -61.88 141.91 57.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.4 -0.812 . . . . 0.0 110.558 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.245 0.545 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -136.22 152.11 74.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo . . . . . 0 C--N 1.312 -1.345 0 O-C-N 123.699 1.368 . . . . 0.0 110.517 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 15.4 p90 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.322 0.582 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.89 151.23 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -0.818 . . . . 0.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.43 -28.05 3.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.794 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.42 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.2 25.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 35.9 m -153.62 156.26 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.458 ' CG2' ' CB ' ' B' ' 19' ' ' PHE . 17.2 tt -128.74 155.59 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.395 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -97.85 133.47 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.85 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 7.6 mttt -130.93 142.68 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.846 . . . . 0.0 109.315 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 20.0 mttt 52.67 62.33 2.74 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 119.675 -1.89 . . . . 0.0 111.199 0.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 2.6 p . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 110.31 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -74.52 81.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.325 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.466 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -121.14 -169.02 13.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 69.0 t -110.92 146.17 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.929 -1.336 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.458 ' CB ' ' CG2' ' B' ' 7' ' ' ILE . 1.2 m-85 -111.27 122.4 47.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.38 92.08 7.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 110.825 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.98 -21.7 61.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.836 178.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.474 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 22.9 mtpt -90.63 -179.18 5.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.419 -0.801 . . . . 0.0 109.889 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.416 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 0.0 OUTLIER 108.32 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.206 -1.559 . . . . 0.0 110.43 0.896 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 40.0 m-85 -109.17 148.58 30.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.01 . . . . 0.0 110.688 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.33 -161.3 0.8 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 70.0 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 110.312 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -137.66 122.29 18.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -1.128 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.489 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.3 tm? -65.85 115.62 6.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 110.445 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' B' ' 31' ' ' GLU . 85.9 t -94.3 74.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -0.853 . . . . 0.0 110.012 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' B' ' 30' ' ' VAL . 3.5 tt0 59.08 154.11 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.648 -0.657 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' B' ' 88' ' ' ARG . 9.4 pt-20 -157.18 161.5 39.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 110.269 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.85 -170.78 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.432 HD23 ' CG ' ' B' ' 86' ' ' ARG . 58.8 mt -90.46 -170.24 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.528 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 14.4 m -147.17 160.71 42.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' B' ' 60' ' ' MET . 27.0 mt -96.07 102.32 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.089 -1.007 . . . . 0.0 109.411 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.67 129.33 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 5.9 mmt180 -145.99 151.71 38.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.26 -179.11 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.39 112.37 23.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.28 -142.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.831 . . . . 0.0 109.568 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -50.82 -25.31 4.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.766 -1.208 . . . . 0.0 109.855 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.486 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 45.6 t-105 -56.05 -64.47 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.918 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.23 -28.37 58.74 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 75.8 m -70.5 -67.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.572 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.85 84.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 110.658 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.478 ' CD1' ' CE ' ' B' ' 60' ' ' MET . 4.3 mm? -90.55 41.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.604 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.24 3.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 110.512 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.14 -81.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' B' ' 66' ' ' ALA . 12.5 m-85 -96.9 52.41 1.17 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 0.0 109.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tp -111.89 131.54 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 111.108 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -92.34 -178.24 4.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.388 -0.82 . . . . 0.0 109.683 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 25.0 p -144.16 123.26 12.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.044 -1.035 . . . . 0.0 111.04 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.451 ' CD ' ' N ' ' B' ' 55' ' ' LYS . 0.4 OUTLIER -111.5 170.6 8.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 178.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' B' ' 54' ' ' ARG . 14.1 mttm -78.54 70.13 4.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.089 . . . . 0.0 110.178 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 1.2 t30 166.58 -28.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.76 -167.83 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.454 -0.779 . . . . 0.0 110.954 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.432 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 37.5 p -120.69 166.84 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.449 -0.782 . . . . 0.0 109.419 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.04 151.54 33.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.93 -1.106 . . . . 0.0 111.058 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.478 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 18.2 tpp -89.43 153.39 20.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.429 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -86.28 91.58 8.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.836 . . . . 0.0 110.88 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.474 ' CD2' ' CD2' ' A' ' 62' ' ' LEU 2.498 0.2 OUTLIER -55.62 -45.24 77.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 110.518 179.432 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.74 -140.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.432 ' HB3' ' CD1' ' B' ' 67' ' ' ILE . 29.0 m-85 -91.02 11.21 23.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -1.143 . . . . 0.0 110.823 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -47.39 -30.8 6.2 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' B' ' 50' ' ' TYR . . . -66.54 -75.46 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.179 -1.189 . . . . 0.0 109.84 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.489 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.4 pp -56.48 -18.99 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.476 ' CE2' HG22 ' B' ' 103' ' ' ILE . 0.2 OUTLIER -51.65 132.36 30.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.907 -1.12 . . . . 0.0 109.85 178.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.466 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 13.3 m-20 -108.9 177.92 4.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.018 -1.051 . . . . 0.0 111.351 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' B' ' 71' ' ' SER . 13.2 t60 -104.04 157.33 17.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' SER . . . . . 0.52 ' N ' ' CD2' ' B' ' 70' ' ' HIS . 29.5 t -149.79 140.85 22.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.632 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.81 49.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.8 96.02 39.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.395 -0.816 . . . . 0.0 109.961 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.97 119.75 6.79 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.655 1.345 . . . . 0.0 110.682 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.427 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 19.7 p30 -110.56 -21.84 11.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.36 149.9 34.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.332 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.406 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 3.4 mtt180 -128.11 -173.34 2.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.179 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.4 ' CD2' ' C ' ' B' ' 78' ' ' HIS . 2.7 p-80 -128.88 175.98 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 110.671 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -137.66 153.21 49.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 110.431 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.42 ' CD2' ' HG2' ' B' ' 87' ' ' MET . 80.3 mt -123.8 135.52 53.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 110.215 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 83' ' ' GLY . 0.0 OUTLIER -79.99 -168.69 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -0.905 . . . . 0.0 110.113 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 110.495 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.424 ' HA3' ' NZ ' ' B' ' 85' ' ' LYS . . . 87.16 58.32 1.89 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.426 HD13 ' CB ' ' B' ' 54' ' ' ARG . 8.0 mt 55.76 -111.68 0.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.408 -1.054 . . . . 0.0 110.078 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.424 ' NZ ' ' HA3' ' B' ' 83' ' ' GLY . 0.2 OUTLIER 58.44 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.586 -1.321 . . . . 0.0 111.076 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.432 ' CG ' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -97.28 139.79 32.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.489 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.528 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 11.1 mtp -129.59 144.48 51.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 110.438 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.434 ' HA ' ' CB ' ' B' ' 32' ' ' GLU . 5.5 mtp180 -124.86 162.92 23.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.423 HG21 HD12 ' B' ' 89' ' ' ILE . 81.1 mt -123.01 99.75 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.825 . . . . 0.0 109.617 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.489 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 2.0 m-85 -96.31 -174.17 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.737 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -127.52 98.83 5.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' B' ' 77' ' ' ARG . 45.4 pt -55.62 -25.07 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.632 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.427 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.1 OUTLIER -144.48 146.79 33.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 110.497 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.2 125.9 20.6 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.709 1.373 . . . . 0.0 110.439 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.96 144.42 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 110.333 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.42 156.93 18.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.465 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 73.3 mt -66.84 113.63 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.47 30.75 2.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.99 -170.31 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 110.281 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 43.3 tt0 -128.43 133.5 48.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.289 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 27.1 mt -88.96 131.35 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 110.104 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.432 HG23 ' CB ' ' B' ' 69' ' ' ASN . 1.0 OUTLIER -158.87 164.68 35.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.785 -0.572 . . . . 0.0 109.727 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.476 HG22 ' CE2' ' B' ' 68' ' ' PHE . 8.2 pt -132.95 162.35 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.436 ' HA ' ' ND1' ' B' ' 70' ' ' HIS . 1.4 m -91.73 174.8 7.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' B' ' 70' ' ' HIS . 15.8 m-85 -126.76 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 110.501 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 67.42 -163.59 45.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.63 -86.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.439 -1.036 . . . . 0.0 110.635 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -100.14 -42.62 6.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.275 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.435 ' HB2' ' CB ' ' B' ' 105' ' ' TYR . 19.2 m-85 -61.7 141.98 57.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.339 -0.85 . . . . 0.0 110.558 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.2 0.524 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -136.24 152.15 74.68 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.395 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 C--N 1.313 -1.342 0 O-C-N 123.662 1.348 . . . . 0.0 110.545 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.478 ' CD1' HD13 ' A' ' 7' ' ' ILE . 14.6 t80 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.41 0.624 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' ARG . 11.8 m120 -90.17 55.36 3.06 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.405 -0.809 . . . . 0.0 110.046 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t70 52.97 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 111.371 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 3' ' ' ASN . 0.2 OUTLIER -50.55 -33.82 23.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 111.01 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 5' ' ' ARG . 89.2 t -152.37 138.5 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.067 -1.021 . . . . 0.0 111.245 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.478 HD13 ' CD1' ' A' ' 2' ' ' PHE . 12.7 tt -114.61 162.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 110.062 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.1 t -106.85 120.06 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 16.7 mttt -116.69 144.03 44.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 25.0 mttt 52.38 63.04 2.4 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.725 -1.86 . . . . 0.0 111.355 0.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.827 . . . . 0.0 110.344 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 71.6 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.349 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -108.69 -172.32 21.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 94.1 t -113.55 158.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.299 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CG ' ' HE3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -121.0 127.91 52.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.157 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.84 95.2 10.13 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.571 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -64.14 -24.95 67.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.838 . . . . 0.0 109.665 178.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -86.02 179.27 7.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.443 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.511 0.0 OUTLIER 103.37 11.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.141 -1.599 . . . . 0.0 110.603 1.118 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.6 m-85 -107.67 150.96 26.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.702 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.26 -152.63 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 110.131 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 13.7 tttm -100.58 69.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 110.43 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.03 75.2 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.73 7.55 3.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -1.146 . . . . 0.0 110.984 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HG ' ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER 61.45 131.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -103.38 -74.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.117 -0.99 . . . . 0.0 110.697 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.46 160.82 37.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.704 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.63 142.17 37.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.221 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.424 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.4 p -150.15 -174.99 4.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 2.8 mm? -97.66 174.43 6.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.85 168.59 22.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 62' ' ' LEU . 79.3 mt -100.37 150.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.883 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 84' ' ' LEU . 49.7 t -125.58 82.07 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.41 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -109.07 146.45 33.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.606 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 41.0 m170 -61.73 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.007 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -89.58 -137.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 5.0 m-20 60.54 -134.4 0.72 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.956 -1.09 . . . . 0.0 110.222 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -45.94 -26.15 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.907 -1.121 . . . . 0.0 111.155 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.533 ' CZ3' HD12 ' A' ' 47' ' ' LEU . 65.4 t-105 -67.54 -58.6 4.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -25.55 42.21 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.7 m -81.14 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 110.537 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.8 -58.02 8.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 110.086 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 ' CZ3' ' A' ' 43' ' ' TRP . 4.8 mp -90.82 51.83 2.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.285 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.04 56.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.894 -1.129 . . . . 0.0 111.583 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER 174.21 154.06 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.805 -1.184 . . . . 0.0 110.335 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.401 ' CD1' ' HB2' ' A' ' 66' ' ' ALA . 5.9 m-85 60.48 22.7 12.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.844 . . . . 0.0 111.012 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.483 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 22.6 mt -105.48 113.38 26.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.087 . . . . 0.0 111.156 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -88.86 102.31 14.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.5 p -99.65 157.03 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.087 -1.008 . . . . 0.0 111.694 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' CZ ' ' O ' ' A' ' 83' ' ' GLY . 26.1 mtm180 -117.68 -171.98 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.633 -0.667 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.68 80.54 9.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 109.06 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 156.02 -21.2 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.731 -0.605 . . . . 0.0 110.124 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -169.32 0.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.035 -1.04 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.444 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 15.5 m -128.69 150.12 50.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -135.01 176.37 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 110.403 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.401 ' CB ' ' HB ' ' A' ' 36' ' ' ILE . 2.9 ttt -121.56 156.58 32.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.487 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -88.8 92.12 9.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' CD2' HG13 ' A' ' 36' ' ' ILE 2.51 0.0 OUTLIER -53.24 -70.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.887 -178.37 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.68 -138.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 87.7 m-85 -86.21 48.0 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 110.635 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -86.27 -22.08 49.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . . . -87.44 -51.36 5.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 110.511 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.7 pp -44.29 -24.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 111.827 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 89' ' ' ILE . 16.4 m-85 -55.88 142.8 33.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.774 -1.204 . . . . 0.0 110.314 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' CA ' ' A' ' 17' ' ' GLY . 55.0 m-20 -119.39 -178.9 3.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 111.339 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -102.74 152.82 20.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.549 -0.72 . . . . 0.0 109.634 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.57 22.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.098 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.49 23.67 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.03 -1.044 . . . . 0.0 110.298 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -174.44 66.18 0.28 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.808 . . . . 0.0 109.797 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 22.1 Cg_endo -65.56 93.42 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.775 1.408 . . . . 0.0 110.93 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.96 66.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.847 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' THR . . . -128.07 127.76 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 110.166 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 -171.92 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 110.419 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.46 158.05 23.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 14.0 tp10 -138.21 126.32 22.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 110.067 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD13 ' HD3' ' A' ' 54' ' ' ARG . 28.1 mt -105.22 131.26 52.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.978 . . . . 0.0 110.55 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.56 -166.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 110.419 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CZ ' ' A' ' 54' ' ' ARG . . . 138.72 -116.52 1.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' O ' ' CG2' ' A' ' 37' ' ' VAL . 25.5 tp -168.92 45.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.17 -16.94 9.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 110.694 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -131.2 147.76 52.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.593 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.29 158.57 26.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.669 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.443 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 6.5 mtt180 -147.5 115.57 6.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.822 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.484 HG12 ' CE2' ' A' ' 68' ' ' PHE . 2.7 mp -88.95 117.13 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.854 -1.154 . . . . 0.0 110.402 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.499 ' CE2' ' HG ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -106.72 163.51 12.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.412 HG22 ' CD1' ' A' ' 95' ' ' ILE . 10.6 p -107.3 87.93 2.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 93' ' ' LYS . 9.5 pt -54.34 -22.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 110.319 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.5 mttt -133.58 142.35 43.6 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 110.204 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.401 ' HG3' ' HB2' ' A' ' 26' ' ' LYS . 33.8 Cg_exo -55.65 128.99 32.66 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.599 1.315 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.412 ' CD1' HG22 ' A' ' 91' ' ' THR . 77.3 mt -107.58 138.51 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 110.342 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.73 164.8 14.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 4.4 mt -70.95 112.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.71 0.89 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.37 -176.59 3.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -1.183 . . . . 0.0 110.37 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -123.33 126.21 46.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 110.032 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 102' ' ' THR . 56.6 mt -88.81 126.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.167 -0.958 . . . . 0.0 109.844 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 22.0 p -155.4 143.11 19.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.566 . . . . 0.0 109.929 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.1 pp -123.92 147.69 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.513 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.6 t -85.13 -166.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.534 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -124.44 -65.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 0.0 110.07 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.17 15.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.17 -30.5 2.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.436 -1.038 . . . . 0.0 111.454 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -42.79 82.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -109.65 115.54 30.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.091 -1.005 . . . . 0.0 110.454 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.437 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 28.5 t-105 . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.789 -0.569 . . . . 0.0 111.067 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 28.7 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.273 0.558 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.09 147.6 2.29 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo . . . . . 0 C--N 1.312 -1.369 0 O-C-N 123.745 1.392 . . . . 0.0 110.503 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' B' ' 7' ' ' ILE . 14.6 t80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.389 0.614 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 5' ' ' ARG . 11.8 m120 -90.23 55.24 3.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.028 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.1 t70 52.96 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.706 -0.621 . . . . 0.0 111.355 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' B' ' 3' ' ' ASN . 0.2 OUTLIER -50.55 -33.92 23.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 111.027 -178.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' B' ' 5' ' ' ARG . 89.4 t -152.31 138.53 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.036 -1.04 . . . . 0.0 111.211 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' B' ' 2' ' ' PHE . 12.7 tt -114.64 162.33 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -106.86 120.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.431 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.517 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 16.7 mttt -116.74 144.0 44.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.875 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 25.2 mttt 52.43 62.94 2.44 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.752 -1.842 . . . . 0.0 111.403 0.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.402 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.413 -0.804 . . . . 0.0 110.32 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 71.7 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -1.135 . . . . 0.0 110.385 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.416 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -108.94 -172.19 21.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 95.1 t -113.57 158.47 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.016 -1.285 . . . . 0.0 110.718 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.473 ' CG ' ' HE3' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -120.99 127.88 52.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 110.164 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.78 95.17 10.12 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.362 -0.836 . . . . 0.0 110.542 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -64.15 -24.88 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.684 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -86.07 179.21 7.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.552 -0.718 . . . . 0.0 109.373 179.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.454 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.511 0.0 OUTLIER 103.3 11.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.111 -1.618 . . . . 0.0 110.541 1.19 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.7 m-85 -107.63 150.99 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.048 -1.032 . . . . 0.0 110.777 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.29 -152.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -100.57 69.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.06 75.29 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.71 7.49 3.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 110.976 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER 61.5 131.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.178 -0.951 . . . . 0.0 110.129 -179.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 98.1 t -103.22 -74.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.991 -1.068 . . . . 0.0 110.551 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.53 160.84 37.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.008 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.58 142.3 37.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 110.183 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.43 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.4 p -150.3 -175.01 4.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.8 mm? -97.78 174.4 6.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.189 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 92.2 m -148.82 168.56 22.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 110.743 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.457 HG13 ' CD2' ' B' ' 62' ' ' LEU . 79.4 mt -100.46 150.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.841 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 49.5 t -125.48 82.08 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.434 ' HB3' ' CD2' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -109.1 146.43 34.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 110.55 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . 0.479 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 40.9 m170 -61.65 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' B' ' 41' ' ' ASP . 0.2 OUTLIER -89.52 -137.64 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 5.0 m-20 60.56 -134.42 0.72 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.007 -1.058 . . . . 0.0 110.23 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -45.97 -26.04 0.65 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.903 -1.123 . . . . 0.0 111.201 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.524 ' CH2' ' CD2' ' B' ' 47' ' ' LEU . 65.4 t-105 -67.66 -58.58 4.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.41 -25.61 41.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 60.3 m -81.2 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 110.512 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.83 -57.44 10.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.181 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.524 ' CD2' ' CH2' ' B' ' 43' ' ' TRP . 4.7 mp -91.61 52.21 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 110.239 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.23 56.23 0.15 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.029 -1.044 . . . . 0.0 111.581 -178.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.5 OUTLIER 174.15 154.09 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.853 -1.154 . . . . 0.0 110.359 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.406 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 5.9 m-85 60.5 22.77 12.45 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.383 -0.823 . . . . 0.0 110.985 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.476 HD21 ' CZ2' ' B' ' 43' ' ' TRP . 22.5 mt -105.51 112.85 26.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.9 -1.125 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -88.29 102.28 14.68 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.3 p -99.62 157.0 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.103 -0.998 . . . . 0.0 111.753 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.421 ' CZ ' ' O ' ' B' ' 83' ' ' GLY . 26.3 mtm180 -118.17 -174.49 2.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.699 -0.625 . . . . 0.0 109.711 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 80.27 6.56 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.188 -0.945 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 155.89 -21.3 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.577 -0.702 . . . . 0.0 110.177 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 -169.31 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.058 -1.026 . . . . 0.0 110.944 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 15.5 m -128.71 150.12 50.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.453 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -135.03 176.36 8.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 110.44 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' MET . . . . . . . . . . . . . 2.9 ttt -121.71 156.03 33.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 110.56 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -88.12 92.12 9.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.89 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.457 ' CD2' HG13 ' B' ' 36' ' ' ILE 2.509 0.0 OUTLIER -53.3 -70.92 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.896 -178.459 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.71 -138.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.483 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 87.9 m-85 -86.2 48.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.133 . . . . 0.0 110.656 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -86.27 -22.18 49.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.39 -51.39 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -1.199 . . . . 0.0 110.5 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.7 pp -44.22 -24.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.598 -0.689 . . . . 0.0 111.843 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.492 ' CE2' HG12 ' B' ' 89' ' ' ILE . 16.4 m-85 -55.67 143.39 30.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.796 -1.19 . . . . 0.0 110.258 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.416 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 56.0 m-20 -120.08 -178.45 3.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 111.228 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -103.62 152.68 21.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.45 22.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.959 -1.088 . . . . 0.0 111.075 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.63 23.62 2.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.045 . . . . 0.0 110.222 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -174.47 66.2 0.28 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.42 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 22.2 Cg_endo -65.54 93.37 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.783 1.412 . . . . 0.0 110.934 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.93 66.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.08 127.81 43.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.01 -171.93 2.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.451 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.37 157.83 23.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.496 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . 0.441 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 14.0 tp10 -137.96 126.54 23.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.164 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 28.1 mt -105.2 131.35 52.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 0.0 110.51 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.73 -166.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.349 -0.845 . . . . 0.0 110.257 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.06 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 110.455 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.421 ' O ' ' CZ ' ' B' ' 54' ' ' ARG . . . 138.73 -116.61 1.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.417 ' O ' ' CG2' ' B' ' 37' ' ' VAL . 25.5 tp -168.91 46.0 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -1.137 . . . . 0.0 110.425 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.15 -16.99 9.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.674 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -131.2 147.8 52.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.093 -1.004 . . . . 0.0 110.556 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 5.6 mmm -120.26 158.57 26.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 110.719 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.441 ' CB ' ' HB3' ' B' ' 79' ' ' GLU . 6.5 mtt180 -147.54 115.21 6.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 109.885 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.492 HG12 ' CE2' ' B' ' 68' ' ' PHE . 2.7 mp -88.39 117.11 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.042 . . . . 0.0 110.523 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.501 ' CE2' ' HG ' ' B' ' 29' ' ' LEU . 0.9 OUTLIER -106.81 163.49 12.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.345 -0.847 . . . . 0.0 110.643 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.414 HG22 ' CD1' ' B' ' 95' ' ' ILE . 10.4 p -107.24 87.86 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' B' ' 74' ' ' PRO . 9.5 pt -54.25 -22.88 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.917 . . . . 0.0 110.358 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.418 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.5 mttt -133.55 142.45 43.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.216 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.95 129.16 33.47 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.561 1.295 . . . . 0.0 110.454 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' B' ' 91' ' ' THR . 77.4 mt -107.58 138.4 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 110.313 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 164.79 14.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.178 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 4.4 mt -70.94 112.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.75 0.89 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.43 -176.56 3.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -1.165 . . . . 0.0 110.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -123.45 125.74 45.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.114 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' B' ' 102' ' ' THR . 56.1 mt -88.0 126.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 110.075 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 22.0 p -155.45 143.08 19.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.578 -0.701 . . . . 0.0 109.903 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.436 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.1 pp -123.89 147.68 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 43.5 t -85.17 -166.34 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 110.486 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.49 -65.58 1.03 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.948 . . . . 0.0 110.065 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.92 173.23 15.22 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.14 -30.41 2.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -1.01 . . . . 0.0 111.514 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -42.94 81.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.082 -1.012 . . . . 0.0 110.932 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' B' ' 110' ' ' TRP . 0.1 OUTLIER -109.31 115.71 30.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 0.0 110.563 -179.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.431 ' HB3' ' O ' ' B' ' 109' ' ' TYR . 28.3 t-105 . . . . . 0 N--CA 1.497 1.924 0 O-C-N 121.893 -0.504 . . . . 0.0 111.06 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 28.7 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.299 0.571 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.04 147.63 2.32 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 110.394 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--N 1.313 -1.312 0 O-C-N 123.648 1.341 . . . . 0.0 110.568 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 52.9 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.378 0.609 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' ARG . 8.7 p-10 -148.04 164.28 34.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.885 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.16 62.28 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.588 -0.695 . . . . 0.0 110.754 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.438 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 4.8 tpt180 179.69 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.284 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 7' ' ' ILE . 54.9 t -157.07 169.41 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 110.1 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.44 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 11.8 tt -144.77 146.61 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.442 HG12 ' CE ' ' A' ' 10' ' ' LYS . 94.7 t -89.65 102.53 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 111.027 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 1.1 mmtt -124.06 137.58 54.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 49.85 50.23 18.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 119.407 -2.058 . . . . 0.0 111.699 4.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' CE2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.902 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.003 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.487 ' CE2' ' HE3' ' A' ' 10' ' ' LYS . 3.5 m-85 -115.24 110.44 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -1.114 . . . . 0.0 110.803 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.5 173.77 22.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.462 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 97.9 t -98.3 130.08 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.999 -1.295 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE2' ' CB ' ' A' ' 11' ' ' SER . 1.6 m-85 -107.68 133.82 51.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 110.147 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.93 88.47 4.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.404 -0.81 . . . . 0.0 110.542 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.21 -27.15 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.38 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 14.7 mtpt -83.61 178.98 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.45 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 0.1 OUTLIER 102.24 20.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.0 -1.687 . . . . 0.0 109.563 3.145 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.487 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 15.2 m-85 -112.68 150.24 31.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.09 -158.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.845 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -80.41 -1.17 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.07 67.57 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -118.07 120.76 38.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.124 . . . . 0.0 110.275 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 90' ' ' PHE . 25.8 tp -53.71 127.36 25.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 6' ' ' VAL . 47.2 t -103.41 72.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 32' ' ' GLU . 9.2 tp10 57.04 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 6.8 pt-20 -158.58 156.01 29.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 110.327 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.55 -161.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.367 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 4.6 mm? -96.7 -179.17 4.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 110.543 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.21 178.16 8.8 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.435 -0.791 . . . . 0.0 109.535 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 36' ' ' ILE . 20.9 mt -113.97 138.49 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 110.26 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.85 113.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.032 -1.043 . . . . 0.0 110.325 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 1.5 tpp180 -146.61 159.73 43.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 110.404 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.475 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 64.2 m170 -71.4 -173.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -86.37 -137.28 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.833 . . . . 0.0 110.117 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.42 -139.91 0.43 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.739 -1.226 . . . . 0.0 110.304 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -46.36 -26.95 0.92 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.983 -1.073 . . . . 0.0 111.11 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.483 ' CE2' ' HB3' ' A' ' 38' ' ' ARG . 67.8 t-105 -61.06 -55.94 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.819 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.23 69.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.3 m -69.82 -70.42 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.8 -53.42 48.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.133 -0.98 . . . . 0.0 110.185 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.487 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 2.6 mm? -90.45 46.49 1.34 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -5.88 35.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.851 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.35 147.19 43.76 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.95 -1.094 . . . . 0.0 110.021 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CE1' ' O ' ' A' ' 66' ' ' ALA . 11.6 m-85 56.09 38.76 30.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.096 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD12 ' CZ2' ' A' ' 43' ' ' TRP . 7.0 tp -123.76 122.81 39.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.896 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.08 132.32 44.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.959 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.6 p -94.27 127.89 40.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -0.962 . . . . 0.0 110.783 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 12.9 tpt180 -105.39 172.94 6.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.407 -0.808 . . . . 0.0 109.608 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -83.08 82.71 8.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.946 -1.096 . . . . 0.0 109.225 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 22.9 p30 146.45 -18.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.79 -0.569 . . . . 0.0 109.765 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.98 -160.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.1 m -140.49 118.59 11.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.149 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -109.44 153.81 23.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.639 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.436 ' CE ' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -93.16 179.58 5.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . . . -86.48 -146.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.16 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.435 HD22 ' CD2' ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER -178.34 -73.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.99 -1.069 . . . . 0.0 109.967 -179.211 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.55 -114.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 40.5 m-85 -91.26 33.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.516 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -90.95 -22.14 33.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -91.09 -20.94 21.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 111.681 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.462 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -92.51 -4.29 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.217 . . . . 0.0 111.835 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD2' ' CD1' ' A' ' 103' ' ' ILE . 5.3 m-85 -55.81 147.78 18.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.823 -1.173 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -117.42 -167.83 1.38 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -103.79 151.2 23.34 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.243 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -161.19 150.07 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -11.75 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 111.053 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.63 67.52 71.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.03 107.12 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.647 1.341 . . . . 0.0 110.459 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.425 ' CB ' ' HD2' ' A' ' 93' ' ' LYS . 47.2 p30 -81.54 -6.53 59.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.69 150.24 35.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.985 -1.072 . . . . 0.0 110.501 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.06 -160.45 0.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.439 ' HB2' ' CE ' ' A' ' 87' ' ' MET . 2.0 p-80 -132.26 166.96 20.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.067 -1.021 . . . . 0.0 110.666 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.15 141.19 29.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 110.455 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.16 145.9 29.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.263 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.428 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 1.6 p -64.87 -62.64 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 110.412 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.82 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.602 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.5 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HB3' ' CB ' ' A' ' 59' ' ' ALA . 29.4 mt 52.32 48.58 22.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.425 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.22 -76.55 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.554 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.428 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -87.22 126.63 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 110.285 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.439 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -100.79 117.75 35.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.895 . . . . 0.0 110.525 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.39 114.59 27.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.042 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mt -89.43 138.35 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 110.151 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 29' ' ' LEU . 13.6 m-85 -128.36 177.86 6.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.431 HG21 ' CG2' ' A' ' 30' ' ' VAL . 1.6 p -115.71 96.47 5.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.316 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 93' ' ' LYS . 23.3 pt -50.45 -35.83 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.568 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' N ' HG13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -130.28 150.48 76.26 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 110.299 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.15 131.69 31.57 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.717 1.378 . . . . 0.0 110.981 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 32.1 mt -113.29 145.32 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.786 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.38 10.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 110.968 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 39.4 mt -65.79 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.06 36.37 1.83 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -101.32 156.26 17.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -1.12 . . . . 0.0 110.167 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.411 ' OE1' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -100.34 110.11 22.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 110.491 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.3 mt -89.55 119.82 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.797 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 32.2 p -141.13 1.59 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 111.601 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 68' ' ' PHE . 35.4 pt 37.42 -145.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.326 -0.859 . . . . 0.0 111.34 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.428 ' N ' HG13 ' A' ' 103' ' ' ILE . 22.9 t -160.59 -168.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 110.727 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.433 ' CB ' ' HB3' ' A' ' 109' ' ' TYR . 10.5 m-85 -123.37 -66.84 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.853 . . . . 0.0 109.686 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 84.69 -160.04 35.31 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t0 55.12 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.552 -0.969 . . . . 0.0 110.581 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 1.9 t70 -153.88 25.12 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.0 110.559 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.433 ' HB3' ' CB ' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -100.98 108.77 20.58 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.181 -0.949 . . . . 0.0 109.753 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.42 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 30.0 t-105 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.118 0.485 . . . . 0.0 110.638 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 2.2 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.233 0.54 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.5 160.59 31.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.95 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 C--N 1.312 -1.386 0 O-C-N 123.744 1.391 . . . . 0.0 110.509 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 52.9 p90 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.326 0.584 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' B' ' 5' ' ' ARG . 8.7 p-10 -147.98 164.44 33.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.34 62.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.0 110.657 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.441 ' O ' ' CG2' ' B' ' 6' ' ' VAL . 4.8 tpt180 179.85 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.413 -0.804 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' B' ' 5' ' ' ARG . 54.6 t -156.92 169.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.668 -0.645 . . . . 0.0 110.138 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.441 ' N ' ' CG1' ' B' ' 6' ' ' VAL . 11.8 tt -144.77 146.42 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.589 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.442 HG12 ' CE ' ' B' ' 10' ' ' LYS . 93.2 t -89.49 102.55 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.056 -1.027 . . . . 0.0 111.086 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' B' ' 10' ' ' LYS . 1.1 mmtt -124.09 137.64 54.54 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 49.89 50.19 18.88 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 119.43 -2.044 . . . . 0.0 111.729 4.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.515 ' CB ' ' CE2' ' B' ' 19' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 109.854 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.487 ' CE2' ' HE3' ' B' ' 10' ' ' LYS . 3.6 m-85 -115.24 110.38 19.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -1.08 . . . . 0.0 110.872 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.54 173.64 22.19 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.457 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 92.9 t -98.17 129.86 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.318 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.515 ' CE2' ' CB ' ' B' ' 11' ' ' SER . 1.6 m-85 -107.63 133.82 51.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 110.151 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.91 88.5 4.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.324 -0.86 . . . . 0.0 110.569 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.6 OUTLIER -57.19 -27.16 61.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 178.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.49 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 14.7 mtpt -83.58 179.02 7.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.455 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.1 OUTLIER 102.21 20.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.003 -1.686 . . . . 0.0 109.581 3.056 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.49 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 15.4 m-85 -112.63 150.36 31.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.31 -0.869 . . . . 0.0 110.222 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.23 -158.77 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.963 . . . . 0.0 109.868 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -80.38 -1.25 40.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.02 67.59 0.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -118.05 120.69 38.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 110.309 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' CZ ' ' B' ' 90' ' ' PHE . 25.9 tp -53.67 127.37 25.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' B' ' 6' ' ' VAL . 47.1 t -103.37 72.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' B' ' 32' ' ' GLU . 9.2 tp10 57.11 163.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.451 -0.781 . . . . 0.0 110.467 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' B' ' 31' ' ' GLU . 6.8 pt-20 -158.65 156.07 29.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.61 -161.7 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' B' ' 34' ' ' LEU . 4.6 mm? -96.83 -179.17 4.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 110.593 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.23 178.14 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.387 -0.82 . . . . 0.0 109.454 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.454 HG22 HD12 ' B' ' 36' ' ' ILE . 20.8 mt -114.0 138.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.018 . . . . 0.0 110.203 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.8 113.4 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.294 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.477 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 1.5 tpp180 -146.68 159.73 43.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 110.463 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 64.2 m170 -71.38 -173.99 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.764 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -86.34 -137.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.36 -139.99 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.808 -1.183 . . . . 0.0 110.295 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -46.23 -27.04 0.9 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.03 -1.044 . . . . 0.0 111.159 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.481 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 67.7 t-105 -60.98 -55.94 27.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.957 . . . . 0.0 109.852 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.21 69.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 92.1 m -69.85 -70.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -1.157 . . . . 0.0 110.519 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.89 -53.13 53.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 2.6 mm? -90.82 46.6 1.34 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -5.92 35.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 110.868 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.24 147.2 43.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.906 -1.121 . . . . 0.0 110.098 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' O ' ' B' ' 66' ' ' ALA . 11.5 m-85 56.11 38.75 30.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.866 . . . . 0.0 110.075 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.476 HD12 ' CZ2' ' B' ' 43' ' ' TRP . 7.1 tp -123.81 122.96 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.826 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -99.24 132.43 44.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 60.5 p -94.29 127.94 40.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.735 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' B' ' 55' ' ' LYS . 13.0 tpt180 -106.01 169.98 8.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.446 -0.784 . . . . 0.0 109.722 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.447 ' N ' ' HG3' ' B' ' 54' ' ' ARG . 0.1 OUTLIER -79.04 82.4 5.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.028 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 22.9 p30 146.31 -18.83 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.667 -0.645 . . . . 0.0 109.668 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.97 -160.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -140.38 118.54 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -109.38 153.89 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 110.73 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.435 ' CA ' HD11 ' B' ' 51' ' ' LEU . 0.1 OUTLIER -93.62 178.22 5.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.399 -0.813 . . . . 0.0 110.308 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.47 -146.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.885 . . . . 0.0 109.632 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.436 HD23 ' CG1' ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER -178.51 -73.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.001 -1.062 . . . . 0.0 110.018 -179.473 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.53 -113.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.472 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 40.4 m-85 -92.04 34.23 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -1.151 . . . . 0.0 110.314 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.437 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -92.02 -21.19 33.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.479 ' O ' ' CE1' ' B' ' 50' ' ' TYR . . . -92.17 -19.52 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.264 . . . . 0.0 111.627 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.457 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.0 OUTLIER -94.14 -3.68 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.873 -1.142 . . . . 0.0 111.491 -178.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.526 ' CD2' ' CD1' ' B' ' 103' ' ' ILE . 5.3 m-85 -56.13 147.82 19.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 110.461 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -117.23 -166.73 1.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -105.37 150.84 24.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.903 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -160.88 150.08 16.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 110.311 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 -11.7 59.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 111.069 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.73 67.56 71.01 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.997 -1.065 . . . . 0.0 110.536 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.08 107.06 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.663 1.349 . . . . 0.0 110.434 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.433 ' CB ' ' HD2' ' B' ' 93' ' ' LYS . 47.1 p30 -81.49 -6.49 59.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.69 150.18 34.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.971 -1.081 . . . . 0.0 110.465 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -160.39 0.95 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.433 ' HB2' ' CE ' ' B' ' 87' ' ' MET . 2.0 p-80 -132.32 167.0 20.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.673 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.16 141.27 29.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.419 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 94.6 mt -105.26 145.89 30.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 110.318 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 1.6 p -64.89 -62.57 1.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.417 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.88 -43.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.54 2.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.429 ' HB3' ' CB ' ' B' ' 59' ' ' ALA . 29.4 mt 52.27 48.54 22.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -1.195 . . . . 0.0 110.407 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.18 -76.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.948 . . . . 0.0 110.536 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.431 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.0 OUTLIER -87.17 126.64 34.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.006 . . . . 0.0 110.281 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.433 ' CE ' ' HB2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -100.81 117.74 35.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 110.548 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.46 114.3 27.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.121 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' B' ' 78' ' ' HIS . 38.5 mt -89.02 138.37 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.511 ' CZ ' ' CD1' ' B' ' 29' ' ' LEU . 13.6 m-85 -128.39 177.92 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 110.472 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.433 HG21 ' CG2' ' B' ' 30' ' ' VAL . 1.6 p -115.75 96.45 5.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.908 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.433 HG13 ' N ' ' B' ' 93' ' ' LYS . 23.4 pt -50.44 -35.82 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.628 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.433 ' N ' HG13 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -130.25 150.52 76.36 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 110.273 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.21 131.73 31.95 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.709 1.373 . . . . 0.0 110.991 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.416 ' CD1' HG22 ' B' ' 91' ' ' THR . 31.9 mt -113.29 145.37 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.476 -0.765 . . . . 0.0 109.795 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.31 10.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.948 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 39.5 mt -65.76 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 110.267 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.1 36.25 1.85 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.28 156.25 17.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.141 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -100.32 110.06 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.11 -0.994 . . . . 0.0 110.49 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . . . . . . . . . 60.0 mt -89.47 119.65 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.8 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.431 ' O ' ' CG1' ' B' ' 103' ' ' ILE . 32.7 p -140.91 1.53 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 111.611 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.526 ' CD1' ' CD2' ' B' ' 68' ' ' PHE . 35.2 pt 37.61 -146.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.46 -0.775 . . . . 0.0 111.388 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.425 ' N ' HG13 ' B' ' 103' ' ' ILE . 22.8 t -160.62 -169.08 2.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.903 -1.123 . . . . 0.0 110.712 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.429 ' CB ' ' HB3' ' B' ' 109' ' ' TYR . 10.4 m-85 -123.06 -66.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.774 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 84.65 -159.95 35.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.4 t0 55.1 -87.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.527 -0.984 . . . . 0.0 110.546 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 106' ' ' GLY . 1.8 t70 -153.85 24.94 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.937 -1.102 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' B' ' 110' ' ' TRP . 0.1 OUTLIER -100.65 108.91 20.92 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 109.91 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.433 ' HB3' ' O ' ' B' ' 109' ' ' TYR . 29.9 t-105 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.084 0.468 . . . . 0.0 110.607 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.2 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.22 0.533 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.59 31.04 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.922 . . . . 0.0 110.391 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo . . . . . 0 C--N 1.313 -1.31 0 O-C-N 123.632 1.333 . . . . 0.0 110.522 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.469 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 35.8 p90 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.347 0.594 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -121.08 163.44 18.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -50.08 -25.61 3.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.423 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 26.9 ttp180 -74.65 -45.39 45.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.56 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 22.9 m -154.25 -178.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.164 -0.96 . . . . 0.0 110.493 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.427 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 9.0 tt -152.91 150.49 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.101 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.4 t -94.48 120.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 mttt -125.59 146.82 49.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.418 -0.801 . . . . 0.0 109.226 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 4.1 mmmt 52.45 59.18 4.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 119.65 -1.906 . . . . 0.0 110.922 2.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.437 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 1.1 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.451 -0.781 . . . . 0.0 110.159 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.96 72.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -1.175 . . . . 0.0 110.581 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.0 -175.97 20.37 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 90.3 t -101.67 146.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.987 -1.302 . . . . 0.0 110.03 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.494 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -110.41 126.36 54.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -0.931 . . . . 0.0 109.754 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.54 89.4 7.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -0.844 . . . . 0.0 110.843 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.415 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.52 -22.52 55.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.325 -0.859 . . . . 0.0 109.65 178.022 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' CG ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -90.82 -178.87 5.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.467 -0.771 . . . . 0.0 109.862 179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.432 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 18.1 m 100.58 17.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.291 -1.506 . . . . 0.0 110.47 0.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -105.19 161.43 14.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.768 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -162.03 0.91 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.356 -0.84 . . . . 0.0 109.88 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.438 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 17.8 tttt -95.53 97.47 9.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.03 58.0 0.84 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.49 121.06 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -1.176 . . . . 0.0 110.43 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -56.14 132.99 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.424 ' CG2' HG23 ' A' ' 91' ' ' THR . 88.8 t -103.35 -39.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.888 . . . . 0.0 110.291 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.21 156.75 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.309 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.43 150.75 30.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 110.289 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.415 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -150.19 -159.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 110.631 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.8 176.07 5.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.693 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.53 150.78 31.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.433 HG13 ' CD2' ' A' ' 62' ' ' LEU . 56.0 mt -89.89 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.623 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.7 t -126.9 106.87 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.632 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 35.3 mmt180 -136.53 157.97 45.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -71.45 176.52 4.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 110.157 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 53.1 p-10 -64.08 -137.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.8 t0 67.12 -149.91 0.18 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.853 -1.154 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -45.89 -34.54 3.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.864 . . . . 0.0 111.373 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.49 ' CD2' ' HB2' ' A' ' 38' ' ' ARG . 48.4 t-105 -57.54 -55.45 34.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 110.241 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.58 68.08 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 94.5 m -80.85 -64.5 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.142 -1.211 . . . . 0.0 110.801 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.78 -48.45 15.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.0 111.047 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.0 mm? -91.94 26.81 2.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -64.35 80.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 7.1 t0 -175.65 -53.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 110.484 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 3.6 m-85 -127.72 54.1 1.72 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.486 HD21 ' CE2' ' A' ' 43' ' ' TRP . 6.0 mt -110.17 114.06 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 111.219 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -89.93 114.4 26.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.898 . . . . 0.0 109.221 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -108.0 134.78 50.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.097 -1.002 . . . . 0.0 111.207 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.429 ' CB ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.89 -171.68 1.89 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 109.865 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -82.33 75.12 9.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.978 -1.076 . . . . 0.0 109.21 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 49.6 m-80 173.1 -33.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.442 -179.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.42 ' CG ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 178.82 -167.71 0.08 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.437 -0.79 . . . . 0.0 110.351 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.3 156.75 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 110.112 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -150.32 148.61 29.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 0.0 110.47 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.429 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 13.7 mmm -91.37 157.77 16.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -86.66 101.89 13.68 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.457 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' B' ' 62' ' ' LEU 2.5 0.0 OUTLIER -59.64 -76.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 -179.156 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.33 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 89.8 m-85 -89.66 41.81 1.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 110.544 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -81.0 -22.67 60.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.9 -55.41 3.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -1.149 . . . . 0.0 111.058 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 1.6 pp -50.48 -22.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 111.155 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 64' ' ' PHE . 0.7 OUTLIER -48.91 122.16 5.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.014 -1.054 . . . . 0.0 110.847 -179.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -94.51 173.63 7.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.51 ' NE2' ' CD1' ' A' ' 110' ' ' TRP . 39.6 t60 -102.04 150.57 23.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 0.0 110.121 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 p -149.64 139.57 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.481 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.52 -25.02 23.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.243 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.69 51.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.207 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.76 98.83 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.658 1.346 . . . . 0.0 110.554 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.8 -17.91 54.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.17 170.96 15.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 110.331 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -149.73 -161.69 1.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.409 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 31.0 p-80 -130.95 -172.86 2.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -151.73 170.98 18.42 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.171 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.86 124.88 17.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -56.92 -168.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.631 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.94 89.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.477 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.73 158.1 32.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 54' ' ' ARG . 2.3 mp -55.35 106.39 0.23 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -1.078 . . . . 0.0 110.348 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 -53.58 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.26 169.38 16.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.897 . . . . 0.0 110.266 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.8 mtp -140.42 133.35 29.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.92 . . . . 0.0 110.494 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -115.1 176.02 5.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.269 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.33 111.98 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE1' ' CD2' ' A' ' 29' ' ' LEU . 56.1 m-85 -106.58 175.18 5.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.544 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.424 HG23 ' CG2' ' A' ' 30' ' ' VAL . 3.1 p -122.95 85.28 2.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.115 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.9 pt -50.13 -25.45 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.825 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.09 134.68 21.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 110.503 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 82.0 Cg_exo -47.51 152.04 2.79 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.489 1.257 . . . . 0.0 111.014 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' CG2' ' HB2' ' A' ' 99' ' ' GLU . 64.1 mt -131.28 148.68 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.64 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.59 157.88 15.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.421 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 53.0 mt -63.36 109.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.206 -0.934 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.08 27.84 2.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.435 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 52.0 mm-40 -106.73 -177.83 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -1.157 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.6 123.1 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.931 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 84.7 mt -89.19 130.78 37.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -154.66 143.77 21.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.817 -0.552 . . . . 0.0 110.002 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.459 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.1 pt -105.26 160.75 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 110.491 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -93.93 -168.87 1.96 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -124.6 -68.85 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 110.3 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 89.73 -168.45 34.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.491 -1.005 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 5.3 t70 -135.19 -36.98 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.908 -1.12 . . . . 0.0 110.918 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.15 117.75 2.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.816 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.51 ' CD1' ' NE2' ' A' ' 70' ' ' HIS . 56.0 t-105 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 110.466 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.5 1.6 m . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.283 0.563 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.78 154.72 3.68 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.409 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 41.6 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 O-C-N 123.702 1.37 . . . . 0.0 110.627 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.473 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 36.4 p90 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.31 0.576 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -121.07 163.49 18.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.338 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -50.16 -25.57 3.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.93 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.424 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 26.8 ttp180 -74.72 -45.37 44.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 110.508 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 22.9 m -154.23 -178.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -0.936 . . . . 0.0 110.476 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.427 HG21 ' CB ' ' B' ' 19' ' ' PHE . 9.0 tt -152.96 150.47 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -94.47 120.23 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 0.0 110.548 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.552 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 32.7 mttt -125.77 146.9 49.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.208 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.552 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 4.1 mmmt 52.47 59.2 4.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.636 -1.915 . . . . 0.0 110.943 2.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.441 ' N ' ' HB3' ' B' ' 9' ' ' LYS . 1.1 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.75 . . . . 0.0 110.139 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 72.04 1.68 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -1.187 . . . . 0.0 110.597 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.07 -175.94 20.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 87.5 t -101.62 145.79 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.011 -1.288 . . . . 0.0 110.075 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.493 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -110.41 126.08 53.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.256 -0.902 . . . . 0.0 109.791 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.22 89.38 7.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 110.925 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.411 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.58 -22.44 55.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 178.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' B' ' 23' ' ' SER . 0.3 OUTLIER -90.83 -178.83 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.442 -0.786 . . . . 0.0 109.883 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.437 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.51 18.1 m 100.6 17.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.314 -1.491 . . . . 0.0 110.481 0.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -105.2 161.46 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 110.759 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.13 -162.07 0.91 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.426 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 17.9 tttt -95.48 97.5 9.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.324 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.05 57.94 0.84 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.5 121.04 26.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.131 . . . . 0.0 110.421 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.525 ' CD2' ' CE1' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -56.05 132.94 51.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.23 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.427 ' CG2' HG23 ' B' ' 91' ' ' THR . 88.3 t -103.36 -39.92 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.19 156.76 8.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.392 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.41 150.88 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.414 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -150.37 -159.78 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.596 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.88 176.41 5.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 110.723 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.98 150.52 30.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 109.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 55.8 mt -89.65 147.47 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 109.656 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.93 106.92 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 110.644 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.49 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 35.3 mmt180 -136.59 157.99 45.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -71.49 176.51 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.196 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 53.2 p-10 -63.99 -138.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.8 t0 67.16 -149.89 0.18 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.812 -1.18 . . . . 0.0 110.708 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -45.88 -34.62 3.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.279 -0.888 . . . . 0.0 111.349 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.49 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 48.2 t-105 -57.52 -55.5 34.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.63 68.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 94.5 m -80.8 -64.45 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 0.0 110.762 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.09 -47.53 17.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 111.144 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.0 mm? -93.02 27.15 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.569 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.3 OUTLIER -64.45 80.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 110.269 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.472 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 7.1 t0 -175.7 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 3.6 m-85 -127.69 54.05 1.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.214 -0.929 . . . . 0.0 109.612 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' B' ' 43' ' ' TRP . 5.9 mt -110.18 114.2 27.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -90.12 114.37 26.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.336 -0.852 . . . . 0.0 109.19 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -107.9 134.73 50.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.007 . . . . 0.0 111.2 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.438 ' CB ' HD11 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -112.54 -174.75 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.514 -0.741 . . . . 0.0 109.892 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -77.87 74.51 4.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 0.0 110.253 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 49.9 m-80 173.1 -33.58 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.426 ' CG ' HD23 ' B' ' 84' ' ' LEU . 0.0 OUTLIER 179.01 -167.68 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 110.483 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.15 156.8 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -150.46 148.63 28.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 110.514 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.427 ' HG2' ' CD2' ' B' ' 51' ' ' LEU . 13.7 mmm -91.64 156.43 17.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 110.303 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.438 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -84.82 101.97 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.807 . . . . 0.0 110.728 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 62' ' ' LEU 2.498 0.0 OUTLIER -59.96 -76.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 111.111 -179.355 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.36 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CD2' ' B' ' 68' ' ' PHE . 89.7 m-85 -89.66 41.86 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -1.171 . . . . 0.0 110.528 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -81.13 -22.24 61.34 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.45 -55.25 3.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 110.979 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.6 pp -50.51 -22.21 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 111.226 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' B' ' 64' ' ' PHE . 0.7 OUTLIER -48.91 122.13 5.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.017 -1.052 . . . . 0.0 110.835 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -94.38 173.98 7.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.843 . . . . 0.0 110.364 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' B' ' 110' ' ' TRP . 39.8 t60 -102.52 150.52 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -149.61 139.62 22.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 110.486 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.54 -25.03 23.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.933 . . . . 0.0 110.218 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.66 51.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.84 98.84 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.699 1.368 . . . . 0.0 110.558 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.76 -17.97 54.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.539 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.15 171.02 15.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.324 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -149.7 -161.74 1.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 110.314 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . 0.418 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 31.3 p-80 -130.9 -172.05 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -153.09 170.05 21.43 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.712 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.53 124.81 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 0.0 110.172 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 9.1 t -57.18 -168.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.463 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.07 89.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 110.581 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.71 158.11 33.01 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.438 HD11 ' CB ' ' B' ' 54' ' ' ARG . 2.3 mp -55.38 106.45 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -1.084 . . . . 0.0 110.353 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -53.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 110.395 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.29 169.36 16.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.8 mtp -140.47 133.38 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.495 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -115.13 176.04 5.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.38 111.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.096 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.525 ' CE1' ' CD2' ' B' ' 29' ' ' LEU . 56.5 m-85 -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.427 HG23 ' CG2' ' B' ' 30' ' ' VAL . 3.0 p -122.99 85.37 2.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.08 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 50.9 pt -50.11 -25.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.833 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.04 134.59 21.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 0.0 110.502 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 83.6 Cg_exo -47.88 152.21 3.25 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.541 1.285 . . . . 0.0 110.979 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.475 HG21 HD13 ' B' ' 95' ' ' ILE . 63.9 mt -131.19 148.67 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.64 157.86 15.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.411 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 53.0 mt -63.31 109.75 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.889 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.09 27.81 2.83 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.439 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 52.4 mm-40 -106.75 -177.91 3.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.268 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.59 122.84 41.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.003 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' B' ' 18' ' ' VAL . 84.3 mt -88.71 130.86 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.249 -0.907 . . . . 0.0 110.388 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -154.78 143.78 20.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.465 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.1 pt -105.21 160.75 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 110.467 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 44.5 t -93.97 -168.86 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 110.504 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -124.55 -68.9 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 110.352 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 89.77 -168.43 34.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -1.04 . . . . 0.0 110.719 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' B' ' 106' ' ' GLY . 5.3 t70 -135.2 -36.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.899 -1.125 . . . . 0.0 110.885 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.12 117.66 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.813 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.518 ' CD1' ' NE2' ' B' ' 70' ' ' HIS . 56.1 t-105 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.498 -0.751 . . . . 0.0 110.467 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 1.6 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.331 0.586 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.76 154.77 3.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.421 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . 0.418 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 41.2 Cg_endo . . . . . 0 C--N 1.312 -1.39 0 O-C-N 123.696 1.367 . . . . 0.0 110.558 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.363 0.602 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 5' ' ' ARG . 1.5 m-80 -111.23 40.72 2.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 110.449 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.53 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.536 -0.727 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.439 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 20.3 mtm180 -52.0 -38.88 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' A' ' 18' ' ' VAL . 98.5 t -135.26 143.82 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 20.0 tt -119.57 165.38 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.556 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -100.15 128.73 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 33.2 mttt -143.62 139.97 29.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.74 55.11 9.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 119.749 -1.845 . . . . 0.0 110.277 1.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.494 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.798 -0.564 . . . . 0.0 110.366 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.2 64.02 8.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.58 -166.43 24.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' A' ' 6' ' ' VAL . 59.7 t -97.88 127.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.962 -1.316 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 11' ' ' SER . 0.1 OUTLIER -90.5 126.9 36.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.109 . . . . 0.0 109.841 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.21 90.87 8.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.699 -0.625 . . . . 0.0 110.635 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 2.7 ttt180 -69.21 -22.13 63.9 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.481 0.658 . . . . 0.0 109.399 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 2.8 mttp -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.497 -0.752 . . . . 0.0 109.38 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.413 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 19.2 m 108.32 34.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.983 -1.698 . . . . 0.0 109.84 1.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 44.2 m-85 -127.28 160.67 30.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 111.076 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.44 -159.88 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.51 -0.743 . . . . 0.0 110.148 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HB2' ' CD ' ' A' ' 94' ' ' PRO . 23.7 tttm -102.19 98.96 9.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.071 -1.018 . . . . 0.0 110.194 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.78 33.91 0.96 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -117.14 141.88 47.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.481 HD12 ' CZ ' ' A' ' 90' ' ' PHE . 2.3 tp -83.76 136.96 33.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.427 ' CG1' HG21 ' A' ' 6' ' ' VAL . 48.5 t -92.42 -62.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 110.422 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -159.03 149.2 19.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.199 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -131.53 137.98 48.72 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.108 -0.995 . . . . 0.0 109.902 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.8 m -140.35 178.88 6.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 110.092 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 34' ' ' LEU . 11.3 mp -91.75 169.41 10.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.396 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 72.8 m -145.51 168.51 20.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.425 HG21 ' N ' ' A' ' 37' ' ' VAL . 39.1 mt -96.76 164.09 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.638 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 51.6 t -143.58 115.85 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 110.828 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 62.5 mmt-85 -144.63 142.49 30.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.144 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.54 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.881 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -98.52 119.76 37.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.727 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -177.38 -141.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.64 -35.49 42.3 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.307 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.483 ' CZ3' ' HG ' ' A' ' 47' ' ' LEU . 13.4 t-105 -63.1 -35.36 79.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -58.1 -66.06 3.08 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 29.6 m -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.325 -1.103 . . . . 0.0 111.011 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -62.56 1.78 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.848 -1.157 . . . . 0.0 108.457 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.1 mm? -92.81 36.32 1.03 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 109.845 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.439 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -71.2 -1.02 11.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.641 -179.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -118.13 150.12 39.89 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.862 -1.148 . . . . 0.0 108.929 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 26.1 m-85 57.5 29.14 16.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 60' ' ' MET . 4.6 tp -129.67 138.12 51.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.441 -0.787 . . . . 0.0 111.035 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -92.89 162.14 14.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.371 -0.83 . . . . 0.0 109.615 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 p -138.51 113.71 9.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 110.639 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.55 179.87 4.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 110.169 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -83.64 86.75 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 109.48 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 41.8 m-80 149.08 -25.54 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.51 -158.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.143 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -139.86 169.5 17.6 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.875 . . . . 0.0 109.946 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -149.9 149.29 30.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.441 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 2.3 ttt -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.423 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -87.1 90.5 8.38 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.18 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' B' ' 62' ' ' LEU 2.502 0.2 OUTLIER -55.32 -73.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.771 -179.662 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.05 -137.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -84.18 51.75 2.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 110.423 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -90.45 -27.8 19.01 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -88.39 -47.34 8.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 110.427 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' VAL . 2.9 pp -47.99 -24.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.29 -0.881 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' A' ' 103' ' ' ILE . 3.7 m-85 -49.16 120.19 3.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.99 . . . . 0.0 110.584 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -95.26 175.73 6.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.429 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -96.0 139.06 32.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 110.661 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.3 t -143.75 161.74 37.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 110.142 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -83.96 -34.33 24.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.456 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 58.28 20.03 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 110.507 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.09 115.86 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.53 1.279 . . . . 0.0 110.397 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 92' ' ' ILE . 42.7 m-80 -89.71 18.74 5.23 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.566 -0.709 . . . . 0.0 110.7 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -122.49 158.95 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -145.59 169.46 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 110.529 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.79 130.69 47.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 110.403 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.82 152.47 24.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 110.261 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.05 131.04 56.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.509 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.413 HG23 ' CB ' ' A' ' 86' ' ' ARG . 40.7 p -57.91 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.9 . . . . 0.0 110.379 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 110.313 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.79 -126.32 1.46 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 4.4 tp -153.09 27.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.16 . . . . 0.0 110.265 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -108.29 -70.73 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 110.585 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.413 ' CB ' HG23 ' A' ' 81' ' ' THR . 12.8 mtt180 -70.61 124.04 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 110.429 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.572 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 20.5 mtp -118.85 124.86 48.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -103.41 164.62 11.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.958 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.3 mt -136.23 126.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.481 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 48.8 m-85 -122.05 169.74 10.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.5 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.011 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 75' ' ' ASN . 2.1 pt -62.81 -24.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 110.532 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 92' ' ' ILE . 24.3 mttt -151.1 131.97 7.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.018 -1.051 . . . . 0.0 110.594 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.494 ' CD ' ' HB2' ' A' ' 26' ' ' LYS . 37.6 Cg_exo -35.47 146.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.275 1.983 . . . . 0.0 112.416 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 99' ' ' GLU . 49.8 mt -127.03 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.41 ' N ' HG23 ' A' ' 95' ' ' ILE . . . -89.17 158.98 17.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.558 -0.714 . . . . 0.0 110.278 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -56.42 -21.52 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 111.474 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.59 61.04 0.31 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 3.5 mt-10 -131.58 175.07 9.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -1.207 . . . . 0.0 110.997 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.17 124.28 44.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 109.68 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.432 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 54.3 mt -88.9 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 110.557 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.52 179.42 8.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.816 -0.552 . . . . 0.0 109.862 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.6 pp -145.87 133.41 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.2 t -61.05 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.397 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.62 -75.92 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.42 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.01 -173.19 42.34 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.41 -12.38 60.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 110.809 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.57 -55.56 2.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.06 -1.025 . . . . 0.0 110.626 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -54.41 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 110.889 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.696 -0.628 . . . . 0.0 111.285 178.56 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.87 155.08 60.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 C--N 1.313 -1.328 0 O-C-N 123.681 1.358 . . . . 0.0 111.263 -179.78 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.295 0.569 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 5' ' ' ARG . 1.5 m-80 -111.15 40.62 2.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.62 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.44 ' HA ' ' CD ' ' B' ' 22' ' ' LYS . 20.4 mtm180 -52.05 -38.85 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.925 -1.109 . . . . 0.0 110.619 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' B' ' 18' ' ' VAL . 98.9 t -135.32 143.72 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 19.9 tt -119.49 165.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.19 128.7 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 110.541 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.514 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 33.2 mttt -143.57 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 109.196 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.82 55.01 9.59 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 119.664 -1.898 . . . . 0.0 110.36 1.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.482 ' HB2' ' CE1' ' B' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.758 -0.589 . . . . 0.0 110.36 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.11 64.4 8.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.519 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.17 -166.43 23.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' B' ' 6' ' ' VAL . 58.5 t -97.89 127.81 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.951 -1.323 . . . . 0.0 110.122 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.485 ' CD2' ' HE3' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -90.48 126.56 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 109.948 179.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.62 90.84 8.57 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.465 -0.772 . . . . 0.0 110.761 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 2.7 ttt180 -69.24 -21.88 63.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.481 -0.762 . . . . 0.0 109.465 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 2.7 mttp -105.53 -177.08 3.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.53 -0.731 . . . . 0.0 109.387 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.427 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 19.5 m 108.33 34.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.063 -1.648 . . . . 0.0 109.859 1.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 43.9 m-85 -127.31 160.84 30.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 111.049 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.58 -159.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.479 ' HB2' ' CD ' ' B' ' 94' ' ' PRO . 23.6 tttm -102.11 98.97 9.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 0.0 110.198 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.73 33.87 0.96 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -117.13 141.89 47.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.484 HD13 ' CE2' ' B' ' 90' ' ' PHE . 2.3 tp -83.8 136.97 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.437 ' CG1' HG21 ' B' ' 6' ' ' VAL . 48.4 t -92.38 -62.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.461 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -159.02 149.27 19.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -131.53 137.86 48.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.401 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 36.5 m -140.42 178.88 7.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 110.015 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 11.3 mp -91.76 169.45 10.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.394 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 72.7 m -145.57 168.42 20.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.42 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 39.3 mt -96.73 164.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' B' ' 84' ' ' LEU . 51.7 t -143.66 115.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 110.83 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.472 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 62.4 mmt-85 -144.69 142.44 30.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 110.114 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -56.5 -167.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.877 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -98.59 119.77 37.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 110.733 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -177.4 -141.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.819 . . . . 0.0 109.431 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.63 -35.48 42.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.725 -1.234 . . . . 0.0 109.304 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.479 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 13.1 t-105 -63.05 -35.29 79.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -58.21 -66.03 3.1 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' B' ' 48' ' ' GLU . 31.1 m -66.7 -37.25 84.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.253 -1.145 . . . . 0.0 111.063 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -61.3 2.7 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.963 -1.086 . . . . 0.0 108.65 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.1 mm? -94.58 37.04 1.13 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.407 177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.44 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 0.4 OUTLIER -71.63 -1.2 12.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 111.545 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -117.83 150.19 39.58 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.903 -1.123 . . . . 0.0 109.017 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 25.8 m-85 57.47 29.1 16.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' B' ' 60' ' ' MET . 4.7 tp -129.73 138.27 51.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 110.999 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -93.09 162.16 14.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -0.83 . . . . 0.0 109.548 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 46.9 p -138.4 113.73 9.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 110.673 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.11 177.31 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -79.95 86.49 5.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 41.5 m-80 148.91 -25.69 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.646 -0.659 . . . . 0.0 109.396 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -177.46 -158.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.696 . . . . 0.0 110.194 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 15.3 m -139.82 169.48 17.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.906 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -149.88 149.29 30.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.049 -1.032 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.438 ' HA ' ' CD1' ' B' ' 51' ' ' LEU . 2.3 ttt -94.43 155.61 16.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.587 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.435 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -85.48 90.32 7.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.847 . . . . 0.0 110.558 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' A' ' 62' ' ' LEU 2.502 0.2 OUTLIER -55.44 -73.71 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.741 -179.736 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -64.08 -137.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -84.17 52.01 2.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 110.406 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -90.75 -27.68 18.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -88.42 -47.27 8.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 110.446 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.44 HD13 ' CG2' ' B' ' 18' ' ' VAL . 2.9 pp -48.08 -24.22 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.339 -0.851 . . . . 0.0 110.879 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.475 ' CG ' HG12 ' B' ' 103' ' ' ILE . 3.7 m-85 -49.16 120.14 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.203 -0.936 . . . . 0.0 110.57 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -95.21 175.76 6.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.519 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -96.01 139.05 32.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.926 . . . . 0.0 110.679 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 20.7 t -143.77 161.65 38.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 110.126 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -83.92 -34.32 24.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.471 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 58.2 19.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.93 115.81 4.29 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.55 1.29 . . . . 0.0 110.322 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.441 ' HA ' ' CD1' ' B' ' 92' ' ' ILE . 42.7 m-80 -89.77 18.8 5.21 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.434 -0.791 . . . . 0.0 110.663 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.419 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -122.44 159.02 28.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.43 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 0.0 OUTLIER -145.63 169.47 18.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 110.489 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.73 130.73 47.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 110.394 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.89 152.53 24.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.414 HG23 ' CB ' ' B' ' 86' ' ' ARG . 40.7 p -57.89 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.376 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.8 -126.31 1.46 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' B' ' 37' ' ' VAL . 4.4 tp -153.07 27.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -1.108 . . . . 0.0 110.269 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -108.27 -70.82 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.559 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.414 ' CB ' HG23 ' B' ' 81' ' ' THR . 12.8 mtt180 -70.58 124.04 23.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.483 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.573 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 20.5 mtp -118.87 124.83 48.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -103.33 164.59 11.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 110.016 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 91.4 mt -136.15 126.8 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.484 ' CE2' HD13 ' B' ' 29' ' ' LEU . 48.8 m-85 -122.03 169.81 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.729 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 35.3 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.976 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' B' ' 75' ' ' ASN . 2.1 pt -62.87 -24.14 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 110.527 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.44 ' HG3' ' CD1' ' B' ' 92' ' ' ILE . 24.3 mttt -151.1 131.8 7.3 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.968 -1.083 . . . . 0.0 110.601 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.479 ' CD ' ' HB2' ' B' ' 26' ' ' LYS . 39.5 Cg_exo -35.32 145.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.806 0 C-N-CA 122.339 2.026 . . . . 0.0 112.36 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' B' ' 99' ' ' GLU . 49.7 mt -127.07 149.81 32.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.468 -0.77 . . . . 0.0 110.561 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.411 ' N ' HG23 ' B' ' 95' ' ' ILE . . . -88.6 159.08 18.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.434 -0.791 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -56.51 -21.52 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 111.423 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.68 61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.438 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 3.4 mt-10 -131.7 174.96 9.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -1.23 . . . . 0.0 111.03 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.25 123.89 43.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.44 -0.788 . . . . 0.0 109.823 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 54.1 mt -88.44 138.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.657 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.61 179.41 8.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.826 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.475 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.6 pp -145.84 133.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 110.242 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 47.2 t -61.09 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 110.432 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.39 -75.88 0.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.45 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.05 -173.21 42.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.4 -12.4 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -1.105 . . . . 0.0 110.825 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.61 -55.49 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 110.619 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -54.35 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 110.875 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 111.242 178.577 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.505 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.29 0.567 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.84 155.06 60.85 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.312 -1.353 0 O-C-N 123.659 1.347 . . . . 0.0 111.237 -179.745 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 28.3 p90 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.399 0.618 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -138.07 143.42 40.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.63 -49.99 18.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.374 -0.828 . . . . 0.0 111.354 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.49 -37.41 80.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 110.772 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.429 HG23 ' CG1' ' A' ' 30' ' ' VAL . 90.2 t -153.54 149.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 tt -118.26 167.11 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.53 126.08 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 110.403 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -150.48 115.51 5.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.689 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 2.2 tmtt? 61.91 66.17 0.85 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 119.546 -1.971 . . . . 0.0 110.742 2.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HB3' ' CG ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 0.0 111.312 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.482 ' CE2' ' CE ' ' A' ' 10' ' ' LYS . 15.1 m-85 -98.03 105.1 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -1.134 . . . . 0.0 110.637 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.04 -171.5 15.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.1 p -123.36 132.13 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.97 -1.312 . . . . 0.0 109.679 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' CE1' ' HB3' ' A' ' 9' ' ' LYS . 3.2 m-30 -95.21 164.04 13.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.823 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB1' HG23 ' A' ' 95' ' ' ILE . . . -124.09 97.97 5.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.478 -0.764 . . . . 0.0 110.623 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.54 -19.62 49.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 5.7 mttm -90.7 178.77 5.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.88 . . . . 0.0 108.982 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.428 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 49.6 m 102.43 18.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.081 -1.637 . . . . 0.0 110.325 1.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 24.1 m-85 -108.73 158.32 17.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.87 -159.59 0.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 110.268 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -97.76 90.37 4.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 110.33 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.68 52.13 0.2 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.35 135.05 49.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.169 . . . . 0.0 110.422 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' CE2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -76.33 105.29 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 91' ' ' THR . 93.0 t -67.66 -46.63 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.247 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.67 152.19 6.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.45 141.97 35.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.404 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -146.2 -177.0 5.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 110.28 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 -178.8 4.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' MET . 25.6 p -148.94 174.3 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.485 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.442 HD12 HG21 ' A' ' 36' ' ' ILE . 46.7 mt -105.73 102.2 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 t -86.82 92.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.141 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 15.2 tpt180 -116.44 154.26 30.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.376 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.429 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.9 m170 -61.21 -167.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.433 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.65 28.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.55 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.48 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 109.228 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -50.75 -25.71 4.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.608 -1.307 . . . . 0.0 109.651 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CZ3' ' HG ' ' A' ' 47' ' ' LEU . 19.0 t-105 -57.81 -56.73 18.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.653 . . . . 0.0 109.447 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.88 86.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 m -62.75 -65.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -1.156 . . . . 0.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.11 -47.7 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 110.227 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.472 ' HG ' ' CZ3' ' A' ' 43' ' ' TRP . 4.4 mm? -90.61 41.0 1.04 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 110.51 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 62.35 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 110.608 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER 179.5 139.23 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.844 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.467 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 13.8 m-85 56.82 33.41 23.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 110.563 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.451 HD23 ' CZ2' ' A' ' 43' ' ' TRP . 8.7 mt -105.51 102.09 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 110.459 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -88.85 102.92 15.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.106 -0.996 . . . . 0.0 109.021 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.441 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 13.2 t -103.2 155.91 18.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 111.453 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 84' ' ' LEU . 11.4 mtp180 -116.97 -173.38 2.38 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -83.61 74.07 10.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 74.1 m-20 167.85 -27.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -174.57 -174.91 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.339 -0.85 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.441 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 2.4 p -117.62 147.13 43.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 36' ' ' ILE . . . -132.1 133.85 44.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 110.605 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -89.29 155.08 19.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 109.935 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -86.63 93.08 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.11 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD11 ' CB ' ' B' ' 62' ' ' LEU 2.505 0.0 OUTLIER -55.64 -70.29 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 110.691 -179.175 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.79 -150.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.4 ' HB3' HG12 ' A' ' 67' ' ' ILE . 42.7 m-85 -76.0 57.72 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.438 -1.036 . . . . 0.0 110.711 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -90.82 -24.68 27.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB3' ' CG ' ' A' ' 50' ' ' TYR . . . -83.29 -42.71 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -1.147 . . . . 0.0 110.532 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 18' ' ' VAL . 1.1 pp -49.91 -29.26 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.975 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' A' ' 89' ' ' ILE . 13.8 m-85 -55.12 140.01 39.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 110.655 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -118.24 -177.69 3.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.201 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.514 ' NE2' ' CE2' ' A' ' 110' ' ' TRP . 18.9 t60 -100.76 125.37 47.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -129.97 141.44 50.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.12 20.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.182 -0.949 . . . . 0.0 110.54 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.49 87.43 41.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.88 . . . . 0.0 110.148 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 10.9 Cg_endo -58.06 105.24 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.605 1.318 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.13 -17.19 57.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 110.613 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.1 166.98 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.569 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.11 -163.73 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.171 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -143.07 163.69 32.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 43.2 tt0 -146.56 112.05 5.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.419 HD11 ' CD ' ' C' ' 218' ' ' PRO . 1.8 mp -91.22 60.22 4.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.079 -1.013 . . . . 0.0 110.427 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.43 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 0.1 OUTLIER 42.15 28.39 0.1 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.592 -0.692 . . . . 0.0 111.212 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.45 24.31 2.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.45 28.33 0.17 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.105 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 62.8 mt 50.99 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.252 . . . . 0.0 110.734 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.46 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.795 . . . . 0.0 110.517 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -145.24 102.9 3.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.125 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.403 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 3.8 mtp -81.24 118.63 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.743 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.406 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -111.02 127.0 55.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.744 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.484 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 10.0 mt -89.1 117.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.092 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE2' ' CD2' ' A' ' 29' ' ' LEU . 18.9 m-85 -107.3 -173.57 2.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.32 -0.863 . . . . 0.0 110.411 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.434 HG23 ' CG2' ' A' ' 30' ' ' VAL . 21.3 p -130.44 93.24 3.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 93' ' ' LYS . 2.4 pt -56.86 -19.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.471 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.65 18.11 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -51.42 141.2 41.94 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.519 1.273 . . . . 0.0 110.452 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.441 HG22 ' CB ' ' A' ' 99' ' ' GLU . 13.9 mt -109.64 150.52 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -94.71 156.9 16.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.59 -0.694 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 21.9 mt -63.58 112.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.72 36.61 3.44 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' CB ' HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -101.11 155.84 17.76 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.294 -1.121 . . . . 0.0 110.57 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.0 115.04 26.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.133 -0.979 . . . . 0.0 109.717 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 18' ' ' VAL . 16.2 mt -89.64 122.46 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 110.435 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 68.6 p -154.77 134.21 12.63 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.1 pp -104.99 153.82 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.096 . . . . 0.0 110.524 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.0 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.524 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -127.14 -68.49 0.79 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.22 24.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.23 -39.63 60.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -1.116 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.58 -61.4 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.275 -0.89 . . . . 0.0 110.109 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -94.37 51.6 1.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.32 -0.862 . . . . 0.0 110.543 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.514 ' CE2' ' NE2' ' A' ' 70' ' ' HIS . 10.5 t-105 . . . . . 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.584 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.228 0.537 . . . . 0.0 110.382 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . 0.44 ' CB ' ' CD ' ' C' ' 218' ' ' PRO . . . -156.61 -176.23 0.59 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' C' ' 217' ' ' ALA . 22.1 Cg_exo . . . . . 0 C--N 1.312 -1.349 0 O-C-N 123.659 1.347 . . . . 0.0 110.586 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 28.3 p90 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.326 0.584 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -137.88 143.66 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 110.153 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.83 -49.89 19.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.823 . . . . 0.0 111.326 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.427 ' O ' ' CG2' ' B' ' 6' ' ' VAL . 0.0 OUTLIER -68.55 -37.4 79.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 110.769 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.434 HG23 ' CG1' ' B' ' 30' ' ' VAL . 89.8 t -153.52 149.14 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 110.185 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -118.2 167.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.582 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 126.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 110.349 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -150.8 115.56 5.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.628 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.528 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 2.2 tmtt? 62.0 66.25 0.83 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.599 -1.938 . . . . 0.0 110.748 2.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 111.037 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.483 ' CE2' ' CE ' ' B' ' 10' ' ' LYS . 15.2 m-85 -98.0 105.01 17.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -1.13 . . . . 0.0 110.688 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.85 -171.55 15.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' B' ' 67' ' ' ILE . 2.2 p -123.25 132.02 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.326 . . . . 0.0 109.794 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' B' ' 9' ' ' LYS . 3.2 m-30 -95.29 164.05 13.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 110.791 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.26 98.07 5.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 110.581 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.51 -19.67 49.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.017 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 5.7 mttm -90.59 178.75 6.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.042 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.429 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 49.9 m 102.45 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.079 -1.638 . . . . 0.0 110.325 1.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 24.1 m-85 -108.67 158.32 17.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -0.973 . . . . 0.0 110.436 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.86 -159.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.26 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -97.69 90.29 4.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.73 52.13 0.2 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.33 135.06 50.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -1.165 . . . . 0.0 110.477 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.512 ' CD2' ' CE2' ' B' ' 90' ' ' PHE . 0.9 OUTLIER -76.35 105.28 7.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 110.254 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.435 ' CG2' HG23 ' B' ' 91' ' ' THR . 92.9 t -67.73 -46.56 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.64 152.26 6.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.5 141.9 35.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.503 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.403 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -146.18 -176.96 5.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.45 -178.7 4.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 110.276 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' B' ' 60' ' ' MET . 25.6 p -149.0 174.31 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.455 HG21 HD12 ' B' ' 36' ' ' ILE . 46.6 mt -105.96 100.76 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 24.8 t -84.84 92.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 110.499 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' B' ' 39' ' ' HIS . 15.1 tpt180 -116.66 154.3 30.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . 0.426 ' N ' ' HG3' ' B' ' 38' ' ' ARG . 3.0 m170 -61.14 -167.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.416 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.66 28.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.53 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.44 -0.787 . . . . 0.0 109.234 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -50.8 -25.65 4.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.69 -1.256 . . . . 0.0 109.616 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.478 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 19.1 t-105 -57.84 -56.75 17.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.65 -0.656 . . . . 0.0 109.415 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.82 86.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 8.9 m -62.76 -65.1 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -1.134 . . . . 0.0 110.412 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.43 75.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.478 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 4.4 mm? -90.94 41.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 110.403 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.02 62.34 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 110.602 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.3 OUTLIER 179.51 139.28 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 0.0 109.876 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.461 ' CG ' ' HB3' ' B' ' 66' ' ' ALA . 13.8 m-85 56.81 33.47 23.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.179 -0.951 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.452 HD23 ' CZ2' ' B' ' 43' ' ' TRP . 8.6 mt -105.5 101.7 11.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.55 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -88.28 102.95 15.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.121 -0.987 . . . . 0.0 109.16 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 13.2 t -103.21 155.86 18.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 111.525 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.41 ' HB2' ' CD1' ' B' ' 84' ' ' LEU . 11.5 mtp180 -117.5 -176.04 2.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.579 -0.701 . . . . 0.0 109.63 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -79.79 73.64 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 73.8 m-20 167.77 -27.22 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -174.43 -174.65 0.88 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.36 -0.838 . . . . 0.0 110.913 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.438 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 2.4 p -117.68 147.09 43.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.409 ' CB ' HD22 ' B' ' 84' ' ' LEU . . . -132.18 133.64 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' B' ' 35' ' ' CYS . 0.0 OUTLIER -89.21 153.72 20.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.148 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.424 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -84.78 93.02 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 110.5 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.441 ' CB ' HD11 ' A' ' 62' ' ' LEU 2.507 0.0 OUTLIER -55.7 -70.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.728 -179.39 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.69 -150.47 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -76.03 58.06 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.406 -1.055 . . . . 0.0 110.627 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -91.34 -24.42 26.54 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' B' ' 50' ' ' TYR . . . -83.36 -42.72 16.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.561 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.432 ' CD1' HG13 ' B' ' 18' ' ' VAL . 1.1 pp -49.94 -29.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.95 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.472 ' CZ ' HG12 ' B' ' 89' ' ' ILE . 13.8 m-85 -55.1 140.08 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.011 -1.055 . . . . 0.0 110.621 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -118.37 -177.73 3.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . 0.528 ' NE2' ' CE2' ' B' ' 110' ' ' TRP . 18.8 t60 -100.7 125.39 47.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 110.292 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.5 t -129.99 141.43 50.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.259 -0.901 . . . . 0.0 110.201 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.17 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.528 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.45 87.41 40.86 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . 0.416 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 10.9 Cg_endo -58.12 105.32 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.669 1.352 . . . . 0.0 110.393 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.18 -17.17 57.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.03 23.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.16 -163.68 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 110.193 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -143.11 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.53 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -146.62 112.03 5.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.336 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.42 HD11 ' CD ' ' D' ' 218' ' ' PRO . 1.8 mp -91.16 60.12 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.451 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 0.1 OUTLIER 42.24 28.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.543 -0.723 . . . . 0.0 111.149 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.42 24.27 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.4 28.27 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.069 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 62.6 mt 51.16 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -1.189 . . . . 0.0 110.704 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.52 -33.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 110.464 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . 0.432 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.1 OUTLIER -145.23 102.94 3.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.119 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.414 ' HG3' ' CD2' ' B' ' 80' ' ' LEU . 3.8 mtp -81.24 118.59 22.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.0 126.7 55.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.831 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.472 HG12 ' CZ ' ' B' ' 68' ' ' PHE . 10.0 mt -88.67 117.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 110.183 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' B' ' 29' ' ' LEU . 18.9 m-85 -107.35 -173.52 2.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 110.461 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.435 HG23 ' CG2' ' B' ' 30' ' ' VAL . 21.3 p -130.44 93.19 3.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.43 HG13 ' N ' ' B' ' 93' ' ' LYS . 2.5 pt -56.88 -19.05 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.43 ' N ' HG13 ' B' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.69 18.17 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 110.115 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.68 141.43 43.73 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.521 1.274 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.45 HG22 ' CB ' ' B' ' 99' ' ' GLU . 14.0 mt -109.7 150.53 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 110.705 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -94.72 156.88 16.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.169 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 22.0 mt -63.53 112.09 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.965 -1.084 . . . . 0.0 110.206 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.65 36.58 3.46 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . 0.45 ' CB ' HG22 ' B' ' 95' ' ' ILE . 0.4 OUTLIER -100.94 155.68 17.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.304 -1.115 . . . . 0.0 110.591 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.96 114.89 26.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.994 . . . . 0.0 109.732 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' B' ' 102' ' ' THR . 16.9 mt -89.36 122.49 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.516 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 66.6 p -154.67 134.28 12.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.434 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.1 pp -104.93 153.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 110.549 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.98 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -127.13 -68.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.229 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.01 179.21 24.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -39.66 60.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -1.143 . . . . 0.0 110.23 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -57.55 -61.5 2.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -94.27 51.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.311 -0.868 . . . . 0.0 110.565 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CE2' ' NE2' ' B' ' 70' ' ' HIS . 10.6 t-105 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.249 0.547 . . . . 0.0 110.429 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . 0.438 ' CB ' ' CD ' ' D' ' 218' ' ' PRO . . . -156.57 -176.2 0.59 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' D' ' 217' ' ' ALA . 22.2 Cg_exo . . . . . 0 C--N 1.312 -1.371 0 O-C-N 123.678 1.357 . . . . 0.0 110.579 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.448 0.642 . . . . 0.0 111.764 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -99.89 147.63 25.33 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.752 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.0 -23.52 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 111.288 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 2.7 mtt180 -102.73 -29.67 11.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.028 -1.045 . . . . 0.0 111.121 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' CG1' ' CG1' ' A' ' 18' ' ' VAL . 94.9 t -153.23 137.31 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.426 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 5.7 tt -117.48 161.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 110.971 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.4 p -88.97 124.24 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.097 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 39.0 mttt -150.35 129.19 12.47 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.392 -0.818 . . . . 0.0 109.281 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.544 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 57.96 74.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 119.669 -1.894 . . . . 0.0 111.928 1.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.359 -0.838 . . . . 0.0 111.579 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.485 ' CG ' ' HD3' ' A' ' 10' ' ' LYS . 1.1 m-85 -58.63 94.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -1.147 . . . . 0.0 110.442 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA3' ' ND2' ' A' ' 69' ' ' ASN . . . -120.28 171.61 14.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.477 ' CG1' ' CG1' ' A' ' 6' ' ' VAL . 95.0 t -93.09 140.43 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.938 -1.33 . . . . 0.0 109.825 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -105.73 132.88 51.32 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.11 -0.993 . . . . 0.0 110.086 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.39 88.45 7.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.702 -0.624 . . . . 0.0 110.446 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -67.4 -15.04 63.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.798 178.089 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 2.0 mttm -106.79 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.41 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.91 20.93 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.154 -1.591 . . . . 0.0 109.846 1.389 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 54.1 m-85 -118.65 163.91 16.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.544 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.34 -178.63 3.65 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 110.025 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -74.45 99.66 3.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.947 . . . . 0.0 110.299 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.25 61.8 0.55 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.3 123.28 23.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 110.505 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.482 HD23 ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -66.63 127.48 32.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.176 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.9 t -88.89 -46.55 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.346 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.47 153.17 6.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.18 136.46 31.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 110.304 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.79 170.32 9.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.697 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.0 -174.2 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CD1' HD23 ' A' ' 62' ' ' LEU . 65.0 mt -123.75 151.97 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 43.7 t -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.8 mmt-85 -134.86 145.68 48.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.269 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -63.31 176.97 0.7 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 110.359 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 40' ' ' ASN . 2.9 m120 -67.48 -131.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.142 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.25 0.24 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.624 -1.298 . . . . 0.0 110.596 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.12 -25.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.0 111.09 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.504 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 60.4 t-105 -69.29 -55.85 9.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.155 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.61 -22.48 56.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.4 m -90.28 -60.15 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -1.212 . . . . 0.0 110.663 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.72 -55.45 11.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.872 -1.143 . . . . 0.0 110.231 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.0 mm? -92.24 33.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 110.085 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 9.8 pt-20 -68.48 64.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.171 -0.956 . . . . 0.0 111.026 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -169.42 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.858 -1.151 . . . . 0.0 111.024 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 25.8 m-85 -128.87 53.51 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.05 -1.031 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 52.7 mt -124.98 118.02 25.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -89.41 101.54 14.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 108.995 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.8 t -98.92 155.52 17.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 111.561 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.61 -168.07 1.72 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.616 -0.678 . . . . 0.0 109.756 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -83.04 79.58 9.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.964 -1.085 . . . . 0.0 109.384 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 1.5 p30 160.91 -25.18 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.766 -0.584 . . . . 0.0 110.049 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.67 -167.82 0.2 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 1.3 m -130.68 139.28 50.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.3 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.434 ' CB ' ' CD2' ' A' ' 84' ' ' LEU . . . -124.13 172.39 9.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.685 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.463 ' HB2' ' CZ2' ' A' ' 43' ' ' TRP . 9.5 ttt -117.01 153.04 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.95 90.9 8.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.445 -0.784 . . . . 0.0 110.369 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.438 HD23 ' CD1' ' A' ' 36' ' ' ILE 2.501 0.5 OUTLIER -55.41 -63.45 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.807 -179.681 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.63 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.472 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 39.7 m-85 -89.71 42.45 1.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -1.138 . . . . 0.0 110.589 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.74 -21.25 56.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -89.06 -59.3 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.6 pp -44.79 -22.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.606 -0.684 . . . . 0.0 112.375 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 64' ' ' PHE . 4.5 m-85 -49.55 153.17 1.2 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.614 -1.304 . . . . 0.0 110.677 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.436 ' HB2' ' CG2' ' A' ' 102' ' ' THR . 26.0 m-20 -119.32 -171.95 2.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 111.322 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -102.81 156.81 17.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.778 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.69 141.08 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.007 -1.058 . . . . 0.0 110.697 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -54.92 -29.3 55.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.9 92.49 39.76 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.438 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.97 104.19 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.659 1.347 . . . . 0.0 110.632 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.49 -21.66 35.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 110.311 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 110.307 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -171.89 2.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -130.77 174.15 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -149.82 141.33 23.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.52 142.81 33.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.208 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.424 HG22 ' CZ ' ' A' ' 88' ' ' ARG . 69.3 p -80.1 85.69 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.2 95.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.691 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.38 28.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' CD2' ' CB ' ' A' ' 59' ' ' ALA . 1.1 mp -109.74 98.86 8.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.127 . . . . 0.0 110.437 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -144.73 -53.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.15 174.89 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 110.017 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.5 mtp -142.76 128.35 19.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.702 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' CZ ' HG22 ' A' ' 81' ' ' THR . 57.9 mtt180 -114.54 140.42 48.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 110.172 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.442 HG12 ' CE2' ' A' ' 68' ' ' PHE . 8.3 mt -99.96 110.25 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.097 -1.002 . . . . 0.0 109.976 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.482 ' CE1' HD23 ' A' ' 29' ' ' LEU . 9.5 m-85 -104.7 171.2 7.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.292 -0.88 . . . . 0.0 110.582 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.6 p -117.09 118.98 33.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.976 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 92' ' ' ILE . 21.6 pt -86.74 13.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.752 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -176.82 142.15 0.53 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.201 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.04 136.34 17.83 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.577 1.304 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.8 mt -116.53 140.88 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 110.734 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.67 153.4 20.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 110.493 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -50.33 -23.06 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 111.168 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.01 57.84 0.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.22 175.0 8.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.246 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.86 128.96 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.962 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.445 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 31.6 mt -92.4 119.37 39.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 0.0 110.414 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 69' ' ' ASN . 58.7 p -150.95 123.93 8.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.649 -0.657 . . . . 0.0 109.673 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.47 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.1 pt -88.91 159.39 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 110.785 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.473 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 5.2 p -83.38 -157.15 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.413 -0.804 . . . . 0.0 110.348 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 104' ' ' SER . 28.3 m-85 -137.57 -66.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.33 -164.42 34.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -29.22 62.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -1.149 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -76.21 -71.28 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.433 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 1.2 m-85 -58.5 99.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 110.405 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.505 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.266 0.555 . . . . 0.0 110.452 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . 0.43 ' CB ' ' CD ' ' C' ' 218' ' ' PRO . . . 55.11 -177.8 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' C' ' 217' ' ' ALA . 25.2 Cg_exo . . . . . 0 C--N 1.312 -1.342 0 O-C-N 123.657 1.346 . . . . 0.0 110.682 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' B' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.439 0.638 . . . . 0.0 111.733 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -99.9 147.74 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -49.02 -23.53 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 111.3 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' B' ' 6' ' ' VAL . 2.7 mtt180 -102.7 -29.76 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.104 . . . . 0.0 111.068 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.485 ' CG1' ' CG1' ' B' ' 18' ' ' VAL . 95.3 t -153.15 137.39 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.358 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 5.8 tt -117.64 160.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.233 -0.917 . . . . 0.0 111.059 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -88.27 124.56 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 0.0 110.16 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.549 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 38.9 mttt -150.81 129.22 12.09 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.371 -0.83 . . . . 0.0 109.286 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.549 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 58.13 74.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 119.55 -1.969 . . . . 0.0 111.907 1.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' B' ' 9' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.306 -0.871 . . . . 0.0 111.24 177.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.484 ' CG ' ' HD3' ' B' ' 10' ' ' LYS . 1.1 m-85 -58.56 94.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 110.457 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.438 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -120.3 171.64 14.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.485 ' CG1' ' CG1' ' B' ' 6' ' ' VAL . 96.3 t -92.97 140.27 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.032 -1.275 . . . . 0.0 109.881 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -105.72 132.2 52.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.123 -0.985 . . . . 0.0 110.297 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.48 88.49 7.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 110.6 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.1 OUTLIER -67.49 -14.92 63.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 178.112 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 2.0 mttm -106.84 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.413 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.87 20.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.205 -1.56 . . . . 0.0 109.855 1.442 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 54.1 m-85 -118.63 163.91 16.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.887 . . . . 0.0 110.534 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 -178.64 3.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -74.48 99.74 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.22 61.81 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.31 123.38 24.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -1.172 . . . . 0.0 110.437 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.483 ' CD2' ' CE2' ' B' ' 90' ' ' PHE . 1.0 OUTLIER -66.78 127.47 32.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 110.163 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.85 -46.51 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 110.308 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.52 153.13 6.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.369 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.15 136.47 31.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 110.268 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.472 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.8 170.31 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.677 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.94 -174.19 4.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.077 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.429 ' CD1' HD23 ' B' ' 62' ' ' LEU . 65.0 mt -123.77 151.91 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 110.429 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' B' ' 84' ' ' LEU . 43.7 t -124.63 104.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.303 -0.873 . . . . 0.0 110.601 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.502 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 14.8 mmt-85 -134.87 145.73 48.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 110.264 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -63.37 177.03 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.32 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 40' ' ' ASN . 2.9 m120 -67.44 -131.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.167 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.17 0.24 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.624 -1.297 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.22 -25.63 0.98 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 111.116 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.502 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 60.3 t-105 -69.27 -55.88 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 110.138 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.7 -22.29 56.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 97.4 m -90.34 -60.09 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -1.219 . . . . 0.0 110.67 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.04 -54.46 15.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.976 -1.077 . . . . 0.0 110.373 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.481 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.0 mm? -93.39 33.46 1.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 109.787 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 9.8 pt-20 -68.51 64.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.205 -0.935 . . . . 0.0 111.075 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' B' ' 47' ' ' LEU . 16.2 t0 -169.4 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.168 . . . . 0.0 110.957 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.482 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 25.8 m-85 -128.84 53.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.992 . . . . 0.0 110.921 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' B' ' 60' ' ' MET . 52.5 mt -125.08 117.83 24.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 111.189 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -89.17 101.6 14.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.023 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.8 t -98.97 155.46 17.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.158 -0.964 . . . . 0.0 111.563 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -170.9 2.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.751 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -78.97 79.24 5.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.14 -0.975 . . . . 0.0 110.208 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.5 p30 160.71 -25.27 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.651 -0.655 . . . . 0.0 110.134 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.5 -167.84 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.057 -1.027 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 1.3 m -130.64 139.28 50.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.348 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.447 ' CB ' ' CD2' ' B' ' 84' ' ' LEU . . . -124.1 172.42 9.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -0.999 . . . . 0.0 110.705 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.476 ' HB2' ' CZ2' ' B' ' 43' ' ' TRP . 9.5 ttt -117.12 152.63 34.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.341 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.41 90.77 8.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 62' ' ' LEU 2.502 0.5 OUTLIER -55.31 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.846 -179.807 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.59 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' B' ' 68' ' ' PHE . 39.6 m-85 -89.68 42.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.127 . . . . 0.0 110.603 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.71 -21.29 56.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -89.03 -59.34 2.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -1.173 . . . . 0.0 110.554 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.6 pp -44.71 -22.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.639 -0.663 . . . . 0.0 112.368 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.5 m-85 -49.48 153.76 1.05 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.628 -1.295 . . . . 0.0 110.668 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.438 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 26.2 m-20 -120.0 -171.46 2.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 111.114 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -103.65 156.64 17.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.429 -0.794 . . . . 0.0 109.676 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.57 141.15 10.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.053 . . . . 0.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -55.2 -29.09 57.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 110.271 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.91 92.52 39.66 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.356 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.07 104.2 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.647 1.341 . . . . 0.0 110.576 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.5 -21.63 35.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 110.31 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.46 140.27 35.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.912 . . . . 0.0 110.31 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.32 -171.91 2.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -130.75 174.07 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 110.644 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -149.83 141.34 23.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.875 . . . . 0.0 110.297 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.55 142.82 33.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.43 HG22 ' CZ ' ' B' ' 88' ' ' ARG . 68.7 p -80.08 85.74 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.718 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.09 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.72 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.35 28.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.447 ' CD2' ' CB ' ' B' ' 59' ' ' ALA . 1.1 mp -109.81 98.87 8.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -1.097 . . . . 0.0 110.423 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.71 -53.78 0.31 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 174.86 10.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.064 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 15.5 mtp -142.78 128.42 19.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.43 ' CZ ' HG22 ' B' ' 81' ' ' THR . 58.4 mtt180 -114.66 140.47 48.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.121 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.437 HG12 ' CE2' ' B' ' 68' ' ' PHE . 8.3 mt -99.92 110.1 26.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.995 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.483 ' CE2' ' CD2' ' B' ' 29' ' ' LEU . 9.5 m-85 -104.62 171.18 7.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 110.549 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -117.11 118.97 33.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.996 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.435 HG22 HD13 ' B' ' 92' ' ' ILE . 21.5 pt -86.69 13.29 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.787 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -176.8 142.12 0.53 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 110.148 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.66 136.73 21.24 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.464 1.244 . . . . 0.0 111.056 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 61.6 mt -116.49 140.9 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.789 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.74 153.42 20.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -50.28 -23.08 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 111.045 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.14 57.93 0.41 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.37 174.84 8.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.24 . . . . 0.0 110.583 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.8 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.444 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 32.3 mt -92.59 119.36 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 110.335 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' B' ' 69' ' ' ASN . 61.3 p -150.83 123.98 8.81 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.608 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.1 pt -88.85 159.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.759 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 5.3 p -83.42 -157.18 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 110.321 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 28.1 m-85 -137.54 -66.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.47 34.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -29.27 62.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -1.157 . . . . 0.0 110.365 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -76.22 -71.28 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.439 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 1.2 m-85 -58.48 99.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.45 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.236 0.541 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . 0.419 ' CB ' ' CD ' ' D' ' 218' ' ' PRO . . . 55.18 -177.76 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' D' ' 217' ' ' ALA . 25.5 Cg_exo . . . . . 0 C--N 1.312 -1.383 0 O-C-N 123.7 1.369 . . . . 0.0 110.651 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.485 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 32.7 p90 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.536 0.684 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -150.69 141.32 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.138 -179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.03 -45.8 32.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 111.046 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.413 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 6.5 mtm-85 -74.69 -33.81 62.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.543 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 84.5 t -153.33 134.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.415 HG21 ' CB ' ' A' ' 19' ' ' PHE . 11.2 tt -117.22 156.37 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 12.7 p -89.35 122.81 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.71 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.2 mttt -151.19 122.01 7.55 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.53 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 59.12 67.09 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.585 -1.947 . . . . 0.0 111.415 1.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.953 . . . . 0.0 111.19 178.629 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CZ ' ' HG3' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.91 6.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -1.159 . . . . 0.0 110.708 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.04 174.6 20.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 82.9 t -97.21 117.42 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.321 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -88.99 127.0 35.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.871 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . . . -90.85 86.88 6.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 110.962 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 1.5 ttp85 -58.65 -19.89 43.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.537 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 11.5 mmtm -105.25 179.27 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 108.965 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.461 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 59.3 m 104.35 23.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.01 -1.681 . . . . 0.0 109.627 2.026 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.1 m-85 -115.89 156.55 25.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 164.28 12.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.377 -0.827 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -62.37 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.22 44.51 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.94 112.09 19.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -1.184 . . . . 0.0 110.443 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.487 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 2.0 tm? -53.48 115.6 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.255 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.0 t -88.89 66.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.6 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.271 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.96 167.29 24.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.288 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.3 179.73 7.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -94.72 -177.26 4.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.9 176.09 11.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.4 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.466 HG23 ' CH2' ' A' ' 43' ' ' TRP . 73.5 mt -109.27 141.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 109.969 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 43.4 t -117.44 115.54 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.049 -1.032 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.483 ' HB3' ' CG ' ' A' ' 43' ' ' TRP . 0.5 OUTLIER -145.96 157.1 43.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 110.416 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.9 177.01 9.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.341 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 29.9 p30 -64.24 -134.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.251 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 7.7 t0 64.83 -148.16 0.26 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.579 -1.325 . . . . 0.0 110.57 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.47 -41.09 13.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.227 -0.921 . . . . 0.0 110.953 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.483 ' CG ' ' HB3' ' A' ' 38' ' ' ARG . 65.9 t-105 -60.92 -35.33 76.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.69 92.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 84.8 m -83.53 -58.32 2.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -1.18 . . . . 0.0 110.687 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.83 -60.07 3.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.181 -0.949 . . . . 0.0 110.489 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.1 mm? -91.72 29.15 1.59 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.882 . . . . 0.0 110.362 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.56 -23.72 0.71 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.0 111.412 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -112.34 167.18 10.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.926 -1.109 . . . . 0.0 109.988 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.422 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 38.2 m-85 52.84 29.94 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 0.0 110.148 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' CG ' ' A' ' 60' ' ' MET . 8.6 tp -116.48 117.4 29.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.338 -0.851 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -89.23 107.71 19.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 23.1 t -106.0 153.81 21.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 -177.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -130.8 -171.53 2.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -82.96 79.75 9.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.979 -1.075 . . . . 0.0 109.263 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.499 0.2 OUTLIER 163.51 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.846 -0.534 . . . . 0.0 109.795 -179.12 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -176.05 -164.29 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.302 -0.874 . . . . 0.0 110.787 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.4 m -136.48 111.93 9.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 110.393 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -102.5 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.368 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.467 ' CG ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.39 163.58 14.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.425 ' HB1' ' N ' ' A' ' 66' ' ' ALA . . . -85.65 87.81 7.45 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' CD1' ' CD1' ' B' ' 62' ' ' LEU 2.515 0.4 OUTLIER -46.65 -84.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.705 -0.622 . . . . 0.0 111.663 -175.614 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -131.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 70.7 m-85 -83.49 50.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 110.734 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.64 -24.54 27.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' N ' ' HB1' ' A' ' 61' ' ' ALA . . . -90.37 -36.59 14.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -1.12 . . . . 0.0 110.55 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 1.3 pp -57.11 -20.88 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.656 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CG ' HG12 ' A' ' 103' ' ' ILE . 12.4 m-85 -56.45 121.67 10.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.005 . . . . 0.0 110.197 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -88.76 177.5 6.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.575 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -98.04 112.08 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 110.356 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.21 157.12 25.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -72.69 -23.17 60.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.396 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -132.17 73.9 77.08 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.56 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.666 1.351 . . . . 0.0 110.562 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.473 ' ND2' ' CE ' ' A' ' 93' ' ' LYS . 13.5 m120 -70.64 -13.51 62.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 110.667 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.76 117.69 30.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 173.6 6.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.127 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -119.54 148.05 43.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.86 139.53 52.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.83 . . . . 0.0 110.156 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.437 ' CD2' HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -113.49 132.66 55.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 110.529 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 p -57.45 -166.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.0 110.297 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.34 59.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.37 -131.47 2.48 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 HD12 ' CD2' ' A' ' 80' ' ' LEU . 4.2 tp -149.22 28.26 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -1.1 . . . . 0.0 110.095 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -100.59 -36.65 9.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.79 145.33 46.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.041 . . . . 0.0 110.892 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.9 ptm -150.24 147.09 27.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.956 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -112.85 161.94 16.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.8 mt -109.57 132.36 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.943 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' A' ' 29' ' ' LEU . 36.7 m-85 -117.79 -178.36 3.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.491 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.6 p -125.83 105.9 9.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.344 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.8 pt -60.65 -16.62 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 110.502 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.473 ' CE ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -148.71 159.61 37.77 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.872 179.156 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.07 130.05 27.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.614 1.323 . . . . 0.0 110.094 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.424 HG22 ' CB ' ' A' ' 20' ' ' ALA . 56.3 mt -98.85 156.42 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.833 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.82 157.39 18.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.532 -0.73 . . . . 0.0 110.968 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.6 mp -61.67 104.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 110.34 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.14 31.03 3.95 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.15 155.55 18.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.23 -1.159 . . . . 0.0 110.074 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.12 117.45 28.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 110.385 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 57.6 mt -95.83 130.01 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.1 p -154.34 170.25 21.76 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.481 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.3 pp -128.88 6.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.004 -1.06 . . . . 0.0 111.427 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 2.2 p 54.75 -151.89 0.36 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.091 -1.006 . . . . 0.0 110.013 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 104' ' ' SER . 25.4 m-85 -133.75 -77.39 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 110.812 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.28 -159.18 20.19 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -90.46 18.8 5.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -1.105 . . . . 0.0 110.595 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.98 -53.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.127 -0.983 . . . . 0.0 110.081 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.447 ' HB3' ' CB ' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -59.99 118.81 6.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 110.32 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.532 -0.73 . . . . 0.0 110.868 179.538 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.504 3.2 m . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.302 0.573 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -115.29 167.71 9.48 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.321 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--N 1.312 -1.364 0 O-C-N 123.643 1.339 . . . . 0.0 110.524 -179.87 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 32.7 p90 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.481 0.658 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -150.97 141.31 22.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 110.124 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 13.3 t70 -47.98 -45.91 31.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.961 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' B' ' 6' ' ' VAL . 6.5 mtm-85 -74.61 -33.92 62.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 84.9 t -153.16 134.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.411 HG21 ' CB ' ' B' ' 19' ' ' PHE . 11.2 tt -117.24 156.07 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 110.588 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' B' ' 8' ' ' VAL . 12.6 p -88.91 123.32 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.66 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.525 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.2 mttt -151.88 121.82 7.09 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 59.08 67.25 0.94 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 119.631 -1.918 . . . . 0.0 111.482 1.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.757 178.473 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.475 ' CZ ' ' HG3' ' B' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.85 6.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -1.149 . . . . 0.0 110.722 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.06 174.56 20.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 85.3 t -97.19 116.75 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.312 . . . . 0.0 110.145 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.524 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 0.5 OUTLIER -88.31 127.05 35.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.014 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.439 ' HB3' ' CD1' ' B' ' 101' ' ' ILE . . . -90.92 86.89 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 110.969 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 1.5 ttp85 -58.74 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 0.0 109.525 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.475 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 11.5 mmtm -105.13 179.3 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 108.953 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.454 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 59.5 m 104.37 23.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.912 -1.742 . . . . 0.0 109.674 1.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.3 m-85 -115.83 156.54 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.376 -0.828 . . . . 0.0 110.622 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 164.25 12.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.339 -0.851 . . . . 0.0 110.042 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -62.37 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.426 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.16 44.52 0.15 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -119.0 112.18 19.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 110.402 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.487 ' CD2' ' CE1' ' B' ' 90' ' ' PHE . 2.0 tm? -53.5 115.58 2.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.83 66.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -0.881 . . . . 0.0 110.093 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.58 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 110.287 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.95 167.38 24.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.328 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.48 179.6 8.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 110.563 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -94.63 -177.34 4.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.83 176.07 11.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 110.382 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.477 HG23 ' CH2' ' B' ' 43' ' ' TRP . 73.1 mt -109.3 141.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' B' ' 84' ' ' LEU . 43.0 t -117.45 115.47 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.478 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.5 OUTLIER -145.87 157.12 43.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 110.409 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.93 176.97 9.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 110.276 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' B' ' 41' ' ' ASP . 29.9 p30 -64.19 -134.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.887 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' B' ' 40' ' ' ASN . 7.6 t0 64.85 -148.16 0.26 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.644 -1.285 . . . . 0.0 110.559 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.41 -41.14 13.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.949 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.478 ' CG ' ' HB3' ' B' ' 38' ' ' ARG . 66.0 t-105 -60.97 -35.29 76.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.771 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -35.58 91.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 85.3 m -83.61 -58.35 2.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.641 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.86 -59.42 3.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 3.1 mm? -92.73 29.49 1.76 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.76 -23.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.173 -0.955 . . . . 0.0 111.335 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -112.26 167.11 10.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.953 -1.092 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.416 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 37.9 m-85 52.93 29.85 8.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.478 ' CD1' ' CG ' ' B' ' 60' ' ' MET . 8.6 tp -116.61 117.19 29.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 111.0 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -88.94 107.75 19.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.868 . . . . 0.0 109.219 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 23.1 t -106.05 153.74 21.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.09 -1.006 . . . . 0.0 111.222 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -131.41 -174.42 3.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.564 -0.71 . . . . 0.0 109.848 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -78.83 79.42 5.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.13 -0.982 . . . . 0.0 110.065 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.2 OUTLIER 163.43 -27.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.756 -0.59 . . . . 0.0 109.839 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -164.01 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.5 m -136.57 112.01 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 110.377 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -102.6 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.407 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.478 ' CG ' ' CD1' ' B' ' 51' ' ' LEU . 0.0 OUTLIER -112.83 161.62 16.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.285 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.414 ' HB1' ' N ' ' B' ' 66' ' ' ALA . . . -82.94 87.73 6.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.936 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.494 ' CD1' ' CD1' ' A' ' 62' ' ' LEU 2.517 0.3 OUTLIER -47.02 -84.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.646 -0.659 . . . . 0.0 111.72 -175.753 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.49 -131.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 71.0 m-85 -83.6 50.92 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.611 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -91.19 -24.19 27.5 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.71 -36.43 14.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -1.139 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.3 pp -57.13 -20.96 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 0.0 110.642 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.479 ' CG ' HG12 ' B' ' 103' ' ' ILE . 12.4 m-85 -56.4 121.67 10.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -88.79 177.4 6.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 110.604 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -97.91 112.15 24.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.358 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.28 157.15 25.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -72.75 -23.17 60.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.356 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -132.12 73.95 77.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.58 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.678 1.357 . . . . 0.0 110.595 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.471 ' ND2' ' CE ' ' B' ' 93' ' ' LYS . 13.5 m120 -70.62 -13.5 62.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.704 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.74 117.72 31.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 110.407 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 173.61 6.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -119.5 147.98 43.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.611 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -127.84 139.57 52.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.436 ' CD2' HD12 ' B' ' 84' ' ' LEU . 0.7 OUTLIER -113.43 132.74 55.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 110.482 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.8 p -57.52 -166.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 110.324 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.41 59.91 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.34 -131.48 2.48 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.437 ' CD2' ' HB2' ' B' ' 59' ' ' ALA . 4.3 tp -149.28 28.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -1.104 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -100.72 -36.51 9.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 110.82 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 145.34 46.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 110.884 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.9 ptm -150.2 147.1 27.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 110.055 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.426 ' HB3' ' CD2' ' B' ' 29' ' ' LEU . 0.0 OUTLIER -112.94 161.98 16.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 110.387 -179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 mt -109.53 132.39 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.968 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' B' ' 29' ' ' LEU . 36.7 m-85 -117.82 -178.36 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 110.473 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 57.6 p -125.79 105.92 9.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 5.8 pt -60.71 -16.6 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.514 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.471 ' CE ' ' ND2' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -148.73 159.79 37.3 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.876 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.31 130.26 28.04 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.59 1.31 . . . . 0.0 110.05 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.419 HG22 ' CB ' ' B' ' 20' ' ' ALA . 56.1 mt -98.92 156.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.0 110.806 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.97 157.44 18.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.912 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.6 mp -61.68 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 110.343 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.24 30.89 3.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.07 155.1 18.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -1.137 . . . . 0.0 110.155 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.48 117.51 27.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.028 -1.045 . . . . 0.0 110.505 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' ILE . . . . . 0.439 ' CD1' ' HB3' ' B' ' 20' ' ' ALA . 57.3 mt -95.96 130.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 110.617 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 30.5 p -154.28 170.23 21.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.726 -0.608 . . . . 0.0 109.487 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.479 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.3 pp -128.71 6.24 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 111.275 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 2.2 p 54.63 -151.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.064 . . . . 0.0 110.059 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 25.4 m-85 -133.7 -77.37 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.99 . . . . 0.0 110.855 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.35 -159.21 20.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.38 18.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.93 -53.35 0.7 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 110.108 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' B' ' 105' ' ' TYR . 0.1 OUTLIER -60.11 118.77 6.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 110.338 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.89 179.641 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 3.2 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.274 0.559 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -115.27 167.7 9.48 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 110.357 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 C--N 1.312 -1.373 0 O-C-N 123.633 1.333 . . . . 0.0 110.526 -179.85 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' CG ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.185 0.517 . . . . 0.0 110.398 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.476 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 22.3 p90 -71.01 145.06 50.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.435 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.14 146.86 33.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 110.251 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.83 -22.65 3.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 110.836 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -90.14 -37.51 14.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.998 . . . . 0.0 110.688 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -152.03 -172.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 110.453 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.04 161.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.212 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.407 HG11 ' CG ' ' A' ' 1' ' ' MET . 9.8 p -97.02 135.46 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 110.765 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 28.4 mttt -139.62 142.71 37.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.78 . . . . 0.0 109.161 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mmtp 52.04 64.31 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 119.797 -1.814 . . . . 0.0 111.217 0.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.477 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -120.64 170.25 7.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.549 -0.719 . . . . 0.0 110.088 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.93 -21.53 56.96 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.603 1.317 . . . . 0.0 110.499 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.94 32.19 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.41 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.05 152.58 21.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.38 -120.07 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -115.2 61.2 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.159 . . . . 0.0 110.331 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.56 24.1 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 67' ' ' ILE . 54.7 t -103.22 154.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.978 -1.307 . . . . 0.0 110.092 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m-85 -113.95 127.85 56.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.301 -0.874 . . . . 0.0 110.127 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' A' ' 101' ' ' ILE . . . -90.23 92.08 8.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.416 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 7.0 ttt180 -58.31 -22.8 54.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 0.0 109.47 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -88.85 178.25 6.49 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.507 -0.746 . . . . 0.0 109.487 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . 2.513 73.9 m 98.58 17.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.231 -1.543 . . . . 0.0 110.351 0.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' A' ' 91' ' ' THR . 19.4 m-85 -108.0 164.36 12.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.1 -165.66 1.01 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 5.4 tttt -85.41 96.47 9.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 110.423 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.6 0.64 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -119.68 123.04 42.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -1.195 . . . . 0.0 110.433 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.476 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -68.27 96.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 110.0 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 89' ' ' ILE . 72.3 t -67.75 -39.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -168.49 164.42 12.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 110.258 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.17 141.55 18.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.421 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 52.7 m -144.96 -176.05 4.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 110.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.25 171.6 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.473 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 65.3 m -146.58 -178.22 6.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 110.168 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 55.9 mt -122.3 143.0 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.6 t -117.39 102.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.5 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.7 mmt180 -125.87 160.47 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -79.64 173.79 12.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 110.405 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.214 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.6 t0 66.52 -150.39 0.2 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.721 -1.237 . . . . 0.0 110.605 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.25 -36.74 4.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.369 -0.832 . . . . 0.0 111.307 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.5 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 57.4 t-105 -55.33 -59.79 4.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.56 57.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 98.4 m -73.83 -70.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.186 . . . . 0.0 110.607 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.67 -43.84 26.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.107 -0.996 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -92.12 16.73 10.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.265 -0.897 . . . . 0.0 111.38 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -59.98 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.984 -1.072 . . . . 0.0 110.449 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.1 t0 -179.03 -69.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.003 -1.061 . . . . 0.0 110.333 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 19.3 m-85 -114.33 61.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD21 ' HG2' ' A' ' 60' ' ' MET . 24.7 mt -111.9 117.45 32.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 111.027 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -88.25 92.64 9.24 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 85.8 p -94.68 145.34 24.91 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 111.497 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -109.77 -172.81 2.11 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.09 72.59 10.11 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.983 -1.073 . . . . 0.0 109.241 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.0 OUTLIER 169.96 -26.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.99 -168.13 0.93 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.283 -0.886 . . . . 0.0 111.262 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.432 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.7 p -129.76 123.98 32.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 0.0 109.806 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -109.43 169.16 8.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.071 -1.018 . . . . 0.0 111.054 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.408 ' HG2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.29 151.13 23.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.27 85.53 7.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 110.007 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.439 ' CB ' HD22 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -52.87 -69.02 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.452 -0.78 . . . . 0.0 110.708 -179.488 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -69.55 -151.26 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.486 ' CD2' HG12 ' A' ' 67' ' ' ILE . 3.7 m-85 -83.94 51.4 2.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -1.05 . . . . 0.0 110.66 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.57 -23.72 49.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . . . -82.55 -49.24 10.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 110.469 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.486 HG12 ' CD2' ' A' ' 64' ' ' PHE . 2.6 pp -45.76 -24.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.753 . . . . 0.0 111.701 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 67' ' ' ILE . 17.2 m-85 -62.2 109.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.844 -1.16 . . . . 0.0 110.024 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -82.1 -176.86 6.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.745 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' CG ' HD11 ' A' ' 111' ' ' LEU . 4.2 t-160 -102.25 119.46 38.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.5 t -121.32 158.96 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.51 -20.37 60.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 20.8 t0 -141.04 63.77 19.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 110.486 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.434 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 17.2 Cg_exo -62.92 114.61 2.5 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.671 1.353 . . . . 0.0 110.025 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -90.95 24.17 2.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.746 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.66 142.47 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.412 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.1 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.37 168.77 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.91 161.26 30.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 110.092 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.0 mt -133.35 127.69 34.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.445 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 83' ' ' GLY . 3.4 p -69.73 -167.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.53 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 105.4 -177.29 22.9 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.14 51.4 1.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -1.128 . . . . 0.0 110.329 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.9 -80.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.826 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.71 130.84 35.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 110.716 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.748 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.5 mtp -115.89 133.6 55.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.9 mtp85 -120.28 163.58 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.583 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 30' ' ' VAL . 89.9 mt -129.83 98.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.476 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 26.5 m-85 -91.42 -176.85 4.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.432 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.498 ' CG2' ' CD1' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.73 81.89 1.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 111.075 -179.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 1.4 pt -60.12 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.12 -0.988 . . . . 0.0 108.571 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 84.42 121.77 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.363 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 84.6 Cg_exo -43.79 148.25 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.526 1.277 . . . . 0.0 111.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.498 ' CD1' ' CG2' ' A' ' 91' ' ' THR . 74.7 mt -119.91 151.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 110.418 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.19 14.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -63.5 117.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.61 5.05 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -104.03 178.45 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -1.21 . . . . 0.0 110.147 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.23 123.69 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.804 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 101' ' ' ILE . 73.9 mt -89.52 127.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 110.122 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 16.7 p -155.44 176.4 12.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.946 -0.471 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.436 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.3 pp -140.42 158.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.01 -1.056 . . . . 0.0 110.563 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.01 -164.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 110.369 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 109' ' ' TYR . 19.4 m-85 -124.16 -81.3 0.63 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.85 -152.61 24.52 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.817 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.13 -53.28 21.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -1.149 . . . . 0.0 110.05 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.91 -167.7 0.91 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.435 -0.791 . . . . 0.0 109.351 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.484 ' HB3' ' CG ' ' A' ' 105' ' ' TYR . 2.7 m-85 46.09 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 111.002 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.466 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 29.6 p-90 -83.55 151.47 25.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.402 0.62 . . . . 0.0 110.601 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 70' ' ' HIS . 1.1 tp -89.41 -78.62 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.595 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 t -176.75 -81.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.001 -1.062 . . . . 0.0 110.474 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -94.55 122.54 60.72 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.155 -0.965 . . . . 0.0 110.364 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.94 64.53 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.497 1.262 . . . . 0.0 110.487 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -115.76 39.57 2.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.35 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.61 45.9 1.6 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.912 . . . . 0.0 110.412 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 96.7 m -155.36 149.77 26.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 110.33 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.22 28.41 8.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.927 . . . . 0.0 110.304 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.386 -179.885 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 7.5 mttt 52.85 45.93 27.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -1.127 . . . . 0.0 110.394 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -170.42 164.14 5.79 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 110.429 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -67.45 111.35 2.29 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.688 1.362 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.24 148.17 26.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.321 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -126.32 104.56 8.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.391 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -75.76 -55.01 6.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.308 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.78 153.97 39.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.903 . . . . 0.0 110.255 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.27 124.67 4.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.343 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -66.37 -31.09 71.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.282 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.72 43.64 1.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 110.301 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -86.5 96.97 10.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 110.406 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.35 -169.92 1.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.335 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -125.55 -85.04 0.63 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.472 ' HE3' ' CE2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 2.9 t -56.33 -168.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.443 -0.785 . . . . 0.0 110.664 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' C' ' 218' ' ' PRO . . . -123.97 176.21 2.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.336 -0.852 . . . . 0.0 110.222 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' C' ' 217' ' ' ALA . 21.5 Cg_endo -66.33 -37.41 24.05 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.623 1.328 . . . . 0.0 110.594 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.38 60.23 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 110.374 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 97.9 m -148.9 84.85 1.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 110.343 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.849 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.406 ' CG ' HG11 ' B' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.239 0.542 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 22.3 p90 -71.03 145.1 50.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.13 146.93 33.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.88 -22.69 3.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -90.08 -37.62 14.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -151.95 -172.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.96 161.83 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 110.219 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.406 HG11 ' CG ' ' B' ' 1' ' ' MET . 10.0 p -97.02 135.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.818 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.504 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 28.4 mttt -139.62 142.76 37.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 109.161 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.504 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mmtp 52.16 64.23 1.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 119.796 -1.815 . . . . 0.0 111.233 0.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.47 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.3 OUTLIER -120.58 170.3 7.39 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -65.94 -21.54 56.9 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.638 1.336 . . . . 0.0 110.471 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.95 32.24 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.439 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.03 152.6 21.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.42 -120.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.404 ' HB2' ' N ' ' B' ' 302' ' ' SAH . 31.5 m-85 -115.17 61.35 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 110.403 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.44 -171.52 23.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.426 ' CG2' HD13 ' B' ' 67' ' ' ILE . 54.2 t -103.24 154.03 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.934 -1.333 . . . . 0.0 110.084 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.479 ' CD1' ' HD2' ' B' ' 9' ' ' LYS . 1.1 m-85 -113.9 127.92 56.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 110.148 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.431 ' HB1' ' CG1' ' B' ' 101' ' ' ILE . . . -90.16 91.86 8.71 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 110.557 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.419 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 7.0 ttt180 -58.17 -22.75 52.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -89.01 178.26 6.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.52 -0.738 . . . . 0.0 109.518 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . 2.514 73.8 m 98.58 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.311 -1.493 . . . . 0.0 110.339 0.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.425 ' CB ' HG21 ' B' ' 91' ' ' THR . 19.6 m-85 -108.07 164.4 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 110.382 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.04 -165.65 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.425 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 5.4 tttt -85.43 96.38 9.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 110.466 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.01 52.66 0.64 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -119.7 122.98 42.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.0 110.411 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.481 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -68.26 96.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 110.044 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.69 -39.96 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.366 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -168.46 164.44 12.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.24 141.5 18.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.431 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 52.5 m -144.85 -176.06 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.923 . . . . 0.0 110.406 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.19 171.66 8.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.535 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.749 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 65.2 m -146.64 -178.27 6.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 55.7 mt -122.29 142.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 39.6 t -117.3 102.91 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.396 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.491 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 14.7 mmt180 -125.81 160.5 29.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -79.65 173.79 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.412 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.6 t0 66.54 -150.32 0.2 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.698 -1.251 . . . . 0.0 110.64 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.36 -36.74 4.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 111.277 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.491 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 57.3 t-105 -55.33 -59.86 4.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 110.181 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.35 -31.54 56.9 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 98.1 m -73.91 -70.64 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -1.233 . . . . 0.0 110.621 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.82 -42.93 27.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.081 -1.012 . . . . 0.0 111.002 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.5 mm? -93.48 17.37 11.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 111.014 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 0.1 OUTLIER -60.28 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.091 . . . . 0.0 110.408 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 47' ' ' LEU . 1.1 t0 -179.01 -69.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.95 -1.094 . . . . 0.0 110.345 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.481 ' CD1' ' HB3' ' B' ' 66' ' ' ALA . 19.4 m-85 -114.38 61.9 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.117 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.4 mt -112.07 116.67 30.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.169 -0.957 . . . . 0.0 111.153 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -87.23 92.64 9.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 0.0 108.795 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.434 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 85.6 p -94.74 145.36 24.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 0.0 111.529 -176.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -110.38 -175.65 2.78 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.541 -0.724 . . . . 0.0 109.48 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.11 72.17 5.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 0.0 OUTLIER 169.77 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.8 -168.17 0.96 Allowed 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.336 -0.852 . . . . 0.0 111.351 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.434 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 1.7 p -129.69 123.97 32.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.688 . . . . 0.0 109.781 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -109.45 169.25 8.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.002 . . . . 0.0 111.054 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.4 ' HE3' ' CD1' ' B' ' 47' ' ' LEU . 0.0 OUTLIER -104.59 149.99 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 110.26 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.66 85.44 7.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.255 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.439 HD22 ' CB ' ' A' ' 62' ' ' LEU 2.501 0.1 OUTLIER -53.0 -69.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.723 -179.646 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -69.49 -151.22 0.49 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.484 ' CD2' HG12 ' B' ' 67' ' ' ILE . 3.7 m-85 -84.02 51.36 2.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.422 -1.046 . . . . 0.0 110.652 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.49 -23.76 49.5 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' CD1' ' B' ' 50' ' ' TYR . . . -82.58 -49.27 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 110.398 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.484 HG12 ' CD2' ' B' ' 64' ' ' PHE . 2.6 pp -45.75 -24.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.491 -0.756 . . . . 0.0 111.749 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.481 ' CG ' HD12 ' B' ' 67' ' ' ILE . 17.2 m-85 -62.32 109.75 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.902 -1.124 . . . . 0.0 110.024 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -81.99 -176.46 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.716 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.458 ' CG ' ' CD1' ' B' ' 111' ' ' LEU . 4.3 t-160 -102.78 119.45 38.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -0.841 . . . . 0.0 110.024 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 36.7 t -121.35 158.94 27.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 -20.43 60.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.42 ' N ' ' HD3' ' B' ' 74' ' ' PRO . 20.7 t0 -140.99 63.63 19.01 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 110.505 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 17.2 Cg_exo -62.79 114.68 2.51 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.627 1.33 . . . . 0.0 110.04 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -91.08 24.29 2.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.701 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.62 142.45 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.401 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.434 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.04 1.01 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.529 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.401 ' HA ' ' HA ' ' B' ' 89' ' ' ILE . 47.3 p-80 -142.42 168.72 19.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.755 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.89 161.27 30.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -0.827 . . . . 0.0 110.037 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.37 127.61 33.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.002 . . . . 0.0 110.487 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' B' ' 83' ' ' GLY . 3.4 p -69.71 -167.35 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 110.278 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 110.229 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 81' ' ' THR . . . 105.43 -177.22 22.85 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.21 51.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 110.291 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.92 -80.77 0.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 110.82 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.69 130.82 35.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.741 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.749 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.6 mtp -115.87 133.64 55.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -120.31 163.55 17.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.641 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' B' ' 78' ' ' HIS . 89.5 mt -129.75 98.65 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.481 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 26.3 m-85 -91.36 -176.8 4.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.386 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.495 ' CG2' ' CD1' ' B' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 81.86 1.76 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.148 -0.97 . . . . 0.0 110.996 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' B' ' 93' ' ' LYS . 1.4 pt -59.96 103.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.657 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 92' ' ' ILE . 0.0 OUTLIER 84.15 121.44 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 C-N-CA 123.541 0.736 . . . . 0.0 109.425 -177.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.425 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 88.2 Cg_exo -44.13 148.51 1.09 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.468 1.246 . . . . 0.0 111.436 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.495 ' CD1' ' CG2' ' B' ' 91' ' ' THR . 74.0 mt -119.92 151.91 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.285 -0.884 . . . . 0.0 110.421 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.18 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.364 -0.835 . . . . 0.0 110.344 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -63.47 117.17 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.05 27.59 5.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -104.03 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.236 . . . . 0.0 110.156 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.29 123.68 48.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.81 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.431 ' CG1' ' HB1' ' B' ' 20' ' ' ALA . 74.3 mt -89.34 127.37 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 110.181 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 16.6 p -155.42 176.43 12.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.664 -0.647 . . . . 0.0 109.798 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.3 pp -140.43 158.07 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.084 -1.01 . . . . 0.0 110.573 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.98 -164.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 0.0 110.37 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' B' ' 109' ' ' TYR . 19.6 m-85 -124.12 -81.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 110.327 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.76 -152.69 24.59 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.06 -53.31 20.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.287 -1.125 . . . . 0.0 110.101 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.86 -167.46 0.85 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.421 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.485 ' CE2' ' HE3' ' D' ' 215' ' ' MLZ . 2.8 m-85 45.81 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.389 -0.82 . . . . 0.0 111.157 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.478 ' O ' ' CE3' ' B' ' 110' ' ' TRP . 30.1 p-90 -83.57 151.58 25.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 110.598 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.458 ' CD1' ' CG ' ' B' ' 70' ' ' HIS . 1.1 tp -89.37 -78.64 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 110.639 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 11.6 t -176.75 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.034 -1.041 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' B' ' 115' ' ' ARG . 9.1 mtt180 -94.57 122.53 60.7 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 110.344 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.87 64.4 0.93 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.474 1.249 . . . . 0.0 110.49 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' B' ' 113' ' ' ARG . 24.2 mmm180 -115.69 39.59 2.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 110.362 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.67 45.97 1.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 110.379 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 96.3 m -155.38 149.8 26.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.341 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.17 28.27 8.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.345 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.414 -179.84 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 52.85 45.94 27.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -1.146 . . . . 0.0 110.402 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -170.41 164.15 5.8 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.419 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -67.46 111.39 2.3 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.654 1.344 . . . . 0.0 110.552 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.25 148.05 26.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 110.35 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -126.27 104.58 8.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 110.382 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -75.68 -55.05 6.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 110.388 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.77 153.91 39.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 110.281 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.24 124.66 4.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 110.395 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -66.34 -31.04 71.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.34 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.73 43.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 110.226 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -86.47 96.9 10.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.94 . . . . 0.0 110.431 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.3 -169.81 1.7 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.343 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' B' ' 109' ' ' TYR . 30.7 mtp85 -125.61 -84.95 0.63 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 110.292 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.485 ' HE3' ' CE2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.504 2.9 t -56.29 -168.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 0.0 110.682 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' D' ' 218' ' ' PRO . . . -124.01 176.19 2.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' D' ' 217' ' ' ALA . 21.4 Cg_endo -66.31 -37.46 23.99 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.644 1.339 . . . . 0.0 110.542 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.31 60.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.398 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 98.0 m -148.89 84.83 1.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 110.34 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.55 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.425 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.421 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.226 0.536 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 54.5 p90 -53.16 132.84 39.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 110.634 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ARG . 46.7 t30 -150.14 161.29 42.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.82 62.01 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.618 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.433 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.2 OUTLIER 174.75 -34.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.0 109.218 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 16.5 m -156.55 -172.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 109.737 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 10.2 tt -160.64 164.29 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.4 ' N ' HG12 ' A' ' 7' ' ' ILE . 7.7 p -89.14 120.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.098 -1.002 . . . . 0.0 110.474 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 26.2 mttt -148.39 127.72 13.03 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.535 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 54.44 42.11 31.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.795 -1.816 . . . . 0.0 110.088 4.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.51 ' CB ' ' CE1' ' A' ' 19' ' ' PHE . 2.1 p -92.83 -171.05 0.25 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.677 -0.64 . . . . 0.0 109.905 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 40.9 Cg_exo -52.24 108.27 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.441 1.232 . . . . 0.0 110.725 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 4.5 mm? 52.67 54.62 10.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.613 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.49 165.68 25.46 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.43 -163.9 17.11 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 10' ' ' LYS . 3.8 m-85 -95.08 99.67 11.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.249 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.72 -160.51 9.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 79.7 t -113.1 138.32 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.837 -1.39 . . . . 0.0 110.414 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CG ' ' CD ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -104.28 140.99 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . . . -104.14 91.01 3.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 110.974 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -60.18 -26.2 66.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 6.2 mtpp -94.28 -177.38 4.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.566 -0.709 . . . . 0.0 109.567 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.431 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 0.1 OUTLIER 108.58 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.123 -1.61 . . . . 0.0 110.109 1.879 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.487 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 48.8 m-85 -114.76 160.82 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.652 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.2 172.27 6.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.978 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 29.5 tttm -72.03 80.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.552 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.43 40.87 0.12 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -119.3 158.52 25.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.386 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.519 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 1.5 tm? -92.41 128.11 38.14 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' CG1' HG13 ' A' ' 6' ' ' VAL . 81.7 t -94.37 -45.61 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -170.32 152.07 3.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 110.64 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.51 35.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.05 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.427 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -146.67 -157.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 110.743 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.91 175.47 5.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.415 -0.803 . . . . 0.0 110.551 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.734 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 3.3 m -150.7 154.93 38.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.393 -0.817 . . . . 0.0 109.988 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.423 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 54.7 mt -94.89 164.01 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.96 106.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -0.962 . . . . 0.0 110.65 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.522 ' CB ' ' CG ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -112.82 -163.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.205 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -128.7 62.45 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 26.8 m120 52.35 -149.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 0.0 110.631 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 17.6 m-20 60.51 -144.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.211 -0.93 . . . . 0.0 110.106 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -46.63 -29.05 1.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.009 -1.057 . . . . 0.0 111.149 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.522 ' CG ' ' CB ' ' A' ' 38' ' ' ARG . 66.1 t-105 -65.07 -44.45 88.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 110.232 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.37 -40.15 97.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.8 m -67.07 -65.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.31 -58.43 7.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? -90.63 50.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -0.4 22.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 111.015 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -129.6 156.8 43.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.942 -1.099 . . . . 0.0 109.681 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 33.3 m-85 54.93 24.09 5.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 109.857 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.485 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 7.5 tp -117.05 123.4 46.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 110.851 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 36.2 m-85 -90.04 118.59 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.444 ' HB2' ' CB ' ' C' ' 214' ' ' ARG . 4.1 m -96.35 138.43 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.112 -0.993 . . . . 0.0 110.967 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' CD1' ' A' ' 84' ' ' LEU . 4.3 ttp180 -109.76 176.47 5.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.449 -0.782 . . . . 0.0 110.228 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -84.18 81.6 8.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.03 -1.044 . . . . 0.0 109.221 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.505 8.9 m-80 148.29 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 109.733 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.7 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -150.9 164.81 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.709 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -150.63 155.85 40.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.531 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.44 ' CE ' HD12 ' A' ' 47' ' ' LEU . 27.5 tpp -102.61 159.68 15.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 110.135 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 60' ' ' MET . . . -87.39 94.26 9.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.101 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.438 HD21 ' CB ' ' B' ' 62' ' ' LEU 2.499 0.1 OUTLIER -55.34 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.804 . . . . 0.0 111.165 -178.978 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.53 -132.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.427 ' HB3' ' CD1' ' A' ' 67' ' ' ILE . 89.2 m-85 -90.16 39.14 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -1.094 . . . . 0.0 110.664 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -79.15 -20.27 70.31 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.97 -48.27 7.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -1.198 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 1.3 pp -55.77 -17.29 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 111.259 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CG ' HG12 ' A' ' 103' ' ' ILE . 4.6 m-85 -49.01 134.29 17.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.881 -1.137 . . . . 0.0 110.832 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' O ' ' CG2' ' A' ' 102' ' ' THR . 10.9 m-20 -97.18 -164.33 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 110.875 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -102.36 157.44 16.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.782 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 t -174.41 130.08 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.015 . . . . 0.0 110.565 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.65 79.36 47.93 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 18.7 Cg_endo -63.76 100.45 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.653 1.344 . . . . 0.0 110.451 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -54.85 -21.06 10.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 110.487 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.67 163.45 27.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.972 . . . . 0.0 110.481 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -143.44 156.71 44.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 110.241 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.423 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 37.2 p-80 -89.85 166.42 13.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 110.382 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -148.07 161.25 41.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.9 . . . . 0.0 110.405 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.9 mt -123.59 148.54 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.92 64.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.58 40.13 29.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.47 -133.79 2.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' CD1' ' HD3' ' A' ' 54' ' ' ARG . 2.0 tp -137.23 23.1 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 110.234 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -85.95 -67.16 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 111.065 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.14 164.12 12.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 111.017 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.734 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 4.3 mtp -134.28 148.41 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -133.09 167.3 20.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 0.0 110.448 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -133.38 95.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.519 ' CE1' ' CD2' ' A' ' 29' ' ' LEU . 54.2 m-85 -90.39 -179.53 5.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 110.547 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.419 HG21 ' CD1' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -117.72 94.16 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 110.189 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 74' ' ' PRO . 10.9 pt -55.87 -20.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 110.592 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.9 mttt -137.71 160.15 66.08 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 110.454 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 23.5 Cg_exo -58.03 158.31 21.89 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.651 1.342 . . . . 0.0 110.507 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 95' ' ' ILE . 39.5 mt -144.57 136.44 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.71 166.07 11.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.585 -0.697 . . . . 0.0 110.831 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 3.3 mp -65.11 110.39 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.546 -0.721 . . . . 0.0 110.316 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 22.8 5.02 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -94.71 -179.36 4.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 110.094 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.19 122.33 35.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.846 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 23.5 mt -89.66 131.08 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 69' ' ' ASN . 49.5 m -162.8 147.62 11.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.474 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.4 pt -115.0 165.21 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.033 -1.042 . . . . 0.0 110.769 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.22 -159.11 0.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.373 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.12 -93.35 0.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.425 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.23 169.24 41.76 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.752 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.81 -58.64 7.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -39.21 79.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.0 OUTLIER -89.94 31.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.937 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -176.43 -171.06 0.38 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -51.55 155.47 1.56 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.513 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.9 t -69.82 110.51 5.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 110.459 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.59 82.99 0.23 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 110.406 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.99 101.97 1.28 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.705 1.371 . . . . 0.0 110.254 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -81.16 127.45 32.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 0.0 110.384 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.6 21.16 8.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 110.559 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.1 m -73.58 144.89 45.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -67.65 143.86 55.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.928 . . . . 0.0 110.339 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.283 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.09 28.97 5.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -1.143 . . . . 0.0 110.402 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . 0.487 ' N ' ' CD ' ' C' ' 204' ' ' PRO . . . -70.8 -48.67 15.1 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 110.842 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' C' ' 203' ' ' ALA . 22.9 Cg_exo -60.18 82.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.352 1.185 . . . . 0.0 110.534 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' C' ' 203' ' ' ALA . 0.1 OUTLIER -160.71 158.84 29.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.928 . . . . 0.0 110.426 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp 52.35 62.09 2.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.43 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -78.67 -170.51 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.58 161.25 20.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 110.3 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.89 149.94 41.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.314 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 20.9 p -57.01 -22.67 40.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 110.33 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 7.7 tttp 52.48 78.19 0.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.451 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.59 -176.63 3.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.326 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -163.97 -67.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 110.418 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.476 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 0.5 OUTLIER -160.43 -171.18 3.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 110.401 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.4 t -52.79 -54.62 31.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.666 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.48 174.84 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.423 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 25.3 Cg_exo -59.84 175.65 0.87 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.616 1.324 . . . . 0.0 110.583 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -129.28 41.44 3.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 6.7 t -56.93 172.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 110.432 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.085 0 CA-C-O 118.027 -1.43 . . . . 0.0 109.976 -179.519 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.282 0.563 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 54.6 p90 -53.17 132.97 39.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 110.63 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -150.18 161.5 42.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.081 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.06 61.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.369 -0.832 . . . . 0.0 110.578 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.426 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 0.2 OUTLIER 174.83 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.342 -0.849 . . . . 0.0 109.21 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 16.7 m -156.48 -172.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.664 -0.647 . . . . 0.0 109.819 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 10.3 tt -160.68 163.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.977 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.59 120.72 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.967 . . . . 0.0 110.538 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 26.1 mttt -148.57 127.75 12.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 54.47 42.09 31.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.642 -1.911 . . . . 0.0 110.106 4.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.517 ' CB ' ' CE1' ' B' ' 19' ' ' PHE . 2.1 p -92.78 -171.15 0.25 Allowed Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.675 -0.64 . . . . 0.0 109.932 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 41.3 Cg_exo -52.19 108.31 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.454 1.239 . . . . 0.0 110.725 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' B' ' 13' ' ' LEU . 4.5 mm? 52.67 54.65 10.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.302 -0.874 . . . . 0.0 110.625 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.56 165.47 25.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.32 -163.86 16.58 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' B' ' 10' ' ' LYS . 3.8 m-85 -95.0 99.69 11.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.054 -1.262 . . . . 0.0 110.495 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.71 -160.34 9.54 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 81.2 t -113.24 138.08 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.386 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CG ' ' CD ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -104.21 141.05 36.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.788 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.423 ' HB3' ' CG1' ' B' ' 101' ' ' ILE . . . -104.19 91.09 3.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.947 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.3 OUTLIER -60.27 -26.07 66.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 6.2 mtpp -94.4 -177.14 4.16 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 109.572 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.432 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.511 0.1 OUTLIER 108.69 17.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.133 -1.605 . . . . 0.0 110.133 1.755 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 49.3 m-85 -114.67 160.9 18.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.639 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.3 172.29 6.87 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.517 -0.739 . . . . 0.0 110.025 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.423 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 29.4 tttm -72.23 80.36 0.99 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.37 40.95 0.12 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -119.44 158.48 26.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -1.214 . . . . 0.0 110.336 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.511 ' CD2' ' CE1' ' B' ' 90' ' ' PHE . 1.5 tm? -92.35 128.07 38.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.968 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.422 ' CG1' HG13 ' B' ' 6' ' ' VAL . 82.6 t -94.35 -45.66 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -170.26 152.11 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.55 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 110.028 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.418 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -146.75 -157.4 0.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 110.757 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.93 175.86 5.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 3.4 m -151.12 154.77 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.953 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 54.7 mt -94.85 163.97 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.825 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.87 106.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.967 . . . . 0.0 110.678 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.528 ' CB ' ' CG ' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -113.0 -163.34 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -128.61 62.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 110.963 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' B' ' 41' ' ' ASP . 26.7 m120 52.42 -149.31 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.647 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 17.4 m-20 60.5 -144.13 0.5 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.232 -0.917 . . . . 0.0 110.14 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -46.63 -29.04 1.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.07 -1.019 . . . . 0.0 111.147 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.528 ' CG ' ' CB ' ' B' ' 38' ' ' ARG . 66.2 t-105 -65.04 -44.51 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.172 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.33 -40.16 97.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 98.5 m -67.15 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 110.434 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.3 -58.28 8.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 110.324 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.481 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 2.7 mm? -90.96 50.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -0.56 22.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' B' ' 49' ' ' ASP . 39.9 p-10 -129.45 156.89 43.39 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.009 -1.057 . . . . 0.0 109.779 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 32.9 m-85 54.88 24.01 5.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.155 -0.966 . . . . 0.0 109.885 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.483 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 7.5 tp -117.01 123.54 47.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.379 -0.826 . . . . 0.0 110.85 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' B' ' 52' ' ' PHE . 35.9 m-85 -90.17 118.6 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.601 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.442 ' HB2' ' CB ' ' D' ' 214' ' ' ARG . 4.2 m -96.35 138.39 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' CD1' ' B' ' 84' ' ' LEU . 4.3 ttp180 -110.23 174.06 6.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.498 -0.751 . . . . 0.0 110.32 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -80.82 81.33 7.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.506 8.8 m-80 148.14 -19.66 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 109.77 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.61 -149.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.481 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.479 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -151.38 164.84 35.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 110.69 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -150.93 155.71 39.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.86 . . . . 0.0 110.464 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.44 ' CE ' HD12 ' B' ' 47' ' ' LEU . 27.5 tpp -102.7 158.66 16.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.326 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' B' ' 60' ' ' MET . . . -85.93 94.19 9.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.438 ' CB ' HD21 ' A' ' 62' ' ' LEU 2.5 0.1 OUTLIER -55.45 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 111.206 -179.177 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.59 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.432 ' HB3' ' CD1' ' B' ' 67' ' ' ILE . 89.1 m-85 -90.21 39.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.414 -1.051 . . . . 0.0 110.745 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.46 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -79.26 -19.82 71.08 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.5 -48.1 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.111 -1.229 . . . . 0.0 111.145 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.3 pp -55.82 -17.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.166 -0.959 . . . . 0.0 111.355 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.482 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.6 m-85 -49.04 134.29 17.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.785 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.425 ' O ' ' CG2' ' B' ' 102' ' ' THR . 11.5 m-20 -97.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -103.05 157.3 17.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.729 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.0 t -174.33 130.14 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -0.998 . . . . 0.0 110.542 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -36.59 77.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 110.207 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.59 79.3 47.33 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 110.248 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 18.5 Cg_endo -63.7 100.44 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.681 1.358 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.93 -21.0 10.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -0.922 . . . . 0.0 110.524 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.65 163.45 27.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 110.506 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -143.42 156.71 44.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.427 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 37.3 p-80 -89.75 166.42 13.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.455 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -148.08 161.22 41.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 110.404 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 25.9 mt -123.6 148.52 46.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.81 64.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.56 40.16 29.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.456 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.43 -133.74 2.85 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.432 ' CD1' ' HD3' ' B' ' 54' ' ' ARG . 2.0 tp -137.25 23.15 3.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -1.097 . . . . 0.0 110.241 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -86.03 -67.15 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 111.039 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.13 164.16 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 111.085 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.742 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 4.3 mtp -134.3 148.38 50.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 110.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -133.02 167.34 20.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.498 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.403 HG22 HD11 ' B' ' 89' ' ' ILE . 65.2 mt -133.42 95.29 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.511 ' CE1' ' CD2' ' B' ' 29' ' ' LEU . 54.0 m-85 -90.53 -179.5 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 110.48 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.401 HG21 ' CD1' ' B' ' 95' ' ' ILE . 1.0 OUTLIER -117.76 94.18 4.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' B' ' 74' ' ' PRO . 10.9 pt -55.83 -20.77 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 110.514 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.417 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.9 mttt -137.7 160.24 65.75 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 110.375 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 23.8 Cg_exo -58.29 158.53 22.15 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.65 1.342 . . . . 0.0 110.421 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.43 HD11 HG23 ' B' ' 95' ' ' ILE . 39.4 mt -144.64 136.48 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.271 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.77 166.01 11.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 110.767 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 3.3 mp -65.1 110.43 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.515 -0.741 . . . . 0.0 110.293 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.41 22.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.73 -179.33 4.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -1.171 . . . . 0.0 110.102 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.2 122.25 35.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.821 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.437 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 23.9 mt -89.49 131.14 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.48 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' B' ' 69' ' ' ASN . 47.9 m -162.82 147.62 11.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.726 -0.609 . . . . 0.0 109.597 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.482 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.4 pt -114.98 165.2 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.753 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.17 -159.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.08 -93.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.937 . . . . 0.0 110.449 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.32 169.22 41.7 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.84 -58.62 7.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -1.121 . . . . 0.0 110.194 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -39.21 79.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.0 OUTLIER -89.83 31.51 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.974 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -176.41 -171.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.989 -1.069 . . . . 0.0 110.506 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -51.5 155.45 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.482 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 30.9 t -69.81 110.51 5.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.452 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.61 82.95 0.23 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 110.387 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.97 102.04 1.28 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.685 1.361 . . . . 0.0 110.283 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -81.34 127.55 32.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.945 . . . . 0.0 110.423 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.6 21.19 8.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 110.557 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 27.9 m -73.56 144.84 45.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.897 . . . . 0.0 110.371 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -67.62 143.87 55.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 110.314 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.328 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 28.96 5.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -1.155 . . . . 0.0 110.382 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . 0.481 ' N ' ' CD ' ' D' ' 204' ' ' PRO . . . -70.86 -48.59 14.72 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 110.831 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' D' ' 203' ' ' ALA . 22.8 Cg_exo -60.21 82.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.404 1.213 . . . . 0.0 110.538 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' D' ' 203' ' ' ALA . 0.1 OUTLIER -160.68 158.77 29.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 110.463 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp 52.41 62.1 2.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 110.388 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -78.7 -170.55 2.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 110.347 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.47 161.25 20.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 110.343 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.86 149.97 41.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 110.363 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 20.8 p -57.14 -22.59 41.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.942 . . . . 0.0 110.291 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 7.7 tttp 52.45 78.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.459 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.57 -176.62 3.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.347 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -163.92 -67.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 110.436 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.486 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 0.5 OUTLIER -160.43 -171.16 3.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.887 . . . . 0.0 110.358 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.506 2.4 t -52.88 -54.55 33.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.665 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.47 174.87 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.348 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . 0.427 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 25.3 Cg_exo -59.87 175.56 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.701 1.369 . . . . 0.0 110.572 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -129.27 41.53 3.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.28 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 6.6 t -56.97 171.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.353 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.057 -1.413 . . . . 0.0 109.978 -179.584 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.439 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.441 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.226 0.536 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.471 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 25.7 p90 -176.8 133.38 0.2 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.157 -0.964 . . . . 0.0 110.564 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.06 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.29 -22.11 6.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.583 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -81.55 -41.1 22.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 0.0 110.593 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.3 m -151.31 179.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.412 HG21 ' CB ' ' A' ' 19' ' ' PHE . 9.4 tt -152.04 166.83 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.168 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -104.66 125.15 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.958 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 20.5 mttt -128.59 142.73 50.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mtpp 52.09 58.14 5.75 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.717 -1.865 . . . . 0.0 111.066 1.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.6 p -107.06 -173.47 0.28 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.519 -0.738 . . . . 0.0 110.268 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 36.3 Cg_exo -56.22 -52.75 6.51 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.617 1.325 . . . . 0.0 110.551 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.23 -49.86 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.551 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.23 -165.19 27.1 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.68 135.66 2.8 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.4 91.66 5.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 110.57 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -126.7 -168.74 12.63 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 101' ' ' ILE . 2.5 p -113.1 125.95 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.299 . . . . 0.0 109.524 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CE1' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -90.1 161.79 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 110.497 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.73 96.71 5.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 110.634 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -20.0 65.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.0 109.793 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HE2' ' CD1' ' A' ' 24' ' ' PHE . 14.2 mtpt -91.81 179.97 5.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.381 -0.824 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.4 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 39.9 m 103.9 16.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.166 -1.584 . . . . 0.0 110.403 0.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CD1' ' HE2' ' A' ' 22' ' ' LYS . 42.3 m-85 -109.55 168.5 9.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.367 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 -167.18 1.32 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.966 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.12 4.08 18.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.43 86.73 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -151.04 147.98 27.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -1.17 . . . . 0.0 110.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' CD2' ' CE2' ' A' ' 90' ' ' PHE . 1.1 tm? -86.3 122.86 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.257 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -81.88 -52.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -162.43 177.69 9.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.129 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.21 149.49 8.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 110.492 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.19 -157.84 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.275 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 72.8 mt -109.13 -178.51 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 85' ' ' LYS . 72.4 m -145.41 174.2 11.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 60.6 mt -116.2 125.18 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.886 . . . . 0.0 109.832 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG23 ' CB ' ' A' ' 84' ' ' LEU . 26.0 t -97.82 100.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 110.579 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.475 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 2.6 mmp_? -119.44 -172.05 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.383 -0.823 . . . . 0.0 110.214 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 36.8 m80 -104.29 -165.03 1.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.339 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 76.2 m-20 -91.04 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 16.9 m-20 58.07 -137.5 0.9 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.869 -1.144 . . . . 0.0 110.435 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.44 -40.04 7.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.996 -1.065 . . . . 0.0 111.498 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.475 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 76.1 t-105 -57.66 -45.69 85.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.87 73.71 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.98 -63.51 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.24 . . . . 0.0 110.527 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.16 -55.61 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.9 mm? -89.49 52.37 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 57.42 3.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 -76.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' CG ' ' HB2' ' A' ' 66' ' ' ALA . 5.0 m-85 -89.52 48.21 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.449 ' CD2' ' NE1' ' A' ' 43' ' ' TRP . 6.1 tp -117.66 109.64 16.91 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.399 -0.813 . . . . 0.0 111.243 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -89.56 105.2 17.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.105 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.3 p -97.38 161.02 13.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 111.144 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -127.97 -172.36 2.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.481 -0.762 . . . . 0.0 109.959 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -83.69 84.63 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.031 -1.043 . . . . 0.0 109.334 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.8 OUTLIER 153.19 -22.01 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.75 -0.594 . . . . 0.0 109.778 -178.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.59 -168.1 0.22 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.281 -0.887 . . . . 0.0 110.735 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.1 m -132.22 134.82 45.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.469 -0.769 . . . . 0.0 109.921 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -127.88 166.69 17.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 111.031 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.43 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 1.2 ttt -96.1 170.46 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.857 . . . . 0.0 109.822 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -86.32 -54.04 4.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.156 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.47 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.497 0.0 OUTLIER 92.3 -81.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.819 -1.176 . . . . 0.0 110.513 -179.51 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.79 -143.48 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.33 56.65 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -1.065 . . . . 0.0 110.358 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.472 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -89.74 -43.31 5.17 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 50' ' ' TYR . . . -63.39 -47.61 81.3 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.984 -1.304 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 68' ' ' PHE . 2.8 pp -49.53 -22.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.876 . . . . 0.0 111.441 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.489 ' CG ' HG12 ' A' ' 103' ' ' ILE . 4.9 m-85 -50.19 113.45 0.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.767 -1.208 . . . . 0.0 110.415 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -102.0 -165.82 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 111.204 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.476 ' CE1' HD13 ' A' ' 111' ' ' LEU . 1.8 t-160 -94.46 140.89 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.531 -0.731 . . . . 0.0 110.449 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.44 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.337 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.417 ' HD2' ' CD2' ' A' ' 116' ' ' LEU . 4.6 tppp? -85.47 -19.48 31.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 110.528 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.54 74.93 53.88 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.57 106.04 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.697 1.367 . . . . 0.0 110.467 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 76' ' ' ALA . 50.4 p-10 -85.06 -13.9 48.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 75' ' ' ASN . . . -142.51 141.16 32.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.985 -1.072 . . . . 0.0 110.46 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.05 -176.44 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -124.36 161.98 24.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 110.517 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.45 154.15 51.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.412 HD22 ' CD2' ' A' ' 84' ' ' LEU . 43.8 tp -132.42 139.97 48.26 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.67 -168.99 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.85 107.92 18.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 110.408 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.61 12.95 4.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CB ' HG23 ' A' ' 37' ' ' VAL . 16.5 mt 52.39 32.85 11.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.0 110.405 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 35' ' ' CYS . 2.7 mmtp -100.21 -62.29 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 111.147 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -97.49 162.26 13.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.64 147.59 27.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.145 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.02 171.92 13.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.376 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.78 116.25 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 29' ' ' LEU . 21.5 m-85 -108.11 171.07 7.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -112.36 87.39 2.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 93' ' ' LYS . 3.2 pt -52.03 -23.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 110.583 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.433 ' N ' HG13 ' A' ' 92' ' ' ILE . 5.2 mmtt -132.03 151.13 77.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.401 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.08 143.88 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.666 1.35 . . . . 0.0 110.292 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.0 mt -126.27 141.0 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.532 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.42 163.61 12.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 110.182 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.8 mt -63.75 121.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 110.511 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.6 38.71 2.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -117.54 170.34 8.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -1.17 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -114.89 126.06 54.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.269 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 18' ' ' VAL . 98.0 mt -96.59 127.21 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 35.6 p -156.03 176.64 12.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.489 HG12 ' CG ' ' A' ' 68' ' ' PHE . 2.5 pp -147.91 155.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.667 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 33.0 t -68.75 -149.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 110.464 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -135.89 -69.43 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.449 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.63 -177.92 30.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -64.03 -40.41 96.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 110.404 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -61.22 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.98 106.99 3.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.477 ' CE3' ' O ' ' A' ' 111' ' ' LEU . 63.6 p-90 -48.88 128.78 16.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.638 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.477 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 16.4 tp -89.66 -110.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.346 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -174.52 112.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.395 -1.44 . . . . 0.0 110.693 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.404 ' HB3' ' NH1' ' A' ' 115' ' ' ARG . 0.0 OUTLIER 48.26 65.67 6.74 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.893 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.0 118.37 5.24 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.611 1.322 . . . . 0.0 110.528 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 113' ' ' ARG . 10.6 ptt-85 -174.51 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.378 -0.826 . . . . 0.0 110.678 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.417 ' CD2' ' HD2' ' A' ' 72' ' ' LYS . 0.8 OUTLIER 52.51 -162.84 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 87.0 m -137.92 -61.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.158 -0.964 . . . . 0.0 110.332 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.23 155.96 49.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.882 . . . . 0.0 110.334 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.325 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.07 90.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -1.151 . . . . 0.0 110.415 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . 0.482 ' CB ' ' CD ' ' C' ' 204' ' ' PRO . . . -55.02 -57.81 17.8 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 110.558 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' C' ' 203' ' ' ALA . 29.9 Cg_endo -70.18 102.13 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.474 1.25 . . . . 0.0 110.536 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -34.63 4.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.373 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -108.5 135.93 48.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -69.02 80.83 0.31 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 110.245 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.78 -178.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 110.298 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.59 173.31 14.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.7 t -125.48 56.43 1.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.883 . . . . 0.0 110.34 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -113.86 -33.04 5.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 110.374 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.86 76.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 110.417 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.1 71.51 2.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.269 -0.895 . . . . 0.0 110.376 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -116.52 177.28 4.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.333 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER -53.6 164.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -124.57 168.49 12.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.338 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -67.21 -35.53 24.34 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.706 1.371 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 53.06 85.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 9.5 t -174.8 179.06 1.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.542 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.252 0.549 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 25.7 p90 -176.8 133.4 0.2 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.155 -0.966 . . . . 0.0 110.596 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.09 22.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.27 -22.1 6.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 110.627 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 -81.55 -41.2 21.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.59 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 28.8 m -151.24 179.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.007 . . . . 0.0 110.559 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' B' ' 19' ' ' PHE . 9.4 tt -152.0 166.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.198 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -104.67 125.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -0.951 . . . . 0.0 110.957 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 20.4 mttt -128.6 142.7 50.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mtpp 52.06 58.2 5.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.738 -1.852 . . . . 0.0 111.033 1.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.6 p -107.1 -173.46 0.28 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.513 -0.742 . . . . 0.0 110.28 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 36.6 Cg_exo -56.17 -52.67 6.72 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.624 1.328 . . . . 0.0 110.556 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.48 -49.86 17.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 110.559 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.4 -165.17 27.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.67 135.6 2.78 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 91.76 5.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 110.579 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.81 -168.9 12.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.6 p -112.82 125.8 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.937 -1.331 . . . . 0.0 109.685 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.455 ' CE1' ' HG3' ' B' ' 100' ' ' GLU . 0.5 OUTLIER -90.09 161.73 15.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 110.497 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.67 96.63 5.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -19.96 65.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.867 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.498 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 14.2 mtpt -91.93 -179.94 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 109.799 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' B' ' 22' ' ' LYS 2.514 39.3 m 103.93 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.207 -1.558 . . . . 0.0 110.356 0.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 42.2 m-85 -109.48 168.61 9.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.404 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.59 -167.14 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.09 4.04 18.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.97 . . . . 0.0 110.9 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.35 86.7 0.12 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -151.05 147.97 27.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -1.168 . . . . 0.0 110.45 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.495 ' CD2' ' CE2' ' B' ' 90' ' ' PHE . 1.2 tm? -86.33 122.77 30.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.85 -52.62 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.405 ' CG ' ' CD1' ' B' ' 89' ' ' ILE . 1.9 pt-20 -162.41 177.73 9.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.25 149.56 8.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.976 . . . . 0.0 110.517 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.21 -157.91 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 110.237 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 72.8 mt -109.08 -178.47 3.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.423 ' N ' ' O ' ' B' ' 85' ' ' LYS . 72.4 m -145.5 174.13 11.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.305 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.478 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 60.3 mt -116.12 125.18 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.792 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' B' ' 84' ' ' LEU . 26.3 t -97.89 100.21 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.042 -1.036 . . . . 0.0 110.587 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 2.6 mmp_? -119.72 -172.15 2.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 36.7 m80 -104.07 -165.02 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.12 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 58.18 -137.54 0.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.912 -1.117 . . . . 0.0 110.413 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.43 -40.05 7.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.016 -1.053 . . . . 0.0 111.495 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.477 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 76.1 t-105 -57.69 -45.64 85.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 0.0 110.283 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.94 -21.92 73.67 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.97 -63.48 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.23 -55.56 33.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.482 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 3.9 mm? -89.53 52.43 2.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.244 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.33 57.44 3.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -76.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.487 ' CG ' ' CB ' ' B' ' 66' ' ' ALA . 5.0 m-85 -89.46 48.23 1.58 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.857 . . . . 0.0 109.424 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.451 ' CD2' ' NE1' ' B' ' 43' ' ' TRP . 6.0 tp -117.69 109.5 16.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.352 -0.842 . . . . 0.0 111.353 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -89.47 105.14 17.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 14.2 p -97.34 160.95 14.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 111.162 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -128.43 -174.88 3.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.535 -0.728 . . . . 0.0 109.99 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -80.0 84.41 5.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -0.954 . . . . 0.0 110.067 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.8 OUTLIER 153.0 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.41 -168.06 0.23 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.801 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 5.1 m -132.24 134.87 45.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -127.92 166.75 17.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.08 -1.013 . . . . 0.0 111.06 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.426 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 1.2 ttt -96.41 169.18 10.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.956 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.425 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -84.31 -55.02 4.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 111.487 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.478 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.499 0.0 OUTLIER 92.7 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.888 -1.133 . . . . 0.0 110.475 -179.181 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.85 -143.41 0.06 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.38 56.55 2.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -1.088 . . . . 0.0 110.362 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.469 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -89.73 -43.24 5.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.487 ' CB ' ' CG ' ' B' ' 50' ' ' TYR . . . -63.4 -47.6 81.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 110.396 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.438 HD11 ' N ' ' B' ' 68' ' ' PHE . 2.8 pp -49.59 -22.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 111.448 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.493 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.9 m-85 -50.23 113.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.701 -1.25 . . . . 0.0 110.43 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -102.06 -165.84 1.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.483 ' CE1' HD13 ' B' ' 111' ' ' LEU . 1.8 t-160 -94.37 140.89 29.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.742 . . . . 0.0 110.491 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.46 16.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.308 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.426 ' HD2' ' CD2' ' B' ' 116' ' ' LEU . 4.6 tppp? -85.46 -19.56 31.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 110.49 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.47 74.86 53.07 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.14 -0.975 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.52 105.98 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.688 1.362 . . . . 0.0 110.494 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 76' ' ' ALA . 50.3 p-10 -85.05 -13.85 49.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.757 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.409 ' N ' ' OD1' ' B' ' 75' ' ' ASN . . . -142.57 141.19 31.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.012 -1.055 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.07 -176.45 2.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.318 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -124.39 161.91 24.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.545 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.4 154.21 51.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.407 HD22 ' CD2' ' B' ' 84' ' ' LEU . 44.4 tp -132.44 139.93 48.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.68 -168.95 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.93 107.88 18.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.63 12.91 4.85 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.423 ' CB ' HG23 ' B' ' 37' ' ' VAL . 16.6 mt 52.38 32.85 11.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.862 -1.375 . . . . 0.0 110.462 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 35' ' ' CYS . 2.8 mmtp -100.21 -62.32 1.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 111.123 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -97.47 162.28 13.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.994 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.62 147.58 27.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.0 171.97 12.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 110.324 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.405 ' CD1' ' CG ' ' B' ' 31' ' ' GLU . 96.3 mt -135.78 116.17 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.495 ' CE2' ' CD2' ' B' ' 29' ' ' LEU . 21.5 m-85 -108.16 171.1 7.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -112.4 87.42 2.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.427 HG13 ' N ' ' B' ' 93' ' ' LYS . 3.2 pt -52.15 -23.31 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.427 ' N ' HG13 ' B' ' 92' ' ' ILE . 5.2 mmtt -132.01 151.19 78.02 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -61.38 144.1 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.608 1.32 . . . . 0.0 110.213 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -126.31 141.04 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 110.531 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.44 163.6 12.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 4.8 mt -63.79 121.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 110.545 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.7 2.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -117.5 170.36 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -1.179 . . . . 0.0 110.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.455 ' HG3' ' CE1' ' B' ' 19' ' ' PHE . 0.4 OUTLIER -114.88 126.15 54.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' B' ' 102' ' ' THR . 97.8 mt -96.56 127.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 35.1 p -155.95 176.74 12.25 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.493 HG12 ' CG ' ' B' ' 68' ' ' PHE . 2.5 pp -147.94 155.86 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 110.699 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' B' ' 103' ' ' ILE . 33.0 t -68.74 -149.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 110.483 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -135.89 -69.32 0.49 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.56 -177.97 29.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.98 -40.5 96.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 110.403 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -61.23 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.05 107.1 3.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.475 ' CD2' ' O ' ' B' ' 110' ' ' TRP . 63.5 p-90 -48.93 128.73 16.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.688 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.483 HD13 ' CE1' ' B' ' 70' ' ' HIS . 16.4 tp -89.59 -110.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.376 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -174.48 112.67 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.316 -1.49 . . . . 0.0 110.678 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.408 ' HB3' ' NH1' ' B' ' 115' ' ' ARG . 0.0 OUTLIER 48.22 65.63 6.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.265 -0.897 . . . . 0.0 110.912 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -60.94 118.34 5.2 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.609 1.32 . . . . 0.0 110.464 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' B' ' 113' ' ' ARG . 10.5 ptt-85 -174.57 -36.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.299 -0.876 . . . . 0.0 110.589 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.426 ' CD2' ' HD2' ' B' ' 72' ' ' LYS . 0.8 OUTLIER 52.45 -162.78 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.367 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 86.9 m -137.84 -61.22 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.975 . . . . 0.0 110.371 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.19 155.94 49.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.328 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.01 90.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -1.189 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . 0.486 ' CB ' ' CD ' ' D' ' 204' ' ' PRO . . . -55.09 -57.74 18.27 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 110.502 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' D' ' 203' ' ' ALA . 29.7 Cg_endo -70.18 102.18 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.499 1.263 . . . . 0.0 110.476 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.15 -34.53 4.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.37 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 7.4 mtpp -108.6 135.93 49.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.381 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -69.03 80.86 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 110.28 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.76 -178.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 110.258 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.56 173.36 14.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 110.338 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 5.7 t -125.49 56.48 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 110.344 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -113.94 -32.89 5.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 110.397 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.81 76.26 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 110.408 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.03 71.44 2.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 110.359 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -116.5 177.26 4.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER -53.53 164.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.464 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -124.51 168.56 12.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.25 -35.48 24.27 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.723 1.38 . . . . 0.0 110.566 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 53.0 85.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 9.5 t -174.82 179.04 1.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 110.34 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mmm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.945 0.403 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 32.5 p90 -133.76 106.92 7.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.961 -1.087 . . . . 0.0 110.464 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 5' ' ' ARG . 10.3 p30 -153.31 -172.57 4.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 111.02 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.68 -85.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.737 -0.602 . . . . 0.0 111.26 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' ASN . 7.3 mtm-85 -153.48 17.12 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.976 -1.078 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 5' ' ' ARG . 93.3 t -153.05 160.98 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.967 -1.083 . . . . 0.0 110.92 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.469 ' CG2' ' CB ' ' A' ' 19' ' ' PHE . 1.6 tt -124.02 154.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.64 141.06 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.796 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 10' ' ' LYS . 72.3 mttt -146.9 145.03 29.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.441 -0.787 . . . . 0.0 108.936 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.4 tppt? 52.4 80.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 119.629 -1.92 . . . . 0.0 110.273 2.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -122.89 -174.49 0.32 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.346 -178.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 31.3 Cg_exo -54.62 -58.22 1.36 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.637 1.335 . . . . 0.0 110.563 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.03 -30.96 58.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.96 -139.51 10.91 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.23 145.09 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -118.44 83.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 110.355 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.3 -170.68 12.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.459 ' CG2' HD13 ' A' ' 67' ' ' ILE . 95.1 t -97.14 149.58 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.748 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 1.6 m-85 -114.83 121.89 44.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.426 -0.796 . . . . 0.0 109.286 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' CB ' HG23 ' A' ' 95' ' ' ILE . . . -89.57 86.99 6.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.125 -0.984 . . . . 0.0 111.009 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.19 -24.95 65.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.237 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.458 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 14.0 mttm -89.25 -179.73 5.93 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.458 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 102.4 20.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 119.953 -1.717 . . . . 0.0 109.808 2.589 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 3.8 m-85 -111.52 152.13 27.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.534 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -95.06 -165.14 1.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -95.62 120.23 35.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.62 5.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.99 128.61 46.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -1.152 . . . . 0.0 110.486 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.459 ' CD1' ' CG ' ' A' ' 88' ' ' ARG . 40.0 tp -53.28 164.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.932 . . . . 0.0 110.057 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.419 ' CG1' HG23 ' A' ' 6' ' ' VAL . 94.9 t -133.54 -71.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.36 66.44 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.519 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.84 148.86 23.99 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.79 -165.59 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 110.408 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.35 160.1 15.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.865 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 53.4 m -134.41 -179.57 5.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 36' ' ' ILE . 75.3 mt -113.35 151.34 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 84' ' ' LEU . 52.4 t -123.1 99.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -131.58 133.75 45.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 110.457 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.453 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -51.31 178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.977 . . . . 0.0 110.675 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -75.66 -132.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 0.0 110.423 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.93 -145.79 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.71 -1.244 . . . . 0.0 110.593 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.71 -28.06 0.94 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.194 -0.941 . . . . 0.0 111.394 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.493 ' CZ2' HD22 ' A' ' 51' ' ' LEU . 38.4 t-105 -57.34 -54.95 40.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 110.25 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' HA3' ' NH2' ' C' ' 214' ' ' ARG . . . -67.23 -50.27 46.49 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.11 -44.19 42.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -1.159 . . . . 0.0 111.108 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 -49.27 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.553 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.1 mm? -91.42 28.22 1.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.93 . . . . 0.0 110.874 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 75.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.02 -1.05 . . . . 0.0 110.573 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.47 -37.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 110.95 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 39.4 m-85 -133.42 50.05 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.493 HD22 ' CZ2' ' A' ' 43' ' ' TRP . 52.3 mt -124.11 131.02 53.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 111.423 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -91.2 105.93 18.15 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.7 p -87.78 111.43 21.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.114 -0.991 . . . . 0.0 111.058 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -177.16 3.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -0.76 . . . . 0.0 109.825 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -83.1 83.97 7.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.005 -1.059 . . . . 0.0 109.555 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.509 2.0 p-10 154.0 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.698 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -176.77 -160.64 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 110.673 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.421 ' O ' ' NE1' ' A' ' 43' ' ' TRP . 1.1 m -141.33 125.91 17.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -109.21 155.47 21.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 110.809 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.432 ' CB ' ' HB ' ' A' ' 36' ' ' ILE . 9.6 ttt -89.49 168.68 11.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.086 -1.009 . . . . 0.0 109.801 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.32 -24.89 27.48 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.241 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CB ' HD23 ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER 62.49 -92.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 111.096 177.914 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.72 -144.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 93.0 m-85 -82.59 51.47 1.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -1.084 . . . . 0.0 110.829 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.73 -25.9 23.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.4 -43.87 10.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.691 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.5 pp -45.09 -23.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.553 -0.717 . . . . 0.0 112.083 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CE2' ' O ' ' A' ' 64' ' ' PHE . 23.1 m-85 -55.17 142.21 31.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.61 -1.306 . . . . 0.0 109.775 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -118.83 -169.46 1.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.03 . . . . 0.0 111.254 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.478 ' CE1' HD12 ' A' ' 111' ' ' LEU . 22.0 t-160 -102.49 111.06 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 109.974 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.34 19.69 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 0.0 110.659 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt 52.62 23.33 2.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -174.38 65.24 0.28 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.055 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.41 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 11.8 Cg_endo -59.63 83.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.632 1.333 . . . . 0.0 110.601 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.421 ' O ' ' CG1' ' A' ' 92' ' ' ILE . 22.1 m120 -59.12 -17.93 31.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.03 143.84 50.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.47 11.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 110.555 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -107.5 136.2 47.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.355 -0.841 . . . . 0.0 110.301 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -124.59 166.97 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.6 mt -126.24 147.96 49.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 72.1 p -71.98 -79.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.54 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.81 23.1 4.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.422 ' O ' ' CG2' ' A' ' 37' ' ' VAL . 43.7 mt 52.06 36.87 19.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -1.205 . . . . 0.0 110.512 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -104.52 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 110.751 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 8.1 mtt180 -84.88 179.29 7.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.976 . . . . 0.0 110.319 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.865 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.3 mtp -148.28 128.44 13.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.736 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' CD ' ' CE1' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -114.38 106.16 13.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.44 -0.788 . . . . 0.0 110.091 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.48 113.27 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 109.929 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CE1' ' CD ' ' A' ' 88' ' ' ARG . 1.3 m-85 -101.93 177.17 4.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 p -113.92 99.32 7.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 110.028 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.429 HG13 ' N ' ' A' ' 93' ' ' LYS . 4.2 pt -53.04 -22.21 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.135 -0.978 . . . . 0.0 110.399 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.429 ' N ' HG13 ' A' ' 92' ' ' ILE . 45.1 mttt -148.24 146.75 23.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.16 -0.963 . . . . 0.0 110.175 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.84 129.41 34.44 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.673 1.354 . . . . 0.0 110.243 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.402 HG23 ' CB ' ' A' ' 20' ' ' ALA . 71.5 mt -104.76 148.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 110.594 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 167.35 11.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.575 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -71.32 123.41 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.503 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.85 39.97 2.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -124.65 -169.42 1.97 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -1.188 . . . . 0.0 110.381 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 23.7 tt0 -135.15 125.13 25.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 110.15 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 97.7 mt -89.39 137.99 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 45.4 p -154.07 -174.2 4.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.651 -0.656 . . . . 0.0 110.073 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.455 HG12 ' CD2' ' A' ' 68' ' ' PHE . 1.5 pp -149.5 158.46 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.136 -0.977 . . . . 0.0 110.454 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 32.3 t -95.79 -164.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 12.8 m-85 -133.82 -66.61 0.63 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.211 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.04 -157.96 53.64 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 55.82 -86.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.948 . . . . 0.0 110.691 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.3 t0 -122.55 -31.41 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 110.644 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.5 m-85 -51.16 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.569 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 51.9 p-90 -51.9 144.09 12.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.73 . . . . 0.0 110.695 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.478 HD12 ' CE1' ' A' ' 70' ' ' HIS . 17.2 tp -91.63 157.1 17.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 110.508 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.6 m -64.86 -162.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.82 111.91 2.81 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.457 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.01 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.449 1.236 . . . . 0.0 110.577 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -140.71 -54.58 0.5 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.283 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 49.76 94.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.271 -0.893 . . . . 0.0 110.741 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.452 ' O ' ' CG ' ' A' ' 118' ' ' GLN . 18.7 m -52.08 -84.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.613 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.452 ' CG ' ' O ' ' A' ' 117' ' ' THR . 10.1 pt20 38.59 -155.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.218 0.532 . . . . 0.0 111.813 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.049 -0.976 . . . . 0.0 110.393 -179.892 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -146.24 47.18 1.22 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -1.167 . . . . 0.0 110.374 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -169.06 71.67 0.73 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 110.408 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -66.68 -47.48 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.611 1.321 . . . . 0.0 110.514 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 55.12 1.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.414 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -127.35 157.76 39.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.422 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.33 163.74 35.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 110.372 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.85 105.78 10.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.86 83.48 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 110.334 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -115.67 -23.62 8.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.11 109.94 12.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 110.404 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.13 -61.96 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 110.323 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.48 -177.38 5.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.411 ' NH2' ' HA3' ' A' ' 44' ' ' GLY . 6.4 mtt85 -132.69 -149.54 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.114 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.467 ' HG2' ' CE1' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.0 OUTLIER -53.79 175.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.907 . . . . 0.0 110.356 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.54 170.22 11.66 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.38 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.18 -29.1 89.55 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.659 1.347 . . . . 0.0 110.507 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.84 89.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 110.338 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.9 p -53.22 179.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 110.414 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.49 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mmm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.006 0.432 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 32.2 p90 -133.63 108.3 8.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.912 -1.117 . . . . 0.0 110.233 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' B' ' 5' ' ' ARG . 10.4 p30 -155.1 -173.21 4.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 110.815 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.97 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.707 -0.621 . . . . 0.0 111.211 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' B' ' 3' ' ' ASN . 7.3 mtm-85 -153.5 17.3 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.989 -1.069 . . . . 0.0 111.064 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' B' ' 18' ' ' VAL . 94.1 t -153.08 160.98 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 0.0 110.98 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.465 ' CG2' ' CB ' ' B' ' 19' ' ' PHE . 1.6 tt -124.0 154.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.781 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.7 141.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 110.831 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' B' ' 10' ' ' LYS . 72.2 mttt -147.09 145.0 29.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 108.967 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.511 ' HB3' ' HA ' ' B' ' 9' ' ' LYS . 3.4 tppt? 52.41 80.62 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.539 -1.976 . . . . 0.0 110.356 2.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.483 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 0.7 OUTLIER -122.96 -174.5 0.32 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 31.3 Cg_exo -54.57 -58.3 1.33 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.62 1.326 . . . . 0.0 110.558 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -75.98 -30.98 58.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.95 -139.51 10.91 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.31 145.03 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -118.29 83.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -1.112 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.56 -170.62 12.66 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' B' ' 67' ' ' ILE . 95.7 t -97.07 149.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.947 -1.325 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' B' ' 9' ' ' LYS . 1.6 m-85 -114.9 121.69 43.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.406 ' CB ' HG23 ' B' ' 95' ' ' ILE . . . -89.28 86.97 6.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 111.113 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 109.225 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.46 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 13.9 mttm -89.19 -179.64 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.46 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.0 OUTLIER 102.45 20.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 119.938 -1.726 . . . . 0.0 109.805 2.493 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' B' ' 5' ' ' ARG . 3.8 m-85 -111.45 152.13 27.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 110.615 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -95.04 -165.07 1.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.217 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -95.6 120.22 35.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.61 46.56 5.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.02 128.6 46.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -1.12 . . . . 0.0 110.508 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.464 ' CD1' ' CG ' ' B' ' 88' ' ' ARG . 39.7 tp -53.19 164.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.944 . . . . 0.0 110.089 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' B' ' 6' ' ' VAL . 94.8 t -133.57 -71.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.32 66.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.529 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.92 148.86 24.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 110.201 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.76 -165.58 2.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 160.22 15.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.858 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 53.8 m -134.48 -179.66 5.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 110.228 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.481 HD13 HG23 ' B' ' 36' ' ' ILE . 75.3 mt -113.25 151.28 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.058 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 52.8 t -123.05 99.36 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.17 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.479 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -131.6 133.75 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 110.444 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . 0.443 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.4 OUTLIER -51.34 178.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 110.669 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -75.64 -132.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.415 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.0 -145.93 0.45 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.828 -1.17 . . . . 0.0 110.525 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.56 -28.13 0.89 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.211 -0.931 . . . . 0.0 111.443 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.491 ' CZ2' HD22 ' B' ' 51' ' ' LEU . 38.2 t-105 -57.32 -55.0 40.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 110.228 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' B' ' 48' ' ' GLU . . . -67.2 -50.32 46.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.04 -44.24 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.293 -1.122 . . . . 0.0 111.099 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.13 -48.66 13.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -0.99 . . . . 0.0 110.6 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.1 mm? -92.15 28.33 1.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.706 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 76.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.007 -1.058 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.5 OUTLIER -175.48 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.892 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.483 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 39.3 m-85 -133.31 50.13 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.102 -0.998 . . . . 0.0 110.447 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.491 HD22 ' CZ2' ' B' ' 43' ' ' TRP . 52.3 mt -124.17 131.21 53.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -91.42 104.9 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 85.9 p -86.24 111.44 20.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.102 -0.999 . . . . 0.0 111.327 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -179.91 4.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.436 -0.79 . . . . 0.0 109.878 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -79.01 83.63 5.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.512 2.0 p-10 153.89 -27.61 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.656 -0.652 . . . . 0.0 109.743 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.1 OUTLIER -176.57 -160.45 0.06 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.37 -0.831 . . . . 0.0 110.698 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.415 ' O ' ' NE1' ' B' ' 43' ' ' TRP . 1.1 m -141.33 126.03 17.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.946 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -109.36 155.29 21.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.421 ' CB ' ' HB ' ' B' ' 36' ' ' ILE . 9.6 ttt -89.56 166.85 13.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.59 -26.19 32.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.431 HD23 ' CB ' ' A' ' 62' ' ' LEU 2.5 0.1 OUTLIER 62.95 -92.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 111.125 178.568 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.68 -144.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 93.1 m-85 -82.65 51.87 1.97 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -1.082 . . . . 0.0 110.758 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -91.29 -25.61 23.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.483 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.77 -43.74 9.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -1.17 . . . . 0.0 110.683 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.468 HD13 ' CG2' ' B' ' 18' ' ' VAL . 2.5 pp -45.13 -23.56 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.571 -0.705 . . . . 0.0 112.069 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.47 ' CE2' ' O ' ' B' ' 64' ' ' PHE . 23.1 m-85 -55.06 142.47 30.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.544 -1.348 . . . . 0.0 109.792 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' B' ' 102' ' ' THR . 82.4 m-20 -119.11 -169.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 111.184 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.484 ' CE1' HD12 ' B' ' 111' ' ' LEU . 22.1 t-160 -103.09 110.95 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.2 19.56 13.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 110.629 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt 52.73 23.31 2.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 110.206 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' B' ' 75' ' ' ASN . 0.9 OUTLIER -174.41 65.28 0.28 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 110.012 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 11.9 Cg_endo -59.56 83.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.68 1.358 . . . . 0.0 110.591 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' B' ' 92' ' ' ILE . 22.2 m120 -59.16 -17.88 31.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.08 143.8 50.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.46 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.575 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -107.45 136.06 47.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -124.47 167.04 14.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 110.305 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 24.7 mt -126.24 147.94 49.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.513 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.42 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 71.7 p -71.94 -79.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.55 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.83 23.08 4.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' B' ' 37' ' ' VAL . 44.0 mt 52.05 36.84 19.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.238 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -104.45 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.42 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 8.1 mtt180 -84.86 179.24 7.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.307 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.858 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.3 mtp -148.3 128.47 13.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 0.0 110.733 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.524 ' CD ' ' CE1' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -114.5 105.93 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 110.116 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.07 113.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 110.05 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.524 ' CE1' ' CD ' ' B' ' 88' ' ' ARG . 1.3 m-85 -101.98 177.12 4.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.552 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.9 p -113.87 99.33 7.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.431 HG13 ' N ' ' B' ' 93' ' ' LYS . 4.2 pt -53.01 -22.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.392 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.431 ' N ' HG13 ' B' ' 92' ' ' ILE . 45.1 mttt -148.16 146.68 23.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.193 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.77 129.42 34.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.633 1.333 . . . . 0.0 110.247 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.406 HG23 ' CB ' ' B' ' 20' ' ' ALA . 71.4 mt -104.73 148.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.598 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.3 167.29 11.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.85 . . . . 0.0 110.562 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -71.27 123.38 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 110.463 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.87 39.93 2.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -124.65 -169.39 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -1.177 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 23.7 tt0 -135.26 124.88 25.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 97.8 mt -88.92 137.96 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 110.35 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 44.7 p -154.12 -174.13 4.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.527 -0.733 . . . . 0.0 110.02 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.442 HG12 ' CD2' ' B' ' 68' ' ' PHE . 1.5 pp -149.48 158.46 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 0.0 110.444 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.464 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 32.3 t -95.8 -164.16 1.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.347 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.471 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 12.9 m-85 -133.88 -66.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.99 -157.92 53.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' B' ' 106' ' ' GLY . 14.6 t0 55.8 -86.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.499 -1.0 . . . . 0.0 110.72 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 106' ' ' GLY . 10.3 t0 -122.58 -31.4 3.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 110.646 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.471 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.4 m-85 -51.13 96.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 110.585 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' B' ' 110' ' ' TRP . 52.0 p-90 -51.76 144.87 10.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.807 . . . . 0.0 110.557 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.484 HD12 ' CE1' ' B' ' 70' ' ' HIS . 17.4 tp -92.73 156.92 16.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.369 -0.832 . . . . 0.0 110.368 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 68.7 m -64.63 -162.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.0 110.5 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.77 111.95 2.82 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.431 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.09 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.473 1.249 . . . . 0.0 110.589 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -140.72 -54.57 0.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.282 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 49.84 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 0.0 110.712 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.449 ' O ' ' CG ' ' B' ' 118' ' ' GLN . 18.7 m -52.18 -84.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 110.577 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 117' ' ' THR . 10.1 pt20 38.63 -155.49 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.235 0.54 . . . . 0.0 111.786 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.388 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -146.15 47.19 1.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -1.119 . . . . 0.0 110.355 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -168.96 71.65 0.74 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 110.4 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -66.63 -47.48 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.672 1.354 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.72 55.13 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.392 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -127.39 157.8 39.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 110.37 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.37 163.71 35.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.368 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.82 105.77 10.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.413 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.85 83.4 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -115.62 -23.65 8.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.455 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.07 109.95 12.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 110.448 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.17 -61.95 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 110.311 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -90.58 -177.4 5.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 110.346 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.404 ' NH2' ' HA3' ' B' ' 44' ' ' GLY . 6.4 mtt85 -132.65 -149.57 0.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.47 ' HG2' ' CE1' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.0 OUTLIER -53.77 175.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.329 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.5 170.25 11.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -59.13 -29.17 89.78 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.714 1.376 . . . . 0.0 110.536 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.9 89.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.331 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.8 p -53.18 179.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.408 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.433 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.431 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.462 ' C ' ' CG ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.889 0.376 . . . . 0.0 110.378 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 21.9 p90 36.03 93.31 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 CA-C-O 121.475 0.655 . . . . 0.0 111.945 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.93 144.97 25.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.27 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.61 -45.09 47.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.877 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -37.89 83.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.937 . . . . 0.0 110.566 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.419 ' CG1' ' CG1' ' A' ' 18' ' ' VAL . 56.2 t -150.22 141.04 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' CG2' ' HD2' ' A' ' 21' ' ' ARG . 14.7 tt -113.67 153.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 110.612 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.82 131.68 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 110.108 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 54.5 mttt -147.86 123.61 10.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.022 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.8 mptt 59.36 64.23 1.4 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 119.664 -1.898 . . . . 0.0 111.07 0.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.518 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.2 t -153.9 -65.21 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.339 -0.851 . . . . 0.0 110.622 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 16.0 Cg_endo -61.17 -161.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.053 1.028 . . . . 0.0 110.27 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.78 -30.72 65.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 110.397 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.04 151.52 14.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.97 149.33 5.1 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CD2' ' HD3' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.82 88.64 2.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -1.159 . . . . 0.0 110.639 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.05 -171.27 12.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 89.0 t -103.71 139.46 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.93 -1.335 . . . . 0.0 110.331 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 2.0 m-85 -109.44 124.6 51.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.747 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 101' ' ' ILE . . . -89.85 97.52 11.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.29 -0.881 . . . . 0.0 111.137 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' HD2' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.39 -20.24 64.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.458 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 6.9 mttt -93.84 179.53 5.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.282 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.458 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 12.2 m 103.12 17.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.047 -1.658 . . . . 0.0 110.191 1.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.412 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 14.3 m-85 -112.03 165.5 12.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.557 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.33 -156.59 0.58 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 110.201 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 11.4 tttp -100.5 105.49 16.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.511 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.08 41.26 1.83 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.41 55.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -1.22 . . . . 0.0 110.444 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.515 ' CD2' ' CE2' ' A' ' 90' ' ' PHE . 1.1 tm? -64.28 124.31 21.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.383 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -102.74 79.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 109.984 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.81 134.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -125.21 159.68 31.0 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.287 -0.883 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.4 -169.16 3.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 110.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.15 173.87 6.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 110.485 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -138.85 -173.73 3.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.473 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 50.0 mt -119.55 141.57 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.263 -0.898 . . . . 0.0 109.998 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.8 t -111.68 122.38 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.962 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' CG ' ' CG ' ' A' ' 43' ' ' TRP . 27.1 tpt180 -150.11 131.92 15.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.398 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -53.5 -174.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.206 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.81 117.96 33.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.36 -0.838 . . . . 0.0 110.732 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.79 -141.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.76 -24.85 6.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.656 -1.277 . . . . 0.0 109.36 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 52.1 t-105 -56.59 -56.19 24.46 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.544 -0.722 . . . . 0.0 109.615 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.12 -28.39 70.54 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -72.96 -44.7 60.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -1.195 . . . . 0.0 110.679 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.4 -40.6 29.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.0 110.482 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.2 mm? -90.72 22.93 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 48' ' ' GLU . 0.2 OUTLIER -64.64 78.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.101 -0.999 . . . . 0.0 110.454 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -169.18 -62.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.016 -1.052 . . . . 0.0 110.79 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 28.1 m-85 -121.98 55.84 1.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.057 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.492 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 15.5 mt -109.15 112.3 24.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 0.0 111.11 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' C' ' 215' ' ' MLZ . 0.2 OUTLIER -89.42 101.59 14.27 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.288 -0.882 . . . . 0.0 108.693 176.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.425 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 24.9 p -100.99 142.09 32.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -177.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.409 ' HG3' ' CB ' ' C' ' 217' ' ' ALA . 1.7 ttt180 -101.31 -170.96 1.91 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.479 -0.763 . . . . 0.0 109.844 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -83.43 80.76 8.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 36.4 t-20 155.29 -20.75 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.708 -0.62 . . . . 0.0 110.242 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.18 -177.58 1.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.968 -1.083 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.425 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.437 ' CB ' HD21 ' A' ' 84' ' ' LEU . . . -135.74 161.92 34.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 109.945 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.449 ' CE ' HD13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -95.75 169.93 9.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.865 -1.147 . . . . 0.0 109.843 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -84.97 -14.91 46.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.714 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.473 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.5 0.0 OUTLIER 61.1 -94.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 111.293 177.567 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -133.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.44 41.81 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.098 . . . . 0.0 110.747 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -81.05 -19.43 67.25 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' HB3' ' CG ' ' A' ' 50' ' ' TYR . . . -87.69 -51.16 6.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.0 110.656 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.7 pp -46.67 -24.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 111.491 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CG ' HG12 ' A' ' 103' ' ' ILE . 10.0 m-85 -52.56 142.02 19.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.642 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -96.88 96.53 8.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 110.022 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.5 m -115.22 143.04 45.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 110.513 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.95 136.48 57.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.21 2.95 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 14.5 Cg_endo -61.01 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.685 1.361 . . . . 0.0 110.508 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -58.09 -19.44 32.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.431 ' CB ' HG21 ' A' ' 101' ' ' ILE . . . -123.53 150.19 44.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 0.0 110.567 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.32 -172.42 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -135.46 156.26 49.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 110.644 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.94 124.24 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.03 149.79 21.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 110.522 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 p -94.64 152.98 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.15 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.77 -5.79 3.74 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.279 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 HD21 ' CB ' ' A' ' 59' ' ' ALA . 1.8 tp 56.09 20.99 4.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.826 -1.396 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -22.29 19.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 111.085 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.57 157.96 45.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.901 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.78 138.09 49.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.765 . . . . 0.0 110.051 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -116.55 151.32 36.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 110.616 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.88 121.24 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 29' ' ' LEU . 15.6 m-85 -117.81 -170.14 1.81 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.454 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -131.51 93.84 3.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.893 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 93' ' ' LYS . 48.4 pt -51.07 -29.79 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -137.59 143.53 41.14 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 50.2 Cg_exo -49.91 149.88 10.59 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.529 1.279 . . . . 0.0 110.669 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.463 HG21 HD12 ' A' ' 95' ' ' ILE . 69.1 mt -122.52 150.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.727 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.01 161.91 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 110.155 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.5 mt -65.82 96.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.249 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.23 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 35.0 mm-40 -116.94 168.46 10.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -1.104 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -107.14 117.95 35.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.989 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.444 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 97.5 mt -89.63 128.22 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.515 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.5 p -153.99 176.76 11.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.877 -0.514 . . . . 0.0 109.678 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.482 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.2 pp -143.65 158.94 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 110.435 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.62 -158.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.32 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.47 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 34.1 m-85 -133.19 -59.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.06 -167.09 36.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.55 -34.2 77.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -1.136 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.359 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.479 ' CE2' ' HG3' ' C' ' 215' ' ' MLZ . 2.1 m-85 -51.99 110.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.703 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 34.1 m95 52.15 -166.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.9 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 112' ' ' SER . 14.2 tp -61.14 157.76 15.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 110.491 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.426 ' N ' ' HG ' ' A' ' 111' ' ' LEU . 49.3 m -64.62 -62.61 1.47 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.278 -0.889 . . . . 0.0 110.411 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -140.29 160.07 61.23 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 110.481 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 116' ' ' LEU . 25.9 Cg_exo -59.69 -57.54 0.82 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.763 1.402 . . . . 0.0 110.601 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -69.73 0.09 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.408 -0.808 . . . . 0.0 110.506 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 114' ' ' PRO . 3.7 mt 53.34 91.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.392 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 68.0 m -67.84 155.95 38.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 110.399 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.09 82.46 2.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 110.327 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.333 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -133.39 35.83 3.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -1.107 . . . . 0.0 110.329 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . 0.482 ' N ' ' CD ' ' C' ' 204' ' ' PRO . . . -54.95 -50.21 87.63 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 110.644 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' C' ' 203' ' ' ALA . 44.9 Cg_exo -51.39 97.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.537 1.282 . . . . 0.0 110.611 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.84 80.62 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.476 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.63 128.53 35.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.29 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -58.88 134.65 57.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 70.9 mt -67.67 -171.25 0.19 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.379 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.81 141.87 10.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 110.341 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 1.6 p -112.87 43.78 1.62 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.312 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -72.14 83.61 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 110.42 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.22 102.34 13.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.33 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.72 160.34 33.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 110.421 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -160.93 0.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.218 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.479 ' HG3' ' CE2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER -53.8 -178.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.586 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . 0.409 ' CB ' ' HG3' ' A' ' 54' ' ' ARG . . . -150.96 123.8 4.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.391 -0.818 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.4 157.18 19.01 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.364 1.191 . . . . 0.0 110.568 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -104.19 -21.67 13.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 110.327 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -57.0 -169.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 110.313 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.79 179.761 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.456 ' C ' ' CG ' ' B' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.821 0.344 . . . . 0.0 110.414 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 21.9 p90 36.04 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.49 0.662 . . . . 0.0 111.944 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.91 144.96 25.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.58 -45.12 47.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -37.94 83.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.586 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.424 ' CG1' ' CG1' ' B' ' 18' ' ' VAL . 56.0 t -150.16 141.06 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 14.7 tt -113.66 153.04 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 110.645 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 82.9 t -89.7 131.76 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 54.4 mttt -148.05 123.73 10.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.8 mptt 59.49 64.17 1.39 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.726 -1.859 . . . . 0.0 111.037 0.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.2 t -153.87 -65.19 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.64 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 16.2 Cg_endo -61.11 -161.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.021 1.011 . . . . 0.0 110.287 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -30.67 65.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 110.408 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.1 151.58 14.15 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.97 149.29 5.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.459 ' CD2' ' HD3' ' B' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 88.67 2.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 110.588 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.01 -171.36 12.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 86.2 t -103.66 139.25 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.955 -1.321 . . . . 0.0 110.373 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 2.0 m-85 -109.41 124.57 51.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 109.759 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' B' ' 101' ' ' ILE . . . -89.78 97.54 11.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 111.14 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -20.24 64.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.714 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.449 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 6.9 mttt -93.78 179.62 5.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.274 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.449 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.511 12.0 m 103.2 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.055 -1.653 . . . . 0.0 110.17 1.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 14.1 m-85 -112.1 165.56 12.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.138 -0.976 . . . . 0.0 110.573 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.38 -156.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 110.159 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.402 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 11.3 tttp -100.51 105.51 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 110.549 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.09 41.27 1.83 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.43 55.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 110.437 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' CE2' ' B' ' 90' ' ' PHE . 1.1 tm? -64.23 124.3 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 110.451 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -102.78 79.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 110.017 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.85 134.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.511 -0.743 . . . . 0.0 110.741 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -125.22 159.63 31.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.428 -0.795 . . . . 0.0 109.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.53 -169.19 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.554 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.24 173.89 6.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 110.521 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -138.81 -173.81 3.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 49.4 mt -119.49 141.52 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.0 110.002 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 91.6 t -111.62 122.41 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.964 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.507 ' CG ' ' CG ' ' B' ' 43' ' ' TRP . 27.1 tpt180 -150.17 131.82 14.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.0 110.477 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -53.44 -174.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 0.0 111.154 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.79 117.85 33.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.73 -141.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.7 -25.03 6.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.609 -1.307 . . . . 0.0 109.35 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.507 ' CG ' ' CG ' ' B' ' 38' ' ' ARG . 52.2 t-105 -56.49 -56.23 23.84 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.62 -0.675 . . . . 0.0 109.628 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.37 70.37 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.1 m -73.01 -44.76 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -1.155 . . . . 0.0 110.598 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.47 -40.28 30.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 110.464 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.2 mm? -91.14 23.16 3.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.583 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 0.2 OUTLIER -64.78 78.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 110.4 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.2 OUTLIER -169.14 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 110.79 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.478 ' CG ' ' HB3' ' B' ' 66' ' ' ALA . 28.2 m-85 -121.86 55.94 1.09 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.985 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.487 HD21 ' CZ2' ' B' ' 43' ' ' TRP . 15.5 mt -109.19 112.35 24.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 111.208 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' D' ' 215' ' ' MLZ . 0.2 OUTLIER -89.49 101.47 14.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.71 176.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.426 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 24.8 p -100.86 142.09 32.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.441 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.408 ' HG3' ' CB ' ' D' ' 217' ' ' ALA . 1.7 ttt180 -101.79 -173.67 2.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.469 -0.77 . . . . 0.0 109.853 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -79.67 80.48 6.05 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 36.7 t-20 155.22 -20.96 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.621 -0.675 . . . . 0.0 110.231 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.09 -177.55 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 111.078 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 0.9 OUTLIER -123.88 143.06 50.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.536 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -135.8 161.92 34.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.005 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.43 ' CG ' HD22 ' B' ' 51' ' ' LEU . 0.0 OUTLIER -96.28 167.97 10.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.985 179.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -82.03 -16.41 50.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 111.142 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.47 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.501 0.0 OUTLIER 61.73 -94.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 111.29 178.221 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.25 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -88.53 41.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -1.104 . . . . 0.0 110.76 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -81.0 -19.49 67.25 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' B' ' 50' ' ' TYR . . . -87.71 -51.12 6.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.162 -1.199 . . . . 0.0 110.645 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.7 pp -46.62 -24.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.844 . . . . 0.0 111.528 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.477 ' CG ' HG12 ' B' ' 103' ' ' ILE . 10.0 m-85 -52.51 142.02 18.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.857 -1.152 . . . . 0.0 110.351 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.957 . . . . 0.0 110.662 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -96.89 96.28 8.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 110.049 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 34.1 m -114.91 143.17 45.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.99 136.43 57.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.3 2.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.418 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 14.7 Cg_endo -60.99 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.664 1.35 . . . . 0.0 110.536 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -58.11 -19.5 32.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.581 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.429 ' CB ' HG21 ' B' ' 101' ' ' ILE . . . -123.44 150.26 44.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.636 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.39 -172.48 2.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 110.186 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -135.39 156.21 49.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 0.0 110.675 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.93 124.33 17.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 110.187 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -91.03 149.7 21.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.544 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 21.3 p -94.61 153.01 18.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.253 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.14 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 110.182 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.76 -5.87 3.75 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.24 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.438 HD21 ' CB ' ' B' ' 59' ' ' ALA . 1.8 tp 56.11 20.98 4.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.843 -1.387 . . . . 0.0 110.272 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.56 -22.16 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 111.091 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.62 157.98 45.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.034 -1.041 . . . . 0.0 110.913 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.74 138.01 49.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.071 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -116.47 151.38 36.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 110.68 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 73.4 mt -125.85 121.16 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.882 . . . . 0.0 109.95 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.517 ' CE2' ' CD2' ' B' ' 29' ' ' LEU . 15.6 m-85 -117.75 -170.15 1.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.491 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -131.5 93.88 3.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.891 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.43 HG13 ' N ' ' B' ' 93' ' ' LYS . 48.2 pt -51.03 -29.83 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.681 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.43 ' N ' HG13 ' B' ' 92' ' ' ILE . 1.0 OUTLIER -137.6 143.57 41.26 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 110.361 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 50.6 Cg_exo -50.05 149.9 11.01 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.596 1.314 . . . . 0.0 110.631 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' B' ' 99' ' ' GLU . 69.1 mt -122.53 150.55 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.98 161.93 13.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.395 -0.816 . . . . 0.0 110.127 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 10.6 mt -65.89 96.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.21 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 34.9 mm-40 -117.0 168.44 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -1.17 . . . . 0.0 110.402 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -107.07 117.95 35.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.912 . . . . 0.0 110.042 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.432 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 96.9 mt -89.53 128.25 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 61.3 p -153.98 176.85 11.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.716 -0.615 . . . . 0.0 109.67 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.477 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.2 pp -143.63 158.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -158.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 34.1 m-85 -133.21 -59.68 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.98 -167.13 36.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.49 -34.27 77.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 0.0 110.356 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.483 ' CE2' ' HG3' ' D' ' 215' ' ' MLZ . 2.1 m-85 -52.03 110.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.728 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' B' ' 110' ' ' TRP . 34.1 m95 52.26 -166.59 0.05 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.878 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.419 ' HG ' ' N ' ' B' ' 112' ' ' SER . 14.1 tp -61.15 157.71 15.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.419 ' N ' ' HG ' ' B' ' 111' ' ' LEU . 49.0 m -64.56 -62.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -0.88 . . . . 0.0 110.4 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -140.28 160.14 60.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 110.503 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' B' ' 116' ' ' LEU . 25.8 Cg_exo -59.72 -57.45 0.84 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.689 1.363 . . . . 0.0 110.631 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.49 -69.66 0.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.408 -0.807 . . . . 0.0 110.608 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' B' ' 114' ' ' PRO . 3.7 mt 53.29 91.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.432 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 67.1 m -67.9 155.97 38.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 110.349 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.04 82.47 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.087 -0.959 . . . . 0.0 110.405 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -133.41 35.78 3.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -1.165 . . . . 0.0 110.308 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . 0.473 ' N ' ' CD ' ' D' ' 204' ' ' PRO . . . -54.98 -50.14 88.07 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.63 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' D' ' 203' ' ' ALA . 45.0 Cg_exo -51.45 97.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.51 1.268 . . . . 0.0 110.625 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.84 80.7 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.447 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.71 128.53 35.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.341 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -58.9 134.61 57.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 110.261 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.65 -171.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.78 141.84 10.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 110.401 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 1.6 p -112.9 43.86 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 110.347 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -72.16 83.67 1.01 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 110.415 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.28 102.38 13.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 110.293 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.78 160.3 33.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 110.455 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.06 -160.93 0.73 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 110.213 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.483 ' HG3' ' CE2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER -53.98 -178.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.561 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . 0.408 ' CB ' ' HG3' ' B' ' 54' ' ' ARG . . . -150.89 123.75 4.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.41 157.19 19.01 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.322 1.169 . . . . 0.0 110.539 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -104.25 -21.6 13.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 110.306 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -57.06 -168.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.324 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.791 179.852 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.423 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.438 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mmt . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.015 0.436 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 10.0 p90 -54.01 143.56 21.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.971 -1.081 . . . . 0.0 110.328 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.93 162.58 37.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.85 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.539 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.421 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.9 OUTLIER 178.33 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.414 -0.804 . . . . 0.0 109.414 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.436 HG12 ' CG1' ' A' ' 30' ' ' VAL . 18.9 m -155.4 179.98 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 109.727 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.44 166.58 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 110.04 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.39 144.78 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.784 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 4.9 mttt -140.84 142.72 34.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.3 56.99 6.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.663 -1.898 . . . . 0.0 110.6 2.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.474 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -104.24 -173.82 0.3 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.629 -0.67 . . . . 0.0 109.988 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 31.7 Cg_exo -53.72 -47.49 26.94 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.61 1.321 . . . . 0.0 110.392 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.62 31.04 0.32 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 110.388 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.72 -155.34 25.21 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.78 -147.1 18.54 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.427 ' HB2' ' N ' ' A' ' 301' ' ' SAH . 2.5 m-85 -106.2 77.93 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -1.216 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.97 -165.0 14.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' CD1' ' A' ' 67' ' ' ILE . 1.5 p -117.75 130.02 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.927 -1.337 . . . . 0.0 108.839 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.486 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -89.77 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 111.06 -177.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' CB ' ' CG1' ' A' ' 101' ' ' ILE . . . -107.0 96.23 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -0.764 . . . . 0.0 110.385 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 -70.14 -18.31 63.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 0.0 109.98 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -97.54 177.96 5.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.531 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.442 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.515 50.6 m 106.48 21.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.097 -1.627 . . . . 0.0 110.12 1.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 20.3 m-85 -114.47 155.21 26.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.395 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 94' ' ' PRO . 1.1 mt-10 -88.17 -82.81 0.22 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.798 . . . . 0.0 109.885 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 24.5 tttt -175.91 92.19 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.924 -1.11 . . . . 0.0 110.012 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.67 19.34 4.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -97.59 152.36 19.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.235 . . . . 0.0 110.307 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.481 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -78.02 121.55 24.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 110.379 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' CG1' HG12 ' A' ' 6' ' ' VAL . 88.6 t -84.64 -46.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.65 145.37 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 110.201 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -128.76 149.39 50.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.425 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 64.5 m -140.91 -154.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 110.123 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -110.35 175.94 5.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 110.623 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.1 m -147.23 164.34 33.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.409 -0.807 . . . . 0.0 109.592 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.492 HG21 HD11 ' A' ' 36' ' ' ILE . 22.4 mt -108.14 141.75 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 109.985 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 84' ' ' LEU . 61.0 t -117.31 120.97 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 110.537 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 21.7 tpt180 -148.82 143.21 26.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.445 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.33 -169.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.46 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.808 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -162.62 -136.14 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -51.63 -25.12 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 109.518 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.489 ' CE2' ' HB3' ' A' ' 38' ' ' ARG . 34.3 t-105 -58.52 -56.59 20.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.585 -0.697 . . . . 0.0 109.462 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.84 -34.21 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.8 m -70.82 -67.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 110.404 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.53 -51.72 58.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 110.538 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.472 ' HG ' ' CZ3' ' A' ' 43' ' ' TRP . 4.4 mm? -90.39 39.57 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 110.62 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 61.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.775 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.482 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -179.5 140.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.236 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 9.7 m-85 61.41 31.92 19.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.248 -0.908 . . . . 0.0 110.448 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 47' ' ' LEU . 15.3 mt -106.3 134.57 49.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -108.88 103.33 12.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' C' ' 214' ' ' ARG . 12.0 t -89.54 127.63 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 0.0 111.553 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' CZ ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -101.91 -174.48 2.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.539 -0.725 . . . . 0.0 109.752 178.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.36 73.88 9.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.016 -1.053 . . . . 0.0 109.124 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.505 5.2 t30 169.92 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.878 -0.514 . . . . 0.0 109.988 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -176.15 -168.13 0.25 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.261 -0.899 . . . . 0.0 110.952 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 1.3 p -116.58 138.8 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.17 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -131.59 168.09 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 110.375 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.4 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -105.84 172.92 6.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 109.857 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -85.23 -35.61 21.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.478 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.09 -94.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 111.288 178.128 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -70.3 -118.91 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -90.35 27.34 1.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.345 -1.091 . . . . 0.0 110.934 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.445 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -77.43 -22.6 69.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.94 -47.37 7.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.452 ' CD1' HG12 ' A' ' 18' ' ' VAL . 2.4 pp -47.66 -25.88 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.208 -0.932 . . . . 0.0 110.789 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.487 ' CG ' HG12 ' A' ' 103' ' ' ILE . 6.5 m-85 -46.39 113.25 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -92.3 179.19 5.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 110.87 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -101.77 116.91 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.828 . . . . 0.0 109.882 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.11 130.71 51.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.373 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -52.62 -23.71 7.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 110.329 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.56 71.52 0.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 110.368 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.54 112.12 1.85 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.648 1.341 . . . . 0.0 110.312 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.409 ' HA ' ' CE ' ' A' ' 93' ' ' LYS . 18.9 m-20 -111.32 18.49 19.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 110.616 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.7 162.56 40.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.0 ttt-85 -146.03 158.55 43.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.431 ' HB2' ' CE ' ' A' ' 87' ' ' MET . 19.5 p-80 -110.09 158.78 17.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -141.35 142.63 33.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.429 ' CD2' ' HG2' ' A' ' 87' ' ' MET . 6.6 mt -106.75 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -90.08 68.2 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.15 34.41 11.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.24 171.68 38.77 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.423 ' O ' ' CG2' ' A' ' 37' ' ' VAL . 85.4 mt -93.45 32.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -1.148 . . . . 0.0 109.998 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -93.34 -71.76 0.64 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.331 -0.856 . . . . 0.0 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.68 159.52 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.431 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 1.1 tmm? -142.47 138.77 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.569 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.08 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -0.96 . . . . 0.0 110.124 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.05 124.4 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.481 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 17.7 m-85 -113.35 -176.5 2.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.432 HG23 ' CG2' ' A' ' 30' ' ' VAL . 18.4 p -124.93 95.78 4.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 77' ' ' ARG . 30.7 pt -51.16 -24.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.6 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 75' ' ' ASN . 0.5 OUTLIER -145.68 157.05 52.21 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 25' ' ' GLU . 23.9 Cg_exo -59.12 147.19 91.63 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.738 1.388 . . . . 0.0 111.179 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.8 mt -131.7 145.29 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.606 -0.684 . . . . 0.0 110.33 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.25 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.373 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mt -66.97 112.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.36 26.09 2.51 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -113.69 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.241 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -116.47 135.9 53.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 110.631 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.49 ' CG1' ' CB ' ' A' ' 20' ' ' ALA . 39.2 mt -99.89 125.95 53.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.748 0.785 . . . . 0.0 110.521 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.9 p -154.73 171.57 19.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.487 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.2 pp -146.96 165.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.098 . . . . 0.0 110.655 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.75 -164.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CD2' ' NE1' ' A' ' 110' ' ' TRP . 17.3 m-85 -123.47 -66.25 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.041 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.58 153.92 9.79 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.25 -24.33 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -1.166 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -55.1 4.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 110.064 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 3.5 t80 -71.56 60.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 110.661 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.467 ' NE1' ' CD2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER 177.32 -162.94 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.24 -0.913 . . . . 0.0 110.317 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -163.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.388 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.2 p -124.25 136.9 54.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.208 -0.932 . . . . 0.0 110.277 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.4 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 13.4 mtt180 52.26 55.03 14.62 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 110.394 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 113' ' ' ARG . 33.5 Cg_endo -69.04 133.67 27.5 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.64 1.337 . . . . 0.0 110.143 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 63.95 1.51 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 110.331 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -41.33 61.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.615 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -139.02 162.58 34.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.576 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -74.25 62.59 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 110.445 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 t30 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.374 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.87 100.24 9.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -1.15 . . . . 0.0 110.363 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.45 58.34 1.65 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 110.272 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -66.52 155.17 71.49 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.683 1.36 . . . . 0.0 110.43 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.07 22.54 0.86 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 110.456 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 36.49 4.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 110.415 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -115.19 -40.9 3.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.491 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.48 30.13 1.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.388 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -106.23 34.08 3.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.865 . . . . 0.0 110.324 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 66.3 p -126.47 169.84 12.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -139.27 161.85 36.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.462 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -125.32 81.26 1.95 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 110.389 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.55 147.84 23.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.49 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 7.0 mtt-85 -111.87 -160.42 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 110.395 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER -56.33 -167.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 110.402 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -116.62 167.93 9.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.8 -79.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.696 1.366 . . . . 0.0 110.534 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -174.14 42.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 110.451 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 1.1 p -81.81 57.64 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 110.302 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mmt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.034 0.445 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.0 p90 -54.0 143.58 21.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.896 -1.128 . . . . 0.0 110.374 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.92 162.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.223 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.9 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.432 -0.792 . . . . 0.0 110.537 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.428 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 0.9 OUTLIER 178.36 -35.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.395 -0.816 . . . . 0.0 109.404 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.437 HG12 ' CG1' ' B' ' 30' ' ' VAL . 18.9 m -155.37 -179.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.494 -0.754 . . . . 0.0 109.791 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.45 166.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.31 144.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 110.816 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 5.0 mttt -140.83 142.8 34.56 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.31 56.97 6.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 119.703 -1.873 . . . . 0.0 110.626 2.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.485 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 0.9 OUTLIER -104.2 -173.85 0.31 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 110.007 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 31.7 Cg_exo -53.73 -47.54 26.68 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.593 1.312 . . . . 0.0 110.389 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.59 31.02 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.399 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.7 -155.34 25.23 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.81 -147.06 18.47 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.422 ' HB2' ' N ' ' B' ' 302' ' ' SAH . 2.5 m-85 -106.22 78.11 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 110.541 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.22 -165.27 14.66 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.446 HG12 ' CD1' ' B' ' 67' ' ' ILE . 1.6 p -117.39 129.8 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.295 . . . . 0.0 109.153 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.482 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.6 OUTLIER -89.76 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 111.088 -177.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.487 ' CB ' ' CG1' ' B' ' 101' ' ' ILE . . . -106.99 96.1 6.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.38 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -70.06 -18.37 63.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 110.027 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -97.44 178.08 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.447 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 50.8 m 106.53 21.27 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.066 -1.646 . . . . 0.0 110.112 1.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 20.4 m-85 -114.69 154.48 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.527 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' B' ' 94' ' ' PRO . 1.2 mt-10 -87.23 -83.07 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' B' ' 25' ' ' GLU . 24.7 tttt -175.8 92.17 0.05 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.921 -1.112 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.68 19.37 4.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -97.62 152.35 19.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.268 . . . . 0.0 110.297 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.481 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.8 OUTLIER -78.04 121.55 24.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.442 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.437 ' CG1' HG12 ' B' ' 6' ' ' VAL . 88.4 t -84.65 -46.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 110.163 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.69 145.35 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 110.192 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.69 149.4 50.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.962 . . . . 0.0 110.435 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.434 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 64.3 m -140.91 -154.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.13 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.31 175.96 5.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 110.645 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 11.9 m -147.33 164.26 33.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.453 -0.779 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.479 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 22.2 mt -108.07 141.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.001 -1.062 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 61.1 t -117.28 120.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.515 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.481 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 21.6 tpt180 -148.76 143.24 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.36 -169.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.45 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.735 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -162.63 -136.23 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -51.53 -25.16 6.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.557 -1.339 . . . . 0.0 109.571 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 34.3 t-105 -58.51 -56.58 20.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.555 -0.715 . . . . 0.0 109.481 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.85 -34.19 64.78 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 48.0 m -70.76 -67.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -1.144 . . . . 0.0 110.433 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.71 -51.45 60.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 110.547 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.486 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 4.4 mm? -90.63 39.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.36 61.28 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.746 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.481 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -179.51 140.18 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 9.7 m-85 61.31 32.02 19.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.306 -0.871 . . . . 0.0 110.369 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' B' ' 47' ' ' LEU . 15.2 mt -106.23 134.81 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.986 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -109.17 103.04 11.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' D' ' 214' ' ' ARG . 11.8 t -89.09 127.62 35.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.068 -1.02 . . . . 0.0 111.597 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.421 ' CZ ' HD13 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -102.59 -177.56 3.42 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.577 -0.702 . . . . 0.0 109.832 178.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.95 73.37 4.51 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 110.129 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.507 5.4 t30 169.8 -30.8 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.721 -0.612 . . . . 0.0 109.994 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -175.97 -167.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 111.078 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 1.3 p -116.61 138.73 51.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.214 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -131.62 168.03 18.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.444 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.431 ' CE ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -106.18 170.95 7.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.429 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -82.31 -36.96 26.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 111.126 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.479 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.64 -94.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.0 111.271 178.765 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -70.34 -118.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -90.56 27.33 1.76 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -1.092 . . . . 0.0 110.933 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.447 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -77.46 -22.22 70.73 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.61 -47.14 7.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.121 -1.223 . . . . 0.0 110.823 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' B' ' 18' ' ' VAL . 2.4 pp -47.75 -25.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.266 -0.897 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.488 ' CG ' HG12 ' B' ' 103' ' ' ILE . 6.5 m-85 -46.38 113.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 111.138 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -92.34 179.41 5.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.812 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -102.03 116.84 33.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.4 -0.812 . . . . 0.0 109.845 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.01 130.78 51.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.193 -0.942 . . . . 0.0 110.417 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -52.61 -23.77 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.58 71.5 0.92 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.318 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.38 112.01 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.685 1.361 . . . . 0.0 110.266 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.419 ' HA ' ' CE ' ' B' ' 93' ' ' LYS . 19.1 m-20 -111.29 18.51 19.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.395 -0.815 . . . . 0.0 110.478 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.67 162.59 40.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.54 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.442 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.0 ttt-85 -146.11 158.45 43.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.16 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.424 ' HB2' ' CE ' ' B' ' 87' ' ' MET . 19.5 p-80 -110.0 158.81 17.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.38 142.67 33.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.281 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.428 ' CD2' ' HG2' ' B' ' 87' ' ' MET . 6.6 mt -106.76 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.445 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.4 p -90.05 68.16 7.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.18 34.34 11.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.399 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.26 171.68 38.78 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.435 ' HB3' ' CB ' ' B' ' 59' ' ' ALA . 85.2 mt -93.41 32.29 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.248 -1.148 . . . . 0.0 110.08 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -93.57 -71.66 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.56 14.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.499 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.428 ' HG2' ' CD2' ' B' ' 80' ' ' LEU . 1.0 OUTLIER -142.57 138.75 31.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.563 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.1 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 110.114 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.04 124.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.495 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.481 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 17.8 m-85 -113.24 -176.52 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.344 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.434 HG23 ' CG2' ' B' ' 30' ' ' VAL . 18.3 p -124.94 95.91 4.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.097 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' B' ' 77' ' ' ARG . 30.5 pt -51.16 -24.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 110.572 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' B' ' 75' ' ' ASN . 0.5 OUTLIER -145.63 157.17 52.19 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.177 -0.952 . . . . 0.0 110.551 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' B' ' 25' ' ' GLU . 24.1 Cg_exo -59.5 147.33 92.0 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.704 1.37 . . . . 0.0 111.111 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 67.1 mt -131.67 145.4 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.577 -0.702 . . . . 0.0 110.308 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.28 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mt -66.95 112.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 110.348 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 26.11 2.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -113.7 179.45 3.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -1.226 . . . . 0.0 110.034 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -116.3 136.03 53.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.045 . . . . 0.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.487 ' CG1' ' CB ' ' B' ' 20' ' ' ALA . 40.6 mt -99.98 126.06 53.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.471 -0.768 . . . . 0.0 110.538 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -154.69 171.72 19.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.488 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.2 pp -147.0 165.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.927 -1.108 . . . . 0.0 110.669 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.8 -164.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.422 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.47 ' CD2' ' NE1' ' B' ' 110' ' ' TRP . 17.3 m-85 -123.1 -66.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.52 153.96 9.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.22 -24.41 4.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -55.11 4.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 3.5 t80 -71.52 60.32 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 110.693 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.47 ' NE1' ' CD2' ' B' ' 105' ' ' TYR . 0.0 OUTLIER 177.45 -162.89 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 179.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -163.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 110.381 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 15.6 p -124.3 136.85 54.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 110.26 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 13.5 mtt180 52.3 54.94 14.47 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 110.423 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 33.1 Cg_endo -68.99 133.74 27.77 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.666 1.35 . . . . 0.0 110.121 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.86 64.39 1.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 110.182 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -41.29 61.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.366 -0.834 . . . . 0.0 110.671 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 3.4 m -139.06 162.59 34.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.586 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -74.19 62.55 0.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 110.444 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.386 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.87 100.28 9.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -1.163 . . . . 0.0 110.31 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.45 58.3 1.64 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 110.299 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.55 155.18 71.48 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.685 1.361 . . . . 0.0 110.463 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.1 22.58 0.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 110.479 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.6 36.53 4.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 110.388 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -115.26 -40.95 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.418 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.43 30.03 1.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 110.428 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -106.19 34.09 3.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.883 . . . . 0.0 110.32 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 66.1 p -126.47 169.78 12.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.401 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -139.24 161.86 36.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.468 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -125.27 81.26 1.95 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.354 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.54 147.85 23.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.917 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.481 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 7.0 mtt-85 -111.89 -160.44 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER -56.36 -167.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.217 -0.927 . . . . 0.0 110.432 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -116.64 168.0 9.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -61.83 -79.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.696 1.366 . . . . 0.0 110.561 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -174.2 42.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.954 . . . . 0.0 110.496 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 1.1 p -81.76 57.61 3.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.32 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.427 ' N ' ' HB2' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.422 ' N ' ' HB2' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.15 0.5 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 21.8 p90 -51.26 139.89 17.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 110.617 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.83 156.04 49.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.14 -18.45 15.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.791 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.428 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 2.1 mtm-85 -97.6 -29.03 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 110.914 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 27.1 m -153.45 -172.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 110.415 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 13.6 tt -154.81 165.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 110.205 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.77 137.83 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.98 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 31.1 mttt -142.21 143.64 33.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.536 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER 52.73 66.21 1.29 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.757 -1.839 . . . . 0.0 111.161 1.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -126.93 174.04 4.64 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.568 178.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -53.4 100.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.498 1.262 . . . . 0.0 110.319 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.2 50.18 15.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.414 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.67 165.54 24.16 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -148.27 5.87 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -102.58 73.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.247 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.71 -165.22 23.4 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.43 HG11 ' CD1' ' A' ' 67' ' ' ILE . 1.9 p -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.951 -1.323 . . . . 0.0 109.553 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m-85 -89.79 158.55 17.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.564 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.09 105.32 13.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 110.645 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -63.71 -28.45 69.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.516 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 5.3 mttm -86.5 -178.36 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.442 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.507 4.8 t 99.53 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.031 -1.668 . . . . 0.0 110.493 1.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 22.2 m-85 -96.83 158.63 15.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.047 -1.033 . . . . 0.0 110.893 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 -155.69 0.48 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.479 -0.763 . . . . 0.0 110.011 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 58.8 tttt -95.94 30.88 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.27 86.21 0.06 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -150.07 124.6 9.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 110.337 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 3.4 tm? -54.34 119.96 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.3 -52.72 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' N ' HD13 ' A' ' 29' ' ' LEU . 8.6 pt-20 -170.73 97.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.25 152.24 34.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -150.36 -151.22 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.77 171.93 7.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 1.03 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 1.3 m -150.14 150.42 31.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 36' ' ' ILE . 56.2 mt -91.18 142.71 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 42.0 t -117.63 127.91 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 110.769 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 19.2 mmt180 -150.36 178.2 9.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -92.14 -173.73 3.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.111 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.57 -141.93 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.407 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.74 -135.02 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.06 -1.025 . . . . 0.0 110.826 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.63 -49.06 7.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 111.521 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 38' ' ' ARG . 36.8 t-105 -51.54 -46.71 63.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.26 76.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.414 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 44.9 m -74.46 -59.96 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -1.216 . . . . 0.0 110.826 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' O ' ' NH2' ' B' ' 38' ' ' ARG . . . -50.69 -54.48 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.639 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.1 mm? -91.91 23.3 3.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 45' ' ' THR . 2.0 pp20? -50.67 154.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.952 -1.092 . . . . 0.0 110.005 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 54.9 t0 60.86 147.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.778 . . . . 0.0 110.164 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.28 13.68 7.18 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.145 -0.972 . . . . 0.0 110.303 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' CD2' ' NE1' ' A' ' 43' ' ' TRP . 8.9 tp -112.52 107.79 16.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.87 119.06 29.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -109.27 136.0 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 0.0 111.066 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' CD ' HD11 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -102.29 -172.04 2.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.391 -0.818 . . . . 0.0 109.806 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.03 72.91 9.09 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.958 -1.089 . . . . 0.0 108.967 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 6.3 m120 175.08 -33.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.434 ' HG2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.59 -173.51 0.33 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.352 -0.842 . . . . 0.0 110.331 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -112.75 146.92 37.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -141.8 151.64 43.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.618 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.433 ' CA ' HD13 ' A' ' 51' ' ' LEU . 29.3 tpp -90.17 156.77 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.429 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -87.83 93.39 9.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.426 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.497 0.1 OUTLIER -54.53 -65.5 0.56 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 110.427 179.194 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -60.69 -159.49 0.07 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.418 ' HB3' ' CD1' ' A' ' 67' ' ' ILE . 5.1 m-85 -75.36 58.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -1.091 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -90.16 -36.34 7.16 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.7 73.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 110.661 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.43 ' CD1' HG11 ' A' ' 18' ' ' VAL . 1.2 pp -51.84 -34.44 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.188 -0.945 . . . . 0.0 111.24 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' HB3' ' CG1' ' A' ' 103' ' ' ILE . 11.8 m-85 -49.96 119.9 3.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.986 -1.071 . . . . 0.0 110.697 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -95.52 176.46 6.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.404 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -95.39 107.57 19.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.4 t -115.65 129.98 56.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -53.6 -26.37 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.26 76.52 0.4 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.857 . . . . 0.0 110.052 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 17.0 Cg_endo -62.32 104.37 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.719 1.379 . . . . 0.0 110.656 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -94.38 -19.82 20.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.71 178.0 5.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.327 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.433 ' NH1' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -149.56 168.18 24.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.409 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.468 ' CD2' ' O ' ' A' ' 78' ' ' HIS . 33.5 p-80 -121.42 127.06 50.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 26.8 tt0 -109.17 172.44 6.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.427 HD11 ' CD ' ' A' ' 54' ' ' ARG . 6.0 mt -121.63 146.13 47.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 110.487 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 37.2 m -117.07 144.7 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.484 -0.76 . . . . 0.0 110.273 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 85' ' ' LYS . . . 52.93 34.03 15.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.03 -95.65 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' CD2' ' HG2' ' A' ' 57' ' ' MET . 1.0 OUTLIER -124.12 26.58 7.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -1.15 . . . . 0.0 110.219 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 82' ' ' ALA . 1.2 mmtp -89.79 -73.12 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 110.482 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.428 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -102.17 177.84 4.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.41 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 1.03 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 64.5 mtp -136.91 150.51 48.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 110.369 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HD3' ' CE1' ' A' ' 90' ' ' PHE . 15.1 ttm180 -133.5 104.41 6.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.93 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 mt -89.08 140.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.964 . . . . 0.0 110.314 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.497 ' CE1' ' HD3' ' A' ' 88' ' ' ARG . 1.7 m-85 -129.53 -168.11 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.4 p -125.36 97.1 5.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 110.366 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.433 HG21 ' NH1' ' A' ' 77' ' ' ARG . 49.3 pt -59.87 -17.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.534 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.43 134.73 12.67 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 110.005 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 97.2 Cg_exo -46.59 135.49 16.48 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.49 1.258 . . . . 0.0 111.255 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.416 HG23 ' CB ' ' A' ' 99' ' ' GLU . 80.6 mt -115.71 142.38 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.5 163.33 15.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 28.1 mt -65.07 115.11 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -0.81 . . . . 0.0 110.409 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.06 40.85 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.416 ' CB ' HG23 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -111.6 177.6 4.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.138 . . . . 0.0 110.347 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.58 30.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.463 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 102' ' ' THR . 62.8 mt -90.31 124.85 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 110.395 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 17.5 p -157.51 135.92 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.1 pp -100.85 170.44 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.965 -1.084 . . . . 0.0 110.447 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.4 p -105.63 -166.83 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.478 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.408 ' CD1' ' HG3' ' C' ' 215' ' ' MLZ . 12.4 m-85 -123.58 -58.56 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.57 160.32 0.44 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.6 OUTLIER 57.45 109.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.434 -1.039 . . . . 0.0 110.977 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 107' ' ' ASP . 16.5 t0 57.57 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.844 -0.535 . . . . 0.0 111.768 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -43.34 111.03 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.311 -0.868 . . . . 0.0 111.706 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 49.64 -160.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 111.019 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 140.26 15.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.803 . . . . 0.0 110.647 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -148.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.877 . . . . 0.0 110.16 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -48.63 106.33 0.6 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.148 -0.97 . . . . 0.0 110.74 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.42 95.41 0.86 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.512 1.269 . . . . 0.0 110.468 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.74 99.74 9.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 110.442 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.0 151.64 51.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 110.377 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -122.26 163.26 19.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.347 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.31 100.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.375 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.058 -0.973 . . . . 0.0 110.409 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.48 -167.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -1.161 . . . . 0.0 110.412 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -133.5 158.16 76.29 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.395 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.93 125.39 17.55 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.707 1.372 . . . . 0.0 110.499 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 105.56 15.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 110.299 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.13 147.02 41.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 110.42 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.5 161.86 8.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.325 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 18.5 mt -117.04 -24.11 7.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 110.441 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.52 134.34 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.366 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 55.5 m -137.31 69.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 110.348 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 mttt 52.56 80.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 110.493 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.81 97.37 3.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 110.244 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.27 160.7 15.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 110.424 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -89.05 -150.01 0.19 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 110.129 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.408 ' HG3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 0.1 OUTLIER -53.03 178.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 110.339 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.33 16.51 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.943 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.22 -168.09 0.32 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.571 1.301 . . . . 0.0 110.538 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -105.8 148.19 27.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 110.218 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 22.0 m -140.49 104.38 4.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.176 -0.953 . . . . 0.0 110.329 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.086 0.47 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 21.6 p90 -51.44 139.87 18.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.117 -0.99 . . . . 0.0 110.573 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.78 156.13 49.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.295 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.18 -18.44 15.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.764 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.421 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 2.1 mtm-85 -97.66 -29.08 13.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.884 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 27.0 m -153.4 -172.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 tt -154.79 165.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.95 . . . . 0.0 110.23 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.79 137.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 110.726 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.539 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 31.1 mttt -142.17 143.72 33.1 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.539 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.0 OUTLIER 52.77 66.3 1.26 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.861 -1.774 . . . . 0.0 111.083 1.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -127.03 173.99 4.72 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.568 178.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -53.3 100.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.494 1.26 . . . . 0.0 110.289 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.12 50.3 15.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 0.0 110.373 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.74 165.53 24.18 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -148.28 5.87 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -102.52 73.3 1.3 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -1.231 . . . . 0.0 110.641 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.68 -165.33 23.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.436 HG11 ' CD1' ' B' ' 67' ' ' ILE . 2.0 p -121.69 130.72 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.322 . . . . 0.0 109.674 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.492 ' CD1' ' HD2' ' B' ' 9' ' ' LYS . 1.1 m-85 -89.83 158.5 17.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 110.528 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.18 105.39 13.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 110.581 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.418 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.2 OUTLIER -63.7 -28.39 69.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.441 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 5.3 mttm -86.54 -178.36 6.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.441 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.506 4.8 t 99.53 10.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 119.958 -1.714 . . . . 0.0 110.5 1.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 22.1 m-85 -96.69 158.67 15.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.064 -1.022 . . . . 0.0 110.921 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.09 -155.69 0.48 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.464 -0.773 . . . . 0.0 110.016 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -95.93 30.84 2.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.393 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.29 86.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -150.17 124.6 9.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' B' ' 90' ' ' PHE . 3.4 tm? -54.36 119.95 5.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 95.1 t -81.26 -52.73 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.841 . . . . 0.0 110.372 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.433 ' N ' HD13 ' B' ' 29' ' ' LEU . 8.6 pt-20 -170.73 97.46 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 152.4 34.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.433 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.3 OUTLIER -150.55 -151.33 0.39 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.645 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.7 171.96 7.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.521 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 1.034 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 1.3 m -150.18 150.36 31.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.516 HG21 HD12 ' B' ' 36' ' ' ILE . 55.8 mt -91.04 142.77 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' B' ' 84' ' ' LEU . 42.1 t -117.67 128.01 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 110.745 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 19.1 mmt180 -150.5 178.18 9.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.7 OUTLIER -92.11 -173.73 3.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 110.106 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.6 -141.95 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.35 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.75 -135.05 0.8 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.129 -0.982 . . . . 0.0 110.805 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.59 -49.1 7.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.001 -1.062 . . . . 0.0 111.506 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 36.9 t-105 -51.53 -46.7 63.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 110.046 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.27 76.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 44.9 m -74.47 -59.88 2.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.138 -1.213 . . . . 0.0 110.808 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -53.67 30.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 0.0 110.656 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.478 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 3.2 mm? -93.0 23.63 4.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 110.603 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' B' ' 45' ' ' THR . 2.0 pp20? -50.76 154.52 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.033 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 54.2 t0 60.91 147.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.504 -0.747 . . . . 0.0 110.177 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.2 13.73 7.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.115 -0.991 . . . . 0.0 110.18 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.465 ' CD2' ' NE1' ' B' ' 43' ' ' TRP . 8.9 tp -112.6 107.81 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 110.936 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.85 119.08 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.564 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 42.6 t -109.25 135.93 49.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -0.99 . . . . 0.0 111.094 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.437 ' CB ' HD13 ' B' ' 84' ' ' LEU . 0.9 OUTLIER -102.93 -175.19 2.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.74 . . . . 0.0 109.808 178.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.46 72.3 4.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -0.962 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 6.3 m120 175.02 -33.51 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.43 ' CG ' HD21 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.3 -173.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.347 -0.845 . . . . 0.0 110.391 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -112.74 146.89 37.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -141.74 151.62 43.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.446 ' CA ' HD13 ' B' ' 51' ' ' LEU . 29.3 tpp -90.32 155.93 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.423 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -86.65 93.4 9.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.851 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.436 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.497 0.1 OUTLIER -54.93 -65.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.369 179.246 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.7 -159.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.412 ' HB3' ' CD1' ' B' ' 67' ' ' ILE . 5.1 m-85 -75.4 59.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -90.34 -36.27 7.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.68 73.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 110.658 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.436 ' CD1' HG11 ' B' ' 18' ' ' VAL . 1.2 pp -51.87 -34.4 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 0.0 111.246 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.445 ' HB3' ' CG1' ' B' ' 103' ' ' ILE . 11.8 m-85 -49.95 119.89 3.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.918 -1.114 . . . . 0.0 110.709 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -95.53 176.47 6.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.869 . . . . 0.0 110.451 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -95.4 107.57 19.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 110.253 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 31.5 t -115.67 130.02 56.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 0.0 110.498 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' B' ' 74' ' ' PRO . 0.4 OUTLIER -53.59 -26.36 21.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.293 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.27 76.5 0.4 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.09 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.419 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 17.0 Cg_endo -62.31 104.39 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.715 1.377 . . . . 0.0 110.688 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -94.42 -19.78 20.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.74 178.02 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 110.295 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.437 ' NH1' HG21 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -149.55 168.2 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.962 . . . . 0.0 110.445 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.459 ' O ' ' CD2' ' B' ' 78' ' ' HIS . 33.6 p-80 -121.42 126.92 50.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 110.386 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' B' ' 88' ' ' ARG . 27.0 tt0 -109.07 172.37 6.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.428 HD11 ' CD ' ' B' ' 54' ' ' ARG . 6.0 mt -121.46 146.21 47.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.453 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.433 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 38.5 m -117.08 144.7 44.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.41 -0.806 . . . . 0.0 110.279 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.93 34.01 15.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.253 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.08 -95.72 2.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.437 ' HB3' ' CG2' ' B' ' 37' ' ' VAL . 1.0 OUTLIER -124.11 26.53 7.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -1.163 . . . . 0.0 110.228 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -89.69 -73.09 0.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 110.522 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.433 ' CB ' ' HB ' ' B' ' 81' ' ' THR . 0.3 OUTLIER -102.24 177.87 4.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.349 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 1.034 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 64.5 mtp -136.92 150.6 48.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.492 ' HD3' ' CE1' ' B' ' 90' ' ' PHE . 15.0 ttm180 -133.76 104.08 6.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.476 -0.765 . . . . 0.0 109.982 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.1 mt -88.39 140.22 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.461 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.492 ' CE1' ' HD3' ' B' ' 88' ' ' ARG . 1.7 m-85 -129.73 -168.13 1.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.89 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 26.5 p -125.32 97.07 5.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 110.397 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.437 HG21 ' NH1' ' B' ' 77' ' ' ARG . 49.2 pt -59.84 -17.54 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.42 134.62 12.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.89 135.75 17.49 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.467 1.246 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.421 HG23 ' CB ' ' B' ' 99' ' ' GLU . 80.9 mt -115.77 142.19 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.18 163.39 15.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.622 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 28.1 mt -65.06 115.04 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 110.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.07 40.87 2.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.421 ' CB ' HG23 ' B' ' 95' ' ' ILE . 0.2 OUTLIER -111.59 177.64 4.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.73 31.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.401 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' B' ' 102' ' ' THR . 63.1 mt -90.45 124.83 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 110.44 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 17.4 p -157.38 135.98 11.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 109.659 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.445 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.1 pp -100.83 170.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 89.5 p -105.64 -166.98 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.441 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.408 ' CD1' ' HG3' ' D' ' 215' ' ' MLZ . 12.4 m-85 -123.44 -58.75 1.59 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.939 . . . . 0.0 110.036 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.84 160.31 0.47 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.6 OUTLIER 57.41 109.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.432 -1.04 . . . . 0.0 111.003 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 107' ' ' ASP . 16.7 t0 57.79 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.867 -0.521 . . . . 0.0 111.774 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' B' ' 107' ' ' ASP . 0.2 OUTLIER -43.45 111.0 0.23 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.302 -0.874 . . . . 0.0 111.719 -178.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 49.7 -160.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 0.0 110.934 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 140.24 15.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 110.612 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -148.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 110.169 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -48.56 106.33 0.6 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 110.739 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.44 95.39 0.86 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.517 1.272 . . . . 0.0 110.463 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.69 99.71 9.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.436 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.02 151.63 50.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 110.368 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -122.26 163.24 20.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 110.351 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.23 100.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 110.358 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.442 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.46 -167.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -1.153 . . . . 0.0 110.4 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -133.47 158.2 76.2 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.96 125.42 17.61 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.665 1.35 . . . . 0.0 110.469 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.52 105.53 15.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 147.01 41.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.49 161.86 8.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.287 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 18.6 mt -117.05 -24.15 7.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.4 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.45 134.39 20.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 55.5 m -137.31 69.61 1.4 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 110.379 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 mttt 52.69 80.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.461 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.76 97.34 3.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.296 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.24 160.79 15.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 110.398 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -89.13 -149.98 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.14 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.408 ' HG3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.1 OUTLIER -53.05 178.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.38 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.3 16.48 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 110.413 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.2 -168.12 0.32 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.538 1.283 . . . . 0.0 110.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -105.79 148.19 27.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.903 . . . . 0.0 110.198 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 22.0 m -140.47 104.34 4.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 110.392 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.262 0.553 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 48.9 p90 -126.71 123.32 37.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 110.439 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -126.03 148.11 49.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.415 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 26.1 t70 -46.51 -48.66 19.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.437 -0.79 . . . . 0.0 111.053 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.437 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 20.6 mmt85 -59.65 -45.7 91.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 110.495 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 27.3 m -154.81 152.16 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.384 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.428 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 11.6 tt -117.75 167.12 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.941 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -89.35 127.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.433 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.559 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 12.9 mttt -144.54 139.02 27.92 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER 52.61 73.47 0.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.585 -1.947 . . . . 0.0 109.798 6.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.436 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -131.78 177.61 2.16 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 121.869 -0.52 . . . . 0.0 110.135 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 11' ' ' SER . 19.5 Cg_endo -65.76 -37.45 27.85 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.609 1.321 . . . . 0.0 110.438 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.28 -32.67 73.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 110.272 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.14 122.48 5.11 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.29 133.9 2.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.58 66.66 6.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -1.2 . . . . 0.0 110.627 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.54 -163.75 17.65 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.487 HG13 ' CE1' ' A' ' 68' ' ' PHE . 2.4 p -105.89 133.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.238 . . . . 0.0 109.063 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.51 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -90.0 144.12 26.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 110.521 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' CB ' ' CG1' ' A' ' 101' ' ' ILE . . . -97.26 89.24 4.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.466 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.416 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.6 OUTLIER -63.29 -18.59 63.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.282 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HD2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.76 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.416 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 0.0 OUTLIER 97.57 8.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.414 -1.429 . . . . 0.0 110.609 0.812 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CZ ' ' HD2' ' A' ' 22' ' ' LYS . 14.6 m-85 -105.44 163.46 12.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.995 -1.065 . . . . 0.0 110.511 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.3 -148.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.027 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -107.94 82.47 1.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . . . 124.37 46.5 0.25 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.57 144.81 51.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -1.172 . . . . 0.0 110.531 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.492 HD22 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -74.87 141.76 44.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.477 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 28.6 m -121.81 -23.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.18 -0.95 . . . . 0.0 110.995 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 4.7 tt0 -171.8 153.82 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.104 -0.997 . . . . 0.0 110.216 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.46 ' CG ' ' HA ' ' A' ' 88' ' ' ARG . 3.1 mt-10 -146.63 151.0 36.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 110.484 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 27.0 p -150.59 -160.85 1.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.652 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 HD21 ' CG ' ' A' ' 86' ' ' ARG . 54.0 mt -114.73 -179.87 3.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.466 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.7 170.89 17.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.439 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 48.2 mt -105.78 144.26 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.226 -0.922 . . . . 0.0 109.793 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.25 89.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.005 -1.059 . . . . 0.0 110.386 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.38 177.81 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -88.61 175.06 7.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.121 -0.987 . . . . 0.0 109.771 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 5.7 t-20 -74.89 -135.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.099 -1.001 . . . . 0.0 110.252 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.3 t0 65.84 -146.86 0.21 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.69 -1.257 . . . . 0.0 110.379 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.03 -28.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.213 -0.93 . . . . 0.0 111.033 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.548 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 65.9 t-105 -68.41 -52.11 36.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.833 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.77 -23.53 55.98 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 90.7 m -83.76 -67.09 0.82 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -1.188 . . . . 0.0 110.748 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.63 -49.92 18.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 0.0 110.988 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.548 ' CD2' ' CH2' ' A' ' 43' ' ' TRP . 4.4 mp -91.86 31.87 1.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.02 64.09 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.939 -1.101 . . . . 0.0 110.61 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.42 -68.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.038 -1.039 . . . . 0.0 110.585 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 13.0 m-85 -98.34 34.39 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 47' ' ' LEU . 2.3 tp -101.5 116.86 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.549 -0.72 . . . . 0.0 111.01 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -89.35 103.73 16.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.117 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 33.7 t -90.77 139.93 30.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.148 -0.97 . . . . 0.0 111.561 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' NH2' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -121.63 -175.36 3.07 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.583 -0.698 . . . . 0.0 109.674 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 79.69 8.88 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 109.363 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.506 0.2 OUTLIER 162.88 -28.91 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.847 -0.533 . . . . 0.0 109.844 -179.307 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.84 -161.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.3 m -128.28 141.7 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -129.12 175.42 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.859 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.434 ' CE ' HD23 ' A' ' 47' ' ' LEU . 1.3 tpt -114.11 169.45 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' N ' ' HG3' ' A' ' 60' ' ' MET . . . -84.96 -37.28 20.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.083 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.433 ' CB ' HD23 ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER 76.14 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.005 . . . . 0.0 111.186 177.657 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -66.35 -128.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.446 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.19 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -1.049 . . . . 0.0 110.84 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.77 -26.71 21.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 50' ' ' TYR . . . -90.15 -35.78 15.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -1.114 . . . . 0.0 110.585 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.464 HD12 ' CD1' ' A' ' 68' ' ' PHE . 2.1 pp -47.01 -37.0 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.487 ' CE1' HG13 ' A' ' 18' ' ' VAL . 28.9 m-85 -46.39 129.37 10.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.343 -0.848 . . . . 0.0 110.919 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.49 -177.4 3.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 110.65 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -93.24 124.72 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 110.03 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 m -145.35 157.18 44.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 110.555 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.22 25.91 2.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.495 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.26 67.84 4.1 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 13.1 Cg_endo -60.55 110.24 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.764 1.402 . . . . 0.0 110.465 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.436 ' HB3' ' CD1' ' A' ' 95' ' ' ILE . 3.1 m120 -89.84 -18.65 25.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' CB ' HG22 ' A' ' 101' ' ' ILE . . . -151.55 122.66 7.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.13 -0.982 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.445 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.2 mtt180 -93.89 -171.23 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 110.033 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -130.39 150.59 51.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.177 -0.952 . . . . 0.0 110.281 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 4.4 tp10 -117.32 141.81 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 84' ' ' LEU . 51.2 tp -114.5 131.13 56.74 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 110.131 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -54.81 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 110.379 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' ' NH2' ' A' ' 54' ' ' ARG . . . -52.42 -23.27 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 110.389 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.54 -164.27 11.79 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 59' ' ' ALA . 8.9 mt -102.8 42.47 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -1.129 . . . . 0.0 110.226 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.23 -65.63 0.98 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.168 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' CG ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.46 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 110.886 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.97 24.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 110.13 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.46 ' HA ' ' CG ' ' A' ' 32' ' ' GLU . 0.4 OUTLIER -128.03 172.47 10.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 110.91 -179.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.477 ' CG2' ' CG2' ' A' ' 30' ' ' VAL . 16.6 mt -145.89 91.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.492 ' CD2' HD22 ' A' ' 29' ' ' LEU . 2.4 m-85 -98.41 150.39 21.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.586 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLY . 2.9 p -89.13 114.13 25.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.061 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 77' ' ' ARG . 13.6 pt -75.83 -13.53 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.62 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 8.3 ptpt -148.19 156.7 43.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.058 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.87 124.41 15.29 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.582 1.306 . . . . 0.0 110.597 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 75' ' ' ASN . 61.8 mt -111.4 145.6 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 110.373 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.89 156.61 17.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.367 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -59.91 111.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.864 . . . . 0.0 110.326 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.76 32.19 1.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -114.3 170.54 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' OE2' ' CG2' ' A' ' 102' ' ' THR . 0.7 OUTLIER -110.31 139.8 45.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.444 ' CG1' ' CB ' ' A' ' 20' ' ' ALA . 41.0 mt -109.02 122.1 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 110.619 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.415 ' CG2' ' OE2' ' A' ' 100' ' ' GLU . 58.4 p -149.7 143.71 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.479 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -111.61 169.86 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.021 -1.049 . . . . 0.0 110.571 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.51 -168.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 110.428 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 11.1 m-85 -123.49 -62.33 1.33 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.21 -0.932 . . . . 0.0 109.867 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 70.16 -169.83 45.65 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.87 -67.86 0.11 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.533 -0.981 . . . . 0.0 110.813 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -144.12 -39.02 0.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.994 -1.066 . . . . 0.0 110.767 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.6 m-85 -47.51 107.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 111.241 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 26.3 m95 53.17 -96.97 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 110.908 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.04 -175.78 4.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.698 -1.251 . . . . 0.0 110.792 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.65 -47.87 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.38 -0.825 . . . . 0.0 110.244 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.74 57.97 15.06 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.244 -0.91 . . . . 0.0 110.297 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.52 -24.89 70.19 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.73 1.384 . . . . 0.0 110.568 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.85 79.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.449 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.85 169.04 15.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 110.438 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.439 ' CG2' ' O ' ' A' ' 117' ' ' THR . 73.4 m 54.11 20.84 2.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 110.645 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -174.79 150.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.872 -1.142 . . . . 0.0 110.437 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.343 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -116.2 -28.33 6.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -1.176 . . . . 0.0 110.361 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . 0.427 ' N ' ' HD3' ' C' ' 204' ' ' PRO . . . 52.5 63.35 8.97 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 110.431 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' C' ' 203' ' ' ALA . 24.6 Cg_exo -60.05 -39.07 73.42 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.611 1.322 . . . . 0.0 110.51 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -52.8 -72.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 110.46 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' C' ' 208' ' ' LEU . 0.7 OUTLIER -71.31 -154.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.361 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.59 -75.89 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.425 -0.797 . . . . 0.0 110.705 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' C' ' 206' ' ' LYS . 24.4 mt 53.22 -178.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.301 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.12 165.94 14.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 110.503 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.7 t -169.55 159.52 8.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 110.185 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -166.94 127.48 1.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 110.521 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -133.32 111.43 10.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.89 . . . . 0.0 110.2 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' C' ' 214' ' ' ARG . . . -161.14 -147.05 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 110.359 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' C' ' 213' ' ' ALA . 1.7 mmt-85 61.16 125.4 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.416 -0.803 . . . . 0.0 110.458 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t -61.0 -146.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.363 -0.836 . . . . 0.0 110.525 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.44 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.209 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.2 175.24 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.596 1.313 . . . . 0.0 110.447 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -53.15 -64.52 0.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 99.9 m 52.3 64.11 1.98 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.499 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.221 0.534 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 49.0 p90 -126.68 123.28 37.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 110.474 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -125.96 148.26 49.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . 0.409 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 26.1 t70 -46.56 -48.7 19.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.371 -0.831 . . . . 0.0 110.985 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.426 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 20.5 mmt85 -59.67 -45.69 91.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 110.539 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 27.3 m -154.72 152.22 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 11.7 tt -117.89 166.75 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -88.83 127.86 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.571 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 13.0 mttt -144.71 139.15 27.74 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.576 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.8 OUTLIER 52.71 73.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.52 -1.988 . . . . 0.0 109.851 6.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . 0.4 OUTLIER -131.84 177.57 2.18 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.895 -0.503 . . . . 0.0 110.097 -178.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' B' ' 11' ' ' SER . 19.3 Cg_endo -65.78 -37.47 27.71 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.567 1.299 . . . . 0.0 110.365 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.26 -32.69 73.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 110.286 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.13 122.46 5.11 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.34 133.92 2.73 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -90.55 66.96 6.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -1.145 . . . . 0.0 110.616 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.87 -163.94 17.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.483 HG13 ' CE1' ' B' ' 68' ' ' PHE . 2.5 p -105.59 132.94 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.021 -1.282 . . . . 0.0 109.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.519 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.054 -1.028 . . . . 0.0 110.556 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.437 ' CB ' ' CG1' ' B' ' 101' ' ' ILE . . . -97.21 89.19 4.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.6 OUTLIER -63.4 -18.54 63.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.472 ' HD2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.85 6.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.414 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.509 0.0 OUTLIER 97.63 8.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.434 -1.416 . . . . 0.0 110.625 0.786 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.472 ' CZ ' ' HD2' ' B' ' 22' ' ' LYS . 14.4 m-85 -105.34 163.52 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.024 -1.048 . . . . 0.0 110.487 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.36 -148.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -107.96 82.45 1.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.13 -0.981 . . . . 0.0 110.486 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 91' ' ' THR . . . 124.37 46.57 0.25 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.55 144.74 51.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -1.197 . . . . 0.0 110.575 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER -74.84 141.84 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 109.813 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.471 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 28.4 m -121.97 -23.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.12 -0.987 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.429 ' HB3' ' CD1' ' B' ' 89' ' ' ILE . 4.6 tt0 -171.75 153.77 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' B' ' 88' ' ' ARG . 3.1 mt-10 -146.59 151.26 37.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 0.0 110.434 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.411 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 27.0 p -150.98 -161.02 1.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.432 HD21 ' CG ' ' B' ' 86' ' ' ARG . 53.7 mt -114.66 -179.84 3.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -149.68 170.86 17.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 47.8 mt -105.76 144.2 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.791 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.18 89.35 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.41 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.28 177.8 4.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.361 -0.837 . . . . 0.0 110.163 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -88.54 175.0 7.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.12 -0.987 . . . . 0.0 109.785 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 5.7 t-20 -74.83 -135.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 4.4 t0 65.87 -146.89 0.21 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.712 -1.243 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.0 -28.39 1.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.169 -0.957 . . . . 0.0 111.022 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.544 ' CH2' ' CD2' ' B' ' 47' ' ' LEU . 65.8 t-105 -68.45 -52.06 36.75 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.79 -23.52 56.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.418 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 91.1 m -83.71 -67.16 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 110.699 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.73 -49.03 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.188 -0.945 . . . . 0.0 111.046 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.544 ' CD2' ' CH2' ' B' ' 43' ' ' TRP . 4.4 mp -93.21 32.44 1.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.13 64.09 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.564 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.46 -68.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.047 . . . . 0.0 110.596 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.488 ' CG ' ' HB3' ' B' ' 66' ' ' ALA . 13.0 m-85 -98.22 34.29 2.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.224 -0.922 . . . . 0.0 109.955 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.402 ' CD1' ' SD ' ' B' ' 60' ' ' MET . 2.3 tp -101.51 116.66 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 111.145 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -89.05 103.79 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.184 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 33.8 t -90.82 139.88 30.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 111.526 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.415 ' NH2' ' O ' ' B' ' 82' ' ' ALA . 0.2 OUTLIER -122.2 -178.36 3.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.587 -0.696 . . . . 0.0 109.696 178.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.25 79.35 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 110.253 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 0.2 OUTLIER 162.71 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.694 -0.629 . . . . 0.0 109.88 -179.474 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.4 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -177.67 -161.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.3 m -128.35 141.7 51.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.13 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -129.07 175.34 8.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.015 . . . . 0.0 110.955 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.438 ' CE ' HD23 ' B' ' 47' ' ' LEU . 1.3 tpt -114.47 167.34 10.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.0 109.793 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' B' ' 60' ' ' MET . . . -81.82 -38.74 25.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -0.965 . . . . 0.0 110.56 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.433 HD23 ' CB ' ' A' ' 62' ' ' LEU 2.501 0.1 OUTLIER 76.7 -95.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 111.202 178.359 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -66.36 -128.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.44 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.59 1.26 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -1.06 . . . . 0.0 110.788 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -91.39 -26.42 20.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.488 ' HB3' ' CG ' ' B' ' 50' ' ' TYR . . . -90.33 -35.73 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -1.093 . . . . 0.0 110.595 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.459 HD12 ' CD1' ' B' ' 68' ' ' PHE . 2.2 pp -46.97 -37.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.483 ' CE1' HG13 ' B' ' 18' ' ' VAL . 29.1 m-85 -46.31 129.36 10.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.322 -0.861 . . . . 0.0 110.983 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.5 -177.32 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -93.27 124.63 37.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.3 m -145.36 157.25 44.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.39 26.08 2.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -157.22 67.73 4.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.427 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 13.2 Cg_endo -60.47 110.3 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.727 1.383 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.434 ' HB3' ' CD1' ' B' ' 95' ' ' ILE . 3.1 m120 -89.91 -18.65 25.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' B' ' 101' ' ' ILE . . . -151.54 122.7 7.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.436 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.3 mtt180 -93.85 -171.17 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.327 -0.858 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -130.48 150.49 51.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.437 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 4.4 tp10 -117.23 141.88 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' B' ' 84' ' ' LEU . 51.6 tp -114.5 131.12 56.74 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.17 -0.956 . . . . 0.0 110.238 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -54.9 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.329 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.415 ' O ' ' NH2' ' B' ' 54' ' ' ARG . . . -52.4 -23.32 5.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 110.345 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.48 -164.22 11.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.436 ' HB3' ' CB ' ' B' ' 59' ' ' ALA . 8.9 mt -102.9 42.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -1.106 . . . . 0.0 110.144 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.46 -65.48 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 111.173 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.432 ' CG ' HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.47 27.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.823 -178.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.87 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 110.127 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.451 ' HA ' ' CG ' ' B' ' 32' ' ' GLU . 0.4 OUTLIER -127.78 172.62 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 30' ' ' VAL . 16.7 mt -145.99 91.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.52 -0.738 . . . . 0.0 109.964 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.495 ' CD2' HD22 ' B' ' 29' ' ' LEU . 2.4 m-85 -98.44 150.01 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 110.593 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.426 ' O ' ' N ' ' B' ' 27' ' ' GLY . 3.0 p -88.66 114.19 25.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.164 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' B' ' 77' ' ' ARG . 13.7 pt -75.82 -13.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.666 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 8.3 ptpt -148.17 156.71 43.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.966 . . . . 0.0 110.039 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.82 124.42 15.34 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.676 1.356 . . . . 0.0 110.64 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' B' ' 75' ' ' ASN . 61.9 mt -111.4 145.64 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.92 156.61 17.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -59.91 111.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 32.16 1.78 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -114.29 170.49 8.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 110.236 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.41 ' OE2' ' CG2' ' B' ' 102' ' ' THR . 0.7 OUTLIER -110.29 139.88 45.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.957 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.437 ' CG1' ' CB ' ' B' ' 20' ' ' ALA . 41.5 mt -108.89 122.2 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.41 ' CG2' ' OE2' ' B' ' 100' ' ' GLU . 57.4 p -149.7 143.73 25.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 109.631 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.479 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.0 OUTLIER -111.53 169.75 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.51 -168.89 1.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.487 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 10.9 m-85 -123.12 -62.41 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.95 . . . . 0.0 109.936 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.15 -169.8 45.67 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.89 -67.87 0.11 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.521 -0.987 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -144.07 -39.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.053 -1.029 . . . . 0.0 110.757 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.6 m-85 -47.45 107.14 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' B' ' 110' ' ' TRP . 26.2 m95 53.18 -96.59 0.05 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.437 -0.789 . . . . 0.0 111.004 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.69 -175.89 4.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.655 -1.278 . . . . 0.0 110.657 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.53 -47.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.377 -0.827 . . . . 0.0 110.194 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.78 57.98 14.99 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 110.278 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.47 -24.94 70.51 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.685 1.36 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.86 79.36 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.911 . . . . 0.0 110.387 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.85 169.05 15.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.451 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.44 ' O ' ' CG2' ' B' ' 117' ' ' THR . 72.7 m 54.15 20.82 2.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.842 . . . . 0.0 110.598 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -174.77 150.59 1.32 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.933 -1.105 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.371 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -116.18 -28.37 6.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -1.16 . . . . 0.0 110.363 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' D' ' 204' ' ' PRO . . . 52.49 63.36 8.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 110.428 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' D' ' 203' ' ' ALA . 24.6 Cg_exo -59.98 -39.08 73.91 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.662 1.348 . . . . 0.0 110.519 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -52.8 -72.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.439 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' D' ' 208' ' ' LEU . 0.7 OUTLIER -71.35 -154.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 0.0 110.384 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.59 -75.88 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.454 -0.779 . . . . 0.0 110.642 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' D' ' 206' ' ' LYS . 24.4 mt 53.17 -178.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.337 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.13 165.96 14.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.901 . . . . 0.0 110.508 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 5.8 t -169.64 159.5 8.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.365 -0.834 . . . . 0.0 110.15 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -166.92 127.51 1.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 110.52 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -133.36 111.4 10.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 110.205 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' D' ' 214' ' ' ARG . . . -161.12 -147.06 0.14 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' D' ' 213' ' ' ALA . 1.7 mmt-85 61.17 125.42 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 110.456 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t -60.96 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.396 -0.815 . . . . 0.0 110.521 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.45 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.26 175.23 3.44 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.633 1.333 . . . . 0.0 110.48 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -53.17 -64.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -0.952 . . . . 0.0 110.297 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 99.1 m 52.35 64.09 1.99 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.447 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.886 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.473 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.475 ' O ' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.29 0.567 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.473 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 10.8 p90 -50.09 140.58 12.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.182 -0.949 . . . . 0.0 110.713 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.52 143.57 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 110.292 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.6 -33.15 6.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.953 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.431 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -77.32 -44.13 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 27.2 m -154.15 147.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 110.192 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 14.3 tt -114.81 166.1 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.907 . . . . 0.0 110.061 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.59 122.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 110.896 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' CB ' ' CD1' ' A' ' 19' ' ' PHE . 41.8 mttt -150.03 128.86 12.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 9' ' ' LYS . 3.0 mttt 51.44 40.11 25.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.718 -1.864 . . . . 0.0 109.879 6.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.409 ' HA ' ' HG2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -48.15 165.18 0.24 Allowed Pre-proline 0 N--CA 1.489 1.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.708 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 31.6 Cg_exo -54.53 -21.55 24.69 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.684 1.36 . . . . 0.0 110.257 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.21 -46.7 7.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 110.387 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.55 171.72 25.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 16' ' ' TYR . . . 116.59 -179.09 17.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 15' ' ' GLY . 37.5 m-85 -152.55 91.77 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.038 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' HA2' ' CG2' ' A' ' 67' ' ' ILE . . . -151.18 -169.25 16.67 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.465 HG23 ' CE1' ' A' ' 68' ' ' PHE . 87.2 t -100.81 124.13 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.031 -1.276 . . . . 0.0 109.616 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' CB ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -88.45 129.37 35.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.989 -1.07 . . . . 0.0 110.777 -178.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.22 85.27 3.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.557 -0.714 . . . . 0.0 110.082 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 4.7 mtp180 -56.09 -25.13 44.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 109.485 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.482 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 5.1 mtpp -84.63 -179.72 7.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.446 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 7.0 m 100.36 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.054 -1.654 . . . . 0.0 110.038 2.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 16.1 m-85 -107.63 142.79 37.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.75 171.07 9.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.091 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 18.7 tttt -67.04 100.81 0.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.45 -20.75 11.02 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.57 123.69 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -1.179 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.48 HD23 ' CE2' ' A' ' 90' ' ' PHE . 1.2 tm? -65.99 113.65 4.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.4 t -72.04 -53.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -174.14 144.44 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.25 157.98 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.436 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.1 p -150.56 -171.82 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 110.651 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.7 mt -100.61 167.65 10.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.783 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.7 m -145.15 161.59 39.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 60' ' ' MET . 55.1 mt -92.16 148.26 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.0 90.45 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.659 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 39.8 mmt180 -117.93 168.43 10.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -87.08 -176.27 5.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.068 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 26.2 m120 -72.24 -137.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.0 t0 65.97 -148.09 0.21 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 110.541 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.27 -34.74 4.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.243 -0.91 . . . . 0.0 111.109 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.485 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 60.6 t-105 -52.88 -57.21 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.029 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -60.34 -31.31 73.47 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.97 -65.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.522 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.22 70.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 110.14 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.6 mm? -91.74 34.03 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.686 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 1.9 tm-20 -56.31 -17.54 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 111.365 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.89 156.47 19.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.913 -1.117 . . . . 0.0 110.966 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' CE1' ' OXT' ' A' ' 301' ' ' SAH . 7.0 m-30 55.25 26.29 8.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.854 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' CZ2' ' A' ' 43' ' ' TRP . 10.5 tp -108.71 105.88 15.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.867 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -89.11 105.32 17.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 3.1 t -105.39 147.52 28.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.938 . . . . 0.0 110.915 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HG2' ' CD1' ' A' ' 84' ' ' LEU . 10.4 ptm180 -115.13 -167.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 77.62 9.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.075 -1.016 . . . . 0.0 109.264 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.499 3.0 t30 166.02 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.902 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -176.98 -164.44 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.947 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.414 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 6.2 t -130.2 141.05 50.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.459 -0.776 . . . . 0.0 110.286 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.424 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -132.71 149.42 52.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 110.626 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 32.9 tpp -93.24 155.91 17.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.52 92.1 8.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.704 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 36' ' ' ILE 2.506 0.1 OUTLIER -52.19 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 110.895 -178.605 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -61.05 -155.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CA ' ' CD1' ' A' ' 67' ' ' ILE . 31.6 m-85 -90.16 54.12 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.132 . . . . 0.0 111.152 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.481 ' HA2' ' CE2' ' A' ' 68' ' ' PHE . . . -92.83 -15.52 52.08 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 50' ' ' TYR . . . -91.72 4.37 52.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.894 -1.356 . . . . 0.0 112.355 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.485 ' CD1' ' CA ' ' A' ' 64' ' ' PHE . 3.8 mp -88.56 -20.75 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.716 -1.24 . . . . 0.0 110.829 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 23.1 m-85 -52.43 143.6 14.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.89 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -112.4 -159.67 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.525 ' CE1' ' CD2' ' A' ' 111' ' ' LEU . 57.7 t60 -102.01 136.12 42.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.405 -0.81 . . . . 0.0 109.414 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' ASP . 1.8 m -152.06 35.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.027 -1.045 . . . . 0.0 110.567 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp 58.11 -82.63 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.542 -0.724 . . . . 0.0 110.273 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' SER . 4.5 m-20 -99.33 91.78 1.55 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 11.5 Cg_endo -58.04 106.56 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.564 1.297 . . . . 0.0 110.524 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -50.48 -23.8 2.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.619 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.71 159.56 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.995 . . . . 0.0 110.426 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.47 ' NH2' ' NE2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -136.99 -173.89 3.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.195 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.47 ' NE2' ' NH2' ' A' ' 77' ' ' ARG . 7.5 p-80 -119.74 172.71 7.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -142.35 155.07 45.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.38 143.36 50.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 110.371 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.427 HG21 ' CZ ' ' A' ' 88' ' ' ARG . 20.4 p -72.93 -66.47 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.354 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.88 -35.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 110.524 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.66 26.66 19.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.436 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 34.6 mt 51.73 28.84 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.605 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.22 -36.25 10.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 110.76 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.87 135.8 54.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 110.691 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 mtp -126.85 116.72 21.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 110.199 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.427 ' CZ ' HG21 ' A' ' 81' ' ' THR . 45.2 mtt180 -101.35 131.92 47.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.25 98.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.022 . . . . 0.0 109.591 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.48 ' CE2' HD23 ' A' ' 29' ' ' LEU . 13.9 m-85 -89.76 -169.29 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.547 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.9 p -132.57 98.43 4.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.083 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 74' ' ' PRO . 33.7 pt -54.54 -22.18 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.106 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.72 161.23 38.55 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 34.1 Cg_exo -53.74 156.57 11.65 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.635 1.334 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 59.2 mt -138.55 134.91 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.3 167.86 10.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 110.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -64.53 119.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.341 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.63 30.75 5.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.19 141.06 36.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.113 -1.228 . . . . 0.0 110.325 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' OE1' ' CG2' ' A' ' 102' ' ' THR . 1.3 tm-20 -88.39 121.39 30.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 109.674 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 60.6 mt -89.11 123.59 41.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.78 . . . . 0.0 110.586 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.416 ' CG2' ' OE1' ' A' ' 100' ' ' GLU . 73.2 p -145.46 -176.71 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.436 HG12 ' CB ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -151.74 160.31 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 0.0 110.384 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.54 -173.05 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 13.0 m-85 -125.51 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 109.86 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.5 -160.29 54.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.94 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.988 . . . . 0.0 110.692 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -129.44 -35.54 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.067 . . . . 0.0 110.706 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.44 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -48.66 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.93 . . . . 0.0 110.928 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.476 ' O ' ' CD2' ' A' ' 110' ' ' TRP . 54.8 p-90 -54.07 120.52 6.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' CD2' ' CE1' ' A' ' 70' ' ' HIS . 6.7 tp -83.74 -148.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.918 . . . . 0.0 110.759 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -117.61 82.48 1.83 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -178.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 2.7 ttt85 51.85 52.36 11.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.503 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 113' ' ' ARG . 18.2 Cg_endo -65.85 -62.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.643 1.338 . . . . 0.0 110.557 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.94 -73.59 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.41 -0.806 . . . . 0.0 110.328 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 114' ' ' PRO . 4.4 mm? 53.22 42.25 32.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.48 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.7 m -59.27 157.6 10.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 110.315 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 47.48 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.419 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.357 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.86 -38.74 6.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -1.175 . . . . 0.0 110.381 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -122.97 153.47 64.07 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.0 110.433 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -65.67 125.65 14.7 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.691 1.363 . . . . 0.0 110.546 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -94.14 157.05 16.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 110.369 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 -40.63 2.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 110.39 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -76.13 165.62 24.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.32 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.0 mt -148.59 165.05 32.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.432 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.51 116.93 31.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 110.443 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 10.1 p -104.17 -32.56 9.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 110.287 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.48 177.31 6.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 110.321 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.75 -169.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 0.0 110.485 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 108' ' ' ASP . . . 52.86 64.4 1.87 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.342 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.411 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 3.8 mmp_? -106.3 -170.62 1.75 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 110.366 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.6 p -53.87 173.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.355 -0.841 . . . . 0.0 110.321 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.09 165.59 17.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 110.328 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.16 -177.87 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.675 1.355 . . . . 0.0 110.452 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.84 79.53 0.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.331 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 2.0 p -147.35 60.69 1.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 110.372 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.215 0.531 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.9 p90 -49.97 140.55 12.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.707 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.45 143.69 31.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.69 -33.24 6.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.363 -0.836 . . . . 0.0 110.894 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.421 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -77.25 -44.19 30.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 27.1 m -154.04 147.43 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 14.3 tt -114.77 165.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 110.102 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.4 122.28 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 110.969 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.528 ' CB ' ' CD1' ' B' ' 19' ' ' PHE . 42.1 mttt -150.13 129.17 12.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.495 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 3.0 mttt 51.8 40.01 26.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.511 -1.993 . . . . 0.0 109.889 6.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -48.18 165.29 0.24 Allowed Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.696 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.403 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 31.2 Cg_exo -54.58 -21.56 25.0 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.678 1.357 . . . . 0.0 110.235 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.14 -46.74 7.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 110.369 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.54 171.67 25.68 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' B' ' 16' ' ' TYR . . . 116.63 -179.05 17.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' B' ' 15' ' ' GLY . 37.3 m-85 -152.5 91.58 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.433 ' HA2' ' CG2' ' B' ' 67' ' ' ILE . . . -151.03 -169.15 16.43 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.463 HG23 ' CE1' ' B' ' 68' ' ' PHE . 88.5 t -100.93 123.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.254 . . . . 0.0 109.71 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' CB ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -87.35 129.37 35.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.015 . . . . 0.0 110.94 -178.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.31 85.25 3.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.438 -0.789 . . . . 0.0 110.13 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 4.7 mtp180 -56.03 -25.09 43.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.545 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' CD2' ' B' ' 24' ' ' PHE . 5.2 mtpp -84.6 -179.62 7.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.45 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.513 6.8 m 100.46 13.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.041 -1.662 . . . . 0.0 109.98 2.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 16.3 m-85 -107.59 142.63 37.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.195 -0.94 . . . . 0.0 110.275 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.48 171.08 9.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.415 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 18.7 tttt -67.05 100.85 0.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.43 -20.87 10.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.62 123.74 11.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -1.163 . . . . 0.0 110.547 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.479 HD21 ' CE1' ' B' ' 90' ' ' PHE . 1.2 tm? -66.02 113.65 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 99.5 t -72.03 -53.14 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.184 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -174.14 144.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.314 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.26 158.19 34.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 110.406 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.433 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.1 p -150.81 -171.96 4.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 54.9 mt -100.53 167.7 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 95.2 m -145.19 161.56 39.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.058 -1.026 . . . . 0.0 110.524 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' B' ' 60' ' ' MET . 54.9 mt -92.06 148.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.02 90.5 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.95 . . . . 0.0 110.604 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.488 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 39.8 mmt180 -117.96 168.43 10.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -87.07 -176.31 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.883 . . . . 0.0 110.167 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.22 -137.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.976 . . . . 0.0 110.148 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 66.07 -148.11 0.21 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.805 -1.184 . . . . 0.0 110.547 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.26 -34.78 4.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.219 -0.926 . . . . 0.0 111.123 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.488 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 60.8 t-105 -52.81 -57.22 10.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 110.077 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.416 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -60.36 -31.3 73.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.93 -65.19 0.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -50.54 73.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.256 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 3.6 mm? -92.79 34.41 1.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 110.465 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.416 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 1.9 tm-20 -56.53 -17.59 8.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.049 -1.032 . . . . 0.0 111.299 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.76 156.44 19.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.971 -1.081 . . . . 0.0 111.073 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 7.0 m-30 55.28 26.36 8.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.475 -0.766 . . . . 0.0 110.775 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.482 HD12 ' CZ2' ' B' ' 43' ' ' TRP . 10.6 tp -108.79 105.51 15.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 110.937 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' B' ' 52' ' ' PHE . 42.4 m-85 -88.56 105.27 17.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.409 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 3.1 t -105.4 147.51 28.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.152 -0.967 . . . . 0.0 110.907 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.443 ' HG2' ' CD1' ' B' ' 84' ' ' LEU . 10.3 ptm180 -115.66 -170.07 1.71 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.109 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.55 77.21 5.03 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.242 -0.911 . . . . 0.0 110.226 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.505 3.1 t30 165.94 -29.21 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.679 -0.638 . . . . 0.0 109.935 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.83 -164.15 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 110.934 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 6.2 t -130.27 141.09 50.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 110.241 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -132.78 149.43 52.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.637 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.467 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 32.9 tpp -93.48 154.84 17.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 110.215 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.07 92.05 8.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' B' ' 36' ' ' ILE 2.505 0.1 OUTLIER -52.29 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.949 -178.734 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.97 -155.15 0.03 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.48 ' CA ' ' CD1' ' B' ' 67' ' ' ILE . 31.6 m-85 -90.22 55.38 3.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -1.119 . . . . 0.0 111.053 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' B' ' 68' ' ' PHE . . . -94.92 -13.82 51.64 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.185 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.416 ' HB2' ' CG ' ' B' ' 50' ' ' TYR . . . -93.2 4.86 53.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.933 -1.334 . . . . 0.0 112.096 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.48 ' CD1' ' CA ' ' B' ' 64' ' ' PHE . 3.8 mp -88.76 -20.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.691 -1.256 . . . . 0.0 110.817 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.477 ' CE2' ' HA2' ' B' ' 65' ' ' GLY . 23.0 m-85 -52.43 143.62 14.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.917 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -112.33 -159.43 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.527 ' CE1' ' CD2' ' B' ' 111' ' ' LEU . 57.4 t60 -102.42 136.12 42.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.358 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 73' ' ' ASP . 1.8 m -152.01 35.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.085 -1.009 . . . . 0.0 110.646 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp 58.11 -82.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.428 -0.795 . . . . 0.0 110.288 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' B' ' 71' ' ' SER . 4.5 m-20 -99.38 91.85 1.59 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.235 -0.916 . . . . 0.0 109.789 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 11.4 Cg_endo -58.07 106.66 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.616 1.324 . . . . 0.0 110.476 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -50.59 -23.76 2.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.593 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.73 159.53 42.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 110.442 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.462 ' NH2' ' NE2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -136.95 -173.85 3.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 110.177 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.462 ' NE2' ' NH2' ' B' ' 77' ' ' ARG . 7.5 p-80 -119.71 172.62 7.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 110.618 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -142.28 155.19 45.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.38 143.34 50.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 110.428 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.433 HG21 ' CZ ' ' B' ' 88' ' ' ARG . 20.3 p -73.0 -66.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 110.337 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.91 -35.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.483 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.66 26.6 19.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.443 ' CD1' ' HG2' ' B' ' 54' ' ' ARG . 34.7 mt 51.82 28.79 5.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -1.182 . . . . 0.0 110.631 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.32 -36.15 10.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.84 135.76 54.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.705 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 13.0 mtp -126.78 116.69 21.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 110.258 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.433 ' CZ ' HG21 ' B' ' 81' ' ' THR . 45.2 mtt180 -101.49 131.53 47.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 110.397 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.3 mt -88.68 98.44 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.479 ' CE1' HD21 ' B' ' 29' ' ' LEU . 14.0 m-85 -89.57 -169.24 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 26.7 p -132.62 98.42 4.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 110.087 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' B' ' 74' ' ' PRO . 33.6 pt -54.6 -22.15 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.72 161.23 38.51 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.18 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 34.2 Cg_exo -53.77 156.51 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.6 1.316 . . . . 0.0 110.823 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' B' ' 24' ' ' PHE . 59.2 mt -138.49 134.99 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.35 167.93 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -64.51 119.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.59 30.79 5.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.36 140.41 37.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -1.22 . . . . 0.0 110.365 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' B' ' 102' ' ' THR . 1.3 tm-20 -87.49 121.08 29.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.01 -1.056 . . . . 0.0 109.946 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' B' ' 18' ' ' VAL . 60.6 mt -88.62 123.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.402 -0.811 . . . . 0.0 110.79 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.412 ' CG2' ' OE1' ' B' ' 100' ' ' GLU . 72.0 p -145.55 -176.69 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.708 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.444 HG12 ' CB ' ' B' ' 68' ' ' PHE . 1.0 OUTLIER -151.67 160.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.356 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.5 -173.02 2.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.437 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 13.0 m-85 -125.53 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.339 -0.851 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 71.45 -160.27 54.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.96 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -1.0 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.2 OUTLIER -129.43 -35.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.742 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.437 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.5 OUTLIER -48.67 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.929 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.469 ' CD2' ' O ' ' B' ' 110' ' ' TRP . 54.8 p-90 -54.02 120.54 6.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' B' ' 70' ' ' HIS . 6.7 tp -83.72 -148.94 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.761 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.479 ' HB2' ' CD2' ' B' ' 70' ' ' HIS . 0.1 OUTLIER -117.68 82.53 1.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.025 . . . . 0.0 110.57 -178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 2.7 ttt85 51.92 52.32 11.27 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.464 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 18.2 Cg_endo -65.82 -62.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.677 1.356 . . . . 0.0 110.577 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.85 -73.58 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.383 -0.823 . . . . 0.0 110.364 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' B' ' 114' ' ' PRO . 4.4 mm? 53.18 42.34 32.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 110.466 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 35.2 m -59.28 157.59 10.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 110.301 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 47.52 0.87 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.36 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.9 -38.69 6.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -1.121 . . . . 0.0 110.378 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -122.96 153.48 64.06 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.394 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.74 125.7 14.75 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.721 1.38 . . . . 0.0 110.526 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 -94.21 157.04 16.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.319 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -40.6 2.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -0.872 . . . . 0.0 110.353 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -76.13 165.61 24.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.334 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 3.0 mt -148.53 165.07 32.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.44 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.55 116.91 31.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.303 -0.873 . . . . 0.0 110.414 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 10.0 p -104.17 -32.53 9.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 110.25 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.45 177.28 6.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.333 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.82 -169.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 110.424 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . 0.423 ' HA ' ' CB ' ' B' ' 108' ' ' ASP . . . 52.85 64.41 1.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 110.35 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.409 ' CB ' ' HB3' ' B' ' 53' ' ' SER . 3.8 mmp_? -106.36 -170.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.927 . . . . 0.0 110.335 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 2.6 p -53.78 173.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 110.391 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.08 165.56 17.22 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.21 -177.88 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.601 1.316 . . . . 0.0 110.458 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.9 79.53 0.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 110.323 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 2.1 p -147.36 60.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 110.444 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.492 ' OXT' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.492 ' OXT' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.236 0.541 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 41.3 p90 -166.13 128.56 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 110.345 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -119.39 167.0 12.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.358 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.67 64.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 177.89 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 0.0 109.623 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' CG1' ' CG2' ' A' ' 18' ' ' VAL . 96.4 t -153.55 158.97 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.462 ' CG2' ' CB ' ' A' ' 19' ' ' PHE . 5.1 tt -134.95 158.94 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.442 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG1' ' HE2' ' A' ' 10' ' ' LYS . 61.7 t -99.24 114.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 110.795 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.497 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 14.1 mttt -127.6 141.68 51.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER 52.4 56.65 7.39 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 119.821 -1.799 . . . . 0.0 110.196 2.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -108.66 175.51 1.94 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.596 -0.69 . . . . 0.0 110.263 -179.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -68.18 -20.92 42.92 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.7 1.369 . . . . 0.0 110.432 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.57 56.12 0.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.881 . . . . 0.0 110.408 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.4 -146.13 4.36 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.67 -162.46 9.85 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CE2' ' HD3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -77.9 59.13 2.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 110.299 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -105.13 -165.59 23.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.477 ' CG2' ' CG1' ' A' ' 6' ' ' VAL . 2.3 p -114.03 131.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.903 -1.351 . . . . 0.0 109.502 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 11' ' ' SER . 0.4 OUTLIER -88.57 141.77 28.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.363 -0.835 . . . . 0.0 110.602 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.58 93.54 8.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.699 -0.626 . . . . 0.0 110.706 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -65.63 -15.75 63.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 0.0 109.877 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 6.7 mttt -108.61 179.05 4.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.448 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 20.1 m 102.25 21.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.012 -1.68 . . . . 0.0 109.727 2.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 17.5 m-85 -114.6 161.47 18.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 110.637 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.37 170.95 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -72.53 88.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 110.46 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.91 52.15 0.21 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.18 136.57 52.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.489 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 2.0 tm? -67.09 117.29 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 110.211 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG2' ' CG2' ' A' ' 91' ' ' THR . 38.3 t -98.53 85.42 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.32 -0.863 . . . . 0.0 109.563 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.62 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 110.304 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -154.13 160.53 41.96 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.011 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 1.062 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 26.7 p -150.75 160.96 43.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 111.072 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.9 mt -96.65 176.78 5.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.872 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' CG ' ' A' ' 87' ' ' MET . 83.8 m -149.25 166.39 29.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 48.4 mt -103.13 154.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 84' ' ' LEU . 41.2 t -131.17 118.49 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.893 -1.129 . . . . 0.0 110.641 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 29.7 mmt180 -136.79 147.77 46.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.58 58.78 2.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 111.297 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 1.9 t-20 49.8 -141.31 0.7 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 111.019 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 44' ' ' GLY . 2.3 t70 67.35 -144.8 0.14 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.036 -1.04 . . . . 0.0 110.169 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.13 -35.85 12.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.935 -1.103 . . . . 0.0 110.297 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.522 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 17.2 t-105 -63.73 -34.61 78.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 109.129 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -62.43 -60.38 7.94 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.418 ' HA ' ' HG3' ' A' ' 48' ' ' GLU . 54.6 m -66.17 -45.84 79.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.19 -1.182 . . . . 0.0 110.666 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -62.0 2.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 0.0 109.1 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.3 mm? -93.19 36.27 1.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.471 -0.768 . . . . 0.0 110.795 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.454 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -69.4 61.71 0.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.093 -1.004 . . . . 0.0 110.325 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.479 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 178.78 145.36 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.487 -0.758 . . . . 0.0 109.015 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 11.2 m-85 57.35 26.72 12.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.918 -1.113 . . . . 0.0 109.31 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.47 ' CD1' ' CG ' ' A' ' 60' ' ' MET . 3.1 tp -107.86 112.93 25.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 111.285 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -89.4 108.44 19.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.161 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.433 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 23.2 t -107.39 143.91 35.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.509 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.86 -165.62 1.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.522 -0.736 . . . . 0.0 109.781 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 75.4 8.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.363 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.86 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.507 -179.609 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.423 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 179.95 -174.6 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.591 -0.693 . . . . 0.0 110.324 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.464 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 26.0 p -111.95 134.89 53.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.336 -0.852 . . . . 0.0 110.432 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.427 ' CB ' HD22 ' A' ' 84' ' ' LEU . . . -117.12 174.44 6.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.47 ' CG ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -120.35 160.09 23.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.788 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HB1' ' N ' ' A' ' 66' ' ' ALA . . . -89.09 99.13 12.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 110.226 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.497 0.1 OUTLIER -58.4 -81.11 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.86 . . . . 0.0 110.922 -179.437 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.3 -130.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.88 45.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 110.769 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -90.5 -20.67 40.2 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.69 -43.56 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.434 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 1.3 pp -48.97 -25.64 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.213 -0.929 . . . . 0.0 110.367 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' HB3' ' CG1' ' A' ' 103' ' ' ILE . 9.2 m-85 -48.96 144.99 4.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 110.638 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -118.65 174.69 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.577 ' CE1' ' CE2' ' A' ' 110' ' ' TRP . 1.8 t-160 -101.54 109.52 21.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.07 146.67 48.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.44 127.54 32.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.78 71.0 1.57 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.952 . . . . 0.0 110.255 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.65 174.25 1.74 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.663 1.349 . . . . 0.0 110.595 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -117.66 -13.12 10.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 110.569 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.05 143.96 51.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.06 166.93 13.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -0.933 . . . . 0.0 110.081 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.21 158.99 17.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.731 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 87' ' ' MET . 19.6 tt0 -132.94 136.68 46.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 110.147 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.6 145.13 42.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.037 -1.039 . . . . 0.0 110.419 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 p -53.93 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 110.396 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.38 -60.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.66 42.81 1.86 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.427 HD22 ' CB ' ' A' ' 59' ' ' ALA . 4.4 tp 59.25 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.298 -1.119 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -177.2 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 110.084 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -113.3 140.1 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.756 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 1.062 ' SD ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 ppp? -137.24 169.85 17.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.113 -0.992 . . . . 0.0 110.666 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -131.37 -179.74 5.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.346 -0.846 . . . . 0.0 110.637 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.411 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 6.5 mt -130.21 108.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 0.0 109.646 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.489 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 51.8 m-85 -97.2 -170.68 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.48 ' CG2' ' CG2' ' A' ' 30' ' ' VAL . 23.1 p -128.35 98.95 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.5 pt -60.06 -16.58 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 110.696 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -148.69 156.94 41.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.189 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.96 142.86 93.61 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.582 1.306 . . . . 0.0 110.379 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.456 ' CG2' ' CB ' ' A' ' 99' ' ' GLU . 54.4 mt -124.33 141.97 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.671 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.76 153.66 20.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.882 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -48.25 -24.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.46 -0.775 . . . . 0.0 111.313 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.34 60.68 0.32 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.456 ' CB ' ' CG2' ' A' ' 95' ' ' ILE . 3.3 mm-40 -116.28 165.05 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 111.274 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.19 115.56 29.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.432 ' O ' HG12 ' A' ' 18' ' ' VAL . 58.5 mt -88.79 127.49 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.3 p -155.55 148.41 24.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.434 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.3 pp -115.91 155.32 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 0.0 110.749 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.485 ' HA ' ' CD2' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -90.61 -173.95 3.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 110.06 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.522 ' CD2' ' ND1' ' A' ' 70' ' ' HIS . 9.0 m-85 -123.63 -66.36 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.988 . . . . 0.0 110.093 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.43 -175.28 44.37 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.71 -33.28 68.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -1.166 . . . . 0.0 110.377 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -66.95 0.6 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.366 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CD2' ' HG2' ' C' ' 215' ' ' MLZ . 0.2 OUTLIER -68.48 71.93 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.92 . . . . 0.0 110.493 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.577 ' CE2' ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -153.82 -156.15 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.441 179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.28 -71.21 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 110.593 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.37 -79.57 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 0.0 110.701 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.45 61.5 13.72 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.582 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.07 -40.3 2.6 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.597 1.314 . . . . 0.0 110.6 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 54.97 19.85 2.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.34 -0.85 . . . . 0.0 110.754 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 47.2 39.42 8.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 111.098 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.7 m -132.16 -69.54 0.59 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 110.514 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.18 57.8 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.388 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 60.51 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -1.12 . . . . 0.0 110.311 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -92.85 144.48 28.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.923 . . . . 0.0 110.48 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.25 -33.52 97.97 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.651 1.343 . . . . 0.0 110.582 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 53.31 84.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 0.0 110.331 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.12 111.73 7.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 110.398 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 53.7 176.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.45 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.98 178.47 6.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.176 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.77 -54.03 49.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.943 . . . . 0.0 110.293 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 7.6 m 52.59 52.96 13.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.453 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -60.36 -67.03 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 110.321 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -174.88 79.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.33 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -149.27 91.84 1.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.391 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.431 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 2.1 tpp180 -77.12 -148.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.274 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.418 ' HG2' ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 3.4 p -52.55 176.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 110.392 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.63 167.99 12.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.927 . . . . 0.0 110.39 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.36 -43.8 37.94 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.734 1.386 . . . . 0.0 110.425 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.33 82.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 110.477 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -101.85 160.56 14.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.295 0.569 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 41.5 p90 -166.15 128.63 1.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.345 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 12.7 p30 -119.4 167.01 12.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 110.373 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.71 64.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 110.345 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER 177.87 -33.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.39 -0.819 . . . . 0.0 109.639 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.48 ' CG1' ' CG2' ' B' ' 18' ' ' VAL . 96.6 t -153.45 159.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.461 ' CG2' ' CB ' ' B' ' 19' ' ' PHE . 5.1 tt -134.98 158.9 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.412 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.432 ' CG1' ' HE2' ' B' ' 10' ' ' LYS . 62.0 t -99.27 114.81 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.483 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 14.1 mttt -127.72 141.83 51.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.483 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER 52.59 56.59 7.43 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 119.777 -1.827 . . . . 0.0 110.13 1.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.469 ' HB2' ' CZ ' ' B' ' 19' ' ' PHE . 0.0 OUTLIER -108.68 175.51 1.94 Allowed Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.554 -0.716 . . . . 0.0 110.304 -179.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -68.22 -20.87 42.72 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.637 1.335 . . . . 0.0 110.457 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.59 56.18 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 110.385 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.44 -146.09 4.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . -134.72 -162.42 9.82 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.48 ' CE2' ' HD3' ' B' ' 10' ' ' LYS . 0.2 OUTLIER -77.7 59.42 2.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 110.353 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 9' ' ' LYS . . . -105.63 -165.73 23.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.48 ' CG2' ' CG1' ' B' ' 6' ' ' VAL . 2.4 p -113.95 130.83 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.927 -1.337 . . . . 0.0 109.637 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.481 ' CD2' ' HD2' ' B' ' 9' ' ' LYS . 0.4 OUTLIER -87.71 141.86 28.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.835 . . . . 0.0 110.773 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.71 93.54 8.06 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 110.735 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.1 OUTLIER -65.64 -15.62 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.914 178.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 6.7 mttt -108.68 179.01 4.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 108.757 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.445 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 20.1 m 102.25 20.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.064 -1.648 . . . . 0.0 109.757 2.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 17.5 m-85 -114.52 161.51 17.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 110.685 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.48 170.97 8.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.964 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -72.5 88.76 1.24 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 110.432 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.85 52.2 0.21 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.22 136.58 52.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.495 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 2.0 tm? -67.14 117.38 9.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.483 ' CG2' ' CG2' ' B' ' 91' ' ' THR . 38.4 t -98.58 85.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.577 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' B' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.708 -0.62 . . . . 0.0 110.256 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -154.11 160.8 42.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 1.071 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 26.7 p -151.08 160.9 43.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 111.031 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.67 176.73 5.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.301 -0.874 . . . . 0.0 109.851 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -149.16 166.42 28.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.079 . . . . 0.0 111.369 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.439 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 48.2 mt -103.12 154.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.16 118.47 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.972 -1.08 . . . . 0.0 110.586 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.526 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 29.6 mmt180 -136.78 147.76 46.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.218 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.48 58.71 2.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 111.317 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 1.9 t-20 49.79 -141.33 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.127 -0.983 . . . . 0.0 111.085 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 2.3 t70 67.43 -144.9 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.022 -1.049 . . . . 0.0 110.116 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -48.11 -35.83 12.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.9 -1.125 . . . . 0.0 110.272 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.526 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 17.1 t-105 -63.77 -34.58 78.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 0.0 109.154 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -62.42 -60.44 7.86 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' B' ' 48' ' ' GLU . 54.1 m -65.88 -46.04 79.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -1.197 . . . . 0.0 110.64 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.414 ' O ' ' NH2' ' A' ' 38' ' ' ARG . . . -57.02 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.885 -1.135 . . . . 0.0 109.276 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.4 mm? -94.98 36.96 1.16 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.444 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -69.66 61.68 0.16 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -0.953 . . . . 0.0 110.274 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.481 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.9 OUTLIER 178.73 145.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 11.1 m-85 57.37 26.7 12.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.923 -1.111 . . . . 0.0 109.287 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.472 ' CD1' ' CG ' ' B' ' 60' ' ' MET . 3.1 tp -107.82 112.8 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 111.401 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -89.22 108.5 19.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 23.0 t -107.36 143.89 35.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.006 . . . . 0.0 111.508 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.46 -168.72 1.63 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.523 -0.736 . . . . 0.0 109.735 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 74.81 4.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.369 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.79 -35.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -179.735 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.416 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -179.75 -174.27 0.28 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.522 -0.736 . . . . 0.0 110.367 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.463 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 26.4 p -112.16 134.9 53.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 110.399 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -117.09 174.41 6.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 110.65 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.472 ' CG ' ' CD1' ' B' ' 51' ' ' LEU . 0.0 OUTLIER -120.34 159.76 24.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.421 ' HB1' ' N ' ' B' ' 66' ' ' ALA . . . -88.65 99.18 12.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.818 . . . . 0.0 110.238 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.496 0.1 OUTLIER -58.49 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -179.528 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.25 -130.39 0.01 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -90.06 46.22 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -1.162 . . . . 0.0 110.68 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -90.98 -20.16 40.41 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.25 -43.33 9.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 110.627 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.445 ' CD1' ' HB ' ' B' ' 18' ' ' VAL . 1.3 pp -49.09 -25.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.197 -0.939 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.434 ' CD2' ' HA2' ' B' ' 65' ' ' GLY . 9.2 m-85 -48.96 145.29 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 110.627 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.401 ' HB2' ' CG2' ' B' ' 102' ' ' THR . 73.1 m-80 -118.94 174.75 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.517 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.578 ' CE1' ' CE2' ' B' ' 110' ' ' TRP . 1.8 t-160 -101.68 109.54 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 110.19 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.06 146.71 48.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.5 127.61 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.65 71.1 1.55 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.228 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.66 174.23 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.71 1.374 . . . . 0.0 110.555 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.412 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 17.4 p30 -117.65 -13.09 10.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.07 144.01 51.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.038 -1.039 . . . . 0.0 110.201 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.08 166.91 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.19 159.02 17.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.766 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' B' ' 87' ' ' MET . 19.7 tt0 -133.06 136.6 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.151 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 mt -114.51 145.17 42.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.063 -1.023 . . . . 0.0 110.453 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 14.2 p -53.95 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 110.385 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.36 -60.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 110.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.59 42.76 1.88 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.424 HD22 ' CB ' ' B' ' 59' ' ' ALA . 4.4 tp 59.33 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.273 -1.133 . . . . 0.0 110.513 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -177.23 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.03 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -113.31 140.06 48.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 1.071 ' SD ' ' SG ' ' B' ' 33' ' ' CYS . 3.9 ppp? -137.2 169.83 17.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 110.71 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -179.66 5.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 0.0 110.648 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.405 HG12 ' CZ ' ' B' ' 68' ' ' PHE . 6.5 mt -130.32 108.13 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.817 . . . . 0.0 109.597 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.495 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 51.7 m-85 -97.22 -170.66 2.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 110.653 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' B' ' 30' ' ' VAL . 23.2 p -128.34 98.86 5.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.429 -0.794 . . . . 0.0 110.162 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 pt -59.98 -16.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.688 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 1.1 ptpm? -148.67 156.92 41.66 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 110.175 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.94 142.86 93.5 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.633 1.333 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.462 ' CG2' ' CB ' ' B' ' 99' ' ' GLU . 54.6 mt -124.32 141.9 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 110.684 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.65 153.7 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.805 . . . . 0.0 110.886 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -48.2 -24.97 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 111.243 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.37 60.8 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.462 ' CB ' ' CG2' ' B' ' 95' ' ' ILE . 3.4 mm-40 -116.36 165.0 13.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.267 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -112.31 115.0 28.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.476 -0.765 . . . . 0.0 109.003 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.421 ' O ' HG12 ' B' ' 18' ' ' VAL . 58.4 mt -87.95 127.6 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.997 . . . . 0.0 111.261 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' B' ' 69' ' ' ASN . 15.8 p -155.68 148.46 24.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.432 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.3 pp -115.86 155.25 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 110.793 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.484 ' HA ' ' CD2' ' B' ' 70' ' ' HIS . 0.6 OUTLIER -90.66 -174.08 3.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.527 ' CD2' ' ND1' ' B' ' 70' ' ' HIS . 8.9 m-85 -123.37 -66.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.201 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 -175.28 44.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -33.25 68.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -1.124 . . . . 0.0 110.371 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -66.91 0.61 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.422 ' CD2' ' HG2' ' D' ' 215' ' ' MLZ . 0.2 OUTLIER -68.5 71.94 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.578 ' CE2' ' CE1' ' B' ' 70' ' ' HIS . 0.0 OUTLIER -153.86 -156.19 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 110.417 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.26 -71.24 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.387 -0.821 . . . . 0.0 110.539 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.33 -79.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 110.673 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.46 61.54 13.77 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.579 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.17 -40.33 2.5 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.603 1.317 . . . . 0.0 110.553 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 55.15 19.74 3.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.31 -0.869 . . . . 0.0 110.7 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 47.22 39.41 8.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.871 . . . . 0.0 111.082 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -132.23 -69.48 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.519 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.16 57.8 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 110.305 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.369 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.66 60.45 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -1.15 . . . . 0.0 110.312 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -92.78 144.53 28.72 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 110.509 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.21 -33.62 98.13 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.623 1.328 . . . . 0.0 110.535 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 53.43 84.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.324 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.16 111.81 7.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 110.415 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 53.6 176.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.479 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.99 178.47 6.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 110.167 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.74 -54.04 49.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 110.311 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 7.5 m 52.65 52.89 13.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 110.473 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -60.35 -67.01 0.43 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 110.331 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -174.92 79.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.332 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -149.2 91.82 1.88 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 110.393 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.431 ' CB ' ' HB3' ' B' ' 53' ' ' SER . 2.1 tpp180 -77.09 -148.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.288 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.422 ' HG2' ' CD2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 3.3 p -52.56 176.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 110.339 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.66 167.87 12.85 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 110.439 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -59.16 -43.91 38.28 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.709 1.373 . . . . 0.0 110.46 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.4 82.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -101.91 160.5 14.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 110.427 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.509 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' SD ' ' SG ' ' B' ' 33' ' ' CYS . 1.2 tpt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.256 0.55 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 12.9 p90 -151.94 70.99 0.95 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.244 -0.91 . . . . 0.0 110.189 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 5' ' ' ARG . 2.4 m120 -153.93 -81.96 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 111.477 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 6' ' ' VAL . 31.9 t0 -41.3 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 3' ' ' ASN . 15.3 mtt180 42.49 20.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.485 -0.759 . . . . 0.0 112.785 177.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 5' ' ' ARG . 44.7 t -158.34 156.29 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.667 -1.271 . . . . 0.0 110.842 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 15.5 tt -143.65 142.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.607 . . . . 0.0 109.717 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.07 135.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.936 -177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.9 mttt -141.45 143.86 34.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.548 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.73 56.92 6.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 119.535 -1.978 . . . . 0.0 110.281 4.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -113.0 178.74 0.9 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.776 -0.577 . . . . 0.0 110.034 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.434 ' CD ' ' HB2' ' A' ' 11' ' ' SER . 5.0 Cg_exo -71.99 -24.46 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.592 1.312 . . . . 0.0 110.31 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.65 27.37 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.055 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.43 169.33 22.33 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . -92.13 -145.56 16.14 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.31 68.29 3.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -1.189 . . . . 0.0 110.496 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.37 -162.88 14.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.488 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 89.0 t -99.87 136.39 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.281 . . . . 0.0 110.205 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -101.06 128.09 47.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.117 -0.989 . . . . 0.0 109.603 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.28 97.89 11.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.566 -0.709 . . . . 0.0 111.077 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 5.0 ttt180 -75.24 -19.73 59.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.77 4.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.383 -0.823 . . . . 0.0 109.224 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . 2.516 59.4 m 102.2 24.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.119 -1.613 . . . . 0.0 109.922 1.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 26.1 m-85 -116.0 160.49 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 110.909 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.37 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.429 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 16.7 tttm -97.37 86.75 3.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 110.145 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.2 78.87 1.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' C ' ' CD2' ' A' ' 90' ' ' PHE . 1.2 mt-10 -155.14 138.14 15.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 110.453 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' N ' ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -54.48 153.7 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.978 . . . . 0.0 109.612 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' CG2' HG23 ' A' ' 91' ' ' THR . 95.3 t -137.98 -49.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.981 -1.074 . . . . 0.0 110.218 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG2' ' CD1' ' A' ' 64' ' ' PHE . 7.1 tp10 -161.36 115.94 2.03 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.408 -0.808 . . . . 0.0 109.916 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -124.35 144.8 49.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 110.149 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.425 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 74.8 m -139.68 -160.96 1.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.089 -1.007 . . . . 0.0 111.055 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.427 HD23 ' NE ' ' A' ' 86' ' ' ARG . 3.0 mm? -94.54 178.56 5.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.371 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -150.91 159.34 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 36' ' ' ILE . 48.3 mt -105.57 107.02 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 84' ' ' LEU . 87.6 t -88.82 122.33 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.384 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 17.3 tpt180 -139.63 148.73 42.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.34 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.12 -172.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.622 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -96.81 114.43 26.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.511 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.08 -139.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.76 -26.43 3.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.801 -1.187 . . . . 0.0 109.733 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.49 ' CD1' ' HB3' ' A' ' 38' ' ' ARG . 20.3 t-105 -70.63 -43.77 68.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.638 -0.664 . . . . 0.0 109.21 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.88 -28.3 60.45 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -90.61 -63.79 1.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -1.137 . . . . 0.0 110.693 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.89 -58.81 4.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.161 -0.962 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.0 mm? -91.8 41.0 1.05 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.331 -0.856 . . . . 0.0 109.644 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -8.49 31.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.985 . . . . 0.0 111.052 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.43 169.39 9.36 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.894 -1.129 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CE1' ' OXT' ' A' ' 301' ' ' SAH . 24.1 m-85 52.03 25.95 3.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.428 -0.795 . . . . 0.0 110.57 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -115.93 126.56 54.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 0.0 111.077 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -88.85 104.05 16.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 36.1 t -89.02 120.58 30.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.09 -1.007 . . . . 0.0 111.228 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -179.5 4.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.702 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -83.35 80.78 8.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.974 -1.079 . . . . 0.0 109.269 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.21 -23.69 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.777 -0.577 . . . . 0.0 109.922 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.71 -178.47 0.89 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 110.835 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 16.7 m -123.36 139.08 54.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.974 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -132.82 153.22 51.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 111.073 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.462 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 38.6 tpp -89.64 155.18 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -88.76 93.62 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.627 -0.671 . . . . 0.0 110.639 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.431 HD22 ' CB ' ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -55.95 -34.19 65.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 179.847 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' A' ' 33' ' ' CYS . . . -86.94 -136.94 4.88 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 85.0 m-85 -90.49 19.46 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.349 -1.089 . . . . 0.0 110.617 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -61.85 -21.18 60.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.52 -59.18 2.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -1.215 . . . . 0.0 111.144 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.488 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.5 pp -53.79 -18.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.283 -0.886 . . . . 0.0 111.648 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CG ' HG12 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -49.07 146.47 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.852 -1.155 . . . . 0.0 110.735 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.3 171.5 8.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -93.16 148.49 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.58 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.33 131.43 5.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.42 -27.9 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.495 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -117.53 76.51 9.99 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.89 . . . . 0.0 110.386 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.416 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 18.6 Cg_endo -64.98 104.18 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.665 1.35 . . . . 0.0 110.468 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.44 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 5.5 m-20 -72.15 -10.76 60.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.657 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.22 160.6 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.953 -1.092 . . . . 0.0 110.855 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.03 155.36 43.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 78' ' ' HIS . 21.0 p-80 -90.02 136.13 33.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.613 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.41 13.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 110.164 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.9 mt -121.82 161.53 22.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.499 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.437 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 24.0 m -131.32 119.58 21.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.44 -0.787 . . . . 0.0 110.082 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.11 64.57 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.49 -119.51 6.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HB3' ' CB ' ' A' ' 59' ' ' ALA . 60.7 mt -118.54 26.51 9.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -1.136 . . . . 0.0 110.346 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.73 -56.69 4.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 110.431 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -119.09 150.38 40.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.75 147.77 41.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -0.999 . . . . 0.0 110.603 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 3.4 mtt180 -125.25 163.03 23.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 110.324 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 31' ' ' GLU . 26.7 mt -136.08 113.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.442 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.529 ' CE2' ' N ' ' A' ' 29' ' ' LEU . 6.3 m-85 -112.58 178.08 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.908 . . . . 0.0 110.792 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.428 HG23 ' CG2' ' A' ' 30' ' ' VAL . 15.2 p -121.64 99.07 6.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.376 -0.828 . . . . 0.0 110.496 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 93' ' ' LYS . 21.5 pt -52.8 -28.4 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.044 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -135.04 144.11 48.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 109.974 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 44.5 Cg_exo -49.21 145.67 14.51 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.619 1.326 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.418 HD13 ' CG2' ' A' ' 91' ' ' THR . 73.4 mt -122.51 148.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.937 . . . . 0.0 110.568 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.88 152.26 21.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 110.294 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 43.8 mt -53.95 -20.29 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.79 . . . . 0.0 111.148 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.58 59.3 0.38 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.13 179.1 6.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.145 -1.209 . . . . 0.0 110.718 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.22 128.43 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 110.013 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.409 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 61.3 mt -89.37 132.54 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 110.548 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.8 p -151.37 166.24 31.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.641 -0.662 . . . . 0.0 109.888 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.428 HG12 ' CG ' ' A' ' 68' ' ' PHE . 2.2 pp -137.86 156.45 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.117 -0.989 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 37.0 t -91.83 -163.5 1.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.358 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 104' ' ' SER . 15.3 m-85 -132.32 -55.96 0.97 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.298 -0.876 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.74 163.88 2.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.8 OUTLIER 54.62 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -1.017 . . . . 0.0 111.151 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 2.6 m-20 58.75 -73.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.478 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.4 OUTLIER -42.09 107.82 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.449 -0.782 . . . . 0.0 111.944 -177.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.463 ' CH2' " O2'" ' A' ' 301' ' ' SAH . 0.8 OUTLIER 46.12 -151.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.801 . . . . 0.0 111.488 178.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 113' ' ' ARG . 9.1 tt -46.8 138.42 6.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.448 -0.782 . . . . 0.0 111.258 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.0 m -115.1 -21.6 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -0.829 . . . . 0.0 110.195 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.438 ' CB ' ' HD2' ' A' ' 114' ' ' PRO . 11.9 mtt-85 -50.92 175.21 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 110.378 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 113' ' ' ARG . 9.5 Cg_endo -56.66 -162.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.681 1.358 . . . . 0.0 110.854 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' A' ' 115' ' ' ARG . 4.9 mpt_? -109.48 43.65 1.28 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.26 -0.9 . . . . 0.0 110.786 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 49.93 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.273 -0.892 . . . . 0.0 110.872 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -91.46 126.65 36.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 110.271 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 53.11 72.61 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 110.329 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.371 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.6 176.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -1.152 . . . . 0.0 110.339 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.09 67.05 4.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -58.13 88.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.588 1.309 . . . . 0.0 110.553 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? 52.47 59.52 4.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.426 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.83 59.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 110.38 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -170.73 91.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 110.381 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 tp -122.98 -40.33 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.89 . . . . 0.0 110.257 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.59 168.15 28.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 110.268 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 32.7 p -127.68 -41.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 110.511 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -115.1 165.29 13.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 110.304 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -123.83 -170.26 2.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.25 27.78 9.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.478 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 3.0 mpp_? 49.15 -163.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.875 . . . . 0.0 110.871 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m -51.95 170.66 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 0.0 110.471 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.56 144.3 49.18 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.3 -163.4 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.623 1.328 . . . . 0.0 110.856 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -116.71 106.1 13.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.7 t -155.34 -156.85 0.69 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 110.295 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.283 0.563 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' B' ' 7' ' ' ILE . 13.2 p90 -151.98 72.59 1.02 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.023 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 5' ' ' ARG . 2.4 m120 -155.8 -81.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' B' ' 6' ' ' VAL . 31.9 t0 -41.59 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' B' ' 3' ' ' ASN . 15.3 mtt180 42.57 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 112.841 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' B' ' 5' ' ' ARG . 44.6 t -158.31 156.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.591 -1.318 . . . . 0.0 110.831 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 15.4 tt -143.9 142.28 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.65 -0.656 . . . . 0.0 109.789 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 p -88.56 135.47 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 111.088 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.7 mttt -141.72 143.85 33.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.895 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.568 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.81 56.89 6.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.617 -1.927 . . . . 0.0 110.297 4.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.9 OUTLIER -113.05 178.64 0.92 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.725 -0.609 . . . . 0.0 110.037 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' B' ' 11' ' ' SER . 4.8 Cg_exo -71.89 -24.48 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.584 1.308 . . . . 0.0 110.366 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.65 27.42 1.22 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 110.047 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.45 169.29 22.36 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . -92.1 -145.52 16.01 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.28 68.36 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.428 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.6 -162.81 14.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.487 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 85.8 t -99.84 136.23 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.263 . . . . 0.0 110.247 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.497 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -101.03 127.83 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.84 97.87 11.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 111.139 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.429 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 5.0 ttt180 -75.26 -19.62 59.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.412 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.464 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.82 4.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . 2.518 60.7 m 102.26 24.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.187 -1.571 . . . . 0.0 109.909 1.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 26.1 m-85 -115.9 160.54 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 110.92 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.492 -0.755 . . . . 0.0 109.965 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.426 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 16.6 tttm -97.36 86.7 3.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.145 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.18 78.92 1.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.415 ' C ' ' CD2' ' B' ' 90' ' ' PHE . 1.2 mt-10 -155.15 138.12 15.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -1.179 . . . . 0.0 110.471 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.53 ' N ' ' CE2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER -54.38 153.73 5.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.123 -0.986 . . . . 0.0 109.602 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' B' ' 91' ' ' THR . 95.5 t -138.05 -49.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.001 -1.062 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' B' ' 89' ' ' ILE . 7.1 tp10 -161.42 116.0 2.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -124.42 144.8 49.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.083 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.543 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 75.9 m -139.68 -160.91 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.019 . . . . 0.0 111.004 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.424 HD23 ' NE ' ' B' ' 86' ' ' ARG . 3.0 mm? -94.53 179.03 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 110.405 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -151.5 159.09 44.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.278 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' B' ' 60' ' ' MET . 48.9 mt -105.61 106.53 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 109.798 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.424 HG23 ' CB ' ' B' ' 84' ' ' LEU . 89.9 t -88.13 122.37 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.51 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.487 ' HB3' ' CD1' ' B' ' 43' ' ' TRP . 17.3 tpt180 -139.67 148.72 42.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.372 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.11 -172.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.6 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -96.79 114.46 26.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.12 -140.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 109.488 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.74 -26.49 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.871 -1.143 . . . . 0.0 109.732 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.487 ' CD1' ' HB3' ' B' ' 38' ' ' ARG . 20.3 t-105 -70.54 -43.8 68.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.9 -27.99 60.12 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 88.1 m -91.03 -63.63 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -1.151 . . . . 0.0 110.608 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.11 -58.11 5.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.147 -0.97 . . . . 0.0 110.042 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.482 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 4.0 mm? -92.79 41.29 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -8.48 32.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 111.024 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.38 169.32 9.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.952 -1.093 . . . . 0.0 110.163 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.48 ' CE1' ' OXT' ' B' ' 302' ' ' SAH . 24.0 m-85 52.17 25.76 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 110.63 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.404 HD11 ' O ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -115.9 126.1 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 111.187 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.35 103.59 15.97 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 38.1 t -88.24 120.67 29.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.985 . . . . 0.0 111.381 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 177.73 5.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.725 . . . . 0.0 109.709 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -79.43 80.43 5.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 110.126 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.09 -23.82 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.913 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.64 -178.43 0.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.896 . . . . 0.0 110.817 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 16.5 m -123.32 139.01 54.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -132.95 153.04 51.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.014 -1.054 . . . . 0.0 111.112 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.458 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 38.7 tpp -89.49 154.73 19.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.452 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -88.19 93.6 9.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.431 ' CB ' HD22 ' A' ' 62' ' ' LEU 2.499 0.1 OUTLIER -56.03 -34.11 65.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 179.781 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' B' ' 33' ' ' CYS . . . -86.9 -136.75 4.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.431 ' CD1' ' HG2' ' B' ' 31' ' ' GLU . 85.2 m-85 -90.8 19.55 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 110.534 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -61.87 -20.94 60.47 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.89 -59.1 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.237 . . . . 0.0 111.076 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.487 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.5 pp -53.81 -18.3 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.374 -0.829 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.439 ' CG ' HG12 ' B' ' 103' ' ' ILE . 0.2 OUTLIER -49.06 146.54 3.39 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.876 -1.14 . . . . 0.0 110.731 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.38 171.47 8.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -0.917 . . . . 0.0 110.515 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -93.19 148.52 21.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 110.561 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.34 131.36 5.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -27.89 17.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.56 76.51 10.07 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 110.428 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.423 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 18.7 Cg_endo -64.94 104.17 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.667 1.351 . . . . 0.0 110.496 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.432 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 5.6 m-20 -72.13 -10.78 60.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.283 -0.886 . . . . 0.0 110.704 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' B' ' 91' ' ' THR . . . -146.26 160.64 41.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.064 -1.022 . . . . 0.0 110.822 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.05 155.31 43.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 110.13 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' B' ' 78' ' ' HIS . 21.1 p-80 -89.96 136.14 33.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 110.622 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.413 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.42 13.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.351 -0.843 . . . . 0.0 110.147 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 17.7 mt -121.71 161.66 22.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 110.526 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 24.2 m -131.43 119.66 21.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 110.104 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.01 64.62 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.5 -119.57 6.19 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.434 ' HB3' ' CB ' ' B' ' 59' ' ' ALA . 60.9 mt -118.47 26.52 9.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -1.166 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.69 -56.65 4.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.453 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.441 ' CB ' ' HB ' ' B' ' 81' ' ' THR . 0.0 OUTLIER -119.23 150.49 39.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.244 -0.91 . . . . 0.0 110.2 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.82 147.78 41.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.549 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' B' ' 79' ' ' GLU . 3.4 mtt180 -125.29 163.01 23.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' B' ' 31' ' ' GLU . 26.7 mt -136.05 113.3 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.53 ' CE2' ' N ' ' B' ' 29' ' ' LEU . 6.4 m-85 -112.58 178.05 4.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 110.804 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.43 HG23 ' CG2' ' B' ' 30' ' ' VAL . 15.1 p -121.63 99.19 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -0.862 . . . . 0.0 110.474 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.443 HG13 ' N ' ' B' ' 93' ' ' LYS . 21.7 pt -52.86 -28.4 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.443 ' N ' HG13 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -135.05 144.13 48.94 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 0.0 109.951 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 46.9 Cg_exo -49.44 145.84 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.599 1.315 . . . . 0.0 110.688 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.418 HD13 ' CG2' ' B' ' 91' ' ' THR . 73.0 mt -122.53 148.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.71 152.2 21.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 43.7 mt -53.86 -20.4 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.436 -0.79 . . . . 0.0 111.116 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.63 59.37 0.37 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.2 178.93 6.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.073 -1.251 . . . . 0.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -125.28 128.29 48.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.417 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 61.3 mt -89.13 132.54 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.88 . . . . 0.0 110.623 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 13.5 p -151.32 166.27 31.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.843 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.439 HG12 ' CG ' ' B' ' 68' ' ' PHE . 2.2 pp -137.85 156.38 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 110.596 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 36.6 t -91.78 -163.51 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.416 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 15.3 m-85 -132.27 -56.14 0.97 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.91 163.84 2.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.8 OUTLIER 54.67 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -1.025 . . . . 0.0 111.126 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 107' ' ' ASP . 2.5 m-20 58.73 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.477 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.4 OUTLIER -42.05 107.73 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 112.016 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.467 ' CH2' " O2'" ' B' ' 302' ' ' SAH . 0.8 OUTLIER 46.13 -151.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 111.48 178.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.431 HD23 ' N ' ' B' ' 113' ' ' ARG . 9.1 tt -46.8 138.41 6.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.412 -0.805 . . . . 0.0 111.273 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 68.9 m -115.12 -21.64 9.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 110.156 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.442 ' CB ' ' HD2' ' B' ' 114' ' ' PRO . 11.7 mtt-85 -50.93 175.16 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.406 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' B' ' 113' ' ' ARG . 9.4 Cg_endo -56.52 -162.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.644 1.339 . . . . 0.0 110.95 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . 0.476 ' CD ' ' N ' ' B' ' 115' ' ' ARG . 5.0 mpt_? -109.53 43.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 110.74 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 49.94 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.878 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -91.36 126.63 36.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 110.29 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 53.06 72.68 0.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.336 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.399 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.59 176.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -1.116 . . . . 0.0 110.362 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.12 67.01 4.13 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -58.14 89.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.583 1.307 . . . . 0.0 110.572 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? 52.43 59.56 4.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.391 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.86 59.89 1.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.366 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -170.77 91.89 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 110.359 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 tp -122.98 -40.34 2.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 110.292 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.61 168.27 27.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 110.224 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 32.5 p -127.77 -41.94 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 110.516 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -115.08 165.35 13.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -123.87 -170.3 2.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 110.255 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.25 27.73 9.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 110.215 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.477 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 3.0 mpp_? 49.18 -163.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.836 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m -52.02 170.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.834 . . . . 0.0 110.506 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.5 144.32 49.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.282 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.34 -163.36 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.667 1.351 . . . . 0.0 110.788 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -116.77 106.11 13.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.478 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.7 t -155.33 -156.88 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 110.252 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.501 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.487 ' OXT' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.48 ' OXT' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.226 0.536 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 47.3 p90 -56.66 140.74 46.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.556 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 39.1 p-10 -131.97 164.7 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -50.23 -24.06 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.717 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 6.3 mmm-85 -78.33 -44.62 24.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 110.707 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 29.8 m -153.37 -172.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.481 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.454 ' CG2' ' CB ' ' A' ' 19' ' ' PHE . 3.0 tt -145.43 143.21 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.349 -0.844 . . . . 0.0 109.777 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.66 118.34 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.951 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 10.3 mttt -121.77 144.39 48.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.412 -0.805 . . . . 0.0 109.197 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.72 71.55 0.47 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.658 -1.901 . . . . 0.0 111.641 0.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.478 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -113.18 -171.98 0.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 110.069 179.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 57.0 Cg_endo -84.49 6.53 5.69 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.467 1.246 . . . . 0.0 111.06 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.6 mt -124.17 -42.29 2.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.962 -1.086 . . . . 0.0 110.353 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.98 152.12 6.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.0 123.75 4.31 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -91.8 104.42 16.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -1.134 . . . . 0.0 110.295 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.88 -170.6 15.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG21 ' CE2' ' A' ' 64' ' ' PHE . 75.9 t -105.52 145.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.969 -1.312 . . . . 0.0 110.49 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 1.6 m-85 -109.99 120.44 42.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.395 -0.815 . . . . 0.0 109.405 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.54 90.13 8.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 111.123 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.23 -24.43 59.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 177.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.482 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 13.7 mtpt -94.9 178.99 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 51.8 m 104.11 23.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.007 -1.683 . . . . 0.0 109.67 2.007 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 12.2 m-85 -112.23 159.94 18.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 110.567 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -91.13 -157.63 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.888 . . . . 0.0 110.316 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 59.2 tttt -98.85 73.58 2.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 110.564 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.87 77.12 0.84 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -138.34 18.45 2.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -1.141 . . . . 0.0 110.565 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 16.3 tp 59.61 147.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.49 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.8 t -126.97 -39.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.973 -1.08 . . . . 0.0 110.243 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.95 161.67 8.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.37 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.6 143.93 22.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.506 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -149.25 -164.96 2.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 110.399 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 34' ' ' LEU . 11.0 mp -100.36 176.97 5.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.358 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 153.59 41.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.484 HG21 HD12 ' A' ' 36' ' ' ILE . 39.3 mt -94.75 97.29 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.958 . . . . 0.0 109.268 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 59.6 t -88.42 114.63 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.295 -0.878 . . . . 0.0 110.466 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -126.07 148.75 49.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 110.391 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.35 159.87 5.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.242 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -69.92 113.22 6.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.38 -142.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.854 . . . . 0.0 109.543 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.52 -25.26 3.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.869 -1.145 . . . . 0.0 109.986 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 43.8 t-105 -66.06 -54.55 24.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.788 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.8 -32.65 59.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -78.3 -63.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.1 -51.86 49.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.669 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.478 ' HG ' ' CZ3' ' A' ' 43' ' ' TRP . 4.1 mm? -91.14 30.07 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 110.729 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.43 -24.7 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.291 -0.881 . . . . 0.0 111.547 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 3.3 p30 -99.88 151.8 20.88 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.947 -1.095 . . . . 0.0 110.55 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD2' ' OD1' ' A' ' 49' ' ' ASP . 9.6 m-85 61.01 19.27 9.74 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.779 -0.576 . . . . 0.0 111.048 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 43' ' ' TRP . 6.7 mt -104.81 123.2 47.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.017 . . . . 0.0 110.789 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -89.12 105.9 18.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 108.455 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.2 p -87.87 118.91 27.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.169 -0.957 . . . . 0.0 111.071 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.434 ' HD3' ' CD1' ' A' ' 84' ' ' LEU . 5.4 ttp180 -98.76 -178.83 4.1 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.73 . . . . 0.0 110.038 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -83.87 81.54 8.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.054 . . . . 0.0 109.373 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.51 23.6 p30 149.06 -20.76 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.769 -0.582 . . . . 0.0 109.914 -178.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 1.5 ptm -177.01 -162.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.286 -0.883 . . . . 0.0 110.612 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 81.3 p -143.17 153.18 42.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.402 -0.811 . . . . 0.0 110.114 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.436 ' CB ' HD22 ' A' ' 84' ' ' LEU . . . -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.717 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.474 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 28.3 tpp -89.44 152.98 21.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.049 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.89 109.11 19.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.852 . . . . 0.0 110.294 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD2' ' CD1' ' A' ' 36' ' ' ILE 2.497 0.2 OUTLIER -56.68 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.785 . . . . 0.0 110.985 -179.775 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.15 -168.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.503 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -73.14 56.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -1.169 . . . . 0.0 111.323 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -91.5 -23.45 28.73 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . . . -91.13 2.7 56.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 111.502 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.529 ' CD1' ' CD1' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -90.31 -8.6 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.794 -1.191 . . . . 0.0 110.733 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.529 ' CD1' ' CD1' ' A' ' 67' ' ' ILE . 18.3 m-85 -56.03 131.93 48.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 0.0 109.925 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -98.48 179.1 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.974 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.57 115.92 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.832 . . . . 0.0 110.405 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.11 141.54 46.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 110.535 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -61.64 120.85 11.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.942 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.26 84.34 0.21 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.13 107.28 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.691 1.364 . . . . 0.0 110.467 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.29 -18.51 27.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.603 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.4 119.44 21.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.972 . . . . 0.0 110.346 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.73 -170.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.427 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 26.5 p-80 -129.19 163.07 26.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.838 . . . . 0.0 110.314 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -139.63 159.29 42.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.529 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 82' ' ' ALA . 8.7 mt -118.38 150.16 39.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.181 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.421 HG23 ' CB ' ' A' ' 86' ' ' ARG . 6.6 p -68.93 67.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 80' ' ' LEU . . . 51.24 39.83 24.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.56 -136.46 4.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.436 HD22 ' CB ' ' A' ' 59' ' ' ALA . 5.5 tp -132.08 86.67 2.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -1.107 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -49.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.514 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' CB ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER -124.76 123.62 40.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.1 mtp -95.24 154.7 17.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -138.75 164.23 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.043 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.31 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' A' ' 29' ' ' LEU . 18.3 m-85 -91.79 157.95 16.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 110.602 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.423 HG21 ' CD1' ' A' ' 95' ' ' ILE . 7.7 p -101.94 83.11 2.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 93' ' ' LYS . 6.1 pt -52.88 -23.48 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 110.555 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.44 ' N ' HG13 ' A' ' 92' ' ' ILE . 17.9 mmtt -137.48 134.57 18.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 89.6 Cg_exo -46.35 140.61 11.23 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.437 1.23 . . . . 0.0 111.119 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.423 ' CD1' HG21 ' A' ' 91' ' ' THR . 58.9 mt -117.95 141.81 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.61 166.49 13.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 110.449 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 3.0 mt -71.58 127.11 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.58 18.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -100.21 -175.77 3.03 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.139 -1.212 . . . . 0.0 110.022 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -126.16 124.47 40.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.106 -0.996 . . . . 0.0 110.307 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 102' ' ' THR . 62.8 mt -89.86 130.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.193 -0.942 . . . . 0.0 110.548 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 72.8 p -154.67 -166.85 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.435 HG12 ' CB ' ' A' ' 68' ' ' PHE . 1.2 pp -148.68 -167.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 110.444 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.409 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.4 t -102.71 -148.26 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 110.154 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.85 -86.55 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.418 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.07 1.69 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' HA ' ' CB ' ' A' ' 112' ' ' SER . 0.2 OUTLIER -109.49 -1.07 18.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 110.996 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.97 -40.39 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.967 -1.083 . . . . 0.0 110.565 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.483 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.2 OUTLIER -65.84 105.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.952 . . . . 0.0 110.599 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.471 ' CE2' " H3'" ' A' ' 301' ' ' SAH . 15.6 m95 55.78 -86.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 111.083 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 109' ' ' TYR . 1.3 tt -48.79 172.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.913 -1.117 . . . . 0.0 111.127 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.422 ' CB ' ' HA ' ' A' ' 107' ' ' ASP . 5.1 t 58.55 52.4 7.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.446 -0.784 . . . . 0.0 110.807 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.517 ' CB ' ' HD3' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 178.33 -55.27 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.165 -0.96 . . . . 0.0 110.826 178.541 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 113' ' ' ARG . 57.8 Cg_endo -80.94 7.39 4.94 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.726 1.382 . . . . 0.0 111.309 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 56.78 167.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.956 -1.09 . . . . 0.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.68 126.91 48.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.948 . . . . 0.0 110.481 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.8 m -157.32 99.26 1.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 0.0 110.245 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.32 104.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.881 . . . . 0.0 110.481 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.354 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 52.8 57.79 6.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -146.57 173.66 4.04 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 110.482 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.9 -64.55 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.67 1.353 . . . . 0.0 110.416 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 52.27 26.08 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.867 . . . . 0.0 110.398 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.54 89.01 7.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.366 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.6 87.53 1.94 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 110.425 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 12.7 tp 53.08 28.24 6.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.398 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.1 72.76 1.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 110.326 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 69.6 p -111.78 93.92 4.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 110.3 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -170.09 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.496 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.65 -68.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.248 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.12 83.73 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 110.504 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 1.1 mtt180 -66.11 -84.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.208 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.3 OUTLIER -50.61 -31.98 17.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.192 -0.943 . . . . 0.0 110.724 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.98 172.72 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 110.448 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.427 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 19.2 Cg_exo -63.01 -170.21 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.613 1.323 . . . . 0.0 110.443 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -89.93 155.29 19.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 110.238 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 5.3 t -150.3 60.86 0.96 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 110.38 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 CA-C-O 117.996 -1.447 . . . . 0.0 109.519 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.237 0.541 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 47.3 p90 -56.68 140.77 46.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.355 -0.84 . . . . 0.0 110.512 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 38.9 p-10 -131.98 164.81 25.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 110.226 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -50.3 -24.09 2.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 110.664 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.416 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 6.3 mmm-85 -78.27 -44.68 24.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.651 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 30.2 m -153.35 -172.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.458 ' CG2' ' CB ' ' B' ' 19' ' ' PHE . 3.0 tt -145.43 143.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.48 118.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.036 -1.04 . . . . 0.0 110.99 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 10.2 mttt -121.9 144.37 48.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.472 -0.767 . . . . 0.0 109.221 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.528 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.74 71.62 0.47 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.711 -1.868 . . . . 0.0 111.569 0.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.49 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 0.2 OUTLIER -113.22 -171.94 0.22 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 56.8 Cg_endo -84.55 6.5 5.7 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.462 1.243 . . . . 0.0 111.025 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 51.7 mt -124.19 -42.29 2.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.067 -1.021 . . . . 0.0 110.301 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.96 152.1 6.45 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.09 123.79 4.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 104.57 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -1.158 . . . . 0.0 110.364 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.1 -170.64 15.56 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' B' ' 64' ' ' PHE . 77.2 t -105.53 145.06 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.946 -1.326 . . . . 0.0 110.449 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.483 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 1.6 m-85 -110.0 120.35 42.18 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.466 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.41 90.14 8.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 111.18 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.415 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.31 -24.34 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 177.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.478 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 13.7 mtpt -94.92 179.04 5.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.524 -0.735 . . . . 0.0 109.031 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.444 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 51.9 m 104.09 23.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.095 -1.628 . . . . 0.0 109.677 2.012 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.478 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 12.3 m-85 -112.21 159.96 18.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.619 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -91.16 -157.62 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.261 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.434 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 59.1 tttt -98.83 73.55 2.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.548 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 77.02 0.83 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -138.3 18.4 2.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 110.586 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 16.2 tp 59.75 147.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.418 -0.802 . . . . 0.0 110.503 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 83.8 t -127.02 -39.82 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.042 . . . . 0.0 110.279 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.97 161.71 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.336 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.66 143.86 22.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.453 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -149.17 -164.95 2.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.398 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 11.0 mp -100.34 176.95 5.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.94 153.57 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.474 HG21 HD12 ' B' ' 36' ' ' ILE . 39.4 mt -94.78 96.4 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.393 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' B' ' 59' ' ' ALA . 54.8 t -87.21 114.7 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 110.651 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.492 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -126.21 148.71 49.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.31 159.88 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -69.87 113.15 6.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.451 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.35 -142.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.523 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.48 -25.33 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.812 -1.18 . . . . 0.0 110.004 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.492 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 43.7 t-105 -66.02 -54.55 24.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.593 -0.692 . . . . 0.0 109.781 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.85 -32.52 59.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -78.39 -63.23 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.153 . . . . 0.0 110.533 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.21 -51.4 54.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 110.69 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.1 mm? -91.83 30.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.484 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.52 -24.74 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.245 -0.91 . . . . 0.0 111.505 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.469 ' OD1' ' CD2' ' B' ' 50' ' ' TYR . 3.2 p30 -99.72 151.79 20.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.469 ' CD2' ' OD1' ' B' ' 49' ' ' ASP . 9.4 m-85 60.96 19.2 9.61 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.654 -0.654 . . . . 0.0 111.057 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' B' ' 43' ' ' TRP . 6.6 mt -104.89 123.02 46.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 0.0 110.893 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -88.77 104.98 17.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.706 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 57.0 p -86.55 119.04 26.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 111.322 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.425 ' HD3' ' CD1' ' B' ' 84' ' ' LEU . 5.4 ttp180 -99.49 178.67 4.8 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.473 -0.767 . . . . 0.0 110.066 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -80.2 81.17 6.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.957 . . . . 0.0 110.187 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 23.5 p30 148.96 -20.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.677 -0.64 . . . . 0.0 109.942 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.4 ptm -176.83 -161.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.934 . . . . 0.0 110.745 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.451 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 81.4 p -143.2 153.2 42.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 110.044 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' B' ' 37' ' ' VAL . . . -139.58 145.69 38.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 110.703 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.472 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 28.5 tpp -89.34 152.15 21.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.83 109.02 19.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.451 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' B' ' 36' ' ' ILE 2.5 0.2 OUTLIER -56.68 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -0.794 . . . . 0.0 110.919 -179.908 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.36 -168.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.492 ' CG ' ' O ' ' B' ' 64' ' ' PHE . 0.1 OUTLIER -73.19 57.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.18 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.486 ' HA2' ' CZ ' ' B' ' 68' ' ' PHE . . . -92.52 -22.48 28.89 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' B' ' 50' ' ' TYR . . . -92.03 3.09 56.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 111.378 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.533 ' CD1' ' CD1' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -90.53 -8.55 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.811 -1.18 . . . . 0.0 110.724 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' CD1' ' B' ' 67' ' ' ILE . 18.3 m-85 -56.05 131.98 48.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 0.0 109.907 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -98.57 179.12 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.967 . . . . 0.0 110.968 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.56 115.95 21.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.84 . . . . 0.0 110.404 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.13 141.6 46.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -61.68 120.86 11.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.31 84.27 0.21 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.04 107.33 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.734 1.386 . . . . 0.0 110.484 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.32 -18.49 27.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 110.632 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.4 119.36 21.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 0.0 110.382 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.7 -170.46 1.8 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 110.454 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.426 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 26.5 p-80 -129.2 162.99 26.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -139.64 159.32 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 110.514 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 mt -118.36 150.15 40.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 6.4 p -69.01 67.26 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 110.562 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.3 39.78 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.765 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.63 -136.51 4.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.43 HD22 ' CB ' ' B' ' 59' ' ' ALA . 5.5 tp -132.05 86.73 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -1.083 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.4 -49.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.0 OUTLIER -124.74 123.7 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 110.171 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 22.1 mtp -95.29 154.57 17.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 110.656 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -138.64 164.3 29.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.24 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.978 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -91.79 157.96 16.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.418 HG21 ' CD1' ' B' ' 95' ' ' ILE . 7.8 p -101.89 83.08 2.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.183 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.421 HG13 ' N ' ' B' ' 93' ' ' LYS . 6.1 pt -52.93 -23.46 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.895 . . . . 0.0 110.548 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.421 ' N ' HG13 ' B' ' 92' ' ' ILE . 17.9 mmtt -137.45 134.37 18.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 85.4 Cg_exo -46.6 140.88 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.424 1.223 . . . . 0.0 111.08 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.418 ' CD1' HG21 ' B' ' 91' ' ' THR . 59.0 mt -117.99 141.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.616 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.21 166.61 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.51 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 3.0 mt -71.71 127.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.4 23.57 18.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -100.01 -176.04 3.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.258 -1.142 . . . . 0.0 110.076 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -126.08 124.46 40.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.998 . . . . 0.0 110.282 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' B' ' 102' ' ' THR . 62.7 mt -89.84 130.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 72.2 p -154.55 -166.77 2.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.0 109.664 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.429 HG12 ' CB ' ' B' ' 68' ' ' PHE . 1.2 pp -148.73 -167.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.459 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' B' ' 103' ' ' ILE . 3.4 t -102.64 -148.3 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 110.159 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.82 -86.57 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.98 -132.04 1.68 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . 0.421 ' HA ' ' CB ' ' B' ' 112' ' ' SER . 0.2 OUTLIER -109.54 -1.03 18.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 0.0 110.977 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.89 -40.46 0.61 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.929 -1.107 . . . . 0.0 110.614 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.48 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.2 OUTLIER -65.79 105.14 1.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.608 -179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.476 ' CE2' " H3'" ' B' ' 302' ' ' SAH . 15.7 m95 55.77 -86.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.517 -0.739 . . . . 0.0 111.06 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' B' ' 109' ' ' TYR . 1.3 tt -48.8 172.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.919 -1.113 . . . . 0.0 111.113 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.421 ' CB ' ' HA ' ' B' ' 107' ' ' ASP . 5.0 t 58.54 52.59 6.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.405 -0.809 . . . . 0.0 110.859 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.485 ' CB ' ' HD3' ' B' ' 114' ' ' PRO . 0.0 OUTLIER 177.82 -55.03 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.113 -0.992 . . . . 0.0 110.481 178.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.485 ' HD3' ' CB ' ' B' ' 113' ' ' ARG . 58.1 Cg_endo -80.79 7.45 4.87 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.553 1.291 . . . . 0.0 111.365 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 56.68 168.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.862 -1.149 . . . . 0.0 110.112 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -122.7 126.84 48.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.482 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 90.1 m -157.28 99.25 1.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 110.252 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.32 104.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 110.471 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.366 179.906 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 52.84 57.79 6.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -1.185 . . . . 0.0 110.422 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -146.64 173.64 4.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 110.432 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -56.91 -64.54 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.675 1.355 . . . . 0.0 110.444 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 52.36 26.08 3.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 110.393 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 88.97 7.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.58 87.6 1.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -0.945 . . . . 0.0 110.404 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 12.7 tp 53.05 28.22 6.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.12 72.76 1.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.348 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 69.4 p -111.73 93.85 4.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 110.33 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -170.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 110.491 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.64 -68.71 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 110.293 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.06 83.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.498 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.48 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 1.1 mtt180 -66.11 -84.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 110.19 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.3 OUTLIER -50.63 -31.98 17.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -0.912 . . . . 0.0 110.7 -179.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.9 172.78 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.478 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . 0.426 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 19.0 Cg_exo -62.99 -170.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.651 1.342 . . . . 0.0 110.439 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -89.94 155.28 19.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.271 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 5.3 t -150.28 60.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 110.386 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.549 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.471 " H3'" ' CE2' ' A' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.476 " H3'" ' CE2' ' B' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mmt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.231 0.538 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 15.2 p90 -127.29 110.12 12.51 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.885 . . . . 0.0 110.501 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.88 151.25 36.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.47 -28.04 3.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.3 -0.875 . . . . 0.0 110.825 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.415 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.12 25.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 110.352 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 36.0 m -153.71 156.24 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.272 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.466 ' CG2' ' CB ' ' A' ' 19' ' ' PHE . 17.2 tt -128.74 155.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -97.89 133.42 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.862 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 7.6 mttt -130.86 142.73 50.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.35 -0.844 . . . . 0.0 109.313 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 20.0 mttt 52.74 62.23 2.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 119.631 -1.918 . . . . 0.0 111.219 0.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p -114.54 -176.92 0.4 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.459 -0.776 . . . . 0.0 110.296 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 18.4 Cg_exo -63.89 -63.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.658 1.346 . . . . 0.0 110.413 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.96 -23.04 7.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.638 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.26 172.2 22.55 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.89 -159.42 35.35 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.424 ' HB2' ' N ' ' A' ' 301' ' ' SAH . 1.5 m-85 -74.47 81.81 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -1.201 . . . . 0.0 110.353 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.467 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -121.13 -169.07 13.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 72.4 t -110.86 146.6 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.892 -1.358 . . . . 0.0 110.396 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CB ' ' CG2' ' A' ' 7' ' ' ILE . 1.2 m-85 -111.33 122.41 47.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 109.998 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.34 92.01 7.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 110.839 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.415 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.0 -21.63 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 178.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 22.7 mtpt -90.68 -179.3 5.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.88 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.416 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 108.29 15.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.167 -1.583 . . . . 0.0 110.378 0.922 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 40.1 m-85 -109.18 148.59 30.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.083 -1.011 . . . . 0.0 110.716 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.29 -161.33 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 69.99 3.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -137.69 122.23 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -1.171 . . . . 0.0 110.24 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.487 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.3 tm? -65.8 115.69 6.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.893 . . . . 0.0 110.417 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 85.3 t -94.39 74.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 110.057 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 30' ' ' VAL . 3.5 tt0 59.06 154.1 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.5 0.667 . . . . 0.0 110.821 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 88' ' ' ARG . 9.4 pt-20 -157.28 161.24 39.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.26 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.53 -170.7 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.622 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 HD23 ' CG ' ' A' ' 86' ' ' ARG . 58.4 mt -90.47 -170.24 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.436 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 14.0 m -147.18 160.77 42.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 110.024 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 36' ' ' ILE . 27.2 mt -96.07 102.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 109.345 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.6 129.24 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 110.663 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 6.0 mmt180 -145.81 151.69 38.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.437 -0.789 . . . . 0.0 110.127 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.3 -179.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.972 . . . . 0.0 110.369 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.37 112.37 23.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.53 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.25 -142.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -50.81 -25.25 4.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.719 -1.238 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.479 ' CD1' ' HB2' ' A' ' 38' ' ' ARG . 45.6 t-105 -56.12 -64.44 0.86 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.25 -28.39 58.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.7 m -70.54 -67.75 0.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -1.179 . . . . 0.0 110.523 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.03 84.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.558 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.473 ' CD1' ' CE ' ' A' ' 60' ' ' MET . 4.3 mm? -90.34 41.02 1.03 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.623 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.34 3.97 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.106 -0.996 . . . . 0.0 110.519 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.12 -81.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.484 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 66' ' ' ALA . 12.5 m-85 -96.96 52.38 1.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.368 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tp -111.89 131.45 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 111.167 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.479 ' CD1' ' CB ' ' C' ' 215' ' ' MLZ . 17.7 m-85 -92.35 -178.29 4.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -144.22 123.21 12.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 111.042 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -110.82 173.52 6.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.608 -0.682 . . . . 0.0 109.372 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 54' ' ' ARG . 13.1 mttm -82.68 70.8 9.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.0 109.237 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.2 t30 166.5 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.96 -167.87 0.25 Allowed 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 37.6 p -120.71 166.88 13.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.443 -0.786 . . . . 0.0 109.434 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.06 151.69 33.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.922 -1.111 . . . . 0.0 111.062 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.473 ' CE ' ' CD1' ' A' ' 47' ' ' LEU . 18.2 tpp -89.55 154.32 20.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -87.57 91.64 8.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' CD2' ' CD2' ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -55.54 -45.27 77.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.51 179.591 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.73 -141.22 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.439 ' HB3' ' CD1' ' A' ' 67' ' ' ILE . 29.3 m-85 -90.6 11.09 23.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -1.185 . . . . 0.0 110.903 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -47.37 -30.79 6.15 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.459 ' HA ' ' CG ' ' A' ' 50' ' ' TYR . . . -66.51 -75.28 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.199 -1.177 . . . . 0.0 109.793 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.489 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.4 pp -56.74 -18.8 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 111.364 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CD2' HG22 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -51.81 132.42 31.53 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.04 -1.038 . . . . 0.0 109.936 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.467 ' ND2' ' CA ' ' A' ' 17' ' ' GLY . 13.4 m-20 -109.05 177.26 4.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.957 -1.089 . . . . 0.0 111.451 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.522 ' CD2' ' N ' ' A' ' 71' ' ' SER . 13.3 t60 -103.0 157.56 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.522 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 29.3 t -149.96 140.93 22.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 110.603 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -29.78 50.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.87 96.07 39.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.0 119.71 6.75 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.648 1.341 . . . . 0.0 110.649 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.424 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 19.7 p30 -110.58 -21.77 11.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.35 149.93 34.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.292 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.401 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 3.4 mtt180 -128.19 -173.39 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 110.186 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -128.81 175.95 8.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.649 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -137.66 153.26 49.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.42 ' CD2' ' HG2' ' A' ' 87' ' ' MET . 80.1 mt -123.83 135.5 53.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -79.92 -168.76 1.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 88.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 110.467 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 87.12 58.38 1.89 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.423 HD13 ' CB ' ' A' ' 54' ' ' ARG . 8.0 mt 55.72 -111.6 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.375 -1.074 . . . . 0.0 110.084 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER 58.55 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.625 -1.297 . . . . 0.0 111.078 179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' CG ' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -97.38 139.82 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 110.536 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.533 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 11.0 mtp -129.64 144.47 51.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HA ' ' CB ' ' A' ' 32' ' ' GLU . 5.5 mtp180 -124.87 162.93 23.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.21 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 89' ' ' ILE . 81.2 mt -123.0 99.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.848 . . . . 0.0 109.661 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 2.0 m-85 -96.36 -174.2 2.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.718 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 p -127.48 98.89 5.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.401 ' CG2' ' HB2' ' A' ' 77' ' ' ARG . 45.4 pt -55.64 -25.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.617 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.424 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -144.53 146.77 33.72 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.172 -0.955 . . . . 0.0 110.438 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.12 125.89 20.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.685 1.361 . . . . 0.0 110.492 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.9 144.58 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.59 156.88 18.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 110.457 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 73.3 mt -66.8 113.68 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.38 30.71 2.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.92 -170.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.296 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 43.1 tt0 -128.39 133.7 48.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 26.4 mt -89.32 131.32 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.2 -0.937 . . . . 0.0 109.932 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.431 ' CB ' ' O ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -158.9 164.56 35.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.119 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.479 HG22 ' CD2' ' A' ' 68' ' ' PHE . 8.2 pt -132.94 162.41 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.618 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.437 ' HA ' ' ND1' ' A' ' 70' ' ' HIS . 1.4 m -91.71 174.83 7.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.205 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 70' ' ' HIS . 15.8 m-85 -126.86 -70.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 67.35 -163.67 45.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.66 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -1.045 . . . . 0.0 110.622 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -100.04 -42.47 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 0.0 110.341 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.432 ' HB2' ' CB ' ' A' ' 105' ' ' TYR . 19.1 m-85 -61.88 141.91 57.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -117.99 37.99 3.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.4 -0.812 . . . . 0.0 110.558 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 112' ' ' SER . 2.5 tm? -51.73 145.73 8.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.406 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.456 ' N ' ' CD1' ' A' ' 111' ' ' LEU . 0.4 OUTLIER 60.78 128.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.631 0.729 . . . . 0.0 110.804 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.517 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 13.5 mtm-85 -77.21 -50.97 2.1 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.293 -0.879 . . . . 0.0 111.55 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 50.5 Cg_endo -77.78 -13.23 16.19 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.716 1.377 . . . . 0.0 111.244 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.41 ' CD ' ' O ' ' A' ' 112' ' ' SER . 44.9 mmm-85 54.97 -152.77 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.129 -0.982 . . . . 0.0 110.529 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.1 mt -121.84 56.75 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 110.428 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.5 m -127.58 118.89 24.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 110.348 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 53.46 -172.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.417 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.386 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.59 -68.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -1.133 . . . . 0.0 110.298 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -114.77 91.56 26.28 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.81 139.16 67.21 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.698 1.367 . . . . 0.0 110.444 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -95.16 -69.31 0.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.957 . . . . 0.0 110.332 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 52.73 -171.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 110.436 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -59.39 -167.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.902 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.35 84.22 1.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.919 . . . . 0.0 110.403 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . 52.75 92.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.369 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 27.7 m -72.34 -46.13 56.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.896 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -127.56 128.03 44.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.406 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.12 158.77 3.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 110.362 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.82 107.96 10.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.397 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -107.51 164.36 12.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.479 ' CB ' ' CD1' ' A' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t -57.25 -164.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 110.277 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -136.22 152.11 74.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.84 -34.12 97.86 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.699 1.368 . . . . 0.0 110.517 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -112.81 92.45 4.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 110.328 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 36.0 p -109.29 46.52 0.98 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.397 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.247 0.546 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 15.4 p90 -127.21 110.13 12.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.25 -0.906 . . . . 0.0 110.517 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.89 151.23 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -0.818 . . . . 0.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.43 -28.05 3.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.794 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.42 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.2 25.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 35.9 m -153.62 156.26 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.458 ' CG2' ' CB ' ' B' ' 19' ' ' PHE . 17.2 tt -128.74 155.59 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.395 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -97.85 133.47 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.85 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 7.6 mttt -130.93 142.68 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.846 . . . . 0.0 109.315 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 20.0 mttt 52.67 62.33 2.74 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 119.675 -1.89 . . . . 0.0 111.199 0.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 2.6 p -114.64 -176.84 0.4 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 110.31 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 18.2 Cg_exo -63.87 -63.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.62 1.326 . . . . 0.0 110.401 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.91 -23.13 7.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 110.663 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.21 172.08 22.59 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.78 -159.39 35.36 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.431 ' HB2' ' N ' ' B' ' 302' ' ' SAH . 1.5 m-85 -74.52 81.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.325 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.466 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -121.14 -169.02 13.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 69.0 t -110.92 146.17 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.929 -1.336 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.458 ' CB ' ' CG2' ' B' ' 7' ' ' ILE . 1.2 m-85 -111.27 122.4 47.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.38 92.08 7.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 110.825 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.98 -21.7 61.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.836 178.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.474 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 22.9 mtpt -90.63 -179.18 5.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.419 -0.801 . . . . 0.0 109.889 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.416 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 0.0 OUTLIER 108.32 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.206 -1.559 . . . . 0.0 110.43 0.896 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 40.0 m-85 -109.17 148.58 30.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.01 . . . . 0.0 110.688 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.33 -161.3 0.8 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 70.0 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 110.312 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -137.66 122.29 18.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -1.128 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.489 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.3 tm? -65.85 115.62 6.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 110.445 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' B' ' 31' ' ' GLU . 85.9 t -94.3 74.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -0.853 . . . . 0.0 110.012 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' B' ' 30' ' ' VAL . 3.5 tt0 59.08 154.11 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.648 -0.657 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' B' ' 88' ' ' ARG . 9.4 pt-20 -157.18 161.5 39.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 110.269 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.85 -170.78 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.432 HD23 ' CG ' ' B' ' 86' ' ' ARG . 58.8 mt -90.46 -170.24 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.528 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 14.4 m -147.17 160.71 42.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' B' ' 60' ' ' MET . 27.0 mt -96.07 102.32 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.089 -1.007 . . . . 0.0 109.411 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.67 129.33 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 5.9 mmt180 -145.99 151.71 38.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.26 -179.11 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.39 112.37 23.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.28 -142.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.831 . . . . 0.0 109.568 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -50.82 -25.31 4.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.766 -1.208 . . . . 0.0 109.855 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.486 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 45.6 t-105 -56.05 -64.47 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.918 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.23 -28.37 58.74 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 75.8 m -70.5 -67.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.572 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.85 84.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 110.658 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.478 ' CD1' ' CE ' ' B' ' 60' ' ' MET . 4.3 mm? -90.55 41.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.604 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.24 3.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 110.512 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.14 -81.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' B' ' 66' ' ' ALA . 12.5 m-85 -96.9 52.41 1.17 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 0.0 109.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tp -111.89 131.54 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 111.108 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' D' ' 215' ' ' MLZ . 17.7 m-85 -92.34 -178.24 4.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.388 -0.82 . . . . 0.0 109.683 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 25.0 p -144.16 123.26 12.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.044 -1.035 . . . . 0.0 111.04 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.451 ' CD ' ' N ' ' B' ' 55' ' ' LYS . 0.4 OUTLIER -111.5 170.6 8.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 178.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' B' ' 54' ' ' ARG . 14.1 mttm -78.54 70.13 4.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.089 . . . . 0.0 110.178 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 1.2 t30 166.58 -28.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.76 -167.83 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.454 -0.779 . . . . 0.0 110.954 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.432 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 37.5 p -120.69 166.84 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.449 -0.782 . . . . 0.0 109.419 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.04 151.54 33.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.93 -1.106 . . . . 0.0 111.058 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.478 ' CE ' ' CD1' ' B' ' 47' ' ' LEU . 18.2 tpp -89.43 153.39 20.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.429 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -86.28 91.58 8.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.836 . . . . 0.0 110.88 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.474 ' CD2' ' CD2' ' A' ' 62' ' ' LEU 2.498 0.2 OUTLIER -55.62 -45.24 77.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 110.518 179.432 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.74 -140.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.432 ' HB3' ' CD1' ' B' ' 67' ' ' ILE . 29.0 m-85 -91.02 11.21 23.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -1.143 . . . . 0.0 110.823 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -47.39 -30.8 6.2 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' B' ' 50' ' ' TYR . . . -66.54 -75.46 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.179 -1.189 . . . . 0.0 109.84 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.489 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.4 pp -56.48 -18.99 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.476 ' CE2' HG22 ' B' ' 103' ' ' ILE . 0.2 OUTLIER -51.65 132.36 30.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.907 -1.12 . . . . 0.0 109.85 178.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.466 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 13.3 m-20 -108.9 177.92 4.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.018 -1.051 . . . . 0.0 111.351 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' B' ' 71' ' ' SER . 13.2 t60 -104.04 157.33 17.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' SER . . . . . 0.52 ' N ' ' CD2' ' B' ' 70' ' ' HIS . 29.5 t -149.79 140.85 22.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.632 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.81 49.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.8 96.02 39.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.395 -0.816 . . . . 0.0 109.961 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.97 119.75 6.79 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.655 1.345 . . . . 0.0 110.682 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.427 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 19.7 p30 -110.56 -21.84 11.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.36 149.9 34.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.332 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.406 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 3.4 mtt180 -128.11 -173.34 2.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.179 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.4 ' CD2' ' C ' ' B' ' 78' ' ' HIS . 2.7 p-80 -128.88 175.98 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 110.671 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -137.66 153.21 49.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 110.431 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.42 ' CD2' ' HG2' ' B' ' 87' ' ' MET . 80.3 mt -123.8 135.52 53.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 110.215 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 83' ' ' GLY . 0.0 OUTLIER -79.99 -168.69 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -0.905 . . . . 0.0 110.113 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 110.495 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.424 ' HA3' ' NZ ' ' B' ' 85' ' ' LYS . . . 87.16 58.32 1.89 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.426 HD13 ' CB ' ' B' ' 54' ' ' ARG . 8.0 mt 55.76 -111.68 0.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.408 -1.054 . . . . 0.0 110.078 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.424 ' NZ ' ' HA3' ' B' ' 83' ' ' GLY . 0.2 OUTLIER 58.44 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.586 -1.321 . . . . 0.0 111.076 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.432 ' CG ' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -97.28 139.79 32.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.489 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.528 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 11.1 mtp -129.59 144.48 51.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 110.438 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.434 ' HA ' ' CB ' ' B' ' 32' ' ' GLU . 5.5 mtp180 -124.86 162.92 23.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.423 HG21 HD12 ' B' ' 89' ' ' ILE . 81.1 mt -123.01 99.75 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.825 . . . . 0.0 109.617 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.489 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 2.0 m-85 -96.31 -174.17 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.737 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -127.52 98.83 5.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' B' ' 77' ' ' ARG . 45.4 pt -55.62 -25.07 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.632 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.427 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.1 OUTLIER -144.48 146.79 33.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 110.497 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.2 125.9 20.6 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.709 1.373 . . . . 0.0 110.439 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.96 144.42 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 110.333 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.42 156.93 18.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.465 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 73.3 mt -66.84 113.63 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.47 30.75 2.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.99 -170.31 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 110.281 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 43.3 tt0 -128.43 133.5 48.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.289 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 27.1 mt -88.96 131.35 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 110.104 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.432 HG23 ' CB ' ' B' ' 69' ' ' ASN . 1.0 OUTLIER -158.87 164.68 35.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.785 -0.572 . . . . 0.0 109.727 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.476 HG22 ' CE2' ' B' ' 68' ' ' PHE . 8.2 pt -132.95 162.35 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.436 ' HA ' ' ND1' ' B' ' 70' ' ' HIS . 1.4 m -91.73 174.8 7.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' B' ' 70' ' ' HIS . 15.8 m-85 -126.76 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 110.501 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 67.42 -163.59 45.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.63 -86.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.439 -1.036 . . . . 0.0 110.635 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -100.14 -42.62 6.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.275 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.435 ' HB2' ' CB ' ' B' ' 105' ' ' TYR . 19.2 m-85 -61.7 141.98 57.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -118.08 38.03 3.8 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.339 -0.85 . . . . 0.0 110.558 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' B' ' 112' ' ' SER . 2.5 tm? -51.74 145.77 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.161 -0.962 . . . . 0.0 110.45 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.465 ' N ' ' CD1' ' B' ' 111' ' ' LEU . 0.4 OUTLIER 60.73 128.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.643 0.735 . . . . 0.0 110.779 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 13.2 mtm-85 -77.69 -50.58 1.95 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 111.106 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 48.6 Cg_endo -77.8 -13.42 16.07 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.695 1.366 . . . . 0.0 111.115 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . 0.42 ' CD ' ' O ' ' B' ' 112' ' ' SER . 44.9 mmm-85 54.82 -152.82 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.99 . . . . 0.0 110.529 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 14.1 mt -121.66 56.71 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 110.457 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 27.6 m -127.57 119.01 25.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 0.0 110.239 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.4 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 110.428 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.383 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.61 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -1.092 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -114.85 91.55 26.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.8 139.12 67.05 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.641 1.338 . . . . 0.0 110.475 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -95.15 -69.21 0.76 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 110.383 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 52.64 -171.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -59.3 -167.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.417 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.31 84.16 1.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 110.408 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . 52.76 92.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.376 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 27.6 m -72.3 -46.2 56.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.378 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -127.56 128.04 44.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 110.453 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.09 158.79 3.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 110.385 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.77 107.93 10.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 110.407 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -107.52 164.38 12.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.933 . . . . 0.0 110.271 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.481 ' HB2' ' CD1' ' B' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t -57.25 -164.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -0.882 . . . . 0.0 110.295 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -136.24 152.15 74.68 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.395 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.85 -34.07 97.8 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.662 1.348 . . . . 0.0 110.545 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -112.88 92.46 4.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 35.9 p -109.32 46.59 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 110.438 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.434 ' N7 ' ' HB3' ' A' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.431 ' N ' ' HB2' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.244 0.545 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.478 ' CD1' HD13 ' A' ' 7' ' ' ILE . 14.6 t80 53.06 68.38 0.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' ARG . 11.8 m120 -90.17 55.36 3.06 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.405 -0.809 . . . . 0.0 110.046 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t70 52.97 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 111.371 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 3' ' ' ASN . 0.2 OUTLIER -50.55 -33.82 23.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 111.01 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 5' ' ' ARG . 89.2 t -152.37 138.5 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.067 -1.021 . . . . 0.0 111.245 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.478 HD13 ' CD1' ' A' ' 2' ' ' PHE . 12.7 tt -114.61 162.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 110.062 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.1 t -106.85 120.06 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 16.7 mttt -116.69 144.03 44.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 25.0 mttt 52.38 63.04 2.4 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.725 -1.86 . . . . 0.0 111.355 0.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -115.83 173.46 2.98 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.827 . . . . 0.0 110.344 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.72 -31.84 93.16 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.696 1.366 . . . . 0.0 110.405 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.58 -36.56 28.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.73 -164.68 15.62 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.24 -177.88 42.13 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 71.6 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.349 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -108.69 -172.32 21.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 94.1 t -113.55 158.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.299 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CG ' ' HE3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -121.0 127.91 52.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.157 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.84 95.2 10.13 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.571 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -64.14 -24.95 67.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.838 . . . . 0.0 109.665 178.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -86.02 179.27 7.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.443 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.511 0.0 OUTLIER 103.37 11.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.141 -1.599 . . . . 0.0 110.603 1.118 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.6 m-85 -107.67 150.96 26.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.702 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.26 -152.63 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 110.131 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 13.7 tttm -100.58 69.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 110.43 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.03 75.2 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.73 7.55 3.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -1.146 . . . . 0.0 110.984 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HG ' ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER 61.45 131.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -103.38 -74.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.117 -0.99 . . . . 0.0 110.697 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.46 160.82 37.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.704 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.63 142.17 37.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.221 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.424 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.4 p -150.15 -174.99 4.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 2.8 mm? -97.66 174.43 6.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.85 168.59 22.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 62' ' ' LEU . 79.3 mt -100.37 150.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.883 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 84' ' ' LEU . 49.7 t -125.58 82.07 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.41 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -109.07 146.45 33.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.606 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 41.0 m170 -61.73 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.007 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -89.58 -137.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 5.0 m-20 60.54 -134.4 0.72 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.956 -1.09 . . . . 0.0 110.222 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -45.94 -26.15 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.907 -1.121 . . . . 0.0 111.155 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.533 ' CZ3' HD12 ' A' ' 47' ' ' LEU . 65.4 t-105 -67.54 -58.6 4.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -25.55 42.21 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.7 m -81.14 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 110.537 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.8 -58.02 8.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 110.086 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 ' CZ3' ' A' ' 43' ' ' TRP . 4.8 mp -90.82 51.83 2.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.285 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.04 56.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.894 -1.129 . . . . 0.0 111.583 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER 174.21 154.06 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.805 -1.184 . . . . 0.0 110.335 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.401 ' CD1' ' HB2' ' A' ' 66' ' ' ALA . 5.9 m-85 60.48 22.7 12.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.844 . . . . 0.0 111.012 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.483 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 22.6 mt -105.48 113.38 26.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.087 . . . . 0.0 111.156 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -88.86 102.31 14.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.5 p -99.65 157.03 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.087 -1.008 . . . . 0.0 111.694 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' CZ ' ' O ' ' A' ' 83' ' ' GLY . 26.1 mtm180 -117.68 -171.98 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.633 -0.667 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.68 80.54 9.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 109.06 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 156.02 -21.2 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.731 -0.605 . . . . 0.0 110.124 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -169.32 0.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.035 -1.04 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.444 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 15.5 m -128.69 150.12 50.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -135.01 176.37 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 110.403 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.401 ' CB ' ' HB ' ' A' ' 36' ' ' ILE . 2.9 ttt -121.56 156.58 32.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.487 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -88.8 92.12 9.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.445 ' CD2' HG13 ' A' ' 36' ' ' ILE 2.51 0.0 OUTLIER -53.24 -70.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.887 -178.37 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.68 -138.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 87.7 m-85 -86.21 48.0 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 110.635 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -86.27 -22.08 49.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . . . -87.44 -51.36 5.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 110.511 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.7 pp -44.29 -24.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 111.827 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 89' ' ' ILE . 16.4 m-85 -55.88 142.8 33.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.774 -1.204 . . . . 0.0 110.314 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' CA ' ' A' ' 17' ' ' GLY . 55.0 m-20 -119.39 -178.9 3.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 111.339 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -102.74 152.82 20.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.549 -0.72 . . . . 0.0 109.634 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.57 22.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.098 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.49 23.67 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.03 -1.044 . . . . 0.0 110.298 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -174.44 66.18 0.28 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.808 . . . . 0.0 109.797 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 22.1 Cg_endo -65.56 93.42 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.775 1.408 . . . . 0.0 110.93 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.96 66.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.847 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' THR . . . -128.07 127.76 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 110.166 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 -171.92 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 110.419 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.46 158.05 23.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 14.0 tp10 -138.21 126.32 22.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 110.067 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD13 ' HD3' ' A' ' 54' ' ' ARG . 28.1 mt -105.22 131.26 52.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.978 . . . . 0.0 110.55 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.56 -166.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 110.419 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CZ ' ' A' ' 54' ' ' ARG . . . 138.72 -116.52 1.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' O ' ' CG2' ' A' ' 37' ' ' VAL . 25.5 tp -168.92 45.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.17 -16.94 9.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 110.694 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -131.2 147.76 52.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.593 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.29 158.57 26.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.669 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.443 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 6.5 mtt180 -147.5 115.57 6.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.822 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.484 HG12 ' CE2' ' A' ' 68' ' ' PHE . 2.7 mp -88.95 117.13 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.854 -1.154 . . . . 0.0 110.402 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.499 ' CE2' ' HG ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -106.72 163.51 12.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.412 HG22 ' CD1' ' A' ' 95' ' ' ILE . 10.6 p -107.3 87.93 2.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 93' ' ' LYS . 9.5 pt -54.34 -22.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 110.319 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.5 mttt -133.58 142.35 43.6 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 110.204 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.401 ' HG3' ' HB2' ' A' ' 26' ' ' LYS . 33.8 Cg_exo -55.65 128.99 32.66 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.599 1.315 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.412 ' CD1' HG22 ' A' ' 91' ' ' THR . 77.3 mt -107.58 138.51 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 110.342 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.73 164.8 14.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 4.4 mt -70.95 112.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.71 0.89 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.37 -176.59 3.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -1.183 . . . . 0.0 110.37 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -123.33 126.21 46.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 110.032 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 102' ' ' THR . 56.6 mt -88.81 126.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.167 -0.958 . . . . 0.0 109.844 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 22.0 p -155.4 143.11 19.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.566 . . . . 0.0 109.929 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.1 pp -123.92 147.69 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.513 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.6 t -85.13 -166.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.534 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.472 ' CE1' ' HE3' ' C' ' 215' ' ' MLZ . 7.4 m-85 -124.44 -65.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 0.0 110.07 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.17 15.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.17 -30.5 2.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.436 -1.038 . . . . 0.0 111.454 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -42.79 82.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -109.65 115.54 30.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.091 -1.005 . . . . 0.0 110.454 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 28.5 t-105 58.71 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.789 -0.569 . . . . 0.0 111.067 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 10.6 tp -46.83 163.19 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.087 -1.008 . . . . 0.0 110.975 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.45 118.3 5.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.721 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.462 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 2.9 tpt180 47.68 50.4 8.8 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.31 -0.869 . . . . 0.0 111.1 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 113' ' ' ARG . 55.2 Cg_endo -75.53 146.9 31.34 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.526 1.277 . . . . 0.0 110.522 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -128.44 -39.33 1.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 110.272 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.24 38.34 17.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.639 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.0 m -129.09 154.17 46.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 0.0 110.379 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.402 ' OE1' ' N ' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -126.22 140.33 52.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.338 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.402 ' N ' ' OE1' ' A' ' 118' ' ' GLN . 20.1 p30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.22 114.38 16.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.33 93.75 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 110.387 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -59.41 -40.45 67.2 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.67 1.353 . . . . 0.0 110.573 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.06 23.91 6.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.161 -0.962 . . . . 0.0 110.452 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt 51.68 68.65 0.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.534 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -88.8 103.44 15.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.293 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.72 94.19 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 110.42 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.97 143.49 52.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 1.2 p -122.65 83.68 2.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 110.402 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -84.28 67.5 9.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 110.339 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.42 118.5 1.4 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 110.456 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . 54.7 172.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.504 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 13.6 mtt-85 -141.75 -84.72 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 110.254 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.472 ' HE3' ' CE1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 28.7 t -50.56 154.79 1.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.839 . . . . 0.0 110.659 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.09 147.6 2.29 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.4 -173.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.745 1.392 . . . . 0.0 110.503 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -164.57 115.83 1.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 9.8 t -136.88 -163.97 1.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.376 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.867 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.218 0.533 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' B' ' 7' ' ' ILE . 14.6 t80 53.14 68.34 0.85 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.915 . . . . 0.0 110.171 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 5' ' ' ARG . 11.8 m120 -90.23 55.24 3.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.028 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.1 t70 52.96 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.706 -0.621 . . . . 0.0 111.355 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' B' ' 3' ' ' ASN . 0.2 OUTLIER -50.55 -33.92 23.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 111.027 -178.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' B' ' 5' ' ' ARG . 89.4 t -152.31 138.53 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.036 -1.04 . . . . 0.0 111.211 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' B' ' 2' ' ' PHE . 12.7 tt -114.64 162.33 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -106.86 120.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.431 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.517 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 16.7 mttt -116.74 144.0 44.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.875 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 25.2 mttt 52.43 62.94 2.44 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.752 -1.842 . . . . 0.0 111.403 0.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.402 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 0.5 OUTLIER -115.82 173.45 2.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.413 -0.804 . . . . 0.0 110.32 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.76 -31.76 93.04 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.637 1.336 . . . . 0.0 110.428 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.66 -36.53 28.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 110.327 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.68 -164.69 15.58 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.29 -177.89 42.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 71.7 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -1.135 . . . . 0.0 110.385 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.416 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -108.94 -172.19 21.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 95.1 t -113.57 158.47 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.016 -1.285 . . . . 0.0 110.718 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.473 ' CG ' ' HE3' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -120.99 127.88 52.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 110.164 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.78 95.17 10.12 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.362 -0.836 . . . . 0.0 110.542 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -64.15 -24.88 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.684 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -86.07 179.21 7.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.552 -0.718 . . . . 0.0 109.373 179.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.454 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.511 0.0 OUTLIER 103.3 11.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.111 -1.618 . . . . 0.0 110.541 1.19 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.7 m-85 -107.63 150.99 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.048 -1.032 . . . . 0.0 110.777 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.29 -152.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -100.57 69.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.06 75.29 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.71 7.49 3.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 110.976 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER 61.5 131.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.178 -0.951 . . . . 0.0 110.129 -179.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 98.1 t -103.22 -74.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.991 -1.068 . . . . 0.0 110.551 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.53 160.84 37.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.008 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.58 142.3 37.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 110.183 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.43 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.4 p -150.3 -175.01 4.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.8 mm? -97.78 174.4 6.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.189 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 92.2 m -148.82 168.56 22.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 110.743 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.457 HG13 ' CD2' ' B' ' 62' ' ' LEU . 79.4 mt -100.46 150.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.841 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 49.5 t -125.48 82.08 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.434 ' HB3' ' CD2' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -109.1 146.43 34.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 110.55 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . 0.479 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 40.9 m170 -61.65 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' B' ' 41' ' ' ASP . 0.2 OUTLIER -89.52 -137.64 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 5.0 m-20 60.56 -134.42 0.72 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.007 -1.058 . . . . 0.0 110.23 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -45.97 -26.04 0.65 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.903 -1.123 . . . . 0.0 111.201 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.524 ' CH2' ' CD2' ' B' ' 47' ' ' LEU . 65.4 t-105 -67.66 -58.58 4.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.41 -25.61 41.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 60.3 m -81.2 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 110.512 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.83 -57.44 10.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.181 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.524 ' CD2' ' CH2' ' B' ' 43' ' ' TRP . 4.7 mp -91.61 52.21 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 110.239 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.23 56.23 0.15 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.029 -1.044 . . . . 0.0 111.581 -178.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.5 OUTLIER 174.15 154.09 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.853 -1.154 . . . . 0.0 110.359 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.406 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 5.9 m-85 60.5 22.77 12.45 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.383 -0.823 . . . . 0.0 110.985 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.476 HD21 ' CZ2' ' B' ' 43' ' ' TRP . 22.5 mt -105.51 112.85 26.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.9 -1.125 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -88.29 102.28 14.68 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.3 p -99.62 157.0 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.103 -0.998 . . . . 0.0 111.753 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.421 ' CZ ' ' O ' ' B' ' 83' ' ' GLY . 26.3 mtm180 -118.17 -174.49 2.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.699 -0.625 . . . . 0.0 109.711 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 80.27 6.56 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.188 -0.945 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 155.89 -21.3 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.577 -0.702 . . . . 0.0 110.177 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 -169.31 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.058 -1.026 . . . . 0.0 110.944 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 15.5 m -128.71 150.12 50.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.453 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -135.03 176.36 8.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 110.44 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' MET . . . . . . . . . . . . . 2.9 ttt -121.71 156.03 33.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 110.56 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -88.12 92.12 9.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.89 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.457 ' CD2' HG13 ' B' ' 36' ' ' ILE 2.509 0.0 OUTLIER -53.3 -70.92 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.896 -178.459 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.71 -138.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.483 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 87.9 m-85 -86.2 48.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.133 . . . . 0.0 110.656 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -86.27 -22.18 49.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.39 -51.39 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -1.199 . . . . 0.0 110.5 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.7 pp -44.22 -24.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.598 -0.689 . . . . 0.0 111.843 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.492 ' CE2' HG12 ' B' ' 89' ' ' ILE . 16.4 m-85 -55.67 143.39 30.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.796 -1.19 . . . . 0.0 110.258 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.416 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 56.0 m-20 -120.08 -178.45 3.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 111.228 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -103.62 152.68 21.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.45 22.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.959 -1.088 . . . . 0.0 111.075 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.63 23.62 2.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.045 . . . . 0.0 110.222 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -174.47 66.2 0.28 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.42 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 22.2 Cg_endo -65.54 93.37 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.783 1.412 . . . . 0.0 110.934 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.93 66.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.08 127.81 43.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.01 -171.93 2.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.451 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.37 157.83 23.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.496 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.441 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 14.0 tp10 -137.96 126.54 23.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.164 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 28.1 mt -105.2 131.35 52.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 0.0 110.51 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.73 -166.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.349 -0.845 . . . . 0.0 110.257 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.06 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 110.455 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.421 ' O ' ' CZ ' ' B' ' 54' ' ' ARG . . . 138.73 -116.61 1.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.417 ' O ' ' CG2' ' B' ' 37' ' ' VAL . 25.5 tp -168.91 46.0 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -1.137 . . . . 0.0 110.425 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.15 -16.99 9.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.674 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -131.2 147.8 52.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.093 -1.004 . . . . 0.0 110.556 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 5.6 mmm -120.26 158.57 26.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 110.719 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.441 ' CB ' ' HB3' ' B' ' 79' ' ' GLU . 6.5 mtt180 -147.54 115.21 6.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 109.885 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.492 HG12 ' CE2' ' B' ' 68' ' ' PHE . 2.7 mp -88.39 117.11 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.042 . . . . 0.0 110.523 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.501 ' CE2' ' HG ' ' B' ' 29' ' ' LEU . 0.9 OUTLIER -106.81 163.49 12.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.345 -0.847 . . . . 0.0 110.643 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.414 HG22 ' CD1' ' B' ' 95' ' ' ILE . 10.4 p -107.24 87.86 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' B' ' 74' ' ' PRO . 9.5 pt -54.25 -22.88 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.917 . . . . 0.0 110.358 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.418 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.5 mttt -133.55 142.45 43.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.216 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.95 129.16 33.47 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.561 1.295 . . . . 0.0 110.454 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' B' ' 91' ' ' THR . 77.4 mt -107.58 138.4 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 110.313 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 164.79 14.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.178 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 4.4 mt -70.94 112.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.75 0.89 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.43 -176.56 3.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -1.165 . . . . 0.0 110.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -123.45 125.74 45.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.114 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' B' ' 102' ' ' THR . 56.1 mt -88.0 126.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 110.075 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 22.0 p -155.45 143.08 19.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.578 -0.701 . . . . 0.0 109.903 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.436 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.1 pp -123.89 147.68 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 43.5 t -85.17 -166.34 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 110.486 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.465 ' CE1' ' HE3' ' D' ' 215' ' ' MLZ . 7.5 m-85 -124.49 -65.58 1.03 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.948 . . . . 0.0 110.065 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.92 173.23 15.22 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.14 -30.41 2.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -1.01 . . . . 0.0 111.514 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -42.94 81.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.082 -1.012 . . . . 0.0 110.932 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -109.31 115.71 30.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 0.0 110.563 -179.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' B' ' 111' ' ' LEU . 28.3 t-105 58.55 -77.8 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.893 -0.504 . . . . 0.0 111.06 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' B' ' 110' ' ' TRP . 10.6 tp -46.71 163.03 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.062 -1.024 . . . . 0.0 110.969 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.34 118.33 5.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 110.668 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.463 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 2.9 tpt180 47.56 50.45 8.85 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.89 . . . . 0.0 111.108 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 55.3 Cg_endo -75.49 146.88 31.44 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.533 1.28 . . . . 0.0 110.551 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -128.44 -39.31 1.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 110.279 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.25 38.36 17.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.673 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 24.9 m -129.16 154.18 47.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 110.377 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.23 140.32 52.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 110.301 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.1 p30 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.376 -179.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.26 114.41 16.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -1.142 . . . . 0.0 110.42 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.37 93.75 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -59.43 -40.52 66.31 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.609 1.321 . . . . 0.0 110.529 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.02 23.89 6.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 110.545 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt 51.73 68.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 110.526 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -88.75 103.4 15.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 110.305 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.66 94.13 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 110.455 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.97 143.49 52.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.356 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 1.2 p -122.63 83.63 2.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.928 . . . . 0.0 110.391 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -84.23 67.51 9.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 110.344 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.49 118.4 1.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 110.47 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 54.73 172.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 110.501 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -141.72 -84.67 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 110.255 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.465 ' HE3' ' CE1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 28.7 t -50.55 154.76 1.24 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.677 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.04 147.63 2.32 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 110.394 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.4 -173.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.648 1.341 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -164.59 115.77 1.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 110.405 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 9.8 t -136.86 -164.0 1.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 110.44 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.544 179.93 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.0 0.428 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 52.9 p90 -129.76 136.45 49.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.797 -1.189 . . . . 0.0 110.77 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' ARG . 8.7 p-10 -148.04 164.28 34.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.885 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.16 62.28 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.588 -0.695 . . . . 0.0 110.754 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.438 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 4.8 tpt180 179.69 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.284 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 7' ' ' ILE . 54.9 t -157.07 169.41 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 110.1 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.44 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 11.8 tt -144.77 146.61 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.442 HG12 ' CE ' ' A' ' 10' ' ' LYS . 94.7 t -89.65 102.53 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 111.027 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 1.1 mmtt -124.06 137.58 54.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 49.85 50.23 18.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 119.407 -2.058 . . . . 0.0 111.699 4.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' CE2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -104.13 -55.55 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.902 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.506 ' HD3' ' CB ' ' A' ' 11' ' ' SER . 87.7 Cg_endo -92.87 34.56 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.11 1.058 . . . . 0.0 110.264 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.69 51.3 11.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.119 -0.988 . . . . 0.0 109.864 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.3 -123.1 3.35 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.13 -150.58 26.92 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.487 ' CE2' ' HE3' ' A' ' 10' ' ' LYS . 3.5 m-85 -115.24 110.44 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -1.114 . . . . 0.0 110.803 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.5 173.77 22.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.462 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 97.9 t -98.3 130.08 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.999 -1.295 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE2' ' CB ' ' A' ' 11' ' ' SER . 1.6 m-85 -107.68 133.82 51.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 110.147 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.93 88.47 4.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.404 -0.81 . . . . 0.0 110.542 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.21 -27.15 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.38 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 14.7 mtpt -83.61 178.98 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.45 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 0.1 OUTLIER 102.24 20.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.0 -1.687 . . . . 0.0 109.563 3.145 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.487 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 15.2 m-85 -112.68 150.24 31.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.09 -158.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.845 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -80.41 -1.17 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.07 67.57 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -118.07 120.76 38.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.124 . . . . 0.0 110.275 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 90' ' ' PHE . 25.8 tp -53.71 127.36 25.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 6' ' ' VAL . 47.2 t -103.41 72.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 32' ' ' GLU . 9.2 tp10 57.04 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 6.8 pt-20 -158.58 156.01 29.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 110.327 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.55 -161.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.367 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 4.6 mm? -96.7 -179.17 4.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 110.543 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.21 178.16 8.8 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.435 -0.791 . . . . 0.0 109.535 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 36' ' ' ILE . 20.9 mt -113.97 138.49 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 110.26 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.85 113.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.032 -1.043 . . . . 0.0 110.325 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.483 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 1.5 tpp180 -146.61 159.73 43.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 110.404 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.475 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 64.2 m170 -71.4 -173.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -86.37 -137.28 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.833 . . . . 0.0 110.117 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.42 -139.91 0.43 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.739 -1.226 . . . . 0.0 110.304 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -46.36 -26.95 0.92 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.983 -1.073 . . . . 0.0 111.11 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.483 ' CE2' ' HB3' ' A' ' 38' ' ' ARG . 67.8 t-105 -61.06 -55.94 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.819 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.23 69.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.3 m -69.82 -70.42 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.8 -53.42 48.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.133 -0.98 . . . . 0.0 110.185 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 2.6 mm? -90.45 46.49 1.34 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -5.88 35.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.851 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.35 147.19 43.76 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.95 -1.094 . . . . 0.0 110.021 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CE1' ' O ' ' A' ' 66' ' ' ALA . 11.6 m-85 56.09 38.76 30.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.096 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD12 ' CZ2' ' A' ' 43' ' ' TRP . 7.0 tp -123.76 122.81 39.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.896 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.08 132.32 44.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.959 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 60.6 p -94.27 127.89 40.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -0.962 . . . . 0.0 110.783 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 12.9 tpt180 -105.39 172.94 6.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.407 -0.808 . . . . 0.0 109.608 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -83.08 82.71 8.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.946 -1.096 . . . . 0.0 109.225 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 22.9 p30 146.45 -18.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.79 -0.569 . . . . 0.0 109.765 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.98 -160.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.1 m -140.49 118.59 11.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.149 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -109.44 153.81 23.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.639 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.436 ' CE ' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -93.16 179.58 5.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . . . -86.48 -146.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.16 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.435 HD22 ' CD2' ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER -178.34 -73.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.99 -1.069 . . . . 0.0 109.967 -179.211 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.55 -114.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 40.5 m-85 -91.26 33.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.516 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -90.95 -22.14 33.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -91.09 -20.94 21.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 111.681 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.462 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -92.51 -4.29 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.217 . . . . 0.0 111.835 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD2' ' CD1' ' A' ' 103' ' ' ILE . 5.3 m-85 -55.81 147.78 18.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.823 -1.173 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -117.42 -167.83 1.38 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -103.79 151.2 23.34 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.243 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -161.19 150.07 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -11.75 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 111.053 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.63 67.52 71.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.03 107.12 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.647 1.341 . . . . 0.0 110.459 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.425 ' CB ' ' HD2' ' A' ' 93' ' ' LYS . 47.2 p30 -81.54 -6.53 59.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.69 150.24 35.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.985 -1.072 . . . . 0.0 110.501 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.06 -160.45 0.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.439 ' HB2' ' CE ' ' A' ' 87' ' ' MET . 2.0 p-80 -132.26 166.96 20.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.067 -1.021 . . . . 0.0 110.666 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.15 141.19 29.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 110.455 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -105.16 145.9 29.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.263 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.428 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 1.6 p -64.87 -62.64 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 110.412 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.82 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.602 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.5 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HB3' ' CB ' ' A' ' 59' ' ' ALA . 29.4 mt 52.32 48.58 22.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.425 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.22 -76.55 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.554 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.428 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER -87.22 126.63 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 110.285 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.439 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -100.79 117.75 35.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.895 . . . . 0.0 110.525 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.39 114.59 27.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.042 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mt -89.43 138.35 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 110.151 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.514 ' CZ ' ' CD1' ' A' ' 29' ' ' LEU . 13.6 m-85 -128.36 177.86 6.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.431 HG21 ' CG2' ' A' ' 30' ' ' VAL . 1.6 p -115.71 96.47 5.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.316 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 93' ' ' LYS . 23.3 pt -50.45 -35.83 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.568 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' N ' HG13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -130.28 150.48 76.26 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 110.299 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.15 131.69 31.57 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.717 1.378 . . . . 0.0 110.981 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 32.1 mt -113.29 145.32 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.786 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.38 10.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 110.968 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 39.4 mt -65.79 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.06 36.37 1.83 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -101.32 156.26 17.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -1.12 . . . . 0.0 110.167 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.411 ' OE1' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -100.34 110.11 22.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 110.491 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.3 mt -89.55 119.82 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.797 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 32.2 p -141.13 1.59 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 111.601 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 68' ' ' PHE . 35.4 pt 37.42 -145.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.326 -0.859 . . . . 0.0 111.34 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.428 ' N ' HG13 ' A' ' 103' ' ' ILE . 22.9 t -160.59 -168.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 110.727 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.478 ' CD1' ' HG3' ' C' ' 215' ' ' MLZ . 10.5 m-85 -123.37 -66.84 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.853 . . . . 0.0 109.686 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 84.69 -160.04 35.31 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t0 55.12 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.552 -0.969 . . . . 0.0 110.581 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 1.9 t70 -153.88 25.12 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.0 110.559 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -100.98 108.77 20.58 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.181 -0.949 . . . . 0.0 109.753 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 30.0 t-105 58.97 -78.79 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.118 0.485 . . . . 0.0 110.638 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 8.4 tt -62.65 -52.46 63.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.065 -1.022 . . . . 0.0 110.792 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.8 t 54.71 -88.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.765 . . . . 0.0 110.142 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -92.82 131.59 33.26 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.985 -1.072 . . . . 0.0 109.741 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.91 -85.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.343 1.181 . . . . 0.0 110.605 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.57 61.68 3.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 110.703 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.4 mp -82.84 80.94 8.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 110.335 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.9 m -150.72 -66.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 0.0 110.374 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.72 56.7 6.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.357 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.387 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 -58.79 1.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -1.116 . . . . 0.0 110.382 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -116.48 91.48 33.84 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.387 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.62 -60.65 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.681 1.359 . . . . 0.0 110.528 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.68 110.44 0.64 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 110.307 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.38 39.49 0.35 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -0.893 . . . . 0.0 110.304 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -109.6 -53.2 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 110.367 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.89 103.05 2.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 110.352 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.4 -159.99 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.444 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 210' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' C' ' 210' ' ' THR . 5.1 t -60.62 97.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.427 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.96 -60.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 110.277 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.49 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.598 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.87 141.09 49.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 110.081 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.451 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 55.5 mtm-85 -146.94 -172.68 4.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.701 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.478 ' HG3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 2.2 p -50.99 174.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 110.471 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.5 160.59 31.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.95 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.69 137.69 50.89 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.744 1.391 . . . . 0.0 110.509 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -77.77 64.52 3.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 110.379 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 1.4 m 53.41 98.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.425 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.989 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.956 0.407 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 52.9 p90 -129.67 136.47 49.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.813 -1.179 . . . . 0.0 110.761 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' B' ' 5' ' ' ARG . 8.7 p-10 -147.98 164.44 33.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.34 62.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.0 110.657 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.441 ' O ' ' CG2' ' B' ' 6' ' ' VAL . 4.8 tpt180 179.85 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.413 -0.804 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' B' ' 5' ' ' ARG . 54.6 t -156.92 169.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.668 -0.645 . . . . 0.0 110.138 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.441 ' N ' ' CG1' ' B' ' 6' ' ' VAL . 11.8 tt -144.77 146.42 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.589 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.442 HG12 ' CE ' ' B' ' 10' ' ' LYS . 93.2 t -89.49 102.55 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.056 -1.027 . . . . 0.0 111.086 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' B' ' 10' ' ' LYS . 1.1 mmtt -124.09 137.64 54.54 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 49.89 50.19 18.88 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 119.43 -2.044 . . . . 0.0 111.729 4.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.515 ' CB ' ' CE2' ' B' ' 19' ' ' PHE . 0.2 OUTLIER -104.19 -55.51 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 109.854 176.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' B' ' 11' ' ' SER . 88.0 Cg_endo -92.86 34.61 0.23 Allowed 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.204 1.108 . . . . 0.0 110.283 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.67 51.33 11.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.103 -0.998 . . . . 0.0 109.84 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.36 -122.95 3.33 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.04 -150.48 26.84 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.487 ' CE2' ' HE3' ' B' ' 10' ' ' LYS . 3.6 m-85 -115.24 110.38 19.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -1.08 . . . . 0.0 110.872 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.54 173.64 22.19 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.457 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 92.9 t -98.17 129.86 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.318 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.515 ' CE2' ' CB ' ' B' ' 11' ' ' SER . 1.6 m-85 -107.63 133.82 51.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 110.151 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.91 88.5 4.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.324 -0.86 . . . . 0.0 110.569 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.6 OUTLIER -57.19 -27.16 61.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 178.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.49 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 14.7 mtpt -83.58 179.02 7.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.455 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.1 OUTLIER 102.21 20.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.003 -1.686 . . . . 0.0 109.581 3.056 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.49 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 15.4 m-85 -112.63 150.36 31.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.31 -0.869 . . . . 0.0 110.222 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.23 -158.77 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.963 . . . . 0.0 109.868 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -80.38 -1.25 40.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.02 67.59 0.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -118.05 120.69 38.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 110.309 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' CZ ' ' B' ' 90' ' ' PHE . 25.9 tp -53.67 127.37 25.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' B' ' 6' ' ' VAL . 47.1 t -103.37 72.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' B' ' 32' ' ' GLU . 9.2 tp10 57.11 163.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.451 -0.781 . . . . 0.0 110.467 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' B' ' 31' ' ' GLU . 6.8 pt-20 -158.65 156.07 29.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.61 -161.7 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' B' ' 34' ' ' LEU . 4.6 mm? -96.83 -179.17 4.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 110.593 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.23 178.14 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.387 -0.82 . . . . 0.0 109.454 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.454 HG22 HD12 ' B' ' 36' ' ' ILE . 20.8 mt -114.0 138.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.018 . . . . 0.0 110.203 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.8 113.4 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.294 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.477 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 1.5 tpp180 -146.68 159.73 43.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 110.463 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 64.2 m170 -71.38 -173.99 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.764 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -86.34 -137.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.36 -139.99 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.808 -1.183 . . . . 0.0 110.295 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -46.23 -27.04 0.9 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.03 -1.044 . . . . 0.0 111.159 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.481 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 67.7 t-105 -60.98 -55.94 27.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.957 . . . . 0.0 109.852 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.21 69.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 92.1 m -69.85 -70.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -1.157 . . . . 0.0 110.519 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.89 -53.13 53.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 2.6 mm? -90.82 46.6 1.34 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -5.92 35.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 110.868 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.24 147.2 43.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.906 -1.121 . . . . 0.0 110.098 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' O ' ' B' ' 66' ' ' ALA . 11.5 m-85 56.11 38.75 30.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.866 . . . . 0.0 110.075 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.476 HD12 ' CZ2' ' B' ' 43' ' ' TRP . 7.1 tp -123.81 122.96 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.826 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -99.24 132.43 44.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.43 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 60.5 p -94.29 127.94 40.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.735 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' B' ' 55' ' ' LYS . 13.0 tpt180 -106.01 169.98 8.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.446 -0.784 . . . . 0.0 109.722 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.447 ' N ' ' HG3' ' B' ' 54' ' ' ARG . 0.1 OUTLIER -79.04 82.4 5.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.028 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 22.9 p30 146.31 -18.83 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.667 -0.645 . . . . 0.0 109.668 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.97 -160.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -140.38 118.54 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -109.38 153.89 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 110.73 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.435 ' CA ' HD11 ' B' ' 51' ' ' LEU . 0.1 OUTLIER -93.62 178.22 5.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.399 -0.813 . . . . 0.0 110.308 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.47 -146.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.885 . . . . 0.0 109.632 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.436 HD23 ' CG1' ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER -178.51 -73.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.001 -1.062 . . . . 0.0 110.018 -179.473 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.53 -113.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.472 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 40.4 m-85 -92.04 34.23 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -1.151 . . . . 0.0 110.314 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.437 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -92.02 -21.19 33.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.479 ' O ' ' CE1' ' B' ' 50' ' ' TYR . . . -92.17 -19.52 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.264 . . . . 0.0 111.627 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.457 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.0 OUTLIER -94.14 -3.68 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.873 -1.142 . . . . 0.0 111.491 -178.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.526 ' CD2' ' CD1' ' B' ' 103' ' ' ILE . 5.3 m-85 -56.13 147.82 19.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 110.461 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -117.23 -166.73 1.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -105.37 150.84 24.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.903 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -160.88 150.08 16.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 110.311 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 -11.7 59.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 111.069 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.73 67.56 71.01 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.997 -1.065 . . . . 0.0 110.536 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.08 107.06 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.663 1.349 . . . . 0.0 110.434 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.433 ' CB ' ' HD2' ' B' ' 93' ' ' LYS . 47.1 p30 -81.49 -6.49 59.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.69 150.18 34.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.971 -1.081 . . . . 0.0 110.465 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -160.39 0.95 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.433 ' HB2' ' CE ' ' B' ' 87' ' ' MET . 2.0 p-80 -132.32 167.0 20.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.673 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.16 141.27 29.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.419 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 94.6 mt -105.26 145.89 30.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 110.318 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 1.6 p -64.89 -62.57 1.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.417 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.88 -43.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.54 2.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.429 ' HB3' ' CB ' ' B' ' 59' ' ' ALA . 29.4 mt 52.27 48.54 22.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -1.195 . . . . 0.0 110.407 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.18 -76.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.948 . . . . 0.0 110.536 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.431 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.0 OUTLIER -87.17 126.64 34.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.006 . . . . 0.0 110.281 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.433 ' CE ' ' HB2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -100.81 117.74 35.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 110.548 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.46 114.3 27.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.121 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' B' ' 78' ' ' HIS . 38.5 mt -89.02 138.37 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.511 ' CZ ' ' CD1' ' B' ' 29' ' ' LEU . 13.6 m-85 -128.39 177.92 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 110.472 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.433 HG21 ' CG2' ' B' ' 30' ' ' VAL . 1.6 p -115.75 96.45 5.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.908 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.433 HG13 ' N ' ' B' ' 93' ' ' LYS . 23.4 pt -50.44 -35.82 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.628 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.433 ' N ' HG13 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -130.25 150.52 76.36 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 110.273 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.21 131.73 31.95 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.709 1.373 . . . . 0.0 110.991 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.416 ' CD1' HG22 ' B' ' 91' ' ' THR . 31.9 mt -113.29 145.37 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.476 -0.765 . . . . 0.0 109.795 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.31 10.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.948 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 39.5 mt -65.76 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 110.267 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.1 36.25 1.85 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.28 156.25 17.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.141 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -100.32 110.06 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.11 -0.994 . . . . 0.0 110.49 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . . . . . . . . . 60.0 mt -89.47 119.65 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.8 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.431 ' O ' ' CG1' ' B' ' 103' ' ' ILE . 32.7 p -140.91 1.53 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 111.611 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.526 ' CD1' ' CD2' ' B' ' 68' ' ' PHE . 35.2 pt 37.61 -146.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.46 -0.775 . . . . 0.0 111.388 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.425 ' N ' HG13 ' B' ' 103' ' ' ILE . 22.8 t -160.62 -169.08 2.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.903 -1.123 . . . . 0.0 110.712 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.477 ' CD1' ' HG3' ' D' ' 215' ' ' MLZ . 10.4 m-85 -123.06 -66.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.774 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 84.65 -159.95 35.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.4 t0 55.1 -87.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.527 -0.984 . . . . 0.0 110.546 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 106' ' ' GLY . 1.8 t70 -153.85 24.94 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.937 -1.102 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -100.65 108.91 20.92 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 109.91 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.53 ' CD1' ' N ' ' B' ' 111' ' ' LEU . 29.9 t-105 58.93 -78.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.084 0.468 . . . . 0.0 110.607 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' B' ' 110' ' ' TRP . 8.4 tt -62.58 -52.47 63.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.107 -0.996 . . . . 0.0 110.787 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 7.9 t 54.65 -88.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.446 -0.784 . . . . 0.0 110.191 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -92.79 131.53 33.46 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.861 -1.149 . . . . 0.0 109.794 178.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.8 -85.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.353 1.186 . . . . 0.0 110.619 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.64 61.63 3.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.063 -1.023 . . . . 0.0 110.71 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.3 mp -82.81 80.89 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 110.292 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 53.5 m -150.73 -66.87 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 110.366 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.77 56.68 6.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.362 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 -58.75 1.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -1.147 . . . . 0.0 110.376 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -116.55 91.53 34.3 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 110.367 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.62 -60.69 0.13 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.654 1.344 . . . . 0.0 110.487 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' D' ' 205' ' ' ARG . 0.1 OUTLIER -167.66 110.4 0.64 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.336 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 39.46 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -109.63 -53.14 2.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 110.358 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.92 103.06 2.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 110.302 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.44 -160.01 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 110.394 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 210' ' ' THR . . . . . 0.41 ' O ' ' CG2' ' D' ' 210' ' ' THR . 5.1 t -60.54 97.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.434 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -60.64 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.52 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.885 . . . . 0.0 110.535 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.83 141.05 49.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.467 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 55.5 mtm-85 -146.9 -172.61 4.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 110.713 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.477 ' HG3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.2 p -51.16 174.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 0.0 110.462 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.59 31.04 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.922 . . . . 0.0 110.391 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -65.59 137.67 51.25 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.632 1.333 . . . . 0.0 110.522 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -77.76 64.52 3.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 1.4 m 53.43 98.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.449 " O2'" ' CE3' ' A' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.458 " O2'" ' CE3' ' B' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.21 0.529 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.469 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 35.8 p90 -172.31 122.14 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.401 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -121.08 163.44 18.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -50.08 -25.61 3.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 26.9 ttp180 -74.65 -45.39 45.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.56 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 22.9 m -154.25 -178.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.164 -0.96 . . . . 0.0 110.493 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.427 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 9.0 tt -152.91 150.49 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.101 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.4 t -94.48 120.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 mttt -125.59 146.82 49.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.418 -0.801 . . . . 0.0 109.226 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 4.1 mmmt 52.45 59.18 4.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 119.65 -1.906 . . . . 0.0 110.922 2.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.476 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 p -107.77 -173.6 0.28 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.451 -0.781 . . . . 0.0 110.159 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 24.4 Cg_exo -60.25 -39.59 66.7 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.662 1.348 . . . . 0.0 110.407 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.03 -23.33 26.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 110.402 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 -155.25 16.44 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.34 139.26 0.29 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.96 72.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -1.175 . . . . 0.0 110.581 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.0 -175.97 20.37 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 90.3 t -101.67 146.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.987 -1.302 . . . . 0.0 110.03 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.494 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -110.41 126.36 54.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -0.931 . . . . 0.0 109.754 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.54 89.4 7.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -0.844 . . . . 0.0 110.843 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.415 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.52 -22.52 55.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.325 -0.859 . . . . 0.0 109.65 178.022 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' CG ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -90.82 -178.87 5.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.467 -0.771 . . . . 0.0 109.862 179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.432 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 18.1 m 100.58 17.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.291 -1.506 . . . . 0.0 110.47 0.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -105.19 161.43 14.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.768 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -162.03 0.91 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.356 -0.84 . . . . 0.0 109.88 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 17.8 tttt -95.53 97.47 9.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.03 58.0 0.84 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.49 121.06 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -1.176 . . . . 0.0 110.43 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -56.14 132.99 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.424 ' CG2' HG23 ' A' ' 91' ' ' THR . 88.8 t -103.35 -39.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.888 . . . . 0.0 110.291 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.21 156.75 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.309 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.43 150.75 30.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 110.289 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.415 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -150.19 -159.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 110.631 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.8 176.07 5.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.693 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.53 150.78 31.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.433 HG13 ' CD2' ' A' ' 62' ' ' LEU . 56.0 mt -89.89 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.623 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.7 t -126.9 106.87 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.632 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 35.3 mmt180 -136.53 157.97 45.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -71.45 176.52 4.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 110.157 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 53.1 p-10 -64.08 -137.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.8 t0 67.12 -149.91 0.18 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.853 -1.154 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -45.89 -34.54 3.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.864 . . . . 0.0 111.373 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.49 ' CD2' ' HB2' ' A' ' 38' ' ' ARG . 48.4 t-105 -57.54 -55.45 34.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 110.241 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.58 68.08 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 94.5 m -80.85 -64.5 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.142 -1.211 . . . . 0.0 110.801 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.78 -48.45 15.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.0 111.047 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.0 mm? -91.94 26.81 2.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -64.35 80.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 7.1 t0 -175.65 -53.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 110.484 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 3.6 m-85 -127.72 54.1 1.72 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.486 HD21 ' CE2' ' A' ' 43' ' ' TRP . 6.0 mt -110.17 114.06 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 111.219 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.438 ' CE1' ' HD3' ' C' ' 215' ' ' MLZ . 36.5 m-85 -89.93 114.4 26.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.898 . . . . 0.0 109.221 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -108.0 134.78 50.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.097 -1.002 . . . . 0.0 111.207 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.429 ' CB ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.89 -171.68 1.89 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 109.865 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -82.33 75.12 9.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.978 -1.076 . . . . 0.0 109.21 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 49.6 m-80 173.1 -33.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.442 -179.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.42 ' CG ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 178.82 -167.71 0.08 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.437 -0.79 . . . . 0.0 110.351 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.3 156.75 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 110.112 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -150.32 148.61 29.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 0.0 110.47 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.429 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 13.7 mmm -91.37 157.77 16.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -86.66 101.89 13.68 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.457 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' B' ' 62' ' ' LEU 2.5 0.0 OUTLIER -59.64 -76.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 -179.156 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.33 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 89.8 m-85 -89.66 41.81 1.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 110.544 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -81.0 -22.67 60.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.9 -55.41 3.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -1.149 . . . . 0.0 111.058 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 1.6 pp -50.48 -22.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 111.155 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 64' ' ' PHE . 0.7 OUTLIER -48.91 122.16 5.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.014 -1.054 . . . . 0.0 110.847 -179.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -94.51 173.63 7.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.51 ' NE2' ' CD1' ' A' ' 110' ' ' TRP . 39.6 t60 -102.04 150.57 23.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 0.0 110.121 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 p -149.64 139.57 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.481 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.52 -25.02 23.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.243 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.69 51.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.207 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.76 98.83 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.658 1.346 . . . . 0.0 110.554 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.8 -17.91 54.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.17 170.96 15.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 110.331 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -149.73 -161.69 1.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.409 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 31.0 p-80 -130.95 -172.86 2.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -151.73 170.98 18.42 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.171 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.86 124.88 17.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -56.92 -168.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.631 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.94 89.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.477 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.73 158.1 32.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 54' ' ' ARG . 2.3 mp -55.35 106.39 0.23 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -1.078 . . . . 0.0 110.348 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 -53.58 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.26 169.38 16.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.897 . . . . 0.0 110.266 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.8 mtp -140.42 133.35 29.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.92 . . . . 0.0 110.494 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -115.1 176.02 5.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.269 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.33 111.98 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE1' ' CD2' ' A' ' 29' ' ' LEU . 56.1 m-85 -106.58 175.18 5.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.544 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.424 HG23 ' CG2' ' A' ' 30' ' ' VAL . 3.1 p -122.95 85.28 2.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.115 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.9 pt -50.13 -25.45 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.825 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.09 134.68 21.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 110.503 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 82.0 Cg_exo -47.51 152.04 2.79 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.489 1.257 . . . . 0.0 111.014 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' CG2' ' HB2' ' A' ' 99' ' ' GLU . 64.1 mt -131.28 148.68 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.64 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.59 157.88 15.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.421 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 53.0 mt -63.36 109.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.206 -0.934 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.08 27.84 2.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.435 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 52.0 mm-40 -106.73 -177.83 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -1.157 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.6 123.1 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.931 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 84.7 mt -89.19 130.78 37.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -154.66 143.77 21.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.817 -0.552 . . . . 0.0 110.002 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.459 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.1 pt -105.26 160.75 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 110.491 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -93.93 -168.87 1.96 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -124.6 -68.85 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 110.3 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 89.73 -168.45 34.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.491 -1.005 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 5.3 t70 -135.19 -36.98 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.908 -1.12 . . . . 0.0 110.918 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' C' ' 214' ' ' ARG . 0.8 OUTLIER -48.15 117.75 2.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.816 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.525 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 56.0 t-105 55.48 168.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 110.466 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -59.61 -172.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 110.42 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.23 -40.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.303 -0.873 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -50.2 -49.95 72.97 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.884 . . . . 0.0 111.303 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 113' ' ' ARG . 31.4 Cg_exo -52.77 96.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.703 1.37 . . . . 0.0 110.398 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -96.55 -28.38 14.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 110.406 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.21 -87.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -0.854 . . . . 0.0 110.479 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 115' ' ' ARG . 76.2 m -56.83 156.87 6.07 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.955 -1.091 . . . . 0.0 110.158 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 52.95 179.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.319 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.368 179.901 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 34.29 5.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -1.139 . . . . 0.0 110.377 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -94.64 176.06 2.55 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.37 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -56.48 165.44 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.653 1.343 . . . . 0.0 110.495 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.25 -60.35 0.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 110.345 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.08 150.27 30.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.363 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.58 136.91 47.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 110.337 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.13 54.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.44 -72.96 0.36 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 110.351 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 17.5 p -137.92 147.61 44.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 110.332 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -43.56 5.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.472 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.65 -166.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 110.471 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.26 -158.69 0.67 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.352 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.461 ' O ' ' CD1' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -97.01 -92.27 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.214 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.438 ' HD3' ' CE1' ' A' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.5 1.6 m -55.33 -170.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.447 -0.783 . . . . 0.0 110.443 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.78 154.72 3.68 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.409 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 41.6 Cg_endo -70.05 154.98 66.05 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.702 1.37 . . . . 0.0 110.627 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.89 69.13 0.73 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.385 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 4.2 p -84.12 154.04 23.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.338 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.95 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.199 0.523 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.473 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 36.4 p90 -172.32 122.13 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.427 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -121.07 163.49 18.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.338 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -50.16 -25.57 3.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.93 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.424 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 26.8 ttp180 -74.72 -45.37 44.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 110.508 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 22.9 m -154.23 -178.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -0.936 . . . . 0.0 110.476 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.427 HG21 ' CB ' ' B' ' 19' ' ' PHE . 9.0 tt -152.96 150.47 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -94.47 120.23 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 0.0 110.548 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.552 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 32.7 mttt -125.77 146.9 49.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.208 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.552 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 4.1 mmmt 52.47 59.2 4.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.636 -1.915 . . . . 0.0 110.943 2.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.1 p -107.81 -173.6 0.28 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.75 . . . . 0.0 110.139 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 24.5 Cg_exo -60.22 -39.62 66.75 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.636 1.335 . . . . 0.0 110.396 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.04 -23.35 26.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.378 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 -155.26 16.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.37 139.24 0.29 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 72.04 1.68 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -1.187 . . . . 0.0 110.597 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.07 -175.94 20.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 87.5 t -101.62 145.79 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.011 -1.288 . . . . 0.0 110.075 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.493 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -110.41 126.08 53.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.256 -0.902 . . . . 0.0 109.791 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.22 89.38 7.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 110.925 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.411 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.58 -22.44 55.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 178.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' B' ' 23' ' ' SER . 0.3 OUTLIER -90.83 -178.83 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.442 -0.786 . . . . 0.0 109.883 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.437 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.51 18.1 m 100.6 17.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.314 -1.491 . . . . 0.0 110.481 0.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -105.2 161.46 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 110.759 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.13 -162.07 0.91 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.426 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 17.9 tttt -95.48 97.5 9.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.324 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.05 57.94 0.84 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.5 121.04 26.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.131 . . . . 0.0 110.421 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.525 ' CD2' ' CE1' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -56.05 132.94 51.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.23 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.427 ' CG2' HG23 ' B' ' 91' ' ' THR . 88.3 t -103.36 -39.92 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.19 156.76 8.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.392 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.41 150.88 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.414 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -150.37 -159.78 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.596 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.88 176.41 5.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 110.723 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.98 150.52 30.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 109.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 55.8 mt -89.65 147.47 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 109.656 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.93 106.92 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 110.644 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.49 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 35.3 mmt180 -136.59 157.99 45.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -71.49 176.51 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.196 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 53.2 p-10 -63.99 -138.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.8 t0 67.16 -149.89 0.18 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.812 -1.18 . . . . 0.0 110.708 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -45.88 -34.62 3.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.279 -0.888 . . . . 0.0 111.349 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.49 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 48.2 t-105 -57.52 -55.5 34.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.63 68.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 94.5 m -80.8 -64.45 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 0.0 110.762 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.09 -47.53 17.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 111.144 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.0 mm? -93.02 27.15 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.569 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.3 OUTLIER -64.45 80.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 110.269 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.472 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 7.1 t0 -175.7 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 3.6 m-85 -127.69 54.05 1.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.214 -0.929 . . . . 0.0 109.612 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' B' ' 43' ' ' TRP . 5.9 mt -110.18 114.2 27.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . 0.44 ' CE1' ' HD3' ' D' ' 215' ' ' MLZ . 36.3 m-85 -90.12 114.37 26.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.336 -0.852 . . . . 0.0 109.19 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -107.9 134.73 50.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.007 . . . . 0.0 111.2 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.438 ' CB ' HD11 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -112.54 -174.75 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.514 -0.741 . . . . 0.0 109.892 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -77.87 74.51 4.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 0.0 110.253 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 49.9 m-80 173.1 -33.58 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.426 ' CG ' HD23 ' B' ' 84' ' ' LEU . 0.0 OUTLIER 179.01 -167.68 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 110.483 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.15 156.8 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -150.46 148.63 28.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 110.514 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.427 ' HG2' ' CD2' ' B' ' 51' ' ' LEU . 13.7 mmm -91.64 156.43 17.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 110.303 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.438 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -84.82 101.97 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.807 . . . . 0.0 110.728 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 62' ' ' LEU 2.498 0.0 OUTLIER -59.96 -76.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 111.111 -179.355 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.36 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CD2' ' B' ' 68' ' ' PHE . 89.7 m-85 -89.66 41.86 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -1.171 . . . . 0.0 110.528 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -81.13 -22.24 61.34 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.45 -55.25 3.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 110.979 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.6 pp -50.51 -22.21 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 111.226 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' B' ' 64' ' ' PHE . 0.7 OUTLIER -48.91 122.13 5.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.017 -1.052 . . . . 0.0 110.835 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -94.38 173.98 7.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.843 . . . . 0.0 110.364 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' B' ' 110' ' ' TRP . 39.8 t60 -102.52 150.52 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -149.61 139.62 22.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 110.486 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.54 -25.03 23.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.933 . . . . 0.0 110.218 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.66 51.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.84 98.84 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.699 1.368 . . . . 0.0 110.558 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.76 -17.97 54.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.539 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.15 171.02 15.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.324 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -149.7 -161.74 1.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 110.314 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.418 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 31.3 p-80 -130.9 -172.05 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -153.09 170.05 21.43 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.712 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.53 124.81 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 0.0 110.172 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 9.1 t -57.18 -168.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.463 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.07 89.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 110.581 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.71 158.11 33.01 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.438 HD11 ' CB ' ' B' ' 54' ' ' ARG . 2.3 mp -55.38 106.45 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -1.084 . . . . 0.0 110.353 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -53.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 110.395 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.29 169.36 16.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.8 mtp -140.47 133.38 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.495 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -115.13 176.04 5.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.38 111.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.096 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.525 ' CE1' ' CD2' ' B' ' 29' ' ' LEU . 56.5 m-85 -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.427 HG23 ' CG2' ' B' ' 30' ' ' VAL . 3.0 p -122.99 85.37 2.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.08 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 50.9 pt -50.11 -25.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.833 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.04 134.59 21.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 0.0 110.502 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 83.6 Cg_exo -47.88 152.21 3.25 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.541 1.285 . . . . 0.0 110.979 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.475 HG21 HD13 ' B' ' 95' ' ' ILE . 63.9 mt -131.19 148.67 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.64 157.86 15.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.411 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 53.0 mt -63.31 109.75 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.889 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.09 27.81 2.83 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.439 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 52.4 mm-40 -106.75 -177.91 3.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.268 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.59 122.84 41.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.003 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' B' ' 18' ' ' VAL . 84.3 mt -88.71 130.86 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.249 -0.907 . . . . 0.0 110.388 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -154.78 143.78 20.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.465 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.1 pt -105.21 160.75 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 110.467 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 44.5 t -93.97 -168.86 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 110.504 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -124.55 -68.9 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 110.352 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 89.77 -168.43 34.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -1.04 . . . . 0.0 110.719 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' B' ' 106' ' ' GLY . 5.3 t70 -135.2 -36.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.899 -1.125 . . . . 0.0 110.885 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' D' ' 214' ' ' ARG . 0.8 OUTLIER -48.12 117.66 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.813 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.518 ' CD1' ' NE2' ' B' ' 70' ' ' HIS . 56.1 t-105 55.48 168.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.498 -0.751 . . . . 0.0 110.467 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' B' ' 110' ' ' TRP . 0.2 OUTLIER -59.54 -172.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 110.452 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.29 -40.96 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.329 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.497 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 0.7 OUTLIER -50.65 -49.69 77.27 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.26 -0.9 . . . . 0.0 110.904 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 31.4 Cg_exo -52.7 96.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.613 1.323 . . . . 0.0 110.479 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 117' ' ' THR . 0.4 OUTLIER -96.6 -28.38 14.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.386 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.22 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.45 -0.781 . . . . 0.0 110.459 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.432 ' N ' ' O ' ' B' ' 115' ' ' ARG . 75.9 m -56.77 156.8 6.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.947 -1.095 . . . . 0.0 110.162 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.06 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.304 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.351 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 34.35 5.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -1.144 . . . . 0.0 110.384 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -94.63 176.07 2.55 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.5 165.42 4.5 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.601 1.316 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -60.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 110.345 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.1 150.22 30.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.214 -0.929 . . . . 0.0 110.393 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.54 136.96 47.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.18 54.64 0.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.395 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.41 -72.97 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.321 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 17.5 p -137.93 147.64 44.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 110.329 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.91 -43.54 5.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.449 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.6 -166.0 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.907 . . . . 0.0 110.472 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.23 -158.63 0.67 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 110.392 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.475 ' O ' ' CD1' ' B' ' 109' ' ' TYR . 0.0 OUTLIER -96.99 -92.27 0.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 110.245 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.44 ' HD3' ' CE1' ' B' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 1.6 m -55.27 -170.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.455 -0.778 . . . . 0.0 110.43 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.76 154.77 3.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.421 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . 0.418 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 41.2 Cg_endo -70.12 155.01 65.75 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.696 1.367 . . . . 0.0 110.558 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.87 69.15 0.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.418 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 4.3 p -84.19 153.98 23.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 110.302 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tpt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.234 0.54 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -129.82 134.96 47.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 5' ' ' ARG . 1.5 m-80 -111.23 40.72 2.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 110.449 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.53 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.536 -0.727 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.439 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 20.3 mtm180 -52.0 -38.88 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' A' ' 18' ' ' VAL . 98.5 t -135.26 143.82 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 20.0 tt -119.57 165.38 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.556 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -100.15 128.73 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 33.2 mttt -143.62 139.97 29.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.74 55.11 9.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 119.749 -1.845 . . . . 0.0 110.277 1.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.494 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -106.71 177.07 1.42 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.798 -0.564 . . . . 0.0 110.366 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 32.8 Cg_exo -55.22 -20.84 26.12 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.691 1.364 . . . . 0.0 110.563 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.74 -35.18 9.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.409 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.87 171.52 13.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . 96.4 116.54 3.26 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.407 ' HB3' ' N ' ' A' ' 301' ' ' SAH . 0.1 OUTLIER -86.2 64.02 8.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.58 -166.43 24.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' A' ' 6' ' ' VAL . 59.7 t -97.88 127.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.962 -1.316 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 11' ' ' SER . 0.1 OUTLIER -90.5 126.9 36.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.109 . . . . 0.0 109.841 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.21 90.87 8.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.699 -0.625 . . . . 0.0 110.635 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 2.7 ttt180 -69.21 -22.13 63.9 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.481 0.658 . . . . 0.0 109.399 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 2.8 mttp -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.497 -0.752 . . . . 0.0 109.38 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.413 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 19.2 m 108.32 34.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.983 -1.698 . . . . 0.0 109.84 1.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 44.2 m-85 -127.28 160.67 30.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 111.076 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.44 -159.88 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.51 -0.743 . . . . 0.0 110.148 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HB2' ' CD ' ' A' ' 94' ' ' PRO . 23.7 tttm -102.19 98.96 9.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.071 -1.018 . . . . 0.0 110.194 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.78 33.91 0.96 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -117.14 141.88 47.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.481 HD12 ' CZ ' ' A' ' 90' ' ' PHE . 2.3 tp -83.76 136.96 33.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.427 ' CG1' HG21 ' A' ' 6' ' ' VAL . 48.5 t -92.42 -62.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 110.422 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -159.03 149.2 19.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.199 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -131.53 137.98 48.72 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.108 -0.995 . . . . 0.0 109.902 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.8 m -140.35 178.88 6.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 110.092 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 34' ' ' LEU . 11.3 mp -91.75 169.41 10.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.396 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 72.8 m -145.51 168.51 20.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.425 HG21 ' N ' ' A' ' 37' ' ' VAL . 39.1 mt -96.76 164.09 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.638 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 51.6 t -143.58 115.85 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 110.828 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 62.5 mmt-85 -144.63 142.49 30.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.144 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.54 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.881 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -98.52 119.76 37.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.727 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -177.38 -141.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.64 -35.49 42.3 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.307 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.483 ' CZ3' ' HG ' ' A' ' 47' ' ' LEU . 13.4 t-105 -63.1 -35.36 79.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -58.1 -66.06 3.08 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 29.6 m -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.325 -1.103 . . . . 0.0 111.011 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -62.56 1.78 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.848 -1.157 . . . . 0.0 108.457 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.1 mm? -92.81 36.32 1.03 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 109.845 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.439 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -71.2 -1.02 11.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.641 -179.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -118.13 150.12 39.89 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.862 -1.148 . . . . 0.0 108.929 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 26.1 m-85 57.5 29.14 16.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 60' ' ' MET . 4.6 tp -129.67 138.12 51.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.441 -0.787 . . . . 0.0 111.035 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.463 ' CE1' ' HE3' ' C' ' 215' ' ' MLZ . 60.5 m-85 -92.89 162.14 14.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.371 -0.83 . . . . 0.0 109.615 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.439 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 47.0 p -138.51 113.71 9.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 110.639 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.55 179.87 4.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 110.169 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -83.64 86.75 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 109.48 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 41.8 m-80 149.08 -25.54 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.51 -158.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.143 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -139.86 169.5 17.6 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.875 . . . . 0.0 109.946 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -149.9 149.29 30.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.441 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 2.3 ttt -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.423 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -87.1 90.5 8.38 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.18 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' B' ' 62' ' ' LEU 2.502 0.2 OUTLIER -55.32 -73.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.771 -179.662 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.05 -137.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -84.18 51.75 2.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 110.423 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -90.45 -27.8 19.01 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -88.39 -47.34 8.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 110.427 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' VAL . 2.9 pp -47.99 -24.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.29 -0.881 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' A' ' 103' ' ' ILE . 3.7 m-85 -49.16 120.19 3.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.99 . . . . 0.0 110.584 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -95.26 175.73 6.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.429 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -96.0 139.06 32.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 110.661 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.3 t -143.75 161.74 37.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 110.142 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -83.96 -34.33 24.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.456 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 58.28 20.03 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 110.507 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.09 115.86 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.53 1.279 . . . . 0.0 110.397 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 92' ' ' ILE . 42.7 m-80 -89.71 18.74 5.23 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.566 -0.709 . . . . 0.0 110.7 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -122.49 158.95 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.421 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -145.59 169.46 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 110.529 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.79 130.69 47.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 110.403 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.82 152.47 24.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 110.261 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.05 131.04 56.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.509 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.413 HG23 ' CB ' ' A' ' 86' ' ' ARG . 40.7 p -57.91 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.9 . . . . 0.0 110.379 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 110.313 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.79 -126.32 1.46 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 4.4 tp -153.09 27.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.16 . . . . 0.0 110.265 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -108.29 -70.73 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 110.585 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.413 ' CB ' HG23 ' A' ' 81' ' ' THR . 12.8 mtt180 -70.61 124.04 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 110.429 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.572 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 20.5 mtp -118.85 124.86 48.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -103.41 164.62 11.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.958 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.3 mt -136.23 126.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.481 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 48.8 m-85 -122.05 169.74 10.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.5 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.011 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 75' ' ' ASN . 2.1 pt -62.81 -24.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 110.532 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 92' ' ' ILE . 24.3 mttt -151.1 131.97 7.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.018 -1.051 . . . . 0.0 110.594 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.494 ' CD ' ' HB2' ' A' ' 26' ' ' LYS . 37.6 Cg_exo -35.47 146.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.275 1.983 . . . . 0.0 112.416 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 99' ' ' GLU . 49.8 mt -127.03 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.41 ' N ' HG23 ' A' ' 95' ' ' ILE . . . -89.17 158.98 17.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.558 -0.714 . . . . 0.0 110.278 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -56.42 -21.52 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 111.474 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.59 61.04 0.31 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 3.5 mt-10 -131.58 175.07 9.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -1.207 . . . . 0.0 110.997 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.17 124.28 44.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 109.68 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.432 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 54.3 mt -88.9 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 110.557 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.52 179.42 8.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.816 -0.552 . . . . 0.0 109.862 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.6 pp -145.87 133.41 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.2 t -61.05 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.397 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.62 -75.92 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.42 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.01 -173.19 42.34 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.41 -12.38 60.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 110.809 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.57 -55.56 2.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.06 -1.025 . . . . 0.0 110.626 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.466 ' CE2' ' HG3' ' C' ' 215' ' ' MLZ . 3.1 t80 -54.41 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 110.889 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 54.93 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.696 -0.628 . . . . 0.0 111.285 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 109' ' ' TYR . 9.6 tt -50.59 151.78 2.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.01 -1.056 . . . . 0.0 110.876 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.403 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 46.2 p -167.15 -60.02 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.466 -0.771 . . . . 0.0 109.941 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.77 144.5 50.21 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 121.306 -0.871 . . . . 0.0 110.258 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -56.4 91.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.63 1.332 . . . . 0.0 110.584 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -132.33 55.77 1.87 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 110.343 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.3 mp -107.63 125.92 51.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 110.434 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.3 m -121.64 144.2 48.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 110.285 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.0 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.409 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.289 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -51.87 5.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -1.141 . . . . 0.0 110.239 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -126.46 165.65 26.72 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 110.291 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.28 95.51 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.625 1.329 . . . . 0.0 110.509 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.31 114.69 26.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.387 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 44.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 52.76 86.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.88 35.1 4.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 110.387 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.03 109.11 12.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 110.367 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -115.49 22.89 12.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.411 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' C' ' 211' ' ' LYS . 3.8 pttt -166.42 100.29 0.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 110.428 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -112.41 22.94 14.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 110.29 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.2 177.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.455 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.439 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 6.3 mtt180 -131.26 -171.02 2.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -0.878 . . . . 0.0 110.218 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.466 ' HG3' ' CE2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.3 OUTLIER -53.57 -175.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.28 -0.887 . . . . 0.0 110.573 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.87 155.08 60.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.04 -3.17 13.17 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.681 1.358 . . . . 0.0 111.263 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 55.81 171.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.89 -1.131 . . . . 0.0 110.29 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 1.9 p -99.74 -173.5 2.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.43 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.241 0.543 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -129.78 134.95 47.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.393 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 5' ' ' ARG . 1.5 m-80 -111.15 40.62 2.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.62 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.44 ' HA ' ' CD ' ' B' ' 22' ' ' LYS . 20.4 mtm180 -52.05 -38.85 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.925 -1.109 . . . . 0.0 110.619 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' B' ' 18' ' ' VAL . 98.9 t -135.32 143.72 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 19.9 tt -119.49 165.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.19 128.7 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 110.541 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.514 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 33.2 mttt -143.57 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 109.196 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.82 55.01 9.59 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 119.664 -1.898 . . . . 0.0 110.36 1.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.482 ' HB2' ' CE1' ' B' ' 19' ' ' PHE . 0.0 OUTLIER -106.73 177.11 1.41 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.758 -0.589 . . . . 0.0 110.36 -178.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -55.23 -20.87 26.32 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.657 1.346 . . . . 0.0 110.57 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.71 -35.2 9.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.902 . . . . 0.0 110.432 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.9 171.57 13.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . 96.39 116.62 3.27 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.411 ' HB3' ' N ' ' B' ' 302' ' ' SAH . 0.1 OUTLIER -86.11 64.4 8.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.17 -166.43 23.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' B' ' 6' ' ' VAL . 58.5 t -97.89 127.81 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.951 -1.323 . . . . 0.0 110.122 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.485 ' CD2' ' HE3' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -90.48 126.56 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 109.948 179.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.62 90.84 8.57 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.465 -0.772 . . . . 0.0 110.761 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 2.7 ttt180 -69.24 -21.88 63.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.481 -0.762 . . . . 0.0 109.465 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 2.7 mttp -105.53 -177.08 3.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.53 -0.731 . . . . 0.0 109.387 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.427 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 19.5 m 108.33 34.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.063 -1.648 . . . . 0.0 109.859 1.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 43.9 m-85 -127.31 160.84 30.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 111.049 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.58 -159.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.479 ' HB2' ' CD ' ' B' ' 94' ' ' PRO . 23.6 tttm -102.11 98.97 9.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 0.0 110.198 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.73 33.87 0.96 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -117.13 141.89 47.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.484 HD13 ' CE2' ' B' ' 90' ' ' PHE . 2.3 tp -83.8 136.97 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.437 ' CG1' HG21 ' B' ' 6' ' ' VAL . 48.4 t -92.38 -62.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.461 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -159.02 149.27 19.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -131.53 137.86 48.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.401 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 36.5 m -140.42 178.88 7.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 110.015 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 11.3 mp -91.76 169.45 10.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.394 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 72.7 m -145.57 168.42 20.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.42 ' O ' ' CB ' ' B' ' 59' ' ' ALA . 39.3 mt -96.73 164.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' B' ' 84' ' ' LEU . 51.7 t -143.66 115.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 110.83 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.472 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 62.4 mmt-85 -144.69 142.44 30.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 110.114 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -56.5 -167.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.877 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -98.59 119.77 37.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 110.733 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -177.4 -141.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.819 . . . . 0.0 109.431 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.63 -35.48 42.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.725 -1.234 . . . . 0.0 109.304 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.479 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 13.1 t-105 -63.05 -35.29 79.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -58.21 -66.03 3.1 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' B' ' 48' ' ' GLU . 31.1 m -66.7 -37.25 84.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.253 -1.145 . . . . 0.0 111.063 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -61.3 2.7 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.963 -1.086 . . . . 0.0 108.65 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.1 mm? -94.58 37.04 1.13 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.407 177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.44 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 0.4 OUTLIER -71.63 -1.2 12.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 111.545 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -117.83 150.19 39.58 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.903 -1.123 . . . . 0.0 109.017 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 25.8 m-85 57.47 29.1 16.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' B' ' 60' ' ' MET . 4.7 tp -129.73 138.27 51.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 110.999 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . 0.459 ' CE1' ' HE3' ' D' ' 215' ' ' MLZ . 60.1 m-85 -93.09 162.16 14.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -0.83 . . . . 0.0 109.548 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.437 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 46.9 p -138.4 113.73 9.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 110.673 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.11 177.31 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -79.95 86.49 5.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 41.5 m-80 148.91 -25.69 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.646 -0.659 . . . . 0.0 109.396 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -177.46 -158.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.696 . . . . 0.0 110.194 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 15.3 m -139.82 169.48 17.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.906 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' B' ' 36' ' ' ILE . . . -149.88 149.29 30.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.049 -1.032 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.438 ' HA ' ' CD1' ' B' ' 51' ' ' LEU . 2.3 ttt -94.43 155.61 16.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.587 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.435 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -85.48 90.32 7.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.847 . . . . 0.0 110.558 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' A' ' 62' ' ' LEU 2.502 0.2 OUTLIER -55.44 -73.71 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.741 -179.736 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -64.08 -137.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -84.17 52.01 2.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 110.406 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -90.75 -27.68 18.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -88.42 -47.27 8.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 110.446 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.44 HD13 ' CG2' ' B' ' 18' ' ' VAL . 2.9 pp -48.08 -24.22 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.339 -0.851 . . . . 0.0 110.879 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.475 ' CG ' HG12 ' B' ' 103' ' ' ILE . 3.7 m-85 -49.16 120.14 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.203 -0.936 . . . . 0.0 110.57 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -95.21 175.76 6.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.519 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -96.01 139.05 32.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.926 . . . . 0.0 110.679 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 20.7 t -143.77 161.65 38.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 110.126 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -83.92 -34.32 24.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.471 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 58.2 19.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.93 115.81 4.29 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.55 1.29 . . . . 0.0 110.322 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.441 ' HA ' ' CD1' ' B' ' 92' ' ' ILE . 42.7 m-80 -89.77 18.8 5.21 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.434 -0.791 . . . . 0.0 110.663 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.419 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -122.44 159.02 28.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.43 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 0.0 OUTLIER -145.63 169.47 18.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 110.489 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.73 130.73 47.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 110.394 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.89 152.53 24.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.414 HG23 ' CB ' ' B' ' 86' ' ' ARG . 40.7 p -57.89 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.376 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.8 -126.31 1.46 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.433 ' HB3' ' CG2' ' B' ' 37' ' ' VAL . 4.4 tp -153.07 27.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -1.108 . . . . 0.0 110.269 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -108.27 -70.82 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.559 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.414 ' CB ' HG23 ' B' ' 81' ' ' THR . 12.8 mtt180 -70.58 124.04 23.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.483 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.573 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 20.5 mtp -118.87 124.83 48.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -103.33 164.59 11.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 110.016 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 91.4 mt -136.15 126.8 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.484 ' CE2' HD13 ' B' ' 29' ' ' LEU . 48.8 m-85 -122.03 169.81 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.729 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 35.3 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.976 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' B' ' 75' ' ' ASN . 2.1 pt -62.87 -24.14 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 110.527 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.44 ' HG3' ' CD1' ' B' ' 92' ' ' ILE . 24.3 mttt -151.1 131.8 7.3 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.968 -1.083 . . . . 0.0 110.601 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.479 ' CD ' ' HB2' ' B' ' 26' ' ' LYS . 39.5 Cg_exo -35.32 145.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.806 0 C-N-CA 122.339 2.026 . . . . 0.0 112.36 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' B' ' 99' ' ' GLU . 49.7 mt -127.07 149.81 32.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.468 -0.77 . . . . 0.0 110.561 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.411 ' N ' HG23 ' B' ' 95' ' ' ILE . . . -88.6 159.08 18.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.434 -0.791 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -56.51 -21.52 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 111.423 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.68 61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.438 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 3.4 mt-10 -131.7 174.96 9.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -1.23 . . . . 0.0 111.03 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.25 123.89 43.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.44 -0.788 . . . . 0.0 109.823 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 54.1 mt -88.44 138.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.657 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.61 179.41 8.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.826 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.475 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.6 pp -145.84 133.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 110.242 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 47.2 t -61.09 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 110.432 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.39 -75.88 0.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.45 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.05 -173.21 42.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.4 -12.4 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -1.105 . . . . 0.0 110.825 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.61 -55.49 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 110.619 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.473 ' CE2' ' HG3' ' D' ' 215' ' ' MLZ . 3.1 t80 -54.35 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 110.875 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 55.0 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 111.242 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' B' ' 109' ' ' TYR . 9.6 tt -50.64 151.88 2.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.957 -1.089 . . . . 0.0 110.871 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.406 ' N ' ' CD2' ' B' ' 111' ' ' LEU . 47.1 p -167.19 -59.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.436 -0.79 . . . . 0.0 109.975 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.87 144.56 50.58 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.395 -0.816 . . . . 0.0 110.169 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.41 91.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.608 1.32 . . . . 0.0 110.58 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -132.28 55.77 1.86 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.69 125.93 51.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.389 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 82.0 m -121.7 144.16 48.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 110.264 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.04 -179.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.392 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.317 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.91 -51.85 5.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -1.133 . . . . 0.0 110.232 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -126.46 165.61 26.97 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 110.291 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.26 95.51 0.51 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.605 1.318 . . . . 0.0 110.56 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 114.75 26.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 110.375 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.38 44.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.314 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 52.85 86.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.475 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.9 35.14 4.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 110.389 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.11 109.08 12.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -0.965 . . . . 0.0 110.342 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -115.5 22.95 12.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 110.451 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' D' ' 211' ' ' LYS . 3.8 pttt -166.42 100.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 110.464 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -112.39 22.94 14.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.964 . . . . 0.0 110.338 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.23 177.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 110.473 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.437 ' CB ' ' HB3' ' B' ' 53' ' ' SER . 6.3 mtt180 -131.26 -171.04 2.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 110.215 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.473 ' HG3' ' CE2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.505 0.3 OUTLIER -53.74 -175.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.561 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.84 155.06 60.85 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -72.99 -3.19 13.2 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.659 1.347 . . . . 0.0 111.237 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 55.8 171.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.962 -1.086 . . . . 0.0 110.24 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 1.9 p -99.72 -173.47 2.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 110.432 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.968 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.407 ' N ' ' HB3' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.411 ' N ' ' HB3' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.288 0.566 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 28.3 p90 -51.16 141.9 13.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 110.584 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -138.07 143.42 40.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.63 -49.99 18.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.374 -0.828 . . . . 0.0 111.354 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.49 -37.41 80.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 110.772 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.429 HG23 ' CG1' ' A' ' 30' ' ' VAL . 90.2 t -153.54 149.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.9 tt -118.26 167.11 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.53 126.08 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 110.403 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.53 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -150.48 115.51 5.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.689 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 2.2 tmtt? 61.91 66.17 0.85 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 119.546 -1.971 . . . . 0.0 110.742 2.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.468 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -175.06 -48.29 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 0.0 111.312 179.186 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HD3' ' CB ' ' A' ' 11' ' ' SER . 2.7 Cg_exo -79.86 -151.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.393 1.207 . . . . 0.0 110.505 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.65 -12.69 18.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 110.717 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.63 -137.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.31 -143.75 9.86 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.482 ' CE2' ' CE ' ' A' ' 10' ' ' LYS . 15.1 m-85 -98.03 105.1 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -1.134 . . . . 0.0 110.637 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.04 -171.5 15.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.1 p -123.36 132.13 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.97 -1.312 . . . . 0.0 109.679 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' CE1' ' HB3' ' A' ' 9' ' ' LYS . 3.2 m-30 -95.21 164.04 13.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.823 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB1' HG23 ' A' ' 95' ' ' ILE . . . -124.09 97.97 5.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.478 -0.764 . . . . 0.0 110.623 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.54 -19.62 49.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 5.7 mttm -90.7 178.77 5.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.88 . . . . 0.0 108.982 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.428 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 49.6 m 102.43 18.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.081 -1.637 . . . . 0.0 110.325 1.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 24.1 m-85 -108.73 158.32 17.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.87 -159.59 0.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 110.268 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -97.76 90.37 4.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 110.33 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.68 52.13 0.2 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.35 135.05 49.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.169 . . . . 0.0 110.422 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' CE2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -76.33 105.29 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 91' ' ' THR . 93.0 t -67.66 -46.63 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.247 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.67 152.19 6.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.45 141.97 35.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.404 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -146.2 -177.0 5.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 110.28 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 -178.8 4.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' MET . 25.6 p -148.94 174.3 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.485 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.442 HD12 HG21 ' A' ' 36' ' ' ILE . 46.7 mt -105.73 102.2 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.4 t -86.82 92.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.141 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 15.2 tpt180 -116.44 154.26 30.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.376 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.429 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.9 m170 -61.21 -167.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.433 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.65 28.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.55 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.48 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 109.228 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -50.75 -25.71 4.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.608 -1.307 . . . . 0.0 109.651 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CZ3' ' HG ' ' A' ' 47' ' ' LEU . 19.0 t-105 -57.81 -56.73 18.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.653 . . . . 0.0 109.447 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.88 86.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 m -62.75 -65.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -1.156 . . . . 0.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.11 -47.7 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 110.227 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.472 ' HG ' ' CZ3' ' A' ' 43' ' ' TRP . 4.4 mm? -90.61 41.0 1.04 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 110.51 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 62.35 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 110.608 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER 179.5 139.23 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.844 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.478 ' CE1' ' OXT' ' A' ' 301' ' ' SAH . 13.8 m-85 56.82 33.41 23.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 110.563 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.451 HD23 ' CZ2' ' A' ' 43' ' ' TRP . 8.7 mt -105.51 102.09 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 110.459 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.45 ' CD1' ' CB ' ' C' ' 215' ' ' MLZ . 55.2 m-85 -88.85 102.92 15.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.106 -0.996 . . . . 0.0 109.021 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.441 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 13.2 t -103.2 155.91 18.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 111.453 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 84' ' ' LEU . 11.4 mtp180 -116.97 -173.38 2.38 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -83.61 74.07 10.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 74.1 m-20 167.85 -27.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -174.57 -174.91 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.339 -0.85 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.441 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 2.4 p -117.62 147.13 43.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 36' ' ' ILE . . . -132.1 133.85 44.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 110.605 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -89.29 155.08 19.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 109.935 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . . . -86.63 93.08 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.11 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD11 ' CB ' ' B' ' 62' ' ' LEU 2.505 0.0 OUTLIER -55.64 -70.29 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 110.691 -179.175 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.79 -150.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.4 ' HB3' HG12 ' A' ' 67' ' ' ILE . 42.7 m-85 -76.0 57.72 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.438 -1.036 . . . . 0.0 110.711 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . -90.82 -24.68 27.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB3' ' CG ' ' A' ' 50' ' ' TYR . . . -83.29 -42.71 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -1.147 . . . . 0.0 110.532 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 18' ' ' VAL . 1.1 pp -49.91 -29.26 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.975 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' A' ' 89' ' ' ILE . 13.8 m-85 -55.12 140.01 39.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 110.655 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -118.24 -177.69 3.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.201 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.514 ' NE2' ' CE2' ' A' ' 110' ' ' TRP . 18.9 t60 -100.76 125.37 47.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -129.97 141.44 50.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.12 20.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.182 -0.949 . . . . 0.0 110.54 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.49 87.43 41.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.88 . . . . 0.0 110.148 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 10.9 Cg_endo -58.06 105.24 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.605 1.318 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.13 -17.19 57.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 110.613 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.1 166.98 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.569 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.11 -163.73 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.171 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -143.07 163.69 32.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 43.2 tt0 -146.56 112.05 5.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.419 HD11 ' CD ' ' C' ' 218' ' ' PRO . 1.8 mp -91.22 60.22 4.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.079 -1.013 . . . . 0.0 110.427 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.43 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 0.1 OUTLIER 42.15 28.39 0.1 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.592 -0.692 . . . . 0.0 111.212 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.45 24.31 2.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.45 28.33 0.17 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.105 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 62.8 mt 50.99 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.252 . . . . 0.0 110.734 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.46 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.795 . . . . 0.0 110.517 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -145.24 102.9 3.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.125 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.403 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 3.8 mtp -81.24 118.63 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.743 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.406 ' HD3' ' HB3' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -111.02 127.0 55.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.744 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.484 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 10.0 mt -89.1 117.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.092 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE2' ' CD2' ' A' ' 29' ' ' LEU . 18.9 m-85 -107.3 -173.57 2.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.32 -0.863 . . . . 0.0 110.411 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.434 HG23 ' CG2' ' A' ' 30' ' ' VAL . 21.3 p -130.44 93.24 3.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.441 HG13 ' N ' ' A' ' 93' ' ' LYS . 2.4 pt -56.86 -19.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.471 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.65 18.11 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -51.42 141.2 41.94 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.519 1.273 . . . . 0.0 110.452 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.441 HG22 ' CB ' ' A' ' 99' ' ' GLU . 13.9 mt -109.64 150.52 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -94.71 156.9 16.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.59 -0.694 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 21.9 mt -63.58 112.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.72 36.61 3.44 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' CB ' HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -101.11 155.84 17.76 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.294 -1.121 . . . . 0.0 110.57 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.0 115.04 26.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.133 -0.979 . . . . 0.0 109.717 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 18' ' ' VAL . 16.2 mt -89.64 122.46 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 110.435 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 101' ' ' ILE . 68.6 p -154.77 134.21 12.63 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' ' 68' ' ' PHE . 1.1 pp -104.99 153.82 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.096 . . . . 0.0 110.524 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.0 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.524 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CD1' ' HG3' ' C' ' 215' ' ' MLZ . 17.6 m-85 -127.14 -68.49 0.79 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.22 24.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.23 -39.63 60.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -1.116 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.58 -61.4 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.275 -0.89 . . . . 0.0 110.109 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.508 ' CE1' ' CA ' ' C' ' 214' ' ' ARG . 3.2 m-85 -94.37 51.6 1.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.32 -0.862 . . . . 0.0 110.543 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.514 ' CE2' ' NE2' ' A' ' 70' ' ' HIS . 10.5 t-105 -175.1 177.84 1.85 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.584 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -164.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.4 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.69 -77.7 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 110.382 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -155.75 69.22 5.18 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 110.493 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -70.56 126.61 12.96 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.713 1.375 . . . . 0.0 110.353 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.16 115.36 18.27 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 110.635 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.85 -31.72 70.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 110.419 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.8 m -65.1 176.47 1.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -58.98 149.42 27.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.344 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.351 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -102.52 113.92 27.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 110.435 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -99.99 123.9 45.54 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 110.203 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -59.13 -163.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.435 1.229 . . . . 0.0 110.521 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -55.11 -25.98 35.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.247 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.45 139.24 55.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 110.297 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -132.11 -48.88 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.375 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.43 116.6 33.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.54 49.1 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 110.331 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 58.1 m -124.02 47.85 2.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 110.335 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -118.3 87.45 2.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 110.439 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -168.06 -160.08 0.31 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 110.277 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.42 44.59 2.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.423 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.508 ' CA ' ' CE1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER 49.58 -173.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.763 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.488 ' HG3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 0.0 OUTLIER -57.42 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.427 -0.796 . . . . 0.0 110.382 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . 0.44 ' CB ' ' CD ' ' C' ' 218' ' ' PRO . . . -156.61 -176.23 0.59 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' C' ' 217' ' ' ALA . 22.1 Cg_exo -61.95 96.17 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.659 1.347 . . . . 0.0 110.586 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.74 70.96 0.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.536 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 220' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' C' ' 217' ' ' ALA . 1.1 p -79.86 68.43 5.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 CA-C-O 117.98 -1.455 . . . . 0.0 109.479 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.252 0.549 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 28.3 p90 -51.13 141.76 13.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 110.626 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -137.88 143.66 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 110.153 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.83 -49.89 19.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.823 . . . . 0.0 111.326 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.427 ' O ' ' CG2' ' B' ' 6' ' ' VAL . 0.0 OUTLIER -68.55 -37.4 79.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 110.769 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.434 HG23 ' CG1' ' B' ' 30' ' ' VAL . 89.8 t -153.52 149.14 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 110.185 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 15.0 tt -118.2 167.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.582 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 126.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 110.349 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -150.8 115.56 5.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.628 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.528 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 2.2 tmtt? 62.0 66.25 0.83 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.599 -1.938 . . . . 0.0 110.748 2.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.47 ' CB ' ' HD3' ' B' ' 12' ' ' PRO . 0.1 OUTLIER -175.38 -47.94 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 111.037 178.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' B' ' 11' ' ' SER . 2.7 Cg_exo -79.76 -151.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.341 1.18 . . . . 0.0 110.553 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.63 -12.66 19.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 110.68 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.65 -137.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.34 -143.73 9.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.483 ' CE2' ' CE ' ' B' ' 10' ' ' LYS . 15.2 m-85 -98.0 105.01 17.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -1.13 . . . . 0.0 110.688 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.85 -171.55 15.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' B' ' 67' ' ' ILE . 2.2 p -123.25 132.02 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.326 . . . . 0.0 109.794 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' B' ' 9' ' ' LYS . 3.2 m-30 -95.29 164.05 13.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 110.791 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.26 98.07 5.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 110.581 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.51 -19.67 49.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.017 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 5.7 mttm -90.59 178.75 6.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.042 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.429 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 49.9 m 102.45 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.079 -1.638 . . . . 0.0 110.325 1.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 24.1 m-85 -108.67 158.32 17.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -0.973 . . . . 0.0 110.436 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.86 -159.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.26 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -97.69 90.29 4.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.73 52.13 0.2 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.33 135.06 50.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -1.165 . . . . 0.0 110.477 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.512 ' CD2' ' CE2' ' B' ' 90' ' ' PHE . 0.9 OUTLIER -76.35 105.28 7.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 110.254 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.435 ' CG2' HG23 ' B' ' 91' ' ' THR . 92.9 t -67.73 -46.56 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.64 152.26 6.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.5 141.9 35.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.503 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.403 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -146.18 -176.96 5.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.45 -178.7 4.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 110.276 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' B' ' 60' ' ' MET . 25.6 p -149.0 174.31 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.455 HG21 HD12 ' B' ' 36' ' ' ILE . 46.6 mt -105.96 100.76 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 24.8 t -84.84 92.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 110.499 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' B' ' 39' ' ' HIS . 15.1 tpt180 -116.66 154.3 30.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . 0.426 ' N ' ' HG3' ' B' ' 38' ' ' ARG . 3.0 m170 -61.14 -167.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.416 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.66 28.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.53 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.44 -0.787 . . . . 0.0 109.234 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -50.8 -25.65 4.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.69 -1.256 . . . . 0.0 109.616 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.478 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 19.1 t-105 -57.84 -56.75 17.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.65 -0.656 . . . . 0.0 109.415 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.82 86.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 8.9 m -62.76 -65.1 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -1.134 . . . . 0.0 110.412 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.43 75.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.478 ' HG ' ' CZ3' ' B' ' 43' ' ' TRP . 4.4 mm? -90.94 41.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 110.403 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.02 62.34 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 110.602 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.3 OUTLIER 179.51 139.28 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 0.0 109.876 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.474 ' CE1' ' OXT' ' B' ' 302' ' ' SAH . 13.8 m-85 56.81 33.47 23.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.179 -0.951 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.452 HD23 ' CZ2' ' B' ' 43' ' ' TRP . 8.6 mt -105.5 101.7 11.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.55 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . 0.448 ' CD1' ' CB ' ' D' ' 215' ' ' MLZ . 55.6 m-85 -88.28 102.95 15.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.121 -0.987 . . . . 0.0 109.16 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 13.2 t -103.21 155.86 18.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 111.525 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.41 ' HB2' ' CD1' ' B' ' 84' ' ' LEU . 11.5 mtp180 -117.5 -176.04 2.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.579 -0.701 . . . . 0.0 109.63 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -79.79 73.64 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 73.8 m-20 167.77 -27.22 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -174.43 -174.65 0.88 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.36 -0.838 . . . . 0.0 110.913 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.438 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 2.4 p -117.68 147.09 43.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.409 ' CB ' HD22 ' B' ' 84' ' ' LEU . . . -132.18 133.64 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' B' ' 35' ' ' CYS . 0.0 OUTLIER -89.21 153.72 20.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.148 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.424 ' CB ' ' HA3' ' B' ' 65' ' ' GLY . . . -84.78 93.02 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 110.5 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.441 ' CB ' HD11 ' A' ' 62' ' ' LEU 2.507 0.0 OUTLIER -55.7 -70.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.728 -179.39 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.69 -150.47 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -76.03 58.06 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.406 -1.055 . . . . 0.0 110.627 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' B' ' 61' ' ' ALA . . . -91.34 -24.42 26.54 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' B' ' 50' ' ' TYR . . . -83.36 -42.72 16.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.561 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.432 ' CD1' HG13 ' B' ' 18' ' ' VAL . 1.1 pp -49.94 -29.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.95 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.472 ' CZ ' HG12 ' B' ' 89' ' ' ILE . 13.8 m-85 -55.1 140.08 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.011 -1.055 . . . . 0.0 110.621 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -118.37 -177.73 3.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.528 ' NE2' ' CE2' ' B' ' 110' ' ' TRP . 18.8 t60 -100.7 125.39 47.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 110.292 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.5 t -129.99 141.43 50.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.259 -0.901 . . . . 0.0 110.201 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.17 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.528 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.45 87.41 40.86 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.416 ' O ' ' CD1' ' B' ' 92' ' ' ILE . 10.9 Cg_endo -58.12 105.32 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.669 1.352 . . . . 0.0 110.393 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.18 -17.17 57.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.03 23.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.16 -163.68 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 110.193 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -143.11 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.53 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -146.62 112.03 5.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.336 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.42 HD11 ' CD ' ' D' ' 218' ' ' PRO . 1.8 mp -91.16 60.12 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.451 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 0.1 OUTLIER 42.24 28.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.543 -0.723 . . . . 0.0 111.149 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.42 24.27 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.4 28.27 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.069 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' B' ' 85' ' ' LYS . 62.6 mt 51.16 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -1.189 . . . . 0.0 110.704 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.52 -33.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 110.464 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . 0.432 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.1 OUTLIER -145.23 102.94 3.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.119 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.414 ' HG3' ' CD2' ' B' ' 80' ' ' LEU . 3.8 mtp -81.24 118.59 22.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.0 126.7 55.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.831 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.472 HG12 ' CZ ' ' B' ' 68' ' ' PHE . 10.0 mt -88.67 117.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 110.183 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' B' ' 29' ' ' LEU . 18.9 m-85 -107.35 -173.52 2.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 110.461 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.435 HG23 ' CG2' ' B' ' 30' ' ' VAL . 21.3 p -130.44 93.19 3.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.43 HG13 ' N ' ' B' ' 93' ' ' LYS . 2.5 pt -56.88 -19.05 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.43 ' N ' HG13 ' B' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.69 18.17 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 110.115 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.68 141.43 43.73 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.521 1.274 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.45 HG22 ' CB ' ' B' ' 99' ' ' GLU . 14.0 mt -109.7 150.53 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 110.705 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -94.72 156.88 16.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.169 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 22.0 mt -63.53 112.09 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.965 -1.084 . . . . 0.0 110.206 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.65 36.58 3.46 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.45 ' CB ' HG22 ' B' ' 95' ' ' ILE . 0.4 OUTLIER -100.94 155.68 17.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.304 -1.115 . . . . 0.0 110.591 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.96 114.89 26.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.994 . . . . 0.0 109.732 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' B' ' 102' ' ' THR . 16.9 mt -89.36 122.49 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.516 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' B' ' 101' ' ' ILE . 66.6 p -154.67 134.28 12.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.434 ' CG1' ' HB3' ' B' ' 68' ' ' PHE . 1.1 pp -104.93 153.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 110.549 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.98 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.486 ' CD1' ' HG3' ' D' ' 215' ' ' MLZ . 17.6 m-85 -127.13 -68.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.229 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.01 179.21 24.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -39.66 60.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -1.143 . . . . 0.0 110.23 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -57.55 -61.5 2.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.51 ' CE1' ' CA ' ' D' ' 214' ' ' ARG . 3.2 m-85 -94.27 51.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.311 -0.868 . . . . 0.0 110.565 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CE2' ' NE2' ' B' ' 70' ' ' HIS . 10.6 t-105 -175.12 177.79 1.86 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -164.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.437 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -77.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.399 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -155.82 69.15 5.13 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 110.447 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -70.4 126.63 13.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.616 1.324 . . . . 0.0 110.34 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.35 115.55 18.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.329 -0.857 . . . . 0.0 110.652 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.9 -31.71 70.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 110.37 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -65.13 176.48 1.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 110.377 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -58.94 149.44 27.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 110.406 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.363 179.967 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -102.56 113.93 27.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.192 -1.181 . . . . 0.0 110.401 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -99.94 123.9 45.64 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.238 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -59.08 -163.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.355 1.187 . . . . 0.0 110.564 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -55.04 -26.11 35.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.35 139.29 55.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -132.17 -48.85 0.93 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 0.0 110.375 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.49 116.66 33.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 110.387 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.56 49.13 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 58.4 m -124.06 47.85 2.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 110.292 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -118.33 87.47 2.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 110.466 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -168.05 -160.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 110.294 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.36 44.54 2.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.414 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.51 ' CA ' ' CE1' ' B' ' 109' ' ' TYR . 0.8 OUTLIER 49.68 -173.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.674 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.486 ' HG3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 0.0 OUTLIER -57.35 -163.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.294 -0.879 . . . . 0.0 110.429 179.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . 0.438 ' CB ' ' CD ' ' D' ' 218' ' ' PRO . . . -156.57 -176.2 0.59 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' D' ' 217' ' ' ALA . 22.2 Cg_exo -62.03 96.19 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.678 1.357 . . . . 0.0 110.579 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.74 71.03 0.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 110.519 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 220' ' ' THR . . . . . 0.432 ' CG2' ' HB3' ' D' ' 217' ' ' ALA . 1.1 p -79.91 68.44 6.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 110.247 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.524 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.478 ' OXT' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.474 ' OXT' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' O ' ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.166 0.508 . . . . 0.0 110.437 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -59.34 83.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.404 -0.81 . . . . 0.0 111.764 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.7 t-20 -99.89 147.63 25.33 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.752 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.0 -23.52 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 111.288 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 2.7 mtt180 -102.73 -29.67 11.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.028 -1.045 . . . . 0.0 111.121 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' CG1' ' CG1' ' A' ' 18' ' ' VAL . 94.9 t -153.23 137.31 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.426 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 5.7 tt -117.48 161.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 110.971 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.4 p -88.97 124.24 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.097 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 39.0 mttt -150.35 129.19 12.47 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.392 -0.818 . . . . 0.0 109.281 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.544 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 57.96 74.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 119.669 -1.894 . . . . 0.0 111.928 1.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.5 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -173.06 -49.93 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.359 -0.838 . . . . 0.0 111.579 177.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 11' ' ' SER . 16.9 Cg_exo -69.41 -35.11 14.31 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.421 1.222 . . . . 0.0 110.666 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.28 -33.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.76 -155.53 21.07 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.69 89.77 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.485 ' CG ' ' HD3' ' A' ' 10' ' ' LYS . 1.1 m-85 -58.63 94.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -1.147 . . . . 0.0 110.442 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA3' ' ND2' ' A' ' 69' ' ' ASN . . . -120.28 171.61 14.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.477 ' CG1' ' CG1' ' A' ' 6' ' ' VAL . 95.0 t -93.09 140.43 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.938 -1.33 . . . . 0.0 109.825 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -105.73 132.88 51.32 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.11 -0.993 . . . . 0.0 110.086 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.39 88.45 7.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.702 -0.624 . . . . 0.0 110.446 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -67.4 -15.04 63.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.798 178.089 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 2.0 mttm -106.79 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.41 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.91 20.93 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.154 -1.591 . . . . 0.0 109.846 1.389 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 54.1 m-85 -118.65 163.91 16.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.544 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.34 -178.63 3.65 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 110.025 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -74.45 99.66 3.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.947 . . . . 0.0 110.299 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.25 61.8 0.55 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.3 123.28 23.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 110.505 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.482 HD23 ' CE1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -66.63 127.48 32.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.176 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.9 t -88.89 -46.55 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.346 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.47 153.17 6.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.18 136.46 31.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 110.304 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.79 170.32 9.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.697 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.0 -174.2 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CD1' HD23 ' A' ' 62' ' ' LEU . 65.0 mt -123.75 151.97 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 43.7 t -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.8 mmt-85 -134.86 145.68 48.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.269 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -63.31 176.97 0.7 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 110.359 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 40' ' ' ASN . 2.9 m120 -67.48 -131.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.142 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.25 0.24 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.624 -1.298 . . . . 0.0 110.596 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.12 -25.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.0 111.09 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.504 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 60.4 t-105 -69.29 -55.85 9.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.155 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.43 ' HA3' ' NH2' ' C' ' 214' ' ' ARG . . . -59.61 -22.48 56.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.4 m -90.28 -60.15 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -1.212 . . . . 0.0 110.663 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.72 -55.45 11.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.872 -1.143 . . . . 0.0 110.231 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.0 mm? -92.24 33.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 110.085 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 9.8 pt-20 -68.48 64.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.171 -0.956 . . . . 0.0 111.026 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -169.42 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.858 -1.151 . . . . 0.0 111.024 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 25.8 m-85 -128.87 53.51 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.05 -1.031 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 52.7 mt -124.98 118.02 25.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' HA ' ' CB ' ' C' ' 215' ' ' MLZ . 48.3 m-85 -89.41 101.54 14.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 108.995 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.8 t -98.92 155.52 17.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 111.561 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.61 -168.07 1.72 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.616 -0.678 . . . . 0.0 109.756 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -83.04 79.58 9.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.964 -1.085 . . . . 0.0 109.384 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 1.5 p30 160.91 -25.18 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.766 -0.584 . . . . 0.0 110.049 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.67 -167.82 0.2 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 1.3 m -130.68 139.28 50.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.3 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.434 ' CB ' ' CD2' ' A' ' 84' ' ' LEU . . . -124.13 172.39 9.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.685 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.463 ' HB2' ' CZ2' ' A' ' 43' ' ' TRP . 9.5 ttt -117.01 153.04 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.95 90.9 8.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.445 -0.784 . . . . 0.0 110.369 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.438 HD23 ' CD1' ' A' ' 36' ' ' ILE 2.501 0.5 OUTLIER -55.41 -63.45 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.807 -179.681 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.63 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.472 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 39.7 m-85 -89.71 42.45 1.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -1.138 . . . . 0.0 110.589 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.74 -21.25 56.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -89.06 -59.3 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 2.6 pp -44.79 -22.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.606 -0.684 . . . . 0.0 112.375 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 64' ' ' PHE . 4.5 m-85 -49.55 153.17 1.2 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.614 -1.304 . . . . 0.0 110.677 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.436 ' HB2' ' CG2' ' A' ' 102' ' ' THR . 26.0 m-20 -119.32 -171.95 2.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 111.322 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -102.81 156.81 17.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.778 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.69 141.08 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.007 -1.058 . . . . 0.0 110.697 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -54.92 -29.3 55.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.9 92.49 39.76 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.438 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.97 104.19 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.659 1.347 . . . . 0.0 110.632 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.49 -21.66 35.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 110.311 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 110.307 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -171.89 2.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -130.77 174.15 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -149.82 141.33 23.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.52 142.81 33.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.208 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.424 HG22 ' CZ ' ' A' ' 88' ' ' ARG . 69.3 p -80.1 85.69 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.2 95.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.691 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.38 28.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' CD2' ' CB ' ' A' ' 59' ' ' ALA . 1.1 mp -109.74 98.86 8.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.127 . . . . 0.0 110.437 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -144.73 -53.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.15 174.89 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 110.017 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.5 mtp -142.76 128.35 19.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.702 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' CZ ' HG22 ' A' ' 81' ' ' THR . 57.9 mtt180 -114.54 140.42 48.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 110.172 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.442 HG12 ' CE2' ' A' ' 68' ' ' PHE . 8.3 mt -99.96 110.25 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.097 -1.002 . . . . 0.0 109.976 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.482 ' CE1' HD23 ' A' ' 29' ' ' LEU . 9.5 m-85 -104.7 171.2 7.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.292 -0.88 . . . . 0.0 110.582 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.6 p -117.09 118.98 33.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.976 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 92' ' ' ILE . 21.6 pt -86.74 13.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.752 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -176.82 142.15 0.53 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.201 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.04 136.34 17.83 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.577 1.304 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.8 mt -116.53 140.88 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 110.734 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.67 153.4 20.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 110.493 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -50.33 -23.06 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 111.168 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.01 57.84 0.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.22 175.0 8.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.246 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.86 128.96 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.962 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.445 ' HB ' ' CG1' ' A' ' 18' ' ' VAL . 31.6 mt -92.4 119.37 39.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 0.0 110.414 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 69' ' ' ASN . 58.7 p -150.95 123.93 8.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.649 -0.657 . . . . 0.0 109.673 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.47 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.1 pt -88.91 159.39 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 110.785 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.473 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 5.2 p -83.38 -157.15 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.413 -0.804 . . . . 0.0 110.348 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 104' ' ' SER . 28.3 m-85 -137.57 -66.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.33 -164.42 34.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -29.22 62.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -1.149 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -76.21 -71.28 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 1.2 m-85 -58.5 99.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 52.63 -171.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 110.405 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.05 157.42 28.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.336 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.411 ' O ' ' CD ' ' A' ' 114' ' ' PRO . 3.0 t -103.89 -49.57 3.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 110.414 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -107.17 75.88 0.45 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.253 -0.904 . . . . 0.0 110.359 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.411 ' CD ' ' O ' ' A' ' 112' ' ' SER . 28.6 Cg_endo -68.19 62.31 1.04 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.689 1.363 . . . . 0.0 110.598 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -86.81 5.89 34.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 110.823 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 116' ' ' LEU . 3.5 mm? 52.64 -174.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.025 -1.047 . . . . 0.0 110.123 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 119' ' ' ASN . 91.2 m 55.29 105.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.415 -0.803 . . . . 0.0 110.69 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.91 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.347 -0.846 . . . . 0.0 110.478 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 117' ' ' THR . 14.0 t30 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.013 -1.054 . . . . 0.0 110.227 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.58 90.23 8.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -1.136 . . . . 0.0 110.365 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . 52.67 61.92 10.91 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.399 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' C' ' 206' ' ' LYS . 12.8 Cg_endo -60.25 -68.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.623 1.328 . . . . 0.0 110.416 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 55.07 -87.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.562 -0.711 . . . . 0.0 110.758 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' C' ' 204' ' ' PRO . 4.1 mtmp? -147.76 -63.01 0.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.923 -1.11 . . . . 0.0 110.478 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -118.96 176.45 5.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 110.424 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 5.7 tp -155.26 61.76 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.3 -0.875 . . . . 0.0 110.304 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.48 72.77 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 110.278 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 81.2 p -115.08 -58.4 2.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 110.409 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -169.47 151.19 4.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.248 -0.907 . . . . 0.0 110.354 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -173.46 111.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.27 159.2 3.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 110.46 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.456 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 17.3 mtt-85 -118.44 -147.85 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.47 ' HE3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.505 0.0 OUTLIER -55.21 -21.03 12.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 0.0 110.452 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . 0.43 ' CB ' ' CD ' ' C' ' 218' ' ' PRO . . . 55.11 -177.8 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' C' ' 217' ' ' ALA . 25.2 Cg_exo -59.4 -161.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.657 1.346 . . . . 0.0 110.682 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.82 125.84 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.903 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 53.6 p -126.78 -45.7 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.366 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.537 179.805 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.419 ' O ' ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.141 0.496 . . . . 0.0 110.474 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' B' ' 2' ' ' PHE . 0.0 OUTLIER -59.3 83.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.43 -0.794 . . . . 0.0 111.733 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' B' ' 1' ' ' MET . 14.9 t-20 -99.9 147.74 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -49.02 -23.53 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 111.3 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' B' ' 6' ' ' VAL . 2.7 mtt180 -102.7 -29.76 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.104 . . . . 0.0 111.068 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.485 ' CG1' ' CG1' ' B' ' 18' ' ' VAL . 95.3 t -153.15 137.39 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.358 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 5.8 tt -117.64 160.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.233 -0.917 . . . . 0.0 111.059 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -88.27 124.56 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 0.0 110.16 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.549 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 38.9 mttt -150.81 129.22 12.09 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.371 -0.83 . . . . 0.0 109.286 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.549 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 58.13 74.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 119.55 -1.969 . . . . 0.0 111.907 1.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' B' ' 12' ' ' PRO . 0.3 OUTLIER -173.58 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.306 -0.871 . . . . 0.0 111.24 177.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' B' ' 11' ' ' SER . 16.9 Cg_exo -69.16 -35.09 15.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.352 1.185 . . . . 0.0 110.707 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -33.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.883 . . . . 0.0 109.939 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.69 -155.57 21.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.65 89.84 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.484 ' CG ' ' HD3' ' B' ' 10' ' ' LYS . 1.1 m-85 -58.56 94.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 110.457 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.438 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -120.3 171.64 14.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.485 ' CG1' ' CG1' ' B' ' 6' ' ' VAL . 96.3 t -92.97 140.27 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.032 -1.275 . . . . 0.0 109.881 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -105.72 132.2 52.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.123 -0.985 . . . . 0.0 110.297 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.48 88.49 7.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 110.6 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.422 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 0.1 OUTLIER -67.49 -14.92 63.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 178.112 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 2.0 mttm -106.84 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.413 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.87 20.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.205 -1.56 . . . . 0.0 109.855 1.442 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 54.1 m-85 -118.63 163.91 16.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.887 . . . . 0.0 110.534 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 -178.64 3.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -74.48 99.74 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.22 61.81 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.31 123.38 24.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -1.172 . . . . 0.0 110.437 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.483 ' CD2' ' CE2' ' B' ' 90' ' ' PHE . 1.0 OUTLIER -66.78 127.47 32.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 110.163 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.85 -46.51 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 110.308 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.52 153.13 6.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.369 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.15 136.47 31.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 110.268 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.472 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.8 170.31 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.677 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.94 -174.19 4.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.077 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.429 ' CD1' HD23 ' B' ' 62' ' ' LEU . 65.0 mt -123.77 151.91 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 110.429 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' B' ' 84' ' ' LEU . 43.7 t -124.63 104.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.303 -0.873 . . . . 0.0 110.601 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.502 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 14.8 mmt-85 -134.87 145.73 48.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 110.264 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -63.37 177.03 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.32 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 40' ' ' ASN . 2.9 m120 -67.44 -131.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.167 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.17 0.24 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.624 -1.297 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.22 -25.63 0.98 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 111.116 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.502 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 60.3 t-105 -69.27 -55.88 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 110.138 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.421 ' HA3' ' NH2' ' D' ' 214' ' ' ARG . . . -59.7 -22.29 56.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 97.4 m -90.34 -60.09 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -1.219 . . . . 0.0 110.67 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.04 -54.46 15.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.976 -1.077 . . . . 0.0 110.373 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.481 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 4.0 mm? -93.39 33.46 1.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 109.787 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 9.8 pt-20 -68.51 64.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.205 -0.935 . . . . 0.0 111.075 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' B' ' 47' ' ' LEU . 16.2 t0 -169.4 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.168 . . . . 0.0 110.957 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.482 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 25.8 m-85 -128.84 53.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.992 . . . . 0.0 110.921 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' B' ' 60' ' ' MET . 52.5 mt -125.08 117.83 24.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 111.189 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . 0.405 ' HA ' ' CB ' ' D' ' 215' ' ' MLZ . 48.3 m-85 -89.17 101.6 14.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.023 177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.8 t -98.97 155.46 17.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.158 -0.964 . . . . 0.0 111.563 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.12 -170.9 2.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.751 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -78.97 79.24 5.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.14 -0.975 . . . . 0.0 110.208 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.5 p30 160.71 -25.27 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.651 -0.655 . . . . 0.0 110.134 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.5 -167.84 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.057 -1.027 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 1.3 m -130.64 139.28 50.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.348 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.447 ' CB ' ' CD2' ' B' ' 84' ' ' LEU . . . -124.1 172.42 9.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -0.999 . . . . 0.0 110.705 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.476 ' HB2' ' CZ2' ' B' ' 43' ' ' TRP . 9.5 ttt -117.12 152.63 34.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.341 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.41 90.77 8.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 62' ' ' LEU 2.502 0.5 OUTLIER -55.31 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.846 -179.807 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.59 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' B' ' 68' ' ' PHE . 39.6 m-85 -89.68 42.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.127 . . . . 0.0 110.603 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.71 -21.29 56.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -89.03 -59.34 2.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -1.173 . . . . 0.0 110.554 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 2.6 pp -44.71 -22.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.639 -0.663 . . . . 0.0 112.368 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.5 m-85 -49.48 153.76 1.05 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.628 -1.295 . . . . 0.0 110.668 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.438 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 26.2 m-20 -120.0 -171.46 2.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 111.114 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -103.65 156.64 17.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.429 -0.794 . . . . 0.0 109.676 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.57 141.15 10.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.053 . . . . 0.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -55.2 -29.09 57.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 110.271 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.91 92.52 39.66 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.356 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.07 104.2 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.647 1.341 . . . . 0.0 110.576 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.5 -21.63 35.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 110.31 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.46 140.27 35.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.912 . . . . 0.0 110.31 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.32 -171.91 2.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -130.75 174.07 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 110.644 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -149.83 141.34 23.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.875 . . . . 0.0 110.297 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mt -102.55 142.82 33.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.43 HG22 ' CZ ' ' B' ' 88' ' ' ARG . 68.7 p -80.08 85.74 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.718 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.09 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.72 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.35 28.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.447 ' CD2' ' CB ' ' B' ' 59' ' ' ALA . 1.1 mp -109.81 98.87 8.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -1.097 . . . . 0.0 110.423 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.71 -53.78 0.31 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 174.86 10.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.064 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 15.5 mtp -142.78 128.42 19.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.43 ' CZ ' HG22 ' B' ' 81' ' ' THR . 58.4 mtt180 -114.66 140.47 48.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.121 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.437 HG12 ' CE2' ' B' ' 68' ' ' PHE . 8.3 mt -99.92 110.1 26.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.995 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.483 ' CE2' ' CD2' ' B' ' 29' ' ' LEU . 9.5 m-85 -104.62 171.18 7.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 110.549 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -117.11 118.97 33.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.996 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.435 HG22 HD13 ' B' ' 92' ' ' ILE . 21.5 pt -86.69 13.29 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.787 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -176.8 142.12 0.53 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 110.148 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.66 136.73 21.24 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.464 1.244 . . . . 0.0 111.056 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 61.6 mt -116.49 140.9 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.789 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.74 153.42 20.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -50.28 -23.08 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 111.045 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.14 57.93 0.41 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.37 174.84 8.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.24 . . . . 0.0 110.583 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.8 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.444 ' HB ' ' CG1' ' B' ' 18' ' ' VAL . 32.3 mt -92.59 119.36 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 110.335 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' B' ' 69' ' ' ASN . 61.3 p -150.83 123.98 8.81 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.608 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.483 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.1 pt -88.85 159.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.759 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 5.3 p -83.42 -157.18 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 110.321 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 28.1 m-85 -137.54 -66.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.47 34.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -29.27 62.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -1.157 . . . . 0.0 110.365 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -76.22 -71.28 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.454 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 1.2 m-85 -58.48 99.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 52.63 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.45 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.12 157.42 28.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.93 . . . . 0.0 110.316 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' B' ' 114' ' ' PRO . 3.0 t -103.86 -49.58 3.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.421 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -107.15 75.96 0.46 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 110.364 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' B' ' 112' ' ' SER . 28.7 Cg_endo -68.14 62.25 1.02 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.602 1.317 . . . . 0.0 110.6 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -86.82 5.89 34.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 110.808 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' B' ' 116' ' ' LEU . 3.5 mm? 52.67 -174.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.044 -1.035 . . . . 0.0 110.113 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.423 ' O ' ' N ' ' B' ' 119' ' ' ASN . 91.8 m 55.22 105.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.813 . . . . 0.0 110.651 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.83 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.834 . . . . 0.0 110.465 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' B' ' 117' ' ' THR . 14.0 t30 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.02 -1.05 . . . . 0.0 110.266 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.61 90.27 8.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -1.122 . . . . 0.0 110.328 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . 52.64 61.97 10.87 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' D' ' 206' ' ' LYS . 12.8 Cg_endo -60.3 -68.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.611 1.321 . . . . 0.0 110.434 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 55.06 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.563 -0.71 . . . . 0.0 110.694 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' D' ' 204' ' ' PRO . 4.1 mtmp? -147.75 -62.98 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.955 -1.091 . . . . 0.0 110.453 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -119.01 176.44 5.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.915 . . . . 0.0 110.422 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 5.7 tp -155.3 61.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 110.295 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.47 72.69 1.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.246 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 81.2 p -115.06 -58.38 2.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 110.411 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -169.48 151.22 4.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 110.315 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -173.46 111.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.34 159.18 3.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.417 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.454 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 17.2 mtt-85 -118.4 -147.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.905 . . . . 0.0 110.103 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.469 ' HE3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.0 OUTLIER -55.07 -21.13 11.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.472 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . 0.419 ' CB ' ' CD ' ' D' ' 218' ' ' PRO . . . 55.18 -177.76 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' D' ' 217' ' ' ALA . 25.5 Cg_exo -59.59 -161.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.7 1.369 . . . . 0.0 110.651 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.78 125.77 1.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.373 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 53.9 p -126.73 -45.64 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 110.401 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 CA-C-O 117.934 -1.481 . . . . 0.0 109.545 179.815 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.413 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.422 ' O ' ' CB ' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HA ' HG12 ' A' ' 8' ' ' VAL . 29.2 mmt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.119 0.485 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.485 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 32.7 p90 -90.23 133.25 35.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 0.0 110.396 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -150.69 141.32 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.138 -179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.03 -45.8 32.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 111.046 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.413 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 6.5 mtm-85 -74.69 -33.81 62.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.543 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 84.5 t -153.33 134.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.415 HG21 ' CB ' ' A' ' 19' ' ' PHE . 11.2 tt -117.22 156.37 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 12.7 p -89.35 122.81 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.71 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.2 mttt -151.19 122.01 7.55 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.53 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 59.12 67.09 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.585 -1.947 . . . . 0.0 111.415 1.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.5 m -165.41 -61.59 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.953 . . . . 0.0 111.19 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 53.9 Cg_endo -73.78 53.03 2.68 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 123.552 1.29 . . . . 0.0 111.445 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.69 26.27 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.069 -1.019 . . . . 0.0 110.977 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.27 -130.98 6.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.94 -103.86 1.81 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CZ ' ' HG3' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.91 6.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -1.159 . . . . 0.0 110.708 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.04 174.6 20.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 82.9 t -97.21 117.42 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.321 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -88.99 127.0 35.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.871 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . . . -90.85 86.88 6.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 110.962 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 1.5 ttp85 -58.65 -19.89 43.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.537 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 11.5 mmtm -105.25 179.27 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 108.965 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.461 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 59.3 m 104.35 23.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.01 -1.681 . . . . 0.0 109.627 2.026 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.1 m-85 -115.89 156.55 25.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 164.28 12.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.377 -0.827 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -62.37 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.22 44.51 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.94 112.09 19.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -1.184 . . . . 0.0 110.443 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 2.0 tm? -53.48 115.6 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.255 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.0 t -88.89 66.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.6 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.271 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.96 167.29 24.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.288 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.3 179.73 7.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -94.72 -177.26 4.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.9 176.09 11.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.4 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.466 HG23 ' CH2' ' A' ' 43' ' ' TRP . 73.5 mt -109.27 141.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 109.969 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 43.4 t -117.44 115.54 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.049 -1.032 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.483 ' HB3' ' CG ' ' A' ' 43' ' ' TRP . 0.5 OUTLIER -145.96 157.1 43.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 110.416 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.9 177.01 9.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.341 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 29.9 p30 -64.24 -134.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.251 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 7.7 t0 64.83 -148.16 0.26 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.579 -1.325 . . . . 0.0 110.57 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.47 -41.09 13.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.227 -0.921 . . . . 0.0 110.953 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.483 ' CG ' ' HB3' ' A' ' 38' ' ' ARG . 65.9 t-105 -60.92 -35.33 76.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.69 92.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 84.8 m -83.53 -58.32 2.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -1.18 . . . . 0.0 110.687 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.83 -60.07 3.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.181 -0.949 . . . . 0.0 110.489 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.1 mm? -91.72 29.15 1.59 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.882 . . . . 0.0 110.362 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.56 -23.72 0.71 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.0 111.412 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -112.34 167.18 10.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.926 -1.109 . . . . 0.0 109.988 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 38.2 m-85 52.84 29.94 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 0.0 110.148 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' CG ' ' A' ' 60' ' ' MET . 8.6 tp -116.48 117.4 29.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.338 -0.851 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -89.23 107.71 19.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.408 ' HB2' ' CD ' ' C' ' 214' ' ' ARG . 23.1 t -106.0 153.81 21.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 -177.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -130.8 -171.53 2.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -82.96 79.75 9.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.979 -1.075 . . . . 0.0 109.263 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.499 0.2 OUTLIER 163.51 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.846 -0.534 . . . . 0.0 109.795 -179.12 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -176.05 -164.29 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.302 -0.874 . . . . 0.0 110.787 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.4 m -136.48 111.93 9.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 110.393 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 36' ' ' ILE . . . -102.5 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.368 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.467 ' CG ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.39 163.58 14.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.425 ' HB1' ' N ' ' A' ' 66' ' ' ALA . . . -85.65 87.81 7.45 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' CD1' ' CD1' ' B' ' 62' ' ' LEU 2.515 0.4 OUTLIER -46.65 -84.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.705 -0.622 . . . . 0.0 111.663 -175.614 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -131.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 70.7 m-85 -83.49 50.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 110.734 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.64 -24.54 27.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' N ' ' HB1' ' A' ' 61' ' ' ALA . . . -90.37 -36.59 14.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -1.12 . . . . 0.0 110.55 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 1.3 pp -57.11 -20.88 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.656 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CG ' HG12 ' A' ' 103' ' ' ILE . 12.4 m-85 -56.45 121.67 10.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.005 . . . . 0.0 110.197 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -88.76 177.5 6.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.575 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.453 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 62.7 t60 -98.04 112.08 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 110.356 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.21 157.12 25.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -72.69 -23.17 60.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.396 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -132.17 73.9 77.08 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.56 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.666 1.351 . . . . 0.0 110.562 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.473 ' ND2' ' CE ' ' A' ' 93' ' ' LYS . 13.5 m120 -70.64 -13.51 62.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 110.667 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.76 117.69 30.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 173.6 6.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.127 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -119.54 148.05 43.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.86 139.53 52.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.83 . . . . 0.0 110.156 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.437 ' CD2' HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -113.49 132.66 55.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 110.529 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 p -57.45 -166.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.0 110.297 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.34 59.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.37 -131.47 2.48 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 HD12 ' CD2' ' A' ' 80' ' ' LEU . 4.2 tp -149.22 28.26 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -1.1 . . . . 0.0 110.095 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -100.59 -36.65 9.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.79 145.33 46.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.041 . . . . 0.0 110.892 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.9 ptm -150.24 147.09 27.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.956 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -112.85 161.94 16.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.8 mt -109.57 132.36 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.943 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' A' ' 29' ' ' LEU . 36.7 m-85 -117.79 -178.36 3.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.491 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.6 p -125.83 105.9 9.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.344 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.8 pt -60.65 -16.62 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 110.502 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.473 ' CE ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -148.71 159.61 37.77 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.872 179.156 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.07 130.05 27.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.614 1.323 . . . . 0.0 110.094 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.424 HG22 ' CB ' ' A' ' 20' ' ' ALA . 56.3 mt -98.85 156.42 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.833 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.82 157.39 18.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.532 -0.73 . . . . 0.0 110.968 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 21' ' ' ARG . 2.6 mp -61.67 104.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 110.34 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.14 31.03 3.95 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.15 155.55 18.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.23 -1.159 . . . . 0.0 110.074 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.12 117.45 28.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 110.385 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 57.6 mt -95.83 130.01 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.1 p -154.34 170.25 21.76 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.481 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.3 pp -128.88 6.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.004 -1.06 . . . . 0.0 111.427 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 2.2 p 54.75 -151.89 0.36 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.091 -1.006 . . . . 0.0 110.013 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.503 ' CE1' ' CE ' ' C' ' 215' ' ' MLZ . 25.4 m-85 -133.75 -77.39 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 110.812 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.28 -159.18 20.19 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -90.46 18.8 5.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -1.105 . . . . 0.0 110.595 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.98 -53.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.127 -0.983 . . . . 0.0 110.081 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.1 OUTLIER -59.99 118.81 6.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 110.32 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 57.22 -85.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.532 -0.73 . . . . 0.0 110.868 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 7.2 tp -62.79 -146.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.052 . . . . 0.0 110.481 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.99 -43.66 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.05 -1.032 . . . . 0.0 110.549 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.7 142.74 45.91 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.58 75.58 4.8 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.593 1.312 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -156.01 124.56 5.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 110.562 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -122.56 -66.34 1.03 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 110.175 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 68.7 m -112.5 -33.96 6.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.888 . . . . 0.0 110.281 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -164.6 -150.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.299 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.4 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.285 179.85 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.9 -169.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -1.149 . . . . 0.0 110.375 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 203' ' ' ALA . . . . . 0.487 ' CB ' ' CD ' ' C' ' 204' ' ' PRO . . . -178.32 -59.38 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.251 -0.906 . . . . 0.0 110.436 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 204' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' C' ' 203' ' ' ALA . 26.3 Cg_endo -67.87 -24.31 40.25 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.429 1.226 . . . . 0.0 110.432 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 56.91 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.369 -0.832 . . . . 0.0 110.57 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 206' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' C' ' 204' ' ' PRO . 0.5 OUTLIER -156.23 -63.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.983 -1.073 . . . . 0.0 110.323 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.95 45.95 2.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 110.386 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.22 -55.32 4.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 110.398 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -100.87 90.45 4.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 110.315 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 2.6 p -79.97 105.2 11.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.363 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.62 -64.72 1.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 110.389 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.84 23.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.28 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . 60.02 150.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.322 -0.861 . . . . 0.0 110.634 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 214' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 44.8 mtt85 -142.77 -166.13 2.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 110.266 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 215' ' ' MLZ . . . . . 0.503 ' CE ' ' CE1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.504 3.2 m -50.36 176.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.805 . . . . 0.0 110.658 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -115.29 167.71 9.48 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.321 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.28 -72.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.643 1.339 . . . . 0.0 110.524 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -139.44 108.03 5.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.366 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 9.2 t -174.92 38.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.418 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 29.1 mmt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.137 0.494 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 32.7 p90 -90.09 133.43 34.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.106 -0.996 . . . . 0.0 110.337 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -150.97 141.31 22.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 110.124 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 13.3 t70 -47.98 -45.91 31.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.961 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' B' ' 6' ' ' VAL . 6.5 mtm-85 -74.61 -33.92 62.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 84.9 t -153.16 134.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.411 HG21 ' CB ' ' B' ' 19' ' ' PHE . 11.2 tt -117.24 156.07 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 110.588 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' B' ' 8' ' ' VAL . 12.6 p -88.91 123.32 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.66 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.525 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.2 mttt -151.88 121.82 7.09 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 59.08 67.25 0.94 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 119.631 -1.918 . . . . 0.0 111.482 1.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.4 m -165.96 -61.0 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.757 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 55.3 Cg_endo -73.89 52.94 2.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.307 1.162 . . . . 0.0 111.49 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.73 26.24 0.53 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.033 -1.042 . . . . 0.0 111.007 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.34 -131.04 6.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.89 -103.82 1.81 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.475 ' CZ ' ' HG3' ' B' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.85 6.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -1.149 . . . . 0.0 110.722 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.06 174.56 20.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 85.3 t -97.19 116.75 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.312 . . . . 0.0 110.145 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.524 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 0.5 OUTLIER -88.31 127.05 35.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.014 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.439 ' HB3' ' CD1' ' B' ' 101' ' ' ILE . . . -90.92 86.89 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 110.969 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' B' ' 97' ' ' ILE . 1.5 ttp85 -58.74 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 0.0 109.525 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.475 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 11.5 mmtm -105.13 179.3 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 108.953 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.454 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 59.5 m 104.37 23.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.912 -1.742 . . . . 0.0 109.674 1.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.3 m-85 -115.83 156.54 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.376 -0.828 . . . . 0.0 110.622 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 164.25 12.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.339 -0.851 . . . . 0.0 110.042 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -62.37 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.426 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.16 44.52 0.15 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -119.0 112.18 19.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 110.402 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.487 ' CD2' ' CE1' ' B' ' 90' ' ' PHE . 2.0 tm? -53.5 115.58 2.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -88.83 66.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -0.881 . . . . 0.0 110.093 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.58 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 110.287 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.95 167.38 24.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.328 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.48 179.6 8.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 110.563 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -94.63 -177.34 4.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.83 176.07 11.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 110.382 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.477 HG23 ' CH2' ' B' ' 43' ' ' TRP . 73.1 mt -109.3 141.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' B' ' 84' ' ' LEU . 43.0 t -117.45 115.47 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.478 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.5 OUTLIER -145.87 157.12 43.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 110.409 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.93 176.97 9.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 110.276 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' B' ' 41' ' ' ASP . 29.9 p30 -64.19 -134.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.887 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' B' ' 40' ' ' ASN . 7.6 t0 64.85 -148.16 0.26 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.644 -1.285 . . . . 0.0 110.559 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.41 -41.14 13.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.949 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.478 ' CG ' ' HB3' ' B' ' 38' ' ' ARG . 66.0 t-105 -60.97 -35.29 76.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.771 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -35.58 91.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 85.3 m -83.61 -58.35 2.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.641 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.86 -59.42 3.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' B' ' 47' ' ' LEU . 3.1 mm? -92.73 29.49 1.76 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.76 -23.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.173 -0.955 . . . . 0.0 111.335 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -112.26 167.11 10.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.953 -1.092 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.416 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 37.9 m-85 52.93 29.85 8.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.478 ' CD1' ' CG ' ' B' ' 60' ' ' MET . 8.6 tp -116.61 117.19 29.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 111.0 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -88.94 107.75 19.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.868 . . . . 0.0 109.219 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 23.1 t -106.05 153.74 21.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.09 -1.006 . . . . 0.0 111.222 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -131.41 -174.42 3.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.564 -0.71 . . . . 0.0 109.848 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -78.83 79.42 5.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.13 -0.982 . . . . 0.0 110.065 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.2 OUTLIER 163.43 -27.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.756 -0.59 . . . . 0.0 109.839 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -164.01 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.5 m -136.57 112.01 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 110.377 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -102.6 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.407 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.478 ' CG ' ' CD1' ' B' ' 51' ' ' LEU . 0.0 OUTLIER -112.83 161.62 16.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.285 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.414 ' HB1' ' N ' ' B' ' 66' ' ' ALA . . . -82.94 87.73 6.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.936 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.494 ' CD1' ' CD1' ' A' ' 62' ' ' LEU 2.517 0.3 OUTLIER -47.02 -84.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.646 -0.659 . . . . 0.0 111.72 -175.753 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.49 -131.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 71.0 m-85 -83.6 50.92 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.611 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -91.19 -24.19 27.5 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.71 -36.43 14.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -1.139 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' B' ' 18' ' ' VAL . 1.3 pp -57.13 -20.96 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 0.0 110.642 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.479 ' CG ' HG12 ' B' ' 103' ' ' ILE . 12.4 m-85 -56.4 121.67 10.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -88.79 177.4 6.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 110.604 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.466 ' CE1' ' HB2' ' B' ' 111' ' ' LEU . 62.7 t60 -97.91 112.15 24.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.358 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.28 157.15 25.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -72.75 -23.17 60.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.356 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -132.12 73.95 77.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.58 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.678 1.357 . . . . 0.0 110.595 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.471 ' ND2' ' CE ' ' B' ' 93' ' ' LYS . 13.5 m120 -70.62 -13.5 62.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.704 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.74 117.72 31.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 110.407 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 173.61 6.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -119.5 147.98 43.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.611 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -127.84 139.57 52.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.436 ' CD2' HD12 ' B' ' 84' ' ' LEU . 0.7 OUTLIER -113.43 132.74 55.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 110.482 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.8 p -57.52 -166.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 110.324 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.41 59.91 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.34 -131.48 2.48 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.437 ' CD2' ' HB2' ' B' ' 59' ' ' ALA . 4.3 tp -149.28 28.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -1.104 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -100.72 -36.51 9.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 110.82 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.87 145.34 46.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 110.884 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.9 ptm -150.2 147.1 27.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 110.055 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.426 ' HB3' ' CD2' ' B' ' 29' ' ' LEU . 0.0 OUTLIER -112.94 161.98 16.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 110.387 -179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 mt -109.53 132.39 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.968 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' B' ' 29' ' ' LEU . 36.7 m-85 -117.82 -178.36 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 110.473 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 57.6 p -125.79 105.92 9.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 5.8 pt -60.71 -16.6 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.514 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.471 ' CE ' ' ND2' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -148.73 159.79 37.3 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.876 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.31 130.26 28.04 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.59 1.31 . . . . 0.0 110.05 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.419 HG22 ' CB ' ' B' ' 20' ' ' ALA . 56.1 mt -98.92 156.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.0 110.806 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.97 157.44 18.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.912 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' B' ' 21' ' ' ARG . 2.6 mp -61.68 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 110.343 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.24 30.89 3.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.07 155.1 18.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -1.137 . . . . 0.0 110.155 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.48 117.51 27.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.028 -1.045 . . . . 0.0 110.505 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.439 ' CD1' ' HB3' ' B' ' 20' ' ' ALA . 57.3 mt -95.96 130.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 110.617 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 30.5 p -154.28 170.23 21.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.726 -0.608 . . . . 0.0 109.487 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.479 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.3 pp -128.71 6.24 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 111.275 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 2.2 p 54.63 -151.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.064 . . . . 0.0 110.059 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.492 ' CE1' ' CE ' ' D' ' 215' ' ' MLZ . 25.4 m-85 -133.7 -77.37 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.99 . . . . 0.0 110.855 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.35 -159.21 20.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.38 18.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.93 -53.35 0.7 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 110.108 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.1 OUTLIER -60.11 118.77 6.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 110.338 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 57.23 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.89 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.466 ' HB2' ' CE1' ' B' ' 70' ' ' HIS . 7.2 tp -62.74 -146.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.966 -1.084 . . . . 0.0 110.562 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.88 -43.63 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.988 -1.07 . . . . 0.0 110.54 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.8 142.71 45.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.57 75.63 4.78 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.583 1.307 . . . . 0.0 110.398 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -156.15 124.89 5.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -122.61 -66.42 1.03 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.162 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 67.6 m -112.45 -33.96 6.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.897 . . . . 0.0 110.269 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -164.59 -150.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 110.336 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 25.4 t30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.351 179.813 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.84 -169.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -1.167 . . . . 0.0 110.344 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 203' ' ' ALA . . . . . 0.49 ' CB ' ' CD ' ' D' ' 204' ' ' PRO . . . -178.34 -59.43 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.382 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' D' ' 203' ' ' ALA . 26.4 Cg_endo -67.88 -24.28 40.25 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.472 1.248 . . . . 0.0 110.453 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 56.87 -85.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.451 -0.781 . . . . 0.0 110.544 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 206' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' D' ' 204' ' ' PRO . 0.5 OUTLIER -156.29 -63.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.043 -1.036 . . . . 0.0 110.349 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.01 45.93 2.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 110.372 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.26 -55.3 4.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -100.89 90.49 4.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.354 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 2.7 p -79.98 105.14 11.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 110.426 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.55 -64.78 1.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 110.388 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.96 156.8 23.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 60.07 150.51 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.41 -0.806 . . . . 0.0 110.602 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 214' ' ' ARG . . . . . 0.475 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 44.8 mtt85 -142.78 -166.1 2.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 215' ' ' MLZ . . . . . 0.492 ' CE ' ' CE1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 3.2 m -50.43 176.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.865 . . . . 0.0 110.686 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -115.27 167.7 9.48 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 110.357 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.27 -72.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.633 1.333 . . . . 0.0 110.526 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -139.41 108.04 5.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 110.357 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 9.1 t -174.95 38.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.429 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' SAH . . . . . 0.423 " C5'" ' OH ' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 302' ' ' SAH . . . . . 0.427 ' OXT' ' CB ' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.476 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 22.3 p90 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.445 0.641 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.14 146.86 33.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 110.251 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.83 -22.65 3.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 110.836 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.526 ' C ' HG13 ' A' ' 6' ' ' VAL . 7.3 mtm-85 -90.14 -37.51 14.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.998 . . . . 0.0 110.688 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.526 HG13 ' C ' ' A' ' 5' ' ' ARG . 33.1 m -152.03 -172.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 110.453 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.737 HG23 ' HB2' ' A' ' 19' ' ' PHE . 12.6 tt -157.04 161.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.212 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.8 p -97.02 135.46 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 110.765 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.571 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 28.4 mttt -139.62 142.71 37.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.78 . . . . 0.0 109.161 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.571 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mmtp 52.04 64.31 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 119.797 -1.814 . . . . 0.0 111.217 0.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.491 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.549 -0.719 . . . . 0.0 110.088 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 31.4 m-85 -115.2 61.2 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.159 . . . . 0.0 110.331 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.56 24.1 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.932 HG23 HD13 ' A' ' 67' ' ' ILE . 54.7 t -103.22 154.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.978 -1.307 . . . . 0.0 110.092 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.737 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.1 m-85 -113.95 127.85 56.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.301 -0.874 . . . . 0.0 110.127 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.587 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -90.23 92.08 8.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.789 ' O ' HG23 ' A' ' 97' ' ' ILE . 7.0 ttt180 -58.31 -22.8 54.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 0.0 109.47 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 23' ' ' SER . 2.2 mptt -88.85 178.25 6.49 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.507 -0.746 . . . . 0.0 109.487 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 22' ' ' LYS 2.513 73.9 m 98.58 17.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.231 -1.543 . . . . 0.0 110.351 0.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' A' ' 91' ' ' THR . 19.4 m-85 -108.0 164.36 12.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.1 -165.66 1.01 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.446 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 5.4 tttt -85.41 96.47 9.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 110.423 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.6 0.64 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -119.68 123.04 42.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -1.195 . . . . 0.0 110.433 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.841 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -68.27 96.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 110.0 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' A' ' 6' ' ' VAL . 72.3 t -67.75 -39.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.725 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -168.49 164.42 12.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 110.258 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.17 141.55 18.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.437 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 52.7 m -144.96 -176.05 4.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 110.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.25 171.6 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.473 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 65.3 m -146.58 -178.22 6.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 110.168 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 55.9 mt -122.3 143.0 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 84' ' ' LEU . 39.6 t -117.39 102.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.51 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.7 mmt180 -125.87 160.47 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -79.64 173.79 12.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 110.405 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.214 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.6 t0 66.52 -150.39 0.2 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.721 -1.237 . . . . 0.0 110.605 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.25 -36.74 4.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.369 -0.832 . . . . 0.0 111.307 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.51 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 57.4 t-105 -55.33 -59.79 4.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.56 57.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 98.4 m -73.83 -70.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.186 . . . . 0.0 110.607 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.67 -43.84 26.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.107 -0.996 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.658 ' CB ' HD11 ' A' ' 51' ' ' LEU . 4.5 mm? -92.12 16.73 10.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.265 -0.897 . . . . 0.0 111.38 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -59.98 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.984 -1.072 . . . . 0.0 110.449 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.1 t0 -179.03 -69.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.003 -1.061 . . . . 0.0 110.333 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.625 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 19.3 m-85 -114.33 61.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.658 HD11 ' CB ' ' A' ' 47' ' ' LEU . 24.7 mt -111.9 117.45 32.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 111.027 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 4.8 m-85 -88.25 92.64 9.24 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.426 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 85.8 p -94.68 145.34 24.91 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 111.497 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.721 ' HB2' HD11 ' A' ' 84' ' ' LEU . 5.3 ttp180 -109.77 -172.81 2.11 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.09 72.59 10.11 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.983 -1.073 . . . . 0.0 109.241 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.0 OUTLIER 169.96 -26.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.99 -168.13 0.93 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.283 -0.886 . . . . 0.0 111.262 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.7 p -129.76 123.98 32.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 0.0 109.806 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.43 169.16 8.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.071 -1.018 . . . . 0.0 111.054 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.582 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -104.29 151.13 23.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.27 85.53 7.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 110.007 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.705 ' O ' HD13 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -52.87 -69.02 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.452 -0.78 . . . . 0.0 110.708 -179.488 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -69.55 -151.26 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CD2' HG12 ' A' ' 67' ' ' ILE . 3.7 m-85 -83.94 51.4 2.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -1.05 . . . . 0.0 110.66 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.57 -23.72 49.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -82.55 -49.24 10.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 110.469 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.991 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.6 pp -45.76 -24.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.753 . . . . 0.0 111.701 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.991 ' N ' HD12 ' A' ' 67' ' ' ILE . 17.2 m-85 -62.2 109.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.844 -1.16 . . . . 0.0 110.024 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' H ' HG22 ' A' ' 102' ' ' THR . 23.6 m120 -82.1 -176.86 6.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.745 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -102.25 119.46 38.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.5 t -121.32 158.96 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.51 -20.37 60.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 20.8 t0 -141.04 63.77 19.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 110.486 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.653 ' O ' HD11 ' A' ' 92' ' ' ILE . 17.2 Cg_exo -62.92 114.61 2.5 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.671 1.353 . . . . 0.0 110.025 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.43 ' O ' HD11 ' A' ' 95' ' ' ILE . 76.0 m-20 -90.95 24.17 2.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.746 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.483 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -158.66 142.47 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.412 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.1 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.37 168.77 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.91 161.26 30.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 110.092 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.0 mt -133.35 127.69 34.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.445 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 83' ' ' GLY . 3.4 p -69.73 -167.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.53 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 105.4 -177.29 22.9 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.731 ' HB2' HG22 ' A' ' 37' ' ' VAL . 20.9 mt -91.14 51.4 1.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -1.128 . . . . 0.0 110.329 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.9 -80.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.826 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.71 130.84 35.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 110.716 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.748 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.5 mtp -115.89 133.6 55.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.765 ' HB3' HD21 ' A' ' 29' ' ' LEU . 26.9 mtp85 -120.28 163.58 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.583 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.725 HD12 ' HB3' ' A' ' 31' ' ' GLU . 89.9 mt -129.83 98.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.841 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 26.5 m-85 -91.42 -176.85 4.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.432 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.671 ' CG2' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.73 81.89 1.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 111.075 -179.053 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 74' ' ' PRO . 1.4 pt -60.12 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.12 -0.988 . . . . 0.0 108.571 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 84.42 121.77 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.363 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 84.6 Cg_exo -43.79 148.25 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.526 1.277 . . . . 0.0 111.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.671 HD12 ' CG2' ' A' ' 91' ' ' THR . 74.7 mt -119.91 151.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 110.418 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.19 14.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -63.5 117.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.61 5.05 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -104.03 178.45 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -1.21 . . . . 0.0 110.147 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.23 123.69 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.804 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.587 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 73.9 mt -89.52 127.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 110.122 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.7 p -155.44 176.4 12.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.946 -0.471 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.739 HD12 ' O ' ' A' ' 104' ' ' SER . 1.3 pp -140.42 158.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.01 -1.056 . . . . 0.0 110.563 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.739 ' O ' HD12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -83.01 -164.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 110.369 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.507 ' CG ' ' HB3' ' A' ' 109' ' ' TYR . 19.4 m-85 -124.16 -81.3 0.63 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.85 -152.61 24.52 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.817 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.13 -53.28 21.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -1.149 . . . . 0.0 110.05 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.91 -167.7 0.91 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.435 -0.791 . . . . 0.0 109.351 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.507 ' HB3' ' CG ' ' A' ' 105' ' ' TYR . 2.7 m-85 46.09 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 111.002 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.466 ' CE3' ' O ' ' A' ' 110' ' ' TRP . 29.6 p-90 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.402 0.62 . . . . 0.0 110.601 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 2.9 t . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.352 0.596 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -123.97 176.21 2.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.336 -0.852 . . . . 0.0 110.222 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 21.5 Cg_endo . . . . . 0 C--N 1.313 -1.32 0 O-C-N 123.623 1.328 . . . . 0.0 110.594 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 22.3 p90 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.417 0.627 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.13 146.93 33.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.88 -22.69 3.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.514 ' C ' HG13 ' B' ' 6' ' ' VAL . 7.4 mtm-85 -90.08 -37.62 14.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.514 HG13 ' C ' ' B' ' 5' ' ' ARG . 33.1 m -151.95 -172.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.717 HG23 ' HB2' ' B' ' 19' ' ' PHE . 12.6 tt -156.96 161.83 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 110.219 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.404 HG13 ' O ' ' B' ' 8' ' ' VAL . 10.0 p -97.02 135.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.818 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.574 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 28.4 mttt -139.62 142.76 37.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 109.161 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.574 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mmtp 52.16 64.23 1.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 119.796 -1.815 . . . . 0.0 111.233 0.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 31.5 m-85 -115.17 61.35 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 110.403 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.44 -171.52 23.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.933 HG23 HD13 ' B' ' 67' ' ' ILE . 54.2 t -103.24 154.03 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.934 -1.333 . . . . 0.0 110.084 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.717 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.1 m-85 -113.9 127.92 56.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 110.148 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.57 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -90.16 91.86 8.71 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 110.557 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.79 ' O ' HG23 ' B' ' 97' ' ' ILE . 7.0 ttt180 -58.17 -22.75 52.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' B' ' 23' ' ' SER . 2.2 mptt -89.01 178.26 6.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.52 -0.738 . . . . 0.0 109.518 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' B' ' 22' ' ' LYS 2.514 73.8 m 98.58 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.311 -1.493 . . . . 0.0 110.339 0.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' B' ' 91' ' ' THR . 19.6 m-85 -108.07 164.4 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 110.382 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.04 -165.65 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.428 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 5.4 tttt -85.43 96.38 9.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 110.466 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.01 52.66 0.64 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -119.7 122.98 42.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.0 110.411 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.829 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -68.26 96.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 110.044 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.423 ' CG1' HG11 ' B' ' 6' ' ' VAL . 72.2 t -67.69 -39.96 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.366 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.723 ' HB3' HD12 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -168.46 164.44 12.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.24 141.5 18.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.446 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 52.5 m -144.85 -176.06 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.923 . . . . 0.0 110.406 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.19 171.66 8.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.535 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.749 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 65.2 m -146.64 -178.27 6.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.557 ' O ' ' HB1' ' B' ' 59' ' ' ALA . 55.7 mt -122.29 142.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' B' ' 84' ' ' LEU . 39.6 t -117.3 102.91 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' B' ' 36' ' ' ILE . 14.7 mmt180 -125.81 160.5 29.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -79.65 173.79 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.412 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.6 t0 66.54 -150.32 0.2 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.698 -1.251 . . . . 0.0 110.64 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.36 -36.74 4.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 111.277 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.503 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 57.3 t-105 -55.33 -59.86 4.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 110.181 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.35 -31.54 56.9 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.435 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 98.1 m -73.91 -70.64 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -1.233 . . . . 0.0 110.621 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.82 -42.93 27.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.081 -1.012 . . . . 0.0 111.002 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.658 ' CB ' HD11 ' B' ' 51' ' ' LEU . 4.5 mm? -93.48 17.37 11.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 111.014 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.1 OUTLIER -60.28 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.091 . . . . 0.0 110.408 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 47' ' ' LEU . 1.1 t0 -179.01 -69.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.95 -1.094 . . . . 0.0 110.345 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.644 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . 19.4 m-85 -114.38 61.9 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.117 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.658 HD11 ' CB ' ' B' ' 47' ' ' LEU . 24.4 mt -112.07 116.67 30.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.169 -0.957 . . . . 0.0 111.153 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' B' ' 59' ' ' ALA . 5.0 m-85 -87.23 92.64 9.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 0.0 108.795 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.419 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 85.6 p -94.74 145.36 24.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 0.0 111.529 -176.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.722 ' HB2' HD11 ' B' ' 84' ' ' LEU . 5.4 ttp180 -110.38 -175.65 2.78 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.541 -0.724 . . . . 0.0 109.48 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.11 72.17 5.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 0.0 OUTLIER 169.77 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.8 -168.17 0.96 Allowed 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.336 -0.852 . . . . 0.0 111.351 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 1.7 p -129.69 123.97 32.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.688 . . . . 0.0 109.781 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.45 169.25 8.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.002 . . . . 0.0 111.054 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.582 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -104.59 149.99 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 110.26 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.66 85.44 7.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.255 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 62' ' ' LEU 2.501 0.1 OUTLIER -53.0 -69.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.723 -179.646 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -69.49 -151.22 0.49 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.493 ' CD2' HG12 ' B' ' 67' ' ' ILE . 3.7 m-85 -84.02 51.36 2.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.422 -1.046 . . . . 0.0 110.652 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.49 -23.76 49.5 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -82.58 -49.27 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 110.398 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.98 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.6 pp -45.75 -24.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.491 -0.756 . . . . 0.0 111.749 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.98 ' N ' HD12 ' B' ' 67' ' ' ILE . 17.2 m-85 -62.32 109.75 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.902 -1.124 . . . . 0.0 110.024 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.404 ' H ' HG22 ' B' ' 102' ' ' THR . 23.4 m120 -81.99 -176.46 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.716 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -102.78 119.45 38.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -0.841 . . . . 0.0 110.024 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 36.7 t -121.35 158.94 27.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 -20.43 60.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.428 ' N ' ' HD3' ' B' ' 74' ' ' PRO . 20.7 t0 -140.99 63.63 19.01 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 110.505 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.642 ' O ' HD11 ' B' ' 92' ' ' ILE . 17.2 Cg_exo -62.79 114.68 2.51 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.627 1.33 . . . . 0.0 110.04 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.44 ' O ' HD11 ' B' ' 95' ' ' ILE . 76.2 m-20 -91.08 24.29 2.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.701 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.475 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -158.62 142.45 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.401 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.455 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.04 1.01 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.529 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.42 168.72 19.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.755 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.89 161.27 30.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -0.827 . . . . 0.0 110.037 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.37 127.61 33.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.002 . . . . 0.0 110.487 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' B' ' 83' ' ' GLY . 3.4 p -69.71 -167.35 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 110.278 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 110.229 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 81' ' ' THR . . . 105.43 -177.22 22.85 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' B' ' 37' ' ' VAL . 20.9 mt -91.21 51.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.92 -80.77 0.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 110.82 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.69 130.82 35.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.741 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.749 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.6 mtp -115.87 133.64 55.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.746 ' HB3' HD21 ' B' ' 29' ' ' LEU . 26.8 mtp85 -120.31 163.55 17.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.641 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.723 HD12 ' HB3' ' B' ' 31' ' ' GLU . 89.5 mt -129.75 98.65 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.829 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 26.3 m-85 -91.36 -176.8 4.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.386 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.671 ' CG2' HD12 ' B' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 81.86 1.76 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.148 -0.97 . . . . 0.0 110.996 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.642 HD11 ' O ' ' B' ' 74' ' ' PRO . 1.4 pt -59.96 103.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.657 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 92' ' ' ILE . 0.0 OUTLIER 84.15 121.44 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 C-N-CA 123.541 0.736 . . . . 0.0 109.425 -177.031 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 88.2 Cg_exo -44.13 148.51 1.09 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.468 1.246 . . . . 0.0 111.436 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.671 HD12 ' CG2' ' B' ' 91' ' ' THR . 74.0 mt -119.92 151.91 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.285 -0.884 . . . . 0.0 110.421 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.18 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.364 -0.835 . . . . 0.0 110.344 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.79 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -63.47 117.17 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.05 27.59 5.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.404 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 18.8 mm-40 -104.03 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.236 . . . . 0.0 110.156 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.29 123.68 48.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.81 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.57 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 74.3 mt -89.34 127.37 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 110.181 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 101' ' ' ILE . 16.6 p -155.42 176.43 12.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.664 -0.647 . . . . 0.0 109.798 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.736 HD12 ' O ' ' B' ' 104' ' ' SER . 1.3 pp -140.43 158.07 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.084 -1.01 . . . . 0.0 110.573 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.736 ' O ' HD12 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -82.98 -164.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 0.0 110.37 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' B' ' 109' ' ' TYR . 19.6 m-85 -124.12 -81.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 110.327 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.76 -152.69 24.59 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.06 -53.31 20.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.287 -1.125 . . . . 0.0 110.101 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.86 -167.46 0.85 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.421 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HB3' ' CG ' ' B' ' 105' ' ' TYR . 2.8 m-85 45.81 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.389 -0.82 . . . . 0.0 111.157 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.478 ' CE3' ' O ' ' B' ' 110' ' ' TRP . 30.1 p-90 . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 110.598 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.504 2.9 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.328 0.585 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.802 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -124.01 176.19 2.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.802 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 21.4 Cg_endo . . . . . 0 C--N 1.312 -1.376 0 O-C-N 123.644 1.339 . . . . 0.0 110.542 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 54.5 p90 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.327 0.584 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ARG . 46.7 t30 -150.14 161.29 42.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.82 62.01 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.618 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.526 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER 174.75 -34.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.0 109.218 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.625 HG11 ' CG1' ' A' ' 30' ' ' VAL . 16.5 m -156.55 -172.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 109.737 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 10.2 tt -160.64 164.29 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.7 p -89.14 120.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.098 -1.002 . . . . 0.0 110.474 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.584 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 26.2 mttt -148.39 127.72 13.03 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.584 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 54.44 42.11 31.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.795 -1.816 . . . . 0.0 110.088 4.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.51 ' CB ' ' CE1' ' A' ' 19' ' ' PHE . 2.1 p . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.677 -0.64 . . . . 0.0 109.905 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CE1' ' HG3' ' A' ' 10' ' ' LYS . 3.8 m-85 -95.08 99.67 11.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.249 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.72 -160.51 9.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 67' ' ' ILE . 79.7 t -113.1 138.32 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.837 -1.39 . . . . 0.0 110.414 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CG ' ' CD ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -104.28 140.99 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -104.14 91.01 3.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 110.974 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.899 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -60.18 -26.2 66.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HE2' ' CE1' ' A' ' 24' ' ' PHE . 6.2 mtpp -94.28 -177.38 4.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.566 -0.709 . . . . 0.0 109.567 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.443 ' HA ' ' CB ' ' A' ' 22' ' ' LYS 2.512 0.1 OUTLIER 108.58 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.123 -1.61 . . . . 0.0 110.109 1.879 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CE1' ' HE2' ' A' ' 22' ' ' LYS . 48.8 m-85 -114.76 160.82 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.652 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.2 172.27 6.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.978 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' CD ' ' A' ' 94' ' ' PRO . 29.5 tttm -72.03 80.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.552 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.43 40.87 0.12 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 24' ' ' PHE . 14.0 mt-10 -119.3 158.52 25.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.386 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.865 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.5 tm? -92.41 128.11 38.14 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.694 ' N ' HD13 ' A' ' 29' ' ' LEU . 81.7 t -94.37 -45.61 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' HD12 ' A' ' 89' ' ' ILE . 27.3 tp10 -170.32 152.07 3.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 110.64 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.51 35.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.05 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.441 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -146.67 -157.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 110.743 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 34' ' ' LEU . 1.5 mm? -99.91 175.47 5.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.415 -0.803 . . . . 0.0 110.551 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.734 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 3.3 m -150.7 154.93 38.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.393 -0.817 . . . . 0.0 109.988 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.787 HD11 HD23 ' A' ' 62' ' ' LEU . 54.7 mt -94.89 164.01 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 36' ' ' ILE . 48.7 t -144.96 106.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -0.962 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.522 ' CB ' ' CG ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -112.82 -163.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.205 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -128.7 62.45 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 26.8 m120 52.35 -149.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 0.0 110.631 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 17.6 m-20 60.51 -144.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.211 -0.93 . . . . 0.0 110.106 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -46.63 -29.05 1.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.009 -1.057 . . . . 0.0 111.149 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.841 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 66.1 t-105 -65.07 -44.45 88.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 110.232 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.37 -40.15 97.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.8 m -67.07 -65.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.508 ' HB3' HD22 ' A' ' 47' ' ' LEU . . . -54.31 -58.43 7.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.883 ' HB3' HD13 ' A' ' 51' ' ' LEU . 2.7 mm? -90.63 50.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -0.4 22.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 111.015 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -129.6 156.8 43.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.942 -1.099 . . . . 0.0 109.681 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 33.3 m-85 54.93 24.09 5.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 109.857 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.883 HD13 ' HB3' ' A' ' 47' ' ' LEU . 7.5 tp -117.05 123.4 46.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 110.851 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 36.2 m-85 -90.04 118.59 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.1 m -96.35 138.43 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.112 -0.993 . . . . 0.0 110.967 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.901 ' CD ' HD13 ' A' ' 84' ' ' LEU . 4.3 ttp180 -109.76 176.47 5.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.449 -0.782 . . . . 0.0 110.228 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -84.18 81.6 8.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.03 -1.044 . . . . 0.0 109.221 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.505 9.8 m120 148.29 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 109.733 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.7 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.498 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -150.9 164.81 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.709 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.597 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -150.63 155.85 40.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.531 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.881 ' CE ' HD12 ' A' ' 47' ' ' LEU . 27.5 tpp -102.61 159.68 15.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 110.135 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.76 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.39 94.26 9.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.101 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.787 HD23 HD11 ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER -55.34 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.804 . . . . 0.0 111.165 -178.978 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.53 -132.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.71 ' HB3' HD11 ' A' ' 67' ' ' ILE . 89.2 m-85 -90.16 39.14 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -1.094 . . . . 0.0 110.664 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.76 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -79.15 -20.27 70.31 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.97 -48.27 7.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -1.198 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 64' ' ' PHE . 1.3 pp -55.77 -17.29 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 111.259 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CG ' HG12 ' A' ' 103' ' ' ILE . 4.6 m-85 -49.01 134.29 17.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.881 -1.137 . . . . 0.0 110.832 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.452 ' N ' HG23 ' A' ' 102' ' ' THR . 10.9 m-20 -97.18 -164.33 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 110.875 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -102.36 157.44 16.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.782 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 t -174.41 130.08 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.015 . . . . 0.0 110.565 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.65 79.36 47.93 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.746 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.7 Cg_endo -63.76 100.45 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.653 1.344 . . . . 0.0 110.451 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -54.85 -21.06 10.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 110.487 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -130.67 163.45 27.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.972 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HA ' HG22 ' A' ' 103' ' ' ILE . 71.9 ttt180 -143.44 156.71 44.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 110.241 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.59 ' HD1' HD13 ' A' ' 103' ' ' ILE . 37.2 p-80 -89.85 166.42 13.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 110.382 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 24.0 tp10 -148.07 161.25 41.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.9 . . . . 0.0 110.405 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 84' ' ' LEU . 25.9 mt -123.59 148.54 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.92 64.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.58 40.13 29.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.47 -133.79 2.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.901 HD13 ' CD ' ' A' ' 54' ' ' ARG . 2.0 tp -137.23 23.1 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 110.234 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -85.95 -67.16 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 111.065 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.14 164.12 12.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 111.017 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.734 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 4.3 mtp -134.28 148.41 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HB3' HD21 ' A' ' 29' ' ' LEU . 21.4 mtp180 -133.09 167.3 20.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 0.0 110.448 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' HZ ' ' A' ' 68' ' ' PHE . 65.1 mt -133.38 95.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.865 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 54.2 m-85 -90.39 -179.53 5.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 110.547 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.532 ' CG2' HD12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -117.72 94.16 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 110.189 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.746 HD11 ' O ' ' A' ' 74' ' ' PRO . 10.9 pt -55.87 -20.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 110.592 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.9 mttt -137.71 160.15 66.08 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 110.454 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 26' ' ' LYS . 23.5 Cg_exo -58.03 158.31 21.89 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.651 1.342 . . . . 0.0 110.507 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 91' ' ' THR . 39.5 mt -144.57 136.44 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.71 166.07 11.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.585 -0.697 . . . . 0.0 110.831 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.3 mp -65.11 110.39 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.546 -0.721 . . . . 0.0 110.316 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 22.8 5.02 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.408 ' CB ' HG23 ' A' ' 95' ' ' ILE . 18.3 mm-40 -94.71 -179.36 4.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 110.094 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.19 122.33 35.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.846 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.556 HG23 ' CB ' ' A' ' 76' ' ' ALA . 23.5 mt -89.66 131.08 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 69' ' ' ASN . 49.5 m -162.8 147.62 11.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.59 HD13 ' HD1' ' A' ' 78' ' ' HIS . 1.4 pt -115.0 165.21 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.033 -1.042 . . . . 0.0 110.769 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.22 -159.11 0.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.373 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.12 -93.35 0.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.425 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.23 169.24 41.76 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.752 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.81 -58.64 7.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -39.21 79.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.94 31.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.937 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 179.359 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 216' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.507 2.4 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.184 0.516 . . . . 0.0 110.666 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 54.48 174.84 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 25.3 Cg_exo . . . . . 0 C--N 1.313 -1.325 0 O-C-N 123.616 1.324 . . . . 0.0 110.583 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 54.6 p90 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.347 0.594 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -150.18 161.5 42.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.081 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.06 61.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.369 -0.832 . . . . 0.0 110.578 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.512 ' O ' HG13 ' B' ' 6' ' ' VAL . 0.2 OUTLIER 174.83 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.342 -0.849 . . . . 0.0 109.21 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.624 HG11 ' CG1' ' B' ' 30' ' ' VAL . 16.7 m -156.48 -172.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.664 -0.647 . . . . 0.0 109.819 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 10.3 tt -160.68 163.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.977 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.564 HG13 ' O ' ' B' ' 8' ' ' VAL . 7.8 p -88.59 120.72 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.967 . . . . 0.0 110.538 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.613 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 26.1 mttt -148.57 127.75 12.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.613 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 54.47 42.09 31.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.642 -1.911 . . . . 0.0 110.106 4.705 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.517 ' CB ' ' CE1' ' B' ' 19' ' ' PHE . 2.1 p . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.675 -0.64 . . . . 0.0 109.932 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' B' ' 10' ' ' LYS . 3.8 m-85 -95.0 99.69 11.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.054 -1.262 . . . . 0.0 110.495 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.71 -160.34 9.54 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' B' ' 67' ' ' ILE . 81.2 t -113.24 138.08 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.386 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CG ' ' CD ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -104.21 141.05 36.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.788 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -104.19 91.09 3.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.947 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.905 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.3 OUTLIER -60.27 -26.07 66.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.507 ' HE2' ' CE1' ' B' ' 24' ' ' PHE . 6.2 mtpp -94.4 -177.14 4.16 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 109.572 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.511 0.1 OUTLIER 108.69 17.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.133 -1.605 . . . . 0.0 110.133 1.755 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.507 ' CE1' ' HE2' ' B' ' 22' ' ' LYS . 49.3 m-85 -114.67 160.9 18.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.639 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.3 172.29 6.87 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.517 -0.739 . . . . 0.0 110.025 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -72.23 80.36 0.99 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.37 40.95 0.12 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' B' ' 24' ' ' PHE . 13.7 mt-10 -119.44 158.48 26.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -1.214 . . . . 0.0 110.336 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.883 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.5 tm? -92.35 128.07 38.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.968 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.696 ' N ' HD13 ' B' ' 29' ' ' LEU . 82.6 t -94.35 -45.66 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.457 ' HB3' HD12 ' B' ' 89' ' ' ILE . 27.4 tp10 -170.26 152.11 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.55 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 110.028 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.434 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -146.75 -157.4 0.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 110.757 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' B' ' 34' ' ' LEU . 1.5 mm? -99.93 175.86 5.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 3.4 m -151.12 154.77 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.953 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.794 HD11 HD23 ' B' ' 62' ' ' LEU . 54.7 mt -94.85 163.97 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.825 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.415 HG23 ' C ' ' B' ' 36' ' ' ILE . 48.7 t -144.87 106.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.967 . . . . 0.0 110.678 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.528 ' CB ' ' CG ' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -113.0 -163.34 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -128.61 62.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 110.963 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 26.7 m120 52.42 -149.31 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.647 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 17.4 m-20 60.5 -144.13 0.5 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.232 -0.917 . . . . 0.0 110.14 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -46.63 -29.04 1.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.07 -1.019 . . . . 0.0 111.147 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.834 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 66.2 t-105 -65.04 -44.51 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.172 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.33 -40.16 97.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 98.5 m -67.15 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 110.434 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.52 ' HB3' HD22 ' B' ' 47' ' ' LEU . . . -54.3 -58.28 8.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 110.324 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.88 ' HB3' HD13 ' B' ' 51' ' ' LEU . 2.7 mm? -90.96 50.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -0.56 22.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' B' ' 49' ' ' ASP . 39.9 p-10 -129.45 156.89 43.39 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.009 -1.057 . . . . 0.0 109.779 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 32.9 m-85 54.88 24.01 5.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.155 -0.966 . . . . 0.0 109.885 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 47' ' ' LEU . 7.5 tp -117.01 123.54 47.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.379 -0.826 . . . . 0.0 110.85 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' B' ' 52' ' ' PHE . 35.9 m-85 -90.17 118.6 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.601 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.2 m -96.35 138.39 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.921 ' CD ' HD13 ' B' ' 84' ' ' LEU . 4.3 ttp180 -110.23 174.06 6.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.498 -0.751 . . . . 0.0 110.32 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -80.82 81.33 7.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.506 9.8 m120 148.14 -19.66 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 109.77 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.61 -149.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.481 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.495 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -151.38 164.84 35.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 110.69 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -150.93 155.71 39.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.86 . . . . 0.0 110.464 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.879 ' CE ' HD12 ' B' ' 47' ' ' LEU . 27.5 tpp -102.7 158.66 16.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.326 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.749 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -85.93 94.19 9.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.794 HD23 HD11 ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER -55.45 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 111.206 -179.177 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.59 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.737 ' HB3' HD11 ' B' ' 67' ' ' ILE . 89.1 m-85 -90.21 39.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.414 -1.051 . . . . 0.0 110.745 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.749 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -79.26 -19.82 71.08 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.5 -48.1 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.111 -1.229 . . . . 0.0 111.145 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.737 HD11 ' HB3' ' B' ' 64' ' ' PHE . 1.3 pp -55.82 -17.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.166 -0.959 . . . . 0.0 111.355 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.5 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.6 m-85 -49.04 134.29 17.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.785 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.434 ' N ' HG23 ' B' ' 102' ' ' THR . 11.5 m-20 -97.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -103.05 157.3 17.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.729 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.0 t -174.33 130.14 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -0.998 . . . . 0.0 110.542 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -36.59 77.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 110.207 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.59 79.3 47.33 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 110.248 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.731 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.5 Cg_endo -63.7 100.44 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.681 1.358 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.93 -21.0 10.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -0.922 . . . . 0.0 110.524 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.557 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -130.65 163.45 27.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 110.506 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.519 ' HA ' HG22 ' B' ' 103' ' ' ILE . 71.9 ttt180 -143.42 156.71 44.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.582 ' HD1' HD13 ' B' ' 103' ' ' ILE . 37.3 p-80 -89.75 166.42 13.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.455 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -148.08 161.22 41.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 110.404 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' B' ' 84' ' ' LEU . 25.9 mt -123.6 148.52 46.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.313 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.81 64.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.56 40.16 29.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.456 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.43 -133.74 2.85 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.921 HD13 ' CD ' ' B' ' 54' ' ' ARG . 2.0 tp -137.25 23.15 3.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -1.097 . . . . 0.0 110.241 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -86.03 -67.15 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 111.039 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.13 164.16 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 111.085 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.742 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 4.3 mtp -134.3 148.38 50.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 110.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.464 ' HB3' HD21 ' B' ' 29' ' ' LEU . 21.4 mtp180 -133.02 167.34 20.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.498 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.481 HD13 ' HZ ' ' B' ' 68' ' ' PHE . 65.2 mt -133.42 95.29 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.883 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 54.0 m-85 -90.53 -179.5 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 110.48 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.539 ' CG2' HD12 ' B' ' 95' ' ' ILE . 1.0 OUTLIER -117.76 94.18 4.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.731 HD11 ' O ' ' B' ' 74' ' ' PRO . 10.9 pt -55.83 -20.77 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 110.514 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.424 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.9 mttt -137.7 160.24 65.75 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 110.375 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.29 158.53 22.15 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.65 1.342 . . . . 0.0 110.421 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.539 HD12 ' CG2' ' B' ' 91' ' ' THR . 39.4 mt -144.64 136.48 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.271 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.77 166.01 11.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 110.767 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.905 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.3 mp -65.1 110.43 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.515 -0.741 . . . . 0.0 110.293 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.41 22.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.405 ' CB ' HG23 ' B' ' 95' ' ' ILE . 18.5 mm-40 -94.73 -179.33 4.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -1.171 . . . . 0.0 110.102 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.2 122.25 35.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.821 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.557 HG23 ' CB ' ' B' ' 76' ' ' ALA . 23.9 mt -89.49 131.14 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.48 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.434 HG23 ' N ' ' B' ' 69' ' ' ASN . 47.9 m -162.82 147.62 11.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.726 -0.609 . . . . 0.0 109.597 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.582 HD13 ' HD1' ' B' ' 78' ' ' HIS . 1.4 pt -114.98 165.2 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.753 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.17 -159.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.08 -93.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.937 . . . . 0.0 110.449 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.32 169.22 41.7 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.84 -58.62 7.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -1.121 . . . . 0.0 110.194 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -39.21 79.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.83 31.51 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.974 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.989 -1.069 . . . . 0.0 110.506 179.424 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 216' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.506 2.4 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.182 0.515 . . . . 0.0 110.665 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.535 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 54.47 174.87 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.348 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 25.3 Cg_exo . . . . . 0 C--N 1.312 -1.392 0 O-C-N 123.701 1.369 . . . . 0.0 110.572 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.471 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 25.7 p90 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.324 0.583 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.06 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.29 -22.11 6.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.583 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.492 ' C ' HG13 ' A' ' 6' ' ' VAL . 2.2 mmt85 -81.55 -41.1 22.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 0.0 110.593 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.492 HG13 ' C ' ' A' ' 5' ' ' ARG . 28.3 m -151.31 179.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 19' ' ' PHE . 9.4 tt -152.04 166.83 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.168 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 8' ' ' VAL . 12.6 p -104.66 125.15 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.958 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 20.5 mttt -128.59 142.73 50.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.576 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mtpp 52.09 58.14 5.75 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.717 -1.865 . . . . 0.0 111.066 1.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.435 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.519 -0.738 . . . . 0.0 110.268 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -97.4 91.66 5.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 110.57 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -126.7 -168.74 12.63 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.763 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.5 p -113.1 125.95 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.299 . . . . 0.0 109.524 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -90.1 161.79 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 110.497 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 101' ' ' ILE . . . -118.73 96.71 5.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 110.634 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -63.62 -20.0 65.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.0 109.793 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 14.2 mtpt -91.81 179.97 5.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.381 -0.824 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 39.9 m 103.9 16.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.166 -1.584 . . . . 0.0 110.403 0.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 42.3 m-85 -109.55 168.5 9.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.367 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 -167.18 1.32 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.966 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.12 4.08 18.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.43 86.73 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -151.04 147.98 27.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -1.17 . . . . 0.0 110.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.933 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 tm? -86.3 122.86 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.257 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.608 ' N ' HD13 ' A' ' 29' ' ' LEU . 59.2 t -81.88 -52.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.846 ' CG ' HD12 ' A' ' 89' ' ' ILE . 1.9 pt-20 -162.43 177.69 9.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.129 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.21 149.49 8.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 110.492 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.19 -157.84 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.275 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 86' ' ' ARG . 72.8 mt -109.13 -178.51 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 85' ' ' LYS . 72.4 m -145.41 174.2 11.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 ' CD2' ' A' ' 62' ' ' LEU . 60.6 mt -116.2 125.18 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.886 . . . . 0.0 109.832 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 84' ' ' LEU . 26.0 t -97.82 100.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 110.579 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 2.6 mmp_? -119.44 -172.05 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.383 -0.823 . . . . 0.0 110.214 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 36.8 m80 -104.29 -165.03 1.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.339 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -91.04 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 58.07 -137.5 0.9 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.869 -1.144 . . . . 0.0 110.435 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.44 -40.04 7.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.996 -1.065 . . . . 0.0 111.498 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.973 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 76.1 t-105 -57.66 -45.69 85.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.87 73.71 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.98 -63.51 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.24 . . . . 0.0 110.527 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.16 -55.61 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.915 ' HB3' HD13 ' A' ' 51' ' ' LEU . 3.9 mm? -89.49 52.37 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 57.42 3.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 -76.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.492 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 5.0 m-85 -89.52 48.21 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.973 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 6.1 tp -117.66 109.64 16.91 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.399 -0.813 . . . . 0.0 111.243 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -89.56 105.2 17.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.105 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.3 p -97.38 161.02 13.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 111.144 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.809 ' HB2' HD11 ' A' ' 84' ' ' LEU . 3.6 ttp180 -127.97 -172.36 2.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.481 -0.762 . . . . 0.0 109.959 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -83.69 84.63 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.031 -1.043 . . . . 0.0 109.334 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.8 OUTLIER 153.19 -22.01 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.75 -0.594 . . . . 0.0 109.778 -178.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.59 -168.1 0.22 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.281 -0.887 . . . . 0.0 110.735 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.1 m -132.22 134.82 45.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.469 -0.769 . . . . 0.0 109.921 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -127.88 166.69 17.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 111.031 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.847 ' CE ' HD12 ' A' ' 47' ' ' LEU . 1.2 ttt -96.1 170.46 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.857 . . . . 0.0 109.822 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.695 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.32 -54.04 4.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.156 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.497 0.0 OUTLIER 92.3 -81.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.819 -1.176 . . . . 0.0 110.513 -179.51 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.79 -143.48 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.33 56.65 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -1.065 . . . . 0.0 110.358 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.695 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -89.74 -43.31 5.17 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -63.39 -47.61 81.3 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.984 -1.304 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.8 pp -49.53 -22.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.876 . . . . 0.0 111.441 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.833 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.9 m-85 -50.19 113.45 0.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.767 -1.208 . . . . 0.0 110.415 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -102.0 -165.82 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 111.204 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -94.46 140.89 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.531 -0.731 . . . . 0.0 110.449 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.44 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.337 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -85.47 -19.48 31.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 110.528 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.54 74.93 53.88 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.844 ' O ' HD11 ' A' ' 92' ' ' ILE . 32.4 Cg_exo -57.57 106.04 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.697 1.367 . . . . 0.0 110.467 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 76' ' ' ALA . 50.4 p-10 -85.06 -13.9 48.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -142.51 141.16 32.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.985 -1.072 . . . . 0.0 110.46 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.05 -176.44 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -124.36 161.98 24.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 110.517 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.45 154.15 51.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.766 HD11 ' HA ' ' A' ' 84' ' ' LEU . 43.8 tp -132.42 139.97 48.26 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.67 -168.99 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.85 107.92 18.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 110.408 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 37' ' ' VAL . . . 122.61 12.95 4.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 54' ' ' ARG . 16.5 mt 52.39 32.85 11.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.0 110.405 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 35' ' ' CYS . 2.7 mmtp -100.21 -62.29 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 111.147 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.76 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.3 ttt180 -97.49 162.26 13.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.64 147.59 27.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.145 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.601 ' HB3' HD21 ' A' ' 29' ' ' LEU . 36.2 mtt180 -132.02 171.92 13.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.376 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.846 HD12 ' CG ' ' A' ' 31' ' ' GLU . 96.3 mt -135.78 116.25 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.933 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 21.5 m-85 -108.11 171.07 7.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.488 HG23 ' CG2' ' A' ' 30' ' ' VAL . 7.3 p -112.36 87.39 2.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 74' ' ' PRO . 3.2 pt -52.03 -23.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 110.583 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' ILE . 5.2 mmtt -132.03 151.13 77.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.401 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.08 143.88 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.666 1.35 . . . . 0.0 110.292 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.0 mt -126.27 141.0 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.532 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.42 163.61 12.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 110.182 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 21' ' ' ARG . 4.8 mt -63.75 121.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 110.511 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.6 38.71 2.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -117.54 170.34 8.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -1.17 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -114.89 126.06 54.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.269 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.763 ' HB ' HG13 ' A' ' 18' ' ' VAL . 98.0 mt -96.59 127.21 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' ILE . 35.6 p -156.03 176.64 12.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 104' ' ' SER . 2.5 pp -147.91 155.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.667 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.887 ' O ' HD12 ' A' ' 103' ' ' ILE . 33.0 t -68.75 -149.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 110.464 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.417 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 83.0 m-85 -135.89 -69.43 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.449 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.63 -177.92 30.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -64.03 -40.41 96.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 110.404 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -61.22 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.417 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.4 OUTLIER -69.98 106.99 3.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.468 ' CD2' ' O ' ' A' ' 110' ' ' TRP . 63.6 p-90 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.638 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.295 0.569 . . . . 0.0 110.471 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -124.57 168.49 12.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 23.5 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 O-C-N 123.706 1.371 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 25.7 p90 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.363 0.602 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.09 22.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.27 -22.1 6.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 110.627 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.501 ' C ' HG13 ' B' ' 6' ' ' VAL . 2.2 mmt85 -81.55 -41.2 21.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.59 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.501 HG13 ' C ' ' B' ' 5' ' ' ARG . 28.8 m -151.24 179.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.007 . . . . 0.0 110.559 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' B' ' 19' ' ' PHE . 9.4 tt -152.0 166.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.198 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.556 HG13 ' O ' ' B' ' 8' ' ' VAL . 12.6 p -104.67 125.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -0.951 . . . . 0.0 110.957 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 20.4 mttt -128.6 142.7 50.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.59 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mtpp 52.06 58.2 5.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.738 -1.852 . . . . 0.0 111.033 1.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.513 -0.742 . . . . 0.0 110.28 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -97.26 91.76 5.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 110.579 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -126.81 -168.9 12.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.778 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.6 p -112.82 125.8 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.937 -1.331 . . . . 0.0 109.685 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.659 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.5 OUTLIER -90.09 161.73 15.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 110.497 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' B' ' 101' ' ' ILE . . . -118.67 96.63 5.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.752 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -63.57 -19.96 65.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.867 178.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.534 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 14.2 mtpt -91.93 -179.94 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 109.799 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' B' ' 22' ' ' LYS 2.514 39.3 m 103.93 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.207 -1.558 . . . . 0.0 110.356 0.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 42.2 m-85 -109.48 168.61 9.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.404 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.59 -167.14 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.09 4.04 18.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.97 . . . . 0.0 110.9 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.35 86.7 0.12 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -151.05 147.97 27.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -1.168 . . . . 0.0 110.45 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.923 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.2 tm? -86.33 122.77 30.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.609 ' N ' HD13 ' B' ' 29' ' ' LEU . 59.4 t -81.85 -52.62 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.853 ' CG ' HD12 ' B' ' 89' ' ' ILE . 1.9 pt-20 -162.41 177.73 9.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.25 149.56 8.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.976 . . . . 0.0 110.517 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.21 -157.91 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 110.237 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.476 HD23 ' HG3' ' B' ' 86' ' ' ARG . 72.8 mt -109.08 -178.47 3.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.423 ' N ' ' O ' ' B' ' 85' ' ' LYS . 72.4 m -145.5 174.13 11.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.305 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.686 HD11 ' CD2' ' B' ' 62' ' ' LEU . 60.3 mt -116.12 125.18 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.792 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 84' ' ' LEU . 26.3 t -97.89 100.21 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.042 -1.036 . . . . 0.0 110.587 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.494 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 2.6 mmp_? -119.72 -172.15 2.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 36.7 m80 -104.07 -165.02 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.12 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 58.18 -137.54 0.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.912 -1.117 . . . . 0.0 110.413 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.43 -40.05 7.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.016 -1.053 . . . . 0.0 111.495 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.962 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 76.1 t-105 -57.69 -45.64 85.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 0.0 110.283 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.94 -21.92 73.67 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.97 -63.48 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.23 -55.56 33.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.482 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.916 ' HB3' HD13 ' B' ' 51' ' ' LEU . 3.9 mm? -89.53 52.43 2.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.244 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.33 57.44 3.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -76.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.491 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 5.0 m-85 -89.46 48.23 1.58 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.857 . . . . 0.0 109.424 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.962 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 6.0 tp -117.69 109.5 16.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.352 -0.842 . . . . 0.0 111.353 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -89.47 105.14 17.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.2 p -97.34 160.95 14.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 111.162 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.81 ' HB2' HD11 ' B' ' 84' ' ' LEU . 3.5 ttp180 -128.43 -174.88 3.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.535 -0.728 . . . . 0.0 109.99 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -80.0 84.41 5.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -0.954 . . . . 0.0 110.067 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.8 OUTLIER 153.0 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.41 -168.06 0.23 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.801 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.1 m -132.24 134.87 45.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -127.92 166.75 17.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.08 -1.013 . . . . 0.0 111.06 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.836 ' CE ' HD12 ' B' ' 47' ' ' LEU . 1.2 ttt -96.41 169.18 10.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.956 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.7 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.31 -55.02 4.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 111.487 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.93 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.499 0.0 OUTLIER 92.7 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.888 -1.133 . . . . 0.0 110.475 -179.181 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.85 -143.41 0.06 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.38 56.55 2.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -1.088 . . . . 0.0 110.362 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.7 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -89.73 -43.24 5.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.491 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -63.4 -47.6 81.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 110.396 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.814 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.8 pp -49.59 -22.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 111.448 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.814 ' N ' HD12 ' B' ' 67' ' ' ILE . 4.9 m-85 -50.23 113.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.701 -1.25 . . . . 0.0 110.43 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -102.06 -165.84 1.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -94.37 140.89 29.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.742 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.46 16.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.308 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -85.46 -19.56 31.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 110.49 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.47 74.86 53.07 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.14 -0.975 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.839 ' O ' HD11 ' B' ' 92' ' ' ILE . 32.3 Cg_exo -57.52 105.98 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.688 1.362 . . . . 0.0 110.494 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 76' ' ' ALA . 50.3 p-10 -85.05 -13.85 49.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.757 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.447 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -142.57 141.19 31.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.012 -1.055 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.07 -176.45 2.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.318 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -124.39 161.91 24.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.545 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.4 154.21 51.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.757 HD12 ' O ' ' B' ' 86' ' ' ARG . 44.4 tp -132.44 139.93 48.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.68 -168.95 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.93 107.88 18.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.463 ' O ' HG21 ' B' ' 37' ' ' VAL . . . 122.63 12.91 4.85 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.81 HD11 ' HB2' ' B' ' 54' ' ' ARG . 16.6 mt 52.38 32.85 11.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.862 -1.375 . . . . 0.0 110.462 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 35' ' ' CYS . 2.8 mmtp -100.21 -62.32 1.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 111.123 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.757 ' O ' HD12 ' B' ' 80' ' ' LEU . 2.3 ttt180 -97.47 162.28 13.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.994 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.62 147.58 27.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.583 ' HB3' HD21 ' B' ' 29' ' ' LEU . 36.2 mtt180 -132.0 171.97 12.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 110.324 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' B' ' 31' ' ' GLU . 96.3 mt -135.78 116.17 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.923 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 21.5 m-85 -108.16 171.1 7.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.491 HG23 ' CG2' ' B' ' 30' ' ' VAL . 7.3 p -112.4 87.42 2.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.839 HD11 ' O ' ' B' ' 74' ' ' PRO . 3.2 pt -52.15 -23.31 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.427 ' N ' HG13 ' B' ' 92' ' ' ILE . 5.2 mmtt -132.01 151.19 78.02 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -61.38 144.1 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.608 1.32 . . . . 0.0 110.213 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -126.31 141.04 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 110.531 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.44 163.6 12.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.752 HG23 ' O ' ' B' ' 21' ' ' ARG . 4.8 mt -63.79 121.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 110.545 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.7 2.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -117.5 170.36 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -1.179 . . . . 0.0 110.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.477 ' HG3' ' CE1' ' B' ' 19' ' ' PHE . 0.4 OUTLIER -114.88 126.15 54.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.778 ' HB ' HG13 ' B' ' 18' ' ' VAL . 97.8 mt -96.56 127.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.507 HG23 ' C ' ' B' ' 101' ' ' ILE . 35.1 p -155.95 176.74 12.25 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.889 HD12 ' O ' ' B' ' 104' ' ' SER . 2.5 pp -147.94 155.86 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 110.699 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.889 ' O ' HD12 ' B' ' 103' ' ' ILE . 33.0 t -68.74 -149.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 110.483 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.411 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 82.9 m-85 -135.89 -69.32 0.49 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 110.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.56 -177.97 29.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.98 -40.5 96.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 110.403 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -61.23 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.411 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.4 OUTLIER -70.05 107.1 3.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.475 ' CD2' ' O ' ' B' ' 110' ' ' TRP . 63.5 p-90 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.688 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.259 0.552 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -124.51 168.56 12.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 24.0 Cg_endo . . . . . 0 C--N 1.312 -1.393 0 O-C-N 123.723 1.38 . . . . 0.0 110.566 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 32.5 p90 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.357 0.599 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 5' ' ' ARG . 10.3 p30 -153.31 -172.57 4.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 111.02 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.68 -85.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.737 -0.602 . . . . 0.0 111.26 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.537 ' C ' HG23 ' A' ' 6' ' ' VAL . 7.3 mtm-85 -153.48 17.12 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.976 -1.078 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' C ' ' A' ' 5' ' ' ARG . 93.3 t -153.05 160.98 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.967 -1.083 . . . . 0.0 110.92 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.81 HG23 ' HB2' ' A' ' 19' ' ' PHE . 1.6 tt -124.02 154.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.64 141.06 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.796 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 10' ' ' LYS . 72.3 mttt -146.9 145.03 29.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.441 -0.787 . . . . 0.0 108.936 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.4 tppt? 52.4 80.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 119.629 -1.92 . . . . 0.0 110.273 2.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.346 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -118.44 83.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 110.355 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.3 -170.68 12.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.759 HG23 HD13 ' A' ' 67' ' ' ILE . 95.1 t -97.14 149.58 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.748 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.81 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.6 m-85 -114.83 121.89 44.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.426 -0.796 . . . . 0.0 109.286 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.57 86.99 6.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.125 -0.984 . . . . 0.0 111.009 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.824 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.19 -24.95 65.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.237 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 14.0 mttm -89.25 -179.73 5.93 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.47 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 102.4 20.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 119.953 -1.717 . . . . 0.0 109.808 2.589 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 3.8 m-85 -111.52 152.13 27.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.534 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -95.06 -165.14 1.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -95.62 120.23 35.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.62 5.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.99 128.61 46.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -1.152 . . . . 0.0 110.486 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.881 HD13 ' HG3' ' A' ' 88' ' ' ARG . 40.0 tp -53.28 164.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.932 . . . . 0.0 110.057 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.496 ' CG1' HG21 ' A' ' 6' ' ' VAL . 94.9 t -133.54 -71.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.36 66.44 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.519 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.568 ' HG2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.84 148.86 23.99 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.79 -165.59 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 110.408 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.35 160.1 15.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.865 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 53.4 m -134.41 -179.57 5.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.755 HD11 HD23 ' A' ' 62' ' ' LEU . 75.3 mt -113.35 151.34 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 84' ' ' LEU . 52.4 t -123.1 99.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -131.58 133.75 45.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 110.457 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.453 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -51.31 178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.977 . . . . 0.0 110.675 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 28.0 t30 -75.66 -132.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 0.0 110.423 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.93 -145.79 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.71 -1.244 . . . . 0.0 110.593 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.71 -28.06 0.94 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.194 -0.941 . . . . 0.0 111.394 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.67 ' HZ3' HD21 ' B' ' 47' ' ' LEU . 38.4 t-105 -57.34 -54.95 40.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 110.25 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . -67.23 -50.27 46.49 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.11 -44.19 42.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -1.159 . . . . 0.0 111.108 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 -49.27 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.553 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.97 ' HB2' HD11 ' A' ' 51' ' ' LEU . 4.1 mm? -91.42 28.22 1.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.93 . . . . 0.0 110.874 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 75.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.02 -1.05 . . . . 0.0 110.573 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -175.47 -37.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 110.95 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.839 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 39.4 m-85 -133.42 50.05 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.97 HD11 ' HB2' ' A' ' 47' ' ' LEU . 52.3 mt -124.11 131.02 53.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 111.423 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -91.2 105.93 18.15 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.7 p -87.78 111.43 21.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.114 -0.991 . . . . 0.0 111.058 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -177.16 3.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -0.76 . . . . 0.0 109.825 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -83.1 83.97 7.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.005 -1.059 . . . . 0.0 109.555 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.509 2.0 p-10 154.0 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.698 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -176.77 -160.64 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 110.673 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.421 ' O ' ' NE1' ' A' ' 43' ' ' TRP . 1.1 m -141.33 125.91 17.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.21 155.47 21.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 110.809 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.705 ' HA ' HD23 ' A' ' 51' ' ' LEU . 9.6 ttt -89.49 168.68 11.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.086 -1.009 . . . . 0.0 109.801 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.589 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.32 -24.89 27.48 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.241 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.755 HD23 HD11 ' A' ' 36' ' ' ILE 2.501 0.1 OUTLIER 62.49 -92.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 111.096 177.914 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.72 -144.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 93.0 m-85 -82.59 51.47 1.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -1.084 . . . . 0.0 110.829 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.589 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.73 -25.9 23.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.839 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.4 -43.87 10.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.691 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.967 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.5 pp -45.09 -23.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.553 -0.717 . . . . 0.0 112.083 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.967 ' N ' HD12 ' A' ' 67' ' ' ILE . 23.1 m-85 -55.17 142.21 31.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.61 -1.306 . . . . 0.0 109.775 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 102' ' ' THR . 82.7 m-20 -118.83 -169.46 1.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.03 . . . . 0.0 111.254 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -102.49 111.06 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 109.974 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.34 19.69 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 0.0 110.659 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt 52.62 23.33 2.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -174.38 65.24 0.28 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.055 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' O ' HD11 ' A' ' 92' ' ' ILE . 11.8 Cg_endo -59.63 83.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.632 1.333 . . . . 0.0 110.601 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.421 ' O ' ' CG1' ' A' ' 92' ' ' ILE . 22.1 m120 -59.12 -17.93 31.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -132.03 143.84 50.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.47 11.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 110.555 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -107.5 136.2 47.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.355 -0.841 . . . . 0.0 110.301 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 88' ' ' ARG . 32.9 tt0 -124.59 166.97 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.423 HD13 HD23 ' A' ' 84' ' ' LEU . 24.6 mt -126.24 147.96 49.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 86' ' ' ARG . 72.1 p -71.98 -79.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . . . -168.54 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.81 23.1 4.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 37' ' ' VAL . 43.7 mt 52.06 36.87 19.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -1.205 . . . . 0.0 110.512 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -104.52 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 110.751 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HB2' HG21 ' A' ' 81' ' ' THR . 8.1 mtt180 -84.88 179.29 7.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.976 . . . . 0.0 110.319 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.865 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.3 mtp -148.28 128.44 13.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.736 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.881 ' HG3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -114.38 106.16 13.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.44 -0.788 . . . . 0.0 110.091 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.48 113.27 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 109.929 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CE1' ' CD ' ' A' ' 88' ' ' ARG . 1.3 m-85 -101.93 177.17 4.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 p -113.92 99.32 7.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 110.028 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.492 HD12 ' CE ' ' A' ' 93' ' ' LYS . 4.2 pt -53.04 -22.21 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.135 -0.978 . . . . 0.0 110.399 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.492 ' CE ' HD12 ' A' ' 92' ' ' ILE . 45.1 mttt -148.24 146.75 23.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.16 -0.963 . . . . 0.0 110.175 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 93' ' ' LYS . 39.8 Cg_exo -56.84 129.41 34.44 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.673 1.354 . . . . 0.0 110.243 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' A' ' 20' ' ' ALA . 71.5 mt -104.76 148.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 110.594 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 167.35 11.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.575 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -71.32 123.41 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.503 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.85 39.97 2.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -124.65 -169.42 1.97 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -1.188 . . . . 0.0 110.381 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 23.7 tt0 -135.15 125.13 25.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 110.15 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG13 ' HB2' ' A' ' 20' ' ' ALA . 97.7 mt -89.39 137.99 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.533 HG23 ' C ' ' A' ' 101' ' ' ILE . 45.4 p -154.07 -174.2 4.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.651 -0.656 . . . . 0.0 110.073 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.572 HD12 ' O ' ' A' ' 104' ' ' SER . 1.5 pp -149.5 158.46 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.136 -0.977 . . . . 0.0 110.454 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' HD12 ' A' ' 103' ' ' ILE . 32.3 t -95.79 -164.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 12.8 m-85 -133.82 -66.61 0.63 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.211 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.04 -157.96 53.64 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 55.82 -86.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.948 . . . . 0.0 110.691 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.3 t0 -122.55 -31.41 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 110.644 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.5 m-85 -51.16 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.569 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.487 ' CE3' ' O ' ' A' ' 110' ' ' TRP . 51.9 p-90 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.73 . . . . 0.0 110.695 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.206 0.527 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.54 170.22 11.66 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.38 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 C--N 1.312 -1.383 0 O-C-N 123.659 1.347 . . . . 0.0 110.507 -179.817 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 32.2 p90 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.356 0.598 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' B' ' 5' ' ' ARG . 10.4 p30 -155.1 -173.21 4.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 110.815 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 20.6 m-20 54.97 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.707 -0.621 . . . . 0.0 111.211 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.543 ' C ' HG23 ' B' ' 6' ' ' VAL . 7.3 mtm-85 -153.5 17.3 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.989 -1.069 . . . . 0.0 111.064 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.543 HG23 ' C ' ' B' ' 5' ' ' ARG . 94.1 t -153.08 160.98 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 0.0 110.98 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' B' ' 19' ' ' PHE . 1.6 tt -124.0 154.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.781 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.7 141.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 110.831 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' B' ' 10' ' ' LYS . 72.2 mttt -147.09 145.0 29.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 108.967 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.592 ' HB3' ' HA ' ' B' ' 9' ' ' LYS . 3.4 tppt? 52.41 80.62 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.539 -1.976 . . . . 0.0 110.356 2.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.408 ' OG ' ' HB3' ' B' ' 9' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -118.29 83.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -1.112 . . . . 0.0 110.36 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.56 -170.62 12.66 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.742 HG23 HD13 ' B' ' 67' ' ' ILE . 95.7 t -97.07 149.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.947 -1.325 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.796 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.6 m-85 -114.9 121.69 43.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.755 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.28 86.97 6.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 111.113 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.84 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 109.225 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.475 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 13.9 mttm -89.19 -179.64 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.475 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.0 OUTLIER 102.45 20.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 119.938 -1.726 . . . . 0.0 109.805 2.493 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' B' ' 5' ' ' ARG . 3.8 m-85 -111.45 152.13 27.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 110.615 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -95.04 -165.07 1.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.217 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -95.6 120.22 35.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.61 46.56 5.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.02 128.6 46.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -1.12 . . . . 0.0 110.508 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.885 HD13 ' HG3' ' B' ' 88' ' ' ARG . 39.7 tp -53.19 164.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.944 . . . . 0.0 110.089 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.494 ' CG1' HG21 ' B' ' 6' ' ' VAL . 94.8 t -133.57 -71.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.32 66.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.529 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.574 ' HG2' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -57.92 148.86 24.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 110.201 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.76 -165.58 2.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 160.22 15.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.858 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 53.8 m -134.48 -179.66 5.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 110.228 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.757 HD11 HD23 ' B' ' 62' ' ' LEU . 75.3 mt -113.25 151.28 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.058 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.497 HG22 ' O ' ' B' ' 84' ' ' LEU . 52.8 t -123.05 99.36 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.17 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.5 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -131.6 133.75 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 110.444 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.443 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.1 OUTLIER -51.34 178.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 110.669 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 28.0 t30 -75.64 -132.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.415 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.0 -145.93 0.45 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.828 -1.17 . . . . 0.0 110.525 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.56 -28.13 0.89 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.211 -0.931 . . . . 0.0 111.443 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.667 ' HZ3' HD21 ' A' ' 47' ' ' LEU . 38.2 t-105 -57.32 -55.0 40.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 110.228 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' B' ' 48' ' ' GLU . . . -67.2 -50.32 46.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.04 -44.24 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.293 -1.122 . . . . 0.0 111.099 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.13 -48.66 13.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -0.99 . . . . 0.0 110.6 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.976 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.1 mm? -92.15 28.33 1.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.706 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 76.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.007 -1.058 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.5 OUTLIER -175.48 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.892 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.844 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 39.3 m-85 -133.31 50.13 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.102 -0.998 . . . . 0.0 110.447 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.976 HD11 ' HB2' ' B' ' 47' ' ' LEU . 52.3 mt -124.17 131.21 53.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -91.42 104.9 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 85.9 p -86.24 111.44 20.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.102 -0.999 . . . . 0.0 111.327 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -179.91 4.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.436 -0.79 . . . . 0.0 109.878 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -79.01 83.63 5.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.512 2.0 p-10 153.89 -27.61 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.656 -0.652 . . . . 0.0 109.743 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.1 OUTLIER -176.57 -160.45 0.06 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.37 -0.831 . . . . 0.0 110.698 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.415 ' O ' ' NE1' ' B' ' 43' ' ' TRP . 1.1 m -141.33 126.03 17.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.946 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.36 155.29 21.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.704 ' HA ' HD23 ' B' ' 51' ' ' LEU . 9.6 ttt -89.56 166.85 13.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.569 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.59 -26.19 32.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.757 HD23 HD11 ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER 62.95 -92.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 111.125 178.568 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.68 -144.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 93.1 m-85 -82.65 51.87 1.97 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -1.082 . . . . 0.0 110.758 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.569 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.29 -25.61 23.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.844 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.77 -43.74 9.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -1.17 . . . . 0.0 110.683 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.977 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.5 pp -45.13 -23.56 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.571 -0.705 . . . . 0.0 112.069 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.977 ' N ' HD12 ' B' ' 67' ' ' ILE . 23.1 m-85 -55.06 142.47 30.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.544 -1.348 . . . . 0.0 109.792 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.411 ' O ' ' HB ' ' B' ' 102' ' ' THR . 82.4 m-20 -119.11 -169.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 111.184 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -103.09 110.95 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.2 19.56 13.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 110.629 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt 52.73 23.31 2.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 110.206 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' B' ' 75' ' ' ASN . 0.9 OUTLIER -174.41 65.28 0.28 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 110.012 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.505 ' O ' HD11 ' B' ' 92' ' ' ILE . 11.9 Cg_endo -59.56 83.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.68 1.358 . . . . 0.0 110.591 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' B' ' 92' ' ' ILE . 22.2 m120 -59.16 -17.88 31.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.733 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -132.08 143.8 50.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.46 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.575 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -107.45 136.06 47.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' B' ' 88' ' ' ARG . 32.8 tt0 -124.47 167.04 14.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 110.305 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.428 HD13 HD23 ' B' ' 84' ' ' LEU . 24.7 mt -126.24 147.94 49.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.513 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.525 HG21 ' HB2' ' B' ' 86' ' ' ARG . 71.7 p -71.94 -79.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.55 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.83 23.08 4.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 37' ' ' VAL . 44.0 mt 52.05 36.84 19.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.238 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -104.45 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.525 ' HB2' HG21 ' B' ' 81' ' ' THR . 8.1 mtt180 -84.86 179.24 7.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.307 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.858 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.3 mtp -148.3 128.47 13.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 0.0 110.733 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.885 ' HG3' HD13 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -114.5 105.93 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 110.116 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.07 113.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 110.05 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.524 ' CE1' ' CD ' ' B' ' 88' ' ' ARG . 1.3 m-85 -101.98 177.12 4.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.552 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.9 p -113.87 99.33 7.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.505 HD11 ' O ' ' B' ' 74' ' ' PRO . 4.2 pt -53.01 -22.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.392 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.487 ' CE ' HD12 ' B' ' 92' ' ' ILE . 45.1 mttt -148.16 146.68 23.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.193 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.77 129.42 34.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.633 1.333 . . . . 0.0 110.247 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' B' ' 20' ' ' ALA . 71.4 mt -104.73 148.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.598 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.3 167.29 11.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.85 . . . . 0.0 110.562 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.84 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -71.27 123.38 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 110.463 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.87 39.93 2.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -124.65 -169.39 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -1.177 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 23.7 tt0 -135.26 124.88 25.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.755 HG13 ' HB2' ' B' ' 20' ' ' ALA . 97.8 mt -88.92 137.96 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 110.35 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.534 HG23 ' C ' ' B' ' 101' ' ' ILE . 44.7 p -154.12 -174.13 4.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.527 -0.733 . . . . 0.0 110.02 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.57 HD12 ' O ' ' B' ' 104' ' ' SER . 1.5 pp -149.48 158.46 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 0.0 110.444 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.57 ' O ' HD12 ' B' ' 103' ' ' ILE . 32.3 t -95.8 -164.16 1.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.347 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.471 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 12.9 m-85 -133.88 -66.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.99 -157.92 53.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 106' ' ' GLY . 14.6 t0 55.8 -86.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.499 -1.0 . . . . 0.0 110.72 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 106' ' ' GLY . 10.3 t0 -122.58 -31.4 3.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 110.646 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.471 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.4 m-85 -51.13 96.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 110.585 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.485 ' CE3' ' O ' ' B' ' 110' ' ' TRP . 52.0 p-90 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.807 . . . . 0.0 110.557 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.283 0.563 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -135.5 170.25 11.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.311 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 26.7 Cg_exo . . . . . 0 C--N 1.312 -1.388 0 O-C-N 123.714 1.376 . . . . 0.0 110.536 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 21.9 p90 . . . . . 0 N--CA 1.506 2.352 0 CA-C-O 121.475 0.655 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.93 144.97 25.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.27 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.61 -45.09 47.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.877 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.497 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -67.59 -37.89 83.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.937 . . . . 0.0 110.566 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG23 ' C ' ' A' ' 5' ' ' ARG . 56.2 t -150.22 141.04 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.43 ' CG2' ' HD2' ' A' ' 21' ' ' ARG . 14.7 tt -113.67 153.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 110.612 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 82.5 t -89.82 131.68 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 54.5 mttt -147.86 123.61 10.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.022 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.8 mptt 59.36 64.23 1.4 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 119.664 -1.898 . . . . 0.0 111.07 0.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 9' ' ' LYS . 1.2 t . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.339 -0.851 . . . . 0.0 110.622 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.473 ' CD2' ' HD3' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.82 88.64 2.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -1.159 . . . . 0.0 110.639 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.05 -171.27 12.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 67' ' ' ILE . 89.0 t -103.71 139.46 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.93 -1.335 . . . . 0.0 110.331 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 2.0 m-85 -109.44 124.6 51.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.747 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.761 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.85 97.52 11.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.29 -0.881 . . . . 0.0 111.137 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.748 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -68.39 -20.24 64.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 6.9 mttt -93.84 179.53 5.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.282 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.469 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 12.2 m 103.12 17.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.047 -1.658 . . . . 0.0 110.191 1.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 14.3 m-85 -112.03 165.5 12.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.557 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.33 -156.59 0.58 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 110.201 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 11.4 tttp -100.5 105.49 16.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.511 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.08 41.26 1.83 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.41 55.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -1.22 . . . . 0.0 110.444 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.818 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 tm? -64.28 124.31 21.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.383 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.715 ' CG2' HG23 ' A' ' 91' ' ' THR . 44.9 t -102.74 79.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 109.984 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.81 134.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -125.21 159.68 31.0 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.287 -0.883 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.4 -169.16 3.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 110.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.15 173.87 6.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 110.485 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -138.85 -173.73 3.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.952 ' CD1' HD23 ' A' ' 62' ' ' LEU . 50.0 mt -119.55 141.57 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.263 -0.898 . . . . 0.0 109.998 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 84' ' ' LEU . 91.8 t -111.68 122.38 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.962 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' CG ' ' CG ' ' A' ' 43' ' ' TRP . 27.1 tpt180 -150.11 131.92 15.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.398 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -53.5 -174.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.206 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.81 117.96 33.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.36 -0.838 . . . . 0.0 110.732 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.79 -141.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.76 -24.85 6.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.656 -1.277 . . . . 0.0 109.36 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 52.1 t-105 -56.59 -56.19 24.46 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.544 -0.722 . . . . 0.0 109.615 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.12 -28.39 70.54 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -72.96 -44.7 60.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -1.195 . . . . 0.0 110.679 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.4 -40.6 29.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.0 110.482 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.744 ' CB ' HD11 ' A' ' 51' ' ' LEU . 4.2 mm? -90.72 22.93 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 0.2 OUTLIER -64.64 78.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.101 -0.999 . . . . 0.0 110.454 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -169.18 -62.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.016 -1.052 . . . . 0.0 110.79 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.52 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 28.1 m-85 -121.98 55.84 1.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.057 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.744 HD11 ' CB ' ' A' ' 47' ' ' LEU . 15.5 mt -109.15 112.3 24.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 0.0 111.11 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.42 101.59 14.27 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.288 -0.882 . . . . 0.0 108.693 176.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.413 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 24.9 p -100.99 142.09 32.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -177.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.677 ' HD2' HD13 ' A' ' 84' ' ' LEU . 1.7 ttt180 -101.31 -170.96 1.91 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.479 -0.763 . . . . 0.0 109.844 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -83.43 80.76 8.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 36.4 t-20 155.29 -20.75 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.708 -0.62 . . . . 0.0 110.242 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.18 -177.58 1.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.968 -1.083 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.413 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -135.74 161.92 34.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 109.945 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.621 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -95.75 169.93 9.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.865 -1.147 . . . . 0.0 109.843 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.935 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -84.97 -14.91 46.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.714 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.952 HD23 ' CD1' ' A' ' 36' ' ' ILE 2.5 0.0 OUTLIER 61.1 -94.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 111.293 177.567 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -133.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.44 41.81 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.098 . . . . 0.0 110.747 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.935 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -81.05 -19.43 67.25 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -87.69 -51.16 6.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.0 110.656 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.7 pp -46.67 -24.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 111.491 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.62 ' N ' HD12 ' A' ' 67' ' ' ILE . 10.0 m-85 -52.56 142.02 19.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.642 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -96.88 96.53 8.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 110.022 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.5 m -115.22 143.04 45.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 110.513 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.95 136.48 57.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.21 2.95 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 92' ' ' ILE . 14.5 Cg_endo -61.01 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.685 1.361 . . . . 0.0 110.508 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 93' ' ' LYS . 50.7 m-80 -58.09 -19.44 32.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -123.53 150.19 44.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 0.0 110.567 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.568 ' HG3' HG21 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -128.32 -172.42 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 48.6 p-80 -135.46 156.26 49.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 110.644 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.94 124.24 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.616 HD12 ' HD2' ' C' ' 218' ' ' PRO . 13.3 mt -91.03 149.79 21.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 110.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 p -94.64 152.98 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.15 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.77 -5.79 3.74 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.279 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.794 ' HB3' HG22 ' A' ' 37' ' ' VAL . 1.8 tp 56.09 20.99 4.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.826 -1.396 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -22.29 19.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 111.085 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.57 157.96 45.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.901 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.78 138.09 49.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.765 . . . . 0.0 110.051 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' HIS . 4.6 mtt180 -116.55 151.32 36.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 110.616 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.533 ' O ' HD22 ' A' ' 29' ' ' LEU . 74.0 mt -125.88 121.24 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 15.6 m-85 -117.81 -170.14 1.81 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.454 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' CG2' ' A' ' 30' ' ' VAL . 1.1 p -131.51 93.84 3.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.893 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 74' ' ' PRO . 48.4 pt -51.07 -29.79 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.44 ' N ' HG13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -137.59 143.53 41.14 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 149.88 10.59 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.529 1.279 . . . . 0.0 110.669 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 20' ' ' ALA . 69.1 mt -122.52 150.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.727 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.01 161.91 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 110.155 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 21' ' ' ARG . 10.5 mt -65.82 96.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.249 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.23 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.452 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 35.0 mm-40 -116.94 168.46 10.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -1.104 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' OE1' HG21 ' A' ' 102' ' ' THR . 2.9 tm-20 -107.14 117.95 35.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.989 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.761 HG13 ' HB2' ' A' ' 20' ' ' ALA . 97.5 mt -89.63 128.22 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.515 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.522 HG23 ' C ' ' A' ' 101' ' ' ILE . 62.5 p -153.99 176.76 11.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.877 -0.514 . . . . 0.0 109.678 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -143.65 158.94 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 110.435 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -87.62 -158.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.32 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.47 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 34.1 m-85 -133.19 -59.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.06 -167.09 36.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.55 -34.2 77.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -1.136 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.359 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.47 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 2.1 m-85 -51.99 110.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.703 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 34.1 m95 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.9 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.271 0.558 . . . . 0.0 110.586 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.664 ' HB1' ' HG3' ' A' ' 54' ' ' ARG . . . -150.96 123.8 4.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.391 -0.818 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.616 ' HD2' HD12 ' A' ' 80' ' ' LEU . 38.2 Cg_exo . . . . . 0 C--N 1.314 -1.284 0 O-C-N 123.364 1.191 . . . . 0.0 110.568 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 21.9 p90 . . . . . 0 N--CA 1.506 2.339 0 CA-C-O 121.49 0.662 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.91 144.96 25.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.58 -45.12 47.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.495 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.2 OUTLIER -67.54 -37.94 83.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.586 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.495 HG23 ' C ' ' B' ' 5' ' ' ARG . 56.0 t -150.16 141.06 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 14.7 tt -113.66 153.04 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 110.645 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' B' ' 9' ' ' LYS . 82.9 t -89.7 131.76 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.629 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 54.4 mttt -148.05 123.73 10.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.629 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.8 mptt 59.49 64.17 1.39 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.726 -1.859 . . . . 0.0 111.037 0.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.64 179.257 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' B' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 88.67 2.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 110.588 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.01 -171.36 12.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' B' ' 67' ' ' ILE . 86.2 t -103.66 139.25 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.955 -1.321 . . . . 0.0 110.373 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 2.0 m-85 -109.41 124.57 51.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 109.759 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.773 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.78 97.54 11.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 111.14 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.742 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -68.4 -20.24 64.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.714 177.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.459 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 6.9 mttt -93.78 179.62 5.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.274 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.511 12.0 m 103.2 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.055 -1.653 . . . . 0.0 110.17 1.28 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.433 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 14.1 m-85 -112.1 165.56 12.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.138 -0.976 . . . . 0.0 110.573 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.38 -156.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 110.159 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.407 ' HG3' ' HA ' ' B' ' 93' ' ' LYS . 11.3 tttp -100.51 105.51 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 110.549 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.09 41.27 1.83 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.43 55.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 110.437 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.827 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.1 tm? -64.23 124.3 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 110.451 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' B' ' 91' ' ' THR . 45.1 t -102.78 79.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 110.017 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.85 134.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.511 -0.743 . . . . 0.0 110.741 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -125.22 159.63 31.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.428 -0.795 . . . . 0.0 109.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.53 -169.19 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.554 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' B' ' 86' ' ' ARG . 0.1 OUTLIER -112.24 173.89 6.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 110.521 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -138.81 -173.81 3.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.953 ' CD1' HD23 ' B' ' 62' ' ' LEU . 49.4 mt -119.49 141.52 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.0 110.002 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.8 HG22 ' HB3' ' B' ' 84' ' ' LEU . 91.6 t -111.62 122.41 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.964 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.507 ' CG ' ' CG ' ' B' ' 43' ' ' TRP . 27.1 tpt180 -150.17 131.82 14.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.0 110.477 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -53.44 -174.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 0.0 111.154 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.79 117.85 33.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.73 -141.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.7 -25.03 6.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.609 -1.307 . . . . 0.0 109.35 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.507 ' CG ' ' CG ' ' B' ' 38' ' ' ARG . 52.2 t-105 -56.49 -56.23 23.84 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.62 -0.675 . . . . 0.0 109.628 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.37 70.37 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.1 m -73.01 -44.76 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -1.155 . . . . 0.0 110.598 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.47 -40.28 30.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 110.464 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.746 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.2 mm? -91.14 23.16 3.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.583 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 0.2 OUTLIER -64.78 78.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 110.4 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.2 OUTLIER -169.14 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 110.79 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.513 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 28.2 m-85 -121.86 55.94 1.09 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.985 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' B' ' 47' ' ' LEU . 15.5 mt -109.19 112.35 24.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 111.208 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.49 101.47 14.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.71 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.409 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 24.8 p -100.86 142.09 32.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.441 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.683 ' HD2' HD13 ' B' ' 84' ' ' LEU . 1.7 ttt180 -101.79 -173.67 2.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.469 -0.77 . . . . 0.0 109.853 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -79.67 80.48 6.05 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 36.7 t-20 155.22 -20.96 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.621 -0.675 . . . . 0.0 110.231 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.09 -177.55 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 111.078 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 0.9 OUTLIER -123.88 143.06 50.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.536 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.562 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -135.8 161.92 34.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.005 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.613 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -96.28 167.97 10.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.985 179.024 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.956 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.03 -16.41 50.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 111.142 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.953 HD23 ' CD1' ' B' ' 36' ' ' ILE 2.501 0.0 OUTLIER 61.73 -94.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 111.29 178.221 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.25 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -88.53 41.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -1.104 . . . . 0.0 110.76 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.956 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -81.0 -19.49 67.25 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.513 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -87.71 -51.12 6.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.162 -1.199 . . . . 0.0 110.645 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.601 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.7 pp -46.62 -24.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.844 . . . . 0.0 111.528 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.601 ' N ' HD12 ' B' ' 67' ' ' ILE . 10.0 m-85 -52.51 142.02 18.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.857 -1.152 . . . . 0.0 110.351 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.957 . . . . 0.0 110.662 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -96.89 96.28 8.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 110.049 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 34.1 m -114.91 143.17 45.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.99 136.43 57.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.3 2.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.631 ' O ' HD11 ' B' ' 92' ' ' ILE . 14.7 Cg_endo -60.99 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.664 1.35 . . . . 0.0 110.536 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -58.11 -19.5 32.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.581 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -123.44 150.26 44.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.636 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.554 ' HG3' HG21 ' B' ' 92' ' ' ILE . 0.7 OUTLIER -128.39 -172.48 2.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 110.186 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 48.5 p-80 -135.39 156.21 49.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 0.0 110.675 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.93 124.33 17.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 110.187 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' D' ' 218' ' ' PRO . 13.4 mt -91.03 149.7 21.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.544 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 21.3 p -94.61 153.01 18.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.253 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.14 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 110.182 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.76 -5.87 3.75 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.24 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' B' ' 37' ' ' VAL . 1.8 tp 56.11 20.98 4.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.843 -1.387 . . . . 0.0 110.272 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.56 -22.16 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 111.091 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 0.0 OUTLIER -134.62 157.98 45.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.034 -1.041 . . . . 0.0 110.913 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.74 138.01 49.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.071 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' B' ' 78' ' ' HIS . 4.6 mtt180 -116.47 151.38 36.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 110.68 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.527 ' O ' HD22 ' B' ' 29' ' ' LEU . 73.4 mt -125.85 121.16 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.882 . . . . 0.0 109.95 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.827 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 15.6 m-85 -117.75 -170.15 1.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.491 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.72 HG23 ' CG2' ' B' ' 30' ' ' VAL . 1.1 p -131.5 93.88 3.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.891 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.631 HD11 ' O ' ' B' ' 74' ' ' PRO . 48.2 pt -51.03 -29.83 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.681 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.445 ' N ' HG13 ' B' ' 92' ' ' ILE . 1.0 OUTLIER -137.6 143.57 41.26 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 110.361 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.05 149.9 11.01 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.596 1.314 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.486 HG21 ' CB ' ' B' ' 20' ' ' ALA . 69.1 mt -122.53 150.55 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.98 161.93 13.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.395 -0.816 . . . . 0.0 110.127 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.742 HG23 ' O ' ' B' ' 21' ' ' ARG . 10.6 mt -65.89 96.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.21 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.447 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 34.9 mm-40 -117.0 168.44 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -1.17 . . . . 0.0 110.402 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.417 ' OE1' HG21 ' B' ' 102' ' ' THR . 2.9 tm-20 -107.07 117.95 35.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.912 . . . . 0.0 110.042 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.773 HG13 ' HB2' ' B' ' 20' ' ' ALA . 96.9 mt -89.53 128.25 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.513 HG23 ' C ' ' B' ' 101' ' ' ILE . 61.3 p -153.98 176.85 11.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.716 -0.615 . . . . 0.0 109.67 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.659 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -143.63 158.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.659 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.2 OUTLIER -87.7 -158.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 34.1 m-85 -133.21 -59.68 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.98 -167.13 36.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.49 -34.27 77.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 0.0 110.356 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.474 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 2.1 m-85 -52.03 110.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.728 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' B' ' 110' ' ' TRP . 34.1 m95 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.878 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.283 0.563 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.673 ' HB1' ' HG3' ' B' ' 54' ' ' ARG . . . -150.89 123.75 4.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' B' ' 80' ' ' LEU . 37.7 Cg_exo . . . . . 0 C--N 1.314 -1.283 0 O-C-N 123.322 1.169 . . . . 0.0 110.539 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 10.0 p90 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.348 0.594 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 5' ' ' ARG . 42.5 t30 -145.93 162.58 37.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.85 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.539 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.498 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER 178.33 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.414 -0.804 . . . . 0.0 109.414 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG11 ' CG1' ' A' ' 30' ' ' VAL . 18.9 m -155.4 179.98 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 109.727 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.44 166.58 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 110.04 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 8' ' ' VAL . 7.6 p -108.39 144.78 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.784 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 4.9 mttt -140.84 142.72 34.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.617 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.3 56.99 6.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.663 -1.898 . . . . 0.0 110.6 2.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.629 -0.67 . . . . 0.0 109.988 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 2.5 m-85 -106.2 77.93 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -1.216 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -114.97 -165.0 14.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.542 ' HB ' HD13 ' A' ' 67' ' ' ILE . 1.5 p -117.75 130.02 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.927 -1.337 . . . . 0.0 108.839 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -89.77 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 111.06 -177.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -107.0 96.23 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -0.764 . . . . 0.0 110.385 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 97' ' ' ILE . 12.0 ttt-85 -70.14 -18.31 63.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -97.54 177.96 5.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.531 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.447 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.515 50.6 m 106.48 21.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.097 -1.627 . . . . 0.0 110.12 1.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 20.3 m-85 -114.47 155.21 26.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.395 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.43 ' O ' ' CA ' ' A' ' 94' ' ' PRO . 1.1 mt-10 -88.17 -82.81 0.22 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.798 . . . . 0.0 109.885 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 24.5 tttt -175.91 92.19 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.924 -1.11 . . . . 0.0 110.012 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.67 19.34 4.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -97.59 152.36 19.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.235 . . . . 0.0 110.307 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.857 HD21 ' HB3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -78.02 121.55 24.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 110.379 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.606 ' CG2' HG23 ' A' ' 91' ' ' THR . 88.6 t -84.64 -46.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.65 145.37 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 110.201 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -128.76 149.39 50.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.425 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.435 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 64.5 m -140.91 -154.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 110.123 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -110.35 175.94 5.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 110.623 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.1 m -147.23 164.34 33.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.409 -0.807 . . . . 0.0 109.592 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.045 HD11 HD23 ' A' ' 62' ' ' LEU . 22.4 mt -108.14 141.75 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 109.985 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 84' ' ' LEU . 61.0 t -117.31 120.97 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 110.537 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 21.7 tpt180 -148.82 143.21 26.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.445 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.33 -169.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.46 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.808 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -162.62 -136.14 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' B' ' 42' ' ' ASP . 72.5 m-20 -51.63 -25.12 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 109.518 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.638 ' CZ3' HD21 ' B' ' 47' ' ' LEU . 34.3 t-105 -58.52 -56.59 20.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.585 -0.697 . . . . 0.0 109.462 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.84 -34.21 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.8 m -70.82 -67.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 110.404 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.53 -51.72 58.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 110.538 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.667 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.4 mm? -90.39 39.57 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 110.62 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 61.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.775 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -179.5 140.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.236 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 9.7 m-85 61.41 31.92 19.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.248 -0.908 . . . . 0.0 110.448 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 60' ' ' MET . 15.3 mt -106.3 134.57 49.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -108.88 103.33 12.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 12.0 t -89.54 127.63 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 0.0 111.553 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.595 ' CD ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -101.91 -174.48 2.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.539 -0.725 . . . . 0.0 109.752 178.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.36 73.88 9.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.016 -1.053 . . . . 0.0 109.124 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 56' ' ' ASN 2.505 5.9 t-20 169.92 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.878 -0.514 . . . . 0.0 109.988 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -176.15 -168.13 0.25 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.261 -0.899 . . . . 0.0 110.952 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 1.3 p -116.58 138.8 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.17 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.73 ' HB2' HD13 ' A' ' 84' ' ' LEU . . . -131.59 168.09 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 110.375 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.667 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -105.84 172.92 6.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 109.857 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.892 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.23 -35.61 21.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.045 HD23 HD11 ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.09 -94.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 111.288 178.128 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -70.3 -118.91 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -90.35 27.34 1.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.345 -1.091 . . . . 0.0 110.934 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.892 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -77.43 -22.6 69.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -90.94 -47.37 7.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.542 HD13 ' HB ' ' A' ' 18' ' ' VAL . 2.4 pp -47.66 -25.88 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.208 -0.932 . . . . 0.0 110.789 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CG ' HG12 ' A' ' 103' ' ' ILE . 6.5 m-85 -46.39 113.25 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -92.3 179.19 5.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 110.87 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -101.77 116.91 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.828 . . . . 0.0 109.882 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.11 130.71 51.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.373 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -52.62 -23.71 7.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 110.329 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.56 71.52 0.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 110.368 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.797 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.8 Cg_endo -64.54 112.12 1.85 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.648 1.341 . . . . 0.0 110.312 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.413 ' HA ' ' HE2' ' A' ' 93' ' ' LYS . 18.9 m-20 -111.32 18.49 19.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 110.616 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.7 162.56 40.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.0 ttt-85 -146.03 158.55 43.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.479 ' ND1' HD13 ' A' ' 103' ' ' ILE . 19.5 p-80 -110.09 158.78 17.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -141.35 142.63 33.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' A' ' 87' ' ' MET . 6.6 mt -106.75 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -90.08 68.2 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.15 34.41 11.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.24 171.68 38.77 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.73 HD13 ' HB2' ' A' ' 59' ' ' ALA . 85.4 mt -93.45 32.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -1.148 . . . . 0.0 109.998 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -93.34 -71.76 0.64 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.331 -0.856 . . . . 0.0 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.68 159.52 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.451 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 1.1 tmm? -142.47 138.77 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.569 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.857 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -121.08 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -0.96 . . . . 0.0 110.124 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.05 124.4 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.664 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 17.7 m-85 -113.35 -176.5 2.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.606 HG23 ' CG2' ' A' ' 30' ' ' VAL . 18.4 p -124.93 95.78 4.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.797 HD11 ' O ' ' A' ' 74' ' ' PRO . 30.7 pt -51.16 -24.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.6 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 0.5 OUTLIER -145.68 157.05 52.21 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.43 ' CA ' ' O ' ' A' ' 25' ' ' GLU . 23.9 Cg_exo -59.12 147.19 91.63 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.738 1.388 . . . . 0.0 111.179 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.417 HG21 ' CB ' ' A' ' 20' ' ' ALA . 66.8 mt -131.7 145.29 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.606 -0.684 . . . . 0.0 110.33 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.25 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.373 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -66.97 112.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.36 26.09 2.51 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -113.69 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.241 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 85.7 tt0 -116.47 135.9 53.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 110.631 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.961 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 39.2 mt -99.89 125.95 53.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.748 0.785 . . . . 0.0 110.521 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.9 p -154.73 171.57 19.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.761 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -146.96 165.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.098 . . . . 0.0 110.655 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.761 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -88.75 -164.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CD2' ' NE1' ' A' ' 110' ' ' TRP . 17.3 m-85 -123.47 -66.25 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.041 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.58 153.92 9.79 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.25 -24.33 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -1.166 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -55.1 4.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 110.064 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -71.56 60.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 110.661 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.467 ' NE1' ' CD2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.24 -0.913 . . . . 0.0 110.317 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.285 0.564 . . . . 0.0 110.402 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -116.62 167.93 9.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 16.2 Cg_endo . . . . . 0 C--N 1.311 -1.406 0 O-C-N 123.696 1.366 . . . . 0.0 110.534 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.0 p90 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.272 0.558 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' B' ' 5' ' ' ARG . 42.5 t30 -145.92 162.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.223 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.9 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.432 -0.792 . . . . 0.0 110.537 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.494 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.9 OUTLIER 178.36 -35.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.395 -0.816 . . . . 0.0 109.404 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.601 HG11 HG13 ' B' ' 30' ' ' VAL . 18.9 m -155.37 -179.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.494 -0.754 . . . . 0.0 109.791 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.45 166.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.31 144.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 110.816 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.605 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 5.0 mttt -140.83 142.8 34.56 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.605 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.31 56.97 6.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 119.703 -1.873 . . . . 0.0 110.626 2.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.415 ' N ' ' HB3' ' B' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 110.007 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 2.5 m-85 -106.22 78.11 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 110.541 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -115.22 -165.27 14.66 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' B' ' 67' ' ' ILE . 1.6 p -117.39 129.8 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.295 . . . . 0.0 109.153 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.493 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.6 OUTLIER -89.76 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 111.088 -177.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.956 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -106.99 96.1 6.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.38 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.651 ' O ' HG23 ' B' ' 97' ' ' ILE . 11.9 ttt-85 -70.06 -18.37 63.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 110.027 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -97.44 178.08 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.452 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 50.8 m 106.53 21.27 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.066 -1.646 . . . . 0.0 110.112 1.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 20.4 m-85 -114.69 154.48 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.527 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.43 ' O ' ' CA ' ' B' ' 94' ' ' PRO . 1.2 mt-10 -87.23 -83.07 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' B' ' 25' ' ' GLU . 24.7 tttt -175.8 92.17 0.05 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.921 -1.112 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.68 19.37 4.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -97.62 152.35 19.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.268 . . . . 0.0 110.297 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' B' ' 88' ' ' ARG . 0.8 OUTLIER -78.04 121.55 24.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.442 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.601 HG13 HG11 ' B' ' 6' ' ' VAL . 88.4 t -84.65 -46.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 110.163 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.69 145.35 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 110.192 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.69 149.4 50.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.962 . . . . 0.0 110.435 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.441 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 64.3 m -140.91 -154.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.13 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.31 175.96 5.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 110.645 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 11.9 m -147.33 164.26 33.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.453 -0.779 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 1.048 HD11 HD23 ' B' ' 62' ' ' LEU . 22.2 mt -108.07 141.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.001 -1.062 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' B' ' 84' ' ' LEU . 61.1 t -117.28 120.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.515 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.502 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 21.6 tpt180 -148.76 143.24 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.36 -169.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.45 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.735 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -162.63 -136.23 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 72.4 m-20 -51.53 -25.16 6.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.557 -1.339 . . . . 0.0 109.571 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.589 ' CZ3' HD21 ' A' ' 47' ' ' LEU . 34.3 t-105 -58.51 -56.58 20.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.555 -0.715 . . . . 0.0 109.481 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.85 -34.19 64.78 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 48.0 m -70.76 -67.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -1.144 . . . . 0.0 110.433 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.403 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . . . -52.71 -51.45 60.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.671 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.4 mm? -90.63 39.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.36 61.28 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.746 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.478 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -179.51 140.18 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 9.7 m-85 61.31 32.02 19.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.306 -0.871 . . . . 0.0 110.369 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' B' ' 60' ' ' MET . 15.2 mt -106.23 134.81 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.986 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -109.17 103.04 11.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -89.09 127.62 35.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.068 -1.02 . . . . 0.0 111.597 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.585 ' CD ' HD21 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -102.59 -177.56 3.42 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.577 -0.702 . . . . 0.0 109.832 178.266 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.95 73.37 4.51 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 110.129 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' B' ' 56' ' ' ASN 2.507 6.1 t-20 169.8 -30.8 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.721 -0.612 . . . . 0.0 109.994 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.97 -167.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.3 p -116.61 138.73 51.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.214 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.735 ' HB2' HD13 ' B' ' 84' ' ' LEU . . . -131.62 168.03 18.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.444 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.671 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -106.18 170.95 7.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.914 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.31 -36.96 26.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 111.126 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 1.048 HD23 HD11 ' B' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.64 -94.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.0 111.271 178.765 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -70.34 -118.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -90.56 27.33 1.76 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -1.092 . . . . 0.0 110.933 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.914 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -77.46 -22.22 70.73 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -91.61 -47.14 7.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.121 -1.223 . . . . 0.0 110.823 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' B' ' 18' ' ' VAL . 2.4 pp -47.75 -25.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.266 -0.897 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.51 ' CG ' HG12 ' B' ' 103' ' ' ILE . 6.5 m-85 -46.38 113.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 111.138 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -92.34 179.41 5.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.812 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -102.03 116.84 33.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.4 -0.812 . . . . 0.0 109.845 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.01 130.78 51.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.193 -0.942 . . . . 0.0 110.417 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -52.61 -23.77 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.58 71.5 0.92 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.318 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.799 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.4 Cg_endo -64.38 112.01 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.685 1.361 . . . . 0.0 110.266 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 19.1 m-20 -111.29 18.51 19.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.395 -0.815 . . . . 0.0 110.478 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.67 162.59 40.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.54 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.47 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.0 ttt-85 -146.11 158.45 43.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.16 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.48 ' ND1' HD13 ' B' ' 103' ' ' ILE . 19.5 p-80 -110.0 158.81 17.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.38 142.67 33.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.281 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' B' ' 87' ' ' MET . 6.6 mt -106.76 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.445 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.4 p -90.05 68.16 7.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.18 34.34 11.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.399 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.26 171.68 38.78 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.735 HD13 ' HB2' ' B' ' 59' ' ' ALA . 85.2 mt -93.41 32.29 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.248 -1.148 . . . . 0.0 110.08 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -93.57 -71.66 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.56 14.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.499 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.445 ' HG2' ' CD2' ' B' ' 80' ' ' LEU . 1.0 OUTLIER -142.57 138.75 31.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.563 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.855 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -121.1 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 110.114 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.04 124.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.495 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.662 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 17.8 m-85 -113.24 -176.52 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.344 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.593 HG23 ' CG2' ' B' ' 30' ' ' VAL . 18.3 p -124.94 95.91 4.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.097 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.799 HD11 ' O ' ' B' ' 74' ' ' PRO . 30.5 pt -51.16 -24.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 110.572 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 0.5 OUTLIER -145.63 157.17 52.19 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.177 -0.952 . . . . 0.0 110.551 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.43 ' CA ' ' O ' ' B' ' 25' ' ' GLU . 24.1 Cg_exo -59.5 147.33 92.0 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.704 1.37 . . . . 0.0 111.111 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.427 HG21 ' CB ' ' B' ' 20' ' ' ALA . 67.1 mt -131.67 145.4 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.577 -0.702 . . . . 0.0 110.308 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.28 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -66.95 112.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 110.348 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 26.11 2.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -113.7 179.45 3.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -1.226 . . . . 0.0 110.034 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' B' ' 19' ' ' PHE . 85.6 tt0 -116.3 136.03 53.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.045 . . . . 0.0 110.568 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.956 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 40.6 mt -99.98 126.06 53.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.471 -0.768 . . . . 0.0 110.538 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.501 HG23 ' O ' ' B' ' 101' ' ' ILE . 16.6 p -154.69 171.72 19.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.755 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -147.0 165.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.927 -1.108 . . . . 0.0 110.669 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.755 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.4 OUTLIER -88.8 -164.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.422 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.47 ' CD2' ' NE1' ' B' ' 110' ' ' TRP . 17.3 m-85 -123.1 -66.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.52 153.96 9.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.22 -24.41 4.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -55.11 4.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -71.52 60.32 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 110.693 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.47 ' NE1' ' CD2' ' B' ' 105' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.303 0.573 . . . . 0.0 110.432 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -116.64 168.0 9.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 16.3 Cg_endo . . . . . 0 C--N 1.312 -1.37 0 O-C-N 123.696 1.366 . . . . 0.0 110.561 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 21.8 p90 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.32 0.581 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.83 156.04 49.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.14 -18.45 15.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.791 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.514 ' C ' HG13 ' A' ' 6' ' ' VAL . 2.1 mtm-85 -97.6 -29.03 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 110.914 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.514 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.1 m -153.45 -172.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 110.415 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 19' ' ' PHE . 13.6 tt -154.81 165.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 110.205 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.77 137.83 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.98 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 31.1 mttt -142.21 143.64 33.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.588 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER 52.73 66.21 1.29 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.757 -1.839 . . . . 0.0 111.161 1.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.457 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.568 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -102.58 73.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.247 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.71 -165.22 23.4 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.713 HG13 ' HB ' ' A' ' 101' ' ' ILE . 1.9 p -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.951 -1.323 . . . . 0.0 109.553 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.1 m-85 -89.79 158.55 17.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.564 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.692 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -113.09 105.32 13.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 110.645 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -63.71 -28.45 69.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.516 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 5.3 mttm -86.5 -178.36 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.46 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.507 4.8 t 99.53 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.031 -1.668 . . . . 0.0 110.493 1.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 22.2 m-85 -96.83 158.63 15.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.047 -1.033 . . . . 0.0 110.893 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 -155.69 0.48 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.479 -0.763 . . . . 0.0 110.011 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 58.8 tttt -95.94 30.88 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.27 86.21 0.06 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -150.07 124.6 9.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 110.337 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.812 HD23 ' CG ' ' A' ' 88' ' ' ARG . 3.4 tm? -54.34 119.96 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.3 -52.72 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 31' ' ' GLU . 8.6 pt-20 -170.73 97.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.25 152.24 34.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -150.36 -151.22 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.77 171.93 7.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 1.03 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 1.3 m -150.14 150.42 31.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.627 HD11 ' CD2' ' A' ' 62' ' ' LEU . 56.2 mt -91.18 142.71 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 84' ' ' LEU . 42.0 t -117.63 127.91 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 110.769 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.524 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 19.2 mmt180 -150.36 178.2 9.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -92.14 -173.73 3.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.111 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.57 -141.93 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.407 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.74 -135.02 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.06 -1.025 . . . . 0.0 110.826 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.63 -49.06 7.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 111.521 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 1.019 ' NE1' HD21 ' A' ' 51' ' ' LEU . 36.8 t-105 -51.54 -46.71 63.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.26 76.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.414 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 44.9 m -74.46 -59.96 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -1.216 . . . . 0.0 110.826 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' O ' ' NH2' ' B' ' 38' ' ' ARG . . . -50.69 -54.48 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.639 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.023 HD21 HD21 ' B' ' 47' ' ' LEU . 3.1 mm? -91.91 23.3 3.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.0 pp20? -50.67 154.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.952 -1.092 . . . . 0.0 110.005 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 54.9 t0 60.86 147.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.778 . . . . 0.0 110.164 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.28 13.68 7.18 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.145 -0.972 . . . . 0.0 110.303 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.019 HD21 ' NE1' ' A' ' 43' ' ' TRP . 8.9 tp -112.52 107.79 16.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.87 119.06 29.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -109.27 136.0 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 0.0 111.066 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.747 ' HD3' HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -102.29 -172.04 2.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.391 -0.818 . . . . 0.0 109.806 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.03 72.91 9.09 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.958 -1.089 . . . . 0.0 108.967 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 6.3 m120 175.08 -33.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.458 ' HG2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.59 -173.51 0.33 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.352 -0.842 . . . . 0.0 110.331 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -112.75 146.92 37.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -141.8 151.64 43.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.618 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.686 ' HA ' HD12 ' A' ' 51' ' ' LEU . 29.3 tpp -90.17 156.77 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.811 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.83 93.39 9.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.973 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.497 0.1 OUTLIER -54.53 -65.5 0.56 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 110.427 179.194 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -60.69 -159.49 0.07 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' HB3' HD11 ' A' ' 67' ' ' ILE . 5.1 m-85 -75.36 58.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -1.091 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.16 -36.34 7.16 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.7 73.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 110.661 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.693 HD13 ' HB ' ' A' ' 18' ' ' VAL . 1.2 pp -51.84 -34.44 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.188 -0.945 . . . . 0.0 111.24 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HB3' ' CG1' ' A' ' 103' ' ' ILE . 11.8 m-85 -49.96 119.9 3.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.986 -1.071 . . . . 0.0 110.697 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.421 ' H ' HG22 ' A' ' 102' ' ' THR . 22.0 m120 -95.52 176.46 6.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.404 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -95.39 107.57 19.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.4 t -115.65 129.98 56.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -53.6 -26.37 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.26 76.52 0.4 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.857 . . . . 0.0 110.052 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.93 ' O ' HD11 ' A' ' 92' ' ' ILE . 17.0 Cg_endo -62.32 104.37 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.719 1.379 . . . . 0.0 110.656 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 92' ' ' ILE . 70.6 m-20 -94.38 -19.82 20.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 110.383 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' THR . . . -125.71 178.0 5.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.625 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -149.56 168.18 24.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.409 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.894 ' ND1' HD13 ' A' ' 103' ' ' ILE . 33.5 p-80 -121.42 127.06 50.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 26.8 tt0 -109.17 172.44 6.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.747 HD13 ' HD3' ' A' ' 54' ' ' ARG . 6.0 mt -121.63 146.13 47.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 110.487 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 37.2 m -117.07 144.7 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.484 -0.76 . . . . 0.0 110.273 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . . . 52.93 34.03 15.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.03 -95.65 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -124.12 26.58 7.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -1.15 . . . . 0.0 110.219 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.79 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 1.2 mmtp -89.79 -73.12 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 110.482 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.436 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -102.17 177.84 4.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.41 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . 1.03 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 64.5 mtp -136.91 150.51 48.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 110.369 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.812 ' CG ' HD23 ' A' ' 29' ' ' LEU . 15.1 ttm180 -133.5 104.41 6.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.93 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 77' ' ' ARG . 6.2 mt -89.08 140.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.964 . . . . 0.0 110.314 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 88' ' ' ARG . 1.7 m-85 -129.53 -168.11 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 26.4 p -125.36 97.1 5.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.93 HD11 ' O ' ' A' ' 74' ' ' PRO . 49.3 pt -59.87 -17.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.534 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 13.5 mtmt -143.43 134.73 12.67 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 110.005 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.59 135.49 16.48 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.49 1.258 . . . . 0.0 111.255 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 20' ' ' ALA . 80.6 mt -115.71 142.38 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.5 163.33 15.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' A' ' 21' ' ' ARG . 28.1 mt -65.07 115.11 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -0.81 . . . . 0.0 110.409 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.06 40.85 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.6 177.6 4.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.138 . . . . 0.0 110.347 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.58 30.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.463 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.713 ' HB ' HG13 ' A' ' 18' ' ' VAL . 62.8 mt -90.31 124.85 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 110.395 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 101' ' ' ILE . 17.5 p -157.51 135.92 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.894 HD13 ' ND1' ' A' ' 78' ' ' HIS . 1.1 pp -100.85 170.44 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.965 -1.084 . . . . 0.0 110.447 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.619 ' O ' HD12 ' A' ' 103' ' ' ILE . 89.4 p -105.63 -166.83 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.478 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 109' ' ' TYR . 12.4 m-85 -123.58 -58.56 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.57 160.32 0.44 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.6 OUTLIER 57.45 109.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.434 -1.039 . . . . 0.0 110.977 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 107' ' ' ASP . 16.5 t0 57.57 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.844 -0.535 . . . . 0.0 111.768 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -43.34 111.03 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.311 -0.868 . . . . 0.0 111.706 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 111.019 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.273 0.559 . . . . 0.0 110.339 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.33 16.51 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.943 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 C--N 1.314 -1.287 0 O-C-N 123.571 1.301 . . . . 0.0 110.538 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 21.6 p90 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.383 0.611 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.78 156.13 49.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.295 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.18 -18.44 15.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.764 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' B' ' 6' ' ' VAL . 2.1 mtm-85 -97.66 -29.08 13.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.884 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.0 m -153.4 -172.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.635 HG23 ' HB2' ' B' ' 19' ' ' PHE . 13.7 tt -154.79 165.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.95 . . . . 0.0 110.23 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.414 ' H ' HG12 ' B' ' 8' ' ' VAL . 7.2 p -99.79 137.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 110.726 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 31.1 mttt -142.17 143.72 33.1 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.604 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.0 OUTLIER 52.77 66.3 1.26 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.861 -1.774 . . . . 0.0 111.083 1.424 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.455 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.568 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -102.52 73.3 1.3 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -1.231 . . . . 0.0 110.641 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -105.68 -165.33 23.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.71 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.0 p -121.69 130.72 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.322 . . . . 0.0 109.674 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.635 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.1 m-85 -89.83 158.5 17.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 110.528 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -113.18 105.39 13.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 110.581 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.2 OUTLIER -63.7 -28.39 69.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.459 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 5.3 mttm -86.54 -178.36 6.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.506 4.8 t 99.53 10.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 119.958 -1.714 . . . . 0.0 110.5 1.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 22.1 m-85 -96.69 158.67 15.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.064 -1.022 . . . . 0.0 110.921 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.09 -155.69 0.48 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.464 -0.773 . . . . 0.0 110.016 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.412 ' HG3' ' HA ' ' B' ' 93' ' ' LYS . 58.7 tttt -95.93 30.84 2.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.29 86.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -150.17 124.6 9.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.811 HD23 ' CG ' ' B' ' 88' ' ' ARG . 3.4 tm? -54.36 119.95 5.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 95.1 t -81.26 -52.73 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.841 . . . . 0.0 110.372 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' B' ' 31' ' ' GLU . 8.6 pt-20 -170.73 97.46 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 152.4 34.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.45 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.3 OUTLIER -150.55 -151.33 0.39 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.645 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.7 171.96 7.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.521 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 1.034 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 1.3 m -150.18 150.36 31.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.63 HD11 ' CD2' ' B' ' 62' ' ' LEU . 55.8 mt -91.04 142.77 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' B' ' 84' ' ' LEU . 42.1 t -117.67 128.01 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 110.745 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 19.1 mmt180 -150.5 178.18 9.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.7 OUTLIER -92.11 -173.73 3.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 110.106 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.6 -141.95 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.35 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.75 -135.05 0.8 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.129 -0.982 . . . . 0.0 110.805 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.59 -49.1 7.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.001 -1.062 . . . . 0.0 111.506 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 1.022 ' NE1' HD21 ' B' ' 51' ' ' LEU . 36.9 t-105 -51.53 -46.7 63.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 110.046 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.27 76.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 44.9 m -74.47 -59.88 2.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.138 -1.213 . . . . 0.0 110.808 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -53.67 30.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 0.0 110.656 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 1.023 HD21 HD21 ' A' ' 47' ' ' LEU . 3.2 mm? -93.0 23.63 4.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 110.603 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' B' ' 45' ' ' THR . 2.0 pp20? -50.76 154.52 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.033 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' B' ' 48' ' ' GLU . 54.2 t0 60.91 147.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.504 -0.747 . . . . 0.0 110.177 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.2 13.73 7.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.115 -0.991 . . . . 0.0 110.18 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 1.022 HD21 ' NE1' ' B' ' 43' ' ' TRP . 8.9 tp -112.6 107.81 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 110.936 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.85 119.08 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.564 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 42.6 t -109.25 135.93 49.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -0.99 . . . . 0.0 111.094 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.727 ' HD3' HD13 ' B' ' 80' ' ' LEU . 0.9 OUTLIER -102.93 -175.19 2.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.74 . . . . 0.0 109.808 178.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.46 72.3 4.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -0.962 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 6.3 m120 175.02 -33.51 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.45 ' HG2' ' CD2' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.3 -173.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.347 -0.845 . . . . 0.0 110.391 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -112.74 146.89 37.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -141.74 151.62 43.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.688 ' HA ' HD12 ' B' ' 51' ' ' LEU . 29.3 tpp -90.32 155.93 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.818 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -86.65 93.4 9.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.851 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.497 0.1 OUTLIER -54.93 -65.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.369 179.246 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.7 -159.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' B' ' 67' ' ' ILE . 5.1 m-85 -75.4 59.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.818 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -90.34 -36.27 7.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.68 73.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 110.658 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' B' ' 18' ' ' VAL . 1.2 pp -51.87 -34.4 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 0.0 111.246 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.462 ' HB3' ' CG1' ' B' ' 103' ' ' ILE . 11.8 m-85 -49.95 119.89 3.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.918 -1.114 . . . . 0.0 110.709 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.431 ' H ' HG22 ' B' ' 102' ' ' THR . 21.9 m120 -95.53 176.47 6.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.869 . . . . 0.0 110.451 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -95.4 107.57 19.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 110.253 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 31.5 t -115.67 130.02 56.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 0.0 110.498 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' B' ' 74' ' ' PRO . 0.4 OUTLIER -53.59 -26.36 21.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.293 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.27 76.5 0.4 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.09 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.918 ' O ' HD11 ' B' ' 92' ' ' ILE . 17.0 Cg_endo -62.31 104.39 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.715 1.377 . . . . 0.0 110.688 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -94.42 -19.78 20.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' B' ' 91' ' ' THR . . . -125.74 178.02 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 110.295 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.639 ' O ' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -149.55 168.2 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.962 . . . . 0.0 110.445 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.895 ' ND1' HD13 ' B' ' 103' ' ' ILE . 33.6 p-80 -121.42 126.92 50.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 110.386 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' B' ' 88' ' ' ARG . 27.0 tt0 -109.07 172.37 6.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' B' ' 54' ' ' ARG . 6.0 mt -121.46 146.21 47.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.453 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 38.5 m -117.08 144.7 44.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.41 -0.806 . . . . 0.0 110.279 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' B' ' 85' ' ' LYS . . . 52.93 34.01 15.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.08 -95.72 2.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' B' ' 54' ' ' ARG . 1.0 OUTLIER -124.11 26.53 7.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -1.163 . . . . 0.0 110.228 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.79 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 1.2 mmtp -89.69 -73.09 0.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.442 ' CB ' ' HB ' ' B' ' 81' ' ' THR . 0.3 OUTLIER -102.24 177.87 4.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.349 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 87' ' ' MET . . . . . 1.034 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 64.5 mtp -136.92 150.6 48.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.811 ' CG ' HD23 ' B' ' 29' ' ' LEU . 15.0 ttm180 -133.76 104.08 6.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.476 -0.765 . . . . 0.0 109.982 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.639 HG23 ' O ' ' B' ' 77' ' ' ARG . 6.1 mt -88.39 140.22 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.461 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' B' ' 88' ' ' ARG . 1.7 m-85 -129.73 -168.13 1.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.89 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' B' ' 76' ' ' ALA . 26.5 p -125.32 97.07 5.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 110.397 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.918 HD11 ' O ' ' B' ' 74' ' ' PRO . 49.2 pt -59.84 -17.54 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.412 ' HA ' ' HG3' ' B' ' 26' ' ' LYS . 13.5 mtmt -143.42 134.62 12.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.89 135.75 17.49 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.467 1.246 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' B' ' 20' ' ' ALA . 80.9 mt -115.77 142.19 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.18 163.39 15.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.622 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 28.1 mt -65.06 115.04 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 110.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.07 40.87 2.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 177.64 4.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.73 31.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.401 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.71 ' HB ' HG13 ' B' ' 18' ' ' VAL . 63.1 mt -90.45 124.83 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 110.44 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.578 HG23 ' O ' ' B' ' 101' ' ' ILE . 17.4 p -157.38 135.98 11.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 109.659 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.895 HD13 ' ND1' ' B' ' 78' ' ' HIS . 1.1 pp -100.83 170.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.62 ' O ' HD12 ' B' ' 103' ' ' ILE . 89.5 p -105.64 -166.98 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.441 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' B' ' 109' ' ' TYR . 12.4 m-85 -123.44 -58.75 1.59 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.939 . . . . 0.0 110.036 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.84 160.31 0.47 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.6 OUTLIER 57.41 109.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.432 -1.04 . . . . 0.0 111.003 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' B' ' 107' ' ' ASP . 16.7 t0 57.79 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.867 -0.521 . . . . 0.0 111.774 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' B' ' 107' ' ' ASP . 0.2 OUTLIER -43.45 111.0 0.23 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.302 -0.874 . . . . 0.0 111.719 -178.254 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 0.0 110.934 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.214 0.531 . . . . 0.0 110.38 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.3 16.48 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 110.413 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.313 -1.305 0 O-C-N 123.538 1.283 . . . . 0.0 110.489 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 48.9 p90 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.345 0.593 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -126.03 148.11 49.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -46.51 -48.66 19.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.437 -0.79 . . . . 0.0 111.053 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.533 ' C ' HG13 ' A' ' 6' ' ' VAL . 20.6 mmt85 -59.65 -45.7 91.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 110.495 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.533 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.3 m -154.81 152.16 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.384 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 11.6 tt -117.75 167.12 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.941 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.8 p -89.35 127.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.433 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.646 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 12.9 mttt -144.54 139.02 27.92 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER 52.61 73.47 0.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.585 -1.947 . . . . 0.0 109.798 6.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 O-C-N 121.869 -0.52 . . . . 0.0 110.135 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.58 66.66 6.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -1.2 . . . . 0.0 110.627 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -111.54 -163.75 17.65 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.96 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.4 p -105.89 133.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.238 . . . . 0.0 109.063 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.537 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -90.0 144.12 26.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 110.521 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.95 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -97.26 89.24 4.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.466 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.878 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -63.29 -18.59 63.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.282 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HD2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.76 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.474 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 0.0 OUTLIER 97.57 8.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.414 -1.429 . . . . 0.0 110.609 0.812 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CZ ' HG12 ' A' ' 30' ' ' VAL . 14.6 m-85 -105.44 163.46 12.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.995 -1.065 . . . . 0.0 110.511 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.3 -148.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.027 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 10.4 tttt -107.94 82.47 1.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . . . 124.37 46.5 0.25 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.57 144.81 51.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -1.172 . . . . 0.0 110.531 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.925 HD23 ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -74.87 141.76 44.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.854 HG22 ' O ' ' A' ' 89' ' ' ILE . 28.6 m -121.81 -23.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.18 -0.95 . . . . 0.0 110.995 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.982 ' HB3' HD12 ' A' ' 89' ' ' ILE . 4.7 tt0 -171.8 153.82 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.104 -0.997 . . . . 0.0 110.216 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CG ' ' HA ' ' A' ' 88' ' ' ARG . 3.1 mt-10 -146.63 151.0 36.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 110.484 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.427 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 27.0 p -150.59 -160.85 1.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.652 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.703 HD23 ' HG3' ' A' ' 86' ' ' ARG . 54.0 mt -114.73 -179.87 3.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.466 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.7 170.89 17.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.104 HD11 HD23 ' A' ' 62' ' ' LEU . 48.2 mt -105.78 144.26 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.226 -0.922 . . . . 0.0 109.793 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 84' ' ' LEU . 38.2 t -123.25 89.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.005 -1.059 . . . . 0.0 110.386 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.38 177.81 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -88.61 175.06 7.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.121 -0.987 . . . . 0.0 109.771 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 5.7 t-20 -74.89 -135.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.099 -1.001 . . . . 0.0 110.252 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.3 t0 65.84 -146.86 0.21 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.69 -1.257 . . . . 0.0 110.379 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.03 -28.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.213 -0.93 . . . . 0.0 111.033 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.778 ' CH2' HD22 ' A' ' 47' ' ' LEU . 65.9 t-105 -68.41 -52.11 36.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.833 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.77 -23.53 55.98 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 90.7 m -83.76 -67.09 0.82 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -1.188 . . . . 0.0 110.748 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -46.63 -49.92 18.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 0.0 110.988 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.89 ' HB3' HD13 ' A' ' 51' ' ' LEU . 4.4 mp -91.86 31.87 1.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.02 64.09 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.939 -1.101 . . . . 0.0 110.61 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.42 -68.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.038 -1.039 . . . . 0.0 110.585 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 13.0 m-85 -98.34 34.39 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' A' ' 47' ' ' LEU . 2.3 tp -101.5 116.86 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.549 -0.72 . . . . 0.0 111.01 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -89.35 103.73 16.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.117 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 33.7 t -90.77 139.93 30.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.148 -0.97 . . . . 0.0 111.561 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' NH2' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -121.63 -175.36 3.07 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.583 -0.698 . . . . 0.0 109.674 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 79.69 8.88 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 109.363 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.506 0.2 OUTLIER 162.88 -28.91 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.847 -0.533 . . . . 0.0 109.844 -179.307 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.408 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.84 -161.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.3 m -128.28 141.7 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -129.12 175.42 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.859 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.558 ' CE ' HD23 ' A' ' 47' ' ' LEU . 1.3 tpt -114.11 169.45 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.815 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -84.96 -37.28 20.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.083 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.104 HD23 HD11 ' A' ' 36' ' ' ILE 2.501 0.1 OUTLIER 76.14 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.005 . . . . 0.0 111.186 177.657 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -66.35 -128.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.446 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.19 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -1.049 . . . . 0.0 110.84 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.815 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.77 -26.71 21.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -90.15 -35.78 15.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -1.114 . . . . 0.0 110.585 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.1 pp -47.01 -37.0 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' N ' HD12 ' A' ' 67' ' ' ILE . 28.9 m-85 -46.39 129.37 10.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.343 -0.848 . . . . 0.0 110.919 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -108.49 -177.4 3.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 110.65 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -93.24 124.72 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 110.03 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 m -145.35 157.18 44.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 110.555 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.22 25.91 2.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.495 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.26 67.84 4.1 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.908 ' O ' HD11 ' A' ' 92' ' ' ILE . 13.1 Cg_endo -60.55 110.24 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.764 1.402 . . . . 0.0 110.465 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 3.1 m120 -89.84 -18.65 25.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -151.55 122.66 7.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.13 -0.982 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.447 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.2 mtt180 -93.89 -171.23 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 110.033 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.791 ' CE1' HD13 ' A' ' 103' ' ' ILE . 47.3 p-80 -130.39 150.59 51.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.177 -0.952 . . . . 0.0 110.281 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 4.4 tp10 -117.32 141.81 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 84' ' ' LEU . 51.2 tp -114.5 131.13 56.74 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 110.131 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -54.81 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 110.379 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' ' NH2' ' A' ' 54' ' ' ARG . . . -52.42 -23.27 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 110.389 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.54 -164.27 11.79 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.81 ' HA ' HD11 ' A' ' 80' ' ' LEU . 8.9 mt -102.8 42.47 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -1.129 . . . . 0.0 110.226 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.23 -65.63 0.98 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.168 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.703 ' HG3' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.46 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 110.886 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.97 24.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 110.13 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.45 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -128.03 172.47 10.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 110.91 -179.115 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.982 HD12 ' HB3' ' A' ' 31' ' ' GLU . 16.6 mt -145.89 91.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.925 ' CE2' HD23 ' A' ' 29' ' ' LEU . 2.4 m-85 -98.41 150.39 21.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.586 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.585 HG23 ' CG1' ' A' ' 30' ' ' VAL . 2.9 p -89.13 114.13 25.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.061 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.908 HD11 ' O ' ' A' ' 74' ' ' PRO . 13.6 pt -75.83 -13.53 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.62 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 8.3 ptpt -148.19 156.7 43.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.058 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.87 124.41 15.29 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.582 1.306 . . . . 0.0 110.597 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 75' ' ' ASN . 61.8 mt -111.4 145.6 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 110.373 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.89 156.61 17.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.367 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.878 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -59.91 111.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.864 . . . . 0.0 110.326 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.76 32.19 1.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -114.3 170.54 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' OE2' ' CG2' ' A' ' 102' ' ' THR . 0.7 OUTLIER -110.31 139.8 45.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.96 ' HB ' HG13 ' A' ' 18' ' ' VAL . 41.0 mt -109.02 122.1 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 110.619 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.447 HG23 ' C ' ' A' ' 101' ' ' ILE . 58.4 p -149.7 143.71 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.791 HD13 ' CE1' ' A' ' 78' ' ' HIS . 1.0 OUTLIER -111.61 169.86 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.021 -1.049 . . . . 0.0 110.571 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -95.51 -168.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 11.1 m-85 -123.49 -62.33 1.33 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.21 -0.932 . . . . 0.0 109.867 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 70.16 -169.83 45.65 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.87 -67.86 0.11 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.533 -0.981 . . . . 0.0 110.813 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -144.12 -39.02 0.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.994 -1.066 . . . . 0.0 110.767 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.6 m-85 -47.51 107.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 111.241 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 26.3 m95 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 110.908 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.417 0.627 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.44 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.209 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 C--N 1.312 -1.369 0 O-C-N 123.596 1.313 . . . . 0.0 110.447 179.892 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 49.0 p90 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.384 0.612 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -125.96 148.26 49.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 26.1 t70 -46.56 -48.7 19.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.371 -0.831 . . . . 0.0 110.985 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.516 ' C ' HG13 ' B' ' 6' ' ' VAL . 20.5 mmt85 -59.67 -45.69 91.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 110.539 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.516 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.3 m -154.72 152.22 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 11.7 tt -117.89 166.75 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.502 HG13 ' O ' ' B' ' 8' ' ' VAL . 8.0 p -88.83 127.86 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.571 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.657 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 13.0 mttt -144.71 139.15 27.74 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.657 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.8 OUTLIER 52.71 73.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.52 -1.988 . . . . 0.0 109.851 6.05 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.419 ' HB2' ' HD3' ' B' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.895 -0.503 . . . . 0.0 110.097 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -90.55 66.96 6.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -1.145 . . . . 0.0 110.616 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -111.87 -163.94 17.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.938 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.5 p -105.59 132.94 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.021 -1.282 . . . . 0.0 109.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.536 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.054 -1.028 . . . . 0.0 110.556 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -97.21 89.19 4.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.889 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.6 OUTLIER -63.4 -18.54 63.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.493 ' HD2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.85 6.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.469 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.509 0.0 OUTLIER 97.63 8.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.434 -1.416 . . . . 0.0 110.625 0.786 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.632 ' CZ ' HG12 ' B' ' 30' ' ' VAL . 14.4 m-85 -105.34 163.52 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.024 -1.048 . . . . 0.0 110.487 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.36 -148.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 92' ' ' ILE . 10.3 tttt -107.96 82.45 1.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.13 -0.981 . . . . 0.0 110.486 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 91' ' ' THR . . . 124.37 46.57 0.25 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.55 144.74 51.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -1.197 . . . . 0.0 110.575 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.91 HD23 ' CE2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER -74.84 141.84 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 109.813 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.862 HG22 ' O ' ' B' ' 89' ' ' ILE . 28.4 m -121.97 -23.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.12 -0.987 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.98 ' HB3' HD12 ' B' ' 89' ' ' ILE . 4.6 tt0 -171.75 153.77 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' B' ' 88' ' ' ARG . 3.1 mt-10 -146.59 151.26 37.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 0.0 110.434 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.419 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 27.0 p -150.98 -161.02 1.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.679 HD23 ' HG3' ' B' ' 86' ' ' ARG . 53.7 mt -114.66 -179.84 3.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -149.68 170.86 17.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 1.096 HD11 HD23 ' B' ' 62' ' ' LEU . 47.8 mt -105.76 144.2 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.791 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.405 HG22 ' O ' ' B' ' 84' ' ' LEU . 38.1 t -123.18 89.35 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.41 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.28 177.8 4.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.361 -0.837 . . . . 0.0 110.163 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -88.54 175.0 7.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.12 -0.987 . . . . 0.0 109.785 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 5.7 t-20 -74.83 -135.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 4.4 t0 65.87 -146.89 0.21 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.712 -1.243 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.0 -28.39 1.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.169 -0.957 . . . . 0.0 111.022 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.784 ' CH2' HD22 ' B' ' 47' ' ' LEU . 65.8 t-105 -68.45 -52.06 36.75 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.79 -23.52 56.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 91.1 m -83.71 -67.16 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 110.699 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.462 ' HB3' HD12 ' B' ' 47' ' ' LEU . . . -46.73 -49.03 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.188 -0.945 . . . . 0.0 111.046 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.866 ' HB3' HD13 ' B' ' 51' ' ' LEU . 4.4 mp -93.21 32.44 1.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.13 64.09 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.564 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.46 -68.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.047 . . . . 0.0 110.596 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -98.22 34.29 2.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.224 -0.922 . . . . 0.0 109.955 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.866 HD13 ' HB3' ' B' ' 47' ' ' LEU . 2.3 tp -101.51 116.66 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 111.145 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -89.05 103.79 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.184 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 33.8 t -90.82 139.88 30.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 111.526 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.415 ' NH2' ' O ' ' B' ' 82' ' ' ALA . 0.2 OUTLIER -122.2 -178.36 3.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.587 -0.696 . . . . 0.0 109.696 178.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.25 79.35 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 110.253 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 0.2 OUTLIER 162.71 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.694 -0.629 . . . . 0.0 109.88 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.67 -161.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.3 m -128.35 141.7 51.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.13 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -129.07 175.34 8.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.015 . . . . 0.0 110.955 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.559 ' CE ' HD23 ' B' ' 47' ' ' LEU . 1.3 tpt -114.47 167.34 10.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.0 109.793 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.807 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -81.82 -38.74 25.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -0.965 . . . . 0.0 110.56 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 1.096 HD23 HD11 ' B' ' 36' ' ' ILE 2.501 0.1 OUTLIER 76.7 -95.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 111.202 178.359 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -66.36 -128.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.44 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.59 1.26 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -1.06 . . . . 0.0 110.788 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.807 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.39 -26.42 20.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.33 -35.73 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -1.093 . . . . 0.0 110.595 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.532 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.2 pp -46.97 -37.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.532 ' N ' HD12 ' B' ' 67' ' ' ILE . 29.1 m-85 -46.31 129.36 10.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.322 -0.861 . . . . 0.0 110.983 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -108.5 -177.32 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -93.27 124.63 37.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.3 m -145.36 157.25 44.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.39 26.08 2.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -157.22 67.73 4.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.907 ' O ' HD11 ' B' ' 92' ' ' ILE . 13.2 Cg_endo -60.47 110.3 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.727 1.383 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.468 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 3.1 m120 -89.91 -18.65 25.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.849 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -151.54 122.7 7.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.437 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.3 mtt180 -93.85 -171.17 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.327 -0.858 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.786 ' CE1' HD13 ' B' ' 103' ' ' ILE . 47.2 p-80 -130.48 150.49 51.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 110.257 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.447 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 4.4 tp10 -117.23 141.88 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' B' ' 84' ' ' LEU . 51.6 tp -114.5 131.12 56.74 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.17 -0.956 . . . . 0.0 110.238 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -54.9 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.329 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.415 ' O ' ' NH2' ' B' ' 54' ' ' ARG . . . -52.4 -23.32 5.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 110.345 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.48 -164.22 11.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.786 ' HA ' HD11 ' B' ' 80' ' ' LEU . 8.9 mt -102.9 42.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -1.106 . . . . 0.0 110.144 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.46 -65.48 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 111.173 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.679 ' HG3' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.47 27.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.823 -178.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.87 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 110.127 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.448 ' HA ' ' CG ' ' B' ' 32' ' ' GLU . 0.4 OUTLIER -127.78 172.62 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.98 HD12 ' HB3' ' B' ' 31' ' ' GLU . 16.7 mt -145.99 91.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.52 -0.738 . . . . 0.0 109.964 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.91 ' CE2' HD23 ' B' ' 29' ' ' LEU . 2.4 m-85 -98.44 150.01 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 110.593 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.597 HG23 ' CG1' ' B' ' 30' ' ' VAL . 3.0 p -88.66 114.19 25.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.164 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.907 HD11 ' O ' ' B' ' 74' ' ' PRO . 13.7 pt -75.82 -13.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.666 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 8.3 ptpt -148.17 156.71 43.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.966 . . . . 0.0 110.039 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.82 124.42 15.34 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.676 1.356 . . . . 0.0 110.64 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' B' ' 75' ' ' ASN . 61.9 mt -111.4 145.64 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.92 156.61 17.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.889 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -59.91 111.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 32.16 1.78 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -114.29 170.49 8.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 110.236 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.41 ' OE2' ' CG2' ' B' ' 102' ' ' THR . 0.7 OUTLIER -110.29 139.88 45.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.957 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.961 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 41.5 mt -108.89 122.2 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.432 HG23 ' C ' ' B' ' 101' ' ' ILE . 57.4 p -149.7 143.73 25.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 109.631 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.786 HD13 ' CE1' ' B' ' 78' ' ' HIS . 1.0 OUTLIER -111.53 169.75 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.579 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -95.51 -168.89 1.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.487 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 10.9 m-85 -123.12 -62.41 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.95 . . . . 0.0 109.936 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.15 -169.8 45.67 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.89 -67.87 0.11 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.521 -0.987 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -144.07 -39.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.053 -1.029 . . . . 0.0 110.757 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.6 m-85 -47.45 107.14 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' B' ' 110' ' ' TRP . 26.2 m95 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.437 -0.789 . . . . 0.0 111.004 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.443 0.64 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.45 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.312 -1.386 0 O-C-N 123.633 1.333 . . . . 0.0 110.48 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.473 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 10.8 p90 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.337 0.589 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.52 143.57 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 110.292 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.6 -33.15 6.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.953 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.519 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -77.32 -44.13 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.519 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.2 m -154.15 147.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 110.192 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 14.3 tt -114.81 166.1 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.907 . . . . 0.0 110.061 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.1 p -89.59 122.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 110.896 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 41.8 mttt -150.03 128.86 12.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 3.0 mttt 51.44 40.11 25.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.718 -1.864 . . . . 0.0 109.879 6.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.415 ' HA ' ' HG2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.708 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 16' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 15' ' ' GLY . 37.5 m-85 -152.55 91.77 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.038 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.917 ' HA2' HG22 ' A' ' 67' ' ' ILE . . . -151.18 -169.25 16.67 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.499 HG12 HD12 ' A' ' 101' ' ' ILE . 87.2 t -100.81 124.13 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.031 -1.276 . . . . 0.0 109.616 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' CB ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -88.45 129.37 35.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.989 -1.07 . . . . 0.0 110.777 -178.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -97.22 85.27 3.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.557 -0.714 . . . . 0.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 97' ' ' ILE . 4.7 mtp180 -56.09 -25.13 44.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 109.485 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 5.1 mtpp -84.63 -179.72 7.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 7.0 m 100.36 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.054 -1.654 . . . . 0.0 110.038 2.358 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 16.1 m-85 -107.63 142.79 37.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.75 171.07 9.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.091 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 18.7 tttt -67.04 100.81 0.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.45 -20.75 11.02 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.57 123.69 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -1.179 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.845 HD21 ' HB3' ' A' ' 88' ' ' ARG . 1.2 tm? -65.99 113.65 4.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 91' ' ' THR . 99.4 t -72.04 -53.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 89' ' ' ILE . 5.3 tt0 -174.14 144.44 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.25 157.98 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.445 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.1 p -150.56 -171.82 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 110.651 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.7 mt -100.61 167.65 10.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.783 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.7 m -145.15 161.59 39.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.793 HD11 HD23 ' A' ' 62' ' ' LEU . 55.1 mt -92.16 148.26 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 83' ' ' GLY . 42.7 t -124.0 90.45 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.659 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 36' ' ' ILE . 39.8 mmt180 -117.93 168.43 10.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -87.08 -176.27 5.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.068 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 26.2 m120 -72.24 -137.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.0 t0 65.97 -148.09 0.21 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 110.541 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' B' ' 42' ' ' ASP . 26.9 m-20 -46.27 -34.74 4.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.243 -0.91 . . . . 0.0 111.109 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.891 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 60.6 t-105 -52.88 -57.21 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.029 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -60.34 -31.31 73.47 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.97 -65.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.522 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.22 70.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 110.14 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.006 HD12 ' CE ' ' A' ' 60' ' ' MET . 3.6 mm? -91.74 34.03 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.686 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 1.9 tm-20 -56.31 -17.54 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 111.365 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.89 156.47 19.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.913 -1.117 . . . . 0.0 110.966 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 7.0 m-30 55.25 26.29 8.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.854 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.891 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 10.5 tp -108.71 105.88 15.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.867 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -89.11 105.32 17.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.1 t -105.39 147.52 28.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.938 . . . . 0.0 110.915 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.966 ' HG2' HD11 ' A' ' 84' ' ' LEU . 10.4 ptm180 -115.13 -167.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 77.62 9.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.075 -1.016 . . . . 0.0 109.264 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.499 3.0 t30 166.02 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.902 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -176.98 -164.44 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.947 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.414 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 6.2 t -130.2 141.05 50.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.459 -0.776 . . . . 0.0 110.286 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.553 ' HB3' HD22 ' A' ' 84' ' ' LEU . . . -132.71 149.42 52.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 110.626 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 1.006 ' CE ' HD12 ' A' ' 47' ' ' LEU . 32.9 tpp -93.24 155.91 17.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.52 92.1 8.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.704 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.793 HD23 HD11 ' A' ' 36' ' ' ILE 2.506 0.1 OUTLIER -52.19 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 110.895 -178.605 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -61.05 -155.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.697 ' HB3' HD13 ' A' ' 67' ' ' ILE . 31.6 m-85 -90.16 54.12 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.132 . . . . 0.0 111.152 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA2' ' CE2' ' A' ' 68' ' ' PHE . . . -92.83 -15.52 52.08 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -91.72 4.37 52.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.894 -1.356 . . . . 0.0 112.355 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.917 HG22 ' HA2' ' A' ' 17' ' ' GLY . 3.8 mp -88.56 -20.75 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.716 -1.24 . . . . 0.0 110.829 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 23.1 m-85 -52.43 143.6 14.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.89 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -112.4 -159.67 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -102.01 136.12 42.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.405 -0.81 . . . . 0.0 109.414 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' ASP . 1.8 m -152.06 35.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.027 -1.045 . . . . 0.0 110.567 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 mmtp 58.11 -82.63 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.542 -0.724 . . . . 0.0 110.273 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' SER . 4.5 m-20 -99.33 91.78 1.55 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.804 ' O ' HD11 ' A' ' 92' ' ' ILE . 11.5 Cg_endo -58.04 106.56 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.564 1.297 . . . . 0.0 110.524 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 71.6 m-80 -50.48 -23.8 2.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.619 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.859 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -142.71 159.56 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.995 . . . . 0.0 110.426 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.47 ' NH2' ' NE2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -136.99 -173.89 3.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.195 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.47 ' NE2' ' NH2' ' A' ' 77' ' ' ARG . 7.5 p-80 -119.74 172.71 7.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -142.35 155.07 45.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.722 HD12 ' HD2' ' C' ' 218' ' ' PRO . 19.8 mt -123.38 143.36 50.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 110.371 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.455 HG22 ' NH2' ' A' ' 88' ' ' ARG . 20.4 p -72.93 -66.47 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.354 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.88 -35.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 110.524 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 37' ' ' VAL . . . -106.66 26.66 19.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.966 HD11 ' HG2' ' A' ' 54' ' ' ARG . 34.6 mt 51.73 28.84 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.605 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.22 -36.25 10.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 110.76 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.87 135.8 54.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 110.691 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 mtp -126.85 116.72 21.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 110.199 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.845 ' HB3' HD21 ' A' ' 29' ' ' LEU . 45.2 mtt180 -101.35 131.92 47.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -89.25 98.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.022 . . . . 0.0 109.591 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.844 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 13.9 m-85 -89.76 -169.29 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.547 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.523 HG23 HG23 ' A' ' 30' ' ' VAL . 26.9 p -132.57 98.43 4.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.083 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 74' ' ' PRO . 33.7 pt -54.54 -22.18 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.106 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -146.72 161.23 38.55 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 34.1 Cg_exo -53.74 156.57 11.65 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.635 1.334 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 59.2 mt -138.55 134.91 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.3 167.86 10.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 110.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -64.53 119.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.341 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.63 30.75 5.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.19 141.06 36.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.113 -1.228 . . . . 0.0 110.325 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' OE1' HG21 ' A' ' 102' ' ' THR . 1.3 tm-20 -88.39 121.39 30.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 109.674 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 76' ' ' ALA . 60.6 mt -89.11 123.59 41.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.78 . . . . 0.0 110.586 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.497 ' C ' HG23 ' A' ' 103' ' ' ILE . 73.2 p -145.46 -176.71 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.497 HG23 ' C ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -151.74 160.31 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 0.0 110.384 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.54 -173.05 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 13.0 m-85 -125.51 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 109.86 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.5 -160.29 54.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.94 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.988 . . . . 0.0 110.692 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -129.44 -35.54 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.067 . . . . 0.0 110.706 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.465 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -48.66 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.93 . . . . 0.0 110.928 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.476 ' CD2' ' O ' ' A' ' 110' ' ' TRP . 54.8 p-90 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.6 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.232 0.539 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -150.09 165.59 17.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.722 ' HD2' HD12 ' A' ' 80' ' ' LEU . 17.6 Cg_endo . . . . . 0 C--N 1.312 -1.344 0 O-C-N 123.675 1.355 . . . . 0.0 110.452 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.9 p90 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.395 0.617 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.45 143.69 31.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.69 -33.24 6.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.363 -0.836 . . . . 0.0 110.894 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.534 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -77.25 -44.19 30.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.534 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.1 m -154.04 147.43 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 14.3 tt -114.77 165.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 110.102 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.56 HG13 ' O ' ' B' ' 8' ' ' VAL . 7.1 p -89.4 122.28 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 110.969 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.562 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 42.1 mttt -150.13 129.17 12.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.562 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 3.0 mttt 51.8 40.01 26.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.511 -1.993 . . . . 0.0 109.889 6.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.696 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' B' ' 16' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' B' ' 15' ' ' GLY . 37.3 m-85 -152.5 91.58 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.913 ' HA2' HG22 ' B' ' 67' ' ' ILE . . . -151.03 -169.15 16.43 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.514 HG12 HD12 ' B' ' 101' ' ' ILE . 88.5 t -100.93 123.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.254 . . . . 0.0 109.71 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' CB ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -87.35 129.37 35.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.015 . . . . 0.0 110.94 -178.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.814 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -97.31 85.25 3.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.438 -0.789 . . . . 0.0 110.13 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 4.7 mtp180 -56.03 -25.09 43.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.545 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CD2' ' B' ' 24' ' ' PHE . 5.2 mtpp -84.6 -179.62 7.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.464 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.513 6.8 m 100.46 13.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.041 -1.662 . . . . 0.0 109.98 2.209 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 16.3 m-85 -107.59 142.63 37.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.195 -0.94 . . . . 0.0 110.275 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.48 171.08 9.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -67.05 100.85 0.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 110.153 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.43 -20.87 10.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.62 123.74 11.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -1.163 . . . . 0.0 110.547 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.856 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.2 tm? -66.02 113.65 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.527 HG23 HG23 ' B' ' 91' ' ' THR . 99.5 t -72.03 -53.14 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.184 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.421 ' O ' HD12 ' B' ' 89' ' ' ILE . 5.3 tt0 -174.14 144.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.26 158.19 34.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 110.406 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.444 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.1 p -150.81 -171.96 4.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 54.9 mt -100.53 167.7 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 95.2 m -145.19 161.56 39.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.058 -1.026 . . . . 0.0 110.524 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.781 HD11 HD23 ' B' ' 62' ' ' LEU . 54.9 mt -92.06 148.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 83' ' ' GLY . 42.9 t -124.02 90.5 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.95 . . . . 0.0 110.604 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.503 ' HG2' HG22 ' B' ' 36' ' ' ILE . 39.8 mmt180 -117.96 168.43 10.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -87.07 -176.31 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.883 . . . . 0.0 110.167 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.22 -137.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.976 . . . . 0.0 110.148 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 66.07 -148.11 0.21 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.805 -1.184 . . . . 0.0 110.547 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 26.9 m-20 -46.26 -34.78 4.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.219 -0.926 . . . . 0.0 111.123 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.889 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 60.8 t-105 -52.81 -57.22 10.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 110.077 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.416 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -60.36 -31.3 73.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.93 -65.19 0.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -50.54 73.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.256 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 1.008 HD12 ' CE ' ' B' ' 60' ' ' MET . 3.6 mm? -92.79 34.41 1.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 110.465 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.416 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 1.9 tm-20 -56.53 -17.59 8.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.049 -1.032 . . . . 0.0 111.299 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.76 156.44 19.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.971 -1.081 . . . . 0.0 111.073 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' B' ' 50' ' ' TYR . 7.0 m-30 55.28 26.36 8.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.475 -0.766 . . . . 0.0 110.775 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.889 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 10.6 tp -108.79 105.51 15.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 110.937 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' B' ' 52' ' ' PHE . 42.4 m-85 -88.56 105.27 17.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -105.4 147.51 28.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.152 -0.967 . . . . 0.0 110.907 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.975 ' HG2' HD11 ' B' ' 84' ' ' LEU . 10.3 ptm180 -115.66 -170.07 1.71 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.109 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.55 77.21 5.03 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.242 -0.911 . . . . 0.0 110.226 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.505 3.1 t30 165.94 -29.21 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.679 -0.638 . . . . 0.0 109.935 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.83 -164.15 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 110.934 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.402 ' OG ' ' NE1' ' B' ' 43' ' ' TRP . 6.2 t -130.27 141.09 50.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 110.241 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.565 ' HB3' HD22 ' B' ' 84' ' ' LEU . . . -132.78 149.43 52.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.637 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' MET . . . . . 1.008 ' CE ' HD12 ' B' ' 47' ' ' LEU . 32.9 tpp -93.48 154.84 17.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 110.215 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.07 92.05 8.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.781 HD23 HD11 ' B' ' 36' ' ' ILE 2.505 0.1 OUTLIER -52.29 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.949 -178.734 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.97 -155.15 0.03 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.694 ' HB3' HD13 ' B' ' 67' ' ' ILE . 31.6 m-85 -90.22 55.38 3.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -1.119 . . . . 0.0 111.053 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' CE2' ' B' ' 68' ' ' PHE . . . -94.92 -13.82 51.64 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.185 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.438 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -93.2 4.86 53.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.933 -1.334 . . . . 0.0 112.096 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.913 HG22 ' HA2' ' B' ' 17' ' ' GLY . 3.8 mp -88.76 -20.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.691 -1.256 . . . . 0.0 110.817 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.489 ' CE1' HG21 ' B' ' 18' ' ' VAL . 23.0 m-85 -52.43 143.62 14.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.917 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -112.33 -159.43 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -102.42 136.12 42.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.358 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 73' ' ' ASP . 1.8 m -152.01 35.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.085 -1.009 . . . . 0.0 110.646 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' B' ' 74' ' ' PRO . 1.6 mmtp 58.11 -82.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.428 -0.795 . . . . 0.0 110.288 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' B' ' 71' ' ' SER . 4.5 m-20 -99.38 91.85 1.59 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.235 -0.916 . . . . 0.0 109.789 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.823 ' O ' HD11 ' B' ' 92' ' ' ILE . 11.4 Cg_endo -58.07 106.66 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.616 1.324 . . . . 0.0 110.476 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' B' ' 93' ' ' LYS . 71.6 m-80 -50.59 -23.76 2.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.593 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.851 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -142.73 159.53 42.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.462 ' NH2' ' NE2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -136.95 -173.85 3.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 110.177 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.462 ' NE2' ' NH2' ' B' ' 77' ' ' ARG . 7.5 p-80 -119.71 172.62 7.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 110.618 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -142.28 155.19 45.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.725 HD12 ' HD2' ' D' ' 218' ' ' PRO . 19.8 mt -123.38 143.34 50.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 110.428 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.464 HG22 ' NH2' ' B' ' 88' ' ' ARG . 20.3 p -73.0 -66.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 110.337 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.91 -35.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.483 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.443 ' O ' HG21 ' B' ' 37' ' ' VAL . . . -106.66 26.6 19.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.975 HD11 ' HG2' ' B' ' 54' ' ' ARG . 34.7 mt 51.82 28.79 5.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -1.182 . . . . 0.0 110.631 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.32 -36.15 10.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.84 135.76 54.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.705 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 13.0 mtp -126.78 116.69 21.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 110.258 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.821 ' HB3' HD21 ' B' ' 29' ' ' LEU . 45.2 mtt180 -101.49 131.53 47.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 110.397 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.421 HD12 ' O ' ' B' ' 31' ' ' GLU . 12.3 mt -88.68 98.44 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.856 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 14.0 m-85 -89.57 -169.24 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.527 HG23 HG23 ' B' ' 30' ' ' VAL . 26.7 p -132.62 98.42 4.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 110.087 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.823 HD11 ' O ' ' B' ' 74' ' ' PRO . 33.6 pt -54.6 -22.15 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -146.72 161.23 38.51 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.18 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -53.77 156.51 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.6 1.316 . . . . 0.0 110.823 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 76' ' ' ALA . 59.2 mt -138.49 134.99 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.35 167.93 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -64.51 119.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.59 30.79 5.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.36 140.41 37.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -1.22 . . . . 0.0 110.365 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.419 ' OE1' HG21 ' B' ' 102' ' ' THR . 1.3 tm-20 -87.49 121.08 29.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.01 -1.056 . . . . 0.0 109.946 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.851 HG23 ' HB3' ' B' ' 76' ' ' ALA . 60.6 mt -88.62 123.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.402 -0.811 . . . . 0.0 110.79 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.516 ' C ' HG23 ' B' ' 103' ' ' ILE . 72.0 p -145.55 -176.69 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.708 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.516 HG23 ' C ' ' B' ' 102' ' ' THR . 1.0 OUTLIER -151.67 160.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.356 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.5 -173.02 2.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.461 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 13.0 m-85 -125.53 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.339 -0.851 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 71.45 -160.27 54.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.96 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -1.0 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.2 OUTLIER -129.43 -35.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.742 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.461 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.5 OUTLIER -48.67 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.929 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.469 ' CD2' ' O ' ' B' ' 110' ' ' TRP . 54.8 p-90 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 2.6 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -150.08 165.56 17.22 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.725 ' HD2' HD12 ' B' ' 80' ' ' LEU . 17.3 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.601 1.316 . . . . 0.0 110.458 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 41.3 p90 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.24 0.543 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ARG . 12.8 p30 -119.39 167.0 12.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.358 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.67 64.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.538 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 177.89 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 0.0 109.623 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG23 ' C ' ' A' ' 5' ' ' ARG . 96.4 t -153.55 158.97 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.738 HG23 ' HB2' ' A' ' 19' ' ' PHE . 5.1 tt -134.95 158.94 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.442 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' A' ' 10' ' ' LYS . 61.7 t -99.24 114.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 110.795 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 14.1 mttt -127.6 141.68 51.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.614 ' HE2' HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 52.4 56.65 7.39 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 119.821 -1.799 . . . . 0.0 110.196 2.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.596 -0.69 . . . . 0.0 110.263 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.511 ' CZ ' ' HD3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -77.9 59.13 2.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 110.299 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -105.13 -165.59 23.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.3 p -114.03 131.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.903 -1.351 . . . . 0.0 109.502 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -88.57 141.77 28.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.363 -0.835 . . . . 0.0 110.602 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.763 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -93.58 93.54 8.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.699 -0.626 . . . . 0.0 110.706 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -65.63 -15.75 63.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 0.0 109.877 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 6.7 mttt -108.61 179.05 4.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 20.1 m 102.25 21.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.012 -1.68 . . . . 0.0 109.727 2.24 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 17.5 m-85 -114.6 161.47 18.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 110.637 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.37 170.95 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 11.3 tttm -72.53 88.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.91 52.15 0.21 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.18 136.57 52.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.76 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 2.0 tm? -67.09 117.29 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 110.211 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.724 ' CG2' HG23 ' A' ' 91' ' ' THR . 38.3 t -98.53 85.42 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.32 -0.863 . . . . 0.0 109.563 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.508 ' O ' HD11 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.62 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 110.304 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.402 ' OE1' ' HG2' ' A' ' 88' ' ' ARG . 18.4 tt0 -154.13 160.53 41.96 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.011 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 1.062 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 26.7 p -150.75 160.96 43.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 111.072 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.9 mt -96.65 176.78 5.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.872 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' CG ' ' A' ' 87' ' ' MET . 83.8 m -149.25 166.39 29.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.017 HD11 HD23 ' A' ' 62' ' ' LEU . 48.4 mt -103.13 154.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.972 HG13 HD23 ' A' ' 84' ' ' LEU . 41.2 t -131.17 118.49 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.893 -1.129 . . . . 0.0 110.641 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.545 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 29.7 mmt180 -136.79 147.77 46.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.58 58.78 2.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 111.297 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 1.9 t-20 49.8 -141.31 0.7 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 111.019 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 44' ' ' GLY . 2.3 t70 67.35 -144.8 0.14 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.036 -1.04 . . . . 0.0 110.169 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.13 -35.85 12.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.935 -1.103 . . . . 0.0 110.297 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.737 ' CE3' HD21 ' B' ' 47' ' ' LEU . 17.2 t-105 -63.73 -34.61 78.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 109.129 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -62.43 -60.38 7.94 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 54.6 m -66.17 -45.84 79.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.19 -1.182 . . . . 0.0 110.666 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -62.0 2.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 0.0 109.1 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.719 HD21 ' CE3' ' B' ' 43' ' ' TRP . 4.3 mm? -93.19 36.27 1.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.471 -0.768 . . . . 0.0 110.795 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.454 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -69.4 61.71 0.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.093 -1.004 . . . . 0.0 110.325 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 178.78 145.36 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.487 -0.758 . . . . 0.0 109.015 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 11.2 m-85 57.35 26.72 12.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.918 -1.113 . . . . 0.0 109.31 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.737 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 3.1 tp -107.86 112.93 25.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 111.285 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -89.4 108.44 19.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.161 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.414 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 23.2 t -107.39 143.91 35.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.509 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.637 ' HG2' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -118.86 -165.62 1.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.522 -0.736 . . . . 0.0 109.781 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 75.4 8.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.363 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.86 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.507 -179.609 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 179.95 -174.6 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.591 -0.693 . . . . 0.0 110.324 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.464 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 26.0 p -111.95 134.89 53.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.336 -0.852 . . . . 0.0 110.432 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.9 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -117.12 174.44 6.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.674 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -120.35 160.09 23.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.788 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -89.09 99.13 12.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 110.226 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 36' ' ' ILE 2.497 0.1 OUTLIER -58.4 -81.11 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.86 . . . . 0.0 110.922 -179.437 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.3 -130.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.88 45.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 110.769 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' CA ' ' HB1' ' A' ' 61' ' ' ALA . . . -90.5 -20.67 40.2 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . . . -90.69 -43.56 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.45 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 1.3 pp -48.97 -25.64 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.213 -0.929 . . . . 0.0 110.367 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CE1' HG11 ' A' ' 18' ' ' VAL . 9.2 m-85 -48.96 144.99 4.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 110.638 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' CG2' ' A' ' 102' ' ' THR . 32.9 m120 -118.65 174.69 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.577 ' CE1' ' CE2' ' A' ' 110' ' ' TRP . 1.8 t-160 -101.54 109.52 21.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.07 146.67 48.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.44 127.54 32.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.78 71.0 1.57 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.952 . . . . 0.0 110.255 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.532 ' O ' HD11 ' A' ' 92' ' ' ILE . 12.9 Cg_endo -60.65 174.25 1.74 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.663 1.349 . . . . 0.0 110.595 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 93' ' ' LYS . 17.5 p30 -117.66 -13.12 10.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 110.569 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.05 143.96 51.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.06 166.93 13.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -0.933 . . . . 0.0 110.081 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.21 158.99 17.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.731 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 19.6 tt0 -132.94 136.68 46.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 110.147 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.564 HD12 ' HD2' ' C' ' 218' ' ' PRO . 6.1 mt -114.6 145.13 42.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.037 -1.039 . . . . 0.0 110.419 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 86' ' ' ARG . 14.2 p -53.93 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 110.396 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.38 -60.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.66 42.81 1.86 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.972 HD23 HG13 ' A' ' 37' ' ' VAL . 4.4 tp 59.25 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.298 -1.119 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -177.2 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 110.084 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.582 ' O ' HG23 ' A' ' 81' ' ' THR . 1.3 mpt_? -113.3 140.1 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.756 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . 1.062 ' SD ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 ppp? -137.24 169.85 17.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.113 -0.992 . . . . 0.0 110.666 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.734 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -131.37 -179.74 5.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.346 -0.846 . . . . 0.0 110.637 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.403 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 6.5 mt -130.21 108.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 0.0 109.646 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.76 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 51.8 m-85 -97.2 -170.68 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.724 HG23 ' CG2' ' A' ' 30' ' ' VAL . 23.1 p -128.35 98.95 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.532 HD11 ' O ' ' A' ' 74' ' ' PRO . 48.5 pt -60.06 -16.58 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 110.696 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 75' ' ' ASN . 1.1 ptpm? -148.69 156.94 41.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.96 142.86 93.61 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.582 1.306 . . . . 0.0 110.379 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.614 HG23 ' HG3' ' A' ' 99' ' ' GLU . 54.4 mt -124.33 141.97 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.671 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.76 153.66 20.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.882 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -48.25 -24.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.46 -0.775 . . . . 0.0 111.313 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.34 60.68 0.32 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 95' ' ' ILE . 3.3 mm-40 -116.28 165.05 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 111.274 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.19 115.56 29.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.915 ' HB ' HG13 ' A' ' 18' ' ' VAL . 58.5 mt -88.79 127.49 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.3 p -155.55 148.41 24.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 104' ' ' SER . 1.3 pp -115.91 155.32 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 0.0 110.749 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.543 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -90.61 -173.95 3.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 110.06 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.522 ' CD2' ' ND1' ' A' ' 70' ' ' HIS . 9.0 m-85 -123.63 -66.36 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.988 . . . . 0.0 110.093 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.43 -175.28 44.37 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.71 -33.28 68.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -1.166 . . . . 0.0 110.377 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -72.82 -66.95 0.6 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.366 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.48 71.93 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.92 . . . . 0.0 110.493 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.577 ' CE2' ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.441 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 3.4 p . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.217 0.532 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -160.63 167.99 12.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.927 . . . . 0.0 110.39 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 17.6 Cg_endo . . . . . 0 C--N 1.311 -1.397 0 O-C-N 123.734 1.386 . . . . 0.0 110.425 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 41.5 p90 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.256 0.551 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 12.7 p30 -119.4 167.01 12.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 110.373 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.71 64.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 110.345 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.531 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.0 OUTLIER 177.87 -33.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.39 -0.819 . . . . 0.0 109.639 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.531 HG23 ' C ' ' B' ' 5' ' ' ARG . 96.6 t -153.45 159.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.733 HG23 ' HB2' ' B' ' 19' ' ' PHE . 5.1 tt -134.98 158.9 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.412 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.611 HG12 ' HE2' ' B' ' 10' ' ' LYS . 62.0 t -99.27 114.81 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.55 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 14.1 mttt -127.72 141.83 51.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.611 ' HE2' HG12 ' B' ' 8' ' ' VAL . 0.3 OUTLIER 52.59 56.59 7.43 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 119.777 -1.827 . . . . 0.0 110.13 1.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.478 ' HB2' ' CZ ' ' B' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.554 -0.716 . . . . 0.0 110.304 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.505 ' CZ ' ' HD3' ' B' ' 10' ' ' LYS . 0.2 OUTLIER -77.7 59.42 2.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 110.353 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -105.63 -165.73 23.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.952 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.4 p -113.95 130.83 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.927 -1.337 . . . . 0.0 109.637 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.733 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.4 OUTLIER -87.71 141.86 28.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.835 . . . . 0.0 110.773 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.747 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -93.71 93.54 8.06 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.861 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.1 OUTLIER -65.64 -15.62 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.914 178.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 6.7 mttt -108.68 179.01 4.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 108.757 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 20.1 m 102.25 20.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.064 -1.648 . . . . 0.0 109.757 2.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 17.5 m-85 -114.52 161.51 17.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 110.685 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.48 170.97 8.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.964 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -72.5 88.76 1.24 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 110.432 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.85 52.2 0.21 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.22 136.58 52.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.759 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 2.0 tm? -67.14 117.38 9.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.73 ' CG2' HG23 ' B' ' 91' ' ' THR . 38.4 t -98.58 85.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.577 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.502 ' O ' HD11 ' B' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.708 -0.62 . . . . 0.0 110.256 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' B' ' 87' ' ' MET . 18.5 tt0 -154.11 160.8 42.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 1.071 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 26.7 p -151.08 160.9 43.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 111.031 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.67 176.73 5.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.301 -0.874 . . . . 0.0 109.851 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -149.16 166.42 28.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.079 . . . . 0.0 111.369 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 1.008 HD11 HD23 ' B' ' 62' ' ' LEU . 48.2 mt -103.12 154.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.973 HG13 HD23 ' B' ' 84' ' ' LEU . 41.6 t -131.16 118.47 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.972 -1.08 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.548 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 29.6 mmt180 -136.78 147.76 46.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.218 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.48 58.71 2.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 111.317 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 1.9 t-20 49.79 -141.33 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.127 -0.983 . . . . 0.0 111.085 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 2.3 t70 67.43 -144.9 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.022 -1.049 . . . . 0.0 110.116 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -48.11 -35.83 12.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.9 -1.125 . . . . 0.0 110.272 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.725 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 17.1 t-105 -63.77 -34.58 78.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 0.0 109.154 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -62.42 -60.44 7.86 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' B' ' 48' ' ' GLU . 54.1 m -65.88 -46.04 79.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -1.197 . . . . 0.0 110.64 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.414 ' O ' ' NH2' ' A' ' 38' ' ' ARG . . . -57.02 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.885 -1.135 . . . . 0.0 109.276 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.737 HD21 ' CE3' ' A' ' 43' ' ' TRP . 4.4 mm? -94.98 36.96 1.16 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.444 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -69.66 61.68 0.16 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -0.953 . . . . 0.0 110.274 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.477 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.9 OUTLIER 178.73 145.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 11.1 m-85 57.37 26.7 12.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.923 -1.111 . . . . 0.0 109.287 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.725 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 3.1 tp -107.82 112.8 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 111.401 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -89.22 108.5 19.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.414 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 23.0 t -107.36 143.89 35.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.006 . . . . 0.0 111.508 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.627 ' HG2' HD13 ' B' ' 84' ' ' LEU . 0.6 OUTLIER -119.46 -168.72 1.63 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.523 -0.736 . . . . 0.0 109.735 178.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 74.81 4.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.369 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.79 -35.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -179.735 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -179.75 -174.27 0.28 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.522 -0.736 . . . . 0.0 110.367 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.463 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 26.4 p -112.16 134.9 53.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 110.399 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -117.09 174.41 6.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 110.65 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.675 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -120.34 159.76 24.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -88.65 99.18 12.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.818 . . . . 0.0 110.238 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 1.008 HD23 HD11 ' B' ' 36' ' ' ILE 2.496 0.1 OUTLIER -58.49 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -179.528 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -63.25 -130.39 0.01 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -90.06 46.22 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -1.162 . . . . 0.0 110.68 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.528 ' CA ' ' HB1' ' B' ' 61' ' ' ALA . . . -90.98 -20.16 40.41 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' B' ' 61' ' ' ALA . . . -91.25 -43.33 9.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 110.627 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.461 ' CD1' ' HB ' ' B' ' 18' ' ' VAL . 1.3 pp -49.09 -25.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.197 -0.939 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.466 ' CE1' HG11 ' B' ' 18' ' ' VAL . 9.2 m-85 -48.96 145.29 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 110.627 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.402 ' HB2' ' CG2' ' B' ' 102' ' ' THR . 32.9 m120 -118.94 174.75 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.517 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' HIS . . . . . 0.578 ' CE1' ' CE2' ' B' ' 110' ' ' TRP . 1.8 t-160 -101.68 109.54 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 110.19 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.06 146.71 48.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.5 127.61 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.65 71.1 1.55 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.228 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.543 ' O ' HD11 ' B' ' 92' ' ' ILE . 12.9 Cg_endo -60.66 174.23 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.71 1.374 . . . . 0.0 110.555 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.46 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 17.4 p30 -117.65 -13.09 10.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.07 144.01 51.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.038 -1.039 . . . . 0.0 110.201 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.08 166.91 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.19 159.02 17.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.766 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' B' ' 88' ' ' ARG . 19.7 tt0 -133.06 136.6 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.151 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.574 HD12 ' HD2' ' D' ' 218' ' ' PRO . 6.1 mt -114.51 145.17 42.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.063 -1.023 . . . . 0.0 110.453 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.586 HG23 ' O ' ' B' ' 86' ' ' ARG . 14.2 p -53.95 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 110.385 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.36 -60.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 110.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.59 42.76 1.88 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.973 HD23 HG13 ' B' ' 37' ' ' VAL . 4.4 tp 59.33 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.273 -1.133 . . . . 0.0 110.513 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -177.23 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.03 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.586 ' O ' HG23 ' B' ' 81' ' ' THR . 1.3 mpt_? -113.31 140.06 48.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' MET . . . . . 1.071 ' SD ' ' SG ' ' B' ' 33' ' ' CYS . 3.9 ppp? -137.2 169.83 17.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 110.71 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.722 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -131.33 -179.66 5.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 0.0 110.648 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 mt -130.32 108.13 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.817 . . . . 0.0 109.597 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.759 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 51.7 m-85 -97.22 -170.66 2.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 110.653 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.73 HG23 ' CG2' ' B' ' 30' ' ' VAL . 23.2 p -128.34 98.86 5.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.429 -0.794 . . . . 0.0 110.162 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.543 HD11 ' O ' ' B' ' 74' ' ' PRO . 48.6 pt -59.98 -16.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.688 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 1.1 ptpm? -148.67 156.92 41.66 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 110.175 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.94 142.86 93.5 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.633 1.333 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.607 HG23 ' HG3' ' B' ' 99' ' ' GLU . 54.6 mt -124.32 141.9 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 110.684 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.65 153.7 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.805 . . . . 0.0 110.886 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.861 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -48.2 -24.97 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 111.243 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.37 60.8 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' B' ' 95' ' ' ILE . 3.4 mm-40 -116.36 165.0 13.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.267 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -112.31 115.0 28.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.476 -0.765 . . . . 0.0 109.003 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.952 ' HB ' HG13 ' B' ' 18' ' ' VAL . 58.4 mt -87.95 127.6 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.997 . . . . 0.0 111.261 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.521 HG23 ' O ' ' B' ' 101' ' ' ILE . 15.8 p -155.68 148.46 24.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.547 HD12 ' O ' ' B' ' 104' ' ' SER . 1.3 pp -115.86 155.25 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 110.793 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.547 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.6 OUTLIER -90.66 -174.08 3.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.527 ' CD2' ' ND1' ' B' ' 70' ' ' HIS . 8.9 m-85 -123.37 -66.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.201 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 -175.28 44.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -33.25 68.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -1.124 . . . . 0.0 110.371 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -66.91 0.61 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 71.94 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.578 ' CE2' ' CE1' ' B' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 110.417 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 3.3 p . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.211 0.529 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -160.66 167.87 12.85 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 110.439 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 16.9 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 O-C-N 123.709 1.373 . . . . 0.0 110.46 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 12.9 p90 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.145 0.498 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 5' ' ' ARG . 2.4 m120 -153.93 -81.96 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 111.477 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 6' ' ' VAL . 31.9 t0 -41.3 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.3 mtt180 42.49 20.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.485 -0.759 . . . . 0.0 112.785 177.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 5' ' ' ARG . 44.7 t -158.34 156.29 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.667 -1.271 . . . . 0.0 110.842 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 15.5 tt -143.65 142.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.607 . . . . 0.0 109.717 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 8' ' ' VAL . 11.6 p -89.07 135.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.936 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.9 mttt -141.45 143.86 34.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.636 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.73 56.92 6.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 119.535 -1.978 . . . . 0.0 110.281 4.055 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.503 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.776 -0.577 . . . . 0.0 110.034 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -95.31 68.29 3.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -1.189 . . . . 0.0 110.496 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.37 -162.88 14.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 67' ' ' ILE . 89.0 t -99.87 136.39 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.281 . . . . 0.0 110.205 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -101.06 128.09 47.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.117 -0.989 . . . . 0.0 109.603 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.866 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.28 97.89 11.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.566 -0.709 . . . . 0.0 111.077 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.863 ' O ' HG23 ' A' ' 97' ' ' ILE . 5.0 ttt180 -75.24 -19.73 59.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.77 4.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.383 -0.823 . . . . 0.0 109.224 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.438 ' HA ' ' HG3' ' A' ' 22' ' ' LYS 2.516 59.4 m 102.2 24.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.119 -1.613 . . . . 0.0 109.922 1.202 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 26.1 m-85 -116.0 160.49 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 110.909 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.37 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 16.7 tttm -97.37 86.75 3.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 110.145 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.2 78.87 1.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' C ' ' CD2' ' A' ' 90' ' ' PHE . 1.2 mt-10 -155.14 138.14 15.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 110.453 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.72 HD11 ' OE1' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -54.48 153.7 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.978 . . . . 0.0 109.612 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 91' ' ' THR . 95.3 t -137.98 -49.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.981 -1.074 . . . . 0.0 110.218 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.897 ' O ' HD12 ' A' ' 89' ' ' ILE . 7.1 tp10 -161.36 115.94 2.03 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.408 -0.808 . . . . 0.0 109.916 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.72 ' OE1' HD11 ' A' ' 29' ' ' LEU . 20.3 pt-20 -124.35 144.8 49.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 110.149 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.44 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 74.8 m -139.68 -160.96 1.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.089 -1.007 . . . . 0.0 111.055 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' NH2' ' A' ' 86' ' ' ARG . 3.0 mm? -94.54 178.56 5.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.371 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -150.91 159.34 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.638 HD11 ' CD2' ' A' ' 62' ' ' LEU . 48.3 mt -105.57 107.02 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 84' ' ' LEU . 87.6 t -88.82 122.33 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.384 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 17.3 tpt180 -139.63 148.73 42.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.34 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.12 -172.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.622 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -96.81 114.43 26.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.511 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.08 -139.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' B' ' 46' ' ' ALA . 2.7 p30 -49.76 -26.43 3.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.801 -1.187 . . . . 0.0 109.733 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.571 ' CE2' HD21 ' A' ' 51' ' ' LEU . 20.3 t-105 -70.63 -43.77 68.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.638 -0.664 . . . . 0.0 109.21 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.88 -28.3 60.45 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -90.61 -63.79 1.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -1.137 . . . . 0.0 110.693 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' HB2' ' OD1' ' B' ' 42' ' ' ASP . . . -48.89 -58.81 4.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.161 -0.962 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.968 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.0 mm? -91.8 41.0 1.05 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.331 -0.856 . . . . 0.0 109.644 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -8.49 31.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.985 . . . . 0.0 111.052 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.43 169.39 9.36 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.894 -1.129 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 52.03 25.95 3.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.428 -0.795 . . . . 0.0 110.57 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.751 HD22 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -115.93 126.56 54.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 0.0 111.077 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -88.85 104.05 16.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 36.1 t -89.02 120.58 30.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.09 -1.007 . . . . 0.0 111.228 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -179.5 4.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.702 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -83.35 80.78 8.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.974 -1.079 . . . . 0.0 109.269 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.21 -23.69 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.777 -0.577 . . . . 0.0 109.922 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.71 -178.47 0.89 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 110.835 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 16.7 m -123.36 139.08 54.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.974 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -132.82 153.22 51.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 111.073 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.968 ' CE ' HD12 ' A' ' 47' ' ' LEU . 38.6 tpp -89.64 155.18 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.76 93.62 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.627 -0.671 . . . . 0.0 110.639 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -55.95 -34.19 65.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 179.847 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 33' ' ' CYS . . . -86.94 -136.94 4.88 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.843 ' HB3' HD11 ' A' ' 67' ' ' ILE . 85.0 m-85 -90.49 19.46 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.349 -1.089 . . . . 0.0 110.617 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.678 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -61.85 -21.18 60.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.52 -59.18 2.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -1.215 . . . . 0.0 111.144 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' ' 64' ' ' PHE . 2.5 pp -53.79 -18.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.283 -0.886 . . . . 0.0 111.648 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE1' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -49.07 146.47 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.852 -1.155 . . . . 0.0 110.735 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.3 171.5 8.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -93.16 148.49 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.58 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.33 131.43 5.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.42 -27.9 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.495 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -117.53 76.51 9.99 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.89 . . . . 0.0 110.386 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.897 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.6 Cg_endo -64.98 104.18 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.665 1.35 . . . . 0.0 110.468 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.476 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 5.5 m-20 -72.15 -10.76 60.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.657 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 90' ' ' PHE . . . -146.22 160.6 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.953 -1.092 . . . . 0.0 110.855 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.03 155.36 43.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 78' ' ' HIS . 21.0 p-80 -90.02 136.13 33.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.613 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.41 13.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 110.164 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 80' ' ' LEU . 17.9 mt -121.82 161.53 22.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.499 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 24.0 m -131.32 119.58 21.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.44 -0.787 . . . . 0.0 110.082 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.11 64.57 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.49 -119.51 6.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 37' ' ' VAL . 60.7 mt -118.54 26.51 9.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -1.136 . . . . 0.0 110.346 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.73 -56.69 4.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 110.431 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.459 ' NH2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -119.09 150.38 40.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.75 147.77 41.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -0.999 . . . . 0.0 110.603 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 3.4 mtt180 -125.25 163.03 23.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 110.324 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 31' ' ' GLU . 26.7 mt -136.08 113.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.442 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.573 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 6.3 m-85 -112.58 178.08 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.908 . . . . 0.0 110.792 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 30' ' ' VAL . 15.2 p -121.64 99.07 6.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.376 -0.828 . . . . 0.0 110.496 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.897 HD11 ' O ' ' A' ' 74' ' ' PRO . 21.5 pt -52.8 -28.4 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.044 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.476 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -135.04 144.11 48.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 109.974 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 44.5 Cg_exo -49.21 145.67 14.51 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.619 1.326 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.477 HG21 ' HB1' ' A' ' 20' ' ' ALA . 73.4 mt -122.51 148.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.937 . . . . 0.0 110.568 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.88 152.26 21.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 110.294 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 21' ' ' ARG . 43.8 mt -53.95 -20.29 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.79 . . . . 0.0 111.148 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.58 59.3 0.38 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.13 179.1 6.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.145 -1.209 . . . . 0.0 110.718 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 18' ' ' VAL . 10.0 tt0 -125.22 128.43 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 110.013 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.866 HG13 ' HB2' ' A' ' 20' ' ' ALA . 61.3 mt -89.37 132.54 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 110.548 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 101' ' ' ILE . 13.8 p -151.37 166.24 31.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.641 -0.662 . . . . 0.0 109.888 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 104' ' ' SER . 2.2 pp -137.86 156.45 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.117 -0.989 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.642 ' O ' HD12 ' A' ' 103' ' ' ILE . 37.0 t -91.83 -163.5 1.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.358 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 104' ' ' SER . 15.3 m-85 -132.32 -55.96 0.97 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.298 -0.876 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.74 163.88 2.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.8 OUTLIER 54.62 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -1.017 . . . . 0.0 111.151 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 2.6 m-20 58.75 -73.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 107' ' ' ASP . 0.4 OUTLIER -42.09 107.82 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.449 -0.782 . . . . 0.0 111.944 -177.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.801 . . . . 0.0 111.488 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.276 0.56 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.56 144.3 49.18 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.312 -1.363 0 O-C-N 123.623 1.328 . . . . 0.0 110.856 -179.66 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 7' ' ' ILE . 13.2 p90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.266 0.555 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 5' ' ' ARG . 2.4 m120 -155.8 -81.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' B' ' 6' ' ' VAL . 31.9 t0 -41.59 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.586 ' O ' HG23 ' B' ' 6' ' ' VAL . 15.3 mtt180 42.57 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 112.841 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 5' ' ' ARG . 44.6 t -158.31 156.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.591 -1.318 . . . . 0.0 110.831 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 15.4 tt -143.9 142.28 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.65 -0.656 . . . . 0.0 109.789 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 8' ' ' VAL . 11.9 p -88.56 135.47 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 111.088 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.646 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.7 mttt -141.72 143.85 33.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.895 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.81 56.89 6.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.617 -1.927 . . . . 0.0 110.297 4.023 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.499 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.725 -0.609 . . . . 0.0 110.037 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -95.28 68.36 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.6 -162.81 14.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.521 ' CG2' HD11 ' B' ' 67' ' ' ILE . 85.8 t -99.84 136.23 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.263 . . . . 0.0 110.247 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.509 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -101.03 127.83 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.858 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -88.84 97.87 11.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 111.139 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.852 ' O ' HG23 ' B' ' 97' ' ' ILE . 5.0 ttt180 -75.26 -19.62 59.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.412 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.49 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.82 4.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' B' ' 22' ' ' LYS 2.518 60.7 m 102.26 24.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.187 -1.571 . . . . 0.0 109.909 1.157 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 26.1 m-85 -115.9 160.54 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 110.92 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.492 -0.755 . . . . 0.0 109.965 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.423 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 16.6 tttm -97.36 86.7 3.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.145 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.18 78.92 1.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.415 ' C ' ' CD2' ' B' ' 90' ' ' PHE . 1.2 mt-10 -155.15 138.12 15.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -1.179 . . . . 0.0 110.471 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.711 HD11 ' OE1' ' B' ' 32' ' ' GLU . 0.3 OUTLIER -54.38 153.73 5.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.123 -0.986 . . . . 0.0 109.602 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.683 HG21 HG23 ' B' ' 91' ' ' THR . 95.5 t -138.05 -49.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.001 -1.062 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.897 ' O ' HD12 ' B' ' 89' ' ' ILE . 7.1 tp10 -161.42 116.0 2.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.711 ' OE1' HD11 ' B' ' 29' ' ' LEU . 20.3 pt-20 -124.42 144.8 49.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.083 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.447 ' HB2' ' CA ' ' B' ' 63' ' ' GLY . 75.9 m -139.68 -160.91 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.019 . . . . 0.0 111.004 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.473 HD21 ' NH2' ' B' ' 86' ' ' ARG . 3.0 mm? -94.53 179.03 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 110.405 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -151.5 159.09 44.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.278 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.643 HD11 ' CD2' ' B' ' 62' ' ' LEU . 48.9 mt -105.61 106.53 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 109.798 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.698 HG22 ' CB ' ' B' ' 84' ' ' LEU . 89.9 t -88.13 122.37 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.51 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CD1' ' B' ' 43' ' ' TRP . 17.3 tpt180 -139.67 148.72 42.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.372 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.11 -172.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.6 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -96.79 114.46 26.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.12 -140.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 109.488 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.564 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 2.7 p30 -49.74 -26.49 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.871 -1.143 . . . . 0.0 109.732 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.598 ' HZ3' HD11 ' A' ' 47' ' ' LEU . 20.3 t-105 -70.54 -43.8 68.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.9 -27.99 60.12 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 88.1 m -91.03 -63.63 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -1.151 . . . . 0.0 110.608 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.491 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . . . -49.11 -58.11 5.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.147 -0.97 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.985 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.0 mm? -92.79 41.29 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -8.48 32.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 111.024 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.38 169.32 9.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.952 -1.093 . . . . 0.0 110.163 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 52.17 25.76 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 110.63 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.755 HD22 ' O ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -115.9 126.1 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 111.187 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.35 103.59 15.97 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 38.1 t -88.24 120.67 29.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.985 . . . . 0.0 111.381 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 177.73 5.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.725 . . . . 0.0 109.709 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -79.43 80.43 5.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 110.126 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.09 -23.82 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.913 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.64 -178.43 0.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.896 . . . . 0.0 110.817 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 16.5 m -123.32 139.01 54.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -132.95 153.04 51.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.014 -1.054 . . . . 0.0 111.112 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.985 ' CE ' HD12 ' B' ' 47' ' ' LEU . 38.7 tpp -89.49 154.73 19.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.681 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.19 93.6 9.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.499 0.1 OUTLIER -56.03 -34.11 65.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 179.781 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' B' ' 33' ' ' CYS . . . -86.9 -136.75 4.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.82 ' HB3' HD11 ' B' ' 67' ' ' ILE . 85.2 m-85 -90.8 19.55 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 110.534 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.681 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -61.87 -20.94 60.47 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.89 -59.1 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.237 . . . . 0.0 111.076 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' B' ' 64' ' ' PHE . 2.5 pp -53.81 -18.3 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.374 -0.829 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.528 ' HE1' HG22 ' B' ' 101' ' ' ILE . 0.2 OUTLIER -49.06 146.54 3.39 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.876 -1.14 . . . . 0.0 110.731 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.38 171.47 8.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -0.917 . . . . 0.0 110.515 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -93.19 148.52 21.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 110.561 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.34 131.36 5.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -27.89 17.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.56 76.51 10.07 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 110.428 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.928 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.7 Cg_endo -64.94 104.17 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.667 1.351 . . . . 0.0 110.496 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 5.6 m-20 -72.13 -10.78 60.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.283 -0.886 . . . . 0.0 110.704 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' B' ' 90' ' ' PHE . . . -146.26 160.64 41.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.064 -1.022 . . . . 0.0 110.822 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.05 155.31 43.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 110.13 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' B' ' 78' ' ' HIS . 21.1 p-80 -89.96 136.14 33.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 110.622 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.425 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.42 13.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.351 -0.843 . . . . 0.0 110.147 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 80' ' ' LEU . 17.7 mt -121.71 161.66 22.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 24.2 m -131.43 119.66 21.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 110.104 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.01 64.62 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.5 -119.57 6.19 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.698 ' CB ' HG22 ' B' ' 37' ' ' VAL . 60.9 mt -118.47 26.52 9.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -1.166 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.69 -56.65 4.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.453 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.473 ' NH2' HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -119.23 150.49 39.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.244 -0.91 . . . . 0.0 110.2 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.82 147.78 41.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.549 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' B' ' 79' ' ' GLU . 3.4 mtt180 -125.29 163.01 23.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.897 HD12 ' O ' ' B' ' 31' ' ' GLU . 26.7 mt -136.05 113.3 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.578 ' O ' ' HB1' ' B' ' 76' ' ' ALA . 6.4 m-85 -112.58 178.05 4.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 110.804 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.683 HG23 HG21 ' B' ' 30' ' ' VAL . 15.1 p -121.63 99.19 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -0.862 . . . . 0.0 110.474 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.928 HD11 ' O ' ' B' ' 74' ' ' PRO . 21.7 pt -52.86 -28.4 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.464 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -135.05 144.13 48.94 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 0.0 109.951 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 46.9 Cg_exo -49.44 145.84 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.599 1.315 . . . . 0.0 110.688 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.477 HG21 ' HB1' ' B' ' 20' ' ' ALA . 73.0 mt -122.53 148.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.71 152.2 21.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.852 HG23 ' O ' ' B' ' 21' ' ' ARG . 43.7 mt -53.86 -20.4 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.436 -0.79 . . . . 0.0 111.116 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.63 59.37 0.37 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.2 178.93 6.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.073 -1.251 . . . . 0.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' B' ' 18' ' ' VAL . 10.0 tt0 -125.28 128.29 48.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' B' ' 20' ' ' ALA . 61.3 mt -89.13 132.54 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.88 . . . . 0.0 110.623 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.417 HG23 ' O ' ' B' ' 101' ' ' ILE . 13.5 p -151.32 166.27 31.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.843 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.632 HD12 ' O ' ' B' ' 104' ' ' SER . 2.2 pp -137.85 156.38 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 110.596 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.632 ' O ' HD12 ' B' ' 103' ' ' ILE . 36.6 t -91.78 -163.51 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.416 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 15.3 m-85 -132.27 -56.14 0.97 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.91 163.84 2.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.8 OUTLIER 54.67 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -1.025 . . . . 0.0 111.126 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 107' ' ' ASP . 2.5 m-20 58.73 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' B' ' 107' ' ' ASP . 0.4 OUTLIER -42.05 107.73 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 112.016 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 111.48 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.236 0.541 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.5 144.32 49.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.282 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 O-C-N 123.667 1.351 . . . . 0.0 110.788 -179.587 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 47.3 p90 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.31 0.576 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -131.97 164.7 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -50.23 -24.06 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.717 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.521 ' C ' HG13 ' A' ' 6' ' ' VAL . 6.3 mmm-85 -78.33 -44.62 24.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 110.707 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.521 HG13 ' C ' ' A' ' 5' ' ' ARG . 29.8 m -153.37 -172.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.481 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 19' ' ' PHE . 3.0 tt -145.43 143.21 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.349 -0.844 . . . . 0.0 109.777 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.66 118.34 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.951 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.581 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 10.3 mttt -121.77 144.39 48.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.412 -0.805 . . . . 0.0 109.197 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.581 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.72 71.55 0.47 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.658 -1.901 . . . . 0.0 111.641 0.167 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 110.069 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.71 ' OH ' HD21 ' B' ' 34' ' ' LEU . 0.2 OUTLIER -91.8 104.42 16.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -1.134 . . . . 0.0 110.295 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.88 -170.6 15.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.674 HG23 HD13 ' A' ' 67' ' ' ILE . 75.9 t -105.52 145.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.969 -1.312 . . . . 0.0 110.49 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.699 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.6 m-85 -109.99 120.44 42.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.395 -0.815 . . . . 0.0 109.405 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.93 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.54 90.13 8.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 111.123 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.851 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.23 -24.43 59.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 177.674 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.488 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 13.7 mtpt -94.9 178.99 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.467 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 51.8 m 104.11 23.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.007 -1.683 . . . . 0.0 109.67 2.007 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.488 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 12.2 m-85 -112.23 159.94 18.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 110.567 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 1.2 tt0 -91.13 -157.63 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.888 . . . . 0.0 110.316 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 59.2 tttt -98.85 73.58 2.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 110.564 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.87 77.12 0.84 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 25' ' ' GLU . 4.2 mm-40 -138.34 18.45 2.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -1.141 . . . . 0.0 110.565 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 90' ' ' PHE . 16.3 tp 59.61 147.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.49 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.543 ' CG2' HG23 ' A' ' 91' ' ' THR . 83.8 t -126.97 -39.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.973 -1.08 . . . . 0.0 110.243 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.95 161.67 8.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.37 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.6 143.93 22.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.506 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' C ' HD12 ' A' ' 34' ' ' LEU . 1.2 m -149.25 -164.96 2.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.658 HD21 ' OH ' ' B' ' 16' ' ' TYR . 11.0 mp -100.36 176.97 5.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.358 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 153.59 41.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.677 HD11 ' CD2' ' A' ' 62' ' ' LEU . 39.3 mt -94.75 97.29 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.958 . . . . 0.0 109.268 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.884 HG13 HD23 ' A' ' 84' ' ' LEU . 59.6 t -88.42 114.63 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.295 -0.878 . . . . 0.0 110.466 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -126.07 148.75 49.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 110.391 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.35 159.87 5.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.242 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -69.92 113.22 6.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.38 -142.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.854 . . . . 0.0 109.543 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.52 -25.26 3.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.869 -1.145 . . . . 0.0 109.986 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.682 ' CZ2' HD21 ' A' ' 51' ' ' LEU . 43.8 t-105 -66.06 -54.55 24.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.788 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.8 -32.65 59.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -78.3 -63.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.1 -51.86 49.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.669 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.011 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.1 mm? -91.14 30.07 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 110.729 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.43 -24.7 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.291 -0.881 . . . . 0.0 111.547 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 3.3 p30 -99.88 151.8 20.88 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.947 -1.095 . . . . 0.0 110.55 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.511 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 9.6 m-85 61.01 19.27 9.74 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.779 -0.576 . . . . 0.0 111.048 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.682 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 6.7 mt -104.81 123.2 47.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.017 . . . . 0.0 110.789 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -89.12 105.9 18.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 108.455 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.2 p -87.87 118.91 27.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.169 -0.957 . . . . 0.0 111.071 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 1.002 ' HD3' HD13 ' A' ' 84' ' ' LEU . 5.4 ttp180 -98.76 -178.83 4.1 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.73 . . . . 0.0 110.038 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -83.87 81.54 8.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.054 . . . . 0.0 109.373 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.51 23.6 p30 149.06 -20.76 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.769 -0.582 . . . . 0.0 109.914 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -177.01 -162.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.286 -0.883 . . . . 0.0 110.612 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 81.3 p -143.17 153.18 42.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.402 -0.811 . . . . 0.0 110.114 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.675 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.717 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 1.011 ' CE ' HD12 ' A' ' 47' ' ' LEU . 28.3 tpp -89.44 152.98 21.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.049 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -87.89 109.11 19.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.852 . . . . 0.0 110.294 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.743 ' O ' HD13 ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -56.68 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.785 . . . . 0.0 110.985 -179.775 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.15 -168.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.63 ' O ' HD11 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -73.14 56.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -1.169 . . . . 0.0 111.323 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -91.5 -23.45 28.73 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -91.13 2.7 56.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 111.502 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.712 HD12 ' N ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -90.31 -8.6 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.794 -1.191 . . . . 0.0 110.733 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.712 ' N ' HD12 ' A' ' 67' ' ' ILE . 18.3 m-85 -56.03 131.93 48.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 0.0 109.925 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -98.48 179.1 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.974 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.57 115.92 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.832 . . . . 0.0 110.405 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.11 141.54 46.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 110.535 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -61.64 120.85 11.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.942 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.26 84.34 0.21 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.835 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.4 Cg_endo -64.13 107.28 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.691 1.364 . . . . 0.0 110.467 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.29 -18.51 27.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.603 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -131.4 119.44 21.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.972 . . . . 0.0 110.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.73 -170.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.417 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 26.5 p-80 -129.19 163.07 26.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.838 . . . . 0.0 110.314 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -139.63 159.29 42.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.529 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 84' ' ' LEU . 8.7 mt -118.38 150.16 39.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.181 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 86' ' ' ARG . 6.6 p -68.93 67.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 80' ' ' LEU . . . 51.24 39.83 24.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.56 -136.46 4.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.002 HD13 ' HD3' ' A' ' 54' ' ' ARG . 5.5 tp -132.08 86.67 2.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -1.107 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -49.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.514 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.639 ' HB2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -124.76 123.62 40.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.1 mtp -95.24 154.7 17.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' HIS . 83.5 mtt-85 -138.75 164.23 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.043 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.31 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.732 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 18.3 m-85 -91.79 157.95 16.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 110.602 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.543 HG23 ' CG2' ' A' ' 30' ' ' VAL . 7.7 p -101.94 83.11 2.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.835 HD11 ' O ' ' A' ' 74' ' ' PRO . 6.1 pt -52.88 -23.48 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 110.555 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 92' ' ' ILE . 17.9 mmtt -137.48 134.57 18.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 89.6 Cg_exo -46.35 140.61 11.23 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.437 1.23 . . . . 0.0 111.119 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 20' ' ' ALA . 58.9 mt -117.95 141.81 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -89.61 166.49 13.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 110.449 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.851 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.0 mt -71.58 127.11 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.58 18.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 1.1 tm-20 -100.21 -175.77 3.03 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.139 -1.212 . . . . 0.0 110.022 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -126.16 124.47 40.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.106 -0.996 . . . . 0.0 110.307 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.93 HG13 ' HB2' ' A' ' 20' ' ' ALA . 62.8 mt -89.86 130.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.193 -0.942 . . . . 0.0 110.548 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.541 HG23 ' C ' ' A' ' 101' ' ' ILE . 72.8 p -154.67 -166.85 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -148.68 -167.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 110.444 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.673 ' O ' HD12 ' A' ' 103' ' ' ILE . 3.4 t -102.71 -148.26 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 110.154 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.85 -86.55 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.418 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.07 1.69 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.49 -1.07 18.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 110.996 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.97 -40.39 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.967 -1.083 . . . . 0.0 110.565 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.84 105.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.952 . . . . 0.0 110.599 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 15.6 m95 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 111.083 179.333 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 216' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.507 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.724 . . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 54.98 172.72 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 110.448 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 19.2 Cg_exo . . . . . 0 C--N 1.313 -1.325 0 O-C-N 123.613 1.323 . . . . 0.0 110.443 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 47.3 p90 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.351 0.596 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -131.98 164.81 25.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 110.226 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -50.3 -24.09 2.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 110.664 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.538 ' C ' HG13 ' B' ' 6' ' ' VAL . 6.3 mmm-85 -78.27 -44.68 24.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.651 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.538 HG13 ' C ' ' B' ' 5' ' ' ARG . 30.2 m -153.35 -172.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.707 HG23 ' HB2' ' B' ' 19' ' ' PHE . 3.0 tt -145.43 143.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.48 118.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.036 -1.04 . . . . 0.0 110.99 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.598 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 10.2 mttt -121.9 144.37 48.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.472 -0.767 . . . . 0.0 109.221 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.598 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.74 71.62 0.47 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.711 -1.868 . . . . 0.0 111.569 0.186 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.658 ' OH ' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -91.73 104.57 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -1.158 . . . . 0.0 110.364 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.1 -170.64 15.56 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.676 HG23 HD13 ' B' ' 67' ' ' ILE . 77.2 t -105.53 145.06 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.946 -1.326 . . . . 0.0 110.449 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.707 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.6 m-85 -110.0 120.35 42.18 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.466 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.893 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.41 90.14 8.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 111.18 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.31 -24.34 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 177.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.482 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 13.7 mtpt -94.92 179.04 5.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.524 -0.735 . . . . 0.0 109.031 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.453 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 51.9 m 104.09 23.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.095 -1.628 . . . . 0.0 109.677 2.012 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 12.3 m-85 -112.21 159.96 18.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.619 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.409 ' HB2' ' HG3' ' B' ' 28' ' ' GLU . 1.2 tt0 -91.16 -157.62 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.261 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.424 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 59.1 tttt -98.83 73.55 2.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.548 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 77.02 0.83 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' B' ' 25' ' ' GLU . 4.2 mm-40 -138.3 18.4 2.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 110.586 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.737 HD13 ' CZ ' ' B' ' 90' ' ' PHE . 16.2 tp 59.75 147.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.418 -0.802 . . . . 0.0 110.503 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.548 ' CG2' HG23 ' B' ' 91' ' ' THR . 83.8 t -127.02 -39.82 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.042 . . . . 0.0 110.279 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.97 161.71 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.336 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' B' ' 87' ' ' MET . 3.8 pm0 -153.66 143.86 22.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.453 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.483 ' C ' HD12 ' B' ' 34' ' ' LEU . 1.2 m -149.17 -164.95 2.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.398 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.71 HD21 ' OH ' ' A' ' 16' ' ' TYR . 11.0 mp -100.34 176.95 5.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.94 153.57 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.676 HD11 ' CD2' ' B' ' 62' ' ' LEU . 39.4 mt -94.78 96.4 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.393 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.877 HG13 HD23 ' B' ' 84' ' ' LEU . 54.8 t -87.21 114.7 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 110.651 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.511 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -126.21 148.71 49.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.31 159.88 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -69.87 113.15 6.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.451 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.35 -142.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.523 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.48 -25.33 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.812 -1.18 . . . . 0.0 110.004 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.677 ' CZ2' HD21 ' B' ' 51' ' ' LEU . 43.7 t-105 -66.02 -54.55 24.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.593 -0.692 . . . . 0.0 109.781 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.85 -32.52 59.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -78.39 -63.23 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.153 . . . . 0.0 110.533 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.21 -51.4 54.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 110.69 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.998 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.1 mm? -91.83 30.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.484 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.52 -24.74 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.245 -0.91 . . . . 0.0 111.505 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.469 ' OD1' ' CD2' ' B' ' 50' ' ' TYR . 3.2 p30 -99.72 151.79 20.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 9.4 m-85 60.96 19.2 9.61 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.654 -0.654 . . . . 0.0 111.057 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.677 HD21 ' CZ2' ' B' ' 43' ' ' TRP . 6.6 mt -104.89 123.02 46.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 0.0 110.893 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -88.77 104.98 17.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.706 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 57.0 p -86.55 119.04 26.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 111.322 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.992 ' HD3' HD13 ' B' ' 84' ' ' LEU . 5.4 ttp180 -99.49 178.67 4.8 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.473 -0.767 . . . . 0.0 110.066 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -80.2 81.17 6.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.957 . . . . 0.0 110.187 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 23.5 p30 148.96 -20.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.677 -0.64 . . . . 0.0 109.942 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.4 ptm -176.83 -161.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.934 . . . . 0.0 110.745 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.451 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 81.4 p -143.2 153.2 42.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 110.044 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.665 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -139.58 145.69 38.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 110.703 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.998 ' CE ' HD12 ' B' ' 47' ' ' LEU . 28.5 tpp -89.34 152.15 21.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -86.83 109.02 19.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.451 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 62' ' ' LEU 2.5 0.2 OUTLIER -56.68 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -0.794 . . . . 0.0 110.919 -179.908 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.36 -168.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.629 ' O ' HD11 ' B' ' 67' ' ' ILE . 0.1 OUTLIER -73.19 57.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.18 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' B' ' 68' ' ' PHE . . . -92.52 -22.48 28.89 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -92.03 3.09 56.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 111.378 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.721 HD12 ' N ' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -90.53 -8.55 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.811 -1.18 . . . . 0.0 110.724 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.721 ' N ' HD12 ' B' ' 67' ' ' ILE . 18.3 m-85 -56.05 131.98 48.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 0.0 109.907 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -98.57 179.12 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.967 . . . . 0.0 110.968 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.56 115.95 21.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.84 . . . . 0.0 110.404 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.13 141.6 46.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -61.68 120.86 11.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.31 84.27 0.21 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.822 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.5 Cg_endo -64.04 107.33 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.734 1.386 . . . . 0.0 110.484 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.32 -18.49 27.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 110.632 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.565 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -131.4 119.36 21.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 0.0 110.382 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.7 -170.46 1.8 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 110.454 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.415 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 26.5 p-80 -129.2 162.99 26.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -139.64 159.32 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 110.514 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.442 HD22 HD12 ' B' ' 84' ' ' LEU . 8.8 mt -118.36 150.15 40.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.644 HG21 ' HB2' ' B' ' 86' ' ' ARG . 6.4 p -69.01 67.26 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 110.562 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' B' ' 80' ' ' LEU . . . 51.3 39.78 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.765 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.63 -136.51 4.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.992 HD13 ' HD3' ' B' ' 54' ' ' ARG . 5.5 tp -132.05 86.73 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -1.083 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.4 -49.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.644 ' HB2' HG21 ' B' ' 81' ' ' THR . 0.0 OUTLIER -124.74 123.7 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 110.171 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' B' ' 32' ' ' GLU . 22.1 mtp -95.29 154.57 17.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 110.656 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' B' ' 78' ' ' HIS . 83.5 mtt-85 -138.64 164.3 29.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 110.083 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.24 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.978 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.737 ' CZ ' HD13 ' B' ' 29' ' ' LEU . 18.4 m-85 -91.79 157.96 16.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.548 HG23 ' CG2' ' B' ' 30' ' ' VAL . 7.8 p -101.89 83.08 2.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.183 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.822 HD11 ' O ' ' B' ' 74' ' ' PRO . 6.1 pt -52.93 -23.46 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.895 . . . . 0.0 110.548 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.424 ' N ' HG13 ' B' ' 92' ' ' ILE . 17.9 mmtt -137.45 134.37 18.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 85.4 Cg_exo -46.6 140.88 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.424 1.223 . . . . 0.0 111.08 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.42 HG21 ' CB ' ' B' ' 20' ' ' ALA . 59.0 mt -117.99 141.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.616 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -89.21 166.61 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.51 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.0 mt -71.71 127.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.4 23.57 18.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 96' ' ' ALA . 1.1 tm-20 -100.01 -176.04 3.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.258 -1.142 . . . . 0.0 110.076 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -126.08 124.46 40.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.998 . . . . 0.0 110.282 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.893 HG13 ' HB2' ' B' ' 20' ' ' ALA . 62.7 mt -89.84 130.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.533 HG23 ' C ' ' B' ' 101' ' ' ILE . 72.2 p -154.55 -166.77 2.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.0 109.664 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.669 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -148.73 -167.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.459 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.669 ' O ' HD12 ' B' ' 103' ' ' ILE . 3.4 t -102.64 -148.3 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 110.159 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.82 -86.57 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.98 -132.04 1.68 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.54 -1.03 18.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 0.0 110.977 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.89 -40.46 0.61 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.929 -1.107 . . . . 0.0 110.614 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 105.14 1.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.608 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 15.7 m95 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.517 -0.739 . . . . 0.0 111.06 179.313 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 216' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.508 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.175 0.512 . . . . 0.0 110.7 . . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 54.9 172.78 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 19.0 Cg_exo . . . . . 0 C--N 1.312 -1.374 0 O-C-N 123.651 1.342 . . . . 0.0 110.439 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 15.2 p90 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.378 0.608 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.88 151.25 36.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.47 -28.04 3.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.3 -0.875 . . . . 0.0 110.825 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.12 25.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 110.352 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' A' ' 5' ' ' ARG . 36.0 m -153.71 156.24 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.272 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.693 HG23 ' HB2' ' A' ' 19' ' ' PHE . 17.2 tt -128.74 155.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' H ' HG12 ' A' ' 8' ' ' VAL . 8.2 p -97.89 133.42 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.862 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.594 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 7.6 mttt -130.86 142.73 50.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.35 -0.844 . . . . 0.0 109.313 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.594 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 20.0 mttt 52.74 62.23 2.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 119.631 -1.918 . . . . 0.0 111.219 0.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.459 -0.776 . . . . 0.0 110.296 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 1.5 m-85 -74.47 81.81 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -1.201 . . . . 0.0 110.353 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.467 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -121.13 -169.07 13.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 72.4 t -110.86 146.6 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.892 -1.358 . . . . 0.0 110.396 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.693 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.2 m-85 -111.33 122.41 47.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 109.998 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.817 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -92.34 92.01 7.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 110.839 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.0 -21.63 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 178.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 22.7 mtpt -90.68 -179.3 5.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.88 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HE3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 108.29 15.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.167 -1.583 . . . . 0.0 110.378 0.922 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 40.1 m-85 -109.18 148.59 30.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.083 -1.011 . . . . 0.0 110.716 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.29 -161.33 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 69.99 3.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -137.69 122.23 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -1.171 . . . . 0.0 110.24 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 ' HB3' ' A' ' 88' ' ' ARG . 1.3 tm? -65.8 115.69 6.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.893 . . . . 0.0 110.417 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 29' ' ' LEU . 85.3 t -94.39 74.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 110.057 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 30' ' ' VAL . 3.5 tt0 59.06 154.1 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.5 0.667 . . . . 0.0 110.821 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 88' ' ' ARG . 9.4 pt-20 -157.28 161.24 39.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.26 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.53 -170.7 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.622 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ARG . 58.4 mt -90.47 -170.24 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.436 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 14.0 m -147.18 160.77 42.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 110.024 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.607 HD11 ' CD2' ' A' ' 62' ' ' LEU . 27.2 mt -96.07 102.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 109.345 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.6 129.24 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 110.663 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 6.0 mmt180 -145.81 151.69 38.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.437 -0.789 . . . . 0.0 110.127 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.3 -179.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.972 . . . . 0.0 110.369 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.37 112.37 23.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.53 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.25 -142.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -50.81 -25.25 4.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.719 -1.238 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.513 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 45.6 t-105 -56.12 -64.44 0.86 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.25 -28.39 58.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.7 m -70.54 -67.75 0.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -1.179 . . . . 0.0 110.523 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.03 84.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.558 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.995 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.3 mm? -90.34 41.02 1.03 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.623 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.34 3.97 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.106 -0.996 . . . . 0.0 110.519 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.12 -81.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.484 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.467 ' CD1' ' HA ' ' A' ' 66' ' ' ALA . 12.5 m-85 -96.96 52.38 1.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.368 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.708 HD13 ' HB3' ' A' ' 47' ' ' LEU . 1.3 tp -111.89 131.45 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 111.167 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -92.35 -178.29 4.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -144.22 123.21 12.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 111.042 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.608 ' CB ' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -110.82 173.52 6.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.608 -0.682 . . . . 0.0 109.372 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 54' ' ' ARG . 13.1 mttm -82.68 70.8 9.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.0 109.237 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.2 t30 166.5 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.96 -167.87 0.25 Allowed 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 37.6 p -120.71 166.88 13.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.443 -0.786 . . . . 0.0 109.434 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.66 ' HB3' HD22 ' A' ' 84' ' ' LEU . . . -150.06 151.69 33.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.922 -1.111 . . . . 0.0 111.062 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.995 ' CE ' HD12 ' A' ' 47' ' ' LEU . 18.2 tpp -89.55 154.32 20.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.667 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.57 91.64 8.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.945 HD22 HD22 ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -55.54 -45.27 77.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.51 179.591 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.73 -141.22 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.826 ' HB3' HD11 ' A' ' 67' ' ' ILE . 29.3 m-85 -90.6 11.09 23.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -1.185 . . . . 0.0 110.903 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.667 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -47.37 -30.79 6.15 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . . . -66.51 -75.28 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.199 -1.177 . . . . 0.0 109.793 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 64' ' ' PHE . 2.4 pp -56.74 -18.8 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 111.364 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.649 ' HE1' HD13 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -51.81 132.42 31.53 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.04 -1.038 . . . . 0.0 109.936 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.661 ' CB ' HG22 ' A' ' 102' ' ' THR . 13.4 m-20 -109.05 177.26 4.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.957 -1.089 . . . . 0.0 111.451 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.657 ' CD2' ' HA ' ' A' ' 104' ' ' SER . 25.5 t-80 -103.0 157.56 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.3 t -149.96 140.93 22.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 110.603 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -29.78 50.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.87 96.07 39.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.594 ' O ' HD11 ' A' ' 92' ' ' ILE . 31.9 Cg_exo -54.0 119.71 6.75 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.648 1.341 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.463 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 19.7 p30 -110.58 -21.77 11.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -146.35 149.93 34.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.506 ' HB2' HG23 ' A' ' 92' ' ' ILE . 3.4 mtt180 -128.19 -173.39 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 110.186 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 5.4 p80 -128.81 175.95 8.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.649 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 87' ' ' MET . 24.0 tt0 -137.66 153.26 49.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.832 HD23 ' HG2' ' A' ' 87' ' ' MET . 80.1 mt -123.83 135.5 53.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -79.92 -168.76 1.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 88.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 110.467 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 87.12 58.38 1.89 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 59' ' ' ALA . 8.0 mt 55.72 -111.6 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.375 -1.074 . . . . 0.0 110.084 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER 58.55 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.625 -1.297 . . . . 0.0 111.078 179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -97.38 139.82 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 110.536 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.832 ' HG2' HD23 ' A' ' 80' ' ' LEU . 11.0 mtp -129.64 144.47 51.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.869 ' HB3' HD21 ' A' ' 29' ' ' LEU . 5.5 mtp180 -124.87 162.93 23.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.21 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HE1' ' A' ' 68' ' ' PHE . 81.2 mt -123.0 99.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.848 . . . . 0.0 109.661 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 2.0 m-85 -96.36 -174.2 2.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.718 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 11.9 p -127.48 98.89 5.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.594 HD11 ' O ' ' A' ' 74' ' ' PRO . 45.4 pt -55.64 -25.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.617 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -144.53 146.77 33.72 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.172 -0.955 . . . . 0.0 110.438 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.12 125.89 20.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.685 1.361 . . . . 0.0 110.492 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.9 144.58 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.59 156.88 18.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 110.457 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 21' ' ' ARG . 73.3 mt -66.8 113.68 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.38 30.71 2.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.92 -170.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.296 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 43.1 tt0 -128.39 133.7 48.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.817 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 26.4 mt -89.32 131.32 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.2 -0.937 . . . . 0.0 109.932 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.661 HG22 ' CB ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -158.9 164.56 35.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.119 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.604 HG23 ' CE2' ' A' ' 68' ' ' PHE . 8.2 pt -132.94 162.41 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.618 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.657 ' HA ' ' CD2' ' A' ' 70' ' ' HIS . 1.4 m -91.71 174.83 7.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.205 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 70' ' ' HIS . 15.8 m-85 -126.86 -70.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 67.35 -163.67 45.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.66 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -1.045 . . . . 0.0 110.622 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -100.04 -42.47 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 0.0 110.341 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.453 ' HB2' ' CB ' ' A' ' 105' ' ' TYR . 19.1 m-85 -61.88 141.91 57.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.4 -0.812 . . . . 0.0 110.558 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.245 0.545 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' C' ' 218' ' ' PRO . . . -136.22 152.11 74.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 217' ' ' ALA . 33.6 Cg_exo . . . . . 0 C--N 1.312 -1.345 0 O-C-N 123.699 1.368 . . . . 0.0 110.517 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 15.4 p90 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.322 0.582 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.89 151.23 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -0.818 . . . . 0.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.43 -28.05 3.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.794 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.2 25.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' B' ' 5' ' ' ARG . 35.9 m -153.62 156.26 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.719 HG23 ' HB2' ' B' ' 19' ' ' PHE . 17.2 tt -128.74 155.59 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.395 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.424 HG13 ' O ' ' B' ' 8' ' ' VAL . 8.2 p -97.85 133.47 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.85 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 7.6 mttt -130.93 142.68 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.846 . . . . 0.0 109.315 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.6 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 20.0 mttt 52.67 62.33 2.74 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 119.675 -1.89 . . . . 0.0 111.199 0.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 2.6 p . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 110.31 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 1.5 m-85 -74.52 81.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.325 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.466 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -121.14 -169.02 13.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 69.0 t -110.92 146.17 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.929 -1.336 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.719 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.2 m-85 -111.27 122.4 47.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.817 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -92.38 92.08 7.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 110.825 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.98 -21.7 61.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.836 178.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 22.9 mtpt -90.63 -179.18 5.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.419 -0.801 . . . . 0.0 109.889 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.405 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 0.0 OUTLIER 108.32 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.206 -1.559 . . . . 0.0 110.43 0.896 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 40.0 m-85 -109.17 148.58 30.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.01 . . . . 0.0 110.688 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.33 -161.3 0.8 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 70.0 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 110.312 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -137.66 122.29 18.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -1.128 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.846 HD21 ' HB3' ' B' ' 88' ' ' ARG . 1.3 tm? -65.85 115.62 6.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 110.445 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.481 ' N ' HD13 ' B' ' 29' ' ' LEU . 85.9 t -94.3 74.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -0.853 . . . . 0.0 110.012 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' B' ' 30' ' ' VAL . 3.5 tt0 59.08 154.11 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.648 -0.657 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' B' ' 88' ' ' ARG . 9.4 pt-20 -157.18 161.5 39.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 110.269 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.85 -170.78 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.427 HD23 ' CG ' ' B' ' 86' ' ' ARG . 58.8 mt -90.46 -170.24 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 14.4 m -147.17 160.71 42.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' B' ' 62' ' ' LEU . 27.0 mt -96.07 102.32 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.089 -1.007 . . . . 0.0 109.411 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.67 129.33 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 5.9 mmt180 -145.99 151.71 38.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.26 -179.11 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.39 112.37 23.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.28 -142.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.831 . . . . 0.0 109.568 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -50.82 -25.31 4.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.766 -1.208 . . . . 0.0 109.855 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.622 ' HZ3' HD11 ' A' ' 47' ' ' LEU . 45.6 t-105 -56.05 -64.47 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.918 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.23 -28.37 58.74 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 75.8 m -70.5 -67.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.572 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.85 84.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 110.658 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.989 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.3 mm? -90.55 41.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.604 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.24 3.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 110.512 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.14 -81.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.471 ' CD1' ' HA ' ' B' ' 66' ' ' ALA . 12.5 m-85 -96.9 52.41 1.17 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 0.0 109.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' B' ' 47' ' ' LEU . 1.3 tp -111.89 131.54 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 111.108 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -92.34 -178.24 4.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.388 -0.82 . . . . 0.0 109.683 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 25.0 p -144.16 123.26 12.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.044 -1.035 . . . . 0.0 111.04 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.615 ' CB ' HD11 ' B' ' 84' ' ' LEU . 0.4 OUTLIER -111.5 170.6 8.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 178.667 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' B' ' 54' ' ' ARG . 14.1 mttm -78.54 70.13 4.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.089 . . . . 0.0 110.178 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 1.2 t30 166.58 -28.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.76 -167.83 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.454 -0.779 . . . . 0.0 110.954 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.432 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 37.5 p -120.69 166.84 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.449 -0.782 . . . . 0.0 109.419 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.679 ' HB3' HD22 ' B' ' 84' ' ' LEU . . . -150.04 151.54 33.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.93 -1.106 . . . . 0.0 111.058 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.989 ' CE ' HD12 ' B' ' 47' ' ' LEU . 18.2 tpp -89.43 153.39 20.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.653 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -86.28 91.58 8.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.836 . . . . 0.0 110.88 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.945 HD22 HD22 ' A' ' 62' ' ' LEU 2.498 0.2 OUTLIER -55.62 -45.24 77.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 110.518 179.432 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.74 -140.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.814 ' HB3' HD11 ' B' ' 67' ' ' ILE . 29.0 m-85 -91.02 11.21 23.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -1.143 . . . . 0.0 110.823 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.653 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -47.39 -30.8 6.2 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' B' ' 50' ' ' TYR . . . -66.54 -75.46 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.179 -1.189 . . . . 0.0 109.84 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.814 HD11 ' HB3' ' B' ' 64' ' ' PHE . 2.4 pp -56.48 -18.99 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.65 ' HE1' HD13 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -51.65 132.36 30.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.907 -1.12 . . . . 0.0 109.85 178.563 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.644 ' CB ' HG22 ' B' ' 102' ' ' THR . 13.3 m-20 -108.9 177.92 4.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.018 -1.051 . . . . 0.0 111.351 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' HIS . . . . . 0.652 ' CD2' ' HA ' ' B' ' 104' ' ' SER . 24.9 t-80 -104.04 157.33 17.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.5 t -149.79 140.85 22.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.632 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.81 49.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.8 96.02 39.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.395 -0.816 . . . . 0.0 109.961 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.608 ' O ' HD11 ' B' ' 92' ' ' ILE . 31.9 Cg_exo -53.97 119.75 6.79 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.655 1.345 . . . . 0.0 110.682 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.463 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 19.7 p30 -110.56 -21.84 11.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -146.36 149.9 34.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.332 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.515 ' HB2' HG23 ' B' ' 92' ' ' ILE . 3.4 mtt180 -128.11 -173.34 2.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.179 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 5.3 p80 -128.88 175.98 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 110.671 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' B' ' 87' ' ' MET . 23.9 tt0 -137.66 153.21 49.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.797 HD23 ' HG2' ' B' ' 87' ' ' MET . 80.3 mt -123.8 135.52 53.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 110.215 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 83' ' ' GLY . 0.0 OUTLIER -79.99 -168.69 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -0.905 . . . . 0.0 110.113 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 110.495 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.456 ' HA3' ' HZ1' ' B' ' 85' ' ' LYS . . . 87.16 58.32 1.89 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.679 HD22 ' HB3' ' B' ' 59' ' ' ALA . 8.0 mt 55.76 -111.68 0.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.408 -1.054 . . . . 0.0 110.078 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.456 ' HZ1' ' HA3' ' B' ' 83' ' ' GLY . 0.2 OUTLIER 58.44 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.586 -1.321 . . . . 0.0 111.076 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.427 ' CG ' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -97.28 139.79 32.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.489 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.797 ' HG2' HD23 ' B' ' 80' ' ' LEU . 11.1 mtp -129.59 144.48 51.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 110.438 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.846 ' HB3' HD21 ' B' ' 29' ' ' LEU . 5.5 mtp180 -124.86 162.92 23.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.65 HD13 ' HE1' ' B' ' 68' ' ' PHE . 81.1 mt -123.01 99.75 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.825 . . . . 0.0 109.617 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.685 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 2.0 m-85 -96.31 -174.17 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.737 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -127.52 98.83 5.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.608 HD11 ' O ' ' B' ' 74' ' ' PRO . 45.4 pt -55.62 -25.07 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.632 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.1 OUTLIER -144.48 146.79 33.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 110.497 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 93' ' ' LYS . 37.6 Cg_exo -56.2 125.9 20.6 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.709 1.373 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.96 144.42 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 110.333 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.42 156.93 18.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.465 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 73.3 mt -66.84 113.63 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.47 30.75 2.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.99 -170.31 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 110.281 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 43.3 tt0 -128.43 133.5 48.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.289 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.817 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 27.1 mt -88.96 131.35 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 110.104 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.644 HG22 ' CB ' ' B' ' 69' ' ' ASN . 1.0 OUTLIER -158.87 164.68 35.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.785 -0.572 . . . . 0.0 109.727 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 76' ' ' ALA . 8.2 pt -132.95 162.35 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.652 ' HA ' ' CD2' ' B' ' 70' ' ' HIS . 1.4 m -91.73 174.8 7.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' B' ' 70' ' ' HIS . 15.8 m-85 -126.76 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 110.501 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 67.42 -163.59 45.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.63 -86.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.439 -1.036 . . . . 0.0 110.635 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -100.14 -42.62 6.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.275 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.452 ' HB2' ' CB ' ' B' ' 105' ' ' TYR . 19.2 m-85 -61.7 141.98 57.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.339 -0.85 . . . . 0.0 110.558 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.2 0.524 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -136.24 152.15 74.68 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.395 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.406 ' HD3' ' HE1' ' B' ' 78' ' ' HIS . 33.3 Cg_exo . . . . . 0 C--N 1.313 -1.342 0 O-C-N 123.662 1.348 . . . . 0.0 110.545 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.482 ' CD1' HD12 ' A' ' 7' ' ' ILE . 14.6 t80 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.41 0.624 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' ARG . 11.8 m120 -90.17 55.36 3.06 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.405 -0.809 . . . . 0.0 110.046 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t70 52.97 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 111.371 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.529 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -50.55 -33.82 23.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 111.01 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.529 HG23 ' C ' ' A' ' 5' ' ' ARG . 89.2 t -152.37 138.5 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.067 -1.021 . . . . 0.0 111.245 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.602 HG23 ' HB2' ' A' ' 19' ' ' PHE . 12.7 tt -114.61 162.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 110.062 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 64' ' ' PHE . 96.1 t -106.85 120.06 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 16.7 mttt -116.69 144.03 44.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.6 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 25.0 mttt 52.38 63.04 2.4 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.725 -1.86 . . . . 0.0 111.355 0.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.423 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.827 . . . . 0.0 110.344 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 71.6 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.349 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -108.69 -172.32 21.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.858 ' CG2' HD13 ' A' ' 67' ' ' ILE . 94.1 t -113.55 158.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.299 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -121.0 127.91 52.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.157 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.583 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -89.84 95.2 10.13 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.571 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.855 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -64.14 -24.95 67.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.838 . . . . 0.0 109.665 178.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -86.02 179.27 7.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.537 ' OG ' HD11 ' A' ' 97' ' ' ILE 2.511 0.0 OUTLIER 103.37 11.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.141 -1.599 . . . . 0.0 110.603 1.118 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.6 m-85 -107.67 150.96 26.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.702 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.26 -152.63 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 110.131 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 13.7 tttm -100.58 69.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 110.43 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.03 75.2 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.73 7.55 3.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -1.146 . . . . 0.0 110.984 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.602 HD11 ' HE ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER 61.45 131.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.612 ' CG2' HG23 ' A' ' 91' ' ' THR . 97.2 t -103.38 -74.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.117 -0.99 . . . . 0.0 110.697 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.46 160.82 37.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.704 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.63 142.17 37.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.221 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.429 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.4 p -150.15 -174.99 4.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.711 ' N ' HD22 ' A' ' 34' ' ' LEU . 2.8 mm? -97.66 174.43 6.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.85 168.59 22.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.699 HG13 HD22 ' A' ' 62' ' ' LEU . 79.3 mt -100.37 150.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.883 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 84' ' ' LEU . 49.7 t -125.58 82.07 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -109.07 146.45 33.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.606 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 41.0 m170 -61.73 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.007 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -89.58 -137.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 60.54 -134.4 0.72 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.956 -1.09 . . . . 0.0 110.222 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -45.94 -26.15 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.907 -1.121 . . . . 0.0 111.155 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 1.031 ' CH2' HD22 ' A' ' 47' ' ' LEU . 65.4 t-105 -67.54 -58.6 4.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -25.55 42.21 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 59.7 m -81.14 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 110.537 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -52.8 -58.02 8.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.031 HD22 ' CH2' ' A' ' 43' ' ' TRP . 4.8 mp -90.82 51.83 2.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.285 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.04 56.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.894 -1.129 . . . . 0.0 111.583 -178.208 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER 174.21 154.06 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.805 -1.184 . . . . 0.0 110.335 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 5.9 m-85 60.48 22.7 12.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.844 . . . . 0.0 111.012 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.481 HD13 ' NE1' ' A' ' 43' ' ' TRP . 22.6 mt -105.48 113.38 26.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.087 . . . . 0.0 111.156 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 60.3 m-85 -88.86 102.31 14.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.5 p -99.65 157.03 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.087 -1.008 . . . . 0.0 111.694 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.518 ' CD ' HD13 ' A' ' 84' ' ' LEU . 26.1 mtm180 -117.68 -171.98 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.633 -0.667 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.68 80.54 9.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 109.06 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 156.02 -21.2 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.731 -0.605 . . . . 0.0 110.124 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -169.32 0.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.035 -1.04 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 15.5 m -128.69 150.12 50.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.79 ' HB2' HD21 ' A' ' 84' ' ' LEU . . . -135.01 176.37 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 110.403 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.736 ' CE ' HD23 ' A' ' 47' ' ' LEU . 2.9 ttt -121.56 156.58 32.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.487 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.877 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.8 92.12 9.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.699 HD22 HG13 ' A' ' 36' ' ' ILE 2.51 0.0 OUTLIER -53.24 -70.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.887 -178.37 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.68 -138.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 8' ' ' VAL . 87.7 m-85 -86.21 48.0 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 110.635 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.877 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -86.27 -22.08 49.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.44 -51.36 5.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.947 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.7 pp -44.29 -24.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 111.827 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.947 ' N ' HD12 ' A' ' 67' ' ' ILE . 16.4 m-85 -55.88 142.8 33.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.774 -1.204 . . . . 0.0 110.314 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' CA ' ' A' ' 17' ' ' GLY . 55.0 m-20 -119.39 -178.9 3.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 111.339 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -102.74 152.82 20.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.549 -0.72 . . . . 0.0 109.634 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.57 22.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.098 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.49 23.67 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.03 -1.044 . . . . 0.0 110.298 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -174.44 66.18 0.28 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.808 . . . . 0.0 109.797 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.775 ' O ' HD11 ' A' ' 92' ' ' ILE . 22.1 Cg_endo -65.56 93.42 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.775 1.408 . . . . 0.0 110.93 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.96 66.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.847 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -128.07 127.76 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 110.166 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 -171.92 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 110.419 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.46 158.05 23.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 14.0 tp10 -138.21 126.32 22.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 110.067 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.608 HD22 HD12 ' A' ' 84' ' ' LEU . 28.1 mt -105.22 131.26 52.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.978 . . . . 0.0 110.55 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.56 -166.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 110.419 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CZ ' ' A' ' 54' ' ' ARG . . . 138.72 -116.52 1.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' A' ' 59' ' ' ALA . 25.5 tp -168.92 45.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.17 -16.94 9.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 110.694 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.417 ' HG2' HD13 ' A' ' 34' ' ' LEU . 3.0 mtm180 -131.2 147.76 52.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.593 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.29 158.57 26.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.669 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.602 ' HE ' HD11 ' A' ' 29' ' ' LEU . 6.5 mtt180 -147.5 115.57 6.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.822 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.493 HG12 ' CE2' ' A' ' 68' ' ' PHE . 2.7 mp -88.95 117.13 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.854 -1.154 . . . . 0.0 110.402 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE2' ' HG ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -106.72 163.51 12.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.612 HG23 ' CG2' ' A' ' 30' ' ' VAL . 10.6 p -107.3 87.93 2.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.775 HD11 ' O ' ' A' ' 74' ' ' PRO . 9.5 pt -54.34 -22.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 110.319 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.5 mttt -133.58 142.35 43.6 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 110.204 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.41 ' HG3' ' HB2' ' A' ' 26' ' ' LYS . 33.8 Cg_exo -55.65 128.99 32.66 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.599 1.315 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.437 HG21 ' CB ' ' A' ' 20' ' ' ALA . 77.3 mt -107.58 138.51 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 110.342 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.73 164.8 14.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 21' ' ' ARG . 4.4 mt -70.95 112.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.71 0.89 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.37 -176.59 3.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -1.183 . . . . 0.0 110.37 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 11.8 tt0 -123.33 126.21 46.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 110.032 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.583 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 56.6 mt -88.81 126.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.167 -0.958 . . . . 0.0 109.844 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 101' ' ' ILE . 22.0 p -155.4 143.11 19.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.566 . . . . 0.0 109.929 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 76' ' ' ALA . 1.1 pp -123.92 147.69 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.513 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.6 t -85.13 -166.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.534 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -124.44 -65.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 0.0 110.07 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.17 15.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.17 -30.5 2.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.436 -1.038 . . . . 0.0 111.454 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -42.79 82.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -109.65 115.54 30.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.091 -1.005 . . . . 0.0 110.454 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.442 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 28.5 t-105 . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.789 -0.569 . . . . 0.0 111.067 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 28.7 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.273 0.558 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 218' ' ' PRO . . . -171.09 147.6 2.29 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 217' ' ' ALA . 38.0 Cg_exo . . . . . 0 C--N 1.312 -1.369 0 O-C-N 123.745 1.392 . . . . 0.0 110.503 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' HD12 ' B' ' 7' ' ' ILE . 14.6 t80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.389 0.614 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 5' ' ' ARG . 11.8 m120 -90.23 55.24 3.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.028 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.1 t70 52.96 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.706 -0.621 . . . . 0.0 111.355 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.527 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.2 OUTLIER -50.55 -33.92 23.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 111.027 -178.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.527 HG23 ' C ' ' B' ' 5' ' ' ARG . 89.4 t -152.31 138.53 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.036 -1.04 . . . . 0.0 111.211 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.603 HG23 ' HB2' ' B' ' 19' ' ' PHE . 12.7 tt -114.64 162.33 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.539 HG21 ' CE2' ' B' ' 64' ' ' PHE . 95.8 t -106.86 120.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.431 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.595 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 16.7 mttt -116.74 144.0 44.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.875 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.595 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 25.2 mttt 52.43 62.94 2.44 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.752 -1.842 . . . . 0.0 111.403 0.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.413 -0.804 . . . . 0.0 110.32 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 71.7 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -1.135 . . . . 0.0 110.385 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.416 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -108.94 -172.19 21.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.864 ' CG2' HD13 ' B' ' 67' ' ' ILE . 95.1 t -113.57 158.47 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.016 -1.285 . . . . 0.0 110.718 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.603 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.9 OUTLIER -120.99 127.88 52.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 110.164 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.576 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -89.78 95.17 10.12 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.362 -0.836 . . . . 0.0 110.542 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.88 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -64.15 -24.88 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.684 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -86.07 179.21 7.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.552 -0.718 . . . . 0.0 109.373 179.381 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.548 ' OG ' HD11 ' B' ' 97' ' ' ILE 2.511 0.0 OUTLIER 103.3 11.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.111 -1.618 . . . . 0.0 110.541 1.19 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.7 m-85 -107.63 150.99 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.048 -1.032 . . . . 0.0 110.777 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.29 -152.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -100.57 69.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.06 75.29 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.71 7.49 3.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 110.976 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.625 HD11 ' HE ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER 61.5 131.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.178 -0.951 . . . . 0.0 110.129 -179.348 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.608 ' CG2' HG23 ' B' ' 91' ' ' THR . 98.1 t -103.22 -74.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.991 -1.068 . . . . 0.0 110.551 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.53 160.84 37.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.008 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.58 142.3 37.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 110.183 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.436 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.4 p -150.3 -175.01 4.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.714 ' N ' HD22 ' B' ' 34' ' ' LEU . 2.8 mm? -97.78 174.4 6.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.189 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 92.2 m -148.82 168.56 22.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 110.743 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.718 HG13 HD22 ' B' ' 62' ' ' LEU . 79.4 mt -100.46 150.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.841 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 49.5 t -125.48 82.08 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.462 ' HB3' ' CD2' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -109.1 146.43 34.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 110.55 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.479 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 40.9 m170 -61.65 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 41' ' ' ASP . 6.6 t-20 -89.52 -137.64 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 5.0 m-20 60.56 -134.42 0.72 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.007 -1.058 . . . . 0.0 110.23 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -45.97 -26.04 0.65 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.903 -1.123 . . . . 0.0 111.201 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 1.022 ' CH2' HD22 ' B' ' 47' ' ' LEU . 65.4 t-105 -67.66 -58.58 4.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.41 -25.61 41.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 60.3 m -81.2 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 110.512 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' B' ' 47' ' ' LEU . . . -52.83 -57.44 10.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.181 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 1.022 HD22 ' CH2' ' B' ' 43' ' ' TRP . 4.7 mp -91.61 52.21 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 110.239 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.23 56.23 0.15 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.029 -1.044 . . . . 0.0 111.581 -178.364 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.5 OUTLIER 174.15 154.09 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.853 -1.154 . . . . 0.0 110.359 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 5.9 m-85 60.5 22.77 12.45 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.383 -0.823 . . . . 0.0 110.985 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.48 HD13 ' NE1' ' B' ' 43' ' ' TRP . 22.5 mt -105.51 112.85 26.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.9 -1.125 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' B' ' 61' ' ' ALA . 60.8 m-85 -88.29 102.28 14.68 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.3 p -99.62 157.0 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.103 -0.998 . . . . 0.0 111.753 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.516 ' CD ' HD13 ' B' ' 84' ' ' LEU . 26.3 mtm180 -118.17 -174.49 2.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.699 -0.625 . . . . 0.0 109.711 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 80.27 6.56 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.188 -0.945 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 155.89 -21.3 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.577 -0.702 . . . . 0.0 110.177 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 -169.31 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.058 -1.026 . . . . 0.0 110.944 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.462 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 15.5 m -128.71 150.12 50.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.453 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' B' ' 84' ' ' LEU . . . -135.03 176.36 8.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 110.44 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.75 ' CE ' HD23 ' B' ' 47' ' ' LEU . 2.9 ttt -121.71 156.03 33.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.847 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.12 92.12 9.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.89 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.718 HD22 HG13 ' B' ' 36' ' ' ILE 2.509 0.0 OUTLIER -53.3 -70.92 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.896 -178.459 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.71 -138.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' B' ' 8' ' ' VAL . 87.9 m-85 -86.2 48.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.133 . . . . 0.0 110.656 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.847 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -86.27 -22.18 49.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.39 -51.39 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -1.199 . . . . 0.0 110.5 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.956 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.7 pp -44.22 -24.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.598 -0.689 . . . . 0.0 111.843 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.956 ' N ' HD12 ' B' ' 67' ' ' ILE . 16.4 m-85 -55.67 143.39 30.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.796 -1.19 . . . . 0.0 110.258 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.416 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 56.0 m-20 -120.08 -178.45 3.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 111.228 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' HIS . . . . . 0.42 ' CE1' ' HG ' ' B' ' 104' ' ' SER . 26.3 t60 -103.62 152.68 21.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.45 22.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.959 -1.088 . . . . 0.0 111.075 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.63 23.62 2.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.045 . . . . 0.0 110.222 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -174.47 66.2 0.28 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.78 ' O ' HD11 ' B' ' 92' ' ' ILE . 22.2 Cg_endo -65.54 93.37 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.783 1.412 . . . . 0.0 110.934 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.93 66.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.816 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -128.08 127.81 43.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.01 -171.93 2.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.451 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.37 157.83 23.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.496 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.447 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 14.0 tp10 -137.96 126.54 23.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.164 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.596 HD22 HD12 ' B' ' 84' ' ' LEU . 28.1 mt -105.2 131.35 52.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 0.0 110.51 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.73 -166.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.349 -0.845 . . . . 0.0 110.257 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.06 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 110.455 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.421 ' O ' ' CZ ' ' B' ' 54' ' ' ARG . . . 138.73 -116.61 1.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' B' ' 59' ' ' ALA . 25.5 tp -168.91 46.0 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -1.137 . . . . 0.0 110.425 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.15 -16.99 9.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.674 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.413 ' HG2' HD13 ' B' ' 34' ' ' LEU . 3.0 mtm180 -131.2 147.8 52.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.093 -1.004 . . . . 0.0 110.556 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 5.6 mmm -120.26 158.57 26.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 110.719 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.625 ' HE ' HD11 ' B' ' 29' ' ' LEU . 6.5 mtt180 -147.54 115.21 6.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 109.885 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' B' ' 68' ' ' PHE . 2.7 mp -88.39 117.11 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.042 . . . . 0.0 110.523 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' B' ' 29' ' ' LEU . 0.9 OUTLIER -106.81 163.49 12.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.345 -0.847 . . . . 0.0 110.643 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.608 HG23 ' CG2' ' B' ' 30' ' ' VAL . 10.4 p -107.24 87.86 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.78 HD11 ' O ' ' B' ' 74' ' ' PRO . 9.5 pt -54.25 -22.88 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.917 . . . . 0.0 110.358 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.419 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.5 mttt -133.55 142.45 43.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.216 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 93' ' ' LYS . 37.3 Cg_exo -55.95 129.16 33.47 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.561 1.295 . . . . 0.0 110.454 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.442 HG21 ' CB ' ' B' ' 20' ' ' ALA . 77.4 mt -107.58 138.4 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 110.313 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 164.79 14.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.178 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.88 HG23 ' O ' ' B' ' 21' ' ' ARG . 4.4 mt -70.94 112.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.75 0.89 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.43 -176.56 3.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -1.165 . . . . 0.0 110.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' B' ' 19' ' ' PHE . 11.8 tt0 -123.45 125.74 45.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.114 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 56.1 mt -88.0 126.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 110.075 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.53 HG23 ' O ' ' B' ' 101' ' ' ILE . 22.0 p -155.45 143.08 19.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.578 -0.701 . . . . 0.0 109.903 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.816 HG22 ' O ' ' B' ' 76' ' ' ALA . 1.1 pp -123.89 147.68 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.42 ' HG ' ' CE1' ' B' ' 70' ' ' HIS . 43.5 t -85.17 -166.34 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 110.486 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.49 -65.58 1.03 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.948 . . . . 0.0 110.065 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.92 173.23 15.22 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.14 -30.41 2.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -1.01 . . . . 0.0 111.514 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -42.94 81.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.082 -1.012 . . . . 0.0 110.932 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.435 ' O ' ' HB3' ' B' ' 110' ' ' TRP . 0.1 OUTLIER -109.31 115.71 30.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 0.0 110.563 -179.017 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.435 ' HB3' ' O ' ' B' ' 109' ' ' TYR . 28.3 t-105 . . . . . 0 N--CA 1.497 1.924 0 O-C-N 121.893 -0.504 . . . . 0.0 111.06 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 28.7 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.299 0.571 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.04 147.63 2.32 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 110.394 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--N 1.313 -1.312 0 O-C-N 123.648 1.341 . . . . 0.0 110.568 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 52.9 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.378 0.609 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' ARG . 8.7 p-10 -148.04 164.28 34.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.885 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.16 62.28 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.588 -0.695 . . . . 0.0 110.754 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.8 tpt180 179.69 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.284 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 5' ' ' ARG . 54.9 t -157.07 169.41 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 110.1 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 6' ' ' VAL . 11.8 tt -144.77 146.61 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.876 HG12 ' HD3' ' A' ' 10' ' ' LYS . 94.7 t -89.65 102.53 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 111.027 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.656 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 1.1 mmtt -124.06 137.58 54.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.876 ' HD3' HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER 49.85 50.23 18.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 119.407 -2.058 . . . . 0.0 111.699 4.002 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' CE2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.902 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.486 2.003 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.51 ' CE2' ' HE3' ' A' ' 10' ' ' LYS . 3.5 m-85 -115.24 110.44 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -1.114 . . . . 0.0 110.803 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.5 173.77 22.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.715 HG23 HD13 ' A' ' 67' ' ' ILE . 97.9 t -98.3 130.08 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.999 -1.295 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE2' ' CB ' ' A' ' 11' ' ' SER . 1.6 m-85 -107.68 133.82 51.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 110.147 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.771 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -96.93 88.47 4.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.404 -0.81 . . . . 0.0 110.542 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.849 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.21 -27.15 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.38 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 14.7 mtpt -83.61 178.98 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.463 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 0.1 OUTLIER 102.24 20.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.0 -1.687 . . . . 0.0 109.563 3.145 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 15.2 m-85 -112.68 150.24 31.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.09 -158.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.845 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -80.41 -1.17 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.07 67.57 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' A' ' 24' ' ' PHE . 7.1 mt-10 -118.07 120.76 38.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.124 . . . . 0.0 110.275 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.698 HD13 ' CZ ' ' A' ' 90' ' ' PHE . 25.8 tp -53.71 127.36 25.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 6' ' ' VAL . 47.2 t -103.41 72.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 57.04 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.58 156.01 29.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 110.327 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -147.55 -161.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.367 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.6 mm? -96.7 -179.17 4.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 110.543 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.3 m -148.21 178.16 8.8 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.435 -0.791 . . . . 0.0 109.535 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.56 HD11 ' CD2' ' A' ' 62' ' ' LEU . 20.9 mt -113.97 138.49 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 110.26 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.85 113.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.032 -1.043 . . . . 0.0 110.325 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 1.5 tpp180 -146.61 159.73 43.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 110.404 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.475 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 64.2 m170 -71.4 -173.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -86.37 -137.28 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.833 . . . . 0.0 110.117 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.42 -139.91 0.43 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.739 -1.226 . . . . 0.0 110.304 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -46.36 -26.95 0.92 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.983 -1.073 . . . . 0.0 111.11 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.841 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 67.8 t-105 -61.06 -55.94 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.819 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.23 69.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.3 m -69.82 -70.42 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HB3' HD22 ' A' ' 47' ' ' LEU . . . -52.8 -53.42 48.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.133 -0.98 . . . . 0.0 110.185 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.911 ' HB3' HD13 ' A' ' 51' ' ' LEU . 2.6 mm? -90.45 46.49 1.34 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -5.88 35.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.851 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.35 147.19 43.76 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.95 -1.094 . . . . 0.0 110.021 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CE1' ' O ' ' A' ' 66' ' ' ALA . 11.6 m-85 56.09 38.76 30.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.096 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.911 HD13 ' HB3' ' A' ' 47' ' ' LEU . 7.0 tp -123.76 122.81 39.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.896 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.08 132.32 44.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.959 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.6 p -94.27 127.89 40.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -0.962 . . . . 0.0 110.783 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.603 ' CB ' HD11 ' A' ' 84' ' ' LEU . 12.9 tpt180 -105.39 172.94 6.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.407 -0.808 . . . . 0.0 109.608 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -83.08 82.71 8.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.946 -1.096 . . . . 0.0 109.225 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 22.9 p30 146.45 -18.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.79 -0.569 . . . . 0.0 109.765 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.98 -160.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.1 m -140.49 118.59 11.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.149 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.44 153.81 23.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.639 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.782 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -93.16 179.58 5.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -86.48 -146.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.16 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.913 HD13 ' HB2' ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER -178.34 -73.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.99 -1.069 . . . . 0.0 109.967 -179.211 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 33' ' ' CYS . . . -74.55 -114.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 40.5 m-85 -91.26 33.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.516 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -90.95 -22.14 33.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -91.09 -20.94 21.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 111.681 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.715 HD13 HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -92.51 -4.29 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.217 . . . . 0.0 111.835 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' N ' HD12 ' A' ' 67' ' ' ILE . 5.3 m-85 -55.81 147.78 18.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.823 -1.173 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -117.42 -167.83 1.38 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -103.79 151.2 23.34 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.243 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.516 ' CB ' ' HG1' ' A' ' 102' ' ' THR . 67.1 m -161.19 150.07 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -11.75 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 111.053 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.63 67.52 71.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.701 ' O ' HD11 ' A' ' 92' ' ' ILE . 24.5 Cg_exo -60.03 107.12 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.647 1.341 . . . . 0.0 110.459 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.457 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 47.2 p30 -81.54 -6.53 59.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -146.69 150.24 35.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.985 -1.072 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.06 -160.45 0.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.448 ' HB2' ' CE ' ' A' ' 87' ' ' MET . 2.0 p-80 -132.26 166.96 20.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.067 -1.021 . . . . 0.0 110.666 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.15 141.19 29.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 110.455 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.8 HD13 HD23 ' A' ' 84' ' ' LEU . 94.5 mt -105.16 145.9 29.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.263 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.76 HG21 ' HB2' ' A' ' 86' ' ' ARG . 1.6 p -64.87 -62.64 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 110.412 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.82 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.602 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.5 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 80' ' ' LEU . 29.4 mt 52.32 48.58 22.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.425 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.22 -76.55 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.554 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.76 ' HB2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -87.22 126.63 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 110.285 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.448 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -100.79 117.75 35.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.895 . . . . 0.0 110.525 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.39 114.59 27.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.042 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 78' ' ' HIS . 38.9 mt -89.43 138.35 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.698 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 13.6 m-85 -128.36 177.86 6.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.798 HG22 HD12 ' A' ' 95' ' ' ILE . 1.6 p -115.71 96.47 5.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.316 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.701 HD11 ' O ' ' A' ' 74' ' ' PRO . 23.3 pt -50.45 -35.83 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.568 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -130.28 150.48 76.26 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 110.299 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.15 131.69 31.57 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.717 1.378 . . . . 0.0 110.981 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.798 HD12 HG22 ' A' ' 91' ' ' THR . 32.1 mt -113.29 145.32 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.786 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.38 10.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 110.968 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 21' ' ' ARG . 39.4 mt -65.79 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.06 36.37 1.83 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.608 ' CB ' HG23 ' A' ' 95' ' ' ILE . 4.8 mm-40 -101.32 156.26 17.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -1.12 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.411 ' OE1' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -100.34 110.11 22.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 110.491 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 20' ' ' ALA . 59.3 mt -89.55 119.82 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.516 ' HG1' ' CB ' ' A' ' 71' ' ' SER . 32.2 p -141.13 1.59 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 111.601 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 68' ' ' PHE . 35.4 pt 37.42 -145.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.326 -0.859 . . . . 0.0 111.34 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.425 ' N ' HG13 ' A' ' 103' ' ' ILE . 22.9 t -160.59 -168.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 110.727 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' A' ' 109' ' ' TYR . 10.5 m-85 -123.37 -66.84 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.853 . . . . 0.0 109.686 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 84.69 -160.04 35.31 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t0 55.12 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.552 -0.969 . . . . 0.0 110.581 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 1.9 t70 -153.88 25.12 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.0 110.559 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.453 ' HB3' ' CB ' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -100.98 108.77 20.58 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.181 -0.949 . . . . 0.0 109.753 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.427 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 30.0 t-105 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.118 0.485 . . . . 0.0 110.638 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 2.2 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.233 0.54 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.5 160.59 31.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.95 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 C--N 1.312 -1.386 0 O-C-N 123.744 1.391 . . . . 0.0 110.509 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 52.9 p90 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.326 0.584 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 8.7 p-10 -147.98 164.44 33.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.34 62.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.0 110.657 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.53 ' O ' HG23 ' B' ' 6' ' ' VAL . 4.8 tpt180 179.85 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.413 -0.804 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 5' ' ' ARG . 54.6 t -156.92 169.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.668 -0.645 . . . . 0.0 110.138 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.51 ' N ' HG12 ' B' ' 6' ' ' VAL . 11.8 tt -144.77 146.42 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.589 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.885 HG12 ' HD3' ' B' ' 10' ' ' LYS . 93.2 t -89.49 102.55 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.056 -1.027 . . . . 0.0 111.086 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.673 ' HA ' ' HB2' ' B' ' 10' ' ' LYS . 1.1 mmtt -124.09 137.64 54.54 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.885 ' HD3' HG12 ' B' ' 8' ' ' VAL . 0.2 OUTLIER 49.89 50.19 18.88 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 119.43 -2.044 . . . . 0.0 111.729 4.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.515 ' CB ' ' CE2' ' B' ' 19' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 109.854 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.509 ' CE2' ' HE3' ' B' ' 10' ' ' LYS . 3.6 m-85 -115.24 110.38 19.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -1.08 . . . . 0.0 110.872 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.54 173.64 22.19 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.729 HG23 HD13 ' B' ' 67' ' ' ILE . 92.9 t -98.17 129.86 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.318 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.515 ' CE2' ' CB ' ' B' ' 11' ' ' SER . 1.6 m-85 -107.63 133.82 51.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 110.151 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.785 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -96.91 88.5 4.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.324 -0.86 . . . . 0.0 110.569 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.6 OUTLIER -57.19 -27.16 61.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 178.495 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.506 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 14.7 mtpt -83.58 179.02 7.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.465 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.1 OUTLIER 102.21 20.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.003 -1.686 . . . . 0.0 109.581 3.056 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.506 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 15.4 m-85 -112.63 150.36 31.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.31 -0.869 . . . . 0.0 110.222 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.23 -158.77 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.963 . . . . 0.0 109.868 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -80.38 -1.25 40.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.02 67.59 0.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' B' ' 24' ' ' PHE . 7.1 mt-10 -118.05 120.69 38.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 110.309 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.701 HD13 ' CZ ' ' B' ' 90' ' ' PHE . 25.9 tp -53.67 127.37 25.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' B' ' 6' ' ' VAL . 47.1 t -103.37 72.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 57.11 163.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.451 -0.781 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.65 156.07 29.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 0.6 OUTLIER -147.61 -161.7 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 110.334 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' B' ' 34' ' ' LEU . 4.6 mm? -96.83 -179.17 4.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 110.593 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 61' ' ' ALA . 1.3 m -148.23 178.14 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.387 -0.82 . . . . 0.0 109.454 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.551 HD11 ' CD2' ' B' ' 62' ' ' LEU . 20.8 mt -114.0 138.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.018 . . . . 0.0 110.203 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.8 113.4 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.294 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 1.5 tpp180 -146.68 159.73 43.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 110.463 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 64.2 m170 -71.38 -173.99 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.764 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -86.34 -137.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.36 -139.99 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.808 -1.183 . . . . 0.0 110.295 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -46.23 -27.04 0.9 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.03 -1.044 . . . . 0.0 111.159 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.844 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 67.7 t-105 -60.98 -55.94 27.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.957 . . . . 0.0 109.852 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.21 69.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 92.1 m -69.85 -70.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -1.157 . . . . 0.0 110.519 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.574 ' HB3' HD22 ' B' ' 47' ' ' LEU . . . -52.89 -53.13 53.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.88 ' HB3' HD13 ' B' ' 51' ' ' LEU . 2.6 mm? -90.82 46.6 1.34 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -5.92 35.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 110.868 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.24 147.2 43.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.906 -1.121 . . . . 0.0 110.098 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' O ' ' B' ' 66' ' ' ALA . 11.5 m-85 56.11 38.75 30.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.866 . . . . 0.0 110.075 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 47' ' ' LEU . 7.1 tp -123.81 122.96 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.826 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -99.24 132.43 44.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 60.5 p -94.29 127.94 40.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.735 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.603 ' CB ' HD11 ' B' ' 84' ' ' LEU . 13.0 tpt180 -106.01 169.98 8.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.446 -0.784 . . . . 0.0 109.722 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.441 ' N ' ' HG3' ' B' ' 54' ' ' ARG . 0.1 OUTLIER -79.04 82.4 5.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.028 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 22.9 p30 146.31 -18.83 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.667 -0.645 . . . . 0.0 109.668 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.97 -160.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -140.38 118.54 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.38 153.89 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 110.73 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.796 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.1 OUTLIER -93.62 178.22 5.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.399 -0.813 . . . . 0.0 110.308 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' B' ' 35' ' ' CYS . . . -84.47 -146.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.885 . . . . 0.0 109.632 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.913 ' HB2' HD13 ' A' ' 62' ' ' LEU 2.5 0.1 OUTLIER -178.51 -73.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.001 -1.062 . . . . 0.0 110.018 -179.473 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -74.53 -113.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.472 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 40.4 m-85 -92.04 34.23 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -1.151 . . . . 0.0 110.314 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -92.02 -21.19 33.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.479 ' O ' ' CE1' ' B' ' 50' ' ' TYR . . . -92.17 -19.52 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.264 . . . . 0.0 111.627 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.729 HD13 HG23 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -94.14 -3.68 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.873 -1.142 . . . . 0.0 111.491 -178.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.673 ' N ' HD12 ' B' ' 67' ' ' ILE . 5.3 m-85 -56.13 147.82 19.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 110.461 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -117.23 -166.73 1.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -105.37 150.84 24.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.903 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' SER . . . . . 0.517 ' CB ' ' HG1' ' B' ' 102' ' ' THR . 67.1 m -160.88 150.08 16.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 110.311 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 -11.7 59.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 111.069 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.73 67.56 71.01 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.997 -1.065 . . . . 0.0 110.536 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.701 ' O ' HD11 ' B' ' 92' ' ' ILE . 24.5 Cg_exo -60.08 107.06 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.663 1.349 . . . . 0.0 110.434 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.461 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 47.1 p30 -81.49 -6.49 59.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.477 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -146.69 150.18 34.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.971 -1.081 . . . . 0.0 110.465 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -160.39 0.95 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.441 ' HB2' ' CE ' ' B' ' 87' ' ' MET . 2.0 p-80 -132.32 167.0 20.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.673 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.16 141.27 29.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.419 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.791 HD13 HD23 ' B' ' 84' ' ' LEU . 94.6 mt -105.26 145.89 30.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 110.318 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.772 HG21 ' HB2' ' B' ' 86' ' ' ARG . 1.6 p -64.89 -62.57 1.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.417 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.88 -43.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.54 2.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.791 HD23 HD13 ' B' ' 80' ' ' LEU . 29.4 mt 52.27 48.54 22.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -1.195 . . . . 0.0 110.407 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.18 -76.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.948 . . . . 0.0 110.536 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.772 ' HB2' HG21 ' B' ' 81' ' ' THR . 0.0 OUTLIER -87.17 126.64 34.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.006 . . . . 0.0 110.281 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.441 ' CE ' ' HB2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -100.81 117.74 35.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 110.548 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.46 114.3 27.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.121 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' B' ' 78' ' ' HIS . 38.5 mt -89.02 138.37 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.701 ' CZ ' HD13 ' B' ' 29' ' ' LEU . 13.6 m-85 -128.39 177.92 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 110.472 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.822 HG22 HD12 ' B' ' 95' ' ' ILE . 1.6 p -115.75 96.45 5.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.908 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.701 HD11 ' O ' ' B' ' 74' ' ' PRO . 23.4 pt -50.44 -35.82 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.628 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.461 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -130.25 150.52 76.36 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 110.273 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.21 131.73 31.95 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.709 1.373 . . . . 0.0 110.991 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.822 HD12 HG22 ' B' ' 91' ' ' THR . 31.9 mt -113.29 145.37 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.476 -0.765 . . . . 0.0 109.795 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.31 10.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.948 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 39.5 mt -65.76 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 110.267 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.1 36.25 1.85 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.593 ' CB ' HG23 ' B' ' 95' ' ' ILE . 4.9 mm-40 -101.28 156.25 17.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -100.32 110.06 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.11 -0.994 . . . . 0.0 110.49 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.785 HD11 ' HB2' ' B' ' 20' ' ' ALA . 60.0 mt -89.47 119.65 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.8 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.517 ' HG1' ' CB ' ' B' ' 71' ' ' SER . 32.7 p -140.91 1.53 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 111.611 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' B' ' 68' ' ' PHE . 35.2 pt 37.61 -146.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.46 -0.775 . . . . 0.0 111.388 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.423 ' N ' HG13 ' B' ' 103' ' ' ILE . 22.8 t -160.62 -169.08 2.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.903 -1.123 . . . . 0.0 110.712 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.452 ' CB ' ' HB3' ' B' ' 109' ' ' TYR . 10.4 m-85 -123.06 -66.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.774 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 84.65 -159.95 35.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.4 t0 55.1 -87.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.527 -0.984 . . . . 0.0 110.546 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 106' ' ' GLY . 1.8 t70 -153.85 24.94 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.937 -1.102 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.452 ' HB3' ' CB ' ' B' ' 105' ' ' TYR . 0.1 OUTLIER -100.65 108.91 20.92 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 109.91 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.439 ' HB3' ' O ' ' B' ' 109' ' ' TYR . 29.9 t-105 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.084 0.468 . . . . 0.0 110.607 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.2 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.22 0.533 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.59 31.04 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.922 . . . . 0.0 110.391 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo . . . . . 0 C--N 1.313 -1.31 0 O-C-N 123.632 1.333 . . . . 0.0 110.522 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 35.8 p90 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.347 0.594 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -121.08 163.44 18.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -50.08 -25.61 3.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.5 ' C ' HG13 ' A' ' 6' ' ' VAL . 26.9 ttp180 -74.65 -45.39 45.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.56 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.5 HG13 ' C ' ' A' ' 5' ' ' ARG . 22.9 m -154.25 -178.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.164 -0.96 . . . . 0.0 110.493 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 19' ' ' PHE . 9.0 tt -152.91 150.49 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.101 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.4 t -94.48 120.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.625 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 mttt -125.59 146.82 49.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.418 -0.801 . . . . 0.0 109.226 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.625 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 4.1 mmmt 52.45 59.18 4.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 119.65 -1.906 . . . . 0.0 110.922 2.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.442 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 1.1 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.451 -0.781 . . . . 0.0 110.159 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -99.96 72.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -1.175 . . . . 0.0 110.581 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.0 -175.97 20.37 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 90.3 t -101.67 146.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.987 -1.302 . . . . 0.0 110.03 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -110.41 126.36 54.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -0.931 . . . . 0.0 109.754 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.54 89.4 7.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -0.844 . . . . 0.0 110.843 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.52 -22.52 55.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.325 -0.859 . . . . 0.0 109.65 178.022 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -90.82 -178.87 5.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.467 -0.771 . . . . 0.0 109.862 179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 18.1 m 100.58 17.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.291 -1.506 . . . . 0.0 110.47 0.497 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -105.19 161.43 14.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.768 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -162.03 0.91 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.356 -0.84 . . . . 0.0 109.88 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 17.8 tttt -95.53 97.47 9.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.03 58.0 0.84 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.49 121.06 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -1.176 . . . . 0.0 110.43 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.967 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -56.14 132.99 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.793 ' N ' HD13 ' A' ' 29' ' ' LEU . 88.8 t -103.35 -39.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.888 . . . . 0.0 110.291 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.601 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -168.21 156.75 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.309 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.43 150.75 30.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 110.289 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.425 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -150.19 -159.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 110.631 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.8 176.07 5.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.693 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.53 150.78 31.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.78 HG13 HD22 ' A' ' 62' ' ' LEU . 56.0 mt -89.89 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.623 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 84' ' ' LEU . 41.7 t -126.9 106.87 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.632 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 35.3 mmt180 -136.53 157.97 45.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 39.0 m170 -71.45 176.52 4.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 110.157 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 53.1 p-10 -64.08 -137.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.8 t0 67.12 -149.91 0.18 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.853 -1.154 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -45.89 -34.54 3.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.864 . . . . 0.0 111.373 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.642 ' HZ3' HD21 ' B' ' 47' ' ' LEU . 48.4 t-105 -57.54 -55.45 34.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 110.241 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.58 68.08 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 94.5 m -80.85 -64.5 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.142 -1.211 . . . . 0.0 110.801 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.78 -48.45 15.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.0 111.047 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.835 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.0 mm? -91.94 26.81 2.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -64.35 80.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 7.1 t0 -175.65 -53.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 110.484 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 3.6 m-85 -127.72 54.1 1.72 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.756 HD11 ' HB2' ' A' ' 47' ' ' LEU . 6.0 mt -110.17 114.06 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 111.219 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -89.93 114.4 26.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.898 . . . . 0.0 109.221 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -108.0 134.78 50.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.097 -1.002 . . . . 0.0 111.207 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.706 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.89 -171.68 1.89 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 109.865 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -82.33 75.12 9.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.978 -1.076 . . . . 0.0 109.21 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 49.6 m-80 173.1 -33.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.442 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.848 ' HG2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 178.82 -167.71 0.08 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.437 -0.79 . . . . 0.0 110.351 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.3 156.75 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 110.112 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.582 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -150.32 148.61 29.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 0.0 110.47 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.835 ' CE ' HD12 ' A' ' 47' ' ' LEU . 13.7 mmm -91.37 157.77 16.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.866 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.66 101.89 13.68 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.457 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.813 HD12 ' CB ' ' B' ' 62' ' ' LEU 2.5 0.0 OUTLIER -59.64 -76.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 -179.156 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.33 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.761 ' HB3' HD11 ' A' ' 67' ' ' ILE . 89.8 m-85 -89.66 41.81 1.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 110.544 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.866 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -81.0 -22.67 60.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.9 -55.41 3.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -1.149 . . . . 0.0 111.058 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.761 HD11 ' HB3' ' A' ' 64' ' ' PHE . 1.6 pp -50.48 -22.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 111.155 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.478 ' CG ' HG12 ' A' ' 103' ' ' ILE . 0.7 OUTLIER -48.91 122.16 5.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.014 -1.054 . . . . 0.0 110.847 -179.462 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.55 ' HB2' HG22 ' A' ' 102' ' ' THR . 22.4 m-20 -94.51 173.63 7.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.51 ' NE2' ' CD1' ' A' ' 110' ' ' TRP . 39.6 t60 -102.04 150.57 23.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 0.0 110.121 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 p -149.64 139.57 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.481 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.52 -25.02 23.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.243 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.69 51.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.207 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.89 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.5 Cg_endo -62.76 98.83 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.658 1.346 . . . . 0.0 110.554 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.8 -17.91 54.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.17 170.96 15.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 110.331 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.491 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.2 ttt85 -149.73 -161.69 1.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.444 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 31.0 p-80 -130.95 -172.86 2.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 10.4 tt0 -151.73 170.98 18.42 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.171 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD13 ' CD ' ' A' ' 54' ' ' ARG . 0.9 OUTLIER -140.86 124.88 17.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 86' ' ' ARG . 9.3 t -56.92 -168.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.631 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.94 89.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.477 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.73 158.1 32.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.848 HD22 ' HG2' ' A' ' 57' ' ' MET . 2.3 mp -55.35 106.39 0.23 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -1.078 . . . . 0.0 110.348 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 -53.58 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.501 ' H ' HG22 ' A' ' 81' ' ' THR . 0.7 OUTLIER -132.26 169.38 16.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.897 . . . . 0.0 110.266 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 2.8 mtp -140.42 133.35 29.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.92 . . . . 0.0 110.494 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.777 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.8 mtp180 -115.1 176.02 5.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.269 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 31' ' ' GLU . 97.2 mt -135.33 111.98 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.967 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 56.1 m-85 -106.58 175.18 5.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.544 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 p -122.95 85.28 2.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.89 HD11 ' O ' ' A' ' 74' ' ' PRO . 50.9 pt -50.13 -25.45 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.825 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.09 134.68 21.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 110.503 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 82.0 Cg_exo -47.51 152.04 2.79 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.489 1.257 . . . . 0.0 111.014 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 99' ' ' GLU . 64.1 mt -131.28 148.68 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.64 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.59 157.88 15.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.421 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 21' ' ' ARG . 53.0 mt -63.36 109.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.206 -0.934 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.08 27.84 2.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 52.0 mm-40 -106.73 -177.83 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -1.157 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.6 123.1 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.931 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.831 HG13 ' HB2' ' A' ' 20' ' ' ALA . 84.7 mt -89.19 130.78 37.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 69' ' ' ASN . 1.1 p -154.66 143.77 21.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.817 -0.552 . . . . 0.0 110.002 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 77' ' ' ARG . 1.1 pt -105.26 160.75 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 110.491 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -93.93 -168.87 1.96 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -124.6 -68.85 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 110.3 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 89.73 -168.45 34.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.491 -1.005 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 5.3 t70 -135.19 -36.98 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.908 -1.12 . . . . 0.0 110.918 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.15 117.75 2.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.816 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.51 ' CD1' ' NE2' ' A' ' 70' ' ' HIS . 56.0 t-105 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 110.466 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.5 1.6 m . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.283 0.563 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.78 154.72 3.68 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.444 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 41.6 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 O-C-N 123.702 1.37 . . . . 0.0 110.627 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.473 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 36.4 p90 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.31 0.576 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -121.07 163.49 18.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.338 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -50.16 -25.57 3.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.93 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.488 ' C ' HG13 ' B' ' 6' ' ' VAL . 26.8 ttp180 -74.72 -45.37 44.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 110.508 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 5' ' ' ARG . 22.9 m -154.23 -178.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -0.936 . . . . 0.0 110.476 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.573 HG23 ' HB2' ' B' ' 19' ' ' PHE . 9.0 tt -152.96 150.47 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -94.47 120.23 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 0.0 110.548 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.63 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 32.7 mttt -125.77 146.9 49.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.208 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.63 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 4.1 mmmt 52.47 59.2 4.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.636 -1.915 . . . . 0.0 110.943 2.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.441 ' N ' ' HB3' ' B' ' 9' ' ' LYS . 1.1 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.75 . . . . 0.0 110.139 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -99.95 72.04 1.68 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -1.187 . . . . 0.0 110.597 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.07 -175.94 20.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 87.5 t -101.62 145.79 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.011 -1.288 . . . . 0.0 110.075 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.573 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -110.41 126.08 53.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.256 -0.902 . . . . 0.0 109.791 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.825 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.22 89.38 7.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 110.925 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.58 -22.44 55.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 178.083 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' B' ' 23' ' ' SER . 0.3 OUTLIER -90.83 -178.83 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.442 -0.786 . . . . 0.0 109.883 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.51 18.1 m 100.6 17.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.314 -1.491 . . . . 0.0 110.481 0.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -105.2 161.46 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 110.759 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.13 -162.07 0.91 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.418 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 17.9 tttt -95.48 97.5 9.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.324 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.05 57.94 0.84 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.5 121.04 26.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.131 . . . . 0.0 110.421 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.978 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -56.05 132.94 51.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.23 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.795 ' N ' HD13 ' B' ' 29' ' ' LEU . 88.3 t -103.36 -39.92 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.605 ' HB3' HD12 ' B' ' 89' ' ' ILE . 0.9 OUTLIER -168.19 156.76 8.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.392 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.41 150.88 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.425 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -150.37 -159.78 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.596 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.88 176.41 5.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 110.723 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.98 150.52 30.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 109.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.764 HG13 HD22 ' B' ' 62' ' ' LEU . 55.8 mt -89.65 147.47 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 109.656 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 84' ' ' LEU . 41.6 t -126.93 106.92 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 110.644 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.498 ' HB2' ' CD2' ' B' ' 43' ' ' TRP . 35.3 mmt180 -136.59 157.99 45.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 38.9 m170 -71.49 176.51 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.196 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 53.2 p-10 -63.99 -138.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.8 t0 67.16 -149.89 0.18 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.812 -1.18 . . . . 0.0 110.708 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -45.88 -34.62 3.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.279 -0.888 . . . . 0.0 111.349 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.633 ' HZ3' HD21 ' A' ' 47' ' ' LEU . 48.2 t-105 -57.52 -55.5 34.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.63 68.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 94.5 m -80.8 -64.45 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 0.0 110.762 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.09 -47.53 17.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 111.144 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.0 mm? -93.02 27.15 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.569 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.3 OUTLIER -64.45 80.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 110.269 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.473 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 7.1 t0 -175.7 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 3.6 m-85 -127.69 54.05 1.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.214 -0.929 . . . . 0.0 109.612 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' B' ' 47' ' ' LEU . 5.9 mt -110.18 114.2 27.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -90.12 114.37 26.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.336 -0.852 . . . . 0.0 109.19 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -107.9 134.73 50.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.007 . . . . 0.0 111.2 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.707 ' HB2' HD11 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -112.54 -174.75 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.514 -0.741 . . . . 0.0 109.892 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -77.87 74.51 4.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 0.0 110.253 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 49.9 m-80 173.1 -33.58 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.851 ' HG2' HD22 ' B' ' 84' ' ' LEU . 0.0 OUTLIER 179.01 -167.68 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 110.483 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.15 156.8 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.578 ' O ' HD23 ' B' ' 51' ' ' LEU . . . -150.46 148.63 28.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 110.514 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.842 ' CE ' HD12 ' B' ' 47' ' ' LEU . 13.7 mmm -91.64 156.43 17.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 110.303 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.834 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.82 101.97 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.807 . . . . 0.0 110.728 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.813 ' CB ' HD12 ' A' ' 62' ' ' LEU 2.498 0.0 OUTLIER -59.96 -76.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 111.111 -179.355 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.36 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.779 ' HB3' HD11 ' B' ' 67' ' ' ILE . 89.7 m-85 -89.66 41.86 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -1.171 . . . . 0.0 110.528 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.834 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -81.13 -22.24 61.34 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.45 -55.25 3.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 110.979 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' B' ' 64' ' ' PHE . 1.6 pp -50.51 -22.21 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 111.226 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' B' ' 103' ' ' ILE . 0.7 OUTLIER -48.91 122.13 5.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.017 -1.052 . . . . 0.0 110.835 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.543 ' HB2' HG22 ' B' ' 102' ' ' THR . 22.5 m-20 -94.38 173.98 7.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.843 . . . . 0.0 110.364 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' B' ' 110' ' ' TRP . 39.8 t60 -102.52 150.52 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -149.61 139.62 22.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 110.486 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.54 -25.03 23.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.933 . . . . 0.0 110.218 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.66 51.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.891 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.0 Cg_endo -62.84 98.84 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.699 1.368 . . . . 0.0 110.558 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.76 -17.97 54.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.539 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.15 171.02 15.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.324 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.489 ' HA ' HG22 ' B' ' 103' ' ' ILE . 5.2 ttt85 -149.7 -161.74 1.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 110.314 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.454 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 31.3 p-80 -130.9 -172.05 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.414 ' HB3' ' HD3' ' B' ' 88' ' ' ARG . 10.4 tt0 -153.09 170.05 21.43 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.712 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.417 HD13 ' CD ' ' B' ' 54' ' ' ARG . 0.9 OUTLIER -140.53 124.81 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 0.0 110.172 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.5 HG22 ' H ' ' B' ' 86' ' ' ARG . 9.1 t -57.18 -168.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.463 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.07 89.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 110.581 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.71 158.11 33.01 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.851 HD22 ' HG2' ' B' ' 57' ' ' MET . 2.3 mp -55.38 106.45 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -1.084 . . . . 0.0 110.353 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -53.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 110.395 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.5 ' H ' HG22 ' B' ' 81' ' ' THR . 0.7 OUTLIER -132.29 169.36 16.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.8 mtp -140.47 133.38 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.495 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.784 ' HB3' HD21 ' B' ' 29' ' ' LEU . 1.8 mtp180 -115.13 176.04 5.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.605 HD12 ' HB3' ' B' ' 31' ' ' GLU . 97.2 mt -135.38 111.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.096 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.978 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 56.5 m-85 -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -122.99 85.37 2.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.08 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.891 HD11 ' O ' ' B' ' 74' ' ' PRO . 50.9 pt -50.11 -25.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.833 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.04 134.59 21.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 0.0 110.502 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 83.6 Cg_exo -47.88 152.21 3.25 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.541 1.285 . . . . 0.0 110.979 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.459 ' CG2' ' HB2' ' B' ' 99' ' ' GLU . 63.9 mt -131.19 148.67 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.64 157.86 15.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 53.0 mt -63.31 109.75 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.889 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.09 27.81 2.83 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 52.4 mm-40 -106.75 -177.91 3.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.268 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.59 122.84 41.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.003 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.825 HG13 ' HB2' ' B' ' 20' ' ' ALA . 84.3 mt -88.71 130.86 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.249 -0.907 . . . . 0.0 110.388 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.543 HG22 ' HB2' ' B' ' 69' ' ' ASN . 1.1 p -154.78 143.78 20.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' B' ' 77' ' ' ARG . 1.1 pt -105.21 160.75 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 110.467 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 44.5 t -93.97 -168.86 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 110.504 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -124.55 -68.9 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 110.352 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 89.77 -168.43 34.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -1.04 . . . . 0.0 110.719 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' B' ' 106' ' ' GLY . 5.3 t70 -135.2 -36.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.899 -1.125 . . . . 0.0 110.885 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.12 117.66 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.813 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.518 ' CD1' ' NE2' ' B' ' 70' ' ' HIS . 56.1 t-105 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.498 -0.751 . . . . 0.0 110.467 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 1.6 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.331 0.586 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.76 154.77 3.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.421 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.454 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 41.2 Cg_endo . . . . . 0 C--N 1.312 -1.39 0 O-C-N 123.696 1.367 . . . . 0.0 110.558 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.363 0.602 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 5' ' ' ARG . 1.5 m-80 -111.23 40.72 2.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 110.449 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.53 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.536 -0.727 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 20.3 mtm180 -52.0 -38.88 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.491 HG21 HG13 ' A' ' 30' ' ' VAL . 98.5 t -135.26 143.82 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 20.0 tt -119.57 165.38 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.556 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -100.15 128.73 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 33.2 mttt -143.62 139.97 29.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.604 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.74 55.11 9.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 119.749 -1.845 . . . . 0.0 110.277 1.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.798 -0.564 . . . . 0.0 110.366 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.2 64.02 8.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.58 -166.43 24.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' A' ' 6' ' ' VAL . 59.7 t -97.88 127.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.962 -1.316 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 11' ' ' SER . 0.1 OUTLIER -90.5 126.9 36.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.109 . . . . 0.0 109.841 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.86 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.21 90.87 8.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.699 -0.625 . . . . 0.0 110.635 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.835 ' O ' HG23 ' A' ' 97' ' ' ILE . 2.7 ttt180 -69.21 -22.13 63.9 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.481 0.658 . . . . 0.0 109.399 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 2.8 mttp -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.497 -0.752 . . . . 0.0 109.38 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 22' ' ' LYS 2.516 19.2 m 108.32 34.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.983 -1.698 . . . . 0.0 109.84 1.141 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 44.2 m-85 -127.28 160.67 30.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 111.076 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.44 -159.88 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.51 -0.743 . . . . 0.0 110.148 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CA ' ' HD3' ' A' ' 94' ' ' PRO . 23.7 tttm -102.19 98.96 9.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.071 -1.018 . . . . 0.0 110.194 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.78 33.91 0.96 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -117.14 141.88 47.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.511 HD12 ' CE2' ' A' ' 90' ' ' PHE . 2.3 tp -83.76 136.96 33.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 6' ' ' VAL . 48.5 t -92.42 -62.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 110.422 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.724 ' HG2' HD12 ' A' ' 89' ' ' ILE . 1.7 pt-20 -159.03 149.2 19.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.199 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -131.53 137.98 48.72 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.108 -0.995 . . . . 0.0 109.902 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.407 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 36.8 m -140.35 178.88 6.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 110.092 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 34' ' ' LEU . 11.3 mp -91.75 169.41 10.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.396 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.518 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 72.8 m -145.51 168.51 20.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 60' ' ' MET . 39.1 mt -96.76 164.09 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.638 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 84' ' ' LEU . 51.6 t -143.58 115.85 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 110.828 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 62.5 mmt-85 -144.63 142.49 30.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.144 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.54 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.881 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -98.52 119.76 37.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.727 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -177.38 -141.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.64 -35.49 42.3 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.307 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.7 ' CE3' HD21 ' B' ' 47' ' ' LEU . 13.4 t-105 -63.1 -35.36 79.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -58.1 -66.06 3.08 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 29.6 m -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.325 -1.103 . . . . 0.0 111.011 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -62.56 1.78 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.848 -1.157 . . . . 0.0 108.457 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.874 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.1 mm? -92.81 36.32 1.03 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 109.845 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -71.2 -1.02 11.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.641 -179.205 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -118.13 150.12 39.89 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.862 -1.148 . . . . 0.0 108.929 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.436 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 26.1 m-85 57.5 29.14 16.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 60' ' ' MET . 4.6 tp -129.67 138.12 51.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.441 -0.787 . . . . 0.0 111.035 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -92.89 162.14 14.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.371 -0.83 . . . . 0.0 109.615 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 47.0 p -138.51 113.71 9.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 110.639 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.55 179.87 4.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 110.169 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -83.64 86.75 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 109.48 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 41.8 m-80 149.08 -25.54 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.621 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.51 -158.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.143 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 15.2 m -139.86 169.5 17.6 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.875 . . . . 0.0 109.946 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -149.9 149.29 30.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.874 ' CE ' HD12 ' A' ' 47' ' ' LEU . 2.3 ttt -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.1 90.5 8.38 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.18 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 36' ' ' ILE 2.502 0.2 OUTLIER -55.32 -73.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.771 -179.662 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -64.05 -137.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HB3' HD11 ' A' ' 67' ' ' ILE . 62.2 m-85 -84.18 51.75 2.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 110.423 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.81 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.45 -27.8 19.01 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -88.39 -47.34 8.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 110.427 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.864 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.9 pp -47.99 -24.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.29 -0.881 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.864 ' N ' HD12 ' A' ' 67' ' ' ILE . 3.7 m-85 -49.16 120.19 3.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.99 . . . . 0.0 110.584 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.712 ' H ' HG22 ' A' ' 102' ' ' THR . 73.7 m-20 -95.26 175.73 6.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.429 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -96.0 139.06 32.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 110.661 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.3 t -143.75 161.74 37.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 110.142 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -83.96 -34.33 24.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.456 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 58.28 20.03 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 110.507 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.09 115.86 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.53 1.279 . . . . 0.0 110.397 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.753 ' HA ' HD11 ' A' ' 92' ' ' ILE . 42.7 m-80 -89.71 18.74 5.23 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.566 -0.709 . . . . 0.0 110.7 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.474 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -122.49 158.95 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.595 ' HB2' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -145.59 169.46 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 110.529 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.79 130.69 47.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 110.403 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.82 152.47 24.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 110.261 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.05 131.04 56.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.509 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 86' ' ' ARG . 40.7 p -57.91 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.9 . . . . 0.0 110.379 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 110.313 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.79 -126.32 1.46 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.635 ' HB3' HG22 ' A' ' 37' ' ' VAL . 4.4 tp -153.09 27.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.16 . . . . 0.0 110.265 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 37' ' ' VAL . 25.2 mttm -108.29 -70.73 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 110.585 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.606 ' HB2' HG21 ' A' ' 81' ' ' THR . 12.8 mtt180 -70.61 124.04 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 110.429 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.518 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 20.5 mtp -118.85 124.86 48.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -103.41 164.62 11.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.958 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.724 HD12 ' HG2' ' A' ' 31' ' ' GLU . 91.3 mt -136.23 126.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 29' ' ' LEU . 48.8 m-85 -122.05 169.74 10.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.436 HG23 ' CG2' ' A' ' 30' ' ' VAL . 35.5 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.011 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.753 HD11 ' HA ' ' A' ' 75' ' ' ASN . 2.1 pt -62.81 -24.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 110.532 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 92' ' ' ILE . 24.3 mttt -151.1 131.97 7.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.018 -1.051 . . . . 0.0 110.594 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HD3' ' CA ' ' A' ' 26' ' ' LYS . 37.6 Cg_exo -35.47 146.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.275 1.983 . . . . 0.0 112.416 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.557 HG23 ' OE1' ' A' ' 99' ' ' GLU . 49.8 mt -127.03 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.507 ' HB3' ' HG3' ' A' ' 99' ' ' GLU . . . -89.17 158.98 17.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.558 -0.714 . . . . 0.0 110.278 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -56.42 -21.52 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 111.474 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.59 61.04 0.31 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.557 ' OE1' HG23 ' A' ' 95' ' ' ILE . 3.5 mt-10 -131.58 175.07 9.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -1.207 . . . . 0.0 110.997 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.17 124.28 44.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 109.68 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.86 HG13 ' HB2' ' A' ' 20' ' ' ALA . 54.3 mt -88.9 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 110.557 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -159.52 179.42 8.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.816 -0.552 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 104' ' ' SER . 1.6 pp -145.87 133.41 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.575 ' O ' HD12 ' A' ' 103' ' ' ILE . 47.2 t -61.05 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.397 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HB3' ' HB3' ' A' ' 109' ' ' TYR . 24.4 m-85 -123.62 -75.92 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.42 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.01 -173.19 42.34 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.41 -12.38 60.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 110.809 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.57 -55.56 2.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.06 -1.025 . . . . 0.0 110.626 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.437 ' HB3' ' HB3' ' A' ' 105' ' ' TYR . 3.1 t80 -54.41 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 110.889 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.696 -0.628 . . . . 0.0 111.285 178.56 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.87 155.08 60.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 C--N 1.313 -1.328 0 O-C-N 123.681 1.358 . . . . 0.0 111.263 -179.78 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.295 0.569 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 5' ' ' ARG . 1.5 m-80 -111.15 40.62 2.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.62 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.465 ' HA ' ' CD ' ' B' ' 22' ' ' LYS . 20.4 mtm180 -52.05 -38.85 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.925 -1.109 . . . . 0.0 110.619 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.484 HG21 HG13 ' B' ' 30' ' ' VAL . 98.9 t -135.32 143.72 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 19.9 tt -119.49 165.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.19 128.7 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 110.541 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 33.2 mttt -143.57 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 109.196 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.588 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.82 55.01 9.59 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 119.664 -1.898 . . . . 0.0 110.36 1.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.5 ' HB2' ' CE1' ' B' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.758 -0.589 . . . . 0.0 110.36 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -86.11 64.4 8.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.17 -166.43 23.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' B' ' 6' ' ' VAL . 58.5 t -97.89 127.81 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.951 -1.323 . . . . 0.0 110.122 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' B' ' 11' ' ' SER . 0.1 OUTLIER -90.48 126.56 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 109.948 179.342 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.836 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -88.62 90.84 8.57 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.465 -0.772 . . . . 0.0 110.761 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.848 ' O ' HG23 ' B' ' 97' ' ' ILE . 2.7 ttt180 -69.24 -21.88 63.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.481 -0.762 . . . . 0.0 109.465 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.513 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 2.7 mttp -105.53 -177.08 3.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.53 -0.731 . . . . 0.0 109.387 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.423 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 19.5 m 108.33 34.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.063 -1.648 . . . . 0.0 109.859 1.113 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 43.9 m-85 -127.31 160.84 30.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 111.049 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.58 -159.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.514 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 23.6 tttm -102.11 98.97 9.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 0.0 110.198 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.73 33.87 0.96 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -117.13 141.89 47.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.512 HD12 ' CE2' ' B' ' 90' ' ' PHE . 2.3 tp -83.8 136.97 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.484 HG13 HG21 ' B' ' 6' ' ' VAL . 48.4 t -92.38 -62.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.461 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.715 ' CG ' HD12 ' B' ' 89' ' ' ILE . 1.7 pt-20 -159.02 149.27 19.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -131.53 137.86 48.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.408 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 36.5 m -140.42 178.88 7.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 110.015 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.547 HD12 ' N ' ' B' ' 34' ' ' LEU . 11.3 mp -91.76 169.45 10.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.394 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 72.7 m -145.57 168.42 20.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.662 HD12 ' HB3' ' B' ' 60' ' ' MET . 39.3 mt -96.73 164.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.641 HG22 ' HB3' ' B' ' 84' ' ' LEU . 51.7 t -143.66 115.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 110.83 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 62.4 mmt-85 -144.69 142.44 30.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 110.114 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -56.5 -167.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.877 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -98.59 119.77 37.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 110.733 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -177.4 -141.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.819 . . . . 0.0 109.431 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.63 -35.48 42.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.725 -1.234 . . . . 0.0 109.304 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.74 ' CZ3' HD21 ' A' ' 47' ' ' LEU . 13.1 t-105 -63.05 -35.29 79.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -58.21 -66.03 3.1 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.462 ' HA ' ' HB2' ' B' ' 48' ' ' GLU . 31.1 m -66.7 -37.25 84.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.253 -1.145 . . . . 0.0 111.063 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -61.3 2.7 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.963 -1.086 . . . . 0.0 108.65 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.885 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.1 mm? -94.58 37.04 1.13 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.407 177.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -71.63 -1.2 12.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 111.545 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -117.83 150.19 39.58 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.903 -1.123 . . . . 0.0 109.017 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 25.8 m-85 57.47 29.1 16.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' B' ' 60' ' ' MET . 4.7 tp -129.73 138.27 51.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 110.999 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -93.09 162.16 14.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -0.83 . . . . 0.0 109.548 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 46.9 p -138.4 113.73 9.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 110.673 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.11 177.31 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -79.95 86.49 5.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 41.5 m-80 148.91 -25.69 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.646 -0.659 . . . . 0.0 109.396 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -177.46 -158.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.696 . . . . 0.0 110.194 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 15.3 m -139.82 169.48 17.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.906 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.496 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -149.88 149.29 30.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.049 -1.032 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.885 ' CE ' HD12 ' B' ' 47' ' ' LEU . 2.3 ttt -94.43 155.61 16.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.587 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.829 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -85.48 90.32 7.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.847 . . . . 0.0 110.558 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.644 ' CD2' HD11 ' B' ' 36' ' ' ILE 2.502 0.2 OUTLIER -55.44 -73.71 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.741 -179.736 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -64.08 -137.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' B' ' 67' ' ' ILE . 62.2 m-85 -84.17 52.01 2.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 110.406 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.829 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -90.75 -27.68 18.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -88.42 -47.27 8.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 110.446 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.854 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.9 pp -48.08 -24.22 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.339 -0.851 . . . . 0.0 110.879 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.854 ' N ' HD12 ' B' ' 67' ' ' ILE . 3.7 m-85 -49.16 120.14 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.203 -0.936 . . . . 0.0 110.57 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.715 ' H ' HG22 ' B' ' 102' ' ' THR . 74.0 m-20 -95.21 175.76 6.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.519 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -96.01 139.05 32.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.926 . . . . 0.0 110.679 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 20.7 t -143.77 161.65 38.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 110.126 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -83.92 -34.32 24.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.471 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 58.2 19.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.93 115.81 4.29 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.55 1.29 . . . . 0.0 110.322 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.742 ' HA ' HD11 ' B' ' 92' ' ' ILE . 42.7 m-80 -89.77 18.8 5.21 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.434 -0.791 . . . . 0.0 110.663 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.484 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -122.44 159.02 28.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -145.63 169.47 18.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 110.489 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.73 130.73 47.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 110.394 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.89 152.53 24.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.591 HG21 ' HB2' ' B' ' 86' ' ' ARG . 40.7 p -57.89 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.376 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.8 -126.31 1.46 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.641 ' HB3' HG22 ' B' ' 37' ' ' VAL . 4.4 tp -153.07 27.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -1.108 . . . . 0.0 110.269 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.424 ' HG3' HG21 ' B' ' 37' ' ' VAL . 25.2 mttm -108.27 -70.82 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.559 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.591 ' HB2' HG21 ' B' ' 81' ' ' THR . 12.8 mtt180 -70.58 124.04 23.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.483 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.54 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 20.5 mtp -118.87 124.83 48.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -103.33 164.59 11.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 110.016 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.715 HD12 ' CG ' ' B' ' 31' ' ' GLU . 91.4 mt -136.15 126.8 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.512 ' CE2' HD12 ' B' ' 29' ' ' LEU . 48.8 m-85 -122.03 169.81 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.729 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.43 HG23 ' CG2' ' B' ' 30' ' ' VAL . 35.3 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.976 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' B' ' 75' ' ' ASN . 2.1 pt -62.87 -24.14 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 110.527 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.639 ' HG3' HD12 ' B' ' 92' ' ' ILE . 24.3 mttt -151.1 131.8 7.3 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.968 -1.083 . . . . 0.0 110.601 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 39.5 Cg_exo -35.32 145.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.806 0 C-N-CA 122.339 2.026 . . . . 0.0 112.36 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.557 HG23 ' OE1' ' B' ' 99' ' ' GLU . 49.7 mt -127.07 149.81 32.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.468 -0.77 . . . . 0.0 110.561 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.494 ' HB3' ' HG3' ' B' ' 99' ' ' GLU . . . -88.6 159.08 18.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.434 -0.791 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.848 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -56.51 -21.52 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 111.423 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.68 61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.557 ' OE1' HG23 ' B' ' 95' ' ' ILE . 3.4 mt-10 -131.7 174.96 9.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -1.23 . . . . 0.0 111.03 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.25 123.89 43.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.44 -0.788 . . . . 0.0 109.823 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.836 HG13 ' HB2' ' B' ' 20' ' ' ALA . 54.1 mt -88.44 138.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.657 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.715 HG22 ' H ' ' B' ' 69' ' ' ASN . 0.2 OUTLIER -159.61 179.41 8.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.826 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.566 HD12 ' O ' ' B' ' 104' ' ' SER . 1.6 pp -145.84 133.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 110.242 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.566 ' O ' HD12 ' B' ' 103' ' ' ILE . 47.2 t -61.09 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 110.432 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 109' ' ' TYR . 24.4 m-85 -123.39 -75.88 0.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.45 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.05 -173.21 42.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.4 -12.4 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -1.105 . . . . 0.0 110.825 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.61 -55.49 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 110.619 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 105' ' ' TYR . 3.1 t80 -54.35 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 110.875 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 111.242 178.577 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.505 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.29 0.567 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.84 155.06 60.85 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.312 -1.353 0 O-C-N 123.659 1.347 . . . . 0.0 111.237 -179.745 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 28.3 p90 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.399 0.618 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -138.07 143.42 40.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.63 -49.99 18.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.374 -0.828 . . . . 0.0 111.354 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.541 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.49 -37.41 80.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 110.772 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.634 HG21 HG13 ' A' ' 30' ' ' VAL . 90.2 t -153.54 149.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.624 HG23 ' HB2' ' A' ' 19' ' ' PHE . 14.9 tt -118.26 167.11 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.53 126.08 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 110.403 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.597 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -150.48 115.51 5.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.689 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.597 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 2.2 tmtt? 61.91 66.17 0.85 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 119.546 -1.971 . . . . 0.0 110.742 2.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.444 ' HB3' ' CG ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 0.0 111.312 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CZ ' ' HE2' ' A' ' 10' ' ' LYS . 15.1 m-85 -98.03 105.1 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -1.134 . . . . 0.0 110.637 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.04 -171.5 15.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.884 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.1 p -123.36 132.13 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.97 -1.312 . . . . 0.0 109.679 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HB2' HG23 ' A' ' 7' ' ' ILE . 3.2 m-30 -95.21 164.04 13.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.823 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -124.09 97.97 5.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.478 -0.764 . . . . 0.0 110.623 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.54 -19.62 49.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 5.7 mttm -90.7 178.77 5.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.88 . . . . 0.0 108.982 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.437 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 49.6 m 102.43 18.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.081 -1.637 . . . . 0.0 110.325 1.144 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 24.1 m-85 -108.73 158.32 17.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.87 -159.59 0.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 110.268 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 24.9 tttt -97.76 90.37 4.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.68 52.13 0.2 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.35 135.05 49.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.169 . . . . 0.0 110.422 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.913 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -76.33 105.29 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.708 HG23 HG23 ' A' ' 91' ' ' THR . 93.0 t -67.66 -46.63 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.247 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.67 152.19 6.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.45 141.97 35.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.412 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -146.2 -177.0 5.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 110.28 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 -178.8 4.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 60' ' ' MET . 25.6 p -148.94 174.3 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.485 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.873 HG13 HD22 ' A' ' 62' ' ' LEU . 46.7 mt -105.73 102.2 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.588 HG21 ' O ' ' A' ' 84' ' ' LEU . 28.4 t -86.82 92.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.141 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 15.2 tpt180 -116.44 154.26 30.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.376 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.9 m170 -61.21 -167.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.433 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.65 28.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.55 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.48 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 109.228 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -50.75 -25.71 4.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.608 -1.307 . . . . 0.0 109.651 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.481 ' CZ3' ' HG ' ' A' ' 47' ' ' LEU . 19.0 t-105 -57.81 -56.73 18.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.653 . . . . 0.0 109.447 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.88 86.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 m -62.75 -65.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -1.156 . . . . 0.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.11 -47.7 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 110.227 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.693 HD12 ' HE3' ' A' ' 60' ' ' MET . 4.4 mm? -90.61 41.0 1.04 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 110.51 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 62.35 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 110.608 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER 179.5 139.23 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.844 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 56.82 33.41 23.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 110.563 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 51' ' ' LEU . 8.7 mt -105.51 102.09 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 110.459 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 55.2 m-85 -88.85 102.92 15.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.106 -0.996 . . . . 0.0 109.021 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 13.2 t -103.2 155.91 18.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 111.453 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.711 ' HB2' HD11 ' A' ' 84' ' ' LEU . 11.4 mtp180 -116.97 -173.38 2.38 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -83.61 74.07 10.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 74.1 m-20 167.85 -27.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.485 ' CG ' HD12 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -174.57 -174.91 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.339 -0.85 . . . . 0.0 110.89 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 2.4 p -117.62 147.13 43.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.838 ' CB ' HD22 ' A' ' 84' ' ' LEU . . . -132.1 133.85 44.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 110.605 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.693 ' HE3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.29 155.08 19.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 109.935 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.894 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.63 93.08 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.11 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.873 HD22 HG13 ' A' ' 36' ' ' ILE 2.505 0.0 OUTLIER -55.64 -70.29 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 110.691 -179.175 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.79 -150.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.0 57.72 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.438 -1.036 . . . . 0.0 110.711 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.894 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.82 -24.68 27.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.29 -42.71 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -1.147 . . . . 0.0 110.532 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.531 HD13 ' HB ' ' A' ' 18' ' ' VAL . 1.1 pp -49.91 -29.26 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.975 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' A' ' 89' ' ' ILE . 13.8 m-85 -55.12 140.01 39.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 110.655 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -118.24 -177.69 3.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.201 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.514 ' NE2' ' CE2' ' A' ' 110' ' ' TRP . 18.9 t60 -100.76 125.37 47.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -129.97 141.44 50.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.12 20.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.182 -0.949 . . . . 0.0 110.54 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.49 87.43 41.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.88 . . . . 0.0 110.148 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.789 ' O ' HD11 ' A' ' 92' ' ' ILE . 10.9 Cg_endo -58.06 105.24 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.605 1.318 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.13 -17.19 57.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 110.613 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.1 166.98 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.569 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.11 -163.73 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.171 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 50.7 p-80 -143.07 163.69 32.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.545 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 43.2 tt0 -146.56 112.05 5.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD12 ' CD ' ' C' ' 218' ' ' PRO . 1.8 mp -91.22 60.22 4.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.079 -1.013 . . . . 0.0 110.427 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.453 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 0.1 OUTLIER 42.15 28.39 0.1 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.592 -0.692 . . . . 0.0 111.212 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.45 24.31 2.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.45 28.33 0.17 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.105 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.838 HD22 ' CB ' ' A' ' 59' ' ' ALA . 62.8 mt 50.99 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.252 . . . . 0.0 110.734 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.46 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.795 . . . . 0.0 110.517 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -145.24 102.9 3.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.125 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.421 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 3.8 mtp -81.24 118.63 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.743 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.739 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -111.02 127.0 55.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.744 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.476 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 10.0 mt -89.1 117.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.092 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.913 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 18.9 m-85 -107.3 -173.57 2.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.32 -0.863 . . . . 0.0 110.411 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.708 HG23 HG23 ' A' ' 30' ' ' VAL . 21.3 p -130.44 93.24 3.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.789 HD11 ' O ' ' A' ' 74' ' ' PRO . 2.4 pt -56.86 -19.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.471 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.445 ' N ' HG13 ' A' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.65 18.11 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -51.42 141.2 41.94 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.519 1.273 . . . . 0.0 110.452 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.464 HG23 ' HG3' ' A' ' 99' ' ' GLU . 13.9 mt -109.64 150.52 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -94.71 156.9 16.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.59 -0.694 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.839 HG23 ' O ' ' A' ' 21' ' ' ARG . 21.9 mt -63.58 112.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.72 36.61 3.44 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -101.11 155.84 17.76 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.294 -1.121 . . . . 0.0 110.57 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.0 115.04 26.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.133 -0.979 . . . . 0.0 109.717 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.957 HD11 ' HB2' ' A' ' 20' ' ' ALA . 16.2 mt -89.64 122.46 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 110.435 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' C ' ' A' ' 101' ' ' ILE . 68.6 p -154.77 134.21 12.63 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 104' ' ' SER . 1.1 pp -104.99 153.82 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.096 . . . . 0.0 110.524 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -80.0 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.524 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 109' ' ' TYR . 17.6 m-85 -127.14 -68.49 0.79 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.22 24.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.23 -39.63 60.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -1.116 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.58 -61.4 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.275 -0.89 . . . . 0.0 110.109 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 105' ' ' TYR . 3.2 m-85 -94.37 51.6 1.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.32 -0.862 . . . . 0.0 110.543 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.514 ' CE2' ' NE2' ' A' ' 70' ' ' HIS . 10.5 t-105 . . . . . 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.584 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.228 0.537 . . . . 0.0 110.382 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -156.61 -176.23 0.59 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.706 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 22.1 Cg_exo . . . . . 0 C--N 1.312 -1.349 0 O-C-N 123.659 1.347 . . . . 0.0 110.586 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 28.3 p90 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.326 0.584 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -137.88 143.66 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 110.153 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.83 -49.89 19.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.823 . . . . 0.0 111.326 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.535 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.0 OUTLIER -68.55 -37.4 79.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 110.769 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.635 HG21 HG13 ' B' ' 30' ' ' VAL . 89.8 t -153.52 149.14 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 110.185 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.616 HG23 ' HB2' ' B' ' 19' ' ' PHE . 15.0 tt -118.2 167.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.582 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 126.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 110.349 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.591 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -150.8 115.56 5.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.628 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.591 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 2.2 tmtt? 62.0 66.25 0.83 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.599 -1.938 . . . . 0.0 110.748 2.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.449 ' HB3' ' CG ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 111.037 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.511 ' CZ ' ' HE2' ' B' ' 10' ' ' LYS . 15.2 m-85 -98.0 105.01 17.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -1.13 . . . . 0.0 110.688 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.85 -171.55 15.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.897 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.2 p -123.25 132.02 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.326 . . . . 0.0 109.794 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.616 ' HB2' HG23 ' B' ' 7' ' ' ILE . 3.2 m-30 -95.29 164.05 13.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 110.791 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.986 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -124.26 98.07 5.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.834 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.51 -19.67 49.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.017 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 5.7 mttm -90.59 178.75 6.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.042 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.441 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 49.9 m 102.45 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.079 -1.638 . . . . 0.0 110.325 1.128 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 24.1 m-85 -108.67 158.32 17.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -0.973 . . . . 0.0 110.436 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.86 -159.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.26 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -97.69 90.29 4.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.73 52.13 0.2 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.33 135.06 50.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -1.165 . . . . 0.0 110.477 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.896 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.9 OUTLIER -76.35 105.28 7.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 110.254 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.719 HG23 HG23 ' B' ' 91' ' ' THR . 92.9 t -67.73 -46.56 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.64 152.26 6.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.5 141.9 35.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.503 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.412 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -146.18 -176.96 5.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.45 -178.7 4.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 110.276 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 60' ' ' MET . 25.6 p -149.0 174.31 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.894 HG13 HD22 ' B' ' 62' ' ' LEU . 46.6 mt -105.96 100.76 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.575 HG21 ' O ' ' B' ' 84' ' ' LEU . 24.8 t -84.84 92.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 110.499 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' B' ' 39' ' ' HIS . 15.1 tpt180 -116.66 154.3 30.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.414 ' N ' ' HG3' ' B' ' 38' ' ' ARG . 3.0 m170 -61.14 -167.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.416 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.66 28.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.53 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.44 -0.787 . . . . 0.0 109.234 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -50.8 -25.65 4.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.69 -1.256 . . . . 0.0 109.616 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 19.1 t-105 -57.84 -56.75 17.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.65 -0.656 . . . . 0.0 109.415 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.82 86.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 8.9 m -62.76 -65.1 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -1.134 . . . . 0.0 110.412 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.43 75.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.728 HD12 ' HE3' ' B' ' 60' ' ' MET . 4.4 mm? -90.94 41.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 110.403 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.02 62.34 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 110.602 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.3 OUTLIER 179.51 139.28 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 0.0 109.876 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 56.81 33.47 23.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.179 -0.951 . . . . 0.0 110.491 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' B' ' 51' ' ' LEU . 8.6 mt -105.5 101.7 11.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.55 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' B' ' 59' ' ' ALA . 55.6 m-85 -88.28 102.95 15.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.121 -0.987 . . . . 0.0 109.16 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 13.2 t -103.21 155.86 18.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 111.525 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.705 ' HB2' HD11 ' B' ' 84' ' ' LEU . 11.5 mtp180 -117.5 -176.04 2.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.579 -0.701 . . . . 0.0 109.63 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -79.79 73.64 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 73.8 m-20 167.77 -27.22 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.491 ' CG ' HD12 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -174.43 -174.65 0.88 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.36 -0.838 . . . . 0.0 110.913 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 2.4 p -117.68 147.09 43.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.832 ' CB ' HD22 ' B' ' 84' ' ' LEU . . . -132.18 133.64 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.728 ' HE3' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -89.21 153.72 20.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.148 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.861 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.78 93.02 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 110.5 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.894 HD22 HG13 ' B' ' 36' ' ' ILE 2.507 0.0 OUTLIER -55.7 -70.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.728 -179.39 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.69 -150.47 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -76.03 58.06 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.406 -1.055 . . . . 0.0 110.627 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.861 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.34 -24.42 26.54 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.36 -42.72 16.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.524 HD13 ' HB ' ' B' ' 18' ' ' VAL . 1.1 pp -49.94 -29.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.95 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.466 ' CZ ' HG12 ' B' ' 89' ' ' ILE . 13.8 m-85 -55.1 140.08 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.011 -1.055 . . . . 0.0 110.621 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -118.37 -177.73 3.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' HIS . . . . . 0.528 ' NE2' ' CE2' ' B' ' 110' ' ' TRP . 18.8 t60 -100.7 125.39 47.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 110.292 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.5 t -129.99 141.43 50.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.259 -0.901 . . . . 0.0 110.201 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.17 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.528 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.45 87.41 40.86 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.794 ' O ' HD11 ' B' ' 92' ' ' ILE . 10.9 Cg_endo -58.12 105.32 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.669 1.352 . . . . 0.0 110.393 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.18 -17.17 57.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.03 23.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.16 -163.68 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 110.193 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 50.8 p-80 -143.11 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.53 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' B' ' 88' ' ' ARG . 43.3 tt0 -146.62 112.03 5.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.336 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.504 HD12 ' CD ' ' D' ' 218' ' ' PRO . 1.8 mp -91.16 60.12 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.451 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 0.1 OUTLIER 42.24 28.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.543 -0.723 . . . . 0.0 111.149 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.42 24.27 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.4 28.27 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.069 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.832 HD22 ' CB ' ' B' ' 59' ' ' ALA . 62.6 mt 51.16 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -1.189 . . . . 0.0 110.704 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.52 -33.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 110.464 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.454 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.1 OUTLIER -145.23 102.94 3.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.119 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' B' ' 80' ' ' LEU . 3.8 mtp -81.24 118.59 22.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -111.0 126.7 55.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.831 179.142 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.466 HG12 ' CZ ' ' B' ' 68' ' ' PHE . 10.0 mt -88.67 117.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 110.183 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.896 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 18.9 m-85 -107.35 -173.52 2.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 110.461 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.719 HG23 HG23 ' B' ' 30' ' ' VAL . 21.3 p -130.44 93.19 3.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.794 HD11 ' O ' ' B' ' 74' ' ' PRO . 2.5 pt -56.88 -19.05 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.429 ' N ' HG13 ' B' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.69 18.17 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 110.115 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.68 141.43 43.73 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.521 1.274 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.463 HG23 ' CB ' ' B' ' 99' ' ' GLU . 14.0 mt -109.7 150.53 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 110.705 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -94.72 156.88 16.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.169 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.834 HG23 ' O ' ' B' ' 21' ' ' ARG . 22.0 mt -63.53 112.09 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.965 -1.084 . . . . 0.0 110.206 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.65 36.58 3.46 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLU . . . . . 0.463 ' CB ' HG23 ' B' ' 95' ' ' ILE . 0.4 OUTLIER -100.94 155.68 17.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.304 -1.115 . . . . 0.0 110.591 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.96 114.89 26.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.994 . . . . 0.0 109.732 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.986 HD11 ' HB2' ' B' ' 20' ' ' ALA . 16.9 mt -89.36 122.49 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.516 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.535 HG23 ' C ' ' B' ' 101' ' ' ILE . 66.6 p -154.67 134.28 12.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.589 HD12 ' O ' ' B' ' 104' ' ' SER . 1.1 pp -104.93 153.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 110.549 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.589 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.5 OUTLIER -79.98 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' B' ' 109' ' ' TYR . 17.6 m-85 -127.13 -68.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.229 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.01 179.21 24.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -39.66 60.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -1.143 . . . . 0.0 110.23 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -57.55 -61.5 2.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' B' ' 105' ' ' TYR . 3.2 m-85 -94.27 51.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.311 -0.868 . . . . 0.0 110.565 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CE2' ' NE2' ' B' ' 70' ' ' HIS . 10.6 t-105 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.249 0.547 . . . . 0.0 110.429 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -156.57 -176.2 0.59 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.719 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 22.2 Cg_exo . . . . . 0 C--N 1.312 -1.371 0 O-C-N 123.678 1.357 . . . . 0.0 110.579 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.448 0.642 . . . . 0.0 111.764 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -99.89 147.63 25.33 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.752 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.0 -23.52 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 111.288 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.532 ' C ' HG23 ' A' ' 6' ' ' VAL . 2.7 mtt180 -102.73 -29.67 11.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.028 -1.045 . . . . 0.0 111.121 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.532 HG23 ' C ' ' A' ' 5' ' ' ARG . 94.9 t -153.23 137.31 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.426 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 5.7 tt -117.48 161.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 110.971 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.4 p -88.97 124.24 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.097 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 39.0 mttt -150.35 129.19 12.47 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.392 -0.818 . . . . 0.0 109.281 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.603 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 57.96 74.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 119.669 -1.894 . . . . 0.0 111.928 1.482 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.359 -0.838 . . . . 0.0 111.579 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CG ' ' HD3' ' A' ' 10' ' ' LYS . 1.1 m-85 -58.63 94.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -1.147 . . . . 0.0 110.442 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' ND2' ' A' ' 69' ' ' ASN . . . -120.28 171.61 14.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.72 ' CG2' HD13 ' A' ' 67' ' ' ILE . 95.0 t -93.09 140.43 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.938 -1.33 . . . . 0.0 109.825 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.555 ' CD1' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -105.73 132.88 51.32 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.11 -0.993 . . . . 0.0 110.086 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -88.39 88.45 7.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.702 -0.624 . . . . 0.0 110.446 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.88 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -67.4 -15.04 63.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.798 178.089 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 2.0 mttm -106.79 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.91 20.93 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.154 -1.591 . . . . 0.0 109.846 1.389 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 54.1 m-85 -118.65 163.91 16.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.544 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.34 -178.63 3.65 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 110.025 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -74.45 99.66 3.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.947 . . . . 0.0 110.299 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.25 61.8 0.55 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.3 123.28 23.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 110.505 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.918 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -66.63 127.48 32.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.176 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.704 ' N ' HD13 ' A' ' 29' ' ' LEU . 90.9 t -88.89 -46.55 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.346 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.47 153.17 6.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.18 136.46 31.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 110.304 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.429 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.79 170.32 9.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.697 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.0 -174.2 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.685 ' CD1' HD21 ' A' ' 62' ' ' LEU . 65.0 mt -123.75 151.97 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 84' ' ' LEU . 43.7 t -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.519 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.8 mmt-85 -134.86 145.68 48.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.269 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -63.31 176.97 0.7 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 110.359 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 40' ' ' ASN . 2.9 m120 -67.48 -131.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.142 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.25 0.24 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.624 -1.298 . . . . 0.0 110.596 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.12 -25.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.0 111.09 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.519 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 60.4 t-105 -69.29 -55.85 9.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.155 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.61 -22.48 56.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 48' ' ' GLU . 97.4 m -90.28 -60.15 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -1.212 . . . . 0.0 110.663 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.72 -55.45 11.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.872 -1.143 . . . . 0.0 110.231 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.953 ' HB2' HD11 ' A' ' 51' ' ' LEU . 4.0 mm? -92.24 33.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 110.085 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 9.8 pt-20 -68.48 64.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.171 -0.956 . . . . 0.0 111.026 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.2 t0 -169.42 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.858 -1.151 . . . . 0.0 111.024 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 25.8 m-85 -128.87 53.51 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.05 -1.031 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' A' ' 47' ' ' LEU . 52.7 mt -124.98 118.02 25.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 48.3 m-85 -89.41 101.54 14.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 108.995 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.8 t -98.92 155.52 17.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 111.561 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -123.61 -168.07 1.72 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.616 -0.678 . . . . 0.0 109.756 178.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -83.04 79.58 9.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.964 -1.085 . . . . 0.0 109.384 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 0.2 OUTLIER 160.91 -25.18 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.766 -0.584 . . . . 0.0 110.049 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.67 -167.82 0.2 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.425 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.3 m -130.68 139.28 50.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.3 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.898 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -124.13 172.39 9.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.685 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.63 ' CE ' HD12 ' A' ' 47' ' ' LEU . 9.5 ttt -117.01 153.04 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.697 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.95 90.9 8.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.445 -0.784 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.846 HD22 HD22 ' B' ' 62' ' ' LEU 2.501 0.5 OUTLIER -55.41 -63.45 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.807 -179.681 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 33' ' ' CYS . . . -63.63 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.605 ' HB3' HD11 ' A' ' 67' ' ' ILE . 39.7 m-85 -89.71 42.45 1.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -1.138 . . . . 0.0 110.589 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.697 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -84.74 -21.25 56.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -89.06 -59.3 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.981 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.6 pp -44.79 -22.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.606 -0.684 . . . . 0.0 112.375 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.981 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.5 m-85 -49.55 153.17 1.2 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.614 -1.304 . . . . 0.0 110.677 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.536 ' HB2' HG22 ' A' ' 102' ' ' THR . 26.0 m-20 -119.32 -171.95 2.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 111.322 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -102.81 156.81 17.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.778 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.69 141.08 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.007 -1.058 . . . . 0.0 110.697 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -54.92 -29.3 55.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.9 92.49 39.76 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.438 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.842 ' O ' HD11 ' A' ' 92' ' ' ILE . 32.3 Cg_exo -53.97 104.19 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.659 1.347 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.49 -21.66 35.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 110.311 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 110.307 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -171.89 2.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 47.0 p-80 -130.77 174.15 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 87' ' ' MET . 29.8 tt0 -149.82 141.33 23.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 86' ' ' ARG . 5.0 mt -102.52 142.81 33.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.208 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.481 HG22 ' NH2' ' A' ' 88' ' ' ARG . 69.3 p -80.1 85.69 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.2 95.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.691 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.38 28.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.898 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 1.1 mp -109.74 98.86 8.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.127 . . . . 0.0 110.437 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -144.73 -53.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.752 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -136.15 174.89 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 110.017 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 mtp -142.76 128.35 19.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.702 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.774 ' HB3' HD21 ' A' ' 29' ' ' LEU . 57.9 mtt180 -114.54 140.42 48.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 110.172 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.452 HG12 ' CE2' ' A' ' 68' ' ' PHE . 8.3 mt -99.96 110.25 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.097 -1.002 . . . . 0.0 109.976 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.918 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 9.5 m-85 -104.7 171.2 7.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.292 -0.88 . . . . 0.0 110.582 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.6 p -117.09 118.98 33.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.976 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.842 HD11 ' O ' ' A' ' 74' ' ' PRO . 21.6 pt -86.74 13.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.752 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HG2' HG13 ' A' ' 92' ' ' ILE . 7.3 ptpt -176.82 142.15 0.53 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.201 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.04 136.34 17.83 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.577 1.304 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.455 HG21 ' HB1' ' A' ' 20' ' ' ALA . 61.8 mt -116.53 140.88 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 110.734 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.67 153.4 20.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 110.493 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -50.33 -23.06 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 111.168 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.01 57.84 0.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.22 175.0 8.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.246 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.86 128.96 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.962 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.539 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 31.6 mt -92.4 119.37 39.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 0.0 110.414 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 69' ' ' ASN . 58.7 p -150.95 123.93 8.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.649 -0.657 . . . . 0.0 109.673 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 104' ' ' SER . 1.1 pt -88.91 159.39 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 110.785 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.522 ' O ' HD12 ' A' ' 103' ' ' ILE . 5.2 p -83.38 -157.15 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.413 -0.804 . . . . 0.0 110.348 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 104' ' ' SER . 28.3 m-85 -137.57 -66.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.33 -164.42 34.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -29.22 62.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -1.149 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -76.21 -71.28 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 1.2 m-85 -58.5 99.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 110.405 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 216' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.505 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.266 0.555 . . . . 0.0 110.452 . . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.713 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 55.11 -177.8 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.713 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 25.2 Cg_exo . . . . . 0 C--N 1.312 -1.342 0 O-C-N 123.657 1.346 . . . . 0.0 110.682 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' B' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.439 0.638 . . . . 0.0 111.733 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -99.9 147.74 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -49.02 -23.53 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 111.3 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.533 ' C ' HG23 ' B' ' 6' ' ' VAL . 2.7 mtt180 -102.7 -29.76 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.104 . . . . 0.0 111.068 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.533 HG23 ' C ' ' B' ' 5' ' ' ARG . 95.3 t -153.15 137.39 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.358 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 5.8 tt -117.64 160.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.233 -0.917 . . . . 0.0 111.059 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.555 HG13 ' O ' ' B' ' 8' ' ' VAL . 9.5 p -88.27 124.56 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 0.0 110.16 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.613 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 38.9 mttt -150.81 129.22 12.09 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.371 -0.83 . . . . 0.0 109.286 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.613 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 58.13 74.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 119.55 -1.969 . . . . 0.0 111.907 1.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' B' ' 9' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.306 -0.871 . . . . 0.0 111.24 177.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.51 ' CG ' ' HD3' ' B' ' 10' ' ' LYS . 1.1 m-85 -58.56 94.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 110.457 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.448 ' HA3' ' ND2' ' B' ' 69' ' ' ASN . . . -120.3 171.64 14.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.714 ' CG2' HD13 ' B' ' 67' ' ' ILE . 96.3 t -92.97 140.27 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.032 -1.275 . . . . 0.0 109.881 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -105.72 132.2 52.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.123 -0.985 . . . . 0.0 110.297 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.547 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -87.48 88.49 7.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 110.6 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.876 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.1 OUTLIER -67.49 -14.92 63.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 178.112 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 2.0 mttm -106.84 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.87 20.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.205 -1.56 . . . . 0.0 109.855 1.442 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 54.1 m-85 -118.63 163.91 16.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.887 . . . . 0.0 110.534 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 -178.64 3.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -74.48 99.74 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.22 61.81 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.31 123.38 24.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -1.172 . . . . 0.0 110.437 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.925 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.0 OUTLIER -66.78 127.47 32.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 110.163 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.704 ' N ' HD13 ' B' ' 29' ' ' LEU . 90.6 t -88.85 -46.51 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 110.308 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.52 153.13 6.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.369 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.15 136.47 31.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 110.268 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.413 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.472 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.8 170.31 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.677 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.94 -174.19 4.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.077 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.692 ' CD1' HD21 ' B' ' 62' ' ' LEU . 65.0 mt -123.77 151.91 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 110.429 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' B' ' 84' ' ' LEU . 43.7 t -124.63 104.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.303 -0.873 . . . . 0.0 110.601 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 14.8 mmt-85 -134.87 145.73 48.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 110.264 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.405 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 34.5 m170 -63.37 177.03 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.32 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 40' ' ' ASN . 2.9 m120 -67.44 -131.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.167 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.17 0.24 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.624 -1.297 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.22 -25.63 0.98 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 111.116 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.519 ' CZ2' HD22 ' B' ' 51' ' ' LEU . 60.3 t-105 -69.27 -55.88 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 110.138 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.7 -22.29 56.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' B' ' 48' ' ' GLU . 97.4 m -90.34 -60.09 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -1.219 . . . . 0.0 110.67 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.04 -54.46 15.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.976 -1.077 . . . . 0.0 110.373 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.953 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.0 mm? -93.39 33.46 1.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 109.787 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' B' ' 48' ' ' GLU . 9.8 pt-20 -68.51 64.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.205 -0.935 . . . . 0.0 111.075 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' B' ' 47' ' ' LEU . 16.2 t0 -169.4 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.168 . . . . 0.0 110.957 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.488 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 25.8 m-85 -128.84 53.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.992 . . . . 0.0 110.921 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' B' ' 47' ' ' LEU . 52.5 mt -125.08 117.83 24.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 111.189 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' B' ' 61' ' ' ALA . 48.3 m-85 -89.17 101.6 14.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.023 177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.8 t -98.97 155.46 17.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.158 -0.964 . . . . 0.0 111.563 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.439 ' HD3' HD13 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -124.12 -170.9 2.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.751 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -78.97 79.24 5.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.14 -0.975 . . . . 0.0 110.208 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 0.2 OUTLIER 160.71 -25.27 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.651 -0.655 . . . . 0.0 110.134 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.5 -167.84 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.057 -1.027 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.3 m -130.64 139.28 50.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.348 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.9 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -124.1 172.42 9.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -0.999 . . . . 0.0 110.705 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.632 ' HA ' HD23 ' B' ' 51' ' ' LEU . 9.5 ttt -117.12 152.63 34.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.341 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.698 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.41 90.77 8.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.846 HD22 HD22 ' A' ' 62' ' ' LEU 2.502 0.5 OUTLIER -55.31 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.846 -179.807 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -63.59 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.611 ' HB3' HD11 ' B' ' 67' ' ' ILE . 39.6 m-85 -89.68 42.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.127 . . . . 0.0 110.603 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.698 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -84.71 -21.29 56.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -89.03 -59.34 2.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -1.173 . . . . 0.0 110.554 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.97 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.6 pp -44.71 -22.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.639 -0.663 . . . . 0.0 112.368 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.97 ' N ' HD12 ' B' ' 67' ' ' ILE . 4.5 m-85 -49.48 153.76 1.05 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.628 -1.295 . . . . 0.0 110.668 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.525 ' HB2' HG22 ' B' ' 102' ' ' THR . 26.2 m-20 -120.0 -171.46 2.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 111.114 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -103.65 156.64 17.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.429 -0.794 . . . . 0.0 109.676 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.57 141.15 10.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.053 . . . . 0.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -55.2 -29.09 57.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 110.271 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.91 92.52 39.66 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.356 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' PRO . . . . . 0.826 ' O ' HD11 ' B' ' 92' ' ' ILE . 32.4 Cg_exo -54.07 104.2 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.647 1.341 . . . . 0.0 110.576 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.5 -21.63 35.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 110.31 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.431 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -140.46 140.27 35.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.912 . . . . 0.0 110.31 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.32 -171.91 2.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 47.0 p-80 -130.75 174.07 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 87' ' ' MET . 29.8 tt0 -149.83 141.34 23.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.875 . . . . 0.0 110.297 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.749 HD23 ' O ' ' B' ' 86' ' ' ARG . 5.0 mt -102.55 142.82 33.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.208 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.473 HG22 ' CZ ' ' B' ' 88' ' ' ARG . 68.7 p -80.08 85.74 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.718 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.09 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.72 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.35 28.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.9 ' CD2' ' HB2' ' B' ' 59' ' ' ALA . 1.1 mp -109.81 98.87 8.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -1.097 . . . . 0.0 110.423 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.71 -53.78 0.31 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.749 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -136.14 174.86 10.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.064 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' B' ' 79' ' ' GLU . 15.5 mtp -142.78 128.42 19.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 110.706 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.796 ' HB3' HD21 ' B' ' 29' ' ' LEU . 58.4 mtt180 -114.66 140.47 48.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.121 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.448 HG12 ' CE2' ' B' ' 68' ' ' PHE . 8.3 mt -99.92 110.1 26.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.995 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.925 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 9.5 m-85 -104.62 171.18 7.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 110.549 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -117.11 118.97 33.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.996 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.826 HD11 ' O ' ' B' ' 74' ' ' PRO . 21.5 pt -86.69 13.29 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.787 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.423 ' HG2' HG13 ' B' ' 92' ' ' ILE . 7.3 ptpt -176.8 142.12 0.53 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.66 136.73 21.24 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.464 1.244 . . . . 0.0 111.056 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.45 HG21 ' HB1' ' B' ' 20' ' ' ALA . 61.6 mt -116.49 140.9 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.789 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.74 153.42 20.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.876 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -50.28 -23.08 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 111.045 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.14 57.93 0.41 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.37 174.84 8.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.24 . . . . 0.0 110.583 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.8 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.547 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 32.3 mt -92.59 119.36 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 110.335 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.525 HG22 ' HB2' ' B' ' 69' ' ' ASN . 61.3 p -150.83 123.98 8.81 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.608 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.512 HD12 ' O ' ' B' ' 104' ' ' SER . 1.1 pt -88.85 159.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.759 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.512 ' O ' HD12 ' B' ' 103' ' ' ILE . 5.3 p -83.42 -157.18 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 110.321 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 28.1 m-85 -137.54 -66.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.47 34.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -29.27 62.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -1.157 . . . . 0.0 110.365 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -76.22 -71.28 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.462 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 1.2 m-85 -58.48 99.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.45 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 216' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.507 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.236 0.541 . . . . 0.0 110.472 . . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 55.18 -177.76 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 25.5 Cg_exo . . . . . 0 C--N 1.312 -1.383 0 O-C-N 123.7 1.369 . . . . 0.0 110.651 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.485 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 32.7 p90 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.536 0.684 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -150.69 141.32 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.138 -179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.03 -45.8 32.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 111.046 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.535 ' C ' HG23 ' A' ' 6' ' ' VAL . 6.5 mtm-85 -74.69 -33.81 62.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.543 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 5' ' ' ARG . 84.5 t -153.33 134.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 11.2 tt -117.22 156.37 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 8' ' ' VAL . 12.7 p -89.35 122.81 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.71 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.2 mttt -151.19 122.01 7.55 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.53 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.602 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 59.12 67.09 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.585 -1.947 . . . . 0.0 111.415 1.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.953 . . . . 0.0 111.19 178.629 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CZ ' ' HG3' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.91 6.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -1.159 . . . . 0.0 110.708 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.04 174.6 20.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 68' ' ' PHE . 82.9 t -97.21 117.42 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.321 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -88.99 127.0 35.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.871 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -90.85 86.88 6.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 110.962 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.5 ttp85 -58.65 -19.89 43.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.537 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 11.5 mmtm -105.25 179.27 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 108.965 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.47 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 59.3 m 104.35 23.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.01 -1.681 . . . . 0.0 109.627 2.026 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.1 m-85 -115.89 156.55 25.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 164.28 12.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.377 -0.827 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 30.5 tttt -62.37 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.22 44.51 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 24' ' ' PHE . 4.3 mt-10 -118.94 112.09 19.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -1.184 . . . . 0.0 110.443 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.978 HD21 ' HB3' ' A' ' 88' ' ' ARG . 2.0 tm? -53.48 115.6 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.255 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.452 ' N ' HD13 ' A' ' 29' ' ' LEU . 54.0 t -88.89 66.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.6 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.271 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.96 167.29 24.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.288 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.3 179.73 7.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.612 HD23 ' HG3' ' A' ' 86' ' ' ARG . 2.8 mt -94.72 -177.26 4.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.9 176.09 11.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.4 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 62' ' ' LEU . 73.5 mt -109.27 141.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 109.969 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 84' ' ' LEU . 43.4 t -117.44 115.54 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.049 -1.032 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.507 ' HB3' ' CG ' ' A' ' 43' ' ' TRP . 0.5 OUTLIER -145.96 157.1 43.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 110.416 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.9 177.01 9.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.341 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 29.9 p30 -64.24 -134.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.251 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 7.7 t0 64.83 -148.16 0.26 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.579 -1.325 . . . . 0.0 110.57 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.47 -41.09 13.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.227 -0.921 . . . . 0.0 110.953 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.731 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 65.9 t-105 -60.92 -35.33 76.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.69 92.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 84.8 m -83.53 -58.32 2.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -1.18 . . . . 0.0 110.687 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' CB ' HD22 ' A' ' 47' ' ' LEU . . . -48.83 -60.07 3.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.181 -0.949 . . . . 0.0 110.489 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.811 HD12 ' CE ' ' A' ' 60' ' ' MET . 3.1 mm? -91.72 29.15 1.59 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.882 . . . . 0.0 110.362 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.56 -23.72 0.71 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.0 111.412 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -112.34 167.18 10.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.926 -1.109 . . . . 0.0 109.988 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.58 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 38.2 m-85 52.84 29.94 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 0.0 110.148 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.777 HD13 ' HB3' ' A' ' 47' ' ' LEU . 8.6 tp -116.48 117.4 29.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.338 -0.851 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 13.0 m-85 -89.23 107.71 19.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -106.0 153.81 21.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -130.8 -171.53 2.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -82.96 79.75 9.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.979 -1.075 . . . . 0.0 109.263 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.499 0.2 OUTLIER 163.51 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.846 -0.534 . . . . 0.0 109.795 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.05 -164.29 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.302 -0.874 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 m -136.48 111.93 9.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 110.393 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.863 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -102.5 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.368 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.811 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -112.39 163.58 14.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.773 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.65 87.81 7.45 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 36' ' ' ILE 2.515 0.4 OUTLIER -46.65 -84.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.705 -0.622 . . . . 0.0 111.663 -175.614 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -131.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 70.7 m-85 -83.49 50.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 110.734 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.773 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.64 -24.54 27.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.58 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.37 -36.59 14.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -1.12 . . . . 0.0 110.55 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.503 HD12 HG23 ' A' ' 18' ' ' VAL . 1.3 pp -57.11 -20.88 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.656 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.707 ' CE1' HG21 ' A' ' 18' ' ' VAL . 12.4 m-85 -56.45 121.67 10.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.005 . . . . 0.0 110.197 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 102' ' ' THR . 41.3 m-20 -88.76 177.5 6.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.575 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -98.04 112.08 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 110.356 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.21 157.12 25.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -72.69 -23.17 60.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.396 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -132.17 73.9 77.08 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.56 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.666 1.351 . . . . 0.0 110.562 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.401 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 67.1 m-20 -70.64 -13.51 62.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 110.667 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -115.76 117.69 30.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -98.38 173.6 6.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.127 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -119.54 148.05 43.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.86 139.53 52.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.83 . . . . 0.0 110.156 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.798 HD22 HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -113.49 132.66 55.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 110.529 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 p -57.45 -166.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.0 110.297 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.34 59.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.37 -131.47 2.48 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.863 HD23 ' HB2' ' A' ' 59' ' ' ALA . 4.2 tp -149.22 28.26 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -1.1 . . . . 0.0 110.095 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -100.59 -36.65 9.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.612 ' HG3' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -135.79 145.33 46.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.041 . . . . 0.0 110.892 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.406 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 2.9 ptm -150.24 147.09 27.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.956 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.978 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -112.85 161.94 16.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' HZ ' ' A' ' 68' ' ' PHE . 14.8 mt -109.57 132.36 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.943 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.854 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 36.7 m-85 -117.79 -178.36 3.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.491 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.442 HG23 HG23 ' A' ' 30' ' ' VAL . 57.6 p -125.83 105.9 9.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.344 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.42 HG23 ' HB2' ' A' ' 77' ' ' ARG . 5.8 pt -60.65 -16.62 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 110.502 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' HG3' ' HB3' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -148.71 159.61 37.77 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.872 179.156 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.07 130.05 27.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.614 1.323 . . . . 0.0 110.094 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' HB1' ' A' ' 20' ' ' ALA . 56.3 mt -98.85 156.42 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.833 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.82 157.39 18.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.532 -0.73 . . . . 0.0 110.968 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.6 mp -61.67 104.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 110.34 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.14 31.03 3.95 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.15 155.55 18.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.23 -1.159 . . . . 0.0 110.074 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.12 117.45 28.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 110.385 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' A' ' 20' ' ' ALA . 57.6 mt -95.83 130.01 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.489 HG23 ' C ' ' A' ' 101' ' ' ILE . 31.1 p -154.34 170.25 21.76 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.502 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.3 pp -128.88 6.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.004 -1.06 . . . . 0.0 111.427 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 2.2 p 54.75 -151.89 0.36 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.091 -1.006 . . . . 0.0 110.013 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 104' ' ' SER . 25.4 m-85 -133.75 -77.39 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 110.812 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.28 -159.18 20.19 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -90.46 18.8 5.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -1.105 . . . . 0.0 110.595 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.98 -53.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.127 -0.983 . . . . 0.0 110.081 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.471 ' HB3' ' CB ' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -59.99 118.81 6.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 110.32 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.532 -0.73 . . . . 0.0 110.868 179.538 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.504 3.2 m . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.302 0.573 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 217' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -115.29 167.71 9.48 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.321 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 19.1 Cg_endo . . . . . 0 C--N 1.312 -1.364 0 O-C-N 123.643 1.339 . . . . 0.0 110.524 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 32.7 p90 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.481 0.658 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -150.97 141.31 22.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 110.124 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 13.3 t70 -47.98 -45.91 31.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.961 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.522 ' C ' HG23 ' B' ' 6' ' ' VAL . 6.5 mtm-85 -74.61 -33.92 62.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.522 HG23 ' C ' ' B' ' 5' ' ' ARG . 84.9 t -153.16 134.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 11.2 tt -117.24 156.07 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 110.588 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.582 HG13 ' O ' ' B' ' 8' ' ' VAL . 12.6 p -88.91 123.32 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.66 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.2 mttt -151.88 121.82 7.09 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.59 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 59.08 67.25 0.94 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 119.631 -1.918 . . . . 0.0 111.482 1.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.757 178.473 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.501 ' CZ ' ' HG3' ' B' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.85 6.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -1.149 . . . . 0.0 110.722 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.06 174.56 20.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.705 HG21 ' CE1' ' B' ' 68' ' ' PHE . 85.3 t -97.19 116.75 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.312 . . . . 0.0 110.145 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.524 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 0.5 OUTLIER -88.31 127.05 35.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.014 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.78 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -90.92 86.89 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 110.969 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ARG . . . . . 0.882 ' O ' HG23 ' B' ' 97' ' ' ILE . 1.5 ttp85 -58.74 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 0.0 109.525 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 11.5 mmtm -105.13 179.3 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 108.953 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.464 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 59.5 m 104.37 23.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.912 -1.742 . . . . 0.0 109.674 1.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.3 m-85 -115.83 156.54 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.376 -0.828 . . . . 0.0 110.622 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 164.25 12.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.339 -0.851 . . . . 0.0 110.042 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 92' ' ' ILE . 30.4 tttt -62.37 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.16 44.52 0.15 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' B' ' 24' ' ' PHE . 4.3 mt-10 -119.0 112.18 19.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.976 HD21 ' HB3' ' B' ' 88' ' ' ARG . 2.0 tm? -53.5 115.58 2.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.452 HG23 HG23 ' B' ' 91' ' ' THR . 53.8 t -88.83 66.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -0.881 . . . . 0.0 110.093 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.58 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 110.287 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.95 167.38 24.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.328 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.48 179.6 8.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 110.563 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.622 HD23 ' HG3' ' B' ' 86' ' ' ARG . 2.8 mt -94.63 -177.34 4.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.83 176.07 11.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 110.382 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 1.012 HD11 HD13 ' B' ' 62' ' ' LEU . 73.1 mt -109.3 141.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' B' ' 84' ' ' LEU . 43.0 t -117.45 115.47 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.5 OUTLIER -145.87 157.12 43.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 110.409 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 39' ' ' HIS . . . . . 0.4 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 0.9 OUTLIER -81.93 176.97 9.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 110.276 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' B' ' 41' ' ' ASP . 29.9 p30 -64.19 -134.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.887 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' B' ' 40' ' ' ASN . 7.6 t0 64.85 -148.16 0.26 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.644 -1.285 . . . . 0.0 110.559 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.41 -41.14 13.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.949 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.734 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 66.0 t-105 -60.97 -35.29 76.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.771 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -35.58 91.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 85.3 m -83.61 -58.35 2.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.641 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.414 ' CB ' HD22 ' B' ' 47' ' ' LEU . . . -48.86 -59.42 3.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.809 HD12 ' CE ' ' B' ' 60' ' ' MET . 3.1 mm? -92.73 29.49 1.76 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.76 -23.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.173 -0.955 . . . . 0.0 111.335 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -112.26 167.11 10.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.953 -1.092 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.578 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 37.9 m-85 52.93 29.85 8.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.785 HD13 ' HB3' ' B' ' 47' ' ' LEU . 8.6 tp -116.61 117.19 29.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 111.0 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' B' ' 61' ' ' ALA . 13.1 m-85 -88.94 107.75 19.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.868 . . . . 0.0 109.219 177.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 23.1 t -106.05 153.74 21.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.09 -1.006 . . . . 0.0 111.222 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -131.41 -174.42 3.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.564 -0.71 . . . . 0.0 109.848 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -78.83 79.42 5.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.13 -0.982 . . . . 0.0 110.065 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.2 OUTLIER 163.43 -27.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.756 -0.59 . . . . 0.0 109.839 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -164.01 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.5 m -136.57 112.01 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 110.377 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.841 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -102.6 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.407 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.809 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -112.83 161.62 16.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.285 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.744 ' HB1' ' CA ' ' B' ' 65' ' ' GLY . . . -82.94 87.73 6.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.936 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 1.012 HD13 HD11 ' B' ' 36' ' ' ILE 2.517 0.3 OUTLIER -47.02 -84.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.646 -0.659 . . . . 0.0 111.72 -175.753 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.49 -131.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 71.0 m-85 -83.6 50.92 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.611 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.744 ' CA ' ' HB1' ' B' ' 61' ' ' ALA . . . -91.19 -24.19 27.5 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.578 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.71 -36.43 14.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -1.139 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.492 HD12 HG23 ' B' ' 18' ' ' VAL . 1.3 pp -57.13 -20.96 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 0.0 110.642 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' B' ' 18' ' ' VAL . 12.4 m-85 -56.4 121.67 10.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -88.79 177.4 6.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 110.604 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -97.91 112.15 24.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.358 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.28 157.15 25.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -72.75 -23.17 60.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.356 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -132.12 73.95 77.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.58 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.678 1.357 . . . . 0.0 110.595 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.401 ' HB3' ' HG3' ' B' ' 93' ' ' LYS . 67.1 m-20 -70.62 -13.5 62.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.704 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -115.74 117.72 31.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.419 ' HB2' HG23 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -98.38 173.61 6.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -119.5 147.98 43.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.611 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -127.84 139.57 52.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.814 HD22 HD12 ' B' ' 84' ' ' LEU . 0.7 OUTLIER -113.43 132.74 55.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 110.482 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.8 p -57.52 -166.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 110.324 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.41 59.91 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.34 -131.48 2.48 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.841 HD23 ' HB2' ' B' ' 59' ' ' ALA . 4.3 tp -149.28 28.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -1.104 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -100.72 -36.51 9.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 110.82 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ARG . . . . . 0.622 ' HG3' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -135.87 145.34 46.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 110.884 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.9 ptm -150.2 147.1 27.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 110.055 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.976 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -112.94 161.98 16.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 110.387 -179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.49 HD13 ' HZ ' ' B' ' 68' ' ' PHE . 14.9 mt -109.53 132.39 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.968 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' PHE . . . . . 0.854 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 36.7 m-85 -117.82 -178.36 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 110.473 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.452 HG23 HG23 ' B' ' 30' ' ' VAL . 57.6 p -125.79 105.92 9.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.419 HG23 ' HB2' ' B' ' 77' ' ' ARG . 5.8 pt -60.71 -16.6 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.514 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.401 ' HG3' ' HB3' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -148.73 159.79 37.3 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.876 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.31 130.26 28.04 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.59 1.31 . . . . 0.0 110.05 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.49 HG21 ' HB1' ' B' ' 20' ' ' ALA . 56.1 mt -98.92 156.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.0 110.806 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.97 157.44 18.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.912 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' ILE . . . . . 0.882 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.6 mp -61.68 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 110.343 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.24 30.89 3.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.07 155.1 18.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -1.137 . . . . 0.0 110.155 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.48 117.51 27.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.028 -1.045 . . . . 0.0 110.505 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' B' ' 20' ' ' ALA . 57.3 mt -95.96 130.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 110.617 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.475 HG23 ' C ' ' B' ' 101' ' ' ILE . 30.5 p -154.28 170.23 21.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.726 -0.608 . . . . 0.0 109.487 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.5 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.3 pp -128.71 6.24 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 111.275 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 2.2 p 54.63 -151.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.064 . . . . 0.0 110.059 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 25.4 m-85 -133.7 -77.37 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.99 . . . . 0.0 110.855 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.35 -159.21 20.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.38 18.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.93 -53.35 0.7 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 110.108 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.457 ' HB3' ' CB ' ' B' ' 105' ' ' TYR . 0.1 OUTLIER -60.11 118.77 6.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 110.338 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.89 179.641 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 3.2 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.274 0.559 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 217' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -115.27 167.7 9.48 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 110.357 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 218' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 19.4 Cg_endo . . . . . 0 C--N 1.312 -1.373 0 O-C-N 123.633 1.333 . . . . 0.0 110.526 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' CG ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.185 0.517 . . . . 0.0 110.398 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.476 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 22.3 p90 -71.01 145.06 50.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.435 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.14 146.86 33.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 110.251 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.83 -22.65 3.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 110.836 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.526 ' C ' HG13 ' A' ' 6' ' ' VAL . 7.3 mtm-85 -90.14 -37.51 14.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.998 . . . . 0.0 110.688 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.526 HG13 ' C ' ' A' ' 5' ' ' ARG . 33.1 m -152.03 -172.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 110.453 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.737 HG23 ' HB2' ' A' ' 19' ' ' PHE . 12.6 tt -157.04 161.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.212 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG11 ' CG ' ' A' ' 1' ' ' MET . 9.8 p -97.02 135.46 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 110.765 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.571 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 28.4 mttt -139.62 142.71 37.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.78 . . . . 0.0 109.161 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.571 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mmtp 52.04 64.31 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 119.797 -1.814 . . . . 0.0 111.217 0.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.491 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -120.64 170.25 7.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.549 -0.719 . . . . 0.0 110.088 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.93 -21.53 56.96 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.603 1.317 . . . . 0.0 110.499 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.94 32.19 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.41 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.05 152.58 21.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.38 -120.07 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' HN2' ' A' ' 301' ' ' SAH . 31.4 m-85 -115.2 61.2 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.159 . . . . 0.0 110.331 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.56 24.1 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.932 HG23 HD13 ' A' ' 67' ' ' ILE . 54.7 t -103.22 154.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.978 -1.307 . . . . 0.0 110.092 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.737 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.1 m-85 -113.95 127.85 56.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.301 -0.874 . . . . 0.0 110.127 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.587 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -90.23 92.08 8.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.789 ' O ' HG23 ' A' ' 97' ' ' ILE . 7.0 ttt180 -58.31 -22.8 54.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 0.0 109.47 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 23' ' ' SER . 2.2 mptt -88.85 178.25 6.49 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.507 -0.746 . . . . 0.0 109.487 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 22' ' ' LYS 2.513 73.9 m 98.58 17.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.231 -1.543 . . . . 0.0 110.351 0.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' A' ' 91' ' ' THR . 19.4 m-85 -108.0 164.36 12.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.1 -165.66 1.01 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.446 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 5.4 tttt -85.41 96.47 9.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 110.423 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.6 0.64 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -119.68 123.04 42.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -1.195 . . . . 0.0 110.433 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.841 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -68.27 96.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 110.0 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' A' ' 6' ' ' VAL . 72.3 t -67.75 -39.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.725 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -168.49 164.42 12.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 110.258 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.17 141.55 18.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.437 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 52.7 m -144.96 -176.05 4.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 110.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.25 171.6 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.473 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 65.3 m -146.58 -178.22 6.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 110.168 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 55.9 mt -122.3 143.0 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 84' ' ' LEU . 39.6 t -117.39 102.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.51 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.7 mmt180 -125.87 160.47 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -79.64 173.79 12.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 110.405 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.214 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.6 t0 66.52 -150.39 0.2 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.721 -1.237 . . . . 0.0 110.605 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.25 -36.74 4.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.369 -0.832 . . . . 0.0 111.307 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.51 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 57.4 t-105 -55.33 -59.79 4.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.56 57.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 98.4 m -73.83 -70.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.186 . . . . 0.0 110.607 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.67 -43.84 26.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.107 -0.996 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.658 ' CB ' HD11 ' A' ' 51' ' ' LEU . 4.5 mm? -92.12 16.73 10.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.265 -0.897 . . . . 0.0 111.38 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -59.98 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.984 -1.072 . . . . 0.0 110.449 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.1 t0 -179.03 -69.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.003 -1.061 . . . . 0.0 110.333 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.625 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 19.3 m-85 -114.33 61.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.658 HD11 ' CB ' ' A' ' 47' ' ' LEU . 24.7 mt -111.9 117.45 32.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 111.027 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 4.8 m-85 -88.25 92.64 9.24 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.426 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 85.8 p -94.68 145.34 24.91 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 111.497 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.721 ' HB2' HD11 ' A' ' 84' ' ' LEU . 5.3 ttp180 -109.77 -172.81 2.11 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.09 72.59 10.11 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.983 -1.073 . . . . 0.0 109.241 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.0 OUTLIER 169.96 -26.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.99 -168.13 0.93 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.283 -0.886 . . . . 0.0 111.262 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.7 p -129.76 123.98 32.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 0.0 109.806 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.43 169.16 8.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.071 -1.018 . . . . 0.0 111.054 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.582 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -104.29 151.13 23.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.27 85.53 7.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 110.007 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.705 ' O ' HD13 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -52.87 -69.02 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.452 -0.78 . . . . 0.0 110.708 -179.488 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -69.55 -151.26 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CD2' HG12 ' A' ' 67' ' ' ILE . 3.7 m-85 -83.94 51.4 2.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -1.05 . . . . 0.0 110.66 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.57 -23.72 49.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -82.55 -49.24 10.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 110.469 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.991 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.6 pp -45.76 -24.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.753 . . . . 0.0 111.701 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.991 ' N ' HD12 ' A' ' 67' ' ' ILE . 17.2 m-85 -62.2 109.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.844 -1.16 . . . . 0.0 110.024 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' H ' HG22 ' A' ' 102' ' ' THR . 84.3 m-20 -82.1 -176.86 6.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.745 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.776 ' CG ' HD12 ' A' ' 111' ' ' LEU . 4.2 t-160 -102.25 119.46 38.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.5 t -121.32 158.96 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.51 -20.37 60.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 20.8 t0 -141.04 63.77 19.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 110.486 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.653 ' O ' HD11 ' A' ' 92' ' ' ILE . 17.2 Cg_exo -62.92 114.61 2.5 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.671 1.353 . . . . 0.0 110.025 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.43 ' O ' HD11 ' A' ' 95' ' ' ILE . 76.0 m-20 -90.95 24.17 2.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.746 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.483 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -158.66 142.47 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.412 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.1 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.37 168.77 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.91 161.26 30.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 110.092 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.0 mt -133.35 127.69 34.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.445 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 83' ' ' GLY . 3.4 p -69.73 -167.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.53 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 105.4 -177.29 22.9 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.731 ' HB2' HG22 ' A' ' 37' ' ' VAL . 20.9 mt -91.14 51.4 1.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -1.128 . . . . 0.0 110.329 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.9 -80.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.826 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.71 130.84 35.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 110.716 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.748 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.5 mtp -115.89 133.6 55.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.765 ' HB3' HD21 ' A' ' 29' ' ' LEU . 26.9 mtp85 -120.28 163.58 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.583 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.725 HD12 ' HB3' ' A' ' 31' ' ' GLU . 89.9 mt -129.83 98.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.841 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 26.5 m-85 -91.42 -176.85 4.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.432 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.671 ' CG2' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.73 81.89 1.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 111.075 -179.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 74' ' ' PRO . 1.4 pt -60.12 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.12 -0.988 . . . . 0.0 108.571 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 84.42 121.77 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.363 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 84.6 Cg_exo -43.79 148.25 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.526 1.277 . . . . 0.0 111.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.671 HD12 ' CG2' ' A' ' 91' ' ' THR . 74.7 mt -119.91 151.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 110.418 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.19 14.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -63.5 117.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.61 5.05 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -104.03 178.45 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -1.21 . . . . 0.0 110.147 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.23 123.69 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.804 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.587 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 73.9 mt -89.52 127.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 110.122 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.7 p -155.44 176.4 12.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.946 -0.471 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.739 HD12 ' O ' ' A' ' 104' ' ' SER . 1.3 pp -140.42 158.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.01 -1.056 . . . . 0.0 110.563 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.739 ' O ' HD12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -83.01 -164.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 110.369 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.507 ' CG ' ' HB3' ' A' ' 109' ' ' TYR . 19.4 m-85 -124.16 -81.3 0.63 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.85 -152.61 24.52 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.817 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.13 -53.28 21.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -1.149 . . . . 0.0 110.05 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.91 -167.7 0.91 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.435 -0.791 . . . . 0.0 109.351 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.507 ' HB3' ' CG ' ' A' ' 105' ' ' TYR . 2.7 m-85 46.09 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 111.002 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.466 ' CE3' ' O ' ' A' ' 110' ' ' TRP . 29.6 p-90 -83.55 151.47 25.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.402 0.62 . . . . 0.0 110.601 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.776 HD12 ' CG ' ' A' ' 70' ' ' HIS . 1.1 tp -89.41 -78.62 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.595 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 t -176.75 -81.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.001 -1.062 . . . . 0.0 110.474 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -94.55 122.54 60.72 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.155 -0.965 . . . . 0.0 110.364 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.94 64.53 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.497 1.262 . . . . 0.0 110.487 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.511 ' C ' HD12 ' A' ' 116' ' ' LEU . 24.3 mmm180 -115.76 39.57 2.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.35 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 115' ' ' ARG . 6.8 mp -115.61 45.9 1.6 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.912 . . . . 0.0 110.412 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 119' ' ' ASN . 96.7 m -155.36 149.77 26.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 110.33 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.481 ' O ' ' NE2' ' A' ' 118' ' ' GLN . 0.9 OUTLIER -112.22 28.41 8.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.927 . . . . 0.0 110.304 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.702 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 m120 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.386 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 7.5 mttt 52.85 45.93 27.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -1.127 . . . . 0.0 110.394 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.429 ' HB1' ' HD2' ' C' ' 204' ' ' PRO . . . -170.42 164.14 5.79 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 110.429 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.429 ' HD2' ' HB1' ' C' ' 203' ' ' ALA . 26.9 Cg_endo -67.45 111.35 2.29 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.688 1.362 . . . . 0.0 110.562 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.24 148.17 26.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.321 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -126.32 104.56 8.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.391 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -75.76 -55.01 6.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.308 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.78 153.97 39.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.903 . . . . 0.0 110.255 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.27 124.67 4.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.343 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -66.37 -31.09 71.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.282 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.72 43.64 1.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 110.301 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -86.5 96.97 10.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 110.406 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.35 -169.92 1.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.335 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.411 ' HD3' ' HB2' ' A' ' 51' ' ' LEU . 30.6 mtp85 -125.55 -85.04 0.63 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.485 ' HE3' ' CE2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 2.9 t -56.33 -168.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.443 -0.785 . . . . 0.0 110.664 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -123.97 176.21 2.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.336 -0.852 . . . . 0.0 110.222 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 21.5 Cg_endo -66.33 -37.41 24.05 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.623 1.328 . . . . 0.0 110.594 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.38 60.23 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 110.374 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 97.9 m -148.9 84.85 1.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 110.343 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.849 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.479 ' CG ' HG11 ' B' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.239 0.542 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 22.3 p90 -71.03 145.1 50.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.13 146.93 33.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.88 -22.69 3.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.514 ' C ' HG13 ' B' ' 6' ' ' VAL . 7.4 mtm-85 -90.08 -37.62 14.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.514 HG13 ' C ' ' B' ' 5' ' ' ARG . 33.1 m -151.95 -172.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.717 HG23 ' HB2' ' B' ' 19' ' ' PHE . 12.6 tt -156.96 161.83 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 110.219 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.479 HG11 ' CG ' ' B' ' 1' ' ' MET . 10.0 p -97.02 135.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.818 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.574 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 28.4 mttt -139.62 142.76 37.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 109.161 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.574 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mmtp 52.16 64.23 1.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 119.796 -1.815 . . . . 0.0 111.233 0.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.3 OUTLIER -120.58 170.3 7.39 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -65.94 -21.54 56.9 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.638 1.336 . . . . 0.0 110.471 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.95 32.24 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.439 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.03 152.6 21.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.42 -120.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.572 ' HB2' ' HN2' ' B' ' 302' ' ' SAH . 31.5 m-85 -115.17 61.35 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 110.403 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.44 -171.52 23.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.933 HG23 HD13 ' B' ' 67' ' ' ILE . 54.2 t -103.24 154.03 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.934 -1.333 . . . . 0.0 110.084 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.717 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.1 m-85 -113.9 127.92 56.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 110.148 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.57 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -90.16 91.86 8.71 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 110.557 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.79 ' O ' HG23 ' B' ' 97' ' ' ILE . 7.0 ttt180 -58.17 -22.75 52.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' B' ' 23' ' ' SER . 2.2 mptt -89.01 178.26 6.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.52 -0.738 . . . . 0.0 109.518 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' B' ' 22' ' ' LYS 2.514 73.8 m 98.58 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.311 -1.493 . . . . 0.0 110.339 0.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' B' ' 91' ' ' THR . 19.6 m-85 -108.07 164.4 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 110.382 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.04 -165.65 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.428 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 5.4 tttt -85.43 96.38 9.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 110.466 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.01 52.66 0.64 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -119.7 122.98 42.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.0 110.411 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.829 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -68.26 96.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 110.044 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.423 ' CG1' HG11 ' B' ' 6' ' ' VAL . 72.2 t -67.69 -39.96 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.366 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.723 ' HB3' HD12 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -168.46 164.44 12.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.24 141.5 18.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.446 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 52.5 m -144.85 -176.06 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.923 . . . . 0.0 110.406 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.422 HD13 ' CE ' ' A' ' 1' ' ' MET . 1.1 mp -95.19 171.66 8.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.535 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.749 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 65.2 m -146.64 -178.27 6.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.557 ' O ' ' HB1' ' B' ' 59' ' ' ALA . 55.7 mt -122.29 142.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' B' ' 84' ' ' LEU . 39.6 t -117.3 102.91 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' B' ' 36' ' ' ILE . 14.7 mmt180 -125.81 160.5 29.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -79.65 173.79 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.412 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.6 t0 66.54 -150.32 0.2 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.698 -1.251 . . . . 0.0 110.64 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.36 -36.74 4.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 111.277 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.503 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 57.3 t-105 -55.33 -59.86 4.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 110.181 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.35 -31.54 56.9 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.435 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 98.1 m -73.91 -70.64 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -1.233 . . . . 0.0 110.621 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.82 -42.93 27.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.081 -1.012 . . . . 0.0 111.002 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.658 ' CB ' HD11 ' B' ' 51' ' ' LEU . 4.5 mm? -93.48 17.37 11.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 111.014 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.1 OUTLIER -60.28 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.091 . . . . 0.0 110.408 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 47' ' ' LEU . 1.1 t0 -179.01 -69.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.95 -1.094 . . . . 0.0 110.345 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.644 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . 19.4 m-85 -114.38 61.9 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.117 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.658 HD11 ' CB ' ' B' ' 47' ' ' LEU . 24.4 mt -112.07 116.67 30.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.169 -0.957 . . . . 0.0 111.153 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' B' ' 59' ' ' ALA . 5.0 m-85 -87.23 92.64 9.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 0.0 108.795 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.419 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 85.6 p -94.74 145.36 24.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 0.0 111.529 -176.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.722 ' HB2' HD11 ' B' ' 84' ' ' LEU . 5.4 ttp180 -110.38 -175.65 2.78 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.541 -0.724 . . . . 0.0 109.48 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.11 72.17 5.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 0.0 OUTLIER 169.77 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.8 -168.17 0.96 Allowed 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.336 -0.852 . . . . 0.0 111.351 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 1.7 p -129.69 123.97 32.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.688 . . . . 0.0 109.781 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.45 169.25 8.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.002 . . . . 0.0 111.054 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.582 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -104.59 149.99 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 110.26 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.66 85.44 7.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.255 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 62' ' ' LEU 2.501 0.1 OUTLIER -53.0 -69.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.723 -179.646 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -69.49 -151.22 0.49 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.493 ' CD2' HG12 ' B' ' 67' ' ' ILE . 3.7 m-85 -84.02 51.36 2.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.422 -1.046 . . . . 0.0 110.652 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.49 -23.76 49.5 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -82.58 -49.27 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 110.398 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.98 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.6 pp -45.75 -24.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.491 -0.756 . . . . 0.0 111.749 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.98 ' N ' HD12 ' B' ' 67' ' ' ILE . 17.2 m-85 -62.32 109.75 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.902 -1.124 . . . . 0.0 110.024 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.404 ' H ' HG22 ' B' ' 102' ' ' THR . 84.3 m-20 -81.99 -176.46 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.716 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.775 ' CG ' HD12 ' B' ' 111' ' ' LEU . 4.3 t-160 -102.78 119.45 38.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -0.841 . . . . 0.0 110.024 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 36.7 t -121.35 158.94 27.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 -20.43 60.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.428 ' N ' ' HD3' ' B' ' 74' ' ' PRO . 20.7 t0 -140.99 63.63 19.01 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 110.505 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.642 ' O ' HD11 ' B' ' 92' ' ' ILE . 17.2 Cg_exo -62.79 114.68 2.51 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.627 1.33 . . . . 0.0 110.04 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.44 ' O ' HD11 ' B' ' 95' ' ' ILE . 76.2 m-20 -91.08 24.29 2.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.701 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.475 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -158.62 142.45 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.401 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.455 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.04 1.01 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.529 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.42 168.72 19.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.755 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.89 161.27 30.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -0.827 . . . . 0.0 110.037 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.37 127.61 33.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.002 . . . . 0.0 110.487 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' B' ' 83' ' ' GLY . 3.4 p -69.71 -167.35 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 110.278 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 110.229 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 81' ' ' THR . . . 105.43 -177.22 22.85 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' B' ' 37' ' ' VAL . 20.9 mt -91.21 51.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.92 -80.77 0.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 110.82 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.69 130.82 35.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.741 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.749 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.6 mtp -115.87 133.64 55.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.746 ' HB3' HD21 ' B' ' 29' ' ' LEU . 26.8 mtp85 -120.31 163.55 17.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.641 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.723 HD12 ' HB3' ' B' ' 31' ' ' GLU . 89.5 mt -129.75 98.65 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.829 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 26.3 m-85 -91.36 -176.8 4.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.386 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.671 ' CG2' HD12 ' B' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 81.86 1.76 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.148 -0.97 . . . . 0.0 110.996 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.642 HD11 ' O ' ' B' ' 74' ' ' PRO . 1.4 pt -59.96 103.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.657 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 92' ' ' ILE . 0.0 OUTLIER 84.15 121.44 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 C-N-CA 123.541 0.736 . . . . 0.0 109.425 -177.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 88.2 Cg_exo -44.13 148.51 1.09 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.468 1.246 . . . . 0.0 111.436 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.671 HD12 ' CG2' ' B' ' 91' ' ' THR . 74.0 mt -119.92 151.91 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.285 -0.884 . . . . 0.0 110.421 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.18 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.364 -0.835 . . . . 0.0 110.344 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.79 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -63.47 117.17 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.05 27.59 5.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.404 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 18.8 mm-40 -104.03 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.236 . . . . 0.0 110.156 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.29 123.68 48.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.81 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.57 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 74.3 mt -89.34 127.37 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 110.181 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 101' ' ' ILE . 16.6 p -155.42 176.43 12.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.664 -0.647 . . . . 0.0 109.798 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.736 HD12 ' O ' ' B' ' 104' ' ' SER . 1.3 pp -140.43 158.07 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.084 -1.01 . . . . 0.0 110.573 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.736 ' O ' HD12 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -82.98 -164.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 0.0 110.37 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' B' ' 109' ' ' TYR . 19.6 m-85 -124.12 -81.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 110.327 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.76 -152.69 24.59 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.06 -53.31 20.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.287 -1.125 . . . . 0.0 110.101 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.86 -167.46 0.85 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.421 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HB3' ' CG ' ' B' ' 105' ' ' TYR . 2.8 m-85 45.81 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.389 -0.82 . . . . 0.0 111.157 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.478 ' CE3' ' O ' ' B' ' 110' ' ' TRP . 30.1 p-90 -83.57 151.58 25.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 110.598 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.775 HD12 ' CG ' ' B' ' 70' ' ' HIS . 1.1 tp -89.37 -78.64 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 110.639 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 11.6 t -176.75 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.034 -1.041 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' B' ' 115' ' ' ARG . 9.1 mtt180 -94.57 122.53 60.7 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 110.344 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.87 64.4 0.93 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.474 1.249 . . . . 0.0 110.49 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ARG . . . . . 0.503 ' C ' HD12 ' B' ' 116' ' ' LEU . 24.2 mmm180 -115.69 39.59 2.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 110.362 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.503 HD12 ' C ' ' B' ' 115' ' ' ARG . 6.8 mp -115.67 45.97 1.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 110.379 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.699 HG22 ' H ' ' B' ' 119' ' ' ASN . 96.3 m -155.38 149.8 26.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.341 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' B' ' 118' ' ' GLN . 0.9 OUTLIER -112.17 28.27 8.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.345 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.699 ' H ' HG22 ' B' ' 117' ' ' THR . 1.4 m120 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.414 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 52.85 45.94 27.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -1.146 . . . . 0.0 110.402 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.448 ' HB1' ' HD2' ' D' ' 204' ' ' PRO . . . -170.41 164.15 5.8 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.419 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.448 ' HD2' ' HB1' ' D' ' 203' ' ' ALA . 26.8 Cg_endo -67.46 111.39 2.3 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.654 1.344 . . . . 0.0 110.552 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.25 148.05 26.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 110.35 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -126.27 104.58 8.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 110.382 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -75.68 -55.05 6.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 110.388 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.77 153.91 39.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 110.281 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.24 124.66 4.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 110.395 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -66.34 -31.04 71.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.34 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.73 43.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 110.226 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -86.47 96.9 10.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.94 . . . . 0.0 110.431 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.3 -169.81 1.7 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.343 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.409 ' HD3' ' HB2' ' B' ' 51' ' ' LEU . 30.7 mtp85 -125.61 -84.95 0.63 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 110.292 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.498 ' HE3' ' CE2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.504 2.9 t -56.29 -168.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 0.0 110.682 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.802 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -124.01 176.19 2.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.802 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 21.4 Cg_endo -66.31 -37.46 23.99 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.644 1.339 . . . . 0.0 110.542 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.31 60.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.398 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 98.0 m -148.89 84.83 1.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 110.34 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.55 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.563 ' HN2' ' HB2' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.572 ' HN2' ' HB2' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.226 0.536 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 54.5 p90 -53.16 132.84 39.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 110.634 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ARG . 46.7 t30 -150.14 161.29 42.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.82 62.01 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.618 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.526 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER 174.75 -34.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.0 109.218 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.625 HG11 ' CG1' ' A' ' 30' ' ' VAL . 16.5 m -156.55 -172.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 109.737 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 10.2 tt -160.64 164.29 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.7 p -89.14 120.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.098 -1.002 . . . . 0.0 110.474 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.584 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 26.2 mttt -148.39 127.72 13.03 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.584 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 54.44 42.11 31.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.795 -1.816 . . . . 0.0 110.088 4.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.51 ' CB ' ' CE1' ' A' ' 19' ' ' PHE . 2.1 p -92.83 -171.05 0.25 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.677 -0.64 . . . . 0.0 109.905 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 40.9 Cg_exo -52.24 108.27 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.441 1.232 . . . . 0.0 110.725 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 13' ' ' LEU . 4.5 mm? 52.67 54.62 10.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.613 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.49 165.68 25.46 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.43 -163.9 17.11 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CE1' ' HG3' ' A' ' 10' ' ' LYS . 3.8 m-85 -95.08 99.67 11.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.249 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.72 -160.51 9.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 67' ' ' ILE . 79.7 t -113.1 138.32 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.837 -1.39 . . . . 0.0 110.414 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CG ' ' CD ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -104.28 140.99 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -104.14 91.01 3.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 110.974 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.899 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -60.18 -26.2 66.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HE2' ' CE1' ' A' ' 24' ' ' PHE . 6.2 mtpp -94.28 -177.38 4.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.566 -0.709 . . . . 0.0 109.567 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.443 ' HA ' ' CB ' ' A' ' 22' ' ' LYS 2.512 0.1 OUTLIER 108.58 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.123 -1.61 . . . . 0.0 110.109 1.879 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CE1' ' HE2' ' A' ' 22' ' ' LYS . 48.8 m-85 -114.76 160.82 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.652 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.2 172.27 6.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.978 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' CD ' ' A' ' 94' ' ' PRO . 29.5 tttm -72.03 80.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.552 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.43 40.87 0.12 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 24' ' ' PHE . 14.0 mt-10 -119.3 158.52 25.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.386 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.865 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.5 tm? -92.41 128.11 38.14 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.694 ' N ' HD13 ' A' ' 29' ' ' LEU . 81.7 t -94.37 -45.61 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' HD12 ' A' ' 89' ' ' ILE . 27.3 tp10 -170.32 152.07 3.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 110.64 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.51 35.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.05 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.441 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -146.67 -157.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 110.743 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 34' ' ' LEU . 1.5 mm? -99.91 175.47 5.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.415 -0.803 . . . . 0.0 110.551 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.734 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 3.3 m -150.7 154.93 38.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.393 -0.817 . . . . 0.0 109.988 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.787 HD11 HD23 ' A' ' 62' ' ' LEU . 54.7 mt -94.89 164.01 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 36' ' ' ILE . 48.7 t -144.96 106.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -0.962 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.522 ' CB ' ' CG ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -112.82 -163.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.205 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -128.7 62.45 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 26.8 m120 52.35 -149.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 0.0 110.631 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 17.6 m-20 60.51 -144.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.211 -0.93 . . . . 0.0 110.106 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -46.63 -29.05 1.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.009 -1.057 . . . . 0.0 111.149 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.841 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 66.1 t-105 -65.07 -44.45 88.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 110.232 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.37 -40.15 97.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.8 m -67.07 -65.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.508 ' HB3' HD22 ' A' ' 47' ' ' LEU . . . -54.31 -58.43 7.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.883 ' HB3' HD13 ' A' ' 51' ' ' LEU . 2.7 mm? -90.63 50.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -0.4 22.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 111.015 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -129.6 156.8 43.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.942 -1.099 . . . . 0.0 109.681 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 33.3 m-85 54.93 24.09 5.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 109.857 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.883 HD13 ' HB3' ' A' ' 47' ' ' LEU . 7.5 tp -117.05 123.4 46.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 110.851 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 36.2 m-85 -90.04 118.59 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.1 m -96.35 138.43 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.112 -0.993 . . . . 0.0 110.967 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.901 ' CD ' HD13 ' A' ' 84' ' ' LEU . 4.3 ttp180 -109.76 176.47 5.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.449 -0.782 . . . . 0.0 110.228 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -84.18 81.6 8.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.03 -1.044 . . . . 0.0 109.221 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.505 9.8 m120 148.29 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 109.733 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.7 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.498 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -150.9 164.81 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.709 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.597 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -150.63 155.85 40.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.531 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.881 ' CE ' HD12 ' A' ' 47' ' ' LEU . 27.5 tpp -102.61 159.68 15.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 110.135 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.76 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.39 94.26 9.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.101 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.787 HD23 HD11 ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER -55.34 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.804 . . . . 0.0 111.165 -178.978 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.53 -132.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.71 ' HB3' HD11 ' A' ' 67' ' ' ILE . 89.2 m-85 -90.16 39.14 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -1.094 . . . . 0.0 110.664 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.76 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -79.15 -20.27 70.31 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.97 -48.27 7.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -1.198 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 64' ' ' PHE . 1.3 pp -55.77 -17.29 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 111.259 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CG ' HG12 ' A' ' 103' ' ' ILE . 4.6 m-85 -49.01 134.29 17.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.881 -1.137 . . . . 0.0 110.832 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.452 ' N ' HG23 ' A' ' 102' ' ' THR . 10.9 m-20 -97.18 -164.33 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 110.875 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -102.36 157.44 16.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.782 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 t -174.41 130.08 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.015 . . . . 0.0 110.565 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.658 ' CG ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.65 79.36 47.93 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.746 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.7 Cg_endo -63.76 100.45 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.653 1.344 . . . . 0.0 110.451 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -54.85 -21.06 10.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 110.487 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -130.67 163.45 27.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.972 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HA ' HG22 ' A' ' 103' ' ' ILE . 71.9 ttt180 -143.44 156.71 44.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 110.241 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.59 ' HD1' HD13 ' A' ' 103' ' ' ILE . 37.2 p-80 -89.85 166.42 13.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 110.382 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 24.0 tp10 -148.07 161.25 41.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.9 . . . . 0.0 110.405 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 84' ' ' LEU . 25.9 mt -123.59 148.54 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.92 64.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.58 40.13 29.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.47 -133.79 2.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.901 HD13 ' CD ' ' A' ' 54' ' ' ARG . 2.0 tp -137.23 23.1 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 110.234 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -85.95 -67.16 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 111.065 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.14 164.12 12.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 111.017 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.734 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 4.3 mtp -134.28 148.41 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HB3' HD21 ' A' ' 29' ' ' LEU . 21.4 mtp180 -133.09 167.3 20.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 0.0 110.448 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' HZ ' ' A' ' 68' ' ' PHE . 65.1 mt -133.38 95.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.865 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 54.2 m-85 -90.39 -179.53 5.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 110.547 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.532 ' CG2' HD12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -117.72 94.16 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 110.189 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.746 HD11 ' O ' ' A' ' 74' ' ' PRO . 10.9 pt -55.87 -20.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 110.592 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.9 mttt -137.71 160.15 66.08 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 110.454 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 26' ' ' LYS . 23.5 Cg_exo -58.03 158.31 21.89 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.651 1.342 . . . . 0.0 110.507 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 91' ' ' THR . 39.5 mt -144.57 136.44 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.71 166.07 11.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.585 -0.697 . . . . 0.0 110.831 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.3 mp -65.11 110.39 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.546 -0.721 . . . . 0.0 110.316 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 22.8 5.02 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.408 ' CB ' HG23 ' A' ' 95' ' ' ILE . 18.3 mm-40 -94.71 -179.36 4.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 110.094 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.19 122.33 35.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.846 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.556 HG23 ' CB ' ' A' ' 76' ' ' ALA . 23.5 mt -89.66 131.08 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 69' ' ' ASN . 49.5 m -162.8 147.62 11.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.59 HD13 ' HD1' ' A' ' 78' ' ' HIS . 1.4 pt -115.0 165.21 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.033 -1.042 . . . . 0.0 110.769 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.22 -159.11 0.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.373 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.12 -93.35 0.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.425 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.23 169.24 41.76 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.752 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.81 -58.64 7.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -39.21 79.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.0 OUTLIER -89.94 31.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.937 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -176.43 -171.06 0.38 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -51.55 155.47 1.56 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.513 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.9 t -69.82 110.51 5.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 110.459 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.59 82.99 0.23 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 110.406 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.99 101.97 1.28 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.705 1.371 . . . . 0.0 110.254 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -81.16 127.45 32.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 0.0 110.384 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.658 HD21 ' CG ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -124.6 21.16 8.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 110.559 -179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.1 m -73.58 144.89 45.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -67.65 143.86 55.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.928 . . . . 0.0 110.339 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.283 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.09 28.97 5.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -1.143 . . . . 0.0 110.402 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' C' ' 204' ' ' PRO . . . -70.8 -48.67 15.1 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 110.842 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' C' ' 203' ' ' ALA . 22.9 Cg_exo -60.18 82.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.352 1.185 . . . . 0.0 110.534 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 205' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' C' ' 203' ' ' ALA . 0.1 OUTLIER -160.71 158.84 29.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.928 . . . . 0.0 110.426 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp 52.35 62.09 2.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.43 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -78.67 -170.51 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.58 161.25 20.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 110.3 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.89 149.94 41.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.314 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 20.9 p -57.01 -22.67 40.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 110.33 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 7.7 tttp 52.48 78.19 0.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.451 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.59 -176.63 3.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.326 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -163.97 -67.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 110.418 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.508 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 0.5 OUTLIER -160.43 -171.18 3.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 110.401 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 216' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.507 2.4 t -52.79 -54.62 31.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.666 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 54.48 174.84 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 25.3 Cg_exo -59.84 175.65 0.87 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.616 1.324 . . . . 0.0 110.583 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -129.28 41.44 3.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 6.7 t -56.93 172.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 110.432 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.085 0 CA-C-O 118.027 -1.43 . . . . 0.0 109.976 -179.519 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.282 0.563 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 54.6 p90 -53.17 132.97 39.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 110.63 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -150.18 161.5 42.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.081 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.06 61.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.369 -0.832 . . . . 0.0 110.578 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.512 ' O ' HG13 ' B' ' 6' ' ' VAL . 0.2 OUTLIER 174.83 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.342 -0.849 . . . . 0.0 109.21 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.624 HG11 ' CG1' ' B' ' 30' ' ' VAL . 16.7 m -156.48 -172.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.664 -0.647 . . . . 0.0 109.819 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 10.3 tt -160.68 163.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.977 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.564 HG13 ' O ' ' B' ' 8' ' ' VAL . 7.8 p -88.59 120.72 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.967 . . . . 0.0 110.538 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.613 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 26.1 mttt -148.57 127.75 12.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.613 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 54.47 42.09 31.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.642 -1.911 . . . . 0.0 110.106 4.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.517 ' CB ' ' CE1' ' B' ' 19' ' ' PHE . 2.1 p -92.78 -171.15 0.25 Allowed Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.675 -0.64 . . . . 0.0 109.932 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 41.3 Cg_exo -52.19 108.31 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.454 1.239 . . . . 0.0 110.725 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' B' ' 13' ' ' LEU . 4.5 mm? 52.67 54.65 10.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.302 -0.874 . . . . 0.0 110.625 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.56 165.47 25.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.32 -163.86 16.58 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' B' ' 10' ' ' LYS . 3.8 m-85 -95.0 99.69 11.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.054 -1.262 . . . . 0.0 110.495 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.71 -160.34 9.54 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' B' ' 67' ' ' ILE . 81.2 t -113.24 138.08 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.386 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CG ' ' CD ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -104.21 141.05 36.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.788 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -104.19 91.09 3.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.947 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.905 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.3 OUTLIER -60.27 -26.07 66.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.507 ' HE2' ' CE1' ' B' ' 24' ' ' PHE . 6.2 mtpp -94.4 -177.14 4.16 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 109.572 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.511 0.1 OUTLIER 108.69 17.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.133 -1.605 . . . . 0.0 110.133 1.755 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.507 ' CE1' ' HE2' ' B' ' 22' ' ' LYS . 49.3 m-85 -114.67 160.9 18.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.639 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.3 172.29 6.87 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.517 -0.739 . . . . 0.0 110.025 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -72.23 80.36 0.99 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.37 40.95 0.12 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' B' ' 24' ' ' PHE . 13.7 mt-10 -119.44 158.48 26.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -1.214 . . . . 0.0 110.336 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.883 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.5 tm? -92.35 128.07 38.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.968 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.696 ' N ' HD13 ' B' ' 29' ' ' LEU . 82.6 t -94.35 -45.66 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.457 ' HB3' HD12 ' B' ' 89' ' ' ILE . 27.4 tp10 -170.26 152.11 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.55 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 110.028 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.434 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -146.75 -157.4 0.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 110.757 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' B' ' 34' ' ' LEU . 1.5 mm? -99.93 175.86 5.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 3.4 m -151.12 154.77 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.953 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.794 HD11 HD23 ' B' ' 62' ' ' LEU . 54.7 mt -94.85 163.97 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.825 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.415 HG23 ' C ' ' B' ' 36' ' ' ILE . 48.7 t -144.87 106.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.967 . . . . 0.0 110.678 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.528 ' CB ' ' CG ' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -113.0 -163.34 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -128.61 62.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 110.963 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 26.7 m120 52.42 -149.31 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.647 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 17.4 m-20 60.5 -144.13 0.5 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.232 -0.917 . . . . 0.0 110.14 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -46.63 -29.04 1.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.07 -1.019 . . . . 0.0 111.147 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.834 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 66.2 t-105 -65.04 -44.51 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.172 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.33 -40.16 97.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 98.5 m -67.15 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 110.434 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.52 ' HB3' HD22 ' B' ' 47' ' ' LEU . . . -54.3 -58.28 8.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 110.324 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.88 ' HB3' HD13 ' B' ' 51' ' ' LEU . 2.7 mm? -90.96 50.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -0.56 22.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' B' ' 49' ' ' ASP . 39.9 p-10 -129.45 156.89 43.39 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.009 -1.057 . . . . 0.0 109.779 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 32.9 m-85 54.88 24.01 5.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.155 -0.966 . . . . 0.0 109.885 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 47' ' ' LEU . 7.5 tp -117.01 123.54 47.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.379 -0.826 . . . . 0.0 110.85 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' B' ' 52' ' ' PHE . 35.9 m-85 -90.17 118.6 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.601 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.2 m -96.35 138.39 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.921 ' CD ' HD13 ' B' ' 84' ' ' LEU . 4.3 ttp180 -110.23 174.06 6.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.498 -0.751 . . . . 0.0 110.32 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -80.82 81.33 7.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.506 9.8 m120 148.14 -19.66 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 109.77 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.61 -149.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.481 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.495 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -151.38 164.84 35.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 110.69 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -150.93 155.71 39.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.86 . . . . 0.0 110.464 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.879 ' CE ' HD12 ' B' ' 47' ' ' LEU . 27.5 tpp -102.7 158.66 16.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.326 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.749 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -85.93 94.19 9.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.794 HD23 HD11 ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER -55.45 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 111.206 -179.177 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.59 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.737 ' HB3' HD11 ' B' ' 67' ' ' ILE . 89.1 m-85 -90.21 39.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.414 -1.051 . . . . 0.0 110.745 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.749 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -79.26 -19.82 71.08 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.5 -48.1 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.111 -1.229 . . . . 0.0 111.145 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.737 HD11 ' HB3' ' B' ' 64' ' ' PHE . 1.3 pp -55.82 -17.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.166 -0.959 . . . . 0.0 111.355 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.5 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.6 m-85 -49.04 134.29 17.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.785 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.434 ' N ' HG23 ' B' ' 102' ' ' THR . 11.5 m-20 -97.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -103.05 157.3 17.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.729 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.0 t -174.33 130.14 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -0.998 . . . . 0.0 110.542 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.664 ' CG ' HD21 ' B' ' 116' ' ' LEU . 0.1 OUTLIER -60.08 -36.59 77.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 110.207 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.59 79.3 47.33 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 110.248 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.731 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.5 Cg_endo -63.7 100.44 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.681 1.358 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.93 -21.0 10.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -0.922 . . . . 0.0 110.524 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.557 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -130.65 163.45 27.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 110.506 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.519 ' HA ' HG22 ' B' ' 103' ' ' ILE . 71.9 ttt180 -143.42 156.71 44.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.582 ' HD1' HD13 ' B' ' 103' ' ' ILE . 37.3 p-80 -89.75 166.42 13.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.455 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -148.08 161.22 41.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 110.404 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' B' ' 84' ' ' LEU . 25.9 mt -123.6 148.52 46.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.313 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.81 64.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.56 40.16 29.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.456 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.43 -133.74 2.85 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.921 HD13 ' CD ' ' B' ' 54' ' ' ARG . 2.0 tp -137.25 23.15 3.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -1.097 . . . . 0.0 110.241 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -86.03 -67.15 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 111.039 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.13 164.16 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 111.085 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.742 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 4.3 mtp -134.3 148.38 50.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 110.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.464 ' HB3' HD21 ' B' ' 29' ' ' LEU . 21.4 mtp180 -133.02 167.34 20.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.498 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.481 HD13 ' HZ ' ' B' ' 68' ' ' PHE . 65.2 mt -133.42 95.29 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.883 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 54.0 m-85 -90.53 -179.5 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 110.48 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.539 ' CG2' HD12 ' B' ' 95' ' ' ILE . 1.0 OUTLIER -117.76 94.18 4.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.731 HD11 ' O ' ' B' ' 74' ' ' PRO . 10.9 pt -55.83 -20.77 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 110.514 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.424 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.9 mttt -137.7 160.24 65.75 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 110.375 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.29 158.53 22.15 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.65 1.342 . . . . 0.0 110.421 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.539 HD12 ' CG2' ' B' ' 91' ' ' THR . 39.4 mt -144.64 136.48 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.271 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.77 166.01 11.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 110.767 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.905 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.3 mp -65.1 110.43 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.515 -0.741 . . . . 0.0 110.293 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.41 22.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.405 ' CB ' HG23 ' B' ' 95' ' ' ILE . 18.5 mm-40 -94.73 -179.33 4.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -1.171 . . . . 0.0 110.102 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.2 122.25 35.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.821 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.557 HG23 ' CB ' ' B' ' 76' ' ' ALA . 23.9 mt -89.49 131.14 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.48 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.434 HG23 ' N ' ' B' ' 69' ' ' ASN . 47.9 m -162.82 147.62 11.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.726 -0.609 . . . . 0.0 109.597 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.582 HD13 ' HD1' ' B' ' 78' ' ' HIS . 1.4 pt -114.98 165.2 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.753 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.17 -159.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.08 -93.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.937 . . . . 0.0 110.449 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.32 169.22 41.7 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.84 -58.62 7.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -1.121 . . . . 0.0 110.194 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -39.21 79.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.517 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.0 OUTLIER -89.83 31.51 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.974 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -176.41 -171.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.989 -1.069 . . . . 0.0 110.506 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -51.5 155.45 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.482 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 30.9 t -69.81 110.51 5.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.452 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.61 82.95 0.23 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 110.387 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.97 102.04 1.28 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.685 1.361 . . . . 0.0 110.283 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -81.34 127.55 32.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.945 . . . . 0.0 110.423 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.664 HD21 ' CG ' ' B' ' 72' ' ' LYS . 0.2 OUTLIER -124.6 21.19 8.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 110.557 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 27.9 m -73.56 144.84 45.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.897 . . . . 0.0 110.371 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -67.62 143.87 55.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 110.314 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.328 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 28.96 5.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -1.155 . . . . 0.0 110.382 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.832 ' HB3' ' HD3' ' D' ' 204' ' ' PRO . . . -70.86 -48.59 14.72 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 110.831 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' D' ' 203' ' ' ALA . 22.8 Cg_exo -60.21 82.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.404 1.213 . . . . 0.0 110.538 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 205' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' D' ' 203' ' ' ALA . 0.1 OUTLIER -160.68 158.77 29.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 110.463 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp 52.41 62.1 2.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 110.388 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -78.7 -170.55 2.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 110.347 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.47 161.25 20.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 110.343 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.86 149.97 41.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 110.363 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 20.8 p -57.14 -22.59 41.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.942 . . . . 0.0 110.291 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 7.7 tttp 52.45 78.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.459 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.57 -176.62 3.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.347 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -163.92 -67.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 110.436 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 0.5 OUTLIER -160.43 -171.16 3.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.887 . . . . 0.0 110.358 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 216' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.506 2.4 t -52.88 -54.55 33.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.665 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.535 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 54.47 174.87 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.348 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 25.3 Cg_exo -59.87 175.56 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.701 1.369 . . . . 0.0 110.572 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -129.27 41.53 3.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.28 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 6.6 t -56.97 171.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.353 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.057 -1.413 . . . . 0.0 109.978 -179.584 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.468 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.468 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' HD21 ' B' ' 34' ' ' LEU . 6.1 mtp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.226 0.536 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.471 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 25.7 p90 -176.8 133.38 0.2 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.157 -0.964 . . . . 0.0 110.564 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.06 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.29 -22.11 6.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.583 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.492 ' C ' HG13 ' A' ' 6' ' ' VAL . 2.2 mmt85 -81.55 -41.1 22.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 0.0 110.593 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.492 HG13 ' C ' ' A' ' 5' ' ' ARG . 28.3 m -151.31 179.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 19' ' ' PHE . 9.4 tt -152.04 166.83 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.168 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 8' ' ' VAL . 12.6 p -104.66 125.15 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.958 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 20.5 mttt -128.59 142.73 50.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.576 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mtpp 52.09 58.14 5.75 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.717 -1.865 . . . . 0.0 111.066 1.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.6 p -107.06 -173.47 0.28 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.519 -0.738 . . . . 0.0 110.268 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 36.3 Cg_exo -56.22 -52.75 6.51 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.617 1.325 . . . . 0.0 110.551 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.23 -49.86 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.551 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.23 -165.19 27.1 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.68 135.66 2.8 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -97.4 91.66 5.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 110.57 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -126.7 -168.74 12.63 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.763 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.5 p -113.1 125.95 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.299 . . . . 0.0 109.524 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -90.1 161.79 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 110.497 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 101' ' ' ILE . . . -118.73 96.71 5.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 110.634 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -63.62 -20.0 65.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.0 109.793 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 14.2 mtpt -91.81 179.97 5.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.381 -0.824 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 39.9 m 103.9 16.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.166 -1.584 . . . . 0.0 110.403 0.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 42.3 m-85 -109.55 168.5 9.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.367 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 -167.18 1.32 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.966 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.12 4.08 18.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.43 86.73 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -151.04 147.98 27.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -1.17 . . . . 0.0 110.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.933 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 tm? -86.3 122.86 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.257 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.608 ' N ' HD13 ' A' ' 29' ' ' LEU . 59.2 t -81.88 -52.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.846 ' CG ' HD12 ' A' ' 89' ' ' ILE . 1.9 pt-20 -162.43 177.69 9.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.129 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.21 149.49 8.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 110.492 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.19 -157.84 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.275 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 86' ' ' ARG . 72.8 mt -109.13 -178.51 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 85' ' ' LYS . 72.4 m -145.41 174.2 11.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 ' CD2' ' A' ' 62' ' ' LEU . 60.6 mt -116.2 125.18 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.886 . . . . 0.0 109.832 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 84' ' ' LEU . 26.0 t -97.82 100.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 110.579 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 2.6 mmp_? -119.44 -172.05 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.383 -0.823 . . . . 0.0 110.214 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 36.8 m80 -104.29 -165.03 1.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.339 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -91.04 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 58.07 -137.5 0.9 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.869 -1.144 . . . . 0.0 110.435 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.44 -40.04 7.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.996 -1.065 . . . . 0.0 111.498 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.973 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 76.1 t-105 -57.66 -45.69 85.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.87 73.71 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.98 -63.51 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.24 . . . . 0.0 110.527 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.16 -55.61 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.915 ' HB3' HD13 ' A' ' 51' ' ' LEU . 3.9 mm? -89.49 52.37 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 57.42 3.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 -76.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 5.0 m-85 -89.52 48.21 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.973 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 6.1 tp -117.66 109.64 16.91 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.399 -0.813 . . . . 0.0 111.243 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -89.56 105.2 17.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.105 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.3 p -97.38 161.02 13.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 111.144 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.809 ' HB2' HD11 ' A' ' 84' ' ' LEU . 3.6 ttp180 -127.97 -172.36 2.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.481 -0.762 . . . . 0.0 109.959 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -83.69 84.63 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.031 -1.043 . . . . 0.0 109.334 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.8 OUTLIER 153.19 -22.01 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.75 -0.594 . . . . 0.0 109.778 -178.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.59 -168.1 0.22 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.281 -0.887 . . . . 0.0 110.735 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.1 m -132.22 134.82 45.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.469 -0.769 . . . . 0.0 109.921 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -127.88 166.69 17.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 111.031 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.847 ' CE ' HD12 ' A' ' 47' ' ' LEU . 1.2 ttt -96.1 170.46 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.857 . . . . 0.0 109.822 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.695 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.32 -54.04 4.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.156 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.497 0.0 OUTLIER 92.3 -81.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.819 -1.176 . . . . 0.0 110.513 -179.51 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.79 -143.48 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.33 56.65 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -1.065 . . . . 0.0 110.358 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.695 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -89.74 -43.31 5.17 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -63.39 -47.61 81.3 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.984 -1.304 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.8 pp -49.53 -22.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.876 . . . . 0.0 111.441 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.833 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.9 m-85 -50.19 113.45 0.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.767 -1.208 . . . . 0.0 110.415 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -102.0 -165.82 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 111.204 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.475 ' NE2' ' CD1' ' A' ' 111' ' ' LEU . 1.8 t-160 -94.46 140.89 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.531 -0.731 . . . . 0.0 110.449 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.44 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.337 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.684 ' HD2' HD22 ' A' ' 116' ' ' LEU . 4.6 tppp? -85.47 -19.48 31.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 110.528 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.54 74.93 53.88 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.844 ' O ' HD11 ' A' ' 92' ' ' ILE . 32.4 Cg_exo -57.57 106.04 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.697 1.367 . . . . 0.0 110.467 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 76' ' ' ALA . 50.4 p-10 -85.06 -13.9 48.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -142.51 141.16 32.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.985 -1.072 . . . . 0.0 110.46 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.05 -176.44 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -124.36 161.98 24.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 110.517 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.45 154.15 51.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.766 HD11 ' HA ' ' A' ' 84' ' ' LEU . 43.8 tp -132.42 139.97 48.26 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.67 -168.99 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.85 107.92 18.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 110.408 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 37' ' ' VAL . . . 122.61 12.95 4.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 54' ' ' ARG . 16.5 mt 52.39 32.85 11.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.0 110.405 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 35' ' ' CYS . 2.7 mmtp -100.21 -62.29 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 111.147 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.76 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.3 ttt180 -97.49 162.26 13.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.64 147.59 27.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.145 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.601 ' HB3' HD21 ' A' ' 29' ' ' LEU . 36.2 mtt180 -132.02 171.92 13.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.376 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.846 HD12 ' CG ' ' A' ' 31' ' ' GLU . 96.3 mt -135.78 116.25 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.933 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 21.5 m-85 -108.11 171.07 7.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.488 HG23 ' CG2' ' A' ' 30' ' ' VAL . 7.3 p -112.36 87.39 2.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 74' ' ' PRO . 3.2 pt -52.03 -23.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 110.583 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' ILE . 5.2 mmtt -132.03 151.13 77.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.401 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.08 143.88 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.666 1.35 . . . . 0.0 110.292 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.0 mt -126.27 141.0 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.532 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.42 163.61 12.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 110.182 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 21' ' ' ARG . 4.8 mt -63.75 121.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 110.511 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.6 38.71 2.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -117.54 170.34 8.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -1.17 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -114.89 126.06 54.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.269 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.763 ' HB ' HG13 ' A' ' 18' ' ' VAL . 98.0 mt -96.59 127.21 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' ILE . 35.6 p -156.03 176.64 12.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 104' ' ' SER . 2.5 pp -147.91 155.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.667 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.887 ' O ' HD12 ' A' ' 103' ' ' ILE . 33.0 t -68.75 -149.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 110.464 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.417 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 83.0 m-85 -135.89 -69.43 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.449 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.63 -177.92 30.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -64.03 -40.41 96.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 110.404 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -61.22 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.417 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.4 OUTLIER -69.98 106.99 3.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.477 ' CE3' ' O ' ' A' ' 111' ' ' LEU . 63.6 p-90 -48.88 128.78 16.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.638 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.477 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 16.4 tp -89.66 -110.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.346 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -174.52 112.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.395 -1.44 . . . . 0.0 110.693 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.424 ' HB3' ' NH1' ' A' ' 115' ' ' ARG . 0.0 OUTLIER 48.26 65.67 6.74 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.893 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.0 118.37 5.24 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.611 1.322 . . . . 0.0 110.528 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 113' ' ' ARG . 10.6 ptt-85 -174.51 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.378 -0.826 . . . . 0.0 110.678 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.684 HD22 ' HD2' ' A' ' 72' ' ' LYS . 0.8 OUTLIER 52.51 -162.84 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 87.0 m -137.92 -61.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.158 -0.964 . . . . 0.0 110.332 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.23 155.96 49.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.882 . . . . 0.0 110.334 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.325 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.07 90.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -1.151 . . . . 0.0 110.415 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.873 ' HB3' ' HD3' ' C' ' 204' ' ' PRO . . . -55.02 -57.81 17.8 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 110.558 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.873 ' HD3' ' HB3' ' C' ' 203' ' ' ALA . 29.9 Cg_endo -70.18 102.13 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.474 1.25 . . . . 0.0 110.536 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -34.63 4.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.373 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -108.5 135.93 48.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -69.02 80.83 0.31 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 110.245 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.78 -178.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 110.298 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.59 173.31 14.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.7 t -125.48 56.43 1.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.883 . . . . 0.0 110.34 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -113.86 -33.04 5.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 110.374 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.86 76.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 110.417 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.1 71.51 2.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.269 -0.895 . . . . 0.0 110.376 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -116.52 177.28 4.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.333 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER -53.6 164.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -124.57 168.49 12.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 23.5 Cg_endo -67.21 -35.53 24.34 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.706 1.371 . . . . 0.0 110.533 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 53.06 85.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 9.5 t -174.8 179.06 1.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.542 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.425 ' SD ' HD21 ' A' ' 34' ' ' LEU . 6.1 mtp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.252 0.549 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 25.7 p90 -176.8 133.4 0.2 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.155 -0.966 . . . . 0.0 110.596 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.09 22.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.27 -22.1 6.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 110.627 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.501 ' C ' HG13 ' B' ' 6' ' ' VAL . 2.2 mmt85 -81.55 -41.2 21.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.59 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.501 HG13 ' C ' ' B' ' 5' ' ' ARG . 28.8 m -151.24 179.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.007 . . . . 0.0 110.559 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' B' ' 19' ' ' PHE . 9.4 tt -152.0 166.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.198 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.556 HG13 ' O ' ' B' ' 8' ' ' VAL . 12.6 p -104.67 125.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -0.951 . . . . 0.0 110.957 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 20.4 mttt -128.6 142.7 50.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.59 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mtpp 52.06 58.2 5.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.738 -1.852 . . . . 0.0 111.033 1.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.6 p -107.1 -173.46 0.28 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.513 -0.742 . . . . 0.0 110.28 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 36.6 Cg_exo -56.17 -52.67 6.72 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.624 1.328 . . . . 0.0 110.556 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.48 -49.86 17.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 110.559 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.4 -165.17 27.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.67 135.6 2.78 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -97.26 91.76 5.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 110.579 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -126.81 -168.9 12.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.778 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.6 p -112.82 125.8 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.937 -1.331 . . . . 0.0 109.685 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.659 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.5 OUTLIER -90.09 161.73 15.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 110.497 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' B' ' 101' ' ' ILE . . . -118.67 96.63 5.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.752 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -63.57 -19.96 65.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.867 178.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.534 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 14.2 mtpt -91.93 -179.94 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 109.799 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' B' ' 22' ' ' LYS 2.514 39.3 m 103.93 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.207 -1.558 . . . . 0.0 110.356 0.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 42.2 m-85 -109.48 168.61 9.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.404 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.59 -167.14 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.09 4.04 18.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.97 . . . . 0.0 110.9 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.35 86.7 0.12 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -151.05 147.97 27.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -1.168 . . . . 0.0 110.45 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.923 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.2 tm? -86.33 122.77 30.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.609 ' N ' HD13 ' B' ' 29' ' ' LEU . 59.4 t -81.85 -52.62 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.853 ' CG ' HD12 ' B' ' 89' ' ' ILE . 1.9 pt-20 -162.41 177.73 9.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.25 149.56 8.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.976 . . . . 0.0 110.517 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.21 -157.91 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 110.237 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.515 HD21 ' SD ' ' A' ' 1' ' ' MET . 72.8 mt -109.08 -178.47 3.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.423 ' N ' ' O ' ' B' ' 85' ' ' LYS . 72.4 m -145.5 174.13 11.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.305 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.686 HD11 ' CD2' ' B' ' 62' ' ' LEU . 60.3 mt -116.12 125.18 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.792 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 84' ' ' LEU . 26.3 t -97.89 100.21 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.042 -1.036 . . . . 0.0 110.587 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.494 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 2.6 mmp_? -119.72 -172.15 2.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 36.7 m80 -104.07 -165.02 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.12 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 58.18 -137.54 0.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.912 -1.117 . . . . 0.0 110.413 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.43 -40.05 7.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.016 -1.053 . . . . 0.0 111.495 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.962 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 76.1 t-105 -57.69 -45.64 85.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 0.0 110.283 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.94 -21.92 73.67 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.97 -63.48 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.23 -55.56 33.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.482 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.916 ' HB3' HD13 ' B' ' 51' ' ' LEU . 3.9 mm? -89.53 52.43 2.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.244 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.33 57.44 3.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -76.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.491 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 5.0 m-85 -89.46 48.23 1.58 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.857 . . . . 0.0 109.424 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.962 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 6.0 tp -117.69 109.5 16.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.352 -0.842 . . . . 0.0 111.353 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -89.47 105.14 17.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.2 p -97.34 160.95 14.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 111.162 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.81 ' HB2' HD11 ' B' ' 84' ' ' LEU . 3.5 ttp180 -128.43 -174.88 3.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.535 -0.728 . . . . 0.0 109.99 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -80.0 84.41 5.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -0.954 . . . . 0.0 110.067 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.8 OUTLIER 153.0 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.41 -168.06 0.23 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.801 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.1 m -132.24 134.87 45.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -127.92 166.75 17.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.08 -1.013 . . . . 0.0 111.06 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.836 ' CE ' HD12 ' B' ' 47' ' ' LEU . 1.2 ttt -96.41 169.18 10.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.956 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.7 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.31 -55.02 4.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 111.487 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.93 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.499 0.0 OUTLIER 92.7 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.888 -1.133 . . . . 0.0 110.475 -179.181 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.85 -143.41 0.06 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.38 56.55 2.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -1.088 . . . . 0.0 110.362 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.7 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -89.73 -43.24 5.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.491 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -63.4 -47.6 81.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 110.396 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.814 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.8 pp -49.59 -22.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 111.448 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.814 ' N ' HD12 ' B' ' 67' ' ' ILE . 4.9 m-85 -50.23 113.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.701 -1.25 . . . . 0.0 110.43 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -102.06 -165.84 1.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.472 ' NE2' ' CD1' ' B' ' 111' ' ' LEU . 1.8 t-160 -94.37 140.89 29.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.742 . . . . 0.0 110.491 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.46 16.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.308 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.677 ' HD2' HD22 ' B' ' 116' ' ' LEU . 4.6 tppp? -85.46 -19.56 31.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 110.49 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.47 74.86 53.07 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.14 -0.975 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.839 ' O ' HD11 ' B' ' 92' ' ' ILE . 32.3 Cg_exo -57.52 105.98 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.688 1.362 . . . . 0.0 110.494 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 76' ' ' ALA . 50.3 p-10 -85.05 -13.85 49.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.757 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.447 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -142.57 141.19 31.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.012 -1.055 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.07 -176.45 2.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.318 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -124.39 161.91 24.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.545 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.4 154.21 51.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.757 HD12 ' O ' ' B' ' 86' ' ' ARG . 44.4 tp -132.44 139.93 48.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.68 -168.95 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.93 107.88 18.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.463 ' O ' HG21 ' B' ' 37' ' ' VAL . . . 122.63 12.91 4.85 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.81 HD11 ' HB2' ' B' ' 54' ' ' ARG . 16.6 mt 52.38 32.85 11.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.862 -1.375 . . . . 0.0 110.462 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 35' ' ' CYS . 2.8 mmtp -100.21 -62.32 1.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 111.123 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.757 ' O ' HD12 ' B' ' 80' ' ' LEU . 2.3 ttt180 -97.47 162.28 13.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.994 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.62 147.58 27.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.583 ' HB3' HD21 ' B' ' 29' ' ' LEU . 36.2 mtt180 -132.0 171.97 12.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 110.324 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' B' ' 31' ' ' GLU . 96.3 mt -135.78 116.17 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.923 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 21.5 m-85 -108.16 171.1 7.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.491 HG23 ' CG2' ' B' ' 30' ' ' VAL . 7.3 p -112.4 87.42 2.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.839 HD11 ' O ' ' B' ' 74' ' ' PRO . 3.2 pt -52.15 -23.31 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.427 ' N ' HG13 ' B' ' 92' ' ' ILE . 5.2 mmtt -132.01 151.19 78.02 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -61.38 144.1 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.608 1.32 . . . . 0.0 110.213 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -126.31 141.04 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 110.531 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.44 163.6 12.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.752 HG23 ' O ' ' B' ' 21' ' ' ARG . 4.8 mt -63.79 121.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 110.545 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.7 2.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -117.5 170.36 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -1.179 . . . . 0.0 110.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.477 ' HG3' ' CE1' ' B' ' 19' ' ' PHE . 0.4 OUTLIER -114.88 126.15 54.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.778 ' HB ' HG13 ' B' ' 18' ' ' VAL . 97.8 mt -96.56 127.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.507 HG23 ' C ' ' B' ' 101' ' ' ILE . 35.1 p -155.95 176.74 12.25 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.889 HD12 ' O ' ' B' ' 104' ' ' SER . 2.5 pp -147.94 155.86 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 110.699 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.889 ' O ' HD12 ' B' ' 103' ' ' ILE . 33.0 t -68.74 -149.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 110.483 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.411 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 82.9 m-85 -135.89 -69.32 0.49 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 110.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.56 -177.97 29.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.98 -40.5 96.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 110.403 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -61.23 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.411 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.4 OUTLIER -70.05 107.1 3.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.475 ' CD2' ' O ' ' B' ' 110' ' ' TRP . 63.5 p-90 -48.93 128.73 16.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.688 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.472 ' CD1' ' NE2' ' B' ' 70' ' ' HIS . 16.4 tp -89.59 -110.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.376 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -174.48 112.67 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.316 -1.49 . . . . 0.0 110.678 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' B' ' 115' ' ' ARG . 0.0 OUTLIER 48.22 65.63 6.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.265 -0.897 . . . . 0.0 110.912 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -60.94 118.34 5.2 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.609 1.32 . . . . 0.0 110.464 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' B' ' 113' ' ' ARG . 10.5 ptt-85 -174.57 -36.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.299 -0.876 . . . . 0.0 110.589 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.677 HD22 ' HD2' ' B' ' 72' ' ' LYS . 0.8 OUTLIER 52.45 -162.78 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.367 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 86.9 m -137.84 -61.22 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.975 . . . . 0.0 110.371 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.19 155.94 49.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.328 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.01 90.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -1.189 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.875 ' HB3' ' HD3' ' D' ' 204' ' ' PRO . . . -55.09 -57.74 18.27 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 110.502 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.875 ' HD3' ' HB3' ' D' ' 203' ' ' ALA . 29.7 Cg_endo -70.18 102.18 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.499 1.263 . . . . 0.0 110.476 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.15 -34.53 4.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.37 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 7.4 mtpp -108.6 135.93 49.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.381 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -69.03 80.86 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 110.28 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.76 -178.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 110.258 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.56 173.36 14.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 110.338 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 5.7 t -125.49 56.48 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 110.344 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -113.94 -32.89 5.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 110.397 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.81 76.26 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 110.408 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.03 71.44 2.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 110.359 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -116.5 177.26 4.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER -53.53 164.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.464 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -124.51 168.56 12.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 24.0 Cg_endo -67.25 -35.48 24.27 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.723 1.38 . . . . 0.0 110.566 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 53.0 85.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 9.5 t -174.82 179.04 1.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 110.34 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.407 ' C6 ' ' HB3' ' A' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.404 ' C6 ' ' HB3' ' B' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 86.2 mmm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.945 0.403 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 32.5 p90 -133.76 106.92 7.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.961 -1.087 . . . . 0.0 110.464 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 5' ' ' ARG . 10.3 p30 -153.31 -172.57 4.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 111.02 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.68 -85.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.737 -0.602 . . . . 0.0 111.26 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.537 ' C ' HG23 ' A' ' 6' ' ' VAL . 7.3 mtm-85 -153.48 17.12 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.976 -1.078 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' C ' ' A' ' 5' ' ' ARG . 93.3 t -153.05 160.98 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.967 -1.083 . . . . 0.0 110.92 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.81 HG23 ' HB2' ' A' ' 19' ' ' PHE . 1.6 tt -124.02 154.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 1' ' ' MET . 89.6 t -102.64 141.06 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.796 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 10' ' ' LYS . 72.3 mttt -146.9 145.03 29.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.441 -0.787 . . . . 0.0 108.936 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.4 tppt? 52.4 80.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 119.629 -1.92 . . . . 0.0 110.273 2.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -122.89 -174.49 0.32 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.346 -178.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 31.3 Cg_exo -54.62 -58.22 1.36 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.637 1.335 . . . . 0.0 110.563 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 13' ' ' LEU . 1.9 mm? -76.03 -30.96 58.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.96 -139.51 10.91 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.23 145.09 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -118.44 83.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 110.355 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.3 -170.68 12.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.759 HG23 HD13 ' A' ' 67' ' ' ILE . 95.1 t -97.14 149.58 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.748 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.81 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.6 m-85 -114.83 121.89 44.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.426 -0.796 . . . . 0.0 109.286 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.57 86.99 6.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.125 -0.984 . . . . 0.0 111.009 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.824 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.19 -24.95 65.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.237 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 14.0 mttm -89.25 -179.73 5.93 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.47 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 102.4 20.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 119.953 -1.717 . . . . 0.0 109.808 2.589 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 3.8 m-85 -111.52 152.13 27.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.534 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -95.06 -165.14 1.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -95.62 120.23 35.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.62 5.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.99 128.61 46.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -1.152 . . . . 0.0 110.486 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.881 HD13 ' HG3' ' A' ' 88' ' ' ARG . 40.0 tp -53.28 164.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.932 . . . . 0.0 110.057 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.496 ' CG1' HG21 ' A' ' 6' ' ' VAL . 94.9 t -133.54 -71.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.36 66.44 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.519 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.568 ' HG2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.84 148.86 23.99 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.79 -165.59 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 110.408 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.35 160.1 15.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.865 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 53.4 m -134.41 -179.57 5.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.755 HD11 HD23 ' A' ' 62' ' ' LEU . 75.3 mt -113.35 151.34 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 84' ' ' LEU . 52.4 t -123.1 99.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -131.58 133.75 45.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 110.457 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.453 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -51.31 178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.977 . . . . 0.0 110.675 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 28.0 t30 -75.66 -132.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 0.0 110.423 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.93 -145.79 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.71 -1.244 . . . . 0.0 110.593 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.71 -28.06 0.94 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.194 -0.941 . . . . 0.0 111.394 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.67 ' HZ3' HD21 ' B' ' 47' ' ' LEU . 38.4 t-105 -57.34 -54.95 40.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 110.25 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.421 ' HA3' ' NH2' ' C' ' 214' ' ' ARG . . . -67.23 -50.27 46.49 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.11 -44.19 42.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -1.159 . . . . 0.0 111.108 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 -49.27 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.553 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.97 ' HB2' HD11 ' A' ' 51' ' ' LEU . 4.1 mm? -91.42 28.22 1.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.93 . . . . 0.0 110.874 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 75.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.02 -1.05 . . . . 0.0 110.573 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -175.47 -37.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 110.95 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.839 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 39.4 m-85 -133.42 50.05 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.97 HD11 ' HB2' ' A' ' 47' ' ' LEU . 52.3 mt -124.11 131.02 53.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 111.423 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -91.2 105.93 18.15 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.7 p -87.78 111.43 21.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.114 -0.991 . . . . 0.0 111.058 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -177.16 3.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -0.76 . . . . 0.0 109.825 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -83.1 83.97 7.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.005 -1.059 . . . . 0.0 109.555 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.509 2.0 p-10 154.0 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.698 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -176.77 -160.64 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 110.673 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.421 ' O ' ' NE1' ' A' ' 43' ' ' TRP . 1.1 m -141.33 125.91 17.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.21 155.47 21.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 110.809 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.705 ' HA ' HD23 ' A' ' 51' ' ' LEU . 9.6 ttt -89.49 168.68 11.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.086 -1.009 . . . . 0.0 109.801 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.589 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.32 -24.89 27.48 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.241 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.755 HD23 HD11 ' A' ' 36' ' ' ILE 2.501 0.1 OUTLIER 62.49 -92.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 111.096 177.914 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.72 -144.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 93.0 m-85 -82.59 51.47 1.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -1.084 . . . . 0.0 110.829 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.589 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.73 -25.9 23.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.839 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.4 -43.87 10.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.691 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.967 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.5 pp -45.09 -23.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.553 -0.717 . . . . 0.0 112.083 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.967 ' N ' HD12 ' A' ' 67' ' ' ILE . 23.1 m-85 -55.17 142.21 31.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.61 -1.306 . . . . 0.0 109.775 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 102' ' ' THR . 82.7 m-20 -118.83 -169.46 1.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.03 . . . . 0.0 111.254 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.622 ' CE1' HD11 ' A' ' 111' ' ' LEU . 22.0 t-160 -102.49 111.06 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 109.974 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.34 19.69 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 0.0 110.659 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt 52.62 23.33 2.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -174.38 65.24 0.28 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.055 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' O ' HD11 ' A' ' 92' ' ' ILE . 11.8 Cg_endo -59.63 83.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.632 1.333 . . . . 0.0 110.601 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.421 ' O ' ' CG1' ' A' ' 92' ' ' ILE . 22.1 m120 -59.12 -17.93 31.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -132.03 143.84 50.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.47 11.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 110.555 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -107.5 136.2 47.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.355 -0.841 . . . . 0.0 110.301 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 88' ' ' ARG . 32.9 tt0 -124.59 166.97 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.423 HD13 HD23 ' A' ' 84' ' ' LEU . 24.6 mt -126.24 147.96 49.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 86' ' ' ARG . 72.1 p -71.98 -79.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . . . -168.54 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.81 23.1 4.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 37' ' ' VAL . 43.7 mt 52.06 36.87 19.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -1.205 . . . . 0.0 110.512 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -104.52 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 110.751 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HB2' HG21 ' A' ' 81' ' ' THR . 8.1 mtt180 -84.88 179.29 7.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.976 . . . . 0.0 110.319 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.865 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.3 mtp -148.28 128.44 13.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.736 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.881 ' HG3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -114.38 106.16 13.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.44 -0.788 . . . . 0.0 110.091 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.48 113.27 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 109.929 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CE1' ' CD ' ' A' ' 88' ' ' ARG . 1.3 m-85 -101.93 177.17 4.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 p -113.92 99.32 7.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 110.028 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.492 HD12 ' CE ' ' A' ' 93' ' ' LYS . 4.2 pt -53.04 -22.21 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.135 -0.978 . . . . 0.0 110.399 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.492 ' CE ' HD12 ' A' ' 92' ' ' ILE . 45.1 mttt -148.24 146.75 23.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.16 -0.963 . . . . 0.0 110.175 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 93' ' ' LYS . 39.8 Cg_exo -56.84 129.41 34.44 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.673 1.354 . . . . 0.0 110.243 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' A' ' 20' ' ' ALA . 71.5 mt -104.76 148.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 110.594 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 167.35 11.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.575 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -71.32 123.41 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.503 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.85 39.97 2.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -124.65 -169.42 1.97 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -1.188 . . . . 0.0 110.381 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 23.7 tt0 -135.15 125.13 25.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 110.15 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG13 ' HB2' ' A' ' 20' ' ' ALA . 97.7 mt -89.39 137.99 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.533 HG23 ' C ' ' A' ' 101' ' ' ILE . 45.4 p -154.07 -174.2 4.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.651 -0.656 . . . . 0.0 110.073 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.572 HD12 ' O ' ' A' ' 104' ' ' SER . 1.5 pp -149.5 158.46 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.136 -0.977 . . . . 0.0 110.454 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' HD12 ' A' ' 103' ' ' ILE . 32.3 t -95.79 -164.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 12.8 m-85 -133.82 -66.61 0.63 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.211 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.04 -157.96 53.64 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 55.82 -86.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.948 . . . . 0.0 110.691 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' C' ' 213' ' ' ALA . 10.3 t0 -122.55 -31.41 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 110.644 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.5 m-85 -51.16 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.569 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.487 ' CE3' ' O ' ' A' ' 110' ' ' TRP . 51.9 p-90 -51.9 144.09 12.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.73 . . . . 0.0 110.695 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.622 HD11 ' CE1' ' A' ' 70' ' ' HIS . 17.2 tp -91.63 157.1 17.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 110.508 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.6 m -64.86 -162.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.82 111.91 2.81 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.457 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.01 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.449 1.236 . . . . 0.0 110.577 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -140.71 -54.58 0.5 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.283 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.679 HD23 ' OE1' ' A' ' 118' ' ' GLN . 0.1 OUTLIER 49.76 94.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.271 -0.893 . . . . 0.0 110.741 179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 118' ' ' GLN . 18.7 m -52.08 -84.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.613 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.679 ' OE1' HD23 ' A' ' 116' ' ' LEU . 10.1 pt20 38.59 -155.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.218 0.532 . . . . 0.0 111.813 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.049 -0.976 . . . . 0.0 110.393 -179.892 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -146.24 47.18 1.22 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -1.167 . . . . 0.0 110.374 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -169.06 71.67 0.73 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 110.408 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -66.68 -47.48 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.611 1.321 . . . . 0.0 110.514 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 55.12 1.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.414 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -127.35 157.76 39.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.422 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.33 163.74 35.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 110.372 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.85 105.78 10.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.86 83.48 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 110.334 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -115.67 -23.62 8.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.11 109.94 12.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 110.404 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.13 -61.96 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 110.323 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 213' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 108' ' ' ASP . . . -90.48 -177.38 5.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.421 ' NH2' ' HA3' ' A' ' 44' ' ' GLY . 6.4 mtt85 -132.69 -149.54 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.114 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.481 HCM1 ' CD1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.0 OUTLIER -53.79 175.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.907 . . . . 0.0 110.356 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.54 170.22 11.66 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.38 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.18 -29.1 89.55 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.659 1.347 . . . . 0.0 110.507 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.84 89.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 110.338 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.9 p -53.22 179.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 110.414 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.49 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.415 ' HB3' ' HB ' ' B' ' 8' ' ' VAL . 86.2 mmm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.006 0.432 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 32.2 p90 -133.63 108.3 8.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.912 -1.117 . . . . 0.0 110.233 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' B' ' 5' ' ' ARG . 10.4 p30 -155.1 -173.21 4.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 110.815 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 20.6 m-20 54.97 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.707 -0.621 . . . . 0.0 111.211 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.543 ' C ' HG23 ' B' ' 6' ' ' VAL . 7.3 mtm-85 -153.5 17.3 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.989 -1.069 . . . . 0.0 111.064 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.543 HG23 ' C ' ' B' ' 5' ' ' ARG . 94.1 t -153.08 160.98 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 0.0 110.98 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' B' ' 19' ' ' PHE . 1.6 tt -124.0 154.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.781 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' B' ' 1' ' ' MET . 89.7 t -102.7 141.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 110.831 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' B' ' 10' ' ' LYS . 72.2 mttt -147.09 145.0 29.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 108.967 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.592 ' HB3' ' HA ' ' B' ' 9' ' ' LYS . 3.4 tppt? 52.41 80.62 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.539 -1.976 . . . . 0.0 110.356 2.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.483 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 0.7 OUTLIER -122.96 -174.5 0.32 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 31.3 Cg_exo -54.57 -58.3 1.33 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.62 1.326 . . . . 0.0 110.558 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' B' ' 13' ' ' LEU . 1.9 mm? -75.98 -30.98 58.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.95 -139.51 10.91 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.31 145.03 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -118.29 83.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -1.112 . . . . 0.0 110.36 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.56 -170.62 12.66 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.742 HG23 HD13 ' B' ' 67' ' ' ILE . 95.7 t -97.07 149.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.947 -1.325 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.796 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.6 m-85 -114.9 121.69 43.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.755 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.28 86.97 6.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 111.113 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.84 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 109.225 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.475 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 13.9 mttm -89.19 -179.64 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.475 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.0 OUTLIER 102.45 20.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 119.938 -1.726 . . . . 0.0 109.805 2.493 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' B' ' 5' ' ' ARG . 3.8 m-85 -111.45 152.13 27.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 110.615 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -95.04 -165.07 1.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.217 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -95.6 120.22 35.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.61 46.56 5.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.02 128.6 46.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -1.12 . . . . 0.0 110.508 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.885 HD13 ' HG3' ' B' ' 88' ' ' ARG . 39.7 tp -53.19 164.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.944 . . . . 0.0 110.089 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.494 ' CG1' HG21 ' B' ' 6' ' ' VAL . 94.8 t -133.57 -71.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.32 66.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.529 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.574 ' HG2' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -57.92 148.86 24.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 110.201 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.76 -165.58 2.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 160.22 15.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.858 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 53.8 m -134.48 -179.66 5.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 110.228 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.757 HD11 HD23 ' B' ' 62' ' ' LEU . 75.3 mt -113.25 151.28 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.058 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.497 HG22 ' O ' ' B' ' 84' ' ' LEU . 52.8 t -123.05 99.36 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.17 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.5 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -131.6 133.75 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 110.444 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.443 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.1 OUTLIER -51.34 178.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 110.669 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 28.0 t30 -75.64 -132.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.415 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.0 -145.93 0.45 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.828 -1.17 . . . . 0.0 110.525 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.56 -28.13 0.89 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.211 -0.931 . . . . 0.0 111.443 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.667 ' HZ3' HD21 ' A' ' 47' ' ' LEU . 38.2 t-105 -57.32 -55.0 40.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 110.228 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.413 ' HA3' ' NH2' ' D' ' 214' ' ' ARG . . . -67.2 -50.32 46.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.04 -44.24 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.293 -1.122 . . . . 0.0 111.099 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.13 -48.66 13.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -0.99 . . . . 0.0 110.6 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.976 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.1 mm? -92.15 28.33 1.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.706 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 76.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.007 -1.058 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.5 OUTLIER -175.48 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.892 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.844 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 39.3 m-85 -133.31 50.13 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.102 -0.998 . . . . 0.0 110.447 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.976 HD11 ' HB2' ' B' ' 47' ' ' LEU . 52.3 mt -124.17 131.21 53.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -91.42 104.9 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 85.9 p -86.24 111.44 20.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.102 -0.999 . . . . 0.0 111.327 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -179.91 4.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.436 -0.79 . . . . 0.0 109.878 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -79.01 83.63 5.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.512 2.0 p-10 153.89 -27.61 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.656 -0.652 . . . . 0.0 109.743 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.1 OUTLIER -176.57 -160.45 0.06 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.37 -0.831 . . . . 0.0 110.698 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.415 ' O ' ' NE1' ' B' ' 43' ' ' TRP . 1.1 m -141.33 126.03 17.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.946 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.36 155.29 21.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.704 ' HA ' HD23 ' B' ' 51' ' ' LEU . 9.6 ttt -89.56 166.85 13.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.569 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.59 -26.19 32.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.757 HD23 HD11 ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER 62.95 -92.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 111.125 178.568 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.68 -144.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 93.1 m-85 -82.65 51.87 1.97 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -1.082 . . . . 0.0 110.758 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.569 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.29 -25.61 23.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.844 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.77 -43.74 9.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -1.17 . . . . 0.0 110.683 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.977 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.5 pp -45.13 -23.56 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.571 -0.705 . . . . 0.0 112.069 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.977 ' N ' HD12 ' B' ' 67' ' ' ILE . 23.1 m-85 -55.06 142.47 30.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.544 -1.348 . . . . 0.0 109.792 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.411 ' O ' ' HB ' ' B' ' 102' ' ' THR . 82.4 m-20 -119.11 -169.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 111.184 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.636 ' CE1' HD11 ' B' ' 111' ' ' LEU . 22.1 t-160 -103.09 110.95 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.2 19.56 13.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 110.629 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt 52.73 23.31 2.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 110.206 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' B' ' 75' ' ' ASN . 0.9 OUTLIER -174.41 65.28 0.28 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 110.012 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.505 ' O ' HD11 ' B' ' 92' ' ' ILE . 11.9 Cg_endo -59.56 83.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.68 1.358 . . . . 0.0 110.591 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' B' ' 92' ' ' ILE . 22.2 m120 -59.16 -17.88 31.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.733 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -132.08 143.8 50.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.46 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.575 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -107.45 136.06 47.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' B' ' 88' ' ' ARG . 32.8 tt0 -124.47 167.04 14.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 110.305 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.428 HD13 HD23 ' B' ' 84' ' ' LEU . 24.7 mt -126.24 147.94 49.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.513 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.525 HG21 ' HB2' ' B' ' 86' ' ' ARG . 71.7 p -71.94 -79.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.55 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.83 23.08 4.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 37' ' ' VAL . 44.0 mt 52.05 36.84 19.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.238 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -104.45 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.525 ' HB2' HG21 ' B' ' 81' ' ' THR . 8.1 mtt180 -84.86 179.24 7.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.307 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.858 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.3 mtp -148.3 128.47 13.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 0.0 110.733 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.885 ' HG3' HD13 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -114.5 105.93 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 110.116 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.07 113.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 110.05 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.524 ' CE1' ' CD ' ' B' ' 88' ' ' ARG . 1.3 m-85 -101.98 177.12 4.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.552 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.9 p -113.87 99.33 7.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.505 HD11 ' O ' ' B' ' 74' ' ' PRO . 4.2 pt -53.01 -22.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.392 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.487 ' CE ' HD12 ' B' ' 92' ' ' ILE . 45.1 mttt -148.16 146.68 23.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.193 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.77 129.42 34.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.633 1.333 . . . . 0.0 110.247 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' B' ' 20' ' ' ALA . 71.4 mt -104.73 148.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.598 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.3 167.29 11.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.85 . . . . 0.0 110.562 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.84 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -71.27 123.38 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 110.463 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.87 39.93 2.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -124.65 -169.39 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -1.177 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 23.7 tt0 -135.26 124.88 25.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.755 HG13 ' HB2' ' B' ' 20' ' ' ALA . 97.8 mt -88.92 137.96 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 110.35 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.534 HG23 ' C ' ' B' ' 101' ' ' ILE . 44.7 p -154.12 -174.13 4.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.527 -0.733 . . . . 0.0 110.02 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.57 HD12 ' O ' ' B' ' 104' ' ' SER . 1.5 pp -149.48 158.46 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 0.0 110.444 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.57 ' O ' HD12 ' B' ' 103' ' ' ILE . 32.3 t -95.8 -164.16 1.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.347 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.475 ' CE1' ' HE3' ' D' ' 215' ' ' MLZ . 12.9 m-85 -133.88 -66.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.99 -157.92 53.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 106' ' ' GLY . 14.6 t0 55.8 -86.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.499 -1.0 . . . . 0.0 110.72 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.575 ' HB2' ' HB3' ' D' ' 213' ' ' ALA . 10.3 t0 -122.58 -31.4 3.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 110.646 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.485 ' CE1' ' HG2' ' D' ' 215' ' ' MLZ . 1.4 m-85 -51.13 96.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 110.585 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.485 ' CE3' ' O ' ' B' ' 110' ' ' TRP . 52.0 p-90 -51.76 144.87 10.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.807 . . . . 0.0 110.557 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.636 HD11 ' CE1' ' B' ' 70' ' ' HIS . 17.4 tp -92.73 156.92 16.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.369 -0.832 . . . . 0.0 110.368 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 68.7 m -64.63 -162.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.0 110.5 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.77 111.95 2.82 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.431 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.09 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.473 1.249 . . . . 0.0 110.589 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -140.72 -54.57 0.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.282 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.676 HD23 ' OE1' ' B' ' 118' ' ' GLN . 0.1 OUTLIER 49.84 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 0.0 110.712 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.502 HG22 ' N ' ' B' ' 118' ' ' GLN . 18.7 m -52.18 -84.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 110.577 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLN . . . . . 0.676 ' OE1' HD23 ' B' ' 116' ' ' LEU . 10.1 pt20 38.63 -155.49 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.235 0.54 . . . . 0.0 111.786 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.388 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -146.15 47.19 1.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -1.119 . . . . 0.0 110.355 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -168.96 71.65 0.74 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 110.4 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -66.63 -47.48 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.672 1.354 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.72 55.13 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.392 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -127.39 157.8 39.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 110.37 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.37 163.71 35.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.368 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.82 105.77 10.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.413 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.85 83.4 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -115.62 -23.65 8.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.455 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.07 109.95 12.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 110.448 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.17 -61.95 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 110.311 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 213' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' B' ' 108' ' ' ASP . . . -90.58 -177.4 5.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 110.346 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.413 ' NH2' ' HA3' ' B' ' 44' ' ' GLY . 6.4 mtt85 -132.65 -149.57 0.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.485 ' HG2' ' CE1' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.0 OUTLIER -53.77 175.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.329 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -135.5 170.25 11.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.311 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 26.7 Cg_exo -59.13 -29.17 89.78 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.714 1.376 . . . . 0.0 110.536 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.9 89.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.331 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.8 p -53.18 179.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.408 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.444 ' N7 ' ' HB3' ' A' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.442 ' N7 ' ' HB3' ' B' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' C ' ' CG ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.889 0.376 . . . . 0.0 110.378 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 21.9 p90 36.03 93.31 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 CA-C-O 121.475 0.655 . . . . 0.0 111.945 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.93 144.97 25.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.27 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.61 -45.09 47.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.877 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.497 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -67.59 -37.89 83.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.937 . . . . 0.0 110.566 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG23 ' C ' ' A' ' 5' ' ' ARG . 56.2 t -150.22 141.04 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.43 ' CG2' ' HD2' ' A' ' 21' ' ' ARG . 14.7 tt -113.67 153.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 110.612 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 82.5 t -89.82 131.68 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 54.5 mttt -147.86 123.61 10.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.022 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.8 mptt 59.36 64.23 1.4 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 119.664 -1.898 . . . . 0.0 111.07 0.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.518 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.2 t -153.9 -65.21 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.339 -0.851 . . . . 0.0 110.622 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 16.0 Cg_endo -61.17 -161.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.053 1.028 . . . . 0.0 110.27 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.78 -30.72 65.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 110.397 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.04 151.52 14.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.97 149.33 5.1 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.473 ' CD2' ' HD3' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.82 88.64 2.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -1.159 . . . . 0.0 110.639 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.05 -171.27 12.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 67' ' ' ILE . 89.0 t -103.71 139.46 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.93 -1.335 . . . . 0.0 110.331 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 2.0 m-85 -109.44 124.6 51.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.747 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.761 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.85 97.52 11.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.29 -0.881 . . . . 0.0 111.137 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.748 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -68.39 -20.24 64.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 6.9 mttt -93.84 179.53 5.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.282 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.469 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 12.2 m 103.12 17.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.047 -1.658 . . . . 0.0 110.191 1.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 14.3 m-85 -112.03 165.5 12.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.557 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.33 -156.59 0.58 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 110.201 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 11.4 tttp -100.5 105.49 16.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.511 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.08 41.26 1.83 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.41 55.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -1.22 . . . . 0.0 110.444 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.818 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 tm? -64.28 124.31 21.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.383 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.715 ' CG2' HG23 ' A' ' 91' ' ' THR . 44.9 t -102.74 79.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 109.984 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.81 134.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -125.21 159.68 31.0 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.287 -0.883 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.4 -169.16 3.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 110.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.15 173.87 6.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 110.485 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -138.85 -173.73 3.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.952 ' CD1' HD23 ' A' ' 62' ' ' LEU . 50.0 mt -119.55 141.57 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.263 -0.898 . . . . 0.0 109.998 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 84' ' ' LEU . 91.8 t -111.68 122.38 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.962 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' CG ' ' CG ' ' A' ' 43' ' ' TRP . 27.1 tpt180 -150.11 131.92 15.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.398 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -53.5 -174.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.206 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.81 117.96 33.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.36 -0.838 . . . . 0.0 110.732 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.79 -141.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.76 -24.85 6.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.656 -1.277 . . . . 0.0 109.36 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 52.1 t-105 -56.59 -56.19 24.46 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.544 -0.722 . . . . 0.0 109.615 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.12 -28.39 70.54 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -72.96 -44.7 60.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -1.195 . . . . 0.0 110.679 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.4 -40.6 29.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.0 110.482 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.744 ' CB ' HD11 ' A' ' 51' ' ' LEU . 4.2 mm? -90.72 22.93 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 0.2 OUTLIER -64.64 78.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.101 -0.999 . . . . 0.0 110.454 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -169.18 -62.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.016 -1.052 . . . . 0.0 110.79 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.52 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 28.1 m-85 -121.98 55.84 1.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.057 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.744 HD11 ' CB ' ' A' ' 47' ' ' LEU . 15.5 mt -109.15 112.3 24.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 0.0 111.11 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' C' ' 215' ' ' MLZ . 0.2 OUTLIER -89.42 101.59 14.27 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.288 -0.882 . . . . 0.0 108.693 176.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.413 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 24.9 p -100.99 142.09 32.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -177.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.677 ' HD2' HD13 ' A' ' 84' ' ' LEU . 1.7 ttt180 -101.31 -170.96 1.91 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.479 -0.763 . . . . 0.0 109.844 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -83.43 80.76 8.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 36.4 t-20 155.29 -20.75 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.708 -0.62 . . . . 0.0 110.242 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.18 -177.58 1.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.968 -1.083 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.413 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -135.74 161.92 34.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 109.945 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.621 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -95.75 169.93 9.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.865 -1.147 . . . . 0.0 109.843 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.935 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -84.97 -14.91 46.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.714 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.952 HD23 ' CD1' ' A' ' 36' ' ' ILE 2.5 0.0 OUTLIER 61.1 -94.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 111.293 177.567 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -133.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.44 41.81 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.098 . . . . 0.0 110.747 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.935 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -81.05 -19.43 67.25 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -87.69 -51.16 6.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.0 110.656 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.7 pp -46.67 -24.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 111.491 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.62 ' N ' HD12 ' A' ' 67' ' ' ILE . 10.0 m-85 -52.56 142.02 19.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.642 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -96.88 96.53 8.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 110.022 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.5 m -115.22 143.04 45.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 110.513 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.95 136.48 57.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.21 2.95 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 92' ' ' ILE . 14.5 Cg_endo -61.01 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.685 1.361 . . . . 0.0 110.508 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 93' ' ' LYS . 50.7 m-80 -58.09 -19.44 32.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -123.53 150.19 44.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 0.0 110.567 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.568 ' HG3' HG21 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -128.32 -172.42 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 48.6 p-80 -135.46 156.26 49.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 110.644 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.94 124.24 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.616 HD12 ' HD2' ' C' ' 218' ' ' PRO . 13.3 mt -91.03 149.79 21.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 110.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 p -94.64 152.98 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.15 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.77 -5.79 3.74 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.279 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.794 ' HB3' HG22 ' A' ' 37' ' ' VAL . 1.8 tp 56.09 20.99 4.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.826 -1.396 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -22.29 19.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 111.085 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.57 157.96 45.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.901 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.78 138.09 49.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.765 . . . . 0.0 110.051 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' HIS . 4.6 mtt180 -116.55 151.32 36.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 110.616 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.533 ' O ' HD22 ' A' ' 29' ' ' LEU . 74.0 mt -125.88 121.24 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 15.6 m-85 -117.81 -170.14 1.81 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.454 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' CG2' ' A' ' 30' ' ' VAL . 1.1 p -131.51 93.84 3.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.893 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 74' ' ' PRO . 48.4 pt -51.07 -29.79 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.44 ' N ' HG13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -137.59 143.53 41.14 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 149.88 10.59 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.529 1.279 . . . . 0.0 110.669 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 20' ' ' ALA . 69.1 mt -122.52 150.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.727 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.01 161.91 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 110.155 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 21' ' ' ARG . 10.5 mt -65.82 96.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.249 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.23 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.452 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 35.0 mm-40 -116.94 168.46 10.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -1.104 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' OE1' HG21 ' A' ' 102' ' ' THR . 2.9 tm-20 -107.14 117.95 35.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.989 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.761 HG13 ' HB2' ' A' ' 20' ' ' ALA . 97.5 mt -89.63 128.22 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.515 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.522 HG23 ' C ' ' A' ' 101' ' ' ILE . 62.5 p -153.99 176.76 11.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.877 -0.514 . . . . 0.0 109.678 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -143.65 158.94 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 110.435 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -87.62 -158.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.32 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.47 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 34.1 m-85 -133.19 -59.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.06 -167.09 36.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.55 -34.2 77.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -1.136 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.359 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' C' ' 215' ' ' MLZ . 2.1 m-85 -51.99 110.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.703 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 34.1 m95 52.15 -166.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.9 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 112' ' ' SER . 14.2 tp -61.14 157.76 15.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 110.491 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.434 ' N ' ' HG ' ' A' ' 111' ' ' LEU . 49.3 m -64.62 -62.61 1.47 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.278 -0.889 . . . . 0.0 110.411 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -140.29 160.07 61.23 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 110.481 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 116' ' ' LEU . 25.9 Cg_exo -59.69 -57.54 0.82 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.763 1.402 . . . . 0.0 110.601 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -69.73 0.09 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.408 -0.808 . . . . 0.0 110.506 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 114' ' ' PRO . 3.7 mt 53.34 91.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.392 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 68.0 m -67.84 155.95 38.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 110.399 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.09 82.46 2.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 110.327 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.333 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -133.39 35.83 3.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -1.107 . . . . 0.0 110.329 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.837 ' HB3' ' HD3' ' C' ' 204' ' ' PRO . . . -54.95 -50.21 87.63 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 110.644 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.837 ' HD3' ' HB3' ' C' ' 203' ' ' ALA . 44.9 Cg_exo -51.39 97.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.537 1.282 . . . . 0.0 110.611 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.84 80.62 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.476 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.63 128.53 35.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.29 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -58.88 134.65 57.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 70.9 mt -67.67 -171.25 0.19 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.379 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.81 141.87 10.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 110.341 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 1.6 p -112.87 43.78 1.62 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.312 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -72.14 83.61 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 110.42 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.22 102.34 13.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.33 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.72 160.34 33.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 110.421 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -160.93 0.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.218 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.495 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER -53.8 -178.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.586 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.664 ' HB1' ' HG3' ' A' ' 54' ' ' ARG . . . -150.96 123.8 4.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.391 -0.818 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.616 ' HD2' HD12 ' A' ' 80' ' ' LEU . 38.2 Cg_exo -56.4 157.18 19.01 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.364 1.191 . . . . 0.0 110.568 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -104.19 -21.67 13.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 110.327 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -57.0 -169.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 110.313 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.79 179.761 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.456 ' C ' ' CG ' ' B' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.821 0.344 . . . . 0.0 110.414 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 21.9 p90 36.04 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.49 0.662 . . . . 0.0 111.944 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.91 144.96 25.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.58 -45.12 47.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.495 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.2 OUTLIER -67.54 -37.94 83.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.586 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.495 HG23 ' C ' ' B' ' 5' ' ' ARG . 56.0 t -150.16 141.06 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 14.7 tt -113.66 153.04 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 110.645 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' B' ' 9' ' ' LYS . 82.9 t -89.7 131.76 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.629 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 54.4 mttt -148.05 123.73 10.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.629 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.8 mptt 59.49 64.17 1.39 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.726 -1.859 . . . . 0.0 111.037 0.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.2 t -153.87 -65.19 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.64 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 16.2 Cg_endo -61.11 -161.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.021 1.011 . . . . 0.0 110.287 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -30.67 65.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 110.408 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.1 151.58 14.15 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.97 149.29 5.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' B' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 88.67 2.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 110.588 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.01 -171.36 12.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' B' ' 67' ' ' ILE . 86.2 t -103.66 139.25 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.955 -1.321 . . . . 0.0 110.373 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 2.0 m-85 -109.41 124.57 51.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 109.759 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.773 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.78 97.54 11.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 111.14 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.742 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -68.4 -20.24 64.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.714 177.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.459 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 6.9 mttt -93.78 179.62 5.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.274 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.511 12.0 m 103.2 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.055 -1.653 . . . . 0.0 110.17 1.28 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.433 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 14.1 m-85 -112.1 165.56 12.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.138 -0.976 . . . . 0.0 110.573 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.38 -156.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 110.159 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.407 ' HG3' ' HA ' ' B' ' 93' ' ' LYS . 11.3 tttp -100.51 105.51 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 110.549 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.09 41.27 1.83 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.43 55.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 110.437 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.827 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.1 tm? -64.23 124.3 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 110.451 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' B' ' 91' ' ' THR . 45.1 t -102.78 79.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 110.017 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.85 134.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.511 -0.743 . . . . 0.0 110.741 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -125.22 159.63 31.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.428 -0.795 . . . . 0.0 109.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.53 -169.19 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.554 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' B' ' 86' ' ' ARG . 0.1 OUTLIER -112.24 173.89 6.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 110.521 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -138.81 -173.81 3.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.953 ' CD1' HD23 ' B' ' 62' ' ' LEU . 49.4 mt -119.49 141.52 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.0 110.002 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.8 HG22 ' HB3' ' B' ' 84' ' ' LEU . 91.6 t -111.62 122.41 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.964 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.507 ' CG ' ' CG ' ' B' ' 43' ' ' TRP . 27.1 tpt180 -150.17 131.82 14.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.0 110.477 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -53.44 -174.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 0.0 111.154 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.79 117.85 33.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.73 -141.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.7 -25.03 6.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.609 -1.307 . . . . 0.0 109.35 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.507 ' CG ' ' CG ' ' B' ' 38' ' ' ARG . 52.2 t-105 -56.49 -56.23 23.84 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.62 -0.675 . . . . 0.0 109.628 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.37 70.37 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.1 m -73.01 -44.76 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -1.155 . . . . 0.0 110.598 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.47 -40.28 30.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 110.464 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.746 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.2 mm? -91.14 23.16 3.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.583 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 0.2 OUTLIER -64.78 78.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 110.4 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.2 OUTLIER -169.14 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 110.79 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.513 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 28.2 m-85 -121.86 55.94 1.09 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.985 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' B' ' 47' ' ' LEU . 15.5 mt -109.19 112.35 24.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 111.208 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' D' ' 215' ' ' MLZ . 0.2 OUTLIER -89.49 101.47 14.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.71 176.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.409 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 24.8 p -100.86 142.09 32.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.441 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.683 ' HD2' HD13 ' B' ' 84' ' ' LEU . 1.7 ttt180 -101.79 -173.67 2.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.469 -0.77 . . . . 0.0 109.853 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -79.67 80.48 6.05 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 36.7 t-20 155.22 -20.96 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.621 -0.675 . . . . 0.0 110.231 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.09 -177.55 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 111.078 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 0.9 OUTLIER -123.88 143.06 50.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.536 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.562 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -135.8 161.92 34.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.005 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.613 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -96.28 167.97 10.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.985 179.024 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.956 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.03 -16.41 50.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 111.142 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.953 HD23 ' CD1' ' B' ' 36' ' ' ILE 2.501 0.0 OUTLIER 61.73 -94.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 111.29 178.221 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.25 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -88.53 41.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -1.104 . . . . 0.0 110.76 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.956 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -81.0 -19.49 67.25 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.513 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -87.71 -51.12 6.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.162 -1.199 . . . . 0.0 110.645 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.601 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.7 pp -46.62 -24.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.844 . . . . 0.0 111.528 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.601 ' N ' HD12 ' B' ' 67' ' ' ILE . 10.0 m-85 -52.51 142.02 18.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.857 -1.152 . . . . 0.0 110.351 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.957 . . . . 0.0 110.662 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -96.89 96.28 8.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 110.049 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 34.1 m -114.91 143.17 45.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.99 136.43 57.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.3 2.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.631 ' O ' HD11 ' B' ' 92' ' ' ILE . 14.7 Cg_endo -60.99 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.664 1.35 . . . . 0.0 110.536 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -58.11 -19.5 32.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.581 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -123.44 150.26 44.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.636 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.554 ' HG3' HG21 ' B' ' 92' ' ' ILE . 0.7 OUTLIER -128.39 -172.48 2.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 110.186 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 48.5 p-80 -135.39 156.21 49.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 0.0 110.675 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.93 124.33 17.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 110.187 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' D' ' 218' ' ' PRO . 13.4 mt -91.03 149.7 21.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.544 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 21.3 p -94.61 153.01 18.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.253 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.14 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 110.182 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.76 -5.87 3.75 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.24 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' B' ' 37' ' ' VAL . 1.8 tp 56.11 20.98 4.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.843 -1.387 . . . . 0.0 110.272 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.56 -22.16 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 111.091 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 0.0 OUTLIER -134.62 157.98 45.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.034 -1.041 . . . . 0.0 110.913 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.74 138.01 49.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.071 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' B' ' 78' ' ' HIS . 4.6 mtt180 -116.47 151.38 36.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 110.68 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.527 ' O ' HD22 ' B' ' 29' ' ' LEU . 73.4 mt -125.85 121.16 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.882 . . . . 0.0 109.95 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.827 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 15.6 m-85 -117.75 -170.15 1.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.491 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.72 HG23 ' CG2' ' B' ' 30' ' ' VAL . 1.1 p -131.5 93.88 3.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.891 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.631 HD11 ' O ' ' B' ' 74' ' ' PRO . 48.2 pt -51.03 -29.83 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.681 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.445 ' N ' HG13 ' B' ' 92' ' ' ILE . 1.0 OUTLIER -137.6 143.57 41.26 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 110.361 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.05 149.9 11.01 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.596 1.314 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.486 HG21 ' CB ' ' B' ' 20' ' ' ALA . 69.1 mt -122.53 150.55 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.98 161.93 13.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.395 -0.816 . . . . 0.0 110.127 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.742 HG23 ' O ' ' B' ' 21' ' ' ARG . 10.6 mt -65.89 96.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.21 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.447 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 34.9 mm-40 -117.0 168.44 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -1.17 . . . . 0.0 110.402 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.417 ' OE1' HG21 ' B' ' 102' ' ' THR . 2.9 tm-20 -107.07 117.95 35.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.912 . . . . 0.0 110.042 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.773 HG13 ' HB2' ' B' ' 20' ' ' ALA . 96.9 mt -89.53 128.25 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.513 HG23 ' C ' ' B' ' 101' ' ' ILE . 61.3 p -153.98 176.85 11.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.716 -0.615 . . . . 0.0 109.67 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.659 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -143.63 158.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.659 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.2 OUTLIER -87.7 -158.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 34.1 m-85 -133.21 -59.68 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.98 -167.13 36.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.49 -34.27 77.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 0.0 110.356 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.497 ' CE2' ' HG3' ' D' ' 215' ' ' MLZ . 2.1 m-85 -52.03 110.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.728 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' B' ' 110' ' ' TRP . 34.1 m95 52.26 -166.59 0.05 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.878 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' B' ' 112' ' ' SER . 14.1 tp -61.15 157.71 15.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.428 ' N ' ' HG ' ' B' ' 111' ' ' LEU . 49.0 m -64.56 -62.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -0.88 . . . . 0.0 110.4 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -140.28 160.14 60.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 110.503 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' B' ' 116' ' ' LEU . 25.8 Cg_exo -59.72 -57.45 0.84 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.689 1.363 . . . . 0.0 110.631 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.49 -69.66 0.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.408 -0.807 . . . . 0.0 110.608 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' B' ' 114' ' ' PRO . 3.7 mt 53.29 91.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.432 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 67.1 m -67.9 155.97 38.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 110.349 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.04 82.47 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.087 -0.959 . . . . 0.0 110.405 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -133.41 35.78 3.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -1.165 . . . . 0.0 110.308 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.865 ' HB3' ' HD3' ' D' ' 204' ' ' PRO . . . -54.98 -50.14 88.07 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.63 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.865 ' HD3' ' HB3' ' D' ' 203' ' ' ALA . 45.0 Cg_exo -51.45 97.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.51 1.268 . . . . 0.0 110.625 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.84 80.7 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.447 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.71 128.53 35.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.341 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -58.9 134.61 57.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 110.261 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.65 -171.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.78 141.84 10.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 110.401 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 1.6 p -112.9 43.86 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 110.347 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -72.16 83.67 1.01 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 110.415 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.28 102.38 13.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 110.293 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.78 160.3 33.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 110.455 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.06 -160.93 0.73 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 110.213 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.497 ' HG3' ' CE2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER -53.98 -178.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.561 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.673 ' HB1' ' HG3' ' B' ' 54' ' ' ARG . . . -150.89 123.75 4.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' B' ' 80' ' ' LEU . 37.7 Cg_exo -56.41 157.19 19.01 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.322 1.169 . . . . 0.0 110.539 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -104.25 -21.6 13.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 110.306 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -57.06 -168.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.324 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.791 179.852 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.438 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.458 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.748 ' SD ' HG11 ' A' ' 8' ' ' VAL . 4.3 mmt . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.015 0.436 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 10.0 p90 -54.01 143.56 21.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.971 -1.081 . . . . 0.0 110.328 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 5' ' ' ARG . 42.5 t30 -145.93 162.58 37.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.85 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.539 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.498 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER 178.33 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.414 -0.804 . . . . 0.0 109.414 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG11 ' CG1' ' A' ' 30' ' ' VAL . 18.9 m -155.4 179.98 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 109.727 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.44 166.58 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 110.04 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.748 HG11 ' SD ' ' A' ' 1' ' ' MET . 7.6 p -108.39 144.78 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.784 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 4.9 mttt -140.84 142.72 34.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.617 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.3 56.99 6.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.663 -1.898 . . . . 0.0 110.6 2.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.474 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -104.24 -173.82 0.3 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.629 -0.67 . . . . 0.0 109.988 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 31.7 Cg_exo -53.72 -47.49 26.94 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.61 1.321 . . . . 0.0 110.392 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.62 31.04 0.32 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 110.388 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.72 -155.34 25.21 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.78 -147.1 18.54 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.529 ' HB2' ' HN2' ' A' ' 301' ' ' SAH . 2.5 m-85 -106.2 77.93 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -1.216 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -114.97 -165.0 14.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.542 ' HB ' HD13 ' A' ' 67' ' ' ILE . 1.5 p -117.75 130.02 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.927 -1.337 . . . . 0.0 108.839 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -89.77 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 111.06 -177.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -107.0 96.23 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -0.764 . . . . 0.0 110.385 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 97' ' ' ILE . 12.0 ttt-85 -70.14 -18.31 63.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -97.54 177.96 5.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.531 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.447 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.515 50.6 m 106.48 21.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.097 -1.627 . . . . 0.0 110.12 1.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 20.3 m-85 -114.47 155.21 26.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.395 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.43 ' O ' ' CA ' ' A' ' 94' ' ' PRO . 1.1 mt-10 -88.17 -82.81 0.22 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.798 . . . . 0.0 109.885 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 24.5 tttt -175.91 92.19 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.924 -1.11 . . . . 0.0 110.012 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.67 19.34 4.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -97.59 152.36 19.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.235 . . . . 0.0 110.307 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.857 HD21 ' HB3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -78.02 121.55 24.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 110.379 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.606 ' CG2' HG23 ' A' ' 91' ' ' THR . 88.6 t -84.64 -46.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.65 145.37 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 110.201 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -128.76 149.39 50.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.425 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.435 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 64.5 m -140.91 -154.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 110.123 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -110.35 175.94 5.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 110.623 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.1 m -147.23 164.34 33.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.409 -0.807 . . . . 0.0 109.592 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.045 HD11 HD23 ' A' ' 62' ' ' LEU . 22.4 mt -108.14 141.75 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 109.985 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 84' ' ' LEU . 61.0 t -117.31 120.97 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 110.537 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 21.7 tpt180 -148.82 143.21 26.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.445 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.33 -169.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.46 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.808 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -162.62 -136.14 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' B' ' 42' ' ' ASP . 72.5 m-20 -51.63 -25.12 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 109.518 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.638 ' CZ3' HD21 ' B' ' 47' ' ' LEU . 34.3 t-105 -58.52 -56.59 20.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.585 -0.697 . . . . 0.0 109.462 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.84 -34.21 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.8 m -70.82 -67.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 110.404 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.53 -51.72 58.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 110.538 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.667 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.4 mm? -90.39 39.57 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 110.62 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 61.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.775 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -179.5 140.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.236 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 9.7 m-85 61.41 31.92 19.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.248 -0.908 . . . . 0.0 110.448 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 60' ' ' MET . 15.3 mt -106.3 134.57 49.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -108.88 103.33 12.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' C' ' 214' ' ' ARG . 12.0 t -89.54 127.63 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 0.0 111.553 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.595 ' CD ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -101.91 -174.48 2.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.539 -0.725 . . . . 0.0 109.752 178.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.36 73.88 9.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.016 -1.053 . . . . 0.0 109.124 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 56' ' ' ASN 2.505 5.9 t-20 169.92 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.878 -0.514 . . . . 0.0 109.988 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -176.15 -168.13 0.25 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.261 -0.899 . . . . 0.0 110.952 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 1.3 p -116.58 138.8 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.17 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.73 ' HB2' HD13 ' A' ' 84' ' ' LEU . . . -131.59 168.09 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 110.375 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.667 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -105.84 172.92 6.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 109.857 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.892 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.23 -35.61 21.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.045 HD23 HD11 ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.09 -94.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 111.288 178.128 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -70.3 -118.91 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -90.35 27.34 1.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.345 -1.091 . . . . 0.0 110.934 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.892 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -77.43 -22.6 69.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -90.94 -47.37 7.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.542 HD13 ' HB ' ' A' ' 18' ' ' VAL . 2.4 pp -47.66 -25.88 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.208 -0.932 . . . . 0.0 110.789 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CG ' HG12 ' A' ' 103' ' ' ILE . 6.5 m-85 -46.39 113.25 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -92.3 179.19 5.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 110.87 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -101.77 116.91 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.828 . . . . 0.0 109.882 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.11 130.71 51.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.373 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -52.62 -23.71 7.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 110.329 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.56 71.52 0.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 110.368 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.797 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.8 Cg_endo -64.54 112.12 1.85 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.648 1.341 . . . . 0.0 110.312 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.413 ' HA ' ' HE2' ' A' ' 93' ' ' LYS . 18.9 m-20 -111.32 18.49 19.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 110.616 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.7 162.56 40.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.0 ttt-85 -146.03 158.55 43.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.479 ' ND1' HD13 ' A' ' 103' ' ' ILE . 19.5 p-80 -110.09 158.78 17.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -141.35 142.63 33.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' A' ' 87' ' ' MET . 6.6 mt -106.75 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -90.08 68.2 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.15 34.41 11.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.24 171.68 38.77 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.73 HD13 ' HB2' ' A' ' 59' ' ' ALA . 85.4 mt -93.45 32.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -1.148 . . . . 0.0 109.998 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -93.34 -71.76 0.64 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.331 -0.856 . . . . 0.0 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.68 159.52 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.451 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 1.1 tmm? -142.47 138.77 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.569 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.857 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -121.08 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -0.96 . . . . 0.0 110.124 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.05 124.4 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.664 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 17.7 m-85 -113.35 -176.5 2.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.606 HG23 ' CG2' ' A' ' 30' ' ' VAL . 18.4 p -124.93 95.78 4.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.797 HD11 ' O ' ' A' ' 74' ' ' PRO . 30.7 pt -51.16 -24.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.6 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 0.5 OUTLIER -145.68 157.05 52.21 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.43 ' CA ' ' O ' ' A' ' 25' ' ' GLU . 23.9 Cg_exo -59.12 147.19 91.63 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.738 1.388 . . . . 0.0 111.179 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.417 HG21 ' CB ' ' A' ' 20' ' ' ALA . 66.8 mt -131.7 145.29 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.606 -0.684 . . . . 0.0 110.33 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.25 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.373 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -66.97 112.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.36 26.09 2.51 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -113.69 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.241 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 85.7 tt0 -116.47 135.9 53.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 110.631 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.961 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 39.2 mt -99.89 125.95 53.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.748 0.785 . . . . 0.0 110.521 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.9 p -154.73 171.57 19.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.761 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -146.96 165.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.098 . . . . 0.0 110.655 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.761 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -88.75 -164.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CD2' ' NE1' ' A' ' 110' ' ' TRP . 17.3 m-85 -123.47 -66.25 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.041 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.58 153.92 9.79 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.25 -24.33 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -1.166 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -55.1 4.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 110.064 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 3.5 t80 -71.56 60.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 110.661 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.467 ' NE1' ' CD2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER 177.32 -162.94 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.24 -0.913 . . . . 0.0 110.317 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 112' ' ' SER . 0.1 OUTLIER -59.6 -163.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.388 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.435 ' H ' HD23 ' A' ' 111' ' ' LEU . 15.2 p -124.25 136.9 54.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.208 -0.932 . . . . 0.0 110.277 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.4 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 13.4 mtt180 52.26 55.03 14.62 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 110.394 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.404 ' O ' ' HD3' ' A' ' 115' ' ' ARG . 33.5 Cg_endo -69.04 133.67 27.5 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.64 1.337 . . . . 0.0 110.143 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -129.61 63.95 1.51 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 110.331 -179.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -74.12 -41.33 61.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.615 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -139.02 162.58 34.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.576 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -74.25 62.59 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 110.445 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 t30 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.374 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.87 100.24 9.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -1.15 . . . . 0.0 110.363 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.45 58.34 1.65 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 110.272 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -66.52 155.17 71.49 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.683 1.36 . . . . 0.0 110.43 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.07 22.54 0.86 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 110.456 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 36.49 4.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 110.415 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -115.19 -40.9 3.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.491 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.48 30.13 1.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.388 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -106.23 34.08 3.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.865 . . . . 0.0 110.324 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 66.3 p -126.47 169.84 12.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -139.27 161.85 36.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.462 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -125.32 81.26 1.95 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 110.389 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.55 147.84 23.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.534 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 7.0 mtt-85 -111.87 -160.42 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 110.395 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER -56.33 -167.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 110.402 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -116.62 167.93 9.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 16.2 Cg_endo -61.8 -79.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.696 1.366 . . . . 0.0 110.534 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -174.14 42.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 110.451 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 1.1 p -81.81 57.64 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 110.302 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.756 ' SD ' HG11 ' B' ' 8' ' ' VAL . 4.3 mmt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.034 0.445 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.0 p90 -54.0 143.58 21.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.896 -1.128 . . . . 0.0 110.374 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' B' ' 5' ' ' ARG . 42.5 t30 -145.92 162.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.223 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.9 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.432 -0.792 . . . . 0.0 110.537 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.494 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.9 OUTLIER 178.36 -35.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.395 -0.816 . . . . 0.0 109.404 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.601 HG11 HG13 ' B' ' 30' ' ' VAL . 18.9 m -155.37 -179.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.494 -0.754 . . . . 0.0 109.791 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.45 166.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.756 HG11 ' SD ' ' B' ' 1' ' ' MET . 7.7 p -108.31 144.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 110.816 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.605 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 5.0 mttt -140.83 142.8 34.56 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.605 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.31 56.97 6.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 119.703 -1.873 . . . . 0.0 110.626 2.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.485 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 0.9 OUTLIER -104.2 -173.85 0.31 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 110.007 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 31.7 Cg_exo -53.73 -47.54 26.68 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.593 1.312 . . . . 0.0 110.389 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.59 31.02 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.399 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.7 -155.34 25.23 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.81 -147.06 18.47 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.526 ' HB2' ' HN2' ' B' ' 302' ' ' SAH . 2.5 m-85 -106.22 78.11 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 110.541 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -115.22 -165.27 14.66 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' B' ' 67' ' ' ILE . 1.6 p -117.39 129.8 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.295 . . . . 0.0 109.153 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.493 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.6 OUTLIER -89.76 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 111.088 -177.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.956 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -106.99 96.1 6.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.38 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.651 ' O ' HG23 ' B' ' 97' ' ' ILE . 11.9 ttt-85 -70.06 -18.37 63.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 110.027 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -97.44 178.08 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.452 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 50.8 m 106.53 21.27 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.066 -1.646 . . . . 0.0 110.112 1.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 20.4 m-85 -114.69 154.48 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.527 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.43 ' O ' ' CA ' ' B' ' 94' ' ' PRO . 1.2 mt-10 -87.23 -83.07 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' B' ' 25' ' ' GLU . 24.7 tttt -175.8 92.17 0.05 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.921 -1.112 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.68 19.37 4.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -97.62 152.35 19.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.268 . . . . 0.0 110.297 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' B' ' 88' ' ' ARG . 0.8 OUTLIER -78.04 121.55 24.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.442 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.601 HG13 HG11 ' B' ' 6' ' ' VAL . 88.4 t -84.65 -46.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 110.163 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.69 145.35 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 110.192 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.69 149.4 50.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.962 . . . . 0.0 110.435 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.441 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 64.3 m -140.91 -154.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.13 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.31 175.96 5.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 110.645 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 11.9 m -147.33 164.26 33.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.453 -0.779 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 1.048 HD11 HD23 ' B' ' 62' ' ' LEU . 22.2 mt -108.07 141.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.001 -1.062 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' B' ' 84' ' ' LEU . 61.1 t -117.28 120.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.515 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.502 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 21.6 tpt180 -148.76 143.24 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.36 -169.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.45 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.735 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -162.63 -136.23 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 72.4 m-20 -51.53 -25.16 6.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.557 -1.339 . . . . 0.0 109.571 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.589 ' CZ3' HD21 ' A' ' 47' ' ' LEU . 34.3 t-105 -58.51 -56.58 20.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.555 -0.715 . . . . 0.0 109.481 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.85 -34.19 64.78 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 48.0 m -70.76 -67.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -1.144 . . . . 0.0 110.433 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.403 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . . . -52.71 -51.45 60.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.671 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.4 mm? -90.63 39.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.36 61.28 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.746 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.478 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -179.51 140.18 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 9.7 m-85 61.31 32.02 19.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.306 -0.871 . . . . 0.0 110.369 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' B' ' 60' ' ' MET . 15.2 mt -106.23 134.81 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.986 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -109.17 103.04 11.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' D' ' 214' ' ' ARG . 11.8 t -89.09 127.62 35.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.068 -1.02 . . . . 0.0 111.597 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.585 ' CD ' HD21 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -102.59 -177.56 3.42 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.577 -0.702 . . . . 0.0 109.832 178.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.95 73.37 4.51 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 110.129 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' B' ' 56' ' ' ASN 2.507 6.1 t-20 169.8 -30.8 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.721 -0.612 . . . . 0.0 109.994 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.97 -167.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.3 p -116.61 138.73 51.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.214 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.735 ' HB2' HD13 ' B' ' 84' ' ' LEU . . . -131.62 168.03 18.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.444 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.671 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -106.18 170.95 7.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.914 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.31 -36.96 26.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 111.126 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 1.048 HD23 HD11 ' B' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.64 -94.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.0 111.271 178.765 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -70.34 -118.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -90.56 27.33 1.76 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -1.092 . . . . 0.0 110.933 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.914 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -77.46 -22.22 70.73 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -91.61 -47.14 7.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.121 -1.223 . . . . 0.0 110.823 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' B' ' 18' ' ' VAL . 2.4 pp -47.75 -25.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.266 -0.897 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.51 ' CG ' HG12 ' B' ' 103' ' ' ILE . 6.5 m-85 -46.38 113.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 111.138 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -92.34 179.41 5.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.812 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -102.03 116.84 33.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.4 -0.812 . . . . 0.0 109.845 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.01 130.78 51.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.193 -0.942 . . . . 0.0 110.417 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -52.61 -23.77 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.58 71.5 0.92 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.318 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.799 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.4 Cg_endo -64.38 112.01 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.685 1.361 . . . . 0.0 110.266 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 19.1 m-20 -111.29 18.51 19.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.395 -0.815 . . . . 0.0 110.478 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.67 162.59 40.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.54 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.47 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.0 ttt-85 -146.11 158.45 43.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.16 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.48 ' ND1' HD13 ' B' ' 103' ' ' ILE . 19.5 p-80 -110.0 158.81 17.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.38 142.67 33.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.281 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' B' ' 87' ' ' MET . 6.6 mt -106.76 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.445 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.4 p -90.05 68.16 7.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.18 34.34 11.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.399 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.26 171.68 38.78 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.735 HD13 ' HB2' ' B' ' 59' ' ' ALA . 85.2 mt -93.41 32.29 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.248 -1.148 . . . . 0.0 110.08 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -93.57 -71.66 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.56 14.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.499 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.445 ' HG2' ' CD2' ' B' ' 80' ' ' LEU . 1.0 OUTLIER -142.57 138.75 31.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.563 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.855 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -121.1 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 110.114 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.04 124.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.495 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.662 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 17.8 m-85 -113.24 -176.52 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.344 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.593 HG23 ' CG2' ' B' ' 30' ' ' VAL . 18.3 p -124.94 95.91 4.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.097 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.799 HD11 ' O ' ' B' ' 74' ' ' PRO . 30.5 pt -51.16 -24.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 110.572 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 0.5 OUTLIER -145.63 157.17 52.19 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.177 -0.952 . . . . 0.0 110.551 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.43 ' CA ' ' O ' ' B' ' 25' ' ' GLU . 24.1 Cg_exo -59.5 147.33 92.0 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.704 1.37 . . . . 0.0 111.111 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.427 HG21 ' CB ' ' B' ' 20' ' ' ALA . 67.1 mt -131.67 145.4 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.577 -0.702 . . . . 0.0 110.308 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.28 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -66.95 112.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 110.348 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 26.11 2.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -113.7 179.45 3.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -1.226 . . . . 0.0 110.034 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' B' ' 19' ' ' PHE . 85.6 tt0 -116.3 136.03 53.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.045 . . . . 0.0 110.568 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.956 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 40.6 mt -99.98 126.06 53.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.471 -0.768 . . . . 0.0 110.538 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.501 HG23 ' O ' ' B' ' 101' ' ' ILE . 16.6 p -154.69 171.72 19.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.755 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -147.0 165.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.927 -1.108 . . . . 0.0 110.669 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.755 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.4 OUTLIER -88.8 -164.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.422 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.47 ' CD2' ' NE1' ' B' ' 110' ' ' TRP . 17.3 m-85 -123.1 -66.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.52 153.96 9.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.22 -24.41 4.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -55.11 4.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 3.5 t80 -71.52 60.32 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 110.693 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.47 ' NE1' ' CD2' ' B' ' 105' ' ' TYR . 0.0 OUTLIER 177.45 -162.89 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 179.341 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.422 HD23 ' H ' ' B' ' 112' ' ' SER . 0.1 OUTLIER -59.64 -163.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 110.381 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.422 ' H ' HD23 ' B' ' 111' ' ' LEU . 15.6 p -124.3 136.85 54.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 13.5 mtt180 52.3 54.94 14.47 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 110.423 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 33.1 Cg_endo -68.99 133.74 27.77 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.666 1.35 . . . . 0.0 110.121 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' B' ' 114' ' ' PRO . 0.0 OUTLIER -129.86 64.39 1.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 110.182 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -41.29 61.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.366 -0.834 . . . . 0.0 110.671 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 3.4 m -139.06 162.59 34.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.586 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -74.19 62.55 0.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 110.444 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.386 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.87 100.28 9.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -1.163 . . . . 0.0 110.31 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.45 58.3 1.64 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 110.299 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.55 155.18 71.48 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.685 1.361 . . . . 0.0 110.463 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.1 22.58 0.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 110.479 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.6 36.53 4.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 110.388 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -115.26 -40.95 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.418 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.43 30.03 1.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 110.428 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -106.19 34.09 3.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.883 . . . . 0.0 110.32 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 66.1 p -126.47 169.78 12.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.401 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -139.24 161.86 36.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.468 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -125.27 81.26 1.95 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.354 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.54 147.85 23.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.917 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.531 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 7.0 mtt-85 -111.89 -160.44 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER -56.36 -167.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.217 -0.927 . . . . 0.0 110.432 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -116.64 168.0 9.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 16.3 Cg_endo -61.83 -79.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.696 1.366 . . . . 0.0 110.561 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -174.2 42.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.954 . . . . 0.0 110.496 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 1.1 p -81.76 57.61 3.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.32 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.529 ' HN2' ' HB2' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.526 ' HN2' ' HB2' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' HG11 ' A' ' 8' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.15 0.5 . . . . 0.0 110.324 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 21.8 p90 -51.26 139.89 17.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 110.617 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.83 156.04 49.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.14 -18.45 15.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.791 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.514 ' C ' HG13 ' A' ' 6' ' ' VAL . 2.1 mtm-85 -97.6 -29.03 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 110.914 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.514 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.1 m -153.45 -172.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 110.415 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 19' ' ' PHE . 13.6 tt -154.81 165.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 110.205 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG11 ' SD ' ' A' ' 1' ' ' MET . 7.3 p -99.77 137.83 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.98 . . . . 0.0 110.704 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 31.1 mttt -142.21 143.64 33.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.588 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER 52.73 66.21 1.29 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.757 -1.839 . . . . 0.0 111.161 1.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.457 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -126.93 174.04 4.64 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.568 178.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 11' ' ' SER . 34.7 Cg_exo -53.4 100.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.498 1.262 . . . . 0.0 110.319 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.2 50.18 15.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.414 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.67 165.54 24.16 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -148.27 5.87 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -102.58 73.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.247 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.71 -165.22 23.4 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.713 HG13 ' HB ' ' A' ' 101' ' ' ILE . 1.9 p -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.951 -1.323 . . . . 0.0 109.553 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.1 m-85 -89.79 158.55 17.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.564 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.692 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -113.09 105.32 13.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 110.645 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -63.71 -28.45 69.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.516 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 5.3 mttm -86.5 -178.36 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.46 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.507 4.8 t 99.53 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.031 -1.668 . . . . 0.0 110.493 1.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 22.2 m-85 -96.83 158.63 15.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.047 -1.033 . . . . 0.0 110.893 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 -155.69 0.48 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.479 -0.763 . . . . 0.0 110.011 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 58.8 tttt -95.94 30.88 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.27 86.21 0.06 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -150.07 124.6 9.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 110.337 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.812 HD23 ' CG ' ' A' ' 88' ' ' ARG . 3.4 tm? -54.34 119.96 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.3 -52.72 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 31' ' ' GLU . 8.6 pt-20 -170.73 97.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.25 152.24 34.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -150.36 -151.22 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.77 171.93 7.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 1.03 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 1.3 m -150.14 150.42 31.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.627 HD11 ' CD2' ' A' ' 62' ' ' LEU . 56.2 mt -91.18 142.71 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 84' ' ' LEU . 42.0 t -117.63 127.91 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 110.769 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.524 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 19.2 mmt180 -150.36 178.2 9.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -92.14 -173.73 3.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.111 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.57 -141.93 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.407 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.74 -135.02 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.06 -1.025 . . . . 0.0 110.826 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.63 -49.06 7.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 111.521 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 1.019 ' NE1' HD21 ' A' ' 51' ' ' LEU . 36.8 t-105 -51.54 -46.71 63.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.26 76.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.414 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 44.9 m -74.46 -59.96 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -1.216 . . . . 0.0 110.826 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' O ' ' NH2' ' B' ' 38' ' ' ARG . . . -50.69 -54.48 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.639 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.023 HD21 HD21 ' B' ' 47' ' ' LEU . 3.1 mm? -91.91 23.3 3.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.0 pp20? -50.67 154.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.952 -1.092 . . . . 0.0 110.005 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 54.9 t0 60.86 147.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.778 . . . . 0.0 110.164 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.28 13.68 7.18 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.145 -0.972 . . . . 0.0 110.303 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.019 HD21 ' NE1' ' A' ' 43' ' ' TRP . 8.9 tp -112.52 107.79 16.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.87 119.06 29.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -109.27 136.0 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 0.0 111.066 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.747 ' HD3' HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -102.29 -172.04 2.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.391 -0.818 . . . . 0.0 109.806 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.03 72.91 9.09 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.958 -1.089 . . . . 0.0 108.967 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 6.3 m120 175.08 -33.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.458 ' HG2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.59 -173.51 0.33 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.352 -0.842 . . . . 0.0 110.331 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -112.75 146.92 37.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -141.8 151.64 43.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.618 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.686 ' HA ' HD12 ' A' ' 51' ' ' LEU . 29.3 tpp -90.17 156.77 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.811 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.83 93.39 9.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.973 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.497 0.1 OUTLIER -54.53 -65.5 0.56 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 110.427 179.194 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -60.69 -159.49 0.07 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' HB3' HD11 ' A' ' 67' ' ' ILE . 5.1 m-85 -75.36 58.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -1.091 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.16 -36.34 7.16 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 301' ' ' SAH . . . -70.02 -41.7 73.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 110.661 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.693 HD13 ' HB ' ' A' ' 18' ' ' VAL . 1.2 pp -51.84 -34.44 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.188 -0.945 . . . . 0.0 111.24 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HB3' ' CG1' ' A' ' 103' ' ' ILE . 11.8 m-85 -49.96 119.9 3.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.986 -1.071 . . . . 0.0 110.697 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.428 HD21 ' HG2' ' A' ' 301' ' ' SAH . 22.0 m120 -95.52 176.46 6.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.404 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -95.39 107.57 19.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.4 t -115.65 129.98 56.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -53.6 -26.37 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.26 76.52 0.4 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.857 . . . . 0.0 110.052 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.93 ' O ' HD11 ' A' ' 92' ' ' ILE . 17.0 Cg_endo -62.32 104.37 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.719 1.379 . . . . 0.0 110.656 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 92' ' ' ILE . 70.6 m-20 -94.38 -19.82 20.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 110.383 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' THR . . . -125.71 178.0 5.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.625 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -149.56 168.18 24.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.409 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.894 ' ND1' HD13 ' A' ' 103' ' ' ILE . 33.5 p-80 -121.42 127.06 50.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 26.8 tt0 -109.17 172.44 6.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.747 HD13 ' HD3' ' A' ' 54' ' ' ARG . 6.0 mt -121.63 146.13 47.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 110.487 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 37.2 m -117.07 144.7 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.484 -0.76 . . . . 0.0 110.273 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . . . 52.93 34.03 15.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.03 -95.65 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -124.12 26.58 7.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -1.15 . . . . 0.0 110.219 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.79 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 1.2 mmtp -89.79 -73.12 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 110.482 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.436 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -102.17 177.84 4.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.41 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . 1.03 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 64.5 mtp -136.91 150.51 48.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 110.369 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.812 ' CG ' HD23 ' A' ' 29' ' ' LEU . 15.1 ttm180 -133.5 104.41 6.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.93 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 77' ' ' ARG . 6.2 mt -89.08 140.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.964 . . . . 0.0 110.314 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 88' ' ' ARG . 1.7 m-85 -129.53 -168.11 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 26.4 p -125.36 97.1 5.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.93 HD11 ' O ' ' A' ' 74' ' ' PRO . 49.3 pt -59.87 -17.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.534 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 13.5 mtmt -143.43 134.73 12.67 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 110.005 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.59 135.49 16.48 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.49 1.258 . . . . 0.0 111.255 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 20' ' ' ALA . 80.6 mt -115.71 142.38 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.5 163.33 15.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' A' ' 21' ' ' ARG . 28.1 mt -65.07 115.11 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -0.81 . . . . 0.0 110.409 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.06 40.85 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.6 177.6 4.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.138 . . . . 0.0 110.347 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.58 30.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.463 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.713 ' HB ' HG13 ' A' ' 18' ' ' VAL . 62.8 mt -90.31 124.85 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 110.395 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 101' ' ' ILE . 17.5 p -157.51 135.92 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.894 HD13 ' ND1' ' A' ' 78' ' ' HIS . 1.1 pp -100.85 170.44 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.965 -1.084 . . . . 0.0 110.447 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.619 ' O ' HD12 ' A' ' 103' ' ' ILE . 89.4 p -105.63 -166.83 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.478 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.424 ' CD1' ' HG3' ' C' ' 215' ' ' MLZ . 12.4 m-85 -123.58 -58.56 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.57 160.32 0.44 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.6 OUTLIER 57.45 109.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.434 -1.039 . . . . 0.0 110.977 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 107' ' ' ASP . 16.5 t0 57.57 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.844 -0.535 . . . . 0.0 111.768 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -43.34 111.03 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.311 -0.868 . . . . 0.0 111.706 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 49.64 -160.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 111.019 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 140.26 15.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.803 . . . . 0.0 110.647 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -148.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.877 . . . . 0.0 110.16 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -48.63 106.33 0.6 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.148 -0.97 . . . . 0.0 110.74 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.42 95.41 0.86 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.512 1.269 . . . . 0.0 110.468 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.74 99.74 9.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 110.442 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.0 151.64 51.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 110.377 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -122.26 163.26 19.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.347 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.31 100.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.375 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.058 -0.973 . . . . 0.0 110.409 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.48 -167.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -1.161 . . . . 0.0 110.412 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -133.5 158.16 76.29 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.395 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.93 125.39 17.55 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.707 1.372 . . . . 0.0 110.499 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 105.56 15.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 110.299 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.13 147.02 41.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 110.42 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.5 161.86 8.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.325 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 18.5 mt -117.04 -24.11 7.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 110.441 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.52 134.34 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.366 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 55.5 m -137.31 69.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 110.348 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 mttt 52.56 80.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 110.493 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.81 97.37 3.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 110.244 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.27 160.7 15.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 110.424 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -89.05 -150.01 0.19 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 110.129 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.424 ' HG3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 0.1 OUTLIER -53.03 178.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 110.339 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.33 16.51 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.943 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.22 -168.09 0.32 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.571 1.301 . . . . 0.0 110.538 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -105.8 148.19 27.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 110.218 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 22.0 m -140.49 104.38 4.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.176 -0.953 . . . . 0.0 110.329 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.919 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.472 ' SD ' HG11 ' B' ' 8' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.086 0.47 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 21.6 p90 -51.44 139.87 18.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.117 -0.99 . . . . 0.0 110.573 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.78 156.13 49.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.295 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.18 -18.44 15.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.764 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' B' ' 6' ' ' VAL . 2.1 mtm-85 -97.66 -29.08 13.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.884 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.0 m -153.4 -172.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.635 HG23 ' HB2' ' B' ' 19' ' ' PHE . 13.7 tt -154.79 165.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.95 . . . . 0.0 110.23 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.472 HG11 ' SD ' ' B' ' 1' ' ' MET . 7.2 p -99.79 137.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 110.726 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 31.1 mttt -142.17 143.72 33.1 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.604 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.0 OUTLIER 52.77 66.3 1.26 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.861 -1.774 . . . . 0.0 111.083 1.424 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.455 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -127.03 173.99 4.72 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.568 178.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' B' ' 11' ' ' SER . 34.9 Cg_exo -53.3 100.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.494 1.26 . . . . 0.0 110.289 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.12 50.3 15.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 0.0 110.373 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.74 165.53 24.18 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -148.28 5.87 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -102.52 73.3 1.3 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -1.231 . . . . 0.0 110.641 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -105.68 -165.33 23.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.71 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.0 p -121.69 130.72 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.322 . . . . 0.0 109.674 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.635 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.1 m-85 -89.83 158.5 17.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 110.528 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -113.18 105.39 13.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 110.581 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.2 OUTLIER -63.7 -28.39 69.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.459 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 5.3 mttm -86.54 -178.36 6.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.506 4.8 t 99.53 10.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 119.958 -1.714 . . . . 0.0 110.5 1.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 22.1 m-85 -96.69 158.67 15.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.064 -1.022 . . . . 0.0 110.921 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.09 -155.69 0.48 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.464 -0.773 . . . . 0.0 110.016 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.412 ' HG3' ' HA ' ' B' ' 93' ' ' LYS . 58.7 tttt -95.93 30.84 2.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.29 86.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -150.17 124.6 9.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.811 HD23 ' CG ' ' B' ' 88' ' ' ARG . 3.4 tm? -54.36 119.95 5.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 95.1 t -81.26 -52.73 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.841 . . . . 0.0 110.372 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' B' ' 31' ' ' GLU . 8.6 pt-20 -170.73 97.46 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 152.4 34.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.45 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.3 OUTLIER -150.55 -151.33 0.39 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.645 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.7 171.96 7.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.521 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 1.034 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 1.3 m -150.18 150.36 31.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.63 HD11 ' CD2' ' B' ' 62' ' ' LEU . 55.8 mt -91.04 142.77 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' B' ' 84' ' ' LEU . 42.1 t -117.67 128.01 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 110.745 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 19.1 mmt180 -150.5 178.18 9.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.7 OUTLIER -92.11 -173.73 3.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 110.106 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.6 -141.95 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.35 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.75 -135.05 0.8 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.129 -0.982 . . . . 0.0 110.805 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.59 -49.1 7.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.001 -1.062 . . . . 0.0 111.506 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 1.022 ' NE1' HD21 ' B' ' 51' ' ' LEU . 36.9 t-105 -51.53 -46.7 63.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 110.046 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.27 76.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 44.9 m -74.47 -59.88 2.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.138 -1.213 . . . . 0.0 110.808 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -53.67 30.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 0.0 110.656 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 1.023 HD21 HD21 ' A' ' 47' ' ' LEU . 3.2 mm? -93.0 23.63 4.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 110.603 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' B' ' 45' ' ' THR . 2.0 pp20? -50.76 154.52 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.033 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' B' ' 48' ' ' GLU . 54.2 t0 60.91 147.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.504 -0.747 . . . . 0.0 110.177 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.2 13.73 7.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.115 -0.991 . . . . 0.0 110.18 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 1.022 HD21 ' NE1' ' B' ' 43' ' ' TRP . 8.9 tp -112.6 107.81 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 110.936 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.85 119.08 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.564 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 42.6 t -109.25 135.93 49.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -0.99 . . . . 0.0 111.094 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.727 ' HD3' HD13 ' B' ' 80' ' ' LEU . 0.9 OUTLIER -102.93 -175.19 2.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.74 . . . . 0.0 109.808 178.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.46 72.3 4.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -0.962 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 6.3 m120 175.02 -33.51 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.45 ' HG2' ' CD2' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.3 -173.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.347 -0.845 . . . . 0.0 110.391 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -112.74 146.89 37.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -141.74 151.62 43.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.688 ' HA ' HD12 ' B' ' 51' ' ' LEU . 29.3 tpp -90.32 155.93 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.818 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -86.65 93.4 9.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.851 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.497 0.1 OUTLIER -54.93 -65.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.369 179.246 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.7 -159.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' B' ' 67' ' ' ILE . 5.1 m-85 -75.4 59.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.818 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -90.34 -36.27 7.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' B' ' 302' ' ' SAH . . . -70.06 -41.68 73.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 110.658 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' B' ' 18' ' ' VAL . 1.2 pp -51.87 -34.4 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 0.0 111.246 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.462 ' HB3' ' CG1' ' B' ' 103' ' ' ILE . 11.8 m-85 -49.95 119.89 3.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.918 -1.114 . . . . 0.0 110.709 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.431 ' H ' HG22 ' B' ' 102' ' ' THR . 21.9 m120 -95.53 176.47 6.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.869 . . . . 0.0 110.451 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -95.4 107.57 19.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 110.253 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 31.5 t -115.67 130.02 56.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 0.0 110.498 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' B' ' 74' ' ' PRO . 0.4 OUTLIER -53.59 -26.36 21.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.293 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.27 76.5 0.4 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.09 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.918 ' O ' HD11 ' B' ' 92' ' ' ILE . 17.0 Cg_endo -62.31 104.39 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.715 1.377 . . . . 0.0 110.688 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -94.42 -19.78 20.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' B' ' 91' ' ' THR . . . -125.74 178.02 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 110.295 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.639 ' O ' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -149.55 168.2 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.962 . . . . 0.0 110.445 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.895 ' ND1' HD13 ' B' ' 103' ' ' ILE . 33.6 p-80 -121.42 126.92 50.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 110.386 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' B' ' 88' ' ' ARG . 27.0 tt0 -109.07 172.37 6.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' B' ' 54' ' ' ARG . 6.0 mt -121.46 146.21 47.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.453 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 38.5 m -117.08 144.7 44.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.41 -0.806 . . . . 0.0 110.279 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' B' ' 85' ' ' LYS . . . 52.93 34.01 15.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.08 -95.72 2.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' B' ' 54' ' ' ARG . 1.0 OUTLIER -124.11 26.53 7.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -1.163 . . . . 0.0 110.228 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.79 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 1.2 mmtp -89.69 -73.09 0.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.442 ' CB ' ' HB ' ' B' ' 81' ' ' THR . 0.3 OUTLIER -102.24 177.87 4.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.349 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 87' ' ' MET . . . . . 1.034 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 64.5 mtp -136.92 150.6 48.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.811 ' CG ' HD23 ' B' ' 29' ' ' LEU . 15.0 ttm180 -133.76 104.08 6.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.476 -0.765 . . . . 0.0 109.982 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.639 HG23 ' O ' ' B' ' 77' ' ' ARG . 6.1 mt -88.39 140.22 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.461 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' B' ' 88' ' ' ARG . 1.7 m-85 -129.73 -168.13 1.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.89 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' B' ' 76' ' ' ALA . 26.5 p -125.32 97.07 5.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 110.397 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.918 HD11 ' O ' ' B' ' 74' ' ' PRO . 49.2 pt -59.84 -17.54 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.412 ' HA ' ' HG3' ' B' ' 26' ' ' LYS . 13.5 mtmt -143.42 134.62 12.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.89 135.75 17.49 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.467 1.246 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' B' ' 20' ' ' ALA . 80.9 mt -115.77 142.19 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.18 163.39 15.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.622 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 28.1 mt -65.06 115.04 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 110.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.07 40.87 2.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 177.64 4.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.73 31.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.401 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.71 ' HB ' HG13 ' B' ' 18' ' ' VAL . 63.1 mt -90.45 124.83 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 110.44 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.578 HG23 ' O ' ' B' ' 101' ' ' ILE . 17.4 p -157.38 135.98 11.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 109.659 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.895 HD13 ' ND1' ' B' ' 78' ' ' HIS . 1.1 pp -100.83 170.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.62 ' O ' HD12 ' B' ' 103' ' ' ILE . 89.5 p -105.64 -166.98 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.441 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' B' ' 109' ' ' TYR . 12.4 m-85 -123.44 -58.75 1.59 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.939 . . . . 0.0 110.036 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.84 160.31 0.47 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.6 OUTLIER 57.41 109.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.432 -1.04 . . . . 0.0 111.003 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' B' ' 107' ' ' ASP . 16.7 t0 57.79 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.867 -0.521 . . . . 0.0 111.774 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' B' ' 107' ' ' ASP . 0.2 OUTLIER -43.45 111.0 0.23 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.302 -0.874 . . . . 0.0 111.719 -178.254 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 49.7 -160.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 0.0 110.934 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 140.24 15.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 110.612 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -148.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 110.169 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -48.56 106.33 0.6 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 110.739 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.44 95.39 0.86 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.517 1.272 . . . . 0.0 110.463 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.69 99.71 9.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.436 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.02 151.63 50.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 110.368 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -122.26 163.24 20.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 110.351 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.23 100.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 110.358 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.442 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.46 -167.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -1.153 . . . . 0.0 110.4 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -133.47 158.2 76.2 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.96 125.42 17.61 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.665 1.35 . . . . 0.0 110.469 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.52 105.53 15.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 147.01 41.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.49 161.86 8.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.287 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 18.6 mt -117.05 -24.15 7.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.4 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.45 134.39 20.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 55.5 m -137.31 69.61 1.4 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 110.379 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 mttt 52.69 80.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.461 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.76 97.34 3.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.296 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.24 160.79 15.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 110.398 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -89.13 -149.98 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.14 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.422 ' HG3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.1 OUTLIER -53.05 178.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.38 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.3 16.48 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 110.413 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.2 -168.12 0.32 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.538 1.283 . . . . 0.0 110.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -105.79 148.19 27.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.903 . . . . 0.0 110.198 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 22.0 m -140.47 104.34 4.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 110.392 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.428 ' HG2' HD21 ' A' ' 69' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.428 ' HG2' HD21 ' B' ' 69' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.262 0.553 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 48.9 p90 -126.71 123.32 37.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 110.439 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -126.03 148.11 49.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -46.51 -48.66 19.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.437 -0.79 . . . . 0.0 111.053 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.533 ' C ' HG13 ' A' ' 6' ' ' VAL . 20.6 mmt85 -59.65 -45.7 91.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 110.495 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.533 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.3 m -154.81 152.16 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.384 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 11.6 tt -117.75 167.12 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.941 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.8 p -89.35 127.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.433 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.646 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 12.9 mttt -144.54 139.02 27.92 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER 52.61 73.47 0.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.585 -1.947 . . . . 0.0 109.798 6.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -131.78 177.61 2.16 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 121.869 -0.52 . . . . 0.0 110.135 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 11' ' ' SER . 19.5 Cg_endo -65.76 -37.45 27.85 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.609 1.321 . . . . 0.0 110.438 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -67.28 -32.67 73.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 110.272 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.14 122.48 5.11 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.29 133.9 2.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.469 ' HB2' ' HN2' ' A' ' 301' ' ' SAH . 5.3 m-85 -90.58 66.66 6.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -1.2 . . . . 0.0 110.627 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -111.54 -163.75 17.65 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.96 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.4 p -105.89 133.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.238 . . . . 0.0 109.063 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.537 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -90.0 144.12 26.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 110.521 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.95 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -97.26 89.24 4.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.466 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.878 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -63.29 -18.59 63.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.282 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HD2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.76 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.474 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 0.0 OUTLIER 97.57 8.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.414 -1.429 . . . . 0.0 110.609 0.812 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CZ ' HG12 ' A' ' 30' ' ' VAL . 14.6 m-85 -105.44 163.46 12.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.995 -1.065 . . . . 0.0 110.511 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.3 -148.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.027 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 10.4 tttt -107.94 82.47 1.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . . . 124.37 46.5 0.25 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.57 144.81 51.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -1.172 . . . . 0.0 110.531 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.925 HD23 ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -74.87 141.76 44.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.854 HG22 ' O ' ' A' ' 89' ' ' ILE . 28.6 m -121.81 -23.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.18 -0.95 . . . . 0.0 110.995 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.982 ' HB3' HD12 ' A' ' 89' ' ' ILE . 4.7 tt0 -171.8 153.82 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.104 -0.997 . . . . 0.0 110.216 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CG ' ' HA ' ' A' ' 88' ' ' ARG . 3.1 mt-10 -146.63 151.0 36.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 110.484 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.427 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 27.0 p -150.59 -160.85 1.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.652 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.703 HD23 ' HG3' ' A' ' 86' ' ' ARG . 54.0 mt -114.73 -179.87 3.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.466 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.7 170.89 17.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.104 HD11 HD23 ' A' ' 62' ' ' LEU . 48.2 mt -105.78 144.26 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.226 -0.922 . . . . 0.0 109.793 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 84' ' ' LEU . 38.2 t -123.25 89.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.005 -1.059 . . . . 0.0 110.386 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.38 177.81 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -88.61 175.06 7.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.121 -0.987 . . . . 0.0 109.771 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 5.7 t-20 -74.89 -135.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.099 -1.001 . . . . 0.0 110.252 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.3 t0 65.84 -146.86 0.21 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.69 -1.257 . . . . 0.0 110.379 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.03 -28.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.213 -0.93 . . . . 0.0 111.033 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.778 ' CH2' HD22 ' A' ' 47' ' ' LEU . 65.9 t-105 -68.41 -52.11 36.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.833 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.77 -23.53 55.98 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 90.7 m -83.76 -67.09 0.82 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -1.188 . . . . 0.0 110.748 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -46.63 -49.92 18.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 0.0 110.988 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.89 ' HB3' HD13 ' A' ' 51' ' ' LEU . 4.4 mp -91.86 31.87 1.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.02 64.09 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.939 -1.101 . . . . 0.0 110.61 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.42 -68.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.038 -1.039 . . . . 0.0 110.585 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' A' ' 301' ' ' SAH . 13.0 m-85 -98.34 34.39 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' A' ' 47' ' ' LEU . 2.3 tp -101.5 116.86 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.549 -0.72 . . . . 0.0 111.01 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -89.35 103.73 16.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.117 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 33.7 t -90.77 139.93 30.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.148 -0.97 . . . . 0.0 111.561 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' NH2' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -121.63 -175.36 3.07 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.583 -0.698 . . . . 0.0 109.674 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 79.69 8.88 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 109.363 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.506 0.2 OUTLIER 162.88 -28.91 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.847 -0.533 . . . . 0.0 109.844 -179.307 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.408 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.84 -161.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.3 m -128.28 141.7 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -129.12 175.42 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.859 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.558 ' CE ' HD23 ' A' ' 47' ' ' LEU . 1.3 tpt -114.11 169.45 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.815 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -84.96 -37.28 20.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.083 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.104 HD23 HD11 ' A' ' 36' ' ' ILE 2.501 0.1 OUTLIER 76.14 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.005 . . . . 0.0 111.186 177.657 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -66.35 -128.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.446 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.19 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -1.049 . . . . 0.0 110.84 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.815 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.77 -26.71 21.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 301' ' ' SAH . . . -90.15 -35.78 15.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -1.114 . . . . 0.0 110.585 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.1 pp -47.01 -37.0 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' N ' HD12 ' A' ' 67' ' ' ILE . 28.9 m-85 -46.39 129.37 10.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.343 -0.848 . . . . 0.0 110.919 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.49 -177.4 3.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 110.65 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -93.24 124.72 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 110.03 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 m -145.35 157.18 44.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 110.555 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.22 25.91 2.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.495 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.26 67.84 4.1 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.908 ' O ' HD11 ' A' ' 92' ' ' ILE . 13.1 Cg_endo -60.55 110.24 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.764 1.402 . . . . 0.0 110.465 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 3.1 m120 -89.84 -18.65 25.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -151.55 122.66 7.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.13 -0.982 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.447 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.2 mtt180 -93.89 -171.23 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 110.033 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.791 ' CE1' HD13 ' A' ' 103' ' ' ILE . 47.3 p-80 -130.39 150.59 51.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.177 -0.952 . . . . 0.0 110.281 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 4.4 tp10 -117.32 141.81 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 84' ' ' LEU . 51.2 tp -114.5 131.13 56.74 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 110.131 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -54.81 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 110.379 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' ' NH2' ' A' ' 54' ' ' ARG . . . -52.42 -23.27 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 110.389 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.54 -164.27 11.79 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.81 ' HA ' HD11 ' A' ' 80' ' ' LEU . 8.9 mt -102.8 42.47 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -1.129 . . . . 0.0 110.226 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.23 -65.63 0.98 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.168 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.703 ' HG3' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.46 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 110.886 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.97 24.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 110.13 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.45 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -128.03 172.47 10.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 110.91 -179.115 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.982 HD12 ' HB3' ' A' ' 31' ' ' GLU . 16.6 mt -145.89 91.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.925 ' CE2' HD23 ' A' ' 29' ' ' LEU . 2.4 m-85 -98.41 150.39 21.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.586 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.585 HG23 ' CG1' ' A' ' 30' ' ' VAL . 2.9 p -89.13 114.13 25.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.061 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.908 HD11 ' O ' ' A' ' 74' ' ' PRO . 13.6 pt -75.83 -13.53 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.62 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 8.3 ptpt -148.19 156.7 43.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.058 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.87 124.41 15.29 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.582 1.306 . . . . 0.0 110.597 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 75' ' ' ASN . 61.8 mt -111.4 145.6 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 110.373 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.89 156.61 17.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.367 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.878 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -59.91 111.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.864 . . . . 0.0 110.326 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.76 32.19 1.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -114.3 170.54 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' OE2' ' CG2' ' A' ' 102' ' ' THR . 0.7 OUTLIER -110.31 139.8 45.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.96 ' HB ' HG13 ' A' ' 18' ' ' VAL . 41.0 mt -109.02 122.1 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 110.619 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.447 HG23 ' C ' ' A' ' 101' ' ' ILE . 58.4 p -149.7 143.71 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.791 HD13 ' CE1' ' A' ' 78' ' ' HIS . 1.0 OUTLIER -111.61 169.86 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.021 -1.049 . . . . 0.0 110.571 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -95.51 -168.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 11.1 m-85 -123.49 -62.33 1.33 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.21 -0.932 . . . . 0.0 109.867 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 70.16 -169.83 45.65 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.87 -67.86 0.11 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.533 -0.981 . . . . 0.0 110.813 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -144.12 -39.02 0.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.994 -1.066 . . . . 0.0 110.767 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.6 m-85 -47.51 107.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 111.241 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 26.3 m95 53.17 -96.97 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 110.908 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.615 HD22 ' HB3' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -91.04 -175.78 4.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.698 -1.251 . . . . 0.0 110.792 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.65 -47.87 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.38 -0.825 . . . . 0.0 110.244 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.74 57.97 15.06 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.244 -0.91 . . . . 0.0 110.297 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.615 ' HB3' HD22 ' A' ' 111' ' ' LEU . 19.2 Cg_endo -63.52 -24.89 70.19 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.73 1.384 . . . . 0.0 110.568 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.85 79.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.449 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -83.85 169.04 15.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 110.438 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 117' ' ' THR . 73.4 m 54.11 20.84 2.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 110.645 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -174.79 150.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.872 -1.142 . . . . 0.0 110.437 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.343 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -116.2 -28.33 6.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -1.176 . . . . 0.0 110.361 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.43 ' N ' ' HD3' ' C' ' 204' ' ' PRO . . . 52.5 63.35 8.97 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 110.431 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' C' ' 203' ' ' ALA . 24.6 Cg_exo -60.05 -39.07 73.42 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.611 1.322 . . . . 0.0 110.51 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -52.8 -72.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 110.46 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 206' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' C' ' 208' ' ' LEU . 0.7 OUTLIER -71.31 -154.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.361 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.59 -75.89 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.425 -0.797 . . . . 0.0 110.705 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' C' ' 206' ' ' LYS . 24.4 mt 53.22 -178.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.301 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.12 165.94 14.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 110.503 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.7 t -169.55 159.52 8.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 110.185 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -166.94 127.48 1.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 110.521 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -133.32 111.43 10.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.89 . . . . 0.0 110.2 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -161.14 -147.05 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 110.359 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 61.16 125.4 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.416 -0.803 . . . . 0.0 110.458 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.401 ' HG2' ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t -61.0 -146.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.363 -0.836 . . . . 0.0 110.525 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.44 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.209 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.2 175.24 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.596 1.313 . . . . 0.0 110.447 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -53.15 -64.52 0.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 220' ' ' THR . . . . . 0.541 HG22 ' O ' ' C' ' 220' ' ' THR . 99.9 m 52.3 64.11 1.98 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.499 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.503 ' SD ' HG11 ' B' ' 8' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.221 0.534 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 49.0 p90 -126.68 123.28 37.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 110.474 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -125.96 148.26 49.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 26.1 t70 -46.56 -48.7 19.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.371 -0.831 . . . . 0.0 110.985 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.516 ' C ' HG13 ' B' ' 6' ' ' VAL . 20.5 mmt85 -59.67 -45.69 91.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 110.539 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.516 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.3 m -154.72 152.22 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 11.7 tt -117.89 166.75 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.503 HG11 ' SD ' ' B' ' 1' ' ' MET . 8.0 p -88.83 127.86 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.571 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.657 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 13.0 mttt -144.71 139.15 27.74 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.657 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.8 OUTLIER 52.71 73.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.52 -1.988 . . . . 0.0 109.851 6.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.442 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . 0.4 OUTLIER -131.84 177.57 2.18 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.895 -0.503 . . . . 0.0 110.097 -178.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' B' ' 11' ' ' SER . 19.3 Cg_endo -65.78 -37.47 27.71 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.567 1.299 . . . . 0.0 110.365 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.26 -32.69 73.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 110.286 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.13 122.46 5.11 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.34 133.92 2.73 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.469 ' HB2' ' HN2' ' B' ' 302' ' ' SAH . 5.2 m-85 -90.55 66.96 6.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -1.145 . . . . 0.0 110.616 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -111.87 -163.94 17.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.938 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.5 p -105.59 132.94 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.021 -1.282 . . . . 0.0 109.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.536 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.054 -1.028 . . . . 0.0 110.556 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -97.21 89.19 4.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.889 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.6 OUTLIER -63.4 -18.54 63.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.493 ' HD2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.85 6.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.469 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.509 0.0 OUTLIER 97.63 8.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.434 -1.416 . . . . 0.0 110.625 0.786 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.632 ' CZ ' HG12 ' B' ' 30' ' ' VAL . 14.4 m-85 -105.34 163.52 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.024 -1.048 . . . . 0.0 110.487 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.36 -148.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 92' ' ' ILE . 10.3 tttt -107.96 82.45 1.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.13 -0.981 . . . . 0.0 110.486 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 91' ' ' THR . . . 124.37 46.57 0.25 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.55 144.74 51.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -1.197 . . . . 0.0 110.575 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.91 HD23 ' CE2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER -74.84 141.84 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 109.813 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.862 HG22 ' O ' ' B' ' 89' ' ' ILE . 28.4 m -121.97 -23.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.12 -0.987 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.98 ' HB3' HD12 ' B' ' 89' ' ' ILE . 4.6 tt0 -171.75 153.77 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' B' ' 88' ' ' ARG . 3.1 mt-10 -146.59 151.26 37.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 0.0 110.434 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.419 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 27.0 p -150.98 -161.02 1.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.679 HD23 ' HG3' ' B' ' 86' ' ' ARG . 53.7 mt -114.66 -179.84 3.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -149.68 170.86 17.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 1.096 HD11 HD23 ' B' ' 62' ' ' LEU . 47.8 mt -105.76 144.2 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.791 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.405 HG22 ' O ' ' B' ' 84' ' ' LEU . 38.1 t -123.18 89.35 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.41 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.28 177.8 4.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.361 -0.837 . . . . 0.0 110.163 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -88.54 175.0 7.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.12 -0.987 . . . . 0.0 109.785 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 5.7 t-20 -74.83 -135.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 4.4 t0 65.87 -146.89 0.21 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.712 -1.243 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.0 -28.39 1.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.169 -0.957 . . . . 0.0 111.022 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.784 ' CH2' HD22 ' B' ' 47' ' ' LEU . 65.8 t-105 -68.45 -52.06 36.75 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.79 -23.52 56.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 91.1 m -83.71 -67.16 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 110.699 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.462 ' HB3' HD12 ' B' ' 47' ' ' LEU . . . -46.73 -49.03 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.188 -0.945 . . . . 0.0 111.046 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.866 ' HB3' HD13 ' B' ' 51' ' ' LEU . 4.4 mp -93.21 32.44 1.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.13 64.09 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.564 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.46 -68.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.047 . . . . 0.0 110.596 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.475 ' CE1' ' O ' ' B' ' 302' ' ' SAH . 13.0 m-85 -98.22 34.29 2.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.224 -0.922 . . . . 0.0 109.955 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.866 HD13 ' HB3' ' B' ' 47' ' ' LEU . 2.3 tp -101.51 116.66 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 111.145 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -89.05 103.79 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.184 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 33.8 t -90.82 139.88 30.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 111.526 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.415 ' NH2' ' O ' ' B' ' 82' ' ' ALA . 0.2 OUTLIER -122.2 -178.36 3.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.587 -0.696 . . . . 0.0 109.696 178.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.25 79.35 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 110.253 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 0.2 OUTLIER 162.71 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.694 -0.629 . . . . 0.0 109.88 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.67 -161.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.3 m -128.35 141.7 51.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.13 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -129.07 175.34 8.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.015 . . . . 0.0 110.955 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.559 ' CE ' HD23 ' B' ' 47' ' ' LEU . 1.3 tpt -114.47 167.34 10.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.0 109.793 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.807 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -81.82 -38.74 25.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -0.965 . . . . 0.0 110.56 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 1.096 HD23 HD11 ' B' ' 36' ' ' ILE 2.501 0.1 OUTLIER 76.7 -95.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 111.202 178.359 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -66.36 -128.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.44 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.59 1.26 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -1.06 . . . . 0.0 110.788 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.807 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.39 -26.42 20.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' B' ' 302' ' ' SAH . . . -90.33 -35.73 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -1.093 . . . . 0.0 110.595 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.532 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.2 pp -46.97 -37.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.532 ' N ' HD12 ' B' ' 67' ' ' ILE . 29.1 m-85 -46.31 129.36 10.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.322 -0.861 . . . . 0.0 110.983 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.5 -177.32 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -93.27 124.63 37.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.3 m -145.36 157.25 44.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.39 26.08 2.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -157.22 67.73 4.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.907 ' O ' HD11 ' B' ' 92' ' ' ILE . 13.2 Cg_endo -60.47 110.3 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.727 1.383 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.468 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 3.1 m120 -89.91 -18.65 25.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.849 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -151.54 122.7 7.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.437 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.3 mtt180 -93.85 -171.17 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.327 -0.858 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.786 ' CE1' HD13 ' B' ' 103' ' ' ILE . 47.2 p-80 -130.48 150.49 51.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 110.257 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.447 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 4.4 tp10 -117.23 141.88 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' B' ' 84' ' ' LEU . 51.6 tp -114.5 131.12 56.74 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.17 -0.956 . . . . 0.0 110.238 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -54.9 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.329 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.415 ' O ' ' NH2' ' B' ' 54' ' ' ARG . . . -52.4 -23.32 5.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 110.345 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.48 -164.22 11.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.786 ' HA ' HD11 ' B' ' 80' ' ' LEU . 8.9 mt -102.9 42.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -1.106 . . . . 0.0 110.144 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.46 -65.48 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 111.173 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.679 ' HG3' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.47 27.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.823 -178.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.87 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 110.127 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.448 ' HA ' ' CG ' ' B' ' 32' ' ' GLU . 0.4 OUTLIER -127.78 172.62 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.98 HD12 ' HB3' ' B' ' 31' ' ' GLU . 16.7 mt -145.99 91.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.52 -0.738 . . . . 0.0 109.964 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.91 ' CE2' HD23 ' B' ' 29' ' ' LEU . 2.4 m-85 -98.44 150.01 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 110.593 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.597 HG23 ' CG1' ' B' ' 30' ' ' VAL . 3.0 p -88.66 114.19 25.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.164 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.907 HD11 ' O ' ' B' ' 74' ' ' PRO . 13.7 pt -75.82 -13.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.666 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 8.3 ptpt -148.17 156.71 43.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.966 . . . . 0.0 110.039 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.82 124.42 15.34 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.676 1.356 . . . . 0.0 110.64 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' B' ' 75' ' ' ASN . 61.9 mt -111.4 145.64 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.92 156.61 17.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.889 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -59.91 111.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 32.16 1.78 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -114.29 170.49 8.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 110.236 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.41 ' OE2' ' CG2' ' B' ' 102' ' ' THR . 0.7 OUTLIER -110.29 139.88 45.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.957 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.961 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 41.5 mt -108.89 122.2 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.432 HG23 ' C ' ' B' ' 101' ' ' ILE . 57.4 p -149.7 143.73 25.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 109.631 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.786 HD13 ' CE1' ' B' ' 78' ' ' HIS . 1.0 OUTLIER -111.53 169.75 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.579 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -95.51 -168.89 1.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.487 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 10.9 m-85 -123.12 -62.41 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.95 . . . . 0.0 109.936 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.15 -169.8 45.67 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.89 -67.87 0.11 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.521 -0.987 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -144.07 -39.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.053 -1.029 . . . . 0.0 110.757 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.6 m-85 -47.45 107.14 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' B' ' 110' ' ' TRP . 26.2 m95 53.18 -96.59 0.05 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.437 -0.789 . . . . 0.0 111.004 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' B' ' 114' ' ' PRO . 0.2 OUTLIER -91.69 -175.89 4.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.655 -1.278 . . . . 0.0 110.657 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.53 -47.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.377 -0.827 . . . . 0.0 110.194 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.78 57.98 14.99 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 110.278 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.632 ' HB3' HD22 ' B' ' 111' ' ' LEU . 19.1 Cg_endo -63.47 -24.94 70.51 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.685 1.36 . . . . 0.0 110.565 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.86 79.36 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.911 . . . . 0.0 110.387 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.565 HD23 ' H ' ' B' ' 117' ' ' THR . 0.2 OUTLIER -83.85 169.05 15.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.451 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 117' ' ' THR . 72.7 m 54.15 20.82 2.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.842 . . . . 0.0 110.598 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -174.77 150.59 1.32 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.933 -1.105 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.371 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -116.18 -28.37 6.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -1.16 . . . . 0.0 110.363 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' D' ' 204' ' ' PRO . . . 52.49 63.36 8.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 110.428 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' D' ' 203' ' ' ALA . 24.6 Cg_exo -59.98 -39.08 73.91 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.662 1.348 . . . . 0.0 110.519 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -52.8 -72.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.439 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 206' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' D' ' 208' ' ' LEU . 0.7 OUTLIER -71.35 -154.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 0.0 110.384 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.59 -75.88 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.454 -0.779 . . . . 0.0 110.642 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 208' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' D' ' 206' ' ' LYS . 24.4 mt 53.17 -178.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.337 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.13 165.96 14.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.901 . . . . 0.0 110.508 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 5.8 t -169.64 159.5 8.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.365 -0.834 . . . . 0.0 110.15 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -166.92 127.51 1.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 110.52 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -133.36 111.4 10.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 110.205 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -161.12 -147.06 0.14 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 61.17 125.42 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 110.456 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.401 ' HG2' ' CD2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t -60.96 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.396 -0.815 . . . . 0.0 110.521 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.45 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.26 175.23 3.44 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.633 1.333 . . . . 0.0 110.48 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -53.17 -64.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -0.952 . . . . 0.0 110.297 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 220' ' ' THR . . . . . 0.559 HG22 ' O ' ' D' ' 220' ' ' THR . 99.1 m 52.35 64.09 1.99 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.447 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.886 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.594 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.604 ' O ' ' HB1' ' B' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.29 0.567 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.473 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 10.8 p90 -50.09 140.58 12.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.182 -0.949 . . . . 0.0 110.713 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.52 143.57 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 110.292 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.6 -33.15 6.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.953 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -77.32 -44.13 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.519 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.2 m -154.15 147.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 110.192 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 14.3 tt -114.81 166.1 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.907 . . . . 0.0 110.061 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.1 p -89.59 122.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 110.896 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 41.8 mttt -150.03 128.86 12.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 3.0 mttt 51.44 40.11 25.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.718 -1.864 . . . . 0.0 109.879 6.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.415 ' HA ' ' HG2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -48.15 165.18 0.24 Allowed Pre-proline 0 N--CA 1.489 1.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.708 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 31.6 Cg_exo -54.53 -21.55 24.69 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.684 1.36 . . . . 0.0 110.257 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -93.21 -46.7 7.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 110.387 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.55 171.72 25.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 16' ' ' TYR . . . 116.59 -179.09 17.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 15' ' ' GLY . 37.5 m-85 -152.55 91.77 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.038 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.917 ' HA2' HG22 ' A' ' 67' ' ' ILE . . . -151.18 -169.25 16.67 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.499 HG12 HD12 ' A' ' 101' ' ' ILE . 87.2 t -100.81 124.13 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.031 -1.276 . . . . 0.0 109.616 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' CB ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -88.45 129.37 35.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.989 -1.07 . . . . 0.0 110.777 -178.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -97.22 85.27 3.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.557 -0.714 . . . . 0.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 97' ' ' ILE . 4.7 mtp180 -56.09 -25.13 44.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 109.485 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 5.1 mtpp -84.63 -179.72 7.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 7.0 m 100.36 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.054 -1.654 . . . . 0.0 110.038 2.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 16.1 m-85 -107.63 142.79 37.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.75 171.07 9.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.091 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 18.7 tttt -67.04 100.81 0.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.45 -20.75 11.02 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.57 123.69 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -1.179 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.845 HD21 ' HB3' ' A' ' 88' ' ' ARG . 1.2 tm? -65.99 113.65 4.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 91' ' ' THR . 99.4 t -72.04 -53.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 89' ' ' ILE . 5.3 tt0 -174.14 144.44 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.25 157.98 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.445 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.1 p -150.56 -171.82 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 110.651 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.7 mt -100.61 167.65 10.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.783 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.7 m -145.15 161.59 39.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.793 HD11 HD23 ' A' ' 62' ' ' LEU . 55.1 mt -92.16 148.26 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 83' ' ' GLY . 42.7 t -124.0 90.45 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.659 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 36' ' ' ILE . 39.8 mmt180 -117.93 168.43 10.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -87.08 -176.27 5.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.068 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 26.2 m120 -72.24 -137.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.0 t0 65.97 -148.09 0.21 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 110.541 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' B' ' 42' ' ' ASP . 26.9 m-20 -46.27 -34.74 4.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.243 -0.91 . . . . 0.0 111.109 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.891 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 60.6 t-105 -52.88 -57.21 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.029 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -60.34 -31.31 73.47 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.97 -65.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.522 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.22 70.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 110.14 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.006 HD12 ' CE ' ' A' ' 60' ' ' MET . 3.6 mm? -91.74 34.03 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.686 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 1.9 tm-20 -56.31 -17.54 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 111.365 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.89 156.47 19.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.913 -1.117 . . . . 0.0 110.966 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' CE1' ' OXT' ' A' ' 301' ' ' SAH . 7.0 m-30 55.25 26.29 8.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.854 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.891 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 10.5 tp -108.71 105.88 15.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.867 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -89.11 105.32 17.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.429 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 3.1 t -105.39 147.52 28.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.938 . . . . 0.0 110.915 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.966 ' HG2' HD11 ' A' ' 84' ' ' LEU . 10.4 ptm180 -115.13 -167.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 77.62 9.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.075 -1.016 . . . . 0.0 109.264 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.499 3.0 t30 166.02 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.902 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -176.98 -164.44 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.947 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.414 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 6.2 t -130.2 141.05 50.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.459 -0.776 . . . . 0.0 110.286 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.553 ' HB3' HD22 ' A' ' 84' ' ' LEU . . . -132.71 149.42 52.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 110.626 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 1.006 ' CE ' HD12 ' A' ' 47' ' ' LEU . 32.9 tpp -93.24 155.91 17.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.52 92.1 8.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.704 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.793 HD23 HD11 ' A' ' 36' ' ' ILE 2.506 0.1 OUTLIER -52.19 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 110.895 -178.605 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -61.05 -155.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.697 ' HB3' HD13 ' A' ' 67' ' ' ILE . 31.6 m-85 -90.16 54.12 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.132 . . . . 0.0 111.152 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA2' ' CE2' ' A' ' 68' ' ' PHE . . . -92.83 -15.52 52.08 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -91.72 4.37 52.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.894 -1.356 . . . . 0.0 112.355 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.917 HG22 ' HA2' ' A' ' 17' ' ' GLY . 3.8 mp -88.56 -20.75 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.716 -1.24 . . . . 0.0 110.829 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 23.1 m-85 -52.43 143.6 14.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.89 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -112.4 -159.67 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.416 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 18.0 t-80 -102.01 136.12 42.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.405 -0.81 . . . . 0.0 109.414 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' ASP . 1.8 m -152.06 35.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.027 -1.045 . . . . 0.0 110.567 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 mmtp 58.11 -82.63 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.542 -0.724 . . . . 0.0 110.273 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' SER . 4.5 m-20 -99.33 91.78 1.55 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.804 ' O ' HD11 ' A' ' 92' ' ' ILE . 11.5 Cg_endo -58.04 106.56 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.564 1.297 . . . . 0.0 110.524 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 71.6 m-80 -50.48 -23.8 2.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.619 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.859 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -142.71 159.56 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.995 . . . . 0.0 110.426 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.47 ' NH2' ' NE2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -136.99 -173.89 3.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.195 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.47 ' NE2' ' NH2' ' A' ' 77' ' ' ARG . 7.5 p-80 -119.74 172.71 7.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -142.35 155.07 45.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.722 HD12 ' HD2' ' C' ' 218' ' ' PRO . 19.8 mt -123.38 143.36 50.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 110.371 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.455 HG22 ' NH2' ' A' ' 88' ' ' ARG . 20.4 p -72.93 -66.47 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.354 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.88 -35.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 110.524 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 37' ' ' VAL . . . -106.66 26.66 19.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.966 HD11 ' HG2' ' A' ' 54' ' ' ARG . 34.6 mt 51.73 28.84 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.605 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.22 -36.25 10.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 110.76 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.87 135.8 54.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 110.691 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 mtp -126.85 116.72 21.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 110.199 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.845 ' HB3' HD21 ' A' ' 29' ' ' LEU . 45.2 mtt180 -101.35 131.92 47.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -89.25 98.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.022 . . . . 0.0 109.591 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.844 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 13.9 m-85 -89.76 -169.29 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.547 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.523 HG23 HG23 ' A' ' 30' ' ' VAL . 26.9 p -132.57 98.43 4.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.083 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 74' ' ' PRO . 33.7 pt -54.54 -22.18 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.106 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -146.72 161.23 38.55 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 34.1 Cg_exo -53.74 156.57 11.65 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.635 1.334 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 59.2 mt -138.55 134.91 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.3 167.86 10.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 110.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -64.53 119.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.341 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.63 30.75 5.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.19 141.06 36.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.113 -1.228 . . . . 0.0 110.325 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' OE1' HG21 ' A' ' 102' ' ' THR . 1.3 tm-20 -88.39 121.39 30.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 109.674 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 76' ' ' ALA . 60.6 mt -89.11 123.59 41.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.78 . . . . 0.0 110.586 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.497 ' C ' HG23 ' A' ' 103' ' ' ILE . 73.2 p -145.46 -176.71 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.497 HG23 ' C ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -151.74 160.31 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 0.0 110.384 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.54 -173.05 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 13.0 m-85 -125.51 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 109.86 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.5 -160.29 54.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.94 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.988 . . . . 0.0 110.692 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -129.44 -35.54 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.067 . . . . 0.0 110.706 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.465 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -48.66 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.93 . . . . 0.0 110.928 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.476 ' CD2' ' O ' ' A' ' 110' ' ' TRP . 54.8 p-90 -54.07 120.52 6.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.437 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 6.7 tp -83.74 -148.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.918 . . . . 0.0 110.759 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.61 82.48 1.83 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 2.7 ttt85 51.85 52.36 11.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.503 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 113' ' ' ARG . 18.2 Cg_endo -65.85 -62.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.643 1.338 . . . . 0.0 110.557 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.94 -73.59 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.41 -0.806 . . . . 0.0 110.328 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 116' ' ' LEU . 4.4 mm? 53.22 42.25 32.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.48 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.7 m -59.27 157.6 10.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 110.315 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 47.48 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.419 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.357 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.86 -38.74 6.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -1.175 . . . . 0.0 110.381 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -122.97 153.47 64.07 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.0 110.433 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -65.67 125.65 14.7 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.691 1.363 . . . . 0.0 110.546 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -94.14 157.05 16.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 110.369 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 -40.63 2.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 110.39 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -76.13 165.62 24.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.32 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.0 mt -148.59 165.05 32.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.432 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.51 116.93 31.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 110.443 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 10.1 p -104.17 -32.56 9.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 110.287 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.48 177.31 6.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 110.321 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.75 -169.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 0.0 110.485 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 213' ' ' ALA . . . . . 0.427 ' HA ' ' CB ' ' A' ' 108' ' ' ASP . . . 52.86 64.4 1.87 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.342 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.429 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 3.8 mmp_? -106.3 -170.62 1.75 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 110.366 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.6 p -53.87 173.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.355 -0.841 . . . . 0.0 110.321 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -150.09 165.59 17.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.722 ' HD2' HD12 ' A' ' 80' ' ' LEU . 17.6 Cg_endo -62.16 -177.87 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.675 1.355 . . . . 0.0 110.452 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.84 79.53 0.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.331 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 2.0 p -147.35 60.69 1.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 110.372 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.215 0.531 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.9 p90 -49.97 140.55 12.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.707 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.45 143.69 31.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.69 -33.24 6.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.363 -0.836 . . . . 0.0 110.894 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.534 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -77.25 -44.19 30.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.534 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.1 m -154.04 147.43 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 14.3 tt -114.77 165.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 110.102 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.56 HG13 ' O ' ' B' ' 8' ' ' VAL . 7.1 p -89.4 122.28 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 110.969 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.562 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 42.1 mttt -150.13 129.17 12.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.562 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 3.0 mttt 51.8 40.01 26.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.511 -1.993 . . . . 0.0 109.889 6.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -48.18 165.29 0.24 Allowed Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.696 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.406 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 31.2 Cg_exo -54.58 -21.56 25.0 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.678 1.357 . . . . 0.0 110.235 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' B' ' 13' ' ' LEU . 0.4 OUTLIER -93.14 -46.74 7.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 110.369 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.54 171.67 25.68 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' B' ' 16' ' ' TYR . . . 116.63 -179.05 17.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' B' ' 15' ' ' GLY . 37.3 m-85 -152.5 91.58 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.913 ' HA2' HG22 ' B' ' 67' ' ' ILE . . . -151.03 -169.15 16.43 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.514 HG12 HD12 ' B' ' 101' ' ' ILE . 88.5 t -100.93 123.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.254 . . . . 0.0 109.71 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' CB ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -87.35 129.37 35.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.015 . . . . 0.0 110.94 -178.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.814 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -97.31 85.25 3.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.438 -0.789 . . . . 0.0 110.13 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 4.7 mtp180 -56.03 -25.09 43.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.545 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CD2' ' B' ' 24' ' ' PHE . 5.2 mtpp -84.6 -179.62 7.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.464 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.513 6.8 m 100.46 13.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.041 -1.662 . . . . 0.0 109.98 2.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 16.3 m-85 -107.59 142.63 37.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.195 -0.94 . . . . 0.0 110.275 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.48 171.08 9.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -67.05 100.85 0.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 110.153 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.43 -20.87 10.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.62 123.74 11.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -1.163 . . . . 0.0 110.547 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.856 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.2 tm? -66.02 113.65 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.527 HG23 HG23 ' B' ' 91' ' ' THR . 99.5 t -72.03 -53.14 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.184 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.421 ' O ' HD12 ' B' ' 89' ' ' ILE . 5.3 tt0 -174.14 144.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.26 158.19 34.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 110.406 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.444 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.1 p -150.81 -171.96 4.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 54.9 mt -100.53 167.7 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 95.2 m -145.19 161.56 39.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.058 -1.026 . . . . 0.0 110.524 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.781 HD11 HD23 ' B' ' 62' ' ' LEU . 54.9 mt -92.06 148.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 83' ' ' GLY . 42.9 t -124.02 90.5 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.95 . . . . 0.0 110.604 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.503 ' HG2' HG22 ' B' ' 36' ' ' ILE . 39.8 mmt180 -117.96 168.43 10.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -87.07 -176.31 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.883 . . . . 0.0 110.167 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.22 -137.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.976 . . . . 0.0 110.148 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 66.07 -148.11 0.21 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.805 -1.184 . . . . 0.0 110.547 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 26.9 m-20 -46.26 -34.78 4.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.219 -0.926 . . . . 0.0 111.123 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.889 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 60.8 t-105 -52.81 -57.22 10.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 110.077 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.416 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -60.36 -31.3 73.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.93 -65.19 0.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -50.54 73.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.256 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 1.008 HD12 ' CE ' ' B' ' 60' ' ' MET . 3.6 mm? -92.79 34.41 1.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 110.465 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.416 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 1.9 tm-20 -56.53 -17.59 8.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.049 -1.032 . . . . 0.0 111.299 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.76 156.44 19.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.971 -1.081 . . . . 0.0 111.073 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' B' ' 50' ' ' TYR . 7.0 m-30 55.28 26.36 8.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.475 -0.766 . . . . 0.0 110.775 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.889 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 10.6 tp -108.79 105.51 15.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 110.937 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' B' ' 52' ' ' PHE . 42.4 m-85 -88.56 105.27 17.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 3.1 t -105.4 147.51 28.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.152 -0.967 . . . . 0.0 110.907 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.975 ' HG2' HD11 ' B' ' 84' ' ' LEU . 10.3 ptm180 -115.66 -170.07 1.71 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.109 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.55 77.21 5.03 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.242 -0.911 . . . . 0.0 110.226 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.505 3.1 t30 165.94 -29.21 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.679 -0.638 . . . . 0.0 109.935 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.83 -164.15 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 110.934 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.402 ' OG ' ' NE1' ' B' ' 43' ' ' TRP . 6.2 t -130.27 141.09 50.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 110.241 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.565 ' HB3' HD22 ' B' ' 84' ' ' LEU . . . -132.78 149.43 52.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.637 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' MET . . . . . 1.008 ' CE ' HD12 ' B' ' 47' ' ' LEU . 32.9 tpp -93.48 154.84 17.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 110.215 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.07 92.05 8.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.781 HD23 HD11 ' B' ' 36' ' ' ILE 2.505 0.1 OUTLIER -52.29 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.949 -178.734 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.97 -155.15 0.03 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.694 ' HB3' HD13 ' B' ' 67' ' ' ILE . 31.6 m-85 -90.22 55.38 3.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -1.119 . . . . 0.0 111.053 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' CE2' ' B' ' 68' ' ' PHE . . . -94.92 -13.82 51.64 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.185 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.438 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -93.2 4.86 53.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.933 -1.334 . . . . 0.0 112.096 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.913 HG22 ' HA2' ' B' ' 17' ' ' GLY . 3.8 mp -88.76 -20.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.691 -1.256 . . . . 0.0 110.817 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.489 ' CE1' HG21 ' B' ' 18' ' ' VAL . 23.0 m-85 -52.43 143.62 14.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.917 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -112.33 -159.43 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.414 ' CD2' ' HG ' ' B' ' 111' ' ' LEU . 17.9 t-80 -102.42 136.12 42.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.358 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 73' ' ' ASP . 1.8 m -152.01 35.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.085 -1.009 . . . . 0.0 110.646 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' B' ' 74' ' ' PRO . 1.6 mmtp 58.11 -82.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.428 -0.795 . . . . 0.0 110.288 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' B' ' 71' ' ' SER . 4.5 m-20 -99.38 91.85 1.59 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.235 -0.916 . . . . 0.0 109.789 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.823 ' O ' HD11 ' B' ' 92' ' ' ILE . 11.4 Cg_endo -58.07 106.66 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.616 1.324 . . . . 0.0 110.476 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' B' ' 93' ' ' LYS . 71.6 m-80 -50.59 -23.76 2.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.593 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.851 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -142.73 159.53 42.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.462 ' NH2' ' NE2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -136.95 -173.85 3.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 110.177 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.462 ' NE2' ' NH2' ' B' ' 77' ' ' ARG . 7.5 p-80 -119.71 172.62 7.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 110.618 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -142.28 155.19 45.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.725 HD12 ' HD2' ' D' ' 218' ' ' PRO . 19.8 mt -123.38 143.34 50.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 110.428 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.464 HG22 ' NH2' ' B' ' 88' ' ' ARG . 20.3 p -73.0 -66.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 110.337 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.91 -35.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.483 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.443 ' O ' HG21 ' B' ' 37' ' ' VAL . . . -106.66 26.6 19.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.975 HD11 ' HG2' ' B' ' 54' ' ' ARG . 34.7 mt 51.82 28.79 5.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -1.182 . . . . 0.0 110.631 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.32 -36.15 10.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.84 135.76 54.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.705 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 13.0 mtp -126.78 116.69 21.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 110.258 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.821 ' HB3' HD21 ' B' ' 29' ' ' LEU . 45.2 mtt180 -101.49 131.53 47.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 110.397 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.421 HD12 ' O ' ' B' ' 31' ' ' GLU . 12.3 mt -88.68 98.44 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.856 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 14.0 m-85 -89.57 -169.24 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.527 HG23 HG23 ' B' ' 30' ' ' VAL . 26.7 p -132.62 98.42 4.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 110.087 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.823 HD11 ' O ' ' B' ' 74' ' ' PRO . 33.6 pt -54.6 -22.15 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -146.72 161.23 38.51 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.18 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -53.77 156.51 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.6 1.316 . . . . 0.0 110.823 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 76' ' ' ALA . 59.2 mt -138.49 134.99 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.35 167.93 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -64.51 119.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.59 30.79 5.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.36 140.41 37.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -1.22 . . . . 0.0 110.365 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.419 ' OE1' HG21 ' B' ' 102' ' ' THR . 1.3 tm-20 -87.49 121.08 29.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.01 -1.056 . . . . 0.0 109.946 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.851 HG23 ' HB3' ' B' ' 76' ' ' ALA . 60.6 mt -88.62 123.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.402 -0.811 . . . . 0.0 110.79 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.516 ' C ' HG23 ' B' ' 103' ' ' ILE . 72.0 p -145.55 -176.69 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.708 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.516 HG23 ' C ' ' B' ' 102' ' ' THR . 1.0 OUTLIER -151.67 160.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.356 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.5 -173.02 2.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.461 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 13.0 m-85 -125.53 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.339 -0.851 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 71.45 -160.27 54.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.96 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -1.0 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.43 ' CB ' ' HA ' ' D' ' 213' ' ' ALA . 0.2 OUTLIER -129.43 -35.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.742 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.461 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.5 OUTLIER -48.67 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.929 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.469 ' CD2' ' O ' ' B' ' 110' ' ' TRP . 54.8 p-90 -54.02 120.54 6.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' B' ' 111' ' ' LEU . 6.7 tp -83.72 -148.94 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.761 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.68 82.53 1.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.025 . . . . 0.0 110.57 -178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 2.7 ttt85 51.92 52.32 11.27 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.464 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 18.2 Cg_endo -65.82 -62.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.677 1.356 . . . . 0.0 110.577 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.85 -73.58 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.383 -0.823 . . . . 0.0 110.364 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.477 HD13 ' HA ' ' B' ' 116' ' ' LEU . 4.4 mm? 53.18 42.34 32.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 110.466 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 35.2 m -59.28 157.59 10.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 110.301 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 47.52 0.87 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.36 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.9 -38.69 6.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -1.121 . . . . 0.0 110.378 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -122.96 153.48 64.06 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.394 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.74 125.7 14.75 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.721 1.38 . . . . 0.0 110.526 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 -94.21 157.04 16.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.319 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -40.6 2.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -0.872 . . . . 0.0 110.353 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -76.13 165.61 24.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.334 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 3.0 mt -148.53 165.07 32.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.44 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.55 116.91 31.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.303 -0.873 . . . . 0.0 110.414 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 10.0 p -104.17 -32.53 9.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 110.25 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.45 177.28 6.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.333 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.82 -169.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 110.424 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 213' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' B' ' 108' ' ' ASP . . . 52.85 64.41 1.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 110.35 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' B' ' 53' ' ' SER . 3.8 mmp_? -106.36 -170.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.927 . . . . 0.0 110.335 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 2.6 p -53.78 173.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 110.391 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -150.08 165.56 17.22 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.725 ' HD2' HD12 ' B' ' 80' ' ' LEU . 17.3 Cg_endo -62.21 -177.88 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.601 1.316 . . . . 0.0 110.458 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.9 79.53 0.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 110.323 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 2.1 p -147.36 60.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 110.444 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.492 ' OXT' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.492 ' OXT' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' SD ' HG11 ' A' ' 8' ' ' VAL . 3.0 mmt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.236 0.541 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 41.3 p90 -166.13 128.56 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 110.345 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ARG . 12.8 p30 -119.39 167.0 12.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.358 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.67 64.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.538 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 177.89 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 0.0 109.623 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG23 ' C ' ' A' ' 5' ' ' ARG . 96.4 t -153.55 158.97 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.738 HG23 ' HB2' ' A' ' 19' ' ' PHE . 5.1 tt -134.95 158.94 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.442 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' A' ' 10' ' ' LYS . 61.7 t -99.24 114.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 110.795 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 14.1 mttt -127.6 141.68 51.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.614 ' HE2' HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 52.4 56.65 7.39 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 119.821 -1.799 . . . . 0.0 110.196 2.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -108.66 175.51 1.94 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.596 -0.69 . . . . 0.0 110.263 -179.005 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -68.18 -20.92 42.92 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.7 1.369 . . . . 0.0 110.432 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.57 56.12 0.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.881 . . . . 0.0 110.408 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.4 -146.13 4.36 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.67 -162.46 9.85 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.511 ' CZ ' ' HD3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -77.9 59.13 2.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 110.299 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -105.13 -165.59 23.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.3 p -114.03 131.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.903 -1.351 . . . . 0.0 109.502 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -88.57 141.77 28.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.363 -0.835 . . . . 0.0 110.602 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.763 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -93.58 93.54 8.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.699 -0.626 . . . . 0.0 110.706 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -65.63 -15.75 63.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 0.0 109.877 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 6.7 mttt -108.61 179.05 4.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 20.1 m 102.25 21.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.012 -1.68 . . . . 0.0 109.727 2.24 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 17.5 m-85 -114.6 161.47 18.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 110.637 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.37 170.95 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 11.3 tttm -72.53 88.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.91 52.15 0.21 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.18 136.57 52.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.76 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 2.0 tm? -67.09 117.29 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 110.211 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.724 ' CG2' HG23 ' A' ' 91' ' ' THR . 38.3 t -98.53 85.42 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.32 -0.863 . . . . 0.0 109.563 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.508 ' O ' HD11 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.62 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 110.304 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.402 ' OE1' ' HG2' ' A' ' 88' ' ' ARG . 18.4 tt0 -154.13 160.53 41.96 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.011 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 1.062 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 26.7 p -150.75 160.96 43.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 111.072 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.9 mt -96.65 176.78 5.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.872 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' CG ' ' A' ' 87' ' ' MET . 83.8 m -149.25 166.39 29.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.017 HD11 HD23 ' A' ' 62' ' ' LEU . 48.4 mt -103.13 154.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.972 HG13 HD23 ' A' ' 84' ' ' LEU . 41.2 t -131.17 118.49 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.893 -1.129 . . . . 0.0 110.641 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 29.7 mmt180 -136.79 147.77 46.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.58 58.78 2.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 111.297 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 1.9 t-20 49.8 -141.31 0.7 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 111.019 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 44' ' ' GLY . 2.3 t70 67.35 -144.8 0.14 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.036 -1.04 . . . . 0.0 110.169 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.13 -35.85 12.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.935 -1.103 . . . . 0.0 110.297 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.737 ' CE3' HD21 ' B' ' 47' ' ' LEU . 17.2 t-105 -63.73 -34.61 78.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 109.129 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -62.43 -60.38 7.94 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 54.6 m -66.17 -45.84 79.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.19 -1.182 . . . . 0.0 110.666 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -62.0 2.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 0.0 109.1 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.719 HD21 ' CE3' ' B' ' 43' ' ' TRP . 4.3 mm? -93.19 36.27 1.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.471 -0.768 . . . . 0.0 110.795 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.454 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -69.4 61.71 0.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.093 -1.004 . . . . 0.0 110.325 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 178.78 145.36 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.487 -0.758 . . . . 0.0 109.015 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 11.2 m-85 57.35 26.72 12.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.918 -1.113 . . . . 0.0 109.31 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.737 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 3.1 tp -107.86 112.93 25.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 111.285 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HA ' ' HB3' ' C' ' 215' ' ' MLZ . 74.1 m-85 -89.4 108.44 19.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.161 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.455 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 23.2 t -107.39 143.91 35.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.509 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.637 ' HG2' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -118.86 -165.62 1.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.522 -0.736 . . . . 0.0 109.781 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 75.4 8.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.363 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.86 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.507 -179.609 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 179.95 -174.6 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.591 -0.693 . . . . 0.0 110.324 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.464 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 26.0 p -111.95 134.89 53.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.336 -0.852 . . . . 0.0 110.432 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.9 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -117.12 174.44 6.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.674 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -120.35 160.09 23.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.788 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -89.09 99.13 12.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 110.226 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 36' ' ' ILE 2.497 0.1 OUTLIER -58.4 -81.11 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.86 . . . . 0.0 110.922 -179.437 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.3 -130.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.88 45.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 110.769 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' CA ' ' HB1' ' A' ' 61' ' ' ALA . . . -90.5 -20.67 40.2 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . . . -90.69 -43.56 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.45 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 1.3 pp -48.97 -25.64 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.213 -0.929 . . . . 0.0 110.367 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CE1' HG11 ' A' ' 18' ' ' VAL . 9.2 m-85 -48.96 144.99 4.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 110.638 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' CG2' ' A' ' 102' ' ' THR . 32.9 m120 -118.65 174.69 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.577 ' CE1' ' CE2' ' A' ' 110' ' ' TRP . 1.8 t-160 -101.54 109.52 21.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.07 146.67 48.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.44 127.54 32.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.78 71.0 1.57 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.952 . . . . 0.0 110.255 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.532 ' O ' HD11 ' A' ' 92' ' ' ILE . 12.9 Cg_endo -60.65 174.25 1.74 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.663 1.349 . . . . 0.0 110.595 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 93' ' ' LYS . 17.5 p30 -117.66 -13.12 10.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 110.569 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.05 143.96 51.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.06 166.93 13.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -0.933 . . . . 0.0 110.081 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.21 158.99 17.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.731 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 19.6 tt0 -132.94 136.68 46.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 110.147 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.564 HD12 ' HD2' ' C' ' 218' ' ' PRO . 6.1 mt -114.6 145.13 42.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.037 -1.039 . . . . 0.0 110.419 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 86' ' ' ARG . 14.2 p -53.93 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 110.396 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.38 -60.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.66 42.81 1.86 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.972 HD23 HG13 ' A' ' 37' ' ' VAL . 4.4 tp 59.25 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.298 -1.119 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -177.2 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 110.084 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.582 ' O ' HG23 ' A' ' 81' ' ' THR . 1.3 mpt_? -113.3 140.1 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.756 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . 1.062 ' SD ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 ppp? -137.24 169.85 17.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.113 -0.992 . . . . 0.0 110.666 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.734 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -131.37 -179.74 5.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.346 -0.846 . . . . 0.0 110.637 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.403 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 6.5 mt -130.21 108.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 0.0 109.646 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.76 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 51.8 m-85 -97.2 -170.68 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.724 HG23 ' CG2' ' A' ' 30' ' ' VAL . 23.1 p -128.35 98.95 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.532 HD11 ' O ' ' A' ' 74' ' ' PRO . 48.5 pt -60.06 -16.58 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 110.696 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 75' ' ' ASN . 1.1 ptpm? -148.69 156.94 41.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.96 142.86 93.61 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.582 1.306 . . . . 0.0 110.379 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.614 HG23 ' HG3' ' A' ' 99' ' ' GLU . 54.4 mt -124.33 141.97 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.671 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.76 153.66 20.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.882 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -48.25 -24.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.46 -0.775 . . . . 0.0 111.313 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.34 60.68 0.32 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 95' ' ' ILE . 3.3 mm-40 -116.28 165.05 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 111.274 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.19 115.56 29.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.915 ' HB ' HG13 ' A' ' 18' ' ' VAL . 58.5 mt -88.79 127.49 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.3 p -155.55 148.41 24.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 104' ' ' SER . 1.3 pp -115.91 155.32 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 0.0 110.749 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.543 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -90.61 -173.95 3.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 110.06 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.522 ' CD2' ' ND1' ' A' ' 70' ' ' HIS . 9.0 m-85 -123.63 -66.36 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.988 . . . . 0.0 110.093 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.43 -175.28 44.37 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.71 -33.28 68.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -1.166 . . . . 0.0 110.377 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -72.82 -66.95 0.6 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.366 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.443 ' CD2' ' HG2' ' C' ' 215' ' ' MLZ . 0.2 OUTLIER -68.48 71.93 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.92 . . . . 0.0 110.493 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.577 ' CE2' ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -153.82 -156.15 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.441 179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.28 -71.21 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 110.593 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.37 -79.57 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 0.0 110.701 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.45 61.5 13.72 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.582 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.07 -40.3 2.6 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.597 1.314 . . . . 0.0 110.6 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 54.97 19.85 2.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.34 -0.85 . . . . 0.0 110.754 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER 47.2 39.42 8.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 111.098 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.7 m -132.16 -69.54 0.59 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 110.514 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.18 57.8 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.388 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 60.51 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -1.12 . . . . 0.0 110.311 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' C' ' 204' ' ' PRO . . . -92.85 144.48 28.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.923 . . . . 0.0 110.48 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' C' ' 203' ' ' ALA . 25.0 Cg_exo -59.25 -33.52 97.97 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.651 1.343 . . . . 0.0 110.582 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 53.31 84.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 0.0 110.331 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.12 111.73 7.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 110.398 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 53.7 176.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.45 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.98 178.47 6.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.176 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.77 -54.03 49.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.943 . . . . 0.0 110.293 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 7.6 m 52.59 52.96 13.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.453 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -60.36 -67.03 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 110.321 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -174.88 79.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.33 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -149.27 91.84 1.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.391 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.455 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 2.1 tpp180 -77.12 -148.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.274 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.443 ' HG2' ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 3.4 p -52.55 176.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 110.392 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -160.63 167.99 12.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.927 . . . . 0.0 110.39 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 17.6 Cg_endo -59.36 -43.8 37.94 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.734 1.386 . . . . 0.0 110.425 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.33 82.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 110.477 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -101.85 160.56 14.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.903 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.424 ' SD ' HG11 ' B' ' 8' ' ' VAL . 3.0 mmt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.295 0.569 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 41.5 p90 -166.15 128.63 1.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.345 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 12.7 p30 -119.4 167.01 12.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 110.373 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.71 64.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 110.345 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.531 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.0 OUTLIER 177.87 -33.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.39 -0.819 . . . . 0.0 109.639 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.531 HG23 ' C ' ' B' ' 5' ' ' ARG . 96.6 t -153.45 159.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.733 HG23 ' HB2' ' B' ' 19' ' ' PHE . 5.1 tt -134.98 158.9 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.412 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.611 HG12 ' HE2' ' B' ' 10' ' ' LYS . 62.0 t -99.27 114.81 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.55 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 14.1 mttt -127.72 141.83 51.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.611 ' HE2' HG12 ' B' ' 8' ' ' VAL . 0.3 OUTLIER 52.59 56.59 7.43 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 119.777 -1.827 . . . . 0.0 110.13 1.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.478 ' HB2' ' CZ ' ' B' ' 19' ' ' PHE . 0.0 OUTLIER -108.68 175.51 1.94 Allowed Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.554 -0.716 . . . . 0.0 110.304 -179.042 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -68.22 -20.87 42.72 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.637 1.335 . . . . 0.0 110.457 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.59 56.18 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 110.385 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.44 -146.09 4.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . -134.72 -162.42 9.82 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.505 ' CZ ' ' HD3' ' B' ' 10' ' ' LYS . 0.2 OUTLIER -77.7 59.42 2.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 110.353 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -105.63 -165.73 23.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.952 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.4 p -113.95 130.83 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.927 -1.337 . . . . 0.0 109.637 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.733 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.4 OUTLIER -87.71 141.86 28.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.835 . . . . 0.0 110.773 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.747 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -93.71 93.54 8.06 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.861 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.1 OUTLIER -65.64 -15.62 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.914 178.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 6.7 mttt -108.68 179.01 4.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 108.757 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 20.1 m 102.25 20.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.064 -1.648 . . . . 0.0 109.757 2.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 17.5 m-85 -114.52 161.51 17.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 110.685 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.48 170.97 8.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.964 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -72.5 88.76 1.24 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 110.432 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.85 52.2 0.21 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.22 136.58 52.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.759 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 2.0 tm? -67.14 117.38 9.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.73 ' CG2' HG23 ' B' ' 91' ' ' THR . 38.4 t -98.58 85.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.577 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.502 ' O ' HD11 ' B' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.708 -0.62 . . . . 0.0 110.256 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' B' ' 87' ' ' MET . 18.5 tt0 -154.11 160.8 42.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 1.071 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 26.7 p -151.08 160.9 43.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 111.031 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.67 176.73 5.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.301 -0.874 . . . . 0.0 109.851 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -149.16 166.42 28.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.079 . . . . 0.0 111.369 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 1.008 HD11 HD23 ' B' ' 62' ' ' LEU . 48.2 mt -103.12 154.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.973 HG13 HD23 ' B' ' 84' ' ' LEU . 41.6 t -131.16 118.47 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.972 -1.08 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.548 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 29.6 mmt180 -136.78 147.76 46.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.218 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.48 58.71 2.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 111.317 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 1.9 t-20 49.79 -141.33 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.127 -0.983 . . . . 0.0 111.085 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 2.3 t70 67.43 -144.9 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.022 -1.049 . . . . 0.0 110.116 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -48.11 -35.83 12.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.9 -1.125 . . . . 0.0 110.272 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.725 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 17.1 t-105 -63.77 -34.58 78.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 0.0 109.154 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -62.42 -60.44 7.86 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' B' ' 48' ' ' GLU . 54.1 m -65.88 -46.04 79.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -1.197 . . . . 0.0 110.64 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.414 ' O ' ' NH2' ' A' ' 38' ' ' ARG . . . -57.02 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.885 -1.135 . . . . 0.0 109.276 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.737 HD21 ' CE3' ' A' ' 43' ' ' TRP . 4.4 mm? -94.98 36.96 1.16 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.444 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -69.66 61.68 0.16 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -0.953 . . . . 0.0 110.274 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.477 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.9 OUTLIER 178.73 145.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 11.1 m-85 57.37 26.7 12.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.923 -1.111 . . . . 0.0 109.287 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.725 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 3.1 tp -107.82 112.8 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 111.401 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.408 ' HA ' ' HB3' ' D' ' 215' ' ' MLZ . 74.4 m-85 -89.22 108.5 19.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.458 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 23.0 t -107.36 143.89 35.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.006 . . . . 0.0 111.508 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.627 ' HG2' HD13 ' B' ' 84' ' ' LEU . 0.6 OUTLIER -119.46 -168.72 1.63 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.523 -0.736 . . . . 0.0 109.735 178.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 74.81 4.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.369 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.79 -35.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -179.735 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -179.75 -174.27 0.28 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.522 -0.736 . . . . 0.0 110.367 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.463 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 26.4 p -112.16 134.9 53.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 110.399 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -117.09 174.41 6.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 110.65 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.675 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -120.34 159.76 24.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -88.65 99.18 12.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.818 . . . . 0.0 110.238 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 1.008 HD23 HD11 ' B' ' 36' ' ' ILE 2.496 0.1 OUTLIER -58.49 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -179.528 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -63.25 -130.39 0.01 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -90.06 46.22 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -1.162 . . . . 0.0 110.68 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.528 ' CA ' ' HB1' ' B' ' 61' ' ' ALA . . . -90.98 -20.16 40.41 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' B' ' 61' ' ' ALA . . . -91.25 -43.33 9.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 110.627 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.461 ' CD1' ' HB ' ' B' ' 18' ' ' VAL . 1.3 pp -49.09 -25.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.197 -0.939 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.466 ' CE1' HG11 ' B' ' 18' ' ' VAL . 9.2 m-85 -48.96 145.29 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 110.627 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.402 ' HB2' ' CG2' ' B' ' 102' ' ' THR . 32.9 m120 -118.94 174.75 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.517 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.578 ' CE1' ' CE2' ' B' ' 110' ' ' TRP . 1.8 t-160 -101.68 109.54 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 110.19 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.06 146.71 48.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.5 127.61 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.65 71.1 1.55 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.228 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.543 ' O ' HD11 ' B' ' 92' ' ' ILE . 12.9 Cg_endo -60.66 174.23 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.71 1.374 . . . . 0.0 110.555 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.46 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 17.4 p30 -117.65 -13.09 10.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.07 144.01 51.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.038 -1.039 . . . . 0.0 110.201 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.08 166.91 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.19 159.02 17.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.766 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' B' ' 88' ' ' ARG . 19.7 tt0 -133.06 136.6 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.151 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.574 HD12 ' HD2' ' D' ' 218' ' ' PRO . 6.1 mt -114.51 145.17 42.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.063 -1.023 . . . . 0.0 110.453 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.586 HG23 ' O ' ' B' ' 86' ' ' ARG . 14.2 p -53.95 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 110.385 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.36 -60.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 110.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.59 42.76 1.88 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.973 HD23 HG13 ' B' ' 37' ' ' VAL . 4.4 tp 59.33 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.273 -1.133 . . . . 0.0 110.513 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -177.23 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.03 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.586 ' O ' HG23 ' B' ' 81' ' ' THR . 1.3 mpt_? -113.31 140.06 48.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' MET . . . . . 1.071 ' SD ' ' SG ' ' B' ' 33' ' ' CYS . 3.9 ppp? -137.2 169.83 17.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 110.71 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.722 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -131.33 -179.66 5.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 0.0 110.648 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 mt -130.32 108.13 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.817 . . . . 0.0 109.597 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.759 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 51.7 m-85 -97.22 -170.66 2.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 110.653 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.73 HG23 ' CG2' ' B' ' 30' ' ' VAL . 23.2 p -128.34 98.86 5.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.429 -0.794 . . . . 0.0 110.162 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.543 HD11 ' O ' ' B' ' 74' ' ' PRO . 48.6 pt -59.98 -16.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.688 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 1.1 ptpm? -148.67 156.92 41.66 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 110.175 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.94 142.86 93.5 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.633 1.333 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.607 HG23 ' HG3' ' B' ' 99' ' ' GLU . 54.6 mt -124.32 141.9 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 110.684 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.65 153.7 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.805 . . . . 0.0 110.886 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.861 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -48.2 -24.97 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 111.243 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.37 60.8 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' B' ' 95' ' ' ILE . 3.4 mm-40 -116.36 165.0 13.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.267 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -112.31 115.0 28.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.476 -0.765 . . . . 0.0 109.003 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.952 ' HB ' HG13 ' B' ' 18' ' ' VAL . 58.4 mt -87.95 127.6 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.997 . . . . 0.0 111.261 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.521 HG23 ' O ' ' B' ' 101' ' ' ILE . 15.8 p -155.68 148.46 24.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.547 HD12 ' O ' ' B' ' 104' ' ' SER . 1.3 pp -115.86 155.25 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 110.793 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.547 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.6 OUTLIER -90.66 -174.08 3.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.527 ' CD2' ' ND1' ' B' ' 70' ' ' HIS . 8.9 m-85 -123.37 -66.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.201 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 -175.28 44.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -33.25 68.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -1.124 . . . . 0.0 110.371 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -66.91 0.61 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.447 ' CD2' ' HG2' ' D' ' 215' ' ' MLZ . 0.2 OUTLIER -68.5 71.94 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.578 ' CE2' ' CE1' ' B' ' 70' ' ' HIS . 0.0 OUTLIER -153.86 -156.19 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 110.417 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.26 -71.24 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.387 -0.821 . . . . 0.0 110.539 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.33 -79.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 110.673 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.46 61.54 13.77 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.579 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.17 -40.33 2.5 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.603 1.317 . . . . 0.0 110.553 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 55.15 19.74 3.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.31 -0.869 . . . . 0.0 110.7 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' B' ' 116' ' ' LEU . 0.1 OUTLIER 47.22 39.41 8.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.871 . . . . 0.0 111.082 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -132.23 -69.48 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.519 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.16 57.8 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 110.305 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.369 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.66 60.45 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -1.15 . . . . 0.0 110.312 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' D' ' 204' ' ' PRO . . . -92.78 144.53 28.72 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 110.509 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' D' ' 203' ' ' ALA . 25.2 Cg_exo -59.21 -33.62 98.13 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.623 1.328 . . . . 0.0 110.535 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 53.43 84.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.324 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.16 111.81 7.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 110.415 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 53.6 176.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.479 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.99 178.47 6.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 110.167 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.74 -54.04 49.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 110.311 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 7.5 m 52.65 52.89 13.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 110.473 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -60.35 -67.01 0.43 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 110.331 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -174.92 79.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.332 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -149.2 91.82 1.88 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 110.393 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.458 ' CB ' ' HB3' ' B' ' 53' ' ' SER . 2.1 tpp180 -77.09 -148.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.288 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.447 ' HG2' ' CD2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 3.3 p -52.56 176.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 110.339 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -160.66 167.87 12.85 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 110.439 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 16.9 Cg_endo -59.16 -43.91 38.28 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.709 1.373 . . . . 0.0 110.46 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.4 82.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -101.91 160.5 14.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 110.427 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.509 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.476 ' HN2' ' CB ' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.476 ' HN2' ' CB ' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.543 ' SD ' ' SG ' ' B' ' 33' ' ' CYS . 1.2 tpt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.256 0.55 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 12.9 p90 -151.94 70.99 0.95 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.244 -0.91 . . . . 0.0 110.189 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 5' ' ' ARG . 2.4 m120 -153.93 -81.96 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 111.477 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 6' ' ' VAL . 31.9 t0 -41.3 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.3 mtt180 42.49 20.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.485 -0.759 . . . . 0.0 112.785 177.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 5' ' ' ARG . 44.7 t -158.34 156.29 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.667 -1.271 . . . . 0.0 110.842 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 15.5 tt -143.65 142.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.607 . . . . 0.0 109.717 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 8' ' ' VAL . 11.6 p -89.07 135.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.936 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.9 mttt -141.45 143.86 34.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.636 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.73 56.92 6.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 119.535 -1.978 . . . . 0.0 110.281 4.055 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.503 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -113.0 178.74 0.9 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.776 -0.577 . . . . 0.0 110.034 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 11' ' ' SER . 5.0 Cg_exo -71.99 -24.46 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.592 1.312 . . . . 0.0 110.31 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.65 27.37 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.055 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.43 169.33 22.33 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . -92.13 -145.56 16.14 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -95.31 68.29 3.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -1.189 . . . . 0.0 110.496 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.37 -162.88 14.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 67' ' ' ILE . 89.0 t -99.87 136.39 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.281 . . . . 0.0 110.205 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -101.06 128.09 47.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.117 -0.989 . . . . 0.0 109.603 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.866 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.28 97.89 11.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.566 -0.709 . . . . 0.0 111.077 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.863 ' O ' HG23 ' A' ' 97' ' ' ILE . 5.0 ttt180 -75.24 -19.73 59.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.77 4.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.383 -0.823 . . . . 0.0 109.224 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.438 ' HA ' ' HG3' ' A' ' 22' ' ' LYS 2.516 59.4 m 102.2 24.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.119 -1.613 . . . . 0.0 109.922 1.202 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 26.1 m-85 -116.0 160.49 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 110.909 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.37 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 16.7 tttm -97.37 86.75 3.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 110.145 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.2 78.87 1.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' C ' ' CD2' ' A' ' 90' ' ' PHE . 1.2 mt-10 -155.14 138.14 15.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 110.453 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.72 HD11 ' OE1' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -54.48 153.7 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.978 . . . . 0.0 109.612 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 91' ' ' THR . 95.3 t -137.98 -49.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.981 -1.074 . . . . 0.0 110.218 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.897 ' O ' HD12 ' A' ' 89' ' ' ILE . 7.1 tp10 -161.36 115.94 2.03 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.408 -0.808 . . . . 0.0 109.916 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.72 ' OE1' HD11 ' A' ' 29' ' ' LEU . 20.3 pt-20 -124.35 144.8 49.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 110.149 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.44 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 74.8 m -139.68 -160.96 1.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.089 -1.007 . . . . 0.0 111.055 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' NH2' ' A' ' 86' ' ' ARG . 3.0 mm? -94.54 178.56 5.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.371 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -150.91 159.34 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.638 HD11 ' CD2' ' A' ' 62' ' ' LEU . 48.3 mt -105.57 107.02 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 84' ' ' LEU . 87.6 t -88.82 122.33 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.384 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 17.3 tpt180 -139.63 148.73 42.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.34 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.12 -172.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.622 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -96.81 114.43 26.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.511 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.08 -139.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' B' ' 46' ' ' ALA . 2.7 p30 -49.76 -26.43 3.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.801 -1.187 . . . . 0.0 109.733 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.571 ' CE2' HD21 ' A' ' 51' ' ' LEU . 20.3 t-105 -70.63 -43.77 68.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.638 -0.664 . . . . 0.0 109.21 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.88 -28.3 60.45 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -90.61 -63.79 1.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -1.137 . . . . 0.0 110.693 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' HB2' ' OD1' ' B' ' 42' ' ' ASP . . . -48.89 -58.81 4.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.161 -0.962 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.968 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.0 mm? -91.8 41.0 1.05 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.331 -0.856 . . . . 0.0 109.644 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -8.49 31.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.985 . . . . 0.0 111.052 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.43 169.39 9.36 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.894 -1.129 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CE1' ' OXT' ' A' ' 301' ' ' SAH . 24.1 m-85 52.03 25.95 3.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.428 -0.795 . . . . 0.0 110.57 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.751 HD22 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -115.93 126.56 54.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 0.0 111.077 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -88.85 104.05 16.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 36.1 t -89.02 120.58 30.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.09 -1.007 . . . . 0.0 111.228 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -179.5 4.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.702 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -83.35 80.78 8.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.974 -1.079 . . . . 0.0 109.269 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.21 -23.69 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.777 -0.577 . . . . 0.0 109.922 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.71 -178.47 0.89 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 110.835 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 16.7 m -123.36 139.08 54.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.974 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -132.82 153.22 51.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 111.073 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.968 ' CE ' HD12 ' A' ' 47' ' ' LEU . 38.6 tpp -89.64 155.18 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.76 93.62 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.627 -0.671 . . . . 0.0 110.639 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -55.95 -34.19 65.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 179.847 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 33' ' ' CYS . . . -86.94 -136.94 4.88 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.843 ' HB3' HD11 ' A' ' 67' ' ' ILE . 85.0 m-85 -90.49 19.46 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.349 -1.089 . . . . 0.0 110.617 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.678 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -61.85 -21.18 60.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.52 -59.18 2.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -1.215 . . . . 0.0 111.144 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' ' 64' ' ' PHE . 2.5 pp -53.79 -18.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.283 -0.886 . . . . 0.0 111.648 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE1' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -49.07 146.47 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.852 -1.155 . . . . 0.0 110.735 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.3 171.5 8.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -93.16 148.49 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.58 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.33 131.43 5.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' CG ' ' HG ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -52.42 -27.9 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.495 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -117.53 76.51 9.99 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.89 . . . . 0.0 110.386 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.897 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.6 Cg_endo -64.98 104.18 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.665 1.35 . . . . 0.0 110.468 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.476 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 5.5 m-20 -72.15 -10.76 60.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.657 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 90' ' ' PHE . . . -146.22 160.6 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.953 -1.092 . . . . 0.0 110.855 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.03 155.36 43.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 78' ' ' HIS . 21.0 p-80 -90.02 136.13 33.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.613 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.41 13.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 110.164 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 80' ' ' LEU . 17.9 mt -121.82 161.53 22.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.499 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 24.0 m -131.32 119.58 21.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.44 -0.787 . . . . 0.0 110.082 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.11 64.57 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.49 -119.51 6.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 37' ' ' VAL . 60.7 mt -118.54 26.51 9.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -1.136 . . . . 0.0 110.346 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.73 -56.69 4.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 110.431 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.459 ' NH2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -119.09 150.38 40.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.75 147.77 41.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -0.999 . . . . 0.0 110.603 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 3.4 mtt180 -125.25 163.03 23.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 110.324 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 31' ' ' GLU . 26.7 mt -136.08 113.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.442 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.573 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 6.3 m-85 -112.58 178.08 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.908 . . . . 0.0 110.792 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 30' ' ' VAL . 15.2 p -121.64 99.07 6.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.376 -0.828 . . . . 0.0 110.496 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.897 HD11 ' O ' ' A' ' 74' ' ' PRO . 21.5 pt -52.8 -28.4 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.044 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.476 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -135.04 144.11 48.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 109.974 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 44.5 Cg_exo -49.21 145.67 14.51 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.619 1.326 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.477 HG21 ' HB1' ' A' ' 20' ' ' ALA . 73.4 mt -122.51 148.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.937 . . . . 0.0 110.568 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.88 152.26 21.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 110.294 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 21' ' ' ARG . 43.8 mt -53.95 -20.29 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.79 . . . . 0.0 111.148 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.58 59.3 0.38 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.13 179.1 6.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.145 -1.209 . . . . 0.0 110.718 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 18' ' ' VAL . 10.0 tt0 -125.22 128.43 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 110.013 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.866 HG13 ' HB2' ' A' ' 20' ' ' ALA . 61.3 mt -89.37 132.54 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 110.548 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 101' ' ' ILE . 13.8 p -151.37 166.24 31.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.641 -0.662 . . . . 0.0 109.888 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 104' ' ' SER . 2.2 pp -137.86 156.45 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.117 -0.989 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.642 ' O ' HD12 ' A' ' 103' ' ' ILE . 37.0 t -91.83 -163.5 1.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.358 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 104' ' ' SER . 15.3 m-85 -132.32 -55.96 0.97 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.298 -0.876 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.74 163.88 2.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.8 OUTLIER 54.62 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -1.017 . . . . 0.0 111.151 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' C' ' 213' ' ' ALA . 2.6 m-20 58.75 -73.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.507 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.4 OUTLIER -42.09 107.82 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.449 -0.782 . . . . 0.0 111.944 -177.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.463 ' CH2' " O2'" ' A' ' 301' ' ' SAH . 0.8 OUTLIER 46.12 -151.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.801 . . . . 0.0 111.488 178.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 111' ' ' LEU . 9.1 tt -46.8 138.42 6.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.448 -0.782 . . . . 0.0 111.258 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.402 ' N ' HD23 ' A' ' 111' ' ' LEU . 69.0 m -115.1 -21.6 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -0.829 . . . . 0.0 110.195 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.445 ' CB ' ' HD2' ' A' ' 114' ' ' PRO . 11.9 mtt-85 -50.92 175.21 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 110.378 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 113' ' ' ARG . 9.5 Cg_endo -56.66 -162.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.681 1.358 . . . . 0.0 110.854 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' A' ' 115' ' ' ARG . 4.9 mpt_? -109.48 43.65 1.28 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.26 -0.9 . . . . 0.0 110.786 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 116' ' ' LEU . 4.1 mm? 49.93 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.273 -0.892 . . . . 0.0 110.872 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -91.46 126.65 36.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 110.271 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 53.11 72.61 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 110.329 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 6.5 t30 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.371 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.6 176.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -1.152 . . . . 0.0 110.339 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.09 67.05 4.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -58.13 88.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.588 1.309 . . . . 0.0 110.553 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? 52.47 59.52 4.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.426 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.83 59.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 110.38 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -170.73 91.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 110.381 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 tp -122.98 -40.33 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.89 . . . . 0.0 110.257 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.59 168.15 28.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 110.268 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 32.7 p -127.68 -41.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 110.511 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -115.1 165.29 13.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 110.304 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -123.83 -170.26 2.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 213' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 108' ' ' ASP . . . -115.25 27.78 9.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 3.0 mpp_? 49.15 -163.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.875 . . . . 0.0 110.871 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m -51.95 170.66 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 0.0 110.471 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.56 144.3 49.18 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.3 -163.4 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.623 1.328 . . . . 0.0 110.856 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -116.71 106.1 13.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.7 t -155.34 -156.85 0.69 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 110.295 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.283 0.563 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 7' ' ' ILE . 13.2 p90 -151.98 72.59 1.02 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.023 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 5' ' ' ARG . 2.4 m120 -155.8 -81.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' B' ' 6' ' ' VAL . 31.9 t0 -41.59 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.586 ' O ' HG23 ' B' ' 6' ' ' VAL . 15.3 mtt180 42.57 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 112.841 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 5' ' ' ARG . 44.6 t -158.31 156.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.591 -1.318 . . . . 0.0 110.831 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 15.4 tt -143.9 142.28 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.65 -0.656 . . . . 0.0 109.789 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 8' ' ' VAL . 11.9 p -88.56 135.47 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 111.088 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.646 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.7 mttt -141.72 143.85 33.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.895 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.81 56.89 6.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.617 -1.927 . . . . 0.0 110.297 4.023 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.499 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.9 OUTLIER -113.05 178.64 0.92 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.725 -0.609 . . . . 0.0 110.037 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.432 ' CD ' ' HB2' ' B' ' 11' ' ' SER . 4.8 Cg_exo -71.89 -24.48 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.584 1.308 . . . . 0.0 110.366 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.65 27.42 1.22 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 110.047 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.45 169.29 22.36 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . -92.1 -145.52 16.01 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -95.28 68.36 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.6 -162.81 14.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.521 ' CG2' HD11 ' B' ' 67' ' ' ILE . 85.8 t -99.84 136.23 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.263 . . . . 0.0 110.247 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.509 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -101.03 127.83 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.858 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -88.84 97.87 11.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 111.139 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.852 ' O ' HG23 ' B' ' 97' ' ' ILE . 5.0 ttt180 -75.26 -19.62 59.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.412 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.49 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.82 4.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' B' ' 22' ' ' LYS 2.518 60.7 m 102.26 24.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.187 -1.571 . . . . 0.0 109.909 1.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 26.1 m-85 -115.9 160.54 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 110.92 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.492 -0.755 . . . . 0.0 109.965 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.423 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 16.6 tttm -97.36 86.7 3.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.145 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.18 78.92 1.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.415 ' C ' ' CD2' ' B' ' 90' ' ' PHE . 1.2 mt-10 -155.15 138.12 15.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -1.179 . . . . 0.0 110.471 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.711 HD11 ' OE1' ' B' ' 32' ' ' GLU . 0.3 OUTLIER -54.38 153.73 5.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.123 -0.986 . . . . 0.0 109.602 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.683 HG21 HG23 ' B' ' 91' ' ' THR . 95.5 t -138.05 -49.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.001 -1.062 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.897 ' O ' HD12 ' B' ' 89' ' ' ILE . 7.1 tp10 -161.42 116.0 2.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.711 ' OE1' HD11 ' B' ' 29' ' ' LEU . 20.3 pt-20 -124.42 144.8 49.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.083 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.543 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 75.9 m -139.68 -160.91 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.019 . . . . 0.0 111.004 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.473 HD21 ' NH2' ' B' ' 86' ' ' ARG . 3.0 mm? -94.53 179.03 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 110.405 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -151.5 159.09 44.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.278 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.643 HD11 ' CD2' ' B' ' 62' ' ' LEU . 48.9 mt -105.61 106.53 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 109.798 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.698 HG22 ' CB ' ' B' ' 84' ' ' LEU . 89.9 t -88.13 122.37 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.51 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CD1' ' B' ' 43' ' ' TRP . 17.3 tpt180 -139.67 148.72 42.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.372 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.11 -172.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.6 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -96.79 114.46 26.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.12 -140.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 109.488 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.564 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 2.7 p30 -49.74 -26.49 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.871 -1.143 . . . . 0.0 109.732 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.598 ' HZ3' HD11 ' A' ' 47' ' ' LEU . 20.3 t-105 -70.54 -43.8 68.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.9 -27.99 60.12 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 88.1 m -91.03 -63.63 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -1.151 . . . . 0.0 110.608 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.491 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . . . -49.11 -58.11 5.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.147 -0.97 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.985 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.0 mm? -92.79 41.29 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -8.48 32.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 111.024 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.38 169.32 9.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.952 -1.093 . . . . 0.0 110.163 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.48 ' CE1' ' OXT' ' B' ' 302' ' ' SAH . 24.0 m-85 52.17 25.76 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 110.63 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.755 HD22 ' O ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -115.9 126.1 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 111.187 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.35 103.59 15.97 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 38.1 t -88.24 120.67 29.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.985 . . . . 0.0 111.381 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 177.73 5.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.725 . . . . 0.0 109.709 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -79.43 80.43 5.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 110.126 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.09 -23.82 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.913 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.64 -178.43 0.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.896 . . . . 0.0 110.817 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 16.5 m -123.32 139.01 54.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -132.95 153.04 51.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.014 -1.054 . . . . 0.0 111.112 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.985 ' CE ' HD12 ' B' ' 47' ' ' LEU . 38.7 tpp -89.49 154.73 19.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.681 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.19 93.6 9.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.499 0.1 OUTLIER -56.03 -34.11 65.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 179.781 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' B' ' 33' ' ' CYS . . . -86.9 -136.75 4.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.82 ' HB3' HD11 ' B' ' 67' ' ' ILE . 85.2 m-85 -90.8 19.55 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 110.534 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.681 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -61.87 -20.94 60.47 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.89 -59.1 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.237 . . . . 0.0 111.076 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' B' ' 64' ' ' PHE . 2.5 pp -53.81 -18.3 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.374 -0.829 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.528 ' HE1' HG22 ' B' ' 101' ' ' ILE . 0.2 OUTLIER -49.06 146.54 3.39 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.876 -1.14 . . . . 0.0 110.731 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.38 171.47 8.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -0.917 . . . . 0.0 110.515 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -93.19 148.52 21.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 110.561 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.34 131.36 5.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -27.89 17.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.56 76.51 10.07 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 110.428 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.928 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.7 Cg_endo -64.94 104.17 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.667 1.351 . . . . 0.0 110.496 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 5.6 m-20 -72.13 -10.78 60.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.283 -0.886 . . . . 0.0 110.704 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' B' ' 90' ' ' PHE . . . -146.26 160.64 41.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.064 -1.022 . . . . 0.0 110.822 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.05 155.31 43.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 110.13 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' B' ' 78' ' ' HIS . 21.1 p-80 -89.96 136.14 33.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 110.622 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.425 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.42 13.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.351 -0.843 . . . . 0.0 110.147 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 80' ' ' LEU . 17.7 mt -121.71 161.66 22.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 24.2 m -131.43 119.66 21.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 110.104 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.01 64.62 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.5 -119.57 6.19 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.698 ' CB ' HG22 ' B' ' 37' ' ' VAL . 60.9 mt -118.47 26.52 9.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -1.166 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.69 -56.65 4.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.453 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.473 ' NH2' HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -119.23 150.49 39.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.244 -0.91 . . . . 0.0 110.2 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.82 147.78 41.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.549 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' B' ' 79' ' ' GLU . 3.4 mtt180 -125.29 163.01 23.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.897 HD12 ' O ' ' B' ' 31' ' ' GLU . 26.7 mt -136.05 113.3 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.578 ' O ' ' HB1' ' B' ' 76' ' ' ALA . 6.4 m-85 -112.58 178.05 4.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 110.804 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.683 HG23 HG21 ' B' ' 30' ' ' VAL . 15.1 p -121.63 99.19 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -0.862 . . . . 0.0 110.474 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.928 HD11 ' O ' ' B' ' 74' ' ' PRO . 21.7 pt -52.86 -28.4 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.464 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -135.05 144.13 48.94 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 0.0 109.951 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 46.9 Cg_exo -49.44 145.84 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.599 1.315 . . . . 0.0 110.688 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.477 HG21 ' HB1' ' B' ' 20' ' ' ALA . 73.0 mt -122.53 148.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.71 152.2 21.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.852 HG23 ' O ' ' B' ' 21' ' ' ARG . 43.7 mt -53.86 -20.4 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.436 -0.79 . . . . 0.0 111.116 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.63 59.37 0.37 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.2 178.93 6.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.073 -1.251 . . . . 0.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' B' ' 18' ' ' VAL . 10.0 tt0 -125.28 128.29 48.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' B' ' 20' ' ' ALA . 61.3 mt -89.13 132.54 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.88 . . . . 0.0 110.623 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.417 HG23 ' O ' ' B' ' 101' ' ' ILE . 13.5 p -151.32 166.27 31.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.843 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.632 HD12 ' O ' ' B' ' 104' ' ' SER . 2.2 pp -137.85 156.38 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 110.596 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.632 ' O ' HD12 ' B' ' 103' ' ' ILE . 36.6 t -91.78 -163.51 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.416 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 15.3 m-85 -132.27 -56.14 0.97 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.91 163.84 2.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.8 OUTLIER 54.67 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -1.025 . . . . 0.0 111.126 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' D' ' 213' ' ' ALA . 2.5 m-20 58.73 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.513 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.4 OUTLIER -42.05 107.73 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 112.016 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.467 ' CH2' " O2'" ' B' ' 302' ' ' SAH . 0.8 OUTLIER 46.13 -151.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 111.48 178.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.627 HD23 ' C ' ' B' ' 111' ' ' LEU . 9.1 tt -46.8 138.41 6.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.412 -0.805 . . . . 0.0 111.273 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.405 ' N ' HD23 ' B' ' 111' ' ' LEU . 68.9 m -115.12 -21.64 9.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 110.156 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.443 ' CB ' ' HD2' ' B' ' 114' ' ' PRO . 11.7 mtt-85 -50.93 175.16 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.406 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' B' ' 113' ' ' ARG . 9.4 Cg_endo -56.52 -162.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.644 1.339 . . . . 0.0 110.95 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' B' ' 115' ' ' ARG . 5.0 mpt_? -109.53 43.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 110.74 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' B' ' 116' ' ' LEU . 4.2 mm? 49.94 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.878 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -91.36 126.63 36.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 110.29 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 53.06 72.68 0.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.336 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' B' ' 119' ' ' ASN . 6.5 t30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.399 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.59 176.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -1.116 . . . . 0.0 110.362 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.12 67.01 4.13 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -58.14 89.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.583 1.307 . . . . 0.0 110.572 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? 52.43 59.56 4.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.391 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.86 59.89 1.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.366 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -170.77 91.89 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 110.359 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 tp -122.98 -40.34 2.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 110.292 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.61 168.27 27.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 110.224 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 32.5 p -127.77 -41.94 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 110.516 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -115.08 165.35 13.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -123.87 -170.3 2.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 110.255 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 213' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' B' ' 108' ' ' ASP . . . -115.25 27.73 9.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 110.215 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.513 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 3.0 mpp_? 49.18 -163.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.836 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m -52.02 170.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.834 . . . . 0.0 110.506 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.5 144.32 49.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.282 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.34 -163.36 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.667 1.351 . . . . 0.0 110.788 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -116.77 106.11 13.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.478 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.7 t -155.33 -156.88 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 110.252 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.501 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.487 ' OXT' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.48 ' OXT' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.226 0.536 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 47.3 p90 -56.66 140.74 46.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.556 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -131.97 164.7 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -50.23 -24.06 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.717 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.521 ' C ' HG13 ' A' ' 6' ' ' VAL . 6.3 mmm-85 -78.33 -44.62 24.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 110.707 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.521 HG13 ' C ' ' A' ' 5' ' ' ARG . 29.8 m -153.37 -172.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.481 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 19' ' ' PHE . 3.0 tt -145.43 143.21 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.349 -0.844 . . . . 0.0 109.777 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.66 118.34 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.951 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.581 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 10.3 mttt -121.77 144.39 48.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.412 -0.805 . . . . 0.0 109.197 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.581 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.72 71.55 0.47 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.658 -1.901 . . . . 0.0 111.641 0.167 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.478 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -113.18 -171.98 0.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 110.069 179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 57.0 Cg_endo -84.49 6.53 5.69 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.467 1.246 . . . . 0.0 111.06 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.6 mt -124.17 -42.29 2.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.962 -1.086 . . . . 0.0 110.353 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.98 152.12 6.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.0 123.75 4.31 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.71 ' OH ' HD21 ' B' ' 34' ' ' LEU . 0.2 OUTLIER -91.8 104.42 16.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -1.134 . . . . 0.0 110.295 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.88 -170.6 15.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.674 HG23 HD13 ' A' ' 67' ' ' ILE . 75.9 t -105.52 145.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.969 -1.312 . . . . 0.0 110.49 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.699 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.6 m-85 -109.99 120.44 42.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.395 -0.815 . . . . 0.0 109.405 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.93 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.54 90.13 8.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 111.123 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.851 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.23 -24.43 59.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 177.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.488 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 13.7 mtpt -94.9 178.99 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.467 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 51.8 m 104.11 23.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.007 -1.683 . . . . 0.0 109.67 2.007 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.488 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 12.2 m-85 -112.23 159.94 18.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 110.567 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 1.2 tt0 -91.13 -157.63 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.888 . . . . 0.0 110.316 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 59.2 tttt -98.85 73.58 2.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 110.564 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.87 77.12 0.84 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 25' ' ' GLU . 4.2 mm-40 -138.34 18.45 2.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -1.141 . . . . 0.0 110.565 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 90' ' ' PHE . 16.3 tp 59.61 147.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.49 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.543 ' CG2' HG23 ' A' ' 91' ' ' THR . 83.8 t -126.97 -39.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.973 -1.08 . . . . 0.0 110.243 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.95 161.67 8.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.37 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.6 143.93 22.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.506 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' C ' HD12 ' A' ' 34' ' ' LEU . 1.2 m -149.25 -164.96 2.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.658 HD21 ' OH ' ' B' ' 16' ' ' TYR . 11.0 mp -100.36 176.97 5.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.358 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 153.59 41.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.677 HD11 ' CD2' ' A' ' 62' ' ' LEU . 39.3 mt -94.75 97.29 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.958 . . . . 0.0 109.268 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.884 HG13 HD23 ' A' ' 84' ' ' LEU . 59.6 t -88.42 114.63 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.295 -0.878 . . . . 0.0 110.466 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -126.07 148.75 49.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 110.391 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.35 159.87 5.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.242 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -69.92 113.22 6.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.38 -142.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.854 . . . . 0.0 109.543 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.52 -25.26 3.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.869 -1.145 . . . . 0.0 109.986 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.682 ' CZ2' HD21 ' A' ' 51' ' ' LEU . 43.8 t-105 -66.06 -54.55 24.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.788 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.8 -32.65 59.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -78.3 -63.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.1 -51.86 49.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.669 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.011 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.1 mm? -91.14 30.07 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 110.729 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.43 -24.7 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.291 -0.881 . . . . 0.0 111.547 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 3.3 p30 -99.88 151.8 20.88 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.947 -1.095 . . . . 0.0 110.55 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.511 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 9.6 m-85 61.01 19.27 9.74 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.779 -0.576 . . . . 0.0 111.048 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.682 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 6.7 mt -104.81 123.2 47.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.017 . . . . 0.0 110.789 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -89.12 105.9 18.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 108.455 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.2 p -87.87 118.91 27.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.169 -0.957 . . . . 0.0 111.071 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 1.002 ' HD3' HD13 ' A' ' 84' ' ' LEU . 5.4 ttp180 -98.76 -178.83 4.1 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.73 . . . . 0.0 110.038 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -83.87 81.54 8.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.054 . . . . 0.0 109.373 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.51 23.6 p30 149.06 -20.76 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.769 -0.582 . . . . 0.0 109.914 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -177.01 -162.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.286 -0.883 . . . . 0.0 110.612 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 81.3 p -143.17 153.18 42.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.402 -0.811 . . . . 0.0 110.114 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.675 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.717 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 1.011 ' CE ' HD12 ' A' ' 47' ' ' LEU . 28.3 tpp -89.44 152.98 21.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.049 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -87.89 109.11 19.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.852 . . . . 0.0 110.294 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.743 ' O ' HD13 ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -56.68 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.785 . . . . 0.0 110.985 -179.775 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.15 -168.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.63 ' O ' HD11 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -73.14 56.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -1.169 . . . . 0.0 111.323 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -91.5 -23.45 28.73 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -91.13 2.7 56.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 111.502 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.712 HD12 ' N ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -90.31 -8.6 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.794 -1.191 . . . . 0.0 110.733 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.712 ' N ' HD12 ' A' ' 67' ' ' ILE . 18.3 m-85 -56.03 131.93 48.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 0.0 109.925 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -98.48 179.1 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.974 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.57 115.92 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.832 . . . . 0.0 110.405 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.11 141.54 46.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 110.535 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.449 ' HD3' HD12 ' A' ' 116' ' ' LEU . 10.4 tptm -61.64 120.85 11.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.942 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.26 84.34 0.21 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.835 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.4 Cg_endo -64.13 107.28 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.691 1.364 . . . . 0.0 110.467 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.29 -18.51 27.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.603 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -131.4 119.44 21.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.972 . . . . 0.0 110.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.73 -170.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.417 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 26.5 p-80 -129.19 163.07 26.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.838 . . . . 0.0 110.314 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -139.63 159.29 42.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.529 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 84' ' ' LEU . 8.7 mt -118.38 150.16 39.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.181 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 86' ' ' ARG . 6.6 p -68.93 67.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 80' ' ' LEU . . . 51.24 39.83 24.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.56 -136.46 4.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.002 HD13 ' HD3' ' A' ' 54' ' ' ARG . 5.5 tp -132.08 86.67 2.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -1.107 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -49.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.514 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.639 ' HB2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -124.76 123.62 40.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.1 mtp -95.24 154.7 17.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' HIS . 83.5 mtt-85 -138.75 164.23 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.043 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.31 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.732 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 18.3 m-85 -91.79 157.95 16.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 110.602 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.543 HG23 ' CG2' ' A' ' 30' ' ' VAL . 7.7 p -101.94 83.11 2.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.835 HD11 ' O ' ' A' ' 74' ' ' PRO . 6.1 pt -52.88 -23.48 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 110.555 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 92' ' ' ILE . 17.9 mmtt -137.48 134.57 18.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 89.6 Cg_exo -46.35 140.61 11.23 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.437 1.23 . . . . 0.0 111.119 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 20' ' ' ALA . 58.9 mt -117.95 141.81 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -89.61 166.49 13.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 110.449 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.851 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.0 mt -71.58 127.11 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.58 18.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 1.1 tm-20 -100.21 -175.77 3.03 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.139 -1.212 . . . . 0.0 110.022 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -126.16 124.47 40.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.106 -0.996 . . . . 0.0 110.307 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.93 HG13 ' HB2' ' A' ' 20' ' ' ALA . 62.8 mt -89.86 130.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.193 -0.942 . . . . 0.0 110.548 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.541 HG23 ' C ' ' A' ' 101' ' ' ILE . 72.8 p -154.67 -166.85 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -148.68 -167.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 110.444 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.673 ' O ' HD12 ' A' ' 103' ' ' ILE . 3.4 t -102.71 -148.26 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 110.154 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.85 -86.55 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.418 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.07 1.69 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 112' ' ' SER . 0.2 OUTLIER -109.49 -1.07 18.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 110.996 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.97 -40.39 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.967 -1.083 . . . . 0.0 110.565 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.523 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.2 OUTLIER -65.84 105.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.952 . . . . 0.0 110.599 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.474 ' CE2' " H3'" ' A' ' 301' ' ' SAH . 15.6 m95 55.78 -86.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 111.083 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 112' ' ' SER . 1.3 tt -48.79 172.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.913 -1.117 . . . . 0.0 111.127 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 111' ' ' LEU . 5.1 t 58.55 52.4 7.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.446 -0.784 . . . . 0.0 110.807 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.52 ' CB ' ' HD3' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 178.33 -55.27 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.165 -0.96 . . . . 0.0 110.826 178.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.52 ' HD3' ' CB ' ' A' ' 113' ' ' ARG . 57.8 Cg_endo -80.94 7.39 4.94 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.726 1.382 . . . . 0.0 111.309 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.548 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER 56.78 167.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.956 -1.09 . . . . 0.0 110.119 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.548 HD22 ' O ' ' A' ' 115' ' ' ARG . 1.4 mm? -122.68 126.91 48.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.948 . . . . 0.0 110.481 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.8 m -157.32 99.26 1.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 0.0 110.245 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.32 104.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.881 . . . . 0.0 110.481 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.354 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 52.8 57.79 6.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' C' ' 204' ' ' PRO . . . -146.57 173.66 4.04 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 110.482 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.529 ' HD2' ' HB1' ' C' ' 203' ' ' ALA . 35.5 Cg_exo -56.9 -64.55 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.67 1.353 . . . . 0.0 110.416 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 52.27 26.08 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.867 . . . . 0.0 110.398 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.54 89.01 7.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.366 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.6 87.53 1.94 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 110.425 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 12.7 tp 53.08 28.24 6.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.398 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.1 72.76 1.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 110.326 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 69.6 p -111.78 93.92 4.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 110.3 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -170.09 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.496 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.65 -68.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.248 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.12 83.73 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 110.504 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.523 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 1.1 mtt180 -66.11 -84.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.208 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 216' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.507 0.3 OUTLIER -50.61 -31.98 17.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.192 -0.943 . . . . 0.0 110.724 -179.468 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 54.98 172.72 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 110.448 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 19.2 Cg_exo -63.01 -170.21 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.613 1.323 . . . . 0.0 110.443 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -89.93 155.29 19.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 110.238 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 220' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 54' ' ' ARG . 5.3 t -150.3 60.86 0.96 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 110.38 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 CA-C-O 117.996 -1.447 . . . . 0.0 109.519 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.237 0.541 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 47.3 p90 -56.68 140.77 46.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.355 -0.84 . . . . 0.0 110.512 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -131.98 164.81 25.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 110.226 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -50.3 -24.09 2.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 110.664 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.538 ' C ' HG13 ' B' ' 6' ' ' VAL . 6.3 mmm-85 -78.27 -44.68 24.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.651 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.538 HG13 ' C ' ' B' ' 5' ' ' ARG . 30.2 m -153.35 -172.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.707 HG23 ' HB2' ' B' ' 19' ' ' PHE . 3.0 tt -145.43 143.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.48 118.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.036 -1.04 . . . . 0.0 110.99 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.598 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 10.2 mttt -121.9 144.37 48.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.472 -0.767 . . . . 0.0 109.221 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.598 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.74 71.62 0.47 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.711 -1.868 . . . . 0.0 111.569 0.186 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.49 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 0.2 OUTLIER -113.22 -171.94 0.22 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 56.8 Cg_endo -84.55 6.5 5.7 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.462 1.243 . . . . 0.0 111.025 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 51.7 mt -124.19 -42.29 2.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.067 -1.021 . . . . 0.0 110.301 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.96 152.1 6.45 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.09 123.79 4.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.658 ' OH ' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -91.73 104.57 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -1.158 . . . . 0.0 110.364 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.1 -170.64 15.56 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.676 HG23 HD13 ' B' ' 67' ' ' ILE . 77.2 t -105.53 145.06 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.946 -1.326 . . . . 0.0 110.449 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.707 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.6 m-85 -110.0 120.35 42.18 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.466 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.893 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.41 90.14 8.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 111.18 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.31 -24.34 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 177.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.482 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 13.7 mtpt -94.92 179.04 5.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.524 -0.735 . . . . 0.0 109.031 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.453 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 51.9 m 104.09 23.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.095 -1.628 . . . . 0.0 109.677 2.012 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 12.3 m-85 -112.21 159.96 18.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.619 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.409 ' HB2' ' HG3' ' B' ' 28' ' ' GLU . 1.2 tt0 -91.16 -157.62 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.261 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.424 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 59.1 tttt -98.83 73.55 2.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.548 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 77.02 0.83 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' B' ' 25' ' ' GLU . 4.2 mm-40 -138.3 18.4 2.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 110.586 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.737 HD13 ' CZ ' ' B' ' 90' ' ' PHE . 16.2 tp 59.75 147.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.418 -0.802 . . . . 0.0 110.503 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.548 ' CG2' HG23 ' B' ' 91' ' ' THR . 83.8 t -127.02 -39.82 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.042 . . . . 0.0 110.279 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.97 161.71 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.336 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' B' ' 87' ' ' MET . 3.8 pm0 -153.66 143.86 22.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.453 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.483 ' C ' HD12 ' B' ' 34' ' ' LEU . 1.2 m -149.17 -164.95 2.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.398 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.71 HD21 ' OH ' ' A' ' 16' ' ' TYR . 11.0 mp -100.34 176.95 5.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.94 153.57 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.676 HD11 ' CD2' ' B' ' 62' ' ' LEU . 39.4 mt -94.78 96.4 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.393 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.877 HG13 HD23 ' B' ' 84' ' ' LEU . 54.8 t -87.21 114.7 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 110.651 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.511 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -126.21 148.71 49.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.31 159.88 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -69.87 113.15 6.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.451 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.35 -142.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.523 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.48 -25.33 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.812 -1.18 . . . . 0.0 110.004 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.677 ' CZ2' HD21 ' B' ' 51' ' ' LEU . 43.7 t-105 -66.02 -54.55 24.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.593 -0.692 . . . . 0.0 109.781 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.85 -32.52 59.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -78.39 -63.23 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.153 . . . . 0.0 110.533 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.21 -51.4 54.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 110.69 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.998 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.1 mm? -91.83 30.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.484 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.52 -24.74 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.245 -0.91 . . . . 0.0 111.505 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.469 ' OD1' ' CD2' ' B' ' 50' ' ' TYR . 3.2 p30 -99.72 151.79 20.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 9.4 m-85 60.96 19.2 9.61 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.654 -0.654 . . . . 0.0 111.057 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.677 HD21 ' CZ2' ' B' ' 43' ' ' TRP . 6.6 mt -104.89 123.02 46.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 0.0 110.893 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -88.77 104.98 17.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.706 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 57.0 p -86.55 119.04 26.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 111.322 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.992 ' HD3' HD13 ' B' ' 84' ' ' LEU . 5.4 ttp180 -99.49 178.67 4.8 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.473 -0.767 . . . . 0.0 110.066 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -80.2 81.17 6.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.957 . . . . 0.0 110.187 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 23.5 p30 148.96 -20.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.677 -0.64 . . . . 0.0 109.942 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.4 ptm -176.83 -161.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.934 . . . . 0.0 110.745 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.451 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 81.4 p -143.2 153.2 42.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 110.044 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.665 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -139.58 145.69 38.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 110.703 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.998 ' CE ' HD12 ' B' ' 47' ' ' LEU . 28.5 tpp -89.34 152.15 21.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -86.83 109.02 19.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.451 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 62' ' ' LEU 2.5 0.2 OUTLIER -56.68 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -0.794 . . . . 0.0 110.919 -179.908 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.36 -168.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.629 ' O ' HD11 ' B' ' 67' ' ' ILE . 0.1 OUTLIER -73.19 57.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.18 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' B' ' 68' ' ' PHE . . . -92.52 -22.48 28.89 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -92.03 3.09 56.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 111.378 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.721 HD12 ' N ' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -90.53 -8.55 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.811 -1.18 . . . . 0.0 110.724 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.721 ' N ' HD12 ' B' ' 67' ' ' ILE . 18.3 m-85 -56.05 131.98 48.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 0.0 109.907 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -98.57 179.12 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.967 . . . . 0.0 110.968 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.56 115.95 21.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.84 . . . . 0.0 110.404 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.13 141.6 46.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.445 ' HD3' HD12 ' B' ' 116' ' ' LEU . 10.4 tptm -61.68 120.86 11.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.31 84.27 0.21 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.822 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.5 Cg_endo -64.04 107.33 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.734 1.386 . . . . 0.0 110.484 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.32 -18.49 27.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 110.632 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.565 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -131.4 119.36 21.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 0.0 110.382 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.7 -170.46 1.8 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 110.454 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.415 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 26.5 p-80 -129.2 162.99 26.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -139.64 159.32 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 110.514 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.442 HD22 HD12 ' B' ' 84' ' ' LEU . 8.8 mt -118.36 150.15 40.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.644 HG21 ' HB2' ' B' ' 86' ' ' ARG . 6.4 p -69.01 67.26 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 110.562 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' B' ' 80' ' ' LEU . . . 51.3 39.78 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.765 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.63 -136.51 4.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.992 HD13 ' HD3' ' B' ' 54' ' ' ARG . 5.5 tp -132.05 86.73 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -1.083 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.4 -49.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.644 ' HB2' HG21 ' B' ' 81' ' ' THR . 0.0 OUTLIER -124.74 123.7 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 110.171 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' B' ' 32' ' ' GLU . 22.1 mtp -95.29 154.57 17.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 110.656 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' B' ' 78' ' ' HIS . 83.5 mtt-85 -138.64 164.3 29.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 110.083 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.24 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.978 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.737 ' CZ ' HD13 ' B' ' 29' ' ' LEU . 18.4 m-85 -91.79 157.96 16.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.548 HG23 ' CG2' ' B' ' 30' ' ' VAL . 7.8 p -101.89 83.08 2.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.183 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.822 HD11 ' O ' ' B' ' 74' ' ' PRO . 6.1 pt -52.93 -23.46 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.895 . . . . 0.0 110.548 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.424 ' N ' HG13 ' B' ' 92' ' ' ILE . 17.9 mmtt -137.45 134.37 18.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 85.4 Cg_exo -46.6 140.88 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.424 1.223 . . . . 0.0 111.08 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.42 HG21 ' CB ' ' B' ' 20' ' ' ALA . 59.0 mt -117.99 141.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.616 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -89.21 166.61 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.51 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.0 mt -71.71 127.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.4 23.57 18.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 96' ' ' ALA . 1.1 tm-20 -100.01 -176.04 3.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.258 -1.142 . . . . 0.0 110.076 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -126.08 124.46 40.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.998 . . . . 0.0 110.282 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.893 HG13 ' HB2' ' B' ' 20' ' ' ALA . 62.7 mt -89.84 130.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.533 HG23 ' C ' ' B' ' 101' ' ' ILE . 72.2 p -154.55 -166.77 2.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.0 109.664 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.669 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -148.73 -167.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.459 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.669 ' O ' HD12 ' B' ' 103' ' ' ILE . 3.4 t -102.64 -148.3 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 110.159 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.82 -86.57 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.98 -132.04 1.68 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' B' ' 112' ' ' SER . 0.2 OUTLIER -109.54 -1.03 18.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 0.0 110.977 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.89 -40.46 0.61 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.929 -1.107 . . . . 0.0 110.614 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.525 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.2 OUTLIER -65.79 105.14 1.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.608 -179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.488 ' CE2' " H3'" ' B' ' 302' ' ' SAH . 15.7 m95 55.77 -86.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.517 -0.739 . . . . 0.0 111.06 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.675 HD23 ' N ' ' B' ' 112' ' ' SER . 1.3 tt -48.8 172.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.919 -1.113 . . . . 0.0 111.113 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.675 ' N ' HD23 ' B' ' 111' ' ' LEU . 5.0 t 58.54 52.59 6.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.405 -0.809 . . . . 0.0 110.859 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.498 ' CB ' ' HD3' ' B' ' 114' ' ' PRO . 0.0 OUTLIER 177.82 -55.03 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.113 -0.992 . . . . 0.0 110.481 178.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' B' ' 113' ' ' ARG . 58.1 Cg_endo -80.79 7.45 4.87 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.553 1.291 . . . . 0.0 111.365 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' ARG . . . . . 0.543 ' O ' HD22 ' B' ' 116' ' ' LEU . 0.2 OUTLIER 56.68 168.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.862 -1.149 . . . . 0.0 110.112 -179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.543 HD22 ' O ' ' B' ' 115' ' ' ARG . 1.4 mm? -122.7 126.84 48.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.482 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 90.1 m -157.28 99.25 1.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 110.252 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.32 104.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 110.471 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.366 179.906 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 52.84 57.79 6.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -1.185 . . . . 0.0 110.422 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.537 ' HB1' ' HD2' ' D' ' 204' ' ' PRO . . . -146.64 173.64 4.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 110.432 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' D' ' 203' ' ' ALA . 35.6 Cg_exo -56.91 -64.54 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.675 1.355 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 52.36 26.08 3.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 110.393 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 88.97 7.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.58 87.6 1.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -0.945 . . . . 0.0 110.404 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 12.7 tp 53.05 28.22 6.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.12 72.76 1.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.348 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 69.4 p -111.73 93.85 4.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 110.33 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -170.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 110.491 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.64 -68.71 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 110.293 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.06 83.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.498 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.525 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 1.1 mtt180 -66.11 -84.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 110.19 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 216' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.508 0.3 OUTLIER -50.63 -31.98 17.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -0.912 . . . . 0.0 110.7 -179.42 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 54.9 172.78 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 19.0 Cg_exo -62.99 -170.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.651 1.342 . . . . 0.0 110.439 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -89.94 155.28 19.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.271 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 220' ' ' THR . . . . . 0.447 ' O ' HG23 ' D' ' 220' ' ' THR . 5.3 t -150.28 60.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 110.386 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.549 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.474 " H3'" ' CE2' ' A' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.488 " H3'" ' CE2' ' B' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.832 ' SD ' HG11 ' A' ' 8' ' ' VAL . 9.0 mmt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.231 0.538 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 15.2 p90 -127.29 110.12 12.51 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.885 . . . . 0.0 110.501 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.88 151.25 36.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.47 -28.04 3.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.3 -0.875 . . . . 0.0 110.825 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.12 25.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 110.352 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' A' ' 5' ' ' ARG . 36.0 m -153.71 156.24 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.272 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.693 HG23 ' HB2' ' A' ' 19' ' ' PHE . 17.2 tt -128.74 155.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.832 HG11 ' SD ' ' A' ' 1' ' ' MET . 8.2 p -97.89 133.42 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.862 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.594 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 7.6 mttt -130.86 142.73 50.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.35 -0.844 . . . . 0.0 109.313 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.594 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 20.0 mttt 52.74 62.23 2.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 119.631 -1.918 . . . . 0.0 111.219 0.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p -114.54 -176.92 0.4 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.459 -0.776 . . . . 0.0 110.296 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 18.4 Cg_exo -63.89 -63.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.658 1.346 . . . . 0.0 110.413 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.96 -23.04 7.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.638 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.26 172.2 22.55 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.89 -159.42 35.35 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.447 ' HB2' ' N ' ' A' ' 301' ' ' SAH . 1.5 m-85 -74.47 81.81 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -1.201 . . . . 0.0 110.353 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.467 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -121.13 -169.07 13.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 72.4 t -110.86 146.6 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.892 -1.358 . . . . 0.0 110.396 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.693 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.2 m-85 -111.33 122.41 47.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 109.998 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.817 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -92.34 92.01 7.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 110.839 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.0 -21.63 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 178.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 22.7 mtpt -90.68 -179.3 5.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.88 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HE3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 108.29 15.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.167 -1.583 . . . . 0.0 110.378 0.922 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 40.1 m-85 -109.18 148.59 30.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.083 -1.011 . . . . 0.0 110.716 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.29 -161.33 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 69.99 3.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -137.69 122.23 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -1.171 . . . . 0.0 110.24 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 ' HB3' ' A' ' 88' ' ' ARG . 1.3 tm? -65.8 115.69 6.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.893 . . . . 0.0 110.417 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 29' ' ' LEU . 85.3 t -94.39 74.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 110.057 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 30' ' ' VAL . 3.5 tt0 59.06 154.1 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.5 0.667 . . . . 0.0 110.821 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 88' ' ' ARG . 9.4 pt-20 -157.28 161.24 39.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.26 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.53 -170.7 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.622 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ARG . 58.4 mt -90.47 -170.24 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.436 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 14.0 m -147.18 160.77 42.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 110.024 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.607 HD11 ' CD2' ' A' ' 62' ' ' LEU . 27.2 mt -96.07 102.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 109.345 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.6 129.24 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 110.663 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 6.0 mmt180 -145.81 151.69 38.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.437 -0.789 . . . . 0.0 110.127 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.3 -179.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.972 . . . . 0.0 110.369 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.37 112.37 23.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.53 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.25 -142.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -50.81 -25.25 4.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.719 -1.238 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.513 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 45.6 t-105 -56.12 -64.44 0.86 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.25 -28.39 58.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.7 m -70.54 -67.75 0.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -1.179 . . . . 0.0 110.523 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.03 84.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.558 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.995 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.3 mm? -90.34 41.02 1.03 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.623 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.34 3.97 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.106 -0.996 . . . . 0.0 110.519 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.12 -81.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.484 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' HD1' HCM1 ' C' ' 215' ' ' MLZ . 12.5 m-85 -96.96 52.38 1.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.368 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.708 HD13 ' HB3' ' A' ' 47' ' ' LEU . 1.3 tp -111.89 131.45 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 111.167 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' C' ' 215' ' ' MLZ . 17.7 m-85 -92.35 -178.29 4.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' C' ' 214' ' ' ARG . 24.8 p -144.22 123.21 12.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 111.042 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.608 ' CB ' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -110.82 173.52 6.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.608 -0.682 . . . . 0.0 109.372 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 54' ' ' ARG . 13.1 mttm -82.68 70.8 9.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.0 109.237 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.2 t30 166.5 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.96 -167.87 0.25 Allowed 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 37.6 p -120.71 166.88 13.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.443 -0.786 . . . . 0.0 109.434 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.66 ' HB3' HD22 ' A' ' 84' ' ' LEU . . . -150.06 151.69 33.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.922 -1.111 . . . . 0.0 111.062 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.995 ' CE ' HD12 ' A' ' 47' ' ' LEU . 18.2 tpp -89.55 154.32 20.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.667 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.57 91.64 8.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.945 HD22 HD22 ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -55.54 -45.27 77.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.51 179.591 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.73 -141.22 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.826 ' HB3' HD11 ' A' ' 67' ' ' ILE . 29.3 m-85 -90.6 11.09 23.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -1.185 . . . . 0.0 110.903 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.667 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -47.37 -30.79 6.15 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . . . -66.51 -75.28 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.199 -1.177 . . . . 0.0 109.793 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 64' ' ' PHE . 2.4 pp -56.74 -18.8 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 111.364 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.649 ' HE1' HD13 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -51.81 132.42 31.53 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.04 -1.038 . . . . 0.0 109.936 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.661 ' CB ' HG22 ' A' ' 102' ' ' THR . 13.4 m-20 -109.05 177.26 4.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.957 -1.089 . . . . 0.0 111.451 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.522 ' CD2' ' N ' ' A' ' 71' ' ' SER . 13.3 t60 -103.0 157.56 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.522 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 29.3 t -149.96 140.93 22.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 110.603 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -29.78 50.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.87 96.07 39.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.594 ' O ' HD11 ' A' ' 92' ' ' ILE . 31.9 Cg_exo -54.0 119.71 6.75 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.648 1.341 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.463 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 19.7 p30 -110.58 -21.77 11.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -146.35 149.93 34.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.506 ' HB2' HG23 ' A' ' 92' ' ' ILE . 3.4 mtt180 -128.19 -173.39 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 110.186 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 5.4 p80 -128.81 175.95 8.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.649 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 87' ' ' MET . 24.0 tt0 -137.66 153.26 49.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.832 HD23 ' HG2' ' A' ' 87' ' ' MET . 80.1 mt -123.83 135.5 53.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -79.92 -168.76 1.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 88.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 110.467 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 87.12 58.38 1.89 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 59' ' ' ALA . 8.0 mt 55.72 -111.6 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.375 -1.074 . . . . 0.0 110.084 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER 58.55 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.625 -1.297 . . . . 0.0 111.078 179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -97.38 139.82 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 110.536 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.832 ' HG2' HD23 ' A' ' 80' ' ' LEU . 11.0 mtp -129.64 144.47 51.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.869 ' HB3' HD21 ' A' ' 29' ' ' LEU . 5.5 mtp180 -124.87 162.93 23.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.21 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HE1' ' A' ' 68' ' ' PHE . 81.2 mt -123.0 99.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.848 . . . . 0.0 109.661 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 2.0 m-85 -96.36 -174.2 2.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.718 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 11.9 p -127.48 98.89 5.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.594 HD11 ' O ' ' A' ' 74' ' ' PRO . 45.4 pt -55.64 -25.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.617 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -144.53 146.77 33.72 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.172 -0.955 . . . . 0.0 110.438 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.12 125.89 20.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.685 1.361 . . . . 0.0 110.492 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.9 144.58 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.59 156.88 18.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 110.457 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 21' ' ' ARG . 73.3 mt -66.8 113.68 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.38 30.71 2.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.92 -170.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.296 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 43.1 tt0 -128.39 133.7 48.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.817 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 26.4 mt -89.32 131.32 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.2 -0.937 . . . . 0.0 109.932 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.661 HG22 ' CB ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -158.9 164.56 35.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.119 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.604 HG23 ' CE2' ' A' ' 68' ' ' PHE . 8.2 pt -132.94 162.41 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.618 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.457 ' HA ' ' ND1' ' A' ' 70' ' ' HIS . 1.4 m -91.71 174.83 7.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.205 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 70' ' ' HIS . 15.8 m-85 -126.86 -70.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 67.35 -163.67 45.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.66 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -1.045 . . . . 0.0 110.622 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -100.04 -42.47 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 0.0 110.341 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.453 ' HB2' ' CB ' ' A' ' 105' ' ' TYR . 19.1 m-85 -61.88 141.91 57.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -117.99 37.99 3.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.4 -0.812 . . . . 0.0 110.558 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.967 HD13 ' N ' ' A' ' 112' ' ' SER . 2.5 tm? -51.73 145.73 8.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.406 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.967 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.4 OUTLIER 60.78 128.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.631 0.729 . . . . 0.0 110.804 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 13.5 mtm-85 -77.21 -50.97 2.1 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.293 -0.879 . . . . 0.0 111.55 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 50.5 Cg_endo -77.78 -13.23 16.19 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.716 1.377 . . . . 0.0 111.244 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 112' ' ' SER . 44.9 mmm-85 54.97 -152.77 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.129 -0.982 . . . . 0.0 110.529 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 116' ' ' LEU . 14.1 mt -121.84 56.75 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 110.428 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.5 m -127.58 118.89 24.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 110.348 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 53.46 -172.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.417 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.386 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.59 -68.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -1.133 . . . . 0.0 110.298 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -114.77 91.56 26.28 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.81 139.16 67.21 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.698 1.367 . . . . 0.0 110.444 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -95.16 -69.31 0.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.957 . . . . 0.0 110.332 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 52.73 -171.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 110.436 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -59.39 -167.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.902 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.35 84.22 1.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.919 . . . . 0.0 110.403 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . 52.75 92.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.369 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 27.7 m -72.34 -46.13 56.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.896 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -127.56 128.03 44.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.406 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.12 158.77 3.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 110.362 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.82 107.96 10.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.397 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.413 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 1.2 tpp180 -107.51 164.36 12.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.541 HCM1 ' HD1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t -57.25 -164.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 110.277 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.603 ' O ' HG23 ' C' ' 220' ' ' THR . . . -136.22 152.11 74.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 217' ' ' ALA . 33.6 Cg_exo -57.84 -34.12 97.86 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.699 1.368 . . . . 0.0 110.517 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -112.81 92.45 4.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 110.328 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 220' ' ' THR . . . . . 0.603 HG23 ' O ' ' C' ' 217' ' ' ALA . 36.0 p -109.29 46.52 0.98 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.397 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.912 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.829 ' SD ' HG11 ' B' ' 8' ' ' VAL . 9.1 mmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.247 0.546 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.463 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 15.4 p90 -127.21 110.13 12.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.25 -0.906 . . . . 0.0 110.517 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.89 151.23 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -0.818 . . . . 0.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.43 -28.05 3.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.794 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.2 25.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' B' ' 5' ' ' ARG . 35.9 m -153.62 156.26 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.719 HG23 ' HB2' ' B' ' 19' ' ' PHE . 17.2 tt -128.74 155.59 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.395 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.829 HG11 ' SD ' ' B' ' 1' ' ' MET . 8.2 p -97.85 133.47 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.85 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 7.6 mttt -130.93 142.68 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.846 . . . . 0.0 109.315 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.6 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 20.0 mttt 52.67 62.33 2.74 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 119.675 -1.89 . . . . 0.0 111.199 0.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 2.6 p -114.64 -176.84 0.4 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 110.31 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 18.2 Cg_exo -63.87 -63.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.62 1.326 . . . . 0.0 110.401 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.91 -23.13 7.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 110.663 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.21 172.08 22.59 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.78 -159.39 35.36 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.455 ' HB2' ' N ' ' B' ' 302' ' ' SAH . 1.5 m-85 -74.52 81.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.325 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.466 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -121.14 -169.02 13.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 69.0 t -110.92 146.17 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.929 -1.336 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.719 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.2 m-85 -111.27 122.4 47.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.817 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -92.38 92.08 7.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 110.825 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.98 -21.7 61.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.836 178.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 22.9 mtpt -90.63 -179.18 5.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.419 -0.801 . . . . 0.0 109.889 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.405 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 0.0 OUTLIER 108.32 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.206 -1.559 . . . . 0.0 110.43 0.896 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 40.0 m-85 -109.17 148.58 30.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.01 . . . . 0.0 110.688 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.33 -161.3 0.8 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 70.0 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 110.312 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -137.66 122.29 18.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -1.128 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.846 HD21 ' HB3' ' B' ' 88' ' ' ARG . 1.3 tm? -65.85 115.62 6.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 110.445 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.481 ' N ' HD13 ' B' ' 29' ' ' LEU . 85.9 t -94.3 74.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -0.853 . . . . 0.0 110.012 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' B' ' 30' ' ' VAL . 3.5 tt0 59.08 154.11 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.648 -0.657 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' B' ' 88' ' ' ARG . 9.4 pt-20 -157.18 161.5 39.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 110.269 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.85 -170.78 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.427 HD23 ' CG ' ' B' ' 86' ' ' ARG . 58.8 mt -90.46 -170.24 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 14.4 m -147.17 160.71 42.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' B' ' 62' ' ' LEU . 27.0 mt -96.07 102.32 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.089 -1.007 . . . . 0.0 109.411 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.67 129.33 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 5.9 mmt180 -145.99 151.71 38.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.26 -179.11 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.39 112.37 23.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.28 -142.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.831 . . . . 0.0 109.568 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -50.82 -25.31 4.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.766 -1.208 . . . . 0.0 109.855 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.622 ' HZ3' HD11 ' A' ' 47' ' ' LEU . 45.6 t-105 -56.05 -64.47 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.918 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.23 -28.37 58.74 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 75.8 m -70.5 -67.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.572 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.85 84.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 110.658 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.989 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.3 mm? -90.55 41.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.604 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.24 3.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 110.512 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.14 -81.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.518 ' HD1' HCM1 ' D' ' 215' ' ' MLZ . 12.5 m-85 -96.9 52.41 1.17 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 0.0 109.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' B' ' 47' ' ' LEU . 1.3 tp -111.89 131.54 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 111.108 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.507 ' CD1' ' HB3' ' D' ' 215' ' ' MLZ . 17.7 m-85 -92.34 -178.24 4.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.388 -0.82 . . . . 0.0 109.683 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' D' ' 214' ' ' ARG . 25.0 p -144.16 123.26 12.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.044 -1.035 . . . . 0.0 111.04 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.615 ' CB ' HD11 ' B' ' 84' ' ' LEU . 0.4 OUTLIER -111.5 170.6 8.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 178.667 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' B' ' 54' ' ' ARG . 14.1 mttm -78.54 70.13 4.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.089 . . . . 0.0 110.178 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 1.2 t30 166.58 -28.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.76 -167.83 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.454 -0.779 . . . . 0.0 110.954 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.432 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 37.5 p -120.69 166.84 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.449 -0.782 . . . . 0.0 109.419 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.679 ' HB3' HD22 ' B' ' 84' ' ' LEU . . . -150.04 151.54 33.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.93 -1.106 . . . . 0.0 111.058 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.989 ' CE ' HD12 ' B' ' 47' ' ' LEU . 18.2 tpp -89.43 153.39 20.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.653 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -86.28 91.58 8.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.836 . . . . 0.0 110.88 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.945 HD22 HD22 ' A' ' 62' ' ' LEU 2.498 0.2 OUTLIER -55.62 -45.24 77.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 110.518 179.432 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.74 -140.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.814 ' HB3' HD11 ' B' ' 67' ' ' ILE . 29.0 m-85 -91.02 11.21 23.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -1.143 . . . . 0.0 110.823 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.653 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -47.39 -30.8 6.2 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' B' ' 50' ' ' TYR . . . -66.54 -75.46 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.179 -1.189 . . . . 0.0 109.84 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.814 HD11 ' HB3' ' B' ' 64' ' ' PHE . 2.4 pp -56.48 -18.99 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.65 ' HE1' HD13 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -51.65 132.36 30.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.907 -1.12 . . . . 0.0 109.85 178.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.644 ' CB ' HG22 ' B' ' 102' ' ' THR . 13.3 m-20 -108.9 177.92 4.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.018 -1.051 . . . . 0.0 111.351 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' B' ' 71' ' ' SER . 13.2 t60 -104.04 157.33 17.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' SER . . . . . 0.52 ' N ' ' CD2' ' B' ' 70' ' ' HIS . 29.5 t -149.79 140.85 22.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.632 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.81 49.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.8 96.02 39.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.395 -0.816 . . . . 0.0 109.961 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.608 ' O ' HD11 ' B' ' 92' ' ' ILE . 31.9 Cg_exo -53.97 119.75 6.79 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.655 1.345 . . . . 0.0 110.682 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.463 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 19.7 p30 -110.56 -21.84 11.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -146.36 149.9 34.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.332 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.515 ' HB2' HG23 ' B' ' 92' ' ' ILE . 3.4 mtt180 -128.11 -173.34 2.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.179 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 5.3 p80 -128.88 175.98 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 110.671 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' B' ' 87' ' ' MET . 23.9 tt0 -137.66 153.21 49.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.797 HD23 ' HG2' ' B' ' 87' ' ' MET . 80.3 mt -123.8 135.52 53.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 110.215 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 83' ' ' GLY . 0.0 OUTLIER -79.99 -168.69 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -0.905 . . . . 0.0 110.113 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 110.495 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.456 ' HA3' ' HZ1' ' B' ' 85' ' ' LYS . . . 87.16 58.32 1.89 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.679 HD22 ' HB3' ' B' ' 59' ' ' ALA . 8.0 mt 55.76 -111.68 0.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.408 -1.054 . . . . 0.0 110.078 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.456 ' HZ1' ' HA3' ' B' ' 83' ' ' GLY . 0.2 OUTLIER 58.44 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.586 -1.321 . . . . 0.0 111.076 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.427 ' CG ' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -97.28 139.79 32.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.489 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.797 ' HG2' HD23 ' B' ' 80' ' ' LEU . 11.1 mtp -129.59 144.48 51.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 110.438 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.846 ' HB3' HD21 ' B' ' 29' ' ' LEU . 5.5 mtp180 -124.86 162.92 23.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.65 HD13 ' HE1' ' B' ' 68' ' ' PHE . 81.1 mt -123.01 99.75 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.825 . . . . 0.0 109.617 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.685 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 2.0 m-85 -96.31 -174.17 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.737 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -127.52 98.83 5.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.608 HD11 ' O ' ' B' ' 74' ' ' PRO . 45.4 pt -55.62 -25.07 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.632 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.1 OUTLIER -144.48 146.79 33.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 110.497 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 93' ' ' LYS . 37.6 Cg_exo -56.2 125.9 20.6 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.709 1.373 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.96 144.42 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 110.333 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.42 156.93 18.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.465 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 73.3 mt -66.84 113.63 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.47 30.75 2.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.99 -170.31 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 110.281 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 43.3 tt0 -128.43 133.5 48.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.289 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.817 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 27.1 mt -88.96 131.35 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 110.104 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.644 HG22 ' CB ' ' B' ' 69' ' ' ASN . 1.0 OUTLIER -158.87 164.68 35.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.785 -0.572 . . . . 0.0 109.727 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 76' ' ' ALA . 8.2 pt -132.95 162.35 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.454 ' HA ' ' ND1' ' B' ' 70' ' ' HIS . 1.4 m -91.73 174.8 7.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' B' ' 70' ' ' HIS . 15.8 m-85 -126.76 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 110.501 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 67.42 -163.59 45.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.63 -86.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.439 -1.036 . . . . 0.0 110.635 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -100.14 -42.62 6.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.275 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.452 ' HB2' ' CB ' ' B' ' 105' ' ' TYR . 19.2 m-85 -61.7 141.98 57.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -118.08 38.03 3.8 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.339 -0.85 . . . . 0.0 110.558 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.98 HD13 ' N ' ' B' ' 112' ' ' SER . 2.5 tm? -51.74 145.77 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.161 -0.962 . . . . 0.0 110.45 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.98 ' N ' HD13 ' B' ' 111' ' ' LEU . 0.4 OUTLIER 60.73 128.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.643 0.735 . . . . 0.0 110.779 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' B' ' 114' ' ' PRO . 13.2 mtm-85 -77.69 -50.58 1.95 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 111.106 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 113' ' ' ARG . 48.6 Cg_endo -77.8 -13.42 16.07 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.695 1.366 . . . . 0.0 111.115 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' B' ' 112' ' ' SER . 44.9 mmm-85 54.82 -152.82 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.99 . . . . 0.0 110.529 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' B' ' 116' ' ' LEU . 14.1 mt -121.66 56.71 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 110.457 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 27.6 m -127.57 119.01 25.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 0.0 110.239 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.4 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 110.428 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.383 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.61 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -1.092 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -114.85 91.55 26.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.8 139.12 67.05 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.641 1.338 . . . . 0.0 110.475 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -95.15 -69.21 0.76 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 110.383 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 52.64 -171.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -59.3 -167.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.417 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.31 84.16 1.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 110.408 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . 52.76 92.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.376 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 27.6 m -72.3 -46.2 56.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.378 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -127.56 128.04 44.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 110.453 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.09 158.79 3.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 110.385 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.77 107.93 10.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 110.407 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' B' ' 53' ' ' SER . 1.2 tpp180 -107.52 164.38 12.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.933 . . . . 0.0 110.271 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.518 HCM1 ' HD1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t -57.25 -164.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -0.882 . . . . 0.0 110.295 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.607 ' O ' HG23 ' D' ' 220' ' ' THR . . . -136.24 152.15 74.68 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.395 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.406 ' HD3' ' HE1' ' B' ' 78' ' ' HIS . 33.3 Cg_exo -57.85 -34.07 97.8 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.662 1.348 . . . . 0.0 110.545 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -112.88 92.46 4.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 220' ' ' THR . . . . . 0.607 HG23 ' O ' ' D' ' 217' ' ' ALA . 35.9 p -109.32 46.59 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 110.438 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.448 ' N7 ' ' HB3' ' A' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.455 ' N ' ' HB2' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.244 0.545 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.482 ' CD1' HD12 ' A' ' 7' ' ' ILE . 14.6 t80 53.06 68.38 0.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' ARG . 11.8 m120 -90.17 55.36 3.06 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.405 -0.809 . . . . 0.0 110.046 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t70 52.97 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 111.371 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.529 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -50.55 -33.82 23.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 111.01 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.529 HG23 ' C ' ' A' ' 5' ' ' ARG . 89.2 t -152.37 138.5 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.067 -1.021 . . . . 0.0 111.245 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.602 HG23 ' HB2' ' A' ' 19' ' ' PHE . 12.7 tt -114.61 162.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 110.062 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 64' ' ' PHE . 96.1 t -106.85 120.06 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 16.7 mttt -116.69 144.03 44.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.6 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 25.0 mttt 52.38 63.04 2.4 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.725 -1.86 . . . . 0.0 111.355 0.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.423 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -115.83 173.46 2.98 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.827 . . . . 0.0 110.344 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 11' ' ' SER . 31.9 Cg_exo -57.72 -31.84 93.16 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.696 1.366 . . . . 0.0 110.405 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.58 -36.56 28.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.73 -164.68 15.62 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.24 -177.88 42.13 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' CB ' ' HN2' ' A' ' 301' ' ' SAH . 0.2 OUTLIER -129.58 71.6 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.349 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -108.69 -172.32 21.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.858 ' CG2' HD13 ' A' ' 67' ' ' ILE . 94.1 t -113.55 158.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.299 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -121.0 127.91 52.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.157 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.583 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -89.84 95.2 10.13 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.571 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.855 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -64.14 -24.95 67.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.838 . . . . 0.0 109.665 178.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -86.02 179.27 7.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.537 ' OG ' HD11 ' A' ' 97' ' ' ILE 2.511 0.0 OUTLIER 103.37 11.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.141 -1.599 . . . . 0.0 110.603 1.118 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.6 m-85 -107.67 150.96 26.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.702 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.26 -152.63 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 110.131 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 13.7 tttm -100.58 69.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 110.43 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.03 75.2 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.73 7.55 3.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -1.146 . . . . 0.0 110.984 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.602 HD11 ' HE ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER 61.45 131.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.612 ' CG2' HG23 ' A' ' 91' ' ' THR . 97.2 t -103.38 -74.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.117 -0.99 . . . . 0.0 110.697 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.46 160.82 37.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.704 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.63 142.17 37.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.221 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.429 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.4 p -150.15 -174.99 4.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.711 ' N ' HD22 ' A' ' 34' ' ' LEU . 2.8 mm? -97.66 174.43 6.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.85 168.59 22.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.699 HG13 HD22 ' A' ' 62' ' ' LEU . 79.3 mt -100.37 150.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.883 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 84' ' ' LEU . 49.7 t -125.58 82.07 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -109.07 146.45 33.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.606 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 41.0 m170 -61.73 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.007 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -89.58 -137.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 60.54 -134.4 0.72 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.956 -1.09 . . . . 0.0 110.222 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -45.94 -26.15 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.907 -1.121 . . . . 0.0 111.155 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 1.031 ' CH2' HD22 ' A' ' 47' ' ' LEU . 65.4 t-105 -67.54 -58.6 4.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -25.55 42.21 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 59.7 m -81.14 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 110.537 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -52.8 -58.02 8.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.031 HD22 ' CH2' ' A' ' 43' ' ' TRP . 4.8 mp -90.82 51.83 2.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.285 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.04 56.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.894 -1.129 . . . . 0.0 111.583 -178.208 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER 174.21 154.06 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.805 -1.184 . . . . 0.0 110.335 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.428 ' HA ' ' HZ ' ' C' ' 215' ' ' MLZ . 5.9 m-85 60.48 22.7 12.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.844 . . . . 0.0 111.012 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.481 HD13 ' NE1' ' A' ' 43' ' ' TRP . 22.6 mt -105.48 113.38 26.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.087 . . . . 0.0 111.156 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 60.3 m-85 -88.86 102.31 14.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.5 p -99.65 157.03 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.087 -1.008 . . . . 0.0 111.694 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.518 ' CD ' HD13 ' A' ' 84' ' ' LEU . 26.1 mtm180 -117.68 -171.98 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.633 -0.667 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.68 80.54 9.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 109.06 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 156.02 -21.2 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.731 -0.605 . . . . 0.0 110.124 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -169.32 0.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.035 -1.04 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 15.5 m -128.69 150.12 50.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.79 ' HB2' HD21 ' A' ' 84' ' ' LEU . . . -135.01 176.37 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 110.403 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.736 ' CE ' HD23 ' A' ' 47' ' ' LEU . 2.9 ttt -121.56 156.58 32.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.487 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.877 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.8 92.12 9.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.699 HD22 HG13 ' A' ' 36' ' ' ILE 2.51 0.0 OUTLIER -53.24 -70.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.887 -178.37 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.68 -138.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 8' ' ' VAL . 87.7 m-85 -86.21 48.0 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 110.635 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.877 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -86.27 -22.08 49.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.44 -51.36 5.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.947 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.7 pp -44.29 -24.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 111.827 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.947 ' N ' HD12 ' A' ' 67' ' ' ILE . 16.4 m-85 -55.88 142.8 33.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.774 -1.204 . . . . 0.0 110.314 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' CA ' ' A' ' 17' ' ' GLY . 55.0 m-20 -119.39 -178.9 3.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 111.339 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -102.74 152.82 20.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.549 -0.72 . . . . 0.0 109.634 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.57 22.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.098 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.49 23.67 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.03 -1.044 . . . . 0.0 110.298 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -174.44 66.18 0.28 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.808 . . . . 0.0 109.797 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.775 ' O ' HD11 ' A' ' 92' ' ' ILE . 22.1 Cg_endo -65.56 93.42 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.775 1.408 . . . . 0.0 110.93 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.96 66.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.847 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -128.07 127.76 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 110.166 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 -171.92 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 110.419 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.46 158.05 23.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 14.0 tp10 -138.21 126.32 22.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 110.067 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.608 HD22 HD12 ' A' ' 84' ' ' LEU . 28.1 mt -105.22 131.26 52.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.978 . . . . 0.0 110.55 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.56 -166.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 110.419 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CZ ' ' A' ' 54' ' ' ARG . . . 138.72 -116.52 1.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' A' ' 59' ' ' ALA . 25.5 tp -168.92 45.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.17 -16.94 9.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 110.694 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.417 ' HG2' HD13 ' A' ' 34' ' ' LEU . 3.0 mtm180 -131.2 147.76 52.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.593 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.29 158.57 26.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.669 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.602 ' HE ' HD11 ' A' ' 29' ' ' LEU . 6.5 mtt180 -147.5 115.57 6.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.822 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.493 HG12 ' CE2' ' A' ' 68' ' ' PHE . 2.7 mp -88.95 117.13 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.854 -1.154 . . . . 0.0 110.402 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE2' ' HG ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -106.72 163.51 12.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.612 HG23 ' CG2' ' A' ' 30' ' ' VAL . 10.6 p -107.3 87.93 2.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.775 HD11 ' O ' ' A' ' 74' ' ' PRO . 9.5 pt -54.34 -22.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 110.319 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.5 mttt -133.58 142.35 43.6 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 110.204 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.41 ' HG3' ' HB2' ' A' ' 26' ' ' LYS . 33.8 Cg_exo -55.65 128.99 32.66 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.599 1.315 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.437 HG21 ' CB ' ' A' ' 20' ' ' ALA . 77.3 mt -107.58 138.51 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 110.342 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.73 164.8 14.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 21' ' ' ARG . 4.4 mt -70.95 112.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.71 0.89 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.37 -176.59 3.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -1.183 . . . . 0.0 110.37 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 11.8 tt0 -123.33 126.21 46.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 110.032 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.583 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 56.6 mt -88.81 126.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.167 -0.958 . . . . 0.0 109.844 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 101' ' ' ILE . 22.0 p -155.4 143.11 19.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.566 . . . . 0.0 109.929 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 76' ' ' ALA . 1.1 pp -123.92 147.69 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.513 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.6 t -85.13 -166.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.534 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.501 ' CE1' ' HE3' ' C' ' 215' ' ' MLZ . 7.4 m-85 -124.44 -65.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 0.0 110.07 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.17 15.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 7.0 p-10 -47.17 -30.5 2.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.436 -1.038 . . . . 0.0 111.454 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' C' ' 214' ' ' ARG . 0.3 OUTLIER -67.56 -42.79 82.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -109.65 115.54 30.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.091 -1.005 . . . . 0.0 110.454 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 28.5 t-105 58.71 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.789 -0.569 . . . . 0.0 111.067 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.577 HD23 ' HG3' ' A' ' 114' ' ' PRO . 10.6 tp -46.83 163.19 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.087 -1.008 . . . . 0.0 110.975 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.45 118.3 5.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.721 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.462 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 2.9 tpt180 47.68 50.4 8.8 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.31 -0.869 . . . . 0.0 111.1 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.577 ' HG3' HD23 ' A' ' 111' ' ' LEU . 55.2 Cg_endo -75.53 146.9 31.34 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.526 1.277 . . . . 0.0 110.522 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -128.44 -39.33 1.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 110.272 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.24 38.34 17.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.639 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.0 m -129.09 154.17 46.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 0.0 110.379 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.402 ' OE1' ' N ' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -126.22 140.33 52.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.338 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.402 ' N ' ' OE1' ' A' ' 118' ' ' GLN . 20.1 p30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.22 114.38 16.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.33 93.75 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 110.387 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -59.41 -40.45 67.2 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.67 1.353 . . . . 0.0 110.573 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.06 23.91 6.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.161 -0.962 . . . . 0.0 110.452 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt 51.68 68.65 0.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.534 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -88.8 103.44 15.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.293 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' C' ' 208' ' ' LEU . 0.2 OUTLIER -65.72 94.19 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 110.42 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.97 143.49 52.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 1.2 p -122.65 83.68 2.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 110.402 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -84.28 67.5 9.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 110.339 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' C' ' 213' ' ' ALA . . . -164.42 118.5 1.4 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 110.456 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 213' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' C' ' 212' ' ' ALA . . . 54.7 172.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.504 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 108' ' ' ASP . 13.6 mtt-85 -141.75 -84.72 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 110.254 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.501 ' HE3' ' CE1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 28.7 t -50.56 154.79 1.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.839 . . . . 0.0 110.659 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 218' ' ' PRO . . . -171.09 147.6 2.29 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 217' ' ' ALA . 38.0 Cg_exo -57.4 -173.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.745 1.392 . . . . 0.0 110.503 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -164.57 115.83 1.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 9.8 t -136.88 -163.97 1.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.376 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.867 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.218 0.533 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' HD12 ' B' ' 7' ' ' ILE . 14.6 t80 53.14 68.34 0.85 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.915 . . . . 0.0 110.171 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 5' ' ' ARG . 11.8 m120 -90.23 55.24 3.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.028 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.1 t70 52.96 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.706 -0.621 . . . . 0.0 111.355 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.527 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.2 OUTLIER -50.55 -33.92 23.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 111.027 -178.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.527 HG23 ' C ' ' B' ' 5' ' ' ARG . 89.4 t -152.31 138.53 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.036 -1.04 . . . . 0.0 111.211 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.603 HG23 ' HB2' ' B' ' 19' ' ' PHE . 12.7 tt -114.64 162.33 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.539 HG21 ' CE2' ' B' ' 64' ' ' PHE . 95.8 t -106.86 120.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.431 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.595 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 16.7 mttt -116.74 144.0 44.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.875 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.595 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 25.2 mttt 52.43 62.94 2.44 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.752 -1.842 . . . . 0.0 111.403 0.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.5 OUTLIER -115.82 173.45 2.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.413 -0.804 . . . . 0.0 110.32 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' B' ' 11' ' ' SER . 32.1 Cg_exo -57.76 -31.76 93.04 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.637 1.336 . . . . 0.0 110.428 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.66 -36.53 28.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 110.327 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.68 -164.69 15.58 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.29 -177.89 42.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.437 ' CB ' ' HN2' ' B' ' 302' ' ' SAH . 0.2 OUTLIER -129.42 71.7 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -1.135 . . . . 0.0 110.385 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.416 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -108.94 -172.19 21.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.864 ' CG2' HD13 ' B' ' 67' ' ' ILE . 95.1 t -113.57 158.47 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.016 -1.285 . . . . 0.0 110.718 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.603 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.9 OUTLIER -120.99 127.88 52.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 110.164 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.576 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -89.78 95.17 10.12 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.362 -0.836 . . . . 0.0 110.542 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.88 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -64.15 -24.88 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.684 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -86.07 179.21 7.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.552 -0.718 . . . . 0.0 109.373 179.381 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.548 ' OG ' HD11 ' B' ' 97' ' ' ILE 2.511 0.0 OUTLIER 103.3 11.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.111 -1.618 . . . . 0.0 110.541 1.19 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.7 m-85 -107.63 150.99 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.048 -1.032 . . . . 0.0 110.777 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.29 -152.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -100.57 69.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.06 75.29 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.71 7.49 3.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 110.976 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.625 HD11 ' HE ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER 61.5 131.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.178 -0.951 . . . . 0.0 110.129 -179.348 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.608 ' CG2' HG23 ' B' ' 91' ' ' THR . 98.1 t -103.22 -74.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.991 -1.068 . . . . 0.0 110.551 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.53 160.84 37.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.008 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.58 142.3 37.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 110.183 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.436 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.4 p -150.3 -175.01 4.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.714 ' N ' HD22 ' B' ' 34' ' ' LEU . 2.8 mm? -97.78 174.4 6.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.189 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 92.2 m -148.82 168.56 22.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 110.743 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.718 HG13 HD22 ' B' ' 62' ' ' LEU . 79.4 mt -100.46 150.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.841 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 49.5 t -125.48 82.08 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.462 ' HB3' ' CD2' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -109.1 146.43 34.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 110.55 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.479 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 40.9 m170 -61.65 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 41' ' ' ASP . 6.6 t-20 -89.52 -137.64 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 5.0 m-20 60.56 -134.42 0.72 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.007 -1.058 . . . . 0.0 110.23 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -45.97 -26.04 0.65 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.903 -1.123 . . . . 0.0 111.201 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 1.022 ' CH2' HD22 ' B' ' 47' ' ' LEU . 65.4 t-105 -67.66 -58.58 4.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.41 -25.61 41.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 60.3 m -81.2 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 110.512 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' B' ' 47' ' ' LEU . . . -52.83 -57.44 10.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.181 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 1.022 HD22 ' CH2' ' B' ' 43' ' ' TRP . 4.7 mp -91.61 52.21 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 110.239 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.23 56.23 0.15 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.029 -1.044 . . . . 0.0 111.581 -178.364 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.5 OUTLIER 174.15 154.09 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.853 -1.154 . . . . 0.0 110.359 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.429 ' HA ' ' HZ ' ' D' ' 215' ' ' MLZ . 5.9 m-85 60.5 22.77 12.45 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.383 -0.823 . . . . 0.0 110.985 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.48 HD13 ' NE1' ' B' ' 43' ' ' TRP . 22.5 mt -105.51 112.85 26.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.9 -1.125 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' B' ' 61' ' ' ALA . 60.8 m-85 -88.29 102.28 14.68 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.3 p -99.62 157.0 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.103 -0.998 . . . . 0.0 111.753 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.516 ' CD ' HD13 ' B' ' 84' ' ' LEU . 26.3 mtm180 -118.17 -174.49 2.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.699 -0.625 . . . . 0.0 109.711 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 80.27 6.56 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.188 -0.945 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 155.89 -21.3 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.577 -0.702 . . . . 0.0 110.177 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 -169.31 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.058 -1.026 . . . . 0.0 110.944 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.462 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 15.5 m -128.71 150.12 50.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.453 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' B' ' 84' ' ' LEU . . . -135.03 176.36 8.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 110.44 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.75 ' CE ' HD23 ' B' ' 47' ' ' LEU . 2.9 ttt -121.71 156.03 33.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.847 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.12 92.12 9.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.89 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.718 HD22 HG13 ' B' ' 36' ' ' ILE 2.509 0.0 OUTLIER -53.3 -70.92 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.896 -178.459 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.71 -138.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' B' ' 8' ' ' VAL . 87.9 m-85 -86.2 48.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.133 . . . . 0.0 110.656 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.847 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -86.27 -22.18 49.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.39 -51.39 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -1.199 . . . . 0.0 110.5 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.956 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.7 pp -44.22 -24.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.598 -0.689 . . . . 0.0 111.843 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.956 ' N ' HD12 ' B' ' 67' ' ' ILE . 16.4 m-85 -55.67 143.39 30.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.796 -1.19 . . . . 0.0 110.258 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.416 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 56.0 m-20 -120.08 -178.45 3.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 111.228 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.42 ' CE1' ' HG ' ' B' ' 104' ' ' SER . 26.3 t60 -103.62 152.68 21.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.45 22.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.959 -1.088 . . . . 0.0 111.075 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.63 23.62 2.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.045 . . . . 0.0 110.222 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -174.47 66.2 0.28 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.78 ' O ' HD11 ' B' ' 92' ' ' ILE . 22.2 Cg_endo -65.54 93.37 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.783 1.412 . . . . 0.0 110.934 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.93 66.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.816 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -128.08 127.81 43.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.01 -171.93 2.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.451 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.37 157.83 23.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.496 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.447 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 14.0 tp10 -137.96 126.54 23.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.164 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.596 HD22 HD12 ' B' ' 84' ' ' LEU . 28.1 mt -105.2 131.35 52.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 0.0 110.51 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.73 -166.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.349 -0.845 . . . . 0.0 110.257 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.06 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 110.455 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.421 ' O ' ' CZ ' ' B' ' 54' ' ' ARG . . . 138.73 -116.61 1.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' B' ' 59' ' ' ALA . 25.5 tp -168.91 46.0 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -1.137 . . . . 0.0 110.425 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.15 -16.99 9.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.674 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.413 ' HG2' HD13 ' B' ' 34' ' ' LEU . 3.0 mtm180 -131.2 147.8 52.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.093 -1.004 . . . . 0.0 110.556 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 5.6 mmm -120.26 158.57 26.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 110.719 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.625 ' HE ' HD11 ' B' ' 29' ' ' LEU . 6.5 mtt180 -147.54 115.21 6.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 109.885 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' B' ' 68' ' ' PHE . 2.7 mp -88.39 117.11 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.042 . . . . 0.0 110.523 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' B' ' 29' ' ' LEU . 0.9 OUTLIER -106.81 163.49 12.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.345 -0.847 . . . . 0.0 110.643 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.608 HG23 ' CG2' ' B' ' 30' ' ' VAL . 10.4 p -107.24 87.86 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.78 HD11 ' O ' ' B' ' 74' ' ' PRO . 9.5 pt -54.25 -22.88 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.917 . . . . 0.0 110.358 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.419 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.5 mttt -133.55 142.45 43.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.216 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 93' ' ' LYS . 37.3 Cg_exo -55.95 129.16 33.47 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.561 1.295 . . . . 0.0 110.454 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.442 HG21 ' CB ' ' B' ' 20' ' ' ALA . 77.4 mt -107.58 138.4 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 110.313 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 164.79 14.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.178 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.88 HG23 ' O ' ' B' ' 21' ' ' ARG . 4.4 mt -70.94 112.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.75 0.89 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.43 -176.56 3.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -1.165 . . . . 0.0 110.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' B' ' 19' ' ' PHE . 11.8 tt0 -123.45 125.74 45.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.114 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 56.1 mt -88.0 126.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 110.075 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.53 HG23 ' O ' ' B' ' 101' ' ' ILE . 22.0 p -155.45 143.08 19.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.578 -0.701 . . . . 0.0 109.903 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.816 HG22 ' O ' ' B' ' 76' ' ' ALA . 1.1 pp -123.89 147.68 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.42 ' HG ' ' CE1' ' B' ' 70' ' ' HIS . 43.5 t -85.17 -166.34 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 110.486 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.492 ' CE1' ' HE3' ' D' ' 215' ' ' MLZ . 7.5 m-85 -124.49 -65.58 1.03 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.948 . . . . 0.0 110.065 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.92 173.23 15.22 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 7.0 p-10 -47.14 -30.41 2.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -1.01 . . . . 0.0 111.514 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' D' ' 214' ' ' ARG . 0.3 OUTLIER -67.66 -42.94 81.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.082 -1.012 . . . . 0.0 110.932 -178.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -109.31 115.71 30.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 0.0 110.563 -179.017 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' B' ' 111' ' ' LEU . 28.3 t-105 58.55 -77.8 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.893 -0.504 . . . . 0.0 111.06 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.561 HD23 ' HG3' ' B' ' 114' ' ' PRO . 10.6 tp -46.71 163.03 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.062 -1.024 . . . . 0.0 110.969 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.34 118.33 5.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 110.668 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.463 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 2.9 tpt180 47.56 50.45 8.85 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.89 . . . . 0.0 111.108 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.561 ' HG3' HD23 ' B' ' 111' ' ' LEU . 55.3 Cg_endo -75.49 146.88 31.44 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.533 1.28 . . . . 0.0 110.551 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -128.44 -39.31 1.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 110.279 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.25 38.36 17.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.673 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 24.9 m -129.16 154.18 47.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 110.377 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.23 140.32 52.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 110.301 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.1 p30 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.376 -179.881 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.26 114.41 16.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -1.142 . . . . 0.0 110.42 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.37 93.75 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -59.43 -40.52 66.31 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.609 1.321 . . . . 0.0 110.529 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.02 23.89 6.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 110.545 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt 51.73 68.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 110.526 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -88.75 103.4 15.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 110.305 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 208' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' D' ' 208' ' ' LEU . 0.2 OUTLIER -65.66 94.13 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 110.455 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.97 143.49 52.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.356 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 1.2 p -122.63 83.63 2.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.928 . . . . 0.0 110.391 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -84.23 67.51 9.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 110.344 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.49 118.4 1.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 110.47 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 54.73 172.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 110.501 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' B' ' 108' ' ' ASP . 13.7 mtt-85 -141.72 -84.67 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 110.255 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.492 ' HE3' ' CE1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 28.7 t -50.55 154.76 1.24 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.677 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.04 147.63 2.32 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 110.394 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.4 -173.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.648 1.341 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -164.59 115.77 1.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 110.405 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 9.8 t -136.86 -164.0 1.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 110.44 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.544 179.93 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.43 ' HN2' ' CB ' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.437 ' HN2' ' CB ' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.0 0.428 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 52.9 p90 -129.76 136.45 49.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.797 -1.189 . . . . 0.0 110.77 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' ARG . 8.7 p-10 -148.04 164.28 34.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.885 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.16 62.28 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.588 -0.695 . . . . 0.0 110.754 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.8 tpt180 179.69 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.284 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 5' ' ' ARG . 54.9 t -157.07 169.41 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 110.1 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 6' ' ' VAL . 11.8 tt -144.77 146.61 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.876 HG12 ' HD3' ' A' ' 10' ' ' LYS . 94.7 t -89.65 102.53 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 111.027 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.656 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 1.1 mmtt -124.06 137.58 54.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.876 ' HD3' HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER 49.85 50.23 18.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 119.407 -2.058 . . . . 0.0 111.699 4.002 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.526 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -104.13 -55.55 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.902 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 11' ' ' SER . 87.7 Cg_endo -92.87 34.56 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.11 1.058 . . . . 0.0 110.264 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.69 51.3 11.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.119 -0.988 . . . . 0.0 109.864 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.3 -123.1 3.35 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . -97.13 -150.58 26.92 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.51 ' CE2' ' HE3' ' A' ' 10' ' ' LYS . 3.5 m-85 -115.24 110.44 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -1.114 . . . . 0.0 110.803 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.5 173.77 22.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.715 HG23 HD13 ' A' ' 67' ' ' ILE . 97.9 t -98.3 130.08 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.999 -1.295 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE2' ' CB ' ' A' ' 11' ' ' SER . 1.6 m-85 -107.68 133.82 51.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 110.147 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.771 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -96.93 88.47 4.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.404 -0.81 . . . . 0.0 110.542 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.849 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.21 -27.15 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.38 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 14.7 mtpt -83.61 178.98 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.463 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 0.1 OUTLIER 102.24 20.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.0 -1.687 . . . . 0.0 109.563 3.145 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 15.2 m-85 -112.68 150.24 31.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.09 -158.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.845 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -80.41 -1.17 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.07 67.57 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' A' ' 24' ' ' PHE . 7.1 mt-10 -118.07 120.76 38.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.124 . . . . 0.0 110.275 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.698 HD13 ' CZ ' ' A' ' 90' ' ' PHE . 25.8 tp -53.71 127.36 25.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 6' ' ' VAL . 47.2 t -103.41 72.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 57.04 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.58 156.01 29.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 110.327 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -147.55 -161.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.367 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.6 mm? -96.7 -179.17 4.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 110.543 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.3 m -148.21 178.16 8.8 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.435 -0.791 . . . . 0.0 109.535 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.56 HD11 ' CD2' ' A' ' 62' ' ' LEU . 20.9 mt -113.97 138.49 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 110.26 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.85 113.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.032 -1.043 . . . . 0.0 110.325 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 1.5 tpp180 -146.61 159.73 43.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 110.404 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.475 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 64.2 m170 -71.4 -173.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -86.37 -137.28 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.833 . . . . 0.0 110.117 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.42 -139.91 0.43 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.739 -1.226 . . . . 0.0 110.304 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -46.36 -26.95 0.92 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.983 -1.073 . . . . 0.0 111.11 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.841 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 67.8 t-105 -61.06 -55.94 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.819 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.23 69.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.3 m -69.82 -70.42 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HB3' HD22 ' A' ' 47' ' ' LEU . . . -52.8 -53.42 48.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.133 -0.98 . . . . 0.0 110.185 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.911 ' HB3' HD13 ' A' ' 51' ' ' LEU . 2.6 mm? -90.45 46.49 1.34 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -5.88 35.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.851 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.35 147.19 43.76 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.95 -1.094 . . . . 0.0 110.021 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CE1' ' O ' ' A' ' 66' ' ' ALA . 11.6 m-85 56.09 38.76 30.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.096 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.911 HD13 ' HB3' ' A' ' 47' ' ' LEU . 7.0 tp -123.76 122.81 39.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.896 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.406 ' CD1' ' HB3' ' C' ' 215' ' ' MLZ . 54.3 m-85 -99.08 132.32 44.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.959 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 60.6 p -94.27 127.89 40.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -0.962 . . . . 0.0 110.783 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.603 ' CB ' HD11 ' A' ' 84' ' ' LEU . 12.9 tpt180 -105.39 172.94 6.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.407 -0.808 . . . . 0.0 109.608 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -83.08 82.71 8.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.946 -1.096 . . . . 0.0 109.225 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 22.9 p30 146.45 -18.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.79 -0.569 . . . . 0.0 109.765 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.98 -160.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.1 m -140.49 118.59 11.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.149 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.44 153.81 23.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.639 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.782 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -93.16 179.58 5.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -86.48 -146.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.16 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.913 HD13 ' HB2' ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER -178.34 -73.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.99 -1.069 . . . . 0.0 109.967 -179.211 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 33' ' ' CYS . . . -74.55 -114.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 40.5 m-85 -91.26 33.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.516 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -90.95 -22.14 33.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -91.09 -20.94 21.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 111.681 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.715 HD13 HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -92.51 -4.29 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.217 . . . . 0.0 111.835 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' N ' HD12 ' A' ' 67' ' ' ILE . 5.3 m-85 -55.81 147.78 18.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.823 -1.173 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -117.42 -167.83 1.38 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.439 ' HE1' HD12 ' A' ' 111' ' ' LEU . 79.6 t60 -103.79 151.2 23.34 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.243 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.516 ' CB ' ' HG1' ' A' ' 102' ' ' THR . 67.1 m -161.19 150.07 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -11.75 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 111.053 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.63 67.52 71.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.701 ' O ' HD11 ' A' ' 92' ' ' ILE . 24.5 Cg_exo -60.03 107.12 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.647 1.341 . . . . 0.0 110.459 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.457 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 47.2 p30 -81.54 -6.53 59.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -146.69 150.24 35.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.985 -1.072 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.06 -160.45 0.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.448 ' HB2' ' CE ' ' A' ' 87' ' ' MET . 2.0 p-80 -132.26 166.96 20.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.067 -1.021 . . . . 0.0 110.666 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.15 141.19 29.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 110.455 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.8 HD13 HD23 ' A' ' 84' ' ' LEU . 94.5 mt -105.16 145.9 29.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.263 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.76 HG21 ' HB2' ' A' ' 86' ' ' ARG . 1.6 p -64.87 -62.64 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 110.412 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.82 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.602 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.5 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 80' ' ' LEU . 29.4 mt 52.32 48.58 22.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.425 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.22 -76.55 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.554 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.76 ' HB2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -87.22 126.63 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 110.285 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.448 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -100.79 117.75 35.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.895 . . . . 0.0 110.525 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.39 114.59 27.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.042 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 78' ' ' HIS . 38.9 mt -89.43 138.35 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.698 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 13.6 m-85 -128.36 177.86 6.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.798 HG22 HD12 ' A' ' 95' ' ' ILE . 1.6 p -115.71 96.47 5.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.316 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.701 HD11 ' O ' ' A' ' 74' ' ' PRO . 23.3 pt -50.45 -35.83 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.568 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -130.28 150.48 76.26 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 110.299 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.15 131.69 31.57 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.717 1.378 . . . . 0.0 110.981 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.798 HD12 HG22 ' A' ' 91' ' ' THR . 32.1 mt -113.29 145.32 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.786 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.38 10.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 110.968 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 21' ' ' ARG . 39.4 mt -65.79 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.06 36.37 1.83 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.608 ' CB ' HG23 ' A' ' 95' ' ' ILE . 4.8 mm-40 -101.32 156.26 17.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -1.12 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.411 ' OE1' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -100.34 110.11 22.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 110.491 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 20' ' ' ALA . 59.3 mt -89.55 119.82 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.516 ' HG1' ' CB ' ' A' ' 71' ' ' SER . 32.2 p -141.13 1.59 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 111.601 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 68' ' ' PHE . 35.4 pt 37.42 -145.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.326 -0.859 . . . . 0.0 111.34 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.425 ' N ' HG13 ' A' ' 103' ' ' ILE . 22.9 t -160.59 -168.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 110.727 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.493 ' CD1' ' HE2' ' C' ' 215' ' ' MLZ . 10.5 m-85 -123.37 -66.84 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.853 . . . . 0.0 109.686 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 84.69 -160.04 35.31 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t0 55.12 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.552 -0.969 . . . . 0.0 110.581 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 1.9 t70 -153.88 25.12 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.0 110.559 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.1 OUTLIER -100.98 108.77 20.58 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.181 -0.949 . . . . 0.0 109.753 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 30.0 t-105 58.97 -78.79 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.118 0.485 . . . . 0.0 110.638 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.6 HD23 ' C ' ' A' ' 111' ' ' LEU . 8.4 tt -62.65 -52.46 63.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.065 -1.022 . . . . 0.0 110.792 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.8 t 54.71 -88.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.765 . . . . 0.0 110.142 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -92.82 131.59 33.26 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.985 -1.072 . . . . 0.0 109.741 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.91 -85.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.343 1.181 . . . . 0.0 110.605 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.57 61.68 3.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 110.703 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.4 mp -82.84 80.94 8.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 110.335 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.9 m -150.72 -66.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 0.0 110.374 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.72 56.7 6.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.357 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.387 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 -58.79 1.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -1.116 . . . . 0.0 110.382 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' C' ' 204' ' ' PRO . . . -116.48 91.48 33.84 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.387 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' C' ' 203' ' ' ALA . 18.6 Cg_endo -64.62 -60.65 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.681 1.359 . . . . 0.0 110.528 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 205' ' ' ARG . . . . . 0.409 ' HD3' ' HB2' ' C' ' 204' ' ' PRO . 0.1 OUTLIER -167.68 110.44 0.64 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 110.307 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.38 39.49 0.35 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -0.893 . . . . 0.0 110.304 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -109.6 -53.2 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 110.367 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.89 103.05 2.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 110.352 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.4 -159.99 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.444 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 210' ' ' THR . . . . . 0.662 HG23 ' O ' ' C' ' 210' ' ' THR . 5.1 t -60.62 97.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.427 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.96 -60.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 110.277 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.49 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.598 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.87 141.09 49.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 110.081 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 55.5 mtm-85 -146.94 -172.68 4.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.701 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.493 ' HE2' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 2.2 p -50.99 174.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 110.471 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.5 160.59 31.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.95 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.69 137.69 50.89 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.744 1.391 . . . . 0.0 110.509 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -77.77 64.52 3.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 110.379 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 1.4 m 53.41 98.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.425 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.989 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.956 0.407 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 52.9 p90 -129.67 136.47 49.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.813 -1.179 . . . . 0.0 110.761 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 8.7 p-10 -147.98 164.44 33.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.34 62.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.0 110.657 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.53 ' O ' HG23 ' B' ' 6' ' ' VAL . 4.8 tpt180 179.85 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.413 -0.804 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 5' ' ' ARG . 54.6 t -156.92 169.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.668 -0.645 . . . . 0.0 110.138 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.51 ' N ' HG12 ' B' ' 6' ' ' VAL . 11.8 tt -144.77 146.42 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.589 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.885 HG12 ' HD3' ' B' ' 10' ' ' LYS . 93.2 t -89.49 102.55 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.056 -1.027 . . . . 0.0 111.086 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.673 ' HA ' ' HB2' ' B' ' 10' ' ' LYS . 1.1 mmtt -124.09 137.64 54.54 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.885 ' HD3' HG12 ' B' ' 8' ' ' VAL . 0.2 OUTLIER 49.89 50.19 18.88 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 119.43 -2.044 . . . . 0.0 111.729 4.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.526 ' CB ' ' HD3' ' B' ' 12' ' ' PRO . 0.2 OUTLIER -104.19 -55.51 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 109.854 176.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' B' ' 11' ' ' SER . 88.0 Cg_endo -92.86 34.61 0.23 Allowed 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.204 1.108 . . . . 0.0 110.283 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.67 51.33 11.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.103 -0.998 . . . . 0.0 109.84 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.36 -122.95 3.33 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 10' ' ' LYS . . . -97.04 -150.48 26.84 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.509 ' CE2' ' HE3' ' B' ' 10' ' ' LYS . 3.6 m-85 -115.24 110.38 19.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -1.08 . . . . 0.0 110.872 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.54 173.64 22.19 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.729 HG23 HD13 ' B' ' 67' ' ' ILE . 92.9 t -98.17 129.86 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.318 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.515 ' CE2' ' CB ' ' B' ' 11' ' ' SER . 1.6 m-85 -107.63 133.82 51.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 110.151 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.785 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -96.91 88.5 4.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.324 -0.86 . . . . 0.0 110.569 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.6 OUTLIER -57.19 -27.16 61.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 178.495 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.506 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 14.7 mtpt -83.58 179.02 7.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.465 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.1 OUTLIER 102.21 20.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.003 -1.686 . . . . 0.0 109.581 3.056 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.506 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 15.4 m-85 -112.63 150.36 31.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.31 -0.869 . . . . 0.0 110.222 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.23 -158.77 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.963 . . . . 0.0 109.868 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -80.38 -1.25 40.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.02 67.59 0.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' B' ' 24' ' ' PHE . 7.1 mt-10 -118.05 120.69 38.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 110.309 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.701 HD13 ' CZ ' ' B' ' 90' ' ' PHE . 25.9 tp -53.67 127.37 25.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' B' ' 6' ' ' VAL . 47.1 t -103.37 72.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 57.11 163.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.451 -0.781 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.65 156.07 29.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 0.6 OUTLIER -147.61 -161.7 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 110.334 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' B' ' 34' ' ' LEU . 4.6 mm? -96.83 -179.17 4.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 110.593 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 61' ' ' ALA . 1.3 m -148.23 178.14 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.387 -0.82 . . . . 0.0 109.454 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.551 HD11 ' CD2' ' B' ' 62' ' ' LEU . 20.8 mt -114.0 138.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.018 . . . . 0.0 110.203 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.8 113.4 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.294 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 1.5 tpp180 -146.68 159.73 43.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 110.463 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 64.2 m170 -71.38 -173.99 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.764 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -86.34 -137.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.36 -139.99 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.808 -1.183 . . . . 0.0 110.295 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -46.23 -27.04 0.9 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.03 -1.044 . . . . 0.0 111.159 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.844 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 67.7 t-105 -60.98 -55.94 27.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.957 . . . . 0.0 109.852 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.21 69.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 92.1 m -69.85 -70.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -1.157 . . . . 0.0 110.519 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.574 ' HB3' HD22 ' B' ' 47' ' ' LEU . . . -52.89 -53.13 53.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.88 ' HB3' HD13 ' B' ' 51' ' ' LEU . 2.6 mm? -90.82 46.6 1.34 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -5.92 35.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 110.868 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.24 147.2 43.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.906 -1.121 . . . . 0.0 110.098 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' O ' ' B' ' 66' ' ' ALA . 11.5 m-85 56.11 38.75 30.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.866 . . . . 0.0 110.075 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 47' ' ' LEU . 7.1 tp -123.81 122.96 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.826 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' D' ' 215' ' ' MLZ . 54.0 m-85 -99.24 132.43 44.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.435 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 60.5 p -94.29 127.94 40.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.735 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.603 ' CB ' HD11 ' B' ' 84' ' ' LEU . 13.0 tpt180 -106.01 169.98 8.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.446 -0.784 . . . . 0.0 109.722 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.441 ' N ' ' HG3' ' B' ' 54' ' ' ARG . 0.1 OUTLIER -79.04 82.4 5.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.028 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 22.9 p30 146.31 -18.83 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.667 -0.645 . . . . 0.0 109.668 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.97 -160.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -140.38 118.54 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.38 153.89 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 110.73 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.796 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.1 OUTLIER -93.62 178.22 5.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.399 -0.813 . . . . 0.0 110.308 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' B' ' 35' ' ' CYS . . . -84.47 -146.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.885 . . . . 0.0 109.632 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.913 ' HB2' HD13 ' A' ' 62' ' ' LEU 2.5 0.1 OUTLIER -178.51 -73.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.001 -1.062 . . . . 0.0 110.018 -179.473 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -74.53 -113.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.472 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 40.4 m-85 -92.04 34.23 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -1.151 . . . . 0.0 110.314 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -92.02 -21.19 33.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.479 ' O ' ' CE1' ' B' ' 50' ' ' TYR . . . -92.17 -19.52 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.264 . . . . 0.0 111.627 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.729 HD13 HG23 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -94.14 -3.68 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.873 -1.142 . . . . 0.0 111.491 -178.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.673 ' N ' HD12 ' B' ' 67' ' ' ILE . 5.3 m-85 -56.13 147.82 19.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 110.461 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -117.23 -166.73 1.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.428 ' HE1' HD12 ' B' ' 111' ' ' LEU . 80.0 t60 -105.37 150.84 24.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.903 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' SER . . . . . 0.517 ' CB ' ' HG1' ' B' ' 102' ' ' THR . 67.1 m -160.88 150.08 16.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 110.311 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 -11.7 59.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 111.069 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.73 67.56 71.01 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.997 -1.065 . . . . 0.0 110.536 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.701 ' O ' HD11 ' B' ' 92' ' ' ILE . 24.5 Cg_exo -60.08 107.06 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.663 1.349 . . . . 0.0 110.434 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.461 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 47.1 p30 -81.49 -6.49 59.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.477 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -146.69 150.18 34.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.971 -1.081 . . . . 0.0 110.465 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -160.39 0.95 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.441 ' HB2' ' CE ' ' B' ' 87' ' ' MET . 2.0 p-80 -132.32 167.0 20.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.673 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.16 141.27 29.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.419 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.791 HD13 HD23 ' B' ' 84' ' ' LEU . 94.6 mt -105.26 145.89 30.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 110.318 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.772 HG21 ' HB2' ' B' ' 86' ' ' ARG . 1.6 p -64.89 -62.57 1.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.417 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.88 -43.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.54 2.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.791 HD23 HD13 ' B' ' 80' ' ' LEU . 29.4 mt 52.27 48.54 22.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -1.195 . . . . 0.0 110.407 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.18 -76.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.948 . . . . 0.0 110.536 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.772 ' HB2' HG21 ' B' ' 81' ' ' THR . 0.0 OUTLIER -87.17 126.64 34.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.006 . . . . 0.0 110.281 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.441 ' CE ' ' HB2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -100.81 117.74 35.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 110.548 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.46 114.3 27.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.121 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' B' ' 78' ' ' HIS . 38.5 mt -89.02 138.37 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.701 ' CZ ' HD13 ' B' ' 29' ' ' LEU . 13.6 m-85 -128.39 177.92 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 110.472 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.822 HG22 HD12 ' B' ' 95' ' ' ILE . 1.6 p -115.75 96.45 5.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.908 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.701 HD11 ' O ' ' B' ' 74' ' ' PRO . 23.4 pt -50.44 -35.82 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.628 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.461 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -130.25 150.52 76.36 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 110.273 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.21 131.73 31.95 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.709 1.373 . . . . 0.0 110.991 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.822 HD12 HG22 ' B' ' 91' ' ' THR . 31.9 mt -113.29 145.37 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.476 -0.765 . . . . 0.0 109.795 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.31 10.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.948 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 39.5 mt -65.76 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 110.267 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.1 36.25 1.85 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.593 ' CB ' HG23 ' B' ' 95' ' ' ILE . 4.9 mm-40 -101.28 156.25 17.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -100.32 110.06 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.11 -0.994 . . . . 0.0 110.49 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.785 HD11 ' HB2' ' B' ' 20' ' ' ALA . 60.0 mt -89.47 119.65 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.8 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.517 ' HG1' ' CB ' ' B' ' 71' ' ' SER . 32.7 p -140.91 1.53 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 111.611 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' B' ' 68' ' ' PHE . 35.2 pt 37.61 -146.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.46 -0.775 . . . . 0.0 111.388 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.423 ' N ' HG13 ' B' ' 103' ' ' ILE . 22.8 t -160.62 -169.08 2.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.903 -1.123 . . . . 0.0 110.712 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.484 ' CD1' ' HE2' ' D' ' 215' ' ' MLZ . 10.4 m-85 -123.06 -66.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.774 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 84.65 -159.95 35.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.4 t0 55.1 -87.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.527 -0.984 . . . . 0.0 110.546 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 106' ' ' GLY . 1.8 t70 -153.85 24.94 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.937 -1.102 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.491 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.1 OUTLIER -100.65 108.91 20.92 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 109.91 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.53 ' CD1' ' N ' ' B' ' 111' ' ' LEU . 29.9 t-105 58.93 -78.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.084 0.468 . . . . 0.0 110.607 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.602 HD23 ' C ' ' B' ' 111' ' ' LEU . 8.4 tt -62.58 -52.47 63.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.107 -0.996 . . . . 0.0 110.787 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 7.9 t 54.65 -88.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.446 -0.784 . . . . 0.0 110.191 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -92.79 131.53 33.46 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.861 -1.149 . . . . 0.0 109.794 178.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.8 -85.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.353 1.186 . . . . 0.0 110.619 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.64 61.63 3.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.063 -1.023 . . . . 0.0 110.71 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.3 mp -82.81 80.89 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 110.292 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 53.5 m -150.73 -66.87 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 110.366 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.77 56.68 6.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.362 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 -58.75 1.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -1.147 . . . . 0.0 110.376 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' D' ' 204' ' ' PRO . . . -116.55 91.53 34.3 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 110.367 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.407 ' HB2' ' HD3' ' D' ' 205' ' ' ARG . 18.7 Cg_endo -64.62 -60.69 0.13 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.654 1.344 . . . . 0.0 110.487 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 205' ' ' ARG . . . . . 0.407 ' HD3' ' HB2' ' D' ' 204' ' ' PRO . 0.1 OUTLIER -167.66 110.4 0.64 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.336 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 39.46 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -109.63 -53.14 2.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 110.358 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.92 103.06 2.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 110.302 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.44 -160.01 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 110.394 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 210' ' ' THR . . . . . 0.671 HG23 ' O ' ' D' ' 210' ' ' THR . 5.1 t -60.54 97.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.434 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -60.64 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.52 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.885 . . . . 0.0 110.535 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.83 141.05 49.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.491 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 55.5 mtm-85 -146.9 -172.61 4.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 110.713 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.484 ' HE2' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.2 p -51.16 174.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 0.0 110.462 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.59 31.04 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.922 . . . . 0.0 110.391 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -65.59 137.67 51.25 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.632 1.333 . . . . 0.0 110.522 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -77.76 64.52 3.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 1.4 m 53.43 98.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.442 " O2'" ' CE3' ' A' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.457 " O2'" ' CE3' ' B' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' SD ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.21 0.529 . . . . 0.0 110.425 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 2' ' ' PHE . 35.8 p90 -172.31 122.14 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.401 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -121.08 163.44 18.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -50.08 -25.61 3.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.5 ' C ' HG13 ' A' ' 6' ' ' VAL . 26.9 ttp180 -74.65 -45.39 45.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.56 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.5 HG13 ' C ' ' A' ' 5' ' ' ARG . 22.9 m -154.25 -178.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.164 -0.96 . . . . 0.0 110.493 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 19' ' ' PHE . 9.0 tt -152.91 150.49 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.101 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG21 ' SD ' ' A' ' 1' ' ' MET . 93.4 t -94.48 120.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 110.525 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.625 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 mttt -125.59 146.82 49.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.418 -0.801 . . . . 0.0 109.226 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.625 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 4.1 mmmt 52.45 59.18 4.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 119.65 -1.906 . . . . 0.0 110.922 2.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.476 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 p -107.77 -173.6 0.28 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.451 -0.781 . . . . 0.0 110.159 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 24.4 Cg_exo -60.25 -39.59 66.7 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.662 1.348 . . . . 0.0 110.407 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.03 -23.33 26.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 110.402 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 -155.25 16.44 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.34 139.26 0.29 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -99.96 72.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -1.175 . . . . 0.0 110.581 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.0 -175.97 20.37 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 90.3 t -101.67 146.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.987 -1.302 . . . . 0.0 110.03 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -110.41 126.36 54.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -0.931 . . . . 0.0 109.754 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.54 89.4 7.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -0.844 . . . . 0.0 110.843 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.52 -22.52 55.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.325 -0.859 . . . . 0.0 109.65 178.022 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -90.82 -178.87 5.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.467 -0.771 . . . . 0.0 109.862 179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 18.1 m 100.58 17.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.291 -1.506 . . . . 0.0 110.47 0.497 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -105.19 161.43 14.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.768 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -162.03 0.91 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.356 -0.84 . . . . 0.0 109.88 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 17.8 tttt -95.53 97.47 9.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.03 58.0 0.84 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.49 121.06 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -1.176 . . . . 0.0 110.43 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.967 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -56.14 132.99 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.793 ' N ' HD13 ' A' ' 29' ' ' LEU . 88.8 t -103.35 -39.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.888 . . . . 0.0 110.291 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.601 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -168.21 156.75 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.309 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.43 150.75 30.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 110.289 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.425 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -150.19 -159.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 110.631 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.8 176.07 5.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.693 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.53 150.78 31.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.78 HG13 HD22 ' A' ' 62' ' ' LEU . 56.0 mt -89.89 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.623 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 84' ' ' LEU . 41.7 t -126.9 106.87 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.632 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 35.3 mmt180 -136.53 157.97 45.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 39.0 m170 -71.45 176.52 4.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 110.157 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 53.1 p-10 -64.08 -137.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.8 t0 67.12 -149.91 0.18 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.853 -1.154 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -45.89 -34.54 3.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.864 . . . . 0.0 111.373 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.642 ' HZ3' HD21 ' B' ' 47' ' ' LEU . 48.4 t-105 -57.54 -55.45 34.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 110.241 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.58 68.08 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 94.5 m -80.85 -64.5 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.142 -1.211 . . . . 0.0 110.801 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.78 -48.45 15.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.0 111.047 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.835 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.0 mm? -91.94 26.81 2.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -64.35 80.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 7.1 t0 -175.65 -53.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 110.484 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 3.6 m-85 -127.72 54.1 1.72 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.756 HD11 ' HB2' ' A' ' 47' ' ' LEU . 6.0 mt -110.17 114.06 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 111.219 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' CE1' ' HD2' ' C' ' 215' ' ' MLZ . 36.5 m-85 -89.93 114.4 26.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.898 . . . . 0.0 109.221 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -108.0 134.78 50.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.097 -1.002 . . . . 0.0 111.207 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.706 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.89 -171.68 1.89 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 109.865 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -82.33 75.12 9.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.978 -1.076 . . . . 0.0 109.21 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 49.6 m-80 173.1 -33.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.442 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.848 ' HG2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 178.82 -167.71 0.08 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.437 -0.79 . . . . 0.0 110.351 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.3 156.75 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 110.112 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.582 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -150.32 148.61 29.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 0.0 110.47 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.835 ' CE ' HD12 ' A' ' 47' ' ' LEU . 13.7 mmm -91.37 157.77 16.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.866 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.66 101.89 13.68 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.457 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.813 HD12 ' CB ' ' B' ' 62' ' ' LEU 2.5 0.0 OUTLIER -59.64 -76.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 -179.156 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.33 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.761 ' HB3' HD11 ' A' ' 67' ' ' ILE . 89.8 m-85 -89.66 41.81 1.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 110.544 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.866 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -81.0 -22.67 60.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.9 -55.41 3.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -1.149 . . . . 0.0 111.058 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.761 HD11 ' HB3' ' A' ' 64' ' ' PHE . 1.6 pp -50.48 -22.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 111.155 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.478 ' CG ' HG12 ' A' ' 103' ' ' ILE . 0.7 OUTLIER -48.91 122.16 5.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.014 -1.054 . . . . 0.0 110.847 -179.462 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.55 ' HB2' HG22 ' A' ' 102' ' ' THR . 22.4 m-20 -94.51 173.63 7.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.51 ' NE2' ' CD1' ' A' ' 110' ' ' TRP . 39.6 t60 -102.04 150.57 23.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 0.0 110.121 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 p -149.64 139.57 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.481 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.466 ' HB3' HD22 ' A' ' 116' ' ' LEU . 11.2 mttt -54.52 -25.02 23.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.243 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.69 51.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.207 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.89 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.5 Cg_endo -62.76 98.83 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.658 1.346 . . . . 0.0 110.554 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.8 -17.91 54.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.17 170.96 15.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 110.331 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.491 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.2 ttt85 -149.73 -161.69 1.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.444 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 31.0 p-80 -130.95 -172.86 2.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 10.4 tt0 -151.73 170.98 18.42 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.171 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD13 ' CD ' ' A' ' 54' ' ' ARG . 0.9 OUTLIER -140.86 124.88 17.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 86' ' ' ARG . 9.3 t -56.92 -168.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.631 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.94 89.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.477 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.73 158.1 32.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.848 HD22 ' HG2' ' A' ' 57' ' ' MET . 2.3 mp -55.35 106.39 0.23 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -1.078 . . . . 0.0 110.348 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 -53.58 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.501 ' H ' HG22 ' A' ' 81' ' ' THR . 0.7 OUTLIER -132.26 169.38 16.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.897 . . . . 0.0 110.266 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 2.8 mtp -140.42 133.35 29.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.92 . . . . 0.0 110.494 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.777 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.8 mtp180 -115.1 176.02 5.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.269 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 31' ' ' GLU . 97.2 mt -135.33 111.98 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.967 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 56.1 m-85 -106.58 175.18 5.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.544 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 p -122.95 85.28 2.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.89 HD11 ' O ' ' A' ' 74' ' ' PRO . 50.9 pt -50.13 -25.45 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.825 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.09 134.68 21.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 110.503 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 82.0 Cg_exo -47.51 152.04 2.79 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.489 1.257 . . . . 0.0 111.014 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 99' ' ' GLU . 64.1 mt -131.28 148.68 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.64 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.59 157.88 15.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.421 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 21' ' ' ARG . 53.0 mt -63.36 109.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.206 -0.934 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.08 27.84 2.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 52.0 mm-40 -106.73 -177.83 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -1.157 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.6 123.1 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.931 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.831 HG13 ' HB2' ' A' ' 20' ' ' ALA . 84.7 mt -89.19 130.78 37.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 69' ' ' ASN . 1.1 p -154.66 143.77 21.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.817 -0.552 . . . . 0.0 110.002 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 77' ' ' ARG . 1.1 pt -105.26 160.75 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 110.491 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -93.93 -168.87 1.96 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -124.6 -68.85 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 110.3 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 89.73 -168.45 34.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.491 -1.005 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 5.3 t70 -135.19 -36.98 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.908 -1.12 . . . . 0.0 110.918 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' C' ' 214' ' ' ARG . 0.8 OUTLIER -48.15 117.75 2.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.816 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.525 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 56.0 t-105 55.48 168.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 110.466 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -59.61 -172.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 110.42 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.23 -40.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.303 -0.873 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -50.2 -49.95 72.97 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.884 . . . . 0.0 111.303 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 113' ' ' ARG . 31.4 Cg_exo -52.77 96.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.703 1.37 . . . . 0.0 110.398 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -96.55 -28.38 14.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 110.406 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER 56.21 -87.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -0.854 . . . . 0.0 110.479 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 115' ' ' ARG . 76.2 m -56.83 156.87 6.07 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.955 -1.091 . . . . 0.0 110.158 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 52.95 179.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.319 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.368 179.901 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 34.29 5.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -1.139 . . . . 0.0 110.377 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' C' ' 204' ' ' PRO . . . -94.64 176.06 2.55 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.37 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' C' ' 203' ' ' ALA . 37.1 Cg_exo -56.48 165.44 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.653 1.343 . . . . 0.0 110.495 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.25 -60.35 0.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 110.345 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.08 150.27 30.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.363 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.58 136.91 47.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 110.337 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.13 54.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.44 -72.96 0.36 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 110.351 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 17.5 p -137.92 147.61 44.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 110.332 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -43.56 5.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.472 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.65 -166.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 110.471 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.26 -158.69 0.67 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.352 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.461 ' O ' ' CD1' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -97.01 -92.27 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.214 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.455 ' HD2' ' CE1' ' A' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.5 1.6 m -55.33 -170.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.447 -0.783 . . . . 0.0 110.443 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.463 ' O ' HG23 ' C' ' 220' ' ' THR . . . -171.78 154.72 3.68 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.444 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 41.6 Cg_endo -70.05 154.98 66.05 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.702 1.37 . . . . 0.0 110.627 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.89 69.13 0.73 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.385 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 220' ' ' THR . . . . . 0.463 HG23 ' O ' ' C' ' 217' ' ' ALA . 4.2 p -84.12 154.04 23.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.338 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.95 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.415 ' SD ' HG21 ' B' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.199 0.523 . . . . 0.0 110.502 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.473 ' CD2' ' O ' ' B' ' 2' ' ' PHE . 36.4 p90 -172.32 122.13 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.427 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -121.07 163.49 18.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.338 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -50.16 -25.57 3.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.93 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.488 ' C ' HG13 ' B' ' 6' ' ' VAL . 26.8 ttp180 -74.72 -45.37 44.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 110.508 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 5' ' ' ARG . 22.9 m -154.23 -178.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -0.936 . . . . 0.0 110.476 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.573 HG23 ' HB2' ' B' ' 19' ' ' PHE . 9.0 tt -152.96 150.47 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.415 HG21 ' SD ' ' B' ' 1' ' ' MET . 92.2 t -94.47 120.23 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 0.0 110.548 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.63 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 32.7 mttt -125.77 146.9 49.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.208 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.63 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 4.1 mmmt 52.47 59.2 4.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.636 -1.915 . . . . 0.0 110.943 2.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.1 p -107.81 -173.6 0.28 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.75 . . . . 0.0 110.139 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 24.5 Cg_exo -60.22 -39.62 66.75 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.636 1.335 . . . . 0.0 110.396 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.04 -23.35 26.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.378 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 -155.26 16.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.37 139.24 0.29 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -99.95 72.04 1.68 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -1.187 . . . . 0.0 110.597 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.07 -175.94 20.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 87.5 t -101.62 145.79 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.011 -1.288 . . . . 0.0 110.075 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.573 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -110.41 126.08 53.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.256 -0.902 . . . . 0.0 109.791 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.825 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.22 89.38 7.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 110.925 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.58 -22.44 55.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 178.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' B' ' 23' ' ' SER . 0.3 OUTLIER -90.83 -178.83 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.442 -0.786 . . . . 0.0 109.883 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.51 18.1 m 100.6 17.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.314 -1.491 . . . . 0.0 110.481 0.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -105.2 161.46 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 110.759 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.13 -162.07 0.91 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.418 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 17.9 tttt -95.48 97.5 9.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.324 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.05 57.94 0.84 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.5 121.04 26.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.131 . . . . 0.0 110.421 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.978 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -56.05 132.94 51.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.23 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.795 ' N ' HD13 ' B' ' 29' ' ' LEU . 88.3 t -103.36 -39.92 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.605 ' HB3' HD12 ' B' ' 89' ' ' ILE . 0.9 OUTLIER -168.19 156.76 8.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.392 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.41 150.88 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.425 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -150.37 -159.78 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.596 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.88 176.41 5.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 110.723 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.98 150.52 30.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 109.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.764 HG13 HD22 ' B' ' 62' ' ' LEU . 55.8 mt -89.65 147.47 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 109.656 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 84' ' ' LEU . 41.6 t -126.93 106.92 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 110.644 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.498 ' HB2' ' CD2' ' B' ' 43' ' ' TRP . 35.3 mmt180 -136.59 157.99 45.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 38.9 m170 -71.49 176.51 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.196 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 53.2 p-10 -63.99 -138.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.8 t0 67.16 -149.89 0.18 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.812 -1.18 . . . . 0.0 110.708 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -45.88 -34.62 3.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.279 -0.888 . . . . 0.0 111.349 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.633 ' HZ3' HD21 ' A' ' 47' ' ' LEU . 48.2 t-105 -57.52 -55.5 34.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.63 68.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 94.5 m -80.8 -64.45 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 0.0 110.762 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.09 -47.53 17.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 111.144 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.0 mm? -93.02 27.15 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.569 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.3 OUTLIER -64.45 80.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 110.269 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.473 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 7.1 t0 -175.7 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 3.6 m-85 -127.69 54.05 1.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.214 -0.929 . . . . 0.0 109.612 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' B' ' 47' ' ' LEU . 5.9 mt -110.18 114.2 27.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.46 ' CE1' ' HD2' ' D' ' 215' ' ' MLZ . 36.3 m-85 -90.12 114.37 26.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.336 -0.852 . . . . 0.0 109.19 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -107.9 134.73 50.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.007 . . . . 0.0 111.2 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.707 ' HB2' HD11 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -112.54 -174.75 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.514 -0.741 . . . . 0.0 109.892 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -77.87 74.51 4.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 0.0 110.253 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 49.9 m-80 173.1 -33.58 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.851 ' HG2' HD22 ' B' ' 84' ' ' LEU . 0.0 OUTLIER 179.01 -167.68 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 110.483 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.15 156.8 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.578 ' O ' HD23 ' B' ' 51' ' ' LEU . . . -150.46 148.63 28.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 110.514 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.842 ' CE ' HD12 ' B' ' 47' ' ' LEU . 13.7 mmm -91.64 156.43 17.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 110.303 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.834 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.82 101.97 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.807 . . . . 0.0 110.728 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.813 ' CB ' HD12 ' A' ' 62' ' ' LEU 2.498 0.0 OUTLIER -59.96 -76.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 111.111 -179.355 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.36 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.779 ' HB3' HD11 ' B' ' 67' ' ' ILE . 89.7 m-85 -89.66 41.86 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -1.171 . . . . 0.0 110.528 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.834 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -81.13 -22.24 61.34 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.45 -55.25 3.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 110.979 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' B' ' 64' ' ' PHE . 1.6 pp -50.51 -22.21 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 111.226 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' B' ' 103' ' ' ILE . 0.7 OUTLIER -48.91 122.13 5.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.017 -1.052 . . . . 0.0 110.835 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.543 ' HB2' HG22 ' B' ' 102' ' ' THR . 22.5 m-20 -94.38 173.98 7.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.843 . . . . 0.0 110.364 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' B' ' 110' ' ' TRP . 39.8 t60 -102.52 150.52 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -149.61 139.62 22.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 110.486 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.467 ' HB3' HD22 ' B' ' 116' ' ' LEU . 11.2 mttt -54.54 -25.03 23.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.933 . . . . 0.0 110.218 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.66 51.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.891 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.0 Cg_endo -62.84 98.84 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.699 1.368 . . . . 0.0 110.558 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.76 -17.97 54.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.539 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.15 171.02 15.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.324 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.489 ' HA ' HG22 ' B' ' 103' ' ' ILE . 5.2 ttt85 -149.7 -161.74 1.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 110.314 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.454 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 31.3 p-80 -130.9 -172.05 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.414 ' HB3' ' HD3' ' B' ' 88' ' ' ARG . 10.4 tt0 -153.09 170.05 21.43 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.712 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.417 HD13 ' CD ' ' B' ' 54' ' ' ARG . 0.9 OUTLIER -140.53 124.81 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 0.0 110.172 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.5 HG22 ' H ' ' B' ' 86' ' ' ARG . 9.1 t -57.18 -168.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.463 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.07 89.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 110.581 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.71 158.11 33.01 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.851 HD22 ' HG2' ' B' ' 57' ' ' MET . 2.3 mp -55.38 106.45 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -1.084 . . . . 0.0 110.353 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -53.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 110.395 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.5 ' H ' HG22 ' B' ' 81' ' ' THR . 0.7 OUTLIER -132.29 169.36 16.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.8 mtp -140.47 133.38 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.495 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.784 ' HB3' HD21 ' B' ' 29' ' ' LEU . 1.8 mtp180 -115.13 176.04 5.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.605 HD12 ' HB3' ' B' ' 31' ' ' GLU . 97.2 mt -135.38 111.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.096 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.978 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 56.5 m-85 -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -122.99 85.37 2.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.08 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.891 HD11 ' O ' ' B' ' 74' ' ' PRO . 50.9 pt -50.11 -25.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.833 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.04 134.59 21.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 0.0 110.502 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 83.6 Cg_exo -47.88 152.21 3.25 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.541 1.285 . . . . 0.0 110.979 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.459 ' CG2' ' HB2' ' B' ' 99' ' ' GLU . 63.9 mt -131.19 148.67 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.64 157.86 15.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 53.0 mt -63.31 109.75 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.889 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.09 27.81 2.83 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 52.4 mm-40 -106.75 -177.91 3.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.268 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.59 122.84 41.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.003 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.825 HG13 ' HB2' ' B' ' 20' ' ' ALA . 84.3 mt -88.71 130.86 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.249 -0.907 . . . . 0.0 110.388 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.543 HG22 ' HB2' ' B' ' 69' ' ' ASN . 1.1 p -154.78 143.78 20.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' B' ' 77' ' ' ARG . 1.1 pt -105.21 160.75 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 110.467 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 44.5 t -93.97 -168.86 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 110.504 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -124.55 -68.9 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 110.352 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 89.77 -168.43 34.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -1.04 . . . . 0.0 110.719 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' B' ' 106' ' ' GLY . 5.3 t70 -135.2 -36.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.899 -1.125 . . . . 0.0 110.885 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' D' ' 214' ' ' ARG . 0.8 OUTLIER -48.12 117.66 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.813 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.518 ' CD1' ' NE2' ' B' ' 70' ' ' HIS . 56.1 t-105 55.48 168.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.498 -0.751 . . . . 0.0 110.467 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' B' ' 110' ' ' TRP . 0.2 OUTLIER -59.54 -172.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 110.452 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.29 -40.96 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.329 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.497 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 0.7 OUTLIER -50.65 -49.69 77.27 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.26 -0.9 . . . . 0.0 110.904 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 31.4 Cg_exo -52.7 96.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.613 1.323 . . . . 0.0 110.479 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 117' ' ' THR . 0.4 OUTLIER -96.6 -28.38 14.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.386 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' B' ' 72' ' ' LYS . 0.4 OUTLIER 56.22 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.45 -0.781 . . . . 0.0 110.459 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.432 ' N ' ' O ' ' B' ' 115' ' ' ARG . 75.9 m -56.77 156.8 6.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.947 -1.095 . . . . 0.0 110.162 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.06 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.304 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.351 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 34.35 5.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -1.144 . . . . 0.0 110.384 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' D' ' 204' ' ' PRO . . . -94.63 176.07 2.55 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' D' ' 203' ' ' ALA . 37.3 Cg_exo -56.5 165.42 4.5 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.601 1.316 . . . . 0.0 110.524 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -60.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 110.345 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.1 150.22 30.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.214 -0.929 . . . . 0.0 110.393 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.54 136.96 47.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.18 54.64 0.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.395 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.41 -72.97 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.321 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 17.5 p -137.93 147.64 44.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 110.329 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.91 -43.54 5.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.449 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.6 -166.0 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.907 . . . . 0.0 110.472 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.23 -158.63 0.67 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 110.392 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.475 ' O ' ' CD1' ' B' ' 109' ' ' TYR . 0.0 OUTLIER -96.99 -92.27 0.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 110.245 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.46 ' HD2' ' CE1' ' B' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 1.6 m -55.27 -170.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.455 -0.778 . . . . 0.0 110.43 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.452 ' O ' HG23 ' D' ' 220' ' ' THR . . . -171.76 154.77 3.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.421 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.454 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 41.2 Cg_endo -70.12 155.01 65.75 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.696 1.367 . . . . 0.0 110.558 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.87 69.15 0.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.418 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 220' ' ' THR . . . . . 0.452 HG23 ' O ' ' D' ' 217' ' ' ALA . 4.3 p -84.19 153.98 23.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 110.302 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 302' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tpt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.234 0.54 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -129.82 134.96 47.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 5' ' ' ARG . 1.5 m-80 -111.23 40.72 2.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 110.449 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.53 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.536 -0.727 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 20.3 mtm180 -52.0 -38.88 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.491 HG21 HG13 ' A' ' 30' ' ' VAL . 98.5 t -135.26 143.82 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 20.0 tt -119.57 165.38 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.556 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -100.15 128.73 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 33.2 mttt -143.62 139.97 29.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.604 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.74 55.11 9.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 119.749 -1.845 . . . . 0.0 110.277 1.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -106.71 177.07 1.42 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.798 -0.564 . . . . 0.0 110.366 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 32.8 Cg_exo -55.22 -20.84 26.12 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.691 1.364 . . . . 0.0 110.563 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 13' ' ' LEU . 3.4 mm? -99.74 -35.18 9.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.409 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.87 171.52 13.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . 96.4 116.54 3.26 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.429 ' HB3' ' N ' ' A' ' 301' ' ' SAH . 0.1 OUTLIER -86.2 64.02 8.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.58 -166.43 24.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' A' ' 6' ' ' VAL . 59.7 t -97.88 127.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.962 -1.316 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 11' ' ' SER . 0.1 OUTLIER -90.5 126.9 36.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.109 . . . . 0.0 109.841 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.86 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.21 90.87 8.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.699 -0.625 . . . . 0.0 110.635 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.835 ' O ' HG23 ' A' ' 97' ' ' ILE . 2.7 ttt180 -69.21 -22.13 63.9 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.481 0.658 . . . . 0.0 109.399 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 2.8 mttp -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.497 -0.752 . . . . 0.0 109.38 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 22' ' ' LYS 2.516 19.2 m 108.32 34.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.983 -1.698 . . . . 0.0 109.84 1.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 44.2 m-85 -127.28 160.67 30.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 111.076 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.44 -159.88 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.51 -0.743 . . . . 0.0 110.148 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CA ' ' HD3' ' A' ' 94' ' ' PRO . 23.7 tttm -102.19 98.96 9.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.071 -1.018 . . . . 0.0 110.194 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.78 33.91 0.96 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -117.14 141.88 47.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.511 HD12 ' CE2' ' A' ' 90' ' ' PHE . 2.3 tp -83.76 136.96 33.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 6' ' ' VAL . 48.5 t -92.42 -62.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 110.422 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.724 ' HG2' HD12 ' A' ' 89' ' ' ILE . 1.7 pt-20 -159.03 149.2 19.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.199 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -131.53 137.98 48.72 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.108 -0.995 . . . . 0.0 109.902 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.407 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 36.8 m -140.35 178.88 6.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 110.092 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 34' ' ' LEU . 11.3 mp -91.75 169.41 10.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.396 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.518 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 72.8 m -145.51 168.51 20.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 60' ' ' MET . 39.1 mt -96.76 164.09 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.638 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 84' ' ' LEU . 51.6 t -143.58 115.85 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 110.828 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 62.5 mmt-85 -144.63 142.49 30.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.144 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.54 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.881 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -98.52 119.76 37.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.727 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -177.38 -141.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.64 -35.49 42.3 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.307 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.7 ' CE3' HD21 ' B' ' 47' ' ' LEU . 13.4 t-105 -63.1 -35.36 79.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -58.1 -66.06 3.08 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 29.6 m -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.325 -1.103 . . . . 0.0 111.011 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -62.56 1.78 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.848 -1.157 . . . . 0.0 108.457 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.874 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.1 mm? -92.81 36.32 1.03 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 109.845 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -71.2 -1.02 11.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.641 -179.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -118.13 150.12 39.89 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.862 -1.148 . . . . 0.0 108.929 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.632 ' HA ' HCM1 ' C' ' 215' ' ' MLZ . 26.1 m-85 57.5 29.14 16.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 60' ' ' MET . 4.6 tp -129.67 138.12 51.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.441 -0.787 . . . . 0.0 111.035 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.485 ' CE1' ' HE3' ' C' ' 215' ' ' MLZ . 60.5 m-85 -92.89 162.14 14.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.371 -0.83 . . . . 0.0 109.615 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 47.0 p -138.51 113.71 9.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 110.639 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.55 179.87 4.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 110.169 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -83.64 86.75 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 109.48 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 41.8 m-80 149.08 -25.54 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.51 -158.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.143 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 15.2 m -139.86 169.5 17.6 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.875 . . . . 0.0 109.946 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -149.9 149.29 30.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.874 ' CE ' HD12 ' A' ' 47' ' ' LEU . 2.3 ttt -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.1 90.5 8.38 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.18 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 36' ' ' ILE 2.502 0.2 OUTLIER -55.32 -73.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.771 -179.662 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -64.05 -137.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HB3' HD11 ' A' ' 67' ' ' ILE . 62.2 m-85 -84.18 51.75 2.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 110.423 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.81 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.45 -27.8 19.01 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -88.39 -47.34 8.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 110.427 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.864 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.9 pp -47.99 -24.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.29 -0.881 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.864 ' N ' HD12 ' A' ' 67' ' ' ILE . 3.7 m-85 -49.16 120.19 3.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.99 . . . . 0.0 110.584 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.712 ' H ' HG22 ' A' ' 102' ' ' THR . 73.7 m-20 -95.26 175.73 6.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.429 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.693 ' NE2' HD12 ' A' ' 111' ' ' LEU . 15.4 t-160 -96.0 139.06 32.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 110.661 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.3 t -143.75 161.74 37.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 110.142 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.757 ' HD3' HD22 ' A' ' 116' ' ' LEU . 21.9 tptp -83.96 -34.33 24.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.456 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 58.28 20.03 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 110.507 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.09 115.86 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.53 1.279 . . . . 0.0 110.397 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.753 ' HA ' HD11 ' A' ' 92' ' ' ILE . 42.7 m-80 -89.71 18.74 5.23 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.566 -0.709 . . . . 0.0 110.7 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.474 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -122.49 158.95 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.595 ' HB2' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -145.59 169.46 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 110.529 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.79 130.69 47.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 110.403 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.82 152.47 24.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 110.261 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.05 131.04 56.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.509 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 86' ' ' ARG . 40.7 p -57.91 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.9 . . . . 0.0 110.379 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 110.313 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.79 -126.32 1.46 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.635 ' HB3' HG22 ' A' ' 37' ' ' VAL . 4.4 tp -153.09 27.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.16 . . . . 0.0 110.265 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 37' ' ' VAL . 25.2 mttm -108.29 -70.73 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 110.585 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.606 ' HB2' HG21 ' A' ' 81' ' ' THR . 12.8 mtt180 -70.61 124.04 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 110.429 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.518 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 20.5 mtp -118.85 124.86 48.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -103.41 164.62 11.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.958 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.724 HD12 ' HG2' ' A' ' 31' ' ' GLU . 91.3 mt -136.23 126.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 29' ' ' LEU . 48.8 m-85 -122.05 169.74 10.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.436 HG23 ' CG2' ' A' ' 30' ' ' VAL . 35.5 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.011 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.753 HD11 ' HA ' ' A' ' 75' ' ' ASN . 2.1 pt -62.81 -24.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 110.532 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 92' ' ' ILE . 24.3 mttt -151.1 131.97 7.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.018 -1.051 . . . . 0.0 110.594 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HD3' ' CA ' ' A' ' 26' ' ' LYS . 37.6 Cg_exo -35.47 146.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.275 1.983 . . . . 0.0 112.416 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.557 HG23 ' OE1' ' A' ' 99' ' ' GLU . 49.8 mt -127.03 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.507 ' HB3' ' HG3' ' A' ' 99' ' ' GLU . . . -89.17 158.98 17.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.558 -0.714 . . . . 0.0 110.278 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -56.42 -21.52 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 111.474 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.59 61.04 0.31 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.557 ' OE1' HG23 ' A' ' 95' ' ' ILE . 3.5 mt-10 -131.58 175.07 9.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -1.207 . . . . 0.0 110.997 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.17 124.28 44.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 109.68 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.86 HG13 ' HB2' ' A' ' 20' ' ' ALA . 54.3 mt -88.9 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 110.557 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -159.52 179.42 8.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.816 -0.552 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 104' ' ' SER . 1.6 pp -145.87 133.41 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.575 ' O ' HD12 ' A' ' 103' ' ' ILE . 47.2 t -61.05 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.397 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HB3' ' HB3' ' A' ' 109' ' ' TYR . 24.4 m-85 -123.62 -75.92 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.42 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.01 -173.19 42.34 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.41 -12.38 60.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 110.809 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.57 -55.56 2.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.06 -1.025 . . . . 0.0 110.626 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.464 ' CE2' ' HG3' ' C' ' 215' ' ' MLZ . 3.1 t80 -54.41 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 110.889 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 54.93 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.696 -0.628 . . . . 0.0 111.285 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.793 HD23 ' N ' ' A' ' 112' ' ' SER . 9.6 tt -50.59 151.78 2.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.01 -1.056 . . . . 0.0 110.876 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.793 ' N ' HD23 ' A' ' 111' ' ' LEU . 46.2 p -167.15 -60.02 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.466 -0.771 . . . . 0.0 109.941 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -126.77 144.5 50.21 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 121.306 -0.871 . . . . 0.0 110.258 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 36.9 Cg_exo -56.4 91.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.63 1.332 . . . . 0.0 110.584 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -132.33 55.77 1.87 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 110.343 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.757 HD22 ' HD3' ' A' ' 72' ' ' LYS . 3.3 mp -107.63 125.92 51.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 110.434 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.3 m -121.64 144.2 48.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 110.285 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.0 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.409 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.289 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -51.87 5.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -1.141 . . . . 0.0 110.239 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' C' ' 204' ' ' PRO . . . -126.46 165.65 26.72 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 110.291 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' C' ' 203' ' ' ALA . 31.2 Cg_endo -69.28 95.51 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.625 1.329 . . . . 0.0 110.509 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.31 114.69 26.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.387 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 206' ' ' LYS . . . . . 0.759 ' HG2' HD23 ' C' ' 208' ' ' LEU . 0.0 OUTLIER -93.35 44.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 52.76 86.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.759 HD23 ' HG2' ' C' ' 206' ' ' LYS . 0.4 OUTLIER -119.88 35.1 4.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 110.387 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.03 109.11 12.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 110.367 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -115.49 22.89 12.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.411 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 211' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' C' ' 211' ' ' LYS . 3.8 pttt -166.42 100.29 0.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 110.428 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -112.41 22.94 14.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 110.29 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.2 177.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.455 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.443 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 6.3 mtt180 -131.26 -171.02 2.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -0.878 . . . . 0.0 110.218 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.632 HCM1 ' HA ' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.3 OUTLIER -53.57 -175.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.28 -0.887 . . . . 0.0 110.573 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.87 155.08 60.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' C' ' 219' ' ' ALA . 39.4 Cg_endo -73.04 -3.17 13.17 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.681 1.358 . . . . 0.0 111.263 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 219' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' C' ' 218' ' ' PRO . . . 55.81 171.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.89 -1.131 . . . . 0.0 110.29 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 1.9 p -99.74 -173.5 2.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.43 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.241 0.543 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -129.78 134.95 47.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.393 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 5' ' ' ARG . 1.5 m-80 -111.15 40.62 2.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.62 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.465 ' HA ' ' CD ' ' B' ' 22' ' ' LYS . 20.4 mtm180 -52.05 -38.85 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.925 -1.109 . . . . 0.0 110.619 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.484 HG21 HG13 ' B' ' 30' ' ' VAL . 98.9 t -135.32 143.72 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 19.9 tt -119.49 165.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.19 128.7 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 110.541 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 33.2 mttt -143.57 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 109.196 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.588 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.82 55.01 9.59 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 119.664 -1.898 . . . . 0.0 110.36 1.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.5 ' HB2' ' CE1' ' B' ' 19' ' ' PHE . 0.0 OUTLIER -106.73 177.11 1.41 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.758 -0.589 . . . . 0.0 110.36 -178.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 32.9 Cg_exo -55.23 -20.87 26.32 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.657 1.346 . . . . 0.0 110.57 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' B' ' 13' ' ' LEU . 3.4 mm? -99.71 -35.2 9.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.902 . . . . 0.0 110.432 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.9 171.57 13.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . 96.39 116.62 3.27 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.433 ' HB3' ' N ' ' B' ' 302' ' ' SAH . 0.1 OUTLIER -86.11 64.4 8.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.17 -166.43 23.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' B' ' 6' ' ' VAL . 58.5 t -97.89 127.81 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.951 -1.323 . . . . 0.0 110.122 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' B' ' 11' ' ' SER . 0.1 OUTLIER -90.48 126.56 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 109.948 179.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.836 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -88.62 90.84 8.57 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.465 -0.772 . . . . 0.0 110.761 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.848 ' O ' HG23 ' B' ' 97' ' ' ILE . 2.7 ttt180 -69.24 -21.88 63.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.481 -0.762 . . . . 0.0 109.465 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.513 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 2.7 mttp -105.53 -177.08 3.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.53 -0.731 . . . . 0.0 109.387 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.423 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 19.5 m 108.33 34.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.063 -1.648 . . . . 0.0 109.859 1.113 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 43.9 m-85 -127.31 160.84 30.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 111.049 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.58 -159.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.514 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 23.6 tttm -102.11 98.97 9.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 0.0 110.198 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.73 33.87 0.96 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -117.13 141.89 47.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.512 HD12 ' CE2' ' B' ' 90' ' ' PHE . 2.3 tp -83.8 136.97 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.484 HG13 HG21 ' B' ' 6' ' ' VAL . 48.4 t -92.38 -62.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.461 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.715 ' CG ' HD12 ' B' ' 89' ' ' ILE . 1.7 pt-20 -159.02 149.27 19.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -131.53 137.86 48.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.408 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 36.5 m -140.42 178.88 7.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 110.015 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.547 HD12 ' N ' ' B' ' 34' ' ' LEU . 11.3 mp -91.76 169.45 10.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.394 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 72.7 m -145.57 168.42 20.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.662 HD12 ' HB3' ' B' ' 60' ' ' MET . 39.3 mt -96.73 164.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.641 HG22 ' HB3' ' B' ' 84' ' ' LEU . 51.7 t -143.66 115.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 110.83 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 62.4 mmt-85 -144.69 142.44 30.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 110.114 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -56.5 -167.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.877 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -98.59 119.77 37.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 110.733 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -177.4 -141.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.819 . . . . 0.0 109.431 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.63 -35.48 42.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.725 -1.234 . . . . 0.0 109.304 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.74 ' CZ3' HD21 ' A' ' 47' ' ' LEU . 13.1 t-105 -63.05 -35.29 79.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -58.21 -66.03 3.1 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.462 ' HA ' ' HB2' ' B' ' 48' ' ' GLU . 31.1 m -66.7 -37.25 84.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.253 -1.145 . . . . 0.0 111.063 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -61.3 2.7 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.963 -1.086 . . . . 0.0 108.65 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.885 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.1 mm? -94.58 37.04 1.13 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.407 177.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -71.63 -1.2 12.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 111.545 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -117.83 150.19 39.58 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.903 -1.123 . . . . 0.0 109.017 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.625 ' HA ' HCM1 ' D' ' 215' ' ' MLZ . 25.8 m-85 57.47 29.1 16.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' B' ' 60' ' ' MET . 4.7 tp -129.73 138.27 51.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 110.999 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.487 ' CZ ' ' HE3' ' D' ' 215' ' ' MLZ . 60.1 m-85 -93.09 162.16 14.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -0.83 . . . . 0.0 109.548 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 46.9 p -138.4 113.73 9.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 110.673 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.11 177.31 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -79.95 86.49 5.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 41.5 m-80 148.91 -25.69 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.646 -0.659 . . . . 0.0 109.396 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -177.46 -158.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.696 . . . . 0.0 110.194 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 15.3 m -139.82 169.48 17.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.906 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.496 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -149.88 149.29 30.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.049 -1.032 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.885 ' CE ' HD12 ' B' ' 47' ' ' LEU . 2.3 ttt -94.43 155.61 16.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.587 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.829 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -85.48 90.32 7.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.847 . . . . 0.0 110.558 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.644 ' CD2' HD11 ' B' ' 36' ' ' ILE 2.502 0.2 OUTLIER -55.44 -73.71 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.741 -179.736 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -64.08 -137.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' B' ' 67' ' ' ILE . 62.2 m-85 -84.17 52.01 2.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 110.406 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.829 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -90.75 -27.68 18.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -88.42 -47.27 8.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 110.446 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.854 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.9 pp -48.08 -24.22 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.339 -0.851 . . . . 0.0 110.879 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.854 ' N ' HD12 ' B' ' 67' ' ' ILE . 3.7 m-85 -49.16 120.14 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.203 -0.936 . . . . 0.0 110.57 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.715 ' H ' HG22 ' B' ' 102' ' ' THR . 74.0 m-20 -95.21 175.76 6.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.519 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.696 ' NE2' HD12 ' B' ' 111' ' ' LEU . 15.4 t-160 -96.01 139.05 32.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.926 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 20.7 t -143.77 161.65 38.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 110.126 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.756 ' HD3' HD22 ' B' ' 116' ' ' LEU . 21.9 tptp -83.92 -34.32 24.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.471 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 58.2 19.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.93 115.81 4.29 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.55 1.29 . . . . 0.0 110.322 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.742 ' HA ' HD11 ' B' ' 92' ' ' ILE . 42.7 m-80 -89.77 18.8 5.21 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.434 -0.791 . . . . 0.0 110.663 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.484 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -122.44 159.02 28.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -145.63 169.47 18.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 110.489 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.73 130.73 47.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 110.394 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.89 152.53 24.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.591 HG21 ' HB2' ' B' ' 86' ' ' ARG . 40.7 p -57.89 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.376 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.8 -126.31 1.46 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.641 ' HB3' HG22 ' B' ' 37' ' ' VAL . 4.4 tp -153.07 27.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -1.108 . . . . 0.0 110.269 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.424 ' HG3' HG21 ' B' ' 37' ' ' VAL . 25.2 mttm -108.27 -70.82 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.559 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.591 ' HB2' HG21 ' B' ' 81' ' ' THR . 12.8 mtt180 -70.58 124.04 23.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.483 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.54 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 20.5 mtp -118.87 124.83 48.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -103.33 164.59 11.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 110.016 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.715 HD12 ' CG ' ' B' ' 31' ' ' GLU . 91.4 mt -136.15 126.8 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.512 ' CE2' HD12 ' B' ' 29' ' ' LEU . 48.8 m-85 -122.03 169.81 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.729 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.43 HG23 ' CG2' ' B' ' 30' ' ' VAL . 35.3 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.976 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' B' ' 75' ' ' ASN . 2.1 pt -62.87 -24.14 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 110.527 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.639 ' HG3' HD12 ' B' ' 92' ' ' ILE . 24.3 mttt -151.1 131.8 7.3 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.968 -1.083 . . . . 0.0 110.601 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 39.5 Cg_exo -35.32 145.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.806 0 C-N-CA 122.339 2.026 . . . . 0.0 112.36 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.557 HG23 ' OE1' ' B' ' 99' ' ' GLU . 49.7 mt -127.07 149.81 32.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.468 -0.77 . . . . 0.0 110.561 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.494 ' HB3' ' HG3' ' B' ' 99' ' ' GLU . . . -88.6 159.08 18.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.434 -0.791 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.848 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -56.51 -21.52 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 111.423 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.68 61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.557 ' OE1' HG23 ' B' ' 95' ' ' ILE . 3.4 mt-10 -131.7 174.96 9.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -1.23 . . . . 0.0 111.03 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.25 123.89 43.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.44 -0.788 . . . . 0.0 109.823 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.836 HG13 ' HB2' ' B' ' 20' ' ' ALA . 54.1 mt -88.44 138.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.657 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.715 HG22 ' H ' ' B' ' 69' ' ' ASN . 0.2 OUTLIER -159.61 179.41 8.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.826 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.566 HD12 ' O ' ' B' ' 104' ' ' SER . 1.6 pp -145.84 133.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 110.242 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.566 ' O ' HD12 ' B' ' 103' ' ' ILE . 47.2 t -61.09 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 110.432 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 109' ' ' TYR . 24.4 m-85 -123.39 -75.88 0.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.45 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.05 -173.21 42.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.4 -12.4 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -1.105 . . . . 0.0 110.825 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.61 -55.49 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 110.619 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.474 ' CE2' ' HG3' ' D' ' 215' ' ' MLZ . 3.1 t80 -54.35 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 110.875 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 55.0 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 111.242 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.788 HD23 ' N ' ' B' ' 112' ' ' SER . 9.6 tt -50.64 151.88 2.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.957 -1.089 . . . . 0.0 110.871 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.788 ' N ' HD23 ' B' ' 111' ' ' LEU . 47.1 p -167.19 -59.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.436 -0.79 . . . . 0.0 109.975 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.87 144.56 50.58 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.395 -0.816 . . . . 0.0 110.169 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.41 91.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.608 1.32 . . . . 0.0 110.58 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -132.28 55.77 1.86 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.756 HD22 ' HD3' ' B' ' 72' ' ' LYS . 3.2 mp -107.69 125.93 51.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.389 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 82.0 m -121.7 144.16 48.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 110.264 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.04 -179.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.392 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.317 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.91 -51.85 5.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -1.133 . . . . 0.0 110.232 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' D' ' 204' ' ' PRO . . . -126.46 165.61 26.97 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 110.291 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' D' ' 203' ' ' ALA . 31.2 Cg_endo -69.26 95.51 0.51 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.605 1.318 . . . . 0.0 110.56 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 114.75 26.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 110.375 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 206' ' ' LYS . . . . . 0.76 ' HG2' HD23 ' D' ' 208' ' ' LEU . 0.0 OUTLIER -93.38 44.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.314 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 52.85 86.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.475 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 208' ' ' LEU . . . . . 0.76 HD23 ' HG2' ' D' ' 206' ' ' LYS . 0.4 OUTLIER -119.9 35.14 4.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 110.389 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.11 109.08 12.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -0.965 . . . . 0.0 110.342 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -115.5 22.95 12.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 110.451 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 211' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' D' ' 211' ' ' LYS . 3.8 pttt -166.42 100.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 110.464 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -112.39 22.94 14.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.964 . . . . 0.0 110.338 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.23 177.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 110.473 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.44 ' CB ' ' HB3' ' B' ' 53' ' ' SER . 6.3 mtt180 -131.26 -171.04 2.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 110.215 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.625 HCM1 ' HA ' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.505 0.3 OUTLIER -53.74 -175.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.561 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.84 155.06 60.85 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' D' ' 219' ' ' ALA . 39.3 Cg_endo -72.99 -3.19 13.2 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.659 1.347 . . . . 0.0 111.237 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 219' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' D' ' 218' ' ' PRO . . . 55.8 171.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.962 -1.086 . . . . 0.0 110.24 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 1.9 p -99.72 -173.47 2.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 110.432 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.968 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.453 ' HB2' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.452 ' HB2' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.737 ' SD ' HG21 ' A' ' 8' ' ' VAL . 2.6 mmt . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.288 0.566 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 28.3 p90 -51.16 141.9 13.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 110.584 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -138.07 143.42 40.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.63 -49.99 18.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.374 -0.828 . . . . 0.0 111.354 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.541 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.49 -37.41 80.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 110.772 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.634 HG21 HG13 ' A' ' 30' ' ' VAL . 90.2 t -153.54 149.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.624 HG23 ' HB2' ' A' ' 19' ' ' PHE . 14.9 tt -118.26 167.11 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.737 HG21 ' SD ' ' A' ' 1' ' ' MET . 87.0 t -99.53 126.08 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.597 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -150.48 115.51 5.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.689 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.597 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 2.2 tmtt? 61.91 66.17 0.85 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 119.546 -1.971 . . . . 0.0 110.742 2.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.479 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -175.06 -48.29 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 0.0 111.312 179.186 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 11' ' ' SER . 2.7 Cg_exo -79.86 -151.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.393 1.207 . . . . 0.0 110.505 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.65 -12.69 18.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 110.717 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.63 -137.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.31 -143.75 9.86 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CZ ' ' HE2' ' A' ' 10' ' ' LYS . 15.1 m-85 -98.03 105.1 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -1.134 . . . . 0.0 110.637 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.04 -171.5 15.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.884 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.1 p -123.36 132.13 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.97 -1.312 . . . . 0.0 109.679 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HB2' HG23 ' A' ' 7' ' ' ILE . 3.2 m-30 -95.21 164.04 13.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.823 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -124.09 97.97 5.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.478 -0.764 . . . . 0.0 110.623 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.54 -19.62 49.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 5.7 mttm -90.7 178.77 5.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.88 . . . . 0.0 108.982 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.437 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 49.6 m 102.43 18.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.081 -1.637 . . . . 0.0 110.325 1.144 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 24.1 m-85 -108.73 158.32 17.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.87 -159.59 0.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 110.268 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 24.9 tttt -97.76 90.37 4.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.68 52.13 0.2 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.35 135.05 49.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.169 . . . . 0.0 110.422 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.913 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -76.33 105.29 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.708 HG23 HG23 ' A' ' 91' ' ' THR . 93.0 t -67.66 -46.63 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.247 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.67 152.19 6.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.45 141.97 35.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.412 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -146.2 -177.0 5.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 110.28 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 -178.8 4.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 60' ' ' MET . 25.6 p -148.94 174.3 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.485 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.873 HG13 HD22 ' A' ' 62' ' ' LEU . 46.7 mt -105.73 102.2 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.588 HG21 ' O ' ' A' ' 84' ' ' LEU . 28.4 t -86.82 92.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.141 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 15.2 tpt180 -116.44 154.26 30.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.376 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.9 m170 -61.21 -167.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.433 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.65 28.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.55 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.48 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 109.228 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -50.75 -25.71 4.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.608 -1.307 . . . . 0.0 109.651 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.481 ' CZ3' ' HG ' ' A' ' 47' ' ' LEU . 19.0 t-105 -57.81 -56.73 18.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.653 . . . . 0.0 109.447 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.88 86.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 m -62.75 -65.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -1.156 . . . . 0.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.11 -47.7 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 110.227 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.693 HD12 ' HE3' ' A' ' 60' ' ' MET . 4.4 mm? -90.61 41.0 1.04 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 110.51 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 62.35 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 110.608 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER 179.5 139.23 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.844 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.478 ' CE1' ' OXT' ' A' ' 301' ' ' SAH . 13.8 m-85 56.82 33.41 23.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 110.563 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 51' ' ' LEU . 8.7 mt -105.51 102.09 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 110.459 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' C' ' 215' ' ' MLZ . 55.2 m-85 -88.85 102.92 15.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.106 -0.996 . . . . 0.0 109.021 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' C' ' 214' ' ' ARG . 13.2 t -103.2 155.91 18.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 111.453 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.711 ' HB2' HD11 ' A' ' 84' ' ' LEU . 11.4 mtp180 -116.97 -173.38 2.38 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -83.61 74.07 10.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 74.1 m-20 167.85 -27.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.485 ' CG ' HD12 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -174.57 -174.91 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.339 -0.85 . . . . 0.0 110.89 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 2.4 p -117.62 147.13 43.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.838 ' CB ' HD22 ' A' ' 84' ' ' LEU . . . -132.1 133.85 44.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 110.605 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.693 ' HE3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.29 155.08 19.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 109.935 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.894 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.63 93.08 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.11 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.873 HD22 HG13 ' A' ' 36' ' ' ILE 2.505 0.0 OUTLIER -55.64 -70.29 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 110.691 -179.175 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.79 -150.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.0 57.72 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.438 -1.036 . . . . 0.0 110.711 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.894 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.82 -24.68 27.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.29 -42.71 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -1.147 . . . . 0.0 110.532 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.531 HD13 ' HB ' ' A' ' 18' ' ' VAL . 1.1 pp -49.91 -29.26 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.975 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' A' ' 89' ' ' ILE . 13.8 m-85 -55.12 140.01 39.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 110.655 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -118.24 -177.69 3.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.201 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.514 ' NE2' ' CE2' ' A' ' 110' ' ' TRP . 18.9 t60 -100.76 125.37 47.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -129.97 141.44 50.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.12 20.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.182 -0.949 . . . . 0.0 110.54 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.49 87.43 41.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.88 . . . . 0.0 110.148 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.789 ' O ' HD11 ' A' ' 92' ' ' ILE . 10.9 Cg_endo -58.06 105.24 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.605 1.318 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.13 -17.19 57.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 110.613 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.1 166.98 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.569 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.11 -163.73 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.171 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 50.7 p-80 -143.07 163.69 32.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.545 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 43.2 tt0 -146.56 112.05 5.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD12 ' CD ' ' C' ' 218' ' ' PRO . 1.8 mp -91.22 60.22 4.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.079 -1.013 . . . . 0.0 110.427 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.453 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 0.1 OUTLIER 42.15 28.39 0.1 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.592 -0.692 . . . . 0.0 111.212 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.45 24.31 2.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.45 28.33 0.17 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.105 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.838 HD22 ' CB ' ' A' ' 59' ' ' ALA . 62.8 mt 50.99 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.252 . . . . 0.0 110.734 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.46 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.795 . . . . 0.0 110.517 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -145.24 102.9 3.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.125 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.421 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 3.8 mtp -81.24 118.63 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.743 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.739 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -111.02 127.0 55.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.744 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.476 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 10.0 mt -89.1 117.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.092 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.913 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 18.9 m-85 -107.3 -173.57 2.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.32 -0.863 . . . . 0.0 110.411 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.708 HG23 HG23 ' A' ' 30' ' ' VAL . 21.3 p -130.44 93.24 3.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.789 HD11 ' O ' ' A' ' 74' ' ' PRO . 2.4 pt -56.86 -19.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.471 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' N ' HG13 ' A' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.65 18.11 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -51.42 141.2 41.94 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.519 1.273 . . . . 0.0 110.452 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.464 HG23 ' HG3' ' A' ' 99' ' ' GLU . 13.9 mt -109.64 150.52 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -94.71 156.9 16.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.59 -0.694 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.839 HG23 ' O ' ' A' ' 21' ' ' ARG . 21.9 mt -63.58 112.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.72 36.61 3.44 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -101.11 155.84 17.76 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.294 -1.121 . . . . 0.0 110.57 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.0 115.04 26.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.133 -0.979 . . . . 0.0 109.717 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.957 HD11 ' HB2' ' A' ' 20' ' ' ALA . 16.2 mt -89.64 122.46 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 110.435 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' C ' ' A' ' 101' ' ' ILE . 68.6 p -154.77 134.21 12.63 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 104' ' ' SER . 1.1 pp -104.99 153.82 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.096 . . . . 0.0 110.524 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -80.0 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.524 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.502 ' CD1' ' HG3' ' C' ' 215' ' ' MLZ . 17.6 m-85 -127.14 -68.49 0.79 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.22 24.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.23 -39.63 60.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -1.116 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.58 -61.4 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.275 -0.89 . . . . 0.0 110.109 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.53 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 3.2 m-85 -94.37 51.6 1.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.32 -0.862 . . . . 0.0 110.543 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.514 ' CE2' ' NE2' ' A' ' 70' ' ' HIS . 10.5 t-105 -175.1 177.84 1.85 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.584 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -164.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.4 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.69 -77.7 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 110.382 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -155.75 69.22 5.18 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 110.493 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.41 ' O ' ' HD3' ' A' ' 115' ' ' ARG . 36.8 Cg_endo -70.56 126.61 12.96 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.713 1.375 . . . . 0.0 110.353 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -128.16 115.36 18.27 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 110.635 -179.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.85 -31.72 70.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 110.419 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 118' ' ' GLN . 1.8 m -65.1 176.47 1.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.323 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 117' ' ' THR . 59.3 tt0 -58.98 149.42 27.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.344 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.351 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -102.52 113.92 27.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 110.435 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -99.99 123.9 45.54 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 110.203 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -59.13 -163.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.435 1.229 . . . . 0.0 110.521 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -55.11 -25.98 35.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.247 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.45 139.24 55.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 110.297 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -132.11 -48.88 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.375 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.43 116.6 33.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.54 49.1 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 110.331 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 210' ' ' THR . . . . . 0.555 HG22 ' O ' ' C' ' 210' ' ' THR . 58.1 m -124.02 47.85 2.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 110.335 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -118.3 87.45 2.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 110.439 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -168.06 -160.08 0.31 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 110.277 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.42 44.59 2.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.423 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.53 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER 49.58 -173.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.763 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.502 ' HG3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 0.0 OUTLIER -57.42 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.427 -0.796 . . . . 0.0 110.382 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.927 ' HB3' HG23 ' C' ' 220' ' ' THR . . . -156.61 -176.23 0.59 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.706 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 22.1 Cg_exo -61.95 96.17 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.659 1.347 . . . . 0.0 110.586 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.74 70.96 0.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.536 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 220' ' ' THR . . . . . 0.927 HG23 ' HB3' ' C' ' 217' ' ' ALA . 1.1 p -79.86 68.43 5.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 CA-C-O 117.98 -1.455 . . . . 0.0 109.479 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.742 ' SD ' HG21 ' B' ' 8' ' ' VAL . 2.6 mmt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.252 0.549 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 28.3 p90 -51.13 141.76 13.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 110.626 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -137.88 143.66 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 110.153 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.83 -49.89 19.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.823 . . . . 0.0 111.326 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.535 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.0 OUTLIER -68.55 -37.4 79.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 110.769 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.635 HG21 HG13 ' B' ' 30' ' ' VAL . 89.8 t -153.52 149.14 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 110.185 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.616 HG23 ' HB2' ' B' ' 19' ' ' PHE . 15.0 tt -118.2 167.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.582 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.742 HG21 ' SD ' ' B' ' 1' ' ' MET . 87.2 t -99.6 126.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 110.349 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.591 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -150.8 115.56 5.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.628 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.591 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 2.2 tmtt? 62.0 66.25 0.83 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.599 -1.938 . . . . 0.0 110.748 2.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.472 ' CB ' ' HD3' ' B' ' 12' ' ' PRO . 0.1 OUTLIER -175.38 -47.94 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 111.037 178.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' B' ' 11' ' ' SER . 2.7 Cg_exo -79.76 -151.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.341 1.18 . . . . 0.0 110.553 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.63 -12.66 19.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 110.68 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.65 -137.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.34 -143.73 9.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.511 ' CZ ' ' HE2' ' B' ' 10' ' ' LYS . 15.2 m-85 -98.0 105.01 17.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -1.13 . . . . 0.0 110.688 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.85 -171.55 15.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.897 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.2 p -123.25 132.02 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.326 . . . . 0.0 109.794 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.616 ' HB2' HG23 ' B' ' 7' ' ' ILE . 3.2 m-30 -95.29 164.05 13.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 110.791 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.986 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -124.26 98.07 5.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.834 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.51 -19.67 49.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.017 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 5.7 mttm -90.59 178.75 6.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.042 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.441 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 49.9 m 102.45 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.079 -1.638 . . . . 0.0 110.325 1.128 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 24.1 m-85 -108.67 158.32 17.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -0.973 . . . . 0.0 110.436 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.86 -159.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.26 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -97.69 90.29 4.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.73 52.13 0.2 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.33 135.06 50.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -1.165 . . . . 0.0 110.477 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.896 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.9 OUTLIER -76.35 105.28 7.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 110.254 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.719 HG23 HG23 ' B' ' 91' ' ' THR . 92.9 t -67.73 -46.56 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.64 152.26 6.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.5 141.9 35.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.503 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.412 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -146.18 -176.96 5.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.45 -178.7 4.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 110.276 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 60' ' ' MET . 25.6 p -149.0 174.31 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.894 HG13 HD22 ' B' ' 62' ' ' LEU . 46.6 mt -105.96 100.76 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.575 HG21 ' O ' ' B' ' 84' ' ' LEU . 24.8 t -84.84 92.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 110.499 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' B' ' 39' ' ' HIS . 15.1 tpt180 -116.66 154.3 30.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.414 ' N ' ' HG3' ' B' ' 38' ' ' ARG . 3.0 m170 -61.14 -167.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.416 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.66 28.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.53 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.44 -0.787 . . . . 0.0 109.234 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -50.8 -25.65 4.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.69 -1.256 . . . . 0.0 109.616 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 19.1 t-105 -57.84 -56.75 17.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.65 -0.656 . . . . 0.0 109.415 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.82 86.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 8.9 m -62.76 -65.1 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -1.134 . . . . 0.0 110.412 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.43 75.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.728 HD12 ' HE3' ' B' ' 60' ' ' MET . 4.4 mm? -90.94 41.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 110.403 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.02 62.34 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 110.602 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.3 OUTLIER 179.51 139.28 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 0.0 109.876 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.474 ' CE1' ' OXT' ' B' ' 302' ' ' SAH . 13.8 m-85 56.81 33.47 23.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.179 -0.951 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' B' ' 51' ' ' LEU . 8.6 mt -105.5 101.7 11.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.55 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' D' ' 215' ' ' MLZ . 55.6 m-85 -88.28 102.95 15.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.121 -0.987 . . . . 0.0 109.16 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' D' ' 214' ' ' ARG . 13.2 t -103.21 155.86 18.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 111.525 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.705 ' HB2' HD11 ' B' ' 84' ' ' LEU . 11.5 mtp180 -117.5 -176.04 2.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.579 -0.701 . . . . 0.0 109.63 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -79.79 73.64 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 73.8 m-20 167.77 -27.22 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.491 ' CG ' HD12 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -174.43 -174.65 0.88 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.36 -0.838 . . . . 0.0 110.913 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 2.4 p -117.68 147.09 43.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.832 ' CB ' HD22 ' B' ' 84' ' ' LEU . . . -132.18 133.64 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.728 ' HE3' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -89.21 153.72 20.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.148 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.861 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.78 93.02 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 110.5 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.894 HD22 HG13 ' B' ' 36' ' ' ILE 2.507 0.0 OUTLIER -55.7 -70.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.728 -179.39 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.69 -150.47 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -76.03 58.06 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.406 -1.055 . . . . 0.0 110.627 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.861 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.34 -24.42 26.54 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.36 -42.72 16.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.524 HD13 ' HB ' ' B' ' 18' ' ' VAL . 1.1 pp -49.94 -29.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.95 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.466 ' CZ ' HG12 ' B' ' 89' ' ' ILE . 13.8 m-85 -55.1 140.08 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.011 -1.055 . . . . 0.0 110.621 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -118.37 -177.73 3.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.528 ' NE2' ' CE2' ' B' ' 110' ' ' TRP . 18.8 t60 -100.7 125.39 47.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 110.292 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.5 t -129.99 141.43 50.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.259 -0.901 . . . . 0.0 110.201 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.17 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.528 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.45 87.41 40.86 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.794 ' O ' HD11 ' B' ' 92' ' ' ILE . 10.9 Cg_endo -58.12 105.32 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.669 1.352 . . . . 0.0 110.393 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.18 -17.17 57.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.03 23.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.16 -163.68 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 110.193 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 50.8 p-80 -143.11 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.53 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' B' ' 88' ' ' ARG . 43.3 tt0 -146.62 112.03 5.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.336 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.504 HD12 ' CD ' ' D' ' 218' ' ' PRO . 1.8 mp -91.16 60.12 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.451 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 0.1 OUTLIER 42.24 28.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.543 -0.723 . . . . 0.0 111.149 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.42 24.27 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.4 28.27 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.069 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.832 HD22 ' CB ' ' B' ' 59' ' ' ALA . 62.6 mt 51.16 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -1.189 . . . . 0.0 110.704 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.52 -33.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 110.464 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.454 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.1 OUTLIER -145.23 102.94 3.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.119 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' B' ' 80' ' ' LEU . 3.8 mtp -81.24 118.59 22.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -111.0 126.7 55.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.831 179.142 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.466 HG12 ' CZ ' ' B' ' 68' ' ' PHE . 10.0 mt -88.67 117.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 110.183 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.896 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 18.9 m-85 -107.35 -173.52 2.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 110.461 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.719 HG23 HG23 ' B' ' 30' ' ' VAL . 21.3 p -130.44 93.19 3.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.794 HD11 ' O ' ' B' ' 74' ' ' PRO . 2.5 pt -56.88 -19.05 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.429 ' N ' HG13 ' B' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.69 18.17 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 110.115 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.68 141.43 43.73 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.521 1.274 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.463 HG23 ' CB ' ' B' ' 99' ' ' GLU . 14.0 mt -109.7 150.53 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 110.705 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -94.72 156.88 16.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.169 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.834 HG23 ' O ' ' B' ' 21' ' ' ARG . 22.0 mt -63.53 112.09 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.965 -1.084 . . . . 0.0 110.206 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.65 36.58 3.46 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.463 ' CB ' HG23 ' B' ' 95' ' ' ILE . 0.4 OUTLIER -100.94 155.68 17.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.304 -1.115 . . . . 0.0 110.591 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.96 114.89 26.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.994 . . . . 0.0 109.732 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.986 HD11 ' HB2' ' B' ' 20' ' ' ALA . 16.9 mt -89.36 122.49 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.516 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.535 HG23 ' C ' ' B' ' 101' ' ' ILE . 66.6 p -154.67 134.28 12.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.589 HD12 ' O ' ' B' ' 104' ' ' SER . 1.1 pp -104.93 153.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 110.549 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.589 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.5 OUTLIER -79.98 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.498 ' CD1' ' HG3' ' D' ' 215' ' ' MLZ . 17.6 m-85 -127.13 -68.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.229 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.01 179.21 24.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -39.66 60.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -1.143 . . . . 0.0 110.23 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -57.55 -61.5 2.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.528 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 3.2 m-85 -94.27 51.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.311 -0.868 . . . . 0.0 110.565 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CE2' ' NE2' ' B' ' 70' ' ' HIS . 10.6 t-105 -175.12 177.79 1.86 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -164.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.437 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -77.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.399 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -155.82 69.15 5.13 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 110.447 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.407 ' O ' ' HD3' ' B' ' 115' ' ' ARG . 36.7 Cg_endo -70.4 126.63 13.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.616 1.324 . . . . 0.0 110.34 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' B' ' 114' ' ' PRO . 0.9 OUTLIER -128.35 115.55 18.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.329 -0.857 . . . . 0.0 110.652 -179.309 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.9 -31.71 70.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 110.37 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.454 HG22 ' H ' ' B' ' 118' ' ' GLN . 1.7 m -65.13 176.48 1.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 110.377 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' GLN . . . . . 0.454 ' H ' HG22 ' B' ' 117' ' ' THR . 59.3 tt0 -58.94 149.44 27.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 110.406 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.363 179.967 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -102.56 113.93 27.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.192 -1.181 . . . . 0.0 110.401 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -99.94 123.9 45.64 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.238 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -59.08 -163.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.355 1.187 . . . . 0.0 110.564 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -55.04 -26.11 35.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.35 139.29 55.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -132.17 -48.85 0.93 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 0.0 110.375 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.49 116.66 33.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 110.387 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.56 49.13 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 210' ' ' THR . . . . . 0.552 HG22 ' O ' ' D' ' 210' ' ' THR . 58.4 m -124.06 47.85 2.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 110.292 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -118.33 87.47 2.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 110.466 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -168.05 -160.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 110.294 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.36 44.54 2.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.414 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.528 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 0.8 OUTLIER 49.68 -173.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.674 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.498 ' HG3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 0.0 OUTLIER -57.35 -163.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.294 -0.879 . . . . 0.0 110.429 179.685 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.93 ' HB3' ' CG2' ' D' ' 220' ' ' THR . . . -156.57 -176.2 0.59 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.719 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 22.2 Cg_exo -62.03 96.19 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.678 1.357 . . . . 0.0 110.579 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.74 71.03 0.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 110.519 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 220' ' ' THR . . . . . 0.93 ' CG2' ' HB3' ' D' ' 217' ' ' ALA . 1.1 p -79.91 68.44 6.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 110.247 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.524 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.478 ' OXT' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.474 ' OXT' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' O ' ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.166 0.508 . . . . 0.0 110.437 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -59.34 83.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.404 -0.81 . . . . 0.0 111.764 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.7 t-20 -99.89 147.63 25.33 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.752 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.0 -23.52 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 111.288 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.532 ' C ' HG23 ' A' ' 6' ' ' VAL . 2.7 mtt180 -102.73 -29.67 11.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.028 -1.045 . . . . 0.0 111.121 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.532 HG23 ' C ' ' A' ' 5' ' ' ARG . 94.9 t -153.23 137.31 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.426 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 5.7 tt -117.48 161.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 110.971 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.4 p -88.97 124.24 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.097 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 39.0 mttt -150.35 129.19 12.47 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.392 -0.818 . . . . 0.0 109.281 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.603 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 57.96 74.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 119.669 -1.894 . . . . 0.0 111.928 1.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.507 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -173.06 -49.93 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.359 -0.838 . . . . 0.0 111.579 177.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' A' ' 11' ' ' SER . 16.9 Cg_exo -69.41 -35.11 14.31 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.421 1.222 . . . . 0.0 110.666 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.28 -33.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.76 -155.53 21.07 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.69 89.77 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CG ' ' HD3' ' A' ' 10' ' ' LYS . 1.1 m-85 -58.63 94.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -1.147 . . . . 0.0 110.442 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' ND2' ' A' ' 69' ' ' ASN . . . -120.28 171.61 14.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.72 ' CG2' HD13 ' A' ' 67' ' ' ILE . 95.0 t -93.09 140.43 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.938 -1.33 . . . . 0.0 109.825 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' CD1' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -105.73 132.88 51.32 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.11 -0.993 . . . . 0.0 110.086 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -88.39 88.45 7.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.702 -0.624 . . . . 0.0 110.446 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.88 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -67.4 -15.04 63.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.798 178.089 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 2.0 mttm -106.79 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.91 20.93 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.154 -1.591 . . . . 0.0 109.846 1.389 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 54.1 m-85 -118.65 163.91 16.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.544 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.34 -178.63 3.65 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 110.025 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -74.45 99.66 3.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.947 . . . . 0.0 110.299 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.25 61.8 0.55 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.3 123.28 23.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 110.505 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.918 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -66.63 127.48 32.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.176 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.704 ' N ' HD13 ' A' ' 29' ' ' LEU . 90.9 t -88.89 -46.55 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.346 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.47 153.17 6.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.18 136.46 31.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 110.304 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.429 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.79 170.32 9.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.697 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.0 -174.2 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.685 ' CD1' HD21 ' A' ' 62' ' ' LEU . 65.0 mt -123.75 151.97 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 84' ' ' LEU . 43.7 t -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.519 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.8 mmt-85 -134.86 145.68 48.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.269 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -63.31 176.97 0.7 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 110.359 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 40' ' ' ASN . 2.9 m120 -67.48 -131.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.142 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.25 0.24 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.624 -1.298 . . . . 0.0 110.596 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.12 -25.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.0 111.09 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.519 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 60.4 t-105 -69.29 -55.85 9.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.155 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' HA3' ' NH2' ' C' ' 214' ' ' ARG . . . -59.61 -22.48 56.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 48' ' ' GLU . 97.4 m -90.28 -60.15 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -1.212 . . . . 0.0 110.663 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.72 -55.45 11.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.872 -1.143 . . . . 0.0 110.231 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.953 ' HB2' HD11 ' A' ' 51' ' ' LEU . 4.0 mm? -92.24 33.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 110.085 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 9.8 pt-20 -68.48 64.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.171 -0.956 . . . . 0.0 111.026 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.2 t0 -169.42 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.858 -1.151 . . . . 0.0 111.024 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 25.8 m-85 -128.87 53.51 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.05 -1.031 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' A' ' 47' ' ' LEU . 52.7 mt -124.98 118.02 25.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 48.3 m-85 -89.41 101.54 14.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 108.995 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.8 t -98.92 155.52 17.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 111.561 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -123.61 -168.07 1.72 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.616 -0.678 . . . . 0.0 109.756 178.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -83.04 79.58 9.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.964 -1.085 . . . . 0.0 109.384 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 0.2 OUTLIER 160.91 -25.18 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.766 -0.584 . . . . 0.0 110.049 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.67 -167.82 0.2 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.425 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.3 m -130.68 139.28 50.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.3 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.898 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -124.13 172.39 9.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.685 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.63 ' CE ' HD12 ' A' ' 47' ' ' LEU . 9.5 ttt -117.01 153.04 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.697 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.95 90.9 8.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.445 -0.784 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.846 HD22 HD22 ' B' ' 62' ' ' LEU 2.501 0.5 OUTLIER -55.41 -63.45 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.807 -179.681 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 33' ' ' CYS . . . -63.63 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.605 ' HB3' HD11 ' A' ' 67' ' ' ILE . 39.7 m-85 -89.71 42.45 1.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -1.138 . . . . 0.0 110.589 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.697 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -84.74 -21.25 56.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -89.06 -59.3 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.981 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.6 pp -44.79 -22.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.606 -0.684 . . . . 0.0 112.375 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.981 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.5 m-85 -49.55 153.17 1.2 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.614 -1.304 . . . . 0.0 110.677 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.536 ' HB2' HG22 ' A' ' 102' ' ' THR . 26.0 m-20 -119.32 -171.95 2.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 111.322 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -102.81 156.81 17.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.778 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.69 141.08 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.007 -1.058 . . . . 0.0 110.697 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HE2' HD11 ' A' ' 116' ' ' LEU . 5.1 mttp -54.92 -29.3 55.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.9 92.49 39.76 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.438 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.842 ' O ' HD11 ' A' ' 92' ' ' ILE . 32.3 Cg_exo -53.97 104.19 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.659 1.347 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.49 -21.66 35.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 110.311 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 110.307 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -171.89 2.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 47.0 p-80 -130.77 174.15 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 87' ' ' MET . 29.8 tt0 -149.82 141.33 23.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 86' ' ' ARG . 5.0 mt -102.52 142.81 33.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.208 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.481 HG22 ' NH2' ' A' ' 88' ' ' ARG . 69.3 p -80.1 85.69 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.2 95.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.691 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.38 28.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.898 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 1.1 mp -109.74 98.86 8.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.127 . . . . 0.0 110.437 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -144.73 -53.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.752 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -136.15 174.89 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 110.017 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 mtp -142.76 128.35 19.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.702 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.774 ' HB3' HD21 ' A' ' 29' ' ' LEU . 57.9 mtt180 -114.54 140.42 48.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 110.172 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.452 HG12 ' CE2' ' A' ' 68' ' ' PHE . 8.3 mt -99.96 110.25 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.097 -1.002 . . . . 0.0 109.976 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.918 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 9.5 m-85 -104.7 171.2 7.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.292 -0.88 . . . . 0.0 110.582 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.6 p -117.09 118.98 33.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.976 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.842 HD11 ' O ' ' A' ' 74' ' ' PRO . 21.6 pt -86.74 13.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.752 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HG2' HG13 ' A' ' 92' ' ' ILE . 7.3 ptpt -176.82 142.15 0.53 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.201 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.04 136.34 17.83 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.577 1.304 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.455 HG21 ' HB1' ' A' ' 20' ' ' ALA . 61.8 mt -116.53 140.88 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 110.734 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.67 153.4 20.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 110.493 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -50.33 -23.06 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 111.168 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.01 57.84 0.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.22 175.0 8.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.246 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.86 128.96 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.962 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.539 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 31.6 mt -92.4 119.37 39.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 0.0 110.414 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 69' ' ' ASN . 58.7 p -150.95 123.93 8.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.649 -0.657 . . . . 0.0 109.673 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 104' ' ' SER . 1.1 pt -88.91 159.39 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 110.785 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.522 ' O ' HD12 ' A' ' 103' ' ' ILE . 5.2 p -83.38 -157.15 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.413 -0.804 . . . . 0.0 110.348 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.496 ' CD1' ' HE3' ' C' ' 215' ' ' MLZ . 28.3 m-85 -137.57 -66.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.33 -164.42 34.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -29.22 62.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -1.149 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -76.21 -71.28 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 1.2 m-85 -58.5 99.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 52.63 -171.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 110.405 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 114' ' ' PRO . 20.6 tp -65.05 157.42 28.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.336 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.411 ' O ' ' CD ' ' A' ' 114' ' ' PRO . 3.0 t -103.89 -49.57 3.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 110.414 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.3 ttt-85 -107.17 75.88 0.45 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.253 -0.904 . . . . 0.0 110.359 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.494 ' HA ' HD23 ' A' ' 111' ' ' LEU . 28.6 Cg_endo -68.19 62.31 1.04 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.689 1.363 . . . . 0.0 110.598 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 113' ' ' ARG . 2.0 tpt85 -86.81 5.89 34.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 110.823 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.676 ' N ' HD22 ' A' ' 116' ' ' LEU . 3.5 mm? 52.64 -174.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.025 -1.047 . . . . 0.0 110.123 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 119' ' ' ASN . 91.2 m 55.29 105.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.415 -0.803 . . . . 0.0 110.69 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.91 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.347 -0.846 . . . . 0.0 110.478 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 117' ' ' THR . 14.0 t30 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.013 -1.054 . . . . 0.0 110.227 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.58 90.23 8.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -1.136 . . . . 0.0 110.365 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . 52.67 61.92 10.91 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.399 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' C' ' 206' ' ' LYS . 12.8 Cg_endo -60.25 -68.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.623 1.328 . . . . 0.0 110.416 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 55.07 -87.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.562 -0.711 . . . . 0.0 110.758 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 206' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' C' ' 204' ' ' PRO . 4.1 mtmp? -147.76 -63.01 0.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.923 -1.11 . . . . 0.0 110.478 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -118.96 176.45 5.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 110.424 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 5.7 tp -155.26 61.76 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.3 -0.875 . . . . 0.0 110.304 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.48 72.77 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 110.278 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 81.2 p -115.08 -58.4 2.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 110.409 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -169.47 151.19 4.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.248 -0.907 . . . . 0.0 110.354 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -173.46 111.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.27 159.2 3.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 110.46 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.5 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 17.3 mtt-85 -118.44 -147.85 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.496 ' HE3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 216' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.505 0.0 OUTLIER -55.21 -21.03 12.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 0.0 110.452 179.926 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.713 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 55.11 -177.8 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.713 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 25.2 Cg_exo -59.4 -161.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.657 1.346 . . . . 0.0 110.682 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.82 125.84 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.903 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 53.6 p -126.78 -45.7 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.366 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.537 179.805 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.419 ' O ' ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.141 0.496 . . . . 0.0 110.474 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' B' ' 2' ' ' PHE . 0.0 OUTLIER -59.3 83.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.43 -0.794 . . . . 0.0 111.733 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' B' ' 1' ' ' MET . 14.9 t-20 -99.9 147.74 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -49.02 -23.53 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 111.3 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.533 ' C ' HG23 ' B' ' 6' ' ' VAL . 2.7 mtt180 -102.7 -29.76 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.104 . . . . 0.0 111.068 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.533 HG23 ' C ' ' B' ' 5' ' ' ARG . 95.3 t -153.15 137.39 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.358 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 5.8 tt -117.64 160.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.233 -0.917 . . . . 0.0 111.059 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.555 HG13 ' O ' ' B' ' 8' ' ' VAL . 9.5 p -88.27 124.56 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 0.0 110.16 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.613 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 38.9 mttt -150.81 129.22 12.09 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.371 -0.83 . . . . 0.0 109.286 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.613 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 58.13 74.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 119.55 -1.969 . . . . 0.0 111.907 1.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.513 ' CB ' ' HD3' ' B' ' 12' ' ' PRO . 0.3 OUTLIER -173.58 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.306 -0.871 . . . . 0.0 111.24 177.428 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' B' ' 11' ' ' SER . 16.9 Cg_exo -69.16 -35.09 15.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.352 1.185 . . . . 0.0 110.707 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -33.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.883 . . . . 0.0 109.939 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.69 -155.57 21.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.65 89.84 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.51 ' CG ' ' HD3' ' B' ' 10' ' ' LYS . 1.1 m-85 -58.56 94.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 110.457 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.448 ' HA3' ' ND2' ' B' ' 69' ' ' ASN . . . -120.3 171.64 14.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.714 ' CG2' HD13 ' B' ' 67' ' ' ILE . 96.3 t -92.97 140.27 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.032 -1.275 . . . . 0.0 109.881 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -105.72 132.2 52.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.123 -0.985 . . . . 0.0 110.297 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.547 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -87.48 88.49 7.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 110.6 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.876 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.1 OUTLIER -67.49 -14.92 63.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 178.112 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 2.0 mttm -106.84 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.87 20.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.205 -1.56 . . . . 0.0 109.855 1.442 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 54.1 m-85 -118.63 163.91 16.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.887 . . . . 0.0 110.534 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 -178.64 3.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -74.48 99.74 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.22 61.81 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.31 123.38 24.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -1.172 . . . . 0.0 110.437 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.925 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.0 OUTLIER -66.78 127.47 32.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 110.163 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.704 ' N ' HD13 ' B' ' 29' ' ' LEU . 90.6 t -88.85 -46.51 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 110.308 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.52 153.13 6.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.369 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.15 136.47 31.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 110.268 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.413 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.472 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.8 170.31 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.677 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.94 -174.19 4.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.077 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.692 ' CD1' HD21 ' B' ' 62' ' ' LEU . 65.0 mt -123.77 151.91 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 110.429 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' B' ' 84' ' ' LEU . 43.7 t -124.63 104.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.303 -0.873 . . . . 0.0 110.601 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 14.8 mmt-85 -134.87 145.73 48.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 110.264 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.405 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 34.5 m170 -63.37 177.03 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.32 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 40' ' ' ASN . 2.9 m120 -67.44 -131.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.167 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.17 0.24 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.624 -1.297 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.22 -25.63 0.98 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 111.116 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.519 ' CZ2' HD22 ' B' ' 51' ' ' LEU . 60.3 t-105 -69.27 -55.88 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 110.138 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.439 ' HA3' ' NH2' ' D' ' 214' ' ' ARG . . . -59.7 -22.29 56.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' B' ' 48' ' ' GLU . 97.4 m -90.34 -60.09 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -1.219 . . . . 0.0 110.67 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.04 -54.46 15.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.976 -1.077 . . . . 0.0 110.373 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.953 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.0 mm? -93.39 33.46 1.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 109.787 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' B' ' 48' ' ' GLU . 9.8 pt-20 -68.51 64.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.205 -0.935 . . . . 0.0 111.075 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' B' ' 47' ' ' LEU . 16.2 t0 -169.4 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.168 . . . . 0.0 110.957 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.488 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 25.8 m-85 -128.84 53.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.992 . . . . 0.0 110.921 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' B' ' 47' ' ' LEU . 52.5 mt -125.08 117.83 24.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 111.189 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' B' ' 61' ' ' ALA . 48.3 m-85 -89.17 101.6 14.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.023 177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.8 t -98.97 155.46 17.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.158 -0.964 . . . . 0.0 111.563 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.439 ' HD3' HD13 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -124.12 -170.9 2.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.751 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -78.97 79.24 5.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.14 -0.975 . . . . 0.0 110.208 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 0.2 OUTLIER 160.71 -25.27 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.651 -0.655 . . . . 0.0 110.134 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.5 -167.84 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.057 -1.027 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.3 m -130.64 139.28 50.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.348 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.9 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -124.1 172.42 9.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -0.999 . . . . 0.0 110.705 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.632 ' HA ' HD23 ' B' ' 51' ' ' LEU . 9.5 ttt -117.12 152.63 34.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.341 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.698 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.41 90.77 8.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.846 HD22 HD22 ' A' ' 62' ' ' LEU 2.502 0.5 OUTLIER -55.31 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.846 -179.807 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -63.59 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.611 ' HB3' HD11 ' B' ' 67' ' ' ILE . 39.6 m-85 -89.68 42.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.127 . . . . 0.0 110.603 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.698 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -84.71 -21.29 56.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -89.03 -59.34 2.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -1.173 . . . . 0.0 110.554 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.97 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.6 pp -44.71 -22.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.639 -0.663 . . . . 0.0 112.368 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.97 ' N ' HD12 ' B' ' 67' ' ' ILE . 4.5 m-85 -49.48 153.76 1.05 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.628 -1.295 . . . . 0.0 110.668 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.525 ' HB2' HG22 ' B' ' 102' ' ' THR . 26.2 m-20 -120.0 -171.46 2.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 111.114 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -103.65 156.64 17.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.429 -0.794 . . . . 0.0 109.676 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.57 141.15 10.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.053 . . . . 0.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' B' ' 116' ' ' LEU . 5.1 mtpp -55.2 -29.09 57.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 110.271 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.91 92.52 39.66 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.356 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.826 ' O ' HD11 ' B' ' 92' ' ' ILE . 32.4 Cg_exo -54.07 104.2 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.647 1.341 . . . . 0.0 110.576 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.5 -21.63 35.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 110.31 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.431 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -140.46 140.27 35.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.912 . . . . 0.0 110.31 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.32 -171.91 2.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 47.0 p-80 -130.75 174.07 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 87' ' ' MET . 29.8 tt0 -149.83 141.34 23.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.875 . . . . 0.0 110.297 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.749 HD23 ' O ' ' B' ' 86' ' ' ARG . 5.0 mt -102.55 142.82 33.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.208 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.473 HG22 ' CZ ' ' B' ' 88' ' ' ARG . 68.7 p -80.08 85.74 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.718 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.09 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.72 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.35 28.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.9 ' CD2' ' HB2' ' B' ' 59' ' ' ALA . 1.1 mp -109.81 98.87 8.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -1.097 . . . . 0.0 110.423 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.71 -53.78 0.31 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.749 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -136.14 174.86 10.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.064 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' B' ' 79' ' ' GLU . 15.5 mtp -142.78 128.42 19.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 110.706 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.796 ' HB3' HD21 ' B' ' 29' ' ' LEU . 58.4 mtt180 -114.66 140.47 48.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.121 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.448 HG12 ' CE2' ' B' ' 68' ' ' PHE . 8.3 mt -99.92 110.1 26.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.995 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.925 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 9.5 m-85 -104.62 171.18 7.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 110.549 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -117.11 118.97 33.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.996 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.826 HD11 ' O ' ' B' ' 74' ' ' PRO . 21.5 pt -86.69 13.29 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.787 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.423 ' HG2' HG13 ' B' ' 92' ' ' ILE . 7.3 ptpt -176.8 142.12 0.53 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.66 136.73 21.24 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.464 1.244 . . . . 0.0 111.056 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.45 HG21 ' HB1' ' B' ' 20' ' ' ALA . 61.6 mt -116.49 140.9 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.789 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.74 153.42 20.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.876 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -50.28 -23.08 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 111.045 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.14 57.93 0.41 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.37 174.84 8.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.24 . . . . 0.0 110.583 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.8 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.547 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 32.3 mt -92.59 119.36 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 110.335 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.525 HG22 ' HB2' ' B' ' 69' ' ' ASN . 61.3 p -150.83 123.98 8.81 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.608 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.512 HD12 ' O ' ' B' ' 104' ' ' SER . 1.1 pt -88.85 159.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.759 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.512 ' O ' HD12 ' B' ' 103' ' ' ILE . 5.3 p -83.42 -157.18 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 110.321 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.491 ' CD1' ' HE3' ' D' ' 215' ' ' MLZ . 28.1 m-85 -137.54 -66.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.47 34.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -29.27 62.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -1.157 . . . . 0.0 110.365 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -76.22 -71.28 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 1.2 m-85 -58.48 99.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 52.63 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.45 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' B' ' 114' ' ' PRO . 20.6 tp -65.12 157.42 28.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.93 . . . . 0.0 110.316 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.414 ' O ' ' HD3' ' B' ' 114' ' ' PRO . 3.0 t -103.86 -49.58 3.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.421 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -107.15 75.96 0.46 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 110.364 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.477 ' HA ' HD23 ' B' ' 111' ' ' LEU . 28.7 Cg_endo -68.14 62.25 1.02 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.602 1.317 . . . . 0.0 110.6 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -86.82 5.89 34.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 110.808 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.663 ' N ' HD22 ' B' ' 116' ' ' LEU . 3.5 mm? 52.67 -174.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.044 -1.035 . . . . 0.0 110.113 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.423 ' O ' ' N ' ' B' ' 119' ' ' ASN . 91.8 m 55.22 105.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.813 . . . . 0.0 110.651 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.83 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.834 . . . . 0.0 110.465 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' B' ' 117' ' ' THR . 14.0 t30 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.02 -1.05 . . . . 0.0 110.266 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.61 90.27 8.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -1.122 . . . . 0.0 110.328 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . 52.64 61.97 10.87 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' D' ' 206' ' ' LYS . 12.8 Cg_endo -60.3 -68.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.611 1.321 . . . . 0.0 110.434 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 55.06 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.563 -0.71 . . . . 0.0 110.694 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 206' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' D' ' 204' ' ' PRO . 4.1 mtmp? -147.75 -62.98 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.955 -1.091 . . . . 0.0 110.453 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -119.01 176.44 5.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.915 . . . . 0.0 110.422 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 5.7 tp -155.3 61.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 110.295 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.47 72.69 1.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.246 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 81.2 p -115.06 -58.38 2.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 110.411 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -169.48 151.22 4.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 110.315 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -173.46 111.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.34 159.18 3.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.417 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.502 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 17.2 mtt-85 -118.4 -147.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.905 . . . . 0.0 110.103 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.491 ' HE3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 216' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.507 0.0 OUTLIER -55.07 -21.13 11.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.472 179.94 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 55.18 -177.76 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 25.5 Cg_exo -59.59 -161.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.7 1.369 . . . . 0.0 110.651 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.78 125.77 1.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.373 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 53.9 p -126.73 -45.64 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 110.401 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 CA-C-O 117.934 -1.481 . . . . 0.0 109.545 179.815 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.441 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.441 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HE3' ' HG ' ' B' ' 34' ' ' LEU . 29.2 mmt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.119 0.485 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.485 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 32.7 p90 -90.23 133.25 35.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 0.0 110.396 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -150.69 141.32 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.138 -179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.03 -45.8 32.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 111.046 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.535 ' C ' HG23 ' A' ' 6' ' ' VAL . 6.5 mtm-85 -74.69 -33.81 62.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.543 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 5' ' ' ARG . 84.5 t -153.33 134.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 11.2 tt -117.22 156.37 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 8' ' ' VAL . 12.7 p -89.35 122.81 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.71 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.2 mttt -151.19 122.01 7.55 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.53 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.602 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 59.12 67.09 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.585 -1.947 . . . . 0.0 111.415 1.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.5 m -165.41 -61.59 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.953 . . . . 0.0 111.19 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 53.9 Cg_endo -73.78 53.03 2.68 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 123.552 1.29 . . . . 0.0 111.445 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.69 26.27 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.069 -1.019 . . . . 0.0 110.977 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.27 -130.98 6.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.94 -103.86 1.81 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CZ ' ' HG3' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.91 6.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -1.159 . . . . 0.0 110.708 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.04 174.6 20.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 68' ' ' PHE . 82.9 t -97.21 117.42 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.321 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -88.99 127.0 35.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.871 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -90.85 86.88 6.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 110.962 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.5 ttp85 -58.65 -19.89 43.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.537 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 11.5 mmtm -105.25 179.27 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 108.965 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.47 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 59.3 m 104.35 23.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.01 -1.681 . . . . 0.0 109.627 2.026 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.1 m-85 -115.89 156.55 25.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 164.28 12.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.377 -0.827 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 30.5 tttt -62.37 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.22 44.51 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 24' ' ' PHE . 4.3 mt-10 -118.94 112.09 19.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -1.184 . . . . 0.0 110.443 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.978 HD21 ' HB3' ' A' ' 88' ' ' ARG . 2.0 tm? -53.48 115.6 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.255 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.452 ' N ' HD13 ' A' ' 29' ' ' LEU . 54.0 t -88.89 66.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.6 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.271 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.96 167.29 24.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.288 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.3 179.73 7.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.612 HD23 ' HG3' ' A' ' 86' ' ' ARG . 2.8 mt -94.72 -177.26 4.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.9 176.09 11.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.4 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 62' ' ' LEU . 73.5 mt -109.27 141.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 109.969 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 84' ' ' LEU . 43.4 t -117.44 115.54 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.049 -1.032 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.507 ' HB3' ' CG ' ' A' ' 43' ' ' TRP . 0.5 OUTLIER -145.96 157.1 43.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 110.416 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.9 177.01 9.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.341 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 29.9 p30 -64.24 -134.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.251 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 7.7 t0 64.83 -148.16 0.26 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.579 -1.325 . . . . 0.0 110.57 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.47 -41.09 13.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.227 -0.921 . . . . 0.0 110.953 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.731 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 65.9 t-105 -60.92 -35.33 76.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.69 92.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 84.8 m -83.53 -58.32 2.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -1.18 . . . . 0.0 110.687 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' CB ' HD22 ' A' ' 47' ' ' LEU . . . -48.83 -60.07 3.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.181 -0.949 . . . . 0.0 110.489 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.811 HD12 ' CE ' ' A' ' 60' ' ' MET . 3.1 mm? -91.72 29.15 1.59 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.882 . . . . 0.0 110.362 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.56 -23.72 0.71 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.0 111.412 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -112.34 167.18 10.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.926 -1.109 . . . . 0.0 109.988 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.58 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 38.2 m-85 52.84 29.94 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 0.0 110.148 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.777 HD13 ' HB3' ' A' ' 47' ' ' LEU . 8.6 tp -116.48 117.4 29.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.338 -0.851 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 13.0 m-85 -89.23 107.71 19.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.429 ' HB2' ' CD ' ' C' ' 214' ' ' ARG . 23.1 t -106.0 153.81 21.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 -177.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -130.8 -171.53 2.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -82.96 79.75 9.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.979 -1.075 . . . . 0.0 109.263 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.499 0.2 OUTLIER 163.51 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.846 -0.534 . . . . 0.0 109.795 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.05 -164.29 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.302 -0.874 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 m -136.48 111.93 9.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 110.393 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.863 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -102.5 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.368 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.811 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -112.39 163.58 14.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.773 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.65 87.81 7.45 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 36' ' ' ILE 2.515 0.4 OUTLIER -46.65 -84.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.705 -0.622 . . . . 0.0 111.663 -175.614 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -131.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 70.7 m-85 -83.49 50.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 110.734 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.773 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.64 -24.54 27.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.58 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.37 -36.59 14.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -1.12 . . . . 0.0 110.55 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.503 HD12 HG23 ' A' ' 18' ' ' VAL . 1.3 pp -57.11 -20.88 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.656 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.707 ' CE1' HG21 ' A' ' 18' ' ' VAL . 12.4 m-85 -56.45 121.67 10.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.005 . . . . 0.0 110.197 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 102' ' ' THR . 41.3 m-20 -88.76 177.5 6.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.575 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.472 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 62.7 t60 -98.04 112.08 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 110.356 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.21 157.12 25.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.755 ' HD3' HD11 ' A' ' 116' ' ' LEU . 7.4 mmtt -72.69 -23.17 60.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.396 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -132.17 73.9 77.08 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.56 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.666 1.351 . . . . 0.0 110.562 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.401 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 67.1 m-20 -70.64 -13.51 62.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 110.667 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -115.76 117.69 30.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -98.38 173.6 6.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.127 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -119.54 148.05 43.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.86 139.53 52.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.83 . . . . 0.0 110.156 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.798 HD22 HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -113.49 132.66 55.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 110.529 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 p -57.45 -166.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.0 110.297 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.34 59.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.37 -131.47 2.48 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.863 HD23 ' HB2' ' A' ' 59' ' ' ALA . 4.2 tp -149.22 28.26 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -1.1 . . . . 0.0 110.095 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -100.59 -36.65 9.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.612 ' HG3' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -135.79 145.33 46.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.041 . . . . 0.0 110.892 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.406 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 2.9 ptm -150.24 147.09 27.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.956 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.978 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -112.85 161.94 16.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' HZ ' ' A' ' 68' ' ' PHE . 14.8 mt -109.57 132.36 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.943 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.854 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 36.7 m-85 -117.79 -178.36 3.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.491 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.442 HG23 HG23 ' A' ' 30' ' ' VAL . 57.6 p -125.83 105.9 9.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.344 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.42 HG23 ' HB2' ' A' ' 77' ' ' ARG . 5.8 pt -60.65 -16.62 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 110.502 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' HG3' ' HB3' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -148.71 159.61 37.77 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.872 179.156 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.07 130.05 27.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.614 1.323 . . . . 0.0 110.094 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' HB1' ' A' ' 20' ' ' ALA . 56.3 mt -98.85 156.42 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.833 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.82 157.39 18.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.532 -0.73 . . . . 0.0 110.968 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.6 mp -61.67 104.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 110.34 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.14 31.03 3.95 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.15 155.55 18.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.23 -1.159 . . . . 0.0 110.074 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.12 117.45 28.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 110.385 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' A' ' 20' ' ' ALA . 57.6 mt -95.83 130.01 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.489 HG23 ' C ' ' A' ' 101' ' ' ILE . 31.1 p -154.34 170.25 21.76 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.502 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.3 pp -128.88 6.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.004 -1.06 . . . . 0.0 111.427 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 2.2 p 54.75 -151.89 0.36 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.091 -1.006 . . . . 0.0 110.013 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.511 ' CE1' ' HE3' ' C' ' 215' ' ' MLZ . 25.4 m-85 -133.75 -77.39 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 110.812 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.28 -159.18 20.19 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' SER . 94.0 m-20 -90.46 18.8 5.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -1.105 . . . . 0.0 110.595 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.98 -53.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.127 -0.983 . . . . 0.0 110.081 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.52 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.1 OUTLIER -59.99 118.81 6.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 110.32 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.453 ' HZ2' HO3' ' A' ' 301' ' ' SAH . 5.6 m95 57.22 -85.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.532 -0.73 . . . . 0.0 110.868 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' A' ' 111' ' ' LEU . 7.2 tp -62.79 -146.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.052 . . . . 0.0 110.481 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -171.99 -43.66 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.05 -1.032 . . . . 0.0 110.549 -178.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.7 142.74 45.91 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.58 75.58 4.8 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.593 1.312 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.571 ' O ' HD22 ' A' ' 116' ' ' LEU . 9.3 ptm180 -156.01 124.56 5.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 110.562 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.755 HD11 ' HD3' ' A' ' 72' ' ' LYS . 1.8 mm? -122.56 -66.34 1.03 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 110.175 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 68.7 m -112.5 -33.96 6.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.888 . . . . 0.0 110.281 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -164.6 -150.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.299 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.4 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.285 179.85 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 202' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' C' ' 203' ' ' ALA . 0.1 OUTLIER 51.9 -169.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -1.149 . . . . 0.0 110.375 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 203' ' ' ALA . . . . . 0.818 ' HB3' ' HD3' ' C' ' 204' ' ' PRO . . . -178.32 -59.38 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.251 -0.906 . . . . 0.0 110.436 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 204' ' ' PRO . . . . . 0.818 ' HD3' ' HB3' ' C' ' 203' ' ' ALA . 26.3 Cg_endo -67.87 -24.31 40.25 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.429 1.226 . . . . 0.0 110.432 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 205' ' ' ARG . . . . . 0.517 ' HB2' HD23 ' C' ' 208' ' ' LEU . 0.2 OUTLIER 56.91 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.369 -0.832 . . . . 0.0 110.57 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 206' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' C' ' 204' ' ' PRO . 0.5 OUTLIER -156.23 -63.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.983 -1.073 . . . . 0.0 110.323 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.95 45.95 2.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 110.386 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' C' ' 205' ' ' ARG . 3.8 mm? -84.22 -55.32 4.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 110.398 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -100.87 90.45 4.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 110.315 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 2.6 p -79.97 105.2 11.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.363 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.62 -64.72 1.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 110.389 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' C' ' 213' ' ' ALA . . . -62.97 156.84 23.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.28 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 213' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 212' ' ' ALA . . . 60.02 150.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.322 -0.861 . . . . 0.0 110.634 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 214' ' ' ARG . . . . . 0.52 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 44.8 mtt85 -142.77 -166.13 2.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 110.266 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 215' ' ' MLZ . . . . . 0.511 ' HE3' ' CE1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.504 3.2 m -50.36 176.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.805 . . . . 0.0 110.658 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -115.29 167.71 9.48 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.321 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 19.1 Cg_endo -67.28 -72.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.643 1.339 . . . . 0.0 110.524 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -139.44 108.03 5.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.366 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 9.2 t -174.92 38.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.418 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 29.1 mmt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.137 0.494 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 32.7 p90 -90.09 133.43 34.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.106 -0.996 . . . . 0.0 110.337 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -150.97 141.31 22.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 110.124 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 13.3 t70 -47.98 -45.91 31.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.961 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.522 ' C ' HG23 ' B' ' 6' ' ' VAL . 6.5 mtm-85 -74.61 -33.92 62.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.522 HG23 ' C ' ' B' ' 5' ' ' ARG . 84.9 t -153.16 134.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 11.2 tt -117.24 156.07 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 110.588 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.582 HG13 ' O ' ' B' ' 8' ' ' VAL . 12.6 p -88.91 123.32 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.66 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.2 mttt -151.88 121.82 7.09 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.59 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 59.08 67.25 0.94 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 119.631 -1.918 . . . . 0.0 111.482 1.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.4 m -165.96 -61.0 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.757 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 55.3 Cg_endo -73.89 52.94 2.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.307 1.162 . . . . 0.0 111.49 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.73 26.24 0.53 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.033 -1.042 . . . . 0.0 111.007 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.34 -131.04 6.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.89 -103.82 1.81 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.501 ' CZ ' ' HG3' ' B' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.85 6.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -1.149 . . . . 0.0 110.722 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.06 174.56 20.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.705 HG21 ' CE1' ' B' ' 68' ' ' PHE . 85.3 t -97.19 116.75 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.312 . . . . 0.0 110.145 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.524 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 0.5 OUTLIER -88.31 127.05 35.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.014 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.78 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -90.92 86.89 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 110.969 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.882 ' O ' HG23 ' B' ' 97' ' ' ILE . 1.5 ttp85 -58.74 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 0.0 109.525 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 11.5 mmtm -105.13 179.3 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 108.953 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.464 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 59.5 m 104.37 23.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.912 -1.742 . . . . 0.0 109.674 1.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.3 m-85 -115.83 156.54 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.376 -0.828 . . . . 0.0 110.622 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 164.25 12.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.339 -0.851 . . . . 0.0 110.042 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 92' ' ' ILE . 30.4 tttt -62.37 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.16 44.52 0.15 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' B' ' 24' ' ' PHE . 4.3 mt-10 -119.0 112.18 19.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.976 HD21 ' HB3' ' B' ' 88' ' ' ARG . 2.0 tm? -53.5 115.58 2.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.452 HG23 HG23 ' B' ' 91' ' ' THR . 53.8 t -88.83 66.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -0.881 . . . . 0.0 110.093 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.58 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 110.287 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.95 167.38 24.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.328 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.48 179.6 8.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 110.563 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.622 HD23 ' HG3' ' B' ' 86' ' ' ARG . 2.8 mt -94.63 -177.34 4.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.83 176.07 11.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 110.382 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 1.012 HD11 HD13 ' B' ' 62' ' ' LEU . 73.1 mt -109.3 141.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' B' ' 84' ' ' LEU . 43.0 t -117.45 115.47 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.5 OUTLIER -145.87 157.12 43.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 110.409 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 39' ' ' HIS . . . . . 0.4 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 0.9 OUTLIER -81.93 176.97 9.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 110.276 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' B' ' 41' ' ' ASP . 29.9 p30 -64.19 -134.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.887 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' B' ' 40' ' ' ASN . 7.6 t0 64.85 -148.16 0.26 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.644 -1.285 . . . . 0.0 110.559 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.41 -41.14 13.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.949 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.734 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 66.0 t-105 -60.97 -35.29 76.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.771 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -35.58 91.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 85.3 m -83.61 -58.35 2.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.641 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.414 ' CB ' HD22 ' B' ' 47' ' ' LEU . . . -48.86 -59.42 3.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.809 HD12 ' CE ' ' B' ' 60' ' ' MET . 3.1 mm? -92.73 29.49 1.76 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.76 -23.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.173 -0.955 . . . . 0.0 111.335 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -112.26 167.11 10.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.953 -1.092 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.578 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 37.9 m-85 52.93 29.85 8.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.785 HD13 ' HB3' ' B' ' 47' ' ' LEU . 8.6 tp -116.61 117.19 29.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 111.0 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' B' ' 61' ' ' ALA . 13.1 m-85 -88.94 107.75 19.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.868 . . . . 0.0 109.219 177.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' SER . . . . . 0.418 ' HB2' ' CD ' ' D' ' 214' ' ' ARG . 23.1 t -106.05 153.74 21.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.09 -1.006 . . . . 0.0 111.222 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -131.41 -174.42 3.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.564 -0.71 . . . . 0.0 109.848 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -78.83 79.42 5.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.13 -0.982 . . . . 0.0 110.065 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.2 OUTLIER 163.43 -27.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.756 -0.59 . . . . 0.0 109.839 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -164.01 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.5 m -136.57 112.01 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 110.377 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.841 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -102.6 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.407 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.809 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -112.83 161.62 16.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.285 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.744 ' HB1' ' CA ' ' B' ' 65' ' ' GLY . . . -82.94 87.73 6.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.936 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 1.012 HD13 HD11 ' B' ' 36' ' ' ILE 2.517 0.3 OUTLIER -47.02 -84.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.646 -0.659 . . . . 0.0 111.72 -175.753 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.49 -131.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 71.0 m-85 -83.6 50.92 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.611 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.744 ' CA ' ' HB1' ' B' ' 61' ' ' ALA . . . -91.19 -24.19 27.5 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.578 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.71 -36.43 14.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -1.139 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.492 HD12 HG23 ' B' ' 18' ' ' VAL . 1.3 pp -57.13 -20.96 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 0.0 110.642 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' B' ' 18' ' ' VAL . 12.4 m-85 -56.4 121.67 10.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -88.79 177.4 6.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 110.604 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.478 ' CE1' ' HB2' ' B' ' 111' ' ' LEU . 62.7 t60 -97.91 112.15 24.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.358 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.28 157.15 25.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.744 ' HD3' HD11 ' B' ' 116' ' ' LEU . 7.5 mmtt -72.75 -23.17 60.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.356 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -132.12 73.95 77.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.58 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.678 1.357 . . . . 0.0 110.595 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.401 ' HB3' ' HG3' ' B' ' 93' ' ' LYS . 67.1 m-20 -70.62 -13.5 62.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.704 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -115.74 117.72 31.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.419 ' HB2' HG23 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -98.38 173.61 6.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -119.5 147.98 43.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.611 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -127.84 139.57 52.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.814 HD22 HD12 ' B' ' 84' ' ' LEU . 0.7 OUTLIER -113.43 132.74 55.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 110.482 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.8 p -57.52 -166.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 110.324 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.41 59.91 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.34 -131.48 2.48 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.841 HD23 ' HB2' ' B' ' 59' ' ' ALA . 4.3 tp -149.28 28.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -1.104 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -100.72 -36.51 9.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 110.82 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ARG . . . . . 0.622 ' HG3' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -135.87 145.34 46.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 110.884 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.9 ptm -150.2 147.1 27.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 110.055 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.976 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -112.94 161.98 16.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 110.387 -179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.49 HD13 ' HZ ' ' B' ' 68' ' ' PHE . 14.9 mt -109.53 132.39 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.968 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.854 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 36.7 m-85 -117.82 -178.36 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 110.473 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.452 HG23 HG23 ' B' ' 30' ' ' VAL . 57.6 p -125.79 105.92 9.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.419 HG23 ' HB2' ' B' ' 77' ' ' ARG . 5.8 pt -60.71 -16.6 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.514 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.401 ' HG3' ' HB3' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -148.73 159.79 37.3 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.876 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.31 130.26 28.04 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.59 1.31 . . . . 0.0 110.05 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.49 HG21 ' HB1' ' B' ' 20' ' ' ALA . 56.1 mt -98.92 156.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.0 110.806 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.97 157.44 18.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.912 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.882 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.6 mp -61.68 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 110.343 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.24 30.89 3.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.07 155.1 18.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -1.137 . . . . 0.0 110.155 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.48 117.51 27.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.028 -1.045 . . . . 0.0 110.505 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' B' ' 20' ' ' ALA . 57.3 mt -95.96 130.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 110.617 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.475 HG23 ' C ' ' B' ' 101' ' ' ILE . 30.5 p -154.28 170.23 21.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.726 -0.608 . . . . 0.0 109.487 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.5 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.3 pp -128.71 6.24 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 111.275 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 2.2 p 54.63 -151.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.064 . . . . 0.0 110.059 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.512 ' CE1' ' HE3' ' D' ' 215' ' ' MLZ . 25.4 m-85 -133.7 -77.37 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.99 . . . . 0.0 110.855 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.35 -159.21 20.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' B' ' 112' ' ' SER . 93.9 m-20 -90.38 18.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.628 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.93 -53.35 0.7 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 110.108 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.1 OUTLIER -60.11 118.77 6.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 110.338 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 57.23 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.89 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' B' ' 70' ' ' HIS . 7.2 tp -62.74 -146.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.966 -1.084 . . . . 0.0 110.562 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 107' ' ' ASP . 0.3 OUTLIER -171.88 -43.63 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.988 -1.07 . . . . 0.0 110.54 -178.488 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.8 142.71 45.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.57 75.63 4.78 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.583 1.307 . . . . 0.0 110.398 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' ARG . . . . . 0.58 ' O ' HD22 ' B' ' 116' ' ' LEU . 9.2 ptm180 -156.15 124.89 5.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.744 HD11 ' HD3' ' B' ' 72' ' ' LYS . 1.8 mm? -122.61 -66.42 1.03 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.162 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 67.6 m -112.45 -33.96 6.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.897 . . . . 0.0 110.269 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -164.59 -150.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 110.336 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 25.4 t30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.351 179.813 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 202' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' D' ' 203' ' ' ALA . 0.1 OUTLIER 51.84 -169.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -1.167 . . . . 0.0 110.344 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 203' ' ' ALA . . . . . 0.815 ' HB3' ' HD3' ' D' ' 204' ' ' PRO . . . -178.34 -59.43 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.382 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.815 ' HD3' ' HB3' ' D' ' 203' ' ' ALA . 26.4 Cg_endo -67.88 -24.28 40.25 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.472 1.248 . . . . 0.0 110.453 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 205' ' ' ARG . . . . . 0.52 ' HB2' HD23 ' D' ' 208' ' ' LEU . 0.2 OUTLIER 56.87 -85.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.451 -0.781 . . . . 0.0 110.544 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 206' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' D' ' 204' ' ' PRO . 0.5 OUTLIER -156.29 -63.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.043 -1.036 . . . . 0.0 110.349 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.01 45.93 2.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 110.372 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 208' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' D' ' 205' ' ' ARG . 3.8 mm? -84.26 -55.3 4.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -100.89 90.49 4.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.354 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 2.7 p -79.98 105.14 11.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 110.426 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.55 -64.78 1.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 110.388 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 212' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' D' ' 213' ' ' ALA . . . -62.96 156.8 23.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 213' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' D' ' 212' ' ' ALA . . . 60.07 150.51 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.41 -0.806 . . . . 0.0 110.602 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 214' ' ' ARG . . . . . 0.508 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 44.8 mtt85 -142.78 -166.1 2.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 215' ' ' MLZ . . . . . 0.512 ' HE3' ' CE1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 3.2 m -50.43 176.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.865 . . . . 0.0 110.686 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 217' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -115.27 167.7 9.48 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 110.357 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 218' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 19.4 Cg_endo -67.27 -72.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.633 1.333 . . . . 0.0 110.526 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -139.41 108.04 5.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 110.357 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 9.1 t -174.95 38.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.429 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' SAH . . . . . 0.453 HO3' ' HZ2' ' A' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 302' ' ' SAH . . . . . 0.427 ' OXT' ' CB ' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 22.3 p90 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.445 0.641 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.14 146.86 33.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 110.251 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.83 -22.65 3.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 110.836 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.526 ' C ' HG13 ' A' ' 6' ' ' VAL . 7.3 mtm-85 -90.14 -37.51 14.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.998 . . . . 0.0 110.688 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.526 HG13 ' C ' ' A' ' 5' ' ' ARG . 33.1 m -152.03 -172.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 110.453 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.737 HG23 ' HB2' ' A' ' 19' ' ' PHE . 12.6 tt -157.04 161.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.212 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.8 p -97.02 135.46 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 110.765 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.571 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 28.4 mttt -139.62 142.71 37.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.78 . . . . 0.0 109.161 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.571 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mmtp 52.04 64.31 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 119.797 -1.814 . . . . 0.0 111.217 0.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.491 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.549 -0.719 . . . . 0.0 110.088 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 31.4 m-85 -115.2 61.2 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.159 . . . . 0.0 110.331 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.56 24.1 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.932 HG23 HD13 ' A' ' 67' ' ' ILE . 54.7 t -103.22 154.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.978 -1.307 . . . . 0.0 110.092 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.737 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.1 m-85 -113.95 127.85 56.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.301 -0.874 . . . . 0.0 110.127 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.587 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -90.23 92.08 8.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.789 ' O ' HG23 ' A' ' 97' ' ' ILE . 7.0 ttt180 -58.31 -22.8 54.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 0.0 109.47 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 23' ' ' SER . 2.2 mptt -88.85 178.25 6.49 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.507 -0.746 . . . . 0.0 109.487 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 22' ' ' LYS 2.513 73.9 m 98.58 17.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.231 -1.543 . . . . 0.0 110.351 0.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' A' ' 91' ' ' THR . 19.4 m-85 -108.0 164.36 12.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.1 -165.66 1.01 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.446 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 5.4 tttt -85.41 96.47 9.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 110.423 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.6 0.64 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -119.68 123.04 42.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -1.195 . . . . 0.0 110.433 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.841 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -68.27 96.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 110.0 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' A' ' 6' ' ' VAL . 72.3 t -67.75 -39.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.725 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -168.49 164.42 12.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 110.258 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.17 141.55 18.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.437 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 52.7 m -144.96 -176.05 4.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 110.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.25 171.6 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.473 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 65.3 m -146.58 -178.22 6.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 110.168 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 55.9 mt -122.3 143.0 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 84' ' ' LEU . 39.6 t -117.39 102.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.51 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.7 mmt180 -125.87 160.47 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -79.64 173.79 12.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 110.405 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.214 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.6 t0 66.52 -150.39 0.2 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.721 -1.237 . . . . 0.0 110.605 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.25 -36.74 4.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.369 -0.832 . . . . 0.0 111.307 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.51 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 57.4 t-105 -55.33 -59.79 4.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.56 57.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 98.4 m -73.83 -70.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.186 . . . . 0.0 110.607 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.67 -43.84 26.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.107 -0.996 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.658 ' CB ' HD11 ' A' ' 51' ' ' LEU . 4.5 mm? -92.12 16.73 10.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.265 -0.897 . . . . 0.0 111.38 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -59.98 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.984 -1.072 . . . . 0.0 110.449 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.1 t0 -179.03 -69.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.003 -1.061 . . . . 0.0 110.333 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.625 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 19.3 m-85 -114.33 61.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.658 HD11 ' CB ' ' A' ' 47' ' ' LEU . 24.7 mt -111.9 117.45 32.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 111.027 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 4.8 m-85 -88.25 92.64 9.24 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.426 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 85.8 p -94.68 145.34 24.91 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 111.497 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.721 ' HB2' HD11 ' A' ' 84' ' ' LEU . 5.3 ttp180 -109.77 -172.81 2.11 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.09 72.59 10.11 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.983 -1.073 . . . . 0.0 109.241 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.0 OUTLIER 169.96 -26.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.99 -168.13 0.93 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.283 -0.886 . . . . 0.0 111.262 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.7 p -129.76 123.98 32.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 0.0 109.806 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.43 169.16 8.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.071 -1.018 . . . . 0.0 111.054 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.582 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -104.29 151.13 23.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.27 85.53 7.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 110.007 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.705 ' O ' HD13 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -52.87 -69.02 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.452 -0.78 . . . . 0.0 110.708 -179.488 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -69.55 -151.26 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CD2' HG12 ' A' ' 67' ' ' ILE . 3.7 m-85 -83.94 51.4 2.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -1.05 . . . . 0.0 110.66 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.57 -23.72 49.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -82.55 -49.24 10.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 110.469 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.991 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.6 pp -45.76 -24.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.753 . . . . 0.0 111.701 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.991 ' N ' HD12 ' A' ' 67' ' ' ILE . 17.2 m-85 -62.2 109.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.844 -1.16 . . . . 0.0 110.024 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' H ' HG22 ' A' ' 102' ' ' THR . 84.3 m-20 -82.1 -176.86 6.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.745 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -102.25 119.46 38.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.5 t -121.32 158.96 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.51 -20.37 60.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 20.8 t0 -141.04 63.77 19.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 110.486 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.653 ' O ' HD11 ' A' ' 92' ' ' ILE . 17.2 Cg_exo -62.92 114.61 2.5 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.671 1.353 . . . . 0.0 110.025 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.43 ' O ' HD11 ' A' ' 95' ' ' ILE . 76.0 m-20 -90.95 24.17 2.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.746 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.483 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -158.66 142.47 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.412 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.1 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.37 168.77 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.91 161.26 30.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 110.092 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.0 mt -133.35 127.69 34.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.445 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 83' ' ' GLY . 3.4 p -69.73 -167.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.53 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 105.4 -177.29 22.9 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.731 ' HB2' HG22 ' A' ' 37' ' ' VAL . 20.9 mt -91.14 51.4 1.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -1.128 . . . . 0.0 110.329 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.9 -80.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.826 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.71 130.84 35.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 110.716 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.748 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.5 mtp -115.89 133.6 55.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.765 ' HB3' HD21 ' A' ' 29' ' ' LEU . 26.9 mtp85 -120.28 163.58 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.583 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.725 HD12 ' HB3' ' A' ' 31' ' ' GLU . 89.9 mt -129.83 98.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.841 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 26.5 m-85 -91.42 -176.85 4.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.432 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.671 ' CG2' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.73 81.89 1.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 111.075 -179.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 74' ' ' PRO . 1.4 pt -60.12 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.12 -0.988 . . . . 0.0 108.571 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 84.42 121.77 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.363 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 84.6 Cg_exo -43.79 148.25 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.526 1.277 . . . . 0.0 111.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.671 HD12 ' CG2' ' A' ' 91' ' ' THR . 74.7 mt -119.91 151.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 110.418 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.19 14.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -63.5 117.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.61 5.05 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -104.03 178.45 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -1.21 . . . . 0.0 110.147 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.23 123.69 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.804 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.587 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 73.9 mt -89.52 127.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 110.122 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.7 p -155.44 176.4 12.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.946 -0.471 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.739 HD12 ' O ' ' A' ' 104' ' ' SER . 1.3 pp -140.42 158.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.01 -1.056 . . . . 0.0 110.563 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.739 ' O ' HD12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -83.01 -164.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 110.369 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.507 ' CG ' ' HB3' ' A' ' 109' ' ' TYR . 19.4 m-85 -124.16 -81.3 0.63 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.85 -152.61 24.52 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.817 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.13 -53.28 21.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -1.149 . . . . 0.0 110.05 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.91 -167.7 0.91 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.435 -0.791 . . . . 0.0 109.351 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.507 ' HB3' ' CG ' ' A' ' 105' ' ' TYR . 2.7 m-85 46.09 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 111.002 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.466 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 29.6 p-90 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.402 0.62 . . . . 0.0 110.601 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 2.9 t . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.352 0.596 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -123.97 176.21 2.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.336 -0.852 . . . . 0.0 110.222 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 21.5 Cg_endo . . . . . 0 C--N 1.313 -1.32 0 O-C-N 123.623 1.328 . . . . 0.0 110.594 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 22.3 p90 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.417 0.627 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.13 146.93 33.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.88 -22.69 3.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.514 ' C ' HG13 ' B' ' 6' ' ' VAL . 7.4 mtm-85 -90.08 -37.62 14.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.514 HG13 ' C ' ' B' ' 5' ' ' ARG . 33.1 m -151.95 -172.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.717 HG23 ' HB2' ' B' ' 19' ' ' PHE . 12.6 tt -156.96 161.83 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 110.219 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.404 HG13 ' O ' ' B' ' 8' ' ' VAL . 10.0 p -97.02 135.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.818 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.574 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 28.4 mttt -139.62 142.76 37.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 109.161 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.574 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mmtp 52.16 64.23 1.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 119.796 -1.815 . . . . 0.0 111.233 0.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 31.5 m-85 -115.17 61.35 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 110.403 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.44 -171.52 23.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.933 HG23 HD13 ' B' ' 67' ' ' ILE . 54.2 t -103.24 154.03 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.934 -1.333 . . . . 0.0 110.084 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.717 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.1 m-85 -113.9 127.92 56.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 110.148 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.57 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -90.16 91.86 8.71 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 110.557 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.79 ' O ' HG23 ' B' ' 97' ' ' ILE . 7.0 ttt180 -58.17 -22.75 52.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' B' ' 23' ' ' SER . 2.2 mptt -89.01 178.26 6.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.52 -0.738 . . . . 0.0 109.518 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' B' ' 22' ' ' LYS 2.514 73.8 m 98.58 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.311 -1.493 . . . . 0.0 110.339 0.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' B' ' 91' ' ' THR . 19.6 m-85 -108.07 164.4 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 110.382 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.04 -165.65 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.428 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 5.4 tttt -85.43 96.38 9.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 110.466 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.01 52.66 0.64 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -119.7 122.98 42.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.0 110.411 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.829 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -68.26 96.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 110.044 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.423 ' CG1' HG11 ' B' ' 6' ' ' VAL . 72.2 t -67.69 -39.96 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.366 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.723 ' HB3' HD12 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -168.46 164.44 12.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.24 141.5 18.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.446 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 52.5 m -144.85 -176.06 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.923 . . . . 0.0 110.406 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.19 171.66 8.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.535 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.749 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 65.2 m -146.64 -178.27 6.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.557 ' O ' ' HB1' ' B' ' 59' ' ' ALA . 55.7 mt -122.29 142.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' B' ' 84' ' ' LEU . 39.6 t -117.3 102.91 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' B' ' 36' ' ' ILE . 14.7 mmt180 -125.81 160.5 29.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -79.65 173.79 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.412 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.6 t0 66.54 -150.32 0.2 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.698 -1.251 . . . . 0.0 110.64 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.36 -36.74 4.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 111.277 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.503 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 57.3 t-105 -55.33 -59.86 4.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 110.181 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.35 -31.54 56.9 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.435 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 98.1 m -73.91 -70.64 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -1.233 . . . . 0.0 110.621 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.82 -42.93 27.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.081 -1.012 . . . . 0.0 111.002 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.658 ' CB ' HD11 ' B' ' 51' ' ' LEU . 4.5 mm? -93.48 17.37 11.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 111.014 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.1 OUTLIER -60.28 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.091 . . . . 0.0 110.408 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 47' ' ' LEU . 1.1 t0 -179.01 -69.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.95 -1.094 . . . . 0.0 110.345 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.644 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . 19.4 m-85 -114.38 61.9 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.117 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.658 HD11 ' CB ' ' B' ' 47' ' ' LEU . 24.4 mt -112.07 116.67 30.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.169 -0.957 . . . . 0.0 111.153 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' B' ' 59' ' ' ALA . 5.0 m-85 -87.23 92.64 9.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 0.0 108.795 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.419 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 85.6 p -94.74 145.36 24.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 0.0 111.529 -176.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.722 ' HB2' HD11 ' B' ' 84' ' ' LEU . 5.4 ttp180 -110.38 -175.65 2.78 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.541 -0.724 . . . . 0.0 109.48 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.11 72.17 5.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 0.0 OUTLIER 169.77 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.8 -168.17 0.96 Allowed 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.336 -0.852 . . . . 0.0 111.351 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 1.7 p -129.69 123.97 32.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.688 . . . . 0.0 109.781 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.45 169.25 8.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.002 . . . . 0.0 111.054 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.582 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -104.59 149.99 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 110.26 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.66 85.44 7.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.255 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 62' ' ' LEU 2.501 0.1 OUTLIER -53.0 -69.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.723 -179.646 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -69.49 -151.22 0.49 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.493 ' CD2' HG12 ' B' ' 67' ' ' ILE . 3.7 m-85 -84.02 51.36 2.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.422 -1.046 . . . . 0.0 110.652 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.49 -23.76 49.5 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -82.58 -49.27 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 110.398 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.98 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.6 pp -45.75 -24.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.491 -0.756 . . . . 0.0 111.749 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.98 ' N ' HD12 ' B' ' 67' ' ' ILE . 17.2 m-85 -62.32 109.75 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.902 -1.124 . . . . 0.0 110.024 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.404 ' H ' HG22 ' B' ' 102' ' ' THR . 84.3 m-20 -81.99 -176.46 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.716 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -102.78 119.45 38.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -0.841 . . . . 0.0 110.024 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 36.7 t -121.35 158.94 27.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 -20.43 60.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.428 ' N ' ' HD3' ' B' ' 74' ' ' PRO . 20.7 t0 -140.99 63.63 19.01 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 110.505 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.642 ' O ' HD11 ' B' ' 92' ' ' ILE . 17.2 Cg_exo -62.79 114.68 2.51 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.627 1.33 . . . . 0.0 110.04 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.44 ' O ' HD11 ' B' ' 95' ' ' ILE . 76.2 m-20 -91.08 24.29 2.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.701 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.475 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -158.62 142.45 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.401 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.455 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.04 1.01 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.529 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.42 168.72 19.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.755 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.89 161.27 30.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -0.827 . . . . 0.0 110.037 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.37 127.61 33.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.002 . . . . 0.0 110.487 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' B' ' 83' ' ' GLY . 3.4 p -69.71 -167.35 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 110.278 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 110.229 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 81' ' ' THR . . . 105.43 -177.22 22.85 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' B' ' 37' ' ' VAL . 20.9 mt -91.21 51.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.92 -80.77 0.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 110.82 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.69 130.82 35.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.741 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.749 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.6 mtp -115.87 133.64 55.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.746 ' HB3' HD21 ' B' ' 29' ' ' LEU . 26.8 mtp85 -120.31 163.55 17.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.641 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.723 HD12 ' HB3' ' B' ' 31' ' ' GLU . 89.5 mt -129.75 98.65 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.829 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 26.3 m-85 -91.36 -176.8 4.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.386 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.671 ' CG2' HD12 ' B' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 81.86 1.76 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.148 -0.97 . . . . 0.0 110.996 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.642 HD11 ' O ' ' B' ' 74' ' ' PRO . 1.4 pt -59.96 103.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.657 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 92' ' ' ILE . 0.0 OUTLIER 84.15 121.44 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 C-N-CA 123.541 0.736 . . . . 0.0 109.425 -177.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 88.2 Cg_exo -44.13 148.51 1.09 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.468 1.246 . . . . 0.0 111.436 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.671 HD12 ' CG2' ' B' ' 91' ' ' THR . 74.0 mt -119.92 151.91 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.285 -0.884 . . . . 0.0 110.421 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.18 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.364 -0.835 . . . . 0.0 110.344 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.79 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -63.47 117.17 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.05 27.59 5.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.404 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 18.8 mm-40 -104.03 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.236 . . . . 0.0 110.156 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.29 123.68 48.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.81 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.57 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 74.3 mt -89.34 127.37 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 110.181 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 101' ' ' ILE . 16.6 p -155.42 176.43 12.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.664 -0.647 . . . . 0.0 109.798 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.736 HD12 ' O ' ' B' ' 104' ' ' SER . 1.3 pp -140.43 158.07 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.084 -1.01 . . . . 0.0 110.573 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.736 ' O ' HD12 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -82.98 -164.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 0.0 110.37 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' B' ' 109' ' ' TYR . 19.6 m-85 -124.12 -81.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 110.327 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.76 -152.69 24.59 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.06 -53.31 20.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.287 -1.125 . . . . 0.0 110.101 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.86 -167.46 0.85 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.421 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HB3' ' CG ' ' B' ' 105' ' ' TYR . 2.8 m-85 45.81 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.389 -0.82 . . . . 0.0 111.157 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.478 ' O ' ' CE3' ' B' ' 110' ' ' TRP . 30.1 p-90 . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 110.598 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.504 2.9 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.328 0.585 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.802 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -124.01 176.19 2.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.802 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 21.4 Cg_endo . . . . . 0 C--N 1.312 -1.376 0 O-C-N 123.644 1.339 . . . . 0.0 110.542 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 54.5 p90 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.327 0.584 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ARG . 46.7 t30 -150.14 161.29 42.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.82 62.01 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.618 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.526 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER 174.75 -34.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.0 109.218 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.625 HG11 ' CG1' ' A' ' 30' ' ' VAL . 16.5 m -156.55 -172.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 109.737 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 10.2 tt -160.64 164.29 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.7 p -89.14 120.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.098 -1.002 . . . . 0.0 110.474 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.584 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 26.2 mttt -148.39 127.72 13.03 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.584 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 54.44 42.11 31.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.795 -1.816 . . . . 0.0 110.088 4.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.51 ' CB ' ' CE1' ' A' ' 19' ' ' PHE . 2.1 p . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.677 -0.64 . . . . 0.0 109.905 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CE1' ' HG3' ' A' ' 10' ' ' LYS . 3.8 m-85 -95.08 99.67 11.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.249 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.72 -160.51 9.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 67' ' ' ILE . 79.7 t -113.1 138.32 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.837 -1.39 . . . . 0.0 110.414 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CG ' ' CD ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -104.28 140.99 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -104.14 91.01 3.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 110.974 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.899 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -60.18 -26.2 66.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HE2' ' CE1' ' A' ' 24' ' ' PHE . 6.2 mtpp -94.28 -177.38 4.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.566 -0.709 . . . . 0.0 109.567 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.443 ' HA ' ' CB ' ' A' ' 22' ' ' LYS 2.512 0.1 OUTLIER 108.58 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.123 -1.61 . . . . 0.0 110.109 1.879 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CE1' ' HE2' ' A' ' 22' ' ' LYS . 48.8 m-85 -114.76 160.82 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.652 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.2 172.27 6.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.978 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' CD ' ' A' ' 94' ' ' PRO . 29.5 tttm -72.03 80.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.552 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.43 40.87 0.12 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 24' ' ' PHE . 14.0 mt-10 -119.3 158.52 25.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.386 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.865 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.5 tm? -92.41 128.11 38.14 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.694 ' N ' HD13 ' A' ' 29' ' ' LEU . 81.7 t -94.37 -45.61 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' HD12 ' A' ' 89' ' ' ILE . 27.3 tp10 -170.32 152.07 3.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 110.64 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.51 35.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.05 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.441 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -146.67 -157.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 110.743 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 34' ' ' LEU . 1.5 mm? -99.91 175.47 5.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.415 -0.803 . . . . 0.0 110.551 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.734 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 3.3 m -150.7 154.93 38.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.393 -0.817 . . . . 0.0 109.988 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.787 HD11 HD23 ' A' ' 62' ' ' LEU . 54.7 mt -94.89 164.01 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 36' ' ' ILE . 48.7 t -144.96 106.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -0.962 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.522 ' CB ' ' CG ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -112.82 -163.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.205 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -128.7 62.45 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 26.8 m120 52.35 -149.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 0.0 110.631 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 17.6 m-20 60.51 -144.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.211 -0.93 . . . . 0.0 110.106 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -46.63 -29.05 1.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.009 -1.057 . . . . 0.0 111.149 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.841 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 66.1 t-105 -65.07 -44.45 88.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 110.232 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.37 -40.15 97.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.8 m -67.07 -65.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.508 ' HB3' HD22 ' A' ' 47' ' ' LEU . . . -54.31 -58.43 7.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.883 ' HB3' HD13 ' A' ' 51' ' ' LEU . 2.7 mm? -90.63 50.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -0.4 22.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 111.015 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -129.6 156.8 43.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.942 -1.099 . . . . 0.0 109.681 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 33.3 m-85 54.93 24.09 5.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 109.857 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.883 HD13 ' HB3' ' A' ' 47' ' ' LEU . 7.5 tp -117.05 123.4 46.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 110.851 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 36.2 m-85 -90.04 118.59 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.1 m -96.35 138.43 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.112 -0.993 . . . . 0.0 110.967 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.901 ' CD ' HD13 ' A' ' 84' ' ' LEU . 4.3 ttp180 -109.76 176.47 5.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.449 -0.782 . . . . 0.0 110.228 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -84.18 81.6 8.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.03 -1.044 . . . . 0.0 109.221 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.505 8.9 m-80 148.29 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 109.733 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.7 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.498 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -150.9 164.81 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.709 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.597 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -150.63 155.85 40.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.531 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.881 ' CE ' HD12 ' A' ' 47' ' ' LEU . 27.5 tpp -102.61 159.68 15.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 110.135 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.76 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.39 94.26 9.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.101 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.787 HD23 HD11 ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER -55.34 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.804 . . . . 0.0 111.165 -178.978 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.53 -132.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.71 ' HB3' HD11 ' A' ' 67' ' ' ILE . 89.2 m-85 -90.16 39.14 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -1.094 . . . . 0.0 110.664 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.76 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -79.15 -20.27 70.31 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.97 -48.27 7.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -1.198 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 64' ' ' PHE . 1.3 pp -55.77 -17.29 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 111.259 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CG ' HG12 ' A' ' 103' ' ' ILE . 4.6 m-85 -49.01 134.29 17.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.881 -1.137 . . . . 0.0 110.832 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.452 ' N ' HG23 ' A' ' 102' ' ' THR . 10.9 m-20 -97.18 -164.33 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 110.875 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -102.36 157.44 16.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.782 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 t -174.41 130.08 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.015 . . . . 0.0 110.565 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.65 79.36 47.93 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.746 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.7 Cg_endo -63.76 100.45 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.653 1.344 . . . . 0.0 110.451 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -54.85 -21.06 10.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 110.487 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -130.67 163.45 27.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.972 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HA ' HG22 ' A' ' 103' ' ' ILE . 71.9 ttt180 -143.44 156.71 44.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 110.241 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.59 ' HD1' HD13 ' A' ' 103' ' ' ILE . 37.2 p-80 -89.85 166.42 13.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 110.382 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 24.0 tp10 -148.07 161.25 41.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.9 . . . . 0.0 110.405 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 84' ' ' LEU . 25.9 mt -123.59 148.54 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.92 64.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.58 40.13 29.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.47 -133.79 2.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.901 HD13 ' CD ' ' A' ' 54' ' ' ARG . 2.0 tp -137.23 23.1 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 110.234 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -85.95 -67.16 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 111.065 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.14 164.12 12.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 111.017 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.734 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 4.3 mtp -134.28 148.41 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HB3' HD21 ' A' ' 29' ' ' LEU . 21.4 mtp180 -133.09 167.3 20.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 0.0 110.448 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' HZ ' ' A' ' 68' ' ' PHE . 65.1 mt -133.38 95.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.865 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 54.2 m-85 -90.39 -179.53 5.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 110.547 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.532 ' CG2' HD12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -117.72 94.16 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 110.189 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.746 HD11 ' O ' ' A' ' 74' ' ' PRO . 10.9 pt -55.87 -20.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 110.592 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.9 mttt -137.71 160.15 66.08 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 110.454 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 26' ' ' LYS . 23.5 Cg_exo -58.03 158.31 21.89 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.651 1.342 . . . . 0.0 110.507 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 91' ' ' THR . 39.5 mt -144.57 136.44 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.71 166.07 11.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.585 -0.697 . . . . 0.0 110.831 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.3 mp -65.11 110.39 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.546 -0.721 . . . . 0.0 110.316 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 22.8 5.02 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.408 ' CB ' HG23 ' A' ' 95' ' ' ILE . 18.3 mm-40 -94.71 -179.36 4.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 110.094 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.19 122.33 35.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.846 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.556 HG23 ' CB ' ' A' ' 76' ' ' ALA . 23.5 mt -89.66 131.08 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 69' ' ' ASN . 49.5 m -162.8 147.62 11.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.59 HD13 ' HD1' ' A' ' 78' ' ' HIS . 1.4 pt -115.0 165.21 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.033 -1.042 . . . . 0.0 110.769 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.22 -159.11 0.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.373 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.12 -93.35 0.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.425 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.23 169.24 41.76 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.752 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.81 -58.64 7.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -39.21 79.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.94 31.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.937 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 179.359 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.507 2.4 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.184 0.516 . . . . 0.0 110.666 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 54.48 174.84 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 25.3 Cg_exo . . . . . 0 C--N 1.313 -1.325 0 O-C-N 123.616 1.324 . . . . 0.0 110.583 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 54.6 p90 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.347 0.594 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -150.18 161.5 42.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.081 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.06 61.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.369 -0.832 . . . . 0.0 110.578 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.512 ' O ' HG13 ' B' ' 6' ' ' VAL . 0.2 OUTLIER 174.83 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.342 -0.849 . . . . 0.0 109.21 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.624 HG11 ' CG1' ' B' ' 30' ' ' VAL . 16.7 m -156.48 -172.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.664 -0.647 . . . . 0.0 109.819 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 10.3 tt -160.68 163.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.977 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.564 HG13 ' O ' ' B' ' 8' ' ' VAL . 7.8 p -88.59 120.72 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.967 . . . . 0.0 110.538 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.613 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 26.1 mttt -148.57 127.75 12.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.613 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 54.47 42.09 31.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.642 -1.911 . . . . 0.0 110.106 4.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.517 ' CB ' ' CE1' ' B' ' 19' ' ' PHE . 2.1 p . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.675 -0.64 . . . . 0.0 109.932 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' B' ' 10' ' ' LYS . 3.8 m-85 -95.0 99.69 11.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.054 -1.262 . . . . 0.0 110.495 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.71 -160.34 9.54 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' B' ' 67' ' ' ILE . 81.2 t -113.24 138.08 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.386 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CG ' ' CD ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -104.21 141.05 36.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.788 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -104.19 91.09 3.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.947 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.905 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.3 OUTLIER -60.27 -26.07 66.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.507 ' HE2' ' CE1' ' B' ' 24' ' ' PHE . 6.2 mtpp -94.4 -177.14 4.16 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 109.572 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.511 0.1 OUTLIER 108.69 17.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.133 -1.605 . . . . 0.0 110.133 1.755 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.507 ' CE1' ' HE2' ' B' ' 22' ' ' LYS . 49.3 m-85 -114.67 160.9 18.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.639 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.3 172.29 6.87 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.517 -0.739 . . . . 0.0 110.025 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -72.23 80.36 0.99 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.37 40.95 0.12 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' B' ' 24' ' ' PHE . 13.7 mt-10 -119.44 158.48 26.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -1.214 . . . . 0.0 110.336 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.883 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.5 tm? -92.35 128.07 38.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.968 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.696 ' N ' HD13 ' B' ' 29' ' ' LEU . 82.6 t -94.35 -45.66 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.457 ' HB3' HD12 ' B' ' 89' ' ' ILE . 27.4 tp10 -170.26 152.11 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.55 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 110.028 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.434 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -146.75 -157.4 0.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 110.757 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' B' ' 34' ' ' LEU . 1.5 mm? -99.93 175.86 5.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 3.4 m -151.12 154.77 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.953 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.794 HD11 HD23 ' B' ' 62' ' ' LEU . 54.7 mt -94.85 163.97 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.825 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.415 HG23 ' C ' ' B' ' 36' ' ' ILE . 48.7 t -144.87 106.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.967 . . . . 0.0 110.678 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.528 ' CB ' ' CG ' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -113.0 -163.34 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -128.61 62.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 110.963 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 26.7 m120 52.42 -149.31 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.647 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 17.4 m-20 60.5 -144.13 0.5 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.232 -0.917 . . . . 0.0 110.14 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -46.63 -29.04 1.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.07 -1.019 . . . . 0.0 111.147 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.834 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 66.2 t-105 -65.04 -44.51 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.172 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.33 -40.16 97.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 98.5 m -67.15 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 110.434 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.52 ' HB3' HD22 ' B' ' 47' ' ' LEU . . . -54.3 -58.28 8.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 110.324 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.88 ' HB3' HD13 ' B' ' 51' ' ' LEU . 2.7 mm? -90.96 50.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -0.56 22.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' B' ' 49' ' ' ASP . 39.9 p-10 -129.45 156.89 43.39 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.009 -1.057 . . . . 0.0 109.779 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 32.9 m-85 54.88 24.01 5.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.155 -0.966 . . . . 0.0 109.885 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 47' ' ' LEU . 7.5 tp -117.01 123.54 47.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.379 -0.826 . . . . 0.0 110.85 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' B' ' 52' ' ' PHE . 35.9 m-85 -90.17 118.6 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.601 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.2 m -96.35 138.39 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.921 ' CD ' HD13 ' B' ' 84' ' ' LEU . 4.3 ttp180 -110.23 174.06 6.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.498 -0.751 . . . . 0.0 110.32 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -80.82 81.33 7.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.506 8.8 m-80 148.14 -19.66 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 109.77 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.61 -149.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.481 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.495 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -151.38 164.84 35.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 110.69 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -150.93 155.71 39.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.86 . . . . 0.0 110.464 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.879 ' CE ' HD12 ' B' ' 47' ' ' LEU . 27.5 tpp -102.7 158.66 16.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.326 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.749 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -85.93 94.19 9.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.794 HD23 HD11 ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER -55.45 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 111.206 -179.177 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.59 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.737 ' HB3' HD11 ' B' ' 67' ' ' ILE . 89.1 m-85 -90.21 39.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.414 -1.051 . . . . 0.0 110.745 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.749 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -79.26 -19.82 71.08 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.5 -48.1 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.111 -1.229 . . . . 0.0 111.145 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.737 HD11 ' HB3' ' B' ' 64' ' ' PHE . 1.3 pp -55.82 -17.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.166 -0.959 . . . . 0.0 111.355 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.5 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.6 m-85 -49.04 134.29 17.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.785 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.434 ' N ' HG23 ' B' ' 102' ' ' THR . 11.5 m-20 -97.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -103.05 157.3 17.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.729 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.0 t -174.33 130.14 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -0.998 . . . . 0.0 110.542 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -36.59 77.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 110.207 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.59 79.3 47.33 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 110.248 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.731 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.5 Cg_endo -63.7 100.44 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.681 1.358 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.93 -21.0 10.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -0.922 . . . . 0.0 110.524 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.557 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -130.65 163.45 27.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 110.506 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.519 ' HA ' HG22 ' B' ' 103' ' ' ILE . 71.9 ttt180 -143.42 156.71 44.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.582 ' HD1' HD13 ' B' ' 103' ' ' ILE . 37.3 p-80 -89.75 166.42 13.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.455 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -148.08 161.22 41.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 110.404 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' B' ' 84' ' ' LEU . 25.9 mt -123.6 148.52 46.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.313 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.81 64.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.56 40.16 29.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.456 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.43 -133.74 2.85 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.921 HD13 ' CD ' ' B' ' 54' ' ' ARG . 2.0 tp -137.25 23.15 3.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -1.097 . . . . 0.0 110.241 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -86.03 -67.15 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 111.039 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.13 164.16 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 111.085 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.742 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 4.3 mtp -134.3 148.38 50.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 110.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.464 ' HB3' HD21 ' B' ' 29' ' ' LEU . 21.4 mtp180 -133.02 167.34 20.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.498 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.481 HD13 ' HZ ' ' B' ' 68' ' ' PHE . 65.2 mt -133.42 95.29 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.883 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 54.0 m-85 -90.53 -179.5 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 110.48 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.539 ' CG2' HD12 ' B' ' 95' ' ' ILE . 1.0 OUTLIER -117.76 94.18 4.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.731 HD11 ' O ' ' B' ' 74' ' ' PRO . 10.9 pt -55.83 -20.77 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 110.514 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.424 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.9 mttt -137.7 160.24 65.75 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 110.375 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.29 158.53 22.15 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.65 1.342 . . . . 0.0 110.421 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.539 HD12 ' CG2' ' B' ' 91' ' ' THR . 39.4 mt -144.64 136.48 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.271 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.77 166.01 11.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 110.767 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.905 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.3 mp -65.1 110.43 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.515 -0.741 . . . . 0.0 110.293 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.41 22.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.405 ' CB ' HG23 ' B' ' 95' ' ' ILE . 18.5 mm-40 -94.73 -179.33 4.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -1.171 . . . . 0.0 110.102 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.2 122.25 35.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.821 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.557 HG23 ' CB ' ' B' ' 76' ' ' ALA . 23.9 mt -89.49 131.14 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.48 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.434 HG23 ' N ' ' B' ' 69' ' ' ASN . 47.9 m -162.82 147.62 11.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.726 -0.609 . . . . 0.0 109.597 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.582 HD13 ' HD1' ' B' ' 78' ' ' HIS . 1.4 pt -114.98 165.2 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.753 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.17 -159.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.08 -93.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.937 . . . . 0.0 110.449 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.32 169.22 41.7 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.84 -58.62 7.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -1.121 . . . . 0.0 110.194 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -39.21 79.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.83 31.51 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.974 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.989 -1.069 . . . . 0.0 110.506 179.424 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.506 2.4 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.182 0.515 . . . . 0.0 110.665 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.535 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 54.47 174.87 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.348 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 25.3 Cg_exo . . . . . 0 C--N 1.312 -1.392 0 O-C-N 123.701 1.369 . . . . 0.0 110.572 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 25.7 p90 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.324 0.583 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.06 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.29 -22.11 6.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.583 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.492 ' C ' HG13 ' A' ' 6' ' ' VAL . 2.2 mmt85 -81.55 -41.1 22.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 0.0 110.593 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.492 HG13 ' C ' ' A' ' 5' ' ' ARG . 28.3 m -151.31 179.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 19' ' ' PHE . 9.4 tt -152.04 166.83 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.168 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 8' ' ' VAL . 12.6 p -104.66 125.15 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.958 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 20.5 mttt -128.59 142.73 50.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.576 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mtpp 52.09 58.14 5.75 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.717 -1.865 . . . . 0.0 111.066 1.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.435 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.519 -0.738 . . . . 0.0 110.268 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -97.4 91.66 5.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 110.57 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -126.7 -168.74 12.63 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.763 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.5 p -113.1 125.95 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.299 . . . . 0.0 109.524 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -90.1 161.79 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 110.497 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 101' ' ' ILE . . . -118.73 96.71 5.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 110.634 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -63.62 -20.0 65.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.0 109.793 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 14.2 mtpt -91.81 179.97 5.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.381 -0.824 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 39.9 m 103.9 16.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.166 -1.584 . . . . 0.0 110.403 0.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 42.3 m-85 -109.55 168.5 9.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.367 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 -167.18 1.32 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.966 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.12 4.08 18.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.43 86.73 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -151.04 147.98 27.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -1.17 . . . . 0.0 110.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.933 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 tm? -86.3 122.86 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.257 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.608 ' N ' HD13 ' A' ' 29' ' ' LEU . 59.2 t -81.88 -52.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.846 ' CG ' HD12 ' A' ' 89' ' ' ILE . 1.9 pt-20 -162.43 177.69 9.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.129 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.21 149.49 8.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 110.492 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.19 -157.84 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.275 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 86' ' ' ARG . 72.8 mt -109.13 -178.51 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 85' ' ' LYS . 72.4 m -145.41 174.2 11.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 ' CD2' ' A' ' 62' ' ' LEU . 60.6 mt -116.2 125.18 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.886 . . . . 0.0 109.832 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 84' ' ' LEU . 26.0 t -97.82 100.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 110.579 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 2.6 mmp_? -119.44 -172.05 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.383 -0.823 . . . . 0.0 110.214 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 36.8 m80 -104.29 -165.03 1.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.339 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -91.04 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 58.07 -137.5 0.9 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.869 -1.144 . . . . 0.0 110.435 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.44 -40.04 7.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.996 -1.065 . . . . 0.0 111.498 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.973 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 76.1 t-105 -57.66 -45.69 85.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.87 73.71 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.98 -63.51 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.24 . . . . 0.0 110.527 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.16 -55.61 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.915 ' HB3' HD13 ' A' ' 51' ' ' LEU . 3.9 mm? -89.49 52.37 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 57.42 3.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 -76.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.492 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 5.0 m-85 -89.52 48.21 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.973 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 6.1 tp -117.66 109.64 16.91 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.399 -0.813 . . . . 0.0 111.243 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -89.56 105.2 17.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.105 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.3 p -97.38 161.02 13.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 111.144 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.809 ' HB2' HD11 ' A' ' 84' ' ' LEU . 3.6 ttp180 -127.97 -172.36 2.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.481 -0.762 . . . . 0.0 109.959 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -83.69 84.63 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.031 -1.043 . . . . 0.0 109.334 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.8 OUTLIER 153.19 -22.01 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.75 -0.594 . . . . 0.0 109.778 -178.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.59 -168.1 0.22 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.281 -0.887 . . . . 0.0 110.735 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.1 m -132.22 134.82 45.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.469 -0.769 . . . . 0.0 109.921 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -127.88 166.69 17.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 111.031 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.847 ' CE ' HD12 ' A' ' 47' ' ' LEU . 1.2 ttt -96.1 170.46 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.857 . . . . 0.0 109.822 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.695 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.32 -54.04 4.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.156 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.497 0.0 OUTLIER 92.3 -81.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.819 -1.176 . . . . 0.0 110.513 -179.51 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.79 -143.48 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.33 56.65 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -1.065 . . . . 0.0 110.358 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.695 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -89.74 -43.31 5.17 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -63.39 -47.61 81.3 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.984 -1.304 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.8 pp -49.53 -22.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.876 . . . . 0.0 111.441 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.833 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.9 m-85 -50.19 113.45 0.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.767 -1.208 . . . . 0.0 110.415 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -102.0 -165.82 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 111.204 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -94.46 140.89 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.531 -0.731 . . . . 0.0 110.449 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.44 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.337 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -85.47 -19.48 31.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 110.528 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.54 74.93 53.88 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.844 ' O ' HD11 ' A' ' 92' ' ' ILE . 32.4 Cg_exo -57.57 106.04 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.697 1.367 . . . . 0.0 110.467 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 76' ' ' ALA . 50.4 p-10 -85.06 -13.9 48.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -142.51 141.16 32.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.985 -1.072 . . . . 0.0 110.46 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.05 -176.44 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -124.36 161.98 24.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 110.517 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.45 154.15 51.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.766 HD11 ' HA ' ' A' ' 84' ' ' LEU . 43.8 tp -132.42 139.97 48.26 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.67 -168.99 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.85 107.92 18.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 110.408 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 37' ' ' VAL . . . 122.61 12.95 4.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 54' ' ' ARG . 16.5 mt 52.39 32.85 11.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.0 110.405 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 35' ' ' CYS . 2.7 mmtp -100.21 -62.29 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 111.147 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.76 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.3 ttt180 -97.49 162.26 13.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.64 147.59 27.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.145 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.601 ' HB3' HD21 ' A' ' 29' ' ' LEU . 36.2 mtt180 -132.02 171.92 13.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.376 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.846 HD12 ' CG ' ' A' ' 31' ' ' GLU . 96.3 mt -135.78 116.25 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.933 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 21.5 m-85 -108.11 171.07 7.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.488 HG23 ' CG2' ' A' ' 30' ' ' VAL . 7.3 p -112.36 87.39 2.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 74' ' ' PRO . 3.2 pt -52.03 -23.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 110.583 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' ILE . 5.2 mmtt -132.03 151.13 77.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.401 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.08 143.88 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.666 1.35 . . . . 0.0 110.292 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.0 mt -126.27 141.0 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.532 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.42 163.61 12.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 110.182 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 21' ' ' ARG . 4.8 mt -63.75 121.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 110.511 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.6 38.71 2.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -117.54 170.34 8.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -1.17 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -114.89 126.06 54.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.269 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.763 ' HB ' HG13 ' A' ' 18' ' ' VAL . 98.0 mt -96.59 127.21 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' ILE . 35.6 p -156.03 176.64 12.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 104' ' ' SER . 2.5 pp -147.91 155.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.667 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.887 ' O ' HD12 ' A' ' 103' ' ' ILE . 33.0 t -68.75 -149.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 110.464 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.417 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 83.0 m-85 -135.89 -69.43 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.449 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.63 -177.92 30.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -64.03 -40.41 96.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 110.404 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -61.22 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.417 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.4 OUTLIER -69.98 106.99 3.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.468 ' O ' ' CD2' ' A' ' 110' ' ' TRP . 63.6 p-90 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.638 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.295 0.569 . . . . 0.0 110.471 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -124.57 168.49 12.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 23.5 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 O-C-N 123.706 1.371 . . . . 0.0 110.533 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 25.7 p90 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.363 0.602 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.09 22.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.27 -22.1 6.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 110.627 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.501 ' C ' HG13 ' B' ' 6' ' ' VAL . 2.2 mmt85 -81.55 -41.2 21.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.59 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.501 HG13 ' C ' ' B' ' 5' ' ' ARG . 28.8 m -151.24 179.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.007 . . . . 0.0 110.559 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' B' ' 19' ' ' PHE . 9.4 tt -152.0 166.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.198 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.556 HG13 ' O ' ' B' ' 8' ' ' VAL . 12.6 p -104.67 125.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -0.951 . . . . 0.0 110.957 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 20.4 mttt -128.6 142.7 50.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.59 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mtpp 52.06 58.2 5.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.738 -1.852 . . . . 0.0 111.033 1.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.513 -0.742 . . . . 0.0 110.28 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -97.26 91.76 5.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 110.579 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -126.81 -168.9 12.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.778 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.6 p -112.82 125.8 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.937 -1.331 . . . . 0.0 109.685 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.659 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.5 OUTLIER -90.09 161.73 15.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 110.497 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' B' ' 101' ' ' ILE . . . -118.67 96.63 5.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.752 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -63.57 -19.96 65.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.867 178.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.534 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 14.2 mtpt -91.93 -179.94 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 109.799 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' B' ' 22' ' ' LYS 2.514 39.3 m 103.93 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.207 -1.558 . . . . 0.0 110.356 0.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 42.2 m-85 -109.48 168.61 9.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.404 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.59 -167.14 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.09 4.04 18.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.97 . . . . 0.0 110.9 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.35 86.7 0.12 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -151.05 147.97 27.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -1.168 . . . . 0.0 110.45 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.923 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.2 tm? -86.33 122.77 30.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.609 ' N ' HD13 ' B' ' 29' ' ' LEU . 59.4 t -81.85 -52.62 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.853 ' CG ' HD12 ' B' ' 89' ' ' ILE . 1.9 pt-20 -162.41 177.73 9.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.25 149.56 8.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.976 . . . . 0.0 110.517 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.21 -157.91 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 110.237 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.476 HD23 ' HG3' ' B' ' 86' ' ' ARG . 72.8 mt -109.08 -178.47 3.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.423 ' N ' ' O ' ' B' ' 85' ' ' LYS . 72.4 m -145.5 174.13 11.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.305 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.686 HD11 ' CD2' ' B' ' 62' ' ' LEU . 60.3 mt -116.12 125.18 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.792 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 84' ' ' LEU . 26.3 t -97.89 100.21 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.042 -1.036 . . . . 0.0 110.587 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.494 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 2.6 mmp_? -119.72 -172.15 2.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 36.7 m80 -104.07 -165.02 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.12 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 58.18 -137.54 0.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.912 -1.117 . . . . 0.0 110.413 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.43 -40.05 7.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.016 -1.053 . . . . 0.0 111.495 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.962 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 76.1 t-105 -57.69 -45.64 85.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 0.0 110.283 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.94 -21.92 73.67 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.97 -63.48 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.23 -55.56 33.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.482 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.916 ' HB3' HD13 ' B' ' 51' ' ' LEU . 3.9 mm? -89.53 52.43 2.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.244 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.33 57.44 3.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -76.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.491 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 5.0 m-85 -89.46 48.23 1.58 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.857 . . . . 0.0 109.424 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.962 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 6.0 tp -117.69 109.5 16.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.352 -0.842 . . . . 0.0 111.353 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -89.47 105.14 17.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.2 p -97.34 160.95 14.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 111.162 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.81 ' HB2' HD11 ' B' ' 84' ' ' LEU . 3.5 ttp180 -128.43 -174.88 3.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.535 -0.728 . . . . 0.0 109.99 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -80.0 84.41 5.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -0.954 . . . . 0.0 110.067 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.8 OUTLIER 153.0 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.41 -168.06 0.23 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.801 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.1 m -132.24 134.87 45.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -127.92 166.75 17.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.08 -1.013 . . . . 0.0 111.06 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.836 ' CE ' HD12 ' B' ' 47' ' ' LEU . 1.2 ttt -96.41 169.18 10.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.956 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.7 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.31 -55.02 4.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 111.487 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.93 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.499 0.0 OUTLIER 92.7 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.888 -1.133 . . . . 0.0 110.475 -179.181 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.85 -143.41 0.06 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.38 56.55 2.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -1.088 . . . . 0.0 110.362 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.7 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -89.73 -43.24 5.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.491 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -63.4 -47.6 81.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 110.396 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.814 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.8 pp -49.59 -22.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 111.448 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.814 ' N ' HD12 ' B' ' 67' ' ' ILE . 4.9 m-85 -50.23 113.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.701 -1.25 . . . . 0.0 110.43 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -102.06 -165.84 1.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -94.37 140.89 29.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.742 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.46 16.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.308 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -85.46 -19.56 31.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 110.49 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.47 74.86 53.07 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.14 -0.975 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.839 ' O ' HD11 ' B' ' 92' ' ' ILE . 32.3 Cg_exo -57.52 105.98 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.688 1.362 . . . . 0.0 110.494 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 76' ' ' ALA . 50.3 p-10 -85.05 -13.85 49.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.757 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.447 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -142.57 141.19 31.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.012 -1.055 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.07 -176.45 2.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.318 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -124.39 161.91 24.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.545 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.4 154.21 51.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.757 HD12 ' O ' ' B' ' 86' ' ' ARG . 44.4 tp -132.44 139.93 48.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.68 -168.95 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.93 107.88 18.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.463 ' O ' HG21 ' B' ' 37' ' ' VAL . . . 122.63 12.91 4.85 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.81 HD11 ' HB2' ' B' ' 54' ' ' ARG . 16.6 mt 52.38 32.85 11.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.862 -1.375 . . . . 0.0 110.462 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 35' ' ' CYS . 2.8 mmtp -100.21 -62.32 1.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 111.123 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.757 ' O ' HD12 ' B' ' 80' ' ' LEU . 2.3 ttt180 -97.47 162.28 13.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.994 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.62 147.58 27.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.583 ' HB3' HD21 ' B' ' 29' ' ' LEU . 36.2 mtt180 -132.0 171.97 12.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 110.324 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' B' ' 31' ' ' GLU . 96.3 mt -135.78 116.17 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.923 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 21.5 m-85 -108.16 171.1 7.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.491 HG23 ' CG2' ' B' ' 30' ' ' VAL . 7.3 p -112.4 87.42 2.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.839 HD11 ' O ' ' B' ' 74' ' ' PRO . 3.2 pt -52.15 -23.31 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.427 ' N ' HG13 ' B' ' 92' ' ' ILE . 5.2 mmtt -132.01 151.19 78.02 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -61.38 144.1 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.608 1.32 . . . . 0.0 110.213 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -126.31 141.04 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 110.531 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.44 163.6 12.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.752 HG23 ' O ' ' B' ' 21' ' ' ARG . 4.8 mt -63.79 121.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 110.545 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.7 2.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -117.5 170.36 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -1.179 . . . . 0.0 110.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.477 ' HG3' ' CE1' ' B' ' 19' ' ' PHE . 0.4 OUTLIER -114.88 126.15 54.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.778 ' HB ' HG13 ' B' ' 18' ' ' VAL . 97.8 mt -96.56 127.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.507 HG23 ' C ' ' B' ' 101' ' ' ILE . 35.1 p -155.95 176.74 12.25 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.889 HD12 ' O ' ' B' ' 104' ' ' SER . 2.5 pp -147.94 155.86 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 110.699 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.889 ' O ' HD12 ' B' ' 103' ' ' ILE . 33.0 t -68.74 -149.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 110.483 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.411 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 82.9 m-85 -135.89 -69.32 0.49 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 110.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.56 -177.97 29.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.98 -40.5 96.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 110.403 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -61.23 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.411 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.4 OUTLIER -70.05 107.1 3.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.475 ' O ' ' CD2' ' B' ' 110' ' ' TRP . 63.5 p-90 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.688 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.259 0.552 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -124.51 168.56 12.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 24.0 Cg_endo . . . . . 0 C--N 1.312 -1.393 0 O-C-N 123.723 1.38 . . . . 0.0 110.566 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 32.5 p90 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.357 0.599 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 5' ' ' ARG . 10.3 p30 -153.31 -172.57 4.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 111.02 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.68 -85.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.737 -0.602 . . . . 0.0 111.26 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.537 ' C ' HG23 ' A' ' 6' ' ' VAL . 7.3 mtm-85 -153.48 17.12 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.976 -1.078 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' C ' ' A' ' 5' ' ' ARG . 93.3 t -153.05 160.98 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.967 -1.083 . . . . 0.0 110.92 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.81 HG23 ' HB2' ' A' ' 19' ' ' PHE . 1.6 tt -124.02 154.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.64 141.06 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.796 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 10' ' ' LYS . 72.3 mttt -146.9 145.03 29.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.441 -0.787 . . . . 0.0 108.936 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.4 tppt? 52.4 80.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 119.629 -1.92 . . . . 0.0 110.273 2.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.346 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -118.44 83.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 110.355 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.3 -170.68 12.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.759 HG23 HD13 ' A' ' 67' ' ' ILE . 95.1 t -97.14 149.58 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.748 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.81 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.6 m-85 -114.83 121.89 44.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.426 -0.796 . . . . 0.0 109.286 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.57 86.99 6.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.125 -0.984 . . . . 0.0 111.009 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.824 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.19 -24.95 65.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.237 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 14.0 mttm -89.25 -179.73 5.93 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.47 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 102.4 20.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 119.953 -1.717 . . . . 0.0 109.808 2.589 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 3.8 m-85 -111.52 152.13 27.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.534 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -95.06 -165.14 1.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -95.62 120.23 35.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.62 5.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.99 128.61 46.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -1.152 . . . . 0.0 110.486 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.881 HD13 ' HG3' ' A' ' 88' ' ' ARG . 40.0 tp -53.28 164.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.932 . . . . 0.0 110.057 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.496 ' CG1' HG21 ' A' ' 6' ' ' VAL . 94.9 t -133.54 -71.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.36 66.44 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.519 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.568 ' HG2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.84 148.86 23.99 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.79 -165.59 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 110.408 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.35 160.1 15.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.865 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 53.4 m -134.41 -179.57 5.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.755 HD11 HD23 ' A' ' 62' ' ' LEU . 75.3 mt -113.35 151.34 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 84' ' ' LEU . 52.4 t -123.1 99.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -131.58 133.75 45.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 110.457 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.453 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -51.31 178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.977 . . . . 0.0 110.675 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 28.0 t30 -75.66 -132.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 0.0 110.423 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.93 -145.79 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.71 -1.244 . . . . 0.0 110.593 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.71 -28.06 0.94 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.194 -0.941 . . . . 0.0 111.394 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.67 ' HZ3' HD21 ' B' ' 47' ' ' LEU . 38.4 t-105 -57.34 -54.95 40.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 110.25 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 48' ' ' GLU . . . -67.23 -50.27 46.49 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.11 -44.19 42.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -1.159 . . . . 0.0 111.108 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 -49.27 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.553 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.97 ' HB2' HD11 ' A' ' 51' ' ' LEU . 4.1 mm? -91.42 28.22 1.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.93 . . . . 0.0 110.874 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 75.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.02 -1.05 . . . . 0.0 110.573 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -175.47 -37.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 110.95 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.839 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 39.4 m-85 -133.42 50.05 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.97 HD11 ' HB2' ' A' ' 47' ' ' LEU . 52.3 mt -124.11 131.02 53.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 111.423 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -91.2 105.93 18.15 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.7 p -87.78 111.43 21.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.114 -0.991 . . . . 0.0 111.058 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -177.16 3.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -0.76 . . . . 0.0 109.825 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -83.1 83.97 7.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.005 -1.059 . . . . 0.0 109.555 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.509 2.0 p-10 154.0 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.698 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -176.77 -160.64 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 110.673 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.421 ' O ' ' NE1' ' A' ' 43' ' ' TRP . 1.1 m -141.33 125.91 17.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.21 155.47 21.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 110.809 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.705 ' HA ' HD23 ' A' ' 51' ' ' LEU . 9.6 ttt -89.49 168.68 11.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.086 -1.009 . . . . 0.0 109.801 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.589 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.32 -24.89 27.48 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.241 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.755 HD23 HD11 ' A' ' 36' ' ' ILE 2.501 0.1 OUTLIER 62.49 -92.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 111.096 177.914 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.72 -144.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 93.0 m-85 -82.59 51.47 1.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -1.084 . . . . 0.0 110.829 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.589 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.73 -25.9 23.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.839 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.4 -43.87 10.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.691 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.967 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.5 pp -45.09 -23.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.553 -0.717 . . . . 0.0 112.083 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.967 ' N ' HD12 ' A' ' 67' ' ' ILE . 23.1 m-85 -55.17 142.21 31.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.61 -1.306 . . . . 0.0 109.775 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 102' ' ' THR . 82.7 m-20 -118.83 -169.46 1.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.03 . . . . 0.0 111.254 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -102.49 111.06 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 109.974 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.34 19.69 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 0.0 110.659 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt 52.62 23.33 2.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -174.38 65.24 0.28 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.055 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' O ' HD11 ' A' ' 92' ' ' ILE . 11.8 Cg_endo -59.63 83.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.632 1.333 . . . . 0.0 110.601 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.421 ' O ' ' CG1' ' A' ' 92' ' ' ILE . 22.1 m120 -59.12 -17.93 31.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -132.03 143.84 50.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.47 11.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 110.555 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -107.5 136.2 47.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.355 -0.841 . . . . 0.0 110.301 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 88' ' ' ARG . 32.9 tt0 -124.59 166.97 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.423 HD13 HD23 ' A' ' 84' ' ' LEU . 24.6 mt -126.24 147.96 49.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 86' ' ' ARG . 72.1 p -71.98 -79.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . . . -168.54 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.81 23.1 4.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 37' ' ' VAL . 43.7 mt 52.06 36.87 19.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -1.205 . . . . 0.0 110.512 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -104.52 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 110.751 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HB2' HG21 ' A' ' 81' ' ' THR . 8.1 mtt180 -84.88 179.29 7.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.976 . . . . 0.0 110.319 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.865 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.3 mtp -148.28 128.44 13.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.736 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.881 ' HG3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -114.38 106.16 13.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.44 -0.788 . . . . 0.0 110.091 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.48 113.27 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 109.929 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CE1' ' CD ' ' A' ' 88' ' ' ARG . 1.3 m-85 -101.93 177.17 4.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 p -113.92 99.32 7.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 110.028 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.492 HD12 ' CE ' ' A' ' 93' ' ' LYS . 4.2 pt -53.04 -22.21 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.135 -0.978 . . . . 0.0 110.399 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.492 ' CE ' HD12 ' A' ' 92' ' ' ILE . 45.1 mttt -148.24 146.75 23.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.16 -0.963 . . . . 0.0 110.175 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 93' ' ' LYS . 39.8 Cg_exo -56.84 129.41 34.44 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.673 1.354 . . . . 0.0 110.243 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' A' ' 20' ' ' ALA . 71.5 mt -104.76 148.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 110.594 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 167.35 11.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.575 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -71.32 123.41 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.503 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.85 39.97 2.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -124.65 -169.42 1.97 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -1.188 . . . . 0.0 110.381 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 23.7 tt0 -135.15 125.13 25.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 110.15 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.767 HG13 ' HB2' ' A' ' 20' ' ' ALA . 97.7 mt -89.39 137.99 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.533 HG23 ' C ' ' A' ' 101' ' ' ILE . 45.4 p -154.07 -174.2 4.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.651 -0.656 . . . . 0.0 110.073 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.572 HD12 ' O ' ' A' ' 104' ' ' SER . 1.5 pp -149.5 158.46 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.136 -0.977 . . . . 0.0 110.454 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' HD12 ' A' ' 103' ' ' ILE . 32.3 t -95.79 -164.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 12.8 m-85 -133.82 -66.61 0.63 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.211 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.04 -157.96 53.64 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 55.82 -86.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.948 . . . . 0.0 110.691 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.3 t0 -122.55 -31.41 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 110.644 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.5 m-85 -51.16 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.569 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 51.9 p-90 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.73 . . . . 0.0 110.695 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.206 0.527 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.54 170.22 11.66 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.38 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 C--N 1.312 -1.383 0 O-C-N 123.659 1.347 . . . . 0.0 110.507 -179.817 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.468 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 32.2 p90 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.356 0.598 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' B' ' 5' ' ' ARG . 10.4 p30 -155.1 -173.21 4.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 110.815 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 20.6 m-20 54.97 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.707 -0.621 . . . . 0.0 111.211 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.543 ' C ' HG23 ' B' ' 6' ' ' VAL . 7.3 mtm-85 -153.5 17.3 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.989 -1.069 . . . . 0.0 111.064 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.543 HG23 ' C ' ' B' ' 5' ' ' ARG . 94.1 t -153.08 160.98 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 0.0 110.98 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' B' ' 19' ' ' PHE . 1.6 tt -124.0 154.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.781 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.7 141.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 110.831 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' B' ' 10' ' ' LYS . 72.2 mttt -147.09 145.0 29.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 108.967 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.592 ' HB3' ' HA ' ' B' ' 9' ' ' LYS . 3.4 tppt? 52.41 80.62 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.539 -1.976 . . . . 0.0 110.356 2.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.408 ' OG ' ' HB3' ' B' ' 9' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -118.29 83.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -1.112 . . . . 0.0 110.36 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.56 -170.62 12.66 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.742 HG23 HD13 ' B' ' 67' ' ' ILE . 95.7 t -97.07 149.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.947 -1.325 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.796 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.6 m-85 -114.9 121.69 43.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.755 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.28 86.97 6.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 111.113 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.84 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 109.225 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.475 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 13.9 mttm -89.19 -179.64 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.475 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.0 OUTLIER 102.45 20.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 119.938 -1.726 . . . . 0.0 109.805 2.493 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' B' ' 5' ' ' ARG . 3.8 m-85 -111.45 152.13 27.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 110.615 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -95.04 -165.07 1.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.217 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -95.6 120.22 35.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.61 46.56 5.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.02 128.6 46.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -1.12 . . . . 0.0 110.508 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.885 HD13 ' HG3' ' B' ' 88' ' ' ARG . 39.7 tp -53.19 164.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.944 . . . . 0.0 110.089 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.494 ' CG1' HG21 ' B' ' 6' ' ' VAL . 94.8 t -133.57 -71.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.32 66.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.529 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.574 ' HG2' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -57.92 148.86 24.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 110.201 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.76 -165.58 2.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 160.22 15.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.858 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 53.8 m -134.48 -179.66 5.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 110.228 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.757 HD11 HD23 ' B' ' 62' ' ' LEU . 75.3 mt -113.25 151.28 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.058 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.497 HG22 ' O ' ' B' ' 84' ' ' LEU . 52.8 t -123.05 99.36 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.17 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.5 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -131.6 133.75 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 110.444 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.443 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.4 OUTLIER -51.34 178.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 110.669 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 28.0 t30 -75.64 -132.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.415 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.0 -145.93 0.45 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.828 -1.17 . . . . 0.0 110.525 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.56 -28.13 0.89 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.211 -0.931 . . . . 0.0 111.443 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.667 ' HZ3' HD21 ' A' ' 47' ' ' LEU . 38.2 t-105 -57.32 -55.0 40.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 110.228 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' B' ' 48' ' ' GLU . . . -67.2 -50.32 46.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.04 -44.24 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.293 -1.122 . . . . 0.0 111.099 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.13 -48.66 13.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -0.99 . . . . 0.0 110.6 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.976 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.1 mm? -92.15 28.33 1.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.706 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 76.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.007 -1.058 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.5 OUTLIER -175.48 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.892 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.844 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 39.3 m-85 -133.31 50.13 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.102 -0.998 . . . . 0.0 110.447 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.976 HD11 ' HB2' ' B' ' 47' ' ' LEU . 52.3 mt -124.17 131.21 53.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -91.42 104.9 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 85.9 p -86.24 111.44 20.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.102 -0.999 . . . . 0.0 111.327 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -179.91 4.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.436 -0.79 . . . . 0.0 109.878 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -79.01 83.63 5.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.512 2.0 p-10 153.89 -27.61 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.656 -0.652 . . . . 0.0 109.743 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.1 OUTLIER -176.57 -160.45 0.06 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.37 -0.831 . . . . 0.0 110.698 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.415 ' O ' ' NE1' ' B' ' 43' ' ' TRP . 1.1 m -141.33 126.03 17.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.946 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.36 155.29 21.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.704 ' HA ' HD23 ' B' ' 51' ' ' LEU . 9.6 ttt -89.56 166.85 13.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.569 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.59 -26.19 32.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.757 HD23 HD11 ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER 62.95 -92.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 111.125 178.568 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.68 -144.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 93.1 m-85 -82.65 51.87 1.97 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -1.082 . . . . 0.0 110.758 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.569 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.29 -25.61 23.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.844 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.77 -43.74 9.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -1.17 . . . . 0.0 110.683 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.977 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.5 pp -45.13 -23.56 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.571 -0.705 . . . . 0.0 112.069 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.977 ' N ' HD12 ' B' ' 67' ' ' ILE . 23.1 m-85 -55.06 142.47 30.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.544 -1.348 . . . . 0.0 109.792 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.411 ' O ' ' HB ' ' B' ' 102' ' ' THR . 82.4 m-20 -119.11 -169.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 111.184 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -103.09 110.95 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.2 19.56 13.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 110.629 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt 52.73 23.31 2.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 110.206 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' B' ' 75' ' ' ASN . 0.9 OUTLIER -174.41 65.28 0.28 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 110.012 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.505 ' O ' HD11 ' B' ' 92' ' ' ILE . 11.9 Cg_endo -59.56 83.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.68 1.358 . . . . 0.0 110.591 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' B' ' 92' ' ' ILE . 22.2 m120 -59.16 -17.88 31.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.733 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -132.08 143.8 50.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.46 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.575 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -107.45 136.06 47.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' B' ' 88' ' ' ARG . 32.8 tt0 -124.47 167.04 14.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 110.305 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.428 HD13 HD23 ' B' ' 84' ' ' LEU . 24.7 mt -126.24 147.94 49.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.513 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.525 HG21 ' HB2' ' B' ' 86' ' ' ARG . 71.7 p -71.94 -79.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.55 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.83 23.08 4.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 37' ' ' VAL . 44.0 mt 52.05 36.84 19.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.238 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -104.45 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.525 ' HB2' HG21 ' B' ' 81' ' ' THR . 8.1 mtt180 -84.86 179.24 7.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.307 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.858 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.3 mtp -148.3 128.47 13.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 0.0 110.733 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.885 ' HG3' HD13 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -114.5 105.93 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 110.116 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.07 113.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 110.05 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.524 ' CE1' ' CD ' ' B' ' 88' ' ' ARG . 1.3 m-85 -101.98 177.12 4.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.552 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.9 p -113.87 99.33 7.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.505 HD11 ' O ' ' B' ' 74' ' ' PRO . 4.2 pt -53.01 -22.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.392 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.487 ' CE ' HD12 ' B' ' 92' ' ' ILE . 45.1 mttt -148.16 146.68 23.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.193 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.77 129.42 34.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.633 1.333 . . . . 0.0 110.247 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' B' ' 20' ' ' ALA . 71.4 mt -104.73 148.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.598 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.3 167.29 11.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.85 . . . . 0.0 110.562 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.84 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -71.27 123.38 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 110.463 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.87 39.93 2.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -124.65 -169.39 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -1.177 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 23.7 tt0 -135.26 124.88 25.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.755 HG13 ' HB2' ' B' ' 20' ' ' ALA . 97.8 mt -88.92 137.96 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 110.35 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.534 HG23 ' C ' ' B' ' 101' ' ' ILE . 44.7 p -154.12 -174.13 4.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.527 -0.733 . . . . 0.0 110.02 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.57 HD12 ' O ' ' B' ' 104' ' ' SER . 1.5 pp -149.48 158.46 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 0.0 110.444 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.57 ' O ' HD12 ' B' ' 103' ' ' ILE . 32.3 t -95.8 -164.16 1.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.347 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.471 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 12.9 m-85 -133.88 -66.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.99 -157.92 53.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 106' ' ' GLY . 14.6 t0 55.8 -86.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.499 -1.0 . . . . 0.0 110.72 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 106' ' ' GLY . 10.3 t0 -122.58 -31.4 3.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 110.646 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.471 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.4 m-85 -51.13 96.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 110.585 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' B' ' 110' ' ' TRP . 52.0 p-90 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.807 . . . . 0.0 110.557 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.283 0.563 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -135.5 170.25 11.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.311 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 26.7 Cg_exo . . . . . 0 C--N 1.312 -1.388 0 O-C-N 123.714 1.376 . . . . 0.0 110.536 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 21.9 p90 . . . . . 0 N--CA 1.506 2.352 0 CA-C-O 121.475 0.655 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.93 144.97 25.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.27 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.61 -45.09 47.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.877 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.497 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -67.59 -37.89 83.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.937 . . . . 0.0 110.566 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG23 ' C ' ' A' ' 5' ' ' ARG . 56.2 t -150.22 141.04 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.43 ' CG2' ' HD2' ' A' ' 21' ' ' ARG . 14.7 tt -113.67 153.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 110.612 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 82.5 t -89.82 131.68 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 54.5 mttt -147.86 123.61 10.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.022 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.8 mptt 59.36 64.23 1.4 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 119.664 -1.898 . . . . 0.0 111.07 0.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 9' ' ' LYS . 1.2 t . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.339 -0.851 . . . . 0.0 110.622 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.473 ' CD2' ' HD3' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.82 88.64 2.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -1.159 . . . . 0.0 110.639 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.05 -171.27 12.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 67' ' ' ILE . 89.0 t -103.71 139.46 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.93 -1.335 . . . . 0.0 110.331 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 2.0 m-85 -109.44 124.6 51.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.747 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.761 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.85 97.52 11.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.29 -0.881 . . . . 0.0 111.137 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.748 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -68.39 -20.24 64.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 6.9 mttt -93.84 179.53 5.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.282 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.469 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 12.2 m 103.12 17.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.047 -1.658 . . . . 0.0 110.191 1.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 14.3 m-85 -112.03 165.5 12.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.557 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.33 -156.59 0.58 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 110.201 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 11.4 tttp -100.5 105.49 16.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.511 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.08 41.26 1.83 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.41 55.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -1.22 . . . . 0.0 110.444 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.818 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 tm? -64.28 124.31 21.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.383 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.715 ' CG2' HG23 ' A' ' 91' ' ' THR . 44.9 t -102.74 79.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 109.984 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.81 134.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -125.21 159.68 31.0 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.287 -0.883 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.4 -169.16 3.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 110.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.15 173.87 6.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 110.485 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -138.85 -173.73 3.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.952 ' CD1' HD23 ' A' ' 62' ' ' LEU . 50.0 mt -119.55 141.57 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.263 -0.898 . . . . 0.0 109.998 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 84' ' ' LEU . 91.8 t -111.68 122.38 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.962 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' CG ' ' CG ' ' A' ' 43' ' ' TRP . 27.1 tpt180 -150.11 131.92 15.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.398 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -53.5 -174.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.206 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.81 117.96 33.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.36 -0.838 . . . . 0.0 110.732 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.79 -141.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.76 -24.85 6.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.656 -1.277 . . . . 0.0 109.36 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 52.1 t-105 -56.59 -56.19 24.46 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.544 -0.722 . . . . 0.0 109.615 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.12 -28.39 70.54 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -72.96 -44.7 60.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -1.195 . . . . 0.0 110.679 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.4 -40.6 29.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.0 110.482 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.744 ' CB ' HD11 ' A' ' 51' ' ' LEU . 4.2 mm? -90.72 22.93 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 0.2 OUTLIER -64.64 78.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.101 -0.999 . . . . 0.0 110.454 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -169.18 -62.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.016 -1.052 . . . . 0.0 110.79 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.52 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 28.1 m-85 -121.98 55.84 1.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.057 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.744 HD11 ' CB ' ' A' ' 47' ' ' LEU . 15.5 mt -109.15 112.3 24.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 0.0 111.11 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.42 101.59 14.27 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.288 -0.882 . . . . 0.0 108.693 176.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.413 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 24.9 p -100.99 142.09 32.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -177.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.677 ' HD2' HD13 ' A' ' 84' ' ' LEU . 1.7 ttt180 -101.31 -170.96 1.91 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.479 -0.763 . . . . 0.0 109.844 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -83.43 80.76 8.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 36.4 t-20 155.29 -20.75 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.708 -0.62 . . . . 0.0 110.242 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.18 -177.58 1.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.968 -1.083 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.413 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -135.74 161.92 34.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 109.945 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.621 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -95.75 169.93 9.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.865 -1.147 . . . . 0.0 109.843 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.935 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -84.97 -14.91 46.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.714 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.952 HD23 ' CD1' ' A' ' 36' ' ' ILE 2.5 0.0 OUTLIER 61.1 -94.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 111.293 177.567 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -133.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.44 41.81 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.098 . . . . 0.0 110.747 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.935 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -81.05 -19.43 67.25 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -87.69 -51.16 6.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.0 110.656 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.7 pp -46.67 -24.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 111.491 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.62 ' N ' HD12 ' A' ' 67' ' ' ILE . 10.0 m-85 -52.56 142.02 19.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.642 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -96.88 96.53 8.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 110.022 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.5 m -115.22 143.04 45.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 110.513 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.95 136.48 57.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.21 2.95 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 92' ' ' ILE . 14.5 Cg_endo -61.01 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.685 1.361 . . . . 0.0 110.508 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 93' ' ' LYS . 50.7 m-80 -58.09 -19.44 32.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -123.53 150.19 44.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 0.0 110.567 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.568 ' HG3' HG21 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -128.32 -172.42 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 48.6 p-80 -135.46 156.26 49.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 110.644 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.94 124.24 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.616 HD12 ' HD2' ' C' ' 218' ' ' PRO . 13.3 mt -91.03 149.79 21.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 110.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 p -94.64 152.98 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.15 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.77 -5.79 3.74 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.279 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.794 ' HB3' HG22 ' A' ' 37' ' ' VAL . 1.8 tp 56.09 20.99 4.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.826 -1.396 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -22.29 19.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 111.085 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.57 157.96 45.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.901 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.78 138.09 49.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.765 . . . . 0.0 110.051 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' HIS . 4.6 mtt180 -116.55 151.32 36.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 110.616 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.533 ' O ' HD22 ' A' ' 29' ' ' LEU . 74.0 mt -125.88 121.24 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 15.6 m-85 -117.81 -170.14 1.81 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.454 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' CG2' ' A' ' 30' ' ' VAL . 1.1 p -131.51 93.84 3.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.893 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 74' ' ' PRO . 48.4 pt -51.07 -29.79 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.44 ' N ' HG13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -137.59 143.53 41.14 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 149.88 10.59 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.529 1.279 . . . . 0.0 110.669 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 20' ' ' ALA . 69.1 mt -122.52 150.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.727 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.01 161.91 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 110.155 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 21' ' ' ARG . 10.5 mt -65.82 96.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.249 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.23 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.452 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 35.0 mm-40 -116.94 168.46 10.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -1.104 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' OE1' HG21 ' A' ' 102' ' ' THR . 2.9 tm-20 -107.14 117.95 35.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.989 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.761 HG13 ' HB2' ' A' ' 20' ' ' ALA . 97.5 mt -89.63 128.22 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.515 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.522 HG23 ' C ' ' A' ' 101' ' ' ILE . 62.5 p -153.99 176.76 11.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.877 -0.514 . . . . 0.0 109.678 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -143.65 158.94 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 110.435 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -87.62 -158.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.32 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.47 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 34.1 m-85 -133.19 -59.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.06 -167.09 36.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.55 -34.2 77.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -1.136 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.359 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.47 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 2.1 m-85 -51.99 110.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.703 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 34.1 m95 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.9 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.271 0.558 . . . . 0.0 110.586 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.664 ' HB1' ' HG3' ' A' ' 54' ' ' ARG . . . -150.96 123.8 4.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.391 -0.818 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.616 ' HD2' HD12 ' A' ' 80' ' ' LEU . 38.2 Cg_exo . . . . . 0 C--N 1.314 -1.284 0 O-C-N 123.364 1.191 . . . . 0.0 110.568 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 21.9 p90 . . . . . 0 N--CA 1.506 2.339 0 CA-C-O 121.49 0.662 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.91 144.96 25.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.58 -45.12 47.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.495 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.2 OUTLIER -67.54 -37.94 83.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.586 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.495 HG23 ' C ' ' B' ' 5' ' ' ARG . 56.0 t -150.16 141.06 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 14.7 tt -113.66 153.04 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 110.645 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' B' ' 9' ' ' LYS . 82.9 t -89.7 131.76 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.629 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 54.4 mttt -148.05 123.73 10.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.629 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.8 mptt 59.49 64.17 1.39 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.726 -1.859 . . . . 0.0 111.037 0.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.64 179.257 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' B' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 88.67 2.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 110.588 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.01 -171.36 12.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' B' ' 67' ' ' ILE . 86.2 t -103.66 139.25 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.955 -1.321 . . . . 0.0 110.373 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 2.0 m-85 -109.41 124.57 51.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 109.759 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.773 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.78 97.54 11.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 111.14 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.742 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -68.4 -20.24 64.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.714 177.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.459 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 6.9 mttt -93.78 179.62 5.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.274 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.511 12.0 m 103.2 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.055 -1.653 . . . . 0.0 110.17 1.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.433 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 14.1 m-85 -112.1 165.56 12.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.138 -0.976 . . . . 0.0 110.573 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.38 -156.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 110.159 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.407 ' HG3' ' HA ' ' B' ' 93' ' ' LYS . 11.3 tttp -100.51 105.51 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 110.549 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.09 41.27 1.83 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.43 55.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 110.437 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.827 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.1 tm? -64.23 124.3 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 110.451 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' B' ' 91' ' ' THR . 45.1 t -102.78 79.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 110.017 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.85 134.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.511 -0.743 . . . . 0.0 110.741 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -125.22 159.63 31.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.428 -0.795 . . . . 0.0 109.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.53 -169.19 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.554 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' B' ' 86' ' ' ARG . 0.1 OUTLIER -112.24 173.89 6.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 110.521 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -138.81 -173.81 3.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.953 ' CD1' HD23 ' B' ' 62' ' ' LEU . 49.4 mt -119.49 141.52 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.0 110.002 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.8 HG22 ' HB3' ' B' ' 84' ' ' LEU . 91.6 t -111.62 122.41 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.964 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.507 ' HG2' ' CD2' ' B' ' 43' ' ' TRP . 27.1 tpt180 -150.17 131.82 14.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.0 110.477 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -53.44 -174.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 0.0 111.154 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.79 117.85 33.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.73 -141.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.7 -25.03 6.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.609 -1.307 . . . . 0.0 109.35 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.507 ' CD2' ' HG2' ' B' ' 38' ' ' ARG . 52.2 t-105 -56.49 -56.23 23.84 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.62 -0.675 . . . . 0.0 109.628 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.37 70.37 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.1 m -73.01 -44.76 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -1.155 . . . . 0.0 110.598 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.47 -40.28 30.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 110.464 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.746 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.2 mm? -91.14 23.16 3.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.583 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 0.2 OUTLIER -64.78 78.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 110.4 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.2 OUTLIER -169.14 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 110.79 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.513 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 28.2 m-85 -121.86 55.94 1.09 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.985 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' B' ' 47' ' ' LEU . 15.5 mt -109.19 112.35 24.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 111.208 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.49 101.47 14.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.71 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.409 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 24.8 p -100.86 142.09 32.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.441 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.683 ' HD2' HD13 ' B' ' 84' ' ' LEU . 1.7 ttt180 -101.79 -173.67 2.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.469 -0.77 . . . . 0.0 109.853 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -79.67 80.48 6.05 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 36.7 t-20 155.22 -20.96 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.621 -0.675 . . . . 0.0 110.231 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.09 -177.55 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 111.078 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 0.9 OUTLIER -123.88 143.06 50.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.536 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.562 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -135.8 161.92 34.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.005 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.613 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -96.28 167.97 10.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.985 179.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.956 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.03 -16.41 50.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 111.142 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.953 HD23 ' CD1' ' B' ' 36' ' ' ILE 2.501 0.0 OUTLIER 61.73 -94.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 111.29 178.221 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.25 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -88.53 41.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -1.104 . . . . 0.0 110.76 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.956 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -81.0 -19.49 67.25 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.513 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -87.71 -51.12 6.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.162 -1.199 . . . . 0.0 110.645 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.601 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.7 pp -46.62 -24.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.844 . . . . 0.0 111.528 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.601 ' N ' HD12 ' B' ' 67' ' ' ILE . 10.0 m-85 -52.51 142.02 18.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.857 -1.152 . . . . 0.0 110.351 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.957 . . . . 0.0 110.662 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -96.89 96.28 8.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 110.049 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 34.1 m -114.91 143.17 45.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.99 136.43 57.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.3 2.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.631 ' O ' HD11 ' B' ' 92' ' ' ILE . 14.7 Cg_endo -60.99 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.664 1.35 . . . . 0.0 110.536 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -58.11 -19.5 32.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.581 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -123.44 150.26 44.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.636 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.554 ' HG3' HG21 ' B' ' 92' ' ' ILE . 0.7 OUTLIER -128.39 -172.48 2.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 110.186 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 48.5 p-80 -135.39 156.21 49.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 0.0 110.675 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.93 124.33 17.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 110.187 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' D' ' 218' ' ' PRO . 13.4 mt -91.03 149.7 21.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.544 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 21.3 p -94.61 153.01 18.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.253 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.14 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 110.182 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.76 -5.87 3.75 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.24 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' B' ' 37' ' ' VAL . 1.8 tp 56.11 20.98 4.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.843 -1.387 . . . . 0.0 110.272 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.56 -22.16 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 111.091 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 0.0 OUTLIER -134.62 157.98 45.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.034 -1.041 . . . . 0.0 110.913 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.74 138.01 49.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.071 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' B' ' 78' ' ' HIS . 4.6 mtt180 -116.47 151.38 36.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 110.68 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.527 ' O ' HD22 ' B' ' 29' ' ' LEU . 73.4 mt -125.85 121.16 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.882 . . . . 0.0 109.95 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.827 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 15.6 m-85 -117.75 -170.15 1.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.491 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.72 HG23 ' CG2' ' B' ' 30' ' ' VAL . 1.1 p -131.5 93.88 3.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.891 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.631 HD11 ' O ' ' B' ' 74' ' ' PRO . 48.2 pt -51.03 -29.83 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.681 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.445 ' N ' HG13 ' B' ' 92' ' ' ILE . 1.0 OUTLIER -137.6 143.57 41.26 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 110.361 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.05 149.9 11.01 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.596 1.314 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.486 HG21 ' CB ' ' B' ' 20' ' ' ALA . 69.1 mt -122.53 150.55 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.98 161.93 13.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.395 -0.816 . . . . 0.0 110.127 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.742 HG23 ' O ' ' B' ' 21' ' ' ARG . 10.6 mt -65.89 96.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.21 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.447 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 34.9 mm-40 -117.0 168.44 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -1.17 . . . . 0.0 110.402 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.417 ' OE1' HG21 ' B' ' 102' ' ' THR . 2.9 tm-20 -107.07 117.95 35.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.912 . . . . 0.0 110.042 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.773 HG13 ' HB2' ' B' ' 20' ' ' ALA . 96.9 mt -89.53 128.25 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.513 HG23 ' C ' ' B' ' 101' ' ' ILE . 61.3 p -153.98 176.85 11.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.716 -0.615 . . . . 0.0 109.67 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.659 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -143.63 158.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.659 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.2 OUTLIER -87.7 -158.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 34.1 m-85 -133.21 -59.68 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.98 -167.13 36.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.49 -34.27 77.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 0.0 110.356 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.474 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 2.1 m-85 -52.03 110.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.728 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.44 ' N ' ' CD1' ' B' ' 110' ' ' TRP . 34.1 m95 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.878 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.283 0.563 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.673 ' HB1' ' HG3' ' B' ' 54' ' ' ARG . . . -150.89 123.75 4.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' B' ' 80' ' ' LEU . 37.7 Cg_exo . . . . . 0 C--N 1.314 -1.283 0 O-C-N 123.322 1.169 . . . . 0.0 110.539 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.464 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 10.0 p90 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.348 0.594 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 5' ' ' ARG . 42.5 t30 -145.93 162.58 37.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.85 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.539 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.498 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER 178.33 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.414 -0.804 . . . . 0.0 109.414 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG11 ' CG1' ' A' ' 30' ' ' VAL . 18.9 m -155.4 179.98 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 109.727 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.44 166.58 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 110.04 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 8' ' ' VAL . 7.6 p -108.39 144.78 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.784 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 4.9 mttt -140.84 142.72 34.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.617 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.3 56.99 6.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.663 -1.898 . . . . 0.0 110.6 2.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.629 -0.67 . . . . 0.0 109.988 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 2.5 m-85 -106.2 77.93 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -1.216 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -114.97 -165.0 14.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.542 ' HB ' HD13 ' A' ' 67' ' ' ILE . 1.5 p -117.75 130.02 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.927 -1.337 . . . . 0.0 108.839 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -89.77 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 111.06 -177.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -107.0 96.23 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -0.764 . . . . 0.0 110.385 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 97' ' ' ILE . 12.0 ttt-85 -70.14 -18.31 63.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -97.54 177.96 5.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.531 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.447 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.515 50.6 m 106.48 21.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.097 -1.627 . . . . 0.0 110.12 1.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 20.3 m-85 -114.47 155.21 26.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.395 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.43 ' O ' ' CA ' ' A' ' 94' ' ' PRO . 1.1 mt-10 -88.17 -82.81 0.22 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.798 . . . . 0.0 109.885 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 24.5 tttt -175.91 92.19 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.924 -1.11 . . . . 0.0 110.012 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.67 19.34 4.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -97.59 152.36 19.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.235 . . . . 0.0 110.307 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.857 HD21 ' HB3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -78.02 121.55 24.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 110.379 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.606 ' CG2' HG23 ' A' ' 91' ' ' THR . 88.6 t -84.64 -46.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.65 145.37 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 110.201 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -128.76 149.39 50.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.425 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.435 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 64.5 m -140.91 -154.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 110.123 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -110.35 175.94 5.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 110.623 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.1 m -147.23 164.34 33.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.409 -0.807 . . . . 0.0 109.592 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.045 HD11 HD23 ' A' ' 62' ' ' LEU . 22.4 mt -108.14 141.75 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 109.985 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 84' ' ' LEU . 61.0 t -117.31 120.97 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 110.537 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 21.7 tpt180 -148.82 143.21 26.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.445 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.33 -169.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.46 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.808 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -162.62 -136.14 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' B' ' 42' ' ' ASP . 72.5 m-20 -51.63 -25.12 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 109.518 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.638 ' CZ3' HD21 ' B' ' 47' ' ' LEU . 34.3 t-105 -58.52 -56.59 20.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.585 -0.697 . . . . 0.0 109.462 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.84 -34.21 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.8 m -70.82 -67.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 110.404 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.53 -51.72 58.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 110.538 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.667 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.4 mm? -90.39 39.57 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 110.62 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 61.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.775 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -179.5 140.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.236 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 9.7 m-85 61.41 31.92 19.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.248 -0.908 . . . . 0.0 110.448 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 60' ' ' MET . 15.3 mt -106.3 134.57 49.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -108.88 103.33 12.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 12.0 t -89.54 127.63 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 0.0 111.553 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.595 ' CD ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -101.91 -174.48 2.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.539 -0.725 . . . . 0.0 109.752 178.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.36 73.88 9.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.016 -1.053 . . . . 0.0 109.124 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.505 5.2 t30 169.92 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.878 -0.514 . . . . 0.0 109.988 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -176.15 -168.13 0.25 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.261 -0.899 . . . . 0.0 110.952 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 1.3 p -116.58 138.8 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.17 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.73 ' HB2' HD13 ' A' ' 84' ' ' LEU . . . -131.59 168.09 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 110.375 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.667 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -105.84 172.92 6.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 109.857 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.892 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.23 -35.61 21.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.045 HD23 HD11 ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.09 -94.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 111.288 178.128 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -70.3 -118.91 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -90.35 27.34 1.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.345 -1.091 . . . . 0.0 110.934 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.892 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -77.43 -22.6 69.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -90.94 -47.37 7.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.542 HD13 ' HB ' ' A' ' 18' ' ' VAL . 2.4 pp -47.66 -25.88 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.208 -0.932 . . . . 0.0 110.789 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CG ' HG12 ' A' ' 103' ' ' ILE . 6.5 m-85 -46.39 113.25 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -92.3 179.19 5.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 110.87 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -101.77 116.91 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.828 . . . . 0.0 109.882 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.11 130.71 51.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.373 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -52.62 -23.71 7.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 110.329 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.56 71.52 0.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 110.368 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.797 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.8 Cg_endo -64.54 112.12 1.85 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.648 1.341 . . . . 0.0 110.312 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.413 ' HA ' ' HE2' ' A' ' 93' ' ' LYS . 18.9 m-20 -111.32 18.49 19.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 110.616 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.7 162.56 40.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.0 ttt-85 -146.03 158.55 43.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.479 ' ND1' HD13 ' A' ' 103' ' ' ILE . 19.5 p-80 -110.09 158.78 17.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -141.35 142.63 33.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' A' ' 87' ' ' MET . 6.6 mt -106.75 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -90.08 68.2 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.15 34.41 11.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.24 171.68 38.77 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.73 HD13 ' HB2' ' A' ' 59' ' ' ALA . 85.4 mt -93.45 32.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -1.148 . . . . 0.0 109.998 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -93.34 -71.76 0.64 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.331 -0.856 . . . . 0.0 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.68 159.52 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.451 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 1.1 tmm? -142.47 138.77 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.569 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.857 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -121.08 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -0.96 . . . . 0.0 110.124 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.05 124.4 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.664 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 17.7 m-85 -113.35 -176.5 2.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.606 HG23 ' CG2' ' A' ' 30' ' ' VAL . 18.4 p -124.93 95.78 4.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.797 HD11 ' O ' ' A' ' 74' ' ' PRO . 30.7 pt -51.16 -24.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.6 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 0.5 OUTLIER -145.68 157.05 52.21 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.43 ' CA ' ' O ' ' A' ' 25' ' ' GLU . 23.9 Cg_exo -59.12 147.19 91.63 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.738 1.388 . . . . 0.0 111.179 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.417 HG21 ' CB ' ' A' ' 20' ' ' ALA . 66.8 mt -131.7 145.29 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.606 -0.684 . . . . 0.0 110.33 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.25 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.373 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -66.97 112.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.36 26.09 2.51 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -113.69 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.241 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 85.7 tt0 -116.47 135.9 53.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 110.631 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.961 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 39.2 mt -99.89 125.95 53.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.748 0.785 . . . . 0.0 110.521 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.9 p -154.73 171.57 19.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.761 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -146.96 165.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.098 . . . . 0.0 110.655 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.761 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -88.75 -164.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CD2' ' NE1' ' A' ' 110' ' ' TRP . 17.3 m-85 -123.47 -66.25 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.041 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.58 153.92 9.79 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.25 -24.33 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -1.166 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -55.1 4.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 110.064 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -71.56 60.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 110.661 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.467 ' NE1' ' CD2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.24 -0.913 . . . . 0.0 110.317 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.285 0.564 . . . . 0.0 110.402 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -116.62 167.93 9.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 16.2 Cg_endo . . . . . 0 C--N 1.311 -1.406 0 O-C-N 123.696 1.366 . . . . 0.0 110.534 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.0 p90 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.272 0.558 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' B' ' 5' ' ' ARG . 42.5 t30 -145.92 162.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.223 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.9 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.432 -0.792 . . . . 0.0 110.537 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.494 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.9 OUTLIER 178.36 -35.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.395 -0.816 . . . . 0.0 109.404 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.601 HG11 HG13 ' B' ' 30' ' ' VAL . 18.9 m -155.37 -179.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.494 -0.754 . . . . 0.0 109.791 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.45 166.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.31 144.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 110.816 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.605 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 5.0 mttt -140.83 142.8 34.56 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.605 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.31 56.97 6.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 119.703 -1.873 . . . . 0.0 110.626 2.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.415 ' N ' ' HB3' ' B' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 110.007 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 2.5 m-85 -106.22 78.11 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 110.541 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -115.22 -165.27 14.66 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' B' ' 67' ' ' ILE . 1.6 p -117.39 129.8 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.295 . . . . 0.0 109.153 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.493 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.6 OUTLIER -89.76 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 111.088 -177.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.956 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -106.99 96.1 6.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.38 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.651 ' O ' HG23 ' B' ' 97' ' ' ILE . 11.9 ttt-85 -70.06 -18.37 63.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 110.027 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -97.44 178.08 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.452 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 50.8 m 106.53 21.27 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.066 -1.646 . . . . 0.0 110.112 1.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 20.4 m-85 -114.69 154.48 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.527 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.43 ' O ' ' CA ' ' B' ' 94' ' ' PRO . 1.2 mt-10 -87.23 -83.07 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' B' ' 25' ' ' GLU . 24.7 tttt -175.8 92.17 0.05 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.921 -1.112 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.68 19.37 4.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -97.62 152.35 19.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.268 . . . . 0.0 110.297 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' B' ' 88' ' ' ARG . 0.8 OUTLIER -78.04 121.55 24.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.442 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.601 HG13 HG11 ' B' ' 6' ' ' VAL . 88.4 t -84.65 -46.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 110.163 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.69 145.35 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 110.192 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.69 149.4 50.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.962 . . . . 0.0 110.435 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.441 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 64.3 m -140.91 -154.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.13 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.31 175.96 5.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 110.645 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 11.9 m -147.33 164.26 33.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.453 -0.779 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 1.048 HD11 HD23 ' B' ' 62' ' ' LEU . 22.2 mt -108.07 141.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.001 -1.062 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' B' ' 84' ' ' LEU . 61.1 t -117.28 120.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.515 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.502 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 21.6 tpt180 -148.76 143.24 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.36 -169.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.45 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.735 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -162.63 -136.23 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 72.4 m-20 -51.53 -25.16 6.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.557 -1.339 . . . . 0.0 109.571 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.589 ' CZ3' HD21 ' A' ' 47' ' ' LEU . 34.3 t-105 -58.51 -56.58 20.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.555 -0.715 . . . . 0.0 109.481 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.85 -34.19 64.78 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 48.0 m -70.76 -67.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -1.144 . . . . 0.0 110.433 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.403 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . . . -52.71 -51.45 60.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.671 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.4 mm? -90.63 39.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.36 61.28 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.746 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.478 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -179.51 140.18 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 9.7 m-85 61.31 32.02 19.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.306 -0.871 . . . . 0.0 110.369 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' B' ' 60' ' ' MET . 15.2 mt -106.23 134.81 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.986 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -109.17 103.04 11.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -89.09 127.62 35.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.068 -1.02 . . . . 0.0 111.597 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.585 ' CD ' HD21 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -102.59 -177.56 3.42 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.577 -0.702 . . . . 0.0 109.832 178.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.95 73.37 4.51 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 110.129 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 5.4 t30 169.8 -30.8 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.721 -0.612 . . . . 0.0 109.994 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.97 -167.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.3 p -116.61 138.73 51.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.214 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.735 ' HB2' HD13 ' B' ' 84' ' ' LEU . . . -131.62 168.03 18.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.444 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.671 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -106.18 170.95 7.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.914 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.31 -36.96 26.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 111.126 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 1.048 HD23 HD11 ' B' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.64 -94.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.0 111.271 178.765 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -70.34 -118.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -90.56 27.33 1.76 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -1.092 . . . . 0.0 110.933 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.914 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -77.46 -22.22 70.73 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -91.61 -47.14 7.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.121 -1.223 . . . . 0.0 110.823 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' B' ' 18' ' ' VAL . 2.4 pp -47.75 -25.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.266 -0.897 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.51 ' CG ' HG12 ' B' ' 103' ' ' ILE . 6.5 m-85 -46.38 113.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 111.138 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -92.34 179.41 5.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.812 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -102.03 116.84 33.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.4 -0.812 . . . . 0.0 109.845 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.01 130.78 51.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.193 -0.942 . . . . 0.0 110.417 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -52.61 -23.77 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.58 71.5 0.92 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.318 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.799 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.4 Cg_endo -64.38 112.01 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.685 1.361 . . . . 0.0 110.266 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 19.1 m-20 -111.29 18.51 19.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.395 -0.815 . . . . 0.0 110.478 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.67 162.59 40.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.54 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.47 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.0 ttt-85 -146.11 158.45 43.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.16 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.48 ' ND1' HD13 ' B' ' 103' ' ' ILE . 19.5 p-80 -110.0 158.81 17.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.38 142.67 33.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.281 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' B' ' 87' ' ' MET . 6.6 mt -106.76 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.445 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.4 p -90.05 68.16 7.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.18 34.34 11.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.399 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.26 171.68 38.78 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.735 HD13 ' HB2' ' B' ' 59' ' ' ALA . 85.2 mt -93.41 32.29 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.248 -1.148 . . . . 0.0 110.08 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -93.57 -71.66 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.56 14.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.499 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.445 ' HG2' ' CD2' ' B' ' 80' ' ' LEU . 1.0 OUTLIER -142.57 138.75 31.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.563 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.855 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -121.1 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 110.114 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.04 124.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.495 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.662 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 17.8 m-85 -113.24 -176.52 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.344 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.593 HG23 ' CG2' ' B' ' 30' ' ' VAL . 18.3 p -124.94 95.91 4.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.097 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.799 HD11 ' O ' ' B' ' 74' ' ' PRO . 30.5 pt -51.16 -24.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 110.572 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 0.5 OUTLIER -145.63 157.17 52.19 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.177 -0.952 . . . . 0.0 110.551 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.43 ' CA ' ' O ' ' B' ' 25' ' ' GLU . 24.1 Cg_exo -59.5 147.33 92.0 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.704 1.37 . . . . 0.0 111.111 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.427 HG21 ' CB ' ' B' ' 20' ' ' ALA . 67.1 mt -131.67 145.4 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.577 -0.702 . . . . 0.0 110.308 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.28 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -66.95 112.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 110.348 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 26.11 2.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -113.7 179.45 3.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -1.226 . . . . 0.0 110.034 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' B' ' 19' ' ' PHE . 85.6 tt0 -116.3 136.03 53.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.045 . . . . 0.0 110.568 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.956 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 40.6 mt -99.98 126.06 53.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.471 -0.768 . . . . 0.0 110.538 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.501 HG23 ' O ' ' B' ' 101' ' ' ILE . 16.6 p -154.69 171.72 19.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.755 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -147.0 165.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.927 -1.108 . . . . 0.0 110.669 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.755 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.4 OUTLIER -88.8 -164.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.422 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.47 ' CD2' ' NE1' ' B' ' 110' ' ' TRP . 17.3 m-85 -123.1 -66.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.52 153.96 9.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.22 -24.41 4.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -55.11 4.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -71.52 60.32 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 110.693 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.47 ' NE1' ' CD2' ' B' ' 105' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.303 0.573 . . . . 0.0 110.432 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -116.64 168.0 9.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 16.3 Cg_endo . . . . . 0 C--N 1.312 -1.37 0 O-C-N 123.696 1.366 . . . . 0.0 110.561 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 21.8 p90 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.32 0.581 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.83 156.04 49.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.14 -18.45 15.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.791 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.514 ' C ' HG13 ' A' ' 6' ' ' VAL . 2.1 mtm-85 -97.6 -29.03 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 110.914 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.514 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.1 m -153.45 -172.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 110.415 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 19' ' ' PHE . 13.6 tt -154.81 165.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 110.205 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.77 137.83 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.98 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 31.1 mttt -142.21 143.64 33.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.588 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER 52.73 66.21 1.29 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.757 -1.839 . . . . 0.0 111.161 1.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.457 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.568 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -102.58 73.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.247 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.71 -165.22 23.4 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.713 HG13 ' HB ' ' A' ' 101' ' ' ILE . 1.9 p -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.951 -1.323 . . . . 0.0 109.553 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.1 m-85 -89.79 158.55 17.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.564 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.692 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -113.09 105.32 13.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 110.645 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -63.71 -28.45 69.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.516 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 5.3 mttm -86.5 -178.36 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.46 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.507 4.8 t 99.53 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.031 -1.668 . . . . 0.0 110.493 1.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 22.2 m-85 -96.83 158.63 15.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.047 -1.033 . . . . 0.0 110.893 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 -155.69 0.48 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.479 -0.763 . . . . 0.0 110.011 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 58.8 tttt -95.94 30.88 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.27 86.21 0.06 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -150.07 124.6 9.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 110.337 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.812 HD23 ' CG ' ' A' ' 88' ' ' ARG . 3.4 tm? -54.34 119.96 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.3 -52.72 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 31' ' ' GLU . 8.6 pt-20 -170.73 97.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.25 152.24 34.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -150.36 -151.22 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.77 171.93 7.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 1.03 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 1.3 m -150.14 150.42 31.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.627 HD11 ' CD2' ' A' ' 62' ' ' LEU . 56.2 mt -91.18 142.71 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 84' ' ' LEU . 42.0 t -117.63 127.91 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 110.769 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.524 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 19.2 mmt180 -150.36 178.2 9.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -92.14 -173.73 3.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.111 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.57 -141.93 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.407 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.74 -135.02 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.06 -1.025 . . . . 0.0 110.826 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.63 -49.06 7.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 111.521 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 1.019 ' NE1' HD21 ' A' ' 51' ' ' LEU . 36.8 t-105 -51.54 -46.71 63.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.26 76.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.414 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 44.9 m -74.46 -59.96 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -1.216 . . . . 0.0 110.826 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' O ' ' NH2' ' B' ' 38' ' ' ARG . . . -50.69 -54.48 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.639 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.023 HD21 HD21 ' B' ' 47' ' ' LEU . 3.1 mm? -91.91 23.3 3.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.0 pp20? -50.67 154.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.952 -1.092 . . . . 0.0 110.005 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 54.9 t0 60.86 147.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.778 . . . . 0.0 110.164 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.28 13.68 7.18 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.145 -0.972 . . . . 0.0 110.303 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.019 HD21 ' NE1' ' A' ' 43' ' ' TRP . 8.9 tp -112.52 107.79 16.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.87 119.06 29.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -109.27 136.0 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 0.0 111.066 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.747 ' HD3' HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -102.29 -172.04 2.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.391 -0.818 . . . . 0.0 109.806 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.03 72.91 9.09 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.958 -1.089 . . . . 0.0 108.967 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 6.3 m120 175.08 -33.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.458 ' HG2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.59 -173.51 0.33 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.352 -0.842 . . . . 0.0 110.331 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -112.75 146.92 37.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -141.8 151.64 43.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.618 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.686 ' HA ' HD12 ' A' ' 51' ' ' LEU . 29.3 tpp -90.17 156.77 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.811 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.83 93.39 9.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.973 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.497 0.1 OUTLIER -54.53 -65.5 0.56 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 110.427 179.194 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -60.69 -159.49 0.07 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' HB3' HD11 ' A' ' 67' ' ' ILE . 5.1 m-85 -75.36 58.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -1.091 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.16 -36.34 7.16 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.7 73.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 110.661 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.693 HD13 ' HB ' ' A' ' 18' ' ' VAL . 1.2 pp -51.84 -34.44 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.188 -0.945 . . . . 0.0 111.24 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HB3' ' CG1' ' A' ' 103' ' ' ILE . 11.8 m-85 -49.96 119.9 3.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.986 -1.071 . . . . 0.0 110.697 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.421 ' H ' HG22 ' A' ' 102' ' ' THR . 76.4 m-20 -95.52 176.46 6.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.404 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -95.39 107.57 19.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.4 t -115.65 129.98 56.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -53.6 -26.37 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.26 76.52 0.4 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.857 . . . . 0.0 110.052 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.93 ' O ' HD11 ' A' ' 92' ' ' ILE . 17.0 Cg_endo -62.32 104.37 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.719 1.379 . . . . 0.0 110.656 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 92' ' ' ILE . 70.6 m-20 -94.38 -19.82 20.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 110.383 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' THR . . . -125.71 178.0 5.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.625 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -149.56 168.18 24.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.409 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.894 ' ND1' HD13 ' A' ' 103' ' ' ILE . 33.5 p-80 -121.42 127.06 50.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 26.8 tt0 -109.17 172.44 6.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.747 HD13 ' HD3' ' A' ' 54' ' ' ARG . 6.0 mt -121.63 146.13 47.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 110.487 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 37.2 m -117.07 144.7 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.484 -0.76 . . . . 0.0 110.273 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . . . 52.93 34.03 15.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.03 -95.65 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -124.12 26.58 7.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -1.15 . . . . 0.0 110.219 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.79 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 1.2 mmtp -89.79 -73.12 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 110.482 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.436 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -102.17 177.84 4.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.41 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 1.03 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 64.5 mtp -136.91 150.51 48.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 110.369 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.812 ' CG ' HD23 ' A' ' 29' ' ' LEU . 15.1 ttm180 -133.5 104.41 6.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.93 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 77' ' ' ARG . 6.2 mt -89.08 140.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.964 . . . . 0.0 110.314 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 88' ' ' ARG . 1.7 m-85 -129.53 -168.11 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 26.4 p -125.36 97.1 5.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.93 HD11 ' O ' ' A' ' 74' ' ' PRO . 49.3 pt -59.87 -17.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.534 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 13.5 mtmt -143.43 134.73 12.67 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 110.005 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.59 135.49 16.48 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.49 1.258 . . . . 0.0 111.255 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 20' ' ' ALA . 80.6 mt -115.71 142.38 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.5 163.33 15.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' A' ' 21' ' ' ARG . 28.1 mt -65.07 115.11 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -0.81 . . . . 0.0 110.409 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.06 40.85 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.6 177.6 4.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.138 . . . . 0.0 110.347 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.58 30.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.463 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.713 ' HB ' HG13 ' A' ' 18' ' ' VAL . 62.8 mt -90.31 124.85 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 110.395 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 101' ' ' ILE . 17.5 p -157.51 135.92 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.894 HD13 ' ND1' ' A' ' 78' ' ' HIS . 1.1 pp -100.85 170.44 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.965 -1.084 . . . . 0.0 110.447 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.619 ' O ' HD12 ' A' ' 103' ' ' ILE . 89.4 p -105.63 -166.83 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.478 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 109' ' ' TYR . 12.4 m-85 -123.58 -58.56 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.57 160.32 0.44 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.6 OUTLIER 57.45 109.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.434 -1.039 . . . . 0.0 110.977 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 107' ' ' ASP . 16.5 t0 57.57 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.844 -0.535 . . . . 0.0 111.768 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -43.34 111.03 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.311 -0.868 . . . . 0.0 111.706 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 111.019 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.273 0.559 . . . . 0.0 110.339 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.33 16.51 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.943 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 C--N 1.314 -1.287 0 O-C-N 123.571 1.301 . . . . 0.0 110.538 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 21.6 p90 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.383 0.611 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.78 156.13 49.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.295 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.18 -18.44 15.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.764 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' B' ' 6' ' ' VAL . 2.1 mtm-85 -97.66 -29.08 13.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.884 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.0 m -153.4 -172.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.635 HG23 ' HB2' ' B' ' 19' ' ' PHE . 13.7 tt -154.79 165.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.95 . . . . 0.0 110.23 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.414 ' H ' HG12 ' B' ' 8' ' ' VAL . 7.2 p -99.79 137.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 110.726 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 31.1 mttt -142.17 143.72 33.1 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.604 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.0 OUTLIER 52.77 66.3 1.26 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.861 -1.774 . . . . 0.0 111.083 1.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.455 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.568 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -102.52 73.3 1.3 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -1.231 . . . . 0.0 110.641 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -105.68 -165.33 23.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.71 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.0 p -121.69 130.72 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.322 . . . . 0.0 109.674 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.635 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.1 m-85 -89.83 158.5 17.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 110.528 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -113.18 105.39 13.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 110.581 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.2 OUTLIER -63.7 -28.39 69.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.459 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 5.3 mttm -86.54 -178.36 6.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.506 4.8 t 99.53 10.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 119.958 -1.714 . . . . 0.0 110.5 1.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 22.1 m-85 -96.69 158.67 15.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.064 -1.022 . . . . 0.0 110.921 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.09 -155.69 0.48 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.464 -0.773 . . . . 0.0 110.016 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.412 ' HG3' ' HA ' ' B' ' 93' ' ' LYS . 58.7 tttt -95.93 30.84 2.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.29 86.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -150.17 124.6 9.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.811 HD23 ' CG ' ' B' ' 88' ' ' ARG . 3.4 tm? -54.36 119.95 5.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 95.1 t -81.26 -52.73 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.841 . . . . 0.0 110.372 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' B' ' 31' ' ' GLU . 8.6 pt-20 -170.73 97.46 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 152.4 34.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.45 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.3 OUTLIER -150.55 -151.33 0.39 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.645 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.7 171.96 7.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.521 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 1.034 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 1.3 m -150.18 150.36 31.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.63 HD11 ' CD2' ' B' ' 62' ' ' LEU . 55.8 mt -91.04 142.77 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' B' ' 84' ' ' LEU . 42.1 t -117.67 128.01 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 110.745 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 19.1 mmt180 -150.5 178.18 9.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.7 OUTLIER -92.11 -173.73 3.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 110.106 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.6 -141.95 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.35 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.75 -135.05 0.8 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.129 -0.982 . . . . 0.0 110.805 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.59 -49.1 7.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.001 -1.062 . . . . 0.0 111.506 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 1.022 ' NE1' HD21 ' B' ' 51' ' ' LEU . 36.9 t-105 -51.53 -46.7 63.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 110.046 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.27 76.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 44.9 m -74.47 -59.88 2.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.138 -1.213 . . . . 0.0 110.808 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -53.67 30.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 0.0 110.656 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 1.023 HD21 HD21 ' A' ' 47' ' ' LEU . 3.2 mm? -93.0 23.63 4.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 110.603 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' B' ' 45' ' ' THR . 2.0 pp20? -50.76 154.52 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.033 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' B' ' 48' ' ' GLU . 54.2 t0 60.91 147.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.504 -0.747 . . . . 0.0 110.177 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.2 13.73 7.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.115 -0.991 . . . . 0.0 110.18 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 1.022 HD21 ' NE1' ' B' ' 43' ' ' TRP . 8.9 tp -112.6 107.81 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 110.936 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.85 119.08 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.564 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 42.6 t -109.25 135.93 49.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -0.99 . . . . 0.0 111.094 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.727 ' HD3' HD13 ' B' ' 80' ' ' LEU . 0.9 OUTLIER -102.93 -175.19 2.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.74 . . . . 0.0 109.808 178.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.46 72.3 4.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -0.962 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 6.3 m120 175.02 -33.51 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.45 ' HG2' ' CD2' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.3 -173.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.347 -0.845 . . . . 0.0 110.391 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -112.74 146.89 37.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -141.74 151.62 43.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.688 ' HA ' HD12 ' B' ' 51' ' ' LEU . 29.3 tpp -90.32 155.93 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.818 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -86.65 93.4 9.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.851 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.497 0.1 OUTLIER -54.93 -65.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.369 179.246 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.7 -159.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' B' ' 67' ' ' ILE . 5.1 m-85 -75.4 59.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.818 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -90.34 -36.27 7.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.68 73.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 110.658 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' B' ' 18' ' ' VAL . 1.2 pp -51.87 -34.4 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 0.0 111.246 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.462 ' HB3' ' CG1' ' B' ' 103' ' ' ILE . 11.8 m-85 -49.95 119.89 3.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.918 -1.114 . . . . 0.0 110.709 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.431 ' H ' HG22 ' B' ' 102' ' ' THR . 76.4 m-20 -95.53 176.47 6.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.869 . . . . 0.0 110.451 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -95.4 107.57 19.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 110.253 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 31.5 t -115.67 130.02 56.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 0.0 110.498 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' B' ' 74' ' ' PRO . 0.4 OUTLIER -53.59 -26.36 21.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.293 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.27 76.5 0.4 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.09 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.918 ' O ' HD11 ' B' ' 92' ' ' ILE . 17.0 Cg_endo -62.31 104.39 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.715 1.377 . . . . 0.0 110.688 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -94.42 -19.78 20.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' B' ' 91' ' ' THR . . . -125.74 178.02 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 110.295 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.639 ' O ' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -149.55 168.2 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.962 . . . . 0.0 110.445 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.895 ' ND1' HD13 ' B' ' 103' ' ' ILE . 33.6 p-80 -121.42 126.92 50.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 110.386 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' B' ' 88' ' ' ARG . 27.0 tt0 -109.07 172.37 6.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' B' ' 54' ' ' ARG . 6.0 mt -121.46 146.21 47.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.453 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 38.5 m -117.08 144.7 44.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.41 -0.806 . . . . 0.0 110.279 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' B' ' 85' ' ' LYS . . . 52.93 34.01 15.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.08 -95.72 2.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' B' ' 54' ' ' ARG . 1.0 OUTLIER -124.11 26.53 7.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -1.163 . . . . 0.0 110.228 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.79 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 1.2 mmtp -89.69 -73.09 0.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.442 ' CB ' ' HB ' ' B' ' 81' ' ' THR . 0.3 OUTLIER -102.24 177.87 4.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.349 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 1.034 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 64.5 mtp -136.92 150.6 48.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.811 ' CG ' HD23 ' B' ' 29' ' ' LEU . 15.0 ttm180 -133.76 104.08 6.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.476 -0.765 . . . . 0.0 109.982 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.639 HG23 ' O ' ' B' ' 77' ' ' ARG . 6.1 mt -88.39 140.22 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.461 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' B' ' 88' ' ' ARG . 1.7 m-85 -129.73 -168.13 1.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.89 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' B' ' 76' ' ' ALA . 26.5 p -125.32 97.07 5.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 110.397 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.918 HD11 ' O ' ' B' ' 74' ' ' PRO . 49.2 pt -59.84 -17.54 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.412 ' HA ' ' HG3' ' B' ' 26' ' ' LYS . 13.5 mtmt -143.42 134.62 12.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.89 135.75 17.49 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.467 1.246 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' B' ' 20' ' ' ALA . 80.9 mt -115.77 142.19 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.18 163.39 15.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.622 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 28.1 mt -65.06 115.04 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 110.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.07 40.87 2.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 177.64 4.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.73 31.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.401 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.71 ' HB ' HG13 ' B' ' 18' ' ' VAL . 63.1 mt -90.45 124.83 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 110.44 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.578 HG23 ' O ' ' B' ' 101' ' ' ILE . 17.4 p -157.38 135.98 11.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 109.659 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.895 HD13 ' ND1' ' B' ' 78' ' ' HIS . 1.1 pp -100.83 170.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.62 ' O ' HD12 ' B' ' 103' ' ' ILE . 89.5 p -105.64 -166.98 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.441 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' B' ' 109' ' ' TYR . 12.4 m-85 -123.44 -58.75 1.59 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.939 . . . . 0.0 110.036 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.84 160.31 0.47 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.6 OUTLIER 57.41 109.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.432 -1.04 . . . . 0.0 111.003 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' B' ' 107' ' ' ASP . 16.7 t0 57.79 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.867 -0.521 . . . . 0.0 111.774 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' B' ' 107' ' ' ASP . 0.2 OUTLIER -43.45 111.0 0.23 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.302 -0.874 . . . . 0.0 111.719 -178.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 0.0 110.934 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.214 0.531 . . . . 0.0 110.38 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.3 16.48 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 110.413 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.313 -1.305 0 O-C-N 123.538 1.283 . . . . 0.0 110.489 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 48.9 p90 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.345 0.593 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -126.03 148.11 49.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -46.51 -48.66 19.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.437 -0.79 . . . . 0.0 111.053 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.533 ' C ' HG13 ' A' ' 6' ' ' VAL . 20.6 mmt85 -59.65 -45.7 91.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 110.495 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.533 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.3 m -154.81 152.16 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.384 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 11.6 tt -117.75 167.12 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.941 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.8 p -89.35 127.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.433 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.646 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 12.9 mttt -144.54 139.02 27.92 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER 52.61 73.47 0.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.585 -1.947 . . . . 0.0 109.798 6.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 O-C-N 121.869 -0.52 . . . . 0.0 110.135 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.58 66.66 6.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -1.2 . . . . 0.0 110.627 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -111.54 -163.75 17.65 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.96 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.4 p -105.89 133.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.238 . . . . 0.0 109.063 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.537 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -90.0 144.12 26.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 110.521 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.95 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -97.26 89.24 4.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.466 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.878 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -63.29 -18.59 63.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.282 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HD2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.76 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.474 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 0.0 OUTLIER 97.57 8.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.414 -1.429 . . . . 0.0 110.609 0.812 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CZ ' HG12 ' A' ' 30' ' ' VAL . 14.6 m-85 -105.44 163.46 12.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.995 -1.065 . . . . 0.0 110.511 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.3 -148.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.027 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 10.4 tttt -107.94 82.47 1.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . . . 124.37 46.5 0.25 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.57 144.81 51.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -1.172 . . . . 0.0 110.531 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.925 HD23 ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -74.87 141.76 44.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.854 HG22 ' O ' ' A' ' 89' ' ' ILE . 28.6 m -121.81 -23.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.18 -0.95 . . . . 0.0 110.995 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.982 ' HB3' HD12 ' A' ' 89' ' ' ILE . 4.7 tt0 -171.8 153.82 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.104 -0.997 . . . . 0.0 110.216 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CG ' ' HA ' ' A' ' 88' ' ' ARG . 3.1 mt-10 -146.63 151.0 36.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 110.484 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.427 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 27.0 p -150.59 -160.85 1.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.652 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.703 HD23 ' HG3' ' A' ' 86' ' ' ARG . 54.0 mt -114.73 -179.87 3.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.466 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.7 170.89 17.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.104 HD11 HD23 ' A' ' 62' ' ' LEU . 48.2 mt -105.78 144.26 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.226 -0.922 . . . . 0.0 109.793 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 84' ' ' LEU . 38.2 t -123.25 89.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.005 -1.059 . . . . 0.0 110.386 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.38 177.81 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -88.61 175.06 7.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.121 -0.987 . . . . 0.0 109.771 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 5.7 t-20 -74.89 -135.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.099 -1.001 . . . . 0.0 110.252 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.3 t0 65.84 -146.86 0.21 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.69 -1.257 . . . . 0.0 110.379 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.03 -28.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.213 -0.93 . . . . 0.0 111.033 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.778 ' CH2' HD22 ' A' ' 47' ' ' LEU . 65.9 t-105 -68.41 -52.11 36.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.833 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.77 -23.53 55.98 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 90.7 m -83.76 -67.09 0.82 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -1.188 . . . . 0.0 110.748 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -46.63 -49.92 18.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 0.0 110.988 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.89 ' HB3' HD13 ' A' ' 51' ' ' LEU . 4.4 mp -91.86 31.87 1.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.02 64.09 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.939 -1.101 . . . . 0.0 110.61 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.42 -68.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.038 -1.039 . . . . 0.0 110.585 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 13.0 m-85 -98.34 34.39 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' A' ' 47' ' ' LEU . 2.3 tp -101.5 116.86 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.549 -0.72 . . . . 0.0 111.01 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -89.35 103.73 16.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.117 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 33.7 t -90.77 139.93 30.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.148 -0.97 . . . . 0.0 111.561 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' NH2' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -121.63 -175.36 3.07 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.583 -0.698 . . . . 0.0 109.674 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 79.69 8.88 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 109.363 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.506 0.2 OUTLIER 162.88 -28.91 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.847 -0.533 . . . . 0.0 109.844 -179.307 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.408 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.84 -161.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.3 m -128.28 141.7 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -129.12 175.42 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.859 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.558 ' CE ' HD23 ' A' ' 47' ' ' LEU . 1.3 tpt -114.11 169.45 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.815 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -84.96 -37.28 20.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.083 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.104 HD23 HD11 ' A' ' 36' ' ' ILE 2.501 0.1 OUTLIER 76.14 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.005 . . . . 0.0 111.186 177.657 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -66.35 -128.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.446 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.19 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -1.049 . . . . 0.0 110.84 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.815 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.77 -26.71 21.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -90.15 -35.78 15.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -1.114 . . . . 0.0 110.585 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.1 pp -47.01 -37.0 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' N ' HD12 ' A' ' 67' ' ' ILE . 28.9 m-85 -46.39 129.37 10.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.343 -0.848 . . . . 0.0 110.919 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.49 -177.4 3.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 110.65 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -93.24 124.72 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 110.03 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 m -145.35 157.18 44.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 110.555 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.22 25.91 2.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.495 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.26 67.84 4.1 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.908 ' O ' HD11 ' A' ' 92' ' ' ILE . 13.1 Cg_endo -60.55 110.24 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.764 1.402 . . . . 0.0 110.465 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 3.1 m120 -89.84 -18.65 25.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -151.55 122.66 7.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.13 -0.982 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.447 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.2 mtt180 -93.89 -171.23 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 110.033 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.791 ' CE1' HD13 ' A' ' 103' ' ' ILE . 47.3 p-80 -130.39 150.59 51.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.177 -0.952 . . . . 0.0 110.281 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 4.4 tp10 -117.32 141.81 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 84' ' ' LEU . 51.2 tp -114.5 131.13 56.74 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 110.131 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -54.81 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 110.379 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' ' NH2' ' A' ' 54' ' ' ARG . . . -52.42 -23.27 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 110.389 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.54 -164.27 11.79 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.81 ' HA ' HD11 ' A' ' 80' ' ' LEU . 8.9 mt -102.8 42.47 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -1.129 . . . . 0.0 110.226 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.23 -65.63 0.98 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.168 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.703 ' HG3' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.46 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 110.886 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.97 24.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 110.13 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.45 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -128.03 172.47 10.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 110.91 -179.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.982 HD12 ' HB3' ' A' ' 31' ' ' GLU . 16.6 mt -145.89 91.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.925 ' CE2' HD23 ' A' ' 29' ' ' LEU . 2.4 m-85 -98.41 150.39 21.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.586 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.585 HG23 ' CG1' ' A' ' 30' ' ' VAL . 2.9 p -89.13 114.13 25.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.061 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.908 HD11 ' O ' ' A' ' 74' ' ' PRO . 13.6 pt -75.83 -13.53 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.62 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 8.3 ptpt -148.19 156.7 43.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.058 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.87 124.41 15.29 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.582 1.306 . . . . 0.0 110.597 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 75' ' ' ASN . 61.8 mt -111.4 145.6 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 110.373 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.89 156.61 17.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.367 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.878 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -59.91 111.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.864 . . . . 0.0 110.326 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.76 32.19 1.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -114.3 170.54 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' OE2' ' CG2' ' A' ' 102' ' ' THR . 0.7 OUTLIER -110.31 139.8 45.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.96 ' HB ' HG13 ' A' ' 18' ' ' VAL . 41.0 mt -109.02 122.1 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 110.619 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.447 HG23 ' C ' ' A' ' 101' ' ' ILE . 58.4 p -149.7 143.71 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.791 HD13 ' CE1' ' A' ' 78' ' ' HIS . 1.0 OUTLIER -111.61 169.86 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.021 -1.049 . . . . 0.0 110.571 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -95.51 -168.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 11.1 m-85 -123.49 -62.33 1.33 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.21 -0.932 . . . . 0.0 109.867 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 70.16 -169.83 45.65 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.87 -67.86 0.11 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.533 -0.981 . . . . 0.0 110.813 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -144.12 -39.02 0.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.994 -1.066 . . . . 0.0 110.767 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.6 m-85 -47.51 107.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 111.241 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 26.3 m95 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 110.908 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.417 0.627 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.44 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.209 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 C--N 1.312 -1.369 0 O-C-N 123.596 1.313 . . . . 0.0 110.447 179.892 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 49.0 p90 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.384 0.612 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -125.96 148.26 49.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 26.1 t70 -46.56 -48.7 19.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.371 -0.831 . . . . 0.0 110.985 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.516 ' C ' HG13 ' B' ' 6' ' ' VAL . 20.5 mmt85 -59.67 -45.69 91.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 110.539 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.516 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.3 m -154.72 152.22 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 11.7 tt -117.89 166.75 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.502 HG13 ' O ' ' B' ' 8' ' ' VAL . 8.0 p -88.83 127.86 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.571 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.657 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 13.0 mttt -144.71 139.15 27.74 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.657 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.8 OUTLIER 52.71 73.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.52 -1.988 . . . . 0.0 109.851 6.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.419 ' HB2' ' HD3' ' B' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.895 -0.503 . . . . 0.0 110.097 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -90.55 66.96 6.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -1.145 . . . . 0.0 110.616 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -111.87 -163.94 17.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.938 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.5 p -105.59 132.94 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.021 -1.282 . . . . 0.0 109.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.536 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.054 -1.028 . . . . 0.0 110.556 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -97.21 89.19 4.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.889 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.6 OUTLIER -63.4 -18.54 63.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.493 ' HD2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.85 6.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.469 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.509 0.0 OUTLIER 97.63 8.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.434 -1.416 . . . . 0.0 110.625 0.786 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.632 ' CZ ' HG12 ' B' ' 30' ' ' VAL . 14.4 m-85 -105.34 163.52 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.024 -1.048 . . . . 0.0 110.487 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.36 -148.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 92' ' ' ILE . 10.3 tttt -107.96 82.45 1.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.13 -0.981 . . . . 0.0 110.486 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 91' ' ' THR . . . 124.37 46.57 0.25 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.55 144.74 51.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -1.197 . . . . 0.0 110.575 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.91 HD23 ' CE2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER -74.84 141.84 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 109.813 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.862 HG22 ' O ' ' B' ' 89' ' ' ILE . 28.4 m -121.97 -23.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.12 -0.987 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.98 ' HB3' HD12 ' B' ' 89' ' ' ILE . 4.6 tt0 -171.75 153.77 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' B' ' 88' ' ' ARG . 3.1 mt-10 -146.59 151.26 37.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 0.0 110.434 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.419 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 27.0 p -150.98 -161.02 1.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.679 HD23 ' HG3' ' B' ' 86' ' ' ARG . 53.7 mt -114.66 -179.84 3.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -149.68 170.86 17.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 1.096 HD11 HD23 ' B' ' 62' ' ' LEU . 47.8 mt -105.76 144.2 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.791 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.405 HG22 ' O ' ' B' ' 84' ' ' LEU . 38.1 t -123.18 89.35 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.41 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.28 177.8 4.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.361 -0.837 . . . . 0.0 110.163 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -88.54 175.0 7.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.12 -0.987 . . . . 0.0 109.785 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 5.7 t-20 -74.83 -135.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 4.4 t0 65.87 -146.89 0.21 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.712 -1.243 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.0 -28.39 1.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.169 -0.957 . . . . 0.0 111.022 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.784 ' CH2' HD22 ' B' ' 47' ' ' LEU . 65.8 t-105 -68.45 -52.06 36.75 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.79 -23.52 56.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 91.1 m -83.71 -67.16 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 110.699 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.462 ' HB3' HD12 ' B' ' 47' ' ' LEU . . . -46.73 -49.03 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.188 -0.945 . . . . 0.0 111.046 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.866 ' HB3' HD13 ' B' ' 51' ' ' LEU . 4.4 mp -93.21 32.44 1.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.13 64.09 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.564 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.46 -68.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.047 . . . . 0.0 110.596 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -98.22 34.29 2.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.224 -0.922 . . . . 0.0 109.955 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.866 HD13 ' HB3' ' B' ' 47' ' ' LEU . 2.3 tp -101.51 116.66 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 111.145 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -89.05 103.79 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.184 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 33.8 t -90.82 139.88 30.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 111.526 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.415 ' NH2' ' O ' ' B' ' 82' ' ' ALA . 0.2 OUTLIER -122.2 -178.36 3.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.587 -0.696 . . . . 0.0 109.696 178.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.25 79.35 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 110.253 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 0.2 OUTLIER 162.71 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.694 -0.629 . . . . 0.0 109.88 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.67 -161.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.3 m -128.35 141.7 51.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.13 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -129.07 175.34 8.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.015 . . . . 0.0 110.955 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.559 ' CE ' HD23 ' B' ' 47' ' ' LEU . 1.3 tpt -114.47 167.34 10.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.0 109.793 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.807 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -81.82 -38.74 25.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -0.965 . . . . 0.0 110.56 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 1.096 HD23 HD11 ' B' ' 36' ' ' ILE 2.501 0.1 OUTLIER 76.7 -95.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 111.202 178.359 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -66.36 -128.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.44 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.59 1.26 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -1.06 . . . . 0.0 110.788 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.807 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.39 -26.42 20.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.33 -35.73 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -1.093 . . . . 0.0 110.595 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.532 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.2 pp -46.97 -37.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.532 ' N ' HD12 ' B' ' 67' ' ' ILE . 29.1 m-85 -46.31 129.36 10.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.322 -0.861 . . . . 0.0 110.983 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.5 -177.32 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -93.27 124.63 37.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.3 m -145.36 157.25 44.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.39 26.08 2.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -157.22 67.73 4.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.907 ' O ' HD11 ' B' ' 92' ' ' ILE . 13.2 Cg_endo -60.47 110.3 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.727 1.383 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.468 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 3.1 m120 -89.91 -18.65 25.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.849 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -151.54 122.7 7.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.437 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.3 mtt180 -93.85 -171.17 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.327 -0.858 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.786 ' CE1' HD13 ' B' ' 103' ' ' ILE . 47.2 p-80 -130.48 150.49 51.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 110.257 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.447 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 4.4 tp10 -117.23 141.88 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' B' ' 84' ' ' LEU . 51.6 tp -114.5 131.12 56.74 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.17 -0.956 . . . . 0.0 110.238 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -54.9 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.329 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.415 ' O ' ' NH2' ' B' ' 54' ' ' ARG . . . -52.4 -23.32 5.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 110.345 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.48 -164.22 11.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.786 ' HA ' HD11 ' B' ' 80' ' ' LEU . 8.9 mt -102.9 42.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -1.106 . . . . 0.0 110.144 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.46 -65.48 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 111.173 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.679 ' HG3' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.47 27.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.823 -178.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.87 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 110.127 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.448 ' HA ' ' CG ' ' B' ' 32' ' ' GLU . 0.4 OUTLIER -127.78 172.62 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.98 HD12 ' HB3' ' B' ' 31' ' ' GLU . 16.7 mt -145.99 91.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.52 -0.738 . . . . 0.0 109.964 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.91 ' CE2' HD23 ' B' ' 29' ' ' LEU . 2.4 m-85 -98.44 150.01 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 110.593 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.597 HG23 ' CG1' ' B' ' 30' ' ' VAL . 3.0 p -88.66 114.19 25.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.164 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.907 HD11 ' O ' ' B' ' 74' ' ' PRO . 13.7 pt -75.82 -13.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.666 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 8.3 ptpt -148.17 156.71 43.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.966 . . . . 0.0 110.039 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.82 124.42 15.34 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.676 1.356 . . . . 0.0 110.64 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' B' ' 75' ' ' ASN . 61.9 mt -111.4 145.64 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.92 156.61 17.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.889 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -59.91 111.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 32.16 1.78 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -114.29 170.49 8.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 110.236 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.41 ' OE2' ' CG2' ' B' ' 102' ' ' THR . 0.7 OUTLIER -110.29 139.88 45.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.957 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.961 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 41.5 mt -108.89 122.2 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.432 HG23 ' C ' ' B' ' 101' ' ' ILE . 57.4 p -149.7 143.73 25.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 109.631 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.786 HD13 ' CE1' ' B' ' 78' ' ' HIS . 1.0 OUTLIER -111.53 169.75 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.579 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -95.51 -168.89 1.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.487 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 10.9 m-85 -123.12 -62.41 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.95 . . . . 0.0 109.936 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.15 -169.8 45.67 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.89 -67.87 0.11 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.521 -0.987 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -144.07 -39.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.053 -1.029 . . . . 0.0 110.757 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.6 m-85 -47.45 107.14 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.491 ' N ' ' CD1' ' B' ' 110' ' ' TRP . 26.2 m95 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.437 -0.789 . . . . 0.0 111.004 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.443 0.64 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.45 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.312 -1.386 0 O-C-N 123.633 1.333 . . . . 0.0 110.48 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 10.8 p90 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.337 0.589 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.52 143.57 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 110.292 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.6 -33.15 6.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.953 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.519 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -77.32 -44.13 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.519 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.2 m -154.15 147.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 110.192 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 14.3 tt -114.81 166.1 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.907 . . . . 0.0 110.061 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.1 p -89.59 122.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 110.896 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 41.8 mttt -150.03 128.86 12.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 3.0 mttt 51.44 40.11 25.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.718 -1.864 . . . . 0.0 109.879 6.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.415 ' HA ' ' HG2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.708 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 16' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 15' ' ' GLY . 37.5 m-85 -152.55 91.77 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.038 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.917 ' HA2' HG22 ' A' ' 67' ' ' ILE . . . -151.18 -169.25 16.67 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.499 HG12 HD12 ' A' ' 101' ' ' ILE . 87.2 t -100.81 124.13 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.031 -1.276 . . . . 0.0 109.616 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' CB ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -88.45 129.37 35.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.989 -1.07 . . . . 0.0 110.777 -178.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -97.22 85.27 3.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.557 -0.714 . . . . 0.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 97' ' ' ILE . 4.7 mtp180 -56.09 -25.13 44.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 109.485 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 5.1 mtpp -84.63 -179.72 7.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 7.0 m 100.36 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.054 -1.654 . . . . 0.0 110.038 2.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 16.1 m-85 -107.63 142.79 37.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.75 171.07 9.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.091 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 18.7 tttt -67.04 100.81 0.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.45 -20.75 11.02 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.57 123.69 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -1.179 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.845 HD21 ' HB3' ' A' ' 88' ' ' ARG . 1.2 tm? -65.99 113.65 4.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 91' ' ' THR . 99.4 t -72.04 -53.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 89' ' ' ILE . 5.3 tt0 -174.14 144.44 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.25 157.98 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.445 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.1 p -150.56 -171.82 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 110.651 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.7 mt -100.61 167.65 10.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.783 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.7 m -145.15 161.59 39.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.793 HD11 HD23 ' A' ' 62' ' ' LEU . 55.1 mt -92.16 148.26 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 83' ' ' GLY . 42.7 t -124.0 90.45 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.659 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 36' ' ' ILE . 39.8 mmt180 -117.93 168.43 10.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -87.08 -176.27 5.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.068 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 26.2 m120 -72.24 -137.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.0 t0 65.97 -148.09 0.21 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 110.541 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' B' ' 42' ' ' ASP . 26.9 m-20 -46.27 -34.74 4.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.243 -0.91 . . . . 0.0 111.109 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.891 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 60.6 t-105 -52.88 -57.21 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.029 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -60.34 -31.31 73.47 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.97 -65.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.522 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.22 70.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 110.14 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.006 HD12 ' CE ' ' A' ' 60' ' ' MET . 3.6 mm? -91.74 34.03 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.686 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 1.9 tm-20 -56.31 -17.54 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 111.365 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.89 156.47 19.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.913 -1.117 . . . . 0.0 110.966 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 7.0 m-30 55.25 26.29 8.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.854 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.891 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 10.5 tp -108.71 105.88 15.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.867 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -89.11 105.32 17.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.1 t -105.39 147.52 28.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.938 . . . . 0.0 110.915 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.966 ' HG2' HD11 ' A' ' 84' ' ' LEU . 10.4 ptm180 -115.13 -167.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 77.62 9.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.075 -1.016 . . . . 0.0 109.264 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.499 3.0 t30 166.02 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.902 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -176.98 -164.44 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.947 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.414 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 6.2 t -130.2 141.05 50.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.459 -0.776 . . . . 0.0 110.286 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.553 ' HB3' HD22 ' A' ' 84' ' ' LEU . . . -132.71 149.42 52.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 110.626 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 1.006 ' CE ' HD12 ' A' ' 47' ' ' LEU . 32.9 tpp -93.24 155.91 17.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.52 92.1 8.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.704 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.793 HD23 HD11 ' A' ' 36' ' ' ILE 2.506 0.1 OUTLIER -52.19 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 110.895 -178.605 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -61.05 -155.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.697 ' HB3' HD13 ' A' ' 67' ' ' ILE . 31.6 m-85 -90.16 54.12 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.132 . . . . 0.0 111.152 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA2' ' CE2' ' A' ' 68' ' ' PHE . . . -92.83 -15.52 52.08 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -91.72 4.37 52.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.894 -1.356 . . . . 0.0 112.355 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.917 HG22 ' HA2' ' A' ' 17' ' ' GLY . 3.8 mp -88.56 -20.75 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.716 -1.24 . . . . 0.0 110.829 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 23.1 m-85 -52.43 143.6 14.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.89 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -112.4 -159.67 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -102.01 136.12 42.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.405 -0.81 . . . . 0.0 109.414 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' ASP . 1.8 m -152.06 35.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.027 -1.045 . . . . 0.0 110.567 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 mmtp 58.11 -82.63 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.542 -0.724 . . . . 0.0 110.273 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' SER . 4.5 m-20 -99.33 91.78 1.55 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.804 ' O ' HD11 ' A' ' 92' ' ' ILE . 11.5 Cg_endo -58.04 106.56 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.564 1.297 . . . . 0.0 110.524 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 71.6 m-80 -50.48 -23.8 2.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.619 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.859 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -142.71 159.56 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.995 . . . . 0.0 110.426 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.47 ' NH2' ' NE2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -136.99 -173.89 3.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.195 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.47 ' NE2' ' NH2' ' A' ' 77' ' ' ARG . 7.5 p-80 -119.74 172.71 7.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -142.35 155.07 45.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.722 HD12 ' HD2' ' C' ' 218' ' ' PRO . 19.8 mt -123.38 143.36 50.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 110.371 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.455 HG22 ' NH2' ' A' ' 88' ' ' ARG . 20.4 p -72.93 -66.47 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.354 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.88 -35.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 110.524 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 37' ' ' VAL . . . -106.66 26.66 19.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.966 HD11 ' HG2' ' A' ' 54' ' ' ARG . 34.6 mt 51.73 28.84 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.605 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.22 -36.25 10.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 110.76 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.87 135.8 54.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 110.691 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 mtp -126.85 116.72 21.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 110.199 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.845 ' HB3' HD21 ' A' ' 29' ' ' LEU . 45.2 mtt180 -101.35 131.92 47.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -89.25 98.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.022 . . . . 0.0 109.591 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.844 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 13.9 m-85 -89.76 -169.29 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.547 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.523 HG23 HG23 ' A' ' 30' ' ' VAL . 26.9 p -132.57 98.43 4.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.083 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 74' ' ' PRO . 33.7 pt -54.54 -22.18 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.106 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -146.72 161.23 38.55 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 34.1 Cg_exo -53.74 156.57 11.65 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.635 1.334 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 59.2 mt -138.55 134.91 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.3 167.86 10.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 110.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -64.53 119.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.341 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.63 30.75 5.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.19 141.06 36.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.113 -1.228 . . . . 0.0 110.325 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' OE1' HG21 ' A' ' 102' ' ' THR . 1.3 tm-20 -88.39 121.39 30.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 109.674 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 76' ' ' ALA . 60.6 mt -89.11 123.59 41.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.78 . . . . 0.0 110.586 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.497 ' C ' HG23 ' A' ' 103' ' ' ILE . 73.2 p -145.46 -176.71 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.497 HG23 ' C ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -151.74 160.31 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 0.0 110.384 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.54 -173.05 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 13.0 m-85 -125.51 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 109.86 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.5 -160.29 54.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.94 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.988 . . . . 0.0 110.692 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -129.44 -35.54 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.067 . . . . 0.0 110.706 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.465 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -48.66 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.93 . . . . 0.0 110.928 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.476 ' O ' ' CD2' ' A' ' 110' ' ' TRP . 54.8 p-90 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.6 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.232 0.539 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -150.09 165.59 17.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.722 ' HD2' HD12 ' A' ' 80' ' ' LEU . 17.6 Cg_endo . . . . . 0 C--N 1.312 -1.344 0 O-C-N 123.675 1.355 . . . . 0.0 110.452 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.9 p90 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.395 0.617 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.45 143.69 31.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.69 -33.24 6.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.363 -0.836 . . . . 0.0 110.894 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.534 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -77.25 -44.19 30.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.534 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.1 m -154.04 147.43 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 14.3 tt -114.77 165.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 110.102 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.56 HG13 ' O ' ' B' ' 8' ' ' VAL . 7.1 p -89.4 122.28 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 110.969 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.562 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 42.1 mttt -150.13 129.17 12.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.562 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 3.0 mttt 51.8 40.01 26.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.511 -1.993 . . . . 0.0 109.889 6.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.696 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' B' ' 16' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' B' ' 15' ' ' GLY . 37.3 m-85 -152.5 91.58 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.913 ' HA2' HG22 ' B' ' 67' ' ' ILE . . . -151.03 -169.15 16.43 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.514 HG12 HD12 ' B' ' 101' ' ' ILE . 88.5 t -100.93 123.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.254 . . . . 0.0 109.71 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' CB ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -87.35 129.37 35.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.015 . . . . 0.0 110.94 -178.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.814 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -97.31 85.25 3.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.438 -0.789 . . . . 0.0 110.13 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 4.7 mtp180 -56.03 -25.09 43.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.545 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CD2' ' B' ' 24' ' ' PHE . 5.2 mtpp -84.6 -179.62 7.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.464 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.513 6.8 m 100.46 13.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.041 -1.662 . . . . 0.0 109.98 2.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 16.3 m-85 -107.59 142.63 37.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.195 -0.94 . . . . 0.0 110.275 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.48 171.08 9.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -67.05 100.85 0.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 110.153 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.43 -20.87 10.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.62 123.74 11.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -1.163 . . . . 0.0 110.547 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.856 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.2 tm? -66.02 113.65 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.527 HG23 HG23 ' B' ' 91' ' ' THR . 99.5 t -72.03 -53.14 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.184 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.421 ' O ' HD12 ' B' ' 89' ' ' ILE . 5.3 tt0 -174.14 144.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.26 158.19 34.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 110.406 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.444 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.1 p -150.81 -171.96 4.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 54.9 mt -100.53 167.7 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 95.2 m -145.19 161.56 39.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.058 -1.026 . . . . 0.0 110.524 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.781 HD11 HD23 ' B' ' 62' ' ' LEU . 54.9 mt -92.06 148.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 83' ' ' GLY . 42.9 t -124.02 90.5 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.95 . . . . 0.0 110.604 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.503 ' HG2' HG22 ' B' ' 36' ' ' ILE . 39.8 mmt180 -117.96 168.43 10.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -87.07 -176.31 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.883 . . . . 0.0 110.167 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.22 -137.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.976 . . . . 0.0 110.148 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 66.07 -148.11 0.21 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.805 -1.184 . . . . 0.0 110.547 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 26.9 m-20 -46.26 -34.78 4.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.219 -0.926 . . . . 0.0 111.123 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.889 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 60.8 t-105 -52.81 -57.22 10.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 110.077 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.416 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -60.36 -31.3 73.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.93 -65.19 0.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -50.54 73.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.256 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 1.008 HD12 ' CE ' ' B' ' 60' ' ' MET . 3.6 mm? -92.79 34.41 1.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 110.465 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.416 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 1.9 tm-20 -56.53 -17.59 8.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.049 -1.032 . . . . 0.0 111.299 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.76 156.44 19.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.971 -1.081 . . . . 0.0 111.073 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 7.0 m-30 55.28 26.36 8.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.475 -0.766 . . . . 0.0 110.775 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.889 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 10.6 tp -108.79 105.51 15.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 110.937 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' B' ' 52' ' ' PHE . 42.4 m-85 -88.56 105.27 17.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -105.4 147.51 28.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.152 -0.967 . . . . 0.0 110.907 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.975 ' HG2' HD11 ' B' ' 84' ' ' LEU . 10.3 ptm180 -115.66 -170.07 1.71 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.109 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.55 77.21 5.03 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.242 -0.911 . . . . 0.0 110.226 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.505 3.1 t30 165.94 -29.21 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.679 -0.638 . . . . 0.0 109.935 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.83 -164.15 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 110.934 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.402 ' OG ' ' NE1' ' B' ' 43' ' ' TRP . 6.2 t -130.27 141.09 50.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 110.241 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.565 ' HB3' HD22 ' B' ' 84' ' ' LEU . . . -132.78 149.43 52.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.637 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 1.008 ' CE ' HD12 ' B' ' 47' ' ' LEU . 32.9 tpp -93.48 154.84 17.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 110.215 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.07 92.05 8.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.781 HD23 HD11 ' B' ' 36' ' ' ILE 2.505 0.1 OUTLIER -52.29 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.949 -178.734 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.97 -155.15 0.03 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.694 ' HB3' HD13 ' B' ' 67' ' ' ILE . 31.6 m-85 -90.22 55.38 3.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -1.119 . . . . 0.0 111.053 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' CE2' ' B' ' 68' ' ' PHE . . . -94.92 -13.82 51.64 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.185 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.438 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -93.2 4.86 53.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.933 -1.334 . . . . 0.0 112.096 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.913 HG22 ' HA2' ' B' ' 17' ' ' GLY . 3.8 mp -88.76 -20.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.691 -1.256 . . . . 0.0 110.817 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.489 ' CE1' HG21 ' B' ' 18' ' ' VAL . 23.0 m-85 -52.43 143.62 14.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.917 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -112.33 -159.43 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -102.42 136.12 42.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.358 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 73' ' ' ASP . 1.8 m -152.01 35.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.085 -1.009 . . . . 0.0 110.646 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' B' ' 74' ' ' PRO . 1.6 mmtp 58.11 -82.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.428 -0.795 . . . . 0.0 110.288 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' B' ' 71' ' ' SER . 4.5 m-20 -99.38 91.85 1.59 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.235 -0.916 . . . . 0.0 109.789 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.823 ' O ' HD11 ' B' ' 92' ' ' ILE . 11.4 Cg_endo -58.07 106.66 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.616 1.324 . . . . 0.0 110.476 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' B' ' 93' ' ' LYS . 71.6 m-80 -50.59 -23.76 2.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.593 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.851 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -142.73 159.53 42.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.462 ' NH2' ' NE2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -136.95 -173.85 3.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 110.177 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.462 ' NE2' ' NH2' ' B' ' 77' ' ' ARG . 7.5 p-80 -119.71 172.62 7.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 110.618 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -142.28 155.19 45.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.725 HD12 ' HD2' ' D' ' 218' ' ' PRO . 19.8 mt -123.38 143.34 50.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 110.428 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.464 HG22 ' NH2' ' B' ' 88' ' ' ARG . 20.3 p -73.0 -66.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 110.337 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.91 -35.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.483 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.443 ' O ' HG21 ' B' ' 37' ' ' VAL . . . -106.66 26.6 19.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.975 HD11 ' HG2' ' B' ' 54' ' ' ARG . 34.7 mt 51.82 28.79 5.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -1.182 . . . . 0.0 110.631 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.32 -36.15 10.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.84 135.76 54.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.705 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 13.0 mtp -126.78 116.69 21.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 110.258 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.821 ' HB3' HD21 ' B' ' 29' ' ' LEU . 45.2 mtt180 -101.49 131.53 47.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 110.397 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.421 HD12 ' O ' ' B' ' 31' ' ' GLU . 12.3 mt -88.68 98.44 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.856 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 14.0 m-85 -89.57 -169.24 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.527 HG23 HG23 ' B' ' 30' ' ' VAL . 26.7 p -132.62 98.42 4.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 110.087 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.823 HD11 ' O ' ' B' ' 74' ' ' PRO . 33.6 pt -54.6 -22.15 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -146.72 161.23 38.51 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.18 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -53.77 156.51 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.6 1.316 . . . . 0.0 110.823 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 76' ' ' ALA . 59.2 mt -138.49 134.99 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.35 167.93 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -64.51 119.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.59 30.79 5.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.36 140.41 37.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -1.22 . . . . 0.0 110.365 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.419 ' OE1' HG21 ' B' ' 102' ' ' THR . 1.3 tm-20 -87.49 121.08 29.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.01 -1.056 . . . . 0.0 109.946 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.851 HG23 ' HB3' ' B' ' 76' ' ' ALA . 60.6 mt -88.62 123.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.402 -0.811 . . . . 0.0 110.79 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.516 ' C ' HG23 ' B' ' 103' ' ' ILE . 72.0 p -145.55 -176.69 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.708 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.516 HG23 ' C ' ' B' ' 102' ' ' THR . 1.0 OUTLIER -151.67 160.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.356 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.5 -173.02 2.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.461 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 13.0 m-85 -125.53 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.339 -0.851 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 71.45 -160.27 54.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.96 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -1.0 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.2 OUTLIER -129.43 -35.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.742 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.461 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.5 OUTLIER -48.67 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.929 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.469 ' O ' ' CD2' ' B' ' 110' ' ' TRP . 54.8 p-90 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 2.6 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -150.08 165.56 17.22 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.725 ' HD2' HD12 ' B' ' 80' ' ' LEU . 17.3 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.601 1.316 . . . . 0.0 110.458 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 41.3 p90 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.24 0.543 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ARG . 12.8 p30 -119.39 167.0 12.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.358 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.67 64.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.538 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 177.89 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 0.0 109.623 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG23 ' C ' ' A' ' 5' ' ' ARG . 96.4 t -153.55 158.97 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.738 HG23 ' HB2' ' A' ' 19' ' ' PHE . 5.1 tt -134.95 158.94 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.442 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' A' ' 10' ' ' LYS . 61.7 t -99.24 114.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 110.795 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 14.1 mttt -127.6 141.68 51.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.614 ' HE2' HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 52.4 56.65 7.39 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 119.821 -1.799 . . . . 0.0 110.196 2.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.596 -0.69 . . . . 0.0 110.263 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.511 ' CZ ' ' HD3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -77.9 59.13 2.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 110.299 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -105.13 -165.59 23.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.3 p -114.03 131.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.903 -1.351 . . . . 0.0 109.502 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -88.57 141.77 28.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.363 -0.835 . . . . 0.0 110.602 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.763 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -93.58 93.54 8.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.699 -0.626 . . . . 0.0 110.706 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -65.63 -15.75 63.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 0.0 109.877 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 6.7 mttt -108.61 179.05 4.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 20.1 m 102.25 21.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.012 -1.68 . . . . 0.0 109.727 2.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 17.5 m-85 -114.6 161.47 18.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 110.637 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.37 170.95 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 11.3 tttm -72.53 88.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.91 52.15 0.21 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.18 136.57 52.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.76 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 2.0 tm? -67.09 117.29 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 110.211 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.724 ' CG2' HG23 ' A' ' 91' ' ' THR . 38.3 t -98.53 85.42 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.32 -0.863 . . . . 0.0 109.563 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.508 ' O ' HD11 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.62 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 110.304 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.402 ' OE1' ' HG2' ' A' ' 88' ' ' ARG . 18.4 tt0 -154.13 160.53 41.96 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.011 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 1.062 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 26.7 p -150.75 160.96 43.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 111.072 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.9 mt -96.65 176.78 5.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.872 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' CG ' ' A' ' 87' ' ' MET . 83.8 m -149.25 166.39 29.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.017 HD11 HD23 ' A' ' 62' ' ' LEU . 48.4 mt -103.13 154.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.972 HG13 HD23 ' A' ' 84' ' ' LEU . 41.2 t -131.17 118.49 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.893 -1.129 . . . . 0.0 110.641 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.545 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 29.7 mmt180 -136.79 147.77 46.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.58 58.78 2.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 111.297 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 1.9 t-20 49.8 -141.31 0.7 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 111.019 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 44' ' ' GLY . 2.3 t70 67.35 -144.8 0.14 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.036 -1.04 . . . . 0.0 110.169 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.13 -35.85 12.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.935 -1.103 . . . . 0.0 110.297 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.737 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 17.2 t-105 -63.73 -34.61 78.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 109.129 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -62.43 -60.38 7.94 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 54.6 m -66.17 -45.84 79.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.19 -1.182 . . . . 0.0 110.666 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -62.0 2.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 0.0 109.1 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.719 HD21 ' CE3' ' B' ' 43' ' ' TRP . 4.3 mm? -93.19 36.27 1.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.471 -0.768 . . . . 0.0 110.795 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.454 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -69.4 61.71 0.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.093 -1.004 . . . . 0.0 110.325 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 178.78 145.36 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.487 -0.758 . . . . 0.0 109.015 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 11.2 m-85 57.35 26.72 12.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.918 -1.113 . . . . 0.0 109.31 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.737 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 3.1 tp -107.86 112.93 25.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 111.285 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -89.4 108.44 19.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.161 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.414 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 23.2 t -107.39 143.91 35.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.509 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.637 ' HG2' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -118.86 -165.62 1.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.522 -0.736 . . . . 0.0 109.781 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 75.4 8.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.363 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.86 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.507 -179.609 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 179.95 -174.6 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.591 -0.693 . . . . 0.0 110.324 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.464 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 26.0 p -111.95 134.89 53.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.336 -0.852 . . . . 0.0 110.432 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.9 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -117.12 174.44 6.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.674 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -120.35 160.09 23.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.788 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -89.09 99.13 12.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 110.226 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 36' ' ' ILE 2.497 0.1 OUTLIER -58.4 -81.11 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.86 . . . . 0.0 110.922 -179.437 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.3 -130.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.88 45.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 110.769 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' CA ' ' HB1' ' A' ' 61' ' ' ALA . . . -90.5 -20.67 40.2 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . . . -90.69 -43.56 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.45 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 1.3 pp -48.97 -25.64 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.213 -0.929 . . . . 0.0 110.367 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CE1' HG11 ' A' ' 18' ' ' VAL . 9.2 m-85 -48.96 144.99 4.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 110.638 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' CG2' ' A' ' 102' ' ' THR . 73.1 m-80 -118.65 174.69 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.577 ' CE1' ' CE2' ' A' ' 110' ' ' TRP . 1.8 t-160 -101.54 109.52 21.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.07 146.67 48.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.44 127.54 32.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.78 71.0 1.57 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.952 . . . . 0.0 110.255 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.532 ' O ' HD11 ' A' ' 92' ' ' ILE . 12.9 Cg_endo -60.65 174.25 1.74 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.663 1.349 . . . . 0.0 110.595 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 93' ' ' LYS . 17.5 p30 -117.66 -13.12 10.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 110.569 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.05 143.96 51.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.06 166.93 13.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -0.933 . . . . 0.0 110.081 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.21 158.99 17.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.731 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 19.6 tt0 -132.94 136.68 46.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 110.147 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.564 HD12 ' HD2' ' C' ' 218' ' ' PRO . 6.1 mt -114.6 145.13 42.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.037 -1.039 . . . . 0.0 110.419 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 86' ' ' ARG . 14.2 p -53.93 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 110.396 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.38 -60.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.66 42.81 1.86 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.972 HD23 HG13 ' A' ' 37' ' ' VAL . 4.4 tp 59.25 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.298 -1.119 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -177.2 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 110.084 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.582 ' O ' HG23 ' A' ' 81' ' ' THR . 1.3 mpt_? -113.3 140.1 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.756 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 1.062 ' SD ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 ppp? -137.24 169.85 17.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.113 -0.992 . . . . 0.0 110.666 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.734 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -131.37 -179.74 5.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.346 -0.846 . . . . 0.0 110.637 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.403 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 6.5 mt -130.21 108.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 0.0 109.646 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.76 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 51.8 m-85 -97.2 -170.68 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.724 HG23 ' CG2' ' A' ' 30' ' ' VAL . 23.1 p -128.35 98.95 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.532 HD11 ' O ' ' A' ' 74' ' ' PRO . 48.5 pt -60.06 -16.58 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 110.696 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 75' ' ' ASN . 1.1 ptpm? -148.69 156.94 41.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.96 142.86 93.61 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.582 1.306 . . . . 0.0 110.379 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.614 HG23 ' HG3' ' A' ' 99' ' ' GLU . 54.4 mt -124.33 141.97 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.671 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.76 153.66 20.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.882 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -48.25 -24.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.46 -0.775 . . . . 0.0 111.313 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.34 60.68 0.32 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 95' ' ' ILE . 3.3 mm-40 -116.28 165.05 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 111.274 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.19 115.56 29.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.915 ' HB ' HG13 ' A' ' 18' ' ' VAL . 58.5 mt -88.79 127.49 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.3 p -155.55 148.41 24.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 104' ' ' SER . 1.3 pp -115.91 155.32 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 0.0 110.749 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.543 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -90.61 -173.95 3.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 110.06 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.522 ' CD2' ' ND1' ' A' ' 70' ' ' HIS . 9.0 m-85 -123.63 -66.36 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.988 . . . . 0.0 110.093 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.43 -175.28 44.37 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.71 -33.28 68.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -1.166 . . . . 0.0 110.377 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -72.82 -66.95 0.6 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.366 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.48 71.93 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.92 . . . . 0.0 110.493 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.577 ' CE2' ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.441 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 3.4 p . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.217 0.532 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -160.63 167.99 12.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.927 . . . . 0.0 110.39 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 17.6 Cg_endo . . . . . 0 C--N 1.311 -1.397 0 O-C-N 123.734 1.386 . . . . 0.0 110.425 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.427 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 41.5 p90 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.256 0.551 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 12.7 p30 -119.4 167.01 12.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 110.373 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.71 64.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 110.345 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.531 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.0 OUTLIER 177.87 -33.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.39 -0.819 . . . . 0.0 109.639 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.531 HG23 ' C ' ' B' ' 5' ' ' ARG . 96.6 t -153.45 159.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.733 HG23 ' HB2' ' B' ' 19' ' ' PHE . 5.1 tt -134.98 158.9 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.412 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.611 HG12 ' HE2' ' B' ' 10' ' ' LYS . 62.0 t -99.27 114.81 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.55 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 14.1 mttt -127.72 141.83 51.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.611 ' HE2' HG12 ' B' ' 8' ' ' VAL . 0.3 OUTLIER 52.59 56.59 7.43 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 119.777 -1.827 . . . . 0.0 110.13 1.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.478 ' HB2' ' CZ ' ' B' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.554 -0.716 . . . . 0.0 110.304 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.505 ' CZ ' ' HD3' ' B' ' 10' ' ' LYS . 0.2 OUTLIER -77.7 59.42 2.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 110.353 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -105.63 -165.73 23.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.952 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.4 p -113.95 130.83 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.927 -1.337 . . . . 0.0 109.637 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.733 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.4 OUTLIER -87.71 141.86 28.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.835 . . . . 0.0 110.773 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.747 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -93.71 93.54 8.06 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.861 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.1 OUTLIER -65.64 -15.62 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.914 178.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 6.7 mttt -108.68 179.01 4.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 108.757 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 20.1 m 102.25 20.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.064 -1.648 . . . . 0.0 109.757 2.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 17.5 m-85 -114.52 161.51 17.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 110.685 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.48 170.97 8.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.964 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -72.5 88.76 1.24 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 110.432 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.85 52.2 0.21 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.22 136.58 52.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.759 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 2.0 tm? -67.14 117.38 9.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.73 ' CG2' HG23 ' B' ' 91' ' ' THR . 38.4 t -98.58 85.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.577 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.502 ' O ' HD11 ' B' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.708 -0.62 . . . . 0.0 110.256 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' B' ' 87' ' ' MET . 18.5 tt0 -154.11 160.8 42.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 1.071 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 26.7 p -151.08 160.9 43.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 111.031 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.67 176.73 5.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.301 -0.874 . . . . 0.0 109.851 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -149.16 166.42 28.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.079 . . . . 0.0 111.369 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 1.008 HD11 HD23 ' B' ' 62' ' ' LEU . 48.2 mt -103.12 154.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.973 HG13 HD23 ' B' ' 84' ' ' LEU . 41.6 t -131.16 118.47 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.972 -1.08 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.548 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 29.6 mmt180 -136.78 147.76 46.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.218 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.48 58.71 2.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 111.317 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 1.9 t-20 49.79 -141.33 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.127 -0.983 . . . . 0.0 111.085 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 2.3 t70 67.43 -144.9 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.022 -1.049 . . . . 0.0 110.116 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -48.11 -35.83 12.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.9 -1.125 . . . . 0.0 110.272 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.725 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 17.1 t-105 -63.77 -34.58 78.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 0.0 109.154 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -62.42 -60.44 7.86 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' B' ' 48' ' ' GLU . 54.1 m -65.88 -46.04 79.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -1.197 . . . . 0.0 110.64 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.414 ' O ' ' NH2' ' A' ' 38' ' ' ARG . . . -57.02 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.885 -1.135 . . . . 0.0 109.276 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.737 HD21 ' CE3' ' A' ' 43' ' ' TRP . 4.4 mm? -94.98 36.96 1.16 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.444 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -69.66 61.68 0.16 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -0.953 . . . . 0.0 110.274 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.477 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.9 OUTLIER 178.73 145.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 11.1 m-85 57.37 26.7 12.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.923 -1.111 . . . . 0.0 109.287 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.725 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 3.1 tp -107.82 112.8 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 111.401 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -89.22 108.5 19.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.414 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 23.0 t -107.36 143.89 35.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.006 . . . . 0.0 111.508 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.627 ' HG2' HD13 ' B' ' 84' ' ' LEU . 0.6 OUTLIER -119.46 -168.72 1.63 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.523 -0.736 . . . . 0.0 109.735 178.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 74.81 4.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.369 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.79 -35.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -179.735 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -179.75 -174.27 0.28 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.522 -0.736 . . . . 0.0 110.367 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.463 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 26.4 p -112.16 134.9 53.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 110.399 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -117.09 174.41 6.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 110.65 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.675 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -120.34 159.76 24.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -88.65 99.18 12.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.818 . . . . 0.0 110.238 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 1.008 HD23 HD11 ' B' ' 36' ' ' ILE 2.496 0.1 OUTLIER -58.49 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -179.528 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -63.25 -130.39 0.01 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -90.06 46.22 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -1.162 . . . . 0.0 110.68 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.528 ' CA ' ' HB1' ' B' ' 61' ' ' ALA . . . -90.98 -20.16 40.41 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' B' ' 61' ' ' ALA . . . -91.25 -43.33 9.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 110.627 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.461 ' CD1' ' HB ' ' B' ' 18' ' ' VAL . 1.3 pp -49.09 -25.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.197 -0.939 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.466 ' CE1' HG11 ' B' ' 18' ' ' VAL . 9.2 m-85 -48.96 145.29 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 110.627 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.402 ' HB2' ' CG2' ' B' ' 102' ' ' THR . 73.1 m-80 -118.94 174.75 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.517 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.578 ' CE1' ' CE2' ' B' ' 110' ' ' TRP . 1.8 t-160 -101.68 109.54 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 110.19 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.06 146.71 48.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.5 127.61 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.65 71.1 1.55 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.228 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.543 ' O ' HD11 ' B' ' 92' ' ' ILE . 12.9 Cg_endo -60.66 174.23 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.71 1.374 . . . . 0.0 110.555 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.46 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 17.4 p30 -117.65 -13.09 10.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.07 144.01 51.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.038 -1.039 . . . . 0.0 110.201 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.08 166.91 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.19 159.02 17.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.766 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' B' ' 88' ' ' ARG . 19.7 tt0 -133.06 136.6 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.151 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.574 HD12 ' HD2' ' D' ' 218' ' ' PRO . 6.1 mt -114.51 145.17 42.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.063 -1.023 . . . . 0.0 110.453 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.586 HG23 ' O ' ' B' ' 86' ' ' ARG . 14.2 p -53.95 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 110.385 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.36 -60.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 110.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.59 42.76 1.88 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.973 HD23 HG13 ' B' ' 37' ' ' VAL . 4.4 tp 59.33 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.273 -1.133 . . . . 0.0 110.513 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -177.23 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.03 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.586 ' O ' HG23 ' B' ' 81' ' ' THR . 1.3 mpt_? -113.31 140.06 48.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 1.071 ' SD ' ' SG ' ' B' ' 33' ' ' CYS . 3.9 ppp? -137.2 169.83 17.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 110.71 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.722 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -131.33 -179.66 5.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 0.0 110.648 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 mt -130.32 108.13 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.817 . . . . 0.0 109.597 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.759 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 51.7 m-85 -97.22 -170.66 2.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 110.653 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.73 HG23 ' CG2' ' B' ' 30' ' ' VAL . 23.2 p -128.34 98.86 5.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.429 -0.794 . . . . 0.0 110.162 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.543 HD11 ' O ' ' B' ' 74' ' ' PRO . 48.6 pt -59.98 -16.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.688 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 1.1 ptpm? -148.67 156.92 41.66 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 110.175 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.94 142.86 93.5 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.633 1.333 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.607 HG23 ' HG3' ' B' ' 99' ' ' GLU . 54.6 mt -124.32 141.9 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 110.684 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.65 153.7 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.805 . . . . 0.0 110.886 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.861 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -48.2 -24.97 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 111.243 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.37 60.8 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' B' ' 95' ' ' ILE . 3.4 mm-40 -116.36 165.0 13.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.267 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -112.31 115.0 28.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.476 -0.765 . . . . 0.0 109.003 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.952 ' HB ' HG13 ' B' ' 18' ' ' VAL . 58.4 mt -87.95 127.6 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.997 . . . . 0.0 111.261 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.521 HG23 ' O ' ' B' ' 101' ' ' ILE . 15.8 p -155.68 148.46 24.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.547 HD12 ' O ' ' B' ' 104' ' ' SER . 1.3 pp -115.86 155.25 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 110.793 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.547 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.6 OUTLIER -90.66 -174.08 3.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.527 ' CD2' ' ND1' ' B' ' 70' ' ' HIS . 8.9 m-85 -123.37 -66.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.201 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 -175.28 44.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -33.25 68.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -1.124 . . . . 0.0 110.371 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -66.91 0.61 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 71.94 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.578 ' CE2' ' CE1' ' B' ' 70' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 110.417 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 3.3 p . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.211 0.529 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -160.66 167.87 12.85 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 110.439 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 16.9 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 O-C-N 123.709 1.373 . . . . 0.0 110.46 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 12.9 p90 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.145 0.498 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 5' ' ' ARG . 2.4 m120 -153.93 -81.96 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 111.477 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 6' ' ' VAL . 31.9 t0 -41.3 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.3 mtt180 42.49 20.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.485 -0.759 . . . . 0.0 112.785 177.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 5' ' ' ARG . 44.7 t -158.34 156.29 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.667 -1.271 . . . . 0.0 110.842 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 15.5 tt -143.65 142.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.607 . . . . 0.0 109.717 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 8' ' ' VAL . 11.6 p -89.07 135.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.936 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.9 mttt -141.45 143.86 34.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.636 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.73 56.92 6.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 119.535 -1.978 . . . . 0.0 110.281 4.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.503 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.776 -0.577 . . . . 0.0 110.034 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -95.31 68.29 3.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -1.189 . . . . 0.0 110.496 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.37 -162.88 14.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 67' ' ' ILE . 89.0 t -99.87 136.39 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.281 . . . . 0.0 110.205 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -101.06 128.09 47.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.117 -0.989 . . . . 0.0 109.603 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.866 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.28 97.89 11.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.566 -0.709 . . . . 0.0 111.077 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.863 ' O ' HG23 ' A' ' 97' ' ' ILE . 5.0 ttt180 -75.24 -19.73 59.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.77 4.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.383 -0.823 . . . . 0.0 109.224 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.438 ' HA ' ' HG3' ' A' ' 22' ' ' LYS 2.516 59.4 m 102.2 24.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.119 -1.613 . . . . 0.0 109.922 1.202 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 26.1 m-85 -116.0 160.49 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 110.909 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.37 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 16.7 tttm -97.37 86.75 3.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 110.145 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.2 78.87 1.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' C ' ' CD2' ' A' ' 90' ' ' PHE . 1.2 mt-10 -155.14 138.14 15.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 110.453 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.72 HD11 ' OE1' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -54.48 153.7 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.978 . . . . 0.0 109.612 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 91' ' ' THR . 95.3 t -137.98 -49.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.981 -1.074 . . . . 0.0 110.218 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.897 ' O ' HD12 ' A' ' 89' ' ' ILE . 7.1 tp10 -161.36 115.94 2.03 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.408 -0.808 . . . . 0.0 109.916 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.72 ' OE1' HD11 ' A' ' 29' ' ' LEU . 20.3 pt-20 -124.35 144.8 49.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 110.149 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.44 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 74.8 m -139.68 -160.96 1.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.089 -1.007 . . . . 0.0 111.055 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' NH2' ' A' ' 86' ' ' ARG . 3.0 mm? -94.54 178.56 5.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.371 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -150.91 159.34 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.638 HD11 ' CD2' ' A' ' 62' ' ' LEU . 48.3 mt -105.57 107.02 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 84' ' ' LEU . 87.6 t -88.82 122.33 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.384 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 17.3 tpt180 -139.63 148.73 42.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.34 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.12 -172.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.622 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -96.81 114.43 26.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.511 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.08 -139.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' B' ' 46' ' ' ALA . 2.7 p30 -49.76 -26.43 3.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.801 -1.187 . . . . 0.0 109.733 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.571 ' CE2' HD21 ' A' ' 51' ' ' LEU . 20.3 t-105 -70.63 -43.77 68.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.638 -0.664 . . . . 0.0 109.21 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.88 -28.3 60.45 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -90.61 -63.79 1.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -1.137 . . . . 0.0 110.693 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' HB2' ' OD1' ' B' ' 42' ' ' ASP . . . -48.89 -58.81 4.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.161 -0.962 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.968 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.0 mm? -91.8 41.0 1.05 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.331 -0.856 . . . . 0.0 109.644 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -8.49 31.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.985 . . . . 0.0 111.052 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.43 169.39 9.36 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.894 -1.129 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 52.03 25.95 3.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.428 -0.795 . . . . 0.0 110.57 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.751 HD22 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -115.93 126.56 54.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 0.0 111.077 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -88.85 104.05 16.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 36.1 t -89.02 120.58 30.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.09 -1.007 . . . . 0.0 111.228 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -179.5 4.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.702 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -83.35 80.78 8.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.974 -1.079 . . . . 0.0 109.269 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.21 -23.69 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.777 -0.577 . . . . 0.0 109.922 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.71 -178.47 0.89 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 110.835 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 16.7 m -123.36 139.08 54.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.974 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -132.82 153.22 51.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 111.073 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.968 ' CE ' HD12 ' A' ' 47' ' ' LEU . 38.6 tpp -89.64 155.18 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.76 93.62 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.627 -0.671 . . . . 0.0 110.639 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -55.95 -34.19 65.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 179.847 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 33' ' ' CYS . . . -86.94 -136.94 4.88 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.843 ' HB3' HD11 ' A' ' 67' ' ' ILE . 85.0 m-85 -90.49 19.46 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.349 -1.089 . . . . 0.0 110.617 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.678 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -61.85 -21.18 60.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.52 -59.18 2.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -1.215 . . . . 0.0 111.144 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' ' 64' ' ' PHE . 2.5 pp -53.79 -18.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.283 -0.886 . . . . 0.0 111.648 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE1' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -49.07 146.47 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.852 -1.155 . . . . 0.0 110.735 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.3 171.5 8.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -93.16 148.49 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.58 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.33 131.43 5.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.42 -27.9 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.495 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -117.53 76.51 9.99 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.89 . . . . 0.0 110.386 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.897 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.6 Cg_endo -64.98 104.18 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.665 1.35 . . . . 0.0 110.468 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.476 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 5.5 m-20 -72.15 -10.76 60.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.657 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 90' ' ' PHE . . . -146.22 160.6 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.953 -1.092 . . . . 0.0 110.855 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.03 155.36 43.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.456 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 21.0 p-80 -90.02 136.13 33.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.613 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.41 13.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 110.164 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 80' ' ' LEU . 17.9 mt -121.82 161.53 22.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.499 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 24.0 m -131.32 119.58 21.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.44 -0.787 . . . . 0.0 110.082 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.11 64.57 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.49 -119.51 6.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 37' ' ' VAL . 60.7 mt -118.54 26.51 9.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -1.136 . . . . 0.0 110.346 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.73 -56.69 4.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 110.431 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.459 ' NH2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -119.09 150.38 40.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.75 147.77 41.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -0.999 . . . . 0.0 110.603 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 3.4 mtt180 -125.25 163.03 23.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 110.324 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 31' ' ' GLU . 26.7 mt -136.08 113.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.442 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.573 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 6.3 m-85 -112.58 178.08 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.908 . . . . 0.0 110.792 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 30' ' ' VAL . 15.2 p -121.64 99.07 6.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.376 -0.828 . . . . 0.0 110.496 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.897 HD11 ' O ' ' A' ' 74' ' ' PRO . 21.5 pt -52.8 -28.4 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.044 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.476 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -135.04 144.11 48.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 109.974 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 44.5 Cg_exo -49.21 145.67 14.51 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.619 1.326 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.477 HG21 ' HB1' ' A' ' 20' ' ' ALA . 73.4 mt -122.51 148.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.937 . . . . 0.0 110.568 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.88 152.26 21.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 110.294 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 21' ' ' ARG . 43.8 mt -53.95 -20.29 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.79 . . . . 0.0 111.148 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.58 59.3 0.38 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.13 179.1 6.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.145 -1.209 . . . . 0.0 110.718 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 18' ' ' VAL . 10.0 tt0 -125.22 128.43 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 110.013 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.866 HG13 ' HB2' ' A' ' 20' ' ' ALA . 61.3 mt -89.37 132.54 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 110.548 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 101' ' ' ILE . 13.8 p -151.37 166.24 31.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.641 -0.662 . . . . 0.0 109.888 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 104' ' ' SER . 2.2 pp -137.86 156.45 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.117 -0.989 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.642 ' O ' HD12 ' A' ' 103' ' ' ILE . 37.0 t -91.83 -163.5 1.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.358 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 104' ' ' SER . 15.3 m-85 -132.32 -55.96 0.97 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.298 -0.876 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.74 163.88 2.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.8 OUTLIER 54.62 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -1.017 . . . . 0.0 111.151 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 107' ' ' ASP . 2.6 m-20 58.75 -73.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 107' ' ' ASP . 0.4 OUTLIER -42.09 107.82 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.449 -0.782 . . . . 0.0 111.944 -177.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.801 . . . . 0.0 111.488 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.276 0.56 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.56 144.3 49.18 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.312 -1.363 0 O-C-N 123.623 1.328 . . . . 0.0 110.856 -179.66 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 7' ' ' ILE . 13.2 p90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.266 0.555 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 5' ' ' ARG . 2.4 m120 -155.8 -81.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' B' ' 6' ' ' VAL . 31.9 t0 -41.59 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.586 ' O ' HG23 ' B' ' 6' ' ' VAL . 15.3 mtt180 42.57 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 112.841 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 5' ' ' ARG . 44.6 t -158.31 156.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.591 -1.318 . . . . 0.0 110.831 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 15.4 tt -143.9 142.28 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.65 -0.656 . . . . 0.0 109.789 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 8' ' ' VAL . 11.9 p -88.56 135.47 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 111.088 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.646 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.7 mttt -141.72 143.85 33.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.895 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.81 56.89 6.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.617 -1.927 . . . . 0.0 110.297 4.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.499 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.725 -0.609 . . . . 0.0 110.037 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -95.28 68.36 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.6 -162.81 14.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.521 ' CG2' HD11 ' B' ' 67' ' ' ILE . 85.8 t -99.84 136.23 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.263 . . . . 0.0 110.247 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.509 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -101.03 127.83 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.858 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -88.84 97.87 11.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 111.139 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.852 ' O ' HG23 ' B' ' 97' ' ' ILE . 5.0 ttt180 -75.26 -19.62 59.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.412 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.49 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.82 4.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' B' ' 22' ' ' LYS 2.518 60.7 m 102.26 24.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.187 -1.571 . . . . 0.0 109.909 1.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 26.1 m-85 -115.9 160.54 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 110.92 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.492 -0.755 . . . . 0.0 109.965 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.423 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 16.6 tttm -97.36 86.7 3.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.145 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.18 78.92 1.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.415 ' C ' ' CD2' ' B' ' 90' ' ' PHE . 1.2 mt-10 -155.15 138.12 15.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -1.179 . . . . 0.0 110.471 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.711 HD11 ' OE1' ' B' ' 32' ' ' GLU . 0.3 OUTLIER -54.38 153.73 5.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.123 -0.986 . . . . 0.0 109.602 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.683 HG21 HG23 ' B' ' 91' ' ' THR . 95.5 t -138.05 -49.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.001 -1.062 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.897 ' O ' HD12 ' B' ' 89' ' ' ILE . 7.1 tp10 -161.42 116.0 2.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.711 ' OE1' HD11 ' B' ' 29' ' ' LEU . 20.3 pt-20 -124.42 144.8 49.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.083 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.447 ' HB2' ' CA ' ' B' ' 63' ' ' GLY . 75.9 m -139.68 -160.91 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.019 . . . . 0.0 111.004 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.473 HD21 ' NH2' ' B' ' 86' ' ' ARG . 3.0 mm? -94.53 179.03 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 110.405 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -151.5 159.09 44.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.278 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.643 HD11 ' CD2' ' B' ' 62' ' ' LEU . 48.9 mt -105.61 106.53 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 109.798 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.698 HG22 ' CB ' ' B' ' 84' ' ' LEU . 89.9 t -88.13 122.37 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.51 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CD1' ' B' ' 43' ' ' TRP . 17.3 tpt180 -139.67 148.72 42.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.372 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.11 -172.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.6 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -96.79 114.46 26.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.12 -140.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 109.488 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.564 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 2.7 p30 -49.74 -26.49 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.871 -1.143 . . . . 0.0 109.732 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.598 ' HZ3' HD11 ' A' ' 47' ' ' LEU . 20.3 t-105 -70.54 -43.8 68.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.9 -27.99 60.12 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 88.1 m -91.03 -63.63 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -1.151 . . . . 0.0 110.608 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.491 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . . . -49.11 -58.11 5.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.147 -0.97 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.985 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.0 mm? -92.79 41.29 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -8.48 32.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 111.024 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.38 169.32 9.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.952 -1.093 . . . . 0.0 110.163 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 52.17 25.76 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 110.63 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.755 HD22 ' O ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -115.9 126.1 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 111.187 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.35 103.59 15.97 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 38.1 t -88.24 120.67 29.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.985 . . . . 0.0 111.381 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 177.73 5.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.725 . . . . 0.0 109.709 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -79.43 80.43 5.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 110.126 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.09 -23.82 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.913 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.64 -178.43 0.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.896 . . . . 0.0 110.817 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 16.5 m -123.32 139.01 54.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -132.95 153.04 51.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.014 -1.054 . . . . 0.0 111.112 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.985 ' CE ' HD12 ' B' ' 47' ' ' LEU . 38.7 tpp -89.49 154.73 19.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.681 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.19 93.6 9.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.499 0.1 OUTLIER -56.03 -34.11 65.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 179.781 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' B' ' 33' ' ' CYS . . . -86.9 -136.75 4.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.82 ' HB3' HD11 ' B' ' 67' ' ' ILE . 85.2 m-85 -90.8 19.55 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 110.534 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.681 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -61.87 -20.94 60.47 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.89 -59.1 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.237 . . . . 0.0 111.076 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' B' ' 64' ' ' PHE . 2.5 pp -53.81 -18.3 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.374 -0.829 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.528 ' HE1' HG22 ' B' ' 101' ' ' ILE . 0.2 OUTLIER -49.06 146.54 3.39 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.876 -1.14 . . . . 0.0 110.731 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.38 171.47 8.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -0.917 . . . . 0.0 110.515 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -93.19 148.52 21.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 110.561 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.34 131.36 5.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -27.89 17.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.56 76.51 10.07 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 110.428 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.928 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.7 Cg_endo -64.94 104.17 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.667 1.351 . . . . 0.0 110.496 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 5.6 m-20 -72.13 -10.78 60.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.283 -0.886 . . . . 0.0 110.704 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' B' ' 90' ' ' PHE . . . -146.26 160.64 41.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.064 -1.022 . . . . 0.0 110.822 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.05 155.31 43.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 110.13 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' B' ' 78' ' ' HIS . 21.1 p-80 -89.96 136.14 33.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 110.622 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.425 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.42 13.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.351 -0.843 . . . . 0.0 110.147 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 80' ' ' LEU . 17.7 mt -121.71 161.66 22.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 24.2 m -131.43 119.66 21.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 110.104 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.01 64.62 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.5 -119.57 6.19 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.698 ' CB ' HG22 ' B' ' 37' ' ' VAL . 60.9 mt -118.47 26.52 9.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -1.166 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.69 -56.65 4.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.453 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.473 ' NH2' HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -119.23 150.49 39.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.244 -0.91 . . . . 0.0 110.2 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.82 147.78 41.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.549 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' B' ' 79' ' ' GLU . 3.4 mtt180 -125.29 163.01 23.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.897 HD12 ' O ' ' B' ' 31' ' ' GLU . 26.7 mt -136.05 113.3 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.578 ' O ' ' HB1' ' B' ' 76' ' ' ALA . 6.4 m-85 -112.58 178.05 4.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 110.804 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.683 HG23 HG21 ' B' ' 30' ' ' VAL . 15.1 p -121.63 99.19 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -0.862 . . . . 0.0 110.474 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.928 HD11 ' O ' ' B' ' 74' ' ' PRO . 21.7 pt -52.86 -28.4 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.464 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -135.05 144.13 48.94 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 0.0 109.951 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 46.9 Cg_exo -49.44 145.84 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.599 1.315 . . . . 0.0 110.688 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.477 HG21 ' HB1' ' B' ' 20' ' ' ALA . 73.0 mt -122.53 148.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.71 152.2 21.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.852 HG23 ' O ' ' B' ' 21' ' ' ARG . 43.7 mt -53.86 -20.4 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.436 -0.79 . . . . 0.0 111.116 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.63 59.37 0.37 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.2 178.93 6.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.073 -1.251 . . . . 0.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' B' ' 18' ' ' VAL . 10.0 tt0 -125.28 128.29 48.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' B' ' 20' ' ' ALA . 61.3 mt -89.13 132.54 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.88 . . . . 0.0 110.623 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.417 HG23 ' O ' ' B' ' 101' ' ' ILE . 13.5 p -151.32 166.27 31.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.843 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.632 HD12 ' O ' ' B' ' 104' ' ' SER . 2.2 pp -137.85 156.38 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 110.596 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.632 ' O ' HD12 ' B' ' 103' ' ' ILE . 36.6 t -91.78 -163.51 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.416 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 15.3 m-85 -132.27 -56.14 0.97 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.91 163.84 2.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.8 OUTLIER 54.67 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -1.025 . . . . 0.0 111.126 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 107' ' ' ASP . 2.5 m-20 58.73 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' B' ' 107' ' ' ASP . 0.4 OUTLIER -42.05 107.73 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 112.016 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 111.48 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.236 0.541 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.5 144.32 49.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.282 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 O-C-N 123.667 1.351 . . . . 0.0 110.788 -179.587 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 47.3 p90 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.31 0.576 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -131.97 164.7 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -50.23 -24.06 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.717 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.521 ' C ' HG13 ' A' ' 6' ' ' VAL . 6.3 mmm-85 -78.33 -44.62 24.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 110.707 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.521 HG13 ' C ' ' A' ' 5' ' ' ARG . 29.8 m -153.37 -172.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.481 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 19' ' ' PHE . 3.0 tt -145.43 143.21 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.349 -0.844 . . . . 0.0 109.777 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.66 118.34 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.951 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.581 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 10.3 mttt -121.77 144.39 48.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.412 -0.805 . . . . 0.0 109.197 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.581 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.72 71.55 0.47 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.658 -1.901 . . . . 0.0 111.641 0.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 110.069 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.71 ' OH ' HD21 ' B' ' 34' ' ' LEU . 0.2 OUTLIER -91.8 104.42 16.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -1.134 . . . . 0.0 110.295 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.88 -170.6 15.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.674 HG23 HD13 ' A' ' 67' ' ' ILE . 75.9 t -105.52 145.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.969 -1.312 . . . . 0.0 110.49 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.699 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.6 m-85 -109.99 120.44 42.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.395 -0.815 . . . . 0.0 109.405 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.93 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.54 90.13 8.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 111.123 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.851 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.23 -24.43 59.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 177.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.488 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 13.7 mtpt -94.9 178.99 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.467 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 51.8 m 104.11 23.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.007 -1.683 . . . . 0.0 109.67 2.007 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.488 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 12.2 m-85 -112.23 159.94 18.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 110.567 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 1.2 tt0 -91.13 -157.63 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.888 . . . . 0.0 110.316 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 59.2 tttt -98.85 73.58 2.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 110.564 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.87 77.12 0.84 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 25' ' ' GLU . 4.2 mm-40 -138.34 18.45 2.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -1.141 . . . . 0.0 110.565 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 90' ' ' PHE . 16.3 tp 59.61 147.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.49 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.543 ' CG2' HG23 ' A' ' 91' ' ' THR . 83.8 t -126.97 -39.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.973 -1.08 . . . . 0.0 110.243 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.95 161.67 8.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.37 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.6 143.93 22.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.506 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' C ' HD12 ' A' ' 34' ' ' LEU . 1.2 m -149.25 -164.96 2.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.658 HD21 ' OH ' ' B' ' 16' ' ' TYR . 11.0 mp -100.36 176.97 5.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.358 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 153.59 41.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.677 HD11 ' CD2' ' A' ' 62' ' ' LEU . 39.3 mt -94.75 97.29 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.958 . . . . 0.0 109.268 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.884 HG13 HD23 ' A' ' 84' ' ' LEU . 59.6 t -88.42 114.63 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.295 -0.878 . . . . 0.0 110.466 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -126.07 148.75 49.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 110.391 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.35 159.87 5.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.242 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -69.92 113.22 6.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.38 -142.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.854 . . . . 0.0 109.543 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.52 -25.26 3.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.869 -1.145 . . . . 0.0 109.986 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.682 ' CZ2' HD21 ' A' ' 51' ' ' LEU . 43.8 t-105 -66.06 -54.55 24.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.788 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.8 -32.65 59.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -78.3 -63.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.1 -51.86 49.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.669 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.011 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.1 mm? -91.14 30.07 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 110.729 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.43 -24.7 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.291 -0.881 . . . . 0.0 111.547 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 3.3 p30 -99.88 151.8 20.88 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.947 -1.095 . . . . 0.0 110.55 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.511 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 9.6 m-85 61.01 19.27 9.74 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.779 -0.576 . . . . 0.0 111.048 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.682 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 6.7 mt -104.81 123.2 47.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.017 . . . . 0.0 110.789 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -89.12 105.9 18.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 108.455 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.2 p -87.87 118.91 27.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.169 -0.957 . . . . 0.0 111.071 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 1.002 ' HD3' HD13 ' A' ' 84' ' ' LEU . 5.4 ttp180 -98.76 -178.83 4.1 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.73 . . . . 0.0 110.038 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -83.87 81.54 8.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.054 . . . . 0.0 109.373 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.51 23.6 p30 149.06 -20.76 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.769 -0.582 . . . . 0.0 109.914 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -177.01 -162.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.286 -0.883 . . . . 0.0 110.612 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 81.3 p -143.17 153.18 42.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.402 -0.811 . . . . 0.0 110.114 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.675 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.717 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 1.011 ' CE ' HD12 ' A' ' 47' ' ' LEU . 28.3 tpp -89.44 152.98 21.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.049 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -87.89 109.11 19.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.852 . . . . 0.0 110.294 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.743 ' O ' HD13 ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -56.68 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.785 . . . . 0.0 110.985 -179.775 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.15 -168.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.63 ' O ' HD11 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -73.14 56.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -1.169 . . . . 0.0 111.323 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -91.5 -23.45 28.73 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -91.13 2.7 56.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 111.502 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.712 HD12 ' N ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -90.31 -8.6 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.794 -1.191 . . . . 0.0 110.733 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.712 ' N ' HD12 ' A' ' 67' ' ' ILE . 18.3 m-85 -56.03 131.93 48.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 0.0 109.925 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -98.48 179.1 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.974 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.57 115.92 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.832 . . . . 0.0 110.405 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.11 141.54 46.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 110.535 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -61.64 120.85 11.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.942 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.26 84.34 0.21 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.835 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.4 Cg_endo -64.13 107.28 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.691 1.364 . . . . 0.0 110.467 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.29 -18.51 27.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.603 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -131.4 119.44 21.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.972 . . . . 0.0 110.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.73 -170.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.417 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 26.5 p-80 -129.19 163.07 26.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.838 . . . . 0.0 110.314 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -139.63 159.29 42.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.529 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 84' ' ' LEU . 8.7 mt -118.38 150.16 39.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.181 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 86' ' ' ARG . 6.6 p -68.93 67.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 80' ' ' LEU . . . 51.24 39.83 24.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.56 -136.46 4.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.002 HD13 ' HD3' ' A' ' 54' ' ' ARG . 5.5 tp -132.08 86.67 2.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -1.107 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -49.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.514 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.639 ' HB2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -124.76 123.62 40.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.1 mtp -95.24 154.7 17.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' HIS . 83.5 mtt-85 -138.75 164.23 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.043 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.31 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.732 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 18.3 m-85 -91.79 157.95 16.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 110.602 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.543 HG23 ' CG2' ' A' ' 30' ' ' VAL . 7.7 p -101.94 83.11 2.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.835 HD11 ' O ' ' A' ' 74' ' ' PRO . 6.1 pt -52.88 -23.48 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 110.555 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 92' ' ' ILE . 17.9 mmtt -137.48 134.57 18.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 89.6 Cg_exo -46.35 140.61 11.23 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.437 1.23 . . . . 0.0 111.119 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 20' ' ' ALA . 58.9 mt -117.95 141.81 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -89.61 166.49 13.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 110.449 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.851 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.0 mt -71.58 127.11 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.58 18.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 1.1 tm-20 -100.21 -175.77 3.03 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.139 -1.212 . . . . 0.0 110.022 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -126.16 124.47 40.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.106 -0.996 . . . . 0.0 110.307 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.93 HG13 ' HB2' ' A' ' 20' ' ' ALA . 62.8 mt -89.86 130.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.193 -0.942 . . . . 0.0 110.548 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.541 HG23 ' C ' ' A' ' 101' ' ' ILE . 72.8 p -154.67 -166.85 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -148.68 -167.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 110.444 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.673 ' O ' HD12 ' A' ' 103' ' ' ILE . 3.4 t -102.71 -148.26 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 110.154 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.85 -86.55 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.418 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.07 1.69 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.49 -1.07 18.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 110.996 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.97 -40.39 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.967 -1.083 . . . . 0.0 110.565 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.84 105.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.952 . . . . 0.0 110.599 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 15.6 m95 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 111.083 179.333 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.507 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.724 . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 54.98 172.72 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 110.448 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 19.2 Cg_exo . . . . . 0 C--N 1.313 -1.325 0 O-C-N 123.613 1.323 . . . . 0.0 110.443 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 47.3 p90 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.351 0.596 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -131.98 164.81 25.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 110.226 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -50.3 -24.09 2.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 110.664 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.538 ' C ' HG13 ' B' ' 6' ' ' VAL . 6.3 mmm-85 -78.27 -44.68 24.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.651 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.538 HG13 ' C ' ' B' ' 5' ' ' ARG . 30.2 m -153.35 -172.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.707 HG23 ' HB2' ' B' ' 19' ' ' PHE . 3.0 tt -145.43 143.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.48 118.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.036 -1.04 . . . . 0.0 110.99 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.598 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 10.2 mttt -121.9 144.37 48.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.472 -0.767 . . . . 0.0 109.221 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.598 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.74 71.62 0.47 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.711 -1.868 . . . . 0.0 111.569 0.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.658 ' OH ' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -91.73 104.57 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -1.158 . . . . 0.0 110.364 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.1 -170.64 15.56 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.676 HG23 HD13 ' B' ' 67' ' ' ILE . 77.2 t -105.53 145.06 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.946 -1.326 . . . . 0.0 110.449 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.707 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.6 m-85 -110.0 120.35 42.18 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.466 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.893 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.41 90.14 8.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 111.18 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.31 -24.34 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 177.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.482 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 13.7 mtpt -94.92 179.04 5.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.524 -0.735 . . . . 0.0 109.031 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.453 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 51.9 m 104.09 23.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.095 -1.628 . . . . 0.0 109.677 2.012 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 12.3 m-85 -112.21 159.96 18.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.619 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.409 ' HB2' ' HG3' ' B' ' 28' ' ' GLU . 1.2 tt0 -91.16 -157.62 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.261 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.424 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 59.1 tttt -98.83 73.55 2.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.548 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 77.02 0.83 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' B' ' 25' ' ' GLU . 4.2 mm-40 -138.3 18.4 2.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 110.586 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.737 HD13 ' CZ ' ' B' ' 90' ' ' PHE . 16.2 tp 59.75 147.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.418 -0.802 . . . . 0.0 110.503 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.548 ' CG2' HG23 ' B' ' 91' ' ' THR . 83.8 t -127.02 -39.82 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.042 . . . . 0.0 110.279 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.97 161.71 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.336 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' B' ' 87' ' ' MET . 3.8 pm0 -153.66 143.86 22.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.453 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.483 ' C ' HD12 ' B' ' 34' ' ' LEU . 1.2 m -149.17 -164.95 2.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.398 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.71 HD21 ' OH ' ' A' ' 16' ' ' TYR . 11.0 mp -100.34 176.95 5.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.94 153.57 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.676 HD11 ' CD2' ' B' ' 62' ' ' LEU . 39.4 mt -94.78 96.4 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.393 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.877 HG13 HD23 ' B' ' 84' ' ' LEU . 54.8 t -87.21 114.7 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 110.651 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.511 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -126.21 148.71 49.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.31 159.88 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -69.87 113.15 6.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.451 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.35 -142.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.523 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.48 -25.33 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.812 -1.18 . . . . 0.0 110.004 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.677 ' CZ2' HD21 ' B' ' 51' ' ' LEU . 43.7 t-105 -66.02 -54.55 24.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.593 -0.692 . . . . 0.0 109.781 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.85 -32.52 59.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -78.39 -63.23 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.153 . . . . 0.0 110.533 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.21 -51.4 54.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 110.69 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.998 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.1 mm? -91.83 30.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.484 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.52 -24.74 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.245 -0.91 . . . . 0.0 111.505 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.469 ' OD1' ' CD2' ' B' ' 50' ' ' TYR . 3.2 p30 -99.72 151.79 20.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 9.4 m-85 60.96 19.2 9.61 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.654 -0.654 . . . . 0.0 111.057 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.677 HD21 ' CZ2' ' B' ' 43' ' ' TRP . 6.6 mt -104.89 123.02 46.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 0.0 110.893 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -88.77 104.98 17.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.706 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 57.0 p -86.55 119.04 26.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 111.322 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.992 ' HD3' HD13 ' B' ' 84' ' ' LEU . 5.4 ttp180 -99.49 178.67 4.8 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.473 -0.767 . . . . 0.0 110.066 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -80.2 81.17 6.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.957 . . . . 0.0 110.187 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 23.5 p30 148.96 -20.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.677 -0.64 . . . . 0.0 109.942 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.4 ptm -176.83 -161.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.934 . . . . 0.0 110.745 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.451 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 81.4 p -143.2 153.2 42.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 110.044 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.665 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -139.58 145.69 38.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 110.703 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.998 ' CE ' HD12 ' B' ' 47' ' ' LEU . 28.5 tpp -89.34 152.15 21.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -86.83 109.02 19.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.451 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 62' ' ' LEU 2.5 0.2 OUTLIER -56.68 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -0.794 . . . . 0.0 110.919 -179.908 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.36 -168.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.629 ' O ' HD11 ' B' ' 67' ' ' ILE . 0.1 OUTLIER -73.19 57.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.18 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' B' ' 68' ' ' PHE . . . -92.52 -22.48 28.89 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -92.03 3.09 56.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 111.378 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.721 HD12 ' N ' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -90.53 -8.55 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.811 -1.18 . . . . 0.0 110.724 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.721 ' N ' HD12 ' B' ' 67' ' ' ILE . 18.3 m-85 -56.05 131.98 48.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 0.0 109.907 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -98.57 179.12 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.967 . . . . 0.0 110.968 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.56 115.95 21.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.84 . . . . 0.0 110.404 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.13 141.6 46.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -61.68 120.86 11.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.31 84.27 0.21 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.822 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.5 Cg_endo -64.04 107.33 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.734 1.386 . . . . 0.0 110.484 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.32 -18.49 27.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 110.632 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.565 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -131.4 119.36 21.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 0.0 110.382 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.7 -170.46 1.8 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 110.454 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.415 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 26.5 p-80 -129.2 162.99 26.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -139.64 159.32 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 110.514 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.442 HD22 HD12 ' B' ' 84' ' ' LEU . 8.8 mt -118.36 150.15 40.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.644 HG21 ' HB2' ' B' ' 86' ' ' ARG . 6.4 p -69.01 67.26 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 110.562 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' B' ' 80' ' ' LEU . . . 51.3 39.78 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.765 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.63 -136.51 4.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.992 HD13 ' HD3' ' B' ' 54' ' ' ARG . 5.5 tp -132.05 86.73 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -1.083 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.4 -49.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.644 ' HB2' HG21 ' B' ' 81' ' ' THR . 0.0 OUTLIER -124.74 123.7 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 110.171 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' B' ' 32' ' ' GLU . 22.1 mtp -95.29 154.57 17.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 110.656 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' B' ' 78' ' ' HIS . 83.5 mtt-85 -138.64 164.3 29.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 110.083 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.24 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.978 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.737 ' CZ ' HD13 ' B' ' 29' ' ' LEU . 18.4 m-85 -91.79 157.96 16.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.548 HG23 ' CG2' ' B' ' 30' ' ' VAL . 7.8 p -101.89 83.08 2.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.183 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.822 HD11 ' O ' ' B' ' 74' ' ' PRO . 6.1 pt -52.93 -23.46 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.895 . . . . 0.0 110.548 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.424 ' N ' HG13 ' B' ' 92' ' ' ILE . 17.9 mmtt -137.45 134.37 18.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 85.4 Cg_exo -46.6 140.88 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.424 1.223 . . . . 0.0 111.08 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.42 HG21 ' CB ' ' B' ' 20' ' ' ALA . 59.0 mt -117.99 141.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.616 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -89.21 166.61 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.51 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.0 mt -71.71 127.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.4 23.57 18.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 96' ' ' ALA . 1.1 tm-20 -100.01 -176.04 3.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.258 -1.142 . . . . 0.0 110.076 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -126.08 124.46 40.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.998 . . . . 0.0 110.282 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.893 HG13 ' HB2' ' B' ' 20' ' ' ALA . 62.7 mt -89.84 130.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.533 HG23 ' C ' ' B' ' 101' ' ' ILE . 72.2 p -154.55 -166.77 2.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.0 109.664 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.669 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -148.73 -167.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.459 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.669 ' O ' HD12 ' B' ' 103' ' ' ILE . 3.4 t -102.64 -148.3 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 110.159 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.82 -86.57 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.98 -132.04 1.68 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.54 -1.03 18.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 0.0 110.977 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.89 -40.46 0.61 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.929 -1.107 . . . . 0.0 110.614 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.79 105.14 1.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.608 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 15.7 m95 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.517 -0.739 . . . . 0.0 111.06 179.313 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.508 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.175 0.512 . . . . 0.0 110.7 . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 54.9 172.78 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 19.0 Cg_exo . . . . . 0 C--N 1.312 -1.374 0 O-C-N 123.651 1.342 . . . . 0.0 110.439 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 15.2 p90 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.378 0.608 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.88 151.25 36.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.47 -28.04 3.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.3 -0.875 . . . . 0.0 110.825 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.12 25.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 110.352 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' A' ' 5' ' ' ARG . 36.0 m -153.71 156.24 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.272 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.693 HG23 ' HB2' ' A' ' 19' ' ' PHE . 17.2 tt -128.74 155.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' H ' HG12 ' A' ' 8' ' ' VAL . 8.2 p -97.89 133.42 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.862 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.594 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 7.6 mttt -130.86 142.73 50.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.35 -0.844 . . . . 0.0 109.313 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.594 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 20.0 mttt 52.74 62.23 2.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 119.631 -1.918 . . . . 0.0 111.219 0.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.459 -0.776 . . . . 0.0 110.296 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 1.5 m-85 -74.47 81.81 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -1.201 . . . . 0.0 110.353 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.467 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -121.13 -169.07 13.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 72.4 t -110.86 146.6 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.892 -1.358 . . . . 0.0 110.396 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.693 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.2 m-85 -111.33 122.41 47.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 109.998 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.817 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -92.34 92.01 7.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 110.839 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.0 -21.63 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 178.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 22.7 mtpt -90.68 -179.3 5.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.88 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HE3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 108.29 15.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.167 -1.583 . . . . 0.0 110.378 0.922 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 40.1 m-85 -109.18 148.59 30.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.083 -1.011 . . . . 0.0 110.716 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.29 -161.33 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 69.99 3.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -137.69 122.23 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -1.171 . . . . 0.0 110.24 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 ' HB3' ' A' ' 88' ' ' ARG . 1.3 tm? -65.8 115.69 6.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.893 . . . . 0.0 110.417 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 29' ' ' LEU . 85.3 t -94.39 74.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 110.057 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 30' ' ' VAL . 3.5 tt0 59.06 154.1 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.5 0.667 . . . . 0.0 110.821 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 88' ' ' ARG . 9.4 pt-20 -157.28 161.24 39.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.26 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.53 -170.7 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.622 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ARG . 58.4 mt -90.47 -170.24 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.436 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 14.0 m -147.18 160.77 42.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 110.024 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.607 HD11 ' CD2' ' A' ' 62' ' ' LEU . 27.2 mt -96.07 102.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 109.345 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.6 129.24 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 110.663 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 6.0 mmt180 -145.81 151.69 38.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.437 -0.789 . . . . 0.0 110.127 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.3 -179.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.972 . . . . 0.0 110.369 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.37 112.37 23.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.53 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.25 -142.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -50.81 -25.25 4.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.719 -1.238 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.513 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 45.6 t-105 -56.12 -64.44 0.86 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.25 -28.39 58.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.7 m -70.54 -67.75 0.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -1.179 . . . . 0.0 110.523 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.03 84.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.558 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.995 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.3 mm? -90.34 41.02 1.03 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.623 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.34 3.97 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.106 -0.996 . . . . 0.0 110.519 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.12 -81.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.484 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.467 ' CD1' ' HA ' ' A' ' 66' ' ' ALA . 12.5 m-85 -96.96 52.38 1.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.368 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.708 HD13 ' HB3' ' A' ' 47' ' ' LEU . 1.3 tp -111.89 131.45 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 111.167 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -92.35 -178.29 4.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 p -144.22 123.21 12.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 111.042 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.608 ' CB ' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -110.82 173.52 6.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.608 -0.682 . . . . 0.0 109.372 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 54' ' ' ARG . 13.1 mttm -82.68 70.8 9.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.0 109.237 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.2 t30 166.5 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.96 -167.87 0.25 Allowed 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 37.6 p -120.71 166.88 13.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.443 -0.786 . . . . 0.0 109.434 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.66 ' HB3' HD22 ' A' ' 84' ' ' LEU . . . -150.06 151.69 33.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.922 -1.111 . . . . 0.0 111.062 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.995 ' CE ' HD12 ' A' ' 47' ' ' LEU . 18.2 tpp -89.55 154.32 20.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.667 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.57 91.64 8.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.945 HD22 HD22 ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -55.54 -45.27 77.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.51 179.591 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.73 -141.22 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.826 ' HB3' HD11 ' A' ' 67' ' ' ILE . 29.3 m-85 -90.6 11.09 23.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -1.185 . . . . 0.0 110.903 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.667 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -47.37 -30.79 6.15 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . . . -66.51 -75.28 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.199 -1.177 . . . . 0.0 109.793 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 64' ' ' PHE . 2.4 pp -56.74 -18.8 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 111.364 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.649 ' HE1' HD13 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -51.81 132.42 31.53 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.04 -1.038 . . . . 0.0 109.936 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.661 ' CB ' HG22 ' A' ' 102' ' ' THR . 13.4 m-20 -109.05 177.26 4.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.957 -1.089 . . . . 0.0 111.451 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.522 ' CD2' ' N ' ' A' ' 71' ' ' SER . 13.3 t60 -103.0 157.56 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.522 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 29.3 t -149.96 140.93 22.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 110.603 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -29.78 50.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.87 96.07 39.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.594 ' O ' HD11 ' A' ' 92' ' ' ILE . 31.9 Cg_exo -54.0 119.71 6.75 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.648 1.341 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.463 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 19.7 p30 -110.58 -21.77 11.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -146.35 149.93 34.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.506 ' HB2' HG23 ' A' ' 92' ' ' ILE . 3.4 mtt180 -128.19 -173.39 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 110.186 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 2.7 p-80 -128.81 175.95 8.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.649 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 87' ' ' MET . 24.0 tt0 -137.66 153.26 49.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.832 HD23 ' HG2' ' A' ' 87' ' ' MET . 80.1 mt -123.83 135.5 53.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -79.92 -168.76 1.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 88.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 110.467 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 87.12 58.38 1.89 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 59' ' ' ALA . 8.0 mt 55.72 -111.6 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.375 -1.074 . . . . 0.0 110.084 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER 58.55 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.625 -1.297 . . . . 0.0 111.078 179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -97.38 139.82 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 110.536 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.832 ' HG2' HD23 ' A' ' 80' ' ' LEU . 11.0 mtp -129.64 144.47 51.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.869 ' HB3' HD21 ' A' ' 29' ' ' LEU . 5.5 mtp180 -124.87 162.93 23.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.21 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HE1' ' A' ' 68' ' ' PHE . 81.2 mt -123.0 99.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.848 . . . . 0.0 109.661 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 2.0 m-85 -96.36 -174.2 2.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.718 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 11.9 p -127.48 98.89 5.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.594 HD11 ' O ' ' A' ' 74' ' ' PRO . 45.4 pt -55.64 -25.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.617 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -144.53 146.77 33.72 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.172 -0.955 . . . . 0.0 110.438 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.12 125.89 20.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.685 1.361 . . . . 0.0 110.492 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.9 144.58 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.59 156.88 18.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 110.457 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 21' ' ' ARG . 73.3 mt -66.8 113.68 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.38 30.71 2.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.92 -170.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.296 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 43.1 tt0 -128.39 133.7 48.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.817 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 26.4 mt -89.32 131.32 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.2 -0.937 . . . . 0.0 109.932 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.661 HG22 ' CB ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -158.9 164.56 35.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.604 HG23 ' CE2' ' A' ' 68' ' ' PHE . 8.2 pt -132.94 162.41 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.618 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.457 ' HA ' ' ND1' ' A' ' 70' ' ' HIS . 1.4 m -91.71 174.83 7.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.205 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 70' ' ' HIS . 15.8 m-85 -126.86 -70.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 67.35 -163.67 45.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.66 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -1.045 . . . . 0.0 110.622 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -100.04 -42.47 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 0.0 110.341 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.453 ' HB2' ' CB ' ' A' ' 105' ' ' TYR . 19.1 m-85 -61.88 141.91 57.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.4 -0.812 . . . . 0.0 110.558 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.245 0.545 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' C' ' 218' ' ' PRO . . . -136.22 152.11 74.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 217' ' ' ALA . 33.6 Cg_exo . . . . . 0 C--N 1.312 -1.345 0 O-C-N 123.699 1.368 . . . . 0.0 110.517 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 15.4 p90 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.322 0.582 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.89 151.23 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -0.818 . . . . 0.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.43 -28.05 3.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.794 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.2 25.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' B' ' 5' ' ' ARG . 35.9 m -153.62 156.26 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.719 HG23 ' HB2' ' B' ' 19' ' ' PHE . 17.2 tt -128.74 155.59 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.395 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.424 HG13 ' O ' ' B' ' 8' ' ' VAL . 8.2 p -97.85 133.47 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.85 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 7.6 mttt -130.93 142.68 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.846 . . . . 0.0 109.315 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.6 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 20.0 mttt 52.67 62.33 2.74 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 119.675 -1.89 . . . . 0.0 111.199 0.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 2.6 p . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 110.31 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 1.5 m-85 -74.52 81.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.325 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.466 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -121.14 -169.02 13.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 69.0 t -110.92 146.17 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.929 -1.336 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.719 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.2 m-85 -111.27 122.4 47.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.817 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -92.38 92.08 7.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 110.825 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.98 -21.7 61.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.836 178.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 22.9 mtpt -90.63 -179.18 5.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.419 -0.801 . . . . 0.0 109.889 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.405 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 0.0 OUTLIER 108.32 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.206 -1.559 . . . . 0.0 110.43 0.896 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 40.0 m-85 -109.17 148.58 30.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.01 . . . . 0.0 110.688 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.33 -161.3 0.8 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 70.0 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 110.312 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -137.66 122.29 18.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -1.128 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.846 HD21 ' HB3' ' B' ' 88' ' ' ARG . 1.3 tm? -65.85 115.62 6.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 110.445 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.481 ' N ' HD13 ' B' ' 29' ' ' LEU . 85.9 t -94.3 74.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -0.853 . . . . 0.0 110.012 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' B' ' 30' ' ' VAL . 3.5 tt0 59.08 154.11 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.648 -0.657 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' B' ' 88' ' ' ARG . 9.4 pt-20 -157.18 161.5 39.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 110.269 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.85 -170.78 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.427 HD23 ' CG ' ' B' ' 86' ' ' ARG . 58.8 mt -90.46 -170.24 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 14.4 m -147.17 160.71 42.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' B' ' 62' ' ' LEU . 27.0 mt -96.07 102.32 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.089 -1.007 . . . . 0.0 109.411 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.67 129.33 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 5.9 mmt180 -145.99 151.71 38.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.26 -179.11 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.39 112.37 23.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.28 -142.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.831 . . . . 0.0 109.568 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -50.82 -25.31 4.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.766 -1.208 . . . . 0.0 109.855 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.622 ' HZ3' HD11 ' A' ' 47' ' ' LEU . 45.6 t-105 -56.05 -64.47 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.918 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.23 -28.37 58.74 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 75.8 m -70.5 -67.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.572 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.85 84.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 110.658 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.989 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.3 mm? -90.55 41.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.604 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.24 3.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 110.512 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.14 -81.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.471 ' CD1' ' HA ' ' B' ' 66' ' ' ALA . 12.5 m-85 -96.9 52.41 1.17 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 0.0 109.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' B' ' 47' ' ' LEU . 1.3 tp -111.89 131.54 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 111.108 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -92.34 -178.24 4.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.388 -0.82 . . . . 0.0 109.683 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 25.0 p -144.16 123.26 12.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.044 -1.035 . . . . 0.0 111.04 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.615 ' CB ' HD11 ' B' ' 84' ' ' LEU . 0.4 OUTLIER -111.5 170.6 8.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 178.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' B' ' 54' ' ' ARG . 14.1 mttm -78.54 70.13 4.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.089 . . . . 0.0 110.178 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 1.2 t30 166.58 -28.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.76 -167.83 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.454 -0.779 . . . . 0.0 110.954 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.432 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 37.5 p -120.69 166.84 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.449 -0.782 . . . . 0.0 109.419 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.679 ' HB3' HD22 ' B' ' 84' ' ' LEU . . . -150.04 151.54 33.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.93 -1.106 . . . . 0.0 111.058 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.989 ' CE ' HD12 ' B' ' 47' ' ' LEU . 18.2 tpp -89.43 153.39 20.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.653 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -86.28 91.58 8.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.836 . . . . 0.0 110.88 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.945 HD22 HD22 ' A' ' 62' ' ' LEU 2.498 0.2 OUTLIER -55.62 -45.24 77.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 110.518 179.432 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.74 -140.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.814 ' HB3' HD11 ' B' ' 67' ' ' ILE . 29.0 m-85 -91.02 11.21 23.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -1.143 . . . . 0.0 110.823 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.653 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -47.39 -30.8 6.2 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' B' ' 50' ' ' TYR . . . -66.54 -75.46 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.179 -1.189 . . . . 0.0 109.84 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.814 HD11 ' HB3' ' B' ' 64' ' ' PHE . 2.4 pp -56.48 -18.99 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.65 ' HE1' HD13 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -51.65 132.36 30.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.907 -1.12 . . . . 0.0 109.85 178.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.644 ' CB ' HG22 ' B' ' 102' ' ' THR . 13.3 m-20 -108.9 177.92 4.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.018 -1.051 . . . . 0.0 111.351 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' B' ' 71' ' ' SER . 13.2 t60 -104.04 157.33 17.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . 0.52 ' N ' ' CD2' ' B' ' 70' ' ' HIS . 29.5 t -149.79 140.85 22.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.632 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.81 49.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.8 96.02 39.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.395 -0.816 . . . . 0.0 109.961 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.608 ' O ' HD11 ' B' ' 92' ' ' ILE . 31.9 Cg_exo -53.97 119.75 6.79 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.655 1.345 . . . . 0.0 110.682 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.463 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 19.7 p30 -110.56 -21.84 11.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -146.36 149.9 34.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.332 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.515 ' HB2' HG23 ' B' ' 92' ' ' ILE . 3.4 mtt180 -128.11 -173.34 2.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.179 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 2.7 p-80 -128.88 175.98 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 110.671 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' B' ' 87' ' ' MET . 23.9 tt0 -137.66 153.21 49.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.797 HD23 ' HG2' ' B' ' 87' ' ' MET . 80.3 mt -123.8 135.52 53.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 110.215 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 83' ' ' GLY . 0.0 OUTLIER -79.99 -168.69 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -0.905 . . . . 0.0 110.113 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 110.495 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.456 ' HA3' ' HZ1' ' B' ' 85' ' ' LYS . . . 87.16 58.32 1.89 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.679 HD22 ' HB3' ' B' ' 59' ' ' ALA . 8.0 mt 55.76 -111.68 0.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.408 -1.054 . . . . 0.0 110.078 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.456 ' HZ1' ' HA3' ' B' ' 83' ' ' GLY . 0.2 OUTLIER 58.44 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.586 -1.321 . . . . 0.0 111.076 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.427 ' CG ' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -97.28 139.79 32.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.489 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.797 ' HG2' HD23 ' B' ' 80' ' ' LEU . 11.1 mtp -129.59 144.48 51.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 110.438 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.846 ' HB3' HD21 ' B' ' 29' ' ' LEU . 5.5 mtp180 -124.86 162.92 23.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.65 HD13 ' HE1' ' B' ' 68' ' ' PHE . 81.1 mt -123.01 99.75 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.825 . . . . 0.0 109.617 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.685 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 2.0 m-85 -96.31 -174.17 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.737 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -127.52 98.83 5.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.608 HD11 ' O ' ' B' ' 74' ' ' PRO . 45.4 pt -55.62 -25.07 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.632 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.1 OUTLIER -144.48 146.79 33.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 110.497 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 93' ' ' LYS . 37.6 Cg_exo -56.2 125.9 20.6 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.709 1.373 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.96 144.42 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 110.333 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.42 156.93 18.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.465 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 73.3 mt -66.84 113.63 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.47 30.75 2.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.99 -170.31 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 110.281 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 43.3 tt0 -128.43 133.5 48.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.289 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.817 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 27.1 mt -88.96 131.35 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 110.104 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.644 HG22 ' CB ' ' B' ' 69' ' ' ASN . 1.0 OUTLIER -158.87 164.68 35.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.785 -0.572 . . . . 0.0 109.727 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 76' ' ' ALA . 8.2 pt -132.95 162.35 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.454 ' HA ' ' ND1' ' B' ' 70' ' ' HIS . 1.4 m -91.73 174.8 7.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' B' ' 70' ' ' HIS . 15.8 m-85 -126.76 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 110.501 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 67.42 -163.59 45.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.63 -86.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.439 -1.036 . . . . 0.0 110.635 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -100.14 -42.62 6.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.275 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.452 ' HB2' ' CB ' ' B' ' 105' ' ' TYR . 19.2 m-85 -61.7 141.98 57.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.339 -0.85 . . . . 0.0 110.558 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.2 0.524 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -136.24 152.15 74.68 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.395 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 C--N 1.313 -1.342 0 O-C-N 123.662 1.348 . . . . 0.0 110.545 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.482 ' CD1' HD12 ' A' ' 7' ' ' ILE . 14.6 t80 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.41 0.624 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' ARG . 11.8 m120 -90.17 55.36 3.06 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.405 -0.809 . . . . 0.0 110.046 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t70 52.97 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 111.371 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.529 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -50.55 -33.82 23.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 111.01 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.529 HG23 ' C ' ' A' ' 5' ' ' ARG . 89.2 t -152.37 138.5 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.067 -1.021 . . . . 0.0 111.245 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.602 HG23 ' HB2' ' A' ' 19' ' ' PHE . 12.7 tt -114.61 162.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 110.062 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 64' ' ' PHE . 96.1 t -106.85 120.06 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 16.7 mttt -116.69 144.03 44.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.6 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 25.0 mttt 52.38 63.04 2.4 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.725 -1.86 . . . . 0.0 111.355 0.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.423 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.827 . . . . 0.0 110.344 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.58 71.6 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.349 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -108.69 -172.32 21.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.858 ' CG2' HD13 ' A' ' 67' ' ' ILE . 94.1 t -113.55 158.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.299 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -121.0 127.91 52.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.157 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.583 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -89.84 95.2 10.13 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.571 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.855 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -64.14 -24.95 67.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.838 . . . . 0.0 109.665 178.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -86.02 179.27 7.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.537 ' OG ' HD11 ' A' ' 97' ' ' ILE 2.511 0.0 OUTLIER 103.37 11.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.141 -1.599 . . . . 0.0 110.603 1.118 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.6 m-85 -107.67 150.96 26.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.702 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.26 -152.63 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 110.131 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 13.7 tttm -100.58 69.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 110.43 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.03 75.2 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.73 7.55 3.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -1.146 . . . . 0.0 110.984 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.602 HD11 ' HE ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER 61.45 131.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.612 ' CG2' HG23 ' A' ' 91' ' ' THR . 97.2 t -103.38 -74.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.117 -0.99 . . . . 0.0 110.697 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.46 160.82 37.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.704 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.63 142.17 37.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.221 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.429 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.4 p -150.15 -174.99 4.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.711 ' N ' HD22 ' A' ' 34' ' ' LEU . 2.8 mm? -97.66 174.43 6.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.85 168.59 22.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.699 HG13 HD22 ' A' ' 62' ' ' LEU . 79.3 mt -100.37 150.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.883 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 84' ' ' LEU . 49.7 t -125.58 82.07 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -109.07 146.45 33.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.606 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 41.0 m170 -61.73 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.007 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 -137.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 60.54 -134.4 0.72 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.956 -1.09 . . . . 0.0 110.222 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -45.94 -26.15 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.907 -1.121 . . . . 0.0 111.155 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 1.031 ' CH2' HD22 ' A' ' 47' ' ' LEU . 65.4 t-105 -67.54 -58.6 4.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -25.55 42.21 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 59.7 m -81.14 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 110.537 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -52.8 -58.02 8.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.031 HD22 ' CH2' ' A' ' 43' ' ' TRP . 4.8 mp -90.82 51.83 2.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.285 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.04 56.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.894 -1.129 . . . . 0.0 111.583 -178.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER 174.21 154.06 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.805 -1.184 . . . . 0.0 110.335 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 5.9 m-85 60.48 22.7 12.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.844 . . . . 0.0 111.012 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.481 HD13 ' NE1' ' A' ' 43' ' ' TRP . 22.6 mt -105.48 113.38 26.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.087 . . . . 0.0 111.156 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 60.3 m-85 -88.86 102.31 14.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.5 p -99.65 157.03 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.087 -1.008 . . . . 0.0 111.694 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.518 ' CD ' HD13 ' A' ' 84' ' ' LEU . 26.1 mtm180 -117.68 -171.98 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.633 -0.667 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.68 80.54 9.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 109.06 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 156.02 -21.2 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.731 -0.605 . . . . 0.0 110.124 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -169.32 0.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.035 -1.04 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 15.5 m -128.69 150.12 50.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.79 ' HB2' HD21 ' A' ' 84' ' ' LEU . . . -135.01 176.37 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 110.403 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.736 ' CE ' HD23 ' A' ' 47' ' ' LEU . 2.9 ttt -121.56 156.58 32.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.487 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.877 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.8 92.12 9.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.699 HD22 HG13 ' A' ' 36' ' ' ILE 2.51 0.0 OUTLIER -53.24 -70.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.887 -178.37 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.68 -138.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 8' ' ' VAL . 87.7 m-85 -86.21 48.0 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 110.635 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.877 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -86.27 -22.08 49.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.44 -51.36 5.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.947 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.7 pp -44.29 -24.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 111.827 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.947 ' N ' HD12 ' A' ' 67' ' ' ILE . 16.4 m-85 -55.88 142.8 33.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.774 -1.204 . . . . 0.0 110.314 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' CA ' ' A' ' 17' ' ' GLY . 55.0 m-20 -119.39 -178.9 3.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 111.339 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -102.74 152.82 20.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.549 -0.72 . . . . 0.0 109.634 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.57 22.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.098 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.49 23.67 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.03 -1.044 . . . . 0.0 110.298 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -174.44 66.18 0.28 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.808 . . . . 0.0 109.797 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.775 ' O ' HD11 ' A' ' 92' ' ' ILE . 22.1 Cg_endo -65.56 93.42 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.775 1.408 . . . . 0.0 110.93 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.96 66.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.847 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -128.07 127.76 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 110.166 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 -171.92 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 110.419 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.46 158.05 23.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 14.0 tp10 -138.21 126.32 22.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 110.067 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.608 HD22 HD12 ' A' ' 84' ' ' LEU . 28.1 mt -105.22 131.26 52.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.978 . . . . 0.0 110.55 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.56 -166.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 110.419 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CZ ' ' A' ' 54' ' ' ARG . . . 138.72 -116.52 1.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' A' ' 59' ' ' ALA . 25.5 tp -168.92 45.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.17 -16.94 9.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 110.694 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.417 ' HG2' HD13 ' A' ' 34' ' ' LEU . 3.0 mtm180 -131.2 147.76 52.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.593 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.29 158.57 26.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.669 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.602 ' HE ' HD11 ' A' ' 29' ' ' LEU . 6.5 mtt180 -147.5 115.57 6.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.822 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.493 HG12 ' CE2' ' A' ' 68' ' ' PHE . 2.7 mp -88.95 117.13 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.854 -1.154 . . . . 0.0 110.402 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE2' ' HG ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -106.72 163.51 12.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.612 HG23 ' CG2' ' A' ' 30' ' ' VAL . 10.6 p -107.3 87.93 2.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.775 HD11 ' O ' ' A' ' 74' ' ' PRO . 9.5 pt -54.34 -22.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 110.319 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.5 mttt -133.58 142.35 43.6 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 110.204 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.41 ' HG3' ' HB2' ' A' ' 26' ' ' LYS . 33.8 Cg_exo -55.65 128.99 32.66 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.599 1.315 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.437 HG21 ' CB ' ' A' ' 20' ' ' ALA . 77.3 mt -107.58 138.51 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 110.342 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.73 164.8 14.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 21' ' ' ARG . 4.4 mt -70.95 112.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.71 0.89 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.37 -176.59 3.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -1.183 . . . . 0.0 110.37 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 11.8 tt0 -123.33 126.21 46.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 110.032 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.583 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 56.6 mt -88.81 126.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.167 -0.958 . . . . 0.0 109.844 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 101' ' ' ILE . 22.0 p -155.4 143.11 19.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.566 . . . . 0.0 109.929 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 76' ' ' ALA . 1.1 pp -123.92 147.69 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.513 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.6 t -85.13 -166.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.534 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -124.44 -65.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 0.0 110.07 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.17 15.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.17 -30.5 2.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.436 -1.038 . . . . 0.0 111.454 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -42.79 82.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -109.65 115.54 30.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.091 -1.005 . . . . 0.0 110.454 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.442 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 28.5 t-105 . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.789 -0.569 . . . . 0.0 111.067 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 28.7 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.273 0.558 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 218' ' ' PRO . . . -171.09 147.6 2.29 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 217' ' ' ALA . 38.0 Cg_exo . . . . . 0 C--N 1.312 -1.369 0 O-C-N 123.745 1.392 . . . . 0.0 110.503 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' HD12 ' B' ' 7' ' ' ILE . 14.6 t80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.389 0.614 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 5' ' ' ARG . 11.8 m120 -90.23 55.24 3.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.028 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.1 t70 52.96 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.706 -0.621 . . . . 0.0 111.355 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.527 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.2 OUTLIER -50.55 -33.92 23.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 111.027 -178.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.527 HG23 ' C ' ' B' ' 5' ' ' ARG . 89.4 t -152.31 138.53 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.036 -1.04 . . . . 0.0 111.211 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.603 HG23 ' HB2' ' B' ' 19' ' ' PHE . 12.7 tt -114.64 162.33 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.539 HG21 ' CE2' ' B' ' 64' ' ' PHE . 95.8 t -106.86 120.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.431 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.595 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 16.7 mttt -116.74 144.0 44.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.875 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.595 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 25.2 mttt 52.43 62.94 2.44 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.752 -1.842 . . . . 0.0 111.403 0.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.413 -0.804 . . . . 0.0 110.32 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 71.7 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -1.135 . . . . 0.0 110.385 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.416 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -108.94 -172.19 21.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.864 ' CG2' HD13 ' B' ' 67' ' ' ILE . 95.1 t -113.57 158.47 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.016 -1.285 . . . . 0.0 110.718 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.603 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.9 OUTLIER -120.99 127.88 52.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 110.164 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.576 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -89.78 95.17 10.12 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.362 -0.836 . . . . 0.0 110.542 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.88 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -64.15 -24.88 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.684 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -86.07 179.21 7.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.552 -0.718 . . . . 0.0 109.373 179.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.548 ' OG ' HD11 ' B' ' 97' ' ' ILE 2.511 0.0 OUTLIER 103.3 11.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.111 -1.618 . . . . 0.0 110.541 1.19 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.7 m-85 -107.63 150.99 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.048 -1.032 . . . . 0.0 110.777 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.29 -152.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -100.57 69.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.06 75.29 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.71 7.49 3.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 110.976 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.625 HD11 ' HE ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER 61.5 131.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.178 -0.951 . . . . 0.0 110.129 -179.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.608 ' CG2' HG23 ' B' ' 91' ' ' THR . 98.1 t -103.22 -74.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.991 -1.068 . . . . 0.0 110.551 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.53 160.84 37.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.008 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.58 142.3 37.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 110.183 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.436 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.4 p -150.3 -175.01 4.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.714 ' N ' HD22 ' B' ' 34' ' ' LEU . 2.8 mm? -97.78 174.4 6.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.189 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 92.2 m -148.82 168.56 22.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 110.743 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.718 HG13 HD22 ' B' ' 62' ' ' LEU . 79.4 mt -100.46 150.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.841 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 49.5 t -125.48 82.08 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.462 ' HB3' ' CD2' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -109.1 146.43 34.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 110.55 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.479 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 40.9 m170 -61.65 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 41' ' ' ASP . 0.2 OUTLIER -89.52 -137.64 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 5.0 m-20 60.56 -134.42 0.72 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.007 -1.058 . . . . 0.0 110.23 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -45.97 -26.04 0.65 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.903 -1.123 . . . . 0.0 111.201 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 1.022 ' CH2' HD22 ' B' ' 47' ' ' LEU . 65.4 t-105 -67.66 -58.58 4.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.41 -25.61 41.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 60.3 m -81.2 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 110.512 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' B' ' 47' ' ' LEU . . . -52.83 -57.44 10.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.181 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 1.022 HD22 ' CH2' ' B' ' 43' ' ' TRP . 4.7 mp -91.61 52.21 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 110.239 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.23 56.23 0.15 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.029 -1.044 . . . . 0.0 111.581 -178.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.5 OUTLIER 174.15 154.09 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.853 -1.154 . . . . 0.0 110.359 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 5.9 m-85 60.5 22.77 12.45 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.383 -0.823 . . . . 0.0 110.985 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.48 HD13 ' NE1' ' B' ' 43' ' ' TRP . 22.5 mt -105.51 112.85 26.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.9 -1.125 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' B' ' 61' ' ' ALA . 60.8 m-85 -88.29 102.28 14.68 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.3 p -99.62 157.0 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.103 -0.998 . . . . 0.0 111.753 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.516 ' CD ' HD13 ' B' ' 84' ' ' LEU . 26.3 mtm180 -118.17 -174.49 2.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.699 -0.625 . . . . 0.0 109.711 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 80.27 6.56 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.188 -0.945 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 155.89 -21.3 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.577 -0.702 . . . . 0.0 110.177 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 -169.31 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.058 -1.026 . . . . 0.0 110.944 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.462 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 15.5 m -128.71 150.12 50.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.453 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' B' ' 84' ' ' LEU . . . -135.03 176.36 8.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 110.44 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.75 ' CE ' HD23 ' B' ' 47' ' ' LEU . 2.9 ttt -121.71 156.03 33.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.847 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.12 92.12 9.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.89 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.718 HD22 HG13 ' B' ' 36' ' ' ILE 2.509 0.0 OUTLIER -53.3 -70.92 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.896 -178.459 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.71 -138.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' B' ' 8' ' ' VAL . 87.9 m-85 -86.2 48.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.133 . . . . 0.0 110.656 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.847 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -86.27 -22.18 49.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.39 -51.39 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -1.199 . . . . 0.0 110.5 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.956 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.7 pp -44.22 -24.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.598 -0.689 . . . . 0.0 111.843 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.956 ' N ' HD12 ' B' ' 67' ' ' ILE . 16.4 m-85 -55.67 143.39 30.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.796 -1.19 . . . . 0.0 110.258 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.416 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 56.0 m-20 -120.08 -178.45 3.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 111.228 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.42 ' CE1' ' HG ' ' B' ' 104' ' ' SER . 26.3 t60 -103.62 152.68 21.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.45 22.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.959 -1.088 . . . . 0.0 111.075 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.63 23.62 2.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.045 . . . . 0.0 110.222 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -174.47 66.2 0.28 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.78 ' O ' HD11 ' B' ' 92' ' ' ILE . 22.2 Cg_endo -65.54 93.37 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.783 1.412 . . . . 0.0 110.934 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.93 66.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.816 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -128.08 127.81 43.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.01 -171.93 2.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.451 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.37 157.83 23.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.496 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.447 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 14.0 tp10 -137.96 126.54 23.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.164 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.596 HD22 HD12 ' B' ' 84' ' ' LEU . 28.1 mt -105.2 131.35 52.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 0.0 110.51 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.73 -166.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.349 -0.845 . . . . 0.0 110.257 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.06 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 110.455 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.421 ' O ' ' CZ ' ' B' ' 54' ' ' ARG . . . 138.73 -116.61 1.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' B' ' 59' ' ' ALA . 25.5 tp -168.91 46.0 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -1.137 . . . . 0.0 110.425 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.15 -16.99 9.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.674 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.413 ' HG2' HD13 ' B' ' 34' ' ' LEU . 3.0 mtm180 -131.2 147.8 52.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.093 -1.004 . . . . 0.0 110.556 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 5.6 mmm -120.26 158.57 26.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 110.719 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.625 ' HE ' HD11 ' B' ' 29' ' ' LEU . 6.5 mtt180 -147.54 115.21 6.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 109.885 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' B' ' 68' ' ' PHE . 2.7 mp -88.39 117.11 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.042 . . . . 0.0 110.523 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' B' ' 29' ' ' LEU . 0.9 OUTLIER -106.81 163.49 12.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.345 -0.847 . . . . 0.0 110.643 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.608 HG23 ' CG2' ' B' ' 30' ' ' VAL . 10.4 p -107.24 87.86 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.78 HD11 ' O ' ' B' ' 74' ' ' PRO . 9.5 pt -54.25 -22.88 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.917 . . . . 0.0 110.358 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.419 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.5 mttt -133.55 142.45 43.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.216 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 93' ' ' LYS . 37.3 Cg_exo -55.95 129.16 33.47 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.561 1.295 . . . . 0.0 110.454 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.442 HG21 ' CB ' ' B' ' 20' ' ' ALA . 77.4 mt -107.58 138.4 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 110.313 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 164.79 14.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.178 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.88 HG23 ' O ' ' B' ' 21' ' ' ARG . 4.4 mt -70.94 112.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.75 0.89 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.43 -176.56 3.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -1.165 . . . . 0.0 110.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' B' ' 19' ' ' PHE . 11.8 tt0 -123.45 125.74 45.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.114 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 56.1 mt -88.0 126.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 110.075 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.53 HG23 ' O ' ' B' ' 101' ' ' ILE . 22.0 p -155.45 143.08 19.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.578 -0.701 . . . . 0.0 109.903 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.816 HG22 ' O ' ' B' ' 76' ' ' ALA . 1.1 pp -123.89 147.68 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.42 ' HG ' ' CE1' ' B' ' 70' ' ' HIS . 43.5 t -85.17 -166.34 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 110.486 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.49 -65.58 1.03 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.948 . . . . 0.0 110.065 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.92 173.23 15.22 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.14 -30.41 2.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -1.01 . . . . 0.0 111.514 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -42.94 81.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.082 -1.012 . . . . 0.0 110.932 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.435 ' O ' ' HB3' ' B' ' 110' ' ' TRP . 0.1 OUTLIER -109.31 115.71 30.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 0.0 110.563 -179.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.435 ' HB3' ' O ' ' B' ' 109' ' ' TYR . 28.3 t-105 . . . . . 0 N--CA 1.497 1.924 0 O-C-N 121.893 -0.504 . . . . 0.0 111.06 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 28.7 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.299 0.571 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.04 147.63 2.32 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 110.394 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--N 1.313 -1.312 0 O-C-N 123.648 1.341 . . . . 0.0 110.568 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 52.9 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.378 0.609 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' ARG . 8.7 p-10 -148.04 164.28 34.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.885 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.16 62.28 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.588 -0.695 . . . . 0.0 110.754 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.8 tpt180 179.69 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.284 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 5' ' ' ARG . 54.9 t -157.07 169.41 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 110.1 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 6' ' ' VAL . 11.8 tt -144.77 146.61 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.876 HG12 ' HD3' ' A' ' 10' ' ' LYS . 94.7 t -89.65 102.53 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 111.027 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.656 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 1.1 mmtt -124.06 137.58 54.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.876 ' HD3' HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER 49.85 50.23 18.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 119.407 -2.058 . . . . 0.0 111.699 4.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.511 ' CB ' ' CE2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.902 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.486 2.003 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.51 ' CE2' ' HE3' ' A' ' 10' ' ' LYS . 3.5 m-85 -115.24 110.44 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -1.114 . . . . 0.0 110.803 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.5 173.77 22.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.715 HG23 HD13 ' A' ' 67' ' ' ILE . 97.9 t -98.3 130.08 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.999 -1.295 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE2' ' CB ' ' A' ' 11' ' ' SER . 1.6 m-85 -107.68 133.82 51.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 110.147 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.771 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -96.93 88.47 4.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.404 -0.81 . . . . 0.0 110.542 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.849 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.21 -27.15 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.38 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 14.7 mtpt -83.61 178.98 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.463 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 0.1 OUTLIER 102.24 20.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.0 -1.687 . . . . 0.0 109.563 3.145 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 15.2 m-85 -112.68 150.24 31.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.09 -158.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.845 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -80.41 -1.17 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.07 67.57 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' A' ' 24' ' ' PHE . 7.1 mt-10 -118.07 120.76 38.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.124 . . . . 0.0 110.275 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.698 HD13 ' CZ ' ' A' ' 90' ' ' PHE . 25.8 tp -53.71 127.36 25.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 6' ' ' VAL . 47.2 t -103.41 72.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 57.04 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.58 156.01 29.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 110.327 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -147.55 -161.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.367 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.6 mm? -96.7 -179.17 4.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 110.543 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.3 m -148.21 178.16 8.8 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.435 -0.791 . . . . 0.0 109.535 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.56 HD11 ' CD2' ' A' ' 62' ' ' LEU . 20.9 mt -113.97 138.49 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 110.26 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.85 113.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.032 -1.043 . . . . 0.0 110.325 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 1.5 tpp180 -146.61 159.73 43.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 110.404 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.475 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 64.2 m170 -71.4 -173.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -86.37 -137.28 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.833 . . . . 0.0 110.117 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.42 -139.91 0.43 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.739 -1.226 . . . . 0.0 110.304 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -46.36 -26.95 0.92 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.983 -1.073 . . . . 0.0 111.11 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.841 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 67.8 t-105 -61.06 -55.94 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.819 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.23 69.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.3 m -69.82 -70.42 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HB3' HD22 ' A' ' 47' ' ' LEU . . . -52.8 -53.42 48.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.133 -0.98 . . . . 0.0 110.185 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.911 ' HB3' HD13 ' A' ' 51' ' ' LEU . 2.6 mm? -90.45 46.49 1.34 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -5.88 35.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.851 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.35 147.19 43.76 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.95 -1.094 . . . . 0.0 110.021 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CE1' ' O ' ' A' ' 66' ' ' ALA . 11.6 m-85 56.09 38.76 30.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.096 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.911 HD13 ' HB3' ' A' ' 47' ' ' LEU . 7.0 tp -123.76 122.81 39.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.896 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.08 132.32 44.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.959 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.6 p -94.27 127.89 40.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -0.962 . . . . 0.0 110.783 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.603 ' CB ' HD11 ' A' ' 84' ' ' LEU . 12.9 tpt180 -105.39 172.94 6.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.407 -0.808 . . . . 0.0 109.608 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -83.08 82.71 8.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.946 -1.096 . . . . 0.0 109.225 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 22.9 p30 146.45 -18.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.79 -0.569 . . . . 0.0 109.765 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.98 -160.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.1 m -140.49 118.59 11.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.149 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.44 153.81 23.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.639 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.782 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -93.16 179.58 5.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -86.48 -146.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.16 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.913 HD13 ' HB2' ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER -178.34 -73.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.99 -1.069 . . . . 0.0 109.967 -179.211 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 33' ' ' CYS . . . -74.55 -114.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 40.5 m-85 -91.26 33.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.516 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -90.95 -22.14 33.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -91.09 -20.94 21.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 111.681 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.715 HD13 HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -92.51 -4.29 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.217 . . . . 0.0 111.835 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' N ' HD12 ' A' ' 67' ' ' ILE . 5.3 m-85 -55.81 147.78 18.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.823 -1.173 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -117.42 -167.83 1.38 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -103.79 151.2 23.34 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.243 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.516 ' CB ' ' HG1' ' A' ' 102' ' ' THR . 67.1 m -161.19 150.07 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -11.75 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 111.053 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.63 67.52 71.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.701 ' O ' HD11 ' A' ' 92' ' ' ILE . 24.5 Cg_exo -60.03 107.12 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.647 1.341 . . . . 0.0 110.459 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.457 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 47.2 p30 -81.54 -6.53 59.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -146.69 150.24 35.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.985 -1.072 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.06 -160.45 0.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.448 ' HB2' ' CE ' ' A' ' 87' ' ' MET . 2.0 p-80 -132.26 166.96 20.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.067 -1.021 . . . . 0.0 110.666 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.15 141.19 29.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 110.455 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.8 HD13 HD23 ' A' ' 84' ' ' LEU . 94.5 mt -105.16 145.9 29.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.263 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.76 HG21 ' HB2' ' A' ' 86' ' ' ARG . 1.6 p -64.87 -62.64 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 110.412 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.82 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.602 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.5 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 80' ' ' LEU . 29.4 mt 52.32 48.58 22.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.425 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.22 -76.55 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.554 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.76 ' HB2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -87.22 126.63 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 110.285 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.448 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -100.79 117.75 35.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.895 . . . . 0.0 110.525 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.39 114.59 27.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.042 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 78' ' ' HIS . 38.9 mt -89.43 138.35 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.698 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 13.6 m-85 -128.36 177.86 6.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.798 HG22 HD12 ' A' ' 95' ' ' ILE . 1.6 p -115.71 96.47 5.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.316 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.701 HD11 ' O ' ' A' ' 74' ' ' PRO . 23.3 pt -50.45 -35.83 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.568 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -130.28 150.48 76.26 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 110.299 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.15 131.69 31.57 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.717 1.378 . . . . 0.0 110.981 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.798 HD12 HG22 ' A' ' 91' ' ' THR . 32.1 mt -113.29 145.32 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.786 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.38 10.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 110.968 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 21' ' ' ARG . 39.4 mt -65.79 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.06 36.37 1.83 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.608 ' CB ' HG23 ' A' ' 95' ' ' ILE . 4.8 mm-40 -101.32 156.26 17.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -1.12 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.411 ' OE1' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -100.34 110.11 22.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 110.491 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 20' ' ' ALA . 59.3 mt -89.55 119.82 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.516 ' HG1' ' CB ' ' A' ' 71' ' ' SER . 32.2 p -141.13 1.59 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 111.601 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 68' ' ' PHE . 35.4 pt 37.42 -145.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.326 -0.859 . . . . 0.0 111.34 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.425 ' N ' HG13 ' A' ' 103' ' ' ILE . 22.9 t -160.59 -168.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 110.727 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' A' ' 109' ' ' TYR . 10.5 m-85 -123.37 -66.84 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.853 . . . . 0.0 109.686 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 84.69 -160.04 35.31 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t0 55.12 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.552 -0.969 . . . . 0.0 110.581 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 1.9 t70 -153.88 25.12 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.0 110.559 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.453 ' HB3' ' CB ' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -100.98 108.77 20.58 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.181 -0.949 . . . . 0.0 109.753 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.427 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 30.0 t-105 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.118 0.485 . . . . 0.0 110.638 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 2.2 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.233 0.54 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.5 160.59 31.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.95 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 C--N 1.312 -1.386 0 O-C-N 123.744 1.391 . . . . 0.0 110.509 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 52.9 p90 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.326 0.584 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 8.7 p-10 -147.98 164.44 33.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.34 62.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.0 110.657 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.53 ' O ' HG23 ' B' ' 6' ' ' VAL . 4.8 tpt180 179.85 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.413 -0.804 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 5' ' ' ARG . 54.6 t -156.92 169.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.668 -0.645 . . . . 0.0 110.138 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.51 ' N ' HG12 ' B' ' 6' ' ' VAL . 11.8 tt -144.77 146.42 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.589 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.885 HG12 ' HD3' ' B' ' 10' ' ' LYS . 93.2 t -89.49 102.55 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.056 -1.027 . . . . 0.0 111.086 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.673 ' HA ' ' HB2' ' B' ' 10' ' ' LYS . 1.1 mmtt -124.09 137.64 54.54 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.885 ' HD3' HG12 ' B' ' 8' ' ' VAL . 0.2 OUTLIER 49.89 50.19 18.88 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 119.43 -2.044 . . . . 0.0 111.729 4.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.515 ' CB ' ' CE2' ' B' ' 19' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 109.854 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.509 ' CE2' ' HE3' ' B' ' 10' ' ' LYS . 3.6 m-85 -115.24 110.38 19.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -1.08 . . . . 0.0 110.872 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.54 173.64 22.19 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.729 HG23 HD13 ' B' ' 67' ' ' ILE . 92.9 t -98.17 129.86 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.318 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.515 ' CE2' ' CB ' ' B' ' 11' ' ' SER . 1.6 m-85 -107.63 133.82 51.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 110.151 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.785 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -96.91 88.5 4.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.324 -0.86 . . . . 0.0 110.569 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.6 OUTLIER -57.19 -27.16 61.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 178.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.506 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 14.7 mtpt -83.58 179.02 7.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.465 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.1 OUTLIER 102.21 20.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.003 -1.686 . . . . 0.0 109.581 3.056 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.506 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 15.4 m-85 -112.63 150.36 31.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.31 -0.869 . . . . 0.0 110.222 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.23 -158.77 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.963 . . . . 0.0 109.868 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -80.38 -1.25 40.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.02 67.59 0.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' B' ' 24' ' ' PHE . 7.1 mt-10 -118.05 120.69 38.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 110.309 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.701 HD13 ' CZ ' ' B' ' 90' ' ' PHE . 25.9 tp -53.67 127.37 25.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' B' ' 6' ' ' VAL . 47.1 t -103.37 72.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 57.11 163.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.451 -0.781 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.65 156.07 29.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 0.6 OUTLIER -147.61 -161.7 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 110.334 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' B' ' 34' ' ' LEU . 4.6 mm? -96.83 -179.17 4.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 110.593 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 61' ' ' ALA . 1.3 m -148.23 178.14 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.387 -0.82 . . . . 0.0 109.454 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.551 HD11 ' CD2' ' B' ' 62' ' ' LEU . 20.8 mt -114.0 138.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.018 . . . . 0.0 110.203 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.8 113.4 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.294 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 1.5 tpp180 -146.68 159.73 43.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 110.463 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 64.2 m170 -71.38 -173.99 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.764 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -86.34 -137.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.36 -139.99 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.808 -1.183 . . . . 0.0 110.295 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -46.23 -27.04 0.9 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.03 -1.044 . . . . 0.0 111.159 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.844 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 67.7 t-105 -60.98 -55.94 27.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.957 . . . . 0.0 109.852 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.21 69.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 92.1 m -69.85 -70.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -1.157 . . . . 0.0 110.519 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.574 ' HB3' HD22 ' B' ' 47' ' ' LEU . . . -52.89 -53.13 53.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.88 ' HB3' HD13 ' B' ' 51' ' ' LEU . 2.6 mm? -90.82 46.6 1.34 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -5.92 35.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 110.868 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.24 147.2 43.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.906 -1.121 . . . . 0.0 110.098 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' O ' ' B' ' 66' ' ' ALA . 11.5 m-85 56.11 38.75 30.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.866 . . . . 0.0 110.075 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 47' ' ' LEU . 7.1 tp -123.81 122.96 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.826 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -99.24 132.43 44.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 60.5 p -94.29 127.94 40.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.735 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.603 ' CB ' HD11 ' B' ' 84' ' ' LEU . 13.0 tpt180 -106.01 169.98 8.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.446 -0.784 . . . . 0.0 109.722 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.441 ' N ' ' HG3' ' B' ' 54' ' ' ARG . 0.1 OUTLIER -79.04 82.4 5.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.028 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 22.9 p30 146.31 -18.83 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.667 -0.645 . . . . 0.0 109.668 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.97 -160.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -140.38 118.54 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.38 153.89 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 110.73 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.796 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.1 OUTLIER -93.62 178.22 5.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.399 -0.813 . . . . 0.0 110.308 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' B' ' 35' ' ' CYS . . . -84.47 -146.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.885 . . . . 0.0 109.632 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.913 ' HB2' HD13 ' A' ' 62' ' ' LEU 2.5 0.1 OUTLIER -178.51 -73.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.001 -1.062 . . . . 0.0 110.018 -179.473 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -74.53 -113.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.472 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 40.4 m-85 -92.04 34.23 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -1.151 . . . . 0.0 110.314 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -92.02 -21.19 33.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.479 ' O ' ' CE1' ' B' ' 50' ' ' TYR . . . -92.17 -19.52 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.264 . . . . 0.0 111.627 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.729 HD13 HG23 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -94.14 -3.68 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.873 -1.142 . . . . 0.0 111.491 -178.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.673 ' N ' HD12 ' B' ' 67' ' ' ILE . 5.3 m-85 -56.13 147.82 19.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 110.461 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -117.23 -166.73 1.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -105.37 150.84 24.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.903 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . 0.517 ' CB ' ' HG1' ' B' ' 102' ' ' THR . 67.1 m -160.88 150.08 16.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 110.311 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 -11.7 59.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 111.069 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.73 67.56 71.01 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.997 -1.065 . . . . 0.0 110.536 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.701 ' O ' HD11 ' B' ' 92' ' ' ILE . 24.5 Cg_exo -60.08 107.06 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.663 1.349 . . . . 0.0 110.434 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.461 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 47.1 p30 -81.49 -6.49 59.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.477 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -146.69 150.18 34.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.971 -1.081 . . . . 0.0 110.465 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -160.39 0.95 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.441 ' HB2' ' CE ' ' B' ' 87' ' ' MET . 2.0 p-80 -132.32 167.0 20.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.673 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.16 141.27 29.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.419 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.791 HD13 HD23 ' B' ' 84' ' ' LEU . 94.6 mt -105.26 145.89 30.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 110.318 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.772 HG21 ' HB2' ' B' ' 86' ' ' ARG . 1.6 p -64.89 -62.57 1.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.417 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.88 -43.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.54 2.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.791 HD23 HD13 ' B' ' 80' ' ' LEU . 29.4 mt 52.27 48.54 22.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -1.195 . . . . 0.0 110.407 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.18 -76.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.948 . . . . 0.0 110.536 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.772 ' HB2' HG21 ' B' ' 81' ' ' THR . 0.0 OUTLIER -87.17 126.64 34.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.006 . . . . 0.0 110.281 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.441 ' CE ' ' HB2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -100.81 117.74 35.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 110.548 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.46 114.3 27.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.121 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' B' ' 78' ' ' HIS . 38.5 mt -89.02 138.37 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.701 ' CZ ' HD13 ' B' ' 29' ' ' LEU . 13.6 m-85 -128.39 177.92 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 110.472 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.822 HG22 HD12 ' B' ' 95' ' ' ILE . 1.6 p -115.75 96.45 5.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.908 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.701 HD11 ' O ' ' B' ' 74' ' ' PRO . 23.4 pt -50.44 -35.82 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.628 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.461 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -130.25 150.52 76.36 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 110.273 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.21 131.73 31.95 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.709 1.373 . . . . 0.0 110.991 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.822 HD12 HG22 ' B' ' 91' ' ' THR . 31.9 mt -113.29 145.37 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.476 -0.765 . . . . 0.0 109.795 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.31 10.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.948 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 39.5 mt -65.76 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 110.267 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.1 36.25 1.85 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.593 ' CB ' HG23 ' B' ' 95' ' ' ILE . 4.9 mm-40 -101.28 156.25 17.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -100.32 110.06 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.11 -0.994 . . . . 0.0 110.49 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.785 HD11 ' HB2' ' B' ' 20' ' ' ALA . 60.0 mt -89.47 119.65 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.8 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.517 ' HG1' ' CB ' ' B' ' 71' ' ' SER . 32.7 p -140.91 1.53 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 111.611 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' B' ' 68' ' ' PHE . 35.2 pt 37.61 -146.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.46 -0.775 . . . . 0.0 111.388 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.423 ' N ' HG13 ' B' ' 103' ' ' ILE . 22.8 t -160.62 -169.08 2.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.903 -1.123 . . . . 0.0 110.712 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.452 ' CB ' ' HB3' ' B' ' 109' ' ' TYR . 10.4 m-85 -123.06 -66.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.774 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 84.65 -159.95 35.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.4 t0 55.1 -87.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.527 -0.984 . . . . 0.0 110.546 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 106' ' ' GLY . 1.8 t70 -153.85 24.94 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.937 -1.102 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.452 ' HB3' ' CB ' ' B' ' 105' ' ' TYR . 0.1 OUTLIER -100.65 108.91 20.92 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 109.91 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.439 ' HB3' ' O ' ' B' ' 109' ' ' TYR . 29.9 t-105 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.084 0.468 . . . . 0.0 110.607 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.2 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.22 0.533 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.59 31.04 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.922 . . . . 0.0 110.391 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo . . . . . 0 C--N 1.313 -1.31 0 O-C-N 123.632 1.333 . . . . 0.0 110.522 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.469 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 35.8 p90 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.347 0.594 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -121.08 163.44 18.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -50.08 -25.61 3.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.5 ' C ' HG13 ' A' ' 6' ' ' VAL . 26.9 ttp180 -74.65 -45.39 45.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.56 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.5 HG13 ' C ' ' A' ' 5' ' ' ARG . 22.9 m -154.25 -178.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.164 -0.96 . . . . 0.0 110.493 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 19' ' ' PHE . 9.0 tt -152.91 150.49 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.101 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.4 t -94.48 120.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 110.525 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.625 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 mttt -125.59 146.82 49.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.418 -0.801 . . . . 0.0 109.226 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.625 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 4.1 mmmt 52.45 59.18 4.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 119.65 -1.906 . . . . 0.0 110.922 2.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.442 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 1.1 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.451 -0.781 . . . . 0.0 110.159 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -99.96 72.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -1.175 . . . . 0.0 110.581 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.0 -175.97 20.37 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 90.3 t -101.67 146.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.987 -1.302 . . . . 0.0 110.03 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -110.41 126.36 54.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -0.931 . . . . 0.0 109.754 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.54 89.4 7.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -0.844 . . . . 0.0 110.843 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.52 -22.52 55.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.325 -0.859 . . . . 0.0 109.65 178.022 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -90.82 -178.87 5.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.467 -0.771 . . . . 0.0 109.862 179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 18.1 m 100.58 17.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.291 -1.506 . . . . 0.0 110.47 0.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -105.19 161.43 14.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.768 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -162.03 0.91 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.356 -0.84 . . . . 0.0 109.88 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 17.8 tttt -95.53 97.47 9.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.03 58.0 0.84 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.49 121.06 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -1.176 . . . . 0.0 110.43 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.967 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -56.14 132.99 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.793 ' N ' HD13 ' A' ' 29' ' ' LEU . 88.8 t -103.35 -39.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.888 . . . . 0.0 110.291 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.601 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -168.21 156.75 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.309 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.43 150.75 30.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 110.289 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.425 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -150.19 -159.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 110.631 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.8 176.07 5.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.693 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.53 150.78 31.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.78 HG13 HD22 ' A' ' 62' ' ' LEU . 56.0 mt -89.89 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.623 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 84' ' ' LEU . 41.7 t -126.9 106.87 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.632 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 35.3 mmt180 -136.53 157.97 45.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 39.0 m170 -71.45 176.52 4.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 110.157 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 53.1 p-10 -64.08 -137.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.8 t0 67.12 -149.91 0.18 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.853 -1.154 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -45.89 -34.54 3.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.864 . . . . 0.0 111.373 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.642 ' HZ3' HD21 ' B' ' 47' ' ' LEU . 48.4 t-105 -57.54 -55.45 34.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 110.241 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.58 68.08 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 94.5 m -80.85 -64.5 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.142 -1.211 . . . . 0.0 110.801 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.78 -48.45 15.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.0 111.047 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.835 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.0 mm? -91.94 26.81 2.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -64.35 80.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 7.1 t0 -175.65 -53.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 110.484 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 3.6 m-85 -127.72 54.1 1.72 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.756 HD11 ' HB2' ' A' ' 47' ' ' LEU . 6.0 mt -110.17 114.06 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 111.219 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -89.93 114.4 26.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.898 . . . . 0.0 109.221 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -108.0 134.78 50.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.097 -1.002 . . . . 0.0 111.207 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.706 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.89 -171.68 1.89 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 109.865 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -82.33 75.12 9.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.978 -1.076 . . . . 0.0 109.21 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 49.6 m-80 173.1 -33.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.442 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.848 ' HG2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 178.82 -167.71 0.08 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.437 -0.79 . . . . 0.0 110.351 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.3 156.75 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 110.112 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.582 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -150.32 148.61 29.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 0.0 110.47 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.835 ' CE ' HD12 ' A' ' 47' ' ' LEU . 13.7 mmm -91.37 157.77 16.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.866 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.66 101.89 13.68 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.457 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.813 HD12 ' CB ' ' B' ' 62' ' ' LEU 2.5 0.0 OUTLIER -59.64 -76.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 -179.156 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.33 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.761 ' HB3' HD11 ' A' ' 67' ' ' ILE . 89.8 m-85 -89.66 41.81 1.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 110.544 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.866 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -81.0 -22.67 60.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.9 -55.41 3.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -1.149 . . . . 0.0 111.058 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.761 HD11 ' HB3' ' A' ' 64' ' ' PHE . 1.6 pp -50.48 -22.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 111.155 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.478 ' CG ' HG12 ' A' ' 103' ' ' ILE . 0.7 OUTLIER -48.91 122.16 5.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.014 -1.054 . . . . 0.0 110.847 -179.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.55 ' HB2' HG22 ' A' ' 102' ' ' THR . 22.4 m-20 -94.51 173.63 7.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.51 ' NE2' ' CD1' ' A' ' 110' ' ' TRP . 39.6 t60 -102.04 150.57 23.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 0.0 110.121 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 p -149.64 139.57 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.481 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.52 -25.02 23.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.243 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.69 51.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.207 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.89 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.5 Cg_endo -62.76 98.83 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.658 1.346 . . . . 0.0 110.554 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.8 -17.91 54.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.17 170.96 15.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 110.331 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.491 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.2 ttt85 -149.73 -161.69 1.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.444 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 31.0 p-80 -130.95 -172.86 2.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 10.4 tt0 -151.73 170.98 18.42 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.171 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD13 ' CD ' ' A' ' 54' ' ' ARG . 0.9 OUTLIER -140.86 124.88 17.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 86' ' ' ARG . 9.3 t -56.92 -168.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.631 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.94 89.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.477 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.73 158.1 32.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.848 HD22 ' HG2' ' A' ' 57' ' ' MET . 2.3 mp -55.35 106.39 0.23 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -1.078 . . . . 0.0 110.348 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 -53.58 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.501 ' H ' HG22 ' A' ' 81' ' ' THR . 0.7 OUTLIER -132.26 169.38 16.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.897 . . . . 0.0 110.266 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 2.8 mtp -140.42 133.35 29.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.92 . . . . 0.0 110.494 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.777 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.8 mtp180 -115.1 176.02 5.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.269 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 31' ' ' GLU . 97.2 mt -135.33 111.98 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.967 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 56.1 m-85 -106.58 175.18 5.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.544 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 p -122.95 85.28 2.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.89 HD11 ' O ' ' A' ' 74' ' ' PRO . 50.9 pt -50.13 -25.45 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.825 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.09 134.68 21.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 110.503 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 82.0 Cg_exo -47.51 152.04 2.79 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.489 1.257 . . . . 0.0 111.014 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 99' ' ' GLU . 64.1 mt -131.28 148.68 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.64 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.59 157.88 15.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.421 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 21' ' ' ARG . 53.0 mt -63.36 109.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.206 -0.934 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.08 27.84 2.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 52.0 mm-40 -106.73 -177.83 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -1.157 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.6 123.1 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.931 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.831 HG13 ' HB2' ' A' ' 20' ' ' ALA . 84.7 mt -89.19 130.78 37.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 69' ' ' ASN . 1.1 p -154.66 143.77 21.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.817 -0.552 . . . . 0.0 110.002 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 77' ' ' ARG . 1.1 pt -105.26 160.75 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 110.491 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -93.93 -168.87 1.96 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -124.6 -68.85 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 110.3 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 89.73 -168.45 34.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.491 -1.005 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 5.3 t70 -135.19 -36.98 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.908 -1.12 . . . . 0.0 110.918 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.15 117.75 2.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.816 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.51 ' CD1' ' NE2' ' A' ' 70' ' ' HIS . 56.0 t-105 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 110.466 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.5 1.6 m . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.283 0.563 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.78 154.72 3.68 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.444 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 41.6 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 O-C-N 123.702 1.37 . . . . 0.0 110.627 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.473 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 36.4 p90 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.31 0.576 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -121.07 163.49 18.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.338 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -50.16 -25.57 3.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.93 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.488 ' C ' HG13 ' B' ' 6' ' ' VAL . 26.8 ttp180 -74.72 -45.37 44.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 110.508 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 5' ' ' ARG . 22.9 m -154.23 -178.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -0.936 . . . . 0.0 110.476 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.573 HG23 ' HB2' ' B' ' 19' ' ' PHE . 9.0 tt -152.96 150.47 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -94.47 120.23 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 0.0 110.548 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.63 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 32.7 mttt -125.77 146.9 49.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.208 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.63 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 4.1 mmmt 52.47 59.2 4.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.636 -1.915 . . . . 0.0 110.943 2.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.441 ' N ' ' HB3' ' B' ' 9' ' ' LYS . 1.1 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.75 . . . . 0.0 110.139 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -99.95 72.04 1.68 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -1.187 . . . . 0.0 110.597 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.07 -175.94 20.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 87.5 t -101.62 145.79 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.011 -1.288 . . . . 0.0 110.075 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.573 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -110.41 126.08 53.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.256 -0.902 . . . . 0.0 109.791 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.825 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.22 89.38 7.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 110.925 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.58 -22.44 55.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 178.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' B' ' 23' ' ' SER . 0.3 OUTLIER -90.83 -178.83 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.442 -0.786 . . . . 0.0 109.883 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.51 18.1 m 100.6 17.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.314 -1.491 . . . . 0.0 110.481 0.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -105.2 161.46 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 110.759 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.13 -162.07 0.91 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.418 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 17.9 tttt -95.48 97.5 9.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.324 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.05 57.94 0.84 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.5 121.04 26.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.131 . . . . 0.0 110.421 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.978 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -56.05 132.94 51.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.23 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.795 ' N ' HD13 ' B' ' 29' ' ' LEU . 88.3 t -103.36 -39.92 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.605 ' HB3' HD12 ' B' ' 89' ' ' ILE . 0.9 OUTLIER -168.19 156.76 8.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.392 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.41 150.88 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.425 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -150.37 -159.78 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.596 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.88 176.41 5.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 110.723 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.98 150.52 30.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 109.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.764 HG13 HD22 ' B' ' 62' ' ' LEU . 55.8 mt -89.65 147.47 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 109.656 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 84' ' ' LEU . 41.6 t -126.93 106.92 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 110.644 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.498 ' HB2' ' CD2' ' B' ' 43' ' ' TRP . 35.3 mmt180 -136.59 157.99 45.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 38.9 m170 -71.49 176.51 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.196 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 53.2 p-10 -63.99 -138.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.8 t0 67.16 -149.89 0.18 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.812 -1.18 . . . . 0.0 110.708 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -45.88 -34.62 3.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.279 -0.888 . . . . 0.0 111.349 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.633 ' HZ3' HD21 ' A' ' 47' ' ' LEU . 48.2 t-105 -57.52 -55.5 34.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.63 68.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 94.5 m -80.8 -64.45 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 0.0 110.762 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.09 -47.53 17.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 111.144 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.0 mm? -93.02 27.15 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.569 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.3 OUTLIER -64.45 80.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 110.269 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.473 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 7.1 t0 -175.7 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 3.6 m-85 -127.69 54.05 1.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.214 -0.929 . . . . 0.0 109.612 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' B' ' 47' ' ' LEU . 5.9 mt -110.18 114.2 27.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -90.12 114.37 26.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.336 -0.852 . . . . 0.0 109.19 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -107.9 134.73 50.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.007 . . . . 0.0 111.2 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.707 ' HB2' HD11 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -112.54 -174.75 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.514 -0.741 . . . . 0.0 109.892 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -77.87 74.51 4.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 0.0 110.253 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 49.9 m-80 173.1 -33.58 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.851 ' HG2' HD22 ' B' ' 84' ' ' LEU . 0.0 OUTLIER 179.01 -167.68 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 110.483 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.15 156.8 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.578 ' O ' HD23 ' B' ' 51' ' ' LEU . . . -150.46 148.63 28.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 110.514 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.842 ' CE ' HD12 ' B' ' 47' ' ' LEU . 13.7 mmm -91.64 156.43 17.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 110.303 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.834 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.82 101.97 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.807 . . . . 0.0 110.728 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.813 ' CB ' HD12 ' A' ' 62' ' ' LEU 2.498 0.0 OUTLIER -59.96 -76.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 111.111 -179.355 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.36 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.779 ' HB3' HD11 ' B' ' 67' ' ' ILE . 89.7 m-85 -89.66 41.86 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -1.171 . . . . 0.0 110.528 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.834 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -81.13 -22.24 61.34 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.45 -55.25 3.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 110.979 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' B' ' 64' ' ' PHE . 1.6 pp -50.51 -22.21 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 111.226 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' B' ' 103' ' ' ILE . 0.7 OUTLIER -48.91 122.13 5.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.017 -1.052 . . . . 0.0 110.835 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.543 ' HB2' HG22 ' B' ' 102' ' ' THR . 22.5 m-20 -94.38 173.98 7.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.843 . . . . 0.0 110.364 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' B' ' 110' ' ' TRP . 39.8 t60 -102.52 150.52 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -149.61 139.62 22.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 110.486 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.54 -25.03 23.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.933 . . . . 0.0 110.218 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.66 51.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.891 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.0 Cg_endo -62.84 98.84 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.699 1.368 . . . . 0.0 110.558 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.76 -17.97 54.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.539 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.15 171.02 15.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.324 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.489 ' HA ' HG22 ' B' ' 103' ' ' ILE . 5.2 ttt85 -149.7 -161.74 1.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 110.314 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.454 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 31.3 p-80 -130.9 -172.05 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.414 ' HB3' ' HD3' ' B' ' 88' ' ' ARG . 10.4 tt0 -153.09 170.05 21.43 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.712 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.417 HD13 ' CD ' ' B' ' 54' ' ' ARG . 0.9 OUTLIER -140.53 124.81 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 0.0 110.172 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.5 HG22 ' H ' ' B' ' 86' ' ' ARG . 9.1 t -57.18 -168.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.463 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.07 89.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 110.581 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.71 158.11 33.01 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.851 HD22 ' HG2' ' B' ' 57' ' ' MET . 2.3 mp -55.38 106.45 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -1.084 . . . . 0.0 110.353 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -53.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 110.395 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.5 ' H ' HG22 ' B' ' 81' ' ' THR . 0.7 OUTLIER -132.29 169.36 16.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.8 mtp -140.47 133.38 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.495 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.784 ' HB3' HD21 ' B' ' 29' ' ' LEU . 1.8 mtp180 -115.13 176.04 5.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.605 HD12 ' HB3' ' B' ' 31' ' ' GLU . 97.2 mt -135.38 111.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.096 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.978 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 56.5 m-85 -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -122.99 85.37 2.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.08 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.891 HD11 ' O ' ' B' ' 74' ' ' PRO . 50.9 pt -50.11 -25.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.833 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.04 134.59 21.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 0.0 110.502 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 83.6 Cg_exo -47.88 152.21 3.25 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.541 1.285 . . . . 0.0 110.979 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.459 ' CG2' ' HB2' ' B' ' 99' ' ' GLU . 63.9 mt -131.19 148.67 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.64 157.86 15.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 53.0 mt -63.31 109.75 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.889 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.09 27.81 2.83 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 52.4 mm-40 -106.75 -177.91 3.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.268 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.59 122.84 41.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.003 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.825 HG13 ' HB2' ' B' ' 20' ' ' ALA . 84.3 mt -88.71 130.86 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.249 -0.907 . . . . 0.0 110.388 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.543 HG22 ' HB2' ' B' ' 69' ' ' ASN . 1.1 p -154.78 143.78 20.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' B' ' 77' ' ' ARG . 1.1 pt -105.21 160.75 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 110.467 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 44.5 t -93.97 -168.86 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 110.504 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -124.55 -68.9 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 110.352 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 89.77 -168.43 34.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -1.04 . . . . 0.0 110.719 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' B' ' 106' ' ' GLY . 5.3 t70 -135.2 -36.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.899 -1.125 . . . . 0.0 110.885 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -48.12 117.66 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.813 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.518 ' CD1' ' NE2' ' B' ' 70' ' ' HIS . 56.1 t-105 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.498 -0.751 . . . . 0.0 110.467 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 1.6 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.331 0.586 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.76 154.77 3.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.421 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.454 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 41.2 Cg_endo . . . . . 0 C--N 1.312 -1.39 0 O-C-N 123.696 1.367 . . . . 0.0 110.558 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.363 0.602 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 5' ' ' ARG . 1.5 m-80 -111.23 40.72 2.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 110.449 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.53 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.536 -0.727 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 20.3 mtm180 -52.0 -38.88 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.491 HG21 HG13 ' A' ' 30' ' ' VAL . 98.5 t -135.26 143.82 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 20.0 tt -119.57 165.38 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.556 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -100.15 128.73 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 33.2 mttt -143.62 139.97 29.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.604 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.74 55.11 9.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 119.749 -1.845 . . . . 0.0 110.277 1.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.798 -0.564 . . . . 0.0 110.366 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.2 64.02 8.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.58 -166.43 24.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' A' ' 6' ' ' VAL . 59.7 t -97.88 127.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.962 -1.316 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 11' ' ' SER . 0.1 OUTLIER -90.5 126.9 36.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.109 . . . . 0.0 109.841 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.86 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.21 90.87 8.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.699 -0.625 . . . . 0.0 110.635 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.835 ' O ' HG23 ' A' ' 97' ' ' ILE . 2.7 ttt180 -69.21 -22.13 63.9 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.481 0.658 . . . . 0.0 109.399 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 2.8 mttp -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.497 -0.752 . . . . 0.0 109.38 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 22' ' ' LYS 2.516 19.2 m 108.32 34.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.983 -1.698 . . . . 0.0 109.84 1.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 44.2 m-85 -127.28 160.67 30.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 111.076 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.44 -159.88 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.51 -0.743 . . . . 0.0 110.148 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CA ' ' HD3' ' A' ' 94' ' ' PRO . 23.7 tttm -102.19 98.96 9.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.071 -1.018 . . . . 0.0 110.194 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.78 33.91 0.96 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -117.14 141.88 47.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.511 HD12 ' CE2' ' A' ' 90' ' ' PHE . 2.3 tp -83.76 136.96 33.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 6' ' ' VAL . 48.5 t -92.42 -62.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 110.422 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.724 ' HG2' HD12 ' A' ' 89' ' ' ILE . 1.7 pt-20 -159.03 149.2 19.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.199 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -131.53 137.98 48.72 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.108 -0.995 . . . . 0.0 109.902 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.407 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 36.8 m -140.35 178.88 6.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 110.092 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 34' ' ' LEU . 11.3 mp -91.75 169.41 10.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.396 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.518 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 72.8 m -145.51 168.51 20.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 60' ' ' MET . 39.1 mt -96.76 164.09 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.638 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 84' ' ' LEU . 51.6 t -143.58 115.85 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 110.828 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 62.5 mmt-85 -144.63 142.49 30.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.144 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.54 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.881 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -98.52 119.76 37.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.727 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -177.38 -141.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.64 -35.49 42.3 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.307 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.7 ' CE3' HD21 ' B' ' 47' ' ' LEU . 13.4 t-105 -63.1 -35.36 79.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -58.1 -66.06 3.08 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 29.6 m -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.325 -1.103 . . . . 0.0 111.011 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -62.56 1.78 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.848 -1.157 . . . . 0.0 108.457 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.874 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.1 mm? -92.81 36.32 1.03 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 109.845 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -71.2 -1.02 11.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.641 -179.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -118.13 150.12 39.89 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.862 -1.148 . . . . 0.0 108.929 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.436 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 26.1 m-85 57.5 29.14 16.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 60' ' ' MET . 4.6 tp -129.67 138.12 51.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.441 -0.787 . . . . 0.0 111.035 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -92.89 162.14 14.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.371 -0.83 . . . . 0.0 109.615 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 47.0 p -138.51 113.71 9.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 110.639 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.55 179.87 4.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 110.169 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -83.64 86.75 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 109.48 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 41.8 m-80 149.08 -25.54 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.51 -158.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.143 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 15.2 m -139.86 169.5 17.6 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.875 . . . . 0.0 109.946 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -149.9 149.29 30.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.874 ' CE ' HD12 ' A' ' 47' ' ' LEU . 2.3 ttt -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.1 90.5 8.38 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.18 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 36' ' ' ILE 2.502 0.2 OUTLIER -55.32 -73.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.771 -179.662 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -64.05 -137.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HB3' HD11 ' A' ' 67' ' ' ILE . 62.2 m-85 -84.18 51.75 2.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 110.423 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.81 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.45 -27.8 19.01 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -88.39 -47.34 8.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 110.427 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.864 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.9 pp -47.99 -24.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.29 -0.881 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.864 ' N ' HD12 ' A' ' 67' ' ' ILE . 3.7 m-85 -49.16 120.19 3.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.99 . . . . 0.0 110.584 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.712 ' H ' HG22 ' A' ' 102' ' ' THR . 73.7 m-20 -95.26 175.73 6.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.429 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -96.0 139.06 32.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 110.661 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.3 t -143.75 161.74 37.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 110.142 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -83.96 -34.33 24.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.456 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 58.28 20.03 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 110.507 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.09 115.86 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.53 1.279 . . . . 0.0 110.397 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.753 ' HA ' HD11 ' A' ' 92' ' ' ILE . 42.7 m-80 -89.71 18.74 5.23 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.566 -0.709 . . . . 0.0 110.7 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.474 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -122.49 158.95 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.595 ' HB2' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -145.59 169.46 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 110.529 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.79 130.69 47.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 110.403 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.82 152.47 24.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 110.261 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.05 131.04 56.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.509 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 86' ' ' ARG . 40.7 p -57.91 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.9 . . . . 0.0 110.379 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 110.313 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.79 -126.32 1.46 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.635 ' HB3' HG22 ' A' ' 37' ' ' VAL . 4.4 tp -153.09 27.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.16 . . . . 0.0 110.265 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 37' ' ' VAL . 25.2 mttm -108.29 -70.73 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 110.585 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.606 ' HB2' HG21 ' A' ' 81' ' ' THR . 12.8 mtt180 -70.61 124.04 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 110.429 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.518 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 20.5 mtp -118.85 124.86 48.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -103.41 164.62 11.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.958 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.724 HD12 ' HG2' ' A' ' 31' ' ' GLU . 91.3 mt -136.23 126.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 29' ' ' LEU . 48.8 m-85 -122.05 169.74 10.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.436 HG23 ' CG2' ' A' ' 30' ' ' VAL . 35.5 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.011 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.753 HD11 ' HA ' ' A' ' 75' ' ' ASN . 2.1 pt -62.81 -24.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 110.532 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 92' ' ' ILE . 24.3 mttt -151.1 131.97 7.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.018 -1.051 . . . . 0.0 110.594 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HD3' ' CA ' ' A' ' 26' ' ' LYS . 37.6 Cg_exo -35.47 146.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.275 1.983 . . . . 0.0 112.416 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.557 HG23 ' OE1' ' A' ' 99' ' ' GLU . 49.8 mt -127.03 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.507 ' HB3' ' HG3' ' A' ' 99' ' ' GLU . . . -89.17 158.98 17.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.558 -0.714 . . . . 0.0 110.278 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -56.42 -21.52 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 111.474 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.59 61.04 0.31 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.557 ' OE1' HG23 ' A' ' 95' ' ' ILE . 3.5 mt-10 -131.58 175.07 9.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -1.207 . . . . 0.0 110.997 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.17 124.28 44.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 109.68 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.86 HG13 ' HB2' ' A' ' 20' ' ' ALA . 54.3 mt -88.9 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 110.557 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -159.52 179.42 8.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.816 -0.552 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 104' ' ' SER . 1.6 pp -145.87 133.41 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.575 ' O ' HD12 ' A' ' 103' ' ' ILE . 47.2 t -61.05 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.397 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HB3' ' HB3' ' A' ' 109' ' ' TYR . 24.4 m-85 -123.62 -75.92 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.42 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.01 -173.19 42.34 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.41 -12.38 60.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 110.809 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.57 -55.56 2.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.06 -1.025 . . . . 0.0 110.626 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.437 ' HB3' ' HB3' ' A' ' 105' ' ' TYR . 3.1 t80 -54.41 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 110.889 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.696 -0.628 . . . . 0.0 111.285 178.56 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.87 155.08 60.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 C--N 1.313 -1.328 0 O-C-N 123.681 1.358 . . . . 0.0 111.263 -179.78 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.295 0.569 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 5' ' ' ARG . 1.5 m-80 -111.15 40.62 2.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.62 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.465 ' HA ' ' CD ' ' B' ' 22' ' ' LYS . 20.4 mtm180 -52.05 -38.85 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.925 -1.109 . . . . 0.0 110.619 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.484 HG21 HG13 ' B' ' 30' ' ' VAL . 98.9 t -135.32 143.72 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 19.9 tt -119.49 165.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.19 128.7 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 110.541 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 33.2 mttt -143.57 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 109.196 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.588 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.82 55.01 9.59 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 119.664 -1.898 . . . . 0.0 110.36 1.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.5 ' HB2' ' CE1' ' B' ' 19' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.758 -0.589 . . . . 0.0 110.36 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -86.11 64.4 8.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.17 -166.43 23.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' B' ' 6' ' ' VAL . 58.5 t -97.89 127.81 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.951 -1.323 . . . . 0.0 110.122 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' B' ' 11' ' ' SER . 0.1 OUTLIER -90.48 126.56 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 109.948 179.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.836 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -88.62 90.84 8.57 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.465 -0.772 . . . . 0.0 110.761 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.848 ' O ' HG23 ' B' ' 97' ' ' ILE . 2.7 ttt180 -69.24 -21.88 63.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.481 -0.762 . . . . 0.0 109.465 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.513 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 2.7 mttp -105.53 -177.08 3.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.53 -0.731 . . . . 0.0 109.387 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.423 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 19.5 m 108.33 34.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.063 -1.648 . . . . 0.0 109.859 1.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 43.9 m-85 -127.31 160.84 30.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 111.049 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.58 -159.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.514 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 23.6 tttm -102.11 98.97 9.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 0.0 110.198 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.73 33.87 0.96 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -117.13 141.89 47.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.512 HD12 ' CE2' ' B' ' 90' ' ' PHE . 2.3 tp -83.8 136.97 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.484 HG13 HG21 ' B' ' 6' ' ' VAL . 48.4 t -92.38 -62.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.461 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.715 ' CG ' HD12 ' B' ' 89' ' ' ILE . 1.7 pt-20 -159.02 149.27 19.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -131.53 137.86 48.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.408 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 36.5 m -140.42 178.88 7.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 110.015 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.547 HD12 ' N ' ' B' ' 34' ' ' LEU . 11.3 mp -91.76 169.45 10.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.394 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 72.7 m -145.57 168.42 20.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.662 HD12 ' HB3' ' B' ' 60' ' ' MET . 39.3 mt -96.73 164.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.641 HG22 ' HB3' ' B' ' 84' ' ' LEU . 51.7 t -143.66 115.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 110.83 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 62.4 mmt-85 -144.69 142.44 30.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 110.114 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -56.5 -167.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.877 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -98.59 119.77 37.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 110.733 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -177.4 -141.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.819 . . . . 0.0 109.431 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.63 -35.48 42.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.725 -1.234 . . . . 0.0 109.304 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.74 ' CZ3' HD21 ' A' ' 47' ' ' LEU . 13.1 t-105 -63.05 -35.29 79.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -58.21 -66.03 3.1 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.462 ' HA ' ' HB2' ' B' ' 48' ' ' GLU . 31.1 m -66.7 -37.25 84.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.253 -1.145 . . . . 0.0 111.063 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -61.3 2.7 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.963 -1.086 . . . . 0.0 108.65 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.885 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.1 mm? -94.58 37.04 1.13 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.407 177.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -71.63 -1.2 12.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 111.545 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -117.83 150.19 39.58 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.903 -1.123 . . . . 0.0 109.017 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 25.8 m-85 57.47 29.1 16.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' B' ' 60' ' ' MET . 4.7 tp -129.73 138.27 51.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 110.999 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -93.09 162.16 14.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -0.83 . . . . 0.0 109.548 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 46.9 p -138.4 113.73 9.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 110.673 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.11 177.31 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -79.95 86.49 5.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 41.5 m-80 148.91 -25.69 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.646 -0.659 . . . . 0.0 109.396 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -177.46 -158.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.696 . . . . 0.0 110.194 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 15.3 m -139.82 169.48 17.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.906 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.496 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -149.88 149.29 30.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.049 -1.032 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.885 ' CE ' HD12 ' B' ' 47' ' ' LEU . 2.3 ttt -94.43 155.61 16.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.587 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.829 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -85.48 90.32 7.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.847 . . . . 0.0 110.558 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.644 ' CD2' HD11 ' B' ' 36' ' ' ILE 2.502 0.2 OUTLIER -55.44 -73.71 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.741 -179.736 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -64.08 -137.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' B' ' 67' ' ' ILE . 62.2 m-85 -84.17 52.01 2.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 110.406 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.829 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -90.75 -27.68 18.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -88.42 -47.27 8.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 110.446 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.854 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.9 pp -48.08 -24.22 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.339 -0.851 . . . . 0.0 110.879 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.854 ' N ' HD12 ' B' ' 67' ' ' ILE . 3.7 m-85 -49.16 120.14 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.203 -0.936 . . . . 0.0 110.57 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.715 ' H ' HG22 ' B' ' 102' ' ' THR . 74.0 m-20 -95.21 175.76 6.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.519 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -96.01 139.05 32.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.926 . . . . 0.0 110.679 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 20.7 t -143.77 161.65 38.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 110.126 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -83.92 -34.32 24.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.471 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 58.2 19.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.93 115.81 4.29 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.55 1.29 . . . . 0.0 110.322 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.742 ' HA ' HD11 ' B' ' 92' ' ' ILE . 42.7 m-80 -89.77 18.8 5.21 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.434 -0.791 . . . . 0.0 110.663 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.484 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -122.44 159.02 28.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -145.63 169.47 18.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 110.489 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.73 130.73 47.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 110.394 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.89 152.53 24.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.591 HG21 ' HB2' ' B' ' 86' ' ' ARG . 40.7 p -57.89 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.376 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.8 -126.31 1.46 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.641 ' HB3' HG22 ' B' ' 37' ' ' VAL . 4.4 tp -153.07 27.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -1.108 . . . . 0.0 110.269 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.424 ' HG3' HG21 ' B' ' 37' ' ' VAL . 25.2 mttm -108.27 -70.82 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.559 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.591 ' HB2' HG21 ' B' ' 81' ' ' THR . 12.8 mtt180 -70.58 124.04 23.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.483 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.54 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 20.5 mtp -118.87 124.83 48.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -103.33 164.59 11.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 110.016 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.715 HD12 ' CG ' ' B' ' 31' ' ' GLU . 91.4 mt -136.15 126.8 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.512 ' CE2' HD12 ' B' ' 29' ' ' LEU . 48.8 m-85 -122.03 169.81 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.729 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.43 HG23 ' CG2' ' B' ' 30' ' ' VAL . 35.3 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.976 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' B' ' 75' ' ' ASN . 2.1 pt -62.87 -24.14 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 110.527 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.639 ' HG3' HD12 ' B' ' 92' ' ' ILE . 24.3 mttt -151.1 131.8 7.3 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.968 -1.083 . . . . 0.0 110.601 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 39.5 Cg_exo -35.32 145.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.806 0 C-N-CA 122.339 2.026 . . . . 0.0 112.36 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.557 HG23 ' OE1' ' B' ' 99' ' ' GLU . 49.7 mt -127.07 149.81 32.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.468 -0.77 . . . . 0.0 110.561 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.494 ' HB3' ' HG3' ' B' ' 99' ' ' GLU . . . -88.6 159.08 18.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.434 -0.791 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.848 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -56.51 -21.52 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 111.423 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.68 61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.557 ' OE1' HG23 ' B' ' 95' ' ' ILE . 3.4 mt-10 -131.7 174.96 9.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -1.23 . . . . 0.0 111.03 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.25 123.89 43.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.44 -0.788 . . . . 0.0 109.823 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.836 HG13 ' HB2' ' B' ' 20' ' ' ALA . 54.1 mt -88.44 138.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.657 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.715 HG22 ' H ' ' B' ' 69' ' ' ASN . 0.2 OUTLIER -159.61 179.41 8.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.826 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.566 HD12 ' O ' ' B' ' 104' ' ' SER . 1.6 pp -145.84 133.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 110.242 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.566 ' O ' HD12 ' B' ' 103' ' ' ILE . 47.2 t -61.09 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 110.432 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 109' ' ' TYR . 24.4 m-85 -123.39 -75.88 0.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.45 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.05 -173.21 42.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.4 -12.4 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -1.105 . . . . 0.0 110.825 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.61 -55.49 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 110.619 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 105' ' ' TYR . 3.1 t80 -54.35 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 110.875 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 111.242 178.577 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.505 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.29 0.567 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.84 155.06 60.85 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.312 -1.353 0 O-C-N 123.659 1.347 . . . . 0.0 111.237 -179.745 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 28.3 p90 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.399 0.618 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -138.07 143.42 40.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.63 -49.99 18.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.374 -0.828 . . . . 0.0 111.354 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.541 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.49 -37.41 80.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 110.772 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.634 HG21 HG13 ' A' ' 30' ' ' VAL . 90.2 t -153.54 149.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.624 HG23 ' HB2' ' A' ' 19' ' ' PHE . 14.9 tt -118.26 167.11 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -99.53 126.08 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 110.403 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.597 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -150.48 115.51 5.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.689 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.597 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 2.2 tmtt? 61.91 66.17 0.85 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 119.546 -1.971 . . . . 0.0 110.742 2.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.444 ' HB3' ' CG ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 0.0 111.312 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CZ ' ' HE2' ' A' ' 10' ' ' LYS . 15.1 m-85 -98.03 105.1 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -1.134 . . . . 0.0 110.637 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.04 -171.5 15.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.884 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.1 p -123.36 132.13 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.97 -1.312 . . . . 0.0 109.679 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HB2' HG23 ' A' ' 7' ' ' ILE . 3.2 m-30 -95.21 164.04 13.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.823 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -124.09 97.97 5.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.478 -0.764 . . . . 0.0 110.623 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.54 -19.62 49.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 5.7 mttm -90.7 178.77 5.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.88 . . . . 0.0 108.982 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.437 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 49.6 m 102.43 18.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.081 -1.637 . . . . 0.0 110.325 1.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 24.1 m-85 -108.73 158.32 17.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.87 -159.59 0.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 110.268 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 24.9 tttt -97.76 90.37 4.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.68 52.13 0.2 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.35 135.05 49.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.169 . . . . 0.0 110.422 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.913 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -76.33 105.29 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.708 HG23 HG23 ' A' ' 91' ' ' THR . 93.0 t -67.66 -46.63 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.247 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.67 152.19 6.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.45 141.97 35.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.412 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -146.2 -177.0 5.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 110.28 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 -178.8 4.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 60' ' ' MET . 25.6 p -148.94 174.3 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.485 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.873 HG13 HD22 ' A' ' 62' ' ' LEU . 46.7 mt -105.73 102.2 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.588 HG21 ' O ' ' A' ' 84' ' ' LEU . 28.4 t -86.82 92.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.141 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 15.2 tpt180 -116.44 154.26 30.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.376 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.9 m170 -61.21 -167.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.433 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.65 28.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.55 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.48 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 109.228 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -50.75 -25.71 4.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.608 -1.307 . . . . 0.0 109.651 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.481 ' CZ3' ' HG ' ' A' ' 47' ' ' LEU . 19.0 t-105 -57.81 -56.73 18.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.653 . . . . 0.0 109.447 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.88 86.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 m -62.75 -65.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -1.156 . . . . 0.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.11 -47.7 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 110.227 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.693 HD12 ' HE3' ' A' ' 60' ' ' MET . 4.4 mm? -90.61 41.0 1.04 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 110.51 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 62.35 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 110.608 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER 179.5 139.23 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.844 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 56.82 33.41 23.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 110.563 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 51' ' ' LEU . 8.7 mt -105.51 102.09 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 110.459 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 55.2 m-85 -88.85 102.92 15.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.106 -0.996 . . . . 0.0 109.021 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 13.2 t -103.2 155.91 18.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 111.453 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.711 ' HB2' HD11 ' A' ' 84' ' ' LEU . 11.4 mtp180 -116.97 -173.38 2.38 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -83.61 74.07 10.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 74.1 m-20 167.85 -27.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.485 ' CG ' HD12 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -174.57 -174.91 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.339 -0.85 . . . . 0.0 110.89 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 2.4 p -117.62 147.13 43.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.838 ' CB ' HD22 ' A' ' 84' ' ' LEU . . . -132.1 133.85 44.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 110.605 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.693 ' HE3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.29 155.08 19.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 109.935 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.894 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.63 93.08 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.11 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.873 HD22 HG13 ' A' ' 36' ' ' ILE 2.505 0.0 OUTLIER -55.64 -70.29 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 110.691 -179.175 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.79 -150.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.0 57.72 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.438 -1.036 . . . . 0.0 110.711 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.894 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.82 -24.68 27.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.29 -42.71 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -1.147 . . . . 0.0 110.532 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.531 HD13 ' HB ' ' A' ' 18' ' ' VAL . 1.1 pp -49.91 -29.26 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.975 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' A' ' 89' ' ' ILE . 13.8 m-85 -55.12 140.01 39.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 110.655 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -118.24 -177.69 3.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.201 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.514 ' NE2' ' CE2' ' A' ' 110' ' ' TRP . 18.9 t60 -100.76 125.37 47.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -129.97 141.44 50.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.12 20.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.182 -0.949 . . . . 0.0 110.54 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.49 87.43 41.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.88 . . . . 0.0 110.148 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.789 ' O ' HD11 ' A' ' 92' ' ' ILE . 10.9 Cg_endo -58.06 105.24 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.605 1.318 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.13 -17.19 57.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 110.613 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.1 166.98 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.569 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.11 -163.73 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.171 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 50.7 p-80 -143.07 163.69 32.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.545 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 43.2 tt0 -146.56 112.05 5.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD12 ' CD ' ' C' ' 218' ' ' PRO . 1.8 mp -91.22 60.22 4.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.079 -1.013 . . . . 0.0 110.427 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.453 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 0.1 OUTLIER 42.15 28.39 0.1 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.592 -0.692 . . . . 0.0 111.212 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.45 24.31 2.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.45 28.33 0.17 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.105 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.838 HD22 ' CB ' ' A' ' 59' ' ' ALA . 62.8 mt 50.99 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.252 . . . . 0.0 110.734 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.46 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.795 . . . . 0.0 110.517 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -145.24 102.9 3.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.125 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.421 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 3.8 mtp -81.24 118.63 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.743 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.739 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -111.02 127.0 55.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.744 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.476 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 10.0 mt -89.1 117.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.092 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.913 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 18.9 m-85 -107.3 -173.57 2.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.32 -0.863 . . . . 0.0 110.411 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.708 HG23 HG23 ' A' ' 30' ' ' VAL . 21.3 p -130.44 93.24 3.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.789 HD11 ' O ' ' A' ' 74' ' ' PRO . 2.4 pt -56.86 -19.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.471 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.445 ' N ' HG13 ' A' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.65 18.11 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -51.42 141.2 41.94 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.519 1.273 . . . . 0.0 110.452 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.464 HG23 ' HG3' ' A' ' 99' ' ' GLU . 13.9 mt -109.64 150.52 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -94.71 156.9 16.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.59 -0.694 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.839 HG23 ' O ' ' A' ' 21' ' ' ARG . 21.9 mt -63.58 112.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.72 36.61 3.44 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -101.11 155.84 17.76 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.294 -1.121 . . . . 0.0 110.57 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.0 115.04 26.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.133 -0.979 . . . . 0.0 109.717 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.957 HD11 ' HB2' ' A' ' 20' ' ' ALA . 16.2 mt -89.64 122.46 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 110.435 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' C ' ' A' ' 101' ' ' ILE . 68.6 p -154.77 134.21 12.63 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 104' ' ' SER . 1.1 pp -104.99 153.82 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.096 . . . . 0.0 110.524 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -80.0 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.524 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HB3' ' HB2' ' A' ' 109' ' ' TYR . 17.6 m-85 -127.14 -68.49 0.79 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.22 24.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.23 -39.63 60.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -1.116 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.58 -61.4 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.275 -0.89 . . . . 0.0 110.109 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 105' ' ' TYR . 3.2 m-85 -94.37 51.6 1.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.32 -0.862 . . . . 0.0 110.543 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.514 ' CE2' ' NE2' ' A' ' 70' ' ' HIS . 10.5 t-105 . . . . . 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.584 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.228 0.537 . . . . 0.0 110.382 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -156.61 -176.23 0.59 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.706 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 22.1 Cg_exo . . . . . 0 C--N 1.312 -1.349 0 O-C-N 123.659 1.347 . . . . 0.0 110.586 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 28.3 p90 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.326 0.584 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -137.88 143.66 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 110.153 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.83 -49.89 19.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.823 . . . . 0.0 111.326 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.535 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.0 OUTLIER -68.55 -37.4 79.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 110.769 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.635 HG21 HG13 ' B' ' 30' ' ' VAL . 89.8 t -153.52 149.14 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 110.185 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.616 HG23 ' HB2' ' B' ' 19' ' ' PHE . 15.0 tt -118.2 167.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.582 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.6 126.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 110.349 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.591 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -150.8 115.56 5.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.628 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.591 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 2.2 tmtt? 62.0 66.25 0.83 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.599 -1.938 . . . . 0.0 110.748 2.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.449 ' HB3' ' CG ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 111.037 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.511 ' CZ ' ' HE2' ' B' ' 10' ' ' LYS . 15.2 m-85 -98.0 105.01 17.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -1.13 . . . . 0.0 110.688 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.85 -171.55 15.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.897 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.2 p -123.25 132.02 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.326 . . . . 0.0 109.794 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.616 ' HB2' HG23 ' B' ' 7' ' ' ILE . 3.2 m-30 -95.29 164.05 13.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 110.791 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.986 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -124.26 98.07 5.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.834 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.51 -19.67 49.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.017 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 5.7 mttm -90.59 178.75 6.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.042 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.441 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 49.9 m 102.45 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.079 -1.638 . . . . 0.0 110.325 1.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 24.1 m-85 -108.67 158.32 17.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -0.973 . . . . 0.0 110.436 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.86 -159.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.26 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -97.69 90.29 4.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.73 52.13 0.2 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.33 135.06 50.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -1.165 . . . . 0.0 110.477 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.896 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.9 OUTLIER -76.35 105.28 7.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 110.254 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.719 HG23 HG23 ' B' ' 91' ' ' THR . 92.9 t -67.73 -46.56 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.64 152.26 6.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.5 141.9 35.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.503 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.412 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -146.18 -176.96 5.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.45 -178.7 4.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 110.276 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 60' ' ' MET . 25.6 p -149.0 174.31 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.894 HG13 HD22 ' B' ' 62' ' ' LEU . 46.6 mt -105.96 100.76 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.575 HG21 ' O ' ' B' ' 84' ' ' LEU . 24.8 t -84.84 92.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 110.499 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' B' ' 39' ' ' HIS . 15.1 tpt180 -116.66 154.3 30.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.414 ' N ' ' HG3' ' B' ' 38' ' ' ARG . 3.0 m170 -61.14 -167.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.416 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.66 28.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.53 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.44 -0.787 . . . . 0.0 109.234 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -50.8 -25.65 4.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.69 -1.256 . . . . 0.0 109.616 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 19.1 t-105 -57.84 -56.75 17.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.65 -0.656 . . . . 0.0 109.415 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.82 86.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 8.9 m -62.76 -65.1 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -1.134 . . . . 0.0 110.412 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.43 75.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.728 HD12 ' HE3' ' B' ' 60' ' ' MET . 4.4 mm? -90.94 41.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 110.403 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.02 62.34 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 110.602 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.3 OUTLIER 179.51 139.28 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 0.0 109.876 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 56.81 33.47 23.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.179 -0.951 . . . . 0.0 110.491 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' B' ' 51' ' ' LEU . 8.6 mt -105.5 101.7 11.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.55 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' B' ' 59' ' ' ALA . 55.6 m-85 -88.28 102.95 15.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.121 -0.987 . . . . 0.0 109.16 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 13.2 t -103.21 155.86 18.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 111.525 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.705 ' HB2' HD11 ' B' ' 84' ' ' LEU . 11.5 mtp180 -117.5 -176.04 2.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.579 -0.701 . . . . 0.0 109.63 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -79.79 73.64 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 73.8 m-20 167.77 -27.22 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.491 ' CG ' HD12 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -174.43 -174.65 0.88 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.36 -0.838 . . . . 0.0 110.913 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 2.4 p -117.68 147.09 43.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.832 ' CB ' HD22 ' B' ' 84' ' ' LEU . . . -132.18 133.64 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.728 ' HE3' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -89.21 153.72 20.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.148 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.861 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.78 93.02 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 110.5 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.894 HD22 HG13 ' B' ' 36' ' ' ILE 2.507 0.0 OUTLIER -55.7 -70.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.728 -179.39 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.69 -150.47 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -76.03 58.06 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.406 -1.055 . . . . 0.0 110.627 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.861 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.34 -24.42 26.54 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.36 -42.72 16.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.524 HD13 ' HB ' ' B' ' 18' ' ' VAL . 1.1 pp -49.94 -29.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.95 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.466 ' CZ ' HG12 ' B' ' 89' ' ' ILE . 13.8 m-85 -55.1 140.08 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.011 -1.055 . . . . 0.0 110.621 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -118.37 -177.73 3.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.528 ' NE2' ' CE2' ' B' ' 110' ' ' TRP . 18.8 t60 -100.7 125.39 47.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 110.292 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.5 t -129.99 141.43 50.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.259 -0.901 . . . . 0.0 110.201 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.17 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.528 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.45 87.41 40.86 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.794 ' O ' HD11 ' B' ' 92' ' ' ILE . 10.9 Cg_endo -58.12 105.32 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.669 1.352 . . . . 0.0 110.393 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.18 -17.17 57.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.03 23.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.16 -163.68 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 110.193 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 50.8 p-80 -143.11 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.53 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' B' ' 88' ' ' ARG . 43.3 tt0 -146.62 112.03 5.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.336 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.504 HD12 ' CD ' ' D' ' 218' ' ' PRO . 1.8 mp -91.16 60.12 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.451 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 0.1 OUTLIER 42.24 28.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.543 -0.723 . . . . 0.0 111.149 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.42 24.27 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.4 28.27 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.069 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.832 HD22 ' CB ' ' B' ' 59' ' ' ALA . 62.6 mt 51.16 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -1.189 . . . . 0.0 110.704 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.52 -33.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 110.464 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.454 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.1 OUTLIER -145.23 102.94 3.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.119 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' B' ' 80' ' ' LEU . 3.8 mtp -81.24 118.59 22.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -111.0 126.7 55.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.831 179.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.466 HG12 ' CZ ' ' B' ' 68' ' ' PHE . 10.0 mt -88.67 117.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 110.183 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.896 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 18.9 m-85 -107.35 -173.52 2.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 110.461 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.719 HG23 HG23 ' B' ' 30' ' ' VAL . 21.3 p -130.44 93.19 3.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.794 HD11 ' O ' ' B' ' 74' ' ' PRO . 2.5 pt -56.88 -19.05 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.429 ' N ' HG13 ' B' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.69 18.17 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 110.115 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.68 141.43 43.73 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.521 1.274 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.463 HG23 ' CB ' ' B' ' 99' ' ' GLU . 14.0 mt -109.7 150.53 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 110.705 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -94.72 156.88 16.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.169 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.834 HG23 ' O ' ' B' ' 21' ' ' ARG . 22.0 mt -63.53 112.09 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.965 -1.084 . . . . 0.0 110.206 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.65 36.58 3.46 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . 0.463 ' CB ' HG23 ' B' ' 95' ' ' ILE . 0.4 OUTLIER -100.94 155.68 17.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.304 -1.115 . . . . 0.0 110.591 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.96 114.89 26.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.994 . . . . 0.0 109.732 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.986 HD11 ' HB2' ' B' ' 20' ' ' ALA . 16.9 mt -89.36 122.49 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.516 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.535 HG23 ' C ' ' B' ' 101' ' ' ILE . 66.6 p -154.67 134.28 12.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.589 HD12 ' O ' ' B' ' 104' ' ' SER . 1.1 pp -104.93 153.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 110.549 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.589 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.5 OUTLIER -79.98 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' B' ' 109' ' ' TYR . 17.6 m-85 -127.13 -68.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.229 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.01 179.21 24.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -39.66 60.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -1.143 . . . . 0.0 110.23 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -57.55 -61.5 2.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' B' ' 105' ' ' TYR . 3.2 m-85 -94.27 51.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.311 -0.868 . . . . 0.0 110.565 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CE2' ' NE2' ' B' ' 70' ' ' HIS . 10.6 t-105 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.249 0.547 . . . . 0.0 110.429 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -156.57 -176.2 0.59 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.719 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 22.2 Cg_exo . . . . . 0 C--N 1.312 -1.371 0 O-C-N 123.678 1.357 . . . . 0.0 110.579 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.448 0.642 . . . . 0.0 111.764 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -99.89 147.63 25.33 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.752 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.0 -23.52 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 111.288 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.532 ' C ' HG23 ' A' ' 6' ' ' VAL . 2.7 mtt180 -102.73 -29.67 11.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.028 -1.045 . . . . 0.0 111.121 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.532 HG23 ' C ' ' A' ' 5' ' ' ARG . 94.9 t -153.23 137.31 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.426 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 5.7 tt -117.48 161.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 110.971 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.4 p -88.97 124.24 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.097 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 39.0 mttt -150.35 129.19 12.47 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.392 -0.818 . . . . 0.0 109.281 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.603 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 57.96 74.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 119.669 -1.894 . . . . 0.0 111.928 1.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.359 -0.838 . . . . 0.0 111.579 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CG ' ' HD3' ' A' ' 10' ' ' LYS . 1.1 m-85 -58.63 94.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -1.147 . . . . 0.0 110.442 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' ND2' ' A' ' 69' ' ' ASN . . . -120.28 171.61 14.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.72 ' CG2' HD13 ' A' ' 67' ' ' ILE . 95.0 t -93.09 140.43 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.938 -1.33 . . . . 0.0 109.825 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.555 ' CD1' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -105.73 132.88 51.32 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.11 -0.993 . . . . 0.0 110.086 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -88.39 88.45 7.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.702 -0.624 . . . . 0.0 110.446 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.88 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -67.4 -15.04 63.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.798 178.089 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 2.0 mttm -106.79 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.91 20.93 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.154 -1.591 . . . . 0.0 109.846 1.389 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 54.1 m-85 -118.65 163.91 16.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.544 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.34 -178.63 3.65 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 110.025 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -74.45 99.66 3.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.947 . . . . 0.0 110.299 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.25 61.8 0.55 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.3 123.28 23.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 110.505 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.918 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -66.63 127.48 32.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.176 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.704 ' N ' HD13 ' A' ' 29' ' ' LEU . 90.9 t -88.89 -46.55 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.346 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.47 153.17 6.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.18 136.46 31.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 110.304 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.429 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.79 170.32 9.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.697 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.0 -174.2 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.685 ' CD1' HD21 ' A' ' 62' ' ' LEU . 65.0 mt -123.75 151.97 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 84' ' ' LEU . 43.7 t -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.519 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.8 mmt-85 -134.86 145.68 48.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.269 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -63.31 176.97 0.7 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 110.359 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 40' ' ' ASN . 2.9 m120 -67.48 -131.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.142 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.25 0.24 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.624 -1.298 . . . . 0.0 110.596 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.12 -25.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.0 111.09 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.519 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 60.4 t-105 -69.29 -55.85 9.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.155 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.61 -22.48 56.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 48' ' ' GLU . 97.4 m -90.28 -60.15 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -1.212 . . . . 0.0 110.663 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.72 -55.45 11.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.872 -1.143 . . . . 0.0 110.231 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.953 ' HB2' HD11 ' A' ' 51' ' ' LEU . 4.0 mm? -92.24 33.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 110.085 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 9.8 pt-20 -68.48 64.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.171 -0.956 . . . . 0.0 111.026 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.2 t0 -169.42 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.858 -1.151 . . . . 0.0 111.024 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 25.8 m-85 -128.87 53.51 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.05 -1.031 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' A' ' 47' ' ' LEU . 52.7 mt -124.98 118.02 25.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 48.3 m-85 -89.41 101.54 14.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 108.995 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.8 t -98.92 155.52 17.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 111.561 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -123.61 -168.07 1.72 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.616 -0.678 . . . . 0.0 109.756 178.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -83.04 79.58 9.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.964 -1.085 . . . . 0.0 109.384 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 1.5 p30 160.91 -25.18 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.766 -0.584 . . . . 0.0 110.049 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.67 -167.82 0.2 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.425 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.3 m -130.68 139.28 50.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.3 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.898 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -124.13 172.39 9.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.685 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.63 ' CE ' HD12 ' A' ' 47' ' ' LEU . 9.5 ttt -117.01 153.04 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.697 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.95 90.9 8.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.445 -0.784 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.846 HD22 HD22 ' B' ' 62' ' ' LEU 2.501 0.5 OUTLIER -55.41 -63.45 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.807 -179.681 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 33' ' ' CYS . . . -63.63 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.605 ' HB3' HD11 ' A' ' 67' ' ' ILE . 39.7 m-85 -89.71 42.45 1.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -1.138 . . . . 0.0 110.589 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.697 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -84.74 -21.25 56.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -89.06 -59.3 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.981 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.6 pp -44.79 -22.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.606 -0.684 . . . . 0.0 112.375 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.981 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.5 m-85 -49.55 153.17 1.2 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.614 -1.304 . . . . 0.0 110.677 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.536 ' HB2' HG22 ' A' ' 102' ' ' THR . 26.0 m-20 -119.32 -171.95 2.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 111.322 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -102.81 156.81 17.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.778 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.69 141.08 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.007 -1.058 . . . . 0.0 110.697 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -54.92 -29.3 55.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.9 92.49 39.76 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.438 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.842 ' O ' HD11 ' A' ' 92' ' ' ILE . 32.3 Cg_exo -53.97 104.19 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.659 1.347 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.49 -21.66 35.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 110.311 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 110.307 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -171.89 2.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 47.0 p-80 -130.77 174.15 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 87' ' ' MET . 29.8 tt0 -149.82 141.33 23.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 86' ' ' ARG . 5.0 mt -102.52 142.81 33.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.208 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.481 HG22 ' NH2' ' A' ' 88' ' ' ARG . 69.3 p -80.1 85.69 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.2 95.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.691 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.38 28.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.898 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 1.1 mp -109.74 98.86 8.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.127 . . . . 0.0 110.437 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -144.73 -53.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.752 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -136.15 174.89 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 110.017 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 mtp -142.76 128.35 19.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.702 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.774 ' HB3' HD21 ' A' ' 29' ' ' LEU . 57.9 mtt180 -114.54 140.42 48.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 110.172 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.452 HG12 ' CE2' ' A' ' 68' ' ' PHE . 8.3 mt -99.96 110.25 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.097 -1.002 . . . . 0.0 109.976 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.918 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 9.5 m-85 -104.7 171.2 7.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.292 -0.88 . . . . 0.0 110.582 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.6 p -117.09 118.98 33.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.976 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.842 HD11 ' O ' ' A' ' 74' ' ' PRO . 21.6 pt -86.74 13.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.752 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HG2' HG13 ' A' ' 92' ' ' ILE . 7.3 ptpt -176.82 142.15 0.53 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.201 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.04 136.34 17.83 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.577 1.304 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.455 HG21 ' HB1' ' A' ' 20' ' ' ALA . 61.8 mt -116.53 140.88 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 110.734 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.67 153.4 20.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 110.493 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -50.33 -23.06 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 111.168 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.01 57.84 0.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.22 175.0 8.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.246 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.86 128.96 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.962 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.539 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 31.6 mt -92.4 119.37 39.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 0.0 110.414 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 69' ' ' ASN . 58.7 p -150.95 123.93 8.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.649 -0.657 . . . . 0.0 109.673 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 104' ' ' SER . 1.1 pt -88.91 159.39 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 110.785 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.522 ' O ' HD12 ' A' ' 103' ' ' ILE . 5.2 p -83.38 -157.15 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.413 -0.804 . . . . 0.0 110.348 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 104' ' ' SER . 28.3 m-85 -137.57 -66.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.33 -164.42 34.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -29.22 62.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -1.149 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -76.21 -71.28 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 1.2 m-85 -58.5 99.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 110.405 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.505 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.266 0.555 . . . . 0.0 110.452 . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.713 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 55.11 -177.8 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.713 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 25.2 Cg_exo . . . . . 0 C--N 1.312 -1.342 0 O-C-N 123.657 1.346 . . . . 0.0 110.682 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' B' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.439 0.638 . . . . 0.0 111.733 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -99.9 147.74 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -49.02 -23.53 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 111.3 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.533 ' C ' HG23 ' B' ' 6' ' ' VAL . 2.7 mtt180 -102.7 -29.76 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.104 . . . . 0.0 111.068 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.533 HG23 ' C ' ' B' ' 5' ' ' ARG . 95.3 t -153.15 137.39 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.358 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 5.8 tt -117.64 160.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.233 -0.917 . . . . 0.0 111.059 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.555 HG13 ' O ' ' B' ' 8' ' ' VAL . 9.5 p -88.27 124.56 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 0.0 110.16 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.613 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 38.9 mttt -150.81 129.22 12.09 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.371 -0.83 . . . . 0.0 109.286 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.613 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 58.13 74.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 119.55 -1.969 . . . . 0.0 111.907 1.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' B' ' 9' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.306 -0.871 . . . . 0.0 111.24 177.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.51 ' CG ' ' HD3' ' B' ' 10' ' ' LYS . 1.1 m-85 -58.56 94.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 110.457 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.448 ' HA3' ' ND2' ' B' ' 69' ' ' ASN . . . -120.3 171.64 14.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.714 ' CG2' HD13 ' B' ' 67' ' ' ILE . 96.3 t -92.97 140.27 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.032 -1.275 . . . . 0.0 109.881 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -105.72 132.2 52.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.123 -0.985 . . . . 0.0 110.297 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.547 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -87.48 88.49 7.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 110.6 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.876 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.1 OUTLIER -67.49 -14.92 63.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 178.112 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 2.0 mttm -106.84 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.87 20.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.205 -1.56 . . . . 0.0 109.855 1.442 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 54.1 m-85 -118.63 163.91 16.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.887 . . . . 0.0 110.534 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 -178.64 3.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -74.48 99.74 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.22 61.81 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.31 123.38 24.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -1.172 . . . . 0.0 110.437 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.925 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.0 OUTLIER -66.78 127.47 32.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 110.163 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.704 ' N ' HD13 ' B' ' 29' ' ' LEU . 90.6 t -88.85 -46.51 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 110.308 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.52 153.13 6.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.369 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.15 136.47 31.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 110.268 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.413 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.472 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.8 170.31 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.677 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.94 -174.19 4.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.077 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.692 ' CD1' HD21 ' B' ' 62' ' ' LEU . 65.0 mt -123.77 151.91 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 110.429 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' B' ' 84' ' ' LEU . 43.7 t -124.63 104.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.303 -0.873 . . . . 0.0 110.601 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 14.8 mmt-85 -134.87 145.73 48.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 110.264 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.405 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 34.5 m170 -63.37 177.03 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.32 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 40' ' ' ASN . 2.9 m120 -67.44 -131.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.167 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.17 0.24 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.624 -1.297 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.22 -25.63 0.98 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 111.116 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.519 ' CZ2' HD22 ' B' ' 51' ' ' LEU . 60.3 t-105 -69.27 -55.88 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 110.138 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.7 -22.29 56.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' B' ' 48' ' ' GLU . 97.4 m -90.34 -60.09 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -1.219 . . . . 0.0 110.67 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.04 -54.46 15.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.976 -1.077 . . . . 0.0 110.373 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.953 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.0 mm? -93.39 33.46 1.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 109.787 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 9.8 pt-20 -68.51 64.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.205 -0.935 . . . . 0.0 111.075 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' B' ' 47' ' ' LEU . 16.2 t0 -169.4 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.168 . . . . 0.0 110.957 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.488 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 25.8 m-85 -128.84 53.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.992 . . . . 0.0 110.921 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' B' ' 47' ' ' LEU . 52.5 mt -125.08 117.83 24.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 111.189 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' B' ' 61' ' ' ALA . 48.3 m-85 -89.17 101.6 14.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.023 177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.8 t -98.97 155.46 17.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.158 -0.964 . . . . 0.0 111.563 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.439 ' HD3' HD13 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -124.12 -170.9 2.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.751 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -78.97 79.24 5.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.14 -0.975 . . . . 0.0 110.208 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.5 p30 160.71 -25.27 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.651 -0.655 . . . . 0.0 110.134 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.5 -167.84 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.057 -1.027 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.3 m -130.64 139.28 50.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.348 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.9 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -124.1 172.42 9.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -0.999 . . . . 0.0 110.705 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.632 ' HA ' HD23 ' B' ' 51' ' ' LEU . 9.5 ttt -117.12 152.63 34.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.341 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.698 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.41 90.77 8.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.846 HD22 HD22 ' A' ' 62' ' ' LEU 2.502 0.5 OUTLIER -55.31 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.846 -179.807 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -63.59 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.611 ' HB3' HD11 ' B' ' 67' ' ' ILE . 39.6 m-85 -89.68 42.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.127 . . . . 0.0 110.603 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.698 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -84.71 -21.29 56.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -89.03 -59.34 2.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -1.173 . . . . 0.0 110.554 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.97 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.6 pp -44.71 -22.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.639 -0.663 . . . . 0.0 112.368 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.97 ' N ' HD12 ' B' ' 67' ' ' ILE . 4.5 m-85 -49.48 153.76 1.05 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.628 -1.295 . . . . 0.0 110.668 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.525 ' HB2' HG22 ' B' ' 102' ' ' THR . 26.2 m-20 -120.0 -171.46 2.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 111.114 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -103.65 156.64 17.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.429 -0.794 . . . . 0.0 109.676 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.57 141.15 10.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.053 . . . . 0.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mtpp -55.2 -29.09 57.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 110.271 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.91 92.52 39.66 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.356 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . 0.826 ' O ' HD11 ' B' ' 92' ' ' ILE . 32.4 Cg_exo -54.07 104.2 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.647 1.341 . . . . 0.0 110.576 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.5 -21.63 35.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 110.31 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.431 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -140.46 140.27 35.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.912 . . . . 0.0 110.31 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.32 -171.91 2.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 47.0 p-80 -130.75 174.07 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 87' ' ' MET . 29.8 tt0 -149.83 141.34 23.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.875 . . . . 0.0 110.297 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.749 HD23 ' O ' ' B' ' 86' ' ' ARG . 5.0 mt -102.55 142.82 33.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.208 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.473 HG22 ' CZ ' ' B' ' 88' ' ' ARG . 68.7 p -80.08 85.74 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.718 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.09 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.72 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.35 28.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.9 ' CD2' ' HB2' ' B' ' 59' ' ' ALA . 1.1 mp -109.81 98.87 8.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -1.097 . . . . 0.0 110.423 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.71 -53.78 0.31 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.749 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -136.14 174.86 10.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.064 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' B' ' 79' ' ' GLU . 15.5 mtp -142.78 128.42 19.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 110.706 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.796 ' HB3' HD21 ' B' ' 29' ' ' LEU . 58.4 mtt180 -114.66 140.47 48.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.121 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.448 HG12 ' CE2' ' B' ' 68' ' ' PHE . 8.3 mt -99.92 110.1 26.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.995 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.925 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 9.5 m-85 -104.62 171.18 7.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 110.549 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -117.11 118.97 33.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.996 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.826 HD11 ' O ' ' B' ' 74' ' ' PRO . 21.5 pt -86.69 13.29 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.787 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.423 ' HG2' HG13 ' B' ' 92' ' ' ILE . 7.3 ptpt -176.8 142.12 0.53 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.66 136.73 21.24 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.464 1.244 . . . . 0.0 111.056 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.45 HG21 ' HB1' ' B' ' 20' ' ' ALA . 61.6 mt -116.49 140.9 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.789 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.74 153.42 20.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.876 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -50.28 -23.08 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 111.045 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.14 57.93 0.41 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.37 174.84 8.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.24 . . . . 0.0 110.583 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.8 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.547 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 32.3 mt -92.59 119.36 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 110.335 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.525 HG22 ' HB2' ' B' ' 69' ' ' ASN . 61.3 p -150.83 123.98 8.81 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.608 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.512 HD12 ' O ' ' B' ' 104' ' ' SER . 1.1 pt -88.85 159.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.759 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.512 ' O ' HD12 ' B' ' 103' ' ' ILE . 5.3 p -83.42 -157.18 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 110.321 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 28.1 m-85 -137.54 -66.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.47 34.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -29.27 62.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -1.157 . . . . 0.0 110.365 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -76.22 -71.28 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.462 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 1.2 m-85 -58.48 99.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.45 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.507 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.236 0.541 . . . . 0.0 110.472 . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 55.18 -177.76 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 25.5 Cg_exo . . . . . 0 C--N 1.312 -1.383 0 O-C-N 123.7 1.369 . . . . 0.0 110.651 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 32.7 p90 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.536 0.684 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -150.69 141.32 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.138 -179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.03 -45.8 32.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 111.046 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.535 ' C ' HG23 ' A' ' 6' ' ' VAL . 6.5 mtm-85 -74.69 -33.81 62.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.543 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 5' ' ' ARG . 84.5 t -153.33 134.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 11.2 tt -117.22 156.37 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 8' ' ' VAL . 12.7 p -89.35 122.81 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.71 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.2 mttt -151.19 122.01 7.55 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.53 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.602 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 59.12 67.09 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.585 -1.947 . . . . 0.0 111.415 1.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.953 . . . . 0.0 111.19 178.629 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CZ ' ' HG3' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.91 6.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -1.159 . . . . 0.0 110.708 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.04 174.6 20.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 68' ' ' PHE . 82.9 t -97.21 117.42 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.321 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -88.99 127.0 35.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.871 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -90.85 86.88 6.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 110.962 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.5 ttp85 -58.65 -19.89 43.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.537 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 11.5 mmtm -105.25 179.27 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 108.965 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.47 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 59.3 m 104.35 23.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.01 -1.681 . . . . 0.0 109.627 2.026 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.1 m-85 -115.89 156.55 25.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 164.28 12.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.377 -0.827 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 30.5 tttt -62.37 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.22 44.51 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 24' ' ' PHE . 4.3 mt-10 -118.94 112.09 19.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -1.184 . . . . 0.0 110.443 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.978 HD21 ' HB3' ' A' ' 88' ' ' ARG . 2.0 tm? -53.48 115.6 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.255 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.452 ' N ' HD13 ' A' ' 29' ' ' LEU . 54.0 t -88.89 66.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.6 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.271 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.96 167.29 24.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.288 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.3 179.73 7.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.612 HD23 ' HG3' ' A' ' 86' ' ' ARG . 2.8 mt -94.72 -177.26 4.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.9 176.09 11.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.4 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 62' ' ' LEU . 73.5 mt -109.27 141.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 109.969 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 84' ' ' LEU . 43.4 t -117.44 115.54 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.049 -1.032 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.507 ' HB3' ' CG ' ' A' ' 43' ' ' TRP . 0.5 OUTLIER -145.96 157.1 43.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 110.416 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.9 177.01 9.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.341 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 29.9 p30 -64.24 -134.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.251 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 7.7 t0 64.83 -148.16 0.26 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.579 -1.325 . . . . 0.0 110.57 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.47 -41.09 13.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.227 -0.921 . . . . 0.0 110.953 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.731 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 65.9 t-105 -60.92 -35.33 76.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.69 92.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 84.8 m -83.53 -58.32 2.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -1.18 . . . . 0.0 110.687 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' CB ' HD22 ' A' ' 47' ' ' LEU . . . -48.83 -60.07 3.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.181 -0.949 . . . . 0.0 110.489 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.811 HD12 ' CE ' ' A' ' 60' ' ' MET . 3.1 mm? -91.72 29.15 1.59 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.882 . . . . 0.0 110.362 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.56 -23.72 0.71 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.0 111.412 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -112.34 167.18 10.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.926 -1.109 . . . . 0.0 109.988 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.58 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 38.2 m-85 52.84 29.94 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 0.0 110.148 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.777 HD13 ' HB3' ' A' ' 47' ' ' LEU . 8.6 tp -116.48 117.4 29.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.338 -0.851 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 13.0 m-85 -89.23 107.71 19.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -106.0 153.81 21.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -130.8 -171.53 2.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -82.96 79.75 9.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.979 -1.075 . . . . 0.0 109.263 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.499 0.2 OUTLIER 163.51 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.846 -0.534 . . . . 0.0 109.795 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.05 -164.29 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.302 -0.874 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 m -136.48 111.93 9.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 110.393 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.863 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -102.5 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.368 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.811 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -112.39 163.58 14.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.773 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.65 87.81 7.45 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 36' ' ' ILE 2.515 0.4 OUTLIER -46.65 -84.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.705 -0.622 . . . . 0.0 111.663 -175.614 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -131.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 70.7 m-85 -83.49 50.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 110.734 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.773 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.64 -24.54 27.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.58 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.37 -36.59 14.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -1.12 . . . . 0.0 110.55 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.503 HD12 HG23 ' A' ' 18' ' ' VAL . 1.3 pp -57.11 -20.88 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.656 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.707 ' CE1' HG21 ' A' ' 18' ' ' VAL . 12.4 m-85 -56.45 121.67 10.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.005 . . . . 0.0 110.197 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 102' ' ' THR . 41.3 m-20 -88.76 177.5 6.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.575 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -98.04 112.08 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 110.356 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.21 157.12 25.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -72.69 -23.17 60.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.396 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -132.17 73.9 77.08 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.56 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.666 1.351 . . . . 0.0 110.562 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.473 ' ND2' ' CE ' ' A' ' 93' ' ' LYS . 13.5 m120 -70.64 -13.51 62.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 110.667 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -115.76 117.69 30.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -98.38 173.6 6.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.127 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -119.54 148.05 43.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.86 139.53 52.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.83 . . . . 0.0 110.156 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.798 HD22 HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -113.49 132.66 55.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 110.529 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 p -57.45 -166.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.0 110.297 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.34 59.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.37 -131.47 2.48 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.863 HD23 ' HB2' ' A' ' 59' ' ' ALA . 4.2 tp -149.22 28.26 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -1.1 . . . . 0.0 110.095 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -100.59 -36.65 9.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.612 ' HG3' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -135.79 145.33 46.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.041 . . . . 0.0 110.892 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.406 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 2.9 ptm -150.24 147.09 27.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.956 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.978 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -112.85 161.94 16.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' HZ ' ' A' ' 68' ' ' PHE . 14.8 mt -109.57 132.36 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.943 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.854 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 36.7 m-85 -117.79 -178.36 3.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.491 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.442 HG23 HG23 ' A' ' 30' ' ' VAL . 57.6 p -125.83 105.9 9.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.344 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.42 HG23 ' HB2' ' A' ' 77' ' ' ARG . 5.8 pt -60.65 -16.62 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 110.502 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.473 ' CE ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -148.71 159.61 37.77 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.872 179.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.07 130.05 27.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.614 1.323 . . . . 0.0 110.094 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' HB1' ' A' ' 20' ' ' ALA . 56.3 mt -98.85 156.42 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.833 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.82 157.39 18.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.532 -0.73 . . . . 0.0 110.968 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.6 mp -61.67 104.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 110.34 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.14 31.03 3.95 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.15 155.55 18.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.23 -1.159 . . . . 0.0 110.074 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.12 117.45 28.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 110.385 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' A' ' 20' ' ' ALA . 57.6 mt -95.83 130.01 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.489 HG23 ' C ' ' A' ' 101' ' ' ILE . 31.1 p -154.34 170.25 21.76 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.502 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.3 pp -128.88 6.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.004 -1.06 . . . . 0.0 111.427 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 2.2 p 54.75 -151.89 0.36 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.091 -1.006 . . . . 0.0 110.013 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 104' ' ' SER . 25.4 m-85 -133.75 -77.39 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 110.812 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.28 -159.18 20.19 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -90.46 18.8 5.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -1.105 . . . . 0.0 110.595 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.98 -53.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.127 -0.983 . . . . 0.0 110.081 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.471 ' HB3' ' CB ' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -59.99 118.81 6.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 110.32 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.532 -0.73 . . . . 0.0 110.868 179.538 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.504 3.2 m . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.302 0.573 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -115.29 167.71 9.48 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.321 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 19.1 Cg_endo . . . . . 0 C--N 1.312 -1.364 0 O-C-N 123.643 1.339 . . . . 0.0 110.524 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 32.7 p90 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.481 0.658 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -150.97 141.31 22.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 110.124 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 13.3 t70 -47.98 -45.91 31.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.961 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.522 ' C ' HG23 ' B' ' 6' ' ' VAL . 6.5 mtm-85 -74.61 -33.92 62.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.522 HG23 ' C ' ' B' ' 5' ' ' ARG . 84.9 t -153.16 134.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 11.2 tt -117.24 156.07 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 110.588 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.582 HG13 ' O ' ' B' ' 8' ' ' VAL . 12.6 p -88.91 123.32 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.66 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.2 mttt -151.88 121.82 7.09 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.59 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 59.08 67.25 0.94 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 119.631 -1.918 . . . . 0.0 111.482 1.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.757 178.473 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.501 ' CZ ' ' HG3' ' B' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.85 6.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -1.149 . . . . 0.0 110.722 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.06 174.56 20.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.705 HG21 ' CE1' ' B' ' 68' ' ' PHE . 85.3 t -97.19 116.75 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.312 . . . . 0.0 110.145 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.524 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 0.5 OUTLIER -88.31 127.05 35.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.014 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.78 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -90.92 86.89 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 110.969 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ARG . . . . . 0.882 ' O ' HG23 ' B' ' 97' ' ' ILE . 1.5 ttp85 -58.74 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 0.0 109.525 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 11.5 mmtm -105.13 179.3 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 108.953 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.464 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 59.5 m 104.37 23.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.912 -1.742 . . . . 0.0 109.674 1.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.3 m-85 -115.83 156.54 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.376 -0.828 . . . . 0.0 110.622 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 164.25 12.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.339 -0.851 . . . . 0.0 110.042 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 92' ' ' ILE . 30.4 tttt -62.37 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.16 44.52 0.15 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' B' ' 24' ' ' PHE . 4.3 mt-10 -119.0 112.18 19.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.976 HD21 ' HB3' ' B' ' 88' ' ' ARG . 2.0 tm? -53.5 115.58 2.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.452 HG23 HG23 ' B' ' 91' ' ' THR . 53.8 t -88.83 66.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -0.881 . . . . 0.0 110.093 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.58 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 110.287 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.95 167.38 24.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.328 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.48 179.6 8.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 110.563 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.622 HD23 ' HG3' ' B' ' 86' ' ' ARG . 2.8 mt -94.63 -177.34 4.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.83 176.07 11.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 110.382 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 1.012 HD11 HD13 ' B' ' 62' ' ' LEU . 73.1 mt -109.3 141.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' B' ' 84' ' ' LEU . 43.0 t -117.45 115.47 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.5 OUTLIER -145.87 157.12 43.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 110.409 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' HIS . . . . . 0.4 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 0.9 OUTLIER -81.93 176.97 9.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 110.276 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' B' ' 41' ' ' ASP . 29.9 p30 -64.19 -134.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.887 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' B' ' 40' ' ' ASN . 7.6 t0 64.85 -148.16 0.26 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.644 -1.285 . . . . 0.0 110.559 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.41 -41.14 13.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.949 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.734 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 66.0 t-105 -60.97 -35.29 76.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.771 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -35.58 91.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 85.3 m -83.61 -58.35 2.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.641 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.414 ' CB ' HD22 ' B' ' 47' ' ' LEU . . . -48.86 -59.42 3.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.809 HD12 ' CE ' ' B' ' 60' ' ' MET . 3.1 mm? -92.73 29.49 1.76 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.76 -23.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.173 -0.955 . . . . 0.0 111.335 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -112.26 167.11 10.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.953 -1.092 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.578 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 37.9 m-85 52.93 29.85 8.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.785 HD13 ' HB3' ' B' ' 47' ' ' LEU . 8.6 tp -116.61 117.19 29.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 111.0 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' B' ' 61' ' ' ALA . 13.1 m-85 -88.94 107.75 19.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.868 . . . . 0.0 109.219 177.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 23.1 t -106.05 153.74 21.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.09 -1.006 . . . . 0.0 111.222 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -131.41 -174.42 3.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.564 -0.71 . . . . 0.0 109.848 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -78.83 79.42 5.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.13 -0.982 . . . . 0.0 110.065 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.2 OUTLIER 163.43 -27.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.756 -0.59 . . . . 0.0 109.839 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -164.01 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.5 m -136.57 112.01 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 110.377 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.841 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -102.6 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.407 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.809 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -112.83 161.62 16.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.285 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.744 ' HB1' ' CA ' ' B' ' 65' ' ' GLY . . . -82.94 87.73 6.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.936 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 1.012 HD13 HD11 ' B' ' 36' ' ' ILE 2.517 0.3 OUTLIER -47.02 -84.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.646 -0.659 . . . . 0.0 111.72 -175.753 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.49 -131.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 71.0 m-85 -83.6 50.92 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.611 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.744 ' CA ' ' HB1' ' B' ' 61' ' ' ALA . . . -91.19 -24.19 27.5 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.578 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.71 -36.43 14.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -1.139 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.492 HD12 HG23 ' B' ' 18' ' ' VAL . 1.3 pp -57.13 -20.96 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 0.0 110.642 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' B' ' 18' ' ' VAL . 12.4 m-85 -56.4 121.67 10.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -88.79 177.4 6.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 110.604 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -97.91 112.15 24.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.358 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.28 157.15 25.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -72.75 -23.17 60.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.356 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -132.12 73.95 77.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.58 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.678 1.357 . . . . 0.0 110.595 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.471 ' ND2' ' CE ' ' B' ' 93' ' ' LYS . 13.5 m120 -70.62 -13.5 62.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.704 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -115.74 117.72 31.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.419 ' HB2' HG23 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -98.38 173.61 6.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -119.5 147.98 43.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.611 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -127.84 139.57 52.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.814 HD22 HD12 ' B' ' 84' ' ' LEU . 0.7 OUTLIER -113.43 132.74 55.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 110.482 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.8 p -57.52 -166.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 110.324 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.41 59.91 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.34 -131.48 2.48 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.841 HD23 ' HB2' ' B' ' 59' ' ' ALA . 4.3 tp -149.28 28.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -1.104 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -100.72 -36.51 9.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 110.82 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ARG . . . . . 0.622 ' HG3' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -135.87 145.34 46.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 110.884 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.9 ptm -150.2 147.1 27.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 110.055 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.976 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -112.94 161.98 16.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 110.387 -179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.49 HD13 ' HZ ' ' B' ' 68' ' ' PHE . 14.9 mt -109.53 132.39 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.968 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' PHE . . . . . 0.854 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 36.7 m-85 -117.82 -178.36 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 110.473 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.452 HG23 HG23 ' B' ' 30' ' ' VAL . 57.6 p -125.79 105.92 9.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.419 HG23 ' HB2' ' B' ' 77' ' ' ARG . 5.8 pt -60.71 -16.6 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.514 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.471 ' CE ' ' ND2' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -148.73 159.79 37.3 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.876 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.31 130.26 28.04 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.59 1.31 . . . . 0.0 110.05 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.49 HG21 ' HB1' ' B' ' 20' ' ' ALA . 56.1 mt -98.92 156.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.0 110.806 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.97 157.44 18.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.912 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' ILE . . . . . 0.882 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.6 mp -61.68 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 110.343 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.24 30.89 3.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.07 155.1 18.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -1.137 . . . . 0.0 110.155 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.48 117.51 27.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.028 -1.045 . . . . 0.0 110.505 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' B' ' 20' ' ' ALA . 57.3 mt -95.96 130.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 110.617 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.475 HG23 ' C ' ' B' ' 101' ' ' ILE . 30.5 p -154.28 170.23 21.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.726 -0.608 . . . . 0.0 109.487 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.5 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.3 pp -128.71 6.24 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 111.275 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 2.2 p 54.63 -151.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.064 . . . . 0.0 110.059 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 25.4 m-85 -133.7 -77.37 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.99 . . . . 0.0 110.855 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.35 -159.21 20.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.38 18.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.93 -53.35 0.7 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 110.108 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.457 ' HB3' ' CB ' ' B' ' 105' ' ' TYR . 0.1 OUTLIER -60.11 118.77 6.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 110.338 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.89 179.641 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 3.2 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.274 0.559 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 217' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -115.27 167.7 9.48 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 110.357 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 218' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 19.4 Cg_endo . . . . . 0 C--N 1.312 -1.373 0 O-C-N 123.633 1.333 . . . . 0.0 110.526 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' CG ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.185 0.517 . . . . 0.0 110.398 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 22.3 p90 -71.01 145.06 50.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.435 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.14 146.86 33.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 110.251 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.83 -22.65 3.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 110.836 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.526 ' C ' HG13 ' A' ' 6' ' ' VAL . 7.3 mtm-85 -90.14 -37.51 14.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.998 . . . . 0.0 110.688 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.526 HG13 ' C ' ' A' ' 5' ' ' ARG . 33.1 m -152.03 -172.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 110.453 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.737 HG23 ' HB2' ' A' ' 19' ' ' PHE . 12.6 tt -157.04 161.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.212 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG11 ' CG ' ' A' ' 1' ' ' MET . 9.8 p -97.02 135.46 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.892 . . . . 0.0 110.765 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.571 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 28.4 mttt -139.62 142.71 37.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.78 . . . . 0.0 109.161 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.571 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mmtp 52.04 64.31 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 119.797 -1.814 . . . . 0.0 111.217 0.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.491 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -120.64 170.25 7.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.549 -0.719 . . . . 0.0 110.088 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.93 -21.53 56.96 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.603 1.317 . . . . 0.0 110.499 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.94 32.19 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.41 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.05 152.58 21.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.38 -120.07 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.563 ' HB2' ' HN2' ' A' ' 301' ' ' SAH . 31.4 m-85 -115.2 61.2 0.69 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.159 . . . . 0.0 110.331 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.56 24.1 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.932 HG23 HD13 ' A' ' 67' ' ' ILE . 54.7 t -103.22 154.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.978 -1.307 . . . . 0.0 110.092 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.737 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.1 m-85 -113.95 127.85 56.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.301 -0.874 . . . . 0.0 110.127 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.587 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -90.23 92.08 8.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.219 -0.926 . . . . 0.0 110.501 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.789 ' O ' HG23 ' A' ' 97' ' ' ILE . 7.0 ttt180 -58.31 -22.8 54.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 0.0 109.47 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 23' ' ' SER . 2.2 mptt -88.85 178.25 6.49 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.507 -0.746 . . . . 0.0 109.487 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 22' ' ' LYS 2.513 73.9 m 98.58 17.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.231 -1.543 . . . . 0.0 110.351 0.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' A' ' 91' ' ' THR . 19.4 m-85 -108.0 164.36 12.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.334 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.1 -165.66 1.01 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 110.394 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.446 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 5.4 tttt -85.41 96.47 9.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 110.423 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.0 52.6 0.64 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -119.68 123.04 42.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -1.195 . . . . 0.0 110.433 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.841 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -68.27 96.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 110.0 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' A' ' 6' ' ' VAL . 72.3 t -67.75 -39.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.725 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -168.49 164.42 12.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 110.258 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.17 141.55 18.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.437 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 52.7 m -144.96 -176.05 4.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 110.423 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.25 171.6 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.473 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.748 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 65.3 m -146.58 -178.22 6.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 110.168 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 55.9 mt -122.3 143.0 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 84' ' ' LEU . 39.6 t -117.39 102.96 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.51 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.7 mmt180 -125.87 160.47 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -79.64 173.79 12.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 110.405 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 110.214 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.6 t0 66.52 -150.39 0.2 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.721 -1.237 . . . . 0.0 110.605 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.25 -36.74 4.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.369 -0.832 . . . . 0.0 111.307 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.51 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 57.4 t-105 -55.33 -59.79 4.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.238 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.56 57.25 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 98.4 m -73.83 -70.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.186 . . . . 0.0 110.607 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.67 -43.84 26.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.107 -0.996 . . . . 0.0 110.849 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.658 ' CB ' HD11 ' A' ' 51' ' ' LEU . 4.5 mm? -92.12 16.73 10.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.265 -0.897 . . . . 0.0 111.38 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -59.98 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.984 -1.072 . . . . 0.0 110.449 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.1 t0 -179.03 -69.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.003 -1.061 . . . . 0.0 110.333 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.625 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 19.3 m-85 -114.33 61.74 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.658 HD11 ' CB ' ' A' ' 47' ' ' LEU . 24.7 mt -111.9 117.45 32.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 111.027 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 4.8 m-85 -88.25 92.64 9.24 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.426 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 85.8 p -94.68 145.34 24.91 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.248 -0.908 . . . . 0.0 111.497 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.721 ' HB2' HD11 ' A' ' 84' ' ' LEU . 5.3 ttp180 -109.77 -172.81 2.11 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.09 72.59 10.11 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.983 -1.073 . . . . 0.0 109.241 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.0 OUTLIER 169.96 -26.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.99 -168.13 0.93 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.283 -0.886 . . . . 0.0 111.262 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.7 p -129.76 123.98 32.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.556 -0.715 . . . . 0.0 109.806 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.43 169.16 8.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.071 -1.018 . . . . 0.0 111.054 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.582 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -104.29 151.13 23.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.407 -0.808 . . . . 0.0 110.102 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.27 85.53 7.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 110.007 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.705 ' O ' HD13 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -52.87 -69.02 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.452 -0.78 . . . . 0.0 110.708 -179.488 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -69.55 -151.26 0.5 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CD2' HG12 ' A' ' 67' ' ' ILE . 3.7 m-85 -83.94 51.4 2.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -1.05 . . . . 0.0 110.66 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.57 -23.72 49.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -82.55 -49.24 10.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 110.469 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.991 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.6 pp -45.76 -24.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.753 . . . . 0.0 111.701 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.991 ' N ' HD12 ' A' ' 67' ' ' ILE . 17.2 m-85 -62.2 109.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.844 -1.16 . . . . 0.0 110.024 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' H ' HG22 ' A' ' 102' ' ' THR . 84.3 m-20 -82.1 -176.86 6.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.745 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.776 ' CG ' HD12 ' A' ' 111' ' ' LEU . 4.2 t-160 -102.25 119.46 38.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.878 . . . . 0.0 110.171 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.5 t -121.32 158.96 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 110.59 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.51 -20.37 60.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 20.8 t0 -141.04 63.77 19.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 110.486 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.653 ' O ' HD11 ' A' ' 92' ' ' ILE . 17.2 Cg_exo -62.92 114.61 2.5 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.671 1.353 . . . . 0.0 110.025 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.43 ' O ' HD11 ' A' ' 95' ' ' ILE . 76.0 m-20 -90.95 24.17 2.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.746 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.483 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -158.66 142.47 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.412 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.1 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.37 168.77 18.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.91 161.26 30.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 110.092 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.0 mt -133.35 127.69 34.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.445 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 83' ' ' GLY . 3.4 p -69.73 -167.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.53 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 105.4 -177.29 22.9 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.731 ' HB2' HG22 ' A' ' 37' ' ' VAL . 20.9 mt -91.14 51.4 1.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -1.128 . . . . 0.0 110.329 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.9 -80.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.826 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.71 130.84 35.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 110.716 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.748 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.5 mtp -115.89 133.6 55.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.765 ' HB3' HD21 ' A' ' 29' ' ' LEU . 26.9 mtp85 -120.28 163.58 17.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.583 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.725 HD12 ' HB3' ' A' ' 31' ' ' GLU . 89.9 mt -129.83 98.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.841 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 26.5 m-85 -91.42 -176.85 4.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 110.432 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.671 ' CG2' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -118.73 81.89 1.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 111.075 -179.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 74' ' ' PRO . 1.4 pt -60.12 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.12 -0.988 . . . . 0.0 108.571 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER 84.42 121.77 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.363 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 84.6 Cg_exo -43.79 148.25 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.526 1.277 . . . . 0.0 111.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.671 HD12 ' CG2' ' A' ' 91' ' ' THR . 74.7 mt -119.91 151.96 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 110.418 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.19 14.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -63.5 117.24 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.61 5.05 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -104.03 178.45 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -1.21 . . . . 0.0 110.147 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.23 123.69 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.804 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.587 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 73.9 mt -89.52 127.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.237 -0.914 . . . . 0.0 110.122 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.7 p -155.44 176.4 12.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.946 -0.471 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.739 HD12 ' O ' ' A' ' 104' ' ' SER . 1.3 pp -140.42 158.12 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.01 -1.056 . . . . 0.0 110.563 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.739 ' O ' HD12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -83.01 -164.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 110.369 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.507 ' CG ' ' HB3' ' A' ' 109' ' ' TYR . 19.4 m-85 -124.16 -81.3 0.63 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.85 -152.61 24.52 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.417 -1.373 . . . . 0.0 109.817 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.13 -53.28 21.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.248 -1.149 . . . . 0.0 110.05 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.91 -167.7 0.91 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.435 -0.791 . . . . 0.0 109.351 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.507 ' HB3' ' CG ' ' A' ' 105' ' ' TYR . 2.7 m-85 46.09 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.412 -0.805 . . . . 0.0 111.002 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.466 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 29.6 p-90 -83.55 151.47 25.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.402 0.62 . . . . 0.0 110.601 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.776 HD12 ' CG ' ' A' ' 70' ' ' HIS . 1.1 tp -89.41 -78.62 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.595 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 t -176.75 -81.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.001 -1.062 . . . . 0.0 110.474 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -94.55 122.54 60.72 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.155 -0.965 . . . . 0.0 110.364 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.94 64.53 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.497 1.262 . . . . 0.0 110.487 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.511 ' C ' HD12 ' A' ' 116' ' ' LEU . 24.3 mmm180 -115.76 39.57 2.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.35 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 115' ' ' ARG . 6.8 mp -115.61 45.9 1.6 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.912 . . . . 0.0 110.412 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 119' ' ' ASN . 96.7 m -155.36 149.77 26.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 110.33 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.22 28.41 8.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.927 . . . . 0.0 110.304 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.702 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 m120 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.386 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 7.5 mttt 52.85 45.93 27.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -1.127 . . . . 0.0 110.394 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.429 ' HB1' ' HD2' ' C' ' 204' ' ' PRO . . . -170.42 164.14 5.79 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 110.429 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.429 ' HD2' ' HB1' ' C' ' 203' ' ' ALA . 26.9 Cg_endo -67.45 111.35 2.29 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.688 1.362 . . . . 0.0 110.562 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.24 148.17 26.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.321 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -126.32 104.56 8.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.391 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -75.76 -55.01 6.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.308 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.78 153.97 39.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.903 . . . . 0.0 110.255 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.27 124.67 4.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.343 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -66.37 -31.09 71.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.282 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.72 43.64 1.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 110.301 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -86.5 96.97 10.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 110.406 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.35 -169.92 1.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.335 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.411 ' HD3' ' HB2' ' A' ' 51' ' ' LEU . 30.6 mtp85 -125.55 -85.04 0.63 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.485 ' HE3' ' CE2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 2.9 t -56.33 -168.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.443 -0.785 . . . . 0.0 110.664 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -123.97 176.21 2.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.336 -0.852 . . . . 0.0 110.222 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 21.5 Cg_endo -66.33 -37.41 24.05 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.623 1.328 . . . . 0.0 110.594 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.38 60.23 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 110.374 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 97.9 m -148.9 84.85 1.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 110.343 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.849 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.479 ' CG ' HG11 ' B' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.239 0.542 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 22.3 p90 -71.03 145.1 50.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.13 146.93 33.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.88 -22.69 3.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.514 ' C ' HG13 ' B' ' 6' ' ' VAL . 7.4 mtm-85 -90.08 -37.62 14.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.514 HG13 ' C ' ' B' ' 5' ' ' ARG . 33.1 m -151.95 -172.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 0.0 110.485 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.717 HG23 ' HB2' ' B' ' 19' ' ' PHE . 12.6 tt -156.96 161.83 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 110.219 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.479 HG11 ' CG ' ' B' ' 1' ' ' MET . 10.0 p -97.02 135.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.818 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.574 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 28.4 mttt -139.62 142.76 37.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 109.161 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.574 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mmtp 52.16 64.23 1.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 119.796 -1.815 . . . . 0.0 111.233 0.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.3 OUTLIER -120.58 170.3 7.39 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -65.94 -21.54 56.9 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.638 1.336 . . . . 0.0 110.471 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.95 32.24 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.439 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.03 152.6 21.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.42 -120.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.572 ' HB2' ' HN2' ' B' ' 302' ' ' SAH . 31.5 m-85 -115.17 61.35 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 110.403 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.44 -171.52 23.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.933 HG23 HD13 ' B' ' 67' ' ' ILE . 54.2 t -103.24 154.03 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.934 -1.333 . . . . 0.0 110.084 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.717 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.1 m-85 -113.9 127.92 56.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.853 . . . . 0.0 110.148 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.57 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -90.16 91.86 8.71 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.289 -0.882 . . . . 0.0 110.557 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.79 ' O ' HG23 ' B' ' 97' ' ' ILE . 7.0 ttt180 -58.17 -22.75 52.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.54 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' B' ' 23' ' ' SER . 2.2 mptt -89.01 178.26 6.44 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.52 -0.738 . . . . 0.0 109.518 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' B' ' 22' ' ' LYS 2.514 73.8 m 98.58 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.311 -1.493 . . . . 0.0 110.339 0.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CB ' HG21 ' B' ' 91' ' ' THR . 19.6 m-85 -108.07 164.4 12.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 110.382 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.04 -165.65 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.4 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.428 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 5.4 tttt -85.43 96.38 9.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 110.466 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.01 52.66 0.64 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -119.7 122.98 42.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.0 110.411 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.829 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -68.26 96.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 110.044 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.423 ' CG1' HG11 ' B' ' 6' ' ' VAL . 72.2 t -67.69 -39.96 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.366 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.723 ' HB3' HD12 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -168.46 164.44 12.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 110.274 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.24 141.5 18.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.446 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 52.5 m -144.85 -176.06 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.923 . . . . 0.0 110.406 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.422 HD13 ' CE ' ' A' ' 1' ' ' MET . 1.1 mp -95.19 171.66 8.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.535 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.749 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 65.2 m -146.64 -178.27 6.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.557 ' O ' ' HB1' ' B' ' 59' ' ' ALA . 55.7 mt -122.29 142.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' B' ' 84' ' ' LEU . 39.6 t -117.3 102.91 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 110.396 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' B' ' 36' ' ' ILE . 14.7 mmt180 -125.81 160.5 29.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -79.65 173.79 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.412 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 77.9 m-20 -64.46 -136.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 110.208 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.6 t0 66.54 -150.32 0.2 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.698 -1.251 . . . . 0.0 110.64 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -45.36 -36.74 4.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 111.277 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.503 ' CE2' ' HB2' ' B' ' 38' ' ' ARG . 57.3 t-105 -55.33 -59.86 4.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 0.0 110.181 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.35 -31.54 56.9 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.435 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 98.1 m -73.91 -70.64 0.37 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -1.233 . . . . 0.0 110.621 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.82 -42.93 27.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.081 -1.012 . . . . 0.0 111.002 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.658 ' CB ' HD11 ' B' ' 51' ' ' LEU . 4.5 mm? -93.48 17.37 11.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 111.014 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.1 OUTLIER -60.28 85.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.091 . . . . 0.0 110.408 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 47' ' ' LEU . 1.1 t0 -179.01 -69.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.95 -1.094 . . . . 0.0 110.345 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.644 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . 19.4 m-85 -114.38 61.9 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 110.117 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.658 HD11 ' CB ' ' B' ' 47' ' ' LEU . 24.4 mt -112.07 116.67 30.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.169 -0.957 . . . . 0.0 111.153 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' B' ' 59' ' ' ALA . 5.0 m-85 -87.23 92.64 9.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 0.0 108.795 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.419 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 85.6 p -94.74 145.36 24.92 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.238 -0.914 . . . . 0.0 111.529 -176.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.722 ' HB2' HD11 ' B' ' 84' ' ' LEU . 5.4 ttp180 -110.38 -175.65 2.78 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.541 -0.724 . . . . 0.0 109.48 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.11 72.17 5.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 0.0 OUTLIER 169.77 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.8 -168.17 0.96 Allowed 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.336 -0.852 . . . . 0.0 111.351 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 1.7 p -129.69 123.97 32.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.599 -0.688 . . . . 0.0 109.781 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.45 169.25 8.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.098 -1.002 . . . . 0.0 111.054 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.582 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -104.59 149.99 25.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 110.26 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.66 85.44 7.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.255 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 62' ' ' LEU 2.501 0.1 OUTLIER -53.0 -69.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.375 -0.828 . . . . 0.0 110.723 -179.646 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -69.49 -151.22 0.49 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.493 ' CD2' HG12 ' B' ' 67' ' ' ILE . 3.7 m-85 -84.02 51.36 2.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.422 -1.046 . . . . 0.0 110.652 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.49 -23.76 49.5 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -82.58 -49.27 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 110.398 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.98 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.6 pp -45.75 -24.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.491 -0.756 . . . . 0.0 111.749 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.98 ' N ' HD12 ' B' ' 67' ' ' ILE . 17.2 m-85 -62.32 109.75 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.902 -1.124 . . . . 0.0 110.024 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.404 ' H ' HG22 ' B' ' 102' ' ' THR . 84.3 m-20 -81.99 -176.46 6.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.716 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.775 ' CG ' HD12 ' B' ' 111' ' ' LEU . 4.3 t-160 -102.78 119.45 38.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -0.841 . . . . 0.0 110.024 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 36.7 t -121.35 158.94 27.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.47 -20.43 60.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.428 ' N ' ' HD3' ' B' ' 74' ' ' PRO . 20.7 t0 -140.99 63.63 19.01 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 110.505 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.642 ' O ' HD11 ' B' ' 92' ' ' ILE . 17.2 Cg_exo -62.79 114.68 2.51 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.627 1.33 . . . . 0.0 110.04 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.44 ' O ' HD11 ' B' ' 95' ' ' ILE . 76.2 m-20 -91.08 24.29 2.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.701 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.475 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -158.62 142.45 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 110.401 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.455 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 5.3 ttp180 -134.99 -160.04 1.01 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.529 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -142.42 168.72 19.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.755 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.89 161.27 30.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -0.827 . . . . 0.0 110.037 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.37 127.61 33.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.002 . . . . 0.0 110.487 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' B' ' 83' ' ' GLY . 3.4 p -69.71 -167.35 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 110.278 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 110.229 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 81' ' ' THR . . . 105.43 -177.22 22.85 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' B' ' 37' ' ' VAL . 20.9 mt -91.21 51.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 110.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -100.92 -80.77 0.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.968 . . . . 0.0 110.82 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -79.69 130.82 35.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.741 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.749 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.6 mtp -115.87 133.64 55.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.746 ' HB3' HD21 ' B' ' 29' ' ' LEU . 26.8 mtp85 -120.31 163.55 17.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.641 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.723 HD12 ' HB3' ' B' ' 31' ' ' GLU . 89.5 mt -129.75 98.65 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.829 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 26.3 m-85 -91.36 -176.8 4.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.386 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.671 ' CG2' HD12 ' B' ' 95' ' ' ILE . 0.2 OUTLIER -118.68 81.86 1.76 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.148 -0.97 . . . . 0.0 110.996 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.642 HD11 ' O ' ' B' ' 74' ' ' PRO . 1.4 pt -59.96 103.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.657 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 92' ' ' ILE . 0.0 OUTLIER 84.15 121.44 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 C-N-CA 123.541 0.736 . . . . 0.0 109.425 -177.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 88.2 Cg_exo -44.13 148.51 1.09 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.468 1.246 . . . . 0.0 111.436 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.671 HD12 ' CG2' ' B' ' 91' ' ' THR . 74.0 mt -119.92 151.91 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.285 -0.884 . . . . 0.0 110.421 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.49 160.18 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.364 -0.835 . . . . 0.0 110.344 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.79 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -63.47 117.17 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 110.367 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.05 27.59 5.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.404 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 18.8 mm-40 -104.03 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.098 -1.236 . . . . 0.0 110.156 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -116.29 123.68 48.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.81 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.57 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 74.3 mt -89.34 127.37 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 110.181 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 101' ' ' ILE . 16.6 p -155.42 176.43 12.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.664 -0.647 . . . . 0.0 109.798 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.736 HD12 ' O ' ' B' ' 104' ' ' SER . 1.3 pp -140.43 158.07 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.084 -1.01 . . . . 0.0 110.573 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.736 ' O ' HD12 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -82.98 -164.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 0.0 110.37 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' B' ' 109' ' ' TYR . 19.6 m-85 -124.12 -81.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 110.327 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.76 -152.69 24.59 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -49.06 -53.31 20.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.287 -1.125 . . . . 0.0 110.101 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.86 -167.46 0.85 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.421 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HB3' ' CG ' ' B' ' 105' ' ' TYR . 2.8 m-85 45.81 92.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.389 -0.82 . . . . 0.0 111.157 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.478 ' O ' ' CE3' ' B' ' 110' ' ' TRP . 30.1 p-90 -83.57 151.58 25.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 110.598 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.775 HD12 ' CG ' ' B' ' 70' ' ' HIS . 1.1 tp -89.37 -78.64 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 110.639 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 11.6 t -176.75 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.034 -1.041 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' B' ' 115' ' ' ARG . 9.1 mtt180 -94.57 122.53 60.7 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 110.344 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.87 64.4 0.93 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.474 1.249 . . . . 0.0 110.49 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . 0.503 ' C ' HD12 ' B' ' 116' ' ' LEU . 24.2 mmm180 -115.69 39.59 2.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 110.362 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.503 HD12 ' C ' ' B' ' 115' ' ' ARG . 6.8 mp -115.67 45.97 1.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 110.379 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.699 HG22 ' H ' ' B' ' 119' ' ' ASN . 96.3 m -155.38 149.8 26.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.341 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.17 28.27 8.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.345 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.699 ' H ' HG22 ' B' ' 117' ' ' THR . 1.4 m120 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.414 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 52.85 45.94 27.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -1.146 . . . . 0.0 110.402 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.448 ' HB1' ' HD2' ' D' ' 204' ' ' PRO . . . -170.41 164.15 5.8 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.419 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.448 ' HD2' ' HB1' ' D' ' 203' ' ' ALA . 26.8 Cg_endo -67.46 111.39 2.3 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.654 1.344 . . . . 0.0 110.552 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.25 148.05 26.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 110.35 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -126.27 104.58 8.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 110.382 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -75.68 -55.05 6.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 110.388 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.77 153.91 39.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 110.281 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.24 124.66 4.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 110.395 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -66.34 -31.04 71.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.34 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.73 43.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 110.226 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -86.47 96.9 10.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.94 . . . . 0.0 110.431 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.3 -169.81 1.7 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.343 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.409 ' HD3' ' HB2' ' B' ' 51' ' ' LEU . 30.7 mtp85 -125.61 -84.95 0.63 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 110.292 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.498 ' HE3' ' CE2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.504 2.9 t -56.29 -168.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 0.0 110.682 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.802 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -124.01 176.19 2.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.802 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 21.4 Cg_endo -66.31 -37.46 23.99 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.644 1.339 . . . . 0.0 110.542 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.31 60.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.398 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 98.0 m -148.89 84.83 1.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 110.34 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.55 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.563 ' HN2' ' HB2' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.572 ' HN2' ' HB2' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.226 0.536 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 54.5 p90 -53.16 132.84 39.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 110.634 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ARG . 46.7 t30 -150.14 161.29 42.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.82 62.01 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.443 -0.786 . . . . 0.0 110.618 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.526 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.2 OUTLIER 174.75 -34.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.0 109.218 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.625 HG11 ' CG1' ' A' ' 30' ' ' VAL . 16.5 m -156.55 -172.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.713 -0.617 . . . . 0.0 109.737 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 10.2 tt -160.64 164.29 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.892 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.7 p -89.14 120.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.098 -1.002 . . . . 0.0 110.474 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.584 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 26.2 mttt -148.39 127.72 13.03 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.584 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 54.44 42.11 31.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.795 -1.816 . . . . 0.0 110.088 4.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.51 ' CB ' ' CE1' ' A' ' 19' ' ' PHE . 2.1 p -92.83 -171.05 0.25 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.677 -0.64 . . . . 0.0 109.905 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 40.9 Cg_exo -52.24 108.27 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.441 1.232 . . . . 0.0 110.725 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 13' ' ' LEU . 4.5 mm? 52.67 54.62 10.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.613 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.49 165.68 25.46 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.43 -163.9 17.11 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CE1' ' HG3' ' A' ' 10' ' ' LYS . 3.8 m-85 -95.08 99.67 11.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.249 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.72 -160.51 9.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 67' ' ' ILE . 79.7 t -113.1 138.32 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.837 -1.39 . . . . 0.0 110.414 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CG ' ' CD ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -104.28 140.99 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -104.14 91.01 3.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 110.974 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.899 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -60.18 -26.2 66.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HE2' ' CE1' ' A' ' 24' ' ' PHE . 6.2 mtpp -94.28 -177.38 4.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.566 -0.709 . . . . 0.0 109.567 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.443 ' HA ' ' CB ' ' A' ' 22' ' ' LYS 2.512 0.1 OUTLIER 108.58 17.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.123 -1.61 . . . . 0.0 110.109 1.879 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CE1' ' HE2' ' A' ' 22' ' ' LYS . 48.8 m-85 -114.76 160.82 18.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.652 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.2 172.27 6.89 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.978 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' CD ' ' A' ' 94' ' ' PRO . 29.5 tttm -72.03 80.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.552 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.43 40.87 0.12 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 24' ' ' PHE . 14.0 mt-10 -119.3 158.52 25.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.177 . . . . 0.0 110.386 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.865 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.5 tm? -92.41 128.11 38.14 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.694 ' N ' HD13 ' A' ' 29' ' ' LEU . 81.7 t -94.37 -45.61 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.211 -0.931 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' HD12 ' A' ' 89' ' ' ILE . 27.3 tp10 -170.32 152.07 3.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 110.64 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.51 35.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.05 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.441 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -146.67 -157.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 110.743 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 34' ' ' LEU . 1.5 mm? -99.91 175.47 5.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.415 -0.803 . . . . 0.0 110.551 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.734 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 3.3 m -150.7 154.93 38.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.393 -0.817 . . . . 0.0 109.988 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.787 HD11 HD23 ' A' ' 62' ' ' LEU . 54.7 mt -94.89 164.01 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.003 . . . . 0.0 109.85 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 36' ' ' ILE . 48.7 t -144.96 106.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -0.962 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.522 ' CB ' ' CG ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -112.82 -163.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.205 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -128.7 62.45 1.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 110.898 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 26.8 m120 52.35 -149.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 0.0 110.631 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 40' ' ' ASN . 17.6 m-20 60.51 -144.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.211 -0.93 . . . . 0.0 110.106 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -46.63 -29.05 1.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.009 -1.057 . . . . 0.0 111.149 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.841 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 66.1 t-105 -65.07 -44.45 88.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 110.232 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.37 -40.15 97.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.8 m -67.07 -65.63 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.494 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.508 ' HB3' HD22 ' A' ' 47' ' ' LEU . . . -54.31 -58.43 7.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.883 ' HB3' HD13 ' A' ' 51' ' ' LEU . 2.7 mm? -90.63 50.52 1.83 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -0.4 22.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 0.0 111.015 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -129.6 156.8 43.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.942 -1.099 . . . . 0.0 109.681 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 33.3 m-85 54.93 24.09 5.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 109.857 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.883 HD13 ' HB3' ' A' ' 47' ' ' LEU . 7.5 tp -117.05 123.4 46.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 110.851 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 36.2 m-85 -90.04 118.59 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.1 m -96.35 138.43 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.112 -0.993 . . . . 0.0 110.967 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.901 ' CD ' HD13 ' A' ' 84' ' ' LEU . 4.3 ttp180 -109.76 176.47 5.06 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.449 -0.782 . . . . 0.0 110.228 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -84.18 81.6 8.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.03 -1.044 . . . . 0.0 109.221 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.505 8.9 m-80 148.29 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 109.733 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.7 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.498 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -150.9 164.81 35.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 110.709 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.597 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -150.63 155.85 40.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.531 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.881 ' CE ' HD12 ' A' ' 47' ' ' LEU . 27.5 tpp -102.61 159.68 15.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 110.135 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.76 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.39 94.26 9.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.101 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.787 HD23 HD11 ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER -55.34 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.804 . . . . 0.0 111.165 -178.978 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.53 -132.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.71 ' HB3' HD11 ' A' ' 67' ' ' ILE . 89.2 m-85 -90.16 39.14 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -1.094 . . . . 0.0 110.664 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.76 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -79.15 -20.27 70.31 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.97 -48.27 7.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -1.198 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 64' ' ' PHE . 1.3 pp -55.77 -17.29 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 111.259 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CG ' HG12 ' A' ' 103' ' ' ILE . 4.6 m-85 -49.01 134.29 17.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.881 -1.137 . . . . 0.0 110.832 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.452 ' N ' HG23 ' A' ' 102' ' ' THR . 10.9 m-20 -97.18 -164.33 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 110.875 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -102.36 157.44 16.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.782 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 t -174.41 130.08 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.015 . . . . 0.0 110.565 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.658 ' CG ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.65 79.36 47.93 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.746 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.7 Cg_endo -63.76 100.45 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.653 1.344 . . . . 0.0 110.451 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -54.85 -21.06 10.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 110.487 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -130.67 163.45 27.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.972 . . . . 0.0 110.481 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HA ' HG22 ' A' ' 103' ' ' ILE . 71.9 ttt180 -143.44 156.71 44.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 110.241 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.59 ' HD1' HD13 ' A' ' 103' ' ' ILE . 37.2 p-80 -89.85 166.42 13.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 110.382 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 24.0 tp10 -148.07 161.25 41.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.9 . . . . 0.0 110.405 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 84' ' ' LEU . 25.9 mt -123.59 148.54 46.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.92 64.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.58 40.13 29.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.47 -133.79 2.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.901 HD13 ' CD ' ' A' ' 54' ' ' ARG . 2.0 tp -137.23 23.1 3.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 110.234 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -85.95 -67.16 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 111.065 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.14 164.12 12.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 111.017 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.734 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 4.3 mtp -134.28 148.41 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.476 ' HB3' HD21 ' A' ' 29' ' ' LEU . 21.4 mtp180 -133.09 167.3 20.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 0.0 110.448 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' HZ ' ' A' ' 68' ' ' PHE . 65.1 mt -133.38 95.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.268 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.865 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 54.2 m-85 -90.39 -179.53 5.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 110.547 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.532 ' CG2' HD12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -117.72 94.16 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 110.189 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.746 HD11 ' O ' ' A' ' 74' ' ' PRO . 10.9 pt -55.87 -20.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 110.592 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.9 mttt -137.71 160.15 66.08 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 110.454 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 26' ' ' LYS . 23.5 Cg_exo -58.03 158.31 21.89 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.651 1.342 . . . . 0.0 110.507 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 91' ' ' THR . 39.5 mt -144.57 136.44 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.71 166.07 11.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.585 -0.697 . . . . 0.0 110.831 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.3 mp -65.11 110.39 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.546 -0.721 . . . . 0.0 110.316 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 22.8 5.02 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.408 ' CB ' HG23 ' A' ' 95' ' ' ILE . 18.3 mm-40 -94.71 -179.36 4.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 110.094 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.19 122.33 35.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.846 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.556 HG23 ' CB ' ' A' ' 76' ' ' ALA . 23.5 mt -89.66 131.08 37.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 110.43 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 69' ' ' ASN . 49.5 m -162.8 147.62 11.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.59 HD13 ' HD1' ' A' ' 78' ' ' HIS . 1.4 pt -115.0 165.21 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.033 -1.042 . . . . 0.0 110.769 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.22 -159.11 0.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.373 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.12 -93.35 0.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.425 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.23 169.24 41.76 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.752 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.81 -58.64 7.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -39.21 79.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.0 OUTLIER -89.94 31.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.937 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -176.43 -171.06 0.38 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -51.55 155.47 1.56 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.513 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.9 t -69.82 110.51 5.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 110.459 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.59 82.99 0.23 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 110.406 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.99 101.97 1.28 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.705 1.371 . . . . 0.0 110.254 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -81.16 127.45 32.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -0.897 . . . . 0.0 110.384 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.658 HD21 ' CG ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -124.6 21.16 8.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 110.559 -179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.1 m -73.58 144.89 45.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -67.65 143.86 55.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.928 . . . . 0.0 110.339 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.283 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.09 28.97 5.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -1.143 . . . . 0.0 110.402 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' C' ' 204' ' ' PRO . . . -70.8 -48.67 15.1 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 110.842 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' C' ' 203' ' ' ALA . 22.9 Cg_exo -60.18 82.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.352 1.185 . . . . 0.0 110.534 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' C' ' 203' ' ' ALA . 0.1 OUTLIER -160.71 158.84 29.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.928 . . . . 0.0 110.426 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp 52.35 62.09 2.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.43 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -78.67 -170.51 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.58 161.25 20.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 110.3 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.89 149.94 41.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.314 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 20.9 p -57.01 -22.67 40.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 110.33 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 7.7 tttp 52.48 78.19 0.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.451 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.59 -176.63 3.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.326 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -163.97 -67.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 110.418 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.508 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 0.5 OUTLIER -160.43 -171.18 3.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 110.401 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.507 2.4 t -52.79 -54.62 31.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.666 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 54.48 174.84 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 25.3 Cg_exo -59.84 175.65 0.87 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.616 1.324 . . . . 0.0 110.583 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -129.28 41.44 3.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 6.7 t -56.93 172.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 110.432 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.085 0 CA-C-O 118.027 -1.43 . . . . 0.0 109.976 -179.519 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.282 0.563 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 54.6 p90 -53.17 132.97 39.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 110.63 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -150.18 161.5 42.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.081 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.06 61.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.369 -0.832 . . . . 0.0 110.578 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.512 ' O ' HG13 ' B' ' 6' ' ' VAL . 0.2 OUTLIER 174.83 -34.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.342 -0.849 . . . . 0.0 109.21 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.624 HG11 ' CG1' ' B' ' 30' ' ' VAL . 16.7 m -156.48 -172.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.664 -0.647 . . . . 0.0 109.819 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 10.3 tt -160.68 163.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.977 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.564 HG13 ' O ' ' B' ' 8' ' ' VAL . 7.8 p -88.59 120.72 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.152 -0.967 . . . . 0.0 110.538 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.613 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 26.1 mttt -148.57 127.75 12.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.613 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 54.47 42.09 31.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.642 -1.911 . . . . 0.0 110.106 4.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.517 ' CB ' ' CE1' ' B' ' 19' ' ' PHE . 2.1 p -92.78 -171.15 0.25 Allowed Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.675 -0.64 . . . . 0.0 109.932 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 41.3 Cg_exo -52.19 108.31 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.454 1.239 . . . . 0.0 110.725 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' B' ' 13' ' ' LEU . 4.5 mm? 52.67 54.65 10.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.302 -0.874 . . . . 0.0 110.625 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.56 165.47 25.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.32 -163.86 16.58 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' B' ' 10' ' ' LYS . 3.8 m-85 -95.0 99.69 11.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.054 -1.262 . . . . 0.0 110.495 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.71 -160.34 9.54 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.504 HG23 ' CD1' ' B' ' 67' ' ' ILE . 81.2 t -113.24 138.08 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.386 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CG ' ' CD ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -104.21 141.05 36.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.788 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -104.19 91.09 3.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.947 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.905 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.3 OUTLIER -60.27 -26.07 66.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.507 ' HE2' ' CE1' ' B' ' 24' ' ' PHE . 6.2 mtpp -94.4 -177.14 4.16 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 109.572 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.464 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.511 0.1 OUTLIER 108.69 17.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.133 -1.605 . . . . 0.0 110.133 1.755 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.507 ' CE1' ' HE2' ' B' ' 22' ' ' LYS . 49.3 m-85 -114.67 160.9 18.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.639 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -104.3 172.29 6.87 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.517 -0.739 . . . . 0.0 110.025 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -72.23 80.36 0.99 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.37 40.95 0.12 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' B' ' 24' ' ' PHE . 13.7 mt-10 -119.44 158.48 26.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -1.214 . . . . 0.0 110.336 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.883 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.5 tm? -92.35 128.07 38.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.0 109.968 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.696 ' N ' HD13 ' B' ' 29' ' ' LEU . 82.6 t -94.35 -45.66 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.457 ' HB3' HD12 ' B' ' 89' ' ' ILE . 27.4 tp10 -170.26 152.11 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.553 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -145.17 149.55 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 110.028 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.434 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -146.75 -157.4 0.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 110.757 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' B' ' 34' ' ' LEU . 1.5 mm? -99.93 175.86 5.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.816 . . . . 0.0 110.574 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 3.4 m -151.12 154.77 37.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 109.953 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.794 HD11 HD23 ' B' ' 62' ' ' LEU . 54.7 mt -94.85 163.97 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.825 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.415 HG23 ' C ' ' B' ' 36' ' ' ILE . 48.7 t -144.87 106.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.967 . . . . 0.0 110.678 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.528 ' CB ' ' CG ' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -113.0 -163.34 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.3 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -128.61 62.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 110.963 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 26.7 m120 52.42 -149.31 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.647 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 17.4 m-20 60.5 -144.13 0.5 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.232 -0.917 . . . . 0.0 110.14 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -46.63 -29.04 1.66 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.07 -1.019 . . . . 0.0 111.147 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.834 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 66.2 t-105 -65.04 -44.51 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 110.172 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.33 -40.16 97.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 98.5 m -67.15 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -1.152 . . . . 0.0 110.434 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.52 ' HB3' HD22 ' B' ' 47' ' ' LEU . . . -54.3 -58.28 8.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 110.324 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.88 ' HB3' HD13 ' B' ' 51' ' ' LEU . 2.7 mm? -90.96 50.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -0.56 22.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' B' ' 49' ' ' ASP . 39.9 p-10 -129.45 156.89 43.39 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.009 -1.057 . . . . 0.0 109.779 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' B' ' 66' ' ' ALA . 32.9 m-85 54.88 24.01 5.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.155 -0.966 . . . . 0.0 109.885 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 47' ' ' LEU . 7.5 tp -117.01 123.54 47.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.379 -0.826 . . . . 0.0 110.85 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' B' ' 52' ' ' PHE . 35.9 m-85 -90.17 118.6 29.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.601 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.2 m -96.35 138.39 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.921 ' CD ' HD13 ' B' ' 84' ' ' LEU . 4.3 ttp180 -110.23 174.06 6.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.498 -0.751 . . . . 0.0 110.32 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -80.82 81.33 7.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.506 8.8 m-80 148.14 -19.66 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 109.77 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.61 -149.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.481 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.495 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -151.38 164.84 35.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 110.69 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -150.93 155.71 39.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.86 . . . . 0.0 110.464 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.879 ' CE ' HD12 ' B' ' 47' ' ' LEU . 27.5 tpp -102.7 158.66 16.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.183 -0.948 . . . . 0.0 110.326 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.749 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -85.93 94.19 9.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.794 HD23 HD11 ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER -55.45 -71.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 111.206 -179.177 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.59 -132.8 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.737 ' HB3' HD11 ' B' ' 67' ' ' ILE . 89.1 m-85 -90.21 39.17 0.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.414 -1.051 . . . . 0.0 110.745 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.749 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -79.26 -19.82 71.08 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.5 -48.1 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.111 -1.229 . . . . 0.0 111.145 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.737 HD11 ' HB3' ' B' ' 64' ' ' PHE . 1.3 pp -55.82 -17.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.166 -0.959 . . . . 0.0 111.355 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.5 ' CG ' HG12 ' B' ' 103' ' ' ILE . 4.6 m-85 -49.04 134.29 17.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.785 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.434 ' N ' HG23 ' B' ' 102' ' ' THR . 11.5 m-20 -97.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -103.05 157.3 17.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 109.729 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.0 t -174.33 130.14 0.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.103 -0.998 . . . . 0.0 110.542 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.664 ' CG ' HD21 ' B' ' 116' ' ' LEU . 0.1 OUTLIER -60.08 -36.59 77.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 110.207 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.59 79.3 47.33 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 110.248 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.731 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.5 Cg_endo -63.7 100.44 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.681 1.358 . . . . 0.0 110.486 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.93 -21.0 10.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -0.922 . . . . 0.0 110.524 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.557 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -130.65 163.45 27.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 110.506 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.519 ' HA ' HG22 ' B' ' 103' ' ' ILE . 71.9 ttt180 -143.42 156.71 44.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.582 ' HD1' HD13 ' B' ' 103' ' ' ILE . 37.3 p-80 -89.75 166.42 13.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.167 -0.958 . . . . 0.0 110.455 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -148.08 161.22 41.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 110.404 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' B' ' 84' ' ' LEU . 25.9 mt -123.6 148.52 46.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.313 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -73.81 64.9 0.99 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 52.56 40.16 29.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.456 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.43 -133.74 2.85 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.921 HD13 ' CD ' ' B' ' 54' ' ' ARG . 2.0 tp -137.25 23.15 3.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -1.097 . . . . 0.0 110.241 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -86.03 -67.15 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 111.039 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -105.13 164.16 12.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 111.085 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.742 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 4.3 mtp -134.3 148.38 50.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 110.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.464 ' HB3' HD21 ' B' ' 29' ' ' LEU . 21.4 mtp180 -133.02 167.34 20.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.498 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.481 HD13 ' HZ ' ' B' ' 68' ' ' PHE . 65.2 mt -133.42 95.29 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.883 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 54.0 m-85 -90.53 -179.5 5.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 110.48 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.539 ' CG2' HD12 ' B' ' 95' ' ' ILE . 1.0 OUTLIER -117.76 94.18 4.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.127 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.731 HD11 ' O ' ' B' ' 74' ' ' PRO . 10.9 pt -55.83 -20.77 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 110.514 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.424 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.9 mttt -137.7 160.24 65.75 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 110.375 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.29 158.53 22.15 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.65 1.342 . . . . 0.0 110.421 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.539 HD12 ' CG2' ' B' ' 91' ' ' THR . 39.4 mt -144.64 136.48 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 110.271 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.77 166.01 11.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 110.767 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.905 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.3 mp -65.1 110.43 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.515 -0.741 . . . . 0.0 110.293 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.41 22.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.405 ' CB ' HG23 ' B' ' 95' ' ' ILE . 18.5 mm-40 -94.73 -179.33 4.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -1.171 . . . . 0.0 110.102 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.2 122.25 35.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 109.821 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.557 HG23 ' CB ' ' B' ' 76' ' ' ALA . 23.9 mt -89.49 131.14 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.48 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.434 HG23 ' N ' ' B' ' 69' ' ' ASN . 47.9 m -162.82 147.62 11.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.726 -0.609 . . . . 0.0 109.597 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.582 HD13 ' HD1' ' B' ' 78' ' ' HIS . 1.4 pt -114.98 165.2 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.753 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 4.6 t -82.17 -159.12 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -126.08 -93.36 0.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.937 . . . . 0.0 110.449 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.32 169.22 41.7 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.84 -58.62 7.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -1.121 . . . . 0.0 110.194 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.47 -39.21 79.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.517 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.0 OUTLIER -89.83 31.51 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.974 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -176.41 -171.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.989 -1.069 . . . . 0.0 110.506 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -51.5 155.45 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.482 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 30.9 t -69.81 110.51 5.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.452 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.61 82.95 0.23 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 110.387 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.97 102.04 1.28 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.685 1.361 . . . . 0.0 110.283 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -81.34 127.55 32.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.945 . . . . 0.0 110.423 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.664 HD21 ' CG ' ' B' ' 72' ' ' LYS . 0.2 OUTLIER -124.6 21.19 8.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 110.557 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 27.9 m -73.56 144.84 45.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.897 . . . . 0.0 110.371 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -67.62 143.87 55.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 110.314 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.035 -0.984 . . . . 0.0 110.328 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 28.96 5.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -1.155 . . . . 0.0 110.382 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.832 ' HB3' ' HD3' ' D' ' 204' ' ' PRO . . . -70.86 -48.59 14.72 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 110.831 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' D' ' 203' ' ' ALA . 22.8 Cg_exo -60.21 82.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.404 1.213 . . . . 0.0 110.538 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' D' ' 203' ' ' ALA . 0.1 OUTLIER -160.68 158.77 29.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 110.463 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp 52.41 62.1 2.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 110.388 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -78.7 -170.55 2.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 110.347 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.47 161.25 20.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 110.343 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -119.86 149.97 41.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 110.363 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 20.8 p -57.14 -22.59 41.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.942 . . . . 0.0 110.291 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 7.7 tttp 52.45 78.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.459 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -76.57 -176.62 3.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.347 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -163.92 -67.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 110.436 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 0.5 OUTLIER -160.43 -171.16 3.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.887 . . . . 0.0 110.358 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.506 2.4 t -52.88 -54.55 33.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.665 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.535 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 54.47 174.87 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.348 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 25.3 Cg_exo -59.87 175.56 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.701 1.369 . . . . 0.0 110.572 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -129.27 41.53 3.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.28 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 6.6 t -56.97 171.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.353 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 118.057 -1.413 . . . . 0.0 109.978 -179.584 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.468 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.468 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' HD21 ' B' ' 34' ' ' LEU . 6.1 mtp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.226 0.536 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 25.7 p90 -176.8 133.38 0.2 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.157 -0.964 . . . . 0.0 110.564 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.06 22.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.29 -22.11 6.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.583 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.492 ' C ' HG13 ' A' ' 6' ' ' VAL . 2.2 mmt85 -81.55 -41.1 22.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 0.0 110.593 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.492 HG13 ' C ' ' A' ' 5' ' ' ARG . 28.3 m -151.31 179.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 19' ' ' PHE . 9.4 tt -152.04 166.83 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.168 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 8' ' ' VAL . 12.6 p -104.66 125.15 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.958 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 20.5 mttt -128.59 142.73 50.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.398 -0.814 . . . . 0.0 109.116 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.576 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 5.5 mtpp 52.09 58.14 5.75 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.717 -1.865 . . . . 0.0 111.066 1.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.6 p -107.06 -173.47 0.28 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.519 -0.738 . . . . 0.0 110.268 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 36.3 Cg_exo -56.22 -52.75 6.51 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.617 1.325 . . . . 0.0 110.551 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.23 -49.86 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.551 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.23 -165.19 27.1 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.68 135.66 2.8 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -97.4 91.66 5.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 110.57 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -126.7 -168.74 12.63 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.756 -1.737 . . . . 0.0 108.756 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.763 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.5 p -113.1 125.95 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.299 . . . . 0.0 109.524 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -90.1 161.79 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 110.497 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 101' ' ' ILE . . . -118.73 96.71 5.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 110.634 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -63.62 -20.0 65.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.0 109.793 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 14.2 mtpt -91.81 179.97 5.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.381 -0.824 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 39.9 m 103.9 16.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.166 -1.584 . . . . 0.0 110.403 0.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 42.3 m-85 -109.55 168.5 9.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.367 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 -167.18 1.32 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.355 -0.84 . . . . 0.0 109.966 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.12 4.08 18.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.984 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.43 86.73 0.12 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -151.04 147.98 27.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -1.17 . . . . 0.0 110.484 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.933 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 tm? -86.3 122.86 30.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 110.257 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.608 ' N ' HD13 ' A' ' 29' ' ' LEU . 59.2 t -81.88 -52.66 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 110.213 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.846 ' CG ' HD12 ' A' ' 89' ' ' ILE . 1.9 pt-20 -162.43 177.69 9.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.129 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.21 149.49 8.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 110.492 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.19 -157.84 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.275 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 86' ' ' ARG . 72.8 mt -109.13 -178.51 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 85' ' ' LYS . 72.4 m -145.41 174.2 11.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 ' CD2' ' A' ' 62' ' ' LEU . 60.6 mt -116.2 125.18 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.886 . . . . 0.0 109.832 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 84' ' ' LEU . 26.0 t -97.82 100.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 110.579 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 2.6 mmp_? -119.44 -172.05 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.383 -0.823 . . . . 0.0 110.214 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 36.8 m80 -104.29 -165.03 1.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.339 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -91.04 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 58.07 -137.5 0.9 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.869 -1.144 . . . . 0.0 110.435 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.44 -40.04 7.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.996 -1.065 . . . . 0.0 111.498 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.973 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 76.1 t-105 -57.66 -45.69 85.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.98 -21.87 73.71 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.98 -63.51 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.24 . . . . 0.0 110.527 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.16 -55.61 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.915 ' HB3' HD13 ' A' ' 51' ' ' LEU . 3.9 mm? -89.49 52.37 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.293 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 57.42 3.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.99 -76.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 5.0 m-85 -89.52 48.21 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.973 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 6.1 tp -117.66 109.64 16.91 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.399 -0.813 . . . . 0.0 111.243 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -89.56 105.2 17.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.105 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.3 p -97.38 161.02 13.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 111.144 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.809 ' HB2' HD11 ' A' ' 84' ' ' LEU . 3.6 ttp180 -127.97 -172.36 2.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.481 -0.762 . . . . 0.0 109.959 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -83.69 84.63 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.031 -1.043 . . . . 0.0 109.334 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 0.8 OUTLIER 153.19 -22.01 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.75 -0.594 . . . . 0.0 109.778 -178.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.59 -168.1 0.22 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.281 -0.887 . . . . 0.0 110.735 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.1 m -132.22 134.82 45.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.469 -0.769 . . . . 0.0 109.921 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -127.88 166.69 17.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 111.031 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.847 ' CE ' HD12 ' A' ' 47' ' ' LEU . 1.2 ttt -96.1 170.46 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.857 . . . . 0.0 109.822 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.695 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.32 -54.04 4.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.156 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.497 0.0 OUTLIER 92.3 -81.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.819 -1.176 . . . . 0.0 110.513 -179.51 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.79 -143.48 0.06 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.33 56.65 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -1.065 . . . . 0.0 110.358 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.695 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -89.74 -43.31 5.17 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -63.39 -47.61 81.3 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.984 -1.304 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.8 pp -49.53 -22.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -0.876 . . . . 0.0 111.441 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.833 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.9 m-85 -50.19 113.45 0.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.767 -1.208 . . . . 0.0 110.415 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -102.0 -165.82 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 111.204 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.475 ' NE2' ' CD1' ' A' ' 111' ' ' LEU . 1.8 t-160 -94.46 140.89 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.531 -0.731 . . . . 0.0 110.449 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.44 16.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.337 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.684 ' HD2' HD22 ' A' ' 116' ' ' LEU . 4.6 tppp? -85.47 -19.48 31.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 110.528 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.54 74.93 53.88 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.956 . . . . 0.0 110.288 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.844 ' O ' HD11 ' A' ' 92' ' ' ILE . 32.4 Cg_exo -57.57 106.04 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.697 1.367 . . . . 0.0 110.467 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 76' ' ' ALA . 50.4 p-10 -85.06 -13.9 48.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -142.51 141.16 32.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.985 -1.072 . . . . 0.0 110.46 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.05 -176.44 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -124.36 161.98 24.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 110.517 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.45 154.15 51.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.353 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.766 HD11 ' HA ' ' A' ' 84' ' ' LEU . 43.8 tp -132.42 139.97 48.26 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.194 -0.941 . . . . 0.0 110.007 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.67 -168.99 1.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.925 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.85 107.92 18.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 110.408 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 37' ' ' VAL . . . 122.61 12.95 4.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 54' ' ' ARG . 16.5 mt 52.39 32.85 11.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.0 110.405 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 35' ' ' CYS . 2.7 mmtp -100.21 -62.29 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 111.147 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.76 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.3 ttt180 -97.49 162.26 13.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.64 147.59 27.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.145 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.601 ' HB3' HD21 ' A' ' 29' ' ' LEU . 36.2 mtt180 -132.02 171.92 13.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.376 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.846 HD12 ' CG ' ' A' ' 31' ' ' GLU . 96.3 mt -135.78 116.25 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.933 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 21.5 m-85 -108.11 171.07 7.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.395 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.488 HG23 ' CG2' ' A' ' 30' ' ' VAL . 7.3 p -112.36 87.39 2.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.844 HD11 ' O ' ' A' ' 74' ' ' PRO . 3.2 pt -52.03 -23.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 110.583 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' ILE . 5.2 mmtt -132.03 151.13 77.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.401 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.08 143.88 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.666 1.35 . . . . 0.0 110.292 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.0 mt -126.27 141.0 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.532 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.42 163.61 12.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 110.182 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 21' ' ' ARG . 4.8 mt -63.75 121.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 110.511 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.6 38.71 2.72 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -117.54 170.34 8.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -1.17 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -114.89 126.06 54.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 110.269 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.763 ' HB ' HG13 ' A' ' 18' ' ' VAL . 98.0 mt -96.59 127.21 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' ILE . 35.6 p -156.03 176.64 12.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.887 HD12 ' O ' ' A' ' 104' ' ' SER . 2.5 pp -147.91 155.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.667 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.887 ' O ' HD12 ' A' ' 103' ' ' ILE . 33.0 t -68.75 -149.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 110.464 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.417 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 83.0 m-85 -135.89 -69.43 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.449 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.63 -177.92 30.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -64.03 -40.41 96.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -1.109 . . . . 0.0 110.404 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -61.22 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.19 -0.944 . . . . 0.0 110.188 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.417 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.4 OUTLIER -69.98 106.99 3.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.477 ' CE3' ' O ' ' A' ' 111' ' ' LEU . 63.6 p-90 -48.88 128.78 16.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.638 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.477 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 16.4 tp -89.66 -110.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.346 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -174.52 112.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.395 -1.44 . . . . 0.0 110.693 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.424 ' HB3' ' NH1' ' A' ' 115' ' ' ARG . 0.0 OUTLIER 48.26 65.67 6.74 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.893 179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.0 118.37 5.24 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.611 1.322 . . . . 0.0 110.528 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 113' ' ' ARG . 10.6 ptt-85 -174.51 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.378 -0.826 . . . . 0.0 110.678 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.684 HD22 ' HD2' ' A' ' 72' ' ' LYS . 0.8 OUTLIER 52.51 -162.84 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 87.0 m -137.92 -61.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.158 -0.964 . . . . 0.0 110.332 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.23 155.96 49.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.882 . . . . 0.0 110.334 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.325 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.07 90.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -1.151 . . . . 0.0 110.415 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.873 ' HB3' ' HD3' ' C' ' 204' ' ' PRO . . . -55.02 -57.81 17.8 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 110.558 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.873 ' HD3' ' HB3' ' C' ' 203' ' ' ALA . 29.9 Cg_endo -70.18 102.13 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.474 1.25 . . . . 0.0 110.536 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -34.63 4.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.373 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -108.5 135.93 48.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 110.389 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -69.02 80.83 0.31 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 110.245 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.78 -178.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 110.298 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.59 173.31 14.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.391 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.7 t -125.48 56.43 1.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.883 . . . . 0.0 110.34 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -113.86 -33.04 5.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 110.374 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.86 76.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 110.417 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.1 71.51 2.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.269 -0.895 . . . . 0.0 110.376 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -116.52 177.28 4.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.333 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER -53.6 164.59 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -124.57 168.49 12.99 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 23.5 Cg_endo -67.21 -35.53 24.34 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.706 1.371 . . . . 0.0 110.533 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 53.06 85.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.241 -0.912 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 9.5 t -174.8 179.06 1.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.347 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.542 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.425 ' SD ' HD21 ' A' ' 34' ' ' LEU . 6.1 mtp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.252 0.549 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 25.7 p90 -176.8 133.4 0.2 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.155 -0.966 . . . . 0.0 110.596 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -126.71 164.09 22.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.166 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.27 -22.1 6.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 110.627 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.501 ' C ' HG13 ' B' ' 6' ' ' VAL . 2.2 mmt85 -81.55 -41.2 21.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.59 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.501 HG13 ' C ' ' B' ' 5' ' ' ARG . 28.8 m -151.24 179.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.007 . . . . 0.0 110.559 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' B' ' 19' ' ' PHE . 9.4 tt -152.0 166.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.198 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.556 HG13 ' O ' ' B' ' 8' ' ' VAL . 12.6 p -104.67 125.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -0.951 . . . . 0.0 110.957 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 20.4 mttt -128.6 142.7 50.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.436 -0.79 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.59 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 5.5 mtpp 52.06 58.2 5.69 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.738 -1.852 . . . . 0.0 111.033 1.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.6 p -107.1 -173.46 0.28 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.513 -0.742 . . . . 0.0 110.28 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 36.6 Cg_exo -56.17 -52.67 6.72 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.624 1.328 . . . . 0.0 110.556 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.48 -49.86 17.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 110.559 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.4 -165.17 27.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.67 135.6 2.78 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -97.26 91.76 5.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 110.579 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -126.81 -168.9 12.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.778 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.6 p -112.82 125.8 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.937 -1.331 . . . . 0.0 109.685 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.659 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.5 OUTLIER -90.09 161.73 15.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 110.497 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' B' ' 101' ' ' ILE . . . -118.67 96.63 5.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.66 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.752 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -63.57 -19.96 65.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.867 178.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.534 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 14.2 mtpt -91.93 -179.94 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 109.799 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' B' ' 22' ' ' LYS 2.514 39.3 m 103.93 16.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.207 -1.558 . . . . 0.0 110.356 0.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 42.2 m-85 -109.48 168.61 9.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.404 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.59 -167.14 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -80.09 4.04 18.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.97 . . . . 0.0 110.9 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.35 86.7 0.12 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -151.05 147.97 27.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -1.168 . . . . 0.0 110.45 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.923 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.2 tm? -86.33 122.77 30.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.609 ' N ' HD13 ' B' ' 29' ' ' LEU . 59.4 t -81.85 -52.62 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.853 ' CG ' HD12 ' B' ' 89' ' ' ILE . 1.9 pt-20 -162.41 177.73 9.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -165.25 149.56 8.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.976 . . . . 0.0 110.517 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.21 -157.91 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 110.237 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.515 HD21 ' SD ' ' A' ' 1' ' ' MET . 72.8 mt -109.08 -178.47 3.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 110.274 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.423 ' N ' ' O ' ' B' ' 85' ' ' LYS . 72.4 m -145.5 174.13 11.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.305 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.686 HD11 ' CD2' ' B' ' 62' ' ' LEU . 60.3 mt -116.12 125.18 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.792 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 84' ' ' LEU . 26.3 t -97.89 100.21 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.042 -1.036 . . . . 0.0 110.587 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.494 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 2.6 mmp_? -119.72 -172.15 2.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 36.7 m80 -104.07 -165.02 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -91.12 -137.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 58.18 -137.54 0.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.912 -1.117 . . . . 0.0 110.413 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -45.43 -40.05 7.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.016 -1.053 . . . . 0.0 111.495 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.962 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 76.1 t-105 -57.69 -45.64 85.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.044 -1.035 . . . . 0.0 110.283 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.94 -21.92 73.67 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -85.97 -63.48 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.23 -55.56 33.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.482 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.916 ' HB3' HD13 ' B' ' 51' ' ' LEU . 3.9 mm? -89.53 52.43 2.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.244 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.33 57.44 3.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -76.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.491 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 5.0 m-85 -89.46 48.23 1.58 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.328 -0.857 . . . . 0.0 109.424 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.962 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 6.0 tp -117.69 109.5 16.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.352 -0.842 . . . . 0.0 111.353 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -89.47 105.14 17.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.2 p -97.34 160.95 14.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.145 -0.972 . . . . 0.0 111.162 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.81 ' HB2' HD11 ' B' ' 84' ' ' LEU . 3.5 ttp180 -128.43 -174.88 3.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.535 -0.728 . . . . 0.0 109.99 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -80.0 84.41 5.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -0.954 . . . . 0.0 110.067 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.8 OUTLIER 153.0 -22.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.65 -0.656 . . . . 0.0 109.838 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.41 -168.06 0.23 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 110.801 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.1 m -132.24 134.87 45.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -127.92 166.75 17.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.08 -1.013 . . . . 0.0 111.06 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.836 ' CE ' HD12 ' B' ' 47' ' ' LEU . 1.2 ttt -96.41 169.18 10.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.956 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.7 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.31 -55.02 4.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 111.487 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.93 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.499 0.0 OUTLIER 92.7 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.888 -1.133 . . . . 0.0 110.475 -179.181 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.85 -143.41 0.06 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.38 56.55 2.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -1.088 . . . . 0.0 110.362 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.7 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -89.73 -43.24 5.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.491 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -63.4 -47.6 81.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 110.396 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.814 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.8 pp -49.59 -22.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 111.448 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.814 ' N ' HD12 ' B' ' 67' ' ' ILE . 4.9 m-85 -50.23 113.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.701 -1.25 . . . . 0.0 110.43 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -102.06 -165.84 1.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 111.183 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.472 ' NE2' ' CD1' ' B' ' 111' ' ' LEU . 1.8 t-160 -94.37 140.89 29.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.742 . . . . 0.0 110.491 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.48 143.46 16.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.308 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.677 ' HD2' HD22 ' B' ' 116' ' ' LEU . 4.6 tppp? -85.46 -19.56 31.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 110.49 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -123.47 74.86 53.07 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.14 -0.975 . . . . 0.0 110.309 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.839 ' O ' HD11 ' B' ' 92' ' ' ILE . 32.3 Cg_exo -57.52 105.98 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.688 1.362 . . . . 0.0 110.494 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' B' ' 76' ' ' ALA . 50.3 p-10 -85.05 -13.85 49.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.862 . . . . 0.0 110.757 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.447 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -142.57 141.19 31.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.012 -1.055 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.07 -176.45 2.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.318 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -124.39 161.91 24.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.545 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -134.4 154.21 51.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.757 HD12 ' O ' ' B' ' 86' ' ' ARG . 44.4 tp -132.44 139.93 48.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -0.93 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -76.68 -168.95 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.93 107.88 18.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.463 ' O ' HG21 ' B' ' 37' ' ' VAL . . . 122.63 12.91 4.85 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.81 HD11 ' HB2' ' B' ' 54' ' ' ARG . 16.6 mt 52.38 32.85 11.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.862 -1.375 . . . . 0.0 110.462 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 35' ' ' CYS . 2.8 mmtp -100.21 -62.32 1.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 111.123 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.757 ' O ' HD12 ' B' ' 80' ' ' LEU . 2.3 ttt180 -97.47 162.28 13.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.994 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 4.5 mtp -150.62 147.58 27.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 110.17 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.583 ' HB3' HD21 ' B' ' 29' ' ' LEU . 36.2 mtt180 -132.0 171.97 12.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 110.324 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' B' ' 31' ' ' GLU . 96.3 mt -135.78 116.17 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.923 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 21.5 m-85 -108.16 171.1 7.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.491 HG23 ' CG2' ' B' ' 30' ' ' VAL . 7.3 p -112.4 87.42 2.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.839 HD11 ' O ' ' B' ' 74' ' ' PRO . 3.2 pt -52.15 -23.31 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.427 ' N ' HG13 ' B' ' 92' ' ' ILE . 5.2 mmtt -132.01 151.19 78.02 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -61.38 144.1 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.608 1.32 . . . . 0.0 110.213 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 72.8 mt -126.31 141.04 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 110.531 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.44 163.6 12.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.752 HG23 ' O ' ' B' ' 21' ' ' ARG . 4.8 mt -63.79 121.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 110.545 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.63 38.7 2.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -117.5 170.36 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -1.179 . . . . 0.0 110.381 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.477 ' HG3' ' CE1' ' B' ' 19' ' ' PHE . 0.4 OUTLIER -114.88 126.15 54.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.255 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.778 ' HB ' HG13 ' B' ' 18' ' ' VAL . 97.8 mt -96.56 127.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.507 HG23 ' C ' ' B' ' 101' ' ' ILE . 35.1 p -155.95 176.74 12.25 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.889 HD12 ' O ' ' B' ' 104' ' ' SER . 2.5 pp -147.94 155.86 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.967 -1.083 . . . . 0.0 110.699 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.889 ' O ' HD12 ' B' ' 103' ' ' ILE . 33.0 t -68.74 -149.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 110.483 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.411 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 82.9 m-85 -135.89 -69.32 0.49 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 110.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.56 -177.97 29.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.98 -40.5 96.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 110.403 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -61.23 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.411 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.4 OUTLIER -70.05 107.1 3.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.475 ' O ' ' CD2' ' B' ' 110' ' ' TRP . 63.5 p-90 -48.93 128.73 16.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 0.0 110.688 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.472 ' CD1' ' NE2' ' B' ' 70' ' ' HIS . 16.4 tp -89.59 -110.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.376 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -174.48 112.67 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.316 -1.49 . . . . 0.0 110.678 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' B' ' 115' ' ' ARG . 0.0 OUTLIER 48.22 65.63 6.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.265 -0.897 . . . . 0.0 110.912 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -60.94 118.34 5.2 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.609 1.32 . . . . 0.0 110.464 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' B' ' 113' ' ' ARG . 10.5 ptt-85 -174.57 -36.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.299 -0.876 . . . . 0.0 110.589 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.677 HD22 ' HD2' ' B' ' 72' ' ' LYS . 0.8 OUTLIER 52.45 -162.78 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.367 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 86.9 m -137.84 -61.22 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.975 . . . . 0.0 110.371 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -135.19 155.94 49.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.328 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.01 90.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -1.189 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.875 ' HB3' ' HD3' ' D' ' 204' ' ' PRO . . . -55.09 -57.74 18.27 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 110.502 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.875 ' HD3' ' HB3' ' D' ' 203' ' ' ALA . 29.7 Cg_endo -70.18 102.18 1.06 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.499 1.263 . . . . 0.0 110.476 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.15 -34.53 4.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 110.37 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 7.4 mtpp -108.6 135.93 49.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.381 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -69.03 80.86 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 110.28 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.76 -178.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 110.258 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.56 173.36 14.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 110.338 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 5.7 t -125.49 56.48 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 110.344 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -113.94 -32.89 5.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 110.397 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.81 76.26 0.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 110.408 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.03 71.44 2.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 110.359 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -116.5 177.26 4.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER -53.53 164.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.464 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -124.51 168.56 12.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 24.0 Cg_endo -67.25 -35.48 24.27 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.723 1.38 . . . . 0.0 110.566 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 53.0 85.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 9.5 t -174.82 179.04 1.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 110.34 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.407 ' C6 ' ' HB3' ' A' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.404 ' C6 ' ' HB3' ' B' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 86.2 mmm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.945 0.403 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 32.5 p90 -133.76 106.92 7.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.961 -1.087 . . . . 0.0 110.464 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 5' ' ' ARG . 10.3 p30 -153.31 -172.57 4.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 111.02 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.68 -85.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.737 -0.602 . . . . 0.0 111.26 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.537 ' C ' HG23 ' A' ' 6' ' ' VAL . 7.3 mtm-85 -153.48 17.12 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.976 -1.078 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' C ' ' A' ' 5' ' ' ARG . 93.3 t -153.05 160.98 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.967 -1.083 . . . . 0.0 110.92 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.81 HG23 ' HB2' ' A' ' 19' ' ' PHE . 1.6 tt -124.02 154.41 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 1' ' ' MET . 89.6 t -102.64 141.06 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 110.796 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 10' ' ' LYS . 72.3 mttt -146.9 145.03 29.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.441 -0.787 . . . . 0.0 108.936 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.4 tppt? 52.4 80.67 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 119.629 -1.92 . . . . 0.0 110.273 2.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -122.89 -174.49 0.32 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.346 -178.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 31.3 Cg_exo -54.62 -58.22 1.36 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.637 1.335 . . . . 0.0 110.563 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 13' ' ' LEU . 1.9 mm? -76.03 -30.96 58.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 110.248 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.96 -139.51 10.91 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.23 145.09 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -118.44 83.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -1.132 . . . . 0.0 110.355 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.3 -170.68 12.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.759 HG23 HD13 ' A' ' 67' ' ' ILE . 95.1 t -97.14 149.58 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.748 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.81 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.6 m-85 -114.83 121.89 44.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.426 -0.796 . . . . 0.0 109.286 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.57 86.99 6.87 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.125 -0.984 . . . . 0.0 111.009 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.824 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.19 -24.95 65.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.237 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 14.0 mttm -89.25 -179.73 5.93 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.47 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 102.4 20.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 119.953 -1.717 . . . . 0.0 109.808 2.589 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 5' ' ' ARG . 3.8 m-85 -111.52 152.13 27.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.534 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -95.06 -165.14 1.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -95.62 120.23 35.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.55 46.62 5.42 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.99 128.61 46.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -1.152 . . . . 0.0 110.486 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.881 HD13 ' HG3' ' A' ' 88' ' ' ARG . 40.0 tp -53.28 164.91 0.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.932 . . . . 0.0 110.057 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.496 ' CG1' HG21 ' A' ' 6' ' ' VAL . 94.9 t -133.54 -71.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 110.494 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.36 66.44 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.519 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.568 ' HG2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -57.84 148.86 23.99 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.246 -0.909 . . . . 0.0 110.217 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.79 -165.59 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 110.408 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.35 160.1 15.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.384 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.865 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 53.4 m -134.41 -179.57 5.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.27 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.755 HD11 HD23 ' A' ' 62' ' ' LEU . 75.3 mt -113.35 151.34 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.007 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 84' ' ' LEU . 52.4 t -123.1 99.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -131.58 133.75 45.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 110.457 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.453 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -51.31 178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.977 . . . . 0.0 110.675 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 28.0 t30 -75.66 -132.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 0.0 110.423 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.93 -145.79 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.71 -1.244 . . . . 0.0 110.593 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.71 -28.06 0.94 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.194 -0.941 . . . . 0.0 111.394 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.67 ' HZ3' HD21 ' B' ' 47' ' ' LEU . 38.4 t-105 -57.34 -54.95 40.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 110.25 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.421 ' HA3' ' NH2' ' C' ' 214' ' ' ARG . . . -67.23 -50.27 46.49 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.11 -44.19 42.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -1.159 . . . . 0.0 111.108 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.01 -49.27 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -0.998 . . . . 0.0 110.553 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.97 ' HB2' HD11 ' A' ' 51' ' ' LEU . 4.1 mm? -91.42 28.22 1.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.93 . . . . 0.0 110.874 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 75.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.02 -1.05 . . . . 0.0 110.573 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -175.47 -37.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 110.95 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.839 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 39.4 m-85 -133.42 50.05 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.092 -1.005 . . . . 0.0 110.556 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.97 HD11 ' HB2' ' A' ' 47' ' ' LEU . 52.3 mt -124.11 131.02 53.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 111.423 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -91.2 105.93 18.15 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.7 p -87.78 111.43 21.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.114 -0.991 . . . . 0.0 111.058 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -177.16 3.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -0.76 . . . . 0.0 109.825 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -83.1 83.97 7.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.005 -1.059 . . . . 0.0 109.555 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.509 2.0 p-10 154.0 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.698 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -176.77 -160.64 0.06 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.349 -0.844 . . . . 0.0 110.673 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.421 ' O ' ' NE1' ' A' ' 43' ' ' TRP . 1.1 m -141.33 125.91 17.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.945 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.21 155.47 21.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.08 -1.013 . . . . 0.0 110.809 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.705 ' HA ' HD23 ' A' ' 51' ' ' LEU . 9.6 ttt -89.49 168.68 11.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.086 -1.009 . . . . 0.0 109.801 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.589 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.32 -24.89 27.48 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.241 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.755 HD23 HD11 ' A' ' 36' ' ' ILE 2.501 0.1 OUTLIER 62.49 -92.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 111.096 177.914 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.72 -144.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 93.0 m-85 -82.59 51.47 1.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -1.084 . . . . 0.0 110.829 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.589 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.73 -25.9 23.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.839 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.4 -43.87 10.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -1.142 . . . . 0.0 110.691 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.967 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.5 pp -45.09 -23.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.553 -0.717 . . . . 0.0 112.083 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.967 ' N ' HD12 ' A' ' 67' ' ' ILE . 23.1 m-85 -55.17 142.21 31.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.61 -1.306 . . . . 0.0 109.775 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 102' ' ' THR . 82.7 m-20 -118.83 -169.46 1.73 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.03 . . . . 0.0 111.254 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.622 ' CE1' HD11 ' A' ' 111' ' ' LEU . 22.0 t-160 -102.49 111.06 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 109.974 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.34 19.69 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 0.0 110.659 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt 52.62 23.33 2.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -174.38 65.24 0.28 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.055 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' O ' HD11 ' A' ' 92' ' ' ILE . 11.8 Cg_endo -59.63 83.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.632 1.333 . . . . 0.0 110.601 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.421 ' O ' ' CG1' ' A' ' 92' ' ' ILE . 22.1 m120 -59.12 -17.93 31.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -132.03 143.84 50.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.47 11.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 110.555 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -107.5 136.2 47.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.355 -0.841 . . . . 0.0 110.301 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 88' ' ' ARG . 32.9 tt0 -124.59 166.97 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.423 HD13 HD23 ' A' ' 84' ' ' LEU . 24.6 mt -126.24 147.96 49.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 86' ' ' ARG . 72.1 p -71.98 -79.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' N ' ' OG1' ' A' ' 81' ' ' THR . . . -168.54 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.81 23.1 4.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 37' ' ' VAL . 43.7 mt 52.06 36.87 19.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -1.205 . . . . 0.0 110.512 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -104.52 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 110.751 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HB2' HG21 ' A' ' 81' ' ' THR . 8.1 mtt180 -84.88 179.29 7.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.976 . . . . 0.0 110.319 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.865 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 3.3 mtp -148.28 128.44 13.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.736 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.881 ' HG3' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -114.38 106.16 13.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.44 -0.788 . . . . 0.0 110.091 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.48 113.27 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 109.929 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CE1' ' CD ' ' A' ' 88' ' ' ARG . 1.3 m-85 -101.93 177.17 4.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 110.54 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 p -113.92 99.32 7.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 110.028 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.492 HD12 ' CE ' ' A' ' 93' ' ' LYS . 4.2 pt -53.04 -22.21 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.135 -0.978 . . . . 0.0 110.399 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.492 ' CE ' HD12 ' A' ' 92' ' ' ILE . 45.1 mttt -148.24 146.75 23.96 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.16 -0.963 . . . . 0.0 110.175 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 93' ' ' LYS . 39.8 Cg_exo -56.84 129.41 34.44 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.673 1.354 . . . . 0.0 110.243 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' A' ' 20' ' ' ALA . 71.5 mt -104.76 148.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 110.594 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.31 167.35 11.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.575 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -71.32 123.41 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.503 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.85 39.97 2.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -124.65 -169.42 1.97 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -1.188 . . . . 0.0 110.381 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 23.7 tt0 -135.15 125.13 25.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 110.15 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.767 HG13 ' HB2' ' A' ' 20' ' ' ALA . 97.7 mt -89.39 137.99 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.533 HG23 ' C ' ' A' ' 101' ' ' ILE . 45.4 p -154.07 -174.2 4.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.651 -0.656 . . . . 0.0 110.073 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.572 HD12 ' O ' ' A' ' 104' ' ' SER . 1.5 pp -149.5 158.46 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.136 -0.977 . . . . 0.0 110.454 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' HD12 ' A' ' 103' ' ' ILE . 32.3 t -95.79 -164.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.357 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 12.8 m-85 -133.82 -66.61 0.63 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.211 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.04 -157.96 53.64 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.6 t0 55.82 -86.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.948 . . . . 0.0 110.691 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.568 ' HB2' ' HB3' ' C' ' 213' ' ' ALA . 10.3 t0 -122.55 -31.41 3.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 110.644 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.481 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.5 m-85 -51.16 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.569 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 110' ' ' TRP . 51.9 p-90 -51.9 144.09 12.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.73 . . . . 0.0 110.695 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.622 HD11 ' CE1' ' A' ' 70' ' ' HIS . 17.2 tp -91.63 157.1 17.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 110.508 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.6 m -64.86 -162.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.486 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.82 111.91 2.81 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.457 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.01 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.449 1.236 . . . . 0.0 110.577 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -140.71 -54.58 0.5 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.283 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.679 HD23 ' OE1' ' A' ' 118' ' ' GLN . 0.1 OUTLIER 49.76 94.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.271 -0.893 . . . . 0.0 110.741 179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 118' ' ' GLN . 18.7 m -52.08 -84.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.613 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.679 ' OE1' HD23 ' A' ' 116' ' ' LEU . 10.1 pt20 38.59 -155.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.218 0.532 . . . . 0.0 111.813 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.049 -0.976 . . . . 0.0 110.393 -179.892 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -146.24 47.18 1.22 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -1.167 . . . . 0.0 110.374 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -169.06 71.67 0.73 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 110.408 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -66.68 -47.48 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.611 1.321 . . . . 0.0 110.514 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 55.12 1.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.414 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -127.35 157.76 39.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.422 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.33 163.74 35.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 110.372 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.85 105.78 10.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.86 83.48 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 110.334 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -115.67 -23.62 8.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.11 109.94 12.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 110.404 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.13 -61.96 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 110.323 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 108' ' ' ASP . . . -90.48 -177.38 5.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.421 ' NH2' ' HA3' ' A' ' 44' ' ' GLY . 6.4 mtt85 -132.69 -149.54 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.114 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.481 HCM1 ' CD1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.0 OUTLIER -53.79 175.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.907 . . . . 0.0 110.356 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.54 170.22 11.66 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.38 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.18 -29.1 89.55 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.659 1.347 . . . . 0.0 110.507 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.84 89.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 110.338 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.9 p -53.22 179.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 110.414 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.49 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.415 ' HB3' ' HB ' ' B' ' 8' ' ' VAL . 86.2 mmm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.006 0.432 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.468 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 32.2 p90 -133.63 108.3 8.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.912 -1.117 . . . . 0.0 110.233 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' B' ' 5' ' ' ARG . 10.4 p30 -155.1 -173.21 4.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 110.815 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' B' ' 5' ' ' ARG . 20.6 m-20 54.97 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.707 -0.621 . . . . 0.0 111.211 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.543 ' C ' HG23 ' B' ' 6' ' ' VAL . 7.3 mtm-85 -153.5 17.3 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.989 -1.069 . . . . 0.0 111.064 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.543 HG23 ' C ' ' B' ' 5' ' ' ARG . 94.1 t -153.08 160.98 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 0.0 110.98 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' B' ' 19' ' ' PHE . 1.6 tt -124.0 154.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -0.781 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' B' ' 1' ' ' MET . 89.7 t -102.7 141.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 110.831 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' B' ' 10' ' ' LYS . 72.2 mttt -147.09 145.0 29.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 108.967 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.592 ' HB3' ' HA ' ' B' ' 9' ' ' LYS . 3.4 tppt? 52.41 80.62 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.539 -1.976 . . . . 0.0 110.356 2.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.483 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 0.7 OUTLIER -122.96 -174.5 0.32 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 31.3 Cg_exo -54.57 -58.3 1.33 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.62 1.326 . . . . 0.0 110.558 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' B' ' 13' ' ' LEU . 1.9 mm? -75.98 -30.98 58.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.95 -139.51 10.91 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.31 145.03 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -118.29 83.17 1.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -1.112 . . . . 0.0 110.36 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.56 -170.62 12.66 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.742 HG23 HD13 ' B' ' 67' ' ' ILE . 95.7 t -97.07 149.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.947 -1.325 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.796 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.6 m-85 -114.9 121.69 43.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.755 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.28 86.97 6.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 111.113 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.84 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 109.225 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.475 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 13.9 mttm -89.19 -179.64 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.475 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.0 OUTLIER 102.45 20.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 119.938 -1.726 . . . . 0.0 109.805 2.493 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' B' ' 5' ' ' ARG . 3.8 m-85 -111.45 152.13 27.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 110.615 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -95.04 -165.07 1.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.217 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -95.6 120.22 35.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.457 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.61 46.56 5.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.02 128.6 46.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -1.12 . . . . 0.0 110.508 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.885 HD13 ' HG3' ' B' ' 88' ' ' ARG . 39.7 tp -53.19 164.91 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.944 . . . . 0.0 110.089 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.494 ' CG1' HG21 ' B' ' 6' ' ' VAL . 94.8 t -133.57 -71.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.32 66.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.529 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.574 ' HG2' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -57.92 148.86 24.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 110.201 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.76 -165.58 2.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 160.22 15.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.858 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 53.8 m -134.48 -179.66 5.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 110.228 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.757 HD11 HD23 ' B' ' 62' ' ' LEU . 75.3 mt -113.25 151.28 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.058 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.497 HG22 ' O ' ' B' ' 84' ' ' LEU . 52.8 t -123.05 99.36 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.17 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.5 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -131.6 133.75 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 110.444 -179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.443 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.4 OUTLIER -51.34 178.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 110.669 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 28.0 t30 -75.64 -132.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.415 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.0 -145.93 0.45 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.828 -1.17 . . . . 0.0 110.525 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -45.56 -28.13 0.89 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.211 -0.931 . . . . 0.0 111.443 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.667 ' HZ3' HD21 ' A' ' 47' ' ' LEU . 38.2 t-105 -57.32 -55.0 40.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.123 -0.985 . . . . 0.0 110.228 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.413 ' HA3' ' NH2' ' D' ' 214' ' ' ARG . . . -67.2 -50.32 46.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.6 m -49.04 -44.24 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.293 -1.122 . . . . 0.0 111.099 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.13 -48.66 13.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -0.99 . . . . 0.0 110.6 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.976 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.1 mm? -92.15 28.33 1.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.706 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -66.18 76.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.007 -1.058 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.5 OUTLIER -175.48 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.892 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.844 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 39.3 m-85 -133.31 50.13 2.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.102 -0.998 . . . . 0.0 110.447 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.976 HD11 ' HB2' ' B' ' 47' ' ' LEU . 52.3 mt -124.17 131.21 53.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -91.42 104.9 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 85.9 p -86.24 111.44 20.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.102 -0.999 . . . . 0.0 111.327 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -179.91 4.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.436 -0.79 . . . . 0.0 109.878 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -79.01 83.63 5.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -0.918 . . . . 0.0 110.374 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.512 2.0 p-10 153.89 -27.61 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.656 -0.652 . . . . 0.0 109.743 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.1 OUTLIER -176.57 -160.45 0.06 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.37 -0.831 . . . . 0.0 110.698 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.415 ' O ' ' NE1' ' B' ' 43' ' ' TRP . 1.1 m -141.33 126.03 17.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.946 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.36 155.29 21.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.083 -1.01 . . . . 0.0 110.802 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.704 ' HA ' HD23 ' B' ' 51' ' ' LEU . 9.6 ttt -89.56 166.85 13.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.569 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.59 -26.19 32.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.671 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.757 HD23 HD11 ' B' ' 36' ' ' ILE 2.5 0.1 OUTLIER 62.95 -92.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.139 -0.975 . . . . 0.0 111.125 178.568 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.68 -144.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 93.1 m-85 -82.65 51.87 1.97 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -1.082 . . . . 0.0 110.758 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.569 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.29 -25.61 23.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.844 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.77 -43.74 9.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -1.17 . . . . 0.0 110.683 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.977 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.5 pp -45.13 -23.56 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.571 -0.705 . . . . 0.0 112.069 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.977 ' N ' HD12 ' B' ' 67' ' ' ILE . 23.1 m-85 -55.06 142.47 30.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.544 -1.348 . . . . 0.0 109.792 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.411 ' O ' ' HB ' ' B' ' 102' ' ' THR . 82.4 m-20 -119.11 -169.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 111.184 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.636 ' CE1' HD11 ' B' ' 111' ' ' LEU . 22.1 t-160 -103.09 110.95 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 11.2 t -118.2 19.56 13.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 0.0 110.629 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt 52.73 23.31 2.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 110.206 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' B' ' 75' ' ' ASN . 0.9 OUTLIER -174.41 65.28 0.28 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.287 -0.883 . . . . 0.0 110.012 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.505 ' O ' HD11 ' B' ' 92' ' ' ILE . 11.9 Cg_endo -59.56 83.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.68 1.358 . . . . 0.0 110.591 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.42 ' O ' ' CG1' ' B' ' 92' ' ' ILE . 22.2 m120 -59.16 -17.88 31.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.733 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -132.08 143.8 50.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 110.195 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -117.93 167.46 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 110.575 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -107.45 136.06 47.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' B' ' 88' ' ' ARG . 32.8 tt0 -124.47 167.04 14.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 110.305 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.428 HD13 HD23 ' B' ' 84' ' ' LEU . 24.7 mt -126.24 147.94 49.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.513 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.525 HG21 ' HB2' ' B' ' 86' ' ' ARG . 71.7 p -71.94 -79.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.55 98.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 110.381 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.83 23.08 4.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.497 ' O ' HG22 ' B' ' 37' ' ' VAL . 44.0 mt 52.05 36.84 19.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.238 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -104.45 -73.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.525 ' HB2' HG21 ' B' ' 81' ' ' THR . 8.1 mtt180 -84.86 179.24 7.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.307 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.858 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 3.3 mtp -148.3 128.47 13.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 0.0 110.733 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.885 ' HG3' HD13 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -114.5 105.93 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 110.116 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.07 113.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 110.05 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.524 ' CE1' ' CD ' ' B' ' 88' ' ' ARG . 1.3 m-85 -101.98 177.12 4.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.552 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.9 p -113.87 99.33 7.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.505 HD11 ' O ' ' B' ' 74' ' ' PRO . 4.2 pt -53.01 -22.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.392 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.487 ' CE ' HD12 ' B' ' 92' ' ' ILE . 45.1 mttt -148.16 146.68 23.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.193 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.77 129.42 34.52 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.633 1.333 . . . . 0.0 110.247 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.441 HG21 ' CB ' ' B' ' 20' ' ' ALA . 71.4 mt -104.73 148.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.598 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.3 167.29 11.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.341 -0.85 . . . . 0.0 110.562 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.84 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -71.27 123.38 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 110.463 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.87 39.93 2.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -124.65 -169.39 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -1.177 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 23.7 tt0 -135.26 124.88 25.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.755 HG13 ' HB2' ' B' ' 20' ' ' ALA . 97.8 mt -88.92 137.96 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 110.35 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.534 HG23 ' C ' ' B' ' 101' ' ' ILE . 44.7 p -154.12 -174.13 4.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.527 -0.733 . . . . 0.0 110.02 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.57 HD12 ' O ' ' B' ' 104' ' ' SER . 1.5 pp -149.48 158.46 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.097 -1.002 . . . . 0.0 110.444 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.57 ' O ' HD12 ' B' ' 103' ' ' ILE . 32.3 t -95.8 -164.16 1.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 110.347 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.475 ' CE1' ' HE3' ' D' ' 215' ' ' MLZ . 12.9 m-85 -133.88 -66.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.99 -157.92 53.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 106' ' ' GLY . 14.6 t0 55.8 -86.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.499 -1.0 . . . . 0.0 110.72 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.575 ' HB2' ' HB3' ' D' ' 213' ' ' ALA . 10.3 t0 -122.58 -31.4 3.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 110.646 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.485 ' CE1' ' HG2' ' D' ' 215' ' ' MLZ . 1.4 m-85 -51.13 96.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 110.585 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' B' ' 110' ' ' TRP . 52.0 p-90 -51.76 144.87 10.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.807 . . . . 0.0 110.557 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.636 HD11 ' CE1' ' B' ' 70' ' ' HIS . 17.4 tp -92.73 156.92 16.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.369 -0.832 . . . . 0.0 110.368 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 68.7 m -64.63 -162.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.0 110.5 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.77 111.95 2.82 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.431 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.09 93.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.473 1.249 . . . . 0.0 110.589 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -140.72 -54.57 0.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.282 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.676 HD23 ' OE1' ' B' ' 118' ' ' GLN . 0.1 OUTLIER 49.84 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 0.0 110.712 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.502 HG22 ' N ' ' B' ' 118' ' ' GLN . 18.7 m -52.18 -84.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 110.577 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . 0.676 ' OE1' HD23 ' B' ' 116' ' ' LEU . 10.1 pt20 38.63 -155.49 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.235 0.54 . . . . 0.0 111.786 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.388 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -146.15 47.19 1.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -1.119 . . . . 0.0 110.355 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -168.96 71.65 0.74 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 110.4 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -66.63 -47.48 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.672 1.354 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.72 55.13 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.392 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -127.39 157.8 39.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 110.37 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.37 163.71 35.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.368 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.82 105.77 10.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 110.413 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.85 83.4 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -115.62 -23.65 8.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.455 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.07 109.95 12.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 110.448 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.17 -61.95 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 110.311 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . 0.575 ' HB3' ' HB2' ' B' ' 108' ' ' ASP . . . -90.58 -177.4 5.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 110.346 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.413 ' NH2' ' HA3' ' B' ' 44' ' ' GLY . 6.4 mtt85 -132.65 -149.57 0.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.485 ' HG2' ' CE1' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.0 OUTLIER -53.77 175.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.329 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -135.5 170.25 11.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.311 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 26.7 Cg_exo -59.13 -29.17 89.78 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.714 1.376 . . . . 0.0 110.536 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.9 89.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.331 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.8 p -53.18 179.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.408 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.444 ' N7 ' ' HB3' ' A' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.442 ' N7 ' ' HB3' ' B' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' C ' ' CG ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.889 0.376 . . . . 0.0 110.378 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 21.9 p90 36.03 93.31 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 CA-C-O 121.475 0.655 . . . . 0.0 111.945 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.93 144.97 25.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.969 . . . . 0.0 110.27 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.61 -45.09 47.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.877 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.497 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -67.59 -37.89 83.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.937 . . . . 0.0 110.566 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG23 ' C ' ' A' ' 5' ' ' ARG . 56.2 t -150.22 141.04 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.43 ' CG2' ' HD2' ' A' ' 21' ' ' ARG . 14.7 tt -113.67 153.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 110.612 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 82.5 t -89.82 131.68 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 110.108 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 54.5 mttt -147.86 123.61 10.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.022 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.8 mptt 59.36 64.23 1.4 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 119.664 -1.898 . . . . 0.0 111.07 0.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.518 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.2 t -153.9 -65.21 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.339 -0.851 . . . . 0.0 110.622 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 16.0 Cg_endo -61.17 -161.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.053 1.028 . . . . 0.0 110.27 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.78 -30.72 65.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 110.397 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.04 151.52 14.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.97 149.33 5.1 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.473 ' CD2' ' HD3' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.82 88.64 2.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -1.159 . . . . 0.0 110.639 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.05 -171.27 12.77 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 67' ' ' ILE . 89.0 t -103.71 139.46 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.93 -1.335 . . . . 0.0 110.331 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 2.0 m-85 -109.44 124.6 51.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.747 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.761 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.85 97.52 11.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.29 -0.881 . . . . 0.0 111.137 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.748 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -68.39 -20.24 64.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 6.9 mttt -93.84 179.53 5.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.282 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.469 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 12.2 m 103.12 17.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.047 -1.658 . . . . 0.0 110.191 1.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 14.3 m-85 -112.03 165.5 12.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.557 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.33 -156.59 0.58 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 110.201 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 11.4 tttp -100.5 105.49 16.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 110.511 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.08 41.26 1.83 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.41 55.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -1.22 . . . . 0.0 110.444 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.818 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 tm? -64.28 124.31 21.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.383 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.715 ' CG2' HG23 ' A' ' 91' ' ' THR . 44.9 t -102.74 79.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 109.984 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.81 134.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 110.81 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -125.21 159.68 31.0 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.287 -0.883 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.4 -169.16 3.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 110.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.15 173.87 6.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 110.485 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -138.85 -173.73 3.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.311 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.952 ' CD1' HD23 ' A' ' 62' ' ' LEU . 50.0 mt -119.55 141.57 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.263 -0.898 . . . . 0.0 109.998 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 84' ' ' LEU . 91.8 t -111.68 122.38 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.962 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' CG ' ' CG ' ' A' ' 43' ' ' TRP . 27.1 tpt180 -150.11 131.92 15.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 110.398 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -53.5 -174.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 111.206 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.81 117.96 33.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.36 -0.838 . . . . 0.0 110.732 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.79 -141.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.76 -24.85 6.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.656 -1.277 . . . . 0.0 109.36 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CG ' ' CG ' ' A' ' 38' ' ' ARG . 52.1 t-105 -56.59 -56.19 24.46 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.544 -0.722 . . . . 0.0 109.615 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.12 -28.39 70.54 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -72.96 -44.7 60.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -1.195 . . . . 0.0 110.679 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.4 -40.6 29.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.0 110.482 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.744 ' CB ' HD11 ' A' ' 51' ' ' LEU . 4.2 mm? -90.72 22.93 3.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 0.2 OUTLIER -64.64 78.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.101 -0.999 . . . . 0.0 110.454 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -169.18 -62.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.016 -1.052 . . . . 0.0 110.79 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.52 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 28.1 m-85 -121.98 55.84 1.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.057 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.744 HD11 ' CB ' ' A' ' 47' ' ' LEU . 15.5 mt -109.15 112.3 24.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.411 -0.806 . . . . 0.0 111.11 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' C' ' 215' ' ' MLZ . 0.2 OUTLIER -89.42 101.59 14.27 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.288 -0.882 . . . . 0.0 108.693 176.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.413 ' CB ' ' HA ' ' A' ' 58' ' ' SER . 24.9 p -100.99 142.09 32.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -177.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.677 ' HD2' HD13 ' A' ' 84' ' ' LEU . 1.7 ttt180 -101.31 -170.96 1.91 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.479 -0.763 . . . . 0.0 109.844 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -83.43 80.76 8.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.993 -1.067 . . . . 0.0 109.445 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 36.4 t-20 155.29 -20.75 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.708 -0.62 . . . . 0.0 110.242 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.18 -177.58 1.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.968 -1.083 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.413 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -135.74 161.92 34.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 109.945 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.621 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -95.75 169.93 9.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.865 -1.147 . . . . 0.0 109.843 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.935 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -84.97 -14.91 46.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.714 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.952 HD23 ' CD1' ' A' ' 36' ' ' ILE 2.5 0.0 OUTLIER 61.1 -94.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 111.293 177.567 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.27 -133.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.44 41.81 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -1.098 . . . . 0.0 110.747 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.935 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -81.05 -19.43 67.25 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -87.69 -51.16 6.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.0 110.656 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.7 pp -46.67 -24.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 111.491 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.62 ' N ' HD12 ' A' ' 67' ' ' ILE . 10.0 m-85 -52.56 142.02 19.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 110.642 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -96.88 96.53 8.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 110.022 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.5 m -115.22 143.04 45.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 110.513 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.95 136.48 57.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.21 2.95 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.625 ' O ' HD11 ' A' ' 92' ' ' ILE . 14.5 Cg_endo -61.01 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.685 1.361 . . . . 0.0 110.508 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 93' ' ' LYS . 50.7 m-80 -58.09 -19.44 32.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 110.631 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -123.53 150.19 44.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 0.0 110.567 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.568 ' HG3' HG21 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -128.32 -172.42 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.219 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 48.6 p-80 -135.46 156.26 49.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 110.644 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.94 124.24 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.616 HD12 ' HD2' ' C' ' 218' ' ' PRO . 13.3 mt -91.03 149.79 21.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 110.522 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 p -94.64 152.98 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.15 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 110.172 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.77 -5.79 3.74 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.279 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.794 ' HB3' HG22 ' A' ' 37' ' ' VAL . 1.8 tp 56.09 20.99 4.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.826 -1.396 . . . . 0.0 110.278 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -22.29 19.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 111.085 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.57 157.96 45.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.901 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.78 138.09 49.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.765 . . . . 0.0 110.051 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' HIS . 4.6 mtt180 -116.55 151.32 36.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 0.0 110.616 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.533 ' O ' HD22 ' A' ' 29' ' ' LEU . 74.0 mt -125.88 121.24 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 109.881 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 15.6 m-85 -117.81 -170.14 1.81 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.454 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' CG2' ' A' ' 30' ' ' VAL . 1.1 p -131.51 93.84 3.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.893 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 74' ' ' PRO . 48.4 pt -51.07 -29.79 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.44 ' N ' HG13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -137.59 143.53 41.14 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 149.88 10.59 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.529 1.279 . . . . 0.0 110.669 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 20' ' ' ALA . 69.1 mt -122.52 150.57 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.727 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -101.01 161.91 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 110.155 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 21' ' ' ARG . 10.5 mt -65.82 96.9 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.249 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.23 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.452 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 35.0 mm-40 -116.94 168.46 10.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -1.104 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' OE1' HG21 ' A' ' 102' ' ' THR . 2.9 tm-20 -107.14 117.95 35.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.989 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.761 HG13 ' HB2' ' A' ' 20' ' ' ALA . 97.5 mt -89.63 128.22 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 110.515 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.522 HG23 ' C ' ' A' ' 101' ' ' ILE . 62.5 p -153.99 176.76 11.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.877 -0.514 . . . . 0.0 109.678 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -143.65 158.94 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.069 -1.019 . . . . 0.0 110.435 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -87.62 -158.91 0.48 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.32 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.47 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 34.1 m-85 -133.19 -59.83 0.87 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.06 -167.09 36.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.55 -34.2 77.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -1.136 . . . . 0.0 110.341 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.359 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' C' ' 215' ' ' MLZ . 2.1 m-85 -51.99 110.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.703 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 34.1 m95 52.15 -166.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 110.9 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 112' ' ' SER . 14.2 tp -61.14 157.76 15.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 110.491 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.434 ' N ' ' HG ' ' A' ' 111' ' ' LEU . 49.3 m -64.62 -62.61 1.47 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.278 -0.889 . . . . 0.0 110.411 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -140.29 160.07 61.23 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 110.481 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 116' ' ' LEU . 25.9 Cg_exo -59.69 -57.54 0.82 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.763 1.402 . . . . 0.0 110.601 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -69.73 0.09 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.408 -0.808 . . . . 0.0 110.506 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 114' ' ' PRO . 3.7 mt 53.34 91.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.392 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 68.0 m -67.84 155.95 38.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 110.399 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.09 82.46 2.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 110.327 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.333 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -133.39 35.83 3.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -1.107 . . . . 0.0 110.329 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.837 ' HB3' ' HD3' ' C' ' 204' ' ' PRO . . . -54.95 -50.21 87.63 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 110.644 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.837 ' HD3' ' HB3' ' C' ' 203' ' ' ALA . 44.9 Cg_exo -51.39 97.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.537 1.282 . . . . 0.0 110.611 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.84 80.62 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.476 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.63 128.53 35.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.29 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -58.88 134.65 57.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 70.9 mt -67.67 -171.25 0.19 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.379 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.81 141.87 10.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 110.341 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 1.6 p -112.87 43.78 1.62 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.312 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -72.14 83.61 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 110.42 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.22 102.34 13.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.33 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.72 160.34 33.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 110.421 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -160.93 0.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.218 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.495 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 0.1 OUTLIER -53.8 -178.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.586 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.664 ' HB1' ' HG3' ' A' ' 54' ' ' ARG . . . -150.96 123.8 4.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.391 -0.818 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.616 ' HD2' HD12 ' A' ' 80' ' ' LEU . 38.2 Cg_exo -56.4 157.18 19.01 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.364 1.191 . . . . 0.0 110.568 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -104.19 -21.67 13.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 110.327 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -57.0 -169.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 110.313 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.79 179.761 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.456 ' C ' ' CG ' ' B' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.821 0.344 . . . . 0.0 110.414 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.489 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 21.9 p90 36.04 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.49 0.662 . . . . 0.0 111.944 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.91 144.96 25.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -49.58 -45.12 47.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.886 . . . . 0.0 110.879 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.495 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.2 OUTLIER -67.54 -37.94 83.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.586 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.495 HG23 ' C ' ' B' ' 5' ' ' ARG . 56.0 t -150.16 141.06 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 14.7 tt -113.66 153.04 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.155 -0.966 . . . . 0.0 110.645 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' B' ' 9' ' ' LYS . 82.9 t -89.7 131.76 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 110.119 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.629 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 54.4 mttt -148.05 123.73 10.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.629 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.8 mptt 59.49 64.17 1.39 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 119.726 -1.859 . . . . 0.0 111.037 0.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.2 t -153.87 -65.19 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.64 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 16.2 Cg_endo -61.11 -161.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.021 1.011 . . . . 0.0 110.287 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -30.67 65.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 110.408 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.1 151.58 14.15 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.97 149.29 5.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' B' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 88.67 2.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 110.588 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.01 -171.36 12.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' B' ' 67' ' ' ILE . 86.2 t -103.66 139.25 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.955 -1.321 . . . . 0.0 110.373 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 2.0 m-85 -109.41 124.57 51.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.283 -0.886 . . . . 0.0 109.759 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.773 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.78 97.54 11.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 111.14 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.742 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -68.4 -20.24 64.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.714 177.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.459 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 6.9 mttt -93.78 179.62 5.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.274 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.511 12.0 m 103.2 17.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.055 -1.653 . . . . 0.0 110.17 1.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.433 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 14.1 m-85 -112.1 165.56 12.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.138 -0.976 . . . . 0.0 110.573 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.38 -156.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 110.159 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.407 ' HG3' ' HA ' ' B' ' 93' ' ' LYS . 11.3 tttp -100.51 105.51 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 110.549 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.09 41.27 1.83 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.25 128.43 55.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -1.201 . . . . 0.0 110.437 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.827 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.1 tm? -64.23 124.3 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 110.451 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' B' ' 91' ' ' THR . 45.1 t -102.78 79.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 110.017 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 61.85 134.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.511 -0.743 . . . . 0.0 110.741 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -125.22 159.63 31.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.428 -0.795 . . . . 0.0 109.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.53 -169.19 3.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.122 -0.986 . . . . 0.0 110.554 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' B' ' 86' ' ' ARG . 0.1 OUTLIER -112.24 173.89 6.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 110.521 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 12.4 m -138.81 -173.81 3.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.953 ' CD1' HD23 ' B' ' 62' ' ' LEU . 49.4 mt -119.49 141.52 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.0 110.002 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.8 HG22 ' HB3' ' B' ' 84' ' ' LEU . 91.6 t -111.62 122.41 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.964 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.507 ' HG2' ' CD2' ' B' ' 43' ' ' TRP . 27.1 tpt180 -150.17 131.82 14.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.0 110.477 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -53.44 -174.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 0.0 111.154 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -97.79 117.85 33.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -176.73 -141.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -51.7 -25.03 6.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.609 -1.307 . . . . 0.0 109.35 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.507 ' CD2' ' HG2' ' B' ' 38' ' ' ARG . 52.2 t-105 -56.49 -56.23 23.84 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.62 -0.675 . . . . 0.0 109.628 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.37 70.37 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.1 m -73.01 -44.76 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -1.155 . . . . 0.0 110.598 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.47 -40.28 30.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 110.464 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.746 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.2 mm? -91.14 23.16 3.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.583 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 0.2 OUTLIER -64.78 78.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 110.4 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.2 OUTLIER -169.14 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 110.79 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.513 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 28.2 m-85 -121.86 55.94 1.09 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.985 -178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' B' ' 47' ' ' LEU . 15.5 mt -109.19 112.35 24.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 111.208 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' D' ' 215' ' ' MLZ . 0.2 OUTLIER -89.49 101.47 14.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.71 176.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.409 ' CB ' ' HA ' ' B' ' 58' ' ' SER . 24.8 p -100.86 142.09 32.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 111.441 -177.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.683 ' HD2' HD13 ' B' ' 84' ' ' LEU . 1.7 ttt180 -101.79 -173.67 2.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.469 -0.77 . . . . 0.0 109.853 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -79.67 80.48 6.05 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 36.7 t-20 155.22 -20.96 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.621 -0.675 . . . . 0.0 110.231 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.09 -177.55 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 111.078 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 0.9 OUTLIER -123.88 143.06 50.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.536 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.562 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -135.8 161.92 34.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.005 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.613 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -96.28 167.97 10.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.985 179.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.956 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.03 -16.41 50.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 111.142 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.953 HD23 ' CD1' ' B' ' 36' ' ' ILE 2.501 0.0 OUTLIER 61.73 -94.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 111.29 178.221 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.25 -132.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -88.53 41.83 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -1.104 . . . . 0.0 110.76 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.956 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -81.0 -19.49 67.25 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.513 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -87.71 -51.12 6.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.162 -1.199 . . . . 0.0 110.645 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.601 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.7 pp -46.62 -24.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.844 . . . . 0.0 111.528 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.601 ' N ' HD12 ' B' ' 67' ' ' ILE . 10.0 m-85 -52.51 142.02 18.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.857 -1.152 . . . . 0.0 110.351 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -117.22 175.36 5.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.168 -0.957 . . . . 0.0 110.662 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -96.89 96.28 8.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 110.049 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 34.1 m -114.91 143.17 45.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.545 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -57.99 136.43 57.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.03 68.3 2.88 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.182 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.631 ' O ' HD11 ' B' ' 92' ' ' ILE . 14.7 Cg_endo -60.99 105.63 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.664 1.35 . . . . 0.0 110.536 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -58.11 -19.5 32.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.581 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -123.44 150.26 44.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 110.636 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.554 ' HG3' HG21 ' B' ' 92' ' ' ILE . 0.7 OUTLIER -128.39 -172.48 2.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 110.186 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 48.5 p-80 -135.39 156.21 49.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 0.0 110.675 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -139.93 124.33 17.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 110.187 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' D' ' 218' ' ' PRO . 13.4 mt -91.03 149.7 21.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.544 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 21.3 p -94.61 153.01 18.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.253 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.14 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 110.182 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.76 -5.87 3.75 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.24 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.8 ' HB3' HG22 ' B' ' 37' ' ' VAL . 1.8 tp 56.11 20.98 4.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.843 -1.387 . . . . 0.0 110.272 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.56 -22.16 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 111.091 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 0.0 OUTLIER -134.62 157.98 45.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.034 -1.041 . . . . 0.0 110.913 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.3 mmm -130.74 138.01 49.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.071 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' B' ' 78' ' ' HIS . 4.6 mtt180 -116.47 151.38 36.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 110.68 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.527 ' O ' HD22 ' B' ' 29' ' ' LEU . 73.4 mt -125.85 121.16 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.882 . . . . 0.0 109.95 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.827 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 15.6 m-85 -117.75 -170.15 1.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.491 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.72 HG23 ' CG2' ' B' ' 30' ' ' VAL . 1.1 p -131.5 93.88 3.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.387 -0.821 . . . . 0.0 109.891 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.631 HD11 ' O ' ' B' ' 74' ' ' PRO . 48.2 pt -51.03 -29.83 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.681 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.445 ' N ' HG13 ' B' ' 92' ' ' ILE . 1.0 OUTLIER -137.6 143.57 41.26 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 110.361 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.05 149.9 11.01 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.596 1.314 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.486 HG21 ' CB ' ' B' ' 20' ' ' ALA . 69.1 mt -122.53 150.55 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 110.737 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.98 161.93 13.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.395 -0.816 . . . . 0.0 110.127 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.742 HG23 ' O ' ' B' ' 21' ' ' ARG . 10.6 mt -65.89 96.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.21 40.52 0.33 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.447 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 34.9 mm-40 -117.0 168.44 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -1.17 . . . . 0.0 110.402 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.417 ' OE1' HG21 ' B' ' 102' ' ' THR . 2.9 tm-20 -107.07 117.95 35.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.912 . . . . 0.0 110.042 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.773 HG13 ' HB2' ' B' ' 20' ' ' ALA . 96.9 mt -89.53 128.25 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.513 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.513 HG23 ' C ' ' B' ' 101' ' ' ILE . 61.3 p -153.98 176.85 11.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.716 -0.615 . . . . 0.0 109.67 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.659 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -143.63 158.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.659 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.2 OUTLIER -87.7 -158.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 34.1 m-85 -133.21 -59.68 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 110.284 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.98 -167.13 36.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.49 -34.27 77.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -1.184 . . . . 0.0 110.356 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.19 -78.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.497 ' CE2' ' HG3' ' D' ' 215' ' ' MLZ . 2.1 m-85 -52.03 110.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.728 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.44 ' N ' ' CD1' ' B' ' 110' ' ' TRP . 34.1 m95 52.26 -166.59 0.05 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.878 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' B' ' 112' ' ' SER . 14.1 tp -61.15 157.71 15.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.428 ' N ' ' HG ' ' B' ' 111' ' ' LEU . 49.0 m -64.56 -62.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -0.88 . . . . 0.0 110.4 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -140.28 160.14 60.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 110.503 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' B' ' 116' ' ' LEU . 25.8 Cg_exo -59.72 -57.45 0.84 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.689 1.363 . . . . 0.0 110.631 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.49 -69.66 0.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.408 -0.807 . . . . 0.0 110.608 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' B' ' 114' ' ' PRO . 3.7 mt 53.29 91.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.432 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 67.1 m -67.9 155.97 38.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 110.349 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.04 82.47 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.087 -0.959 . . . . 0.0 110.405 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -133.41 35.78 3.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -1.165 . . . . 0.0 110.308 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.865 ' HB3' ' HD3' ' D' ' 204' ' ' PRO . . . -54.98 -50.14 88.07 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.63 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.865 ' HD3' ' HB3' ' D' ' 203' ' ' ALA . 45.0 Cg_exo -51.45 97.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.51 1.268 . . . . 0.0 110.625 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.84 80.7 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.447 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.71 128.53 35.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.341 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -58.9 134.61 57.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 110.261 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.65 -171.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.78 141.84 10.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 110.401 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 1.6 p -112.9 43.86 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 110.347 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -72.16 83.67 1.01 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 110.415 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.28 102.38 13.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 110.293 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.78 160.3 33.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 110.455 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.06 -160.93 0.73 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 110.213 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.497 ' HG3' ' CE2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.1 OUTLIER -53.98 -178.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.561 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.673 ' HB1' ' HG3' ' B' ' 54' ' ' ARG . . . -150.89 123.75 4.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' B' ' 80' ' ' LEU . 37.7 Cg_exo -56.41 157.19 19.01 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.322 1.169 . . . . 0.0 110.539 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -104.25 -21.6 13.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 110.306 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -57.06 -168.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.324 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.791 179.852 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.438 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.458 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.748 ' SD ' HG11 ' A' ' 8' ' ' VAL . 4.3 mmt . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.015 0.436 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.464 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 10.0 p90 -54.01 143.56 21.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.971 -1.081 . . . . 0.0 110.328 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 5' ' ' ARG . 42.5 t30 -145.93 162.58 37.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.85 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.747 . . . . 0.0 110.539 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.498 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER 178.33 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.414 -0.804 . . . . 0.0 109.414 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG11 ' CG1' ' A' ' 30' ' ' VAL . 18.9 m -155.4 179.98 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.576 -0.702 . . . . 0.0 109.727 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.44 166.58 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 110.04 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.748 HG11 ' SD ' ' A' ' 1' ' ' MET . 7.6 p -108.39 144.78 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.784 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 4.9 mttt -140.84 142.72 34.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.617 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.3 56.99 6.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.663 -1.898 . . . . 0.0 110.6 2.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.474 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -104.24 -173.82 0.3 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.629 -0.67 . . . . 0.0 109.988 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 31.7 Cg_exo -53.72 -47.49 26.94 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.61 1.321 . . . . 0.0 110.392 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.62 31.04 0.32 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 110.388 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.72 -155.34 25.21 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.78 -147.1 18.54 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.529 ' HB2' ' HN2' ' A' ' 301' ' ' SAH . 2.5 m-85 -106.2 77.93 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.132 -1.216 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -114.97 -165.0 14.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.542 ' HB ' HD13 ' A' ' 67' ' ' ILE . 1.5 p -117.75 130.02 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.927 -1.337 . . . . 0.0 108.839 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -89.77 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 111.06 -177.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -107.0 96.23 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.478 -0.764 . . . . 0.0 110.385 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 97' ' ' ILE . 12.0 ttt-85 -70.14 -18.31 63.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 0.0 109.98 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -97.54 177.96 5.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.531 178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.447 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.515 50.6 m 106.48 21.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.097 -1.627 . . . . 0.0 110.12 1.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 20.3 m-85 -114.47 155.21 26.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.395 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.43 ' O ' ' CA ' ' A' ' 94' ' ' PRO . 1.1 mt-10 -88.17 -82.81 0.22 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.798 . . . . 0.0 109.885 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 24.5 tttt -175.91 92.19 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.924 -1.11 . . . . 0.0 110.012 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.67 19.34 4.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -97.59 152.36 19.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.235 . . . . 0.0 110.307 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.857 HD21 ' HB3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -78.02 121.55 24.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 110.379 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.606 ' CG2' HG23 ' A' ' 91' ' ' THR . 88.6 t -84.64 -46.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.292 -0.88 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.65 145.37 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 110.201 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -128.76 149.39 50.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.425 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.435 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 64.5 m -140.91 -154.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 110.123 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -110.35 175.94 5.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 110.623 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.1 m -147.23 164.34 33.5 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.409 -0.807 . . . . 0.0 109.592 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.045 HD11 HD23 ' A' ' 62' ' ' LEU . 22.4 mt -108.14 141.75 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 109.985 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 84' ' ' LEU . 61.0 t -117.31 120.97 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 110.537 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 21.7 tpt180 -148.82 143.21 26.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.445 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.33 -169.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.46 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.808 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -162.62 -136.14 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' B' ' 42' ' ' ASP . 72.5 m-20 -51.63 -25.12 6.46 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 109.518 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.638 ' CZ3' HD21 ' B' ' 47' ' ' LEU . 34.3 t-105 -58.52 -56.59 20.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.585 -0.697 . . . . 0.0 109.462 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.84 -34.21 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.8 m -70.82 -67.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 110.404 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.53 -51.72 58.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.972 . . . . 0.0 110.538 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.667 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.4 mm? -90.39 39.57 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 110.62 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 61.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.101 -0.999 . . . . 0.0 110.775 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -179.5 140.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.236 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 9.7 m-85 61.41 31.92 19.08 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.248 -0.908 . . . . 0.0 110.448 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 60' ' ' MET . 15.3 mt -106.3 134.57 49.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -108.88 103.33 12.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' C' ' 214' ' ' ARG . 12.0 t -89.54 127.63 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 0.0 111.553 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.595 ' CD ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -101.91 -174.48 2.6 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.539 -0.725 . . . . 0.0 109.752 178.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.36 73.88 9.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.016 -1.053 . . . . 0.0 109.124 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.505 5.2 t30 169.92 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.878 -0.514 . . . . 0.0 109.988 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -176.15 -168.13 0.25 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.261 -0.899 . . . . 0.0 110.952 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 1.3 p -116.58 138.8 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.384 -0.822 . . . . 0.0 110.17 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.73 ' HB2' HD13 ' A' ' 84' ' ' LEU . . . -131.59 168.09 18.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.051 -1.031 . . . . 0.0 110.375 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.667 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -105.84 172.92 6.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 109.857 178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.892 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.23 -35.61 21.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 0.0 110.705 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.045 HD23 HD11 ' A' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.09 -94.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.957 -1.089 . . . . 0.0 111.288 178.128 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -70.3 -118.91 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -90.35 27.34 1.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.345 -1.091 . . . . 0.0 110.934 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.892 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -77.43 -22.6 69.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -90.94 -47.37 7.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -1.179 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.542 HD13 ' HB ' ' A' ' 18' ' ' VAL . 2.4 pp -47.66 -25.88 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.208 -0.932 . . . . 0.0 110.789 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CG ' HG12 ' A' ' 103' ' ' ILE . 6.5 m-85 -46.39 113.25 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.549 -0.719 . . . . 0.0 111.158 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -92.3 179.19 5.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 110.87 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -101.77 116.91 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.376 -0.828 . . . . 0.0 109.882 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.11 130.71 51.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.373 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -52.62 -23.71 7.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 110.329 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.56 71.52 0.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 110.368 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.797 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.8 Cg_endo -64.54 112.12 1.85 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.648 1.341 . . . . 0.0 110.312 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.413 ' HA ' ' HE2' ' A' ' 93' ' ' LYS . 18.9 m-20 -111.32 18.49 19.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 110.616 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.7 162.56 40.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.0 ttt-85 -146.03 158.55 43.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.479 ' ND1' HD13 ' A' ' 103' ' ' ILE . 19.5 p-80 -110.09 158.78 17.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -141.35 142.63 33.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 110.327 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' A' ' 87' ' ' MET . 6.6 mt -106.75 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -90.08 68.2 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.15 34.41 11.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.398 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.24 171.68 38.77 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.73 HD13 ' HB2' ' A' ' 59' ' ' ALA . 85.4 mt -93.45 32.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -1.148 . . . . 0.0 109.998 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -93.34 -71.76 0.64 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.331 -0.856 . . . . 0.0 110.914 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.68 159.52 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.451 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 1.1 tmm? -142.47 138.77 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.569 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.857 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -121.08 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -0.96 . . . . 0.0 110.124 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -133.05 124.4 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.455 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.664 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 17.7 m-85 -113.35 -176.5 2.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.606 HG23 ' CG2' ' A' ' 30' ' ' VAL . 18.4 p -124.93 95.78 4.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.797 HD11 ' O ' ' A' ' 74' ' ' PRO . 30.7 pt -51.16 -24.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.6 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 75' ' ' ASN . 0.5 OUTLIER -145.68 157.05 52.21 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.43 ' CA ' ' O ' ' A' ' 25' ' ' GLU . 23.9 Cg_exo -59.12 147.19 91.63 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.738 1.388 . . . . 0.0 111.179 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.417 HG21 ' CB ' ' A' ' 20' ' ' ALA . 66.8 mt -131.7 145.29 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.606 -0.684 . . . . 0.0 110.33 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.25 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.373 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.4 mt -66.97 112.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 110.281 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.36 26.09 2.51 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -113.69 179.56 3.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.241 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 85.7 tt0 -116.47 135.9 53.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 110.631 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.961 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 39.2 mt -99.89 125.95 53.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.748 0.785 . . . . 0.0 110.521 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.9 p -154.73 171.57 19.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.761 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -146.96 165.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.098 . . . . 0.0 110.655 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.761 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -88.75 -164.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.414 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CD2' ' NE1' ' A' ' 110' ' ' TRP . 17.3 m-85 -123.47 -66.25 1.02 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.041 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.58 153.92 9.79 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.25 -24.33 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -1.166 . . . . 0.0 110.325 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.53 -55.1 4.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 110.064 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 3.5 t80 -71.56 60.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 110.661 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.467 ' NE1' ' CD2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER 177.32 -162.94 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.24 -0.913 . . . . 0.0 110.317 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 112' ' ' SER . 0.1 OUTLIER -59.6 -163.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.388 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.435 ' H ' HD23 ' A' ' 111' ' ' LEU . 15.2 p -124.25 136.9 54.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.208 -0.932 . . . . 0.0 110.277 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.4 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 13.4 mtt180 52.26 55.03 14.62 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 110.394 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.404 ' O ' ' HD3' ' A' ' 115' ' ' ARG . 33.5 Cg_endo -69.04 133.67 27.5 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.64 1.337 . . . . 0.0 110.143 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -129.61 63.95 1.51 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 110.331 -179.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -74.12 -41.33 61.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.615 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -139.02 162.58 34.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.576 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -74.25 62.59 0.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 110.445 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 t30 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.374 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.87 100.24 9.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -1.15 . . . . 0.0 110.363 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.45 58.34 1.65 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 110.272 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -66.52 155.17 71.49 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.683 1.36 . . . . 0.0 110.43 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.07 22.54 0.86 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 110.456 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 36.49 4.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 110.415 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -115.19 -40.9 3.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.491 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.48 30.13 1.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.388 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -106.23 34.08 3.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.865 . . . . 0.0 110.324 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 66.3 p -126.47 169.84 12.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -139.27 161.85 36.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.462 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -125.32 81.26 1.95 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 110.389 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.55 147.84 23.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.534 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 7.0 mtt-85 -111.87 -160.42 0.71 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 110.395 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER -56.33 -167.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 110.402 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -116.62 167.93 9.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 16.2 Cg_endo -61.8 -79.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.696 1.366 . . . . 0.0 110.534 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -174.14 42.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 110.451 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 1.1 p -81.81 57.64 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 110.302 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.756 ' SD ' HG11 ' B' ' 8' ' ' VAL . 4.3 mmt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.034 0.445 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.0 p90 -54.0 143.58 21.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.896 -1.128 . . . . 0.0 110.374 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' B' ' 5' ' ' ARG . 42.5 t30 -145.92 162.67 37.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.223 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.9 62.32 0.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.432 -0.792 . . . . 0.0 110.537 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.494 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.9 OUTLIER 178.36 -35.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.395 -0.816 . . . . 0.0 109.404 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.601 HG11 HG13 ' B' ' 30' ' ' VAL . 18.9 m -155.37 -179.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.494 -0.754 . . . . 0.0 109.791 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 tt -158.45 166.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.077 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.756 HG11 ' SD ' ' B' ' 1' ' ' MET . 7.7 p -108.31 144.73 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 110.816 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.605 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 5.0 mttt -140.83 142.8 34.56 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.605 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.31 56.97 6.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 119.703 -1.873 . . . . 0.0 110.626 2.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.485 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 0.9 OUTLIER -104.2 -173.85 0.31 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.583 -0.698 . . . . 0.0 110.007 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 31.7 Cg_exo -53.73 -47.54 26.68 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.593 1.312 . . . . 0.0 110.389 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.59 31.02 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.399 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.7 -155.34 25.23 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.81 -147.06 18.47 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.526 ' HB2' ' HN2' ' B' ' 302' ' ' SAH . 2.5 m-85 -106.22 78.11 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 110.541 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -115.22 -165.27 14.66 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' B' ' 67' ' ' ILE . 1.6 p -117.39 129.8 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.999 -1.295 . . . . 0.0 109.153 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.493 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.6 OUTLIER -89.76 158.15 17.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 111.088 -177.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.956 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -106.99 96.1 6.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.38 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.651 ' O ' HG23 ' B' ' 97' ' ' ILE . 11.9 ttt-85 -70.06 -18.37 63.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 110.027 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -97.44 178.08 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.452 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 50.8 m 106.53 21.27 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.066 -1.646 . . . . 0.0 110.112 1.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 20.4 m-85 -114.69 154.48 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.527 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.43 ' O ' ' CA ' ' B' ' 94' ' ' PRO . 1.2 mt-10 -87.23 -83.07 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' B' ' 25' ' ' GLU . 24.7 tttt -175.8 92.17 0.05 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.921 -1.112 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.68 19.37 4.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -97.62 152.35 19.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.268 . . . . 0.0 110.297 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' B' ' 88' ' ' ARG . 0.8 OUTLIER -78.04 121.55 24.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.442 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.601 HG13 HG11 ' B' ' 6' ' ' VAL . 88.4 t -84.65 -46.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 110.163 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.69 145.35 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 110.192 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.69 149.4 50.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.962 . . . . 0.0 110.435 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.441 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 64.3 m -140.91 -154.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.13 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.31 175.96 5.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 110.645 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 11.9 m -147.33 164.26 33.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.453 -0.779 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 1.048 HD11 HD23 ' B' ' 62' ' ' LEU . 22.2 mt -108.07 141.65 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.001 -1.062 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' B' ' 84' ' ' LEU . 61.1 t -117.28 120.96 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.515 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.502 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 21.6 tpt180 -148.76 143.24 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -57.36 -169.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -106.4 102.45 11.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.735 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -162.63 -136.23 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 72.4 m-20 -51.53 -25.16 6.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.557 -1.339 . . . . 0.0 109.571 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.589 ' CZ3' HD21 ' A' ' 47' ' ' LEU . 34.3 t-105 -58.51 -56.58 20.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.555 -0.715 . . . . 0.0 109.481 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.85 -34.19 64.78 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 48.0 m -70.76 -67.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -1.144 . . . . 0.0 110.433 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.403 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . . . -52.71 -51.45 60.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.671 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.4 mm? -90.63 39.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.36 61.28 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 0.0 110.746 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.478 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.2 OUTLIER -179.51 140.18 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.478 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 9.7 m-85 61.31 32.02 19.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.306 -0.871 . . . . 0.0 110.369 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' B' ' 60' ' ' MET . 15.2 mt -106.23 134.81 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.986 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -109.17 103.04 11.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' D' ' 214' ' ' ARG . 11.8 t -89.09 127.62 35.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.068 -1.02 . . . . 0.0 111.597 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.585 ' CD ' HD21 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -102.59 -177.56 3.42 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.577 -0.702 . . . . 0.0 109.832 178.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.95 73.37 4.51 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.263 -0.898 . . . . 0.0 110.129 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 5.4 t30 169.8 -30.8 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.721 -0.612 . . . . 0.0 109.994 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.97 -167.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.3 p -116.61 138.73 51.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.214 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.735 ' HB2' HD13 ' B' ' 84' ' ' LEU . . . -131.62 168.03 18.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 110.444 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.671 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -106.18 170.95 7.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 110.045 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.914 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -82.31 -36.96 26.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 111.126 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 1.048 HD23 HD11 ' B' ' 36' ' ' ILE 2.499 0.1 OUTLIER 81.64 -94.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.0 111.271 178.765 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -70.34 -118.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -90.56 27.33 1.76 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -1.092 . . . . 0.0 110.933 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.914 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -77.46 -22.22 70.73 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -91.61 -47.14 7.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.121 -1.223 . . . . 0.0 110.823 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' B' ' 18' ' ' VAL . 2.4 pp -47.75 -25.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.266 -0.897 . . . . 0.0 110.787 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.51 ' CG ' HG12 ' B' ' 103' ' ' ILE . 6.5 m-85 -46.38 113.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 111.138 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -92.34 179.41 5.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.812 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -102.03 116.84 33.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.4 -0.812 . . . . 0.0 109.845 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 47.3 t -126.01 130.78 51.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.193 -0.942 . . . . 0.0 110.417 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -52.61 -23.77 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.58 71.5 0.92 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.318 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.799 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.4 Cg_endo -64.38 112.01 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.685 1.361 . . . . 0.0 110.266 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 19.1 m-20 -111.29 18.51 19.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.395 -0.815 . . . . 0.0 110.478 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.67 162.59 40.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.54 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.47 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.0 ttt-85 -146.11 158.45 43.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.16 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.48 ' ND1' HD13 ' B' ' 103' ' ' ILE . 19.5 p-80 -110.0 158.81 17.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.38 142.67 33.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 110.281 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' B' ' 87' ' ' MET . 6.6 mt -106.76 157.7 17.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.872 . . . . 0.0 110.445 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.4 p -90.05 68.16 7.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.568 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.18 34.34 11.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.399 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 174.26 171.68 38.78 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.735 HD13 ' HB2' ' B' ' 59' ' ' ALA . 85.2 mt -93.41 32.29 1.38 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.248 -1.148 . . . . 0.0 110.08 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -93.57 -71.66 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.56 14.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 110.499 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.445 ' HG2' ' CD2' ' B' ' 80' ' ' LEU . 1.0 OUTLIER -142.57 138.75 31.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.563 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.855 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -121.1 170.71 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 110.114 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.04 124.34 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.495 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.662 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 17.8 m-85 -113.24 -176.52 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 110.344 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.593 HG23 ' CG2' ' B' ' 30' ' ' VAL . 18.3 p -124.94 95.91 4.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 110.097 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.799 HD11 ' O ' ' B' ' 74' ' ' PRO . 30.5 pt -51.16 -24.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 110.572 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 0.5 OUTLIER -145.63 157.17 52.19 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.177 -0.952 . . . . 0.0 110.551 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.43 ' CA ' ' O ' ' B' ' 25' ' ' GLU . 24.1 Cg_exo -59.5 147.33 92.0 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.704 1.37 . . . . 0.0 111.111 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.427 HG21 ' CB ' ' B' ' 20' ' ' ALA . 67.1 mt -131.67 145.4 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.577 -0.702 . . . . 0.0 110.308 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.28 162.63 12.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 110.355 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.4 mt -66.95 112.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 110.348 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 26.11 2.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -113.7 179.45 3.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -1.226 . . . . 0.0 110.034 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' B' ' 19' ' ' PHE . 85.6 tt0 -116.3 136.03 53.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.045 . . . . 0.0 110.568 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.956 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 40.6 mt -99.98 126.06 53.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.471 -0.768 . . . . 0.0 110.538 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.501 HG23 ' O ' ' B' ' 101' ' ' ILE . 16.6 p -154.69 171.72 19.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.755 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -147.0 165.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.927 -1.108 . . . . 0.0 110.669 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.755 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.4 OUTLIER -88.8 -164.95 1.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.422 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.47 ' CD2' ' NE1' ' B' ' 110' ' ' TRP . 17.3 m-85 -123.1 -66.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.52 153.96 9.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -51.22 -24.41 4.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -1.162 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.5 -55.11 4.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 3.5 t80 -71.52 60.32 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 110.693 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.47 ' NE1' ' CD2' ' B' ' 105' ' ' TYR . 0.0 OUTLIER 177.45 -162.89 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.209 -0.932 . . . . 0.0 110.264 179.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.422 HD23 ' H ' ' B' ' 112' ' ' SER . 0.1 OUTLIER -59.64 -163.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 110.381 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.422 ' H ' HD23 ' B' ' 111' ' ' LEU . 15.6 p -124.3 136.85 54.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 110.26 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 13.5 mtt180 52.3 54.94 14.47 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 110.423 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 33.1 Cg_endo -68.99 133.74 27.77 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.666 1.35 . . . . 0.0 110.121 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' B' ' 114' ' ' PRO . 0.0 OUTLIER -129.86 64.39 1.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 110.182 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -41.29 61.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.366 -0.834 . . . . 0.0 110.671 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 3.4 m -139.06 162.59 34.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.586 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -74.19 62.55 0.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 110.444 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 t30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.386 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.87 100.28 9.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -1.163 . . . . 0.0 110.31 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.45 58.3 1.64 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 110.299 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -66.55 155.18 71.48 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.685 1.361 . . . . 0.0 110.463 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.1 22.58 0.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 110.479 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.6 36.53 4.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 110.388 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -115.26 -40.95 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.418 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.43 30.03 1.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 110.428 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -106.19 34.09 3.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.883 . . . . 0.0 110.32 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 66.1 p -126.47 169.78 12.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.401 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -139.24 161.86 36.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.468 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -125.27 81.26 1.95 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.354 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -96.54 147.85 23.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.917 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.531 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 7.0 mtt-85 -111.89 -160.44 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.341 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 0.1 OUTLIER -56.36 -167.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.217 -0.927 . . . . 0.0 110.432 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -116.64 168.0 9.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 16.3 Cg_endo -61.83 -79.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.696 1.366 . . . . 0.0 110.561 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -174.2 42.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.954 . . . . 0.0 110.496 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 1.1 p -81.76 57.61 3.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.32 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.529 ' HN2' ' HB2' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.526 ' HN2' ' HB2' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' HG11 ' A' ' 8' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.15 0.5 . . . . 0.0 110.324 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 21.8 p90 -51.26 139.89 17.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.984 . . . . 0.0 110.617 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.83 156.04 49.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.14 -18.45 15.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.791 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.514 ' C ' HG13 ' A' ' 6' ' ' VAL . 2.1 mtm-85 -97.6 -29.03 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 110.914 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.514 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.1 m -153.45 -172.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 110.415 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 19' ' ' PHE . 13.6 tt -154.81 165.28 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 110.205 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG11 ' SD ' ' A' ' 1' ' ' MET . 7.3 p -99.77 137.83 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.98 . . . . 0.0 110.704 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 31.1 mttt -142.21 143.64 33.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.588 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 1.0 OUTLIER 52.73 66.21 1.29 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.757 -1.839 . . . . 0.0 111.161 1.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.457 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -126.93 174.04 4.64 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.568 178.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 11' ' ' SER . 34.7 Cg_exo -53.4 100.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.498 1.262 . . . . 0.0 110.319 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.2 50.18 15.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.414 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.67 165.54 24.16 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -148.27 5.87 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -102.58 73.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.247 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.71 -165.22 23.4 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.713 HG13 ' HB ' ' A' ' 101' ' ' ILE . 1.9 p -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.951 -1.323 . . . . 0.0 109.553 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.1 m-85 -89.79 158.55 17.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.564 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.692 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -113.09 105.32 13.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 110.645 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -63.71 -28.45 69.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.516 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' HB3' ' CA ' ' A' ' 23' ' ' SER . 5.3 mttm -86.5 -178.36 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.46 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.507 4.8 t 99.53 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.031 -1.668 . . . . 0.0 110.493 1.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.427 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 22.2 m-85 -96.83 158.63 15.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.047 -1.033 . . . . 0.0 110.893 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 -155.69 0.48 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.479 -0.763 . . . . 0.0 110.011 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 58.8 tttt -95.94 30.88 2.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 110.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.27 86.21 0.06 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -150.07 124.6 9.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 110.337 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.812 HD23 ' CG ' ' A' ' 88' ' ' ARG . 3.4 tm? -54.34 119.96 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.3 -52.72 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 110.346 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 31' ' ' GLU . 8.6 pt-20 -170.73 97.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.25 152.24 34.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -150.36 -151.22 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.77 171.93 7.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.545 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 1.03 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 1.3 m -150.14 150.42 31.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.627 HD11 ' CD2' ' A' ' 62' ' ' LEU . 56.2 mt -91.18 142.71 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 84' ' ' LEU . 42.0 t -117.63 127.91 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 110.769 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.524 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 19.2 mmt180 -150.36 178.2 9.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -92.14 -173.73 3.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.111 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.57 -141.93 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.407 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.74 -135.02 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.06 -1.025 . . . . 0.0 110.826 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.63 -49.06 7.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 111.521 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 1.019 ' NE1' HD21 ' A' ' 51' ' ' LEU . 36.8 t-105 -51.54 -46.71 63.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.002 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.26 76.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.414 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 44.9 m -74.46 -59.96 2.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -1.216 . . . . 0.0 110.826 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' O ' ' NH2' ' B' ' 38' ' ' ARG . . . -50.69 -54.48 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 0.0 110.639 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.023 HD21 HD21 ' B' ' 47' ' ' LEU . 3.1 mm? -91.91 23.3 3.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.0 pp20? -50.67 154.56 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.952 -1.092 . . . . 0.0 110.005 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 54.9 t0 60.86 147.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.778 . . . . 0.0 110.164 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.28 13.68 7.18 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.145 -0.972 . . . . 0.0 110.303 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.019 HD21 ' NE1' ' A' ' 43' ' ' TRP . 8.9 tp -112.52 107.79 16.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.87 119.06 29.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 109.524 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -109.27 136.0 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 0.0 111.066 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.747 ' HD3' HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -102.29 -172.04 2.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.391 -0.818 . . . . 0.0 109.806 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.03 72.91 9.09 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.958 -1.089 . . . . 0.0 108.967 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 6.3 m120 175.08 -33.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.554 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.458 ' HG2' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.59 -173.51 0.33 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.352 -0.842 . . . . 0.0 110.331 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -112.75 146.92 37.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -141.8 151.64 43.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.618 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.686 ' HA ' HD12 ' A' ' 51' ' ' LEU . 29.3 tpp -90.17 156.77 18.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.811 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.83 93.39 9.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.973 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.497 0.1 OUTLIER -54.53 -65.5 0.56 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 110.427 179.194 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -60.69 -159.49 0.07 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' HB3' HD11 ' A' ' 67' ' ' ILE . 5.1 m-85 -75.36 58.91 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -1.091 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.16 -36.34 7.16 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 301' ' ' SAH . . . -70.02 -41.7 73.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -1.154 . . . . 0.0 110.661 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.693 HD13 ' HB ' ' A' ' 18' ' ' VAL . 1.2 pp -51.84 -34.44 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.188 -0.945 . . . . 0.0 111.24 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HB3' ' CG1' ' A' ' 103' ' ' ILE . 11.8 m-85 -49.96 119.9 3.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.986 -1.071 . . . . 0.0 110.697 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.421 ' H ' HG22 ' A' ' 102' ' ' THR . 76.4 m-20 -95.52 176.46 6.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 110.404 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -95.39 107.57 19.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.4 t -115.65 129.98 56.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -53.6 -26.37 21.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.26 76.52 0.4 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.857 . . . . 0.0 110.052 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.93 ' O ' HD11 ' A' ' 92' ' ' ILE . 17.0 Cg_endo -62.32 104.37 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.719 1.379 . . . . 0.0 110.656 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 92' ' ' ILE . 70.6 m-20 -94.38 -19.82 20.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 110.383 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' THR . . . -125.71 178.0 5.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.625 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -149.56 168.18 24.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.409 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.894 ' ND1' HD13 ' A' ' 103' ' ' ILE . 33.5 p-80 -121.42 127.06 50.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' ARG . 26.8 tt0 -109.17 172.44 6.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.221 -0.924 . . . . 0.0 110.26 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.747 HD13 ' HD3' ' A' ' 54' ' ' ARG . 6.0 mt -121.63 146.13 47.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 110.487 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 37.2 m -117.07 144.7 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.484 -0.76 . . . . 0.0 110.273 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . . . 52.93 34.03 15.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.03 -95.65 1.99 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -124.12 26.58 7.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -1.15 . . . . 0.0 110.219 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.79 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 1.2 mmtp -89.79 -73.12 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 110.482 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.436 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -102.17 177.84 4.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.41 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 1.03 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 64.5 mtp -136.91 150.51 48.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 110.369 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.812 ' CG ' HD23 ' A' ' 29' ' ' LEU . 15.1 ttm180 -133.5 104.41 6.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.93 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 77' ' ' ARG . 6.2 mt -89.08 140.12 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.964 . . . . 0.0 110.314 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 88' ' ' ARG . 1.7 m-85 -129.53 -168.11 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 26.4 p -125.36 97.1 5.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.93 HD11 ' O ' ' A' ' 74' ' ' PRO . 49.3 pt -59.87 -17.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.534 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 26' ' ' LYS . 13.5 mtmt -143.43 134.73 12.67 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 110.005 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.59 135.49 16.48 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.49 1.258 . . . . 0.0 111.255 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 20' ' ' ALA . 80.6 mt -115.71 142.38 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.5 163.33 15.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 110.561 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' A' ' 21' ' ' ARG . 28.1 mt -65.07 115.11 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -0.81 . . . . 0.0 110.409 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.06 40.85 2.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.6 177.6 4.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -1.138 . . . . 0.0 110.347 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.58 30.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.463 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.713 ' HB ' HG13 ' A' ' 18' ' ' VAL . 62.8 mt -90.31 124.85 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 110.395 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 101' ' ' ILE . 17.5 p -157.51 135.92 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.894 HD13 ' ND1' ' A' ' 78' ' ' HIS . 1.1 pp -100.85 170.44 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.965 -1.084 . . . . 0.0 110.447 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.619 ' O ' HD12 ' A' ' 103' ' ' ILE . 89.4 p -105.63 -166.83 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.478 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.424 ' CD1' ' HG3' ' C' ' 215' ' ' MLZ . 12.4 m-85 -123.58 -58.56 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.913 . . . . 0.0 110.068 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.57 160.32 0.44 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.6 OUTLIER 57.45 109.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.434 -1.039 . . . . 0.0 110.977 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 107' ' ' ASP . 16.5 t0 57.57 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.844 -0.535 . . . . 0.0 111.768 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -43.34 111.03 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.311 -0.868 . . . . 0.0 111.706 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 49.64 -160.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 111.019 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 140.26 15.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.803 . . . . 0.0 110.647 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -148.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.877 . . . . 0.0 110.16 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -48.63 106.33 0.6 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.148 -0.97 . . . . 0.0 110.74 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.42 95.41 0.86 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.512 1.269 . . . . 0.0 110.468 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.74 99.74 9.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 110.442 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.0 151.64 51.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 110.377 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -122.26 163.26 19.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.347 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.31 100.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.375 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.058 -0.973 . . . . 0.0 110.409 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.48 -167.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -1.161 . . . . 0.0 110.412 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -133.5 158.16 76.29 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.395 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.93 125.39 17.55 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.707 1.372 . . . . 0.0 110.499 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 105.56 15.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 110.299 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.13 147.02 41.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 110.42 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.5 161.86 8.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.325 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 18.5 mt -117.04 -24.11 7.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 110.441 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.52 134.34 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.366 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 55.5 m -137.31 69.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 110.348 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 mttt 52.56 80.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 110.493 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.81 97.37 3.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 110.244 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.27 160.7 15.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 110.424 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -89.05 -150.01 0.19 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 110.129 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.424 ' HG3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 0.1 OUTLIER -53.03 178.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 110.339 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.33 16.51 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.943 . . . . 0.0 110.397 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.22 -168.09 0.32 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.571 1.301 . . . . 0.0 110.538 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -105.8 148.19 27.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 110.218 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 22.0 m -140.49 104.38 4.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.176 -0.953 . . . . 0.0 110.329 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.472 ' SD ' HG11 ' B' ' 8' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.086 0.47 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 21.6 p90 -51.44 139.87 18.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.117 -0.99 . . . . 0.0 110.573 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.78 156.13 49.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.295 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -57.18 -18.44 15.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.764 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' B' ' 6' ' ' VAL . 2.1 mtm-85 -97.66 -29.08 13.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.884 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.0 m -153.4 -172.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.431 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.635 HG23 ' HB2' ' B' ' 19' ' ' PHE . 13.7 tt -154.79 165.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.95 . . . . 0.0 110.23 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.472 HG11 ' SD ' ' B' ' 1' ' ' MET . 7.2 p -99.79 137.78 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 110.726 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 31.1 mttt -142.17 143.72 33.1 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.604 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 1.0 OUTLIER 52.77 66.3 1.26 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.861 -1.774 . . . . 0.0 111.083 1.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.455 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -127.03 173.99 4.72 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.0 109.568 178.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' B' ' 11' ' ' SER . 34.9 Cg_exo -53.3 100.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.494 1.26 . . . . 0.0 110.289 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.12 50.3 15.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 0.0 110.373 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.74 165.53 24.18 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -148.28 5.87 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -102.52 73.3 1.3 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -1.231 . . . . 0.0 110.641 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -105.68 -165.33 23.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.71 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.0 p -121.69 130.72 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.953 -1.322 . . . . 0.0 109.674 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.635 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.1 m-85 -89.83 158.5 17.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 110.528 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -113.18 105.39 13.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 110.581 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.2 OUTLIER -63.7 -28.39 69.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.459 ' HB3' ' CA ' ' B' ' 23' ' ' SER . 5.3 mttm -86.54 -178.36 6.39 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.506 4.8 t 99.53 10.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 119.958 -1.714 . . . . 0.0 110.5 1.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 22.1 m-85 -96.69 158.67 15.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.064 -1.022 . . . . 0.0 110.921 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.09 -155.69 0.48 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.464 -0.773 . . . . 0.0 110.016 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.412 ' HG3' ' HA ' ' B' ' 93' ' ' LYS . 58.7 tttt -95.93 30.84 2.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 110.393 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.29 86.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -150.17 124.6 9.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.811 HD23 ' CG ' ' B' ' 88' ' ' ARG . 3.4 tm? -54.36 119.95 5.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 95.1 t -81.26 -52.73 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.841 . . . . 0.0 110.372 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' B' ' 31' ' ' GLU . 8.6 pt-20 -170.73 97.46 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 152.4 34.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 110.342 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.45 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.3 OUTLIER -150.55 -151.33 0.39 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 110.645 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.7 171.96 7.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.521 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 1.034 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 1.3 m -150.18 150.36 31.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.63 HD11 ' CD2' ' B' ' 62' ' ' LEU . 55.8 mt -91.04 142.77 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' B' ' 84' ' ' LEU . 42.1 t -117.67 128.01 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 110.745 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 19.1 mmt180 -150.5 178.18 9.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.7 OUTLIER -92.11 -173.73 3.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 110.106 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.6 -141.95 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.35 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 59.75 -135.05 0.8 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.129 -0.982 . . . . 0.0 110.805 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.59 -49.1 7.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.001 -1.062 . . . . 0.0 111.506 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 1.022 ' NE1' HD21 ' B' ' 51' ' ' LEU . 36.9 t-105 -51.53 -46.7 63.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 110.046 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.45 -45.27 76.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' B' ' 48' ' ' GLU . 44.9 m -74.47 -59.88 2.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.138 -1.213 . . . . 0.0 110.808 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -53.67 30.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 0.0 110.656 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 1.023 HD21 HD21 ' A' ' 47' ' ' LEU . 3.2 mm? -93.0 23.63 4.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 110.603 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' B' ' 45' ' ' THR . 2.0 pp20? -50.76 154.52 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 110.033 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' B' ' 48' ' ' GLU . 54.2 t0 60.91 147.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.504 -0.747 . . . . 0.0 110.177 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 63.2 13.73 7.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.115 -0.991 . . . . 0.0 110.18 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 1.022 HD21 ' NE1' ' B' ' 43' ' ' TRP . 8.9 tp -112.6 107.81 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.021 -1.05 . . . . 0.0 110.936 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -89.85 119.08 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.564 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 42.6 t -109.25 135.93 49.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -0.99 . . . . 0.0 111.094 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.727 ' HD3' HD13 ' B' ' 80' ' ' LEU . 0.9 OUTLIER -102.93 -175.19 2.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.74 . . . . 0.0 109.808 178.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.46 72.3 4.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -0.962 . . . . 0.0 109.974 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 6.3 m120 175.02 -33.51 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.45 ' HG2' ' CD2' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.3 -173.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.347 -0.845 . . . . 0.0 110.391 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -112.74 146.89 37.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -141.74 151.62 43.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.688 ' HA ' HD12 ' B' ' 51' ' ' LEU . 29.3 tpp -90.32 155.93 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.818 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -86.65 93.4 9.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.851 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.497 0.1 OUTLIER -54.93 -65.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.369 179.246 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.7 -159.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' B' ' 67' ' ' ILE . 5.1 m-85 -75.4 59.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.818 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -90.34 -36.27 7.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' B' ' 302' ' ' SAH . . . -70.06 -41.68 73.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -1.15 . . . . 0.0 110.658 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' B' ' 18' ' ' VAL . 1.2 pp -51.87 -34.4 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 0.0 111.246 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.462 ' HB3' ' CG1' ' B' ' 103' ' ' ILE . 11.8 m-85 -49.95 119.89 3.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.918 -1.114 . . . . 0.0 110.709 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.431 ' H ' HG22 ' B' ' 102' ' ' THR . 76.4 m-20 -95.53 176.47 6.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.309 -0.869 . . . . 0.0 110.451 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -95.4 107.57 19.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 110.253 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 31.5 t -115.67 130.02 56.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 0.0 110.498 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' B' ' 74' ' ' PRO . 0.4 OUTLIER -53.59 -26.36 21.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.293 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -106.27 76.5 0.4 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.09 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.918 ' O ' HD11 ' B' ' 92' ' ' ILE . 17.0 Cg_endo -62.31 104.39 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.715 1.377 . . . . 0.0 110.688 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -94.42 -19.78 20.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' B' ' 91' ' ' THR . . . -125.74 178.02 5.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 110.295 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.639 ' O ' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -149.55 168.2 24.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.962 . . . . 0.0 110.445 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.895 ' ND1' HD13 ' B' ' 103' ' ' ILE . 33.6 p-80 -121.42 126.92 50.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 110.386 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' B' ' 88' ' ' ARG . 27.0 tt0 -109.07 172.37 6.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.292 -0.88 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' B' ' 54' ' ' ARG . 6.0 mt -121.46 146.21 47.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.453 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 38.5 m -117.08 144.7 44.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.41 -0.806 . . . . 0.0 110.279 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' B' ' 85' ' ' LYS . . . 52.93 34.01 15.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.253 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.08 -95.72 2.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' B' ' 54' ' ' ARG . 1.0 OUTLIER -124.11 26.53 7.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -1.163 . . . . 0.0 110.228 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.79 ' HB2' ' HB3' ' B' ' 82' ' ' ALA . 1.2 mmtp -89.69 -73.09 0.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 110.522 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.442 ' CB ' ' HB ' ' B' ' 81' ' ' THR . 0.3 OUTLIER -102.24 177.87 4.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.887 . . . . 0.0 110.349 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 1.034 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 64.5 mtp -136.92 150.6 48.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.811 ' CG ' HD23 ' B' ' 29' ' ' LEU . 15.0 ttm180 -133.76 104.08 6.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.476 -0.765 . . . . 0.0 109.982 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.639 HG23 ' O ' ' B' ' 77' ' ' ARG . 6.1 mt -88.39 140.22 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.461 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' B' ' 88' ' ' ARG . 1.7 m-85 -129.73 -168.13 1.91 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.89 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' B' ' 76' ' ' ALA . 26.5 p -125.32 97.07 5.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 110.397 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.918 HD11 ' O ' ' B' ' 74' ' ' PRO . 49.2 pt -59.84 -17.54 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.599 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.412 ' HA ' ' HG3' ' B' ' 26' ' ' LYS . 13.5 mtmt -143.42 134.62 12.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.89 135.75 17.49 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.467 1.246 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' B' ' 20' ' ' ALA . 80.9 mt -115.77 142.19 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.18 163.39 15.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.622 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 28.1 mt -65.06 115.04 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 110.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.07 40.87 2.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.59 177.64 4.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -1.166 . . . . 0.0 110.414 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.73 116.73 31.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.401 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.71 ' HB ' HG13 ' B' ' 18' ' ' VAL . 63.1 mt -90.45 124.83 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 110.44 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.578 HG23 ' O ' ' B' ' 101' ' ' ILE . 17.4 p -157.38 135.98 11.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 109.659 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.895 HD13 ' ND1' ' B' ' 78' ' ' HIS . 1.1 pp -100.83 170.42 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.62 ' O ' HD12 ' B' ' 103' ' ' ILE . 89.5 p -105.64 -166.98 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.441 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' B' ' 109' ' ' TYR . 12.4 m-85 -123.44 -58.75 1.59 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.939 . . . . 0.0 110.036 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.84 160.31 0.47 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.6 OUTLIER 57.41 109.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.432 -1.04 . . . . 0.0 111.003 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' B' ' 107' ' ' ASP . 16.7 t0 57.79 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.867 -0.521 . . . . 0.0 111.774 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' B' ' 107' ' ' ASP . 0.2 OUTLIER -43.45 111.0 0.23 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.302 -0.874 . . . . 0.0 111.719 -178.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 49.7 -160.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 0.0 110.934 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 140.24 15.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.406 -0.809 . . . . 0.0 110.612 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -148.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 110.169 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -48.56 106.33 0.6 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 110.739 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.44 95.39 0.86 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.517 1.272 . . . . 0.0 110.463 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.69 99.71 9.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.436 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.02 151.63 50.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 110.368 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -122.26 163.24 20.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 110.351 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.23 100.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 110.358 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.442 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.46 -167.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -1.153 . . . . 0.0 110.4 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -133.47 158.2 76.2 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.96 125.42 17.61 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.665 1.35 . . . . 0.0 110.469 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.52 105.53 15.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.286 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 147.01 41.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.49 161.86 8.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.287 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 18.6 mt -117.05 -24.15 7.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.4 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.45 134.39 20.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 55.5 m -137.31 69.61 1.4 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 110.379 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 mttt 52.69 80.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.915 . . . . 0.0 110.461 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.76 97.34 3.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.296 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.24 160.79 15.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 110.398 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -89.13 -149.98 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.14 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.422 ' HG3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 0.1 OUTLIER -53.05 178.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.38 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -144.5 140.3 16.48 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 110.413 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.2 -168.12 0.32 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.538 1.283 . . . . 0.0 110.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -105.79 148.19 27.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.903 . . . . 0.0 110.198 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 22.0 m -140.47 104.34 4.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -0.942 . . . . 0.0 110.392 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.414 ' HB2' ' O ' ' B' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.262 0.553 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 48.9 p90 -126.71 123.32 37.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 110.439 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -126.03 148.11 49.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -46.51 -48.66 19.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.437 -0.79 . . . . 0.0 111.053 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.533 ' C ' HG13 ' A' ' 6' ' ' VAL . 20.6 mmt85 -59.65 -45.7 91.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 110.495 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.533 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.3 m -154.81 152.16 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 110.384 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 11.6 tt -117.75 167.12 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.941 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.8 p -89.35 127.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.433 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.646 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 12.9 mttt -144.54 139.02 27.92 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.8 OUTLIER 52.61 73.47 0.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.585 -1.947 . . . . 0.0 109.798 6.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -131.78 177.61 2.16 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 121.869 -0.52 . . . . 0.0 110.135 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 11' ' ' SER . 19.5 Cg_endo -65.76 -37.45 27.85 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.609 1.321 . . . . 0.0 110.438 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -67.28 -32.67 73.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 110.272 179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.14 122.48 5.11 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.29 133.9 2.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.469 ' HB2' ' HN2' ' A' ' 301' ' ' SAH . 5.3 m-85 -90.58 66.66 6.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -1.2 . . . . 0.0 110.627 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -111.54 -163.75 17.65 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.96 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.4 p -105.89 133.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.238 . . . . 0.0 109.063 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.537 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -90.0 144.12 26.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 110.521 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.95 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -97.26 89.24 4.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.466 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.878 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -63.29 -18.59 63.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.282 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HD2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.76 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.474 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 0.0 OUTLIER 97.57 8.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.414 -1.429 . . . . 0.0 110.609 0.812 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CZ ' HG12 ' A' ' 30' ' ' VAL . 14.6 m-85 -105.44 163.46 12.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.995 -1.065 . . . . 0.0 110.511 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.3 -148.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.027 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 10.4 tttt -107.94 82.47 1.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.039 -1.038 . . . . 0.0 110.497 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . . . 124.37 46.5 0.25 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.57 144.81 51.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -1.172 . . . . 0.0 110.531 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.925 HD23 ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -74.87 141.76 44.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.854 HG22 ' O ' ' A' ' 89' ' ' ILE . 28.6 m -121.81 -23.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.18 -0.95 . . . . 0.0 110.995 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.982 ' HB3' HD12 ' A' ' 89' ' ' ILE . 4.7 tt0 -171.8 153.82 3.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.104 -0.997 . . . . 0.0 110.216 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' CG ' ' HA ' ' A' ' 88' ' ' ARG . 3.1 mt-10 -146.63 151.0 36.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 110.484 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.427 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 27.0 p -150.59 -160.85 1.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.652 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.703 HD23 ' HG3' ' A' ' 86' ' ' ARG . 54.0 mt -114.73 -179.87 3.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 110.466 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.7 170.89 17.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.289 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.104 HD11 HD23 ' A' ' 62' ' ' LEU . 48.2 mt -105.78 144.26 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.226 -0.922 . . . . 0.0 109.793 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 84' ' ' LEU . 38.2 t -123.25 89.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.005 -1.059 . . . . 0.0 110.386 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.38 177.81 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -88.61 175.06 7.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.121 -0.987 . . . . 0.0 109.771 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 5.7 t-20 -74.89 -135.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.099 -1.001 . . . . 0.0 110.252 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.3 t0 65.84 -146.86 0.21 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.69 -1.257 . . . . 0.0 110.379 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.03 -28.41 1.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.213 -0.93 . . . . 0.0 111.033 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.778 ' CH2' HD22 ' A' ' 47' ' ' LEU . 65.9 t-105 -68.41 -52.11 36.52 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.833 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.77 -23.53 55.98 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 90.7 m -83.76 -67.09 0.82 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -1.188 . . . . 0.0 110.748 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -46.63 -49.92 18.37 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 0.0 110.988 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.89 ' HB3' HD13 ' A' ' 51' ' ' LEU . 4.4 mp -91.86 31.87 1.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.02 64.09 0.23 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.939 -1.101 . . . . 0.0 110.61 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.42 -68.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.038 -1.039 . . . . 0.0 110.585 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' A' ' 301' ' ' SAH . 13.0 m-85 -98.34 34.39 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 0.0 109.994 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' A' ' 47' ' ' LEU . 2.3 tp -101.5 116.86 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.549 -0.72 . . . . 0.0 111.01 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -89.35 103.73 16.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.117 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 33.7 t -90.77 139.93 30.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.148 -0.97 . . . . 0.0 111.561 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' NH2' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -121.63 -175.36 3.07 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.583 -0.698 . . . . 0.0 109.674 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 79.69 8.88 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.953 -1.092 . . . . 0.0 109.363 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.506 0.2 OUTLIER 162.88 -28.91 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.847 -0.533 . . . . 0.0 109.844 -179.307 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.408 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.84 -161.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 5.3 m -128.28 141.7 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -129.12 175.42 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.859 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.558 ' CE ' HD23 ' A' ' 47' ' ' LEU . 1.3 tpt -114.11 169.45 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.815 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -84.96 -37.28 20.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.083 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.104 HD23 HD11 ' A' ' 36' ' ' ILE 2.501 0.1 OUTLIER 76.14 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.005 . . . . 0.0 111.186 177.657 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -66.35 -128.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.446 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.19 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -1.049 . . . . 0.0 110.84 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.815 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.77 -26.71 21.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 301' ' ' SAH . . . -90.15 -35.78 15.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -1.114 . . . . 0.0 110.585 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.1 pp -47.01 -37.0 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' N ' HD12 ' A' ' 67' ' ' ILE . 28.9 m-85 -46.39 129.37 10.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.343 -0.848 . . . . 0.0 110.919 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.49 -177.4 3.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 110.65 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -93.24 124.72 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 110.03 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 m -145.35 157.18 44.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 110.555 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.22 25.91 2.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.495 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.26 67.84 4.1 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.182 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.908 ' O ' HD11 ' A' ' 92' ' ' ILE . 13.1 Cg_endo -60.55 110.24 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.764 1.402 . . . . 0.0 110.465 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 3.1 m120 -89.84 -18.65 25.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -151.55 122.66 7.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.13 -0.982 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.447 ' HB2' ' CG2' ' A' ' 92' ' ' ILE . 18.2 mtt180 -93.89 -171.23 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 110.033 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.791 ' CE1' HD13 ' A' ' 103' ' ' ILE . 47.3 p-80 -130.39 150.59 51.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.177 -0.952 . . . . 0.0 110.281 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 4.4 tp10 -117.32 141.81 47.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.224 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 84' ' ' LEU . 51.2 tp -114.5 131.13 56.74 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.077 -1.014 . . . . 0.0 110.131 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.8 p -54.81 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 110.379 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' O ' ' NH2' ' A' ' 54' ' ' ARG . . . -52.42 -23.27 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 110.389 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.54 -164.27 11.79 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.81 ' HA ' HD11 ' A' ' 80' ' ' LEU . 8.9 mt -102.8 42.47 1.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -1.129 . . . . 0.0 110.226 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.23 -65.63 0.98 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 111.168 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.703 ' HG3' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.46 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 110.886 -178.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.97 24.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 110.13 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.45 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -128.03 172.47 10.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 110.91 -179.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.982 HD12 ' HB3' ' A' ' 31' ' ' GLU . 16.6 mt -145.89 91.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.925 ' CE2' HD23 ' A' ' 29' ' ' LEU . 2.4 m-85 -98.41 150.39 21.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.586 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.585 HG23 ' CG1' ' A' ' 30' ' ' VAL . 2.9 p -89.13 114.13 25.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.061 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.908 HD11 ' O ' ' A' ' 74' ' ' PRO . 13.6 pt -75.83 -13.53 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.62 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.47 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 8.3 ptpt -148.19 156.7 43.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.058 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.87 124.41 15.29 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.582 1.306 . . . . 0.0 110.597 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 75' ' ' ASN . 61.8 mt -111.4 145.6 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 110.373 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.89 156.61 17.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.367 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.878 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -59.91 111.97 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.864 . . . . 0.0 110.326 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.76 32.19 1.79 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -114.3 170.54 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -1.138 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' OE2' ' CG2' ' A' ' 102' ' ' THR . 0.7 OUTLIER -110.31 139.8 45.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.96 ' HB ' HG13 ' A' ' 18' ' ' VAL . 41.0 mt -109.02 122.1 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 110.619 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.447 HG23 ' C ' ' A' ' 101' ' ' ILE . 58.4 p -149.7 143.71 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.791 HD13 ' CE1' ' A' ' 78' ' ' HIS . 1.0 OUTLIER -111.61 169.86 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.021 -1.049 . . . . 0.0 110.571 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -95.51 -168.64 1.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 110.428 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 109' ' ' TYR . 11.1 m-85 -123.49 -62.33 1.33 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.21 -0.932 . . . . 0.0 109.867 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 70.16 -169.83 45.65 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.87 -67.86 0.11 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.533 -0.981 . . . . 0.0 110.813 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -144.12 -39.02 0.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.994 -1.066 . . . . 0.0 110.767 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.476 ' CB ' ' CB ' ' A' ' 105' ' ' TYR . 1.6 m-85 -47.51 107.15 0.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 111.241 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.473 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 26.3 m95 53.17 -96.97 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 110.908 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.615 HD22 ' HB3' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -91.04 -175.78 4.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.698 -1.251 . . . . 0.0 110.792 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.65 -47.87 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.38 -0.825 . . . . 0.0 110.244 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.74 57.97 15.06 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.244 -0.91 . . . . 0.0 110.297 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.615 ' HB3' HD22 ' A' ' 111' ' ' LEU . 19.2 Cg_endo -63.52 -24.89 70.19 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.73 1.384 . . . . 0.0 110.568 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.85 79.31 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.449 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -83.85 169.04 15.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 110.438 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 117' ' ' THR . 73.4 m 54.11 20.84 2.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 110.645 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -174.79 150.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.872 -1.142 . . . . 0.0 110.437 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.343 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -116.2 -28.33 6.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -1.176 . . . . 0.0 110.361 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.43 ' N ' ' HD3' ' C' ' 204' ' ' PRO . . . 52.5 63.35 8.97 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 110.431 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' C' ' 203' ' ' ALA . 24.6 Cg_exo -60.05 -39.07 73.42 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.611 1.322 . . . . 0.0 110.51 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -52.8 -72.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 110.46 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' C' ' 208' ' ' LEU . 0.7 OUTLIER -71.31 -154.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.361 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.59 -75.89 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.425 -0.797 . . . . 0.0 110.705 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' C' ' 206' ' ' LYS . 24.4 mt 53.22 -178.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.301 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.12 165.94 14.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 110.503 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.7 t -169.55 159.52 8.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 110.185 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -166.94 127.48 1.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 110.521 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -133.32 111.43 10.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.89 . . . . 0.0 110.2 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -161.14 -147.05 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 110.359 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 61.16 125.4 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.416 -0.803 . . . . 0.0 110.458 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.401 ' HG2' ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t -61.0 -146.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.363 -0.836 . . . . 0.0 110.525 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.44 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.209 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.2 175.24 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.596 1.313 . . . . 0.0 110.447 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -53.15 -64.52 0.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . 0.541 HG22 ' O ' ' C' ' 220' ' ' THR . 99.9 m 52.3 64.11 1.98 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.499 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.503 ' SD ' HG11 ' B' ' 8' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.221 0.534 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 49.0 p90 -126.68 123.28 37.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 110.474 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -125.96 148.26 49.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 110.079 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 26.1 t70 -46.56 -48.7 19.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.371 -0.831 . . . . 0.0 110.985 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.516 ' C ' HG13 ' B' ' 6' ' ' VAL . 20.5 mmt85 -59.67 -45.69 91.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 110.539 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.516 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.3 m -154.72 152.22 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 11.7 tt -117.89 166.75 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.503 HG11 ' SD ' ' B' ' 1' ' ' MET . 8.0 p -88.83 127.86 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.571 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.657 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 13.0 mttt -144.71 139.15 27.74 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.657 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.8 OUTLIER 52.71 73.45 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.52 -1.988 . . . . 0.0 109.851 6.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.442 ' CB ' ' HD2' ' B' ' 12' ' ' PRO . 0.4 OUTLIER -131.84 177.57 2.18 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.895 -0.503 . . . . 0.0 110.097 -178.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' B' ' 11' ' ' SER . 19.3 Cg_endo -65.78 -37.47 27.71 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.567 1.299 . . . . 0.0 110.365 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.26 -32.69 73.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 110.286 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.13 122.46 5.11 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.34 133.92 2.73 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.469 ' HB2' ' HN2' ' B' ' 302' ' ' SAH . 5.2 m-85 -90.55 66.96 6.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -1.145 . . . . 0.0 110.616 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -111.87 -163.94 17.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.938 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.5 p -105.59 132.94 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.021 -1.282 . . . . 0.0 109.22 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.536 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -90.15 144.21 26.08 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.054 -1.028 . . . . 0.0 110.556 -178.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.961 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -97.21 89.19 4.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.889 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.6 OUTLIER -63.4 -18.54 63.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.493 ' HD2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -88.21 178.85 6.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 110.035 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.469 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.509 0.0 OUTLIER 97.63 8.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.434 -1.416 . . . . 0.0 110.625 0.786 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.632 ' CZ ' HG12 ' B' ' 30' ' ' VAL . 14.4 m-85 -105.34 163.52 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.024 -1.048 . . . . 0.0 110.487 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.36 -148.42 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.89 . . . . 0.0 110.01 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 92' ' ' ILE . 10.3 tttt -107.96 82.45 1.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.13 -0.981 . . . . 0.0 110.486 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 91' ' ' THR . . . 124.37 46.57 0.25 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -128.55 144.74 51.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -1.197 . . . . 0.0 110.575 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.91 HD23 ' CE2' ' B' ' 90' ' ' PHE . 0.3 OUTLIER -74.84 141.84 44.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 109.813 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.862 HG22 ' O ' ' B' ' 89' ' ' ILE . 28.4 m -121.97 -23.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.12 -0.987 . . . . 0.0 110.886 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.98 ' HB3' HD12 ' B' ' 89' ' ' ILE . 4.6 tt0 -171.75 153.77 3.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 110.344 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' B' ' 88' ' ' ARG . 3.1 mt-10 -146.59 151.26 37.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 0.0 110.434 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.419 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 27.0 p -150.98 -161.02 1.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.679 HD23 ' HG3' ' B' ' 86' ' ' ARG . 53.7 mt -114.66 -179.84 3.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.2 m -149.68 170.86 17.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.282 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 1.096 HD11 HD23 ' B' ' 62' ' ' LEU . 47.8 mt -105.76 144.2 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.791 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.405 HG22 ' O ' ' B' ' 84' ' ' LEU . 38.1 t -123.18 89.35 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.41 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -116.28 177.8 4.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.361 -0.837 . . . . 0.0 110.163 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.442 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -88.54 175.0 7.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.12 -0.987 . . . . 0.0 109.785 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 5.7 t-20 -74.83 -135.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 110.263 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 4.4 t0 65.87 -146.89 0.21 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.712 -1.243 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -46.0 -28.39 1.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.169 -0.957 . . . . 0.0 111.022 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.784 ' CH2' HD22 ' B' ' 47' ' ' LEU . 65.8 t-105 -68.45 -52.06 36.75 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.273 -0.892 . . . . 0.0 109.804 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.79 -23.52 56.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 91.1 m -83.71 -67.16 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -1.173 . . . . 0.0 110.699 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.462 ' HB3' HD12 ' B' ' 47' ' ' LEU . . . -46.73 -49.03 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.188 -0.945 . . . . 0.0 111.046 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.866 ' HB3' HD13 ' B' ' 51' ' ' LEU . 4.4 mp -93.21 32.44 1.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.13 64.09 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.564 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -162.46 -68.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.047 . . . . 0.0 110.596 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.475 ' CE1' ' O ' ' B' ' 302' ' ' SAH . 13.0 m-85 -98.22 34.29 2.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.224 -0.922 . . . . 0.0 109.955 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.866 HD13 ' HB3' ' B' ' 47' ' ' LEU . 2.3 tp -101.51 116.66 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 111.145 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -89.05 103.79 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.184 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 33.8 t -90.82 139.88 30.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 111.526 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.415 ' NH2' ' O ' ' B' ' 82' ' ' ALA . 0.2 OUTLIER -122.2 -178.36 3.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.587 -0.696 . . . . 0.0 109.696 178.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.25 79.35 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 110.253 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 0.2 OUTLIER 162.71 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.694 -0.629 . . . . 0.0 109.88 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.67 -161.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.311 -0.868 . . . . 0.0 110.813 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.3 m -128.35 141.7 51.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.406 -0.809 . . . . 0.0 110.13 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -129.07 175.34 8.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.015 . . . . 0.0 110.955 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.559 ' CE ' HD23 ' B' ' 47' ' ' LEU . 1.3 tpt -114.47 167.34 10.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.807 . . . . 0.0 109.793 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.807 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -81.82 -38.74 25.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.155 -0.965 . . . . 0.0 110.56 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 1.096 HD23 HD11 ' B' ' 36' ' ' ILE 2.501 0.1 OUTLIER 76.7 -95.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 111.202 178.359 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -66.36 -128.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.44 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 96.6 m-85 -86.62 45.59 1.26 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -1.06 . . . . 0.0 110.788 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.807 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.39 -26.42 20.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' B' ' 302' ' ' SAH . . . -90.33 -35.73 15.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -1.093 . . . . 0.0 110.595 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.532 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.2 pp -46.97 -37.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.532 ' N ' HD12 ' B' ' 67' ' ' ILE . 29.1 m-85 -46.31 129.36 10.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.322 -0.861 . . . . 0.0 110.983 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -108.5 -177.32 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -93.27 124.63 37.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.3 m -145.36 157.25 44.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.39 26.08 2.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 110.499 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -157.22 67.73 4.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.907 ' O ' HD11 ' B' ' 92' ' ' ILE . 13.2 Cg_endo -60.47 110.3 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.727 1.383 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.468 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 3.1 m120 -89.91 -18.65 25.73 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.849 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -151.54 122.7 7.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.437 ' HB2' ' CG2' ' B' ' 92' ' ' ILE . 18.3 mtt180 -93.85 -171.17 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.327 -0.858 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.786 ' CE1' HD13 ' B' ' 103' ' ' ILE . 47.2 p-80 -130.48 150.49 51.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 110.257 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.447 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 4.4 tp10 -117.23 141.88 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' B' ' 84' ' ' LEU . 51.6 tp -114.5 131.12 56.74 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.17 -0.956 . . . . 0.0 110.238 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -54.9 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.329 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.415 ' O ' ' NH2' ' B' ' 54' ' ' ARG . . . -52.4 -23.32 5.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 110.345 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.48 -164.22 11.78 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.786 ' HA ' HD11 ' B' ' 80' ' ' LEU . 8.9 mt -102.9 42.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.32 -1.106 . . . . 0.0 110.144 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -93.46 -65.48 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 111.173 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.679 ' HG3' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -104.88 147.47 27.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.823 -178.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.11 156.87 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 110.127 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.448 ' HA ' ' CG ' ' B' ' 32' ' ' GLU . 0.4 OUTLIER -127.78 172.62 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.98 HD12 ' HB3' ' B' ' 31' ' ' GLU . 16.7 mt -145.99 91.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.52 -0.738 . . . . 0.0 109.964 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.91 ' CE2' HD23 ' B' ' 29' ' ' LEU . 2.4 m-85 -98.44 150.01 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.356 -0.84 . . . . 0.0 110.593 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.597 HG23 ' CG1' ' B' ' 30' ' ' VAL . 3.0 p -88.66 114.19 25.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.164 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.907 HD11 ' O ' ' B' ' 74' ' ' PRO . 13.7 pt -75.82 -13.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.666 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 8.3 ptpt -148.17 156.71 43.3 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.966 . . . . 0.0 110.039 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.82 124.42 15.34 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.676 1.356 . . . . 0.0 110.64 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' B' ' 75' ' ' ASN . 61.9 mt -111.4 145.64 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.365 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.92 156.61 17.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.389 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.889 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -59.91 111.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 32.16 1.78 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -114.29 170.49 8.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 110.236 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.41 ' OE2' ' CG2' ' B' ' 102' ' ' THR . 0.7 OUTLIER -110.29 139.88 45.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.957 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.961 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 41.5 mt -108.89 122.2 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 110.661 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.432 HG23 ' C ' ' B' ' 101' ' ' ILE . 57.4 p -149.7 143.73 25.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 109.631 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.786 HD13 ' CE1' ' B' ' 78' ' ' HIS . 1.0 OUTLIER -111.53 169.75 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.987 -1.071 . . . . 0.0 110.543 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.579 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -95.51 -168.89 1.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.487 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 109' ' ' TYR . 10.9 m-85 -123.12 -62.41 1.34 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.95 . . . . 0.0 109.936 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 70.15 -169.8 45.67 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 t70 64.89 -67.87 0.11 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.521 -0.987 . . . . 0.0 110.817 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -144.07 -39.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.053 -1.029 . . . . 0.0 110.757 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CB ' ' CB ' ' B' ' 105' ' ' TYR . 1.6 m-85 -47.45 107.14 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.491 ' N ' ' CD1' ' B' ' 110' ' ' TRP . 26.2 m95 53.18 -96.59 0.05 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.437 -0.789 . . . . 0.0 111.004 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' B' ' 114' ' ' PRO . 0.2 OUTLIER -91.69 -175.89 4.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.655 -1.278 . . . . 0.0 110.657 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.53 -47.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.377 -0.827 . . . . 0.0 110.194 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.78 57.98 14.99 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 110.278 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.632 ' HB3' HD22 ' B' ' 111' ' ' LEU . 19.1 Cg_endo -63.47 -24.94 70.51 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.685 1.36 . . . . 0.0 110.565 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.86 79.36 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.911 . . . . 0.0 110.387 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.565 HD23 ' H ' ' B' ' 117' ' ' THR . 0.2 OUTLIER -83.85 169.05 15.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.451 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.693 HG22 ' O ' ' B' ' 117' ' ' THR . 72.7 m 54.15 20.82 2.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.842 . . . . 0.0 110.598 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -174.77 150.59 1.32 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.933 -1.105 . . . . 0.0 110.433 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.371 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -116.18 -28.37 6.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -1.16 . . . . 0.0 110.363 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' D' ' 204' ' ' PRO . . . 52.49 63.36 8.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 110.428 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' D' ' 203' ' ' ALA . 24.6 Cg_exo -59.98 -39.08 73.91 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.662 1.348 . . . . 0.0 110.519 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -52.8 -72.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.439 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' D' ' 208' ' ' LEU . 0.7 OUTLIER -71.35 -154.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 0.0 110.384 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.59 -75.88 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.454 -0.779 . . . . 0.0 110.642 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' D' ' 206' ' ' LYS . 24.4 mt 53.17 -178.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.337 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -89.13 165.96 14.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.901 . . . . 0.0 110.508 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 5.8 t -169.64 159.5 8.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.365 -0.834 . . . . 0.0 110.15 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -166.92 127.51 1.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 110.52 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -133.36 111.4 10.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 110.205 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -161.12 -147.06 0.14 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 61.17 125.42 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 110.456 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.401 ' HG2' ' CD2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.499 2.2 t -60.96 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.396 -0.815 . . . . 0.0 110.521 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -154.81 150.4 21.45 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.26 175.23 3.44 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.633 1.333 . . . . 0.0 110.48 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -53.17 -64.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -0.952 . . . . 0.0 110.297 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . 0.559 HG22 ' O ' ' D' ' 220' ' ' THR . 99.1 m 52.35 64.09 1.99 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.447 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.886 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.594 ' O ' ' HB1' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.604 ' O ' ' HB1' ' B' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.29 0.567 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 10.8 p90 -50.09 140.58 12.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.182 -0.949 . . . . 0.0 110.713 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.52 143.57 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 110.292 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.6 -33.15 6.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.953 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -77.32 -44.13 30.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.519 HG13 ' C ' ' A' ' 5' ' ' ARG . 27.2 m -154.15 147.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 110.192 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 14.3 tt -114.81 166.1 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.907 . . . . 0.0 110.061 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.1 p -89.59 122.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.002 . . . . 0.0 110.896 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 41.8 mttt -150.03 128.86 12.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 3.0 mttt 51.44 40.11 25.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.718 -1.864 . . . . 0.0 109.879 6.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.415 ' HA ' ' HG2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -48.15 165.18 0.24 Allowed Pre-proline 0 N--CA 1.489 1.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.708 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 31.6 Cg_exo -54.53 -21.55 24.69 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.684 1.36 . . . . 0.0 110.257 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -93.21 -46.7 7.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 110.387 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.55 171.72 25.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 16' ' ' TYR . . . 116.59 -179.09 17.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 15' ' ' GLY . 37.5 m-85 -152.55 91.77 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.038 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.917 ' HA2' HG22 ' A' ' 67' ' ' ILE . . . -151.18 -169.25 16.67 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.499 HG12 HD12 ' A' ' 101' ' ' ILE . 87.2 t -100.81 124.13 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.031 -1.276 . . . . 0.0 109.616 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.521 ' CD1' ' CB ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -88.45 129.37 35.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.989 -1.07 . . . . 0.0 110.777 -178.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -97.22 85.27 3.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.557 -0.714 . . . . 0.0 110.082 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.848 ' O ' HG23 ' A' ' 97' ' ' ILE . 4.7 mtp180 -56.09 -25.13 44.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.0 109.485 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' HB2' ' CD2' ' A' ' 24' ' ' PHE . 5.1 mtpp -84.63 -179.72 7.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.459 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 7.0 m 100.36 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.054 -1.654 . . . . 0.0 110.038 2.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 22' ' ' LYS . 16.1 m-85 -107.63 142.79 37.02 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.75 171.07 9.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.091 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 18.7 tttt -67.04 100.81 0.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.45 -20.75 11.02 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.57 123.69 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -1.179 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.845 HD21 ' HB3' ' A' ' 88' ' ' ARG . 1.2 tm? -65.99 113.65 4.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 110.236 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.523 HG23 HG23 ' A' ' 91' ' ' THR . 99.4 t -72.04 -53.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 89' ' ' ILE . 5.3 tt0 -174.14 144.44 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.25 157.98 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.445 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.1 p -150.56 -171.82 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 110.651 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 54.7 mt -100.61 167.65 10.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.783 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.7 m -145.15 161.59 39.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 110.595 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.793 HD11 HD23 ' A' ' 62' ' ' LEU . 55.1 mt -92.16 148.26 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 83' ' ' GLY . 42.7 t -124.0 90.45 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.168 -0.957 . . . . 0.0 110.659 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 36' ' ' ILE . 39.8 mmt180 -117.93 168.43 10.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 0.0 110.336 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -87.08 -176.27 5.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.068 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 26.2 m120 -72.24 -137.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 4.0 t0 65.97 -148.09 0.21 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.74 -1.225 . . . . 0.0 110.541 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' B' ' 42' ' ' ASP . 26.9 m-20 -46.27 -34.74 4.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.243 -0.91 . . . . 0.0 111.109 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.891 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 60.6 t-105 -52.88 -57.21 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.029 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -60.34 -31.31 73.47 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.97 -65.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -1.172 . . . . 0.0 110.522 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.52 -51.22 70.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 110.14 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.006 HD12 ' CE ' ' A' ' 60' ' ' MET . 3.6 mm? -91.74 34.03 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.686 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 1.9 tm-20 -56.31 -17.54 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 111.365 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.89 156.47 19.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.913 -1.117 . . . . 0.0 110.966 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' CE1' ' OXT' ' A' ' 301' ' ' SAH . 7.0 m-30 55.25 26.29 8.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.854 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.891 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 10.5 tp -108.71 105.88 15.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.867 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -89.11 105.32 17.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.429 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 3.1 t -105.39 147.52 28.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.2 -0.938 . . . . 0.0 110.915 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.966 ' HG2' HD11 ' A' ' 84' ' ' LEU . 10.4 ptm180 -115.13 -167.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.8 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.73 77.62 9.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.075 -1.016 . . . . 0.0 109.264 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.499 3.0 t30 166.02 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.892 -0.505 . . . . 0.0 109.902 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -176.98 -164.44 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.947 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.414 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 6.2 t -130.2 141.05 50.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.459 -0.776 . . . . 0.0 110.286 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.553 ' HB3' HD22 ' A' ' 84' ' ' LEU . . . -132.71 149.42 52.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 110.626 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 1.006 ' CE ' HD12 ' A' ' 47' ' ' LEU . 32.9 tpp -93.24 155.91 17.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.52 92.1 8.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.704 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.793 HD23 HD11 ' A' ' 36' ' ' ILE 2.506 0.1 OUTLIER -52.19 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.35 -0.844 . . . . 0.0 110.895 -178.605 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -61.05 -155.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.697 ' HB3' HD13 ' A' ' 67' ' ' ILE . 31.6 m-85 -90.16 54.12 2.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.132 . . . . 0.0 111.152 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA2' ' CE2' ' A' ' 68' ' ' PHE . . . -92.83 -15.52 52.08 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.569 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -91.72 4.37 52.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.894 -1.356 . . . . 0.0 112.355 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.917 HG22 ' HA2' ' A' ' 17' ' ' GLY . 3.8 mp -88.56 -20.75 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.716 -1.24 . . . . 0.0 110.829 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 65' ' ' GLY . 23.1 m-85 -52.43 143.6 14.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.89 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -112.4 -159.67 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.525 ' CE1' ' CD2' ' A' ' 111' ' ' LEU . 57.7 t60 -102.01 136.12 42.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.405 -0.81 . . . . 0.0 109.414 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' ASP . 1.8 m -152.06 35.45 0.53 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.027 -1.045 . . . . 0.0 110.567 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 mmtp 58.11 -82.63 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.542 -0.724 . . . . 0.0 110.273 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' SER . 4.5 m-20 -99.33 91.78 1.55 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.804 ' O ' HD11 ' A' ' 92' ' ' ILE . 11.5 Cg_endo -58.04 106.56 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.564 1.297 . . . . 0.0 110.524 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 71.6 m-80 -50.48 -23.8 2.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.619 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.859 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -142.71 159.56 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.995 . . . . 0.0 110.426 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.47 ' NH2' ' NE2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -136.99 -173.89 3.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.195 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.47 ' NE2' ' NH2' ' A' ' 77' ' ' ARG . 7.5 p-80 -119.74 172.71 7.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -142.35 155.07 45.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.722 HD12 ' HD2' ' C' ' 218' ' ' PRO . 19.8 mt -123.38 143.36 50.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 110.371 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.455 HG22 ' NH2' ' A' ' 88' ' ' ARG . 20.4 p -72.93 -66.47 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.354 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.88 -35.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 110.524 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 37' ' ' VAL . . . -106.66 26.66 19.03 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.966 HD11 ' HG2' ' A' ' 54' ' ' ARG . 34.6 mt 51.73 28.84 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.605 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.22 -36.25 10.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 110.76 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.87 135.8 54.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 110.691 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.9 mtp -126.85 116.72 21.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 110.199 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.845 ' HB3' HD21 ' A' ' 29' ' ' LEU . 45.2 mtt180 -101.35 131.92 47.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -89.25 98.65 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.022 . . . . 0.0 109.591 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.844 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 13.9 m-85 -89.76 -169.29 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.547 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.523 HG23 HG23 ' A' ' 30' ' ' VAL . 26.9 p -132.57 98.43 4.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.083 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 74' ' ' PRO . 33.7 pt -54.54 -22.18 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.106 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -146.72 161.23 38.55 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 26' ' ' LYS . 34.1 Cg_exo -53.74 156.57 11.65 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.635 1.334 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 24' ' ' PHE . 59.2 mt -138.55 134.91 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 109.944 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.3 167.86 10.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.823 . . . . 0.0 110.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -64.53 119.68 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 110.341 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.63 30.75 5.73 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.19 141.06 36.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.113 -1.228 . . . . 0.0 110.325 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' OE1' HG21 ' A' ' 102' ' ' THR . 1.3 tm-20 -88.39 121.39 30.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.94 -1.1 . . . . 0.0 109.674 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 76' ' ' ALA . 60.6 mt -89.11 123.59 41.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.451 -0.78 . . . . 0.0 110.586 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.497 ' C ' HG23 ' A' ' 103' ' ' ILE . 73.2 p -145.46 -176.71 5.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.497 HG23 ' C ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -151.74 160.31 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 0.0 110.384 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.54 -173.05 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.502 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 109' ' ' TYR . 13.0 m-85 -125.51 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 109.86 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 71.5 -160.29 54.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.94 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.52 -0.988 . . . . 0.0 110.692 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -129.44 -35.54 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.994 -1.067 . . . . 0.0 110.706 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.465 ' CB ' ' HB3' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -48.66 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.93 . . . . 0.0 110.928 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.476 ' O ' ' CD2' ' A' ' 110' ' ' TRP . 54.8 p-90 -54.07 120.52 6.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' CD2' ' CE1' ' A' ' 70' ' ' HIS . 6.7 tp -83.74 -148.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.918 . . . . 0.0 110.759 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.497 ' HB2' ' CD2' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -117.61 82.48 1.83 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -178.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 2.7 ttt85 51.85 52.36 11.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.503 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 113' ' ' ARG . 18.2 Cg_endo -65.85 -62.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.643 1.338 . . . . 0.0 110.557 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.94 -73.59 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.41 -0.806 . . . . 0.0 110.328 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 116' ' ' LEU . 4.4 mm? 53.22 42.25 32.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.48 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.7 m -59.27 157.6 10.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 110.315 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 47.48 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.419 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.357 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.86 -38.74 6.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -1.175 . . . . 0.0 110.381 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -122.97 153.47 64.07 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.0 110.433 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -65.67 125.65 14.7 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.691 1.363 . . . . 0.0 110.546 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -94.14 157.05 16.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 110.369 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 -40.63 2.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 110.39 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -76.13 165.62 24.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.32 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.0 mt -148.59 165.05 32.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.432 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.51 116.93 31.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 110.443 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 10.1 p -104.17 -32.56 9.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 110.287 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.48 177.31 6.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 110.321 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.75 -169.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 0.0 110.485 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . 0.427 ' HA ' ' CB ' ' A' ' 108' ' ' ASP . . . 52.86 64.4 1.87 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.342 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.429 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 3.8 mmp_? -106.3 -170.62 1.75 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 110.366 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.6 p -53.87 173.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.355 -0.841 . . . . 0.0 110.321 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -150.09 165.59 17.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 110.328 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.722 ' HD2' HD12 ' A' ' 80' ' ' LEU . 17.6 Cg_endo -62.16 -177.87 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.675 1.355 . . . . 0.0 110.452 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.84 79.53 0.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.331 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 2.0 p -147.35 60.69 1.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 110.372 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.215 0.531 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 10.9 p90 -49.97 140.55 12.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.707 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -143.45 143.69 31.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -47.69 -33.24 6.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.363 -0.836 . . . . 0.0 110.894 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.534 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -77.25 -44.19 30.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.534 HG13 ' C ' ' B' ' 5' ' ' ARG . 27.1 m -154.04 147.43 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 14.3 tt -114.77 165.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 110.102 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.56 HG13 ' O ' ' B' ' 8' ' ' VAL . 7.1 p -89.4 122.28 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 110.969 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.562 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 42.1 mttt -150.13 129.17 12.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.562 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 3.0 mttt 51.8 40.01 26.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.511 -1.993 . . . . 0.0 109.889 6.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -48.18 165.29 0.24 Allowed Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.696 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.406 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 31.2 Cg_exo -54.58 -21.56 25.0 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.678 1.357 . . . . 0.0 110.235 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' B' ' 13' ' ' LEU . 0.4 OUTLIER -93.14 -46.74 7.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 110.369 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.54 171.67 25.68 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' B' ' 16' ' ' TYR . . . 116.63 -179.05 17.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' B' ' 15' ' ' GLY . 37.3 m-85 -152.5 91.58 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.913 ' HA2' HG22 ' B' ' 67' ' ' ILE . . . -151.03 -169.15 16.43 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.514 HG12 HD12 ' B' ' 101' ' ' ILE . 88.5 t -100.93 123.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.068 -1.254 . . . . 0.0 109.71 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.528 ' CD1' ' CB ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -87.35 129.37 35.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.015 . . . . 0.0 110.94 -178.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.814 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -97.31 85.25 3.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.438 -0.789 . . . . 0.0 110.13 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 4.7 mtp180 -56.03 -25.09 43.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -0.892 . . . . 0.0 109.545 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CD2' ' B' ' 24' ' ' PHE . 5.2 mtpp -84.6 -179.62 7.17 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.464 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.513 6.8 m 100.46 13.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.041 -1.662 . . . . 0.0 109.98 2.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' B' ' 22' ' ' LYS . 16.3 m-85 -107.59 142.63 37.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.195 -0.94 . . . . 0.0 110.275 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -89.48 171.08 9.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -67.05 100.85 0.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 110.153 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.43 -20.87 10.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.62 123.74 11.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -1.163 . . . . 0.0 110.547 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.856 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.2 tm? -66.02 113.65 4.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.527 HG23 HG23 ' B' ' 91' ' ' THR . 99.5 t -72.03 -53.14 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 110.184 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.421 ' O ' HD12 ' B' ' 89' ' ' ILE . 5.3 tt0 -174.14 144.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.332 -0.855 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.26 158.19 34.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 110.406 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.444 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.1 p -150.81 -171.96 4.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 54.9 mt -100.53 167.7 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 95.2 m -145.19 161.56 39.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.058 -1.026 . . . . 0.0 110.524 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.781 HD11 HD23 ' B' ' 62' ' ' LEU . 54.9 mt -92.06 148.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.546 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 83' ' ' GLY . 42.9 t -124.02 90.5 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.95 . . . . 0.0 110.604 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.503 ' HG2' HG22 ' B' ' 36' ' ' ILE . 39.8 mmt180 -117.96 168.43 10.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -87.07 -176.31 5.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.883 . . . . 0.0 110.167 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.22 -137.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.976 . . . . 0.0 110.148 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 66.07 -148.11 0.21 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.805 -1.184 . . . . 0.0 110.547 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 26.9 m-20 -46.26 -34.78 4.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.219 -0.926 . . . . 0.0 111.123 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.889 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 60.8 t-105 -52.81 -57.22 10.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 0.0 110.077 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.416 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -60.36 -31.3 73.52 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -68.93 -65.19 0.73 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.548 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.61 -50.54 73.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 0.0 110.256 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 1.008 HD12 ' CE ' ' B' ' 60' ' ' MET . 3.6 mm? -92.79 34.41 1.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 110.465 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.416 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 1.9 tm-20 -56.53 -17.59 8.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.049 -1.032 . . . . 0.0 111.299 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.76 156.44 19.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.971 -1.081 . . . . 0.0 111.073 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 7.0 m-30 55.28 26.36 8.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.475 -0.766 . . . . 0.0 110.775 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.889 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 10.6 tp -108.79 105.51 15.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 110.937 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' B' ' 52' ' ' PHE . 42.4 m-85 -88.56 105.27 17.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.3 -0.875 . . . . 0.0 109.537 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 3.1 t -105.4 147.51 28.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.152 -0.967 . . . . 0.0 110.907 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.975 ' HG2' HD11 ' B' ' 84' ' ' LEU . 10.3 ptm180 -115.66 -170.07 1.71 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 110.109 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.55 77.21 5.03 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.242 -0.911 . . . . 0.0 110.226 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.505 3.1 t30 165.94 -29.21 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.679 -0.638 . . . . 0.0 109.935 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.83 -164.15 0.1 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 110.934 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.402 ' OG ' ' NE1' ' B' ' 43' ' ' TRP . 6.2 t -130.27 141.09 50.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 110.241 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.565 ' HB3' HD22 ' B' ' 84' ' ' LEU . . . -132.78 149.43 52.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.637 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 1.008 ' CE ' HD12 ' B' ' 47' ' ' LEU . 32.9 tpp -93.48 154.84 17.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.94 . . . . 0.0 110.215 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.07 92.05 8.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.995 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.781 HD23 HD11 ' B' ' 36' ' ' ILE 2.505 0.1 OUTLIER -52.29 -70.19 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.949 -178.734 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -60.97 -155.15 0.03 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.694 ' HB3' HD13 ' B' ' 67' ' ' ILE . 31.6 m-85 -90.22 55.38 3.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -1.119 . . . . 0.0 111.053 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' CE2' ' B' ' 68' ' ' PHE . . . -94.92 -13.82 51.64 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.185 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.438 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -93.2 4.86 53.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.933 -1.334 . . . . 0.0 112.096 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.913 HG22 ' HA2' ' B' ' 17' ' ' GLY . 3.8 mp -88.76 -20.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.691 -1.256 . . . . 0.0 110.817 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.489 ' CE1' HG21 ' B' ' 18' ' ' VAL . 23.0 m-85 -52.43 143.62 14.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 110.917 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -112.33 -159.43 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.192 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.527 ' CE1' ' CD2' ' B' ' 111' ' ' LEU . 57.4 t60 -102.42 136.12 42.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.358 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . 0.455 ' O ' ' N ' ' B' ' 73' ' ' ASP . 1.8 m -152.01 35.51 0.54 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.085 -1.009 . . . . 0.0 110.646 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' B' ' 74' ' ' PRO . 1.6 mmtp 58.11 -82.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.428 -0.795 . . . . 0.0 110.288 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' B' ' 71' ' ' SER . 4.5 m-20 -99.38 91.85 1.59 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.235 -0.916 . . . . 0.0 109.789 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.823 ' O ' HD11 ' B' ' 92' ' ' ILE . 11.4 Cg_endo -58.07 106.66 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.616 1.324 . . . . 0.0 110.476 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' B' ' 93' ' ' LYS . 71.6 m-80 -50.59 -23.76 2.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.593 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.851 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -142.73 159.53 42.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 110.442 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.462 ' NH2' ' NE2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -136.95 -173.85 3.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 110.177 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.462 ' NE2' ' NH2' ' B' ' 77' ' ' ARG . 7.5 p-80 -119.71 172.62 7.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 110.618 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -142.28 155.19 45.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.167 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.725 HD12 ' HD2' ' D' ' 218' ' ' PRO . 19.8 mt -123.38 143.34 50.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 110.428 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.464 HG22 ' NH2' ' B' ' 88' ' ' ARG . 20.3 p -73.0 -66.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 110.337 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.91 -35.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.483 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.443 ' O ' HG21 ' B' ' 37' ' ' VAL . . . -106.66 26.6 19.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.975 HD11 ' HG2' ' B' ' 54' ' ' ARG . 34.7 mt 51.82 28.79 5.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -1.182 . . . . 0.0 110.631 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -98.32 -36.15 10.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.84 135.76 54.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.705 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 13.0 mtp -126.78 116.69 21.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 110.258 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.821 ' HB3' HD21 ' B' ' 29' ' ' LEU . 45.2 mtt180 -101.49 131.53 47.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 110.397 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.421 HD12 ' O ' ' B' ' 31' ' ' GLU . 12.3 mt -88.68 98.44 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.856 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 14.0 m-85 -89.57 -169.24 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.527 HG23 HG23 ' B' ' 30' ' ' VAL . 26.7 p -132.62 98.42 4.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 110.087 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.823 HD11 ' O ' ' B' ' 74' ' ' PRO . 33.6 pt -54.6 -22.15 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -146.72 161.23 38.51 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.18 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -53.77 156.51 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.6 1.316 . . . . 0.0 110.823 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 76' ' ' ALA . 59.2 mt -138.49 134.99 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.35 167.93 10.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -64.51 119.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.59 30.79 5.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -104.36 140.41 37.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -1.22 . . . . 0.0 110.365 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.419 ' OE1' HG21 ' B' ' 102' ' ' THR . 1.3 tm-20 -87.49 121.08 29.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.01 -1.056 . . . . 0.0 109.946 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.851 HG23 ' HB3' ' B' ' 76' ' ' ALA . 60.6 mt -88.62 123.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.402 -0.811 . . . . 0.0 110.79 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.516 ' C ' HG23 ' B' ' 103' ' ' ILE . 72.0 p -145.55 -176.69 5.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.708 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.516 HG23 ' C ' ' B' ' 102' ' ' THR . 1.0 OUTLIER -151.67 160.27 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.05 -1.031 . . . . 0.0 110.356 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 22.9 t -94.5 -173.02 2.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.461 ' HB3' ' CB ' ' B' ' 109' ' ' TYR . 13.0 m-85 -125.53 -64.49 1.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.339 -0.851 . . . . 0.0 109.855 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 71.45 -160.27 54.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.96 -85.72 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -1.0 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.43 ' CB ' ' HA ' ' D' ' 213' ' ' ALA . 0.2 OUTLIER -129.43 -35.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 110.742 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.461 ' CB ' ' HB3' ' B' ' 105' ' ' TYR . 0.5 OUTLIER -48.67 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.929 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.469 ' O ' ' CD2' ' B' ' 110' ' ' TRP . 54.8 p-90 -54.02 120.54 6.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' B' ' 70' ' ' HIS . 6.7 tp -83.72 -148.94 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.761 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.505 ' HB2' ' CD2' ' B' ' 70' ' ' HIS . 0.1 OUTLIER -117.68 82.53 1.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.025 . . . . 0.0 110.57 -178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 2.7 ttt85 51.92 52.32 11.27 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 110.464 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 18.2 Cg_endo -65.82 -62.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.677 1.356 . . . . 0.0 110.577 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.85 -73.58 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.383 -0.823 . . . . 0.0 110.364 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.477 HD13 ' HA ' ' B' ' 116' ' ' LEU . 4.4 mm? 53.18 42.34 32.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 110.466 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 35.2 m -59.28 157.59 10.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 110.301 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 47.52 0.87 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.36 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.9 -38.69 6.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -1.121 . . . . 0.0 110.378 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -122.96 153.48 64.06 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.394 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.74 125.7 14.75 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.721 1.38 . . . . 0.0 110.526 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 -94.21 157.04 16.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.319 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -40.6 2.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -0.872 . . . . 0.0 110.353 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -76.13 165.61 24.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.334 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 3.0 mt -148.53 165.07 32.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.44 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -111.55 116.91 31.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.303 -0.873 . . . . 0.0 110.414 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 10.0 p -104.17 -32.53 9.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 110.25 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.45 177.28 6.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.333 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.82 -169.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 110.424 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' B' ' 108' ' ' ASP . . . 52.85 64.41 1.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 110.35 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' B' ' 53' ' ' SER . 3.8 mmp_? -106.36 -170.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.927 . . . . 0.0 110.335 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 2.6 p -53.78 173.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 110.391 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -150.08 165.56 17.22 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.342 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.725 ' HD2' HD12 ' B' ' 80' ' ' LEU . 17.3 Cg_endo -62.21 -177.88 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.601 1.316 . . . . 0.0 110.458 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.9 79.53 0.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 110.323 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 2.1 p -147.36 60.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 110.444 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.492 ' OXT' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.492 ' OXT' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' SD ' HG11 ' A' ' 8' ' ' VAL . 3.0 mmt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.236 0.541 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 41.3 p90 -166.13 128.56 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 110.345 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ARG . 12.8 p30 -119.39 167.0 12.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.358 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.67 64.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.372 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.538 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 177.89 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 0.0 109.623 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG23 ' C ' ' A' ' 5' ' ' ARG . 96.4 t -153.55 158.97 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.445 -0.785 . . . . 0.0 110.138 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.738 HG23 ' HB2' ' A' ' 19' ' ' PHE . 5.1 tt -134.95 158.94 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.442 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' A' ' 10' ' ' LYS . 61.7 t -99.24 114.71 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 110.795 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 14.1 mttt -127.6 141.68 51.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.614 ' HE2' HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 52.4 56.65 7.39 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 119.821 -1.799 . . . . 0.0 110.196 2.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -108.66 175.51 1.94 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.596 -0.69 . . . . 0.0 110.263 -179.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -68.18 -20.92 42.92 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.7 1.369 . . . . 0.0 110.432 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.57 56.12 0.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.881 . . . . 0.0 110.408 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.4 -146.13 4.36 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.67 -162.46 9.85 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.511 ' CZ ' ' HD3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -77.9 59.13 2.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 110.299 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 67' ' ' ILE . . . -105.13 -165.59 23.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.3 p -114.03 131.54 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.903 -1.351 . . . . 0.0 109.502 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -88.57 141.77 28.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.363 -0.835 . . . . 0.0 110.602 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.763 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -93.58 93.54 8.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.699 -0.626 . . . . 0.0 110.706 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -65.63 -15.75 63.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 0.0 109.877 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 6.7 mttt -108.61 179.05 4.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.512 20.1 m 102.25 21.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.012 -1.68 . . . . 0.0 109.727 2.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 17.5 m-85 -114.6 161.47 18.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 110.637 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.37 170.95 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 11.3 tttm -72.53 88.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.91 52.15 0.21 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.18 136.57 52.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.76 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 2.0 tm? -67.09 117.29 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 110.211 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.724 ' CG2' HG23 ' A' ' 91' ' ' THR . 38.3 t -98.53 85.42 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.32 -0.863 . . . . 0.0 109.563 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.508 ' O ' HD11 ' A' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.62 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 110.304 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.402 ' OE1' ' HG2' ' A' ' 88' ' ' ARG . 18.4 tt0 -154.13 160.53 41.96 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.011 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 1.062 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 26.7 p -150.75 160.96 43.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 111.072 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.9 mt -96.65 176.78 5.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.872 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' CG ' ' A' ' 87' ' ' MET . 83.8 m -149.25 166.39 29.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.022 -1.049 . . . . 0.0 111.356 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.017 HD11 HD23 ' A' ' 62' ' ' LEU . 48.4 mt -103.13 154.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.972 HG13 HD23 ' A' ' 84' ' ' LEU . 41.2 t -131.17 118.49 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.893 -1.129 . . . . 0.0 110.641 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 29.7 mmt180 -136.79 147.77 46.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.58 58.78 2.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 111.297 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 1.9 t-20 49.8 -141.31 0.7 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 111.019 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 44' ' ' GLY . 2.3 t70 67.35 -144.8 0.14 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.036 -1.04 . . . . 0.0 110.169 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.13 -35.85 12.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.935 -1.103 . . . . 0.0 110.297 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.737 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 17.2 t-105 -63.73 -34.61 78.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 109.129 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -62.43 -60.38 7.94 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 54.6 m -66.17 -45.84 79.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.19 -1.182 . . . . 0.0 110.666 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.65 -62.0 2.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 0.0 109.1 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.719 HD21 ' CE3' ' B' ' 43' ' ' TRP . 4.3 mm? -93.19 36.27 1.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.471 -0.768 . . . . 0.0 110.795 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.454 ' CA ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -69.4 61.71 0.14 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.093 -1.004 . . . . 0.0 110.325 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 178.78 145.36 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.487 -0.758 . . . . 0.0 109.015 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 11.2 m-85 57.35 26.72 12.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.918 -1.113 . . . . 0.0 109.31 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.737 HD11 ' CZ2' ' A' ' 43' ' ' TRP . 3.1 tp -107.86 112.93 25.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 111.285 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HA ' ' HB3' ' C' ' 215' ' ' MLZ . 74.1 m-85 -89.4 108.44 19.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.322 -0.861 . . . . 0.0 109.161 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.455 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 23.2 t -107.39 143.91 35.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.509 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.637 ' HG2' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -118.86 -165.62 1.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.522 -0.736 . . . . 0.0 109.781 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 75.4 8.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.967 -1.083 . . . . 0.0 109.363 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.86 -35.14 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.507 -179.609 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 179.95 -174.6 0.27 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.591 -0.693 . . . . 0.0 110.324 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.464 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 26.0 p -111.95 134.89 53.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.336 -0.852 . . . . 0.0 110.432 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.9 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -117.12 174.44 6.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.674 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -120.35 160.09 23.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.089 -1.007 . . . . 0.0 110.788 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -89.09 99.13 12.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 0.0 110.226 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 36' ' ' ILE 2.497 0.1 OUTLIER -58.4 -81.11 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.86 . . . . 0.0 110.922 -179.437 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.3 -130.44 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -89.88 45.84 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 110.769 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' CA ' ' HB1' ' A' ' 61' ' ' ALA . . . -90.5 -20.67 40.2 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . . . -90.69 -43.56 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.45 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 1.3 pp -48.97 -25.64 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.213 -0.929 . . . . 0.0 110.367 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CE1' HG11 ' A' ' 18' ' ' VAL . 9.2 m-85 -48.96 144.99 4.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 110.638 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' CG2' ' A' ' 102' ' ' THR . 73.1 m-80 -118.65 174.69 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.569 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.577 ' CE1' ' CE2' ' A' ' 110' ' ' TRP . 1.8 t-160 -101.54 109.52 21.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.07 146.67 48.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.44 127.54 32.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 110.225 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.78 71.0 1.57 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.952 . . . . 0.0 110.255 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.532 ' O ' HD11 ' A' ' 92' ' ' ILE . 12.9 Cg_endo -60.65 174.25 1.74 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.663 1.349 . . . . 0.0 110.595 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 93' ' ' LYS . 17.5 p30 -117.66 -13.12 10.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.322 -0.861 . . . . 0.0 110.569 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.05 143.96 51.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 110.234 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.06 166.93 13.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -0.933 . . . . 0.0 110.081 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.21 158.99 17.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.731 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 19.6 tt0 -132.94 136.68 46.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 110.147 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.564 HD12 ' HD2' ' C' ' 218' ' ' PRO . 6.1 mt -114.6 145.13 42.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.037 -1.039 . . . . 0.0 110.419 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 86' ' ' ARG . 14.2 p -53.93 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 110.396 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.38 -60.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.66 42.81 1.86 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.972 HD23 HG13 ' A' ' 37' ' ' VAL . 4.4 tp 59.25 115.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.298 -1.119 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -177.2 -81.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 110.084 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.582 ' O ' HG23 ' A' ' 81' ' ' THR . 1.3 mpt_? -113.3 140.1 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.756 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 1.062 ' SD ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 ppp? -137.24 169.85 17.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.113 -0.992 . . . . 0.0 110.666 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.734 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -131.37 -179.74 5.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.346 -0.846 . . . . 0.0 110.637 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.403 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 6.5 mt -130.21 108.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 0.0 109.646 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.76 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 51.8 m-85 -97.2 -170.68 2.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.724 HG23 ' CG2' ' A' ' 30' ' ' VAL . 23.1 p -128.35 98.95 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.532 HD11 ' O ' ' A' ' 74' ' ' PRO . 48.5 pt -60.06 -16.58 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 110.696 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 75' ' ' ASN . 1.1 ptpm? -148.69 156.94 41.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.96 142.86 93.61 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.582 1.306 . . . . 0.0 110.379 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.614 HG23 ' HG3' ' A' ' 99' ' ' GLU . 54.4 mt -124.33 141.97 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 110.671 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.76 153.66 20.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 110.882 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.8 mp -48.25 -24.87 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.46 -0.775 . . . . 0.0 111.313 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.34 60.68 0.32 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 95' ' ' ILE . 3.3 mm-40 -116.28 165.05 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 111.274 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.19 115.56 29.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.915 ' HB ' HG13 ' A' ' 18' ' ' VAL . 58.5 mt -88.79 127.49 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 101' ' ' ILE . 16.3 p -155.55 148.41 24.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 104' ' ' SER . 1.3 pp -115.91 155.32 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 0.0 110.749 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.543 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -90.61 -173.95 3.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.867 . . . . 0.0 110.06 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.522 ' CD2' ' ND1' ' A' ' 70' ' ' HIS . 9.0 m-85 -123.63 -66.36 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.988 . . . . 0.0 110.093 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.43 -175.28 44.37 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.71 -33.28 68.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -1.166 . . . . 0.0 110.377 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -72.82 -66.95 0.6 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.366 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.443 ' CD2' ' HG2' ' C' ' 215' ' ' MLZ . 0.2 OUTLIER -68.48 71.93 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.92 . . . . 0.0 110.493 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.577 ' CE2' ' CE1' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -153.82 -156.15 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.441 179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.28 -71.21 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 110.593 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.37 -79.57 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 0.0 110.701 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.45 61.5 13.72 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.582 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.07 -40.3 2.6 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.597 1.314 . . . . 0.0 110.6 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 54.97 19.85 2.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.34 -0.85 . . . . 0.0 110.754 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER 47.2 39.42 8.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 111.098 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.7 m -132.16 -69.54 0.59 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 110.514 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.18 57.8 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.388 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 60.51 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -1.12 . . . . 0.0 110.311 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' C' ' 204' ' ' PRO . . . -92.85 144.48 28.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.923 . . . . 0.0 110.48 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' C' ' 203' ' ' ALA . 25.0 Cg_exo -59.25 -33.52 97.97 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.651 1.343 . . . . 0.0 110.582 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 53.31 84.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 0.0 110.331 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.12 111.73 7.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 110.398 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 53.7 176.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.289 -0.882 . . . . 0.0 110.45 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.98 178.47 6.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.176 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.77 -54.03 49.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.943 . . . . 0.0 110.293 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 7.6 m 52.59 52.96 13.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.453 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -60.36 -67.03 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 110.321 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -174.88 79.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.33 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -149.27 91.84 1.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.391 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.455 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 2.1 tpp180 -77.12 -148.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.274 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.443 ' HG2' ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 3.4 p -52.55 176.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 110.392 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -160.63 167.99 12.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.927 . . . . 0.0 110.39 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 17.6 Cg_endo -59.36 -43.8 37.94 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.734 1.386 . . . . 0.0 110.425 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.33 82.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 110.477 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -101.85 160.56 14.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.424 ' SD ' HG11 ' B' ' 8' ' ' VAL . 3.0 mmt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.295 0.569 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.427 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 41.5 p90 -166.15 128.63 1.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.345 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 12.7 p30 -119.4 167.01 12.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 110.373 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.71 64.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 110.345 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.531 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.0 OUTLIER 177.87 -33.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.39 -0.819 . . . . 0.0 109.639 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.531 HG23 ' C ' ' B' ' 5' ' ' ARG . 96.6 t -153.45 159.03 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 110.1 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.733 HG23 ' HB2' ' B' ' 19' ' ' PHE . 5.1 tt -134.98 158.9 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.412 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.611 HG12 ' HE2' ' B' ' 10' ' ' LYS . 62.0 t -99.27 114.81 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.55 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 14.1 mttt -127.72 141.83 51.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.611 ' HE2' HG12 ' B' ' 8' ' ' VAL . 0.3 OUTLIER 52.59 56.59 7.43 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 119.777 -1.827 . . . . 0.0 110.13 1.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.478 ' HB2' ' CZ ' ' B' ' 19' ' ' PHE . 0.0 OUTLIER -108.68 175.51 1.94 Allowed Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.554 -0.716 . . . . 0.0 110.304 -179.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -68.22 -20.87 42.72 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.637 1.335 . . . . 0.0 110.457 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.59 56.18 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 110.385 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.44 -146.09 4.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . -134.72 -162.42 9.82 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.505 ' CZ ' ' HD3' ' B' ' 10' ' ' LYS . 0.2 OUTLIER -77.7 59.42 2.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 110.353 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' B' ' 67' ' ' ILE . . . -105.63 -165.73 23.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.952 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.4 p -113.95 130.83 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.927 -1.337 . . . . 0.0 109.637 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.733 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.4 OUTLIER -87.71 141.86 28.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.835 . . . . 0.0 110.773 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.747 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -93.71 93.54 8.06 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.861 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.1 OUTLIER -65.64 -15.62 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.914 178.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 6.7 mttt -108.68 179.01 4.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 108.757 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.456 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 20.1 m 102.25 20.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.064 -1.648 . . . . 0.0 109.757 2.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 17.5 m-85 -114.52 161.51 17.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 110.685 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.48 170.97 8.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.391 -0.818 . . . . 0.0 109.964 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -72.5 88.76 1.24 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 110.432 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.85 52.2 0.21 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.22 136.58 52.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.759 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 2.0 tm? -67.14 117.38 9.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.73 ' CG2' HG23 ' B' ' 91' ' ' THR . 38.4 t -98.58 85.43 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.577 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.502 ' O ' HD11 ' B' ' 29' ' ' LEU . 0.9 OUTLIER 58.42 -177.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.708 -0.62 . . . . 0.0 110.256 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' B' ' 87' ' ' MET . 18.5 tt0 -154.11 160.8 42.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 1.071 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 26.7 p -151.08 160.9 43.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 111.031 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.67 176.73 5.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.301 -0.874 . . . . 0.0 109.851 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -149.16 166.42 28.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.079 . . . . 0.0 111.369 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 1.008 HD11 HD23 ' B' ' 62' ' ' LEU . 48.2 mt -103.12 154.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.973 HG13 HD23 ' B' ' 84' ' ' LEU . 41.6 t -131.16 118.47 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.972 -1.08 . . . . 0.0 110.586 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.548 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 29.6 mmt180 -136.78 147.76 46.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.218 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -79.48 58.71 2.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.908 . . . . 0.0 111.317 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 1.9 t-20 49.79 -141.33 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.127 -0.983 . . . . 0.0 111.085 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 2.3 t70 67.43 -144.9 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.022 -1.049 . . . . 0.0 110.116 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -48.11 -35.83 12.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.9 -1.125 . . . . 0.0 110.272 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.725 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 17.1 t-105 -63.77 -34.58 78.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 0.0 109.154 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -62.42 -60.44 7.86 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' B' ' 48' ' ' GLU . 54.1 m -65.88 -46.04 79.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -1.197 . . . . 0.0 110.64 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.414 ' O ' ' NH2' ' A' ' 38' ' ' ARG . . . -57.02 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.885 -1.135 . . . . 0.0 109.276 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.737 HD21 ' CE3' ' A' ' 43' ' ' TRP . 4.4 mm? -94.98 36.96 1.16 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.444 ' CA ' ' O ' ' B' ' 44' ' ' GLY . 0.1 OUTLIER -69.66 61.68 0.16 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -0.953 . . . . 0.0 110.274 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.477 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.9 OUTLIER 178.73 145.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 11.1 m-85 57.37 26.7 12.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.923 -1.111 . . . . 0.0 109.287 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.725 HD11 ' CZ2' ' B' ' 43' ' ' TRP . 3.1 tp -107.82 112.8 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 111.401 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.408 ' HA ' ' HB3' ' D' ' 215' ' ' MLZ . 74.4 m-85 -89.22 108.5 19.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.458 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 23.0 t -107.36 143.89 35.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.091 -1.006 . . . . 0.0 111.508 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.627 ' HG2' HD13 ' B' ' 84' ' ' LEU . 0.6 OUTLIER -119.46 -168.72 1.63 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.523 -0.736 . . . . 0.0 109.735 178.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 74.81 4.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.369 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.508 0.0 OUTLIER 172.79 -35.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 -179.735 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -179.75 -174.27 0.28 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.522 -0.736 . . . . 0.0 110.367 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.463 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 26.4 p -112.16 134.9 53.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 110.399 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.897 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -117.09 174.41 6.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 110.65 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.675 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -120.34 159.76 24.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -88.65 99.18 12.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.818 . . . . 0.0 110.238 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 1.008 HD23 HD11 ' B' ' 36' ' ' ILE 2.496 0.1 OUTLIER -58.49 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -179.528 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -63.25 -130.39 0.01 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -90.06 46.22 1.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -1.162 . . . . 0.0 110.68 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.528 ' CA ' ' HB1' ' B' ' 61' ' ' ALA . . . -90.98 -20.16 40.41 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' B' ' 61' ' ' ALA . . . -91.25 -43.33 9.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 110.627 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.461 ' CD1' ' HB ' ' B' ' 18' ' ' VAL . 1.3 pp -49.09 -25.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.197 -0.939 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.466 ' CE1' HG11 ' B' ' 18' ' ' VAL . 9.2 m-85 -48.96 145.29 4.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 110.627 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.402 ' HB2' ' CG2' ' B' ' 102' ' ' THR . 73.1 m-80 -118.94 174.75 6.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.517 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.578 ' CE1' ' CE2' ' B' ' 110' ' ' TRP . 1.8 t-160 -101.68 109.54 21.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 110.19 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 1.6 t -124.06 146.71 48.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -58.5 127.61 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 52.65 71.1 1.55 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 110.228 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.543 ' O ' HD11 ' B' ' 92' ' ' ILE . 12.9 Cg_endo -60.66 174.23 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.71 1.374 . . . . 0.0 110.555 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.46 ' HA ' ' HG2' ' B' ' 93' ' ' LYS . 17.4 p30 -117.65 -13.09 10.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.345 -0.847 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.07 144.01 51.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.038 -1.039 . . . . 0.0 110.201 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -121.08 166.91 13.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 110.069 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -110.19 159.02 17.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.766 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' B' ' 88' ' ' ARG . 19.7 tt0 -133.06 136.6 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.151 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.574 HD12 ' HD2' ' D' ' 218' ' ' PRO . 6.1 mt -114.51 145.17 42.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.063 -1.023 . . . . 0.0 110.453 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.586 HG23 ' O ' ' B' ' 86' ' ' ARG . 14.2 p -53.95 -78.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 110.385 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.36 -60.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 110.613 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.59 42.76 1.88 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.973 HD23 HG13 ' B' ' 37' ' ' VAL . 4.4 tp 59.33 115.79 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.273 -1.133 . . . . 0.0 110.513 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -177.23 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.03 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.586 ' O ' HG23 ' B' ' 81' ' ' THR . 1.3 mpt_? -113.31 140.06 48.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 1.071 ' SD ' ' SG ' ' B' ' 33' ' ' CYS . 3.9 ppp? -137.2 169.83 17.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 110.71 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.722 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -131.33 -179.66 5.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 0.0 110.648 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 mt -130.32 108.13 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.392 -0.817 . . . . 0.0 109.597 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.759 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 51.7 m-85 -97.22 -170.66 2.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 110.653 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.73 HG23 ' CG2' ' B' ' 30' ' ' VAL . 23.2 p -128.34 98.86 5.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.429 -0.794 . . . . 0.0 110.162 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.543 HD11 ' O ' ' B' ' 74' ' ' PRO . 48.6 pt -59.98 -16.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 110.688 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' B' ' 75' ' ' ASN . 1.1 ptpm? -148.67 156.92 41.66 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 110.175 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.94 142.86 93.5 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.633 1.333 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.607 HG23 ' HG3' ' B' ' 99' ' ' GLU . 54.6 mt -124.32 141.9 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.137 -0.977 . . . . 0.0 110.684 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.65 153.7 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.805 . . . . 0.0 110.886 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.861 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.8 mp -48.2 -24.97 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 111.243 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.37 60.8 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' B' ' 95' ' ' ILE . 3.4 mm-40 -116.36 165.0 13.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.267 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -112.31 115.0 28.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.476 -0.765 . . . . 0.0 109.003 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.952 ' HB ' HG13 ' B' ' 18' ' ' VAL . 58.4 mt -87.95 127.6 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.997 . . . . 0.0 111.261 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.521 HG23 ' O ' ' B' ' 101' ' ' ILE . 15.8 p -155.68 148.46 24.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.547 HD12 ' O ' ' B' ' 104' ' ' SER . 1.3 pp -115.86 155.25 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 110.793 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.547 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.6 OUTLIER -90.66 -174.08 3.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.527 ' CD2' ' ND1' ' B' ' 70' ' ' HIS . 8.9 m-85 -123.37 -66.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.201 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 -175.28 44.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -33.25 68.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.289 -1.124 . . . . 0.0 110.371 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -66.91 0.61 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 110.402 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.447 ' CD2' ' HG2' ' D' ' 215' ' ' MLZ . 0.2 OUTLIER -68.5 71.94 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.578 ' CE2' ' CE1' ' B' ' 70' ' ' HIS . 0.0 OUTLIER -153.86 -156.19 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 110.417 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.26 -71.24 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.387 -0.821 . . . . 0.0 110.539 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.33 -79.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 110.673 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.46 61.54 13.77 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.579 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.17 -40.33 2.5 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.603 1.317 . . . . 0.0 110.553 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 55.15 19.74 3.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.31 -0.869 . . . . 0.0 110.7 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' B' ' 116' ' ' LEU . 0.1 OUTLIER 47.22 39.41 8.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.871 . . . . 0.0 111.082 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -132.23 -69.48 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.519 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.16 57.8 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 110.305 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.369 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.66 60.45 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -1.15 . . . . 0.0 110.312 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' D' ' 204' ' ' PRO . . . -92.78 144.53 28.72 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 110.509 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' D' ' 203' ' ' ALA . 25.2 Cg_exo -59.21 -33.62 98.13 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.623 1.328 . . . . 0.0 110.535 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 53.43 84.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.324 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.16 111.81 7.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 110.415 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 53.6 176.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.479 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.99 178.47 6.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 110.167 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.74 -54.04 49.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 110.311 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 7.5 m 52.65 52.89 13.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 110.473 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -60.35 -67.01 0.43 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 110.331 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -174.92 79.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.332 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -149.2 91.82 1.88 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 110.393 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.458 ' CB ' ' HB3' ' B' ' 53' ' ' SER . 2.1 tpp180 -77.09 -148.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.288 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.447 ' HG2' ' CD2' ' B' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 3.3 p -52.56 176.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 110.339 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -160.66 167.87 12.85 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 110.439 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 16.9 Cg_endo -59.16 -43.91 38.28 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.709 1.373 . . . . 0.0 110.46 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.4 82.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.1 t -101.91 160.5 14.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 110.427 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.509 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.476 ' HN2' ' CB ' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.476 ' HN2' ' CB ' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.543 ' SD ' ' SG ' ' B' ' 33' ' ' CYS . 1.2 tpt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.256 0.55 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 12.9 p90 -151.94 70.99 0.95 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.244 -0.91 . . . . 0.0 110.189 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 5' ' ' ARG . 2.4 m120 -153.93 -81.96 0.08 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 111.477 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 6' ' ' VAL . 31.9 t0 -41.3 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.3 mtt180 42.49 20.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.485 -0.759 . . . . 0.0 112.785 177.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 5' ' ' ARG . 44.7 t -158.34 156.29 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.667 -1.271 . . . . 0.0 110.842 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 15.5 tt -143.65 142.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.607 . . . . 0.0 109.717 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 8' ' ' VAL . 11.6 p -89.07 135.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.936 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.9 mttt -141.45 143.86 34.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.636 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.73 56.92 6.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 119.535 -1.978 . . . . 0.0 110.281 4.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.503 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -113.0 178.74 0.9 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.776 -0.577 . . . . 0.0 110.034 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 11' ' ' SER . 5.0 Cg_exo -71.99 -24.46 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.592 1.312 . . . . 0.0 110.31 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.65 27.37 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.055 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.43 169.33 22.33 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . -92.13 -145.56 16.14 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -95.31 68.29 3.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -1.189 . . . . 0.0 110.496 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.37 -162.88 14.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 67' ' ' ILE . 89.0 t -99.87 136.39 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.281 . . . . 0.0 110.205 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CG ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -101.06 128.09 47.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.117 -0.989 . . . . 0.0 109.603 178.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.866 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.28 97.89 11.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.566 -0.709 . . . . 0.0 111.077 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.863 ' O ' HG23 ' A' ' 97' ' ' ILE . 5.0 ttt180 -75.24 -19.73 59.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.77 4.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.383 -0.823 . . . . 0.0 109.224 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.438 ' HA ' ' HG3' ' A' ' 22' ' ' LYS 2.516 59.4 m 102.2 24.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.119 -1.613 . . . . 0.0 109.922 1.202 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 26.1 m-85 -116.0 160.49 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 110.909 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.37 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.0 109.963 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 16.7 tttm -97.37 86.75 3.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 110.145 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.2 78.87 1.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' C ' ' CD2' ' A' ' 90' ' ' PHE . 1.2 mt-10 -155.14 138.14 15.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 110.453 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.72 HD11 ' OE1' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -54.48 153.7 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.978 . . . . 0.0 109.612 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 91' ' ' THR . 95.3 t -137.98 -49.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.981 -1.074 . . . . 0.0 110.218 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.897 ' O ' HD12 ' A' ' 89' ' ' ILE . 7.1 tp10 -161.36 115.94 2.03 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.408 -0.808 . . . . 0.0 109.916 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.72 ' OE1' HD11 ' A' ' 29' ' ' LEU . 20.3 pt-20 -124.35 144.8 49.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 110.149 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.44 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 74.8 m -139.68 -160.96 1.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.089 -1.007 . . . . 0.0 111.055 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' NH2' ' A' ' 86' ' ' ARG . 3.0 mm? -94.54 178.56 5.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 110.371 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -150.91 159.34 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.638 HD11 ' CD2' ' A' ' 62' ' ' LEU . 48.3 mt -105.57 107.02 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 84' ' ' LEU . 87.6 t -88.82 122.33 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.384 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB3' ' CD1' ' A' ' 43' ' ' TRP . 17.3 tpt180 -139.63 148.73 42.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.34 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.12 -172.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.622 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -96.81 114.43 26.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.511 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.08 -139.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' B' ' 46' ' ' ALA . 2.7 p30 -49.76 -26.43 3.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.801 -1.187 . . . . 0.0 109.733 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.571 ' CE2' HD21 ' A' ' 51' ' ' LEU . 20.3 t-105 -70.63 -43.77 68.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.638 -0.664 . . . . 0.0 109.21 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.88 -28.3 60.45 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.9 m -90.61 -63.79 1.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -1.137 . . . . 0.0 110.693 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' HB2' ' OD1' ' B' ' 42' ' ' ASP . . . -48.89 -58.81 4.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.161 -0.962 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.968 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.0 mm? -91.8 41.0 1.05 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.331 -0.856 . . . . 0.0 109.644 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -8.49 31.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.985 . . . . 0.0 111.052 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.43 169.39 9.36 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.894 -1.129 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CE1' ' OXT' ' A' ' 301' ' ' SAH . 24.1 m-85 52.03 25.95 3.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.428 -0.795 . . . . 0.0 110.57 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.751 HD22 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -115.93 126.56 54.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 0.0 111.077 -179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -88.85 104.05 16.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 36.1 t -89.02 120.58 30.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.09 -1.007 . . . . 0.0 111.228 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -179.5 4.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.511 -0.743 . . . . 0.0 109.702 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -83.35 80.78 8.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.974 -1.079 . . . . 0.0 109.269 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.21 -23.69 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.777 -0.577 . . . . 0.0 109.922 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.71 -178.47 0.89 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 110.835 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 16.7 m -123.36 139.08 54.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.974 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 84' ' ' LEU . . . -132.82 153.22 51.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 111.073 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.968 ' CE ' HD12 ' A' ' 47' ' ' LEU . 38.6 tpp -89.64 155.18 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.678 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.76 93.62 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.627 -0.671 . . . . 0.0 110.639 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' B' ' 62' ' ' LEU 2.5 0.1 OUTLIER -55.95 -34.19 65.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 110.604 179.847 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 33' ' ' CYS . . . -86.94 -136.94 4.88 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.843 ' HB3' HD11 ' A' ' 67' ' ' ILE . 85.0 m-85 -90.49 19.46 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.349 -1.089 . . . . 0.0 110.617 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.678 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -61.85 -21.18 60.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.52 -59.18 2.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -1.215 . . . . 0.0 111.144 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.843 HD11 ' HB3' ' A' ' 64' ' ' PHE . 2.5 pp -53.79 -18.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.283 -0.886 . . . . 0.0 111.648 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE1' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -49.07 146.47 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.852 -1.155 . . . . 0.0 110.735 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.3 171.5 8.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 110.46 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -93.16 148.49 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.58 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.33 131.43 5.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' CG ' ' HG ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -52.42 -27.9 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.495 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -117.53 76.51 9.99 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.89 . . . . 0.0 110.386 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.897 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.6 Cg_endo -64.98 104.18 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.665 1.35 . . . . 0.0 110.468 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.476 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 5.5 m-20 -72.15 -10.76 60.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.657 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 90' ' ' PHE . . . -146.22 160.6 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.953 -1.092 . . . . 0.0 110.855 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.03 155.36 43.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.456 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 21.0 p-80 -90.02 136.13 33.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.613 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.41 13.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 110.164 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 80' ' ' LEU . 17.9 mt -121.82 161.53 22.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.499 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 86' ' ' ARG . 24.0 m -131.32 119.58 21.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.44 -0.787 . . . . 0.0 110.082 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.11 64.57 1.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.49 -119.51 6.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 37' ' ' VAL . 60.7 mt -118.54 26.51 9.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -1.136 . . . . 0.0 110.346 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.73 -56.69 4.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 110.431 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.459 ' NH2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -119.09 150.38 40.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.75 147.77 41.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -0.999 . . . . 0.0 110.603 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' CB ' ' HB3' ' A' ' 79' ' ' GLU . 3.4 mtt180 -125.25 163.03 23.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 110.324 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 31' ' ' GLU . 26.7 mt -136.08 113.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.442 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.573 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 6.3 m-85 -112.58 178.08 4.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.908 . . . . 0.0 110.792 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 30' ' ' VAL . 15.2 p -121.64 99.07 6.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.376 -0.828 . . . . 0.0 110.496 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.897 HD11 ' O ' ' A' ' 74' ' ' PRO . 21.5 pt -52.8 -28.4 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.044 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.476 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -135.04 144.11 48.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 109.974 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 44.5 Cg_exo -49.21 145.67 14.51 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.619 1.326 . . . . 0.0 110.698 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.477 HG21 ' HB1' ' A' ' 20' ' ' ALA . 73.4 mt -122.51 148.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.937 . . . . 0.0 110.568 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.88 152.26 21.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 110.294 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 21' ' ' ARG . 43.8 mt -53.95 -20.29 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.437 -0.79 . . . . 0.0 111.148 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.58 59.3 0.38 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.13 179.1 6.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.145 -1.209 . . . . 0.0 110.718 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 18' ' ' VAL . 10.0 tt0 -125.22 128.43 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 110.013 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.866 HG13 ' HB2' ' A' ' 20' ' ' ALA . 61.3 mt -89.37 132.54 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.263 -0.898 . . . . 0.0 110.548 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 101' ' ' ILE . 13.8 p -151.37 166.24 31.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.641 -0.662 . . . . 0.0 109.888 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 104' ' ' SER . 2.2 pp -137.86 156.45 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.117 -0.989 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.642 ' O ' HD12 ' A' ' 103' ' ' ILE . 37.0 t -91.83 -163.5 1.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 110.358 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 104' ' ' SER . 15.3 m-85 -132.32 -55.96 0.97 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.298 -0.876 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.74 163.88 2.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 109' ' ' TYR . 0.8 OUTLIER 54.62 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -1.017 . . . . 0.0 111.151 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' C' ' 213' ' ' ALA . 2.6 m-20 58.75 -73.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.507 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.4 OUTLIER -42.09 107.82 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.449 -0.782 . . . . 0.0 111.944 -177.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.463 ' CH2' " O2'" ' A' ' 301' ' ' SAH . 0.8 OUTLIER 46.12 -151.83 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.801 . . . . 0.0 111.488 178.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 111' ' ' LEU . 9.1 tt -46.8 138.42 6.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.448 -0.782 . . . . 0.0 111.258 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.402 ' N ' HD23 ' A' ' 111' ' ' LEU . 69.0 m -115.1 -21.6 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -0.829 . . . . 0.0 110.195 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.445 ' CB ' ' HD2' ' A' ' 114' ' ' PRO . 11.9 mtt-85 -50.92 175.21 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 110.378 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 113' ' ' ARG . 9.5 Cg_endo -56.66 -162.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.681 1.358 . . . . 0.0 110.854 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' A' ' 115' ' ' ARG . 4.9 mpt_? -109.48 43.65 1.28 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.26 -0.9 . . . . 0.0 110.786 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.515 HD12 HD22 ' A' ' 119' ' ' ASN . 4.1 mm? 49.93 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.273 -0.892 . . . . 0.0 110.872 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -91.46 126.65 36.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 110.271 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 53.11 72.61 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 110.329 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.515 HD22 HD12 ' A' ' 116' ' ' LEU . 21.2 t-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.371 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.6 176.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -1.152 . . . . 0.0 110.339 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.09 67.05 4.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -58.13 88.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.588 1.309 . . . . 0.0 110.553 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? 52.47 59.52 4.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 110.426 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.83 59.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 110.38 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -170.73 91.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 110.381 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 tp -122.98 -40.33 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.89 . . . . 0.0 110.257 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.59 168.15 28.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 110.268 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 32.7 p -127.68 -41.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 110.511 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -115.1 165.29 13.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 110.304 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -123.83 -170.26 2.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 108' ' ' ASP . . . -115.25 27.78 9.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 3.0 mpp_? 49.15 -163.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.875 . . . . 0.0 110.871 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m -51.95 170.66 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 0.0 110.471 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.56 144.3 49.18 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.3 -163.4 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.623 1.328 . . . . 0.0 110.856 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -116.71 106.1 13.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 7.7 t -155.34 -156.85 0.69 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 110.295 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.962 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.283 0.563 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' B' ' 7' ' ' ILE . 13.2 p90 -151.98 72.59 1.02 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.023 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 5' ' ' ARG . 2.4 m120 -155.8 -81.81 0.07 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' B' ' 6' ' ' VAL . 31.9 t0 -41.59 86.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -176.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.586 ' O ' HG23 ' B' ' 6' ' ' VAL . 15.3 mtt180 42.57 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.374 -0.829 . . . . 0.0 112.841 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 5' ' ' ARG . 44.6 t -158.31 156.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.591 -1.318 . . . . 0.0 110.831 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 15.4 tt -143.9 142.28 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.65 -0.656 . . . . 0.0 109.789 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 8' ' ' VAL . 11.9 p -88.56 135.47 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 111.088 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.646 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.7 mttt -141.72 143.85 33.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.895 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.646 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.81 56.89 6.96 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.617 -1.927 . . . . 0.0 110.297 4.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.499 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 0.9 OUTLIER -113.05 178.64 0.92 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.725 -0.609 . . . . 0.0 110.037 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.432 ' CD ' ' HB2' ' B' ' 11' ' ' SER . 4.8 Cg_exo -71.89 -24.48 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.584 1.308 . . . . 0.0 110.366 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.65 27.42 1.22 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 110.047 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.45 169.29 22.36 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . -92.1 -145.52 16.01 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -95.28 68.36 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.428 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.6 -162.81 14.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.521 ' CG2' HD11 ' B' ' 67' ' ' ILE . 85.8 t -99.84 136.23 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.052 -1.263 . . . . 0.0 110.247 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.509 ' CG ' ' HD2' ' B' ' 9' ' ' LYS . 0.1 OUTLIER -101.03 127.83 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.177 -0.952 . . . . 0.0 109.667 178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.858 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -88.84 97.87 11.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 111.139 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.852 ' O ' HG23 ' B' ' 97' ' ' ILE . 5.0 ttt180 -75.26 -19.62 59.62 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.363 -0.836 . . . . 0.0 109.412 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.49 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 0.0 OUTLIER -95.75 -179.82 4.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' B' ' 22' ' ' LYS 2.518 60.7 m 102.26 24.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.187 -1.571 . . . . 0.0 109.909 1.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 26.1 m-85 -115.9 160.54 20.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 110.92 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 -158.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.492 -0.755 . . . . 0.0 109.965 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.423 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 16.6 tttm -97.36 86.7 3.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.145 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.18 78.92 1.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.415 ' C ' ' CD2' ' B' ' 90' ' ' PHE . 1.2 mt-10 -155.15 138.12 15.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -1.179 . . . . 0.0 110.471 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.711 HD11 ' OE1' ' B' ' 32' ' ' GLU . 0.3 OUTLIER -54.38 153.73 5.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.123 -0.986 . . . . 0.0 109.602 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.683 HG21 HG23 ' B' ' 91' ' ' THR . 95.5 t -138.05 -49.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.001 -1.062 . . . . 0.0 110.23 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.897 ' O ' HD12 ' B' ' 89' ' ' ILE . 7.1 tp10 -161.42 116.0 2.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.711 ' OE1' HD11 ' B' ' 29' ' ' LEU . 20.3 pt-20 -124.42 144.8 49.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.083 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.543 ' SG ' ' SD ' ' A' ' 1' ' ' MET . 75.9 m -139.68 -160.91 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.069 -1.019 . . . . 0.0 111.004 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.473 HD21 ' NH2' ' B' ' 86' ' ' ARG . 3.0 mm? -94.53 179.03 5.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.492 -0.755 . . . . 0.0 110.405 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -151.5 159.09 44.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.278 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.643 HD11 ' CD2' ' B' ' 62' ' ' LEU . 48.9 mt -105.61 106.53 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.0 109.798 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.698 HG22 ' CB ' ' B' ' 84' ' ' LEU . 89.9 t -88.13 122.37 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.51 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CD1' ' B' ' 43' ' ' TRP . 17.3 tpt180 -139.67 148.72 42.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.372 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -63.11 -172.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.6 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -96.79 114.46 26.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -176.12 -140.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 109.488 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.564 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 2.7 p30 -49.74 -26.49 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.871 -1.143 . . . . 0.0 109.732 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.598 ' HZ3' HD11 ' A' ' 47' ' ' LEU . 20.3 t-105 -70.54 -43.8 68.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.9 -27.99 60.12 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 88.1 m -91.03 -63.63 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -1.151 . . . . 0.0 110.608 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.491 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . . . -49.11 -58.11 5.51 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.147 -0.97 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.985 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.0 mm? -92.79 41.29 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -8.48 32.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 111.024 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -116.38 169.32 9.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.952 -1.093 . . . . 0.0 110.163 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.48 ' CE1' ' OXT' ' B' ' 302' ' ' SAH . 24.0 m-85 52.17 25.76 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.345 -0.847 . . . . 0.0 110.63 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.755 HD22 ' O ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -115.9 126.1 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 111.187 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.35 103.59 15.97 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 38.1 t -88.24 120.67 29.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.125 -0.985 . . . . 0.0 111.381 -176.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 177.73 5.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.54 -0.725 . . . . 0.0 109.709 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -79.43 80.43 5.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.136 -0.977 . . . . 0.0 110.126 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 4.1 m120 157.09 -23.82 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.617 -0.677 . . . . 0.0 109.913 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.64 -178.43 0.9 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.896 . . . . 0.0 110.817 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 16.5 m -123.32 139.01 54.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' B' ' 84' ' ' LEU . . . -132.95 153.04 51.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.014 -1.054 . . . . 0.0 111.112 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.985 ' CE ' HD12 ' B' ' 47' ' ' LEU . 38.7 tpp -89.49 154.73 19.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.224 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.681 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.19 93.6 9.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 110.752 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 62' ' ' LEU 2.499 0.1 OUTLIER -56.03 -34.11 65.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.0 110.665 179.781 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' B' ' 33' ' ' CYS . . . -86.9 -136.75 4.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.82 ' HB3' HD11 ' B' ' 67' ' ' ILE . 85.2 m-85 -90.8 19.55 5.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 110.534 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.681 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -61.87 -20.94 60.47 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.89 -59.1 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.237 . . . . 0.0 111.076 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' B' ' 64' ' ' PHE . 2.5 pp -53.81 -18.3 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.374 -0.829 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.528 ' HE1' HG22 ' B' ' 101' ' ' ILE . 0.2 OUTLIER -49.06 146.54 3.39 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.876 -1.14 . . . . 0.0 110.731 -179.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -118.38 171.47 8.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.234 -0.917 . . . . 0.0 110.515 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -93.19 148.52 21.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 110.561 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 15.7 t -160.34 131.36 5.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -27.89 17.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.56 76.51 10.07 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 110.428 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.928 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.7 Cg_endo -64.94 104.17 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.667 1.351 . . . . 0.0 110.496 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.464 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 5.6 m-20 -72.13 -10.78 60.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.283 -0.886 . . . . 0.0 110.704 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' B' ' 90' ' ' PHE . . . -146.26 160.64 41.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.064 -1.022 . . . . 0.0 110.822 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -127.05 155.31 43.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.0 110.13 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' B' ' 78' ' ' HIS . 21.1 p-80 -89.96 136.14 33.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 110.622 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.425 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 17.1 tt0 -116.82 165.42 13.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.351 -0.843 . . . . 0.0 110.147 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 80' ' ' LEU . 17.7 mt -121.71 161.66 22.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 110.526 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' B' ' 86' ' ' ARG . 24.2 m -131.43 119.66 21.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.434 -0.791 . . . . 0.0 110.104 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 53.01 64.62 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.5 -119.57 6.19 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.698 ' CB ' HG22 ' B' ' 37' ' ' VAL . 60.9 mt -118.47 26.52 9.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -1.166 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -76.69 -56.65 4.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.453 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.473 ' NH2' HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -119.23 150.49 39.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.244 -0.91 . . . . 0.0 110.2 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.82 147.78 41.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.549 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' B' ' 79' ' ' GLU . 3.4 mtt180 -125.29 163.01 23.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.897 HD12 ' O ' ' B' ' 31' ' ' GLU . 26.7 mt -136.05 113.3 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.578 ' O ' ' HB1' ' B' ' 76' ' ' ALA . 6.4 m-85 -112.58 178.05 4.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 110.804 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.683 HG23 HG21 ' B' ' 30' ' ' VAL . 15.1 p -121.63 99.19 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.321 -0.862 . . . . 0.0 110.474 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.928 HD11 ' O ' ' B' ' 74' ' ' PRO . 21.7 pt -52.86 -28.4 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.464 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -135.05 144.13 48.94 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 0.0 109.951 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 46.9 Cg_exo -49.44 145.84 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.599 1.315 . . . . 0.0 110.688 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.477 HG21 ' HB1' ' B' ' 20' ' ' ALA . 73.0 mt -122.53 148.45 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.71 152.2 21.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.852 HG23 ' O ' ' B' ' 21' ' ' ARG . 43.7 mt -53.86 -20.4 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.436 -0.79 . . . . 0.0 111.116 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.63 59.37 0.37 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.2 178.93 6.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.073 -1.251 . . . . 0.0 110.779 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' B' ' 18' ' ' VAL . 10.0 tt0 -125.28 128.29 48.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 110.103 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.858 HG13 ' HB2' ' B' ' 20' ' ' ALA . 61.3 mt -89.13 132.54 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.88 . . . . 0.0 110.623 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.417 HG23 ' O ' ' B' ' 101' ' ' ILE . 13.5 p -151.32 166.27 31.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.462 -0.774 . . . . 0.0 109.843 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.632 HD12 ' O ' ' B' ' 104' ' ' SER . 2.2 pp -137.85 156.38 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 110.596 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.632 ' O ' HD12 ' B' ' 103' ' ' ILE . 36.6 t -91.78 -163.51 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.416 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' O ' ' B' ' 104' ' ' SER . 15.3 m-85 -132.27 -56.14 0.97 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.91 163.84 2.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' B' ' 109' ' ' TYR . 0.8 OUTLIER 54.67 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -1.025 . . . . 0.0 111.126 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' D' ' 213' ' ' ALA . 2.5 m-20 58.73 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.513 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.4 OUTLIER -42.05 107.73 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 112.016 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.467 ' CH2' " O2'" ' B' ' 302' ' ' SAH . 0.8 OUTLIER 46.13 -151.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 111.48 178.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.627 HD23 ' C ' ' B' ' 111' ' ' LEU . 9.1 tt -46.8 138.41 6.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.412 -0.805 . . . . 0.0 111.273 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.405 ' N ' HD23 ' B' ' 111' ' ' LEU . 68.9 m -115.12 -21.64 9.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 110.156 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.443 ' CB ' ' HD2' ' B' ' 114' ' ' PRO . 11.7 mtt-85 -50.93 175.16 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.406 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' B' ' 113' ' ' ARG . 9.4 Cg_endo -56.52 -162.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.644 1.339 . . . . 0.0 110.95 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . 0.476 ' CD ' ' N ' ' B' ' 115' ' ' ARG . 5.0 mpt_? -109.53 43.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 110.74 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.525 HD12 HD22 ' B' ' 119' ' ' ASN . 4.2 mm? 49.94 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.878 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -91.36 126.63 36.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 110.29 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 53.06 72.68 0.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.336 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.525 HD22 HD12 ' B' ' 116' ' ' LEU . 21.1 t-20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.399 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.59 176.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -1.116 . . . . 0.0 110.362 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.12 67.01 4.13 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -58.14 89.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.583 1.307 . . . . 0.0 110.572 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? 52.43 59.56 4.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.391 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.86 59.89 1.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.366 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -170.77 91.89 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 110.359 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 tp -122.98 -40.34 2.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 110.292 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.61 168.27 27.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 110.224 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 32.5 p -127.77 -41.94 1.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 110.516 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -115.08 165.35 13.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -123.87 -170.3 2.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 110.255 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' B' ' 108' ' ' ASP . . . -115.25 27.73 9.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 110.215 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.513 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 3.0 mpp_? 49.18 -163.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.836 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 2.7 m -52.02 170.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.834 . . . . 0.0 110.506 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -126.5 144.32 49.16 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 110.282 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.34 -163.36 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.667 1.351 . . . . 0.0 110.788 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -116.77 106.11 13.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.478 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 7.7 t -155.33 -156.88 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 110.252 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.501 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.487 ' OXT' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.48 ' OXT' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.226 0.536 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 47.3 p90 -56.66 140.74 46.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.556 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 -131.97 164.7 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -50.23 -24.06 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.717 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.521 ' C ' HG13 ' A' ' 6' ' ' VAL . 6.3 mmm-85 -78.33 -44.62 24.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 110.707 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.521 HG13 ' C ' ' A' ' 5' ' ' ARG . 29.8 m -153.37 -172.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 110.481 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 19' ' ' PHE . 3.0 tt -145.43 143.21 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.349 -0.844 . . . . 0.0 109.777 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.66 118.34 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.065 -1.022 . . . . 0.0 110.951 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.581 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 10.3 mttt -121.77 144.39 48.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.412 -0.805 . . . . 0.0 109.197 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.581 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 52.72 71.55 0.47 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.658 -1.901 . . . . 0.0 111.641 0.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.478 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -113.18 -171.98 0.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 110.069 179.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 57.0 Cg_endo -84.49 6.53 5.69 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.467 1.246 . . . . 0.0 111.06 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.6 mt -124.17 -42.29 2.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.962 -1.086 . . . . 0.0 110.353 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.98 152.12 6.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.0 123.75 4.31 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.71 ' OH ' HD21 ' B' ' 34' ' ' LEU . 0.2 OUTLIER -91.8 104.42 16.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -1.134 . . . . 0.0 110.295 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.88 -170.6 15.38 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.674 HG23 HD13 ' A' ' 67' ' ' ILE . 75.9 t -105.52 145.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.969 -1.312 . . . . 0.0 110.49 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.699 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.6 m-85 -109.99 120.44 42.48 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.395 -0.815 . . . . 0.0 109.405 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.93 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.54 90.13 8.14 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 111.123 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.851 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.23 -24.43 59.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 177.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.488 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 13.7 mtpt -94.9 178.99 5.38 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.467 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 51.8 m 104.11 23.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.007 -1.683 . . . . 0.0 109.67 2.007 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.488 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 12.2 m-85 -112.23 159.94 18.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 110.567 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 1.2 tt0 -91.13 -157.63 0.51 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.888 . . . . 0.0 110.316 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 59.2 tttt -98.85 73.58 2.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 110.564 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.87 77.12 0.84 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 25' ' ' GLU . 4.2 mm-40 -138.34 18.45 2.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -1.141 . . . . 0.0 110.565 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 90' ' ' PHE . 16.3 tp 59.61 147.69 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.49 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.543 ' CG2' HG23 ' A' ' 91' ' ' THR . 83.8 t -126.97 -39.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.973 -1.08 . . . . 0.0 110.243 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.95 161.67 8.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 110.37 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.6 143.93 22.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.506 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' C ' HD12 ' A' ' 34' ' ' LEU . 1.2 m -149.25 -164.96 2.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.92 . . . . 0.0 110.399 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.658 HD21 ' OH ' ' B' ' 16' ' ' TYR . 11.0 mp -100.36 176.97 5.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 110.358 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 153.59 41.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.677 HD11 ' CD2' ' A' ' 62' ' ' LEU . 39.3 mt -94.75 97.29 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.958 . . . . 0.0 109.268 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.884 HG13 HD23 ' A' ' 84' ' ' LEU . 59.6 t -88.42 114.63 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.295 -0.878 . . . . 0.0 110.466 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -126.07 148.75 49.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 110.391 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.35 159.87 5.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 110.242 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -69.92 113.22 6.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.428 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.38 -142.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.854 . . . . 0.0 109.543 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.52 -25.26 3.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.869 -1.145 . . . . 0.0 109.986 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.682 ' CZ2' HD21 ' A' ' 51' ' ' LEU . 43.8 t-105 -66.06 -54.55 24.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.788 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.8 -32.65 59.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -78.3 -63.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 110.544 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.1 -51.86 49.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.669 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.011 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.1 mm? -91.14 30.07 1.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 110.729 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.43 -24.7 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.291 -0.881 . . . . 0.0 111.547 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 3.3 p30 -99.88 151.8 20.88 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.947 -1.095 . . . . 0.0 110.55 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.511 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 9.6 m-85 61.01 19.27 9.74 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.779 -0.576 . . . . 0.0 111.048 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.682 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 6.7 mt -104.81 123.2 47.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.017 . . . . 0.0 110.789 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -89.12 105.9 18.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 108.455 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.2 p -87.87 118.91 27.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.169 -0.957 . . . . 0.0 111.071 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 1.002 ' HD3' HD13 ' A' ' 84' ' ' LEU . 5.4 ttp180 -98.76 -178.83 4.1 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.73 . . . . 0.0 110.038 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -83.87 81.54 8.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.014 -1.054 . . . . 0.0 109.373 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.51 23.6 p30 149.06 -20.76 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.769 -0.582 . . . . 0.0 109.914 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -177.01 -162.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.286 -0.883 . . . . 0.0 110.612 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 81.3 p -143.17 153.18 42.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.402 -0.811 . . . . 0.0 110.114 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.675 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.717 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 1.011 ' CE ' HD12 ' A' ' 47' ' ' LEU . 28.3 tpp -89.44 152.98 21.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.049 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -87.89 109.11 19.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.852 . . . . 0.0 110.294 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.743 ' O ' HD13 ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -56.68 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.785 . . . . 0.0 110.985 -179.775 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.15 -168.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.63 ' O ' HD11 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -73.14 56.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -1.169 . . . . 0.0 111.323 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -91.5 -23.45 28.73 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -91.13 2.7 56.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 111.502 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.712 HD12 ' N ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -90.31 -8.6 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.794 -1.191 . . . . 0.0 110.733 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.712 ' N ' HD12 ' A' ' 67' ' ' ILE . 18.3 m-85 -56.03 131.93 48.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 0.0 109.925 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -98.48 179.1 4.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.974 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.57 115.92 21.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.832 . . . . 0.0 110.405 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.11 141.54 46.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 110.535 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.449 ' HD3' HD12 ' A' ' 116' ' ' LEU . 10.4 tptm -61.64 120.85 11.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.942 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.26 84.34 0.21 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.835 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.4 Cg_endo -64.13 107.28 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.691 1.364 . . . . 0.0 110.467 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.29 -18.51 27.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 110.603 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -131.4 119.44 21.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.972 . . . . 0.0 110.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.73 -170.52 1.81 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.407 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.417 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 26.5 p-80 -129.19 163.07 26.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.838 . . . . 0.0 110.314 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -139.63 159.29 42.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.529 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 84' ' ' LEU . 8.7 mt -118.38 150.16 39.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.181 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.639 HG21 ' HB2' ' A' ' 86' ' ' ARG . 6.6 p -68.93 67.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 80' ' ' LEU . . . 51.24 39.83 24.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.56 -136.46 4.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.002 HD13 ' HD3' ' A' ' 54' ' ' ARG . 5.5 tp -132.08 86.67 2.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -1.107 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -49.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.514 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.639 ' HB2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -124.76 123.62 40.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.1 mtp -95.24 154.7 17.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 110.642 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' HIS . 83.5 mtt-85 -138.75 164.23 30.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 110.043 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.31 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.732 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 18.3 m-85 -91.79 157.95 16.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 110.602 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.543 HG23 ' CG2' ' A' ' 30' ' ' VAL . 7.7 p -101.94 83.11 2.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.835 HD11 ' O ' ' A' ' 74' ' ' PRO . 6.1 pt -52.88 -23.48 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 110.555 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 92' ' ' ILE . 17.9 mmtt -137.48 134.57 18.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 89.6 Cg_exo -46.35 140.61 11.23 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.437 1.23 . . . . 0.0 111.119 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 20' ' ' ALA . 58.9 mt -117.95 141.81 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.542 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -89.61 166.49 13.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 110.449 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.851 HG23 ' O ' ' A' ' 21' ' ' ARG . 3.0 mt -71.58 127.11 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.456 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.58 18.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 1.1 tm-20 -100.21 -175.77 3.03 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.139 -1.212 . . . . 0.0 110.022 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -126.16 124.47 40.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.106 -0.996 . . . . 0.0 110.307 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.93 HG13 ' HB2' ' A' ' 20' ' ' ALA . 62.8 mt -89.86 130.81 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.193 -0.942 . . . . 0.0 110.548 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.541 HG23 ' C ' ' A' ' 101' ' ' ILE . 72.8 p -154.67 -166.85 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.843 -0.536 . . . . 0.0 109.672 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 104' ' ' SER . 1.2 pp -148.68 -167.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 110.444 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.673 ' O ' HD12 ' A' ' 103' ' ' ILE . 3.4 t -102.71 -148.26 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 110.154 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.85 -86.55 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 110.418 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.95 -132.07 1.69 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 112' ' ' SER . 0.2 OUTLIER -109.49 -1.07 18.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 110.996 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.97 -40.39 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.967 -1.083 . . . . 0.0 110.565 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.523 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.2 OUTLIER -65.84 105.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.952 . . . . 0.0 110.599 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.474 ' CE2' " H3'" ' A' ' 301' ' ' SAH . 15.6 m95 55.78 -86.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 111.083 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 112' ' ' SER . 1.3 tt -48.79 172.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.913 -1.117 . . . . 0.0 111.127 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 111' ' ' LEU . 5.1 t 58.55 52.4 7.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.446 -0.784 . . . . 0.0 110.807 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.52 ' CB ' ' HD3' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 178.33 -55.27 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.165 -0.96 . . . . 0.0 110.826 178.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.52 ' HD3' ' CB ' ' A' ' 113' ' ' ARG . 57.8 Cg_endo -80.94 7.39 4.94 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.726 1.382 . . . . 0.0 111.309 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.548 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER 56.78 167.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.956 -1.09 . . . . 0.0 110.119 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.548 HD22 ' O ' ' A' ' 115' ' ' ARG . 1.4 mm? -122.68 126.91 48.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.948 . . . . 0.0 110.481 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.8 m -157.32 99.26 1.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 0.0 110.245 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.32 104.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.881 . . . . 0.0 110.481 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.354 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 52.8 57.79 6.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' C' ' 204' ' ' PRO . . . -146.57 173.66 4.04 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 110.482 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.529 ' HD2' ' HB1' ' C' ' 203' ' ' ALA . 35.5 Cg_exo -56.9 -64.55 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.67 1.353 . . . . 0.0 110.416 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 52.27 26.08 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.867 . . . . 0.0 110.398 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.54 89.01 7.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.366 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.6 87.53 1.94 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 110.425 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 12.7 tp 53.08 28.24 6.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.398 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.1 72.76 1.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 110.326 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 69.6 p -111.78 93.92 4.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 110.3 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -170.09 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.496 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.65 -68.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.248 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.12 83.73 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 110.504 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.523 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 1.1 mtt180 -66.11 -84.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.208 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.507 0.3 OUTLIER -50.61 -31.98 17.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.192 -0.943 . . . . 0.0 110.724 -179.468 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 54.98 172.72 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 110.448 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 19.2 Cg_exo -63.01 -170.21 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.613 1.323 . . . . 0.0 110.443 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -89.93 155.29 19.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 110.238 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 54' ' ' ARG . 5.3 t -150.3 60.86 0.96 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 110.38 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 CA-C-O 117.996 -1.447 . . . . 0.0 109.519 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.237 0.541 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 47.3 p90 -56.68 140.77 46.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.355 -0.84 . . . . 0.0 110.512 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -131.98 164.81 25.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 110.226 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -50.3 -24.09 2.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.934 . . . . 0.0 110.664 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.538 ' C ' HG13 ' B' ' 6' ' ' VAL . 6.3 mmm-85 -78.27 -44.68 24.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.651 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.538 HG13 ' C ' ' B' ' 5' ' ' ARG . 30.2 m -153.35 -172.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.707 HG23 ' HB2' ' B' ' 19' ' ' PHE . 3.0 tt -145.43 143.12 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.807 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.48 118.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.036 -1.04 . . . . 0.0 110.99 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.598 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 10.2 mttt -121.9 144.37 48.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.472 -0.767 . . . . 0.0 109.221 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.598 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 52.74 71.62 0.47 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.711 -1.868 . . . . 0.0 111.569 0.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.49 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 0.2 OUTLIER -113.22 -171.94 0.22 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 110.024 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 56.8 Cg_endo -84.55 6.5 5.7 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.462 1.243 . . . . 0.0 111.025 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 51.7 mt -124.19 -42.29 2.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.067 -1.021 . . . . 0.0 110.301 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.96 152.1 6.45 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.09 123.79 4.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.658 ' OH ' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -91.73 104.57 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -1.158 . . . . 0.0 110.364 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.1 -170.64 15.56 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.676 HG23 HD13 ' B' ' 67' ' ' ILE . 77.2 t -105.53 145.06 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.946 -1.326 . . . . 0.0 110.449 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.707 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.6 m-85 -110.0 120.35 42.18 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.456 -0.777 . . . . 0.0 109.466 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.893 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.41 90.14 8.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 111.18 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.31 -24.34 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 177.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.482 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 13.7 mtpt -94.92 179.04 5.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.524 -0.735 . . . . 0.0 109.031 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.453 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 51.9 m 104.09 23.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.095 -1.628 . . . . 0.0 109.677 2.012 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 12.3 m-85 -112.21 159.96 18.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.619 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.409 ' HB2' ' HG3' ' B' ' 28' ' ' GLU . 1.2 tt0 -91.16 -157.62 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.261 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.424 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 59.1 tttt -98.83 73.55 2.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.548 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 77.02 0.83 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' B' ' 25' ' ' GLU . 4.2 mm-40 -138.3 18.4 2.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 110.586 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.737 HD13 ' CZ ' ' B' ' 90' ' ' PHE . 16.2 tp 59.75 147.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.418 -0.802 . . . . 0.0 110.503 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.548 ' CG2' HG23 ' B' ' 91' ' ' THR . 83.8 t -127.02 -39.82 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.042 . . . . 0.0 110.279 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.97 161.71 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.336 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' B' ' 87' ' ' MET . 3.8 pm0 -153.66 143.86 22.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.453 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.483 ' C ' HD12 ' B' ' 34' ' ' LEU . 1.2 m -149.17 -164.95 2.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.398 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.71 HD21 ' OH ' ' A' ' 16' ' ' TYR . 11.0 mp -100.34 176.95 5.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.94 153.57 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 110.225 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.676 HD11 ' CD2' ' B' ' 62' ' ' LEU . 39.4 mt -94.78 96.4 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.393 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.877 HG13 HD23 ' B' ' 84' ' ' LEU . 54.8 t -87.21 114.7 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 110.651 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.511 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 0.0 OUTLIER -126.21 148.71 49.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.818 . . . . 0.0 110.456 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -58.31 159.88 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -69.87 113.15 6.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.451 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -176.35 -142.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.523 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.48 -25.33 3.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.812 -1.18 . . . . 0.0 110.004 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.677 ' CZ2' HD21 ' B' ' 51' ' ' LEU . 43.7 t-105 -66.02 -54.55 24.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.593 -0.692 . . . . 0.0 109.781 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.85 -32.52 59.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -78.39 -63.23 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.153 . . . . 0.0 110.533 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.21 -51.4 54.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 110.69 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.998 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.1 mm? -91.83 30.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.484 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -45.52 -24.74 0.36 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.245 -0.91 . . . . 0.0 111.505 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.469 ' OD1' ' CD2' ' B' ' 50' ' ' TYR . 3.2 p30 -99.72 151.79 20.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.034 -1.041 . . . . 0.0 110.667 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 9.4 m-85 60.96 19.2 9.61 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.654 -0.654 . . . . 0.0 111.057 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.677 HD21 ' CZ2' ' B' ' 43' ' ' TRP . 6.6 mt -104.89 123.02 46.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 0.0 110.893 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -88.77 104.98 17.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.25 -0.906 . . . . 0.0 108.706 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 57.0 p -86.55 119.04 26.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.135 -0.978 . . . . 0.0 111.322 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.992 ' HD3' HD13 ' B' ' 84' ' ' LEU . 5.4 ttp180 -99.49 178.67 4.8 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.473 -0.767 . . . . 0.0 110.066 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -80.2 81.17 6.52 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.957 . . . . 0.0 110.187 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.509 23.5 p30 148.96 -20.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.677 -0.64 . . . . 0.0 109.942 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.4 ptm -176.83 -161.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.934 . . . . 0.0 110.745 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.451 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 81.4 p -143.2 153.2 42.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 110.044 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.665 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -139.58 145.69 38.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 110.703 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.998 ' CE ' HD12 ' B' ' 47' ' ' LEU . 28.5 tpp -89.34 152.15 21.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -86.83 109.02 19.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.451 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 62' ' ' LEU 2.5 0.2 OUTLIER -56.68 -84.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -0.794 . . . . 0.0 110.919 -179.908 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.36 -168.79 0.08 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.629 ' O ' HD11 ' B' ' 67' ' ' ILE . 0.1 OUTLIER -73.19 57.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -1.18 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' B' ' 68' ' ' PHE . . . -92.52 -22.48 28.89 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -92.03 3.09 56.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -1.159 . . . . 0.0 111.378 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.721 HD12 ' N ' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -90.53 -8.55 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.811 -1.18 . . . . 0.0 110.724 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.721 ' N ' HD12 ' B' ' 67' ' ' ILE . 18.3 m-85 -56.05 131.98 48.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.893 -1.13 . . . . 0.0 109.907 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -98.57 179.12 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.967 . . . . 0.0 110.968 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -82.56 115.95 21.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.84 . . . . 0.0 110.404 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.13 141.6 46.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.557 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.445 ' HD3' HD12 ' B' ' 116' ' ' LEU . 10.4 tptm -61.68 120.86 11.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 t0 56.31 84.27 0.21 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.822 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.5 Cg_endo -64.04 107.33 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.734 1.386 . . . . 0.0 110.484 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -58.32 -18.49 27.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 110.632 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.565 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -131.4 119.36 21.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.967 . . . . 0.0 110.382 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.7 -170.46 1.8 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 110.454 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.415 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 26.5 p-80 -129.2 162.99 26.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -139.64 159.32 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 110.514 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.442 HD22 HD12 ' B' ' 84' ' ' LEU . 8.8 mt -118.36 150.15 40.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.184 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.644 HG21 ' HB2' ' B' ' 86' ' ' ARG . 6.4 p -69.01 67.26 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 110.562 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' B' ' 80' ' ' LEU . . . 51.3 39.78 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.765 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.63 -136.51 4.65 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.992 HD13 ' HD3' ' B' ' 54' ' ' ARG . 5.5 tp -132.05 86.73 2.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -1.083 . . . . 0.0 110.505 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.4 -49.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.644 ' HB2' HG21 ' B' ' 81' ' ' THR . 0.0 OUTLIER -124.74 123.7 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 110.171 179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' B' ' 32' ' ' GLU . 22.1 mtp -95.29 154.57 17.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 110.656 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' B' ' 78' ' ' HIS . 83.5 mtt-85 -138.64 164.3 29.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 110.083 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.19 98.24 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.978 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.737 ' CZ ' HD13 ' B' ' 29' ' ' LEU . 18.4 m-85 -91.79 157.96 16.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 110.572 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.548 HG23 ' CG2' ' B' ' 30' ' ' VAL . 7.8 p -101.89 83.08 2.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.183 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.822 HD11 ' O ' ' B' ' 74' ' ' PRO . 6.1 pt -52.93 -23.46 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.895 . . . . 0.0 110.548 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.424 ' N ' HG13 ' B' ' 92' ' ' ILE . 17.9 mmtt -137.45 134.37 18.53 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 0.0 110.28 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 85.4 Cg_exo -46.6 140.88 11.7 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.424 1.223 . . . . 0.0 111.08 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.42 HG21 ' CB ' ' B' ' 20' ' ' ALA . 59.0 mt -117.99 141.46 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.616 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -89.21 166.61 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -0.833 . . . . 0.0 110.51 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 3.0 mt -71.71 127.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.4 23.57 18.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 96' ' ' ALA . 1.1 tm-20 -100.01 -176.04 3.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.258 -1.142 . . . . 0.0 110.076 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -126.08 124.46 40.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.104 -0.998 . . . . 0.0 110.282 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.893 HG13 ' HB2' ' B' ' 20' ' ' ALA . 62.7 mt -89.84 130.75 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.631 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.533 HG23 ' C ' ' B' ' 101' ' ' ILE . 72.2 p -154.55 -166.77 2.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.0 109.664 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.669 HD12 ' O ' ' B' ' 104' ' ' SER . 1.2 pp -148.73 -167.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.459 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.669 ' O ' HD12 ' B' ' 103' ' ' ILE . 3.4 t -102.64 -148.3 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 110.159 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.82 -86.57 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -178.98 -132.04 1.68 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' B' ' 112' ' ' SER . 0.2 OUTLIER -109.54 -1.03 18.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 0.0 110.977 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.89 -40.46 0.61 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.929 -1.107 . . . . 0.0 110.614 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.525 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.2 OUTLIER -65.79 105.14 1.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.608 -179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.488 ' CE2' " H3'" ' B' ' 302' ' ' SAH . 15.7 m95 55.77 -86.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.517 -0.739 . . . . 0.0 111.06 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.675 HD23 ' N ' ' B' ' 112' ' ' SER . 1.3 tt -48.8 172.48 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.919 -1.113 . . . . 0.0 111.113 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.675 ' N ' HD23 ' B' ' 111' ' ' LEU . 5.0 t 58.54 52.59 6.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.405 -0.809 . . . . 0.0 110.859 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.498 ' CB ' ' HD3' ' B' ' 114' ' ' PRO . 0.0 OUTLIER 177.82 -55.03 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.113 -0.992 . . . . 0.0 110.481 178.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' B' ' 113' ' ' ARG . 58.1 Cg_endo -80.79 7.45 4.87 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.553 1.291 . . . . 0.0 111.365 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . 0.543 ' O ' HD22 ' B' ' 116' ' ' LEU . 0.2 OUTLIER 56.68 168.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.862 -1.149 . . . . 0.0 110.112 -179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.543 HD22 ' O ' ' B' ' 115' ' ' ARG . 1.4 mm? -122.7 126.84 48.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.482 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 90.1 m -157.28 99.25 1.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 110.252 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.32 104.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 110.471 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.366 179.906 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 52.84 57.79 6.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -1.185 . . . . 0.0 110.422 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.537 ' HB1' ' HD2' ' D' ' 204' ' ' PRO . . . -146.64 173.64 4.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 110.432 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' D' ' 203' ' ' ALA . 35.6 Cg_exo -56.91 -64.54 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.675 1.355 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 52.36 26.08 3.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 110.393 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 88.97 7.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.58 87.6 1.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -0.945 . . . . 0.0 110.404 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 12.7 tp 53.05 28.22 6.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.12 72.76 1.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.348 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 69.4 p -111.73 93.85 4.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 110.33 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -170.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 110.491 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.64 -68.71 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 110.293 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.06 83.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.498 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.525 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 1.1 mtt180 -66.11 -84.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 110.19 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.508 0.3 OUTLIER -50.63 -31.98 17.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -0.912 . . . . 0.0 110.7 -179.42 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 54.9 172.78 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 19.0 Cg_exo -62.99 -170.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.651 1.342 . . . . 0.0 110.439 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -89.94 155.28 19.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.271 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . 0.447 ' O ' HG23 ' D' ' 220' ' ' THR . 5.3 t -150.28 60.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 110.386 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.549 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.474 " H3'" ' CE2' ' A' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.488 " H3'" ' CE2' ' B' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.832 ' SD ' HG11 ' A' ' 8' ' ' VAL . 9.0 mmt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.231 0.538 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 15.2 p90 -127.29 110.12 12.51 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.283 -0.885 . . . . 0.0 110.501 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.88 151.25 36.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.47 -28.04 3.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.3 -0.875 . . . . 0.0 110.825 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.12 25.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 110.352 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' A' ' 5' ' ' ARG . 36.0 m -153.71 156.24 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.272 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.693 HG23 ' HB2' ' A' ' 19' ' ' PHE . 17.2 tt -128.74 155.6 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.832 HG11 ' SD ' ' A' ' 1' ' ' MET . 8.2 p -97.89 133.42 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.862 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.594 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 7.6 mttt -130.86 142.73 50.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.35 -0.844 . . . . 0.0 109.313 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.594 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 20.0 mttt 52.74 62.23 2.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 119.631 -1.918 . . . . 0.0 111.219 0.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p -114.54 -176.92 0.4 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.459 -0.776 . . . . 0.0 110.296 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 18.4 Cg_exo -63.89 -63.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.658 1.346 . . . . 0.0 110.413 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.96 -23.04 7.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.638 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.26 172.2 22.55 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.89 -159.42 35.35 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.447 ' HB2' ' N ' ' A' ' 301' ' ' SAH . 1.5 m-85 -74.47 81.81 1.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -1.201 . . . . 0.0 110.353 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.467 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -121.13 -169.07 13.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 72.4 t -110.86 146.6 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.892 -1.358 . . . . 0.0 110.396 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.693 ' HB2' HG23 ' A' ' 7' ' ' ILE . 1.2 m-85 -111.33 122.41 47.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 109.998 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.817 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -92.34 92.01 7.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 110.839 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.0 -21.63 61.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 178.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 22.7 mtpt -90.68 -179.3 5.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.88 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HE3' ' A' ' 22' ' ' LYS 2.513 0.0 OUTLIER 108.29 15.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.167 -1.583 . . . . 0.0 110.378 0.922 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 40.1 m-85 -109.18 148.59 30.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.083 -1.011 . . . . 0.0 110.716 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.29 -161.33 0.8 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.992 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 69.99 3.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -137.69 122.23 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -1.171 . . . . 0.0 110.24 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.869 HD21 ' HB3' ' A' ' 88' ' ' ARG . 1.3 tm? -65.8 115.69 6.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.893 . . . . 0.0 110.417 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 29' ' ' LEU . 85.3 t -94.39 74.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 110.057 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 30' ' ' VAL . 3.5 tt0 59.06 154.1 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.5 0.667 . . . . 0.0 110.821 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 88' ' ' ARG . 9.4 pt-20 -157.28 161.24 39.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.26 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.53 -170.7 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.622 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ARG . 58.4 mt -90.47 -170.24 2.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.436 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 14.0 m -147.18 160.77 42.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 110.024 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.607 HD11 ' CD2' ' A' ' 62' ' ' LEU . 27.2 mt -96.07 102.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 109.345 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.6 129.24 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 110.663 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 6.0 mmt180 -145.81 151.69 38.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.437 -0.789 . . . . 0.0 110.127 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.3 -179.06 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.972 . . . . 0.0 110.369 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.37 112.37 23.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.53 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.25 -142.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -50.81 -25.25 4.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.719 -1.238 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.513 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 45.6 t-105 -56.12 -64.44 0.86 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.25 -28.39 58.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 77.7 m -70.54 -67.75 0.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -1.179 . . . . 0.0 110.523 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.03 84.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.558 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.995 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.3 mm? -90.34 41.02 1.03 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.623 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.34 3.97 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.106 -0.996 . . . . 0.0 110.519 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.12 -81.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.484 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' HD1' HCM1 ' C' ' 215' ' ' MLZ . 12.5 m-85 -96.96 52.38 1.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.0 109.368 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.708 HD13 ' HB3' ' A' ' 47' ' ' LEU . 1.3 tp -111.89 131.45 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 111.167 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' C' ' 215' ' ' MLZ . 17.7 m-85 -92.35 -178.29 4.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.288 -0.883 . . . . 0.0 109.646 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' C' ' 214' ' ' ARG . 24.8 p -144.22 123.21 12.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 111.042 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.608 ' CB ' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -110.82 173.52 6.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.608 -0.682 . . . . 0.0 109.372 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 54' ' ' ARG . 13.1 mttm -82.68 70.8 9.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.0 109.237 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.2 t30 166.5 -28.05 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.96 -167.87 0.25 Allowed 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.471 -0.768 . . . . 0.0 110.938 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.437 ' OG ' ' CD1' ' A' ' 43' ' ' TRP . 37.6 p -120.71 166.88 13.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.443 -0.786 . . . . 0.0 109.434 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.66 ' HB3' HD22 ' A' ' 84' ' ' LEU . . . -150.06 151.69 33.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.922 -1.111 . . . . 0.0 111.062 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.995 ' CE ' HD12 ' A' ' 47' ' ' LEU . 18.2 tpp -89.55 154.32 20.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.667 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.57 91.64 8.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.945 HD22 HD22 ' B' ' 62' ' ' LEU 2.497 0.2 OUTLIER -55.54 -45.27 77.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 110.51 179.591 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.73 -141.22 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.826 ' HB3' HD11 ' A' ' 67' ' ' ILE . 29.3 m-85 -90.6 11.09 23.07 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -1.185 . . . . 0.0 110.903 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.667 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -47.37 -30.79 6.15 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . . . -66.51 -75.28 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.199 -1.177 . . . . 0.0 109.793 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.826 HD11 ' HB3' ' A' ' 64' ' ' PHE . 2.4 pp -56.74 -18.8 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 111.364 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.649 ' HE1' HD13 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -51.81 132.42 31.53 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.04 -1.038 . . . . 0.0 109.936 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.661 ' CB ' HG22 ' A' ' 102' ' ' THR . 13.4 m-20 -109.05 177.26 4.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.957 -1.089 . . . . 0.0 111.451 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.522 ' CD2' ' N ' ' A' ' 71' ' ' SER . 13.3 t60 -103.0 157.56 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.576 -0.703 . . . . 0.0 109.918 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.522 ' N ' ' CD2' ' A' ' 70' ' ' HIS . 29.3 t -149.96 140.93 22.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.042 -1.036 . . . . 0.0 110.603 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -29.78 50.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.983 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.87 96.07 39.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.594 ' O ' HD11 ' A' ' 92' ' ' ILE . 31.9 Cg_exo -54.0 119.71 6.75 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.648 1.341 . . . . 0.0 110.649 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.463 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 19.7 p30 -110.58 -21.77 11.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -146.35 149.93 34.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.292 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.506 ' HB2' HG23 ' A' ' 92' ' ' ILE . 3.4 mtt180 -128.19 -173.39 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 110.186 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 2.7 p-80 -128.81 175.95 8.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 110.649 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 87' ' ' MET . 24.0 tt0 -137.66 153.26 49.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.832 HD23 ' HG2' ' A' ' 87' ' ' MET . 80.1 mt -123.83 135.5 53.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -79.92 -168.76 1.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 88.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 110.467 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 81' ' ' THR . . . 87.12 58.38 1.89 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 59' ' ' ALA . 8.0 mt 55.72 -111.6 0.64 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.375 -1.074 . . . . 0.0 110.084 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER 58.55 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.625 -1.297 . . . . 0.0 111.078 179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -97.38 139.82 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 110.536 -179.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.832 ' HG2' HD23 ' A' ' 80' ' ' LEU . 11.0 mtp -129.64 144.47 51.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.439 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.869 ' HB3' HD21 ' A' ' 29' ' ' LEU . 5.5 mtp180 -124.87 162.93 23.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.21 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HE1' ' A' ' 68' ' ' PHE . 81.2 mt -123.0 99.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.848 . . . . 0.0 109.661 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 2.0 m-85 -96.36 -174.2 2.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.718 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 11.9 p -127.48 98.89 5.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.594 HD11 ' O ' ' A' ' 74' ' ' PRO . 45.4 pt -55.64 -25.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.617 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -144.53 146.77 33.72 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.172 -0.955 . . . . 0.0 110.438 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.12 125.89 20.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.685 1.361 . . . . 0.0 110.492 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.9 144.58 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.59 156.88 18.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 110.457 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 21' ' ' ARG . 73.3 mt -66.8 113.68 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.219 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.38 30.71 2.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.92 -170.31 1.76 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 110.296 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 18' ' ' VAL . 43.1 tt0 -128.39 133.7 48.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.817 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 26.4 mt -89.32 131.32 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.2 -0.937 . . . . 0.0 109.932 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.661 HG22 ' CB ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -158.9 164.56 35.56 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.119 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.604 HG23 ' CE2' ' A' ' 68' ' ' PHE . 8.2 pt -132.94 162.41 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.618 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.457 ' HA ' ' ND1' ' A' ' 70' ' ' HIS . 1.4 m -91.71 174.83 7.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 110.205 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 70' ' ' HIS . 15.8 m-85 -126.86 -70.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 67.35 -163.67 45.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.66 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -1.045 . . . . 0.0 110.622 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -100.04 -42.47 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 0.0 110.341 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.453 ' HB2' ' CB ' ' A' ' 105' ' ' TYR . 19.1 m-85 -61.88 141.91 57.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.888 . . . . 0.0 110.312 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -117.99 37.99 3.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.4 -0.812 . . . . 0.0 110.558 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.967 HD13 ' N ' ' A' ' 112' ' ' SER . 2.5 tm? -51.73 145.73 8.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.406 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.967 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.4 OUTLIER 60.78 128.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.631 0.729 . . . . 0.0 110.804 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 13.5 mtm-85 -77.21 -50.97 2.1 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.293 -0.879 . . . . 0.0 111.55 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 50.5 Cg_endo -77.78 -13.23 16.19 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.716 1.377 . . . . 0.0 111.244 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 112' ' ' SER . 44.9 mmm-85 54.97 -152.77 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.129 -0.982 . . . . 0.0 110.529 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 116' ' ' LEU . 14.1 mt -121.84 56.75 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 110.428 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.5 m -127.58 118.89 24.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 110.348 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 53.46 -172.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.417 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.386 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.59 -68.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -1.133 . . . . 0.0 110.298 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -114.77 91.56 26.28 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.81 139.16 67.21 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.698 1.367 . . . . 0.0 110.444 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -95.16 -69.31 0.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.957 . . . . 0.0 110.332 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 52.73 -171.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 110.436 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -59.39 -167.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.902 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.35 84.22 1.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.919 . . . . 0.0 110.403 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . 52.75 92.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.369 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 27.7 m -72.34 -46.13 56.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.896 . . . . 0.0 110.377 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -127.56 128.03 44.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.406 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.12 158.77 3.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 110.362 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.82 107.96 10.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.397 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.413 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 1.2 tpp180 -107.51 164.36 12.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.541 HCM1 ' HD1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t -57.25 -164.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 110.277 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.603 ' O ' HG23 ' C' ' 220' ' ' THR . . . -136.22 152.11 74.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 217' ' ' ALA . 33.6 Cg_exo -57.84 -34.12 97.86 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.699 1.368 . . . . 0.0 110.517 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -112.81 92.45 4.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 110.328 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . 0.603 HG23 ' O ' ' C' ' 217' ' ' ALA . 36.0 p -109.29 46.52 0.98 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.397 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.912 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.829 ' SD ' HG11 ' B' ' 8' ' ' VAL . 9.1 mmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.247 0.546 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 15.4 p90 -127.21 110.13 12.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.25 -0.906 . . . . 0.0 110.517 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -116.89 151.23 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -0.818 . . . . 0.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.43 -28.05 3.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.794 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.536 ' C ' HG13 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -76.13 -47.2 25.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.536 HG13 ' C ' ' B' ' 5' ' ' ARG . 35.9 m -153.62 156.26 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.719 HG23 ' HB2' ' B' ' 19' ' ' PHE . 17.2 tt -128.74 155.59 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.395 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.829 HG11 ' SD ' ' B' ' 1' ' ' MET . 8.2 p -97.85 133.47 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.85 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 7.6 mttt -130.93 142.68 50.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.846 . . . . 0.0 109.315 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.6 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 20.0 mttt 52.67 62.33 2.74 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 119.675 -1.89 . . . . 0.0 111.199 0.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 2.6 p -114.64 -176.84 0.4 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 110.31 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 18.2 Cg_exo -63.87 -63.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.62 1.326 . . . . 0.0 110.401 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.91 -23.13 7.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 110.663 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.21 172.08 22.59 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.78 -159.39 35.36 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.455 ' HB2' ' N ' ' B' ' 302' ' ' SAH . 1.5 m-85 -74.52 81.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.325 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.466 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -121.14 -169.02 13.64 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.489 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 69.0 t -110.92 146.17 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.929 -1.336 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.719 ' HB2' HG23 ' B' ' 7' ' ' ILE . 1.2 m-85 -111.27 122.4 47.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.817 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -92.38 92.08 7.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 110.825 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.866 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.98 -21.7 61.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.836 178.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 22.9 mtpt -90.63 -179.18 5.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.419 -0.801 . . . . 0.0 109.889 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.405 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.514 0.0 OUTLIER 108.32 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.206 -1.559 . . . . 0.0 110.43 0.896 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 40.0 m-85 -109.17 148.58 30.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.01 . . . . 0.0 110.688 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.33 -161.3 0.8 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -95.05 70.0 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 110.312 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.08 66.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -137.66 122.29 18.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -1.128 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.846 HD21 ' HB3' ' B' ' 88' ' ' ARG . 1.3 tm? -65.85 115.62 6.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 110.445 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.481 ' N ' HD13 ' B' ' 29' ' ' LEU . 85.9 t -94.3 74.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -0.853 . . . . 0.0 110.012 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' B' ' 30' ' ' VAL . 3.5 tt0 59.08 154.11 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.648 -0.657 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' B' ' 88' ' ' ARG . 9.4 pt-20 -157.18 161.5 39.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 110.269 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.85 -170.78 3.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 110.631 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.427 HD23 ' CG ' ' B' ' 86' ' ' ARG . 58.8 mt -90.46 -170.24 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.469 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 14.4 m -147.17 160.71 42.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 110.007 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' B' ' 62' ' ' LEU . 27.0 mt -96.07 102.32 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.089 -1.007 . . . . 0.0 109.411 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -87.67 129.33 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 5.9 mmt180 -145.99 151.71 38.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -63.26 -179.11 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.39 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -89.39 112.37 23.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -176.28 -142.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.371 -0.831 . . . . 0.0 109.568 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -50.82 -25.31 4.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.766 -1.208 . . . . 0.0 109.855 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.622 ' HZ3' HD11 ' A' ' 47' ' ' LEU . 45.6 t-105 -56.05 -64.47 0.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.918 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.23 -28.37 58.74 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 75.8 m -70.5 -67.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 110.572 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.85 84.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 110.658 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.989 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.3 mm? -90.55 41.1 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 110.604 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.7 60.24 3.93 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 110.512 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -143.14 -81.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 110.451 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.518 ' HD1' HCM1 ' D' ' 215' ' ' MLZ . 12.5 m-85 -96.9 52.41 1.17 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 0.0 109.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' B' ' 47' ' ' LEU . 1.3 tp -111.89 131.54 55.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 111.108 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.507 ' CD1' ' HB3' ' D' ' 215' ' ' MLZ . 17.7 m-85 -92.34 -178.24 4.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.388 -0.82 . . . . 0.0 109.683 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' D' ' 214' ' ' ARG . 25.0 p -144.16 123.26 12.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.044 -1.035 . . . . 0.0 111.04 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.615 ' CB ' HD11 ' B' ' 84' ' ' LEU . 0.4 OUTLIER -111.5 170.6 8.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 178.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' B' ' 54' ' ' ARG . 14.1 mttm -78.54 70.13 4.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.089 . . . . 0.0 110.178 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 1.2 t30 166.58 -28.33 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.76 -167.83 0.26 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.454 -0.779 . . . . 0.0 110.954 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.432 ' OG ' ' CD1' ' B' ' 43' ' ' TRP . 37.5 p -120.69 166.84 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.449 -0.782 . . . . 0.0 109.419 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.679 ' HB3' HD22 ' B' ' 84' ' ' LEU . . . -150.04 151.54 33.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.93 -1.106 . . . . 0.0 111.058 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.989 ' CE ' HD12 ' B' ' 47' ' ' LEU . 18.2 tpp -89.43 153.39 20.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.653 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -86.28 91.58 8.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.836 . . . . 0.0 110.88 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.945 HD22 HD22 ' A' ' 62' ' ' LEU 2.498 0.2 OUTLIER -55.62 -45.24 77.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.337 -0.852 . . . . 0.0 110.518 179.432 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.74 -140.94 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.814 ' HB3' HD11 ' B' ' 67' ' ' ILE . 29.0 m-85 -91.02 11.21 23.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -1.143 . . . . 0.0 110.823 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.653 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -47.39 -30.8 6.2 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' B' ' 50' ' ' TYR . . . -66.54 -75.46 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.179 -1.189 . . . . 0.0 109.84 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.814 HD11 ' HB3' ' B' ' 64' ' ' PHE . 2.4 pp -56.48 -18.99 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.65 ' HE1' HD13 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -51.65 132.36 30.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.907 -1.12 . . . . 0.0 109.85 178.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.644 ' CB ' HG22 ' B' ' 102' ' ' THR . 13.3 m-20 -108.9 177.92 4.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.018 -1.051 . . . . 0.0 111.351 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' B' ' 71' ' ' SER . 13.2 t60 -104.04 157.33 17.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . 0.52 ' N ' ' CD2' ' B' ' 70' ' ' HIS . 29.5 t -149.79 140.85 22.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.632 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.81 49.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.8 96.02 39.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.395 -0.816 . . . . 0.0 109.961 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.608 ' O ' HD11 ' B' ' 92' ' ' ILE . 31.9 Cg_exo -53.97 119.75 6.79 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.655 1.345 . . . . 0.0 110.682 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.463 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 19.7 p30 -110.56 -21.84 11.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -146.36 149.9 34.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.332 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.515 ' HB2' HG23 ' B' ' 92' ' ' ILE . 3.4 mtt180 -128.11 -173.34 2.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.179 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 2.7 p-80 -128.88 175.98 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 110.671 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' B' ' 87' ' ' MET . 23.9 tt0 -137.66 153.21 49.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.797 HD23 ' HG2' ' B' ' 87' ' ' MET . 80.3 mt -123.8 135.52 53.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 110.215 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 83' ' ' GLY . 0.0 OUTLIER -79.99 -168.69 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.252 -0.905 . . . . 0.0 110.113 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.15 88.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 110.495 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.456 ' HA3' ' HZ1' ' B' ' 85' ' ' LYS . . . 87.16 58.32 1.89 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.679 HD22 ' HB3' ' B' ' 59' ' ' ALA . 8.0 mt 55.76 -111.68 0.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.408 -1.054 . . . . 0.0 110.078 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.456 ' HZ1' ' HA3' ' B' ' 83' ' ' GLY . 0.2 OUTLIER 58.44 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.586 -1.321 . . . . 0.0 111.076 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.427 ' CG ' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -97.28 139.79 32.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.489 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.797 ' HG2' HD23 ' B' ' 80' ' ' LEU . 11.1 mtp -129.59 144.48 51.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 110.438 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.846 ' HB3' HD21 ' B' ' 29' ' ' LEU . 5.5 mtp180 -124.86 162.92 23.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.65 HD13 ' HE1' ' B' ' 68' ' ' PHE . 81.1 mt -123.01 99.75 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.825 . . . . 0.0 109.617 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.685 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 2.0 m-85 -96.31 -174.17 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.737 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -127.52 98.83 5.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.608 HD11 ' O ' ' B' ' 74' ' ' PRO . 45.4 pt -55.62 -25.07 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.632 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.1 OUTLIER -144.48 146.79 33.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.138 -0.976 . . . . 0.0 110.497 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 93' ' ' LYS . 37.6 Cg_exo -56.2 125.9 20.6 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.709 1.373 . . . . 0.0 110.439 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.96 144.42 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 110.333 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.42 156.93 18.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.465 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.866 HG23 ' O ' ' B' ' 21' ' ' ARG . 73.3 mt -66.84 113.63 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.47 30.75 2.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -115.99 -170.31 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 110.281 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.43 ' CG ' ' O ' ' B' ' 18' ' ' VAL . 43.3 tt0 -128.43 133.5 48.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.289 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.817 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 27.1 mt -88.96 131.35 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 110.104 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.644 HG22 ' CB ' ' B' ' 69' ' ' ASN . 1.0 OUTLIER -158.87 164.68 35.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.785 -0.572 . . . . 0.0 109.727 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 76' ' ' ALA . 8.2 pt -132.95 162.35 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.021 -1.05 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.454 ' HA ' ' ND1' ' B' ' 70' ' ' HIS . 1.4 m -91.73 174.8 7.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' B' ' 70' ' ' HIS . 15.8 m-85 -126.76 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 110.501 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 67.42 -163.59 45.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.63 -86.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.439 -1.036 . . . . 0.0 110.635 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' B' ' 106' ' ' GLY . 0.4 OUTLIER -100.14 -42.62 6.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.275 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.452 ' HB2' ' CB ' ' B' ' 105' ' ' TYR . 19.2 m-85 -61.7 141.98 57.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 110.378 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -118.08 38.03 3.8 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.339 -0.85 . . . . 0.0 110.558 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.98 HD13 ' N ' ' B' ' 112' ' ' SER . 2.5 tm? -51.74 145.77 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.161 -0.962 . . . . 0.0 110.45 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.98 ' N ' HD13 ' B' ' 111' ' ' LEU . 0.4 OUTLIER 60.73 128.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.643 0.735 . . . . 0.0 110.779 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' B' ' 114' ' ' PRO . 13.2 mtm-85 -77.69 -50.58 1.95 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 111.106 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 113' ' ' ARG . 48.6 Cg_endo -77.8 -13.42 16.07 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.695 1.366 . . . . 0.0 111.115 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' B' ' 112' ' ' SER . 44.9 mmm-85 54.82 -152.82 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.99 . . . . 0.0 110.529 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' B' ' 116' ' ' LEU . 14.1 mt -121.66 56.71 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 110.457 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 27.6 m -127.57 119.01 25.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 0.0 110.239 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.4 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 110.428 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.383 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.61 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -1.092 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -114.85 91.55 26.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.8 139.12 67.05 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.641 1.338 . . . . 0.0 110.475 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -95.15 -69.21 0.76 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 110.383 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 52.64 -171.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -59.3 -167.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.417 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.31 84.16 1.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 110.408 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . 52.76 92.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.376 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 27.6 m -72.3 -46.2 56.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.378 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -127.56 128.04 44.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 110.453 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -56.09 158.79 3.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 110.385 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.77 107.93 10.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.916 . . . . 0.0 110.407 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' B' ' 53' ' ' SER . 1.2 tpp180 -107.52 164.38 12.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.933 . . . . 0.0 110.271 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.518 HCM1 ' HD1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 12.1 t -57.25 -164.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -0.882 . . . . 0.0 110.295 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.607 ' O ' HG23 ' D' ' 220' ' ' THR . . . -136.24 152.15 74.68 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.395 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.85 -34.07 97.8 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.662 1.348 . . . . 0.0 110.545 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -112.88 92.46 4.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . 0.607 HG23 ' O ' ' D' ' 217' ' ' ALA . 35.9 p -109.32 46.59 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 110.438 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.448 ' N7 ' ' HB3' ' A' ' 70' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.455 ' N ' ' HB2' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.244 0.545 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.482 ' CD1' HD12 ' A' ' 7' ' ' ILE . 14.6 t80 53.06 68.38 0.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.145 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' ARG . 11.8 m120 -90.17 55.36 3.06 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.405 -0.809 . . . . 0.0 110.046 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t70 52.97 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.567 -0.708 . . . . 0.0 111.371 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.529 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -50.55 -33.82 23.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.031 -1.043 . . . . 0.0 111.01 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.529 HG23 ' C ' ' A' ' 5' ' ' ARG . 89.2 t -152.37 138.5 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.067 -1.021 . . . . 0.0 111.245 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.602 HG23 ' HB2' ' A' ' 19' ' ' PHE . 12.7 tt -114.61 162.34 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 110.062 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 64' ' ' PHE . 96.1 t -106.85 120.06 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 16.7 mttt -116.69 144.03 44.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.867 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.6 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 25.0 mttt 52.38 63.04 2.4 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.725 -1.86 . . . . 0.0 111.355 0.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.423 ' CB ' ' HB3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -115.83 173.46 2.98 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.827 . . . . 0.0 110.344 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 11' ' ' SER . 31.9 Cg_exo -57.72 -31.84 93.16 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.696 1.366 . . . . 0.0 110.405 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.58 -36.56 28.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 110.353 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.73 -164.68 15.62 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.24 -177.88 42.13 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' CB ' ' HN2' ' A' ' 301' ' ' SAH . 0.2 OUTLIER -129.58 71.6 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.349 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' CA ' ' ND2' ' A' ' 69' ' ' ASN . . . -108.69 -172.32 21.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.858 ' CG2' HD13 ' A' ' 67' ' ' ILE . 94.1 t -113.55 158.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.992 -1.299 . . . . 0.0 110.653 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -121.0 127.91 52.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.157 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.583 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -89.84 95.2 10.13 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.571 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.855 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -64.14 -24.95 67.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.838 . . . . 0.0 109.665 178.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -86.02 179.27 7.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.537 ' OG ' HD11 ' A' ' 97' ' ' ILE 2.511 0.0 OUTLIER 103.37 11.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.141 -1.599 . . . . 0.0 110.603 1.118 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.6 m-85 -107.67 150.96 26.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 110.702 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.26 -152.63 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 110.131 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' A' ' 94' ' ' PRO . 13.7 tttm -100.58 69.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 110.43 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.03 75.2 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.73 7.55 3.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -1.146 . . . . 0.0 110.984 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.602 HD11 ' HE ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER 61.45 131.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.612 ' CG2' HG23 ' A' ' 91' ' ' THR . 97.2 t -103.38 -74.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.117 -0.99 . . . . 0.0 110.697 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.46 160.82 37.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 110.704 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.63 142.17 37.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.221 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.429 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 25.4 p -150.15 -174.99 4.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.711 ' N ' HD22 ' A' ' 34' ' ' LEU . 2.8 mm? -97.66 174.43 6.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.85 168.59 22.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 110.776 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.699 HG13 HD22 ' A' ' 62' ' ' LEU . 79.3 mt -100.37 150.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.883 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 84' ' ' LEU . 49.7 t -125.58 82.07 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 110.202 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -109.07 146.45 33.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.606 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.47 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 41.0 m170 -61.73 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.007 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 -137.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 60.54 -134.4 0.72 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.956 -1.09 . . . . 0.0 110.222 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -45.94 -26.15 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.907 -1.121 . . . . 0.0 111.155 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 1.031 ' CH2' HD22 ' A' ' 47' ' ' LEU . 65.4 t-105 -67.54 -58.6 4.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.18 -0.95 . . . . 0.0 110.006 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.47 -25.55 42.21 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.401 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 59.7 m -81.14 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 110.537 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -52.8 -58.02 8.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.031 HD22 ' CH2' ' A' ' 43' ' ' TRP . 4.8 mp -90.82 51.83 2.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.285 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -70.04 56.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.894 -1.129 . . . . 0.0 111.583 -178.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER 174.21 154.06 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.805 -1.184 . . . . 0.0 110.335 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.428 ' HA ' ' HZ ' ' C' ' 215' ' ' MLZ . 5.9 m-85 60.48 22.7 12.36 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.349 -0.844 . . . . 0.0 111.012 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.481 HD13 ' NE1' ' A' ' 43' ' ' TRP . 22.6 mt -105.48 113.38 26.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.087 . . . . 0.0 111.156 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 60.3 m-85 -88.86 102.31 14.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 14.5 p -99.65 157.03 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.087 -1.008 . . . . 0.0 111.694 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.518 ' CD ' HD13 ' A' ' 84' ' ' LEU . 26.1 mtm180 -117.68 -171.98 2.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.633 -0.667 . . . . 0.0 109.736 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.68 80.54 9.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 109.06 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 156.02 -21.2 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.731 -0.605 . . . . 0.0 110.124 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -169.32 0.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.035 -1.04 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 15.5 m -128.69 150.12 50.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.79 ' HB2' HD21 ' A' ' 84' ' ' LEU . . . -135.01 176.37 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 110.403 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.736 ' CE ' HD23 ' A' ' 47' ' ' LEU . 2.9 ttt -121.56 156.58 32.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.487 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.877 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.8 92.12 9.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.699 HD22 HG13 ' A' ' 36' ' ' ILE 2.51 0.0 OUTLIER -53.24 -70.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.887 -178.37 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.68 -138.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 8' ' ' VAL . 87.7 m-85 -86.21 48.0 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 110.635 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.877 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -86.27 -22.08 49.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.44 -51.36 5.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.947 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.7 pp -44.29 -24.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.679 -0.638 . . . . 0.0 111.827 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.947 ' N ' HD12 ' A' ' 67' ' ' ILE . 16.4 m-85 -55.88 142.8 33.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.774 -1.204 . . . . 0.0 110.314 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' ND2' ' CA ' ' A' ' 17' ' ' GLY . 55.0 m-20 -119.39 -178.9 3.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 111.339 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -102.74 152.82 20.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.549 -0.72 . . . . 0.0 109.634 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.57 22.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.098 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.49 23.67 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.03 -1.044 . . . . 0.0 110.298 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -174.44 66.18 0.28 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.808 . . . . 0.0 109.797 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.775 ' O ' HD11 ' A' ' 92' ' ' ILE . 22.1 Cg_endo -65.56 93.42 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.775 1.408 . . . . 0.0 110.93 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.96 66.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.847 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -128.07 127.76 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.382 -0.824 . . . . 0.0 110.166 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.93 -171.92 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 110.419 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.46 158.05 23.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 110.508 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 14.0 tp10 -138.21 126.32 22.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 110.067 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.608 HD22 HD12 ' A' ' 84' ' ' LEU . 28.1 mt -105.22 131.26 52.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.978 . . . . 0.0 110.55 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.56 -166.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.327 -0.858 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 110.419 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CZ ' ' A' ' 54' ' ' ARG . . . 138.72 -116.52 1.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' A' ' 59' ' ' ALA . 25.5 tp -168.92 45.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.17 -16.94 9.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 0.0 110.694 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.417 ' HG2' HD13 ' A' ' 34' ' ' LEU . 3.0 mtm180 -131.2 147.76 52.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.084 -1.01 . . . . 0.0 110.593 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.29 158.57 26.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.932 . . . . 0.0 110.669 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.602 ' HE ' HD11 ' A' ' 29' ' ' LEU . 6.5 mtt180 -147.5 115.57 6.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.822 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.493 HG12 ' CE2' ' A' ' 68' ' ' PHE . 2.7 mp -88.95 117.13 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.854 -1.154 . . . . 0.0 110.402 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' CE2' ' HG ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -106.72 163.51 12.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.612 HG23 ' CG2' ' A' ' 30' ' ' VAL . 10.6 p -107.3 87.93 2.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.775 HD11 ' O ' ' A' ' 74' ' ' PRO . 9.5 pt -54.34 -22.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 110.319 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' N ' HG13 ' A' ' 92' ' ' ILE . 10.5 mttt -133.58 142.35 43.6 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 110.204 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.41 ' HG3' ' HB2' ' A' ' 26' ' ' LYS . 33.8 Cg_exo -55.65 128.99 32.66 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.599 1.315 . . . . 0.0 110.545 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.437 HG21 ' CB ' ' A' ' 20' ' ' ALA . 77.3 mt -107.58 138.51 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 110.342 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.73 164.8 14.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 21' ' ' ARG . 4.4 mt -70.95 112.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 110.418 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.71 0.89 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.37 -176.59 3.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -1.183 . . . . 0.0 110.37 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 11.8 tt0 -123.33 126.21 46.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 110.032 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.583 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 56.6 mt -88.81 126.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.167 -0.958 . . . . 0.0 109.844 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 101' ' ' ILE . 22.0 p -155.4 143.11 19.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.566 . . . . 0.0 109.929 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 76' ' ' ALA . 1.1 pp -123.92 147.69 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.513 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.6 t -85.13 -166.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 110.534 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.501 ' CE1' ' HE3' ' C' ' 215' ' ' MLZ . 7.4 m-85 -124.44 -65.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 0.0 110.07 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.17 15.16 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 7.0 p-10 -47.17 -30.5 2.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.436 -1.038 . . . . 0.0 111.454 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' C' ' 214' ' ' ARG . 0.3 OUTLIER -67.56 -42.79 82.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -109.65 115.54 30.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.091 -1.005 . . . . 0.0 110.454 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 28.5 t-105 58.71 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.789 -0.569 . . . . 0.0 111.067 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.577 HD23 ' HG3' ' A' ' 114' ' ' PRO . 10.6 tp -46.83 163.19 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.087 -1.008 . . . . 0.0 110.975 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.45 118.3 5.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.721 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.462 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 2.9 tpt180 47.68 50.4 8.8 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.31 -0.869 . . . . 0.0 111.1 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.577 ' HG3' HD23 ' A' ' 111' ' ' LEU . 55.2 Cg_endo -75.53 146.9 31.34 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.526 1.277 . . . . 0.0 110.522 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -128.44 -39.33 1.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 110.272 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.24 38.34 17.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.639 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.0 m -129.09 154.17 46.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 0.0 110.379 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.402 ' OE1' ' N ' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -126.22 140.33 52.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.338 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.402 ' N ' ' OE1' ' A' ' 118' ' ' GLN . 20.1 p30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.22 114.38 16.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.33 93.75 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 110.387 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -59.41 -40.45 67.2 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.67 1.353 . . . . 0.0 110.573 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.06 23.91 6.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.161 -0.962 . . . . 0.0 110.452 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt 51.68 68.65 0.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.534 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -88.8 103.44 15.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.293 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' C' ' 208' ' ' LEU . 0.2 OUTLIER -65.72 94.19 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 110.42 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.97 143.49 52.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 1.2 p -122.65 83.68 2.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 110.402 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -84.28 67.5 9.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 110.339 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' C' ' 213' ' ' ALA . . . -164.42 118.5 1.4 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 0.0 110.456 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' C' ' 212' ' ' ALA . . . 54.7 172.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.504 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 108' ' ' ASP . 13.6 mtt-85 -141.75 -84.72 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 110.254 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.501 ' HE3' ' CE1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.507 28.7 t -50.56 154.79 1.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.839 . . . . 0.0 110.659 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 218' ' ' PRO . . . -171.09 147.6 2.29 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 217' ' ' ALA . 38.0 Cg_exo -57.4 -173.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.745 1.392 . . . . 0.0 110.503 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -164.57 115.83 1.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 9.8 t -136.88 -163.97 1.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.376 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.867 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.218 0.533 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.472 ' CD1' HD12 ' B' ' 7' ' ' ILE . 14.6 t80 53.14 68.34 0.85 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.915 . . . . 0.0 110.171 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 5' ' ' ARG . 11.8 m120 -90.23 55.24 3.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.028 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 25.1 t70 52.96 -87.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.706 -0.621 . . . . 0.0 111.355 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.527 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.2 OUTLIER -50.55 -33.92 23.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 111.027 -178.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.527 HG23 ' C ' ' B' ' 5' ' ' ARG . 89.4 t -152.31 138.53 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.036 -1.04 . . . . 0.0 111.211 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.603 HG23 ' HB2' ' B' ' 19' ' ' PHE . 12.7 tt -114.64 162.33 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.539 HG21 ' CE2' ' B' ' 64' ' ' PHE . 95.8 t -106.86 120.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.431 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.595 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 16.7 mttt -116.74 144.0 44.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.875 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.595 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 25.2 mttt 52.43 62.94 2.44 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 119.752 -1.842 . . . . 0.0 111.403 0.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HB3' ' B' ' 9' ' ' LYS . 0.5 OUTLIER -115.82 173.45 2.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.413 -0.804 . . . . 0.0 110.32 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' B' ' 11' ' ' SER . 32.1 Cg_exo -57.76 -31.76 93.04 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.637 1.336 . . . . 0.0 110.428 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.66 -36.53 28.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 110.327 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.68 -164.69 15.58 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.29 -177.89 42.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.437 ' CB ' ' HN2' ' B' ' 302' ' ' SAH . 0.2 OUTLIER -129.42 71.7 1.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -1.135 . . . . 0.0 110.385 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.416 ' CA ' ' ND2' ' B' ' 69' ' ' ASN . . . -108.94 -172.19 21.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.864 ' CG2' HD13 ' B' ' 67' ' ' ILE . 95.1 t -113.57 158.47 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.016 -1.285 . . . . 0.0 110.718 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.603 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.9 OUTLIER -120.99 127.88 52.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 110.164 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.576 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -89.78 95.17 10.12 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.362 -0.836 . . . . 0.0 110.542 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.88 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -64.15 -24.88 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.684 178.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -86.07 179.21 7.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.552 -0.718 . . . . 0.0 109.373 179.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.548 ' OG ' HD11 ' B' ' 97' ' ' ILE 2.511 0.0 OUTLIER 103.3 11.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.111 -1.618 . . . . 0.0 110.541 1.19 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.7 m-85 -107.63 150.99 26.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.048 -1.032 . . . . 0.0 110.777 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -93.29 -152.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.847 . . . . 0.0 110.054 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -100.57 69.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.06 75.29 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.71 7.49 3.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -1.141 . . . . 0.0 110.976 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.625 HD11 ' HE ' ' B' ' 88' ' ' ARG . 0.3 OUTLIER 61.5 131.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.178 -0.951 . . . . 0.0 110.129 -179.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.608 ' CG2' HG23 ' B' ' 91' ' ' THR . 98.1 t -103.22 -74.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.991 -1.068 . . . . 0.0 110.551 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.53 160.84 37.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.008 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.58 142.3 37.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 110.183 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.436 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 25.4 p -150.3 -175.01 4.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.714 ' N ' HD22 ' B' ' 34' ' ' LEU . 2.8 mm? -97.78 174.4 6.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.189 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 92.2 m -148.82 168.56 22.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 110.743 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.718 HG13 HD22 ' B' ' 62' ' ' LEU . 79.4 mt -100.46 150.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.841 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' B' ' 84' ' ' LEU . 49.5 t -125.48 82.08 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.462 ' HB3' ' CD2' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -109.1 146.43 34.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 110.55 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.479 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 40.9 m170 -61.65 -175.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 110.008 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 41' ' ' ASP . 0.2 OUTLIER -89.52 -137.64 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 40' ' ' ASN . 5.0 m-20 60.56 -134.42 0.72 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.007 -1.058 . . . . 0.0 110.23 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -45.97 -26.04 0.65 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.903 -1.123 . . . . 0.0 111.201 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 1.022 ' CH2' HD22 ' B' ' 47' ' ' LEU . 65.4 t-105 -67.66 -58.58 4.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.41 -25.61 41.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 60.3 m -81.2 -64.5 1.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -1.172 . . . . 0.0 110.512 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' B' ' 47' ' ' LEU . . . -52.83 -57.44 10.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.181 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 1.022 HD22 ' CH2' ' B' ' 43' ' ' TRP . 4.7 mp -91.61 52.21 2.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 110.239 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' B' ' 45' ' ' THR . 0.0 OUTLIER -70.23 56.23 0.15 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.029 -1.044 . . . . 0.0 111.581 -178.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.42 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 0.5 OUTLIER 174.15 154.09 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.853 -1.154 . . . . 0.0 110.359 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.429 ' HA ' ' HZ ' ' D' ' 215' ' ' MLZ . 5.9 m-85 60.5 22.77 12.45 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.383 -0.823 . . . . 0.0 110.985 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.48 HD13 ' NE1' ' B' ' 43' ' ' TRP . 22.5 mt -105.51 112.85 26.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.9 -1.125 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' B' ' 61' ' ' ALA . 60.8 m-85 -88.29 102.28 14.68 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 14.3 p -99.62 157.0 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.103 -0.998 . . . . 0.0 111.753 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.516 ' CD ' HD13 ' B' ' 84' ' ' LEU . 26.3 mtm180 -118.17 -174.49 2.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.699 -0.625 . . . . 0.0 109.711 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 80.27 6.56 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.188 -0.945 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 3.1 m120 155.89 -21.3 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.577 -0.702 . . . . 0.0 110.177 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 -169.31 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.058 -1.026 . . . . 0.0 110.944 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.462 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 15.5 m -128.71 150.12 50.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 110.453 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' B' ' 84' ' ' LEU . . . -135.03 176.36 8.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 110.44 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.75 ' CE ' HD23 ' B' ' 47' ' ' LEU . 2.9 ttt -121.71 156.03 33.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 110.56 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.847 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.12 92.12 9.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.89 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.718 HD22 HG13 ' B' ' 36' ' ' ILE 2.509 0.0 OUTLIER -53.3 -70.92 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.896 -178.459 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.71 -138.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' B' ' 8' ' ' VAL . 87.9 m-85 -86.2 48.06 1.56 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.133 . . . . 0.0 110.656 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.847 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -86.27 -22.18 49.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.39 -51.39 5.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -1.199 . . . . 0.0 110.5 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.956 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.7 pp -44.22 -24.96 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.598 -0.689 . . . . 0.0 111.843 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.956 ' N ' HD12 ' B' ' 67' ' ' ILE . 16.4 m-85 -55.67 143.39 30.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.796 -1.19 . . . . 0.0 110.258 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.416 ' ND2' ' CA ' ' B' ' 17' ' ' GLY . 56.0 m-20 -120.08 -178.45 3.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 111.228 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.42 ' CE1' ' HG ' ' B' ' 104' ' ' SER . 26.3 t60 -103.62 152.68 21.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.581 -0.699 . . . . 0.0 109.459 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -158.45 22.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.959 -1.088 . . . . 0.0 111.075 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 tptt 52.63 23.62 2.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.045 . . . . 0.0 110.222 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -174.47 66.2 0.28 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.78 ' O ' HD11 ' B' ' 92' ' ' ILE . 22.2 Cg_endo -65.54 93.37 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.783 1.412 . . . . 0.0 110.934 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.72 -24.93 66.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.816 ' O ' HG22 ' B' ' 103' ' ' ILE . . . -128.08 127.81 43.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.01 -171.93 2.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 110.451 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -115.37 157.83 23.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.496 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.447 ' HB3' ' CB ' ' B' ' 88' ' ' ARG . 14.0 tp10 -137.96 126.54 23.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.164 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.596 HD22 HD12 ' B' ' 84' ' ' LEU . 28.1 mt -105.2 131.35 52.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.141 -0.974 . . . . 0.0 110.51 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -59.73 -166.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.349 -0.845 . . . . 0.0 110.257 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.56 81.06 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 110.455 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.421 ' O ' ' CZ ' ' B' ' 54' ' ' ARG . . . 138.73 -116.61 1.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' B' ' 59' ' ' ALA . 25.5 tp -168.91 46.0 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -1.137 . . . . 0.0 110.425 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -119.15 -16.99 9.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.674 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.413 ' HG2' HD13 ' B' ' 34' ' ' LEU . 3.0 mtm180 -131.2 147.8 52.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.093 -1.004 . . . . 0.0 110.556 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 5.6 mmm -120.26 158.57 26.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 110.719 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.625 ' HE ' HD11 ' B' ' 29' ' ' LEU . 6.5 mtt180 -147.54 115.21 6.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 109.885 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' B' ' 68' ' ' PHE . 2.7 mp -88.39 117.11 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.042 . . . . 0.0 110.523 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' B' ' 29' ' ' LEU . 0.9 OUTLIER -106.81 163.49 12.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.345 -0.847 . . . . 0.0 110.643 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.608 HG23 ' CG2' ' B' ' 30' ' ' VAL . 10.4 p -107.24 87.86 2.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.78 HD11 ' O ' ' B' ' 74' ' ' PRO . 9.5 pt -54.25 -22.88 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.917 . . . . 0.0 110.358 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.419 ' N ' HG13 ' B' ' 92' ' ' ILE . 10.5 mttt -133.55 142.45 43.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.216 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 93' ' ' LYS . 37.3 Cg_exo -55.95 129.16 33.47 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.561 1.295 . . . . 0.0 110.454 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.442 HG21 ' CB ' ' B' ' 20' ' ' ALA . 77.4 mt -107.58 138.4 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.335 -0.853 . . . . 0.0 110.313 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 164.79 14.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.178 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.88 HG23 ' O ' ' B' ' 21' ' ' ARG . 4.4 mt -70.94 112.63 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.83 40.75 0.89 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.43 -176.56 3.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -1.165 . . . . 0.0 110.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' B' ' 19' ' ' PHE . 11.8 tt0 -123.45 125.74 45.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.114 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 56.1 mt -88.0 126.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 0.0 110.075 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.53 HG23 ' O ' ' B' ' 101' ' ' ILE . 22.0 p -155.45 143.08 19.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.578 -0.701 . . . . 0.0 109.903 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.816 HG22 ' O ' ' B' ' 76' ' ' ALA . 1.1 pp -123.89 147.68 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.014 . . . . 0.0 110.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.42 ' HG ' ' CE1' ' B' ' 70' ' ' HIS . 43.5 t -85.17 -166.34 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.321 -0.862 . . . . 0.0 110.486 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.492 ' CE1' ' HE3' ' D' ' 215' ' ' MLZ . 7.5 m-85 -124.49 -65.58 1.03 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.948 . . . . 0.0 110.065 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.92 173.23 15.22 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' B' ' 111' ' ' LEU . 7.0 p-10 -47.14 -30.41 2.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -1.01 . . . . 0.0 111.514 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' D' ' 214' ' ' ARG . 0.3 OUTLIER -67.66 -42.94 81.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.082 -1.012 . . . . 0.0 110.932 -178.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' B' ' 111' ' ' LEU . 0.1 OUTLIER -109.31 115.71 30.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 0.0 110.563 -179.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' B' ' 111' ' ' LEU . 28.3 t-105 58.55 -77.8 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.893 -0.504 . . . . 0.0 111.06 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.561 HD23 ' HG3' ' B' ' 114' ' ' PRO . 10.6 tp -46.71 163.03 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.062 -1.024 . . . . 0.0 110.969 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.34 118.33 5.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 110.668 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.463 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 2.9 tpt180 47.56 50.45 8.85 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.89 . . . . 0.0 111.108 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.561 ' HG3' HD23 ' B' ' 111' ' ' LEU . 55.3 Cg_endo -75.49 146.88 31.44 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.533 1.28 . . . . 0.0 110.551 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -128.44 -39.31 1.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 110.279 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.25 38.36 17.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.673 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 24.9 m -129.16 154.18 47.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 110.377 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.23 140.32 52.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 110.301 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.1 p30 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.376 -179.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.26 114.41 16.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -1.142 . . . . 0.0 110.42 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . 53.37 93.75 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -59.43 -40.52 66.31 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.609 1.321 . . . . 0.0 110.529 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.02 23.89 6.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 110.545 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt 51.73 68.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 110.526 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -88.75 103.4 15.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 110.305 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' D' ' 208' ' ' LEU . 0.2 OUTLIER -65.66 94.13 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 110.455 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.97 143.49 52.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.356 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 1.2 p -122.63 83.63 2.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.928 . . . . 0.0 110.391 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -84.23 67.51 9.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 110.344 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -164.49 118.4 1.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 110.47 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 54.73 172.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.871 . . . . 0.0 110.501 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' B' ' 108' ' ' ASP . 13.7 mtt-85 -141.72 -84.67 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 110.255 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.492 ' HE3' ' CE1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.508 28.7 t -50.55 154.76 1.24 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.677 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -171.04 147.63 2.32 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 110.394 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.4 -173.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.648 1.341 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -164.59 115.77 1.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 110.405 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 9.8 t -136.86 -164.0 1.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 110.44 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.544 179.93 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.43 ' HN2' ' CB ' ' A' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.437 ' HN2' ' CB ' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.0 0.428 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 52.9 p90 -129.76 136.45 49.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.797 -1.189 . . . . 0.0 110.77 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' ARG . 8.7 p-10 -148.04 164.28 34.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.885 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.16 62.28 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.588 -0.695 . . . . 0.0 110.754 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.8 tpt180 179.69 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.284 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 5' ' ' ARG . 54.9 t -157.07 169.41 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.688 -0.633 . . . . 0.0 110.1 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 6' ' ' VAL . 11.8 tt -144.77 146.61 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.84 . . . . 0.0 109.48 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.876 HG12 ' HD3' ' A' ' 10' ' ' LYS . 94.7 t -89.65 102.53 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 111.027 -178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.656 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 1.1 mmtt -124.06 137.58 54.56 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.876 ' HD3' HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER 49.85 50.23 18.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 119.407 -2.058 . . . . 0.0 111.699 4.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.526 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -104.13 -55.55 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.902 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 11' ' ' SER . 87.7 Cg_endo -92.87 34.56 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.11 1.058 . . . . 0.0 110.264 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.69 51.3 11.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.119 -0.988 . . . . 0.0 109.864 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.3 -123.1 3.35 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 10' ' ' LYS . . . -97.13 -150.58 26.92 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.51 ' CE2' ' HE3' ' A' ' 10' ' ' LYS . 3.5 m-85 -115.24 110.44 19.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -1.114 . . . . 0.0 110.803 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.5 173.77 22.12 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.715 HG23 HD13 ' A' ' 67' ' ' ILE . 97.9 t -98.3 130.08 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.999 -1.295 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE2' ' CB ' ' A' ' 11' ' ' SER . 1.6 m-85 -107.68 133.82 51.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.976 . . . . 0.0 110.147 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.771 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -96.93 88.47 4.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.404 -0.81 . . . . 0.0 110.542 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.849 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -57.21 -27.15 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.38 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 24' ' ' PHE . 14.7 mtpt -83.61 178.98 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.463 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.514 0.1 OUTLIER 102.24 20.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.0 -1.687 . . . . 0.0 109.563 3.145 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 22' ' ' LYS . 15.2 m-85 -112.68 150.24 31.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.09 -158.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.845 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -80.41 -1.17 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 110.849 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.07 67.57 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' A' ' 24' ' ' PHE . 7.1 mt-10 -118.07 120.76 38.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.124 . . . . 0.0 110.275 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.698 HD13 ' CZ ' ' A' ' 90' ' ' PHE . 25.8 tp -53.71 127.36 25.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 6' ' ' VAL . 47.2 t -103.41 72.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 57.04 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.58 156.01 29.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 110.327 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -147.55 -161.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.367 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.6 mm? -96.7 -179.17 4.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 110.543 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.3 m -148.21 178.16 8.8 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.435 -0.791 . . . . 0.0 109.535 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.56 HD11 ' CD2' ' A' ' 62' ' ' LEU . 20.9 mt -113.97 138.49 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.022 -1.049 . . . . 0.0 110.26 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.85 113.33 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.032 -1.043 . . . . 0.0 110.325 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 1.5 tpp180 -146.61 159.73 43.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 110.404 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.475 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 64.2 m170 -71.4 -173.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -86.37 -137.28 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.833 . . . . 0.0 110.117 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.42 -139.91 0.43 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.739 -1.226 . . . . 0.0 110.304 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -46.36 -26.95 0.92 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.983 -1.073 . . . . 0.0 111.11 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.841 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 67.8 t-105 -61.06 -55.94 26.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.185 -0.947 . . . . 0.0 109.819 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.23 69.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.3 m -69.82 -70.42 0.29 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -1.154 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HB3' HD22 ' A' ' 47' ' ' LEU . . . -52.8 -53.42 48.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.133 -0.98 . . . . 0.0 110.185 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.911 ' HB3' HD13 ' A' ' 51' ' ' LEU . 2.6 mm? -90.45 46.49 1.34 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -5.88 35.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.851 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.35 147.19 43.76 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.95 -1.094 . . . . 0.0 110.021 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.471 ' CE1' ' O ' ' A' ' 66' ' ' ALA . 11.6 m-85 56.09 38.76 30.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.391 -0.818 . . . . 0.0 110.096 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.911 HD13 ' HB3' ' A' ' 47' ' ' LEU . 7.0 tp -123.76 122.81 39.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.43 -0.794 . . . . 0.0 110.896 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.406 ' CD1' ' HB3' ' C' ' 215' ' ' MLZ . 54.3 m-85 -99.08 132.32 44.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.959 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 60.6 p -94.27 127.89 40.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -0.962 . . . . 0.0 110.783 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.603 ' CB ' HD11 ' A' ' 84' ' ' LEU . 12.9 tpt180 -105.39 172.94 6.53 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.407 -0.808 . . . . 0.0 109.608 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -83.08 82.71 8.13 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.946 -1.096 . . . . 0.0 109.225 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.506 22.9 p30 146.45 -18.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.79 -0.569 . . . . 0.0 109.765 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.98 -160.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.1 m -140.49 118.59 11.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.149 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -109.44 153.81 23.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 110.639 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.782 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -93.16 179.58 5.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -86.48 -146.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.16 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.913 HD13 ' HB2' ' B' ' 62' ' ' LEU 2.501 0.1 OUTLIER -178.34 -73.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.99 -1.069 . . . . 0.0 109.967 -179.211 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 33' ' ' CYS . . . -74.55 -114.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 40.5 m-85 -91.26 33.47 0.98 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -1.157 . . . . 0.0 110.516 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 68' ' ' PHE . . . -90.95 -22.14 33.93 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -91.09 -20.94 21.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 111.681 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.715 HD13 HG23 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -92.51 -4.29 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 120.752 -1.217 . . . . 0.0 111.835 -178.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' N ' HD12 ' A' ' 67' ' ' ILE . 5.3 m-85 -55.81 147.78 18.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.823 -1.173 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -117.42 -167.83 1.38 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.862 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.439 ' HE1' HD12 ' A' ' 111' ' ' LEU . 79.6 t60 -103.79 151.2 23.34 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.243 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.516 ' CB ' ' HG1' ' A' ' 102' ' ' THR . 67.1 m -161.19 150.07 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -11.75 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 111.053 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.63 67.52 71.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 110.544 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.701 ' O ' HD11 ' A' ' 92' ' ' ILE . 24.5 Cg_exo -60.03 107.12 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.647 1.341 . . . . 0.0 110.459 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.457 ' HA ' ' CG ' ' A' ' 93' ' ' LYS . 47.2 p30 -81.54 -6.53 59.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 101' ' ' ILE . . . -146.69 150.24 35.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.985 -1.072 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.06 -160.45 0.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.448 ' HB2' ' CE ' ' A' ' 87' ' ' MET . 2.0 p-80 -132.26 166.96 20.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.067 -1.021 . . . . 0.0 110.666 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.15 141.19 29.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 110.455 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.8 HD13 HD23 ' A' ' 84' ' ' LEU . 94.5 mt -105.16 145.9 29.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 110.263 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.76 HG21 ' HB2' ' A' ' 86' ' ' ARG . 1.6 p -64.87 -62.64 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 110.412 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.82 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 110.602 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.5 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 80' ' ' LEU . 29.4 mt 52.32 48.58 22.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.425 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.22 -76.55 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.554 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.76 ' HB2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -87.22 126.63 34.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 110.285 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.448 ' CE ' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -100.79 117.75 35.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.895 . . . . 0.0 110.525 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.39 114.59 27.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.042 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 78' ' ' HIS . 38.9 mt -89.43 138.35 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.698 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 13.6 m-85 -128.36 177.86 6.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 110.463 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.798 HG22 HD12 ' A' ' 95' ' ' ILE . 1.6 p -115.71 96.47 5.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.316 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.701 HD11 ' O ' ' A' ' 74' ' ' PRO . 23.3 pt -50.45 -35.83 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.568 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' CG ' ' HA ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -130.28 150.48 76.26 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 110.299 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.15 131.69 31.57 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.717 1.378 . . . . 0.0 110.981 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.798 HD12 HG22 ' A' ' 91' ' ' THR . 32.1 mt -113.29 145.32 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.786 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.38 10.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 110.968 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 21' ' ' ARG . 39.4 mt -65.79 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.06 36.37 1.83 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.608 ' CB ' HG23 ' A' ' 95' ' ' ILE . 4.8 mm-40 -101.32 156.26 17.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -1.12 . . . . 0.0 110.167 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.411 ' OE1' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER -100.34 110.11 22.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 110.491 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 20' ' ' ALA . 59.3 mt -89.55 119.82 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.797 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.516 ' HG1' ' CB ' ' A' ' 71' ' ' SER . 32.2 p -141.13 1.59 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 111.601 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 68' ' ' PHE . 35.4 pt 37.42 -145.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 121.326 -0.859 . . . . 0.0 111.34 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.425 ' N ' HG13 ' A' ' 103' ' ' ILE . 22.9 t -160.59 -168.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.849 -1.157 . . . . 0.0 110.727 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.493 ' CD1' ' HE2' ' C' ' 215' ' ' MLZ . 10.5 m-85 -123.37 -66.84 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.853 . . . . 0.0 109.686 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 84.69 -160.04 35.31 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.3 t0 55.12 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.552 -0.969 . . . . 0.0 110.581 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 106' ' ' GLY . 1.9 t70 -153.88 25.12 0.5 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.0 110.559 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.1 OUTLIER -100.98 108.77 20.58 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.181 -0.949 . . . . 0.0 109.753 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 30.0 t-105 58.97 -78.79 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.118 0.485 . . . . 0.0 110.638 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.6 HD23 ' C ' ' A' ' 111' ' ' LEU . 8.4 tt -62.65 -52.46 63.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.065 -1.022 . . . . 0.0 110.792 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.8 t 54.71 -88.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.765 . . . . 0.0 110.142 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -92.82 131.59 33.26 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.985 -1.072 . . . . 0.0 109.741 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.91 -85.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 O-C-N 123.343 1.181 . . . . 0.0 110.605 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.57 61.68 3.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 110.703 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.4 mp -82.84 80.94 8.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 110.335 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.9 m -150.72 -66.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 0.0 110.374 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.72 56.7 6.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.357 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.387 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 -58.79 1.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -1.116 . . . . 0.0 110.382 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' C' ' 204' ' ' PRO . . . -116.48 91.48 33.84 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.387 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' C' ' 203' ' ' ALA . 18.6 Cg_endo -64.62 -60.65 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.681 1.359 . . . . 0.0 110.528 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . 0.409 ' HD3' ' HB2' ' C' ' 204' ' ' PRO . 0.1 OUTLIER -167.68 110.44 0.64 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 110.307 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.38 39.49 0.35 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -0.893 . . . . 0.0 110.304 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -109.6 -53.2 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 110.367 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.89 103.05 2.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 110.352 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.4 -159.99 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 110.444 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . 0.662 HG23 ' O ' ' C' ' 210' ' ' THR . 5.1 t -60.62 97.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.427 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.96 -60.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 110.277 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.49 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.598 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.87 141.09 49.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 110.081 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 55.5 mtm-85 -146.94 -172.68 4.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.701 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.493 ' HE2' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.509 2.2 p -50.99 174.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 110.471 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.5 160.59 31.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.95 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.69 137.69 50.89 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.744 1.391 . . . . 0.0 110.509 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -77.77 64.52 3.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 110.379 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 1.4 m 53.41 98.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 110.425 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.989 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.956 0.407 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 52.9 p90 -129.67 136.47 49.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.813 -1.179 . . . . 0.0 110.761 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' B' ' 5' ' ' ARG . 8.7 p-10 -147.98 164.44 33.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -68.34 62.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.0 110.657 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.53 ' O ' HG23 ' B' ' 6' ' ' VAL . 4.8 tpt180 179.85 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.413 -0.804 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 5' ' ' ARG . 54.6 t -156.92 169.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.668 -0.645 . . . . 0.0 110.138 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.51 ' N ' HG12 ' B' ' 6' ' ' VAL . 11.8 tt -144.77 146.42 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.589 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.885 HG12 ' HD3' ' B' ' 10' ' ' LYS . 93.2 t -89.49 102.55 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.056 -1.027 . . . . 0.0 111.086 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.673 ' HA ' ' HB2' ' B' ' 10' ' ' LYS . 1.1 mmtt -124.09 137.64 54.54 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.885 ' HD3' HG12 ' B' ' 8' ' ' VAL . 0.2 OUTLIER 49.89 50.19 18.88 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 119.43 -2.044 . . . . 0.0 111.729 4.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.526 ' CB ' ' HD3' ' B' ' 12' ' ' PRO . 0.2 OUTLIER -104.19 -55.51 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 109.854 176.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' B' ' 11' ' ' SER . 88.0 Cg_endo -92.86 34.61 0.23 Allowed 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.204 1.108 . . . . 0.0 110.283 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.67 51.33 11.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.103 -0.998 . . . . 0.0 109.84 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.36 -122.95 3.33 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 10' ' ' LYS . . . -97.04 -150.48 26.84 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.509 ' CE2' ' HE3' ' B' ' 10' ' ' LYS . 3.6 m-85 -115.24 110.38 19.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -1.08 . . . . 0.0 110.872 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.54 173.64 22.19 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.729 HG23 HD13 ' B' ' 67' ' ' ILE . 92.9 t -98.17 129.86 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.318 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.515 ' CE2' ' CB ' ' B' ' 11' ' ' SER . 1.6 m-85 -107.63 133.82 51.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 110.151 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.785 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -96.91 88.5 4.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.324 -0.86 . . . . 0.0 110.569 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.6 OUTLIER -57.19 -27.16 61.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 178.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.506 ' HD3' ' CZ ' ' B' ' 24' ' ' PHE . 14.7 mtpt -83.58 179.02 7.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.465 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.512 0.1 OUTLIER 102.21 20.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.003 -1.686 . . . . 0.0 109.581 3.056 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.506 ' CZ ' ' HD3' ' B' ' 22' ' ' LYS . 15.4 m-85 -112.63 150.36 31.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.31 -0.869 . . . . 0.0 110.222 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -90.23 -158.77 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.963 . . . . 0.0 109.868 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -80.38 -1.25 40.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.02 67.59 0.28 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' B' ' 24' ' ' PHE . 7.1 mt-10 -118.05 120.69 38.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 110.309 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.701 HD13 ' CZ ' ' B' ' 90' ' ' PHE . 25.9 tp -53.67 127.37 25.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' B' ' 6' ' ' VAL . 47.1 t -103.37 72.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 57.11 163.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.451 -0.781 . . . . 0.0 110.467 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.65 156.07 29.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 0.6 OUTLIER -147.61 -161.7 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 110.334 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' B' ' 34' ' ' LEU . 4.6 mm? -96.83 -179.17 4.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 110.593 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 61' ' ' ALA . 1.3 m -148.23 178.14 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.387 -0.82 . . . . 0.0 109.454 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.551 HD11 ' CD2' ' B' ' 62' ' ' LEU . 20.8 mt -114.0 138.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.018 . . . . 0.0 110.203 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.8 113.4 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.294 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.489 ' HB3' ' CE2' ' B' ' 43' ' ' TRP . 1.5 tpp180 -146.68 159.73 43.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 110.463 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 64.2 m170 -71.38 -173.99 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.764 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -86.34 -137.23 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.36 -139.99 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.808 -1.183 . . . . 0.0 110.295 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -46.23 -27.04 0.9 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.03 -1.044 . . . . 0.0 111.159 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.844 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 67.7 t-105 -60.98 -55.94 27.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.957 . . . . 0.0 109.852 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.62 -34.21 69.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 92.1 m -69.85 -70.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -1.157 . . . . 0.0 110.519 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.574 ' HB3' HD22 ' B' ' 47' ' ' LEU . . . -52.89 -53.13 53.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.88 ' HB3' HD13 ' B' ' 51' ' ' LEU . 2.6 mm? -90.82 46.6 1.34 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 110.309 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -5.92 35.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 110.868 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.24 147.2 43.64 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.906 -1.121 . . . . 0.0 110.098 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' O ' ' B' ' 66' ' ' ALA . 11.5 m-85 56.11 38.75 30.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.866 . . . . 0.0 110.075 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 47' ' ' LEU . 7.1 tp -123.81 122.96 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.826 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' D' ' 215' ' ' MLZ . 54.0 m-85 -99.24 132.43 44.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.435 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 60.5 p -94.29 127.94 40.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.735 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.603 ' CB ' HD11 ' B' ' 84' ' ' LEU . 13.0 tpt180 -106.01 169.98 8.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.446 -0.784 . . . . 0.0 109.722 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.441 ' N ' ' HG3' ' B' ' 54' ' ' ARG . 0.1 OUTLIER -79.04 82.4 5.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.068 -1.02 . . . . 0.0 110.028 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 22.9 p30 146.31 -18.83 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.667 -0.645 . . . . 0.0 109.668 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ptm -175.97 -160.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.272 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -140.38 118.54 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' B' ' 36' ' ' ILE . . . -109.38 153.89 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 110.73 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.796 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.1 OUTLIER -93.62 178.22 5.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.399 -0.813 . . . . 0.0 110.308 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' B' ' 35' ' ' CYS . . . -84.47 -146.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.885 . . . . 0.0 109.632 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.913 ' HB2' HD13 ' A' ' 62' ' ' LEU 2.5 0.1 OUTLIER -178.51 -73.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.001 -1.062 . . . . 0.0 110.018 -179.473 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -74.53 -113.58 0.09 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.472 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 40.4 m-85 -92.04 34.23 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -1.151 . . . . 0.0 110.314 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' B' ' 68' ' ' PHE . . . -92.02 -21.19 33.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.479 ' O ' ' CE1' ' B' ' 50' ' ' TYR . . . -92.17 -19.52 22.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.264 . . . . 0.0 111.627 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.729 HD13 HG23 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -94.14 -3.68 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.873 -1.142 . . . . 0.0 111.491 -178.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.673 ' N ' HD12 ' B' ' 67' ' ' ILE . 5.3 m-85 -56.13 147.82 19.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 110.461 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -117.23 -166.73 1.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.867 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.428 ' HE1' HD12 ' B' ' 111' ' ' LEU . 80.0 t60 -105.37 150.84 24.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.026 . . . . 0.0 109.903 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . 0.517 ' CB ' ' HG1' ' B' ' 102' ' ' THR . 67.1 m -160.88 150.08 16.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 110.311 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 -11.7 59.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 111.069 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -134.73 67.56 71.01 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.997 -1.065 . . . . 0.0 110.536 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.701 ' O ' HD11 ' B' ' 92' ' ' ILE . 24.5 Cg_exo -60.08 107.06 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.663 1.349 . . . . 0.0 110.434 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.461 ' HA ' ' CG ' ' B' ' 93' ' ' LYS . 47.1 p30 -81.49 -6.49 59.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.477 ' HB3' HG23 ' B' ' 101' ' ' ILE . . . -146.69 150.18 34.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.971 -1.081 . . . . 0.0 110.465 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -160.39 0.95 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.441 ' HB2' ' CE ' ' B' ' 87' ' ' MET . 2.0 p-80 -132.32 167.0 20.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.673 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -144.16 141.27 29.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.419 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.791 HD13 HD23 ' B' ' 84' ' ' LEU . 94.6 mt -105.26 145.89 30.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 110.318 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.772 HG21 ' HB2' ' B' ' 86' ' ' ARG . 1.6 p -64.89 -62.57 1.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.417 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.88 -43.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.67 40.54 2.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.791 HD23 HD13 ' B' ' 80' ' ' LEU . 29.4 mt 52.27 48.54 22.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -1.195 . . . . 0.0 110.407 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -111.18 -76.57 0.6 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.182 -0.948 . . . . 0.0 110.536 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.772 ' HB2' HG21 ' B' ' 81' ' ' THR . 0.0 OUTLIER -87.17 126.64 34.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.091 -1.006 . . . . 0.0 110.281 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.441 ' CE ' ' HB2' ' B' ' 78' ' ' HIS . 0.0 OUTLIER -100.81 117.74 35.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.358 -0.839 . . . . 0.0 110.548 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -111.46 114.3 27.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.121 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' B' ' 78' ' ' HIS . 38.5 mt -89.02 138.37 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.701 ' CZ ' HD13 ' B' ' 29' ' ' LEU . 13.6 m-85 -128.39 177.92 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 110.472 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.822 HG22 HD12 ' B' ' 95' ' ' ILE . 1.6 p -115.75 96.45 5.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.908 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.701 HD11 ' O ' ' B' ' 74' ' ' PRO . 23.4 pt -50.44 -35.82 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.628 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.461 ' CG ' ' HA ' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -130.25 150.52 76.36 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 110.273 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.21 131.73 31.95 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.709 1.373 . . . . 0.0 110.991 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.822 HD12 HG22 ' B' ' 91' ' ' THR . 31.9 mt -113.29 145.37 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.476 -0.765 . . . . 0.0 109.795 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.26 167.31 10.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.948 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 39.5 mt -65.76 107.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.815 . . . . 0.0 110.267 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.1 36.25 1.85 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.593 ' CB ' HG23 ' B' ' 95' ' ' ILE . 4.9 mm-40 -101.28 156.25 17.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -100.32 110.06 22.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.11 -0.994 . . . . 0.0 110.49 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.785 HD11 ' HB2' ' B' ' 20' ' ' ALA . 60.0 mt -89.47 119.65 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.8 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.517 ' HG1' ' CB ' ' B' ' 71' ' ' SER . 32.7 p -140.91 1.53 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 111.611 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' B' ' 68' ' ' PHE . 35.2 pt 37.61 -146.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.46 -0.775 . . . . 0.0 111.388 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.423 ' N ' HG13 ' B' ' 103' ' ' ILE . 22.8 t -160.62 -169.08 2.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.903 -1.123 . . . . 0.0 110.712 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.484 ' CD1' ' HE2' ' D' ' 215' ' ' MLZ . 10.4 m-85 -123.06 -66.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.774 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 84.65 -159.95 35.3 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.4 t0 55.1 -87.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.527 -0.984 . . . . 0.0 110.546 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 106' ' ' GLY . 1.8 t70 -153.85 24.94 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.937 -1.102 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.491 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.1 OUTLIER -100.65 108.91 20.92 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 109.91 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.53 ' CD1' ' N ' ' B' ' 111' ' ' LEU . 29.9 t-105 58.93 -78.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.084 0.468 . . . . 0.0 110.607 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.602 HD23 ' C ' ' B' ' 111' ' ' LEU . 8.4 tt -62.58 -52.47 63.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.107 -0.996 . . . . 0.0 110.787 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 7.9 t 54.65 -88.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.446 -0.784 . . . . 0.0 110.191 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' B' ' 111' ' ' LEU . 0.0 OUTLIER -92.79 131.53 33.46 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.861 -1.149 . . . . 0.0 109.794 178.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.8 -85.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.353 1.186 . . . . 0.0 110.619 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.64 61.63 3.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.063 -1.023 . . . . 0.0 110.71 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.3 mp -82.81 80.89 8.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 110.292 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 53.5 m -150.73 -66.87 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 110.366 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.77 56.68 6.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.362 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 -58.75 1.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -1.147 . . . . 0.0 110.376 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' D' ' 204' ' ' PRO . . . -116.55 91.53 34.3 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 110.367 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.407 ' HB2' ' HD3' ' D' ' 205' ' ' ARG . 18.7 Cg_endo -64.62 -60.69 0.13 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.654 1.344 . . . . 0.0 110.487 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . 0.407 ' HD3' ' HB2' ' D' ' 204' ' ' PRO . 0.1 OUTLIER -167.66 110.4 0.64 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.336 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 39.46 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -109.63 -53.14 2.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 110.358 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.92 103.06 2.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 110.302 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.44 -160.01 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 110.394 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . 0.671 HG23 ' O ' ' D' ' 210' ' ' THR . 5.1 t -60.54 97.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.434 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -60.64 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.52 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.885 . . . . 0.0 110.535 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -119.83 141.05 49.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.869 . . . . 0.0 110.142 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.491 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 55.5 mtm-85 -146.9 -172.61 4.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 110.713 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.484 ' HE2' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.507 2.2 p -51.16 174.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 0.0 110.462 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.59 31.04 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.922 . . . . 0.0 110.391 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -65.59 137.67 51.25 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.632 1.333 . . . . 0.0 110.522 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -77.76 64.52 3.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 1.4 m 53.43 98.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.442 " O2'" ' CE3' ' A' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.457 " O2'" ' CE3' ' B' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' SD ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.21 0.529 . . . . 0.0 110.425 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.469 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 35.8 p90 -172.31 122.14 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.401 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -121.08 163.44 18.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -50.08 -25.61 3.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 110.906 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.5 ' C ' HG13 ' A' ' 6' ' ' VAL . 26.9 ttp180 -74.65 -45.39 45.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.56 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.5 HG13 ' C ' ' A' ' 5' ' ' ARG . 22.9 m -154.25 -178.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.164 -0.96 . . . . 0.0 110.493 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 19' ' ' PHE . 9.0 tt -152.91 150.49 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 110.101 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG21 ' SD ' ' A' ' 1' ' ' MET . 93.4 t -94.48 120.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 110.525 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.625 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 mttt -125.59 146.82 49.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.418 -0.801 . . . . 0.0 109.226 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.625 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 4.1 mmmt 52.45 59.18 4.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 119.65 -1.906 . . . . 0.0 110.922 2.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.476 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.1 p -107.77 -173.6 0.28 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.451 -0.781 . . . . 0.0 110.159 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 24.4 Cg_exo -60.25 -39.59 66.7 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.662 1.348 . . . . 0.0 110.407 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.03 -23.33 26.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 110.402 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 -155.25 16.44 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.34 139.26 0.29 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -99.96 72.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -1.175 . . . . 0.0 110.581 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.0 -175.97 20.37 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 67' ' ' ILE . 90.3 t -101.67 146.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.987 -1.302 . . . . 0.0 110.03 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -110.41 126.36 54.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -0.931 . . . . 0.0 109.754 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.54 89.4 7.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -0.844 . . . . 0.0 110.843 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -58.52 -22.52 55.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.325 -0.859 . . . . 0.0 109.65 178.022 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 23' ' ' SER . 0.3 OUTLIER -90.82 -178.87 5.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.467 -0.771 . . . . 0.0 109.862 179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' CG ' ' A' ' 22' ' ' LYS 2.51 18.1 m 100.58 17.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.291 -1.506 . . . . 0.0 110.47 0.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -105.19 161.43 14.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -0.991 . . . . 0.0 110.768 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -162.03 0.91 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.356 -0.84 . . . . 0.0 109.88 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' CB ' ' HD3' ' A' ' 94' ' ' PRO . 17.8 tttt -95.53 97.47 9.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.03 58.0 0.84 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.49 121.06 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -1.176 . . . . 0.0 110.43 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.967 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -56.14 132.99 51.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 110.286 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.793 ' N ' HD13 ' A' ' 29' ' ' LEU . 88.8 t -103.35 -39.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.888 . . . . 0.0 110.291 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.601 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -168.21 156.75 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 110.309 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.43 150.75 30.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 110.289 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.425 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -150.19 -159.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 110.631 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.8 176.07 5.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.693 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.53 150.78 31.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.78 HG13 HD22 ' A' ' 62' ' ' LEU . 56.0 mt -89.89 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.623 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 84' ' ' LEU . 41.7 t -126.9 106.87 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.632 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB2' ' CD2' ' A' ' 43' ' ' TRP . 35.3 mmt180 -136.53 157.97 45.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 43' ' ' TRP . 39.0 m170 -71.45 176.52 4.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 110.157 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 53.1 p-10 -64.08 -137.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.266 -0.896 . . . . 0.0 110.218 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 40' ' ' ASN . 3.8 t0 67.12 -149.91 0.18 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.853 -1.154 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -45.89 -34.54 3.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.864 . . . . 0.0 111.373 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.642 ' HZ3' HD21 ' B' ' 47' ' ' LEU . 48.4 t-105 -57.54 -55.45 34.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.025 -1.047 . . . . 0.0 110.241 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.58 68.08 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 94.5 m -80.85 -64.5 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.142 -1.211 . . . . 0.0 110.801 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.78 -48.45 15.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.262 -0.899 . . . . 0.0 111.047 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.835 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.0 mm? -91.94 26.81 2.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -64.35 80.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.986 -1.071 . . . . 0.0 110.287 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 50' ' ' TYR . 7.1 t0 -175.65 -53.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.012 . . . . 0.0 110.484 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.484 ' CD2' ' HB3' ' A' ' 49' ' ' ASP . 3.6 m-85 -127.72 54.1 1.72 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.756 HD11 ' HB2' ' A' ' 47' ' ' LEU . 6.0 mt -110.17 114.06 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 111.219 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' CE1' ' HD2' ' C' ' 215' ' ' MLZ . 36.5 m-85 -89.93 114.4 26.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.898 . . . . 0.0 109.221 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -108.0 134.78 50.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.097 -1.002 . . . . 0.0 111.207 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.706 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -111.89 -171.68 1.89 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 109.865 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -82.33 75.12 9.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.978 -1.076 . . . . 0.0 109.21 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.508 49.6 m-80 173.1 -33.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.442 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.848 ' HG2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 178.82 -167.71 0.08 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.437 -0.79 . . . . 0.0 110.351 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.3 156.75 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 110.112 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.582 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -150.32 148.61 29.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 0.0 110.47 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.835 ' CE ' HD12 ' A' ' 47' ' ' LEU . 13.7 mmm -91.37 157.77 16.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.866 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.66 101.89 13.68 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.457 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.813 HD12 ' CB ' ' B' ' 62' ' ' LEU 2.5 0.0 OUTLIER -59.64 -76.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.475 -0.766 . . . . 0.0 111.198 -179.156 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.33 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.761 ' HB3' HD11 ' A' ' 67' ' ' ILE . 89.8 m-85 -89.66 41.81 1.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 110.544 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.866 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -81.0 -22.67 60.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -90.9 -55.41 3.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -1.149 . . . . 0.0 111.058 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.761 HD11 ' HB3' ' A' ' 64' ' ' PHE . 1.6 pp -50.48 -22.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.26 -0.9 . . . . 0.0 111.155 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.478 ' CG ' HG12 ' A' ' 103' ' ' ILE . 0.7 OUTLIER -48.91 122.16 5.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.014 -1.054 . . . . 0.0 110.847 -179.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.55 ' HB2' HG22 ' A' ' 102' ' ' THR . 22.4 m-20 -94.51 173.63 7.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.51 ' NE2' ' CD1' ' A' ' 110' ' ' TRP . 39.6 t60 -102.04 150.57 23.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 0.0 110.121 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 p -149.64 139.57 21.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.481 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.466 ' HB3' HD22 ' A' ' 116' ' ' LEU . 11.2 mttt -54.52 -25.02 23.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 110.243 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.69 51.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.207 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.89 ' O ' HD11 ' A' ' 92' ' ' ILE . 18.5 Cg_endo -62.76 98.83 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.658 1.346 . . . . 0.0 110.554 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.8 -17.91 54.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.17 170.96 15.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 110.331 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.491 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.2 ttt85 -149.73 -161.69 1.4 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.444 ' NE2' ' HD3' ' C' ' 218' ' ' PRO . 31.0 p-80 -130.95 -172.86 2.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 110.919 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 10.4 tt0 -151.73 170.98 18.42 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.171 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD13 ' CD ' ' A' ' 54' ' ' ARG . 0.9 OUTLIER -140.86 124.88 17.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.204 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 86' ' ' ARG . 9.3 t -56.92 -168.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.631 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.94 89.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 110.477 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.73 158.1 32.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.848 HD22 ' HG2' ' A' ' 57' ' ' MET . 2.3 mp -55.35 106.39 0.23 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -1.078 . . . . 0.0 110.348 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 -53.58 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.501 ' H ' HG22 ' A' ' 81' ' ' THR . 0.7 OUTLIER -132.26 169.38 16.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.897 . . . . 0.0 110.266 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 2.8 mtp -140.42 133.35 29.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.92 . . . . 0.0 110.494 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.777 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.8 mtp180 -115.1 176.02 5.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 110.269 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 31' ' ' GLU . 97.2 mt -135.33 111.98 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.967 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 56.1 m-85 -106.58 175.18 5.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.544 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 p -122.95 85.28 2.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.115 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.89 HD11 ' O ' ' A' ' 74' ' ' PRO . 50.9 pt -50.13 -25.45 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.825 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.09 134.68 21.81 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 110.503 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 26' ' ' LYS . 82.0 Cg_exo -47.51 152.04 2.79 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.489 1.257 . . . . 0.0 111.014 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 99' ' ' GLU . 64.1 mt -131.28 148.68 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.006 -1.059 . . . . 0.0 110.64 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.59 157.88 15.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.421 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 21' ' ' ARG . 53.0 mt -63.36 109.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.206 -0.934 . . . . 0.0 110.342 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.08 27.84 2.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 95' ' ' ILE . 52.0 mm-40 -106.73 -177.83 3.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -1.157 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.6 123.1 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.931 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.831 HG13 ' HB2' ' A' ' 20' ' ' ALA . 84.7 mt -89.19 130.78 37.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 69' ' ' ASN . 1.1 p -154.66 143.77 21.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.817 -0.552 . . . . 0.0 110.002 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 77' ' ' ARG . 1.1 pt -105.26 160.75 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 110.491 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.4 t -93.93 -168.87 1.96 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 110.503 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -124.6 -68.85 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 110.3 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 108' ' ' ASP . . . 89.73 -168.45 34.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.491 -1.005 . . . . 0.0 110.723 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 106' ' ' GLY . 5.3 t70 -135.19 -36.98 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.908 -1.12 . . . . 0.0 110.918 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' C' ' 214' ' ' ARG . 0.8 OUTLIER -48.15 117.75 2.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.202 -0.936 . . . . 0.0 110.816 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.525 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 56.0 t-105 55.48 168.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 110.466 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -59.61 -172.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 110.42 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.23 -40.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.303 -0.873 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -50.2 -49.95 72.97 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.884 . . . . 0.0 111.303 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 113' ' ' ARG . 31.4 Cg_exo -52.77 96.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.703 1.37 . . . . 0.0 110.398 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -96.55 -28.38 14.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 110.406 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER 56.21 -87.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -0.854 . . . . 0.0 110.479 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 115' ' ' ARG . 76.2 m -56.83 156.87 6.07 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.955 -1.091 . . . . 0.0 110.158 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 52.95 179.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 110.319 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.368 179.901 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 34.29 5.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -1.139 . . . . 0.0 110.377 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' C' ' 204' ' ' PRO . . . -94.64 176.06 2.55 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 0.0 110.37 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' C' ' 203' ' ' ALA . 37.1 Cg_exo -56.48 165.44 4.47 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.653 1.343 . . . . 0.0 110.495 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.25 -60.35 0.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 110.345 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.08 150.27 30.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 110.363 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.58 136.91 47.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 110.337 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.13 54.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 110.34 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.44 -72.96 0.36 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 110.351 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 17.5 p -137.92 147.61 44.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 110.332 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -43.56 5.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.472 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.65 -166.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 110.471 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.26 -158.69 0.67 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.352 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.461 ' O ' ' CD1' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -97.01 -92.27 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.214 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.455 ' HD2' ' CE1' ' A' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.5 1.6 m -55.33 -170.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.447 -0.783 . . . . 0.0 110.443 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.463 ' O ' HG23 ' C' ' 220' ' ' THR . . . -171.78 154.72 3.68 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.444 ' HD3' ' NE2' ' A' ' 78' ' ' HIS . 41.6 Cg_endo -70.05 154.98 66.05 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.702 1.37 . . . . 0.0 110.627 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.89 69.13 0.73 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.385 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . 0.463 HG23 ' O ' ' C' ' 217' ' ' ALA . 4.2 p -84.12 154.04 23.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.338 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.95 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.415 ' SD ' HG21 ' B' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.199 0.523 . . . . 0.0 110.502 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.473 ' O ' ' CD2' ' B' ' 2' ' ' PHE . 36.4 p90 -172.32 122.13 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.427 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -121.07 163.49 18.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 110.338 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -50.16 -25.57 3.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.93 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.488 ' C ' HG13 ' B' ' 6' ' ' VAL . 26.8 ttp180 -74.72 -45.37 44.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 110.508 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 5' ' ' ARG . 22.9 m -154.23 -178.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -0.936 . . . . 0.0 110.476 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.573 HG23 ' HB2' ' B' ' 19' ' ' PHE . 9.0 tt -152.96 150.47 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.415 HG21 ' SD ' ' B' ' 1' ' ' MET . 92.2 t -94.47 120.23 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.132 -0.98 . . . . 0.0 110.548 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.63 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 32.7 mttt -125.77 146.9 49.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.208 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.63 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 4.1 mmmt 52.47 59.2 4.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.636 -1.915 . . . . 0.0 110.943 2.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.1 p -107.81 -173.6 0.28 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.75 . . . . 0.0 110.139 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 24.5 Cg_exo -60.22 -39.62 66.75 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.636 1.335 . . . . 0.0 110.396 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.04 -23.35 26.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 110.378 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 -155.26 16.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.37 139.24 0.29 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -99.95 72.04 1.68 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -1.187 . . . . 0.0 110.597 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.07 -175.94 20.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' B' ' 67' ' ' ILE . 87.5 t -101.62 145.79 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.011 -1.288 . . . . 0.0 110.075 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.573 ' HB2' HG23 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -110.41 126.08 53.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.256 -0.902 . . . . 0.0 109.791 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.825 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -89.22 89.38 7.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 110.925 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.846 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -58.58 -22.44 55.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 178.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' B' ' 23' ' ' SER . 0.3 OUTLIER -90.83 -178.83 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.442 -0.786 . . . . 0.0 109.883 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.489 ' HA ' ' CG ' ' B' ' 22' ' ' LYS 2.51 18.1 m 100.6 17.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.314 -1.491 . . . . 0.0 110.481 0.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -105.2 161.46 14.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 110.759 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.13 -162.07 0.91 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.418 ' CB ' ' HD3' ' B' ' 94' ' ' PRO . 17.9 tttt -95.48 97.5 9.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.324 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.05 57.94 0.84 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -129.5 121.04 26.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.131 . . . . 0.0 110.421 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.978 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.5 OUTLIER -56.05 132.94 51.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.23 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.795 ' N ' HD13 ' B' ' 29' ' ' LEU . 88.3 t -103.36 -39.92 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.605 ' HB3' HD12 ' B' ' 89' ' ' ILE . 0.9 OUTLIER -168.19 156.76 8.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 110.392 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.41 150.88 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 110.251 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.425 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.0 OUTLIER -150.37 -159.78 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.596 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.88 176.41 5.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 110.723 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.98 150.52 30.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 109.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.764 HG13 HD22 ' B' ' 62' ' ' LEU . 55.8 mt -89.65 147.47 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 109.656 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 84' ' ' LEU . 41.6 t -126.93 106.92 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 110.644 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.498 ' HB2' ' CD2' ' B' ' 43' ' ' TRP . 35.3 mmt180 -136.59 157.99 45.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 38.9 m170 -71.49 176.51 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 110.196 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' B' ' 41' ' ' ASP . 53.2 p-10 -63.99 -138.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 40' ' ' ASN . 3.8 t0 67.16 -149.89 0.18 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.812 -1.18 . . . . 0.0 110.708 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -45.88 -34.62 3.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.279 -0.888 . . . . 0.0 111.349 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.633 ' HZ3' HD21 ' A' ' 47' ' ' LEU . 48.2 t-105 -57.52 -55.5 34.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.63 68.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' B' ' 48' ' ' GLU . 94.5 m -80.8 -64.45 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -1.187 . . . . 0.0 110.762 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.09 -47.53 17.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 111.144 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.0 mm? -93.02 27.15 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.569 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' B' ' 45' ' ' THR . 0.3 OUTLIER -64.45 80.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 110.269 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.473 ' HB3' ' CD2' ' B' ' 50' ' ' TYR . 7.1 t0 -175.7 -53.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.055 -1.028 . . . . 0.0 110.484 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' B' ' 49' ' ' ASP . 3.6 m-85 -127.69 54.05 1.72 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.214 -0.929 . . . . 0.0 109.612 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' B' ' 47' ' ' LEU . 5.9 mt -110.18 114.2 27.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 111.228 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.46 ' CE1' ' HD2' ' D' ' 215' ' ' MLZ . 36.3 m-85 -90.12 114.37 26.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.336 -0.852 . . . . 0.0 109.19 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -107.9 134.73 50.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.09 -1.007 . . . . 0.0 111.2 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.707 ' HB2' HD11 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -112.54 -174.75 2.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.514 -0.741 . . . . 0.0 109.892 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -77.87 74.51 4.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 0.0 110.253 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 49.9 m-80 173.1 -33.58 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.851 ' HG2' HD22 ' B' ' 84' ' ' LEU . 0.0 OUTLIER 179.01 -167.68 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.394 -0.817 . . . . 0.0 110.483 179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -117.15 156.8 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 0.0 110.141 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.578 ' O ' HD23 ' B' ' 51' ' ' LEU . . . -150.46 148.63 28.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 110.514 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.842 ' CE ' HD12 ' B' ' 47' ' ' LEU . 13.7 mmm -91.64 156.43 17.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.126 -0.984 . . . . 0.0 110.303 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.834 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.82 101.97 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.807 . . . . 0.0 110.728 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.813 ' CB ' HD12 ' A' ' 62' ' ' LEU 2.498 0.0 OUTLIER -59.96 -76.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 111.111 -179.355 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.36 -129.22 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.779 ' HB3' HD11 ' B' ' 67' ' ' ILE . 89.7 m-85 -89.66 41.86 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -1.171 . . . . 0.0 110.528 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.834 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -81.13 -22.24 61.34 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -91.45 -55.25 3.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 110.979 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' B' ' 64' ' ' PHE . 1.6 pp -50.51 -22.21 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 111.226 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' B' ' 103' ' ' ILE . 0.7 OUTLIER -48.91 122.13 5.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.017 -1.052 . . . . 0.0 110.835 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.543 ' HB2' HG22 ' B' ' 102' ' ' THR . 22.5 m-20 -94.38 173.98 7.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.843 . . . . 0.0 110.364 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' B' ' 110' ' ' TRP . 39.8 t60 -102.52 150.52 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 6.6 p -149.61 139.62 22.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 110.486 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.467 ' HB3' HD22 ' B' ' 116' ' ' LEU . 11.2 mttt -54.54 -25.03 23.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.933 . . . . 0.0 110.218 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -123.08 79.66 51.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.891 ' O ' HD11 ' B' ' 92' ' ' ILE . 18.0 Cg_endo -62.84 98.84 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.699 1.368 . . . . 0.0 110.558 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -78.76 -17.97 54.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.539 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.15 171.02 15.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.324 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.489 ' HA ' HG22 ' B' ' 103' ' ' ILE . 5.2 ttt85 -149.7 -161.74 1.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 110.314 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.454 ' NE2' ' HD3' ' D' ' 218' ' ' PRO . 31.3 p-80 -130.9 -172.05 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.414 ' HB3' ' HD3' ' B' ' 88' ' ' ARG . 10.4 tt0 -153.09 170.05 21.43 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.712 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.417 HD13 ' CD ' ' B' ' 54' ' ' ARG . 0.9 OUTLIER -140.53 124.81 17.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.378 -0.826 . . . . 0.0 110.172 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.5 HG22 ' H ' ' B' ' 86' ' ' ARG . 9.1 t -57.18 -168.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.463 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.07 89.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 110.581 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.71 158.11 33.01 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.851 HD22 ' HG2' ' B' ' 57' ' ' MET . 2.3 mp -55.38 106.45 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -1.084 . . . . 0.0 110.353 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -53.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 110.395 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.5 ' H ' HG22 ' B' ' 81' ' ' THR . 0.7 OUTLIER -132.29 169.36 16.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 110.271 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.8 mtp -140.47 133.38 29.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.495 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.784 ' HB3' HD21 ' B' ' 29' ' ' LEU . 1.8 mtp180 -115.13 176.04 5.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.605 HD12 ' HB3' ' B' ' 31' ' ' GLU . 97.2 mt -135.38 111.98 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.096 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.978 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 56.5 m-85 -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.573 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 3.0 p -122.99 85.37 2.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.08 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.891 HD11 ' O ' ' B' ' 74' ' ' PRO . 50.9 pt -50.11 -25.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 110.833 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -135.04 134.59 21.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 0.0 110.502 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' B' ' 26' ' ' LYS . 83.6 Cg_exo -47.88 152.21 3.25 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.541 1.285 . . . . 0.0 110.979 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.459 ' CG2' ' HB2' ' B' ' 99' ' ' GLU . 63.9 mt -131.19 148.67 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.64 157.86 15.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.846 HG23 ' O ' ' B' ' 21' ' ' ARG . 53.0 mt -63.31 109.75 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.889 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.09 27.81 2.83 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' B' ' 95' ' ' ILE . 52.4 mm-40 -106.75 -177.91 3.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.268 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.59 122.84 41.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.003 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.825 HG13 ' HB2' ' B' ' 20' ' ' ALA . 84.3 mt -88.71 130.86 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.249 -0.907 . . . . 0.0 110.388 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.543 HG22 ' HB2' ' B' ' 69' ' ' ASN . 1.1 p -154.78 143.78 20.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' B' ' 77' ' ' ARG . 1.1 pt -105.21 160.75 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 110.467 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 44.5 t -93.97 -168.86 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 110.504 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -124.55 -68.9 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 110.352 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' B' ' 108' ' ' ASP . . . 89.77 -168.43 34.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t0 54.94 -88.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -1.04 . . . . 0.0 110.719 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' B' ' 106' ' ' GLY . 5.3 t70 -135.2 -36.97 0.79 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.899 -1.125 . . . . 0.0 110.885 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' D' ' 214' ' ' ARG . 0.8 OUTLIER -48.12 117.66 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -0.995 . . . . 0.0 110.813 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.518 ' CD1' ' NE2' ' B' ' 70' ' ' HIS . 56.1 t-105 55.48 168.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.498 -0.751 . . . . 0.0 110.467 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' B' ' 110' ' ' TRP . 0.2 OUTLIER -59.54 -172.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 110.452 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.29 -40.96 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.329 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.497 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 0.7 OUTLIER -50.65 -49.69 77.27 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.26 -0.9 . . . . 0.0 110.904 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' B' ' 113' ' ' ARG . 31.4 Cg_exo -52.7 96.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.613 1.323 . . . . 0.0 110.479 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 117' ' ' THR . 0.4 OUTLIER -96.6 -28.38 14.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.386 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' B' ' 72' ' ' LYS . 0.4 OUTLIER 56.22 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.45 -0.781 . . . . 0.0 110.459 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.432 ' N ' ' O ' ' B' ' 115' ' ' ARG . 75.9 m -56.77 156.8 6.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.947 -1.095 . . . . 0.0 110.162 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 53.06 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.304 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.351 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 34.35 5.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -1.144 . . . . 0.0 110.384 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' D' ' 204' ' ' PRO . . . -94.63 176.07 2.55 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 110.36 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' D' ' 203' ' ' ALA . 37.3 Cg_exo -56.5 165.42 4.5 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.601 1.316 . . . . 0.0 110.524 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -60.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 110.345 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.1 150.22 30.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.214 -0.929 . . . . 0.0 110.393 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.54 136.96 47.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.18 54.64 0.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.395 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -140.41 -72.97 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.321 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 17.5 p -137.93 147.64 44.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 110.329 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.91 -43.54 5.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.449 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . 52.6 -166.0 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.907 . . . . 0.0 110.472 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.23 -158.63 0.67 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.897 . . . . 0.0 110.392 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.475 ' O ' ' CD1' ' B' ' 109' ' ' TYR . 0.0 OUTLIER -96.99 -92.27 0.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 110.245 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.46 ' HD2' ' CE1' ' B' ' 52' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.501 1.6 m -55.27 -170.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.455 -0.778 . . . . 0.0 110.43 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.452 ' O ' HG23 ' D' ' 220' ' ' THR . . . -171.76 154.77 3.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.421 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.454 ' HD3' ' NE2' ' B' ' 78' ' ' HIS . 41.2 Cg_endo -70.12 155.01 65.75 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.696 1.367 . . . . 0.0 110.558 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.87 69.15 0.73 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.418 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . 0.452 HG23 ' O ' ' D' ' 217' ' ' ALA . 4.3 p -84.19 153.98 23.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 110.302 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tpt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.234 0.54 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -129.82 134.96 47.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 5' ' ' ARG . 1.5 m-80 -111.23 40.72 2.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 110.449 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.53 -88.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.536 -0.727 . . . . 0.0 111.02 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 20.3 mtm180 -52.0 -38.88 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.491 HG21 HG13 ' A' ' 30' ' ' VAL . 98.5 t -135.26 143.82 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 20.0 tt -119.57 165.38 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.556 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -100.15 128.73 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 33.2 mttt -143.62 139.97 29.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.604 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.2 OUTLIER 52.74 55.11 9.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 119.749 -1.845 . . . . 0.0 110.277 1.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -106.71 177.07 1.42 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.798 -0.564 . . . . 0.0 110.366 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' A' ' 11' ' ' SER . 32.8 Cg_exo -55.22 -20.84 26.12 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.691 1.364 . . . . 0.0 110.563 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 13' ' ' LEU . 3.4 mm? -99.74 -35.18 9.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.409 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.87 171.52 13.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . 96.4 116.54 3.26 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.429 ' HB3' ' N ' ' A' ' 301' ' ' SAH . 0.1 OUTLIER -86.2 64.02 8.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.58 -166.43 24.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' A' ' 6' ' ' VAL . 59.7 t -97.88 127.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.962 -1.316 . . . . 0.0 110.081 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 11' ' ' SER . 0.1 OUTLIER -90.5 126.9 36.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.109 . . . . 0.0 109.841 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.86 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -89.21 90.87 8.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.699 -0.625 . . . . 0.0 110.635 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.835 ' O ' HG23 ' A' ' 97' ' ' ILE . 2.7 ttt180 -69.21 -22.13 63.9 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.481 0.658 . . . . 0.0 109.399 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 2.8 mttp -105.41 -177.11 3.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.497 -0.752 . . . . 0.0 109.38 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 22' ' ' LYS 2.516 19.2 m 108.32 34.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.983 -1.698 . . . . 0.0 109.84 1.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 44.2 m-85 -127.28 160.67 30.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 111.076 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.44 -159.88 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.51 -0.743 . . . . 0.0 110.148 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CA ' ' HD3' ' A' ' 94' ' ' PRO . 23.7 tttm -102.19 98.96 9.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.071 -1.018 . . . . 0.0 110.194 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.78 33.91 0.96 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -117.14 141.88 47.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.511 HD12 ' CE2' ' A' ' 90' ' ' PHE . 2.3 tp -83.76 136.96 33.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 6' ' ' VAL . 48.5 t -92.42 -62.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 110.422 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.724 ' HG2' HD12 ' A' ' 89' ' ' ILE . 1.7 pt-20 -159.03 149.2 19.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.199 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -131.53 137.98 48.72 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.108 -0.995 . . . . 0.0 109.902 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.407 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 36.8 m -140.35 178.88 6.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 110.092 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 34' ' ' LEU . 11.3 mp -91.75 169.41 10.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.396 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.518 ' SG ' ' SD ' ' A' ' 87' ' ' MET . 72.8 m -145.51 168.51 20.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.323 -0.86 . . . . 0.0 110.075 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 60' ' ' MET . 39.1 mt -96.76 164.09 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.973 . . . . 0.0 109.638 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 84' ' ' LEU . 51.6 t -143.58 115.85 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 110.828 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 62.5 mmt-85 -144.63 142.49 30.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.144 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.54 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.881 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -98.52 119.76 37.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.727 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -177.38 -141.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.64 -35.49 42.3 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.307 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.7 ' CE3' HD21 ' B' ' 47' ' ' LEU . 13.4 t-105 -63.1 -35.36 79.99 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' O ' ' CA ' ' A' ' 48' ' ' GLU . . . -58.1 -66.06 3.08 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 29.6 m -66.93 -37.03 83.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.325 -1.103 . . . . 0.0 111.011 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -62.56 1.78 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.848 -1.157 . . . . 0.0 108.457 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.874 HD12 ' CE ' ' A' ' 60' ' ' MET . 4.1 mm? -92.81 36.32 1.03 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 109.845 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -71.2 -1.02 11.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.106 -0.996 . . . . 0.0 111.641 -179.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -118.13 150.12 39.89 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.862 -1.148 . . . . 0.0 108.929 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.632 ' HA ' HCM1 ' C' ' 215' ' ' MLZ . 26.1 m-85 57.5 29.14 16.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 60' ' ' MET . 4.6 tp -129.67 138.12 51.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.441 -0.787 . . . . 0.0 111.035 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.485 ' CE1' ' HE3' ' C' ' 215' ' ' MLZ . 60.5 m-85 -92.89 162.14 14.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.371 -0.83 . . . . 0.0 109.615 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' CB ' ' C' ' 214' ' ' ARG . 47.0 p -138.51 113.71 9.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.059 -1.026 . . . . 0.0 110.639 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.55 179.87 4.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 110.169 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -83.64 86.75 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 109.48 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 57' ' ' MET 2.508 41.8 m-80 149.08 -25.54 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -177.51 -158.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 110.143 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 15.2 m -139.86 169.5 17.6 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.875 . . . . 0.0 109.946 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -149.9 149.29 30.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.874 ' CE ' HD12 ' A' ' 47' ' ' LEU . 2.3 ttt -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -87.1 90.5 8.38 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.18 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 36' ' ' ILE 2.502 0.2 OUTLIER -55.32 -73.7 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.771 -179.662 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -64.05 -137.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HB3' HD11 ' A' ' 67' ' ' ILE . 62.2 m-85 -84.18 51.75 2.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -1.111 . . . . 0.0 110.423 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.81 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.45 -27.8 19.01 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 50' ' ' TYR . . . -88.39 -47.34 8.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 110.427 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.864 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.9 pp -47.99 -24.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.29 -0.881 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.864 ' N ' HD12 ' A' ' 67' ' ' ILE . 3.7 m-85 -49.16 120.19 3.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.99 . . . . 0.0 110.584 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.712 ' H ' HG22 ' A' ' 102' ' ' THR . 73.7 m-20 -95.26 175.73 6.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -0.924 . . . . 0.0 110.429 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.693 ' NE2' HD12 ' A' ' 111' ' ' LEU . 15.4 t-160 -96.0 139.06 32.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 110.661 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.3 t -143.75 161.74 37.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 110.142 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.757 ' HD3' HD22 ' A' ' 116' ' ' LEU . 21.9 tptp -83.96 -34.33 24.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 0.0 110.456 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 58.28 20.03 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 110.507 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.09 115.86 4.33 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.53 1.279 . . . . 0.0 110.397 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.753 ' HA ' HD11 ' A' ' 92' ' ' ILE . 42.7 m-80 -89.71 18.74 5.23 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.566 -0.709 . . . . 0.0 110.7 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.474 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -122.49 158.95 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.595 ' HB2' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -145.59 169.46 18.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 110.529 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.79 130.69 47.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 110.403 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.82 152.47 24.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 110.261 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.05 131.04 56.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.509 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 86' ' ' ARG . 40.7 p -57.91 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.9 . . . . 0.0 110.379 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 110.313 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.79 -126.32 1.46 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.635 ' HB3' HG22 ' A' ' 37' ' ' VAL . 4.4 tp -153.09 27.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -1.16 . . . . 0.0 110.265 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 37' ' ' VAL . 25.2 mttm -108.29 -70.73 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 110.585 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.606 ' HB2' HG21 ' A' ' 81' ' ' THR . 12.8 mtt180 -70.61 124.04 23.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 110.429 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.518 ' SD ' ' SG ' ' A' ' 35' ' ' CYS . 20.5 mtp -118.85 124.86 48.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 110.571 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -103.41 164.62 11.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.922 . . . . 0.0 109.958 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.724 HD12 ' HG2' ' A' ' 31' ' ' GLU . 91.3 mt -136.23 126.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 29' ' ' LEU . 48.8 m-85 -122.05 169.74 10.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.73 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.436 HG23 ' CG2' ' A' ' 30' ' ' VAL . 35.5 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 0.0 110.011 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.753 HD11 ' HA ' ' A' ' 75' ' ' ASN . 2.1 pt -62.81 -24.15 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 0.0 110.532 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 92' ' ' ILE . 24.3 mttt -151.1 131.97 7.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.018 -1.051 . . . . 0.0 110.594 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HD3' ' CA ' ' A' ' 26' ' ' LYS . 37.6 Cg_exo -35.47 146.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 122.275 1.983 . . . . 0.0 112.416 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.557 HG23 ' OE1' ' A' ' 99' ' ' GLU . 49.8 mt -127.03 150.16 32.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.498 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.507 ' HB3' ' HG3' ' A' ' 99' ' ' GLU . . . -89.17 158.98 17.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.558 -0.714 . . . . 0.0 110.278 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.5 mp -56.42 -21.52 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 111.474 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.59 61.04 0.31 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.557 ' OE1' HG23 ' A' ' 95' ' ' ILE . 3.5 mt-10 -131.58 175.07 9.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -1.207 . . . . 0.0 110.997 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.17 124.28 44.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.453 -0.779 . . . . 0.0 109.68 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.86 HG13 ' HB2' ' A' ' 20' ' ' ALA . 54.3 mt -88.9 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 110.557 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -159.52 179.42 8.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.816 -0.552 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 104' ' ' SER . 1.6 pp -145.87 133.41 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.575 ' O ' HD12 ' A' ' 103' ' ' ILE . 47.2 t -61.05 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.397 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HB3' ' HB3' ' A' ' 109' ' ' TYR . 24.4 m-85 -123.62 -75.92 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.42 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.01 -173.19 42.34 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.41 -12.38 60.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 110.809 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.57 -55.56 2.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.06 -1.025 . . . . 0.0 110.626 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.464 ' CE2' ' HG3' ' C' ' 215' ' ' MLZ . 3.1 t80 -54.41 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 110.889 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 54.93 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.696 -0.628 . . . . 0.0 111.285 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.793 HD23 ' N ' ' A' ' 112' ' ' SER . 9.6 tt -50.59 151.78 2.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.01 -1.056 . . . . 0.0 110.876 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.793 ' N ' HD23 ' A' ' 111' ' ' LEU . 46.2 p -167.15 -60.02 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.466 -0.771 . . . . 0.0 109.941 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -126.77 144.5 50.21 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 121.306 -0.871 . . . . 0.0 110.258 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 36.9 Cg_exo -56.4 91.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.63 1.332 . . . . 0.0 110.584 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -132.33 55.77 1.87 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 110.343 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.757 HD22 ' HD3' ' A' ' 72' ' ' LYS . 3.3 mp -107.63 125.92 51.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 110.434 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 82.3 m -121.64 144.2 48.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 110.285 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.0 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.409 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.289 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -51.87 5.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -1.141 . . . . 0.0 110.239 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' C' ' 204' ' ' PRO . . . -126.46 165.65 26.72 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 110.291 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' C' ' 203' ' ' ALA . 31.2 Cg_endo -69.28 95.51 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.625 1.329 . . . . 0.0 110.509 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.31 114.69 26.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 110.387 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . 0.759 ' HG2' HD23 ' C' ' 208' ' ' LEU . 0.0 OUTLIER -93.35 44.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.905 . . . . 0.0 110.319 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 52.76 86.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.759 HD23 ' HG2' ' C' ' 206' ' ' LYS . 0.4 OUTLIER -119.88 35.1 4.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 110.387 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.03 109.11 12.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 110.367 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -115.49 22.89 12.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.411 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' C' ' 211' ' ' LYS . 3.8 pttt -166.42 100.29 0.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 110.428 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -112.41 22.94 14.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 110.29 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.2 177.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.455 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.443 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 6.3 mtt180 -131.26 -171.02 2.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.295 -0.878 . . . . 0.0 110.218 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.632 HCM1 ' HA ' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.506 0.3 OUTLIER -53.57 -175.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.28 -0.887 . . . . 0.0 110.573 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.87 155.08 60.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.405 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' C' ' 219' ' ' ALA . 39.4 Cg_endo -73.04 -3.17 13.17 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.681 1.358 . . . . 0.0 111.263 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' C' ' 218' ' ' PRO . . . 55.81 171.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.89 -1.131 . . . . 0.0 110.29 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 1.9 p -99.74 -173.5 2.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 110.43 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.241 0.543 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -129.78 134.95 47.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.393 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 5' ' ' ARG . 1.5 m-80 -111.15 40.62 2.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 53.62 -88.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.47 -0.769 . . . . 0.0 111.028 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.465 ' HA ' ' CD ' ' B' ' 22' ' ' LYS . 20.4 mtm180 -52.05 -38.85 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.925 -1.109 . . . . 0.0 110.619 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.484 HG21 HG13 ' B' ' 30' ' ' VAL . 98.9 t -135.32 143.72 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' B' ' 19' ' ' PHE . 19.9 tt -119.49 165.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.19 128.7 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 110.541 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 33.2 mttt -143.57 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 109.196 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.588 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER 52.82 55.01 9.59 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 119.664 -1.898 . . . . 0.0 110.36 1.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.5 ' HB2' ' CE1' ' B' ' 19' ' ' PHE . 0.0 OUTLIER -106.73 177.11 1.41 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.758 -0.589 . . . . 0.0 110.36 -178.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' B' ' 11' ' ' SER . 32.9 Cg_exo -55.23 -20.87 26.32 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.657 1.346 . . . . 0.0 110.57 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' B' ' 13' ' ' LEU . 3.4 mm? -99.71 -35.2 9.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.902 . . . . 0.0 110.432 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.9 171.57 13.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 10' ' ' LYS . . . 96.39 116.62 3.27 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.433 ' HB3' ' N ' ' B' ' 302' ' ' SAH . 0.1 OUTLIER -86.11 64.4 8.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.519 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.17 -166.43 23.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.47 ' CG1' ' CG1' ' B' ' 6' ' ' VAL . 58.5 t -97.89 127.81 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.951 -1.323 . . . . 0.0 110.122 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' B' ' 11' ' ' SER . 0.1 OUTLIER -90.48 126.56 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 109.948 179.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.836 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -88.62 90.84 8.57 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.465 -0.772 . . . . 0.0 110.761 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.848 ' O ' HG23 ' B' ' 97' ' ' ILE . 2.7 ttt180 -69.24 -21.88 63.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.481 -0.762 . . . . 0.0 109.465 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.513 ' HB2' ' CZ ' ' B' ' 24' ' ' PHE . 2.7 mttp -105.53 -177.08 3.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.53 -0.731 . . . . 0.0 109.387 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.423 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 19.5 m 108.33 34.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.063 -1.648 . . . . 0.0 109.859 1.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' B' ' 22' ' ' LYS . 43.9 m-85 -127.31 160.84 30.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 111.049 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -105.58 -159.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.514 ' HB2' ' HD3' ' B' ' 94' ' ' PRO . 23.6 tttm -102.11 98.97 9.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 0.0 110.198 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.73 33.87 0.96 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -117.13 141.89 47.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.512 HD12 ' CE2' ' B' ' 90' ' ' PHE . 2.3 tp -83.8 136.97 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.484 HG13 HG21 ' B' ' 6' ' ' VAL . 48.4 t -92.38 -62.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.461 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.715 ' CG ' HD12 ' B' ' 89' ' ' ILE . 1.7 pt-20 -159.02 149.27 19.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 110.145 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -131.53 137.86 48.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 110.043 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.408 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 36.5 m -140.42 178.88 7.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 110.015 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.547 HD12 ' N ' ' B' ' 34' ' ' LEU . 11.3 mp -91.76 169.45 10.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 110.394 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' SD ' ' B' ' 87' ' ' MET . 72.7 m -145.57 168.42 20.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.662 HD12 ' HB3' ' B' ' 60' ' ' MET . 39.3 mt -96.73 164.21 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.641 HG22 ' HB3' ' B' ' 84' ' ' LEU . 51.7 t -143.66 115.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 110.83 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 62.4 mmt-85 -144.69 142.44 30.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.36 -0.838 . . . . 0.0 110.114 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -56.5 -167.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 110.877 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -98.59 119.77 37.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 110.733 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -177.4 -141.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.819 . . . . 0.0 109.431 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -51.63 -35.48 42.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.725 -1.234 . . . . 0.0 109.304 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.74 ' CZ3' HD21 ' A' ' 47' ' ' LEU . 13.1 t-105 -63.05 -35.29 79.76 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' B' ' 48' ' ' GLU . . . -58.21 -66.03 3.1 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.462 ' HA ' ' HB2' ' B' ' 48' ' ' GLU . 31.1 m -66.7 -37.25 84.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.253 -1.145 . . . . 0.0 111.063 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -61.3 2.7 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.963 -1.086 . . . . 0.0 108.65 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.885 HD12 ' CE ' ' B' ' 60' ' ' MET . 4.1 mm? -94.58 37.04 1.13 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.407 177.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -71.63 -1.2 12.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 111.545 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -117.83 150.19 39.58 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.903 -1.123 . . . . 0.0 109.017 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.625 ' HA ' HCM1 ' D' ' 215' ' ' MLZ . 25.8 m-85 57.47 29.1 16.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.836 HD12 ' HA ' ' B' ' 60' ' ' MET . 4.7 tp -129.73 138.27 51.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 110.999 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.487 ' CZ ' ' HE3' ' D' ' 215' ' ' MLZ . 60.1 m-85 -93.09 162.16 14.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -0.83 . . . . 0.0 109.548 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' D' ' 214' ' ' ARG . 46.9 p -138.4 113.73 9.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 110.673 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.11 177.31 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -79.95 86.49 5.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.22 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' MET 2.51 41.5 m-80 148.91 -25.69 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.646 -0.659 . . . . 0.0 109.396 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -177.46 -158.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.587 -0.696 . . . . 0.0 110.194 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 15.3 m -139.82 169.48 17.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.906 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.496 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -149.88 149.29 30.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.049 -1.032 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.885 ' CE ' HD12 ' B' ' 47' ' ' LEU . 2.3 ttt -94.43 155.61 16.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 0.0 110.587 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.829 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -85.48 90.32 7.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.847 . . . . 0.0 110.558 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.644 ' CD2' HD11 ' B' ' 36' ' ' ILE 2.502 0.2 OUTLIER -55.44 -73.71 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.741 -179.736 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -64.08 -137.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' B' ' 67' ' ' ILE . 62.2 m-85 -84.17 52.01 2.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 110.406 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.829 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -90.75 -27.68 18.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' B' ' 50' ' ' TYR . . . -88.42 -47.27 8.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 110.446 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.854 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.9 pp -48.08 -24.22 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.339 -0.851 . . . . 0.0 110.879 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.854 ' N ' HD12 ' B' ' 67' ' ' ILE . 3.7 m-85 -49.16 120.14 3.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.203 -0.936 . . . . 0.0 110.57 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.715 ' H ' HG22 ' B' ' 102' ' ' THR . 74.0 m-20 -95.21 175.76 6.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.519 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.696 ' NE2' HD12 ' B' ' 111' ' ' LEU . 15.4 t-160 -96.01 139.05 32.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.926 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 20.7 t -143.77 161.65 38.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.384 -0.822 . . . . 0.0 110.126 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.756 ' HD3' HD22 ' B' ' 116' ' ' LEU . 21.9 tptp -83.92 -34.32 24.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.471 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 58.2 19.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.93 115.81 4.29 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.55 1.29 . . . . 0.0 110.322 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.742 ' HA ' HD11 ' B' ' 92' ' ' ILE . 42.7 m-80 -89.77 18.8 5.21 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.434 -0.791 . . . . 0.0 110.663 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.484 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -122.44 159.02 28.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -145.63 169.47 18.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 110.489 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -128.73 130.73 47.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 110.394 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -107.89 152.53 24.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.591 HG21 ' HB2' ' B' ' 86' ' ' ARG . 40.7 p -57.89 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.376 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.45 62.83 1.4 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.8 -126.31 1.46 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.641 ' HB3' HG22 ' B' ' 37' ' ' VAL . 4.4 tp -153.07 27.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -1.108 . . . . 0.0 110.269 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.424 ' HG3' HG21 ' B' ' 37' ' ' VAL . 25.2 mttm -108.27 -70.82 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.559 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.591 ' HB2' HG21 ' B' ' 81' ' ' THR . 12.8 mtt180 -70.58 124.04 23.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.483 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.54 ' SD ' ' SG ' ' B' ' 35' ' ' CYS . 20.5 mtp -118.87 124.83 48.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -103.33 164.59 11.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 110.016 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.715 HD12 ' CG ' ' B' ' 31' ' ' GLU . 91.4 mt -136.15 126.8 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.512 ' CE2' HD12 ' B' ' 29' ' ' LEU . 48.8 m-85 -122.03 169.81 10.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.729 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.43 HG23 ' CG2' ' B' ' 30' ' ' VAL . 35.3 p -108.37 108.03 18.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.976 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' B' ' 75' ' ' ASN . 2.1 pt -62.87 -24.14 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 110.527 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.639 ' HG3' HD12 ' B' ' 92' ' ' ILE . 24.3 mttt -151.1 131.8 7.3 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.968 -1.083 . . . . 0.0 110.601 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' B' ' 26' ' ' LYS . 39.5 Cg_exo -35.32 145.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.482 0.806 0 C-N-CA 122.339 2.026 . . . . 0.0 112.36 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.557 HG23 ' OE1' ' B' ' 99' ' ' GLU . 49.7 mt -127.07 149.81 32.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.468 -0.77 . . . . 0.0 110.561 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.494 ' HB3' ' HG3' ' B' ' 99' ' ' GLU . . . -88.6 159.08 18.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.434 -0.791 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.848 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.5 mp -56.51 -21.52 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 111.423 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.68 61.07 0.31 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.557 ' OE1' HG23 ' B' ' 95' ' ' ILE . 3.4 mt-10 -131.7 174.96 9.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -1.23 . . . . 0.0 111.03 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -121.25 123.89 43.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.44 -0.788 . . . . 0.0 109.823 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.836 HG13 ' HB2' ' B' ' 20' ' ' ALA . 54.1 mt -88.44 138.25 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.657 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.715 HG22 ' H ' ' B' ' 69' ' ' ASN . 0.2 OUTLIER -159.61 179.41 8.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.596 -0.69 . . . . 0.0 109.826 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.566 HD12 ' O ' ' B' ' 104' ' ' SER . 1.6 pp -145.84 133.43 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 110.242 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.566 ' O ' HD12 ' B' ' 103' ' ' ILE . 47.2 t -61.09 -166.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 110.432 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 109' ' ' TYR . 24.4 m-85 -123.39 -75.88 0.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.45 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.05 -173.21 42.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -76.4 -12.4 60.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -1.105 . . . . 0.0 110.825 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.61 -55.49 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 110.619 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.474 ' CE2' ' HG3' ' D' ' 215' ' ' MLZ . 3.1 t80 -54.35 96.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 110.875 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 11.1 m95 55.0 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 0.0 111.242 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.788 HD23 ' N ' ' B' ' 112' ' ' SER . 9.6 tt -50.64 151.88 2.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.957 -1.089 . . . . 0.0 110.871 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.788 ' N ' HD23 ' B' ' 111' ' ' LEU . 47.1 p -167.19 -59.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.436 -0.79 . . . . 0.0 109.975 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.87 144.56 50.58 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.395 -0.816 . . . . 0.0 110.169 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.41 91.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.608 1.32 . . . . 0.0 110.58 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -132.28 55.77 1.86 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.756 HD22 ' HD3' ' B' ' 72' ' ' LYS . 3.2 mp -107.69 125.93 51.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.389 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 82.0 m -121.7 144.16 48.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 110.264 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.04 -179.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.392 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.317 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.91 -51.85 5.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -1.133 . . . . 0.0 110.232 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' D' ' 204' ' ' PRO . . . -126.46 165.61 26.97 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 0.0 110.291 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' D' ' 203' ' ' ALA . 31.2 Cg_endo -69.26 95.51 0.51 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.605 1.318 . . . . 0.0 110.56 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 114.75 26.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 110.375 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . 0.76 ' HG2' HD23 ' D' ' 208' ' ' LEU . 0.0 OUTLIER -93.38 44.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.314 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 52.85 86.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.475 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . 0.76 HD23 ' HG2' ' D' ' 206' ' ' LYS . 0.4 OUTLIER -119.9 35.14 4.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 110.389 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.11 109.08 12.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -0.965 . . . . 0.0 110.342 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -115.5 22.95 12.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 110.451 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' D' ' 211' ' ' LYS . 3.8 pttt -166.42 100.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 110.464 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -112.39 22.94 14.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.964 . . . . 0.0 110.338 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . 53.23 177.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 110.473 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.44 ' CB ' ' HB3' ' B' ' 53' ' ' SER . 6.3 mtt180 -131.26 -171.04 2.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 110.215 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.625 HCM1 ' HA ' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.505 0.3 OUTLIER -53.74 -175.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.561 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . . . . . . . . . . . -121.84 155.06 60.85 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 110.437 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' D' ' 219' ' ' ALA . 39.3 Cg_endo -72.99 -3.19 13.2 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.659 1.347 . . . . 0.0 111.237 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' D' ' 218' ' ' PRO . . . 55.8 171.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.962 -1.086 . . . . 0.0 110.24 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 1.9 p -99.72 -173.47 2.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 110.432 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.968 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.453 ' HB2' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.452 ' HB2' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.737 ' SD ' HG21 ' A' ' 8' ' ' VAL . 2.6 mmt . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.288 0.566 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 28.3 p90 -51.16 141.9 13.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 110.584 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -138.07 143.42 40.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.191 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.63 -49.99 18.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.374 -0.828 . . . . 0.0 111.354 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.541 ' C ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -68.49 -37.41 80.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 110.772 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.634 HG21 HG13 ' A' ' 30' ' ' VAL . 90.2 t -153.54 149.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.192 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.624 HG23 ' HB2' ' A' ' 19' ' ' PHE . 14.9 tt -118.26 167.11 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.589 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.737 HG21 ' SD ' ' A' ' 1' ' ' MET . 87.0 t -99.53 126.08 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.597 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -150.48 115.51 5.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.689 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.597 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 2.2 tmtt? 61.91 66.17 0.85 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 119.546 -1.971 . . . . 0.0 110.742 2.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.479 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -175.06 -48.29 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.412 -0.805 . . . . 0.0 111.312 179.186 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 11' ' ' SER . 2.7 Cg_exo -79.86 -151.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.393 1.207 . . . . 0.0 110.505 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.65 -12.69 18.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 110.717 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.63 -137.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.31 -143.75 9.86 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CZ ' ' HE2' ' A' ' 10' ' ' LYS . 15.1 m-85 -98.03 105.1 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -1.134 . . . . 0.0 110.637 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.04 -171.5 15.37 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.884 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.1 p -123.36 132.13 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.97 -1.312 . . . . 0.0 109.679 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HB2' HG23 ' A' ' 7' ' ' ILE . 3.2 m-30 -95.21 164.04 13.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.823 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -124.09 97.97 5.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.478 -0.764 . . . . 0.0 110.623 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.54 -19.62 49.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.115 178.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 5.7 mttm -90.7 178.77 5.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.88 . . . . 0.0 108.982 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.437 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 49.6 m 102.43 18.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.081 -1.637 . . . . 0.0 110.325 1.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 24.1 m-85 -108.73 158.32 17.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.87 -159.59 0.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 110.268 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 24.9 tttt -97.76 90.37 4.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.68 52.13 0.2 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.35 135.05 49.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.169 . . . . 0.0 110.422 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.913 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -76.33 105.29 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.708 HG23 HG23 ' A' ' 91' ' ' THR . 93.0 t -67.66 -46.63 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.247 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.67 152.19 6.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.45 141.97 35.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 110.488 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.412 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -146.2 -177.0 5.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 110.28 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 -178.8 4.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 60' ' ' MET . 25.6 p -148.94 174.3 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.485 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.873 HG13 HD22 ' A' ' 62' ' ' LEU . 46.7 mt -105.73 102.2 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.588 HG21 ' O ' ' A' ' 84' ' ' LEU . 28.4 t -86.82 92.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -0.953 . . . . 0.0 110.141 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 39' ' ' HIS . 15.2 tpt180 -116.44 154.26 30.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.376 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.9 m170 -61.21 -167.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.433 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.65 28.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.55 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.48 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 109.228 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -50.75 -25.71 4.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.608 -1.307 . . . . 0.0 109.651 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.481 ' CZ3' ' HG ' ' A' ' 47' ' ' LEU . 19.0 t-105 -57.81 -56.73 18.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.656 -0.653 . . . . 0.0 109.447 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.88 86.62 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 m -62.75 -65.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -1.156 . . . . 0.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.11 -47.7 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 110.227 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.693 HD12 ' HE3' ' A' ' 60' ' ' MET . 4.4 mm? -90.61 41.0 1.04 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 110.51 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 62.35 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 0.0 110.608 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER 179.5 139.23 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.844 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.478 ' CE1' ' OXT' ' A' ' 301' ' ' SAH . 13.8 m-85 56.82 33.41 23.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 110.563 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 51' ' ' LEU . 8.7 mt -105.51 102.09 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 110.459 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' C' ' 215' ' ' MLZ . 55.2 m-85 -88.85 102.92 15.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.106 -0.996 . . . . 0.0 109.021 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' C' ' 214' ' ' ARG . 13.2 t -103.2 155.91 18.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 111.453 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.711 ' HB2' HD11 ' A' ' 84' ' ' LEU . 11.4 mtp180 -116.97 -173.38 2.38 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -83.61 74.07 10.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 74.1 m-20 167.85 -27.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.485 ' CG ' HD12 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -174.57 -174.91 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.339 -0.85 . . . . 0.0 110.89 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 2.4 p -117.62 147.13 43.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.838 ' CB ' HD22 ' A' ' 84' ' ' LEU . . . -132.1 133.85 44.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.0 . . . . 0.0 110.605 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.693 ' HE3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -89.29 155.08 19.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 109.935 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.894 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -86.63 93.08 9.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.11 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.873 HD22 HG13 ' A' ' 36' ' ' ILE 2.505 0.0 OUTLIER -55.64 -70.29 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.41 -0.806 . . . . 0.0 110.691 -179.175 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 33' ' ' CYS . . . -63.79 -150.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.0 57.72 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.438 -1.036 . . . . 0.0 110.711 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.894 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.82 -24.68 27.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.29 -42.71 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -1.147 . . . . 0.0 110.532 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.531 HD13 ' HB ' ' A' ' 18' ' ' VAL . 1.1 pp -49.91 -29.26 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.975 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' A' ' 89' ' ' ILE . 13.8 m-85 -55.12 140.01 39.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.014 . . . . 0.0 110.655 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -118.24 -177.69 3.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.201 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.514 ' NE2' ' CE2' ' A' ' 110' ' ' TRP . 18.9 t60 -100.76 125.37 47.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 110.254 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -129.97 141.44 50.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.12 20.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.182 -0.949 . . . . 0.0 110.54 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.49 87.43 41.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.88 . . . . 0.0 110.148 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.789 ' O ' HD11 ' A' ' 92' ' ' ILE . 10.9 Cg_endo -58.06 105.24 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.605 1.318 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.13 -17.19 57.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 110.613 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.1 166.98 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.569 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.11 -163.73 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.171 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 50.7 p-80 -143.07 163.69 32.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.545 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 43.2 tt0 -146.56 112.05 5.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD12 ' CD ' ' C' ' 218' ' ' PRO . 1.8 mp -91.22 60.22 4.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.079 -1.013 . . . . 0.0 110.427 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.453 ' CG2' ' HB2' ' A' ' 86' ' ' ARG . 0.1 OUTLIER 42.15 28.39 0.1 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.592 -0.692 . . . . 0.0 111.212 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.45 24.31 2.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.45 28.33 0.17 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.105 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.838 HD22 ' CB ' ' A' ' 59' ' ' ALA . 62.8 mt 50.99 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.252 . . . . 0.0 110.734 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -178.46 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.795 . . . . 0.0 110.517 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HB2' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -145.24 102.9 3.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.125 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.421 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 3.8 mtp -81.24 118.63 22.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.743 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.739 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -111.02 127.0 55.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.744 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.476 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 10.0 mt -89.1 117.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.092 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.913 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 18.9 m-85 -107.3 -173.57 2.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.32 -0.863 . . . . 0.0 110.411 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.708 HG23 HG23 ' A' ' 30' ' ' VAL . 21.3 p -130.44 93.24 3.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.308 -0.87 . . . . 0.0 110.199 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.789 HD11 ' O ' ' A' ' 74' ' ' PRO . 2.4 pt -56.86 -19.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.471 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' N ' HG13 ' A' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.65 18.11 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -51.42 141.2 41.94 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.519 1.273 . . . . 0.0 110.452 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.464 HG23 ' HG3' ' A' ' 99' ' ' GLU . 13.9 mt -109.64 150.52 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 99' ' ' GLU . . . -94.71 156.9 16.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.59 -0.694 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.839 HG23 ' O ' ' A' ' 21' ' ' ARG . 21.9 mt -63.58 112.04 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.72 36.61 3.44 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -101.11 155.84 17.76 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.294 -1.121 . . . . 0.0 110.57 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.0 115.04 26.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.133 -0.979 . . . . 0.0 109.717 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.957 HD11 ' HB2' ' A' ' 20' ' ' ALA . 16.2 mt -89.64 122.46 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 110.435 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' C ' ' A' ' 101' ' ' ILE . 68.6 p -154.77 134.21 12.63 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 104' ' ' SER . 1.1 pp -104.99 153.82 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.096 . . . . 0.0 110.524 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -80.0 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.524 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.502 ' CD1' ' HG3' ' C' ' 215' ' ' MLZ . 17.6 m-85 -127.14 -68.49 0.79 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.22 24.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.23 -39.63 60.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -1.116 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -57.58 -61.4 2.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.275 -0.89 . . . . 0.0 110.109 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.53 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 3.2 m-85 -94.37 51.6 1.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.32 -0.862 . . . . 0.0 110.543 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.514 ' CE2' ' NE2' ' A' ' 70' ' ' HIS . 10.5 t-105 -175.1 177.84 1.85 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.584 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -164.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.4 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.69 -77.7 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 110.382 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -155.75 69.22 5.18 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 110.493 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.41 ' O ' ' HD3' ' A' ' 115' ' ' ARG . 36.8 Cg_endo -70.56 126.61 12.96 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.713 1.375 . . . . 0.0 110.353 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 114' ' ' PRO . 0.9 OUTLIER -128.16 115.36 18.27 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 110.635 -179.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.85 -31.72 70.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 110.419 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 118' ' ' GLN . 1.8 m -65.1 176.47 1.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 110.323 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 117' ' ' THR . 59.3 tt0 -58.98 149.42 27.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.344 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.351 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -102.52 113.92 27.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 110.435 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . -99.99 123.9 45.54 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 110.203 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -59.13 -163.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.435 1.229 . . . . 0.0 110.521 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -55.11 -25.98 35.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 110.247 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.45 139.24 55.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 110.297 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -132.11 -48.88 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 110.375 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.43 116.6 33.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.54 49.1 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 110.331 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . 0.555 HG22 ' O ' ' C' ' 210' ' ' THR . 58.1 m -124.02 47.85 2.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 110.335 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -118.3 87.45 2.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 110.439 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -168.06 -160.08 0.31 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 110.277 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.42 44.59 2.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.423 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.53 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER 49.58 -173.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.763 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.502 ' HG3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.501 0.0 OUTLIER -57.42 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.427 -0.796 . . . . 0.0 110.382 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.927 ' HB3' HG23 ' C' ' 220' ' ' THR . . . -156.61 -176.23 0.59 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 110.357 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.706 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 22.1 Cg_exo -61.95 96.17 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.659 1.347 . . . . 0.0 110.586 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.74 70.96 0.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 110.536 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . 0.927 HG23 ' HB3' ' C' ' 217' ' ' ALA . 1.1 p -79.86 68.43 5.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.276 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 CA-C-O 117.98 -1.455 . . . . 0.0 109.479 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.742 ' SD ' HG21 ' B' ' 8' ' ' VAL . 2.6 mmt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.252 0.549 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 28.3 p90 -51.13 141.76 13.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 110.626 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -137.88 143.66 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 110.153 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -46.83 -49.89 19.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.823 . . . . 0.0 111.326 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.535 ' C ' HG23 ' B' ' 6' ' ' VAL . 0.0 OUTLIER -68.55 -37.4 79.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 110.769 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.635 HG21 HG13 ' B' ' 30' ' ' VAL . 89.8 t -153.52 149.14 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 110.185 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.616 HG23 ' HB2' ' B' ' 19' ' ' PHE . 15.0 tt -118.2 167.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.582 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.742 HG21 ' SD ' ' B' ' 1' ' ' MET . 87.2 t -99.6 126.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 110.349 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.591 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -150.8 115.56 5.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.628 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.591 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 2.2 tmtt? 62.0 66.25 0.83 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.599 -1.938 . . . . 0.0 110.748 2.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.472 ' CB ' ' HD3' ' B' ' 12' ' ' PRO . 0.1 OUTLIER -175.38 -47.94 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 111.037 178.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' B' ' 11' ' ' SER . 2.7 Cg_exo -79.76 -151.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.341 1.18 . . . . 0.0 110.553 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.63 -12.66 19.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 110.68 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.65 -137.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.34 -143.73 9.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.511 ' CZ ' ' HE2' ' B' ' 10' ' ' LYS . 15.2 m-85 -98.0 105.01 17.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -1.13 . . . . 0.0 110.688 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.85 -171.55 15.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.897 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.2 p -123.25 132.02 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.326 . . . . 0.0 109.794 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.616 ' HB2' HG23 ' B' ' 7' ' ' ILE . 3.2 m-30 -95.29 164.05 13.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 110.791 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.986 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -124.26 98.07 5.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.834 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.0 OUTLIER -59.51 -19.67 49.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 179.017 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.489 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 5.7 mttm -90.59 178.75 6.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.042 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.441 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.516 49.9 m 102.45 18.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.079 -1.638 . . . . 0.0 110.325 1.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 24.1 m-85 -108.67 158.32 17.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -0.973 . . . . 0.0 110.436 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -101.86 -159.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.913 . . . . 0.0 110.26 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -97.69 90.29 4.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.73 52.13 0.2 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.33 135.06 50.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -1.165 . . . . 0.0 110.477 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.896 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 0.9 OUTLIER -76.35 105.28 7.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 110.254 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.719 HG23 HG23 ' B' ' 91' ' ' THR . 92.9 t -67.73 -46.56 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.64 152.26 6.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -140.5 141.9 35.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.503 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.412 ' CB ' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -146.18 -176.96 5.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.301 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.45 -178.7 4.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 110.276 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 60' ' ' MET . 25.6 p -149.0 174.31 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.482 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.894 HG13 HD22 ' B' ' 62' ' ' LEU . 46.6 mt -105.96 100.76 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.575 HG21 ' O ' ' B' ' 84' ' ' LEU . 24.8 t -84.84 92.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 110.499 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' B' ' 39' ' ' HIS . 15.1 tpt180 -116.66 154.3 30.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.414 ' N ' ' HG3' ' B' ' 38' ' ' ARG . 3.0 m170 -61.14 -167.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.416 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -111.02 114.66 28.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -176.53 -138.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.44 -0.787 . . . . 0.0 109.234 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -50.8 -25.65 4.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.69 -1.256 . . . . 0.0 109.616 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' B' ' 47' ' ' LEU . 19.1 t-105 -57.84 -56.75 17.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.65 -0.656 . . . . 0.0 109.415 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.82 86.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 8.9 m -62.76 -65.1 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -1.134 . . . . 0.0 110.412 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.43 75.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.728 HD12 ' HE3' ' B' ' 60' ' ' MET . 4.4 mm? -90.94 41.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 110.403 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.02 62.34 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 110.602 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 47' ' ' LEU . 0.3 OUTLIER 179.51 139.28 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 0.0 109.876 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.474 ' CE1' ' OXT' ' B' ' 302' ' ' SAH . 13.8 m-85 56.81 33.47 23.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.179 -0.951 . . . . 0.0 110.491 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' B' ' 51' ' ' LEU . 8.6 mt -105.5 101.7 11.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.55 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' D' ' 215' ' ' MLZ . 55.6 m-85 -88.28 102.95 15.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.121 -0.987 . . . . 0.0 109.16 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' D' ' 214' ' ' ARG . 13.2 t -103.21 155.86 18.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 111.525 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.705 ' HB2' HD11 ' B' ' 84' ' ' LEU . 11.5 mtp180 -117.5 -176.04 2.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.579 -0.701 . . . . 0.0 109.63 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -79.79 73.64 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.51 73.8 m-20 167.77 -27.22 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.491 ' CG ' HD12 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -174.43 -174.65 0.88 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.36 -0.838 . . . . 0.0 110.913 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' B' ' 53' ' ' SER . 2.4 p -117.68 147.09 43.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.832 ' CB ' HD22 ' B' ' 84' ' ' LEU . . . -132.18 133.64 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.728 ' HE3' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -89.21 153.72 20.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.148 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.861 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -84.78 93.02 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 110.5 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.894 HD22 HG13 ' B' ' 36' ' ' ILE 2.507 0.0 OUTLIER -55.7 -70.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.728 -179.39 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' B' ' 33' ' ' CYS . . . -63.69 -150.47 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -76.03 58.06 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.406 -1.055 . . . . 0.0 110.627 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.861 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -91.34 -24.42 26.54 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.36 -42.72 16.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -1.155 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.524 HD13 ' HB ' ' B' ' 18' ' ' VAL . 1.1 pp -49.94 -29.27 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.0 110.95 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.466 ' CZ ' HG12 ' B' ' 89' ' ' ILE . 13.8 m-85 -55.1 140.08 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.011 -1.055 . . . . 0.0 110.621 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -118.37 -177.73 3.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 110.189 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.528 ' NE2' ' CE2' ' B' ' 110' ' ' TRP . 18.8 t60 -100.7 125.39 47.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 110.292 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.5 t -129.99 141.43 50.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.259 -0.901 . . . . 0.0 110.201 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -51.03 -32.17 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.528 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.45 87.41 40.86 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 110.196 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.794 ' O ' HD11 ' B' ' 92' ' ' ILE . 10.9 Cg_endo -58.12 105.32 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.669 1.352 . . . . 0.0 110.393 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -78.18 -17.17 57.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.875 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.13 167.03 23.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.126 -0.984 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -135.16 -163.68 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 110.193 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 50.8 p-80 -143.11 163.68 32.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.53 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' B' ' 88' ' ' ARG . 43.3 tt0 -146.62 112.03 5.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.336 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.504 HD12 ' CD ' ' D' ' 218' ' ' PRO . 1.8 mp -91.16 60.12 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.451 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' B' ' 86' ' ' ARG . 0.1 OUTLIER 42.24 28.42 0.11 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.543 -0.723 . . . . 0.0 111.149 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.42 24.27 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -167.4 28.27 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.069 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.832 HD22 ' CB ' ' B' ' 59' ' ' ALA . 62.6 mt 51.16 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.179 -1.189 . . . . 0.0 110.704 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' B' ' 84' ' ' LEU . 0.0 OUTLIER -178.52 -33.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.789 . . . . 0.0 110.464 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.454 ' HB2' ' CG2' ' B' ' 81' ' ' THR . 0.1 OUTLIER -145.23 102.94 3.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.119 179.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' B' ' 80' ' ' LEU . 3.8 mtp -81.24 118.59 22.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -111.0 126.7 55.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.831 179.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.466 HG12 ' CZ ' ' B' ' 68' ' ' PHE . 10.0 mt -88.67 117.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 110.183 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.896 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 18.9 m-85 -107.35 -173.52 2.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 110.461 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.719 HG23 HG23 ' B' ' 30' ' ' VAL . 21.3 p -130.44 93.19 3.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.794 HD11 ' O ' ' B' ' 74' ' ' PRO . 2.5 pt -56.88 -19.05 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.429 ' N ' HG13 ' B' ' 92' ' ' ILE . 2.8 ptpt -147.76 143.69 18.17 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 110.115 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.68 141.43 43.73 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.521 1.274 . . . . 0.0 110.378 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.463 HG23 ' CB ' ' B' ' 99' ' ' GLU . 14.0 mt -109.7 150.53 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.15 -0.969 . . . . 0.0 110.705 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 99' ' ' GLU . . . -94.72 156.88 16.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.506 -0.746 . . . . 0.0 110.169 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.834 HG23 ' O ' ' B' ' 21' ' ' ARG . 22.0 mt -63.53 112.09 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.965 -1.084 . . . . 0.0 110.206 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.65 36.58 3.46 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.463 ' CB ' HG23 ' B' ' 95' ' ' ILE . 0.4 OUTLIER -100.94 155.68 17.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.304 -1.115 . . . . 0.0 110.591 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.96 114.89 26.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.994 . . . . 0.0 109.732 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.986 HD11 ' HB2' ' B' ' 20' ' ' ALA . 16.9 mt -89.36 122.49 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.516 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.535 HG23 ' C ' ' B' ' 101' ' ' ILE . 66.6 p -154.67 134.28 12.75 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.589 HD12 ' O ' ' B' ' 104' ' ' SER . 1.1 pp -104.93 153.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.919 -1.113 . . . . 0.0 110.549 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.589 ' O ' HD12 ' B' ' 103' ' ' ILE . 0.5 OUTLIER -79.98 -163.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.498 ' CD1' ' HG3' ' D' ' 215' ' ' MLZ . 17.6 m-85 -127.13 -68.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 110.229 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.01 179.21 24.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.31 -39.66 60.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -1.143 . . . . 0.0 110.23 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -57.55 -61.5 2.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 110.111 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.528 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 3.2 m-85 -94.27 51.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.311 -0.868 . . . . 0.0 110.565 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . 0.528 ' CE2' ' NE2' ' B' ' 70' ' ' HIS . 10.6 t-105 -175.12 177.79 1.86 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -164.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.437 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -77.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.399 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -155.82 69.15 5.13 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 110.447 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.407 ' O ' ' HD3' ' B' ' 115' ' ' ARG . 36.7 Cg_endo -70.4 126.63 13.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.616 1.324 . . . . 0.0 110.34 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' B' ' 114' ' ' PRO . 0.9 OUTLIER -128.35 115.55 18.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.329 -0.857 . . . . 0.0 110.652 -179.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.9 -31.71 70.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 110.37 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.454 HG22 ' H ' ' B' ' 118' ' ' GLN . 1.7 m -65.13 176.48 1.28 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 110.377 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . 0.454 ' H ' HG22 ' B' ' 117' ' ' THR . 59.3 tt0 -58.94 149.44 27.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 110.406 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.363 179.967 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -102.56 113.93 27.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.192 -1.181 . . . . 0.0 110.401 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . -99.94 123.9 45.64 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.238 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -59.08 -163.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.355 1.187 . . . . 0.0 110.564 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -55.04 -26.11 35.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.35 139.29 55.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -132.17 -48.85 0.93 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 0.0 110.375 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.49 116.66 33.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 110.387 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.56 49.13 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . 0.552 HG22 ' O ' ' D' ' 210' ' ' THR . 58.4 m -124.06 47.85 2.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 110.292 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -118.33 87.47 2.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 110.466 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -168.05 -160.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 110.294 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.36 44.54 2.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.414 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.528 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 0.8 OUTLIER 49.68 -173.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.674 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.498 ' HG3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.502 0.0 OUTLIER -57.35 -163.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.294 -0.879 . . . . 0.0 110.429 179.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.93 ' HB3' ' CG2' ' D' ' 220' ' ' THR . . . -156.57 -176.2 0.59 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 110.436 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.719 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 22.2 Cg_exo -62.03 96.19 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.678 1.357 . . . . 0.0 110.579 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . 52.74 71.03 0.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 110.519 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . 0.93 ' CG2' ' HB3' ' D' ' 217' ' ' ALA . 1.1 p -79.91 68.44 6.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 110.247 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.524 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.478 ' OXT' ' CE1' ' A' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.474 ' OXT' ' CE1' ' B' ' 50' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' O ' ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.166 0.508 . . . . 0.0 110.437 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -59.34 83.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.404 -0.81 . . . . 0.0 111.764 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.7 t-20 -99.89 147.63 25.33 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.752 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.0 -23.52 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 111.288 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.532 ' C ' HG23 ' A' ' 6' ' ' VAL . 2.7 mtt180 -102.73 -29.67 11.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.028 -1.045 . . . . 0.0 111.121 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.532 HG23 ' C ' ' A' ' 5' ' ' ARG . 94.9 t -153.23 137.31 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.079 -1.013 . . . . 0.0 110.426 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 5.7 tt -117.48 161.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.244 -0.91 . . . . 0.0 110.971 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.4 p -88.97 124.24 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 110.097 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 39.0 mttt -150.35 129.19 12.47 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.392 -0.818 . . . . 0.0 109.281 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.603 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 57.96 74.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 119.669 -1.894 . . . . 0.0 111.928 1.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.507 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -173.06 -49.93 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.359 -0.838 . . . . 0.0 111.579 177.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' A' ' 11' ' ' SER . 16.9 Cg_exo -69.41 -35.11 14.31 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.421 1.222 . . . . 0.0 110.666 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.28 -33.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.76 -155.53 21.07 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.69 89.77 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CG ' ' HD3' ' A' ' 10' ' ' LYS . 1.1 m-85 -58.63 94.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -1.147 . . . . 0.0 110.442 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' ND2' ' A' ' 69' ' ' ASN . . . -120.28 171.61 14.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.72 ' CG2' HD13 ' A' ' 67' ' ' ILE . 95.0 t -93.09 140.43 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.938 -1.33 . . . . 0.0 109.825 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' CD1' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -105.73 132.88 51.32 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.11 -0.993 . . . . 0.0 110.086 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB2' ' CG1' ' A' ' 101' ' ' ILE . . . -88.39 88.45 7.63 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.702 -0.624 . . . . 0.0 110.446 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.88 ' O ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -67.4 -15.04 63.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.798 178.089 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 2.0 mttm -106.79 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.91 20.93 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.154 -1.591 . . . . 0.0 109.846 1.389 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 54.1 m-85 -118.65 163.91 16.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 110.544 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.34 -178.63 3.65 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.335 -0.853 . . . . 0.0 110.025 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -74.45 99.66 3.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.947 . . . . 0.0 110.299 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.25 61.8 0.55 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.3 123.28 23.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -1.153 . . . . 0.0 110.505 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.918 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -66.63 127.48 32.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 110.176 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.704 ' N ' HD13 ' A' ' 29' ' ' LEU . 90.9 t -88.89 -46.55 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 110.346 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.47 153.17 6.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.408 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.18 136.46 31.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 110.304 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.429 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.79 170.32 9.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.697 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.0 -174.2 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.685 ' CD1' HD21 ' A' ' 62' ' ' LEU . 65.0 mt -123.75 151.97 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 84' ' ' LEU . 43.7 t -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.519 ' HB2' ' CE2' ' A' ' 43' ' ' TRP . 14.8 mmt-85 -134.86 145.68 48.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.269 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -63.31 176.97 0.7 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 110.359 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 40' ' ' ASN . 2.9 m120 -67.48 -131.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.142 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.25 0.24 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.624 -1.298 . . . . 0.0 110.596 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.12 -25.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.158 -0.964 . . . . 0.0 111.09 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.519 ' CE2' ' HB2' ' A' ' 38' ' ' ARG . 60.4 t-105 -69.29 -55.85 9.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.155 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' HA3' ' NH2' ' C' ' 214' ' ' ARG . . . -59.61 -22.48 56.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 48' ' ' GLU . 97.4 m -90.28 -60.15 2.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -1.212 . . . . 0.0 110.663 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.72 -55.45 11.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.872 -1.143 . . . . 0.0 110.231 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.953 ' HB2' HD11 ' A' ' 51' ' ' LEU . 4.0 mm? -92.24 33.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 110.085 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 9.8 pt-20 -68.48 64.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.171 -0.956 . . . . 0.0 111.026 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 47' ' ' LEU . 16.2 t0 -169.42 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.858 -1.151 . . . . 0.0 111.024 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.487 ' CG ' ' HB1' ' A' ' 66' ' ' ALA . 25.8 m-85 -128.87 53.51 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.05 -1.031 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' A' ' 47' ' ' LEU . 52.7 mt -124.98 118.02 25.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 111.118 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 48.3 m-85 -89.41 101.54 14.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 108.995 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.8 t -98.92 155.52 17.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 111.561 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -123.61 -168.07 1.72 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.616 -0.678 . . . . 0.0 109.756 178.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -83.04 79.58 9.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.964 -1.085 . . . . 0.0 109.384 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.509 1.5 p30 160.91 -25.18 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.766 -0.584 . . . . 0.0 110.049 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.67 -167.82 0.2 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.425 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 1.3 m -130.68 139.28 50.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.3 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.898 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . . . -124.13 172.39 9.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.685 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.63 ' CE ' HD12 ' A' ' 47' ' ' LEU . 9.5 ttt -117.01 153.04 33.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.697 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -88.95 90.9 8.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.445 -0.784 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.846 HD22 HD22 ' B' ' 62' ' ' LEU 2.501 0.5 OUTLIER -55.41 -63.45 1.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.807 -179.681 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 33' ' ' CYS . . . -63.63 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.605 ' HB3' HD11 ' A' ' 67' ' ' ILE . 39.7 m-85 -89.71 42.45 1.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -1.138 . . . . 0.0 110.589 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.697 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -84.74 -21.25 56.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' HB1' ' CG ' ' A' ' 50' ' ' TYR . . . -89.06 -59.3 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.981 HD12 ' N ' ' A' ' 68' ' ' PHE . 2.6 pp -44.79 -22.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.606 -0.684 . . . . 0.0 112.375 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.981 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.5 m-85 -49.55 153.17 1.2 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.614 -1.304 . . . . 0.0 110.677 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.536 ' HB2' HG22 ' A' ' 102' ' ' THR . 26.0 m-20 -119.32 -171.95 2.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 111.322 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -102.81 156.81 17.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.778 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.69 141.08 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.007 -1.058 . . . . 0.0 110.697 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HE2' HD11 ' A' ' 116' ' ' LEU . 5.1 mttp -54.92 -29.3 55.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -128.9 92.49 39.76 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.438 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.842 ' O ' HD11 ' A' ' 92' ' ' ILE . 32.3 Cg_exo -53.97 104.19 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.659 1.347 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.49 -21.66 35.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 110.311 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 110.307 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -171.89 2.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 47.0 p-80 -130.77 174.15 10.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.566 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 87' ' ' MET . 29.8 tt0 -149.82 141.33 23.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.352 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 86' ' ' ARG . 5.0 mt -102.52 142.81 33.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.208 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.481 HG22 ' NH2' ' A' ' 88' ' ' ARG . 69.3 p -80.1 85.69 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 110.71 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.2 95.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.691 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.38 28.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.898 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 1.1 mp -109.74 98.86 8.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.127 . . . . 0.0 110.437 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -144.73 -53.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.752 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -136.15 174.89 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 110.017 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 mtp -142.76 128.35 19.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.702 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.774 ' HB3' HD21 ' A' ' 29' ' ' LEU . 57.9 mtt180 -114.54 140.42 48.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 110.172 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.452 HG12 ' CE2' ' A' ' 68' ' ' PHE . 8.3 mt -99.96 110.25 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.097 -1.002 . . . . 0.0 109.976 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.918 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 9.5 m-85 -104.7 171.2 7.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.292 -0.88 . . . . 0.0 110.582 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 49.6 p -117.09 118.98 33.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 109.976 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.842 HD11 ' O ' ' A' ' 74' ' ' PRO . 21.6 pt -86.74 13.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.752 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' HG2' HG13 ' A' ' 92' ' ' ILE . 7.3 ptpt -176.82 142.15 0.53 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.201 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.04 136.34 17.83 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.577 1.304 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.455 HG21 ' HB1' ' A' ' 20' ' ' ALA . 61.8 mt -116.53 140.88 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 110.734 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.67 153.4 20.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 110.493 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.7 mp -50.33 -23.06 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 111.168 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.01 57.84 0.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.22 175.0 8.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.246 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.86 128.96 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.962 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.539 ' CG1' ' HB2' ' A' ' 20' ' ' ALA . 31.6 mt -92.4 119.37 39.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.378 -0.826 . . . . 0.0 110.414 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 69' ' ' ASN . 58.7 p -150.95 123.93 8.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.649 -0.657 . . . . 0.0 109.673 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 104' ' ' SER . 1.1 pt -88.91 159.39 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 0.0 110.785 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.522 ' O ' HD12 ' A' ' 103' ' ' ILE . 5.2 p -83.38 -157.15 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.413 -0.804 . . . . 0.0 110.348 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.496 ' CD1' ' HE3' ' C' ' 215' ' ' MLZ . 28.3 m-85 -137.57 -66.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.33 -164.42 34.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -29.22 62.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -1.149 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -76.21 -71.28 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.926 . . . . 0.0 110.377 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 1.2 m-85 -58.5 99.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 52.63 -171.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 110.405 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 114' ' ' PRO . 20.6 tp -65.05 157.42 28.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.336 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.411 ' O ' ' CD ' ' A' ' 114' ' ' PRO . 3.0 t -103.89 -49.57 3.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 110.414 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.3 ttt-85 -107.17 75.88 0.45 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.253 -0.904 . . . . 0.0 110.359 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.494 ' HA ' HD23 ' A' ' 111' ' ' LEU . 28.6 Cg_endo -68.19 62.31 1.04 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.689 1.363 . . . . 0.0 110.598 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 113' ' ' ARG . 2.0 tpt85 -86.81 5.89 34.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 110.823 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.676 ' N ' HD22 ' A' ' 116' ' ' LEU . 3.5 mm? 52.64 -174.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.025 -1.047 . . . . 0.0 110.123 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 119' ' ' ASN . 91.2 m 55.29 105.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.415 -0.803 . . . . 0.0 110.69 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.91 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.347 -0.846 . . . . 0.0 110.478 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 117' ' ' THR . 14.0 t30 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.013 -1.054 . . . . 0.0 110.227 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.58 90.23 8.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -1.136 . . . . 0.0 110.365 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . . . . . . . . . . . 52.67 61.92 10.91 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.399 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' C' ' 206' ' ' LYS . 12.8 Cg_endo -60.25 -68.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.623 1.328 . . . . 0.0 110.416 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 55.07 -87.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.562 -0.711 . . . . 0.0 110.758 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' C' ' 204' ' ' PRO . 4.1 mtmp? -147.76 -63.01 0.27 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.923 -1.11 . . . . 0.0 110.478 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -118.96 176.45 5.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 110.424 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 5.7 tp -155.26 61.76 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.3 -0.875 . . . . 0.0 110.304 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.48 72.77 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 110.278 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 81.2 p -115.08 -58.4 2.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 110.409 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -169.47 151.19 4.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.248 -0.907 . . . . 0.0 110.354 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -173.46 111.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.27 159.2 3.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 110.46 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.5 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 17.3 mtt-85 -118.44 -147.85 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.496 ' HE3' ' CD1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' C' ' 217' ' ' ALA 2.505 0.0 OUTLIER -55.21 -21.03 12.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 0.0 110.452 179.926 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.713 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . 55.11 -177.8 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.713 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 25.2 Cg_exo -59.4 -161.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.657 1.346 . . . . 0.0 110.682 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.82 125.84 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.903 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 53.6 p -126.78 -45.7 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.366 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.537 179.805 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.419 ' O ' ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.141 0.496 . . . . 0.0 110.474 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' B' ' 2' ' ' PHE . 0.0 OUTLIER -59.3 83.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.43 -0.794 . . . . 0.0 111.733 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' B' ' 1' ' ' MET . 14.9 t-20 -99.9 147.74 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -49.02 -23.53 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 111.3 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.533 ' C ' HG23 ' B' ' 6' ' ' VAL . 2.7 mtt180 -102.7 -29.76 11.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.104 . . . . 0.0 111.068 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.533 HG23 ' C ' ' B' ' 5' ' ' ARG . 95.3 t -153.15 137.39 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 110.358 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 5.8 tt -117.64 160.85 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.233 -0.917 . . . . 0.0 111.059 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.555 HG13 ' O ' ' B' ' 8' ' ' VAL . 9.5 p -88.27 124.56 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 0.0 110.16 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.613 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 38.9 mttt -150.81 129.22 12.09 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.371 -0.83 . . . . 0.0 109.286 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.613 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 58.13 74.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 119.55 -1.969 . . . . 0.0 111.907 1.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.513 ' CB ' ' HD3' ' B' ' 12' ' ' PRO . 0.3 OUTLIER -173.58 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.306 -0.871 . . . . 0.0 111.24 177.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' B' ' 11' ' ' SER . 16.9 Cg_exo -69.16 -35.09 15.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.352 1.185 . . . . 0.0 110.707 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -33.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.883 . . . . 0.0 109.939 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.69 -155.57 21.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.65 89.84 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.51 ' CG ' ' HD3' ' B' ' 10' ' ' LYS . 1.1 m-85 -58.56 94.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -1.184 . . . . 0.0 110.457 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.448 ' HA3' ' ND2' ' B' ' 69' ' ' ASN . . . -120.3 171.64 14.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.714 ' CG2' HD13 ' B' ' 67' ' ' ILE . 96.3 t -92.97 140.27 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.032 -1.275 . . . . 0.0 109.881 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -105.72 132.2 52.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.123 -0.985 . . . . 0.0 110.297 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.547 ' HB2' ' CG1' ' B' ' 101' ' ' ILE . . . -87.48 88.49 7.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 110.6 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.876 ' O ' HG23 ' B' ' 97' ' ' ILE . 0.1 OUTLIER -67.49 -14.92 63.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.46 -0.775 . . . . 0.0 109.815 178.112 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.515 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 2.0 mttm -106.84 -177.51 3.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.179 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' B' ' 22' ' ' LYS 2.515 0.1 OUTLIER 108.87 20.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.205 -1.56 . . . . 0.0 109.855 1.442 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.515 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 54.1 m-85 -118.63 163.91 16.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.887 . . . . 0.0 110.534 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 -178.64 3.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -74.48 99.74 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 110.237 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.22 61.81 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -134.31 123.38 24.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -1.172 . . . . 0.0 110.437 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.925 HD23 ' CZ ' ' B' ' 90' ' ' PHE . 1.0 OUTLIER -66.78 127.47 32.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 110.163 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.704 ' N ' HD13 ' B' ' 29' ' ' LEU . 90.6 t -88.85 -46.51 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 110.308 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -168.52 153.13 6.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.369 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.15 136.47 31.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 110.268 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.413 ' HB2' ' HA3' ' B' ' 63' ' ' GLY . 0.5 OUTLIER -143.48 -167.06 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.472 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.8 170.31 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.677 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.94 -174.19 4.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.077 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.692 ' CD1' HD21 ' B' ' 62' ' ' LEU . 65.0 mt -123.77 151.91 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 0.0 110.429 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' B' ' 84' ' ' LEU . 43.7 t -124.63 104.25 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.303 -0.873 . . . . 0.0 110.601 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' B' ' 43' ' ' TRP . 14.8 mmt-85 -134.87 145.73 48.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.211 -0.931 . . . . 0.0 110.264 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.405 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 34.5 m170 -63.37 177.03 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.32 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 40' ' ' ASN . 2.9 m120 -67.44 -131.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 110.167 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 65.39 -149.17 0.24 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.624 -1.297 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.22 -25.63 0.98 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 111.116 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.519 ' CZ2' HD22 ' B' ' 51' ' ' LEU . 60.3 t-105 -69.27 -55.88 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.939 . . . . 0.0 110.138 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.439 ' HA3' ' NH2' ' D' ' 214' ' ' ARG . . . -59.7 -22.29 56.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' B' ' 48' ' ' GLU . 97.4 m -90.34 -60.09 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -1.219 . . . . 0.0 110.67 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.04 -54.46 15.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.976 -1.077 . . . . 0.0 110.373 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.953 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.0 mm? -93.39 33.46 1.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -0.838 . . . . 0.0 109.787 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' B' ' 48' ' ' GLU . 9.8 pt-20 -68.51 64.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.205 -0.935 . . . . 0.0 111.075 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' B' ' 47' ' ' LEU . 16.2 t0 -169.4 -36.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.83 -1.168 . . . . 0.0 110.957 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.488 ' CG ' ' HB1' ' B' ' 66' ' ' ALA . 25.8 m-85 -128.84 53.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.992 . . . . 0.0 110.921 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' B' ' 47' ' ' LEU . 52.5 mt -125.08 117.83 24.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 111.189 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' B' ' 61' ' ' ALA . 48.3 m-85 -89.17 101.6 14.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.023 177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 58' ' ' SER . 4.8 t -98.97 155.46 17.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.158 -0.964 . . . . 0.0 111.563 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.439 ' HD3' HD13 ' B' ' 84' ' ' LEU . 0.0 OUTLIER -124.12 -170.9 2.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.751 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' B' ' 55' ' ' LYS . 0.1 OUTLIER -78.97 79.24 5.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.14 -0.975 . . . . 0.0 110.208 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.508 1.5 p30 160.71 -25.27 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.651 -0.655 . . . . 0.0 110.134 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.5 -167.84 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.057 -1.027 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 1.3 m -130.64 139.28 50.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.348 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.9 ' HB2' ' CD2' ' B' ' 84' ' ' LEU . . . -124.1 172.42 9.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -0.999 . . . . 0.0 110.705 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.632 ' HA ' HD23 ' B' ' 51' ' ' LEU . 9.5 ttt -117.12 152.63 34.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 110.341 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.698 ' HB1' ' HA3' ' B' ' 65' ' ' GLY . . . -88.41 90.77 8.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.434 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.846 HD22 HD22 ' A' ' 62' ' ' LEU 2.502 0.5 OUTLIER -55.31 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.846 -179.807 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' B' ' 33' ' ' CYS . . . -63.59 -139.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.611 ' HB3' HD11 ' B' ' 67' ' ' ILE . 39.6 m-85 -89.68 42.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.127 . . . . 0.0 110.603 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.698 ' HA3' ' HB1' ' B' ' 61' ' ' ALA . . . -84.71 -21.29 56.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' B' ' 50' ' ' TYR . . . -89.03 -59.34 2.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -1.173 . . . . 0.0 110.554 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.97 HD12 ' N ' ' B' ' 68' ' ' PHE . 2.6 pp -44.71 -22.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.639 -0.663 . . . . 0.0 112.368 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.97 ' N ' HD12 ' B' ' 67' ' ' ILE . 4.5 m-85 -49.48 153.76 1.05 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.628 -1.295 . . . . 0.0 110.668 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.525 ' HB2' HG22 ' B' ' 102' ' ' THR . 26.2 m-20 -120.0 -171.46 2.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 111.114 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -103.65 156.64 17.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.429 -0.794 . . . . 0.0 109.676 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 29.8 t -161.57 141.15 10.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.053 . . . . 0.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.527 ' HE2' HD11 ' B' ' 116' ' ' LEU . 5.1 mtpp -55.2 -29.09 57.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 110.271 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.91 92.52 39.66 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 110.356 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.826 ' O ' HD11 ' B' ' 92' ' ' ILE . 32.4 Cg_exo -54.07 104.2 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.647 1.341 . . . . 0.0 110.576 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -82.5 -21.63 35.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 110.31 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.431 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -140.46 140.27 35.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.912 . . . . 0.0 110.31 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.32 -171.91 2.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' B' ' 88' ' ' ARG . 47.0 p-80 -130.75 174.07 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 87' ' ' MET . 29.8 tt0 -149.83 141.34 23.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.875 . . . . 0.0 110.297 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.749 HD23 ' O ' ' B' ' 86' ' ' ARG . 5.0 mt -102.55 142.82 33.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.208 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.473 HG22 ' CZ ' ' B' ' 88' ' ' ARG . 68.7 p -80.08 85.74 5.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.718 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 51.09 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.72 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.01 -144.35 28.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.9 ' CD2' ' HB2' ' B' ' 59' ' ' ALA . 1.1 mp -109.81 98.87 8.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -1.097 . . . . 0.0 110.423 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.71 -53.78 0.31 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.749 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -136.14 174.86 10.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.064 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' B' ' 79' ' ' GLU . 15.5 mtp -142.78 128.42 19.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 110.706 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.796 ' HB3' HD21 ' B' ' 29' ' ' LEU . 58.4 mtt180 -114.66 140.47 48.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 110.121 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.448 HG12 ' CE2' ' B' ' 68' ' ' PHE . 8.3 mt -99.92 110.1 26.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.995 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.925 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 9.5 m-85 -104.62 171.18 7.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 110.549 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -117.11 118.97 33.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.996 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.826 HD11 ' O ' ' B' ' 74' ' ' PRO . 21.5 pt -86.69 13.29 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.787 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.423 ' HG2' HG13 ' B' ' 92' ' ' ILE . 7.3 ptpt -176.8 142.12 0.53 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.134 -0.979 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.66 136.73 21.24 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.464 1.244 . . . . 0.0 111.056 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.45 HG21 ' HB1' ' B' ' 20' ' ' ALA . 61.6 mt -116.49 140.9 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.789 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.74 153.42 20.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.876 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.7 mp -50.28 -23.08 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 111.045 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.14 57.93 0.41 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -126.37 174.84 8.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.24 . . . . 0.0 110.583 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.8 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.547 ' CG1' ' HB2' ' B' ' 20' ' ' ALA . 32.3 mt -92.59 119.36 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 110.335 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.525 HG22 ' HB2' ' B' ' 69' ' ' ASN . 61.3 p -150.83 123.98 8.81 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.76 . . . . 0.0 109.608 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.512 HD12 ' O ' ' B' ' 104' ' ' SER . 1.1 pt -88.85 159.52 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.759 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.512 ' O ' HD12 ' B' ' 103' ' ' ILE . 5.3 p -83.42 -157.18 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 110.321 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.491 ' CD1' ' HE3' ' D' ' 215' ' ' MLZ . 28.1 m-85 -137.54 -66.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.47 34.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -29.27 62.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -1.157 . . . . 0.0 110.365 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -76.22 -71.28 0.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 1.2 m-85 -58.48 99.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 8.1 m95 52.63 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.45 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' B' ' 114' ' ' PRO . 20.6 tp -65.12 157.42 28.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.93 . . . . 0.0 110.316 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.414 ' O ' ' HD3' ' B' ' 114' ' ' PRO . 3.0 t -103.86 -49.58 3.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.421 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -107.15 75.96 0.46 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 110.364 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.477 ' HA ' HD23 ' B' ' 111' ' ' LEU . 28.7 Cg_endo -68.14 62.25 1.02 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.602 1.317 . . . . 0.0 110.6 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -86.82 5.89 34.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 110.808 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.663 ' N ' HD22 ' B' ' 116' ' ' LEU . 3.5 mm? 52.67 -174.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.044 -1.035 . . . . 0.0 110.113 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.423 ' O ' ' N ' ' B' ' 119' ' ' ASN . 91.8 m 55.22 105.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.813 . . . . 0.0 110.651 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.83 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.834 . . . . 0.0 110.465 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' B' ' 117' ' ' THR . 14.0 t30 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.02 -1.05 . . . . 0.0 110.266 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.61 90.27 8.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -1.122 . . . . 0.0 110.328 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . . . . . . . . . . . 52.64 61.97 10.87 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' D' ' 206' ' ' LYS . 12.8 Cg_endo -60.3 -68.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.611 1.321 . . . . 0.0 110.434 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 55.06 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.563 -0.71 . . . . 0.0 110.694 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' D' ' 204' ' ' PRO . 4.1 mtmp? -147.75 -62.98 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.955 -1.091 . . . . 0.0 110.453 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -119.01 176.44 5.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.915 . . . . 0.0 110.422 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 5.7 tp -155.3 61.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 110.295 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -142.47 72.69 1.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.246 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 81.2 p -115.06 -58.38 2.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 110.411 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -169.48 151.22 4.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 110.315 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -173.46 111.52 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.34 159.18 3.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.417 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.502 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 17.2 mtt-85 -118.4 -147.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.905 . . . . 0.0 110.103 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.491 ' HE3' ' CD1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' D' ' 217' ' ' ALA 2.507 0.0 OUTLIER -55.07 -21.13 11.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.472 179.94 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . 55.18 -177.76 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.491 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 25.5 Cg_exo -59.59 -161.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.7 1.369 . . . . 0.0 110.651 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -166.78 125.77 1.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.373 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 53.9 p -126.73 -45.64 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 110.401 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 CA-C-O 117.934 -1.481 . . . . 0.0 109.545 179.815 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.441 ' C ' ' HA ' ' A' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.441 ' C ' ' HA ' ' B' ' 67' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HE3' ' HG ' ' B' ' 34' ' ' LEU . 29.2 mmt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.119 0.485 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 32.7 p90 -90.23 133.25 35.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 0.0 110.396 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -150.69 141.32 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.138 -179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.03 -45.8 32.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 111.046 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.535 ' C ' HG23 ' A' ' 6' ' ' VAL . 6.5 mtm-85 -74.69 -33.81 62.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.98 . . . . 0.0 110.543 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 5' ' ' ARG . 84.5 t -153.33 134.04 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 2' ' ' PHE . 11.2 tt -117.22 156.37 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 110.651 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 8' ' ' VAL . 12.7 p -89.35 122.81 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 110.71 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 30.2 mttt -151.19 122.01 7.55 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.53 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.602 ' CB ' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 59.12 67.09 0.95 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.585 -1.947 . . . . 0.0 111.415 1.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 1.5 m -165.41 -61.59 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.953 . . . . 0.0 111.19 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 53.9 Cg_endo -73.78 53.03 2.68 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 123.552 1.29 . . . . 0.0 111.445 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.69 26.27 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.069 -1.019 . . . . 0.0 110.977 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.27 -130.98 6.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.94 -103.86 1.81 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CZ ' ' HG3' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.91 6.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -1.159 . . . . 0.0 110.708 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.04 174.6 20.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 68' ' ' PHE . 82.9 t -97.21 117.42 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.321 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' ' CD ' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -88.99 127.0 35.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.871 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HB2' HG13 ' A' ' 101' ' ' ILE . . . -90.85 86.88 6.44 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 110.962 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.5 ttp85 -58.65 -19.89 43.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.537 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.492 ' HB2' ' CE2' ' A' ' 24' ' ' PHE . 11.5 mmtm -105.25 179.27 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 108.965 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.47 ' CA ' ' HB3' ' A' ' 22' ' ' LYS 2.516 59.3 m 104.35 23.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.01 -1.681 . . . . 0.0 109.627 2.026 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 22' ' ' LYS . 19.1 m-85 -115.89 156.55 25.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 164.28 12.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.377 -0.827 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 92' ' ' ILE . 30.5 tttt -62.37 84.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.22 44.51 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 24' ' ' PHE . 4.3 mt-10 -118.94 112.09 19.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -1.184 . . . . 0.0 110.443 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.978 HD21 ' HB3' ' A' ' 88' ' ' ARG . 2.0 tm? -53.48 115.6 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.255 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.452 ' N ' HD13 ' A' ' 29' ' ' LEU . 54.0 t -88.89 66.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 110.115 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.6 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.271 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.96 167.29 24.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.288 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.3 179.73 7.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.612 HD23 ' HG3' ' A' ' 86' ' ' ARG . 2.8 mt -94.72 -177.26 4.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.9 176.09 11.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.4 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 62' ' ' LEU . 73.5 mt -109.27 141.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 109.969 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 84' ' ' LEU . 43.4 t -117.44 115.54 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.049 -1.032 . . . . 0.0 110.504 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.507 ' HB3' ' CG ' ' A' ' 43' ' ' TRP . 0.5 OUTLIER -145.96 157.1 43.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 110.416 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.9 177.01 9.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 110.341 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 29.9 p30 -64.24 -134.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 110.251 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 7.7 t0 64.83 -148.16 0.26 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.579 -1.325 . . . . 0.0 110.57 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.47 -41.09 13.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.227 -0.921 . . . . 0.0 110.953 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.731 ' CZ2' HD11 ' A' ' 51' ' ' LEU . 65.9 t-105 -60.92 -35.33 76.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.69 92.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 84.8 m -83.53 -58.32 2.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.194 -1.18 . . . . 0.0 110.687 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' CB ' HD22 ' A' ' 47' ' ' LEU . . . -48.83 -60.07 3.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.181 -0.949 . . . . 0.0 110.489 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.811 HD12 ' CE ' ' A' ' 60' ' ' MET . 3.1 mm? -91.72 29.15 1.59 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.882 . . . . 0.0 110.362 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.56 -23.72 0.71 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.0 111.412 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -112.34 167.18 10.64 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.926 -1.109 . . . . 0.0 109.988 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.58 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 38.2 m-85 52.84 29.94 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 0.0 110.148 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.777 HD13 ' HB3' ' A' ' 47' ' ' LEU . 8.6 tp -116.48 117.4 29.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.338 -0.851 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 13.0 m-85 -89.23 107.71 19.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.429 ' HB2' ' CD ' ' C' ' 214' ' ' ARG . 23.1 t -106.0 153.81 21.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 111.22 -177.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -130.8 -171.53 2.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.535 -0.728 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -82.96 79.75 9.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.979 -1.075 . . . . 0.0 109.263 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . 2.499 0.2 OUTLIER 163.51 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.846 -0.534 . . . . 0.0 109.795 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.05 -164.29 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.302 -0.874 . . . . 0.0 110.787 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 m -136.48 111.93 9.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 110.393 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.863 ' HB2' HD23 ' A' ' 84' ' ' LEU . . . -102.5 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.368 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.811 ' CE ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -112.39 163.58 14.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.773 ' HB1' ' HA3' ' A' ' 65' ' ' GLY . . . -85.65 87.81 7.45 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 36' ' ' ILE 2.515 0.4 OUTLIER -46.65 -84.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.705 -0.622 . . . . 0.0 111.663 -175.614 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.45 -131.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.458 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 70.7 m-85 -83.49 50.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 110.734 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.773 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -90.64 -24.54 27.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.58 ' HB1' ' CD1' ' A' ' 50' ' ' TYR . . . -90.37 -36.59 14.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -1.12 . . . . 0.0 110.55 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.503 HD12 HG23 ' A' ' 18' ' ' VAL . 1.3 pp -57.11 -20.88 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.656 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.707 ' CE1' HG21 ' A' ' 18' ' ' VAL . 12.4 m-85 -56.45 121.67 10.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.005 . . . . 0.0 110.197 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 102' ' ' THR . 41.3 m-20 -88.76 177.5 6.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 110.575 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.472 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 62.7 t60 -98.04 112.08 24.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 110.356 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.21 157.12 25.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.755 ' HD3' HD11 ' A' ' 116' ' ' LEU . 7.4 mmtt -72.69 -23.17 60.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.396 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -132.17 73.9 77.08 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.56 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.666 1.351 . . . . 0.0 110.562 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.473 ' ND2' ' CE ' ' A' ' 93' ' ' LYS . 13.5 m120 -70.64 -13.51 62.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 110.667 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' A' ' 101' ' ' ILE . . . -115.76 117.69 30.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -98.38 173.6 6.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.127 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -119.54 148.05 43.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.86 139.53 52.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.83 . . . . 0.0 110.156 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.798 HD22 HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -113.49 132.66 55.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 110.529 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.1 p -57.45 -166.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.0 110.297 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.34 59.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 110.356 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.37 -131.47 2.48 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.863 HD23 ' HB2' ' A' ' 59' ' ' ALA . 4.2 tp -149.22 28.26 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -1.1 . . . . 0.0 110.095 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -100.59 -36.65 9.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 110.834 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.612 ' HG3' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -135.79 145.33 46.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.034 -1.041 . . . . 0.0 110.892 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.406 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 2.9 ptm -150.24 147.09 27.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 109.956 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.978 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -112.85 161.94 16.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' HZ ' ' A' ' 68' ' ' PHE . 14.8 mt -109.57 132.36 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.943 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.854 ' CZ ' HD23 ' A' ' 29' ' ' LEU . 36.7 m-85 -117.79 -178.36 3.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.491 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.442 HG23 HG23 ' A' ' 30' ' ' VAL . 57.6 p -125.83 105.9 9.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.344 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.42 HG23 ' HB2' ' A' ' 77' ' ' ARG . 5.8 pt -60.65 -16.62 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 110.502 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.473 ' CE ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -148.71 159.61 37.77 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.872 179.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.07 130.05 27.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.614 1.323 . . . . 0.0 110.094 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' HB1' ' A' ' 20' ' ' ALA . 56.3 mt -98.85 156.42 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.833 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.82 157.39 18.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.532 -0.73 . . . . 0.0 110.968 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 21' ' ' ARG . 2.6 mp -61.67 104.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 110.34 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.14 31.03 3.95 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.15 155.55 18.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.23 -1.159 . . . . 0.0 110.074 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.12 117.45 28.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.962 -1.086 . . . . 0.0 110.385 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' A' ' 20' ' ' ALA . 57.6 mt -95.83 130.01 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.28 -0.888 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.489 HG23 ' C ' ' A' ' 101' ' ' ILE . 31.1 p -154.34 170.25 21.76 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.502 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.3 pp -128.88 6.26 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.004 -1.06 . . . . 0.0 111.427 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 2.2 p 54.75 -151.89 0.36 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.091 -1.006 . . . . 0.0 110.013 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.511 ' CE1' ' HE3' ' C' ' 215' ' ' MLZ . 25.4 m-85 -133.75 -77.39 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 110.812 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.28 -159.18 20.19 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' SER . 94.0 m-20 -90.46 18.8 5.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -1.105 . . . . 0.0 110.595 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.98 -53.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.127 -0.983 . . . . 0.0 110.081 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.52 ' CE1' ' HA ' ' C' ' 214' ' ' ARG . 0.1 OUTLIER -59.99 118.81 6.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.34 -0.85 . . . . 0.0 110.32 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.453 ' HZ2' HO3' ' A' ' 301' ' ' SAH . 5.6 m95 57.22 -85.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.532 -0.73 . . . . 0.0 110.868 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' A' ' 111' ' ' LEU . 7.2 tp -62.79 -146.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.052 . . . . 0.0 110.481 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -171.99 -43.66 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.05 -1.032 . . . . 0.0 110.549 -178.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.7 142.74 45.91 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.58 75.58 4.8 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.593 1.312 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.571 ' O ' HD22 ' A' ' 116' ' ' LEU . 9.3 ptm180 -156.01 124.56 5.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 110.562 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.755 HD11 ' HD3' ' A' ' 72' ' ' LYS . 1.8 mm? -122.56 -66.34 1.03 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 110.175 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 68.7 m -112.5 -33.96 6.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.888 . . . . 0.0 110.281 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -164.6 -150.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.299 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.4 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.285 179.85 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' C' ' 203' ' ' ALA . 0.1 OUTLIER 51.9 -169.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -1.149 . . . . 0.0 110.375 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 203' ' ' ALA . . . . . 0.818 ' HB3' ' HD3' ' C' ' 204' ' ' PRO . . . -178.32 -59.38 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.251 -0.906 . . . . 0.0 110.436 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 204' ' ' PRO . . . . . 0.818 ' HD3' ' HB3' ' C' ' 203' ' ' ALA . 26.3 Cg_endo -67.87 -24.31 40.25 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.429 1.226 . . . . 0.0 110.432 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 205' ' ' ARG . . . . . 0.517 ' HB2' HD23 ' C' ' 208' ' ' LEU . 0.2 OUTLIER 56.91 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.369 -0.832 . . . . 0.0 110.57 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 206' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' C' ' 204' ' ' PRO . 0.5 OUTLIER -156.23 -63.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.983 -1.073 . . . . 0.0 110.323 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.95 45.95 2.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 110.386 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' C' ' 205' ' ' ARG . 3.8 mm? -84.22 -55.32 4.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 110.398 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 209' ' ' ALA . . . . . . . . . . . . . . . -100.87 90.45 4.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 110.315 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 2.6 p -79.97 105.2 11.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.363 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.62 -64.72 1.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 110.389 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' C' ' 213' ' ' ALA . . . -62.97 156.84 23.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.28 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 213' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 212' ' ' ALA . . . 60.02 150.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.322 -0.861 . . . . 0.0 110.634 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 214' ' ' ARG . . . . . 0.52 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 44.8 mtt85 -142.77 -166.13 2.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.918 . . . . 0.0 110.266 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 215' ' ' MLZ . . . . . 0.511 ' HE3' ' CE1' ' A' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 216' ' ' SER . . . . . . . . . . . . 2.504 3.2 m -50.36 176.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.805 . . . . 0.0 110.658 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' C' ' 218' ' ' PRO . . . -115.29 167.71 9.48 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.321 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' C' ' 217' ' ' ALA . 19.1 Cg_endo -67.28 -72.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.643 1.339 . . . . 0.0 110.524 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . . . . . . . . . . . -139.44 108.03 5.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.366 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 220' ' ' THR . . . . . . . . . . . . . 9.2 t -174.92 38.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.418 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 29.1 mmt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.137 0.494 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' B' ' 2' ' ' PHE . 32.7 p90 -90.09 133.43 34.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.106 -0.996 . . . . 0.0 110.337 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' B' ' 6' ' ' VAL . 0.1 OUTLIER -150.97 141.31 22.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 110.124 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . 0.4 ' O ' ' NZ ' ' B' ' 22' ' ' LYS . 13.3 t70 -47.98 -45.91 31.99 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.961 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.522 ' C ' HG23 ' B' ' 6' ' ' VAL . 6.5 mtm-85 -74.61 -33.92 62.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.551 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.522 HG23 ' C ' ' B' ' 5' ' ' ARG . 84.9 t -153.16 134.08 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' B' ' 2' ' ' PHE . 11.2 tt -117.24 156.07 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 110.588 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.582 HG13 ' O ' ' B' ' 8' ' ' VAL . 12.6 p -88.91 123.32 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.66 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' B' ' 10' ' ' LYS . 30.2 mttt -151.88 121.82 7.09 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.59 ' CB ' ' HA ' ' B' ' 9' ' ' LYS . 0.0 OUTLIER 59.08 67.25 0.94 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 119.631 -1.918 . . . . 0.0 111.482 1.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' B' ' 12' ' ' PRO . 1.4 m -165.96 -61.0 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.757 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' B' ' 11' ' ' SER . 55.3 Cg_endo -73.89 52.94 2.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.307 1.162 . . . . 0.0 111.49 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.73 26.24 0.53 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.033 -1.042 . . . . 0.0 111.007 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.34 -131.04 6.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.89 -103.82 1.81 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.501 ' CZ ' ' HG3' ' B' ' 10' ' ' LYS . 0.7 OUTLIER -139.86 109.85 6.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -1.149 . . . . 0.0 110.722 -179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.06 174.56 20.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.705 HG21 ' CE1' ' B' ' 68' ' ' PHE . 85.3 t -97.19 116.75 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.312 . . . . 0.0 110.145 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.524 ' CD2' ' CD ' ' B' ' 9' ' ' LYS . 0.5 OUTLIER -88.31 127.05 35.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.0 110.014 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.78 ' HB2' HG13 ' B' ' 101' ' ' ILE . . . -90.92 86.89 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 110.969 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.882 ' O ' HG23 ' B' ' 97' ' ' ILE . 1.5 ttp85 -58.74 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 0.0 109.525 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' B' ' 24' ' ' PHE . 11.5 mmtm -105.13 179.3 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 108.953 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.464 ' CA ' ' HB3' ' B' ' 22' ' ' LYS 2.515 59.5 m 104.37 23.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.912 -1.742 . . . . 0.0 109.674 1.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' B' ' 22' ' ' LYS . 19.3 m-85 -115.83 156.54 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.376 -0.828 . . . . 0.0 110.622 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.13 164.25 12.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.339 -0.851 . . . . 0.0 110.042 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 92' ' ' ILE . 30.4 tttt -62.37 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.16 44.52 0.15 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' B' ' 24' ' ' PHE . 4.3 mt-10 -119.0 112.18 19.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 110.402 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.976 HD21 ' HB3' ' B' ' 88' ' ' ARG . 2.0 tm? -53.5 115.58 2.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.452 HG23 HG23 ' B' ' 91' ' ' THR . 53.8 t -88.83 66.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -0.881 . . . . 0.0 110.093 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 57.58 163.84 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 110.287 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.95 167.38 24.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.328 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 26.6 p -150.48 179.6 8.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 110.563 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.622 HD23 ' HG3' ' B' ' 86' ' ' ARG . 2.8 mt -94.63 -177.34 4.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.254 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 60.0 m -149.83 176.07 11.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 110.382 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 1.012 HD11 HD13 ' B' ' 62' ' ' LEU . 73.1 mt -109.3 141.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' B' ' 84' ' ' LEU . 43.0 t -117.45 115.47 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.137 -0.977 . . . . 0.0 110.515 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.501 ' HB3' ' CG ' ' B' ' 43' ' ' TRP . 0.5 OUTLIER -145.87 157.12 43.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 110.409 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . 0.4 ' O ' ' HB3' ' B' ' 43' ' ' TRP . 0.9 OUTLIER -81.93 176.97 9.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 110.276 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' B' ' 41' ' ' ASP . 29.9 p30 -64.19 -134.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.887 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' B' ' 40' ' ' ASN . 7.6 t0 64.85 -148.16 0.26 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.644 -1.285 . . . . 0.0 110.559 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.41 -41.14 13.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.949 . . . . 0.0 110.953 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.734 ' CZ2' HD11 ' B' ' 51' ' ' LEU . 66.0 t-105 -60.97 -35.29 76.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.771 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -35.58 91.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 85.3 m -83.61 -58.35 2.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -1.205 . . . . 0.0 110.641 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.414 ' CB ' HD22 ' B' ' 47' ' ' LEU . . . -48.86 -59.42 3.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.147 -0.971 . . . . 0.0 110.549 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.809 HD12 ' CE ' ' B' ' 60' ' ' MET . 3.1 mm? -92.73 29.49 1.76 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 110.05 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -47.76 -23.71 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.173 -0.955 . . . . 0.0 111.335 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -112.26 167.11 10.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.953 -1.092 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.578 ' CD1' ' HB1' ' B' ' 66' ' ' ALA . 37.9 m-85 52.93 29.85 8.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.785 HD13 ' HB3' ' B' ' 47' ' ' LEU . 8.6 tp -116.61 117.19 29.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 111.0 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' B' ' 61' ' ' ALA . 13.1 m-85 -88.94 107.75 19.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.868 . . . . 0.0 109.219 177.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . 0.418 ' HB2' ' CD ' ' D' ' 214' ' ' ARG . 23.1 t -106.05 153.74 21.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.09 -1.006 . . . . 0.0 111.222 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -131.41 -174.42 3.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.564 -0.71 . . . . 0.0 109.848 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -78.83 79.42 5.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.13 -0.982 . . . . 0.0 110.065 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . 2.507 0.2 OUTLIER 163.43 -27.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.756 -0.59 . . . . 0.0 109.839 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -164.01 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.794 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 53' ' ' SER . 5.5 m -136.57 112.01 9.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 110.377 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.841 ' HB2' HD23 ' B' ' 84' ' ' LEU . . . -102.6 173.53 6.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.407 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.809 ' CE ' HD12 ' B' ' 47' ' ' LEU . 0.0 OUTLIER -112.83 161.62 16.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.285 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.744 ' HB1' ' CA ' ' B' ' 65' ' ' GLY . . . -82.94 87.73 6.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.936 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 1.012 HD13 HD11 ' B' ' 36' ' ' ILE 2.517 0.3 OUTLIER -47.02 -84.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.646 -0.659 . . . . 0.0 111.72 -175.753 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.49 -131.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.464 ' O ' ' CE2' ' B' ' 68' ' ' PHE . 71.0 m-85 -83.6 50.92 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.611 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.744 ' CA ' ' HB1' ' B' ' 61' ' ' ALA . . . -91.19 -24.19 27.5 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.578 ' HB1' ' CD1' ' B' ' 50' ' ' TYR . . . -90.71 -36.43 14.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -1.139 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.492 HD12 HG23 ' B' ' 18' ' ' VAL . 1.3 pp -57.13 -20.96 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 0.0 110.642 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' B' ' 18' ' ' VAL . 12.4 m-85 -56.4 121.67 10.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.026 -1.046 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -88.79 177.4 6.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 110.604 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.478 ' CE1' ' HB2' ' B' ' 111' ' ' LEU . 62.7 t60 -97.91 112.15 24.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 110.358 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . . . . . . . . . 28.8 t -116.28 157.15 25.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.744 ' HD3' HD11 ' B' ' 116' ' ' LEU . 7.5 mmtt -72.75 -23.17 60.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.356 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -132.12 73.95 77.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.58 94.11 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.678 1.357 . . . . 0.0 110.595 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.471 ' ND2' ' CE ' ' B' ' 93' ' ' LYS . 13.5 m120 -70.62 -13.5 62.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 110.704 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' B' ' 101' ' ' ILE . . . -115.74 117.72 31.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 110.407 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.419 ' HB2' HG23 ' B' ' 92' ' ' ILE . 0.0 OUTLIER -98.38 173.61 6.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -119.5 147.98 43.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 110.611 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -127.84 139.57 52.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.814 HD22 HD12 ' B' ' 84' ' ' LEU . 0.7 OUTLIER -113.43 132.74 55.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 110.482 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.8 p -57.52 -166.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 110.324 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.41 59.91 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.34 -131.48 2.48 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.841 HD23 ' HB2' ' B' ' 59' ' ' ALA . 4.3 tp -149.28 28.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -1.104 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -100.72 -36.51 9.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 110.82 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . 0.622 ' HG3' HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -135.87 145.34 46.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 110.884 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 2.9 ptm -150.2 147.1 27.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.41 -0.806 . . . . 0.0 110.055 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.976 ' HB3' HD21 ' B' ' 29' ' ' LEU . 0.0 OUTLIER -112.94 161.98 16.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 110.387 -179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.49 HD13 ' HZ ' ' B' ' 68' ' ' PHE . 14.9 mt -109.53 132.39 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.968 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.854 ' CZ ' HD23 ' B' ' 29' ' ' LEU . 36.7 m-85 -117.82 -178.36 3.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 110.473 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.452 HG23 HG23 ' B' ' 30' ' ' VAL . 57.6 p -125.79 105.92 9.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 110.377 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.419 HG23 ' HB2' ' B' ' 77' ' ' ARG . 5.8 pt -60.71 -16.6 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.514 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.471 ' CE ' ' ND2' ' B' ' 75' ' ' ASN . 0.0 OUTLIER -148.73 159.79 37.3 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.876 179.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.31 130.26 28.04 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.59 1.31 . . . . 0.0 110.05 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.49 HG21 ' HB1' ' B' ' 20' ' ' ALA . 56.1 mt -98.92 156.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.0 110.806 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.97 157.44 18.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.912 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.882 HG23 ' O ' ' B' ' 21' ' ' ARG . 2.6 mp -61.68 104.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 110.343 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.24 30.89 3.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -102.07 155.1 18.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -1.137 . . . . 0.0 110.155 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.48 117.51 27.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.028 -1.045 . . . . 0.0 110.505 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' B' ' 20' ' ' ALA . 57.3 mt -95.96 130.12 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 110.617 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.475 HG23 ' C ' ' B' ' 101' ' ' ILE . 30.5 p -154.28 170.23 21.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.726 -0.608 . . . . 0.0 109.487 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.5 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.3 pp -128.71 6.24 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 111.275 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' B' ' 105' ' ' TYR . 2.2 p 54.63 -151.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.064 . . . . 0.0 110.059 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.512 ' CE1' ' HE3' ' D' ' 215' ' ' MLZ . 25.4 m-85 -133.7 -77.37 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.117 -0.99 . . . . 0.0 110.855 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . -174.35 -159.21 20.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' B' ' 112' ' ' SER . 93.9 m-20 -90.38 18.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.628 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.93 -53.35 0.7 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 110.108 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' D' ' 214' ' ' ARG . 0.1 OUTLIER -60.11 118.77 6.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.271 -0.893 . . . . 0.0 110.338 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 5.6 m95 57.23 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.89 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' B' ' 70' ' ' HIS . 7.2 tp -62.74 -146.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.966 -1.084 . . . . 0.0 110.562 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 107' ' ' ASP . 0.3 OUTLIER -171.88 -43.63 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.988 -1.07 . . . . 0.0 110.54 -178.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.8 142.71 45.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.57 75.63 4.78 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.583 1.307 . . . . 0.0 110.398 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . 0.58 ' O ' HD22 ' B' ' 116' ' ' LEU . 9.2 ptm180 -156.15 124.89 5.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.744 HD11 ' HD3' ' B' ' 72' ' ' LYS . 1.8 mm? -122.61 -66.42 1.03 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.162 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 67.6 m -112.45 -33.96 6.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.897 . . . . 0.0 110.269 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -164.59 -150.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 110.336 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 25.4 t30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.351 179.813 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 201' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 202' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' D' ' 203' ' ' ALA . 0.1 OUTLIER 51.84 -169.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -1.167 . . . . 0.0 110.344 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 203' ' ' ALA . . . . . 0.815 ' HB3' ' HD3' ' D' ' 204' ' ' PRO . . . -178.34 -59.43 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.936 . . . . 0.0 110.382 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.815 ' HD3' ' HB3' ' D' ' 203' ' ' ALA . 26.4 Cg_endo -67.88 -24.28 40.25 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.472 1.248 . . . . 0.0 110.453 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 205' ' ' ARG . . . . . 0.52 ' HB2' HD23 ' D' ' 208' ' ' LEU . 0.2 OUTLIER 56.87 -85.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.451 -0.781 . . . . 0.0 110.544 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 206' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' D' ' 204' ' ' PRO . 0.5 OUTLIER -156.29 -63.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.043 -1.036 . . . . 0.0 110.349 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.01 45.93 2.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 110.372 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' D' ' 205' ' ' ARG . 3.8 mm? -84.26 -55.3 4.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 209' ' ' ALA . . . . . . . . . . . . . . . -100.89 90.49 4.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.354 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 210' ' ' THR . . . . . . . . . . . . . 2.7 p -79.98 105.14 11.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 110.426 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.55 -64.78 1.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 110.388 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' D' ' 213' ' ' ALA . . . -62.96 156.8 23.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 213' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' D' ' 212' ' ' ALA . . . 60.07 150.51 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.41 -0.806 . . . . 0.0 110.602 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 214' ' ' ARG . . . . . 0.508 ' HA ' ' CE1' ' B' ' 109' ' ' TYR . 44.8 mtt85 -142.78 -166.1 2.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 215' ' ' MLZ . . . . . 0.512 ' HE3' ' CE1' ' B' ' 105' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 216' ' ' SER . . . . . . . . . . . . 2.503 3.2 m -50.43 176.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.865 . . . . 0.0 110.686 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 217' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' D' ' 218' ' ' PRO . . . -115.27 167.7 9.48 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 110.357 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 218' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' D' ' 217' ' ' ALA . 19.4 Cg_endo -67.27 -72.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.633 1.333 . . . . 0.0 110.526 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . . . . . . . . . . . -139.41 108.04 5.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 110.357 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 220' ' ' THR . . . . . . . . . . . . . 9.1 t -174.95 38.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.429 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' SAH . . . . . 0.453 HO3' ' HZ2' ' A' ' 110' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 302' ' ' SAH . . . . . 0.427 ' OXT' ' CB ' ' B' ' 16' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_